data_2ki8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ki8 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.0 ptm . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.349 0.595 . . . . 74.030000000000001 112.435 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.512 HD13 ' HG ' ' A' ' 65' ' ' LEU . 15.1 mt -107.85 138.24 44.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.934 -0.575 . . . . 75.209999999999994 111.421 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.445 ' HA ' HG23 ' A' ' 126' ' ' THR . 33.0 tt0 -78.45 114.39 17.32 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.915 0.388 . . . . 71.129999999999995 110.781 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 27.4 m -127.5 159.74 37.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.18 0.514 . . . . 74.239999999999995 111.921 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.728 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 57.0 tt0 -98.78 108.99 21.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.064 0.459 . . . . 74.209999999999994 110.073 175.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.406 HG23 HD11 ' A' ' 96' ' ' ILE . 33.6 t -83.59 110.32 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.667 -0.697 . . . . 75.129999999999995 111.611 -175.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.656 HD12 ' HE1' ' A' ' 95' ' ' MET . 8.3 mt -92.39 162.05 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.882 0.373 . . . . 73.319999999999993 111.979 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 64.8 m -137.34 92.61 2.72 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.089 0.471 . . . . 75.200000000000003 111.577 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 C-N-CA 121.158 -0.544 . . . . 55.5 112.362 179.4 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 . . . . . 0 N--CA 1.47 0.539 0 CA-C-O 121.079 0.466 . . . . 73.430000000000007 111.022 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -23.52 64.14 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.327 -0.397 . . . . 74.040000000000006 111.195 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.486 ' HD1' HG21 ' A' ' 137' ' ' VAL . 55.3 t80 -94.4 -0.49 54.8 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.046 0.451 . . . . 74.109999999999999 112.015 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -121.48 -27.63 4.75 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.604 -0.685 . . . . 75.540000000000006 112.275 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.452 ' O ' ' HG2' ' A' ' 99' ' ' PRO . . . -72.5 -62.9 1.28 Allowed 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.35 0.5 . . . . 74.200000000000003 112.35 -176.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.481 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 30.2 m -95.49 21.26 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 112.975 0.731 . . . . 65.120000000000005 112.975 -172.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.595 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -105.01 11.13 33.77 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.317 0.858 . . . . 72.219999999999999 113.317 -172.021 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.458 ' CD2' ' HD2' ' A' ' 87' ' ' LYS . 38.0 p90 -136.18 162.22 33.57 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.65 0.611 . . . . 74.340000000000003 112.65 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -126.83 130.0 49.38 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.66 -0.7 . . . . 73.140000000000001 111.004 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.577 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 43.6 mt-10 -87.38 117.55 26.23 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.167 0.508 . . . . 73.340000000000003 111.086 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 28.2 mt -112.79 142.54 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.663 -0.699 . . . . 73.519999999999996 111.501 -172.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.02 149.01 50.61 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.953 0.406 . . . . 73.439999999999998 111.502 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.442 ' CD ' ' HZ2' ' A' ' 88' ' ' LYS . 9.9 tp10 -53.83 -49.9 67.39 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.127 -0.488 . . . . 75.239999999999995 112.186 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -56.61 -51.66 67.81 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.723 0.296 . . . . 60.340000000000003 111.731 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -66.08 -35.76 81.37 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.097 0.475 . . . . 74.340000000000003 110.878 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -53.22 -50.14 65.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.846 -0.616 . . . . 74.450000000000003 111.009 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -71.31 -37.11 71.8 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.399 -0.364 . . . . 71.129999999999995 111.247 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.53 -33.0 70.84 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.189 0.44 . . . . 74.099999999999994 112.189 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.512 ' HG ' HD13 ' A' ' 24' ' ' LEU . 93.5 mt -90.2 -13.53 35.34 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.417 -0.356 . . . . 74.25 111.874 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.26 53.05 23.72 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.02 -0.609 . . . . 61.340000000000003 112.106 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.673 HD23 ' HE3' ' A' ' 129' ' ' LYS . 75.1 mt -92.3 137.43 32.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.499 0.666 . . . . 74.040000000000006 111.808 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -107.84 142.73 37.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.996 -0.547 . . . . 75.409999999999997 109.725 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -61.84 100.01 0.14 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.676 0.75 . . . . 74.109999999999999 110.997 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.53 -14.73 4.46 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 115.097 -0.956 . . . . 63.399999999999999 112.958 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -72.13 178.64 3.72 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.67 0.748 . . . . 75.400000000000006 112.554 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.427 ' HD3' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -131.74 147.99 52.54 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.42 -0.809 . . . . 75.5 110.242 175.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.547 HG13 ' HB1' ' A' ' 86' ' ' ALA . 19.7 m -124.41 152.77 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.903 0.705 . . . . 71.450000000000003 112.903 -174.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -94.36 122.11 36.57 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.316 -0.856 . . . . 75.150000000000006 110.442 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.8 t -108.42 126.18 65.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.493 -0.321 . . . . 75.219999999999999 110.136 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -133.48 131.98 40.5 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.393 0.616 . . . . 74.010000000000005 112.586 -173.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.668 HG21 ' HA3' ' A' ' 125' ' ' GLY . 39.4 p -134.45 -171.23 2.71 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.495 -0.775 . . . . 70.519999999999996 110.603 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.69 -18.56 60.5 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.993 0.425 . . . . 75.109999999999999 110.664 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -80.91 -52.61 7.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.267 -0.424 . . . . 73.25 111.465 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.69 -150.55 7.62 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.781 -0.723 . . . . 60.109999999999999 113.349 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -148.49 154.39 39.76 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.77 0.319 . . . . 72.549999999999997 111.401 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.5 p -157.88 145.78 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-O 120.663 0.268 . . . . 74.420000000000002 111.534 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.5 t -102.31 116.56 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 122.42 -0.175 . . . . 71.129999999999995 110.637 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.0 m -125.74 166.68 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 120.901 0.381 . . . . 75.129999999999995 111.818 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -69.06 130.8 43.76 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.094 0.473 . . . . 75.409999999999997 111.452 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.547 ' HB1' HG13 ' A' ' 73' ' ' VAL . . . -81.99 120.07 24.79 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.39 -0.368 . . . . 71.409999999999997 111.813 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.458 ' HD2' ' CD2' ' A' ' 54' ' ' TYR . 67.7 mttm -132.43 157.26 45.03 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.025 0.441 . . . . 64.420000000000002 110.614 174.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.442 ' HZ2' ' CD ' ' A' ' 59' ' ' GLU . 36.1 ttmt -94.75 140.75 29.48 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.188 -0.46 . . . . 71.310000000000002 111.259 -175.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.577 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -140.56 167.48 25.53 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.915 -0.66 . . . . 72.549999999999997 113.553 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.93 20.98 2.84 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.19 0.519 . . . . 72.319999999999993 111.948 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 m -73.7 153.61 89.4 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.118 -0.492 . . . . 63.539999999999999 111.16 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.457 ' HG2' ' SD ' ' A' ' 95' ' ' MET . 35.1 Cg_endo -63.85 160.24 38.09 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.307 2.005 . . . . 71.030000000000001 112.837 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -63.86 147.29 52.24 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.03 0.443 . . . . 74.349999999999994 111.461 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 65.76 34.57 89.15 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.02 -0.609 . . . . 72.409999999999997 112.457 -175.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.728 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 23.0 ttt -157.86 137.28 11.91 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.559 -0.377 . . . . 75.310000000000002 110.519 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.406 HD11 HG23 ' A' ' 28' ' ' VAL . 41.6 pt -134.81 143.95 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.05 0.452 . . . . 61.340000000000003 111.689 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -102.52 128.29 49.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.429 -0.351 . . . . 74.140000000000001 111.818 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 30' ' ' SER . 45.1 mt -124.8 133.57 24.9 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-O 120.812 0.339 . . . . 74.099999999999994 110.518 172.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.481 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 37.4 Cg_exo -59.62 130.11 33.89 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.228 1.952 . . . . 74.209999999999994 112.242 173.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.578 ' HE1' HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -54.52 106.1 0.19 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 122.668 0.387 . . . . 73.040000000000006 111.406 -176.45 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -161.64 -172.54 29.14 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.927 -0.654 . . . . 70.420000000000002 112.928 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.424 ' HD2' HG22 ' A' ' 52' ' ' VAL . 15.1 Cg_endo -56.71 -37.39 97.92 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.079 2.519 . . . . 70.329999999999998 112.676 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.438 ' HA ' HD13 ' A' ' 140' ' ' LEU . 35.9 m-85 -60.47 -52.96 62.98 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.234 -0.439 . . . . 74.409999999999997 110.732 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.0 -40.43 93.5 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.266 -0.425 . . . . 75.209999999999994 110.948 175.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -52.06 -26.53 11.2 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.103 0.561 . . . . 74.140000000000001 112.157 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.618 ' SD ' HD22 ' A' ' 140' ' ' LEU . 92.0 mmm -67.12 -31.76 72.44 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 111.912 0.338 . . . . 73.099999999999994 111.912 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.55 -13.74 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 112.906 0.706 . . . . 71.310000000000002 112.906 -171.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.578 HD11 ' HE1' ' A' ' 100' ' ' MET . 11.6 pt -100.87 -179.59 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.138 0.494 . . . . 73.409999999999997 111.766 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 CA--C 1.541 0.627 0 CA-C-N 116.144 -0.48 . . . . 75.120000000000005 110.615 174.018 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.844 0 CA-C-O 121.031 0.239 . . . . 73.430000000000007 113.395 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.9 t -85.98 123.52 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 120.925 0.393 . . . . 74.219999999999999 111.963 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 22.1 mmmt -61.54 148.27 42.72 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.201 0.524 . . . . 74.150000000000006 112.233 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.668 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -178.87 -151.47 9.63 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.946 -0.57 . . . . 74.319999999999993 113.205 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.445 HG23 ' HA ' ' A' ' 25' ' ' GLU . 56.1 p -140.84 160.39 40.15 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.466 -0.432 . . . . 75.120000000000005 111.815 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.1 p -142.22 145.17 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.198 -0.455 . . . . 73.400000000000006 110.971 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -151.08 155.58 39.26 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.503 0.557 . . . . 73.439999999999998 112.503 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.673 ' HE3' HD23 ' A' ' 67' ' ' LEU . 3.1 tppp? -72.88 124.02 24.57 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.258 -0.428 . . . . 74.239999999999995 110.945 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.5 t -129.93 153.85 47.93 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.09 0.471 . . . . 72.120000000000005 111.661 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -82.73 -12.69 57.37 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.064 -0.517 . . . . 62.039999999999999 110.887 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -57.17 166.43 1.11 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.928 1.084 . . . . 75.209999999999994 113.928 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.567 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -86.46 144.14 27.42 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.215 -1.357 . . . . 71.200000000000003 111.16 173.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.37 128.98 22.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.671 -0.24 . . . . 75.310000000000002 110.474 170.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.404 HD21 ' HA ' ' A' ' 135' ' ' LEU . 11.4 mt -61.4 109.04 1.04 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.588 0.218 . . . . 75.040000000000006 111.588 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 53.5 m -58.03 145.4 36.41 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.832 -0.432 . . . . 65.219999999999999 109.832 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.486 HG21 ' HD1' ' A' ' 49' ' ' PHE . 90.8 t -45.9 -47.27 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.549 0.574 . . . . 75.200000000000003 112.549 -173.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -72.66 -40.39 66.36 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 122.195 -0.315 . . . . 73.540000000000006 111.751 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -58.95 -36.07 74.19 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.617 0.723 . . . . 72.099999999999994 110.215 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.618 HD22 ' SD ' ' A' ' 106' ' ' MET . 2.8 tt -59.66 -43.58 93.9 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.064 -0.971 . . . . 74.439999999999998 110.578 173.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 32.5 mt . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 121.436 0.636 . . . . 73.310000000000002 110.4 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.0 ptm . . . . . 0 CA--C 1.542 0.643 0 CA-C-O 120.801 0.334 . . . . 73.109999999999999 110.919 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.53 HD12 ' HB3' ' A' ' 61' ' ' ASP . 14.1 mt -102.25 130.35 48.9 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.252 0.464 . . . . 74.049999999999997 112.252 -175.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.45 ' HA ' HG23 ' A' ' 126' ' ' THR . 37.1 tt0 -75.23 114.65 13.98 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.197 -0.456 . . . . 74.439999999999998 110.273 175.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 31.2 m -126.19 159.94 34.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.155 -0.475 . . . . 64.439999999999998 111.756 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.713 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 37.4 tt0 -99.71 113.08 25.32 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.064 0.459 . . . . 71.530000000000001 110.393 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.1 t -88.48 119.24 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.849 -0.614 . . . . 74.019999999999996 112.182 -173.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.655 HD11 ' HE1' ' A' ' 95' ' ' MET . 1.0 OUTLIER -107.08 162.37 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.715 0.293 . . . . 74.310000000000002 111.38 178.177 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 66.0 m -131.99 106.77 8.24 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.105 0.479 . . . . 74.549999999999997 111.983 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 C-N-CA 121.149 -0.548 . . . . 40.409999999999997 112.314 177.04 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 121.008 0.432 . . . . 74.120000000000005 111.176 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.527 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -70.45 -36.76 74.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.151 0.5 . . . . 73.540000000000006 110.324 -179.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -64.89 -64.94 0.74 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.012 -0.54 . . . . 73.430000000000007 111.1 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -55.74 -17.91 7.08 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.779 0.659 . . . . 65.230000000000004 112.779 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -88.4 -59.01 2.35 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.556 0.576 . . . . 74.209999999999994 112.556 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.621 HG22 ' HD2' ' A' ' 102' ' ' PRO . 20.1 m -96.71 15.33 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 113.225 0.824 . . . . 75.530000000000001 113.225 -171.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -99.16 13.76 31.8 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.89 0.7 . . . . 75.0 112.89 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -138.92 164.55 29.4 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.243 0.544 . . . . 74.049999999999997 111.984 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.63 146.39 51.85 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.723 -0.671 . . . . 74.439999999999998 110.857 175.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -97.62 110.6 23.13 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.774 0.321 . . . . 74.439999999999998 111.235 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.434 HD13 ' N ' ' A' ' 57' ' ' ILE . 4.1 mp -110.35 141.96 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 120.864 0.364 . . . . 74.310000000000002 111.308 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -62.71 139.53 58.67 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.426 -0.352 . . . . 74.109999999999999 110.683 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -54.38 -31.85 55.77 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.485 0.55 . . . . 64.120000000000005 112.485 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.86 -55.46 32.71 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.825 0.345 . . . . 73.230000000000004 111.588 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.53 ' HB3' HD12 ' A' ' 24' ' ' LEU . 29.3 m-20 -66.23 -35.66 81.0 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.509 0.671 . . . . 61.329999999999998 110.325 176.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 47.8 t-105 -53.05 -48.33 67.74 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.85 -1.068 . . . . 75.109999999999999 111.042 174.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -69.57 -34.82 74.72 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.841 -0.618 . . . . 73.129999999999995 111.779 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.44 ' HB1' HD11 ' A' ' 24' ' ' LEU . . . -59.46 -52.02 67.39 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.127 0.489 . . . . 54.439999999999998 111.196 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.431 ' HG ' HD13 ' A' ' 24' ' ' LEU . 94.4 mt -75.96 -4.62 42.08 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.022 -0.535 . . . . 74.209999999999994 111.888 178.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.62 49.45 77.06 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.293 -0.48 . . . . 75.150000000000006 112.594 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' A' ' 129' ' ' LYS . 97.8 mt -86.78 161.26 18.46 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.015 0.912 . . . . 73.129999999999995 113.116 -175.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -136.53 151.97 49.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.61 -1.177 . . . . 74.109999999999999 109.452 173.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 mp0 -63.82 108.27 1.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.499 0.666 . . . . 74.349999999999994 111.444 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.87 -8.33 14.72 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.295 -0.866 . . . . 72.430000000000007 113.046 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -63.79 151.9 40.92 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.162 0.506 . . . . 71.5 111.992 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.58 HH21 ' HA ' ' A' ' 131' ' ' ASP . 25.8 mtm-85 -90.99 113.74 26.07 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.823 -0.626 . . . . 74.319999999999993 110.986 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.29 135.56 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.124 0.488 . . . . 74.549999999999997 111.888 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.405 ' CD ' ' HE3' ' A' ' 76' ' ' LYS . 34.6 ttmt -98.25 147.78 24.29 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.291 0.567 . . . . 74.430000000000007 111.124 174.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 57.1 t -122.27 131.77 72.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.498 -0.774 . . . . 65.239999999999995 109.427 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.48 ' HZ3' ' CD ' ' A' ' 128' ' ' GLU . 20.1 mttt -125.23 125.3 43.37 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.002 0.43 . . . . 65.310000000000002 111.819 -176.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.678 HG21 ' HA3' ' A' ' 125' ' ' GLY . 25.0 p -138.37 -171.79 3.13 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.156 -0.474 . . . . 75.340000000000003 110.663 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.12 -16.63 63.13 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.925 0.393 . . . . 73.340000000000003 111.539 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -88.76 -21.0 24.04 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.196 0.443 . . . . 75.230000000000004 112.196 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.21 -151.46 23.73 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.266 -0.492 . . . . 73.109999999999999 112.857 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 10.3 pt-20 -144.71 149.66 35.98 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.137 0.494 . . . . 60.020000000000003 111.813 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -148.15 148.31 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 116.213 -0.449 . . . . 74.430000000000007 111.25 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -110.0 118.55 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.08 0.152 . . . . 72.219999999999999 110.843 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.453 HG13 ' HD2' ' A' ' 103' ' ' TYR . 33.9 m -128.9 178.27 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 122.699 0.399 . . . . 73.430000000000007 111.933 -177.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -83.06 146.02 28.95 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.106 0.479 . . . . 73.120000000000005 111.446 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.82 127.3 43.68 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.222 0.453 . . . . 73.099999999999994 112.222 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -129.34 142.33 50.85 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.367 0.603 . . . . 72.329999999999998 110.681 173.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -77.72 123.1 26.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.585 -0.734 . . . . 73.540000000000006 111.183 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -126.05 165.98 19.01 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.347 -0.454 . . . . 72.329999999999998 113.507 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -85.84 15.07 5.15 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.546 0.572 . . . . 62.310000000000002 112.546 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.3 m -65.66 154.83 87.63 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 112.051 0.389 . . . . 72.209999999999994 112.051 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.99 149.54 90.3 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.525 2.15 . . . . 72.5 112.616 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -63.9 144.14 57.31 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.748 0.309 . . . . 75.129999999999995 111.532 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 71.23 22.07 78.52 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.121 -0.561 . . . . 74.040000000000006 112.923 -174.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.713 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 23.9 ttt -154.0 136.47 15.05 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 122.495 -0.415 . . . . 73.530000000000001 109.985 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.2 pt -134.37 150.07 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.412 0.625 . . . . 75.030000000000001 112.313 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -106.47 129.25 54.47 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.835 -0.62 . . . . 75.25 110.827 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 30' ' ' SER . 40.8 mt -124.3 132.29 24.28 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 120.633 0.254 . . . . 75.219999999999999 110.657 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -57.86 128.54 29.41 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.19 1.926 . . . . 73.109999999999999 112.169 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.76 113.33 1.43 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.829 0.347 . . . . 72.239999999999995 111.267 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.45 -169.77 27.39 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.686 -0.768 . . . . 64.319999999999993 112.742 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.621 ' HD2' HG22 ' A' ' 52' ' ' VAL . 31.5 Cg_endo -65.15 -27.54 56.8 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.065 1.843 . . . . 71.409999999999997 111.482 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.476 ' HA ' HD11 ' A' ' 140' ' ' LEU . 3.4 m-85 -68.25 -53.8 22.11 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.825 -0.625 . . . . 70.340000000000003 110.249 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.78 -38.12 80.98 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.016 -0.538 . . . . 75.400000000000006 110.99 174.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -54.5 -23.43 16.28 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.365 0.505 . . . . 74.200000000000003 112.365 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 102' ' ' PRO . 77.9 mmm -78.17 -12.6 60.01 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.988 0.366 . . . . 61.420000000000002 111.988 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.7 m -137.39 -13.88 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 113.088 0.773 . . . . 70.150000000000006 113.088 -173.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.529 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.5 pp -105.78 172.18 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 122.081 -0.387 . . . . 73.540000000000006 111.206 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.448 ' N ' HG21 ' A' ' 123' ' ' VAL . 18.9 t0 . . . . . 0 CA--C 1.542 0.645 0 CA-C-O 120.902 0.382 . . . . 65.209999999999994 111.981 -176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.854 0 CA-C-O 120.81 0.117 . . . . 70.409999999999997 113.107 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.448 HG21 ' N ' ' A' ' 109' ' ' ASP . 98.3 t -87.17 130.05 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 O-C-N 122.692 -0.299 . . . . 73.219999999999999 111.561 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -70.12 145.95 51.21 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.274 0.559 . . . . 73.530000000000001 112.241 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.678 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -173.89 -155.47 11.99 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.72 -0.673 . . . . 75.230000000000004 112.693 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 25' ' ' GLU . 79.1 p -135.64 158.59 43.99 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 122.322 -0.517 . . . . 62.140000000000001 111.961 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.4 p -133.57 144.6 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 121.035 0.445 . . . . 71.420000000000002 111.008 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.48 ' CD ' ' HZ3' ' A' ' 76' ' ' LYS . 13.4 pt-20 -152.54 150.76 29.91 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.456 -0.338 . . . . 73.200000000000003 111.393 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.541 ' HB2' HD23 ' A' ' 67' ' ' LEU . 29.0 ttpt -83.53 127.46 33.74 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.994 -0.441 . . . . 74.030000000000001 110.219 170.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.5 t -126.24 156.19 40.67 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.339 0.59 . . . . 73.420000000000002 112.325 -172.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.58 ' HA ' HH21 ' A' ' 72' ' ' ARG . 8.5 p-10 -82.32 -5.6 58.7 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.002 -0.545 . . . . 74.400000000000006 111.22 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -69.36 157.19 37.52 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.943 -0.571 . . . . 74.209999999999994 111.372 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -88.3 157.51 18.73 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.91 0.385 . . . . 73.040000000000006 111.37 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 91.2 t -69.31 138.26 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 116.325 -0.398 . . . . 75.540000000000006 110.951 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.6 mt -70.88 133.76 46.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.698 0.285 . . . . 73.299999999999997 111.464 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 44.7 t -78.42 145.72 34.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.464 -0.569 . . . . 70.420000000000002 109.464 171.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.548 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 96.5 t -46.39 -45.95 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 111.86 0.319 . . . . 63.409999999999997 111.86 -177.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.458 ' HA ' HD11 ' A' ' 141' ' ' LEU . 25.1 ttpp -71.25 -41.25 70.33 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.691 0.281 . . . . 74.430000000000007 111.422 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -55.91 -37.03 68.36 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.918 0.866 . . . . 63.049999999999997 109.611 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.476 HD11 ' HA ' ' A' ' 103' ' ' TYR . 1.0 OUTLIER -68.85 -38.39 79.74 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.528 -1.215 . . . . 75.430000000000007 111.002 176.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 53.9 mt . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 121.609 0.718 . . . . 74.549999999999997 110.227 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 10.4 ptm . . . . . 0 CA--C 1.541 0.598 0 CA-C-O 120.757 0.313 . . . . 74.219999999999999 111.304 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.546 HD13 ' HG ' ' A' ' 65' ' ' LEU . 17.1 mt -118.05 133.83 55.54 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.648 0.61 . . . . 75.239999999999995 112.648 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -79.57 119.08 22.04 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.941 -0.572 . . . . 63.140000000000001 110.2 173.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 29.2 m -133.87 161.3 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.953 0.406 . . . . 73.150000000000006 111.91 -175.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.522 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 31.5 tt0 -99.22 113.43 25.69 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.946 0.403 . . . . 74.120000000000005 110.373 174.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.482 HG22 HD13 ' A' ' 96' ' ' ILE . 45.4 t -89.65 112.93 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.231 0.539 . . . . 71.400000000000006 111.861 -173.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.647 HD11 ' HE1' ' A' ' 95' ' ' MET . 2.7 mt -97.31 159.36 3.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.923 0.392 . . . . 75.409999999999997 111.745 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 75.2 m -135.43 104.65 5.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.085 0.469 . . . . 74.140000000000001 111.303 175.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.444 0 C-N-CA 120.963 -0.636 . . . . 65.400000000000006 112.372 -179.305 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 121.213 0.53 . . . . 73.209999999999994 111.34 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -65.1 -27.4 68.73 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.915 -0.584 . . . . 74.150000000000006 110.494 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.406 ' HD1' HG21 ' A' ' 137' ' ' VAL . 51.7 t80 -83.25 -9.18 59.27 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.941 -0.572 . . . . 73.340000000000003 111.745 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -116.89 -0.49 12.23 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.948 0.404 . . . . 70.319999999999993 111.64 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.81 -52.34 4.12 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.867 0.691 . . . . 72.439999999999998 112.867 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.456 HG22 ' HD2' ' A' ' 102' ' ' PRO . 35.5 m -116.35 19.86 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 113.445 0.906 . . . . 31.41 113.445 -172.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.64 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -100.73 18.57 19.03 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.898 0.703 . . . . 74.409999999999997 112.898 -171.478 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.468 ' CD1' ' HD2' ' A' ' 87' ' ' LYS . 47.1 p90 -144.6 165.58 27.6 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.462 0.542 . . . . 75.040000000000006 112.462 -174.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.32 142.51 49.37 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.623 -0.717 . . . . 73.549999999999997 110.685 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 44.5 mt-10 -101.04 118.48 37.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.938 0.399 . . . . 75.230000000000004 111.475 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.485 HD11 ' N ' ' A' ' 57' ' ' ILE . 3.8 mp -110.55 152.12 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 116.179 -0.464 . . . . 61.210000000000001 111.302 -177.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -68.44 153.77 43.12 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.671 0.388 . . . . 74.420000000000002 111.347 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -57.67 -46.33 84.39 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.115 0.483 . . . . 75.239999999999995 112.096 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.92 -47.9 82.87 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.79 0.329 . . . . 71.109999999999999 111.694 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -65.84 -35.92 82.01 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.199 0.524 . . . . 75.049999999999997 111.165 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.423 ' HZ2' ' N ' ' A' ' 69' ' ' GLU . 40.4 t-105 -55.55 -54.05 48.86 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.78 -0.645 . . . . 75.109999999999999 110.919 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -64.61 -33.83 76.85 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.048 -0.524 . . . . 71.329999999999998 111.475 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.54 ' HB1' HD11 ' A' ' 24' ' ' LEU . . . -60.15 -43.8 95.47 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.912 0.387 . . . . 75.040000000000006 111.947 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.614 HD11 HG12 ' A' ' 127' ' ' VAL . 93.4 mt -84.6 -9.25 58.46 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.001 0.371 . . . . 73.310000000000002 112.001 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.3 45.68 68.49 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.117 -0.563 . . . . 75.510000000000005 112.637 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.669 HD21 ' HE2' ' A' ' 129' ' ' LYS . 74.0 mt -83.37 166.63 18.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.385 0.612 . . . . 75.430000000000007 112.071 -177.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -147.25 121.39 9.49 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.853 -0.612 . . . . 72.329999999999998 109.898 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.423 ' N ' ' HZ2' ' A' ' 62' ' ' TRP . 43.0 mt-10 -44.52 98.62 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.283 0.846 . . . . 74.209999999999994 113.283 -169.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.79 -4.24 8.56 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 115.084 -0.962 . . . . 75.319999999999993 113.735 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.02 -176.61 5.59 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 117.8 0.8 . . . . 63.219999999999999 112.05 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.47 ' HG3' HG22 ' A' ' 134' ' ' VAL . 8.8 mpt_? -107.19 123.61 48.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.125 -0.489 . . . . 72.409999999999997 111.813 -176.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.3 m -115.42 145.04 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.307 0.575 . . . . 64.299999999999997 111.516 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.751 ' HD3' ' HE3' ' A' ' 76' ' ' LYS . 24.0 ttmm -108.73 146.99 32.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.813 -0.63 . . . . 74.109999999999999 110.534 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 64.5 t -130.55 129.57 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.269 -0.423 . . . . 75.319999999999993 110.704 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.751 ' HE3' ' HD3' ' A' ' 74' ' ' LYS . 38.7 mttt -130.94 125.54 33.7 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.929 0.395 . . . . 75.239999999999995 112.058 -175.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.65 HG21 ' HA3' ' A' ' 125' ' ' GLY . 42.6 p -126.45 -171.06 2.31 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 116.507 -0.315 . . . . 75.109999999999999 110.557 177.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.63 -6.46 52.12 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.901 0.382 . . . . 63.130000000000003 111.528 175.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -91.98 -60.78 1.77 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.869 0.366 . . . . 72.030000000000001 110.776 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.33 -144.45 4.03 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.221 -0.514 . . . . 75.010000000000005 112.796 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.406 ' OE1' ' NZ ' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -154.52 159.28 40.86 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 117.12 0.46 . . . . 75.120000000000005 111.204 178.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.8 p -157.46 144.45 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 111.928 0.344 . . . . 75.019999999999996 111.928 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.8 t -105.54 118.52 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 122.48 0.312 . . . . 72.420000000000002 110.587 174.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.484 HG12 ' HD2' ' A' ' 103' ' ' TYR . 35.3 m -128.18 176.5 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 120.996 0.427 . . . . 72.439999999999998 112.06 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -79.49 140.98 37.13 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.976 0.417 . . . . 74.040000000000006 111.34 176.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.8 126.16 36.78 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.758 0.651 . . . . 64.409999999999997 112.758 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 62.3 mttm -126.84 143.71 51.18 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.199 0.523 . . . . 74.400000000000006 110.901 173.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -88.78 121.36 31.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.973 -0.558 . . . . 74.430000000000007 110.573 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.4 -179.62 15.8 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.711 -0.757 . . . . 73.349999999999994 114.21 -174.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -90.66 18.9 5.85 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.958 0.409 . . . . 70.430000000000007 111.353 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.1 m -72.49 151.83 91.76 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.251 -0.431 . . . . 71.530000000000001 111.896 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -62.04 160.57 29.47 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 122.755 2.303 . . . . 74.450000000000003 113.61 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -69.0 138.76 54.78 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.824 0.345 . . . . 74.430000000000007 111.453 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 68.06 26.59 73.98 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.968 -0.634 . . . . 74.099999999999994 112.298 -173.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.647 ' HE1' HD11 ' A' ' 29' ' ' ILE . 23.5 ttt -149.8 136.61 19.4 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.653 -0.322 . . . . 74.239999999999995 110.297 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.482 HD13 HG22 ' A' ' 28' ' ' VAL . 39.8 pt -135.25 146.81 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 121.263 0.554 . . . . 71.239999999999995 111.851 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -106.17 130.15 54.1 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.177 -0.465 . . . . 74.400000000000006 111.564 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 30' ' ' SER . 44.9 mt -124.32 132.06 24.26 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 120.753 0.311 . . . . 72.140000000000001 110.629 173.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.434 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 37.6 Cg_exo -58.91 131.88 44.35 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.229 1.953 . . . . 73.299999999999997 112.368 173.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.518 ' HE1' HD13 ' A' ' 108' ' ' ILE . 5.7 tpt -51.39 107.94 0.22 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 111.906 0.335 . . . . 71.329999999999998 111.906 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.14 -176.84 38.37 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.574 -0.822 . . . . 61.539999999999999 113.413 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.456 ' HD2' HG22 ' A' ' 52' ' ' VAL . 15.2 Cg_endo -55.92 -35.44 94.18 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.169 2.579 . . . . 72.450000000000003 112.952 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.484 ' HD2' HG12 ' A' ' 84' ' ' VAL . 30.7 m-85 -61.87 -51.56 67.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.057 0.456 . . . . 74.219999999999999 110.634 177.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 108' ' ' ILE . . . -62.0 -38.3 88.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.099 0.476 . . . . 74.120000000000005 111.04 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -54.55 -26.17 30.45 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.898 0.479 . . . . 75.409999999999997 112.006 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.539 ' SD ' HD23 ' A' ' 140' ' ' LEU . 84.9 mmm -69.54 -16.78 63.5 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.347 0.499 . . . . 73.310000000000002 112.347 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.84 -19.03 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 113.472 0.916 . . . . 73.349999999999994 113.472 -174.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.567 HG23 ' OG ' ' A' ' 30' ' ' SER . 8.0 pt -98.5 179.96 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 112.852 0.686 . . . . 75.140000000000001 112.852 -175.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.9 t70 . . . . . 0 CA--C 1.545 0.774 0 CA-C-N 115.874 -0.603 . . . . 74.140000000000001 111.03 176.929 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.634 0 CA-C-O 120.778 0.099 . . . . 74.019999999999996 112.928 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 93.5 t -80.12 118.08 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 122.533 -0.392 . . . . 72.340000000000003 111.07 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 39.3 mtpt -67.31 155.55 38.63 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.657 0.741 . . . . 74.019999999999996 112.913 -177.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.65 ' HA3' HG21 ' A' ' 77' ' ' THR . . . 179.68 -147.85 7.75 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.055 -0.975 . . . . 72.430000000000007 112.144 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 45.1 p -138.51 153.3 48.75 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 122.292 -0.534 . . . . 72.420000000000002 111.757 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.614 HG12 HD11 ' A' ' 65' ' ' LEU . 14.8 p -128.11 145.24 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.138 -0.483 . . . . 73.549999999999997 110.254 175.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.461 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 7.3 pt-20 -148.69 151.31 34.7 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.81 0.67 . . . . 74.310000000000002 112.81 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.669 ' HE2' HD21 ' A' ' 67' ' ' LEU . 14.5 tppt? -69.51 106.38 2.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.535 -0.757 . . . . 64.030000000000001 109.966 167.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.1 t -100.8 161.8 13.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.451 0.643 . . . . 74.400000000000006 112.34 -176.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -100.53 0.7 39.98 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.554 -0.748 . . . . 74.349999999999994 110.62 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -88.39 179.52 6.31 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.07 0.767 . . . . 74.299999999999997 113.07 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -100.26 161.61 13.49 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.292 -0.867 . . . . 74.349999999999994 111.609 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.47 HG22 ' HG3' ' A' ' 72' ' ' ARG . 93.3 t -70.1 137.64 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 120.771 0.32 . . . . 65.319999999999993 111.56 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 135' ' ' LEU . 6.5 mt -77.81 98.04 5.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.679 -0.237 . . . . 73.239999999999995 111.219 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 70.9 p -55.19 153.68 6.59 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.696 0.284 . . . . 75.129999999999995 111.45 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.546 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 86.8 t -45.8 -53.73 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.971 0.73 . . . . 75.129999999999995 112.971 -172.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -72.35 -42.0 65.82 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.23 0.456 . . . . 73.340000000000003 112.23 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -56.51 -39.99 74.26 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.564 0.697 . . . . 60.210000000000001 109.977 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.539 HD23 ' SD ' ' A' ' 106' ' ' MET . 2.3 tt -60.58 -41.62 95.05 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.071 -0.968 . . . . 71.109999999999999 110.772 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 68.3 mt . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 121.173 0.511 . . . . 70.319999999999993 110.818 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.412 ' HE2' ' HD3' ' A' ' 76' ' ' LYS . 8.8 ptm . . . . . 0 CA--C 1.539 0.557 0 CA-C-O 120.926 0.393 . . . . 72.340000000000003 110.769 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.629 HD11 ' HB3' ' A' ' 64' ' ' ALA . 32.6 mt -90.53 132.13 35.87 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.831 0.678 . . . . 74.239999999999995 112.831 -173.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -78.74 118.56 20.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.52 -0.764 . . . . 71.299999999999997 111.04 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 35.4 m -139.32 164.38 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.992 -1.004 . . . . 75.120000000000005 112.027 -173.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 34.8 tt0 -99.47 121.85 41.73 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.858 0.361 . . . . 42.32 110.435 171.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.462 HG22 HD11 ' A' ' 96' ' ' ILE . 39.3 t -96.42 110.2 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.258 -0.428 . . . . 74.239999999999995 111.608 -175.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.811 HD11 ' HE2' ' A' ' 95' ' ' MET . 2.9 mt -95.73 161.06 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.927 0.394 . . . . 74.109999999999999 111.905 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 73.5 m -129.33 95.44 4.03 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.01 0.434 . . . . 74.510000000000005 111.212 174.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.696 0 C-N-CA 121.097 -0.573 . . . . 60.539999999999999 113.078 -178.493 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 CA--C 1.538 0.509 0 CA-C-O 121.154 0.502 . . . . 72.329999999999998 110.579 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.481 ' O ' HG21 ' A' ' 52' ' ' VAL . 13.0 t80 -65.5 -43.09 91.22 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.893 -0.594 . . . . 74.109999999999999 110.4 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.484 ' HD1' HG21 ' A' ' 137' ' ' VAL . 75.4 t80 -58.65 -62.07 2.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.716 -0.674 . . . . 75.349999999999994 110.452 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -59.96 -23.89 63.95 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.621 0.6 . . . . 72.439999999999998 112.621 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.78 -33.01 58.07 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.795 0.665 . . . . 73.430000000000007 112.795 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.523 HG22 ' HD2' ' A' ' 102' ' ' PRO . 30.5 m -123.49 14.8 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 113.575 0.954 . . . . 75.230000000000004 113.575 -173.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -96.57 19.66 11.93 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.963 0.727 . . . . 75.129999999999995 112.963 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -145.5 159.21 43.44 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.897 -0.502 . . . . 71.310000000000002 112.279 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.38 141.59 51.98 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.787 -0.642 . . . . 63.420000000000002 110.687 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.768 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 41.5 mt-10 -97.9 111.98 24.08 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.838 0.351 . . . . 71.349999999999994 111.272 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.444 HD13 ' N ' ' A' ' 57' ' ' ILE . 3.9 mp -110.88 149.9 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.333 -0.394 . . . . 73.439999999999998 111.032 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -74.45 144.8 44.09 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.548 0.213 . . . . 73.420000000000002 110.438 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.427 ' HB2' ' HD3' ' A' ' 88' ' ' LYS . 27.6 tt0 -55.33 -32.91 62.89 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.314 0.487 . . . . 75.349999999999994 112.314 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.599 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 17.3 mm-40 -54.97 -57.08 13.11 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 111.977 0.362 . . . . 75.129999999999995 111.977 175.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.02 -34.99 78.93 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.441 0.639 . . . . 72.340000000000003 110.45 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.501 ' HA ' HD11 ' A' ' 67' ' ' LEU . 43.3 t-105 -53.08 -50.27 64.72 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.171 -0.922 . . . . 75.409999999999997 111.478 177.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -69.13 -39.1 79.07 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.155 -0.475 . . . . 71.010000000000005 111.462 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.629 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -56.27 -34.33 66.33 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.245 0.461 . . . . 71.430000000000007 112.245 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.0 mt -91.84 -18.32 23.99 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.377 -0.374 . . . . 75.340000000000003 111.849 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.03 46.33 10.57 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.154 -0.546 . . . . 62.439999999999998 112.657 -176.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.679 HD23 ' HD3' ' A' ' 129' ' ' LYS . 91.6 mt -84.09 143.19 29.87 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.271 0.558 . . . . 72.439999999999998 112.424 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -101.09 156.15 17.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.013 -0.54 . . . . 75.230000000000004 110.645 170.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.35 93.21 1.49 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.735 0.779 . . . . 65.340000000000003 111.11 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.76 -3.62 8.61 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 114.777 -1.101 . . . . 72.430000000000007 112.113 -171.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.47 173.79 1.5 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.23 0.538 . . . . 71.109999999999999 112.093 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -113.86 124.47 52.3 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.267 -0.424 . . . . 74.329999999999998 111.353 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.589 HG13 ' HB1' ' A' ' 86' ' ' ALA . 17.5 m -114.33 142.11 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.333 0.587 . . . . 74.120000000000005 112.232 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.554 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 38.5 ttmt -99.47 147.31 25.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.857 -0.611 . . . . 74.439999999999998 110.172 173.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -128.54 124.03 60.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.239 -0.652 . . . . 74.519999999999996 109.239 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.747 ' HB3' ' HZ1' ' A' ' 76' ' ' LYS . 6.5 mtpm? -133.93 130.12 37.28 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.546 0.573 . . . . 72.140000000000001 112.546 -170.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.722 HG21 ' HA3' ' A' ' 125' ' ' GLY . 25.0 p -136.62 -171.23 2.86 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.797 -0.638 . . . . 75.109999999999999 110.545 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.91 -14.91 63.27 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.961 -0.563 . . . . 63.520000000000003 111.853 175.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -89.2 -38.64 14.11 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 111.796 0.295 . . . . 72.120000000000005 111.796 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.31 -160.93 34.6 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.345 -0.455 . . . . 63.299999999999997 112.979 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.19 149.85 51.04 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.267 0.556 . . . . 64.230000000000004 112.202 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.506 HG22 HD12 ' A' ' 135' ' ' LEU . 12.5 p -147.46 147.26 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.142 -0.481 . . . . 74.310000000000002 110.948 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -111.12 119.07 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 122.31 -0.244 . . . . 71.340000000000003 110.997 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.442 ' HA ' HG11 ' A' ' 134' ' ' VAL . 34.3 m -129.57 174.25 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 111.921 0.341 . . . . 74.420000000000002 111.921 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -75.37 143.38 42.83 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.97 0.414 . . . . 73.430000000000007 111.458 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.589 ' HB1' HG13 ' A' ' 73' ' ' VAL . . . -94.5 122.12 36.75 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.216 0.45 . . . . 74.219999999999999 112.216 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -128.33 141.17 51.51 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.304 0.573 . . . . 72.099999999999994 111.08 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.427 ' HD3' ' HB2' ' A' ' 59' ' ' GLU . 35.3 ttmt -80.11 103.99 10.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.717 -0.674 . . . . 75.209999999999994 110.689 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.768 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -100.51 -163.9 28.29 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 121.256 -0.497 . . . . 71.549999999999997 114.298 -172.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -111.25 32.45 5.32 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.365 0.602 . . . . 51.420000000000002 111.292 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.1 m -92.37 158.41 38.86 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.974 -0.557 . . . . 63.240000000000002 111.817 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.97 163.14 37.59 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.302 2.001 . . . . 74.010000000000005 112.859 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.599 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 78.8 tttt -63.32 143.34 57.88 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.767 0.318 . . . . 71.430000000000007 111.574 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 68.22 28.78 73.18 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.877 -0.678 . . . . 73.340000000000003 112.961 -175.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.811 ' HE2' HD11 ' A' ' 29' ' ' ILE . 23.5 ttt -154.62 137.0 14.95 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.472 -0.428 . . . . 74.239999999999995 110.309 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.462 HD11 HG22 ' A' ' 28' ' ' VAL . 41.9 pt -134.87 144.37 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.359 0.6 . . . . 72.409999999999997 112.082 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -106.09 124.19 49.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.021 -0.536 . . . . 73.420000000000002 111.415 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' A' ' 30' ' ' SER . 54.4 mt -121.02 131.45 24.48 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.559 -0.291 . . . . 73.239999999999995 110.427 174.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.48 138.82 82.89 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.14 1.893 . . . . 65.319999999999993 112.399 175.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.538 ' HE3' ' ND2' ' A' ' 105' ' ' ASN . 0.0 OUTLIER -56.7 104.73 0.16 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.444 -0.344 . . . . 62.409999999999997 110.839 -178.163 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.97 -173.84 25.91 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.712 -0.756 . . . . 63.030000000000001 113.107 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.523 ' HD2' HG22 ' A' ' 52' ' ' VAL . 34.8 Cg_endo -64.7 -31.59 58.56 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.352 2.035 . . . . 73.430000000000007 111.566 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.502 ' HA ' HD13 ' A' ' 140' ' ' LEU . 8.2 m-85 -62.85 -48.17 80.2 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.701 -0.681 . . . . 74.230000000000004 110.146 175.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.439 ' O ' HG22 ' A' ' 108' ' ' ILE . . . -59.64 -43.55 93.81 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.911 -0.586 . . . . 72.010000000000005 111.517 173.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.538 ' ND2' ' HE3' ' A' ' 100' ' ' MET . 22.8 m-80 -54.89 -20.1 8.06 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.536 0.569 . . . . 73.409999999999997 112.536 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.514 ' SD ' HD22 ' A' ' 140' ' ' LEU . 88.5 mmm -69.45 -31.56 69.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.858 0.361 . . . . 72.109999999999999 111.435 177.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.425 ' HB ' HG23 ' A' ' 77' ' ' THR . 31.0 m -123.59 -8.36 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 113.293 0.849 . . . . 65.420000000000002 113.293 -171.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.546 HG21 ' OG ' ' A' ' 30' ' ' SER . 8.0 pt -106.05 177.48 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.565 0.698 . . . . 71.409999999999997 112.452 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.426 ' H ' HG21 ' A' ' 123' ' ' VAL . 25.7 t70 . . . . . 0 CA--C 1.543 0.683 0 CA-C-N 115.544 -0.753 . . . . 64.099999999999994 110.67 175.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . . . . . . 0 CA--C 1.524 0.597 0 CA-C-O 121.15 0.305 . . . . 72.439999999999998 113.133 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.426 HG21 ' H ' ' A' ' 109' ' ' ASP . 89.5 t -86.89 122.28 38.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.633 0.254 . . . . 73.109999999999999 111.515 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 68.0 mttm -71.71 147.32 47.52 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.463 0.649 . . . . 75.510000000000005 112.35 -177.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.722 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -175.15 -138.59 2.8 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.479 -0.782 . . . . 73.099999999999994 112.527 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 57.3 p -140.43 158.64 43.7 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.06 0.457 . . . . 75.230000000000004 111.748 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.1 p -135.29 145.23 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.988 -0.551 . . . . 64.209999999999994 110.472 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.495 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 5.9 pt-20 -149.04 155.21 40.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.684 0.278 . . . . 71.239999999999995 111.383 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.679 ' HD3' HD23 ' A' ' 67' ' ' LEU . 28.0 ttpp -85.68 133.54 34.02 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.607 -0.516 . . . . 75.430000000000007 109.607 168.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.6 t -130.72 161.08 32.46 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.601 0.715 . . . . 60.109999999999999 112.858 -171.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.09 -21.31 33.73 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.409 -0.814 . . . . 74.329999999999998 110.164 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -61.73 157.21 18.38 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.847 -0.615 . . . . 73.319999999999993 112.579 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.432 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -90.52 162.29 15.1 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.912 -0.585 . . . . 74.340000000000003 111.1 179.33 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' A' ' 84' ' ' VAL . 98.4 t -65.81 133.23 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.458 -0.337 . . . . 72.439999999999998 111.035 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.506 HD12 HG22 ' A' ' 82' ' ' VAL . 13.2 mt -63.01 138.28 58.51 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.134 0.492 . . . . 74.450000000000003 111.405 177.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.0 t -85.41 144.93 27.72 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.087 -0.709 . . . . 71.129999999999995 109.087 170.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.484 HG21 ' HD1' ' A' ' 49' ' ' PHE . 86.5 t -48.46 -47.05 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 112.093 0.405 . . . . 71.409999999999997 112.093 -175.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -67.83 -41.46 82.99 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.958 0.408 . . . . 64.450000000000003 111.525 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -62.14 -33.52 74.64 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.581 0.705 . . . . 72.400000000000006 110.404 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.514 HD22 ' SD ' ' A' ' 106' ' ' MET . 1.9 tt -66.63 -34.29 77.55 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.127 -0.942 . . . . 71.230000000000004 110.85 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 56.0 mt . . . . . 0 N--CA 1.472 0.673 0 CA-C-O 121.633 0.73 . . . . 73.530000000000001 109.943 175.144 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 7.8 ptp . . . . . 0 CA--C 1.539 0.531 0 CA-C-O 120.997 0.427 . . . . 64.150000000000006 111.219 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 64' ' ' ALA . 25.3 mt -121.46 127.02 50.66 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.129 0.49 . . . . 74.420000000000002 111.813 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -71.7 115.61 11.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.585 -0.734 . . . . 65.040000000000006 111.02 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 27.8 m -128.51 160.07 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.55 0.574 . . . . 72.400000000000006 112.55 -174.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.623 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 52.9 tt0 -99.27 117.32 33.45 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.945 0.402 . . . . 74.099999999999994 110.696 174.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.49 HG23 HD11 ' A' ' 96' ' ' ILE . 40.9 t -92.35 108.51 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.142 0.496 . . . . 70.540000000000006 112.121 -175.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.769 HD12 ' HE1' ' A' ' 95' ' ' MET . 0.3 OUTLIER -102.24 146.95 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.936 0.398 . . . . 75.049999999999997 112.027 177.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 73.6 m -106.6 104.42 14.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.157 -0.474 . . . . 73.430000000000007 111.667 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.469 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . . . . . . 0 CA--C 1.522 0.528 0 C-N-CA 120.885 -0.674 . . . . 61.43 112.894 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 CA--C 1.538 0.507 0 CA-C-O 120.733 0.302 . . . . 72.430000000000007 111.223 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -58.18 -40.02 80.4 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.298 0.57 . . . . 72.109999999999999 109.849 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -64.52 -62.03 1.85 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.559 -0.746 . . . . 75.299999999999997 110.306 176.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -64.62 -4.31 4.03 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.09 0.774 . . . . 74.319999999999993 113.09 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.22 -33.01 14.86 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.61 0.596 . . . . 51.25 112.61 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.561 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 34.8 m -129.48 20.15 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 113.15 0.796 . . . . 64.430000000000007 113.15 -173.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -103.02 21.53 15.56 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.124 0.787 . . . . 72.129999999999995 113.124 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -140.89 158.43 43.96 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.168 0.509 . . . . 71.409999999999997 112.143 -177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.89 138.79 51.13 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.909 -0.587 . . . . 72.510000000000005 110.853 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.639 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 39.6 mt-10 -93.78 112.66 24.56 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.637 0.256 . . . . 73.439999999999998 111.361 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.414 HD11 ' N ' ' A' ' 57' ' ' ILE . 4.3 mp -109.81 146.06 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 116.529 -0.305 . . . . 74.150000000000006 110.764 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -68.43 143.92 54.88 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.811 0.339 . . . . 72.310000000000002 111.399 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -47.46 -40.05 17.31 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.117 0.567 . . . . 74.420000000000002 112.251 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -58.37 -54.35 47.97 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.087 0.47 . . . . 74.230000000000004 111.399 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -66.37 -33.67 76.25 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.227 0.537 . . . . 75.150000000000006 110.915 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 46.2 t-105 -54.16 -54.23 42.51 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.693 -0.685 . . . . 73.439999999999998 111.429 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -69.42 -36.38 76.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.525 -0.307 . . . . 74.400000000000006 111.66 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.502 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -59.64 -34.65 73.07 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.983 0.42 . . . . 71.140000000000001 111.88 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.484 ' HG ' HD13 ' A' ' 24' ' ' LEU . 94.6 mt -90.91 -12.17 36.9 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.473 -0.331 . . . . 74.310000000000002 111.751 177.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.12 46.51 50.49 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.123 -0.561 . . . . 70.120000000000005 112.657 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.721 ' HA ' ' HZ1' ' A' ' 129' ' ' LYS . 93.7 mt -86.6 159.51 19.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.616 0.722 . . . . 73.400000000000006 112.078 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -140.87 134.78 30.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.184 -0.916 . . . . 74.409999999999997 109.129 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -56.17 97.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.631 0.729 . . . . 74.049999999999997 112.094 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 143.28 -22.9 2.23 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.15 -0.932 . . . . 55.5 113.956 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -86.25 178.0 7.31 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 118.251 1.026 . . . . 73.239999999999995 112.627 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.642 HH11 HG21 ' A' ' 134' ' ' VAL . 60.9 mtt-85 -109.52 139.95 43.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.812 -0.631 . . . . 74.319999999999993 112.003 -169.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.4 m -124.06 140.03 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.921 -0.581 . . . . 73.0 111.212 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -107.99 131.25 54.76 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.921 0.391 . . . . 75.400000000000006 110.896 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 50.5 t -106.81 130.47 58.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.397 -0.365 . . . . 75.25 111.026 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.482 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -117.18 127.88 54.55 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.017 0.437 . . . . 55.329999999999998 111.307 177.475 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.627 HG23 ' HA3' ' A' ' 125' ' ' GLY . 21.4 p -135.53 -172.52 3.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.057 0.456 . . . . 72.439999999999998 110.57 175.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -71.29 -5.62 33.69 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.293 -0.412 . . . . 75.319999999999993 111.963 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -99.81 -20.55 16.15 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.026 0.38 . . . . 74.5 112.026 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 146.6 -151.63 23.87 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.982 -0.627 . . . . 63.420000000000002 113.202 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.482 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 9.5 pt-20 -140.3 149.94 43.41 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.8 0.333 . . . . 55.409999999999997 111.553 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.454 HG23 ' SD ' ' A' ' 106' ' ' MET . 12.8 p -149.11 148.67 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.528 -0.305 . . . . 74.219999999999999 111.135 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.07 117.71 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 120.542 0.21 . . . . 73.219999999999999 111.349 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.4 m -129.84 176.44 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.646 0.379 . . . . 72.409999999999997 111.657 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -79.66 145.97 32.72 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.016 0.436 . . . . 74.510000000000005 111.565 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.76 115.86 26.61 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 112.591 0.589 . . . . 74.319999999999993 112.591 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -113.27 157.39 21.84 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.621 0.725 . . . . 73.450000000000003 111.228 171.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -100.11 112.57 24.88 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.386 -0.825 . . . . 63.039999999999999 110.547 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.639 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -107.92 171.77 16.54 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.147 -0.549 . . . . 73.140000000000001 114.147 -174.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.61 18.34 13.07 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.32 0.581 . . . . 71.150000000000006 110.752 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.8 m -79.1 155.85 77.05 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.852 -0.613 . . . . 71.400000000000006 111.99 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.03 153.17 53.52 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.404 2.069 . . . . 75.340000000000003 112.588 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -62.65 148.75 45.44 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 122.161 -0.337 . . . . 75.040000000000006 111.151 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 66.17 27.29 72.84 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.521 -0.847 . . . . 74.310000000000002 112.41 -174.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.769 ' HE1' HD12 ' A' ' 29' ' ' ILE . 20.9 ttt -149.27 137.01 20.38 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.632 -0.507 . . . . 63.229999999999997 109.632 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.49 HD11 HG23 ' A' ' 28' ' ' VAL . 38.9 pt -132.99 141.54 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 121.249 0.547 . . . . 74.129999999999995 111.864 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.475 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 59.1 t80 -101.87 118.38 36.8 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.966 -0.561 . . . . 75.329999999999998 111.369 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 30' ' ' SER . 51.5 mt -119.97 124.37 27.91 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.623 -0.262 . . . . 75.150000000000006 110.612 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.561 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 11.5 Cg_endo -55.82 137.23 77.98 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.184 1.922 . . . . 71.430000000000007 112.258 176.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.415 ' HE1' ' OD1' ' A' ' 105' ' ' ASN . 0.0 OUTLIER -59.08 103.27 0.16 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.329 -0.396 . . . . 73.230000000000004 110.948 -175.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.59 -176.12 24.85 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.559 -0.829 . . . . 75.430000000000007 112.87 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.506 ' HA ' HD21 ' A' ' 105' ' ' ASN . 22.4 Cg_endo -62.13 -28.03 79.4 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.023 1.815 . . . . 74.150000000000006 111.446 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.5 ' HA ' HD11 ' A' ' 140' ' ' LEU . 8.4 m-85 -66.89 -49.88 64.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.617 -0.72 . . . . 73.310000000000002 110.134 175.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.38 -40.09 81.37 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.854 -0.612 . . . . 73.319999999999993 111.443 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.506 HD21 ' HA ' ' A' ' 102' ' ' PRO . 91.0 m-20 -56.71 -25.11 53.52 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.214 0.53 . . . . 72.409999999999997 111.808 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.454 ' SD ' HG23 ' A' ' 82' ' ' VAL . 35.3 mtp -73.58 -21.53 60.31 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.912 -0.586 . . . . 74.420000000000002 112.313 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.5 m -133.67 -5.96 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.453 0.908 . . . . 74.450000000000003 113.453 -173.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.438 HG21 ' HG ' ' A' ' 30' ' ' SER . 1.6 pp -111.13 172.65 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.957 -0.464 . . . . 74.540000000000006 111.665 -177.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.464 ' N ' HG23 ' A' ' 123' ' ' VAL . 11.6 t70 . . . . . 0 CA--C 1.543 0.707 0 CA-C-N 116.252 -0.431 . . . . 70.219999999999999 111.636 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.6 0 N-CA-C 113.877 0.311 . . . . 74.019999999999996 113.877 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 109' ' ' ASP . 57.7 t -94.2 120.29 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 122.633 -0.333 . . . . 75.439999999999998 110.987 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 39.0 mtpt -73.83 153.5 39.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.015 0.912 . . . . 72.099999999999994 112.779 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.627 ' HA3' HG23 ' A' ' 77' ' ' THR . . . -174.88 -150.1 7.6 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 114.323 -1.308 . . . . 53.240000000000002 111.346 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 44.0 p -132.87 146.95 52.26 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.449 0.625 . . . . 63.299999999999997 111.873 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -121.67 144.01 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.085 -0.507 . . . . 70.409999999999997 110.905 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -149.74 152.4 35.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.921 -0.581 . . . . 72.530000000000001 110.811 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.721 ' HZ1' ' HA ' ' A' ' 67' ' ' LEU . 19.6 ttmm -73.04 134.95 44.81 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.363 -0.606 . . . . 74.420000000000002 109.363 170.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.7 t -126.52 158.84 35.09 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.036 0.754 . . . . 72.519999999999996 113.036 -172.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -85.46 -15.78 41.81 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.11 -0.95 . . . . 74.519999999999996 110.911 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.444 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 19.2 mm-40 -73.81 156.08 38.16 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.496 0.665 . . . . 75.430000000000007 112.587 -177.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.02 156.99 29.8 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.29 -0.868 . . . . 75.430000000000007 111.309 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.642 HG21 HH11 ' A' ' 72' ' ' ARG . 70.4 t -69.7 131.03 34.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 109.85 -0.426 . . . . 75.439999999999998 109.85 173.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.4 HD11 ' HG ' ' A' ' 140' ' ' LEU . 13.5 mt -63.21 132.33 51.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.081 0.467 . . . . 75.549999999999997 112.099 -177.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 65.6 m -75.97 146.07 39.86 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.41 -0.589 . . . . 71.010000000000005 109.41 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 87.5 t -46.76 -50.98 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 112.859 0.689 . . . . 73.120000000000005 112.859 -172.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -72.92 -38.76 66.74 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.057 -0.402 . . . . 64.209999999999994 111.745 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -58.42 -37.7 75.91 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.745 0.783 . . . . 73.319999999999993 110.038 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.5 HD11 ' HA ' ' A' ' 103' ' ' TYR . 5.1 tt -59.59 -42.66 93.03 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.905 -1.043 . . . . 73.109999999999999 110.72 174.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 50.6 mt . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 121.205 0.526 . . . . 73.140000000000001 110.395 177.977 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.515 ' HA ' ' HB3' ' A' ' 128' ' ' GLU . 8.7 ptp . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 112.959 0.726 . . . . 73.230000000000004 112.959 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' A' ' 64' ' ' ALA . 13.5 mt -117.39 140.34 49.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.123 -0.944 . . . . 72.109999999999999 110.887 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -79.26 110.33 14.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.669 0.747 . . . . 75.0 110.974 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 35.0 m -133.51 162.32 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.872 -1.058 . . . . 70.129999999999995 111.873 -171.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.566 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 28.3 tt0 -100.08 117.72 34.94 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.067 0.46 . . . . 55.240000000000002 110.531 172.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.522 HG23 HD11 ' A' ' 96' ' ' ILE . 41.0 t -90.62 110.07 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.315 0.646 . . . . 72.409999999999997 111.457 -175.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.654 HD11 ' HE3' ' A' ' 95' ' ' MET . 8.3 mt -91.98 152.21 3.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.871 0.367 . . . . 73.030000000000001 111.768 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.676 ' HB2' HG23 ' A' ' 108' ' ' ILE . 23.1 t -123.63 93.28 3.89 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.946 0.403 . . . . 74.430000000000007 110.081 172.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.438 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . . . . . . 0 CA--C 1.522 0.498 0 C-N-CA 121.135 -0.555 . . . . 63.409999999999997 113.501 -175.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 CA--C 1.542 0.646 0 CA-C-O 120.761 0.315 . . . . 70.530000000000001 111.445 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -25.86 67.02 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.443 0.64 . . . . 74.310000000000002 109.973 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -86.33 -17.5 34.37 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.864 -0.607 . . . . 74.430000000000007 111.052 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -84.61 -43.23 14.63 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.902 -0.498 . . . . 73.420000000000002 112.067 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.85 -63.78 1.33 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.69 0.996 . . . . 72.530000000000001 113.69 -170.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.525 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 28.3 m -88.31 20.95 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 113.661 0.985 . . . . 72.530000000000001 113.661 -167.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.595 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -105.24 12.22 32.11 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.175 0.806 . . . . 75.430000000000007 113.175 -173.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -137.31 164.74 27.84 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.817 -0.552 . . . . 75.329999999999998 111.834 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.54 141.39 52.06 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.849 -0.614 . . . . 64.409999999999997 111.182 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.508 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 61.8 mt-10 -94.09 112.73 24.58 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.093 -0.503 . . . . 74.319999999999993 111.12 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.412 HD13 ' N ' ' A' ' 57' ' ' ILE . 4.3 mp -109.89 145.76 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.501 -0.318 . . . . 73.5 110.665 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -66.51 151.83 46.44 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.659 0.266 . . . . 73.409999999999997 111.012 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 34.9 tt0 -57.76 -41.96 83.03 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.425 0.528 . . . . 54.43 112.425 -177.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -63.36 -48.52 77.59 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.785 0.326 . . . . 74.230000000000004 111.817 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -65.25 -36.77 85.16 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.12 0.486 . . . . 74.230000000000004 110.605 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.416 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 39.9 t-105 -52.92 -49.39 66.08 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.861 -0.608 . . . . 64.239999999999995 110.905 174.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -66.54 -40.56 89.14 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.782 -0.644 . . . . 71.140000000000001 111.167 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.47 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -60.77 -39.44 88.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.124 0.487 . . . . 62.43 111.95 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.503 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 68.4 mt -80.6 -10.44 59.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.069 -0.514 . . . . 72.540000000000006 111.461 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.49 40.24 97.52 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.404 -0.427 . . . . 74.230000000000004 112.652 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.503 ' HG ' ' HB2' ' A' ' 65' ' ' LEU . 96.1 mt -78.11 161.07 27.66 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.73 0.776 . . . . 71.040000000000006 112.572 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -138.63 130.49 27.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.328 -0.851 . . . . 75.120000000000005 109.59 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -55.51 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.59 0.71 . . . . 74.540000000000006 112.115 -174.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.57 -19.45 1.85 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-N 115.14 -0.936 . . . . 70.109999999999999 113.479 -176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -89.51 -169.95 2.67 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 117.683 0.741 . . . . 74.129999999999995 112.224 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.437 ' HD3' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -135.59 162.06 33.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.168 0.508 . . . . 74.409999999999997 111.977 -174.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 86' ' ' ALA . 23.8 m -132.22 154.86 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.329 0.585 . . . . 72.109999999999999 112.36 -176.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.422 ' HB2' HG23 ' A' ' 130' ' ' THR . 12.5 tppt? -97.98 129.74 44.85 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.516 -0.765 . . . . 73.030000000000001 110.486 173.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 44.7 t -116.16 123.21 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 122.251 0.22 . . . . 63.130000000000003 110.445 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -124.46 124.85 43.19 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.952 0.406 . . . . 74.450000000000003 112.042 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.629 HG21 ' HA3' ' A' ' 125' ' ' GLY . 25.0 p -132.15 -171.43 2.63 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.061 0.458 . . . . 74.239999999999995 111.396 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -71.78 -2.77 18.8 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 112.666 0.617 . . . . 75.430000000000007 112.666 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -106.75 -40.45 5.51 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.931 0.396 . . . . 71.430000000000007 111.863 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.72 -149.0 10.53 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.98 -0.629 . . . . 72.209999999999994 112.633 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 11.4 pt-20 -149.36 150.09 31.91 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.385 0.612 . . . . 74.25 112.289 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 106' ' ' MET . 7.8 p -144.0 155.91 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.799 -0.637 . . . . 74.129999999999995 110.568 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.2 t -116.98 115.61 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.623 0.249 . . . . 64.510000000000005 110.722 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.23 168.65 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 116.263 -0.426 . . . . 74.540000000000006 111.668 -175.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -72.83 132.05 43.07 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.827 0.346 . . . . 74.349999999999994 111.364 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB3' HG13 ' A' ' 73' ' ' VAL . . . -86.24 121.94 29.54 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 111.978 0.362 . . . . 74.109999999999999 111.978 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -133.78 150.19 51.44 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.213 0.53 . . . . 74.329999999999998 111.319 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -85.41 103.47 14.34 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.947 -0.57 . . . . 74.400000000000006 110.357 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.508 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -120.08 -165.81 13.01 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 115.522 0.969 . . . . 64.340000000000003 115.522 -168.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -86.33 77.53 9.48 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.408 0.683 . . . . 64.120000000000005 111.869 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.7 m -149.05 152.37 36.3 Favored Pre-proline 0 N--CA 1.474 0.727 0 CA-C-N 115.443 -0.799 . . . . 75.439999999999998 111.655 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.55 168.52 16.19 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.779 2.32 . . . . 73.200000000000003 112.161 172.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -67.39 144.46 55.78 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.885 -0.509 . . . . 74.450000000000003 111.759 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 75.13 18.92 80.05 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.29 -0.481 . . . . 73.140000000000001 113.376 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.654 ' HE3' HD11 ' A' ' 29' ' ' ILE . 22.0 ttt -152.92 136.91 16.31 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.264 -0.551 . . . . 75.450000000000003 110.649 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.522 HD11 HG23 ' A' ' 28' ' ' VAL . 37.9 pt -132.53 150.72 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 121.179 0.514 . . . . 74.140000000000001 111.703 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.508 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 59.2 t80 -112.6 130.69 55.94 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.284 -0.416 . . . . 74.200000000000003 111.888 -176.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 30' ' ' SER . 40.1 mt -125.77 132.03 24.19 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 120.59 0.233 . . . . 73.150000000000006 110.795 173.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.525 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 51.2 Cg_exo -57.49 141.37 95.07 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.492 2.128 . . . . 74.430000000000007 112.789 176.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -61.03 103.68 0.3 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.799 0.333 . . . . 65.129999999999995 110.807 -178.524 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.26 -178.68 38.62 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.664 -0.779 . . . . 54.549999999999997 113.109 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.471 ' O ' ' HG2' ' A' ' 106' ' ' MET . 11.2 Cg_endo -54.62 -31.67 71.49 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.949 2.433 . . . . 75.310000000000002 112.668 -177.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.472 ' HA ' HD11 ' A' ' 140' ' ' LEU . 43.2 m-85 -66.09 -50.56 63.67 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.837 0.351 . . . . 70.530000000000001 110.843 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.487 ' O ' HG21 ' A' ' 108' ' ' ILE . . . -62.06 -38.4 88.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.007 0.432 . . . . 74.209999999999994 110.778 174.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -53.09 -26.67 17.1 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.106 0.562 . . . . 71.530000000000001 112.241 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.563 ' SD ' HD23 ' A' ' 140' ' ' LEU . 86.9 mmm -73.85 -20.73 60.35 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.097 0.406 . . . . 73.349999999999994 112.097 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.81 -7.24 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 113.1 0.778 . . . . 74.439999999999998 113.1 -173.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.676 HG23 ' HB2' ' A' ' 30' ' ' SER . 11.4 pt -105.7 179.76 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 121.878 -0.514 . . . . 74.450000000000003 111.594 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.578 ' H ' HG21 ' A' ' 123' ' ' VAL . 22.4 t70 . . . . . 0 CA--C 1.54 0.585 0 CA-C-N 116.295 -0.411 . . . . 73.25 110.838 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . . . . . . 0 CA--C 1.526 0.777 0 CA-C-O 120.73 0.072 . . . . 53.409999999999997 112.93 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.578 HG21 ' H ' ' A' ' 109' ' ' ASP . 93.2 t -85.09 126.86 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.913 0.387 . . . . 74.530000000000001 111.324 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 21.7 mtpp -75.08 160.19 30.79 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.771 0.656 . . . . 74.230000000000004 112.771 -174.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.629 ' HA3' HG21 ' A' ' 77' ' ' THR . . . 171.94 -151.53 15.15 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 116.064 -0.516 . . . . 74.230000000000004 113.882 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 70.8 p -137.32 159.82 40.85 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 122.381 -0.482 . . . . 64.5 111.609 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.9 p -148.88 144.07 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 112.047 0.388 . . . . 74.530000000000001 112.047 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.515 ' HB3' ' HA ' ' A' ' 23' ' ' MET . 9.1 pt-20 -153.35 159.65 42.51 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.881 0.472 . . . . 71.430000000000007 110.904 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -83.31 144.11 29.92 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.147 0.498 . . . . 75.040000000000006 111.377 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.422 HG23 ' HB2' ' A' ' 74' ' ' LYS . 4.0 t -150.03 161.84 41.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.861 -0.609 . . . . 52.520000000000003 111.653 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -76.62 -8.0 56.37 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.394 -0.366 . . . . 73.540000000000006 111.28 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -50.2 152.71 1.66 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.528 0.566 . . . . 73.140000000000001 112.528 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.579 ' HD2' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -87.31 146.75 25.8 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.838 -0.619 . . . . 75.420000000000002 111.604 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 71.9 t -68.84 131.97 33.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.799 0.333 . . . . 74.439999999999998 110.585 172.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.435 HD21 ' HG2' ' A' ' 139' ' ' GLU . 17.9 mt -66.98 147.29 53.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.858 0.361 . . . . 75.519999999999996 111.307 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.7 t -90.44 151.28 21.47 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.248 -0.649 . . . . 65.5 109.248 169.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.484 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 73.8 t -48.91 -47.34 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.002 0.43 . . . . 73.5 111.54 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -72.69 -40.41 66.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.296 -0.411 . . . . 74.340000000000003 111.979 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.435 ' HG2' HD21 ' A' ' 135' ' ' LEU . 49.1 tt0 -60.36 -33.71 72.83 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.849 0.833 . . . . 73.019999999999996 110.249 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.563 HD23 ' SD ' ' A' ' 106' ' ' MET . 2.5 tt -65.62 -39.35 91.4 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.914 -1.039 . . . . 71.319999999999993 110.379 174.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 57.1 mt . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 121.091 0.472 . . . . 74.129999999999995 110.386 175.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.71 ' HA ' ' HB3' ' A' ' 128' ' ' GLU . 10.0 ptp . . . . . 0 N--CA 1.466 0.337 0 CA-C-O 121.603 0.716 . . . . 74.549999999999997 112.477 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.61 HD12 ' HB3' ' A' ' 61' ' ' ASP . 10.0 mt -103.11 131.68 49.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.289 -0.869 . . . . 74.310000000000002 110.838 175.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -78.01 106.8 10.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.052 0.929 . . . . 74.129999999999995 111.176 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 32.9 m -132.58 166.85 28.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.392 -1.276 . . . . 75.129999999999995 111.947 -170.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 31.1 tt0 -103.4 123.05 46.12 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.115 0.483 . . . . 75.109999999999999 110.891 171.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.525 HG23 HD11 ' A' ' 96' ' ' ILE . 36.7 t -93.74 114.08 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 115.917 -0.583 . . . . 65.25 111.725 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.592 HD11 ' HE2' ' A' ' 95' ' ' MET . 3.1 mt -98.99 161.5 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 112.244 0.461 . . . . 74.530000000000001 112.244 -176.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.621 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 75.0 m -127.76 105.65 8.6 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.242 -0.436 . . . . 74.409999999999997 110.907 174.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.405 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . . . . . . 0 CA--C 1.526 0.726 0 C-N-CA 121.174 -0.536 . . . . 73.25 113.593 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 N--CA 1.472 0.67 0 CA-C-O 120.826 0.346 . . . . 74.209999999999994 111.366 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.599 ' HE2' ' HD3' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -76.05 -23.02 55.07 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.989 0.423 . . . . 73.019999999999996 111.405 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -75.2 -69.34 0.48 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.325 0.583 . . . . 74.109999999999999 111.116 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -63.51 -8.19 8.84 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.943 0.72 . . . . 72.319999999999993 112.943 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.03 -34.28 13.77 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.632 0.975 . . . . 72.540000000000006 113.632 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 48' ' ' TYR . 28.8 m -131.92 7.58 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 N-CA-C 114.014 1.116 . . . . 75.319999999999993 114.014 -173.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.579 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -90.71 20.58 4.59 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.105 0.78 . . . . 71.519999999999996 113.105 -174.703 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.441 ' CD2' ' HD3' ' A' ' 87' ' ' LYS . 26.3 p90 -140.1 152.75 46.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.166 0.507 . . . . 71.239999999999995 111.829 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -119.44 135.63 54.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.703 -0.681 . . . . 74.239999999999995 110.1 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.504 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 36.0 mt-10 -97.47 115.11 27.17 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.89 0.376 . . . . 73.329999999999998 111.085 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 58' ' ' ASN . 4.2 mp -109.13 156.73 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.169 0.509 . . . . 74.030000000000001 110.734 -177.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.644 ' ND2' HG22 ' A' ' 91' ' ' VAL . 3.1 m120 -63.57 151.78 40.54 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.893 -0.594 . . . . 73.430000000000007 111.308 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 30.1 tt0 -67.16 -41.3 86.25 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 111.847 0.314 . . . . 75.530000000000001 111.847 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -63.9 -49.54 72.26 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.84 0.352 . . . . 75.420000000000002 111.178 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.61 ' HB3' HD12 ' A' ' 24' ' ' LEU . 58.8 m-20 -65.96 -31.02 71.69 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.05 0.452 . . . . 72.349999999999994 111.349 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.413 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 62.7 t-105 -54.45 -54.58 38.93 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.308 0.575 . . . . 74.140000000000001 111.22 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -70.66 -29.8 66.24 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.993 -0.549 . . . . 63.240000000000002 111.14 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.76 -39.36 84.58 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.917 0.389 . . . . 73.109999999999999 111.453 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 128' ' ' GLU . 94.0 mt -88.54 -13.25 40.59 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.447 -0.342 . . . . 73.239999999999995 111.748 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.24 42.61 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.98 -0.628 . . . . 55.130000000000003 112.439 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.706 HD21 ' HE3' ' A' ' 129' ' ' LYS . 90.5 mt -85.36 158.79 20.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.611 0.72 . . . . 73.409999999999997 112.026 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -135.09 130.0 34.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.26 -0.882 . . . . 75.010000000000005 109.062 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.81 90.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.712 0.768 . . . . 64.439999999999998 111.917 -172.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.68 -7.33 2.47 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 114.765 -1.107 . . . . 74.109999999999999 114.38 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -90.71 -175.6 4.45 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 118.527 1.163 . . . . 73.439999999999998 112.735 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.457 ' HG3' HG21 ' A' ' 134' ' ' VAL . 8.5 mpt_? -106.05 133.87 50.08 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.261 0.553 . . . . 74.510000000000005 112.426 -172.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.511 HG13 ' HB3' ' A' ' 86' ' ' ALA . 28.1 m -126.25 144.39 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.021 -0.536 . . . . 74.25 111.392 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.594 ' HD3' ' HE2' ' A' ' 76' ' ' LYS . 23.1 ttmm -105.32 151.06 24.62 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.111 0.481 . . . . 74.019999999999996 110.934 177.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.45 137.24 56.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.907 -0.588 . . . . 74.340000000000003 109.491 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.594 ' HE2' ' HD3' ' A' ' 74' ' ' LYS . 23.4 mttm -137.83 132.33 32.44 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.757 0.651 . . . . 64.310000000000002 112.757 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.503 HG23 ' HA3' ' A' ' 125' ' ' GLY . 32.8 p -136.09 -171.75 2.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.62 -0.718 . . . . 72.150000000000006 110.19 176.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.29 -8.92 57.93 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.796 0.331 . . . . 75.439999999999998 111.501 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -91.3 -38.5 12.61 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.777 0.322 . . . . 71.329999999999998 111.493 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.26 -148.27 11.96 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.127 -0.559 . . . . 24.23 112.994 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -154.5 156.74 37.24 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.254 0.465 . . . . 74.420000000000002 112.254 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.424 HG23 ' SD ' ' A' ' 106' ' ' MET . 12.2 p -153.49 150.34 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 116.213 -0.448 . . . . 71.340000000000003 111.288 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.2 t -110.58 118.02 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 110.399 -0.223 . . . . 74.5 110.399 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.475 HG11 ' CD2' ' A' ' 103' ' ' TYR . 33.6 m -124.78 177.24 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 120.808 0.337 . . . . 72.519999999999996 111.78 -177.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -79.73 144.88 33.25 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.853 0.359 . . . . 75.340000000000003 111.351 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.511 ' HB3' HG13 ' A' ' 73' ' ' VAL . . . -90.27 123.5 34.11 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.482 0.549 . . . . 75.349999999999994 112.482 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.441 ' HD3' ' CD2' ' A' ' 54' ' ' TYR . 43.3 mtpt -133.21 156.75 46.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.021 -0.536 . . . . 61.030000000000001 110.734 173.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -98.15 128.71 44.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.218 -0.446 . . . . 73.340000000000003 111.291 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.504 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -128.35 154.52 20.0 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.976 -0.63 . . . . 62.32 113.47 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.32 46.75 0.75 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.158 0.504 . . . . 44.340000000000003 111.54 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.644 HG22 ' ND2' ' A' ' 58' ' ' ASN . 28.5 m -95.58 159.79 31.83 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 116.09 -0.505 . . . . 74.209999999999994 111.564 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 95' ' ' MET . 38.6 Cg_exo -62.1 134.24 48.25 Favored 'Trans proline' 0 N--CA 1.487 1.104 0 C-N-CA 122.887 2.391 . . . . 74.120000000000005 113.059 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -53.79 134.5 42.32 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 120.775 0.322 . . . . 75.230000000000004 111.821 -175.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 76.49 27.88 60.61 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 120.722 -0.752 . . . . 73.25 112.745 -172.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.592 ' HE2' HD11 ' A' ' 29' ' ' ILE . 22.3 ttt -153.39 135.07 14.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.448 -0.575 . . . . 65.420000000000002 109.448 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.525 HD11 HG23 ' A' ' 28' ' ' VAL . 39.5 pt -128.03 144.27 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.47 0.652 . . . . 75.230000000000004 112.093 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.405 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 77.2 t80 -105.3 119.55 39.35 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.909 -0.587 . . . . 71.420000000000002 111.564 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 30' ' ' SER . 48.2 mt -117.34 128.96 25.67 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 109.916 -0.401 . . . . 73.099999999999994 109.916 172.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.431 ' HB2' HG13 ' A' ' 52' ' ' VAL . 47.8 Cg_exo -57.84 141.8 96.01 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.033 1.822 . . . . 73.409999999999997 112.576 176.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.546 ' HA ' ' HE2' ' A' ' 100' ' ' MET . 4.6 tpt -55.29 102.38 0.07 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.91 0.386 . . . . 75.519999999999996 111.501 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -158.97 179.65 34.46 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.59 -0.814 . . . . 74.540000000000006 113.52 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.599 ' HD3' ' HE2' ' A' ' 48' ' ' TYR . 36.5 Cg_endo -63.54 -26.44 69.8 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.529 2.152 . . . . 73.0 112.213 -176.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.475 ' CD2' HG11 ' A' ' 84' ' ' VAL . 26.9 m-85 -61.49 -48.99 78.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.784 0.802 . . . . 74.140000000000001 109.309 173.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.28 75.25 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.221 -0.899 . . . . 73.150000000000006 111.391 173.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 102' ' ' PRO . 8.7 m120 -62.92 -12.69 26.92 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 122.045 -0.409 . . . . 65.329999999999998 111.844 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.497 ' SD ' HD23 ' A' ' 140' ' ' LEU . 40.6 mtp -89.41 -15.02 34.18 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.576 -0.283 . . . . 75.019999999999996 111.464 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.8 -14.75 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 113.028 0.751 . . . . 73.310000000000002 113.028 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.494 HG23 ' OG ' ' A' ' 30' ' ' SER . 7.5 pt -104.25 178.16 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 O-C-N 121.854 -0.529 . . . . 75.519999999999996 111.861 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 CA--C 1.542 0.67 0 CA-C-N 116.084 -0.507 . . . . 74.120000000000005 110.52 175.154 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . . . . . . 0 CA--C 1.526 0.752 0 CA-C-O 121.009 0.227 . . . . 73.230000000000004 112.982 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.4 t -89.04 123.69 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.816 0.341 . . . . 74.319999999999993 111.636 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 67.5 mttm -66.28 149.54 50.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.573 0.582 . . . . 75.420000000000002 112.573 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.503 ' HA3' HG23 ' A' ' 77' ' ' THR . . . -178.65 -155.86 15.59 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 115.926 -0.579 . . . . 64.439999999999998 112.963 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.412 HG23 ' SD ' ' A' ' 23' ' ' MET . 67.7 p -131.87 159.72 37.76 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 122.244 -0.562 . . . . 64.120000000000005 111.863 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.75 144.44 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 116.31 -0.405 . . . . 73.120000000000005 111.681 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.71 ' HB3' ' HA ' ' A' ' 23' ' ' MET . 13.8 pt-20 -164.84 168.61 17.56 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.314 -0.403 . . . . 75.450000000000003 111.015 173.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.706 ' HE3' HD21 ' A' ' 67' ' ' LEU . 34.7 ttmt -68.75 148.54 50.21 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.222 0.534 . . . . 72.109999999999999 112.182 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 t -146.19 155.95 43.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.088 -0.505 . . . . 74.340000000000003 111.126 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.31 -2.61 58.51 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.139 0.495 . . . . 72.129999999999995 110.99 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.89 173.32 3.67 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.667 0.617 . . . . 54.420000000000002 112.667 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -88.86 148.55 23.81 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.845 -0.616 . . . . 64.319999999999993 111.867 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.457 HG21 ' HG3' ' A' ' 72' ' ' ARG . 73.4 t -69.76 124.32 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.049 -0.523 . . . . 74.219999999999999 109.854 170.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 135' ' ' LEU . 10.3 mt -70.57 89.66 0.72 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.967 -0.293 . . . . 75.140000000000001 111.502 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 37.5 m -47.8 148.62 1.52 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.078 -0.51 . . . . 71.120000000000005 110.816 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.49 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 72.0 t -44.8 -45.15 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 112.465 0.543 . . . . 72.340000000000003 112.465 -173.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -72.15 -47.85 47.93 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.79 0.329 . . . . 73.439999999999998 111.712 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -55.91 -38.23 69.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.233 0.539 . . . . 74.5 110.501 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.497 HD23 ' SD ' ' A' ' 106' ' ' MET . 2.7 tt -61.18 -42.3 98.33 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.465 -0.788 . . . . 72.319999999999993 111.09 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 31.1 mt . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 121.549 0.69 . . . . 73.150000000000006 110.387 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.0 ptm . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 120.682 0.277 . . . . 72.200000000000003 110.444 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.436 HD11 ' HB3' ' A' ' 64' ' ' ALA . 40.1 mt -106.6 124.52 49.73 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.184 0.809 . . . . 75.549999999999997 113.184 -173.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -72.06 102.55 3.01 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.601 -1.182 . . . . 75.200000000000003 110.444 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.39 166.16 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.005 0.431 . . . . 75.209999999999994 111.898 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.618 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 37.1 tt0 -99.84 115.99 30.88 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.807 0.337 . . . . 72.329999999999998 110.436 172.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.566 HG22 HD11 ' A' ' 96' ' ' ILE . 21.2 t -90.46 110.96 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.077 -0.511 . . . . 74.319999999999993 111.724 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.62 HD11 ' HE1' ' A' ' 95' ' ' MET . 1.3 mt -100.09 153.22 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 120.838 0.351 . . . . 75.299999999999997 111.651 -177.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.1 t -120.07 103.63 9.45 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.903 0.383 . . . . 73.239999999999995 110.581 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.566 0 C-N-CA 121.076 -0.583 . . . . 74.25 113.171 -177.482 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 120.951 0.405 . . . . 74.209999999999994 111.237 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.46 ' O ' HG21 ' A' ' 52' ' ' VAL . 2.6 t80 -76.34 -38.17 56.28 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.461 0.648 . . . . 70.519999999999996 110.026 174.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -58.02 -62.94 1.45 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.425 -0.807 . . . . 72.109999999999999 110.435 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -70.68 0.89 6.07 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.54 0.57 . . . . 64.430000000000007 112.54 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.43 -34.64 11.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.59 0.589 . . . . 72.430000000000007 112.59 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.488 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 32.9 m -125.06 2.29 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 113.832 1.049 . . . . 73.420000000000002 113.832 -174.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.451 HD21 ' N ' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -89.76 34.22 0.84 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.005 0.743 . . . . 61.100000000000001 113.005 -176.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -150.24 159.31 44.53 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.626 -0.671 . . . . 73.319999999999993 112.448 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.27 132.4 45.91 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.949 -0.569 . . . . 72.019999999999996 110.9 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.745 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 35.2 mt-10 -87.86 114.96 24.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.208 0.528 . . . . 65.120000000000005 111.016 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.7 mt -111.49 148.46 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.582 -0.735 . . . . 72.209999999999994 111.478 -174.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -70.24 140.8 52.48 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 122.391 -0.193 . . . . 74.319999999999993 110.7 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 37.3 tt0 -54.71 -37.75 66.22 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.084 0.772 . . . . 74.329999999999998 113.084 -177.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.485 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 6.6 mm-40 -56.67 -53.59 55.96 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.152 -0.342 . . . . 74.299999999999997 111.485 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -63.31 -38.11 89.89 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.368 0.604 . . . . 73.219999999999999 110.447 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.417 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 52.5 t-105 -53.65 -45.63 70.3 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.36 -0.836 . . . . 75.549999999999997 111.513 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -69.87 -41.96 74.13 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.232 -0.44 . . . . 75.329999999999998 110.917 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.436 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -61.37 -37.3 82.89 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.546 0.573 . . . . 71.25 112.546 -178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.98 -6.16 58.85 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.319 -0.4 . . . . 72.299999999999997 111.799 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.09 50.62 64.42 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.505 -0.379 . . . . 63.109999999999999 112.848 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.474 ' HA ' ' HZ2' ' A' ' 129' ' ' LYS . 97.8 mt -90.88 160.3 15.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.473 0.654 . . . . 75.140000000000001 112.709 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.5 mp0 -125.32 143.24 51.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.015 -0.993 . . . . 74.299999999999997 110.419 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.16 94.88 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.599 0.714 . . . . 73.230000000000004 111.118 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.62 -6.69 7.47 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.133 -0.939 . . . . 35.210000000000001 114.182 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.44 -177.48 5.79 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.301 1.05 . . . . 71.329999999999998 111.678 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.407 ' HG3' HG21 ' A' ' 134' ' ' VAL . 2.8 mpt_? -105.8 123.48 48.03 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.329 0.492 . . . . 74.299999999999997 112.329 -174.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.586 HG13 ' HB3' ' A' ' 86' ' ' ALA . 26.6 m -114.21 148.71 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.044 -0.525 . . . . 75.400000000000006 110.871 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.447 ' HB2' HG23 ' A' ' 130' ' ' THR . 68.5 tttt -120.62 130.34 54.11 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.025 0.441 . . . . 75.5 111.261 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.9 134.84 49.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.27 -0.423 . . . . 74.109999999999999 111.356 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -125.91 140.53 52.56 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.925 0.393 . . . . 74.430000000000007 111.555 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.6 p -138.41 -172.22 3.23 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.952 0.501 . . . . 73.25 110.122 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.6 2.28 17.03 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.961 0.41 . . . . 63.109999999999999 111.29 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -101.18 -35.31 9.34 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.575 0.35 . . . . 73.329999999999998 111.455 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 163.45 -155.8 27.31 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.175 -0.536 . . . . 71.010000000000005 113.35 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.99 160.26 40.46 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.101 0.408 . . . . 64.439999999999998 112.101 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.5 p -160.57 150.61 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-N 116.041 -0.527 . . . . 74.129999999999995 111.296 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.417 HG21 ' HG3' ' A' ' 74' ' ' LYS . 33.1 t -109.9 123.49 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.22 0.208 . . . . 64.219999999999999 111.304 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.452 ' HA ' HG11 ' A' ' 134' ' ' VAL . 27.5 m -133.38 172.21 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.652 0.381 . . . . 74.200000000000003 111.627 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -75.91 143.73 41.5 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.145 0.498 . . . . 75.310000000000002 111.792 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.586 ' HB3' HG13 ' A' ' 73' ' ' VAL . . . -84.59 128.36 34.56 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.057 -0.52 . . . . 65.310000000000002 112.388 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -129.94 158.3 39.92 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.655 0.74 . . . . 75.120000000000005 111.887 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -101.44 102.49 13.29 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.256 -0.884 . . . . 73.219999999999999 109.617 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.745 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -99.64 -167.28 29.7 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.982 -0.627 . . . . 74.319999999999993 114.581 -170.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.53 9.37 42.61 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 122.846 0.459 . . . . 73.540000000000006 111.545 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.6 m -79.56 158.58 73.41 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 116.311 -0.404 . . . . 73.140000000000001 111.793 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.65 169.6 21.96 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.573 2.182 . . . . 73.439999999999998 112.653 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.485 ' HE2' ' HB3' ' A' ' 60' ' ' GLU . 49.2 tttm -65.91 148.75 51.3 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 120.732 0.301 . . . . 75.209999999999994 111.589 -177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.12 30.46 76.93 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.261 -0.495 . . . . 61.340000000000003 112.816 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.62 ' HE1' HD11 ' A' ' 29' ' ' ILE . 13.2 ttt -153.63 136.97 15.75 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 122.62 -0.341 . . . . 70.129999999999995 110.319 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.566 HD11 HG22 ' A' ' 28' ' ' VAL . 40.3 pt -134.55 138.93 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.472 0.653 . . . . 75.310000000000002 112.021 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -101.44 123.37 45.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.722 -0.672 . . . . 75.109999999999999 111.176 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 30' ' ' SER . 40.2 mt -121.04 127.62 26.12 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 122.277 -0.265 . . . . 75.430000000000007 110.877 175.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.488 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 14.0 Cg_endo -57.37 142.42 95.0 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.476 2.117 . . . . 75.400000000000006 112.708 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.14 103.34 0.27 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.267 -0.424 . . . . 75.200000000000003 111.074 -176.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.69 -178.53 31.82 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.883 -0.675 . . . . 74.549999999999997 112.528 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.561 ' O ' ' HG2' ' A' ' 106' ' ' MET . 23.9 Cg_endo -60.71 -31.35 91.88 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.435 2.09 . . . . 65.120000000000005 111.695 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.441 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 4.8 m-85 -62.58 -53.4 55.15 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.612 -0.722 . . . . 74.140000000000001 110.314 175.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.31 -43.59 88.21 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.051 -0.522 . . . . 50.530000000000001 110.756 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -54.21 -26.39 28.18 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.014 0.526 . . . . 73.319999999999993 112.2 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.561 ' HG2' ' O ' ' A' ' 102' ' ' PRO . 84.6 mmm -66.58 -21.41 66.14 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.191 0.441 . . . . 74.209999999999994 112.191 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.7 m -132.08 -27.48 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 112.87 0.692 . . . . 74.530000000000001 112.87 -172.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.426 HG22 ' HB2' ' A' ' 30' ' ' SER . 1.5 pp -87.02 170.09 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-O 121.033 0.444 . . . . 74.230000000000004 111.308 -176.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 12.6 t0 . . . . . 0 CA--C 1.544 0.738 0 CA-C-N 116.382 -0.372 . . . . 70.420000000000002 111.131 179.555 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.667 0 N-CA-C 112.676 -0.17 . . . . 64.25 112.676 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.0 t -80.8 126.14 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.019 0.377 . . . . 60.439999999999998 112.019 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -62.32 145.78 52.89 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.152 0.427 . . . . 75.109999999999999 112.152 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -174.12 -163.42 27.49 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.393 -0.432 . . . . 63.119999999999997 112.884 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 54.5 p -126.24 142.69 51.43 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.628 -0.336 . . . . 73.010000000000005 111.3 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.0 p -132.01 143.25 40.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 120.9 0.381 . . . . 74.439999999999998 110.76 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.45 169.68 19.99 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.354 -0.385 . . . . 73.030000000000001 110.974 176.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.474 ' HZ2' ' HA ' ' A' ' 67' ' ' LEU . 24.8 ttmm -69.84 141.26 53.29 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.103 -0.373 . . . . 74.540000000000006 110.87 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.447 HG23 ' HB2' ' A' ' 74' ' ' LYS . 10.1 t -132.4 161.4 33.73 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.348 0.594 . . . . 74.430000000000007 112.187 -177.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.03 -18.02 41.24 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.642 -0.708 . . . . 73.219999999999999 111.11 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -69.68 152.51 44.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.581 0.705 . . . . 75.299999999999997 112.513 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.634 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -79.49 160.33 26.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.232 -0.894 . . . . 74.439999999999998 110.696 173.394 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.452 HG11 ' HA ' ' A' ' 84' ' ' VAL . 98.5 t -65.96 126.53 25.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 O-C-N 122.346 -0.222 . . . . 74.099999999999994 110.533 174.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.436 HD12 ' HG ' ' A' ' 140' ' ' LEU . 7.2 mt -56.06 131.83 48.53 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.07 0.462 . . . . 71.129999999999995 112.077 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.9 m -71.94 140.68 49.3 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.697 -0.482 . . . . 71.519999999999996 109.697 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.425 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 89.3 t -46.48 -49.45 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 112.54 0.57 . . . . 71.310000000000002 112.54 -175.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -71.78 -42.53 67.04 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.944 0.402 . . . . 75.349999999999994 111.327 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -55.98 -34.64 65.94 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.682 0.753 . . . . 72.0 110.581 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.436 ' HG ' HD12 ' A' ' 135' ' ' LEU . 2.6 tt -65.89 -42.5 90.19 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.249 -0.887 . . . . 75.430000000000007 110.827 174.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 29.3 mt . . . . . 0 N--CA 1.472 0.67 0 CA-C-O 121.373 0.606 . . . . 73.140000000000001 110.622 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.7 ptm . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 120.927 0.394 . . . . 74.340000000000003 111.425 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.6 mt -115.52 146.2 41.92 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.914 0.387 . . . . 73.010000000000005 111.86 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -92.4 125.21 36.95 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.389 0.614 . . . . 72.310000000000002 111.233 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 27.5 m -142.14 160.64 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.22 -0.9 . . . . 72.420000000000002 111.882 -173.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 34.6 tt0 -98.49 116.9 31.72 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.045 -0.409 . . . . 75.129999999999995 110.53 173.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.603 HG23 HD13 ' A' ' 96' ' ' ILE . 47.1 t -88.25 106.44 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.91 -0.586 . . . . 74.209999999999994 111.627 -176.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.792 HD11 ' HE1' ' A' ' 95' ' ' MET . 15.0 mt -91.91 158.1 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.837 0.351 . . . . 73.049999999999997 111.888 -177.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 62.2 m -140.29 94.47 2.75 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.085 0.469 . . . . 73.319999999999993 111.861 177.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.664 0 CA-C-N 115.98 -0.555 . . . . 64.319999999999993 112.072 178.507 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 CA--C 1.534 0.333 0 CA-C-O 120.708 0.289 . . . . 72.450000000000003 110.973 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.562 ' O ' HG23 ' A' ' 52' ' ' VAL . 1.7 t80 -62.55 -39.08 92.49 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.151 0.5 . . . . 73.109999999999999 110.099 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -63.5 -68.1 0.37 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.826 -0.624 . . . . 71.319999999999993 110.314 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -55.09 -24.2 24.29 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.865 0.691 . . . . 74.219999999999999 112.865 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.54 -38.08 18.92 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.307 0.854 . . . . 74.319999999999993 113.307 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 48' ' ' TYR . 13.7 m -108.35 7.99 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 112.873 0.694 . . . . 75.340000000000003 112.873 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.467 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -98.53 18.98 15.38 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.44 0.904 . . . . 71.329999999999998 113.44 -175.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -135.65 159.39 41.79 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.98 0.733 . . . . 74.319999999999993 112.98 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.42 137.64 49.93 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.229 -0.896 . . . . 73.219999999999999 110.098 173.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.582 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 48.5 mt-10 -97.44 116.86 30.45 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.898 0.38 . . . . 73.310000000000002 111.626 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.491 ' HA ' HG21 ' A' ' 96' ' ' ILE . 4.1 mp -110.0 154.58 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 116.226 -0.443 . . . . 75.310000000000002 111.212 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -68.52 148.78 50.08 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.736 0.414 . . . . 75.439999999999998 111.442 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 9.2 tp10 -52.46 -47.59 66.36 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.311 0.485 . . . . 73.200000000000003 112.311 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.525 ' HA ' HD22 ' A' ' 63' ' ' ASN . 7.7 mm-40 -62.6 -42.1 99.37 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.337 0.495 . . . . 75.5 112.337 -176.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -71.18 -30.51 66.5 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.409 0.623 . . . . 73.239999999999995 110.555 174.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.464 ' HZ2' ' N ' ' A' ' 69' ' ' GLU . 58.6 t-105 -59.14 -52.71 64.55 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.514 -0.766 . . . . 71.239999999999995 111.739 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.525 HD22 ' HA ' ' A' ' 60' ' ' GLU . 5.8 p30 -71.74 -30.34 65.5 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.612 0.227 . . . . 74.329999999999998 111.612 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.54 -43.98 89.43 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.088 0.47 . . . . 73.200000000000003 111.827 177.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 98.0 mt -89.25 -4.92 58.0 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.275 -0.42 . . . . 73.219999999999999 112.033 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.72 50.49 66.96 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.218 -0.515 . . . . 75.409999999999997 112.967 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.467 HD22 ' HE2' ' A' ' 129' ' ' LYS . 86.9 mt -89.27 163.89 15.18 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.041 0.448 . . . . 70.319999999999993 112.162 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -150.52 118.77 6.37 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.192 -0.458 . . . . 65.519999999999996 110.208 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.464 ' N ' ' HZ2' ' A' ' 62' ' ' TRP . 2.2 mp0 -40.2 105.74 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.33 0.863 . . . . 74.129999999999995 113.33 -168.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.66 -10.88 10.38 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 115.289 -0.869 . . . . 74.340000000000003 113.672 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -80.64 176.45 9.79 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 117.889 0.844 . . . . 73.140000000000001 111.31 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -98.25 128.7 44.84 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.115 0.483 . . . . 74.340000000000003 112.045 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.3 m -119.43 135.53 59.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 121.284 0.564 . . . . 73.230000000000004 111.723 174.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.526 ' HB3' ' HG3' ' A' ' 128' ' ' GLU . 5.4 tppp? -88.88 125.31 34.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.839 -0.619 . . . . 73.549999999999997 110.867 175.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 61.7 t -109.54 125.34 66.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.674 -0.491 . . . . 74.329999999999998 109.674 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -132.41 132.89 43.27 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.141 0.496 . . . . 73.439999999999998 112.143 -173.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.603 HG21 ' HA3' ' A' ' 125' ' ' GLY . 37.1 p -136.07 -170.58 2.67 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.922 -0.581 . . . . 60.32 110.943 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.05 -6.39 52.55 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.029 -0.532 . . . . 72.519999999999996 111.709 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 109' ' ' ASP . 98.9 m-85 -99.82 -45.14 5.83 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.769 0.319 . . . . 74.450000000000003 111.582 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.2 -152.4 10.22 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.781 -0.723 . . . . 73.310000000000002 113.336 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 15.4 pt-20 -152.08 152.1 31.93 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.057 0.456 . . . . 61.229999999999997 111.641 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.489 ' HB ' ' HB2' ' A' ' 106' ' ' MET . 8.8 p -152.36 153.88 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.389 -0.369 . . . . 73.010000000000005 111.48 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 t -108.8 120.48 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 122.22 0.208 . . . . 64.019999999999996 110.882 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.421 HG13 ' CD2' ' A' ' 103' ' ' TYR . 32.8 m -130.29 172.5 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 111.992 0.367 . . . . 72.540000000000006 111.992 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -76.36 136.9 39.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.278 -0.419 . . . . 75.219999999999999 111.025 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.19 127.81 35.15 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.394 0.516 . . . . 65.140000000000001 112.394 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 86.9 mttt -127.74 146.91 50.42 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.262 0.553 . . . . 65.25 110.673 172.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -84.68 126.96 33.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.875 -0.602 . . . . 75.219999999999999 110.122 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -118.86 -175.81 16.34 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.735 -0.745 . . . . 75.530000000000001 114.478 -173.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -92.74 9.35 35.41 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.617 0.722 . . . . 70.450000000000003 110.221 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.9 m -75.14 151.51 85.98 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 115.456 -0.793 . . . . 72.450000000000003 112.44 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.27 166.12 28.07 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.019 2.479 . . . . 65.319999999999993 112.943 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -66.14 147.04 53.93 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.769 0.319 . . . . 73.450000000000003 111.287 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 64.74 27.05 71.5 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.767 -0.73 . . . . 65.239999999999995 113.071 -174.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.792 ' HE1' HD11 ' A' ' 29' ' ' ILE . 21.6 ttt -152.11 136.39 16.69 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 122.218 -0.578 . . . . 74.310000000000002 110.406 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.603 HD13 HG23 ' A' ' 28' ' ' VAL . 39.9 pt -136.53 141.58 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 121.193 0.521 . . . . 75.129999999999995 111.975 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -101.46 132.11 47.24 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.858 0.361 . . . . 74.400000000000006 111.532 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' A' ' 30' ' ' SER . 39.1 mt -127.89 136.66 29.33 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.245 -0.434 . . . . 73.299999999999997 110.427 173.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.512 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 31.1 Cg_endo -65.28 131.8 29.51 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.076 1.851 . . . . 73.430000000000007 112.254 172.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.472 ' HE3' HD12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -54.73 104.0 0.1 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.875 0.369 . . . . 74.329999999999998 110.912 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.0 -175.52 28.01 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.925 -0.655 . . . . 54.409999999999997 112.918 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.435 ' O ' ' HG2' ' A' ' 106' ' ' MET . 19.5 Cg_endo -57.04 -34.91 98.58 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.99 2.46 . . . . 74.030000000000001 112.357 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.421 ' CD2' HG13 ' A' ' 84' ' ' VAL . 28.8 m-85 -64.77 -53.64 43.82 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.216 -0.447 . . . . 72.519999999999996 110.832 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.435 ' O ' HG21 ' A' ' 108' ' ' ILE . . . -58.29 -38.47 77.09 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.315 0.578 . . . . 62.509999999999998 111.104 175.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -55.17 -22.29 16.76 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.881 -0.599 . . . . 71.109999999999999 112.408 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.606 ' SD ' HD21 ' A' ' 140' ' ' LEU . 90.2 mmm -78.75 -15.19 58.74 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.222 0.453 . . . . 73.430000000000007 112.222 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.1 m -129.23 -18.36 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 113.179 0.807 . . . . 74.450000000000003 113.179 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.605 HG23 ' OG ' ' A' ' 30' ' ' SER . 12.9 pt -96.75 176.36 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 121.811 -0.556 . . . . 75.5 112.377 -177.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.586 ' H ' HG21 ' A' ' 123' ' ' VAL . 18.7 t0 . . . . . 0 CA--C 1.543 0.687 0 CA-C-N 115.895 -0.593 . . . . 72.510000000000005 110.736 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.711 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . . . . . . 0 CA--C 1.53 0.97 0 N-CA-C 114.36 0.504 . . . . 64.409999999999997 114.36 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.586 HG21 ' H ' ' A' ' 109' ' ' ASP . 86.6 t -92.7 123.61 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 122.747 0.419 . . . . 65.209999999999994 111.431 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 95.9 mttt -72.78 150.54 42.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.111 0.482 . . . . 74.540000000000006 112.192 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.603 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -177.2 -140.89 3.81 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 116.015 -0.539 . . . . 63.039999999999999 113.024 -178.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 67.3 p -142.81 163.55 32.51 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.35 -0.5 . . . . 75.129999999999995 111.879 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.0 p -142.4 145.32 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 116.136 -0.484 . . . . 75.340000000000003 110.884 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.526 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 8.7 pt-20 -152.09 152.3 32.19 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.286 0.476 . . . . 72.239999999999995 112.286 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.467 ' HE2' HD22 ' A' ' 67' ' ' LEU . 9.5 tppt? -62.7 137.31 58.23 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.426 -0.352 . . . . 73.329999999999998 110.93 172.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.0 t -134.7 153.28 52.07 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.05 0.452 . . . . 72.219999999999999 111.957 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.27 6.66 46.17 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.507 0.67 . . . . 65.409999999999997 110.621 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -80.6 -175.96 5.51 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.447 0.641 . . . . 74.140000000000001 112.056 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -101.56 154.0 19.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.615 -0.721 . . . . 74.219999999999999 111.001 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.39 122.26 14.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 110.338 -0.245 . . . . 74.439999999999998 110.338 173.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 135' ' ' LEU . 3.3 mt -62.45 90.96 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.636 0.236 . . . . 74.030000000000001 111.636 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.1 m -46.05 147.66 0.99 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.164 -0.471 . . . . 75.129999999999995 111.669 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.537 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 85.8 t -45.74 -53.6 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 113.118 0.784 . . . . 61.350000000000001 113.118 -173.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.851 ' HD3' HD11 ' A' ' 141' ' ' LEU . 16.1 tppt? -72.49 -39.07 67.94 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.08 -0.387 . . . . 74.150000000000006 111.598 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -55.77 -38.17 69.51 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.666 0.746 . . . . 75.400000000000006 110.205 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.606 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.2 tt -63.76 -40.16 96.03 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.098 -0.955 . . . . 75.420000000000002 110.547 174.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.851 HD11 ' HD3' ' A' ' 138' ' ' LYS . 43.1 mt . . . . . 0 N--CA 1.47 0.568 0 CA-C-O 121.31 0.576 . . . . 75.450000000000003 110.285 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.1 ptm . . . . . 0 CA--C 1.539 0.522 0 CA-C-O 121.132 0.491 . . . . 71.140000000000001 111.704 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.5 mt -116.34 131.42 56.95 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.188 -0.46 . . . . 73.040000000000006 112.109 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.689 ' HG3' HG23 ' A' ' 126' ' ' THR . 1.1 mp0 -73.03 136.58 45.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.505 0.669 . . . . 65.239999999999995 111.42 175.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 15.8 m -148.27 158.1 7.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.069 -0.969 . . . . 74.430000000000007 111.616 -172.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.609 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 32.7 tt0 -99.21 111.85 24.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.018 0.437 . . . . 75.430000000000007 110.183 172.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.496 HG23 HD11 ' A' ' 96' ' ' ILE . 39.6 t -88.48 107.86 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.812 -0.631 . . . . 74.219999999999999 111.497 -174.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.725 HD12 ' HE2' ' A' ' 95' ' ' MET . 3.9 mt -92.29 153.1 3.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.335 -0.393 . . . . 73.519999999999996 111.294 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 20.0 t -133.67 103.52 5.92 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.08 0.466 . . . . 64.340000000000003 111.151 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.837 0 C-N-CA 121.076 -0.583 . . . . 75.519999999999996 113.364 -177.819 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 CA--C 1.541 0.621 0 CA-C-O 121.106 0.479 . . . . 62.43 110.779 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.449 ' O ' HG21 ' A' ' 52' ' ' VAL . 9.5 t80 -66.05 -37.34 85.58 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.293 0.568 . . . . 74.409999999999997 110.231 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -58.61 -62.78 1.61 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.599 -0.728 . . . . 74.430000000000007 111.038 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -55.24 -23.98 25.42 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.771 0.656 . . . . 75.140000000000001 112.771 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.68 -40.32 23.01 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.032 0.752 . . . . 73.530000000000001 113.032 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 48' ' ' TYR . 33.8 m -108.73 13.9 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 113.289 0.848 . . . . 74.409999999999997 113.289 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -104.04 26.1 9.16 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.52 0.934 . . . . 74.319999999999993 113.52 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -145.11 159.81 42.39 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.665 -0.647 . . . . 75.439999999999998 112.355 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.78 146.33 50.62 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.532 -0.758 . . . . 64.219999999999999 111.043 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.673 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 30.9 mt-10 -96.6 116.9 29.88 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.633 0.254 . . . . 75.219999999999999 111.516 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.508 ' HA ' HG23 ' A' ' 96' ' ' ILE . 4.2 mp -110.44 146.97 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 120.782 0.325 . . . . 72.530000000000001 111.255 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -64.19 145.82 55.33 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.593 -0.276 . . . . 71.140000000000001 110.845 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 32.2 tt0 -58.71 -40.76 84.59 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.78 0.659 . . . . 74.239999999999995 112.78 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -60.9 -51.14 70.53 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.955 0.354 . . . . 75.209999999999994 111.955 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -65.55 -36.0 82.52 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.468 0.651 . . . . 74.0 110.457 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.68 ' HA ' HD11 ' A' ' 67' ' ' LEU . 37.0 t-105 -52.91 -53.83 43.66 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.276 -0.874 . . . . 71.219999999999999 111.311 175.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -70.5 -29.69 66.27 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.004 -0.543 . . . . 71.430000000000007 111.394 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.24 -35.22 80.1 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.887 0.375 . . . . 75.25 111.624 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.0 mt -89.86 1.33 56.32 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.38 -0.373 . . . . 62.200000000000003 111.702 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.94 40.48 95.4 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.42 -0.419 . . . . 72.019999999999996 112.728 -177.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.68 HD11 ' HA ' ' A' ' 62' ' ' TRP . 18.4 mt -76.11 141.81 41.86 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.093 0.775 . . . . 71.439999999999998 113.093 -175.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 30.3 tt0 -106.51 147.1 29.79 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.28 -0.873 . . . . 72.120000000000005 109.673 169.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -63.77 102.73 0.49 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.495 0.664 . . . . 72.510000000000005 111.382 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.25 5.02 23.47 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 115.268 -0.878 . . . . 54.409999999999997 112.633 -172.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 68' ' ' GLN . 1.4 t0 -71.69 172.86 8.97 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.81 0.444 . . . . 74.239999999999995 110.838 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.47 124.48 49.67 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.28 0.562 . . . . 74.030000000000001 111.687 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.479 HG13 ' HB1' ' A' ' 86' ' ' ALA . 15.8 m -113.3 132.53 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.139 0.495 . . . . 74.129999999999995 111.481 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -100.66 109.98 22.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.584 0.707 . . . . 75.109999999999999 110.311 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 59.3 t -92.66 127.2 44.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.34 -0.845 . . . . 74.510000000000005 109.824 -175.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.498 ' HG2' ' CB ' ' A' ' 81' ' ' GLU . 46.4 mtpt -133.34 124.77 27.81 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.387 0.613 . . . . 74.140000000000001 112.397 -169.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.611 HG21 ' HA3' ' A' ' 125' ' ' GLY . 29.2 p -132.42 -171.66 2.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.712 -0.676 . . . . 74.329999999999998 111.033 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -76.56 -1.11 25.8 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.272 -0.422 . . . . 73.120000000000005 111.562 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -102.46 -34.71 9.04 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 111.811 0.3 . . . . 74.25 111.811 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.37 -167.1 39.7 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 112.258 -0.337 . . . . 71.430000000000007 112.258 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.498 ' CB ' ' HG2' ' A' ' 76' ' ' LYS . 16.4 pt-20 -143.48 144.11 31.85 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.376 0.588 . . . . 53.049999999999997 112.524 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 p -143.66 150.41 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.934 -0.575 . . . . 72.120000000000005 111.566 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.12 120.34 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 O-C-N 122.301 -0.249 . . . . 73.239999999999995 111.388 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.69 173.17 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 120.858 0.361 . . . . 75.040000000000006 111.966 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -78.28 140.49 38.84 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.038 0.447 . . . . 73.040000000000006 111.354 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.479 ' HB1' HG13 ' A' ' 73' ' ' VAL . . . -93.74 126.3 38.84 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.649 0.611 . . . . 64.019999999999996 112.649 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -125.18 145.66 49.86 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.114 0.483 . . . . 72.439999999999998 110.66 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -82.9 112.37 19.63 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.791 -0.448 . . . . 74.230000000000004 109.791 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.673 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -123.63 169.12 15.77 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.581 -0.818 . . . . 71.219999999999999 114.434 -171.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.85 73.89 6.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.116 0.484 . . . . 72.409999999999997 111.413 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.5 m -132.46 147.95 67.67 Favored Pre-proline 0 CA--C 1.539 0.558 0 CA-C-N 116.018 -0.537 . . . . 74.310000000000002 111.229 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.75 157.29 38.42 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.628 2.219 . . . . 73.400000000000006 112.563 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -64.07 145.34 56.09 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 122.116 -0.365 . . . . 75.409999999999997 111.099 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 62.59 27.8 70.33 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.047 -0.596 . . . . 63.100000000000001 112.677 -174.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.725 ' HE2' HD12 ' A' ' 29' ' ' ILE . 18.8 ttt -148.75 136.43 20.56 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.741 -0.466 . . . . 74.109999999999999 109.741 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' A' ' 57' ' ' ILE . 36.7 pt -137.92 144.68 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 121.294 0.568 . . . . 75.120000000000005 112.194 -176.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -105.4 133.38 50.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.229 -0.442 . . . . 74.120000000000005 111.494 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 30' ' ' SER . 48.8 mt -128.87 134.03 25.86 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 116.342 -0.39 . . . . 74.400000000000006 110.675 174.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.87 136.44 61.71 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 121.975 1.784 . . . . 73.349999999999994 112.231 174.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.31 107.93 0.63 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.898 0.38 . . . . 75.340000000000003 110.895 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.95 -174.61 26.87 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.124 -0.56 . . . . 72.519999999999996 112.487 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.78 -25.77 74.83 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.983 1.789 . . . . 75.219999999999999 111.853 -177.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.524 ' HA ' HD13 ' A' ' 140' ' ' LEU . 3.8 m-85 -71.19 -54.29 11.49 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.677 -0.692 . . . . 73.230000000000004 110.729 178.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.02 -33.35 73.13 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.097 -0.501 . . . . 71.430000000000007 110.617 175.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -58.25 -22.37 52.11 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.936 -0.574 . . . . 71.040000000000006 111.665 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.482 ' SD ' HD22 ' A' ' 140' ' ' LEU . 33.7 mtp -78.37 -29.61 47.51 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.506 -0.315 . . . . 73.340000000000003 111.41 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.8 m -111.94 -18.99 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 112.395 0.517 . . . . 74.239999999999995 112.395 -171.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.511 HG22 ' HB2' ' A' ' 30' ' ' SER . 12.2 pt -94.76 178.84 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.11 0.481 . . . . 74.200000000000003 111.495 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.516 ' H ' HG21 ' A' ' 123' ' ' VAL . 21.3 t70 . . . . . 0 CA--C 1.54 0.583 0 CA-C-N 116.102 -0.499 . . . . 74.299999999999997 110.52 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.686 0 N-CA-C 112.442 -0.263 . . . . 72.109999999999999 112.442 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.516 HG21 ' H ' ' A' ' 109' ' ' ASP . 82.0 t -82.17 119.61 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.063 0.458 . . . . 63.299999999999997 111.661 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 95.8 mttt -73.12 154.01 40.54 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.512 0.56 . . . . 75.340000000000003 112.512 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.611 ' HA3' HG21 ' A' ' 77' ' ' THR . . . 177.81 -140.83 4.9 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.884 -0.598 . . . . 72.030000000000001 112.797 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.689 HG23 ' HG3' ' A' ' 25' ' ' GLU . 67.6 p -136.69 161.67 35.28 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.026 0.441 . . . . 74.540000000000006 111.164 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.79 143.84 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.247 0.546 . . . . 74.519999999999996 110.834 173.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -147.44 144.62 28.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.967 -0.561 . . . . 75.209999999999994 110.363 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.438 ' HD2' HD23 ' A' ' 67' ' ' LEU . 20.6 ttpp -81.87 143.23 31.85 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.19 -0.318 . . . . 73.329999999999998 110.262 176.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.0 t -132.16 156.8 45.77 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.597 0.962 . . . . 75.230000000000004 113.597 -168.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -83.29 -17.1 43.73 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.061 -0.972 . . . . 71.140000000000001 110.41 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -68.98 179.11 1.95 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.702 -0.681 . . . . 75.430000000000007 112.71 -175.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -98.83 159.84 14.68 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.672 -0.694 . . . . 73.540000000000006 111.702 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.8 t -73.97 136.12 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.466 -0.334 . . . . 74.230000000000004 110.908 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 11.9 mt -67.44 140.47 57.12 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.944 0.402 . . . . 72.030000000000001 111.531 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.6 m -86.24 148.84 25.46 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.616 -0.513 . . . . 72.310000000000002 109.616 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.462 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 86.1 t -46.8 -53.43 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 112.564 0.579 . . . . 75.450000000000003 112.564 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -72.25 -39.36 68.48 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 111.704 0.261 . . . . 74.530000000000001 111.704 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.79 -36.67 72.49 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.701 0.762 . . . . 72.129999999999995 110.09 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.524 HD13 ' HA ' ' A' ' 103' ' ' TYR . 4.4 tt -62.25 -43.84 97.9 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.968 -1.014 . . . . 74.040000000000006 110.728 172.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 66.6 mt . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 121.205 0.526 . . . . 75.030000000000001 110.608 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.2 ptp . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 121.249 0.547 . . . . 75.299999999999997 111.861 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.605 HD11 ' HB1' ' A' ' 64' ' ' ALA . 16.4 mt -122.27 139.28 53.97 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.004 -0.544 . . . . 73.109999999999999 111.58 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -79.29 118.25 21.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.309 0.576 . . . . 74.25 110.359 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 28.3 m -138.25 160.51 32.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.61 -0.723 . . . . 75.530000000000001 111.824 -173.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.717 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 72.2 tt0 -98.82 111.92 24.16 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.071 0.462 . . . . 75.25 110.438 175.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.521 HG22 HD11 ' A' ' 96' ' ' ILE . 43.1 t -87.45 105.81 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 115.797 -0.638 . . . . 75.439999999999998 111.72 -175.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.607 HD12 ' HE2' ' A' ' 95' ' ' MET . 2.9 mt -92.14 162.91 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.677 0.275 . . . . 75.120000000000005 111.265 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.673 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 15.6 t -134.58 113.96 12.3 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.781 0.324 . . . . 73.230000000000004 111.826 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.46 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . . . . . . 0 CA--C 1.528 0.878 0 C-N-CA 121.065 -0.588 . . . . 71.099999999999994 113.298 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.575 ' HA ' HD22 ' A' ' 50' ' ' ASN . 44.3 mt-10 . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 121.151 0.5 . . . . 71.129999999999995 111.153 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -68.8 -23.08 64.24 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.939 0.4 . . . . 75.510000000000005 110.702 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -88.17 2.08 52.96 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.033 0.383 . . . . 73.430000000000007 112.033 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.575 HD22 ' HA ' ' A' ' 47' ' ' GLU . 10.9 p30 -122.17 -48.31 2.11 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.483 -0.761 . . . . 72.340000000000003 111.948 170.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.68 -22.77 24.88 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.079 1.14 . . . . 75.230000000000004 114.079 -170.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 19.7 m -130.92 17.82 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 112.858 0.688 . . . . 70.319999999999993 112.858 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.583 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -102.0 17.16 23.9 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.612 0.597 . . . . 64.239999999999995 112.612 -174.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -140.93 162.79 34.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.142 0.496 . . . . 73.329999999999998 112.106 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -126.14 127.19 45.36 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.622 -0.717 . . . . 73.129999999999995 110.813 174.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -87.31 118.4 26.71 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.413 0.625 . . . . 64.329999999999998 110.892 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.03 154.92 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.162 -0.926 . . . . 75.439999999999998 111.828 -169.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -76.19 144.56 40.42 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.525 -0.307 . . . . 75.209999999999994 110.615 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 27.3 tt0 -63.39 -36.86 85.13 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.818 0.673 . . . . 75.299999999999997 112.818 -176.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -62.21 -47.69 83.33 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 122.174 -0.329 . . . . 73.019999999999996 111.413 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.47 ' HB3' HD12 ' A' ' 24' ' ' LEU . 47.0 m-20 -66.8 -36.5 82.52 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.308 0.575 . . . . 74.310000000000002 110.558 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.482 ' HZ2' ' N ' ' A' ' 69' ' ' GLU . 33.7 t-105 -53.11 -45.66 68.38 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.492 -0.776 . . . . 74.030000000000001 110.591 175.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -65.7 -41.02 92.86 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.714 -0.676 . . . . 63.439999999999998 110.961 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.605 ' HB1' HD11 ' A' ' 24' ' ' LEU . . . -61.0 -38.55 86.45 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.242 -0.435 . . . . 62.329999999999998 111.82 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.485 ' HG ' HD13 ' A' ' 24' ' ' LEU . 87.6 mt -85.71 -14.47 45.29 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.425 -0.352 . . . . 75.109999999999999 111.413 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.57 47.4 78.0 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.273 -0.489 . . . . 75.099999999999994 112.581 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.56 HD21 ' HD3' ' A' ' 129' ' ' LYS . 85.3 mt -84.49 164.85 18.56 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.559 0.695 . . . . 74.140000000000001 112.38 -175.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -136.11 123.61 22.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.55 -0.75 . . . . 72.239999999999995 109.905 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.482 ' N ' ' HZ2' ' A' ' 62' ' ' TRP . 48.7 mt-10 -49.88 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.563 0.696 . . . . 75.439999999999998 112.614 -172.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 130.2 0.04 5.55 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.387 -0.824 . . . . 62.409999999999997 114.036 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -90.39 -172.15 3.34 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 117.863 0.831 . . . . 73.019999999999996 112.292 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 72' ' ' ARG . 45.6 mtt180 -111.52 131.25 55.37 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.339 0.496 . . . . 71.239999999999995 112.339 -174.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.448 HG13 ' HB3' ' A' ' 86' ' ' ALA . 30.0 m -123.67 140.85 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.998 0.428 . . . . 64.420000000000002 111.578 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -98.65 131.84 44.51 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.25 0.548 . . . . 73.400000000000006 110.74 174.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.481 HG22 HD11 ' A' ' 98' ' ' ILE . 61.9 t -106.18 128.22 60.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.731 -0.668 . . . . 75.519999999999996 109.661 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -131.06 127.55 38.45 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.51 0.672 . . . . 75.209999999999994 112.506 -171.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.576 HG21 ' HA3' ' A' ' 125' ' ' GLY . 31.0 p -136.37 -170.43 2.66 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.131 -0.941 . . . . 73.239999999999995 110.486 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.22 -13.74 60.16 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.683 0.277 . . . . 70.129999999999995 111.561 176.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -87.83 -38.02 16.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.96 0.409 . . . . 74.439999999999998 111.378 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.07 -157.73 28.75 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.866 -0.683 . . . . 70.310000000000002 113.521 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -144.24 141.82 30.09 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.758 0.313 . . . . 72.219999999999999 111.471 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.48 146.67 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.698 0.285 . . . . 73.540000000000006 111.655 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.0 t -105.4 117.21 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.544 0.211 . . . . 71.109999999999999 110.95 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.0 m -127.34 178.08 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 122.588 0.355 . . . . 74.25 111.821 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -83.2 144.09 30.02 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.911 0.386 . . . . 74.409999999999997 111.312 174.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HB3' HG13 ' A' ' 73' ' ' VAL . . . -90.34 135.74 33.49 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.625 0.602 . . . . 73.400000000000006 112.625 -177.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -133.04 158.23 43.26 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.583 0.706 . . . . 72.510000000000005 111.663 174.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -108.17 99.64 9.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.103 -0.953 . . . . 75.019999999999996 109.608 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.59 86.54 0.19 Allowed Glycine 0 CA--C 1.533 1.186 0 N-CA-C 116.631 1.412 . . . . 74.349999999999994 116.631 -166.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 65.72 -17.44 0.1 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 116.206 1.928 . . . . 72.209999999999994 116.206 161.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.0 m -78.15 148.66 75.14 Favored Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 121.716 -0.615 . . . . 73.439999999999998 112.425 -173.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -72.64 169.58 21.55 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.788 2.325 . . . . 73.230000000000004 112.705 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -68.33 146.58 53.14 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.871 0.367 . . . . 75.129999999999995 111.5 -177.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 68.72 18.02 71.75 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.277 -0.487 . . . . 74.0 113.28 -174.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.717 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 14.2 ttt -147.02 136.61 22.93 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 122.37 -0.488 . . . . 75.219999999999999 110.568 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.521 HD11 HG22 ' A' ' 28' ' ' VAL . 43.6 pt -135.91 144.97 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 121.082 0.468 . . . . 74.340000000000003 111.703 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.46 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 68.1 t80 -107.01 123.87 48.81 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.473 -0.33 . . . . 72.530000000000001 111.302 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.673 ' O ' ' HA ' ' A' ' 30' ' ' SER . 44.2 mt -120.37 127.46 26.3 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 120.805 0.336 . . . . 73.409999999999997 111.142 175.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.513 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 51.4 Cg_exo -57.18 136.9 79.23 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.285 1.99 . . . . 74.340000000000003 113.084 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.416 ' HE3' HD13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -60.46 105.69 0.46 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.212 -0.449 . . . . 75.019999999999996 110.878 -178.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.98 -174.25 30.6 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.912 -0.661 . . . . 70.310000000000002 112.542 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 106' ' ' MET . 14.8 Cg_endo -56.05 -36.01 95.55 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.521 2.148 . . . . 74.340000000000003 111.986 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.492 ' HA ' HD13 ' A' ' 140' ' ' LEU . 41.0 m-85 -61.83 -54.1 46.87 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.957 -0.565 . . . . 75.239999999999995 110.71 177.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -63.41 -33.53 75.76 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.165 0.507 . . . . 75.450000000000003 111.302 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.34 -15.03 45.8 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.124 -0.489 . . . . 75.109999999999999 111.892 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.523 ' SD ' HD22 ' A' ' 140' ' ' LEU . 41.5 mtp -83.66 -22.75 32.03 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.441 -0.345 . . . . 73.5 111.7 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.7 m -123.86 -18.45 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 113.129 0.788 . . . . 74.040000000000006 113.129 -171.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 104' ' ' ALA . 11.2 pt -96.22 177.62 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.381 0.61 . . . . 73.439999999999998 111.834 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.642 ' H ' HG21 ' A' ' 123' ' ' VAL . 16.7 t70 . . . . . 0 CA--C 1.54 0.559 0 CA-C-N 115.806 -0.633 . . . . 64.040000000000006 110.131 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.661 0 N-CA-C 112.948 -0.061 . . . . 71.109999999999999 112.948 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.642 HG21 ' H ' ' A' ' 109' ' ' ASP . 58.3 t -78.19 122.13 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 121.0 0.429 . . . . 73.0 111.419 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.405 ' HD2' ' N ' ' A' ' 124' ' ' LYS . 12.1 mptt -69.47 131.27 44.48 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.906 0.384 . . . . 75.140000000000001 111.549 -177.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.576 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -160.66 -146.03 4.48 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.259 -0.496 . . . . 61.329999999999998 113.358 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 41.4 p -139.8 161.28 37.94 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.887 0.375 . . . . 75.340000000000003 111.542 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.0 p -139.74 144.6 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.132 0.491 . . . . 71.109999999999999 111.462 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.23 156.47 40.94 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.93 -0.577 . . . . 74.450000000000003 111.219 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.56 ' HD3' HD21 ' A' ' 67' ' ' LEU . 27.7 ttpp -90.12 136.95 32.74 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.89 -0.506 . . . . 72.219999999999999 110.586 174.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.3 t -138.34 157.52 46.08 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.092 0.472 . . . . 74.420000000000002 112.217 -173.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -83.02 -4.47 58.36 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.954 -0.566 . . . . 45.210000000000001 111.437 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -70.9 146.5 49.54 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.031 -0.531 . . . . 75.019999999999996 111.832 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.74 152.04 43.08 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.136 0.493 . . . . 74.239999999999995 111.926 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.89 121.9 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.522 -0.308 . . . . 74.109999999999999 110.587 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 135' ' ' LEU . 10.2 mt -62.73 94.24 0.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.005 0.372 . . . . 73.310000000000002 112.005 -178.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.1 m -53.56 150.69 6.6 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.156 -0.474 . . . . 72.109999999999999 110.72 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.544 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 67.9 t -45.09 -48.76 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 112.948 0.721 . . . . 64.209999999999994 112.948 -171.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -72.52 -44.07 62.69 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.213 -0.304 . . . . 72.430000000000007 111.653 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -56.34 -39.61 73.11 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.92 0.867 . . . . 74.219999999999999 110.107 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.523 HD22 ' SD ' ' A' ' 106' ' ' MET . 2.7 tt -60.3 -42.44 95.53 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.791 -1.095 . . . . 73.530000000000001 110.879 175.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 56.6 mt . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 121.24 0.543 . . . . 74.540000000000006 110.508 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.1 ptp . . . . . 0 N--CA 1.467 0.398 0 CA-C-O 121.263 0.554 . . . . 74.219999999999999 111.688 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.568 HD11 ' HB1' ' A' ' 64' ' ' ALA . 20.2 mt -124.58 139.06 54.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.89 -0.596 . . . . 74.530000000000001 111.327 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -78.31 109.01 12.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.658 0.742 . . . . 74.219999999999999 110.618 174.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 34.8 m -132.22 159.13 43.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.731 -1.122 . . . . 70.150000000000006 111.849 -172.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.697 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 44.0 tt0 -99.27 117.62 34.13 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.106 0.479 . . . . 71.219999999999999 111.102 175.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.528 HG22 HD13 ' A' ' 96' ' ' ILE . 38.4 t -89.79 107.81 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.218 0.607 . . . . 73.549999999999997 111.578 -177.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.569 HD12 ' HE1' ' A' ' 95' ' ' MET . 2.5 mt -94.11 148.51 4.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 111.803 0.297 . . . . 75.219999999999999 111.803 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.577 ' OG ' HG23 ' A' ' 108' ' ' ILE . 73.7 m -109.97 106.93 16.64 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.055 0.455 . . . . 72.329999999999998 111.36 175.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.473 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . . . . . . 0 CA--C 1.523 0.561 0 C-N-CA 121.256 -0.497 . . . . 73.519999999999996 113.139 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 . . . . . 0 CA--C 1.537 0.458 0 N-CA-C 112.218 0.451 . . . . 74.219999999999999 112.218 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -71.53 -26.53 62.69 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.498 0.666 . . . . 74.019999999999996 109.789 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.532 ' HD1' HG21 ' A' ' 137' ' ' VAL . 71.4 t80 -89.45 -2.31 58.34 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.616 -0.72 . . . . 72.430000000000007 110.902 175.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -101.66 -44.38 5.58 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.025 -0.422 . . . . 75.109999999999999 111.811 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.52 -64.0 1.29 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.316 0.858 . . . . 71.230000000000004 113.316 -172.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.459 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 32.9 m -79.07 21.8 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 113.338 0.866 . . . . 73.329999999999998 113.338 -170.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.609 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -108.0 11.17 28.04 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.073 0.768 . . . . 63.219999999999999 113.073 -172.546 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -133.2 166.28 22.82 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.598 0.713 . . . . 74.409999999999997 112.487 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.76 135.18 48.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.21 -0.905 . . . . 73.540000000000006 110.042 172.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.597 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 45.0 mt-10 -94.67 115.56 27.69 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.867 0.365 . . . . 64.510000000000005 111.285 177.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.428 HD13 ' N ' ' A' ' 57' ' ' ILE . 4.3 mp -109.79 150.93 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.062 -0.517 . . . . 74.5 110.831 -178.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -71.78 156.86 38.85 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.71 0.291 . . . . 72.230000000000004 111.418 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -54.74 -47.39 73.9 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.173 0.511 . . . . 71.129999999999995 111.864 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.5 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 17.3 mm-40 -56.41 -52.73 63.55 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.206 -0.452 . . . . 64.099999999999994 112.169 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -66.29 -36.57 83.31 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.007 0.432 . . . . 73.319999999999993 111.024 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -55.68 -48.79 74.47 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.96 -0.563 . . . . 75.200000000000003 111.103 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -66.71 -39.38 88.01 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.05 -0.523 . . . . 75.349999999999994 111.185 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.568 ' HB1' HD11 ' A' ' 24' ' ' LEU . . . -61.15 -35.05 76.04 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.058 0.392 . . . . 52.520000000000003 112.058 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.2 mt -89.55 -12.13 40.79 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.042 0.386 . . . . 73.299999999999997 112.042 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.36 48.32 83.22 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.09 -0.576 . . . . 71.299999999999997 112.782 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.662 HD22 ' HD3' ' A' ' 129' ' ' LYS . 92.1 mt -86.88 143.26 27.51 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.259 0.552 . . . . 74.030000000000001 112.474 -175.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -93.61 149.62 21.08 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.989 -0.551 . . . . 74.319999999999993 109.909 171.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -61.26 100.22 0.12 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.452 0.644 . . . . 74.340000000000003 111.279 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.76 29.18 7.05 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.333 -0.848 . . . . 74.030000000000001 112.841 -174.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -82.07 -178.27 6.95 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 122.598 -0.354 . . . . 61.32 111.158 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.598 HH21 ' HA ' ' A' ' 131' ' ' ASP . 24.2 mtm-85 -116.78 123.07 46.22 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.85 0.357 . . . . 73.409999999999997 111.068 -177.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.81 140.82 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.034 0.445 . . . . 75.140000000000001 112.178 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 31.7 ttmt -110.17 126.38 54.03 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.199 0.524 . . . . 71.549999999999997 111.318 174.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 47.0 t -101.07 132.09 47.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.87 -0.604 . . . . 63.049999999999997 110.97 177.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.414 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 4.1 mppt? -118.55 127.65 53.83 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.03 0.443 . . . . 74.209999999999994 111.392 174.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.692 HG21 ' HA3' ' A' ' 125' ' ' GLY . 40.7 p -127.25 -170.91 2.3 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.894 -0.594 . . . . 70.239999999999995 110.253 175.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -72.34 -11.34 60.66 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.87 0.367 . . . . 60.25 111.592 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -96.07 -40.54 9.18 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.087 0.403 . . . . 73.200000000000003 112.087 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.79 -146.95 8.76 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.636 -0.792 . . . . 44.229999999999997 113.744 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 14.0 pt-20 -152.13 153.41 33.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.781 0.324 . . . . 74.530000000000001 111.589 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 12.2 p -157.15 149.46 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 116.653 -0.249 . . . . 74.109999999999999 111.67 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.0 t -108.28 119.74 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 116.762 -0.199 . . . . 70.400000000000006 110.856 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.459 HG11 ' HD2' ' A' ' 103' ' ' TYR . 29.7 m -128.37 172.16 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-O 120.914 0.388 . . . . 74.549999999999997 111.727 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -77.43 143.47 38.56 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.022 0.439 . . . . 75.319999999999993 111.39 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.24 122.95 36.16 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.471 0.545 . . . . 70.430000000000007 112.471 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -123.63 157.86 32.8 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.161 0.505 . . . . 74.450000000000003 110.774 172.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -102.9 107.23 17.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.046 -0.525 . . . . 74.349999999999994 110.28 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.597 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -109.35 -175.18 21.24 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.852 -0.69 . . . . 74.409999999999997 114.171 -172.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -90.26 17.12 7.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.865 0.364 . . . . 74.019999999999996 111.439 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.69 151.87 93.48 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 116.45 -0.341 . . . . 72.430000000000007 111.52 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -67.71 154.49 73.12 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.453 2.102 . . . . 72.329999999999998 112.585 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.5 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 87.9 tttt -57.42 137.15 56.5 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.732 0.301 . . . . 74.409999999999997 111.609 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 71.84 26.92 71.67 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 120.817 -0.706 . . . . 71.239999999999995 113.031 -174.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.697 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 13.9 ttt -150.69 137.5 19.05 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 122.213 -0.58 . . . . 64.340000000000003 110.151 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.528 HD13 HG22 ' A' ' 28' ' ' VAL . 38.0 pt -133.53 144.84 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.355 0.598 . . . . 71.439999999999998 112.166 -178.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.473 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 66.4 t80 -105.78 127.33 53.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.969 -0.56 . . . . 72.329999999999998 111.452 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 30' ' ' SER . 46.1 mt -127.29 128.32 24.09 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 122.337 0.255 . . . . 73.310000000000002 110.563 174.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.459 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 37.1 Cg_exo -57.76 142.91 96.25 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.2 1.933 . . . . 70.209999999999994 112.704 177.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.532 ' HA ' ' HE3' ' A' ' 100' ' ' MET . 4.5 tpt -59.22 103.73 0.2 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.025 0.441 . . . . 72.120000000000005 111.435 -178.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.74 -178.08 34.4 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.678 -0.773 . . . . 71.430000000000007 112.893 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.52 ' O ' ' HG2' ' A' ' 106' ' ' MET . 18.8 Cg_endo -57.53 -34.63 98.34 Favored 'Trans proline' 0 N--CA 1.478 0.579 0 C-N-CA 122.76 2.307 . . . . 72.329999999999998 111.718 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.459 ' HD2' HG11 ' A' ' 84' ' ' VAL . 25.6 m-85 -58.73 -49.38 77.83 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.92 -0.582 . . . . 73.510000000000005 110.4 175.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.464 ' O ' HG21 ' A' ' 108' ' ' ILE . . . -63.06 -42.61 99.72 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.851 -0.613 . . . . 72.340000000000003 111.588 176.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -61.46 -7.46 3.14 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.663 0.616 . . . . 72.409999999999997 112.663 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.567 ' SD ' HD23 ' A' ' 140' ' ' LEU . 90.5 mmm -84.2 -20.21 32.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.772 0.32 . . . . 74.400000000000006 111.556 176.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.3 m -130.83 -12.1 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 113.271 0.841 . . . . 73.209999999999994 113.271 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.577 HG23 ' OG ' ' A' ' 30' ' ' SER . 8.8 pt -96.72 -179.05 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 121.725 -0.609 . . . . 73.450000000000003 112.254 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.594 ' H ' HG21 ' A' ' 123' ' ' VAL . 16.4 t70 . . . . . 0 CA--C 1.543 0.697 0 CA-C-N 116.008 -0.542 . . . . 75.120000000000005 111.133 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.837 0 CA-C-O 120.849 0.139 . . . . 70.219999999999999 113.323 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.594 HG21 ' H ' ' A' ' 109' ' ' ASP . 84.2 t -94.25 123.32 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 111.924 0.342 . . . . 70.530000000000001 111.924 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 54.9 mtmt -75.36 147.19 40.27 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.45 0.537 . . . . 63.409999999999997 112.45 -177.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.692 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -169.6 -157.97 12.8 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.88 -0.6 . . . . 73.200000000000003 112.658 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 45.8 p -124.69 138.72 54.28 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.257 -0.555 . . . . 74.219999999999999 111.586 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.3 p -126.64 144.57 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.883 0.373 . . . . 73.310000000000002 111.64 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.92 156.93 36.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.188 -0.46 . . . . 74.010000000000005 110.999 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.662 ' HD3' HD22 ' A' ' 67' ' ' LEU . 27.1 ttpp -72.24 141.56 48.96 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.908 0.385 . . . . 74.430000000000007 111.185 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.4 t -132.12 160.83 34.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.232 0.539 . . . . 73.150000000000006 112.089 -175.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.598 ' HA ' HH21 ' A' ' 72' ' ' ARG . 5.1 m-20 -92.21 -10.94 36.81 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.826 -0.625 . . . . 74.209999999999994 111.031 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.39 168.25 9.22 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.22 0.533 . . . . 75.120000000000005 112.12 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -86.81 152.71 22.25 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.097 -0.502 . . . . 75.319999999999993 110.915 175.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 83.8 t -63.08 129.31 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.63 0.252 . . . . 73.209999999999994 110.654 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 135' ' ' LEU . 8.9 mt -66.91 90.67 0.18 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.724 0.268 . . . . 75.030000000000001 111.724 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.8 m -49.38 148.88 2.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.068 -0.515 . . . . 73.530000000000001 110.967 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.532 HG21 ' HD1' ' A' ' 49' ' ' PHE . 90.5 t -45.18 -45.14 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 112.123 0.416 . . . . 74.120000000000005 112.123 -175.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -71.95 -43.92 64.45 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.391 -0.368 . . . . 74.540000000000006 111.837 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.42 ' HG2' ' HE3' ' A' ' 133' ' ' LYS . 4.3 tp10 -61.13 -32.47 72.17 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.486 0.66 . . . . 74.239999999999995 110.53 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.567 HD23 ' SD ' ' A' ' 106' ' ' MET . 1.4 tt -65.85 -37.91 87.44 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.376 -0.829 . . . . 75.239999999999995 110.654 176.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 29.6 mt . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 121.581 0.705 . . . . 75.430000000000007 109.944 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.52 ' HB3' ' HB3' ' A' ' 128' ' ' GLU . 6.1 ptp . . . . . 0 N--CA 1.468 0.446 0 CA-C-O 121.358 0.599 . . . . 71.319999999999993 111.914 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.434 HD13 ' HB3' ' A' ' 64' ' ' ALA . 19.0 mt -134.53 139.14 45.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 73.120000000000005 111.603 177.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -84.77 114.06 21.78 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.558 0.694 . . . . 74.150000000000006 110.886 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.435 HG11 ' HA2' ' A' ' 94' ' ' GLY . 34.5 m -134.97 167.17 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 114.959 -1.019 . . . . 75.010000000000005 112.338 -170.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -101.16 132.0 46.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.706 0.289 . . . . 73.420000000000002 110.45 171.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.47 111.15 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 112.154 0.427 . . . . 73.140000000000001 112.154 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.575 HD13 ' HE3' ' A' ' 95' ' ' MET . 0.1 OUTLIER -100.06 151.06 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.065 0.46 . . . . 73.329999999999998 111.213 174.838 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 74.3 m -124.53 110.0 13.93 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.975 0.417 . . . . 72.120000000000005 111.779 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.747 0 C-N-CA 121.277 -0.487 . . . . 61.420000000000002 112.429 178.903 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 CA--C 1.543 0.69 0 N-CA-C 112.433 0.531 . . . . 73.010000000000005 112.433 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.58 -23.08 53.49 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.962 -0.461 . . . . 74.530000000000001 110.635 175.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.411 ' HD1' HG21 ' A' ' 137' ' ' VAL . 57.6 t80 -90.87 0.41 57.49 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 116.181 -0.463 . . . . 74.140000000000001 112.01 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 51' ' ' ALA . 29.8 p30 -121.66 -44.36 2.34 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.528 -0.733 . . . . 70.120000000000005 112.799 176.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.444 ' N ' ' OD1' ' A' ' 50' ' ' ASN . . . -70.19 -30.95 68.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.682 0.993 . . . . 62.049999999999997 113.682 -172.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 33.0 m -118.19 16.1 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 112.769 0.655 . . . . 74.019999999999996 112.769 -177.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.565 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -104.87 17.64 23.76 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.868 0.692 . . . . 70.310000000000002 112.868 -174.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -141.3 168.53 19.55 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.065 0.46 . . . . 73.150000000000006 111.93 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.9 144.41 45.51 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.089 -0.505 . . . . 70.230000000000004 111.284 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 42.1 mt-10 -96.75 113.31 24.85 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.697 0.284 . . . . 74.439999999999998 111.189 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.454 HD13 ' N ' ' A' ' 57' ' ' ILE . 4.0 mp -110.43 147.01 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.368 -0.378 . . . . 74.049999999999997 110.82 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -65.79 143.24 57.62 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.665 -0.243 . . . . 71.420000000000002 110.971 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -58.3 -38.39 76.97 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.103 0.779 . . . . 65.519999999999996 113.103 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -60.44 -48.05 83.45 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.957 -0.464 . . . . 75.010000000000005 110.99 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -63.9 -38.07 89.74 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.012 0.434 . . . . 74.319999999999993 110.837 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 35.8 t-105 -53.26 -51.49 62.1 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.43 0.633 . . . . 74.400000000000006 111.07 175.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -67.92 -35.76 79.01 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.751 -0.659 . . . . 73.439999999999998 111.294 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HB3' HD13 ' A' ' 24' ' ' LEU . . . -61.74 -39.9 93.2 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.185 0.516 . . . . 72.230000000000004 111.621 177.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.52 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 73.5 mt -79.46 -16.15 56.59 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.118 -0.492 . . . . 75.439999999999998 111.603 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.93 53.96 24.17 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.947 -0.644 . . . . 61.329999999999998 111.888 -173.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.624 HD23 ' HE3' ' A' ' 129' ' ' LYS . 96.2 mt -91.31 160.1 15.67 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.774 0.797 . . . . 72.439999999999998 112.932 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -129.51 127.81 41.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.999 -1.0 . . . . 73.420000000000002 109.394 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -50.8 98.8 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.096 0.776 . . . . 73.239999999999995 113.096 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.92 13.4 11.15 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 115.311 -0.859 . . . . 45.509999999999998 113.77 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.409 ' HA ' HH11 ' A' ' 72' ' ' ARG . 46.9 p-10 -88.67 -169.01 2.38 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 117.665 0.732 . . . . 65.400000000000006 112.33 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.617 ' HG3' HG21 ' A' ' 134' ' ' VAL . 2.4 mpt_? -109.1 127.7 54.37 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.913 0.387 . . . . 72.209999999999994 111.9 -173.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.1 m -124.4 138.47 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.023 0.439 . . . . 74.239999999999995 111.33 174.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.423 ' HE3' ' HG3' ' A' ' 132' ' ' GLU . 39.8 ttmt -102.7 125.66 49.52 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.965 0.412 . . . . 71.310000000000002 110.753 177.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.48 131.17 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.361 -0.607 . . . . 71.049999999999997 109.361 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -134.17 132.23 39.55 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.319 0.58 . . . . 75.430000000000007 112.249 -172.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.677 HG21 ' HA3' ' A' ' 125' ' ' GLY . 30.7 p -138.99 -171.22 3.04 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.961 -0.563 . . . . 63.149999999999999 111.626 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.05 -18.18 65.08 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.928 -0.578 . . . . 73.329999999999998 112.01 175.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 109' ' ' ASP . 98.5 m-85 -88.0 -55.36 3.79 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.911 0.386 . . . . 72.540000000000006 111.505 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.9 -154.17 11.23 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.944 -0.646 . . . . 71.120000000000005 112.93 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.07 154.12 50.41 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.2 0.524 . . . . 74.25 111.652 178.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -151.0 145.31 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.241 -0.436 . . . . 74.340000000000003 111.036 177.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.5 t -110.31 117.73 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.808 0.337 . . . . 65.019999999999996 111.099 177.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.51 173.95 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 115.966 -0.561 . . . . 75.209999999999994 111.365 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -78.0 133.32 38.0 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.011 0.434 . . . . 74.120000000000005 111.18 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.94 126.5 33.07 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.179 0.437 . . . . 74.120000000000005 112.179 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -132.01 152.03 51.39 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.368 0.604 . . . . 74.439999999999998 110.871 175.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -90.45 121.97 32.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.66 -0.7 . . . . 65.400000000000006 111.249 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -120.59 -178.5 16.09 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.122 -0.561 . . . . 74.409999999999997 113.801 -174.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -93.66 8.87 39.24 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 122.703 0.401 . . . . 64.420000000000002 111.73 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.1 m -64.17 152.88 87.06 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.473 -0.33 . . . . 75.299999999999997 111.786 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.05 157.71 58.94 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.393 2.062 . . . . 74.430000000000007 112.21 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -64.63 142.2 58.51 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.829 0.347 . . . . 70.129999999999995 111.544 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.435 ' HA2' HG11 ' A' ' 26' ' ' VAL . . . 73.18 25.94 71.95 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.881 -0.676 . . . . 43.409999999999997 112.745 -173.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.575 ' HE3' HD13 ' A' ' 29' ' ' ILE . 26.2 ttt -154.97 136.74 14.44 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.428 -0.454 . . . . 75.030000000000001 110.278 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.2 pt -134.69 145.74 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.116 0.484 . . . . 70.219999999999999 112.264 -177.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.411 ' HA ' HG12 ' A' ' 29' ' ' ILE . 70.4 t80 -103.94 134.86 46.52 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.017 0.437 . . . . 74.129999999999995 111.379 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 30' ' ' SER . 48.3 mt -130.75 132.96 24.27 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.368 -0.378 . . . . 72.299999999999997 110.534 175.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.401 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 33.7 Cg_exo -61.65 129.05 26.43 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.058 1.839 . . . . 72.349999999999994 112.075 174.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.614 ' HE2' HD13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -57.73 104.8 0.2 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.029 0.443 . . . . 74.219999999999999 110.858 -176.417 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.25 -175.03 29.75 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.812 -0.708 . . . . 75.129999999999995 112.854 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.423 ' O ' ' HG2' ' A' ' 106' ' ' MET . 16.0 Cg_endo -56.56 -33.28 92.5 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.656 2.238 . . . . 65.430000000000007 112.254 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.458 ' HA ' HD11 ' A' ' 140' ' ' LEU . 37.5 m-85 -63.35 -50.97 67.89 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.092 0.472 . . . . 74.319999999999993 110.23 175.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -59.97 -41.48 92.04 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.167 -0.47 . . . . 61.039999999999999 111.801 176.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' A' ' 102' ' ' PRO . 91.7 m-20 -53.3 -29.16 32.01 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.15 0.426 . . . . 65.030000000000001 112.15 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.452 ' SD ' HD22 ' A' ' 140' ' ' LEU . 87.8 mmm -65.62 -24.15 66.99 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.29 -0.414 . . . . 75.25 112.112 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.5 -12.92 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 112.945 0.72 . . . . 71.400000000000006 112.945 -173.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.614 HD13 ' HE2' ' A' ' 100' ' ' MET . 6.9 pt -107.44 -179.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.868 -0.52 . . . . 63.340000000000003 111.738 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 29.4 t70 . . . . . 0 CA--C 1.543 0.684 0 CA-C-N 116.141 -0.481 . . . . 64.230000000000004 110.563 173.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.987 0 N-CA-C 113.984 0.354 . . . . 53.229999999999997 113.984 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.42 HG21 ' H ' ' A' ' 109' ' ' ASP . 58.1 t -92.93 133.73 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 122.836 0.454 . . . . 63.420000000000002 111.46 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -74.96 140.84 43.96 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.671 0.619 . . . . 75.200000000000003 112.671 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.677 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -169.62 -165.5 27.09 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.837 -0.62 . . . . 74.129999999999995 113.087 177.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 77.3 p -122.39 155.12 36.71 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.939 0.399 . . . . 70.430000000000007 111.486 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.1 p -129.88 142.77 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.657 -0.498 . . . . 63.340000000000003 109.657 173.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 8.8 pt-20 -143.21 147.65 35.21 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.251 0.834 . . . . 72.319999999999993 113.251 -174.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.624 ' HE3' HD23 ' A' ' 67' ' ' LEU . 1.8 tppp? -77.03 109.28 10.73 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.427 -0.806 . . . . 73.109999999999999 109.675 168.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.1 t -123.22 162.53 22.39 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.348 0.594 . . . . 74.340000000000003 112.456 -173.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.82 -12.14 59.78 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.397 -0.82 . . . . 71.439999999999998 111.209 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.423 ' HG3' ' HE3' ' A' ' 74' ' ' LYS . 6.2 mm-40 -61.1 160.26 10.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.684 0.754 . . . . 74.219999999999999 112.925 -176.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -95.15 160.22 14.66 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.425 -0.807 . . . . 74.109999999999999 110.917 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.617 HG21 ' HG3' ' A' ' 72' ' ' ARG . 71.9 t -72.25 136.42 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 120.733 0.302 . . . . 73.329999999999998 110.751 174.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.404 HD21 ' HG2' ' A' ' 139' ' ' GLU . 14.6 mt -73.4 132.29 42.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.544 -0.298 . . . . 74.340000000000003 111.441 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.4 t -73.15 147.83 44.45 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.208 -0.664 . . . . 74.319999999999993 109.208 170.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.411 HG21 ' HD1' ' A' ' 49' ' ' PHE . 99.3 t -46.05 -52.5 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 112.672 0.619 . . . . 70.340000000000003 112.672 -173.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -73.0 -35.41 66.82 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.04 -0.412 . . . . 73.519999999999996 111.723 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.404 ' HG2' HD21 ' A' ' 135' ' ' LEU . 48.1 tt0 -60.9 -33.83 73.73 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.747 0.784 . . . . 72.329999999999998 110.156 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.458 HD11 ' HA ' ' A' ' 103' ' ' TYR . 4.8 tt -60.37 -44.19 95.84 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.075 -0.966 . . . . 73.230000000000004 110.359 171.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.1 mt . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 121.181 0.515 . . . . 71.319999999999993 110.19 177.019 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.433 ' SD ' HG23 ' A' ' 126' ' ' THR . 7.0 ptp . . . . . 0 N--CA 1.469 0.493 0 CA-C-O 120.872 0.367 . . . . 75.120000000000005 110.855 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.536 HD13 ' HG ' ' A' ' 65' ' ' LEU . 9.5 mt -104.84 127.36 52.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.028 0.442 . . . . 74.25 111.687 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -71.29 113.23 8.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.732 0.777 . . . . 75.209999999999994 111.865 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 35.3 m -134.09 157.62 41.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.71 -1.132 . . . . 73.239999999999995 111.742 -174.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 41.8 tt0 -98.74 117.88 34.21 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.905 0.383 . . . . 74.129999999999995 110.699 175.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.618 HG23 HD13 ' A' ' 96' ' ' ILE . 34.4 t -91.04 110.63 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.944 -0.571 . . . . 71.329999999999998 111.848 -173.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.725 HD12 ' HE1' ' A' ' 95' ' ' MET . 2.0 mt -95.72 159.92 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 122.06 -0.4 . . . . 75.310000000000002 111.731 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.3 t -122.87 111.71 16.99 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.949 0.404 . . . . 63.100000000000001 111.245 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.728 0 C-N-CA 121.319 -0.467 . . . . 60.450000000000003 113.534 -178.766 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 120.859 0.361 . . . . 63.439999999999998 111.066 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.512 ' O ' HG21 ' A' ' 52' ' ' VAL . 8.6 t80 -59.63 -41.23 90.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.55 0.691 . . . . 74.549999999999997 109.876 174.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.424 ' HE2' ' HA ' ' A' ' 136' ' ' SER . 50.5 t80 -63.61 -65.15 0.72 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.24 -0.891 . . . . 63.240000000000002 110.554 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -58.0 -21.54 45.34 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.773 0.656 . . . . 73.439999999999998 112.773 -176.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.28 -32.19 33.32 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.031 0.752 . . . . 74.349999999999994 113.031 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 48' ' ' TYR . 32.7 m -116.93 4.88 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 113.27 0.841 . . . . 73.329999999999998 113.27 -175.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.413 ' ND2' ' CZ ' ' A' ' 103' ' ' TYR . 1.2 m-80 -94.58 28.34 2.66 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.377 0.88 . . . . 74.420000000000002 113.377 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.428 ' CE2' ' HE2' ' A' ' 87' ' ' LYS . 17.8 p90 -144.46 151.62 39.45 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.556 -0.715 . . . . 64.209999999999994 111.979 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.78 139.59 53.7 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.617 -0.72 . . . . 63.32 110.872 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.636 ' HG2' ' HE3' ' A' ' 87' ' ' LYS . 41.3 mt-10 -95.42 112.66 24.33 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.865 0.364 . . . . 73.430000000000007 111.423 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.442 HD13 ' N ' ' A' ' 57' ' ' ILE . 4.0 mp -109.17 145.67 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.275 -0.42 . . . . 74.200000000000003 110.518 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -61.81 151.93 32.92 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.284 0.564 . . . . 64.200000000000003 111.763 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.503 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 14.8 tm-20 -55.92 -52.94 62.36 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.705 -0.679 . . . . 71.420000000000002 111.964 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -55.75 -53.24 59.03 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.325 0.491 . . . . 70.239999999999995 112.325 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -61.09 -35.98 78.46 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.629 0.728 . . . . 75.219999999999999 110.663 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.503 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 43.0 t-105 -52.78 -53.84 42.52 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.023 -0.99 . . . . 74.239999999999995 111.769 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -73.53 -30.15 62.9 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.299 -0.409 . . . . 72.409999999999997 111.644 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.466 ' HB1' HD11 ' A' ' 24' ' ' LEU . . . -58.64 -34.85 71.66 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.032 0.444 . . . . 65.109999999999999 111.581 177.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.536 ' HG ' HD13 ' A' ' 24' ' ' LEU . 82.6 mt -89.64 -13.86 36.15 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.154 -0.475 . . . . 74.109999999999999 111.461 176.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.72 44.72 19.47 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.396 -0.431 . . . . 75.120000000000005 112.825 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' A' ' 129' ' ' LYS . 92.9 mt -85.1 149.97 25.18 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.509 0.671 . . . . 75.129999999999995 112.095 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -114.61 144.96 42.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.691 -0.686 . . . . 73.25 109.213 169.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -61.33 93.37 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.017 0.913 . . . . 73.109999999999999 111.697 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.0 -7.42 3.8 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 114.612 -1.176 . . . . 43.240000000000002 113.267 -175.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -69.35 178.53 2.36 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.04 0.756 . . . . 74.409999999999997 113.04 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.2 mtm-85 -113.61 139.63 48.86 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.688 -0.687 . . . . 73.519999999999996 110.512 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.35 139.64 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.472 0.653 . . . . 73.140000000000001 112.716 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -90.38 131.29 36.24 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.427 -0.806 . . . . 73.150000000000006 110.207 172.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.9 t -119.52 125.72 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.696 -0.483 . . . . 73.099999999999994 109.696 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.425 ' HG2' ' HB3' ' A' ' 81' ' ' GLU . 25.6 mtpp -133.9 131.59 39.3 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.991 0.737 . . . . 74.430000000000007 112.991 -171.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.627 HG21 ' HA3' ' A' ' 125' ' ' GLY . 30.3 p -140.1 -176.23 4.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.529 -0.759 . . . . 74.420000000000002 110.973 178.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.78 -11.4 60.82 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.365 -0.38 . . . . 74.349999999999994 111.681 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 109' ' ' ASP . 93.8 m-85 -89.31 -40.45 12.78 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.802 0.334 . . . . 72.430000000000007 111.296 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.05 -147.26 10.24 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.144 -0.55 . . . . 54.149999999999999 112.652 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.425 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 11.2 pt-20 -155.04 154.43 32.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.143 0.497 . . . . 71.319999999999993 112.218 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.3 p -149.51 155.32 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.999 -0.546 . . . . 75.319999999999993 111.169 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.83 116.94 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 122.382 -0.198 . . . . 74.230000000000004 111.017 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.5 176.28 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 116.496 -0.32 . . . . 75.209999999999994 111.267 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -77.68 160.4 28.5 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.203 0.525 . . . . 75.439999999999998 111.405 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.11 127.2 50.47 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.243 0.544 . . . . 73.329999999999998 111.734 -173.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.636 ' HE3' ' HG2' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -131.24 129.71 41.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.877 -0.601 . . . . 73.129999999999995 111.148 -178.776 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -79.88 98.65 7.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.035 -0.53 . . . . 74.209999999999994 110.828 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.536 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -96.56 161.01 22.01 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.989 -0.55 . . . . 72.450000000000003 114.018 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -87.63 15.24 7.04 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.358 0.599 . . . . 74.099999999999994 111.566 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.8 m -71.12 157.35 90.45 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 115.685 -0.689 . . . . 75.239999999999995 111.421 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.6 157.67 40.74 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.732 2.288 . . . . 72.25 113.723 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -62.59 145.64 53.93 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.282 -0.417 . . . . 75.010000000000005 111.35 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 61.99 32.45 82.22 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.843 -0.694 . . . . 72.519999999999996 112.716 -174.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.725 ' HE1' HD12 ' A' ' 29' ' ' ILE . 21.8 ttt -153.88 136.71 15.34 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.592 -0.358 . . . . 74.329999999999998 110.119 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.618 HD13 HG23 ' A' ' 28' ' ' VAL . 40.8 pt -134.84 150.9 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 121.288 0.566 . . . . 75.239999999999995 112.023 -177.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -112.13 130.9 55.74 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.016 -0.538 . . . . 74.349999999999994 111.241 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 30' ' ' SER . 50.4 mt -130.3 128.5 22.7 Favored Pre-proline 0 N--CA 1.474 0.77 0 CA-C-O 120.548 0.213 . . . . 74.109999999999999 110.998 175.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.51 140.66 89.89 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.27 1.98 . . . . 72.25 112.899 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.457 ' HE3' HD13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -60.01 105.84 0.44 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.122 0.486 . . . . 75.0 110.815 -178.646 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.91 -174.71 27.96 Favored Glycine 0 N--CA 1.46 0.273 0 C-N-CA 120.784 -0.722 . . . . 71.530000000000001 112.57 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.497 ' O ' ' HG2' ' A' ' 106' ' ' MET . 26.5 Cg_endo -61.74 -26.72 80.1 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.272 1.981 . . . . 74.340000000000003 111.563 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.434 ' HA ' HD13 ' A' ' 140' ' ' LEU . 4.1 m-85 -69.17 -53.44 20.04 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.56 -0.745 . . . . 74.150000000000006 110.782 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.436 ' O ' HG22 ' A' ' 108' ' ' ILE . . . -60.05 -39.78 87.16 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.268 -0.424 . . . . 62.310000000000002 110.748 174.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -54.71 -25.92 30.51 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.912 0.485 . . . . 74.129999999999995 112.042 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.623 ' SD ' HD23 ' A' ' 140' ' ' LEU . 89.9 mmm -67.28 -30.2 70.01 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.947 0.351 . . . . 73.040000000000006 111.947 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.07 -14.01 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 113.187 0.81 . . . . 62.420000000000002 113.187 -171.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.457 HD13 ' HE3' ' A' ' 100' ' ' MET . 8.8 pt -102.67 -178.91 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.163 0.506 . . . . 64.040000000000006 111.753 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 21.7 t70 . . . . . 0 CA--C 1.543 0.696 0 CA-C-N 116.076 -0.511 . . . . 71.109999999999999 110.475 173.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . . . . . . 0 CA--C 1.522 0.507 0 CA-C-O 120.957 0.199 . . . . 63.509999999999998 113.091 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.433 HG21 ' HA ' ' A' ' 108' ' ' ILE . 59.5 t -85.32 119.16 33.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.926 0.393 . . . . 73.510000000000005 111.487 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 67.5 mttm -67.46 148.88 50.95 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.245 0.545 . . . . 72.150000000000006 112.366 -177.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.627 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -177.25 -143.52 4.94 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 115.94 -0.573 . . . . 73.230000000000004 113.367 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.433 HG23 ' SD ' ' A' ' 23' ' ' MET . 76.5 p -139.3 159.98 40.88 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 122.398 -0.472 . . . . 73.040000000000006 111.769 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.7 p -144.99 145.02 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.103 0.478 . . . . 74.239999999999995 111.484 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -155.61 161.51 40.81 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.364 -0.38 . . . . 71.510000000000005 110.687 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.449 ' HB2' HD22 ' A' ' 67' ' ' LEU . 31.7 ttpt -79.91 131.15 35.78 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.755 -0.59 . . . . 75.25 110.197 173.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.7 t -118.01 156.25 28.88 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.644 0.609 . . . . 75.409999999999997 112.644 -172.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.02 -13.05 60.23 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.724 -0.671 . . . . 74.420000000000002 110.055 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -70.0 147.68 49.82 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.299 -0.864 . . . . 73.430000000000007 113.195 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.607 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -77.29 157.35 30.79 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.779 -1.1 . . . . 75.430000000000007 111.373 174.265 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.23 130.28 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.87 0.367 . . . . 74.349999999999994 110.826 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.1 mt -66.26 119.45 11.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 75.439999999999998 111.567 178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.424 ' HA ' ' HE2' ' A' ' 49' ' ' PHE . 29.9 t -66.27 148.44 51.85 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.596 -0.52 . . . . 74.319999999999993 109.596 168.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.498 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 62.7 t -46.26 -40.3 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 120.943 0.402 . . . . 75.219999999999999 111.583 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -72.79 -44.39 61.59 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.194 -0.457 . . . . 72.120000000000005 112.165 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -60.91 -36.03 78.21 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.672 0.749 . . . . 74.219999999999999 110.227 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.623 HD23 ' SD ' ' A' ' 106' ' ' MET . 2.5 tt -60.65 -38.87 86.3 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.415 -0.811 . . . . 71.209999999999994 110.799 174.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 54.0 mt . . . . . 0 N--CA 1.47 0.525 0 CA-C-O 121.467 0.651 . . . . 73.219999999999999 110.063 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.5 ptm . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 120.478 0.18 . . . . 73.409999999999997 110.528 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mp -105.32 142.92 34.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.164 0.507 . . . . 75.420000000000002 112.281 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.417 ' HA ' HG23 ' A' ' 126' ' ' THR . 29.6 tt0 -81.14 112.12 18.21 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.809 -0.632 . . . . 74.299999999999997 110.898 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 33.3 m -128.09 160.19 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.809 0.338 . . . . 75.519999999999996 111.886 -174.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.69 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 86.9 tt0 -98.83 115.23 28.34 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.193 0.521 . . . . 72.549999999999997 110.594 175.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.533 HG22 HD13 ' A' ' 96' ' ' ILE . 39.5 t -88.22 113.9 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.708 -0.678 . . . . 71.299999999999997 111.751 -175.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.575 HD12 ' HE1' ' A' ' 95' ' ' MET . 2.8 mt -98.0 159.8 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.569 -0.287 . . . . 74.530000000000001 111.546 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 71.5 m -126.17 106.13 9.34 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.964 0.411 . . . . 75.549999999999997 111.29 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.511 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . . . . . . 0 CA--C 1.524 0.651 0 C-N-CA 121.039 -0.6 . . . . 75.540000000000006 113.597 -176.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 121.12 0.485 . . . . 71.439999999999998 111.268 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -64.78 -32.64 74.43 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.211 -0.449 . . . . 75.430000000000007 110.675 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.458 ' HD1' HG21 ' A' ' 137' ' ' VAL . 52.8 t80 -87.19 4.92 40.54 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.161 0.505 . . . . 75.25 111.673 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -121.44 -36.32 3.09 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.753 -0.592 . . . . 65.430000000000007 111.959 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.4 -56.0 8.7 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.796 0.665 . . . . 72.209999999999994 112.796 -175.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.573 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 34.4 m -96.16 17.16 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 113.078 0.77 . . . . 71.109999999999999 113.078 -173.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.576 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -102.46 19.38 19.04 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.709 0.633 . . . . 74.219999999999999 112.709 -174.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -144.23 171.14 14.72 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.889 -0.507 . . . . 74.530000000000001 112.045 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.55 136.39 44.94 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.884 -0.598 . . . . 72.0 111.388 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.612 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 42.5 mt-10 -86.66 117.28 25.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.088 0.471 . . . . 64.349999999999994 110.7 175.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 28.1 mt -113.52 143.43 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.819 -0.628 . . . . 74.25 111.897 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -66.38 145.07 56.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.495 0.188 . . . . 73.120000000000005 110.622 174.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -62.29 -32.62 73.37 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.529 0.566 . . . . 72.010000000000005 112.529 -176.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.55 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 17.7 mm-40 -58.87 -57.44 13.05 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.213 -0.304 . . . . 60.439999999999998 111.585 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.51 -37.29 85.46 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.345 0.593 . . . . 74.200000000000003 110.64 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.475 ' HA ' HD11 ' A' ' 67' ' ' LEU . 51.5 t-105 -53.43 -52.1 60.5 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.406 -0.815 . . . . 75.439999999999998 110.991 174.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -67.1 -38.65 86.04 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.679 -0.691 . . . . 74.319999999999993 111.35 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.27 -33.91 72.99 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.236 -0.438 . . . . 65.349999999999994 112.028 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -94.78 -7.61 39.93 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.083 0.401 . . . . 73.150000000000006 112.083 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.48 48.15 76.6 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.064 -0.588 . . . . 64.519999999999996 112.634 -177.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.521 HD23 ' HD3' ' A' ' 129' ' ' LYS . 84.8 mt -86.29 142.8 28.26 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.351 0.596 . . . . 75.420000000000002 112.34 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -110.51 151.36 27.67 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.416 -0.811 . . . . 74.150000000000006 109.545 172.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.6 104.31 0.64 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.329 0.585 . . . . 73.25 111.366 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 118.5 0.02 15.95 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-N 115.652 -0.704 . . . . 73.420000000000002 113.62 -176.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -68.65 172.13 6.72 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.304 0.573 . . . . 54.229999999999997 111.868 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.1 mtt85 -109.79 125.51 52.8 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.001 -0.545 . . . . 71.230000000000004 110.949 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.676 HG13 ' HB3' ' A' ' 86' ' ' ALA . 15.5 m -113.8 152.35 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.543 0.687 . . . . 75.209999999999994 111.844 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -124.05 120.86 33.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.606 -0.724 . . . . 74.209999999999994 110.388 -177.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 48.2 t -102.64 130.83 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 111.753 0.279 . . . . 64.239999999999995 111.753 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.91 127.73 53.76 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.631 -0.259 . . . . 74.239999999999995 110.748 175.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.781 HG21 ' HA3' ' A' ' 125' ' ' GLY . 25.4 p -130.81 -172.15 2.75 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.094 0.473 . . . . 73.329999999999998 111.259 177.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.77 -16.43 63.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.373 -0.376 . . . . 75.519999999999996 111.679 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -93.34 -47.07 7.07 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 111.888 0.329 . . . . 74.150000000000006 111.888 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.94 -156.95 19.98 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.879 -0.677 . . . . 54.009999999999998 113.266 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 5.2 pt-20 -133.72 161.23 35.25 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.14 0.495 . . . . 74.239999999999995 111.725 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.9 p -160.59 143.25 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.29 -0.414 . . . . 74.129999999999995 111.34 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.0 t -104.03 118.97 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 122.325 -0.234 . . . . 72.420000000000002 110.761 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.9 m -130.14 177.68 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.853 0.359 . . . . 75.25 111.687 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -80.21 144.11 33.22 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.19 0.519 . . . . 74.230000000000004 111.674 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.676 ' HB3' HG13 ' A' ' 73' ' ' VAL . . . -93.9 120.13 33.75 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.18 0.437 . . . . 73.230000000000004 112.18 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -131.9 150.31 52.19 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.203 0.525 . . . . 75.129999999999995 110.863 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -92.14 122.81 34.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.005 -0.543 . . . . 75.420000000000002 111.068 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.612 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -120.06 172.94 15.06 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.08 -0.581 . . . . 64.420000000000002 113.487 -176.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.9 9.82 9.17 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.81 0.338 . . . . 62.310000000000002 111.861 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.1 m -64.78 152.97 89.16 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.353 -0.385 . . . . 73.140000000000001 111.67 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.18 163.57 38.73 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.803 2.335 . . . . 70.030000000000001 113.218 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.55 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 84.6 tttt -63.88 133.07 52.64 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.406 -0.361 . . . . 73.129999999999995 111.694 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 77.44 24.37 65.7 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.97 -0.633 . . . . 72.219999999999999 113.198 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.69 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 18.2 ttt -149.78 137.09 19.81 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.374 -0.486 . . . . 74.209999999999994 110.471 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.533 HD13 HG22 ' A' ' 28' ' ' VAL . 39.5 pt -130.09 144.75 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.407 0.622 . . . . 75.420000000000002 112.03 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.511 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 74.6 t80 -106.69 119.36 39.1 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.961 -0.563 . . . . 73.340000000000003 111.383 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 30' ' ' SER . 44.4 mt -117.4 126.36 27.45 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 120.673 0.273 . . . . 75.329999999999998 110.801 175.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.573 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 19.5 Cg_endo -58.56 132.0 45.78 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.121 1.881 . . . . 75.209999999999994 111.934 175.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.453 ' HE2' HD12 ' A' ' 108' ' ' ILE . 6.9 tpp -51.51 115.42 1.61 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.17 0.51 . . . . 74.540000000000006 112.265 -176.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -169.03 178.53 42.24 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.786 -0.643 . . . . 72.0 112.496 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.482 ' O ' ' HG2' ' A' ' 106' ' ' MET . 11.9 Cg_endo -52.87 -33.8 63.01 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 122.853 2.369 . . . . 73.510000000000005 112.095 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -64.82 -47.64 77.29 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.738 -0.665 . . . . 74.230000000000004 110.608 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -64.21 -39.83 94.79 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.018 0.437 . . . . 62.43 111.197 175.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -64.03 -7.04 7.38 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.436 0.532 . . . . 71.329999999999998 112.436 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.636 ' SD ' HD23 ' A' ' 140' ' ' LEU . 95.8 mmm -82.62 -25.62 33.01 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.971 0.415 . . . . 73.209999999999994 111.311 173.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.4 m -120.98 -16.52 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 112.335 0.494 . . . . 74.109999999999999 112.335 -170.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.518 HG22 ' OG ' ' A' ' 30' ' ' SER . 5.9 pt -101.99 -178.43 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.102 0.477 . . . . 73.319999999999993 111.603 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.2 t70 . . . . . 0 CA--C 1.545 0.779 0 CA-C-N 116.356 -0.384 . . . . 75.030000000000001 110.553 173.82 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.773 0 CA-C-O 120.913 0.174 . . . . 63.530000000000001 113.292 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.9 t -93.53 120.95 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 122.398 -0.472 . . . . 74.340000000000003 111.528 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 37.3 mtpt -65.63 155.87 34.55 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.73 0.776 . . . . 73.140000000000001 113.09 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.781 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -178.85 -151.39 9.56 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 114.966 -1.016 . . . . 64.5 112.449 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.417 HG23 ' HA ' ' A' ' 25' ' ' GLU . 45.1 p -141.09 147.79 39.1 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.424 -0.457 . . . . 73.129999999999995 111.538 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.0 p -125.43 144.58 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.291 0.567 . . . . 74.430000000000007 111.904 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -153.87 168.87 24.91 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.796 -0.638 . . . . 64.239999999999995 110.561 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.521 ' HD3' HD23 ' A' ' 67' ' ' LEU . 36.8 ttpt -99.72 139.16 35.78 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.13 0.491 . . . . 74.409999999999997 111.257 174.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.9 t -131.75 161.23 33.34 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.307 0.575 . . . . 63.0 111.968 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -90.18 -2.88 58.11 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.809 -0.632 . . . . 75.409999999999997 111.039 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.67 153.28 44.06 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.98 -0.554 . . . . 64.519999999999996 111.353 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.2 pptp? -87.47 156.86 19.37 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.064 0.459 . . . . 72.420000000000002 111.196 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.23 130.73 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.11 -0.495 . . . . 72.209999999999994 111.834 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.409 ' CD2' ' HG2' ' A' ' 139' ' ' GLU . 2.1 mt -61.74 101.09 0.17 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.411 -0.359 . . . . 74.109999999999999 111.223 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.3 m -52.43 143.2 15.75 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 110.783 -0.08 . . . . 65.109999999999999 110.783 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.458 HG21 ' HD1' ' A' ' 49' ' ' PHE . 68.4 t -45.88 -52.84 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 113.026 0.751 . . . . 73.420000000000002 113.026 -172.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -72.04 -39.96 68.73 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 122.101 -0.374 . . . . 74.299999999999997 111.905 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.409 ' HG2' ' CD2' ' A' ' 135' ' ' LEU . 42.3 tt0 -56.1 -36.21 67.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.622 0.725 . . . . 71.129999999999995 110.542 175.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.636 HD23 ' SD ' ' A' ' 106' ' ' MET . 3.7 tt -61.69 -40.96 96.83 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.136 -0.938 . . . . 75.319999999999993 110.5 174.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.4 mt . . . . . 0 N--CA 1.469 0.507 0 CA-C-O 121.29 0.566 . . . . 75.239999999999995 110.17 174.761 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 14.8 ptm . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 120.928 0.394 . . . . 74.239999999999995 111.08 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.736 HD11 ' HB2' ' A' ' 64' ' ' ALA . 36.7 mt -127.74 148.29 50.42 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.787 0.662 . . . . 74.099999999999994 112.787 -176.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -90.85 122.02 33.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.341 -0.845 . . . . 64.439999999999998 110.219 171.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.37 157.79 37.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.727 -0.67 . . . . 75.329999999999998 112.156 -173.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.639 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 39.7 tt0 -99.93 115.2 29.1 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.233 -0.439 . . . . 74.5 109.999 172.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.516 HG23 HD13 ' A' ' 96' ' ' ILE . 51.0 t -89.03 116.13 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 115.996 -0.547 . . . . 72.329999999999998 112.014 -174.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.461 HD12 ' HE3' ' A' ' 95' ' ' MET . 1.1 mt -102.43 156.67 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.967 0.413 . . . . 71.019999999999996 111.535 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 72.3 m -126.89 104.4 8.01 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.94 0.4 . . . . 74.409999999999997 111.054 175.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.553 0 C-N-CA 121.029 -0.605 . . . . 64.239999999999995 113.584 -176.083 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 121.137 0.494 . . . . 73.299999999999997 111.08 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.509 ' O ' HG23 ' A' ' 52' ' ' VAL . 5.5 t80 -64.49 -37.87 89.05 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.929 -0.578 . . . . 72.439999999999998 110.533 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.502 ' HE2' ' HA ' ' A' ' 136' ' ' SER . 47.6 t80 -62.13 -66.86 0.47 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.983 -0.553 . . . . 74.200000000000003 110.724 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -55.82 -21.77 21.38 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.797 0.666 . . . . 61.420000000000002 112.797 -175.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.68 -36.23 32.6 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.901 0.704 . . . . 71.409999999999997 112.901 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 48' ' ' TYR . 33.2 m -116.83 17.66 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 113.14 0.793 . . . . 71.120000000000005 113.14 -174.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -102.66 26.01 8.49 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.143 0.794 . . . . 72.329999999999998 113.143 -177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -147.71 164.27 34.08 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.472 0.545 . . . . 74.530000000000001 112.472 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.24 133.83 47.7 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.817 -0.629 . . . . 72.239999999999995 110.922 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.526 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 33.2 mt-10 -88.66 121.89 31.51 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.238 0.542 . . . . 72.219999999999999 110.931 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.5 mt -118.18 149.87 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 115.637 -0.71 . . . . 74.310000000000002 111.777 -171.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -72.44 154.1 41.05 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.654 0.264 . . . . 55.200000000000003 111.176 176.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.414 ' CD ' ' HZ1' ' A' ' 88' ' ' LYS . 10.6 tp10 -56.46 -46.11 80.51 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.948 0.404 . . . . 75.439999999999998 111.727 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.45 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 25.6 mm-40 -56.83 -55.69 31.18 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.002 0.43 . . . . 72.530000000000001 111.581 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.64 -36.25 80.24 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.218 0.532 . . . . 71.219999999999999 111.004 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -56.51 -53.74 53.93 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.731 -0.668 . . . . 74.219999999999999 111.747 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -74.03 -28.48 61.45 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.028 0.381 . . . . 72.030000000000001 112.028 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.736 ' HB2' HD11 ' A' ' 24' ' ' LEU . . . -63.33 -32.22 73.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.02 0.438 . . . . 72.349999999999994 111.453 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.475 HD13 HG12 ' A' ' 127' ' ' VAL . 74.7 mt -91.33 -4.75 55.5 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.164 -0.471 . . . . 73.109999999999999 111.665 176.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.03 46.26 94.94 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.427 -0.416 . . . . 71.420000000000002 112.828 -177.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.41 HD21 ' HB2' ' A' ' 129' ' ' LYS . 97.7 mt -85.32 156.48 20.89 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.428 0.899 . . . . 74.409999999999997 113.428 -175.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -127.92 145.37 50.98 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.615 -1.175 . . . . 72.120000000000005 109.0 173.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.01 100.42 0.16 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.454 0.645 . . . . 74.510000000000005 111.87 -176.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.08 -6.09 7.77 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.457 -0.792 . . . . 65.329999999999998 113.176 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -68.03 158.59 32.58 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.364 0.602 . . . . 72.510000000000005 112.072 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.5 mtm-85 -102.12 127.65 48.93 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.8 -0.636 . . . . 75.409999999999997 110.647 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.33 150.28 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.154 0.502 . . . . 73.439999999999998 112.029 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -114.49 136.99 52.4 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.257 0.551 . . . . 73.329999999999998 111.115 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 60.9 t -110.01 122.12 64.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.79 -0.641 . . . . 72.230000000000004 110.623 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -111.63 120.89 43.6 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.796 0.332 . . . . 71.049999999999997 111.505 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.724 HG21 ' HA3' ' A' ' 125' ' ' GLY . 27.6 p -122.53 -177.47 3.64 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.938 0.399 . . . . 73.439999999999998 110.902 176.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -70.69 -11.21 60.8 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.48 -0.327 . . . . 72.430000000000007 111.614 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -94.52 -48.68 6.0 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 111.749 0.277 . . . . 72.349999999999994 111.749 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -171.39 -154.31 9.72 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.577 -0.82 . . . . 74.530000000000001 113.603 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 12.2 pt-20 -154.78 141.88 19.35 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.877 0.37 . . . . 74.140000000000001 111.571 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.7 p -145.12 149.41 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 116.573 -0.285 . . . . 75.420000000000002 111.613 -178.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.49 117.38 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-O 120.527 0.203 . . . . 74.299999999999997 111.259 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.445 ' HA ' HG11 ' A' ' 134' ' ' VAL . 34.8 m -128.09 177.63 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 122.886 0.474 . . . . 70.219999999999999 111.488 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -82.62 142.85 31.41 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.044 0.449 . . . . 72.519999999999996 111.548 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.14 121.46 32.94 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.039 0.385 . . . . 74.209999999999994 112.039 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -131.6 157.65 43.1 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.166 0.508 . . . . 73.209999999999994 110.815 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.414 ' HZ1' ' CD ' ' A' ' 59' ' ' GLU . 32.2 ttmt -95.98 140.49 30.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.285 -0.416 . . . . 75.0 110.852 -178.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.526 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -141.02 -174.51 14.14 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.898 -0.668 . . . . 73.510000000000005 113.71 -177.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -94.69 32.24 1.65 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.958 0.408 . . . . 75.439999999999998 111.641 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.8 m -90.6 152.46 45.12 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.461 -0.336 . . . . 75.200000000000003 111.706 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.59 163.71 33.92 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.88 2.387 . . . . 64.450000000000003 113.366 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 86.6 tttt -66.87 143.05 57.09 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.468 -0.333 . . . . 75.030000000000001 111.293 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 69.57 21.42 76.23 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.876 -0.678 . . . . 63.420000000000002 113.098 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.639 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 15.7 ttt -149.41 136.54 19.82 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.894 -0.41 . . . . 71.340000000000003 109.894 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.516 HD13 HG23 ' A' ' 28' ' ' VAL . 37.4 pt -132.21 145.36 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-O 121.371 0.605 . . . . 73.340000000000003 112.108 -177.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -102.79 129.58 49.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.853 -0.612 . . . . 65.400000000000006 111.209 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' A' ' 30' ' ' SER . 28.8 mt -126.17 131.57 24.01 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 120.571 0.224 . . . . 64.129999999999995 110.68 174.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.22 126.43 22.14 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.374 2.05 . . . . 73.430000000000007 112.196 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.82 99.81 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.849 0.357 . . . . 74.409999999999997 110.634 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.87 -175.24 24.13 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.776 -0.726 . . . . 74.530000000000001 113.018 -176.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.01 -26.02 66.29 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.212 1.941 . . . . 75.310000000000002 112.243 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.485 ' HA ' HD13 ' A' ' 140' ' ' LEU . 4.6 m-85 -68.9 -54.24 16.6 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.676 -0.693 . . . . 74.109999999999999 110.516 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.474 ' O ' HG22 ' A' ' 108' ' ' ILE . . . -61.38 -34.13 74.82 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.925 -0.579 . . . . 74.549999999999997 110.632 175.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -60.31 -19.8 56.61 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.97 -0.559 . . . . 72.209999999999994 111.561 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.616 ' SD ' HD22 ' A' ' 140' ' ' LEU . 33.4 mtp -77.07 -28.03 54.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.797 0.332 . . . . 75.219999999999999 111.417 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.3 m -116.24 -18.11 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.048 0.759 . . . . 60.210000000000001 113.048 -171.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 104' ' ' ALA . 14.7 pt -95.14 -176.17 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 121.399 0.619 . . . . 71.439999999999998 112.375 -176.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.605 ' H ' HG21 ' A' ' 123' ' ' VAL . 24.2 t70 . . . . . 0 CA--C 1.542 0.639 0 CA-C-N 115.577 -0.738 . . . . 74.010000000000005 110.653 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.553 0 N-CA-C 112.43 -0.268 . . . . 72.409999999999997 112.43 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.605 HG21 ' H ' ' A' ' 109' ' ' ASP . 84.3 t -86.73 121.02 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 122.465 -0.433 . . . . 70.420000000000002 111.284 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 48.3 mtpt -68.76 162.42 26.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.741 0.781 . . . . 74.150000000000006 113.047 -176.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.724 ' HA3' HG21 ' A' ' 77' ' ' THR . . . 174.17 -151.65 13.31 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 114.886 -1.052 . . . . 62.420000000000002 112.587 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 65.3 p -135.9 152.46 51.04 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.87 0.367 . . . . 73.519999999999996 111.037 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.475 HG12 HD13 ' A' ' 65' ' ' LEU . 14.6 p -132.25 144.76 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.144 0.497 . . . . 74.5 111.343 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -157.64 152.99 26.06 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.773 -0.649 . . . . 55.130000000000003 110.533 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.41 ' HB2' HD21 ' A' ' 67' ' ' LEU . 32.8 ttpt -79.0 139.29 38.23 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.16 0.505 . . . . 72.439999999999998 111.133 174.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.4 t -135.8 150.56 49.49 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.122 0.487 . . . . 73.209999999999994 111.729 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -80.33 -3.13 48.28 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.337 -0.392 . . . . 74.310000000000002 110.834 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -65.37 155.08 36.48 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.985 0.422 . . . . 75.209999999999994 111.83 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -79.12 150.98 31.62 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.999 0.428 . . . . 71.439999999999998 111.605 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.445 HG11 ' HA ' ' A' ' 84' ' ' VAL . 82.6 t -71.3 128.25 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.233 -0.439 . . . . 75.140000000000001 110.342 172.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 11.0 mt -63.47 133.22 53.53 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.979 0.419 . . . . 73.010000000000005 111.858 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.502 ' HA ' ' HE2' ' A' ' 49' ' ' PHE . 45.2 t -73.51 141.94 46.75 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.911 -0.403 . . . . 75.530000000000001 109.911 171.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.49 HG23 ' HD2' ' A' ' 49' ' ' PHE . 60.5 t -46.45 -46.96 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 112.744 0.646 . . . . 73.420000000000002 112.744 -174.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -72.38 -40.65 67.12 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.021 0.378 . . . . 65.340000000000003 112.021 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -64.61 -33.52 76.12 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.219 0.533 . . . . 70.239999999999995 110.534 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.616 HD22 ' SD ' ' A' ' 106' ' ' MET . 4.0 tt -56.22 -41.08 75.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.886 -0.597 . . . . 73.319999999999993 110.275 172.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.8 mt . . . . . 0 CA--C 1.537 0.463 0 CA-C-O 121.276 0.56 . . . . 72.510000000000005 110.263 176.691 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' MET . . . . . 0.501 ' HE2' ' HB ' ' A' ' 126' ' ' THR . 10.1 ptm . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 120.961 0.41 . . . . 73.310000000000002 111.364 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.526 HD13 ' HG ' ' A' ' 65' ' ' LEU . 9.5 mt -110.3 141.37 43.39 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.971 0.415 . . . . 74.140000000000001 111.804 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -89.9 126.1 35.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.286 0.565 . . . . 74.349999999999994 111.298 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.561 HG13 ' HA2' ' A' ' 94' ' ' GLY . 35.1 m -140.95 163.0 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.546 -0.752 . . . . 74.530000000000001 111.892 -174.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 65.7 tt0 -99.18 117.74 34.34 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.962 0.411 . . . . 74.239999999999995 110.652 172.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.494 HG23 HD13 ' A' ' 96' ' ' ILE . 32.0 t -91.4 115.55 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.133 0.492 . . . . 72.519999999999996 111.714 -175.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.818 HD13 ' HE3' ' A' ' 95' ' ' MET . 1.7 mt -102.1 159.41 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.795 0.331 . . . . 74.349999999999994 110.824 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.72 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 33.7 t -150.37 132.15 15.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.73 0.3 . . . . 71.439999999999998 111.587 175.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.595 ' HA2' ' HB2' ' A' ' 100' ' ' MET . . . . . . . . 0 CA--C 1.523 0.565 0 C-N-CA 119.817 -1.182 . . . . 55.310000000000002 114.91 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 120.643 0.259 . . . . 72.109999999999999 111.364 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -60.52 -31.97 71.02 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.266 0.555 . . . . 74.120000000000005 110.674 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -78.28 -28.83 47.66 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.924 -0.58 . . . . 73.319999999999993 111.541 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -98.77 0.07 43.67 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.161 0.43 . . . . 72.129999999999995 112.161 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.23 -44.44 7.27 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.29 0.848 . . . . 74.420000000000002 113.29 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.417 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 34.2 m -127.19 17.93 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 114.412 1.264 . . . . 75.530000000000001 114.412 -167.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.619 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -101.06 18.01 20.89 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 121.62 -0.675 . . . . 74.409999999999997 112.135 -176.101 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -137.62 159.12 42.85 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.995 -0.44 . . . . 73.340000000000003 111.511 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.66 138.51 51.23 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.334 -0.394 . . . . 73.340000000000003 111.662 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.67 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 41.3 mt-10 -90.2 116.71 28.4 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.213 0.53 . . . . 63.130000000000003 111.003 177.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.565 ' HA ' HG21 ' A' ' 96' ' ' ILE . 35.8 mt -111.57 146.98 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 115.609 -0.723 . . . . 75.409999999999997 111.768 -171.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -67.1 142.95 56.93 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.94 0.4 . . . . 73.219999999999999 111.11 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -63.93 -36.53 84.24 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.792 0.664 . . . . 72.430000000000007 112.792 -175.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.55 -49.24 77.48 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.271 0.558 . . . . 72.439999999999998 110.918 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -66.72 -33.48 75.73 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.811 -0.632 . . . . 75.230000000000004 111.071 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.465 ' HA ' HD11 ' A' ' 67' ' ' LEU . 44.2 t-105 -57.05 -53.67 55.49 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.706 -0.679 . . . . 75.540000000000006 110.939 175.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -65.69 -37.15 85.68 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.977 -0.556 . . . . 64.030000000000001 111.542 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.41 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -59.62 -49.17 78.81 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.96 0.409 . . . . 74.140000000000001 111.848 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.526 ' HG ' HD13 ' A' ' 24' ' ' LEU . 95.0 mt -78.23 -4.51 48.12 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.319 -0.401 . . . . 72.409999999999997 111.74 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.76 45.76 93.57 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.255 -0.498 . . . . 54.25 112.761 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.495 ' HA ' ' HZ1' ' A' ' 129' ' ' LYS . 87.3 mt -80.75 153.39 27.83 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.153 0.501 . . . . 72.230000000000004 111.667 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -139.13 114.93 10.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 73.439999999999998 110.645 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -38.53 102.46 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.363 -0.835 . . . . 75.140000000000001 112.971 -171.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.6 -19.1 4.81 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 114.967 -1.015 . . . . 72.540000000000006 113.161 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -78.91 179.39 7.31 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.114 0.483 . . . . 73.310000000000002 111.958 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -107.5 134.51 50.43 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.356 0.598 . . . . 64.349999999999994 111.842 -175.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.504 HG13 ' HB1' ' A' ' 86' ' ' ALA . 14.5 m -115.97 135.99 54.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.967 -0.56 . . . . 73.150000000000006 111.164 174.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -102.17 140.14 36.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.88 -0.6 . . . . 74.140000000000001 110.584 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 41.5 t -122.43 136.2 60.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.329 -0.396 . . . . 64.219999999999999 110.084 -175.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.451 ' HZ1' ' CD ' ' A' ' 128' ' ' GLU . 39.7 mttt -138.68 126.56 22.36 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.058 0.392 . . . . 74.010000000000005 112.058 -173.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.639 HG21 ' HA3' ' A' ' 125' ' ' GLY . 30.8 p -137.1 -172.18 3.13 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.235 -0.439 . . . . 74.129999999999995 110.547 176.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -65.99 -12.97 58.9 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.216 0.451 . . . . 71.439999999999998 112.216 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -91.39 -34.71 14.75 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.116 0.413 . . . . 65.010000000000005 112.116 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.69 -159.47 31.39 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.226 -0.511 . . . . 72.319999999999993 113.16 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 11.4 pt-20 -137.37 154.01 50.09 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.026 0.441 . . . . 74.310000000000002 112.098 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.441 HG22 HD13 ' A' ' 135' ' ' LEU . 11.4 p -153.06 149.36 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 116.378 -0.374 . . . . 74.439999999999998 111.445 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 36.1 t -110.36 120.09 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 122.347 -0.221 . . . . 72.340000000000003 110.878 176.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.23 173.18 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.99 0.424 . . . . 74.230000000000004 111.956 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -76.6 139.16 40.53 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.01 0.433 . . . . 72.040000000000006 111.426 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.504 ' HB1' HG13 ' A' ' 73' ' ' VAL . . . -87.32 126.12 34.65 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.887 0.699 . . . . 64.099999999999994 112.887 -177.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -130.07 148.18 51.89 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.142 0.496 . . . . 73.510000000000005 110.864 172.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -87.66 124.03 33.12 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.918 -0.583 . . . . 74.140000000000001 109.879 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.67 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -124.33 171.74 16.6 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.87 -0.681 . . . . 62.119999999999997 114.065 -173.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.72 29.58 0.38 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.872 0.469 . . . . 71.230000000000004 112.228 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.9 m -91.21 152.03 43.56 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 116.507 -0.315 . . . . 73.319999999999993 111.653 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -72.6 177.15 7.85 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.689 2.259 . . . . 75.140000000000001 113.588 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -62.94 141.35 58.75 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.022 -0.536 . . . . 72.230000000000004 111.999 -177.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.561 ' HA2' HG13 ' A' ' 26' ' ' VAL . . . 58.31 34.28 73.78 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 120.862 -0.685 . . . . 72.109999999999999 112.805 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.818 ' HE3' HD13 ' A' ' 29' ' ' ILE . 16.7 ttt -150.92 136.73 18.11 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.633 -0.334 . . . . 73.439999999999998 110.321 -178.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.565 HG21 ' HA ' ' A' ' 57' ' ' ILE . 36.8 pt -137.65 146.59 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.136 0.493 . . . . 75.420000000000002 111.652 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -110.08 136.74 48.85 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.942 0.401 . . . . 75.230000000000004 111.272 177.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.72 ' O ' ' HA ' ' A' ' 30' ' ' SER . 45.6 mt -126.35 133.65 25.19 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 116.326 -0.397 . . . . 73.430000000000007 110.643 174.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.417 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 78.2 Cg_exo -52.13 141.82 47.01 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 121.904 1.736 . . . . 75.420000000000002 112.539 174.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.595 ' HB2' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -59.65 106.11 0.44 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.667 0.27 . . . . 74.430000000000007 110.976 -178.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.28 178.67 41.29 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 119.972 -1.108 . . . . 74.120000000000005 113.787 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.467 ' O ' ' HG2' ' A' ' 106' ' ' MET . 17.8 Cg_endo -57.98 -34.94 98.99 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.144 2.563 . . . . 74.329999999999998 112.82 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.5 ' HA ' HD13 ' A' ' 140' ' ' LEU . 53.1 m-85 -59.96 -50.14 74.94 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.109 0.481 . . . . 74.409999999999997 110.631 177.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.489 ' O ' HG22 ' A' ' 108' ' ' ILE . . . -65.29 -37.37 86.95 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.124 -0.489 . . . . 75.150000000000006 111.017 174.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.434 ' HB3' ' HA ' ' A' ' 102' ' ' PRO . 5.4 t30 -56.58 -20.09 19.15 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.763 0.425 . . . . 74.409999999999997 111.728 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.59 ' SD ' HD21 ' A' ' 140' ' ' LEU . 90.9 mmm -72.97 -24.05 60.74 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.807 0.336 . . . . 64.400000000000006 111.779 177.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.5 m -129.06 -9.03 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 113.027 0.751 . . . . 63.439999999999998 113.027 -171.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 104' ' ' ALA . 5.8 pt -104.91 -177.54 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.167 0.508 . . . . 75.120000000000005 111.531 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.41 ' N ' HG23 ' A' ' 123' ' ' VAL . 30.1 t70 . . . . . 0 CA--C 1.542 0.649 0 CA-C-N 116.107 -0.497 . . . . 62.119999999999997 110.916 175.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 N-CA-C 114.009 0.364 . . . . 71.230000000000004 114.009 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.41 HG23 ' N ' ' A' ' 109' ' ' ASP . 52.5 t -100.3 118.63 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.806 0.336 . . . . 62.130000000000003 111.543 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 55.5 mtmt -72.82 155.41 39.96 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.274 0.559 . . . . 75.340000000000003 112.186 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.639 ' HA3' HG21 ' A' ' 77' ' ' THR . . . 177.84 -135.0 2.57 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.782 -0.645 . . . . 65.230000000000004 112.84 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.501 ' HB ' ' HE2' ' A' ' 23' ' ' MET . 60.8 p -140.55 154.84 46.67 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.269 0.47 . . . . 73.450000000000003 112.269 -177.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.1 p -133.97 147.98 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.931 -0.577 . . . . 73.25 110.677 175.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.451 ' CD ' ' HZ1' ' A' ' 76' ' ' LYS . 9.5 pt-20 -151.9 161.89 41.93 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.37 -0.377 . . . . 75.030000000000001 111.462 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.495 ' HZ1' ' HA ' ' A' ' 67' ' ' LEU . 17.6 ttmm -87.24 140.65 29.33 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 110.226 -0.287 . . . . 72.340000000000003 110.226 170.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.2 t -139.47 142.82 37.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.302 0.572 . . . . 73.219999999999999 111.864 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -75.31 -11.24 60.02 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.617 -0.72 . . . . 74.530000000000001 110.827 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -61.91 154.3 26.64 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.861 -0.609 . . . . 65.239999999999995 112.071 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -80.89 162.08 24.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.748 -0.66 . . . . 74.25 111.927 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 76.5 t -76.28 136.17 25.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.651 -0.704 . . . . 74.420000000000002 111.101 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.441 HD13 HG22 ' A' ' 82' ' ' VAL . 17.8 mt -59.65 133.58 56.23 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.502 -0.317 . . . . 72.239999999999995 111.298 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.6 t -76.76 143.77 39.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.691 -0.855 . . . . 75.109999999999999 108.691 169.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.3 t -48.26 -41.16 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.084 0.469 . . . . 75.219999999999999 111.899 -174.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -72.02 -41.6 67.36 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.026 -0.534 . . . . 71.450000000000003 111.65 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -58.52 -37.2 75.11 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.78 0.8 . . . . 71.519999999999996 110.15 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.59 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.5 tt -62.29 -38.3 88.82 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.05 -0.977 . . . . 74.310000000000002 111.033 176.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.0 mt . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 121.486 0.66 . . . . 73.319999999999993 110.056 176.077 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.2 ptp . . . . . 0 CA--C 1.539 0.551 0 CA-C-O 121.26 0.553 . . . . 71.430000000000007 112.027 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.4 mt -127.37 131.64 50.31 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.768 -0.651 . . . . 75.340000000000003 111.104 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -73.13 111.11 7.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.865 0.364 . . . . 73.109999999999999 110.849 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.469 HG11 ' HA2' ' A' ' 94' ' ' GLY . 31.1 m -127.84 159.62 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.351 -0.386 . . . . 74.310000000000002 111.964 -174.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 35.4 tt0 -98.79 118.53 35.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.884 0.373 . . . . 61.530000000000001 110.605 174.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.504 HG22 HD13 ' A' ' 96' ' ' ILE . 40.1 t -93.23 108.16 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.109 -0.496 . . . . 75.329999999999998 111.74 -175.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.721 HD12 ' HE1' ' A' ' 95' ' ' MET . 1.3 mt -97.73 160.56 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.826 0.346 . . . . 75.319999999999993 111.234 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.619 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 74.3 m -136.5 100.48 4.37 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.078 0.466 . . . . 73.010000000000005 111.929 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.58 0 C-N-CA 121.049 -0.596 . . . . 51.030000000000001 112.397 178.129 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 CA--C 1.542 0.647 0 CA-C-O 120.832 0.348 . . . . 72.310000000000002 111.467 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -60.09 -36.78 78.16 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.431 0.634 . . . . 73.319999999999993 110.604 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.488 ' HD1' HG21 ' A' ' 137' ' ' VAL . 58.0 t80 -81.09 -7.57 59.59 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.59 -0.732 . . . . 60.32 112.046 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -118.43 2.17 11.82 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.877 -0.514 . . . . 64.420000000000002 111.814 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.09 -57.04 2.45 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.378 0.51 . . . . 73.349999999999994 112.378 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.463 HG22 ' HD2' ' A' ' 102' ' ' PRO . 34.7 m -108.33 20.48 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 112.873 0.694 . . . . 75.340000000000003 112.873 -173.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.616 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -104.08 18.48 21.96 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.66 0.615 . . . . 72.140000000000001 112.66 -172.363 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -141.55 165.13 28.33 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.223 0.535 . . . . 74.510000000000005 112.426 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.96 130.94 45.71 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.709 -0.678 . . . . 63.43 110.884 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.652 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 31.8 mt-10 -88.65 120.24 29.86 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.351 0.596 . . . . 74.510000000000005 111.638 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.1 mt -118.76 148.27 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.32 -0.855 . . . . 72.540000000000006 111.615 -170.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -75.42 142.73 42.98 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.771 0.32 . . . . 72.239999999999995 110.386 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 62' ' ' TRP . 27.0 tt0 -56.04 -36.97 68.6 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.481 0.548 . . . . 73.140000000000001 112.481 -174.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -54.66 -51.63 64.87 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 111.894 0.331 . . . . 71.230000000000004 111.894 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -69.7 -36.82 76.27 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.337 0.589 . . . . 75.430000000000007 110.579 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.462 ' HA ' HD11 ' A' ' 67' ' ' LEU . 31.0 t-105 -53.22 -52.08 60.08 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.466 -0.788 . . . . 73.239999999999995 111.69 176.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -65.62 -38.87 90.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.129 -0.487 . . . . 73.519999999999996 111.296 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.37 -43.4 88.43 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.169 0.509 . . . . 73.129999999999995 111.55 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.9 mt -79.91 -1.83 41.03 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.201 -0.454 . . . . 73.540000000000006 112.038 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.93 44.9 96.71 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.435 -0.412 . . . . 73.120000000000005 112.998 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.721 HD22 ' HD3' ' A' ' 129' ' ' LYS . 67.0 mt -87.04 142.51 27.87 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.032 0.752 . . . . 74.540000000000006 113.032 -175.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -115.0 150.11 36.35 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.942 -0.762 . . . . 72.319999999999993 108.942 170.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.31 103.9 0.11 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.168 0.509 . . . . 74.25 111.898 -177.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.51 -8.34 10.23 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 115.888 -0.596 . . . . 60.030000000000001 113.783 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.67 167.54 7.2 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.618 0.723 . . . . 62.100000000000001 112.665 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -113.08 126.52 55.56 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.295 -0.866 . . . . 71.120000000000005 111.36 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.443 HG13 ' HB1' ' A' ' 86' ' ' ALA . 21.1 m -114.51 139.24 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.175 0.512 . . . . 72.120000000000005 112.054 -178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.491 ' HG2' ' HD2' ' A' ' 76' ' ' LYS . 22.9 ttmm -103.18 111.84 24.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.072 -0.513 . . . . 74.129999999999995 110.395 177.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 47.9 t -96.68 126.25 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 116.468 -0.333 . . . . 70.030000000000001 111.523 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.549 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -117.72 139.64 50.76 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.061 0.458 . . . . 74.209999999999994 111.735 178.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.2 p -134.63 -171.9 2.89 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.402 -0.363 . . . . 72.25 110.246 173.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.23 -4.08 39.93 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 122.158 -0.339 . . . . 74.030000000000001 111.229 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -99.6 -48.33 4.78 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.714 0.293 . . . . 73.430000000000007 111.346 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.94 -158.21 19.75 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.136 -0.554 . . . . 62.100000000000001 112.779 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.549 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 8.8 pt-20 -144.68 160.22 41.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.265 0.555 . . . . 73.239999999999995 112.325 178.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.3 p -156.71 147.27 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.963 -0.562 . . . . 75.319999999999993 111.115 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.9 t -105.45 117.79 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 O-C-N 122.327 -0.233 . . . . 75.129999999999995 110.963 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 m -126.98 178.05 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.953 0.406 . . . . 70.120000000000005 111.826 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -82.43 140.17 33.57 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.023 0.439 . . . . 74.120000000000005 111.374 176.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.443 ' HB1' HG13 ' A' ' 73' ' ' VAL . . . -89.98 124.88 35.12 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.436 0.532 . . . . 70.129999999999995 112.436 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -122.57 159.04 28.6 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.279 0.561 . . . . 71.219999999999999 111.592 174.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.405 ' HD3' ' HB2' ' A' ' 59' ' ' GLU . 30.0 ttmt -99.61 114.88 28.21 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.81 -0.632 . . . . 73.340000000000003 110.282 175.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.652 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -119.82 -177.67 16.24 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.852 -0.689 . . . . 30.25 114.495 -172.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -89.26 34.43 0.8 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.209 0.603 . . . . 64.239999999999995 111.536 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.1 m -100.27 149.67 36.25 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 112.514 0.561 . . . . 74.230000000000004 112.514 -174.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.83 163.69 21.18 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.724 2.283 . . . . 74.129999999999995 112.4 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -68.72 146.91 52.54 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.105 -0.372 . . . . 72.239999999999995 111.352 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.469 ' HA2' HG11 ' A' ' 26' ' ' VAL . . . 63.67 32.59 84.67 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.902 -0.666 . . . . 75.409999999999997 112.491 -174.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.721 ' HE1' HD12 ' A' ' 29' ' ' ILE . 21.6 ttt -152.37 136.32 16.38 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.911 -0.403 . . . . 74.349999999999994 109.911 -177.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.504 HD13 HG22 ' A' ' 28' ' ' VAL . 33.6 pt -137.74 138.6 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.431 0.634 . . . . 73.040000000000006 112.322 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -100.45 129.07 46.36 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.891 -0.595 . . . . 71.140000000000001 111.039 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.619 ' O ' ' HA ' ' A' ' 30' ' ' SER . 38.9 mt -122.42 132.63 24.23 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 120.523 0.201 . . . . 72.340000000000003 110.479 174.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.413 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 31.3 Cg_exo -60.43 127.19 22.04 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.04 1.826 . . . . 74.099999999999994 111.711 173.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.414 ' HE3' ' H ' ' A' ' 101' ' ' GLY . 6.1 tpt -54.07 111.81 0.84 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.98 0.419 . . . . 73.310000000000002 111.88 -175.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.414 ' H ' ' HE3' ' A' ' 100' ' ' MET . . . -163.02 -174.4 32.89 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.861 -0.685 . . . . 71.299999999999997 112.751 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.463 ' HD2' HG22 ' A' ' 52' ' ' VAL . 18.8 Cg_endo -56.54 -34.06 94.27 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.802 2.335 . . . . 71.219999999999999 112.157 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.413 ' HA ' HD13 ' A' ' 140' ' ' LEU . 46.8 m-85 -63.82 -53.82 44.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.888 -0.597 . . . . 71.319999999999993 111.059 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.465 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.58 -38.36 87.24 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.187 0.518 . . . . 72.5 111.136 175.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -57.59 -17.15 12.71 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.071 0.549 . . . . 73.310000000000002 112.454 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.544 ' SD ' HD22 ' A' ' 140' ' ' LEU . 87.5 mmm -77.19 -22.82 51.81 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.195 0.443 . . . . 73.439999999999998 112.195 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.1 m -123.23 -26.22 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 112.748 0.647 . . . . 75.329999999999998 112.748 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.545 HG22 ' OG ' ' A' ' 30' ' ' SER . 6.9 pt -84.01 179.36 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.892 0.377 . . . . 70.340000000000003 111.786 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 CA--C 1.54 0.577 0 CA-C-N 116.522 -0.308 . . . . 64.5 111.178 178.068 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.434 0 CA-C-O 121.029 0.239 . . . . 63.130000000000003 113.381 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 66.2 t -84.53 118.7 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.816 0.341 . . . . 74.549999999999997 111.128 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 54.6 mtmt -76.01 156.01 34.43 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.575 0.703 . . . . 74.099999999999994 112.675 -176.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -177.18 -145.36 5.72 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.131 -0.94 . . . . 65.019999999999996 112.307 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 57.6 p -136.79 146.46 45.74 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.526 -0.396 . . . . 75.400000000000006 111.474 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.8 p -128.38 143.48 40.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.927 0.394 . . . . 73.129999999999995 111.153 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.52 148.29 30.05 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.319 -0.4 . . . . 73.299999999999997 110.814 176.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.721 ' HD3' HD22 ' A' ' 67' ' ' LEU . 28.7 ttpp -73.28 139.44 46.13 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.934 -0.395 . . . . 73.219999999999999 109.934 175.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.6 t -127.08 161.51 28.26 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.371 0.878 . . . . 64.340000000000003 113.371 -168.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -92.54 7.04 44.96 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.329 -0.85 . . . . 62.310000000000002 110.448 173.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -87.38 165.54 15.51 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.813 -0.63 . . . . 74.319999999999993 111.65 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.41 161.13 15.71 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.075 -0.511 . . . . 73.209999999999994 111.336 177.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 92.4 t -71.53 128.14 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.679 -0.237 . . . . 74.030000000000001 110.7 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.462 ' HA ' HD22 ' A' ' 135' ' ' LEU . 8.8 mt -65.24 88.3 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.776 0.322 . . . . 74.230000000000004 111.351 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.7 m -51.87 150.01 4.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.943 -0.572 . . . . 72.420000000000002 110.541 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.488 HG21 ' HD1' ' A' ' 49' ' ' PHE . 66.9 t -44.8 -48.78 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 113.063 0.764 . . . . 74.519999999999996 113.063 -168.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -73.1 -39.85 65.46 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.977 -0.452 . . . . 74.510000000000005 111.777 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -57.84 -36.33 72.13 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.772 0.796 . . . . 72.239999999999995 109.919 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.544 HD22 ' SD ' ' A' ' 106' ' ' MET . 3.1 tt -62.55 -42.57 99.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.851 -1.068 . . . . 74.239999999999995 110.677 174.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 50.9 mt . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 121.364 0.602 . . . . 75.400000000000006 109.859 175.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.5 ptm . . . . . 0 CA--C 1.541 0.608 0 CA-C-O 120.865 0.364 . . . . 72.510000000000005 111.333 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.512 HD13 ' HG ' ' A' ' 65' ' ' LEU . 14.8 mt -96.96 132.66 42.53 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.463 0.542 . . . . 73.239999999999995 112.463 -176.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -83.06 109.75 17.4 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.313 0.578 . . . . 71.349999999999994 110.897 174.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.459 HG13 ' HA2' ' A' ' 94' ' ' GLY . 32.0 m -132.37 161.51 41.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.383 -0.826 . . . . 74.129999999999995 111.174 -174.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 33.2 tt0 -98.81 123.85 43.32 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.04 0.448 . . . . 73.340000000000003 111.174 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.43 117.13 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.913 -0.585 . . . . 74.319999999999993 111.907 -175.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.5 HD13 ' HE2' ' A' ' 95' ' ' MET . 1.2 mt -103.13 163.05 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 122.24 -0.288 . . . . 74.140000000000001 111.172 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 11.7 t -131.95 120.51 22.59 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.915 0.388 . . . . 72.340000000000003 111.492 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.933 0 C-N-CA 121.093 -0.575 . . . . 73.200000000000003 113.178 -179.114 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.437 ' HA ' HD22 ' A' ' 50' ' ' ASN . 42.3 tt0 . . . . . 0 CA--C 1.536 0.432 0 CA-C-O 120.629 0.252 . . . . 72.219999999999999 111.301 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.524 ' O ' HG21 ' A' ' 52' ' ' VAL . 5.6 t80 -61.76 -35.54 78.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.284 0.564 . . . . 72.450000000000003 109.982 178.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -61.6 -68.31 0.33 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.793 -0.64 . . . . 75.239999999999995 110.793 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.437 HD22 ' HA ' ' A' ' 47' ' ' GLU . 10.1 p30 -62.53 -15.1 48.88 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.145 0.424 . . . . 73.129999999999995 112.145 -176.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.412 ' O ' ' HG2' ' A' ' 99' ' ' PRO . . . -80.51 -48.53 12.64 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.576 0.584 . . . . 73.420000000000002 112.576 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.545 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 21.0 m -100.93 5.39 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 113.463 0.912 . . . . 71.140000000000001 113.463 -173.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.432 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -91.79 17.61 8.81 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.476 0.917 . . . . 73.25 113.476 -176.029 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -137.79 164.18 29.56 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.229 0.538 . . . . 74.319999999999993 112.158 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.77 144.23 51.11 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.652 -0.703 . . . . 74.510000000000005 110.654 173.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.713 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 86.3 mt-10 -95.32 115.67 27.74 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.603 0.24 . . . . 74.519999999999996 111.395 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.456 HD11 ' N ' ' A' ' 57' ' ' ILE . 4.2 mp -110.24 150.89 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 120.88 0.371 . . . . 73.019999999999996 110.966 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -70.11 154.88 41.39 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.826 0.451 . . . . 62.43 111.529 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -54.37 -48.93 70.92 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.485 0.55 . . . . 70.109999999999999 112.485 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -67.23 -44.8 78.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.798 0.332 . . . . 73.409999999999997 111.747 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.412 ' HB3' HD12 ' A' ' 24' ' ' LEU . 40.9 m-20 -67.1 -36.51 82.09 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.116 0.484 . . . . 74.239999999999995 111.324 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.6 t-105 -53.13 -54.21 39.07 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.705 -0.68 . . . . 74.140000000000001 111.282 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -71.74 -28.12 63.45 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.681 -0.69 . . . . 63.210000000000001 111.818 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.21 -37.66 83.78 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.162 0.506 . . . . 74.340000000000003 111.457 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.57 HD12 HG12 ' A' ' 127' ' ' VAL . 92.4 mt -88.41 -8.19 55.4 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.254 -0.43 . . . . 74.409999999999997 111.639 177.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.4 46.99 73.69 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.071 -0.585 . . . . 72.310000000000002 112.708 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.641 HD23 ' HE3' ' A' ' 129' ' ' LYS . 79.9 mt -86.16 152.3 22.95 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.129 0.49 . . . . 73.340000000000003 111.965 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.521 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 61.3 tt0 -119.62 145.58 46.31 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.097 -0.502 . . . . 74.329999999999998 109.789 172.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -56.35 110.11 0.71 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.113 0.482 . . . . 75.219999999999999 111.741 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.88 4.03 39.35 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 115.89 -0.595 . . . . 73.109999999999999 113.274 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.521 ' HB2' ' O ' ' A' ' 68' ' ' GLN . 0.5 OUTLIER -69.85 174.16 5.53 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.579 0.585 . . . . 75.409999999999997 112.579 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -105.42 123.74 48.39 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.042 -0.526 . . . . 74.420000000000002 110.689 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.424 HG12 ' HB3' ' A' ' 86' ' ' ALA . 17.9 m -118.35 144.48 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.331 0.586 . . . . 71.120000000000005 112.271 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.612 ' HD2' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -96.02 137.13 35.53 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.815 -0.63 . . . . 74.219999999999999 110.374 175.396 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 61.5 t -124.98 120.72 59.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.348 -0.612 . . . . 63.509999999999998 109.348 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.572 ' HZ2' ' HB3' ' A' ' 76' ' ' LYS . 4.8 mtpm? -129.88 132.15 46.32 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.098 0.475 . . . . 75.310000000000002 112.076 -171.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.702 HG21 ' HA3' ' A' ' 125' ' ' GLY . 30.8 p -135.81 -172.33 3.08 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.269 0.557 . . . . 75.319999999999993 111.072 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -72.21 -6.15 40.8 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.13 -0.486 . . . . 71.140000000000001 111.847 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -95.59 -52.6 4.05 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.789 0.328 . . . . 71.140000000000001 111.138 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.27 -162.59 27.84 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.349 -0.453 . . . . 64.349999999999994 112.7 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.612 ' HB2' ' HD2' ' A' ' 74' ' ' LYS . 0.4 OUTLIER -135.61 150.22 49.59 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.285 0.564 . . . . 65.439999999999998 112.141 178.671 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.44 HG21 ' HA ' ' A' ' 103' ' ' TYR . 8.8 p -143.84 153.56 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 116.02 -0.536 . . . . 75.209999999999994 111.245 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.6 t -112.78 121.76 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 122.211 0.205 . . . . 75.530000000000001 110.843 177.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.4 HG11 ' CD2' ' A' ' 103' ' ' TYR . 35.0 m -132.86 172.4 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.23 0.455 . . . . 73.329999999999998 112.23 -177.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -73.67 146.1 44.76 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.074 0.464 . . . . 75.099999999999994 110.998 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB3' HG12 ' A' ' 73' ' ' VAL . . . -96.31 119.54 34.98 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.625 0.602 . . . . 72.209999999999994 112.625 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -124.63 152.96 42.97 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.151 0.501 . . . . 75.349999999999994 110.678 172.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -96.11 114.9 26.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.18 -0.464 . . . . 73.530000000000001 110.042 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.713 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -113.86 -161.37 14.13 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.465 -0.874 . . . . 75.120000000000005 114.773 -170.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -93.79 23.2 4.94 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.12 0.485 . . . . 73.450000000000003 111.588 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.2 m -87.36 144.66 36.18 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.19 -0.459 . . . . 75.439999999999998 112.225 -175.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.89 174.71 12.37 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.646 2.231 . . . . 64.430000000000007 113.391 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -57.53 126.12 25.92 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.963 -0.562 . . . . 71.120000000000005 111.86 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.459 ' HA2' HG13 ' A' ' 26' ' ' VAL . . . 73.31 29.21 64.56 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.171 -0.538 . . . . 73.510000000000005 114.15 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.63 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 15.0 ttt -148.8 139.82 23.01 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.383 -0.481 . . . . 74.099999999999994 110.214 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.413 HG22 ' HA ' ' A' ' 57' ' ' ILE . 40.0 pt -134.06 148.88 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.401 0.619 . . . . 72.420000000000002 112.078 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -109.06 130.25 55.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.981 -0.554 . . . . 74.549999999999997 111.54 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 30' ' ' SER . 49.5 mt -123.26 129.58 24.87 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 120.858 0.361 . . . . 73.409999999999997 110.967 174.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.545 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 50.5 Cg_exo -57.66 142.28 95.73 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.406 2.071 . . . . 73.019999999999996 112.572 175.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.51 ' HA ' ' HE3' ' A' ' 100' ' ' MET . 4.2 tpt -59.44 107.05 0.52 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.173 0.511 . . . . 75.310000000000002 111.564 -177.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.41 -176.51 38.81 Favored Glycine 0 CA--C 1.521 0.406 0 C-N-CA 120.114 -1.041 . . . . 70.420000000000002 113.612 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.488 ' HG3' HG11 ' A' ' 137' ' ' VAL . 19.5 Cg_endo -57.28 -34.64 98.2 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.034 2.489 . . . . 64.140000000000001 111.941 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.44 ' HA ' HG21 ' A' ' 82' ' ' VAL . 72.1 m-85 -61.75 -51.49 68.12 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.659 -0.7 . . . . 74.040000000000006 110.704 177.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.424 ' O ' HG22 ' A' ' 108' ' ' ILE . . . -62.86 -36.43 83.25 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.202 -0.454 . . . . 62.399999999999999 111.152 175.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -56.68 -23.82 44.59 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.05 0.54 . . . . 72.349999999999994 111.963 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.498 ' SD ' HD22 ' A' ' 140' ' ' LEU . 86.2 mmm -74.24 -22.08 59.5 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.907 0.336 . . . . 65.409999999999997 111.907 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.5 -21.1 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 113.169 0.803 . . . . 61.219999999999999 113.169 -170.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.424 HG22 ' O ' ' A' ' 104' ' ' ALA . 7.0 pt -95.98 -179.42 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.282 0.563 . . . . 74.099999999999994 111.841 -177.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.461 ' H ' HG23 ' A' ' 123' ' ' VAL . 22.0 t70 . . . . . 0 CA--C 1.545 0.754 0 CA-C-N 116.029 -0.532 . . . . 73.239999999999995 111.016 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.681 0 CA-C-O 121.115 0.286 . . . . 72.099999999999994 113.669 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.461 HG23 ' H ' ' A' ' 109' ' ' ASP . 61.2 t -94.28 119.15 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 122.606 -0.35 . . . . 71.310000000000002 111.259 175.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 6.8 ttpt -66.78 152.82 44.79 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.409 0.623 . . . . 73.239999999999995 112.347 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.702 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -174.05 -144.67 4.89 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.553 -0.749 . . . . 60.109999999999999 112.635 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 65.9 p -140.97 160.23 40.51 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.488 0.315 . . . . 71.439999999999998 111.704 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.57 HG12 HD12 ' A' ' 65' ' ' LEU . 13.6 p -142.97 144.6 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 120.855 0.359 . . . . 71.349999999999994 111.311 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -154.95 165.0 38.08 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.246 0.546 . . . . 73.329999999999998 112.44 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.641 ' HE3' HD23 ' A' ' 67' ' ' LEU . 5.5 tppp? -70.51 138.77 51.32 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.107 -0.497 . . . . 74.099999999999994 111.11 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 t -144.54 149.82 36.5 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.437 0.637 . . . . 65.129999999999995 112.431 175.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -90.19 -5.55 56.29 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.609 -0.723 . . . . 71.109999999999999 111.009 176.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.474 ' CD ' ' HZ3' ' A' ' 74' ' ' LYS . 27.8 mt-10 -63.67 165.48 8.23 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.081 -0.509 . . . . 74.430000000000007 111.591 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -92.34 155.41 17.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.026 0.441 . . . . 75.140000000000001 111.095 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 99.1 t -58.9 127.74 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.237 -0.438 . . . . 73.349999999999994 110.979 173.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.37 86.83 0.83 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.717 0.294 . . . . 71.200000000000003 111.103 -178.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.5 m -44.49 141.74 1.85 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.774 -0.648 . . . . 71.030000000000001 111.908 -175.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 51.4 t -45.14 -50.11 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.879 0.696 . . . . 74.25 112.879 -172.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -70.5 -43.58 69.4 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.625 0.25 . . . . 75.530000000000001 111.435 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -55.14 -41.64 72.02 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.795 0.807 . . . . 72.510000000000005 110.381 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.498 HD22 ' SD ' ' A' ' 106' ' ' MET . 2.4 tt -61.22 -37.77 84.21 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.018 -0.992 . . . . 75.530000000000001 111.351 177.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 52.2 mt . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 121.301 0.572 . . . . 75.239999999999995 110.506 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.4 ptm . . . . . 0 CA--C 1.538 0.511 0 CA-C-O 120.637 0.256 . . . . 74.540000000000006 110.93 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 mp -117.16 148.85 41.22 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.07 0.462 . . . . 74.099999999999994 112.179 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.39 128.01 34.57 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.569 0.699 . . . . 72.409999999999997 111.45 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.465 HG11 ' HA2' ' A' ' 94' ' ' GLY . 27.4 m -140.67 162.46 23.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.337 -0.847 . . . . 75.450000000000003 110.97 -176.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.725 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 41.9 tt0 -98.88 112.46 24.55 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.122 0.487 . . . . 75.510000000000005 110.127 175.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.3 t -86.98 119.26 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.782 -0.644 . . . . 73.109999999999999 111.87 -172.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.429 HD12 ' HE1' ' A' ' 95' ' ' MET . 2.8 mt -103.56 154.99 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.793 0.33 . . . . 75.120000000000005 111.531 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.632 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 11.4 t -133.78 107.66 8.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.942 0.401 . . . . 62.450000000000003 111.077 175.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.603 0 C-N-CA 121.161 -0.542 . . . . 65.299999999999997 113.134 -177.44 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 CA--C 1.536 0.437 0 CA-C-O 121.033 0.444 . . . . 73.25 111.039 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.539 ' O ' HG21 ' A' ' 52' ' ' VAL . 4.1 t80 -59.3 -44.02 92.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.289 0.566 . . . . 75.129999999999995 109.583 176.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.5 ' HD2' HG21 ' A' ' 137' ' ' VAL . 57.8 t80 -60.44 -60.51 3.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.572 -0.74 . . . . 64.439999999999998 110.16 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -53.08 -28.42 24.99 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.884 -0.598 . . . . 74.409999999999997 112.313 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.24 -37.87 25.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.271 0.841 . . . . 64.109999999999999 113.271 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 48' ' ' TYR . 19.3 m -109.76 9.61 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 113.494 0.924 . . . . 74.439999999999998 113.494 -172.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -98.38 25.91 5.9 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.061 0.763 . . . . 54.509999999999998 113.061 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.431 ' CD1' ' HD2' ' A' ' 87' ' ' LYS . 52.8 p90 -146.5 158.56 43.91 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.012 -0.43 . . . . 70.120000000000005 111.752 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.49 139.26 51.63 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.302 -0.408 . . . . 61.539999999999999 111.484 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.649 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 42.7 mt-10 -87.68 113.15 23.09 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.219 0.533 . . . . 73.540000000000006 110.943 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.8 mt -112.44 150.71 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.561 -0.745 . . . . 75.140000000000001 111.593 -171.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.655 ' ND2' HG22 ' A' ' 91' ' ' VAL . 1.9 m120 -72.19 135.17 46.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.498 -0.319 . . . . 72.030000000000001 110.976 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 37.4 tt0 -54.18 -40.17 67.3 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.629 0.603 . . . . 62.409999999999997 112.629 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -64.14 -49.56 71.66 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.543 0.572 . . . . 74.310000000000002 112.543 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -70.42 -29.4 66.0 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.657 0.742 . . . . 71.329999999999998 110.284 177.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.505 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 32.2 t-105 -55.83 -47.54 77.05 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.169 -0.923 . . . . 75.510000000000005 110.401 172.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -65.12 -41.44 94.87 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.848 -0.615 . . . . 73.349999999999994 111.037 174.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.95 -39.27 74.24 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 111.939 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.4 mt -88.03 -12.53 44.08 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.24 -0.437 . . . . 74.540000000000006 111.782 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.89 50.59 51.95 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.193 -0.527 . . . . 61.439999999999998 112.642 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.624 HD23 ' HE3' ' A' ' 129' ' ' LYS . 86.1 mt -88.65 155.21 19.74 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.471 0.653 . . . . 73.200000000000003 112.467 -176.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -127.14 151.95 47.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.619 -0.719 . . . . 74.439999999999998 109.501 173.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -63.52 98.68 0.18 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.525 0.678 . . . . 75.040000000000006 111.762 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.13 -17.92 5.91 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.119 -0.946 . . . . 72.109999999999999 112.888 -175.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -56.48 155.69 6.93 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.314 0.578 . . . . 73.439999999999998 112.242 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -94.89 123.08 38.15 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.746 -0.661 . . . . 73.530000000000001 110.66 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.49 HG13 ' HB1' ' A' ' 86' ' ' ALA . 31.6 m -116.5 147.38 19.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.018 0.437 . . . . 75.120000000000005 111.377 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.485 ' HB2' HG22 ' A' ' 83' ' ' VAL . 4.6 ttpm? -114.66 138.76 50.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.477 0.656 . . . . 72.200000000000003 110.969 176.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 57.7 t -116.95 134.33 60.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.45 -0.796 . . . . 73.219999999999999 109.669 -175.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -133.58 123.72 25.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.263 0.468 . . . . 70.439999999999998 112.263 -172.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.693 HG21 ' HA3' ' A' ' 125' ' ' GLY . 36.9 p -126.2 -172.26 2.58 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.209 -0.45 . . . . 74.519999999999996 110.703 174.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.63 -14.42 61.6 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.809 0.338 . . . . 74.239999999999995 111.151 175.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -84.51 -52.79 5.87 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.778 0.323 . . . . 73.329999999999998 111.376 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.08 -159.62 20.06 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.979 -0.629 . . . . 71.430000000000007 113.122 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 0.4 OUTLIER -143.61 153.16 42.24 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.034 0.445 . . . . 64.230000000000004 111.606 176.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.1 p -150.77 145.93 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.332 -0.395 . . . . 74.319999999999993 111.377 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 74' ' ' LYS . 60.9 t -107.34 118.93 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 120.532 0.206 . . . . 74.450000000000003 111.169 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.74 178.11 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 122.802 0.441 . . . . 75.409999999999997 111.576 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -81.65 146.73 29.9 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.221 0.534 . . . . 74.340000000000003 111.754 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.49 ' HB1' HG13 ' A' ' 73' ' ' VAL . . . -93.52 129.11 39.85 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.888 0.699 . . . . 75.340000000000003 112.888 -177.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HD2' ' CD1' ' A' ' 54' ' ' TYR . 67.3 mttm -135.3 151.77 50.85 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.973 -0.558 . . . . 75.510000000000005 109.978 172.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -78.01 147.43 34.84 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.069 -0.394 . . . . 71.129999999999995 110.511 173.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.649 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -134.73 168.72 23.47 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.804 -0.712 . . . . 75.120000000000005 114.018 -175.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -89.22 23.95 2.32 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.365 0.602 . . . . 72.049999999999997 110.958 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.655 HG22 ' ND2' ' A' ' 58' ' ' ASN . 17.3 m -91.28 151.94 43.37 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 115.925 -0.579 . . . . 64.140000000000001 112.221 -175.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.19 145.57 55.04 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.098 2.532 . . . . 74.150000000000006 112.782 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -52.54 142.31 18.23 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.386 0.513 . . . . 74.439999999999998 112.386 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.465 ' HA2' HG11 ' A' ' 26' ' ' VAL . . . 71.55 25.79 74.49 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.806 -0.711 . . . . 64.040000000000006 113.195 -174.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' MET . . . . . 0.725 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 19.0 ttt -154.43 135.03 13.51 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.42 -0.459 . . . . 74.450000000000003 110.029 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.421 ' O ' HG13 ' A' ' 29' ' ' ILE . 41.8 pt -133.22 145.67 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 120.998 0.428 . . . . 74.319999999999993 112.154 -174.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -105.27 130.19 53.46 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.429 -0.351 . . . . 74.109999999999999 111.424 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 30' ' ' SER . 50.8 mt -125.31 130.34 24.17 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 120.776 0.322 . . . . 71.219999999999999 110.714 175.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.41 135.23 69.08 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.334 2.023 . . . . 62.32 112.853 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.448 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 5.1 tpt -54.14 109.7 0.51 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.262 -0.426 . . . . 74.329999999999998 111.904 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.62 -174.35 32.42 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.866 -0.683 . . . . 72.430000000000007 112.513 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.544 ' O ' ' HG2' ' A' ' 106' ' ' MET . 32.3 Cg_endo -65.11 -26.44 57.7 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.808 1.672 . . . . 74.120000000000005 111.57 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.497 ' HA ' HD11 ' A' ' 140' ' ' LEU . 4.6 m-85 -67.53 -53.85 24.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.6 -0.727 . . . . 73.099999999999994 110.496 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.476 ' O ' HG22 ' A' ' 108' ' ' ILE . . . -61.43 -40.61 95.07 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.075 -0.511 . . . . 72.219999999999999 110.798 174.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -53.52 -26.89 22.89 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.308 -0.405 . . . . 63.329999999999998 111.916 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.611 ' SD ' HD22 ' A' ' 140' ' ' LEU . 83.1 mmm -64.96 -34.33 78.16 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.754 0.311 . . . . 74.329999999999998 111.835 177.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.432 ' HB ' HG23 ' A' ' 77' ' ' THR . 27.1 m -115.82 -19.88 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.846 0.684 . . . . 74.120000000000005 112.846 -168.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.619 HG21 ' HB2' ' A' ' 30' ' ' SER . 10.1 pt -90.65 -176.21 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-O 121.177 0.513 . . . . 75.239999999999995 111.962 -178.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.591 ' N ' HG21 ' A' ' 123' ' ' VAL . 18.0 t70 . . . . . 0 CA--C 1.542 0.661 0 CA-C-N 116.242 -0.435 . . . . 73.040000000000006 111.507 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.544 0 CA-C-O 121.261 0.367 . . . . 53.409999999999997 113.695 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.591 HG21 ' N ' ' A' ' 109' ' ' ASP . 62.0 t -93.82 121.29 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 112.226 0.454 . . . . 74.439999999999998 112.226 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.507 ' HD2' ' N ' ' A' ' 125' ' ' GLY . 0.3 OUTLIER -60.94 141.51 57.19 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.024 0.529 . . . . 75.010000000000005 111.923 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . 0.693 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -170.35 -147.26 5.48 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 116.221 -0.445 . . . . 63.340000000000003 113.087 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 57.2 p -138.7 159.16 42.78 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.775 0.43 . . . . 72.230000000000004 111.711 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -140.39 145.61 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.906 0.384 . . . . 72.310000000000002 111.374 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.66 154.78 32.1 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.379 -0.373 . . . . 73.519999999999996 111.502 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.624 ' HE3' HD23 ' A' ' 67' ' ' LEU . 36.1 ttmt -71.33 144.38 49.94 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.505 -0.554 . . . . 74.329999999999998 109.505 168.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.0 t -131.98 145.66 51.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 122.05 0.928 . . . . 54.109999999999999 113.355 -176.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -77.32 -10.67 59.58 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.422 -1.263 . . . . 73.340000000000003 111.621 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -82.11 -179.94 7.59 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.478 0.656 . . . . 75.409999999999997 112.503 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -97.25 154.85 17.14 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.741 -0.663 . . . . 74.209999999999994 111.192 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.8 134.35 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.798 0.333 . . . . 74.239999999999995 110.661 172.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 21.1 mt -70.42 125.43 26.76 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.13 0.418 . . . . 75.400000000000006 112.13 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.437 ' HA ' ' HE2' ' A' ' 49' ' ' PHE . 74.0 m -65.05 149.09 50.48 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.386 -0.598 . . . . 72.439999999999998 109.386 167.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.5 HG21 ' HD2' ' A' ' 49' ' ' PHE . 94.7 t -48.61 -48.02 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 111.85 0.315 . . . . 74.239999999999995 111.85 -175.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -72.44 -37.93 68.45 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.234 -0.291 . . . . 63.32 111.574 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -55.4 -40.52 71.51 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.846 0.831 . . . . 74.510000000000005 109.518 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.611 HD22 ' SD ' ' A' ' 106' ' ' MET . 4.0 tt -58.53 -46.15 87.39 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.4 -1.273 . . . . 73.109999999999999 111.236 173.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 39.6 mt . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 121.523 0.677 . . . . 70.540000000000006 110.829 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.896 0.379 . . . . 74.329999999999998 111.037 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.64 122.89 0.76 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.173 -0.537 . . . . 55.200000000000003 113.422 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.8 p -157.83 131.79 8.05 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.921 0.391 . . . . 72.030000000000001 111.14 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.9 p -162.12 132.59 4.87 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.398 -0.364 . . . . 70.420000000000002 110.875 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -168.26 177.14 5.58 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.941 0.4 . . . . 72.530000000000001 111.824 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -119.87 138.62 53.3 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.313 -0.403 . . . . 73.239999999999995 111.121 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -123.21 125.6 45.4 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.841 0.353 . . . . 65.129999999999995 111.441 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -90.78 158.27 16.94 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.899 0.381 . . . . 75.120000000000005 111.336 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -123.46 87.73 2.79 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.791 -0.448 . . . . 74.109999999999999 109.791 173.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -113.32 132.78 55.44 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.329 0.585 . . . . 74.409999999999997 112.447 -174.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.1 m -135.67 -175.23 3.89 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.46 -0.791 . . . . 73.150000000000006 109.903 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.8 t -145.61 130.31 18.03 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.647 0.61 . . . . 74.230000000000004 112.647 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.69 106.66 2.96 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.71 -0.556 . . . . 75.230000000000004 111.71 172.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -120.2 137.35 54.24 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.112 0.412 . . . . 75.030000000000001 112.112 -174.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -80.99 143.82 32.27 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.196 -0.456 . . . . 74.329999999999998 110.839 174.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -157.62 121.05 4.04 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.684 0.278 . . . . 65.439999999999998 111.455 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 mp -105.8 135.49 47.13 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.799 0.333 . . . . 73.409999999999997 111.173 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -114.48 140.0 49.08 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.146 0.498 . . . . 74.510000000000005 111.408 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -98.64 -53.61 3.26 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.052 0.39 . . . . 72.439999999999998 112.052 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 57.27 87.13 0.07 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.274 0.559 . . . . 74.540000000000006 110.539 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.95 -159.9 35.29 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.121 -0.49 . . . . 74.329999999999998 114.172 -174.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -151.96 115.07 4.7 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.9 0.48 . . . . 71.420000000000002 110.889 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.0 ptm -76.42 145.89 39.02 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.349 0.595 . . . . 74.030000000000001 112.435 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.512 HD13 ' HG ' ' A' ' 65' ' ' LEU . 15.1 mt -107.85 138.24 44.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.934 -0.575 . . . . 75.209999999999994 111.421 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.445 ' HA ' HG23 ' A' ' 126' ' ' THR . 33.0 tt0 -78.45 114.39 17.32 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.915 0.388 . . . . 71.129999999999995 110.781 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 27.4 m -127.5 159.74 37.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.18 0.514 . . . . 74.239999999999995 111.921 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.728 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 57.0 tt0 -98.78 108.99 21.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.064 0.459 . . . . 74.209999999999994 110.073 175.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.406 HG23 HD11 ' A' ' 96' ' ' ILE . 33.6 t -83.59 110.32 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.667 -0.697 . . . . 75.129999999999995 111.611 -175.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.656 HD12 ' HE1' ' A' ' 95' ' ' MET . 8.3 mt -92.39 162.05 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.882 0.373 . . . . 73.319999999999993 111.979 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 64.8 m -137.34 92.61 2.72 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.089 0.471 . . . . 75.200000000000003 111.577 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.3 133.32 11.55 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.158 -0.544 . . . . 55.5 112.362 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -74.41 83.94 1.96 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 117.297 0.549 . . . . 72.5 112.248 -175.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.7 p -92.01 -52.29 4.78 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.168 0.508 . . . . 71.439999999999998 110.399 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -84.3 103.33 13.39 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.357 -0.608 . . . . 74.329999999999998 109.357 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -69.06 136.17 51.94 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.216 0.532 . . . . 74.310000000000002 112.23 -175.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.578 ' NE2' ' SD ' ' A' ' 100' ' ' MET . 78.8 mt-30 -91.72 -161.38 0.82 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.613 -0.721 . . . . 74.409999999999997 112.358 -174.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 118.79 -13.67 11.62 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.638 -0.585 . . . . 72.420000000000002 111.638 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.445 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . . . -135.52 174.24 10.83 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 122.699 0.4 . . . . 63.039999999999999 111.142 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.8 p -87.86 162.01 17.19 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.846 0.355 . . . . 75.349999999999994 110.79 174.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.4 m -61.52 -24.72 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.998 0.428 . . . . 72.530000000000001 111.208 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.406 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 36.5 tt0 -72.35 -44.53 62.47 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.129 0.49 . . . . 74.420000000000002 110.644 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.403 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 11.6 tp10 -63.12 -33.37 75.3 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.501 0.667 . . . . 72.299999999999997 110.781 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.445 ' HE2' ' HB2' ' A' ' 38' ' ' ALA . 68.3 mttm -105.29 36.3 2.54 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.802 -0.635 . . . . 73.299999999999997 111.146 175.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.406 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 0.5 OUTLIER -67.32 84.68 0.16 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.281 0.563 . . . . 74.140000000000001 110.779 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.7 t -150.07 171.95 16.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.827 -0.624 . . . . 73.549999999999997 111.429 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -64.69 -27.45 68.93 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.595 -0.275 . . . . 72.129999999999995 111.649 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -53.89 -46.72 71.46 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.079 0.466 . . . . 73.430000000000007 111.022 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.424 ' HE2' ' HD2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -68.96 -23.52 64.14 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.327 -0.397 . . . . 74.040000000000006 111.195 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.486 ' HD1' HG21 ' A' ' 137' ' ' VAL . 55.3 t80 -94.4 -0.49 54.8 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.046 0.451 . . . . 74.109999999999999 112.015 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -121.48 -27.63 4.75 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.604 -0.685 . . . . 75.540000000000006 112.275 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.452 ' O ' ' HG2' ' A' ' 99' ' ' PRO . . . -72.5 -62.9 1.28 Allowed 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.35 0.5 . . . . 74.200000000000003 112.35 -176.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.481 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 30.2 m -95.49 21.26 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 112.975 0.731 . . . . 65.120000000000005 112.975 -172.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.595 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -105.01 11.13 33.77 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.317 0.858 . . . . 72.219999999999999 113.317 -172.021 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.458 ' CD2' ' HD2' ' A' ' 87' ' ' LYS . 38.0 p90 -136.18 162.22 33.57 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.65 0.611 . . . . 74.340000000000003 112.65 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -126.83 130.0 49.38 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.66 -0.7 . . . . 73.140000000000001 111.004 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.577 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 43.6 mt-10 -87.38 117.55 26.23 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.167 0.508 . . . . 73.340000000000003 111.086 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 28.2 mt -112.79 142.54 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.663 -0.699 . . . . 73.519999999999996 111.501 -172.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.02 149.01 50.61 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.953 0.406 . . . . 73.439999999999998 111.502 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.442 ' CD ' ' HZ2' ' A' ' 88' ' ' LYS . 9.9 tp10 -53.83 -49.9 67.39 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.127 -0.488 . . . . 75.239999999999995 112.186 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -56.61 -51.66 67.81 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.723 0.296 . . . . 60.340000000000003 111.731 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -66.08 -35.76 81.37 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.097 0.475 . . . . 74.340000000000003 110.878 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -53.22 -50.14 65.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.846 -0.616 . . . . 74.450000000000003 111.009 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -71.31 -37.11 71.8 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.399 -0.364 . . . . 71.129999999999995 111.247 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.53 -33.0 70.84 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.189 0.44 . . . . 74.099999999999994 112.189 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.512 ' HG ' HD13 ' A' ' 24' ' ' LEU . 93.5 mt -90.2 -13.53 35.34 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.417 -0.356 . . . . 74.25 111.874 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.26 53.05 23.72 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.02 -0.609 . . . . 61.340000000000003 112.106 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.673 HD23 ' HE3' ' A' ' 129' ' ' LYS . 75.1 mt -92.3 137.43 32.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.499 0.666 . . . . 74.040000000000006 111.808 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -107.84 142.73 37.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.996 -0.547 . . . . 75.409999999999997 109.725 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -61.84 100.01 0.14 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.676 0.75 . . . . 74.109999999999999 110.997 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.53 -14.73 4.46 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 115.097 -0.956 . . . . 63.399999999999999 112.958 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -72.13 178.64 3.72 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.67 0.748 . . . . 75.400000000000006 112.554 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.427 ' HD3' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -131.74 147.99 52.54 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.42 -0.809 . . . . 75.5 110.242 175.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.547 HG13 ' HB1' ' A' ' 86' ' ' ALA . 19.7 m -124.41 152.77 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.903 0.705 . . . . 71.450000000000003 112.903 -174.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -94.36 122.11 36.57 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.316 -0.856 . . . . 75.150000000000006 110.442 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.8 t -108.42 126.18 65.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.493 -0.321 . . . . 75.219999999999999 110.136 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -133.48 131.98 40.5 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.393 0.616 . . . . 74.010000000000005 112.586 -173.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.668 HG21 ' HA3' ' A' ' 125' ' ' GLY . 39.4 p -134.45 -171.23 2.71 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.495 -0.775 . . . . 70.519999999999996 110.603 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.69 -18.56 60.5 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.993 0.425 . . . . 75.109999999999999 110.664 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -80.91 -52.61 7.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.267 -0.424 . . . . 73.25 111.465 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.69 -150.55 7.62 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.781 -0.723 . . . . 60.109999999999999 113.349 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -148.49 154.39 39.76 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.77 0.319 . . . . 72.549999999999997 111.401 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.5 p -157.88 145.78 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-O 120.663 0.268 . . . . 74.420000000000002 111.534 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.5 t -102.31 116.56 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 122.42 -0.175 . . . . 71.129999999999995 110.637 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.0 m -125.74 166.68 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 120.901 0.381 . . . . 75.129999999999995 111.818 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -69.06 130.8 43.76 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.094 0.473 . . . . 75.409999999999997 111.452 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.547 ' HB1' HG13 ' A' ' 73' ' ' VAL . . . -81.99 120.07 24.79 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.39 -0.368 . . . . 71.409999999999997 111.813 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.458 ' HD2' ' CD2' ' A' ' 54' ' ' TYR . 67.7 mttm -132.43 157.26 45.03 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.025 0.441 . . . . 64.420000000000002 110.614 174.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.442 ' HZ2' ' CD ' ' A' ' 59' ' ' GLU . 36.1 ttmt -94.75 140.75 29.48 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.188 -0.46 . . . . 71.310000000000002 111.259 -175.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.577 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -140.56 167.48 25.53 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.915 -0.66 . . . . 72.549999999999997 113.553 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.93 20.98 2.84 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.19 0.519 . . . . 72.319999999999993 111.948 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 m -73.7 153.61 89.4 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.118 -0.492 . . . . 63.539999999999999 111.16 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.457 ' HG2' ' SD ' ' A' ' 95' ' ' MET . 35.1 Cg_endo -63.85 160.24 38.09 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.307 2.005 . . . . 71.030000000000001 112.837 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -63.86 147.29 52.24 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.03 0.443 . . . . 74.349999999999994 111.461 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 65.76 34.57 89.15 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.02 -0.609 . . . . 72.409999999999997 112.457 -175.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.728 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 23.0 ttt -157.86 137.28 11.91 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.559 -0.377 . . . . 75.310000000000002 110.519 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.406 HD11 HG23 ' A' ' 28' ' ' VAL . 41.6 pt -134.81 143.95 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.05 0.452 . . . . 61.340000000000003 111.689 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -102.52 128.29 49.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.429 -0.351 . . . . 74.140000000000001 111.818 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 30' ' ' SER . 45.1 mt -124.8 133.57 24.9 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-O 120.812 0.339 . . . . 74.099999999999994 110.518 172.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.481 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 37.4 Cg_exo -59.62 130.11 33.89 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.228 1.952 . . . . 74.209999999999994 112.242 173.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.578 ' SD ' ' NE2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -54.52 106.1 0.19 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 122.668 0.387 . . . . 73.040000000000006 111.406 -176.45 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -161.64 -172.54 29.14 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.927 -0.654 . . . . 70.420000000000002 112.928 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.424 ' HD2' HG22 ' A' ' 52' ' ' VAL . 15.1 Cg_endo -56.71 -37.39 97.92 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.079 2.519 . . . . 70.329999999999998 112.676 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.438 ' HA ' HD13 ' A' ' 140' ' ' LEU . 35.9 m-85 -60.47 -52.96 62.98 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.234 -0.439 . . . . 74.409999999999997 110.732 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.0 -40.43 93.5 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.266 -0.425 . . . . 75.209999999999994 110.948 175.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -52.06 -26.53 11.2 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.103 0.561 . . . . 74.140000000000001 112.157 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.618 ' SD ' HD22 ' A' ' 140' ' ' LEU . 92.0 mmm -67.12 -31.76 72.44 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 111.912 0.338 . . . . 73.099999999999994 111.912 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.1 m -119.55 -13.74 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 112.906 0.706 . . . . 71.310000000000002 112.906 -171.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.578 HD11 ' HE1' ' A' ' 100' ' ' MET . 11.6 pt -100.87 -179.59 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.138 0.494 . . . . 73.409999999999997 111.766 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . 27.0 t70 -97.85 115.63 65.74 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 116.144 -0.48 . . . . 75.120000000000005 110.615 174.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 109' ' ' ASP . 3.0 Cg_endo -82.14 4.83 6.75 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.933 2.422 . . . . 75.010000000000005 113.466 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.1 t -91.87 -29.67 16.58 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.023 0.379 . . . . 74.030000000000001 112.023 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.426 HG21 ' O ' ' A' ' 109' ' ' ASP . 8.0 t -60.68 -177.3 0.07 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.779 0.659 . . . . 75.530000000000001 112.779 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -61.1 -27.37 68.32 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.43 0.53 . . . . 72.409999999999997 112.43 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 53.29 28.01 33.85 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.377 -0.44 . . . . 65.150000000000006 113.318 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.9 m -133.22 129.86 38.29 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.481 0.312 . . . . 71.519999999999996 111.025 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 163.84 149.18 5.66 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 121.282 -0.485 . . . . 32.32 112.772 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.544 ' HE3' ' HD2' ' A' ' 118' ' ' PRO . 95.7 mmm -81.63 147.2 58.63 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 120.817 0.341 . . . . 74.329999999999998 111.185 178.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.544 ' HD2' ' HE3' ' A' ' 117' ' ' MET . 47.1 Cg_endo -67.78 91.27 0.36 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.432 2.088 . . . . 75.239999999999995 113.496 -173.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -130.99 -56.64 1.04 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.118 -0.492 . . . . 73.109999999999999 110.522 173.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -160.34 -159.64 0.71 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.738 -0.664 . . . . 74.209999999999994 109.772 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.503 ' O ' HG21 ' A' ' 29' ' ' ILE . 7.1 tmtm? 70.84 98.1 0.07 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.156 0.503 . . . . 74.310000000000002 111.508 174.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.68 -180.0 26.92 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.743 -0.741 . . . . 73.430000000000007 113.395 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.9 t -85.98 123.52 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 120.925 0.393 . . . . 74.219999999999999 111.963 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 22.1 mmmt -61.54 148.27 42.72 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.201 0.524 . . . . 74.150000000000006 112.233 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.668 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -178.87 -151.47 9.63 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.946 -0.57 . . . . 74.319999999999993 113.205 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.445 HG23 ' HA ' ' A' ' 25' ' ' GLU . 56.1 p -140.84 160.39 40.15 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.466 -0.432 . . . . 75.120000000000005 111.815 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.1 p -142.22 145.17 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.198 -0.455 . . . . 73.400000000000006 110.971 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -151.08 155.58 39.26 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.503 0.557 . . . . 73.439999999999998 112.503 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.673 ' HE3' HD23 ' A' ' 67' ' ' LEU . 3.1 tppp? -72.88 124.02 24.57 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.258 -0.428 . . . . 74.239999999999995 110.945 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.5 t -129.93 153.85 47.93 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.09 0.471 . . . . 72.120000000000005 111.661 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -82.73 -12.69 57.37 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.064 -0.517 . . . . 62.039999999999999 110.887 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -57.17 166.43 1.11 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.928 1.084 . . . . 75.209999999999994 113.928 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.567 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -86.46 144.14 27.42 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.215 -1.357 . . . . 71.200000000000003 111.16 173.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.37 128.98 22.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.671 -0.24 . . . . 75.310000000000002 110.474 170.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.404 HD21 ' HA ' ' A' ' 135' ' ' LEU . 11.4 mt -61.4 109.04 1.04 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.588 0.218 . . . . 75.040000000000006 111.588 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 53.5 m -58.03 145.4 36.41 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.832 -0.432 . . . . 65.219999999999999 109.832 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.486 HG21 ' HD1' ' A' ' 49' ' ' PHE . 90.8 t -45.9 -47.27 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.549 0.574 . . . . 75.200000000000003 112.549 -173.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -72.66 -40.39 66.36 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 122.195 -0.315 . . . . 73.540000000000006 111.751 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -58.95 -36.07 74.19 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.617 0.723 . . . . 72.099999999999994 110.215 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.618 HD22 ' SD ' ' A' ' 106' ' ' MET . 2.8 tt -59.66 -43.58 93.9 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.064 -0.971 . . . . 74.439999999999998 110.578 173.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 32.5 mt -60.47 -44.59 95.73 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.436 0.636 . . . . 73.310000000000002 110.4 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -66.36 -33.12 75.01 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.862 -0.608 . . . . 72.030000000000001 111.018 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.63 -40.02 76.8 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.614 0.598 . . . . 73.209999999999994 112.614 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.2 -8.96 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.518 0.562 . . . . 74.140000000000001 112.518 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 133.03 -18.9 4.44 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.011 -0.614 . . . . 74.450000000000003 113.725 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.473 0.681 0 O-C-N 122.175 -0.603 . . . . 72.109999999999999 111.403 -179.029 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.1 mtp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.81 0.338 . . . . 62.409999999999997 111.276 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.16 179.17 21.34 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 116.408 -0.36 . . . . 63.240000000000002 112.643 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.7 p -134.85 168.76 18.48 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 122.304 -0.527 . . . . 54.140000000000001 111.618 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.2 t -143.47 146.74 33.66 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.965 0.412 . . . . 71.109999999999999 111.092 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -138.6 56.75 1.7 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.161 0.505 . . . . 74.540000000000006 110.41 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -70.35 99.98 1.66 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.492 0.663 . . . . 73.219999999999999 111.578 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -165.77 127.51 1.95 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.571 -0.74 . . . . 74.510000000000005 110.384 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -159.08 143.68 15.61 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.653 0.263 . . . . 73.230000000000004 111.13 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -81.35 -41.64 21.73 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.828 0.347 . . . . 64.400000000000006 111.085 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.1 t60 60.31 -1.57 0.2 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.276 0.843 . . . . 73.219999999999999 113.276 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.4 p -80.5 91.49 5.76 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.949 -0.469 . . . . 74.140000000000001 111.68 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.2 t -168.94 96.54 0.36 Allowed 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.145 -0.479 . . . . 60.32 111.176 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.43 177.77 31.08 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 121.182 -0.532 . . . . 75.409999999999997 113.325 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -158.21 177.63 11.07 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.152 0.501 . . . . 74.510000000000005 111.561 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -110.35 154.08 24.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.009 -0.541 . . . . 71.430000000000007 110.103 174.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -124.34 159.8 29.52 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.266 0.839 . . . . 74.219999999999999 113.266 -169.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mp -104.89 139.0 40.27 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.385 -0.825 . . . . 74.209999999999994 110.702 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -76.98 125.53 29.46 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.2 0.524 . . . . 73.239999999999995 112.047 -176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -118.12 129.67 55.67 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.961 -0.563 . . . . 62.210000000000001 110.903 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -144.76 121.86 11.45 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.163 0.431 . . . . 73.25 112.163 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.76 93.05 0.72 Allowed Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.882 -0.599 . . . . 60.219999999999999 112.905 174.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -66.43 90.15 0.15 Allowed 'General case' 0 CA--C 1.539 0.519 0 O-C-N 122.575 -0.367 . . . . 74.200000000000003 111.76 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.0 ptm -65.17 140.7 58.8 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.801 0.334 . . . . 73.109999999999999 110.919 174.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.53 HD12 ' HB3' ' A' ' 61' ' ' ASP . 14.1 mt -102.25 130.35 48.9 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.252 0.464 . . . . 74.049999999999997 112.252 -175.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.45 ' HA ' HG23 ' A' ' 126' ' ' THR . 37.1 tt0 -75.23 114.65 13.98 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.197 -0.456 . . . . 74.439999999999998 110.273 175.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 31.2 m -126.19 159.94 34.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.155 -0.475 . . . . 64.439999999999998 111.756 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.713 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 37.4 tt0 -99.71 113.08 25.32 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.064 0.459 . . . . 71.530000000000001 110.393 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.1 t -88.48 119.24 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.849 -0.614 . . . . 74.019999999999996 112.182 -173.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.655 HD11 ' HE1' ' A' ' 95' ' ' MET . 1.0 OUTLIER -107.08 162.37 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.715 0.293 . . . . 74.310000000000002 111.38 178.177 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 66.0 m -131.99 106.77 8.24 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.105 0.479 . . . . 74.549999999999997 111.983 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -92.99 111.3 4.07 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.149 -0.548 . . . . 40.409999999999997 112.314 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.407 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 54.8 ttp180 -81.87 77.81 8.66 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.297 0.57 . . . . 75.209999999999994 111.445 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.1 t -99.71 -29.12 12.83 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.939 -0.573 . . . . 71.010000000000005 111.523 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.639 HD21 ' HG2' ' A' ' 47' ' ' GLU . 2.8 tm? -83.11 -63.31 1.39 Allowed 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.222 0.534 . . . . 63.43 111.045 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 17.3 p-10 -94.09 55.0 1.99 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.178 0.436 . . . . 73.239999999999995 112.178 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 32' ' ' ARG . 48.3 mt-30 -64.79 -28.24 69.44 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.706 0.632 . . . . 64.430000000000007 112.706 -176.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.26 14.27 3.02 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.465 -0.874 . . . . 75.019999999999996 114.45 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 35' ' ' ASN . . . -146.17 155.28 42.61 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 117.47 0.635 . . . . 74.5 112.04 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.0 p -86.01 170.68 12.05 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.378 -0.374 . . . . 73.310000000000002 111.314 175.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.25 -44.81 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.938 0.399 . . . . 73.209999999999994 111.692 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -58.61 -23.66 59.36 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.338 0.496 . . . . 73.519999999999996 112.338 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -80.68 -26.06 37.83 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.929 0.395 . . . . 74.319999999999993 111.744 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.419 ' HB2' ' CD2' ' A' ' 48' ' ' TYR . 27.8 mtpp -125.75 42.63 3.25 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.244 -0.434 . . . . 73.150000000000006 112.019 -172.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.11 80.01 0.5 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.215 0.531 . . . . 72.319999999999993 111.528 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.2 t -151.83 174.33 13.7 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.273 -0.421 . . . . 74.219999999999999 111.865 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.425 ' HG2' ' ND2' ' A' ' 50' ' ' ASN . 40.0 tt0 -55.37 -34.33 64.22 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.91 0.386 . . . . 74.319999999999993 111.733 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.639 ' HG2' HD21 ' A' ' 34' ' ' LEU . 33.8 tt0 -53.49 -43.3 68.1 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.008 0.432 . . . . 74.120000000000005 111.176 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.527 ' O ' HG21 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -70.45 -36.76 74.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.151 0.5 . . . . 73.540000000000006 110.324 -179.512 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -64.89 -64.94 0.74 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.012 -0.54 . . . . 73.430000000000007 111.1 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.425 ' ND2' ' HG2' ' A' ' 46' ' ' GLU . 72.0 m-20 -55.74 -17.91 7.08 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.779 0.659 . . . . 65.230000000000004 112.779 -176.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -88.4 -59.01 2.35 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.556 0.576 . . . . 74.209999999999994 112.556 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.621 HG22 ' HD2' ' A' ' 102' ' ' PRO . 20.1 m -96.71 15.33 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 113.225 0.824 . . . . 75.530000000000001 113.225 -171.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -99.16 13.76 31.8 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.89 0.7 . . . . 75.0 112.89 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -138.92 164.55 29.4 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.243 0.544 . . . . 74.049999999999997 111.984 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.63 146.39 51.85 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.723 -0.671 . . . . 74.439999999999998 110.857 175.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -97.62 110.6 23.13 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.774 0.321 . . . . 74.439999999999998 111.235 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.434 HD13 ' N ' ' A' ' 57' ' ' ILE . 4.1 mp -110.35 141.96 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 120.864 0.364 . . . . 74.310000000000002 111.308 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -62.71 139.53 58.67 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.426 -0.352 . . . . 74.109999999999999 110.683 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -54.38 -31.85 55.77 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.485 0.55 . . . . 64.120000000000005 112.485 -177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.86 -55.46 32.71 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.825 0.345 . . . . 73.230000000000004 111.588 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.53 ' HB3' HD12 ' A' ' 24' ' ' LEU . 29.3 m-20 -66.23 -35.66 81.0 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.509 0.671 . . . . 61.329999999999998 110.325 176.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 47.8 t-105 -53.05 -48.33 67.74 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.85 -1.068 . . . . 75.109999999999999 111.042 174.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -69.57 -34.82 74.72 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.841 -0.618 . . . . 73.129999999999995 111.779 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.44 ' HB1' HD11 ' A' ' 24' ' ' LEU . . . -59.46 -52.02 67.39 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.127 0.489 . . . . 54.439999999999998 111.196 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.431 ' HG ' HD13 ' A' ' 24' ' ' LEU . 94.4 mt -75.96 -4.62 42.08 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.022 -0.535 . . . . 74.209999999999994 111.888 178.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.62 49.45 77.06 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.293 -0.48 . . . . 75.150000000000006 112.594 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' A' ' 129' ' ' LYS . 97.8 mt -86.78 161.26 18.46 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.015 0.912 . . . . 73.129999999999995 113.116 -175.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -136.53 151.97 49.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.61 -1.177 . . . . 74.109999999999999 109.452 173.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 mp0 -63.82 108.27 1.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.499 0.666 . . . . 74.349999999999994 111.444 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.87 -8.33 14.72 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.295 -0.866 . . . . 72.430000000000007 113.046 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -63.79 151.9 40.92 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.162 0.506 . . . . 71.5 111.992 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.58 HH21 ' HA ' ' A' ' 131' ' ' ASP . 25.8 mtm-85 -90.99 113.74 26.07 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.823 -0.626 . . . . 74.319999999999993 110.986 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.29 135.56 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.124 0.488 . . . . 74.549999999999997 111.888 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.405 ' CD ' ' HE3' ' A' ' 76' ' ' LYS . 34.6 ttmt -98.25 147.78 24.29 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.291 0.567 . . . . 74.430000000000007 111.124 174.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 57.1 t -122.27 131.77 72.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.498 -0.774 . . . . 65.239999999999995 109.427 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.48 ' HZ3' ' CD ' ' A' ' 128' ' ' GLU . 20.1 mttt -125.23 125.3 43.37 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.002 0.43 . . . . 65.310000000000002 111.819 -176.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.678 HG21 ' HA3' ' A' ' 125' ' ' GLY . 25.0 p -138.37 -171.79 3.13 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.156 -0.474 . . . . 75.340000000000003 110.663 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.12 -16.63 63.13 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.925 0.393 . . . . 73.340000000000003 111.539 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -88.76 -21.0 24.04 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.196 0.443 . . . . 75.230000000000004 112.196 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.21 -151.46 23.73 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.266 -0.492 . . . . 73.109999999999999 112.857 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.434 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 10.3 pt-20 -144.71 149.66 35.98 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.137 0.494 . . . . 60.020000000000003 111.813 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -148.15 148.31 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 116.213 -0.449 . . . . 74.430000000000007 111.25 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -110.0 118.55 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.08 0.152 . . . . 72.219999999999999 110.843 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.453 HG13 ' HD2' ' A' ' 103' ' ' TYR . 33.9 m -128.9 178.27 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 122.699 0.399 . . . . 73.430000000000007 111.933 -177.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -83.06 146.02 28.95 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.106 0.479 . . . . 73.120000000000005 111.446 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.82 127.3 43.68 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.222 0.453 . . . . 73.099999999999994 112.222 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -129.34 142.33 50.85 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.367 0.603 . . . . 72.329999999999998 110.681 173.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -77.72 123.1 26.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.585 -0.734 . . . . 73.540000000000006 111.183 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -126.05 165.98 19.01 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.347 -0.454 . . . . 72.329999999999998 113.507 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -85.84 15.07 5.15 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.546 0.572 . . . . 62.310000000000002 112.546 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.3 m -65.66 154.83 87.63 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 112.051 0.389 . . . . 72.209999999999994 112.051 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.99 149.54 90.3 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.525 2.15 . . . . 72.5 112.616 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -63.9 144.14 57.31 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.748 0.309 . . . . 75.129999999999995 111.532 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 71.23 22.07 78.52 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.121 -0.561 . . . . 74.040000000000006 112.923 -174.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.713 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 23.9 ttt -154.0 136.47 15.05 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 122.495 -0.415 . . . . 73.530000000000001 109.985 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 43.2 pt -134.37 150.07 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.412 0.625 . . . . 75.030000000000001 112.313 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -106.47 129.25 54.47 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.835 -0.62 . . . . 75.25 110.827 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 30' ' ' SER . 40.8 mt -124.3 132.29 24.28 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 120.633 0.254 . . . . 75.219999999999999 110.657 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -57.86 128.54 29.41 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.19 1.926 . . . . 73.109999999999999 112.169 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.76 113.33 1.43 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.829 0.347 . . . . 72.239999999999995 111.267 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.45 -169.77 27.39 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.686 -0.768 . . . . 64.319999999999993 112.742 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.621 ' HD2' HG22 ' A' ' 52' ' ' VAL . 31.5 Cg_endo -65.15 -27.54 56.8 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.065 1.843 . . . . 71.409999999999997 111.482 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.476 ' HA ' HD11 ' A' ' 140' ' ' LEU . 3.4 m-85 -68.25 -53.8 22.11 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.825 -0.625 . . . . 70.340000000000003 110.249 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.78 -38.12 80.98 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.016 -0.538 . . . . 75.400000000000006 110.99 174.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -54.5 -23.43 16.28 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.365 0.505 . . . . 74.200000000000003 112.365 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.501 ' HG2' ' O ' ' A' ' 102' ' ' PRO . 77.9 mmm -78.17 -12.6 60.01 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.988 0.366 . . . . 61.420000000000002 111.988 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.7 m -137.39 -13.88 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 113.088 0.773 . . . . 70.150000000000006 113.088 -173.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.529 HG22 ' OG ' ' A' ' 30' ' ' SER . 1.5 pp -105.78 172.18 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 122.081 -0.387 . . . . 73.540000000000006 111.206 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.448 ' N ' HG21 ' A' ' 123' ' ' VAL . 18.9 t0 -94.63 109.81 45.58 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-O 120.902 0.382 . . . . 65.209999999999994 111.981 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.94 8.64 4.35 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.71 2.273 . . . . 73.299999999999997 113.375 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.9 m -79.74 -6.15 56.68 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.127 0.489 . . . . 70.010000000000005 110.858 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 48.5 p -81.93 142.43 32.46 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.949 -0.569 . . . . 73.519999999999996 112.322 -175.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.95 -64.06 1.12 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.214 -0.448 . . . . 74.310000000000002 111.001 175.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 61.55 -111.45 3.9 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 116.306 -0.406 . . . . 71.409999999999997 113.522 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.8 m 70.46 -67.03 0.26 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.215 0.606 . . . . 75.150000000000006 112.563 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' A' ' 117' ' ' MET . . . -91.92 131.53 10.83 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.179 -0.534 . . . . 64.109999999999999 113.519 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 116' ' ' GLY . 47.7 mtt 75.71 158.02 0.16 Allowed Pre-proline 0 N--CA 1.476 0.844 0 N-CA-C 113.217 0.821 . . . . 75.129999999999995 113.217 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.4 96.21 0.79 Allowed 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.452 2.101 . . . . 73.299999999999997 112.748 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -84.8 115.65 22.84 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.042 0.448 . . . . 75.120000000000005 111.33 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -89.38 -176.36 5.04 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.326 -0.397 . . . . 73.129999999999995 111.249 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.741 ' HZ3' ' HB2' ' A' ' 121' ' ' LYS . 0.1 OUTLIER 65.52 131.82 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.316 0.579 . . . . 72.409999999999997 111.623 -174.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -128.68 -160.94 10.5 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.137 -0.554 . . . . 70.409999999999997 113.107 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.448 HG21 ' N ' ' A' ' 109' ' ' ASP . 98.3 t -87.17 130.05 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 O-C-N 122.692 -0.299 . . . . 73.219999999999999 111.561 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -70.12 145.95 51.21 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.274 0.559 . . . . 73.530000000000001 112.241 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.678 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -173.89 -155.47 11.99 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.72 -0.673 . . . . 75.230000000000004 112.693 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 25' ' ' GLU . 79.1 p -135.64 158.59 43.99 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 122.322 -0.517 . . . . 62.140000000000001 111.961 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.4 p -133.57 144.6 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 121.035 0.445 . . . . 71.420000000000002 111.008 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.48 ' CD ' ' HZ3' ' A' ' 76' ' ' LYS . 13.4 pt-20 -152.54 150.76 29.91 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.456 -0.338 . . . . 73.200000000000003 111.393 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.541 ' HB2' HD23 ' A' ' 67' ' ' LEU . 29.0 ttpt -83.53 127.46 33.74 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.994 -0.441 . . . . 74.030000000000001 110.219 170.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.5 t -126.24 156.19 40.67 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.339 0.59 . . . . 73.420000000000002 112.325 -172.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.58 ' HA ' HH21 ' A' ' 72' ' ' ARG . 8.5 p-10 -82.32 -5.6 58.7 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.002 -0.545 . . . . 74.400000000000006 111.22 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -69.36 157.19 37.52 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.943 -0.571 . . . . 74.209999999999994 111.372 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -88.3 157.51 18.73 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.91 0.385 . . . . 73.040000000000006 111.37 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 91.2 t -69.31 138.26 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 116.325 -0.398 . . . . 75.540000000000006 110.951 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.6 mt -70.88 133.76 46.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.698 0.285 . . . . 73.299999999999997 111.464 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 44.7 t -78.42 145.72 34.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.464 -0.569 . . . . 70.420000000000002 109.464 171.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.548 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 96.5 t -46.39 -45.95 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 111.86 0.319 . . . . 63.409999999999997 111.86 -177.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.458 ' HA ' HD11 ' A' ' 141' ' ' LEU . 25.1 ttpp -71.25 -41.25 70.33 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.691 0.281 . . . . 74.430000000000007 111.422 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -55.91 -37.03 68.36 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.918 0.866 . . . . 63.049999999999997 109.611 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.476 HD11 ' HA ' ' A' ' 103' ' ' TYR . 1.0 OUTLIER -68.85 -38.39 79.74 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.528 -1.215 . . . . 75.430000000000007 111.002 176.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 53.9 mt -59.25 -49.51 77.55 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.609 0.718 . . . . 74.549999999999997 110.227 176.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -65.29 -30.04 70.86 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.017 -0.992 . . . . 72.319999999999993 111.317 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.28 -51.37 45.71 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 111.963 0.357 . . . . 63.130000000000003 111.963 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.9 pp -75.59 -22.44 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 112.139 0.422 . . . . 74.099999999999994 112.139 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 122.76 -64.73 0.52 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.251 -0.5 . . . . 74.120000000000005 113.088 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 120.924 0.392 . . . . 73.209999999999994 111.657 -178.709 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.0 mtm . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.656 0.265 . . . . 75.340000000000003 111.282 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.24 39.19 3.33 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.27 -0.49 . . . . 75.329999999999998 113.308 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.1 p -86.15 -70.27 0.61 Allowed 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.509 -0.406 . . . . 74.299999999999997 111.606 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.0 t -91.81 -51.98 4.96 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.974 0.416 . . . . 64.049999999999997 110.978 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -65.69 90.76 0.12 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.121 0.486 . . . . 73.530000000000001 110.768 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -74.9 126.37 30.83 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.858 -0.61 . . . . 73.219999999999999 111.369 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -125.26 123.47 39.59 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.947 -0.57 . . . . 70.439999999999998 109.984 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -54.1 140.74 30.98 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.883 0.373 . . . . 72.430000000000007 111.267 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -74.24 70.11 1.61 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.557 0.577 . . . . 72.549999999999997 112.557 -169.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -90.26 -69.64 0.71 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.147 0.499 . . . . 73.530000000000001 110.045 175.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.1 p -108.66 -36.63 6.12 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.228 0.537 . . . . 73.230000000000004 110.401 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.9 t -141.1 -170.62 3.09 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.694 -0.684 . . . . 61.329999999999998 111.139 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.0 -44.48 0.74 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.55 -1.02 . . . . 63.130000000000003 110.55 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -165.38 112.8 0.97 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.871 -0.789 . . . . 72.329999999999998 108.871 170.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.409 ' H ' ' CD ' ' A' ' 15' ' ' GLU . 0.8 OUTLIER -70.03 -17.96 63.28 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.133 1.16 . . . . 74.230000000000004 114.133 -167.599 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -78.44 102.8 7.99 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.153 0.427 . . . . 64.400000000000006 112.153 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -120.14 -179.61 3.99 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.524 0.678 . . . . 74.010000000000005 112.281 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -130.32 147.87 52.08 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.562 -0.745 . . . . 74.019999999999996 111.064 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -130.47 -179.27 5.17 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.087 0.402 . . . . 73.450000000000003 112.087 -175.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -148.5 163.92 35.75 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.994 0.425 . . . . 72.109999999999999 112.121 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.22 142.99 11.57 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.388 -0.434 . . . . 72.019999999999996 113.876 175.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -148.93 89.91 1.71 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 122.579 -0.365 . . . . 75.209999999999994 111.243 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 10.4 ptm -77.85 166.01 23.43 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.757 0.313 . . . . 74.219999999999999 111.304 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.546 HD13 ' HG ' ' A' ' 65' ' ' LEU . 17.1 mt -118.05 133.83 55.54 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.648 0.61 . . . . 75.239999999999995 112.648 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -79.57 119.08 22.04 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.941 -0.572 . . . . 63.140000000000001 110.2 173.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 29.2 m -133.87 161.3 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.953 0.406 . . . . 73.150000000000006 111.91 -175.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.522 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 31.5 tt0 -99.22 113.43 25.69 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.946 0.403 . . . . 74.120000000000005 110.373 174.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.482 HG22 HD13 ' A' ' 96' ' ' ILE . 45.4 t -89.65 112.93 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.231 0.539 . . . . 71.400000000000006 111.861 -173.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.647 HD11 ' HE1' ' A' ' 95' ' ' MET . 2.7 mt -97.31 159.36 3.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.923 0.392 . . . . 75.409999999999997 111.745 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.599 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 75.2 m -135.43 104.65 5.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.085 0.469 . . . . 74.140000000000001 111.303 175.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.8 119.09 4.77 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.963 -0.636 . . . . 65.400000000000006 112.372 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -62.3 94.9 0.06 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.738 0.78 . . . . 73.329999999999998 111.825 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.563 HG23 HD22 ' A' ' 34' ' ' LEU . 5.0 t -127.04 -175.38 3.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.978 -1.01 . . . . 71.200000000000003 109.926 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.737 ' HB3' ' HZ2' ' A' ' 43' ' ' LYS . 4.2 mm? 61.88 28.89 17.67 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 111.755 0.28 . . . . 72.409999999999997 111.755 -177.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.6 t30 72.64 89.21 0.1 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.48 0.712 . . . . 62.109999999999999 112.395 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 60.13 -80.71 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.604 0.762 . . . . 74.129999999999995 112.083 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 177.19 54.11 0.07 OUTLIER Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.709 -0.678 . . . . 72.040000000000006 112.883 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.88 154.59 29.62 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.647 0.26 . . . . 54.149999999999999 111.358 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.7 p -68.81 171.33 8.05 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.135 0.493 . . . . 73.019999999999996 111.206 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.653 HG21 HD13 ' A' ' 141' ' ' LEU . 17.7 m -63.76 -26.47 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.505 -0.316 . . . . 74.219999999999999 111.555 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.45 -38.0 77.6 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.993 0.368 . . . . 71.030000000000001 111.993 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.81 -36.12 67.08 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.816 0.341 . . . . 73.329999999999998 111.261 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.737 ' HZ2' ' HB3' ' A' ' 34' ' ' LEU . 0.0 OUTLIER -131.12 51.67 2.12 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.103 0.478 . . . . 73.030000000000001 111.321 177.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.82 83.25 0.91 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.301 0.572 . . . . 74.049999999999997 110.045 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.417 HG22 ' HB2' ' A' ' 47' ' ' GLU . 2.7 t -152.74 169.29 23.11 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.716 -0.675 . . . . 64.120000000000005 111.579 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -53.93 -32.92 55.21 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.175 0.512 . . . . 70.310000000000002 111.389 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.417 ' HB2' HG22 ' A' ' 45' ' ' THR . 20.4 mm-40 -53.61 -42.89 68.17 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.213 0.53 . . . . 73.209999999999994 111.34 176.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -65.1 -27.4 68.73 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.915 -0.584 . . . . 74.150000000000006 110.494 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.406 ' HD1' HG21 ' A' ' 137' ' ' VAL . 51.7 t80 -83.25 -9.18 59.27 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.941 -0.572 . . . . 73.340000000000003 111.745 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -116.89 -0.49 12.23 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.948 0.404 . . . . 70.319999999999993 111.64 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.672 ' HB2' HD21 ' A' ' 34' ' ' LEU . . . -95.81 -52.34 4.12 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.867 0.691 . . . . 72.439999999999998 112.867 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.456 HG22 ' HD2' ' A' ' 102' ' ' PRO . 35.5 m -116.35 19.86 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 113.445 0.906 . . . . 31.41 113.445 -172.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.64 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -100.73 18.57 19.03 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.898 0.703 . . . . 74.409999999999997 112.898 -171.478 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.468 ' CD1' ' HD2' ' A' ' 87' ' ' LYS . 47.1 p90 -144.6 165.58 27.6 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.462 0.542 . . . . 75.040000000000006 112.462 -174.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.32 142.51 49.37 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.623 -0.717 . . . . 73.549999999999997 110.685 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.481 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 44.5 mt-10 -101.04 118.48 37.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.938 0.399 . . . . 75.230000000000004 111.475 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.485 HD11 ' N ' ' A' ' 57' ' ' ILE . 3.8 mp -110.55 152.12 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 116.179 -0.464 . . . . 61.210000000000001 111.302 -177.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -68.44 153.77 43.12 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.671 0.388 . . . . 74.420000000000002 111.347 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -57.67 -46.33 84.39 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.115 0.483 . . . . 75.239999999999995 112.096 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.92 -47.9 82.87 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.79 0.329 . . . . 71.109999999999999 111.694 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -65.84 -35.92 82.01 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.199 0.524 . . . . 75.049999999999997 111.165 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.423 ' HZ2' ' N ' ' A' ' 69' ' ' GLU . 40.4 t-105 -55.55 -54.05 48.86 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.78 -0.645 . . . . 75.109999999999999 110.919 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -64.61 -33.83 76.85 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.048 -0.524 . . . . 71.329999999999998 111.475 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.54 ' HB1' HD11 ' A' ' 24' ' ' LEU . . . -60.15 -43.8 95.47 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.912 0.387 . . . . 75.040000000000006 111.947 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.614 HD11 HG12 ' A' ' 127' ' ' VAL . 93.4 mt -84.6 -9.25 58.46 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.001 0.371 . . . . 73.310000000000002 112.001 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.3 45.68 68.49 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.117 -0.563 . . . . 75.510000000000005 112.637 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.669 HD21 ' HE2' ' A' ' 129' ' ' LYS . 74.0 mt -83.37 166.63 18.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.385 0.612 . . . . 75.430000000000007 112.071 -177.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -147.25 121.39 9.49 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.853 -0.612 . . . . 72.329999999999998 109.898 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.423 ' N ' ' HZ2' ' A' ' 62' ' ' TRP . 43.0 mt-10 -44.52 98.62 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.283 0.846 . . . . 74.209999999999994 113.283 -169.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.79 -4.24 8.56 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 115.084 -0.962 . . . . 75.319999999999993 113.735 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.02 -176.61 5.59 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 117.8 0.8 . . . . 63.219999999999999 112.05 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.47 ' HG3' HG22 ' A' ' 134' ' ' VAL . 8.8 mpt_? -107.19 123.61 48.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.125 -0.489 . . . . 72.409999999999997 111.813 -176.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.3 m -115.42 145.04 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.307 0.575 . . . . 64.299999999999997 111.516 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.751 ' HD3' ' HE3' ' A' ' 76' ' ' LYS . 24.0 ttmm -108.73 146.99 32.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.813 -0.63 . . . . 74.109999999999999 110.534 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 64.5 t -130.55 129.57 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.269 -0.423 . . . . 75.319999999999993 110.704 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.751 ' HE3' ' HD3' ' A' ' 74' ' ' LYS . 38.7 mttt -130.94 125.54 33.7 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.929 0.395 . . . . 75.239999999999995 112.058 -175.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.65 HG21 ' HA3' ' A' ' 125' ' ' GLY . 42.6 p -126.45 -171.06 2.31 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 116.507 -0.315 . . . . 75.109999999999999 110.557 177.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.63 -6.46 52.12 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.901 0.382 . . . . 63.130000000000003 111.528 175.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -91.98 -60.78 1.77 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.869 0.366 . . . . 72.030000000000001 110.776 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.33 -144.45 4.03 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.221 -0.514 . . . . 75.010000000000005 112.796 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.406 ' OE1' ' NZ ' ' A' ' 74' ' ' LYS . 0.3 OUTLIER -154.52 159.28 40.86 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 117.12 0.46 . . . . 75.120000000000005 111.204 178.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.8 p -157.46 144.45 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 111.928 0.344 . . . . 75.019999999999996 111.928 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.8 t -105.54 118.52 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 122.48 0.312 . . . . 72.420000000000002 110.587 174.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.484 HG12 ' HD2' ' A' ' 103' ' ' TYR . 35.3 m -128.18 176.5 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 120.996 0.427 . . . . 72.439999999999998 112.06 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -79.49 140.98 37.13 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.976 0.417 . . . . 74.040000000000006 111.34 176.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.8 126.16 36.78 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.758 0.651 . . . . 64.409999999999997 112.758 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 62.3 mttm -126.84 143.71 51.18 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.199 0.523 . . . . 74.400000000000006 110.901 173.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -88.78 121.36 31.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.973 -0.558 . . . . 74.430000000000007 110.573 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.4 -179.62 15.8 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.711 -0.757 . . . . 73.349999999999994 114.21 -174.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -90.66 18.9 5.85 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.958 0.409 . . . . 70.430000000000007 111.353 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.1 m -72.49 151.83 91.76 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.251 -0.431 . . . . 71.530000000000001 111.896 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -62.04 160.57 29.47 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 122.755 2.303 . . . . 74.450000000000003 113.61 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -69.0 138.76 54.78 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.824 0.345 . . . . 74.430000000000007 111.453 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 68.06 26.59 73.98 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.968 -0.634 . . . . 74.099999999999994 112.298 -173.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.647 ' HE1' HD11 ' A' ' 29' ' ' ILE . 23.5 ttt -149.8 136.61 19.4 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.653 -0.322 . . . . 74.239999999999995 110.297 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.482 HD13 HG22 ' A' ' 28' ' ' VAL . 39.8 pt -135.25 146.81 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 121.263 0.554 . . . . 71.239999999999995 111.851 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -106.17 130.15 54.1 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.177 -0.465 . . . . 74.400000000000006 111.564 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.599 ' O ' ' HA ' ' A' ' 30' ' ' SER . 44.9 mt -124.32 132.06 24.26 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 120.753 0.311 . . . . 72.140000000000001 110.629 173.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.434 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 37.6 Cg_exo -58.91 131.88 44.35 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.229 1.953 . . . . 73.299999999999997 112.368 173.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.518 ' HE1' HD13 ' A' ' 108' ' ' ILE . 5.7 tpt -51.39 107.94 0.22 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 111.906 0.335 . . . . 71.329999999999998 111.906 -179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.14 -176.84 38.37 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.574 -0.822 . . . . 61.539999999999999 113.413 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.456 ' HD2' HG22 ' A' ' 52' ' ' VAL . 15.2 Cg_endo -55.92 -35.44 94.18 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.169 2.579 . . . . 72.450000000000003 112.952 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.484 ' HD2' HG12 ' A' ' 84' ' ' VAL . 30.7 m-85 -61.87 -51.56 67.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.057 0.456 . . . . 74.219999999999999 110.634 177.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 108' ' ' ILE . . . -62.0 -38.3 88.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.099 0.476 . . . . 74.120000000000005 111.04 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -54.55 -26.17 30.45 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.898 0.479 . . . . 75.409999999999997 112.006 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.539 ' SD ' HD23 ' A' ' 140' ' ' LEU . 84.9 mmm -69.54 -16.78 63.5 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.347 0.499 . . . . 73.310000000000002 112.347 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.84 -19.03 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 113.472 0.916 . . . . 73.349999999999994 113.472 -174.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.567 HG23 ' OG ' ' A' ' 30' ' ' SER . 8.0 pt -98.5 179.96 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 112.852 0.686 . . . . 75.140000000000001 112.852 -175.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -104.2 117.5 59.24 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 115.874 -0.603 . . . . 74.140000000000001 111.03 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -84.49 9.2 4.23 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.832 2.355 . . . . 74.219999999999999 113.959 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.9 m -83.04 32.75 0.44 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 120.844 0.354 . . . . 71.010000000000005 111.728 -177.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.7 p -79.12 2.11 21.98 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.389 0.885 . . . . 72.409999999999997 113.389 -171.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -70.82 135.28 48.0 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.146 0.498 . . . . 64.030000000000001 112.199 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.63 9.74 71.42 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.178 -0.465 . . . . 70.129999999999995 113.555 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.5 p -102.1 144.03 31.18 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.211 -0.581 . . . . 43.310000000000002 111.797 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -114.45 132.2 10.32 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.071 -0.513 . . . . 55.229999999999997 112.088 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 90.3 mmm 67.15 134.41 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 122.915 0.486 . . . . 73.400000000000006 111.623 -175.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.54 -39.86 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.668 2.245 . . . . 74.340000000000003 113.921 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.422 ' HG2' ' N ' ' A' ' 120' ' ' PHE . 39.4 tt0 65.95 150.81 0.05 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.098 0.559 . . . . 74.049999999999997 111.435 -174.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.422 ' N ' ' HG2' ' A' ' 119' ' ' GLN . 93.3 m-85 -74.84 77.73 2.12 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.972 -0.455 . . . . 65.219999999999999 112.043 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.09 164.56 38.26 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.014 0.435 . . . . 75.099999999999994 111.116 172.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -144.95 -175.92 18.51 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.049 -0.596 . . . . 74.019999999999996 112.928 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 93.5 t -80.12 118.08 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 122.533 -0.392 . . . . 72.340000000000003 111.07 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 39.3 mtpt -67.31 155.55 38.63 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.657 0.741 . . . . 74.019999999999996 112.913 -177.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.65 ' HA3' HG21 ' A' ' 77' ' ' THR . . . 179.68 -147.85 7.75 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.055 -0.975 . . . . 72.430000000000007 112.144 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 45.1 p -138.51 153.3 48.75 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 122.292 -0.534 . . . . 72.420000000000002 111.757 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.614 HG12 HD11 ' A' ' 65' ' ' LEU . 14.8 p -128.11 145.24 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.138 -0.483 . . . . 73.549999999999997 110.254 175.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.461 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 7.3 pt-20 -148.69 151.31 34.7 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.81 0.67 . . . . 74.310000000000002 112.81 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.669 ' HE2' HD21 ' A' ' 67' ' ' LEU . 14.5 tppt? -69.51 106.38 2.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.535 -0.757 . . . . 64.030000000000001 109.966 167.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.1 t -100.8 161.8 13.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.451 0.643 . . . . 74.400000000000006 112.34 -176.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -100.53 0.7 39.98 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.554 -0.748 . . . . 74.349999999999994 110.62 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -88.39 179.52 6.31 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.07 0.767 . . . . 74.299999999999997 113.07 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -100.26 161.61 13.49 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.292 -0.867 . . . . 74.349999999999994 111.609 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.47 HG22 ' HG3' ' A' ' 72' ' ' ARG . 93.3 t -70.1 137.64 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 120.771 0.32 . . . . 65.319999999999993 111.56 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 135' ' ' LEU . 6.5 mt -77.81 98.04 5.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.679 -0.237 . . . . 73.239999999999995 111.219 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 70.9 p -55.19 153.68 6.59 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.696 0.284 . . . . 75.129999999999995 111.45 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.546 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 86.8 t -45.8 -53.73 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.971 0.73 . . . . 75.129999999999995 112.971 -172.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -72.35 -42.0 65.82 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.23 0.456 . . . . 73.340000000000003 112.23 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -56.51 -39.99 74.26 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.564 0.697 . . . . 60.210000000000001 109.977 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.539 HD23 ' SD ' ' A' ' 106' ' ' MET . 2.3 tt -60.58 -41.62 95.05 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.071 -0.968 . . . . 71.109999999999999 110.772 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.653 HD13 HG21 ' A' ' 40' ' ' VAL . 68.3 mt -58.59 -55.23 37.69 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.173 0.511 . . . . 70.319999999999993 110.818 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -64.72 -30.96 71.98 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.815 -0.63 . . . . 70.439999999999998 111.432 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.1 -52.44 64.89 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.349 -0.387 . . . . 70.109999999999999 111.634 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.414 HD13 ' N ' ' A' ' 146' ' ' SER . 2.9 pp -81.49 -18.1 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 112.333 0.494 . . . . 74.310000000000002 112.333 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 119.39 -68.28 0.37 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.336 -0.459 . . . . 73.409999999999997 113.062 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.414 ' N ' HD13 ' A' ' 144' ' ' ILE . 49.4 m . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 121.048 0.451 . . . . 73.420000000000002 111.503 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.565 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.761 0.315 . . . . 74.129999999999995 111.101 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.07 124.71 0.82 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.33 -0.462 . . . . 65.109999999999999 112.41 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.9 p -103.29 114.7 29.19 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.086 0.443 . . . . 72.230000000000004 112.169 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.1 m -99.57 -179.26 4.15 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.302 -0.408 . . . . 75.310000000000002 110.259 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -152.53 153.43 33.44 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.503 0.557 . . . . 72.420000000000002 112.503 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -155.7 138.73 15.45 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.572 -0.74 . . . . 73.400000000000006 110.783 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -160.91 142.49 12.04 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.221 0.209 . . . . 70.120000000000005 110.5 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -163.7 141.33 7.36 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.477 0.917 . . . . 73.310000000000002 113.477 -174.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -120.95 167.7 12.29 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.927 -0.579 . . . . 63.350000000000001 109.679 169.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -149.54 138.56 21.2 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.857 0.36 . . . . 75.230000000000004 111.954 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.6 m -107.71 142.56 37.52 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.385 -0.37 . . . . 72.0 110.826 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.2 p -140.97 132.78 27.44 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.742 0.306 . . . . 73.150000000000006 111.261 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.95 138.83 2.51 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.445 -0.884 . . . . 43.439999999999998 114.049 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -134.04 126.5 30.31 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.771 0.428 . . . . 75.319999999999993 110.356 174.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -82.3 167.38 18.64 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.085 0.402 . . . . 75.129999999999995 112.085 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -51.02 131.41 26.99 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.589 0.589 . . . . 75.430000000000007 112.589 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.21 129.11 36.5 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.863 -0.608 . . . . 70.319999999999993 111.239 178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 56.39 -163.06 0.17 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.894 0.701 . . . . 74.219999999999999 112.894 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -117.36 -175.03 2.72 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.264 -0.425 . . . . 74.120000000000005 111.354 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -95.12 158.53 15.42 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.158 0.504 . . . . 72.439999999999998 112.091 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.92 -147.05 18.0 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.903 -0.665 . . . . 61.420000000000002 113.725 172.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -151.8 117.62 5.46 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.717 0.294 . . . . 64.25 111.721 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.412 ' HE2' ' HD3' ' A' ' 76' ' ' LYS . 8.8 ptm -88.62 139.55 30.36 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.926 0.393 . . . . 72.340000000000003 110.769 176.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.629 HD11 ' HB3' ' A' ' 64' ' ' ALA . 32.6 mt -90.53 132.13 35.87 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.831 0.678 . . . . 74.239999999999995 112.831 -173.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -78.74 118.56 20.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.52 -0.764 . . . . 71.299999999999997 111.04 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 35.4 m -139.32 164.38 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.992 -1.004 . . . . 75.120000000000005 112.027 -173.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 34.8 tt0 -99.47 121.85 41.73 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.858 0.361 . . . . 42.32 110.435 171.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.462 HG22 HD11 ' A' ' 96' ' ' ILE . 39.3 t -96.42 110.2 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.258 -0.428 . . . . 74.239999999999995 111.608 -175.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.811 HD11 ' HE2' ' A' ' 95' ' ' MET . 2.9 mt -95.73 161.06 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.927 0.394 . . . . 74.109999999999999 111.905 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 73.5 m -129.33 95.44 4.03 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.01 0.434 . . . . 74.510000000000005 111.212 174.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.67 124.32 6.55 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.097 -0.573 . . . . 60.539999999999999 113.078 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -71.7 86.09 0.92 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.033 0.444 . . . . 70.129999999999995 111.592 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.5 p -69.12 -49.37 57.69 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.138 0.494 . . . . 74.0 111.085 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.8 mt -73.3 110.14 7.35 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.97 -0.559 . . . . 64.540000000000006 111.03 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -62.21 -22.06 65.63 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.474 0.546 . . . . 73.109999999999999 112.474 -177.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -85.05 -22.62 28.92 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.049 0.389 . . . . 74.140000000000001 112.049 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.79 -97.51 0.57 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.941 -0.647 . . . . 72.439999999999998 112.293 -173.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 62.12 -172.06 0.15 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.297 0.48 . . . . 71.510000000000005 112.297 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.5 p -99.38 -176.58 3.33 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.747 -0.464 . . . . 73.420000000000002 109.747 170.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.11 -37.3 76.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.047 0.388 . . . . 73.030000000000001 112.047 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -72.31 -17.63 61.85 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.87 0.693 . . . . 73.310000000000002 112.87 -174.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -70.73 -49.91 41.87 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.997 0.427 . . . . 74.140000000000001 110.271 170.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 45' ' ' THR . 0.1 OUTLIER -101.95 55.96 0.81 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.438 -0.347 . . . . 73.200000000000003 110.811 173.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.9 tp -74.56 27.05 0.08 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.363 0.601 . . . . 65.319999999999993 112.174 -175.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.436 ' H ' ' C ' ' A' ' 43' ' ' LYS . 3.1 t -86.34 161.0 18.93 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.161 0.505 . . . . 74.420000000000002 112.229 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.45 -29.43 67.78 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.203 0.525 . . . . 71.099999999999994 110.756 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -55.9 -36.71 67.97 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.759 -0.655 . . . . 72.329999999999998 110.579 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.481 ' O ' HG21 ' A' ' 52' ' ' VAL . 13.0 t80 -65.5 -43.09 91.22 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.893 -0.594 . . . . 74.109999999999999 110.4 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.484 ' HD1' HG21 ' A' ' 137' ' ' VAL . 75.4 t80 -58.65 -62.07 2.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.716 -0.674 . . . . 75.349999999999994 110.452 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -59.96 -23.89 63.95 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.621 0.6 . . . . 72.439999999999998 112.621 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.78 -33.01 58.07 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.795 0.665 . . . . 73.430000000000007 112.795 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.523 HG22 ' HD2' ' A' ' 102' ' ' PRO . 30.5 m -123.49 14.8 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 113.575 0.954 . . . . 75.230000000000004 113.575 -173.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -96.57 19.66 11.93 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.963 0.727 . . . . 75.129999999999995 112.963 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -145.5 159.21 43.44 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.897 -0.502 . . . . 71.310000000000002 112.279 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.38 141.59 51.98 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.787 -0.642 . . . . 63.420000000000002 110.687 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.768 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 41.5 mt-10 -97.9 111.98 24.08 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.838 0.351 . . . . 71.349999999999994 111.272 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.444 HD13 ' N ' ' A' ' 57' ' ' ILE . 3.9 mp -110.88 149.9 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.333 -0.394 . . . . 73.439999999999998 111.032 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -74.45 144.8 44.09 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.548 0.213 . . . . 73.420000000000002 110.438 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.427 ' HB2' ' HD3' ' A' ' 88' ' ' LYS . 27.6 tt0 -55.33 -32.91 62.89 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.314 0.487 . . . . 75.349999999999994 112.314 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.599 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 17.3 mm-40 -54.97 -57.08 13.11 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 111.977 0.362 . . . . 75.129999999999995 111.977 175.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.02 -34.99 78.93 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.441 0.639 . . . . 72.340000000000003 110.45 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.501 ' HA ' HD11 ' A' ' 67' ' ' LEU . 43.3 t-105 -53.08 -50.27 64.72 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.171 -0.922 . . . . 75.409999999999997 111.478 177.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -69.13 -39.1 79.07 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.155 -0.475 . . . . 71.010000000000005 111.462 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.629 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -56.27 -34.33 66.33 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.245 0.461 . . . . 71.430000000000007 112.245 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.0 mt -91.84 -18.32 23.99 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.377 -0.374 . . . . 75.340000000000003 111.849 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.03 46.33 10.57 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.154 -0.546 . . . . 62.439999999999998 112.657 -176.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.679 HD23 ' HD3' ' A' ' 129' ' ' LYS . 91.6 mt -84.09 143.19 29.87 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.271 0.558 . . . . 72.439999999999998 112.424 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -101.09 156.15 17.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.013 -0.54 . . . . 75.230000000000004 110.645 170.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.35 93.21 1.49 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.735 0.779 . . . . 65.340000000000003 111.11 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.76 -3.62 8.61 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 114.777 -1.101 . . . . 72.430000000000007 112.113 -171.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.47 173.79 1.5 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.23 0.538 . . . . 71.109999999999999 112.093 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -113.86 124.47 52.3 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.267 -0.424 . . . . 74.329999999999998 111.353 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.589 HG13 ' HB1' ' A' ' 86' ' ' ALA . 17.5 m -114.33 142.11 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.333 0.587 . . . . 74.120000000000005 112.232 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.554 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 38.5 ttmt -99.47 147.31 25.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.857 -0.611 . . . . 74.439999999999998 110.172 173.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -128.54 124.03 60.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.239 -0.652 . . . . 74.519999999999996 109.239 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.747 ' HB3' ' HZ1' ' A' ' 76' ' ' LYS . 6.5 mtpm? -133.93 130.12 37.28 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.546 0.573 . . . . 72.140000000000001 112.546 -170.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.722 HG21 ' HA3' ' A' ' 125' ' ' GLY . 25.0 p -136.62 -171.23 2.86 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.797 -0.638 . . . . 75.109999999999999 110.545 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.91 -14.91 63.27 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.961 -0.563 . . . . 63.520000000000003 111.853 175.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -89.2 -38.64 14.11 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 111.796 0.295 . . . . 72.120000000000005 111.796 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.31 -160.93 34.6 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.345 -0.455 . . . . 63.299999999999997 112.979 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.19 149.85 51.04 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.267 0.556 . . . . 64.230000000000004 112.202 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.506 HG22 HD12 ' A' ' 135' ' ' LEU . 12.5 p -147.46 147.26 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.142 -0.481 . . . . 74.310000000000002 110.948 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -111.12 119.07 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 122.31 -0.244 . . . . 71.340000000000003 110.997 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.442 ' HA ' HG11 ' A' ' 134' ' ' VAL . 34.3 m -129.57 174.25 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 111.921 0.341 . . . . 74.420000000000002 111.921 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -75.37 143.38 42.83 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.97 0.414 . . . . 73.430000000000007 111.458 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.589 ' HB1' HG13 ' A' ' 73' ' ' VAL . . . -94.5 122.12 36.75 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.216 0.45 . . . . 74.219999999999999 112.216 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -128.33 141.17 51.51 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.304 0.573 . . . . 72.099999999999994 111.08 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.427 ' HD3' ' HB2' ' A' ' 59' ' ' GLU . 35.3 ttmt -80.11 103.99 10.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.717 -0.674 . . . . 75.209999999999994 110.689 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.768 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -100.51 -163.9 28.29 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 121.256 -0.497 . . . . 71.549999999999997 114.298 -172.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -111.25 32.45 5.32 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.365 0.602 . . . . 51.420000000000002 111.292 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.1 m -92.37 158.41 38.86 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.974 -0.557 . . . . 63.240000000000002 111.817 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.97 163.14 37.59 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.302 2.001 . . . . 74.010000000000005 112.859 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.599 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 78.8 tttt -63.32 143.34 57.88 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.767 0.318 . . . . 71.430000000000007 111.574 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 68.22 28.78 73.18 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.877 -0.678 . . . . 73.340000000000003 112.961 -175.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.811 ' HE2' HD11 ' A' ' 29' ' ' ILE . 23.5 ttt -154.62 137.0 14.95 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.472 -0.428 . . . . 74.239999999999995 110.309 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.462 HD11 HG22 ' A' ' 28' ' ' VAL . 41.9 pt -134.87 144.37 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.359 0.6 . . . . 72.409999999999997 112.082 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -106.09 124.19 49.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.021 -0.536 . . . . 73.420000000000002 111.415 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' A' ' 30' ' ' SER . 54.4 mt -121.02 131.45 24.48 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.559 -0.291 . . . . 73.239999999999995 110.427 174.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.48 138.82 82.89 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.14 1.893 . . . . 65.319999999999993 112.399 175.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.538 ' HE3' ' ND2' ' A' ' 105' ' ' ASN . 0.0 OUTLIER -56.7 104.73 0.16 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.444 -0.344 . . . . 62.409999999999997 110.839 -178.163 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.97 -173.84 25.91 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.712 -0.756 . . . . 63.030000000000001 113.107 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.523 ' HD2' HG22 ' A' ' 52' ' ' VAL . 34.8 Cg_endo -64.7 -31.59 58.56 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.352 2.035 . . . . 73.430000000000007 111.566 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.502 ' HA ' HD13 ' A' ' 140' ' ' LEU . 8.2 m-85 -62.85 -48.17 80.2 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.701 -0.681 . . . . 74.230000000000004 110.146 175.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.439 ' O ' HG22 ' A' ' 108' ' ' ILE . . . -59.64 -43.55 93.81 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.911 -0.586 . . . . 72.010000000000005 111.517 173.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.538 ' ND2' ' HE3' ' A' ' 100' ' ' MET . 22.8 m-80 -54.89 -20.1 8.06 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.536 0.569 . . . . 73.409999999999997 112.536 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.514 ' SD ' HD22 ' A' ' 140' ' ' LEU . 88.5 mmm -69.45 -31.56 69.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.858 0.361 . . . . 72.109999999999999 111.435 177.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.425 ' HB ' HG23 ' A' ' 77' ' ' THR . 31.0 m -123.59 -8.36 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 113.293 0.849 . . . . 65.420000000000002 113.293 -171.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.546 HG21 ' OG ' ' A' ' 30' ' ' SER . 8.0 pt -106.05 177.48 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.565 0.698 . . . . 71.409999999999997 112.452 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.532 ' O ' HG23 ' A' ' 112' ' ' THR . 25.7 t70 -102.21 122.87 45.27 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 115.544 -0.753 . . . . 64.099999999999994 110.67 175.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.99 18.41 0.64 Allowed 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.846 2.364 . . . . 73.510000000000005 114.304 -176.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 61.8 m -114.4 -16.16 12.0 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.516 0.561 . . . . 74.510000000000005 112.516 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.532 HG23 ' O ' ' A' ' 109' ' ' ASP . 3.4 t -71.98 -41.68 67.39 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.732 0.642 . . . . 71.409999999999997 112.732 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -86.37 103.07 14.59 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.053 0.454 . . . . 72.209999999999994 111.525 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.77 -45.32 0.07 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.367 -0.444 . . . . 53.119999999999997 113.025 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 76.9 p -114.08 -171.8 1.97 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.019 0.438 . . . . 62.140000000000001 111.018 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.68 104.59 1.1 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 120.892 -0.67 . . . . 72.140000000000001 112.483 174.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 49.6 tpp -69.61 116.8 46.84 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 120.735 0.302 . . . . 74.530000000000001 110.804 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -80.96 -19.17 8.49 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.127 2.552 . . . . 71.120000000000005 113.772 -175.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -129.55 153.43 48.04 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.998 0.428 . . . . 73.200000000000003 112.14 -172.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -78.76 90.58 4.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.06 0.457 . . . . 74.319999999999993 111.106 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -135.82 136.18 40.43 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.33 -0.396 . . . . 73.540000000000006 110.978 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.47 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . -136.32 -171.2 12.21 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.946 -0.645 . . . . 72.439999999999998 113.133 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.426 HG21 ' H ' ' A' ' 109' ' ' ASP . 89.5 t -86.89 122.28 38.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.633 0.254 . . . . 73.109999999999999 111.515 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 68.0 mttm -71.71 147.32 47.52 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.463 0.649 . . . . 75.510000000000005 112.35 -177.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.722 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -175.15 -138.59 2.8 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.479 -0.782 . . . . 73.099999999999994 112.527 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 57.3 p -140.43 158.64 43.7 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.06 0.457 . . . . 75.230000000000004 111.748 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.1 p -135.29 145.23 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.988 -0.551 . . . . 64.209999999999994 110.472 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.495 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 5.9 pt-20 -149.04 155.21 40.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.684 0.278 . . . . 71.239999999999995 111.383 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.679 ' HD3' HD23 ' A' ' 67' ' ' LEU . 28.0 ttpp -85.68 133.54 34.02 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.607 -0.516 . . . . 75.430000000000007 109.607 168.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.6 t -130.72 161.08 32.46 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.601 0.715 . . . . 60.109999999999999 112.858 -171.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.09 -21.31 33.73 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.409 -0.814 . . . . 74.329999999999998 110.164 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -61.73 157.21 18.38 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.847 -0.615 . . . . 73.319999999999993 112.579 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.432 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -90.52 162.29 15.1 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.912 -0.585 . . . . 74.340000000000003 111.1 179.33 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.442 HG11 ' HA ' ' A' ' 84' ' ' VAL . 98.4 t -65.81 133.23 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.458 -0.337 . . . . 72.439999999999998 111.035 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.506 HD12 HG22 ' A' ' 82' ' ' VAL . 13.2 mt -63.01 138.28 58.51 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.134 0.492 . . . . 74.450000000000003 111.405 177.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.0 t -85.41 144.93 27.72 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.087 -0.709 . . . . 71.129999999999995 109.087 170.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.484 HG21 ' HD1' ' A' ' 49' ' ' PHE . 86.5 t -48.46 -47.05 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 112.093 0.405 . . . . 71.409999999999997 112.093 -175.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -67.83 -41.46 82.99 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.958 0.408 . . . . 64.450000000000003 111.525 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -62.14 -33.52 74.64 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.581 0.705 . . . . 72.400000000000006 110.404 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.514 HD22 ' SD ' ' A' ' 106' ' ' MET . 1.9 tt -66.63 -34.29 77.55 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.127 -0.942 . . . . 71.230000000000004 110.85 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.06 -41.58 92.64 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.633 0.73 . . . . 73.530000000000001 109.943 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -66.49 -35.89 81.39 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.464 -0.789 . . . . 65.510000000000005 110.675 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.76 -44.1 86.86 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.259 0.466 . . . . 53.329999999999998 112.259 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.9 pp -77.62 -8.63 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 120.86 0.362 . . . . 72.209999999999994 111.949 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 83.69 38.4 10.65 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 114.41 0.524 . . . . 64.340000000000003 114.41 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.474 0.768 0 CA-C-N 117.464 0.632 . . . . 61.329999999999998 111.349 176.673 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.558 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 120.725 0.298 . . . . 75.430000000000007 111.354 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 155.83 79.07 0.02 OUTLIER Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.129 -0.558 . . . . 63.240000000000002 112.929 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.4 p -76.77 126.24 30.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.115 0.483 . . . . 73.540000000000006 111.865 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.2 m -83.86 151.56 25.06 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.988 0.423 . . . . 64.129999999999995 111.728 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -157.89 138.8 13.19 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.309 -0.405 . . . . 75.219999999999999 111.043 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -120.62 144.81 47.94 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.983 0.42 . . . . 71.230000000000004 111.959 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -85.0 154.95 21.79 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.22 -0.445 . . . . 63.140000000000001 111.229 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -124.85 143.41 50.84 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.876 0.369 . . . . 71.430000000000007 111.869 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -154.84 151.99 29.27 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.582 -0.281 . . . . 74.400000000000006 111.304 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -114.11 116.63 29.43 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.063 0.459 . . . . 75.129999999999995 110.993 175.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.4 m -76.84 97.99 4.72 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.921 0.391 . . . . 64.120000000000005 111.028 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.7 m -105.37 121.69 44.41 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.374 -0.375 . . . . 74.019999999999996 111.31 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -136.48 -163.78 9.96 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.315 -0.469 . . . . 72.519999999999996 113.244 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -117.99 -176.99 3.16 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.014 0.435 . . . . 63.549999999999997 111.654 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.13 170.5 8.22 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.371 0.605 . . . . 74.439999999999998 112.506 -175.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -105.84 114.24 28.27 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.97 -0.559 . . . . 73.530000000000001 111.007 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 17' ' ' LEU . 6.8 mp -78.53 162.08 26.57 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.982 0.42 . . . . 73.430000000000007 112.063 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -92.87 125.24 37.38 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.211 0.529 . . . . 64.439999999999998 112.104 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -107.74 142.32 37.93 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.094 -0.503 . . . . 74.25 110.766 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -96.69 94.83 7.53 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.021 0.439 . . . . 73.420000000000002 111.124 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.65 112.69 0.28 Allowed Glycine 0 CA--C 1.529 0.933 0 CA-C-N 116.152 -0.476 . . . . 74.049999999999997 112.845 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -96.63 113.69 25.27 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.488 -0.419 . . . . 73.120000000000005 111.9 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 7.8 ptp -81.23 167.18 19.88 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.997 0.427 . . . . 64.150000000000006 111.219 176.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.502 HD11 ' HB3' ' A' ' 64' ' ' ALA . 25.3 mt -121.46 127.02 50.66 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.129 0.49 . . . . 74.420000000000002 111.813 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -71.7 115.61 11.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.585 -0.734 . . . . 65.040000000000006 111.02 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 27.8 m -128.51 160.07 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.55 0.574 . . . . 72.400000000000006 112.55 -174.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.623 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 52.9 tt0 -99.27 117.32 33.45 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.945 0.402 . . . . 74.099999999999994 110.696 174.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.49 HG23 HD11 ' A' ' 96' ' ' ILE . 40.9 t -92.35 108.51 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.142 0.496 . . . . 70.540000000000006 112.121 -175.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.769 HD12 ' HE1' ' A' ' 95' ' ' MET . 0.3 OUTLIER -102.24 146.95 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.936 0.398 . . . . 75.049999999999997 112.027 177.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 73.6 m -106.6 104.42 14.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.157 -0.474 . . . . 73.430000000000007 111.667 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.469 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . -73.11 94.67 0.71 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.885 -0.674 . . . . 61.43 112.894 178.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -68.64 89.49 0.38 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.39 0.614 . . . . 74.439999999999998 111.607 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.6 p -110.19 172.98 6.54 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.85 -0.613 . . . . 73.439999999999998 111.105 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 33.5 tp 73.45 -48.94 0.68 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.308 0.643 . . . . 73.450000000000003 112.182 178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 60.47 95.06 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.621 0.724 . . . . 74.200000000000003 111.762 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.513 ' HG3' ' HE3' ' A' ' 43' ' ' LYS . 76.4 mm-40 -134.65 -51.59 0.8 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.805 -0.634 . . . . 72.010000000000005 111.785 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.68 -7.69 61.4 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.11 -0.567 . . . . 53.109999999999999 113.567 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.36 145.13 33.59 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 122.554 0.341 . . . . 75.329999999999998 111.71 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.2 t -61.34 153.8 25.7 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.659 -0.246 . . . . 74.310000000000002 110.942 173.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.404 HG13 ' OH ' ' A' ' 48' ' ' TYR . 10.3 m -57.14 -30.89 35.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 120.714 0.292 . . . . 75.150000000000006 111.282 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -60.65 -33.27 72.55 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.162 -0.472 . . . . 70.319999999999993 111.863 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -56.17 -40.73 74.35 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.179 0.514 . . . . 74.510000000000005 110.519 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.549 ' HB2' ' CD2' ' A' ' 48' ' ' TYR . 63.9 mttm -104.9 -65.1 1.06 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.585 0.587 . . . . 75.329999999999998 112.585 -173.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.0 mt 48.35 20.81 0.31 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 113.215 0.82 . . . . 75.519999999999996 113.215 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.509 HG21 ' H ' ' A' ' 48' ' ' TYR . 6.5 t -80.35 156.4 26.74 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.654 0.264 . . . . 75.409999999999997 111.487 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -50.04 -38.7 39.05 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.105 0.479 . . . . 75.409999999999997 111.371 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -60.97 -37.84 83.82 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.086 -0.506 . . . . 72.430000000000007 111.223 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.549 ' CD2' ' HB2' ' A' ' 43' ' ' LYS . 1.7 t80 -58.18 -40.02 80.4 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.298 0.57 . . . . 72.109999999999999 109.849 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -64.52 -62.03 1.85 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.559 -0.746 . . . . 75.299999999999997 110.306 176.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -64.62 -4.31 4.03 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.09 0.774 . . . . 74.319999999999993 113.09 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.22 -33.01 14.86 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.61 0.596 . . . . 51.25 112.61 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.561 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 34.8 m -129.48 20.15 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 113.15 0.796 . . . . 64.430000000000007 113.15 -173.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -103.02 21.53 15.56 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.124 0.787 . . . . 72.129999999999995 113.124 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -140.89 158.43 43.96 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.168 0.509 . . . . 71.409999999999997 112.143 -177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.89 138.79 51.13 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.909 -0.587 . . . . 72.510000000000005 110.853 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.639 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 39.6 mt-10 -93.78 112.66 24.56 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.637 0.256 . . . . 73.439999999999998 111.361 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.414 HD11 ' N ' ' A' ' 57' ' ' ILE . 4.3 mp -109.81 146.06 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 116.529 -0.305 . . . . 74.150000000000006 110.764 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -68.43 143.92 54.88 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.811 0.339 . . . . 72.310000000000002 111.399 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -47.46 -40.05 17.31 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.117 0.567 . . . . 74.420000000000002 112.251 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -58.37 -54.35 47.97 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.087 0.47 . . . . 74.230000000000004 111.399 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -66.37 -33.67 76.25 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.227 0.537 . . . . 75.150000000000006 110.915 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 46.2 t-105 -54.16 -54.23 42.51 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.693 -0.685 . . . . 73.439999999999998 111.429 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -69.42 -36.38 76.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.525 -0.307 . . . . 74.400000000000006 111.66 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.502 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -59.64 -34.65 73.07 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.983 0.42 . . . . 71.140000000000001 111.88 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.484 ' HG ' HD13 ' A' ' 24' ' ' LEU . 94.6 mt -90.91 -12.17 36.9 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.473 -0.331 . . . . 74.310000000000002 111.751 177.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.12 46.51 50.49 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.123 -0.561 . . . . 70.120000000000005 112.657 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.721 ' HA ' ' HZ1' ' A' ' 129' ' ' LYS . 93.7 mt -86.6 159.51 19.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.616 0.722 . . . . 73.400000000000006 112.078 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -140.87 134.78 30.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.184 -0.916 . . . . 74.409999999999997 109.129 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -56.17 97.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.631 0.729 . . . . 74.049999999999997 112.094 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 143.28 -22.9 2.23 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.15 -0.932 . . . . 55.5 113.956 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -86.25 178.0 7.31 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 118.251 1.026 . . . . 73.239999999999995 112.627 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.642 HH11 HG21 ' A' ' 134' ' ' VAL . 60.9 mtt-85 -109.52 139.95 43.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.812 -0.631 . . . . 74.319999999999993 112.003 -169.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 31.4 m -124.06 140.03 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.921 -0.581 . . . . 73.0 111.212 177.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -107.99 131.25 54.76 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.921 0.391 . . . . 75.400000000000006 110.896 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 50.5 t -106.81 130.47 58.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.397 -0.365 . . . . 75.25 111.026 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.482 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -117.18 127.88 54.55 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.017 0.437 . . . . 55.329999999999998 111.307 177.475 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.627 HG23 ' HA3' ' A' ' 125' ' ' GLY . 21.4 p -135.53 -172.52 3.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.057 0.456 . . . . 72.439999999999998 110.57 175.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -71.29 -5.62 33.69 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.293 -0.412 . . . . 75.319999999999993 111.963 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -99.81 -20.55 16.15 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.026 0.38 . . . . 74.5 112.026 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 146.6 -151.63 23.87 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.982 -0.627 . . . . 63.420000000000002 113.202 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.482 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 9.5 pt-20 -140.3 149.94 43.41 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.8 0.333 . . . . 55.409999999999997 111.553 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.454 HG23 ' SD ' ' A' ' 106' ' ' MET . 12.8 p -149.11 148.67 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.528 -0.305 . . . . 74.219999999999999 111.135 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.07 117.71 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 120.542 0.21 . . . . 73.219999999999999 111.349 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.4 m -129.84 176.44 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.646 0.379 . . . . 72.409999999999997 111.657 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -79.66 145.97 32.72 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.016 0.436 . . . . 74.510000000000005 111.565 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -88.76 115.86 26.61 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 112.591 0.589 . . . . 74.319999999999993 112.591 -178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -113.27 157.39 21.84 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.621 0.725 . . . . 73.450000000000003 111.228 171.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -100.11 112.57 24.88 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.386 -0.825 . . . . 63.039999999999999 110.547 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.639 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -107.92 171.77 16.54 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.147 -0.549 . . . . 73.140000000000001 114.147 -174.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.61 18.34 13.07 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.32 0.581 . . . . 71.150000000000006 110.752 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.8 m -79.1 155.85 77.05 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.852 -0.613 . . . . 71.400000000000006 111.99 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.03 153.17 53.52 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.404 2.069 . . . . 75.340000000000003 112.588 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -62.65 148.75 45.44 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 122.161 -0.337 . . . . 75.040000000000006 111.151 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 66.17 27.29 72.84 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.521 -0.847 . . . . 74.310000000000002 112.41 -174.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.769 ' HE1' HD12 ' A' ' 29' ' ' ILE . 20.9 ttt -149.27 137.01 20.38 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.632 -0.507 . . . . 63.229999999999997 109.632 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.49 HD11 HG23 ' A' ' 28' ' ' VAL . 38.9 pt -132.99 141.54 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 121.249 0.547 . . . . 74.129999999999995 111.864 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.475 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 59.1 t80 -101.87 118.38 36.8 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.966 -0.561 . . . . 75.329999999999998 111.369 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.54 ' O ' ' HA ' ' A' ' 30' ' ' SER . 51.5 mt -119.97 124.37 27.91 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.623 -0.262 . . . . 75.150000000000006 110.612 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.561 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 11.5 Cg_endo -55.82 137.23 77.98 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.184 1.922 . . . . 71.430000000000007 112.258 176.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.415 ' HE1' ' OD1' ' A' ' 105' ' ' ASN . 0.0 OUTLIER -59.08 103.27 0.16 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.329 -0.396 . . . . 73.230000000000004 110.948 -175.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.59 -176.12 24.85 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.559 -0.829 . . . . 75.430000000000007 112.87 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.506 ' HA ' HD21 ' A' ' 105' ' ' ASN . 22.4 Cg_endo -62.13 -28.03 79.4 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.023 1.815 . . . . 74.150000000000006 111.446 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.5 ' HA ' HD11 ' A' ' 140' ' ' LEU . 8.4 m-85 -66.89 -49.88 64.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.617 -0.72 . . . . 73.310000000000002 110.134 175.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.38 -40.09 81.37 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.854 -0.612 . . . . 73.319999999999993 111.443 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.506 HD21 ' HA ' ' A' ' 102' ' ' PRO . 91.0 m-20 -56.71 -25.11 53.52 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.214 0.53 . . . . 72.409999999999997 111.808 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.454 ' SD ' HG23 ' A' ' 82' ' ' VAL . 35.3 mtp -73.58 -21.53 60.31 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.912 -0.586 . . . . 74.420000000000002 112.313 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.5 m -133.67 -5.96 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.453 0.908 . . . . 74.450000000000003 113.453 -173.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.438 HG21 ' HG ' ' A' ' 30' ' ' SER . 1.6 pp -111.13 172.65 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.957 -0.464 . . . . 74.540000000000006 111.665 -177.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.464 ' N ' HG23 ' A' ' 123' ' ' VAL . 11.6 t70 -96.83 120.11 62.36 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 116.252 -0.431 . . . . 70.219999999999999 111.636 -177.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -86.9 2.04 7.19 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.562 2.175 . . . . 71.340000000000003 113.396 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.0 m -86.71 0.05 55.39 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.945 0.402 . . . . 74.329999999999998 111.595 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 54.4 p -68.31 82.66 0.24 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.299 0.571 . . . . 75.450000000000003 110.992 175.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -66.12 113.93 4.87 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.058 -0.519 . . . . 75.340000000000003 110.877 -176.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.93 75.95 0.88 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 114.16 0.424 . . . . 74.040000000000006 114.16 -174.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 63.0 p -124.49 36.99 4.5 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.237 0.541 . . . . 71.530000000000001 111.144 175.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.33 10.24 18.01 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 116.181 -0.463 . . . . 72.420000000000002 113.283 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.493 ' N ' ' SD ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -68.64 147.04 97.98 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 112.215 0.45 . . . . 75.319999999999993 112.215 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.25 121.34 7.7 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.694 2.263 . . . . 54.310000000000002 113.319 -175.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -80.62 41.64 0.57 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.764 0.793 . . . . 72.219999999999999 111.028 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -137.02 -14.49 1.57 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.282 -0.872 . . . . 74.239999999999995 111.296 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -87.55 127.9 35.25 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.68 0.276 . . . . 71.450000000000003 110.803 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -124.1 177.65 16.67 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.649 -0.786 . . . . 74.019999999999996 113.877 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 109' ' ' ASP . 57.7 t -94.2 120.29 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 122.633 -0.333 . . . . 75.439999999999998 110.987 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 39.0 mtpt -73.83 153.5 39.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.015 0.912 . . . . 72.099999999999994 112.779 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.627 ' HA3' HG23 ' A' ' 77' ' ' THR . . . -174.88 -150.1 7.6 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 114.323 -1.308 . . . . 53.240000000000002 111.346 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 44.0 p -132.87 146.95 52.26 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.449 0.625 . . . . 63.299999999999997 111.873 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -121.67 144.01 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.085 -0.507 . . . . 70.409999999999997 110.905 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -149.74 152.4 35.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.921 -0.581 . . . . 72.530000000000001 110.811 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.721 ' HZ1' ' HA ' ' A' ' 67' ' ' LEU . 19.6 ttmm -73.04 134.95 44.81 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.363 -0.606 . . . . 74.420000000000002 109.363 170.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.7 t -126.52 158.84 35.09 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.036 0.754 . . . . 72.519999999999996 113.036 -172.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -85.46 -15.78 41.81 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.11 -0.95 . . . . 74.519999999999996 110.911 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.444 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 19.2 mm-40 -73.81 156.08 38.16 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.496 0.665 . . . . 75.430000000000007 112.587 -177.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.02 156.99 29.8 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.29 -0.868 . . . . 75.430000000000007 111.309 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.642 HG21 HH11 ' A' ' 72' ' ' ARG . 70.4 t -69.7 131.03 34.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 109.85 -0.426 . . . . 75.439999999999998 109.85 173.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.4 HD11 ' HG ' ' A' ' 140' ' ' LEU . 13.5 mt -63.21 132.33 51.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.081 0.467 . . . . 75.549999999999997 112.099 -177.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 65.6 m -75.97 146.07 39.86 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.41 -0.589 . . . . 71.010000000000005 109.41 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 87.5 t -46.76 -50.98 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 112.859 0.689 . . . . 73.120000000000005 112.859 -172.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -72.92 -38.76 66.74 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.057 -0.402 . . . . 64.209999999999994 111.745 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -58.42 -37.7 75.91 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.745 0.783 . . . . 73.319999999999993 110.038 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.5 HD11 ' HA ' ' A' ' 103' ' ' TYR . 5.1 tt -59.59 -42.66 93.03 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.905 -1.043 . . . . 73.109999999999999 110.72 174.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 50.6 mt -58.03 -46.99 84.42 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.205 0.526 . . . . 73.140000000000001 110.395 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.89 -33.48 74.29 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.946 -0.57 . . . . 74.340000000000003 111.169 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.21 -45.01 62.08 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.547 0.573 . . . . 74.299999999999997 112.547 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.05 -8.95 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 112.855 0.687 . . . . 75.519999999999996 112.855 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.43 -43.14 0.86 Allowed Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.925 -0.655 . . . . 73.200000000000003 113.234 177.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.6 m . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 121.136 0.493 . . . . 70.319999999999993 111.139 -179.143 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.568 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.834 0.349 . . . . 73.109999999999999 111.423 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.51 166.08 24.52 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.309 -0.472 . . . . 51.229999999999997 113.092 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.2 p -155.84 108.79 2.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.27 0.557 . . . . 72.150000000000006 111.538 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 t -79.0 155.0 29.05 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.295 -0.411 . . . . 64.450000000000003 111.129 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -156.27 90.25 1.18 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.328 0.585 . . . . 72.019999999999996 112.299 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -117.25 124.72 49.73 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.9 0.381 . . . . 74.349999999999994 110.533 174.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -132.69 131.8 41.68 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.118 0.485 . . . . 74.409999999999997 111.745 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -152.03 140.52 20.63 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.035 -0.53 . . . . 73.409999999999997 110.299 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -140.29 144.87 36.63 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.602 0.593 . . . . 75.510000000000005 112.602 -173.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -145.32 124.37 12.82 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.878 -0.601 . . . . 75.329999999999998 110.648 172.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.2 p -150.89 133.56 15.7 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.318 -0.401 . . . . 54.439999999999998 110.705 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.4 m -152.64 132.46 13.24 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.107 0.41 . . . . 74.530000000000001 112.107 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.74 172.96 21.43 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 112.013 -0.435 . . . . 51.399999999999999 112.013 172.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -160.6 134.93 7.28 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.084 -0.656 . . . . 74.329999999999998 112.366 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -89.42 -179.13 5.76 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.609 -0.723 . . . . 70.209999999999994 112.054 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -140.7 159.26 42.59 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.244 -0.435 . . . . 73.140000000000001 110.147 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.1 tt -46.8 129.68 11.58 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.138 0.494 . . . . 75.140000000000001 111.662 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -90.5 138.08 31.84 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.802 0.667 . . . . 75.239999999999995 112.802 -173.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -84.98 -179.81 7.14 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.075 -0.511 . . . . 74.349999999999994 110.859 173.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -81.06 -46.7 14.6 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.802 0.668 . . . . 75.219999999999999 112.802 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.17 -59.56 4.88 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.968 -0.634 . . . . 63.329999999999998 111.965 -173.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 30.7 t60 64.83 84.71 0.15 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.173 0.589 . . . . 73.400000000000006 111.752 174.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.515 ' HA ' ' HB3' ' A' ' 128' ' ' GLU . 8.7 ptp -78.67 152.46 31.65 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.959 0.726 . . . . 73.230000000000004 112.959 -177.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' A' ' 64' ' ' ALA . 13.5 mt -117.39 140.34 49.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.123 -0.944 . . . . 72.109999999999999 110.887 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -79.26 110.33 14.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.669 0.747 . . . . 75.0 110.974 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 35.0 m -133.51 162.32 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.872 -1.058 . . . . 70.129999999999995 111.873 -171.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.566 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 28.3 tt0 -100.08 117.72 34.94 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.067 0.46 . . . . 55.240000000000002 110.531 172.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.522 HG23 HD11 ' A' ' 96' ' ' ILE . 41.0 t -90.62 110.07 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.315 0.646 . . . . 72.409999999999997 111.457 -175.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.654 HD11 ' HE3' ' A' ' 95' ' ' MET . 8.3 mt -91.98 152.21 3.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.871 0.367 . . . . 73.030000000000001 111.768 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.676 ' HB2' HG23 ' A' ' 108' ' ' ILE . 23.1 t -123.63 93.28 3.89 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.946 0.403 . . . . 74.430000000000007 110.081 172.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.438 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . -80.66 143.56 24.62 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.135 -0.555 . . . . 63.409999999999997 113.501 -175.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 -65.99 82.08 0.08 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.423 0.63 . . . . 74.209999999999994 111.394 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 57.0 p -103.02 131.72 49.8 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.833 -0.621 . . . . 75.310000000000002 111.382 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.8 mp 62.68 -179.01 0.14 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.228 0.537 . . . . 73.099999999999994 111.224 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -88.44 117.78 27.61 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.539 -0.3 . . . . 72.230000000000004 111.367 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.452 ' HB3' ' H ' ' A' ' 37' ' ' GLY . 2.3 mp0 -77.45 -154.14 0.06 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.3 -0.409 . . . . 75.239999999999995 110.425 173.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' H ' ' HB3' ' A' ' 36' ' ' GLN . . . 82.73 -57.97 5.03 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.641 -0.79 . . . . 64.120000000000005 112.586 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.93 142.53 54.7 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.814 0.34 . . . . 74.319999999999993 111.762 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.6 p -67.58 155.48 39.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.766 0.317 . . . . 75.439999999999998 110.419 173.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.535 HG21 HD22 ' A' ' 141' ' ' LEU . 30.2 m -58.0 -24.78 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.063 0.458 . . . . 75.319999999999993 110.271 175.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -62.89 -51.98 64.87 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.752 -0.658 . . . . 74.530000000000001 110.884 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -56.53 -44.42 80.82 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.228 0.537 . . . . 71.319999999999993 111.295 175.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.4 mtpp -98.48 31.13 2.95 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.88 -0.6 . . . . 75.25 111.399 -178.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.09 82.8 0.12 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.089 0.471 . . . . 74.420000000000002 110.515 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 t -145.23 159.63 42.72 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.964 0.412 . . . . 71.129999999999995 111.905 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -53.98 -30.75 48.42 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.03 -0.532 . . . . 73.319999999999993 111.565 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.73 -36.48 76.67 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.761 0.315 . . . . 70.530000000000001 111.445 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -25.86 67.02 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.443 0.64 . . . . 74.310000000000002 109.973 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -86.33 -17.5 34.37 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.864 -0.607 . . . . 74.430000000000007 111.052 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -84.61 -43.23 14.63 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.902 -0.498 . . . . 73.420000000000002 112.067 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.85 -63.78 1.33 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.69 0.996 . . . . 72.530000000000001 113.69 -170.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.525 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 28.3 m -88.31 20.95 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 113.661 0.985 . . . . 72.530000000000001 113.661 -167.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.595 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -105.24 12.22 32.11 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.175 0.806 . . . . 75.430000000000007 113.175 -173.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -137.31 164.74 27.84 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.817 -0.552 . . . . 75.329999999999998 111.834 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.54 141.39 52.06 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.849 -0.614 . . . . 64.409999999999997 111.182 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.508 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 61.8 mt-10 -94.09 112.73 24.58 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.093 -0.503 . . . . 74.319999999999993 111.12 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.412 HD13 ' N ' ' A' ' 57' ' ' ILE . 4.3 mp -109.89 145.76 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.501 -0.318 . . . . 73.5 110.665 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -66.51 151.83 46.44 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.659 0.266 . . . . 73.409999999999997 111.012 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 34.9 tt0 -57.76 -41.96 83.03 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.425 0.528 . . . . 54.43 112.425 -177.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -63.36 -48.52 77.59 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.785 0.326 . . . . 74.230000000000004 111.817 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -65.25 -36.77 85.16 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.12 0.486 . . . . 74.230000000000004 110.605 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.416 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 39.9 t-105 -52.92 -49.39 66.08 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.861 -0.608 . . . . 64.239999999999995 110.905 174.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -66.54 -40.56 89.14 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.782 -0.644 . . . . 71.140000000000001 111.167 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.47 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -60.77 -39.44 88.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.124 0.487 . . . . 62.43 111.95 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.503 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 68.4 mt -80.6 -10.44 59.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.069 -0.514 . . . . 72.540000000000006 111.461 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.49 40.24 97.52 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.404 -0.427 . . . . 74.230000000000004 112.652 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.503 ' HG ' ' HB2' ' A' ' 65' ' ' LEU . 96.1 mt -78.11 161.07 27.66 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.73 0.776 . . . . 71.040000000000006 112.572 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -138.63 130.49 27.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.328 -0.851 . . . . 75.120000000000005 109.59 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -55.51 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.59 0.71 . . . . 74.540000000000006 112.115 -174.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.57 -19.45 1.85 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-N 115.14 -0.936 . . . . 70.109999999999999 113.479 -176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -89.51 -169.95 2.67 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 117.683 0.741 . . . . 74.129999999999995 112.224 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.437 ' HD3' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -135.59 162.06 33.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.168 0.508 . . . . 74.409999999999997 111.977 -174.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.525 HG13 ' HB3' ' A' ' 86' ' ' ALA . 23.8 m -132.22 154.86 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.329 0.585 . . . . 72.109999999999999 112.36 -176.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.422 ' HB2' HG23 ' A' ' 130' ' ' THR . 12.5 tppt? -97.98 129.74 44.85 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.516 -0.765 . . . . 73.030000000000001 110.486 173.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 44.7 t -116.16 123.21 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 122.251 0.22 . . . . 63.130000000000003 110.445 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -124.46 124.85 43.19 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.952 0.406 . . . . 74.450000000000003 112.042 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.629 HG21 ' HA3' ' A' ' 125' ' ' GLY . 25.0 p -132.15 -171.43 2.63 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.061 0.458 . . . . 74.239999999999995 111.396 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -71.78 -2.77 18.8 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 112.666 0.617 . . . . 75.430000000000007 112.666 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -106.75 -40.45 5.51 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.931 0.396 . . . . 71.430000000000007 111.863 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.72 -149.0 10.53 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.98 -0.629 . . . . 72.209999999999994 112.633 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 11.4 pt-20 -149.36 150.09 31.91 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.385 0.612 . . . . 74.25 112.289 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' A' ' 106' ' ' MET . 7.8 p -144.0 155.91 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.799 -0.637 . . . . 74.129999999999995 110.568 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.2 t -116.98 115.61 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.623 0.249 . . . . 64.510000000000005 110.722 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.23 168.65 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 116.263 -0.426 . . . . 74.540000000000006 111.668 -175.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -72.83 132.05 43.07 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.827 0.346 . . . . 74.349999999999994 111.364 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.525 ' HB3' HG13 ' A' ' 73' ' ' VAL . . . -86.24 121.94 29.54 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 111.978 0.362 . . . . 74.109999999999999 111.978 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -133.78 150.19 51.44 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.213 0.53 . . . . 74.329999999999998 111.319 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -85.41 103.47 14.34 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.947 -0.57 . . . . 74.400000000000006 110.357 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.508 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -120.08 -165.81 13.01 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 115.522 0.969 . . . . 64.340000000000003 115.522 -168.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -86.33 77.53 9.48 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.408 0.683 . . . . 64.120000000000005 111.869 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.7 m -149.05 152.37 36.3 Favored Pre-proline 0 N--CA 1.474 0.727 0 CA-C-N 115.443 -0.799 . . . . 75.439999999999998 111.655 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.55 168.52 16.19 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.779 2.32 . . . . 73.200000000000003 112.161 172.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -67.39 144.46 55.78 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.885 -0.509 . . . . 74.450000000000003 111.759 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 75.13 18.92 80.05 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.29 -0.481 . . . . 73.140000000000001 113.376 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.654 ' HE3' HD11 ' A' ' 29' ' ' ILE . 22.0 ttt -152.92 136.91 16.31 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.264 -0.551 . . . . 75.450000000000003 110.649 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.522 HD11 HG23 ' A' ' 28' ' ' VAL . 37.9 pt -132.53 150.72 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 121.179 0.514 . . . . 74.140000000000001 111.703 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.508 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 59.2 t80 -112.6 130.69 55.94 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.284 -0.416 . . . . 74.200000000000003 111.888 -176.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 30' ' ' SER . 40.1 mt -125.77 132.03 24.19 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 120.59 0.233 . . . . 73.150000000000006 110.795 173.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.525 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 51.2 Cg_exo -57.49 141.37 95.07 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.492 2.128 . . . . 74.430000000000007 112.789 176.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -61.03 103.68 0.3 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.799 0.333 . . . . 65.129999999999995 110.807 -178.524 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.26 -178.68 38.62 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.664 -0.779 . . . . 54.549999999999997 113.109 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.471 ' O ' ' HG2' ' A' ' 106' ' ' MET . 11.2 Cg_endo -54.62 -31.67 71.49 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.949 2.433 . . . . 75.310000000000002 112.668 -177.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.472 ' HA ' HD11 ' A' ' 140' ' ' LEU . 43.2 m-85 -66.09 -50.56 63.67 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.837 0.351 . . . . 70.530000000000001 110.843 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.487 ' O ' HG21 ' A' ' 108' ' ' ILE . . . -62.06 -38.4 88.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.007 0.432 . . . . 74.209999999999994 110.778 174.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -53.09 -26.67 17.1 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.106 0.562 . . . . 71.530000000000001 112.241 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.563 ' SD ' HD23 ' A' ' 140' ' ' LEU . 86.9 mmm -73.85 -20.73 60.35 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.097 0.406 . . . . 73.349999999999994 112.097 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.81 -7.24 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 113.1 0.778 . . . . 74.439999999999998 113.1 -173.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.676 HG23 ' HB2' ' A' ' 30' ' ' SER . 11.4 pt -105.7 179.76 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 121.878 -0.514 . . . . 74.450000000000003 111.594 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.578 ' H ' HG21 ' A' ' 123' ' ' VAL . 22.4 t70 -91.11 110.95 45.86 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 116.295 -0.411 . . . . 73.25 110.838 175.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.84 -13.96 21.67 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.365 2.043 . . . . 73.010000000000005 112.625 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.4 m -62.14 -69.22 0.26 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.398 -0.365 . . . . 61.149999999999999 110.885 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.9 p 49.49 -163.87 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 112.719 0.637 . . . . 64.519999999999996 112.719 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -149.06 157.48 43.43 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.628 -0.26 . . . . 74.349999999999994 110.563 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.96 -22.9 60.82 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.301 -0.476 . . . . 63.5 113.844 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.4 p -86.24 -71.87 0.52 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.957 0.378 . . . . 74.420000000000002 111.774 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.07 146.02 18.49 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.405 -0.426 . . . . 72.239999999999995 113.137 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 81.1 mtp -86.88 150.31 49.97 Favored Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 122.507 -0.408 . . . . 73.25 111.708 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.31 -176.18 3.07 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.501 2.134 . . . . 71.430000000000007 112.565 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 64.85 167.02 0.17 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.362 0.601 . . . . 75.420000000000002 112.481 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -73.06 110.69 7.54 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.383 0.611 . . . . 73.140000000000001 111.724 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -146.81 138.92 24.68 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.0 0.428 . . . . 72.310000000000002 111.552 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.423 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . -142.9 -177.17 17.65 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.296 -0.478 . . . . 53.409999999999997 112.93 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.578 HG21 ' H ' ' A' ' 109' ' ' ASP . 93.2 t -85.09 126.86 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.913 0.387 . . . . 74.530000000000001 111.324 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 21.7 mtpp -75.08 160.19 30.79 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.771 0.656 . . . . 74.230000000000004 112.771 -174.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.629 ' HA3' HG21 ' A' ' 77' ' ' THR . . . 171.94 -151.53 15.15 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 116.064 -0.516 . . . . 74.230000000000004 113.882 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 70.8 p -137.32 159.82 40.85 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 122.381 -0.482 . . . . 64.5 111.609 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.9 p -148.88 144.07 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 112.047 0.388 . . . . 74.530000000000001 112.047 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.515 ' HB3' ' HA ' ' A' ' 23' ' ' MET . 9.1 pt-20 -153.35 159.65 42.51 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.881 0.472 . . . . 71.430000000000007 110.904 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -83.31 144.11 29.92 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.147 0.498 . . . . 75.040000000000006 111.377 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.422 HG23 ' HB2' ' A' ' 74' ' ' LYS . 4.0 t -150.03 161.84 41.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.861 -0.609 . . . . 52.520000000000003 111.653 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -76.62 -8.0 56.37 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.394 -0.366 . . . . 73.540000000000006 111.28 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -50.2 152.71 1.66 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.528 0.566 . . . . 73.140000000000001 112.528 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.579 ' HD2' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -87.31 146.75 25.8 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.838 -0.619 . . . . 75.420000000000002 111.604 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 71.9 t -68.84 131.97 33.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.799 0.333 . . . . 74.439999999999998 110.585 172.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.435 HD21 ' HG2' ' A' ' 139' ' ' GLU . 17.9 mt -66.98 147.29 53.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.858 0.361 . . . . 75.519999999999996 111.307 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 46.7 t -90.44 151.28 21.47 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.248 -0.649 . . . . 65.5 109.248 169.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.484 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 73.8 t -48.91 -47.34 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.002 0.43 . . . . 73.5 111.54 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -72.69 -40.41 66.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.296 -0.411 . . . . 74.340000000000003 111.979 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.435 ' HG2' HD21 ' A' ' 135' ' ' LEU . 49.1 tt0 -60.36 -33.71 72.83 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.849 0.833 . . . . 73.019999999999996 110.249 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.563 HD23 ' SD ' ' A' ' 106' ' ' MET . 2.5 tt -65.62 -39.35 91.4 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.914 -1.039 . . . . 71.319999999999993 110.379 174.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.535 HD22 HG21 ' A' ' 40' ' ' VAL . 57.1 mt -60.22 -47.82 84.35 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.091 0.472 . . . . 74.129999999999995 110.386 175.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -57.84 -35.11 70.46 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.879 -0.6 . . . . 73.430000000000007 111.01 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.26 -46.77 66.46 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.166 0.432 . . . . 75.230000000000004 112.166 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.7 pp -81.57 -4.81 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 112.184 0.439 . . . . 75.239999999999995 112.184 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 86.31 40.28 7.47 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.391 -0.433 . . . . 71.150000000000006 114.147 174.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.439 ' HB3' ' HB3' ' A' ' 141' ' ' LEU . 48.2 t . . . . . 0 N--CA 1.476 0.833 0 CA-C-N 116.985 0.392 . . . . 75.549999999999997 111.286 175.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.513 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.878 0.37 . . . . 74.319999999999993 111.549 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -153.08 151.41 23.2 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.289 -0.481 . . . . 64.120000000000005 113.047 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.5 t -153.18 104.24 2.78 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.532 -0.393 . . . . 73.129999999999995 111.289 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.9 p -93.2 79.48 4.5 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.55 0.69 . . . . 70.030000000000001 111.51 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -87.83 105.04 17.14 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.711 0.767 . . . . 74.030000000000001 110.834 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -102.56 165.9 10.82 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.708 -0.678 . . . . 75.030000000000001 112.616 -172.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -148.64 137.03 21.2 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.704 -0.68 . . . . 74.349999999999994 110.657 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -130.43 101.54 5.78 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.202 0.525 . . . . 74.030000000000001 112.162 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -146.64 141.24 26.68 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.097 -0.501 . . . . 70.430000000000007 110.82 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -150.07 103.75 3.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.162 -0.472 . . . . 71.549999999999997 110.461 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.5 p -137.62 143.85 41.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.032 0.444 . . . . 75.120000000000005 112.04 -175.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.8 m -155.36 146.05 22.22 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.188 -0.46 . . . . 72.219999999999999 110.964 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.3 172.02 31.48 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.117 -0.563 . . . . 53.520000000000003 112.911 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -143.01 108.41 5.04 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.917 0.389 . . . . 73.400000000000006 111.336 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -161.22 92.1 0.89 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.077 0.465 . . . . 73.340000000000003 111.075 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -118.62 107.96 14.36 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.2 -0.454 . . . . 74.209999999999994 111.28 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.94 160.97 14.87 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.004 0.43 . . . . 73.430000000000007 111.409 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -75.97 167.48 21.8 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.87 0.367 . . . . 74.430000000000007 111.762 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -165.52 113.47 0.98 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.321 -0.4 . . . . 72.239999999999995 110.827 175.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -125.54 128.41 47.92 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.555 -0.293 . . . . 74.409999999999997 111.413 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -175.39 162.87 32.53 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 116.269 -0.423 . . . . 64.409999999999997 112.671 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -157.79 98.53 1.64 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.964 0.412 . . . . 72.439999999999998 111.549 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.71 ' HA ' ' HB3' ' A' ' 128' ' ' GLU . 10.0 ptp -81.86 154.6 25.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.603 0.716 . . . . 74.549999999999997 112.477 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.61 HD12 ' HB3' ' A' ' 61' ' ' ASP . 10.0 mt -103.11 131.68 49.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.289 -0.869 . . . . 74.310000000000002 110.838 175.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -78.01 106.8 10.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.052 0.929 . . . . 74.129999999999995 111.176 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 32.9 m -132.58 166.85 28.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.392 -1.276 . . . . 75.129999999999995 111.947 -170.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 31.1 tt0 -103.4 123.05 46.12 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.115 0.483 . . . . 75.109999999999999 110.891 171.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.525 HG23 HD11 ' A' ' 96' ' ' ILE . 36.7 t -93.74 114.08 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 115.917 -0.583 . . . . 65.25 111.725 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.592 HD11 ' HE2' ' A' ' 95' ' ' MET . 3.1 mt -98.99 161.5 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 112.244 0.461 . . . . 74.530000000000001 112.244 -176.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.621 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 75.0 m -127.76 105.65 8.6 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.242 -0.436 . . . . 74.409999999999997 110.907 174.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.405 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . -108.1 135.24 12.69 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.174 -0.536 . . . . 73.25 113.593 -176.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.502 ' HD3' ' HA ' ' A' ' 35' ' ' ASN . 39.1 ttm180 -64.79 95.84 0.16 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.668 0.618 . . . . 74.519999999999996 112.668 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 47.0 p -89.28 -19.59 25.14 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.319 -0.401 . . . . 74.5 110.683 170.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.1 mt -111.08 113.22 25.6 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.962 -0.563 . . . . 64.510000000000005 110.207 174.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.502 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 88.2 m-20 -80.25 -24.38 40.17 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.302 0.482 . . . . 63.43 112.302 -176.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -70.56 114.91 9.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.821 0.343 . . . . 75.140000000000001 111.207 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -75.58 72.0 1.78 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.821 -0.704 . . . . 72.019999999999996 112.874 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.553 ' HB2' ' HE2' ' A' ' 43' ' ' LYS . . . -114.53 172.27 7.13 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.123 0.487 . . . . 73.340000000000003 111.603 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.6 p -86.27 163.42 17.74 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.23 -0.441 . . . . 74.230000000000004 111.348 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.7 t -58.85 -38.59 73.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.279 0.561 . . . . 74.030000000000001 110.257 173.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -58.78 -44.09 90.58 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.559 -0.746 . . . . 72.319999999999993 111.226 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.469 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 4.5 tp10 -60.32 -32.57 71.36 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.236 0.541 . . . . 74.349999999999994 111.847 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.553 ' HE2' ' HB2' ' A' ' 38' ' ' ALA . 65.9 mttm -112.58 31.44 6.34 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.756 0.651 . . . . 74.310000000000002 112.756 -174.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.3 mt -64.11 83.8 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.235 0.541 . . . . 71.25 111.331 175.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 t -170.71 -179.25 2.83 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.773 -0.649 . . . . 74.310000000000002 111.079 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -58.09 -26.67 62.87 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 111.924 0.342 . . . . 63.299999999999997 111.924 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -54.15 -40.91 67.87 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.826 0.346 . . . . 74.209999999999994 111.366 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.599 ' HE2' ' HD3' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -76.05 -23.02 55.07 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.989 0.423 . . . . 73.019999999999996 111.405 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -75.2 -69.34 0.48 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.325 0.583 . . . . 74.109999999999999 111.116 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -63.51 -8.19 8.84 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.943 0.72 . . . . 72.319999999999993 112.943 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.03 -34.28 13.77 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.632 0.975 . . . . 72.540000000000006 113.632 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 48' ' ' TYR . 28.8 m -131.92 7.58 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 N-CA-C 114.014 1.116 . . . . 75.319999999999993 114.014 -173.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.579 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -90.71 20.58 4.59 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.105 0.78 . . . . 71.519999999999996 113.105 -174.703 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.441 ' CD2' ' HD3' ' A' ' 87' ' ' LYS . 26.3 p90 -140.1 152.75 46.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.166 0.507 . . . . 71.239999999999995 111.829 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -119.44 135.63 54.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.703 -0.681 . . . . 74.239999999999995 110.1 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.504 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 36.0 mt-10 -97.47 115.11 27.17 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.89 0.376 . . . . 73.329999999999998 111.085 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.418 HG22 ' N ' ' A' ' 58' ' ' ASN . 4.2 mp -109.13 156.73 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.169 0.509 . . . . 74.030000000000001 110.734 -177.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.644 ' ND2' HG22 ' A' ' 91' ' ' VAL . 3.1 m120 -63.57 151.78 40.54 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.893 -0.594 . . . . 73.430000000000007 111.308 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 30.1 tt0 -67.16 -41.3 86.25 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 111.847 0.314 . . . . 75.530000000000001 111.847 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -63.9 -49.54 72.26 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.84 0.352 . . . . 75.420000000000002 111.178 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.61 ' HB3' HD12 ' A' ' 24' ' ' LEU . 58.8 m-20 -65.96 -31.02 71.69 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.05 0.452 . . . . 72.349999999999994 111.349 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.413 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 62.7 t-105 -54.45 -54.58 38.93 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.308 0.575 . . . . 74.140000000000001 111.22 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -70.66 -29.8 66.24 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.993 -0.549 . . . . 63.240000000000002 111.14 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.76 -39.36 84.58 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.917 0.389 . . . . 73.109999999999999 111.453 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.451 HD13 ' HA ' ' A' ' 128' ' ' GLU . 94.0 mt -88.54 -13.25 40.59 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.447 -0.342 . . . . 73.239999999999995 111.748 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.24 42.61 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.98 -0.628 . . . . 55.130000000000003 112.439 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.706 HD21 ' HE3' ' A' ' 129' ' ' LYS . 90.5 mt -85.36 158.79 20.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.611 0.72 . . . . 73.409999999999997 112.026 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -135.09 130.0 34.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.26 -0.882 . . . . 75.010000000000005 109.062 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.81 90.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.712 0.768 . . . . 64.439999999999998 111.917 -172.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.68 -7.33 2.47 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 114.765 -1.107 . . . . 74.109999999999999 114.38 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -90.71 -175.6 4.45 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 118.527 1.163 . . . . 73.439999999999998 112.735 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.457 ' HG3' HG21 ' A' ' 134' ' ' VAL . 8.5 mpt_? -106.05 133.87 50.08 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.261 0.553 . . . . 74.510000000000005 112.426 -172.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.511 HG13 ' HB3' ' A' ' 86' ' ' ALA . 28.1 m -126.25 144.39 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.021 -0.536 . . . . 74.25 111.392 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.594 ' HD3' ' HE2' ' A' ' 76' ' ' LYS . 23.1 ttmm -105.32 151.06 24.62 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.111 0.481 . . . . 74.019999999999996 110.934 177.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.45 137.24 56.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.907 -0.588 . . . . 74.340000000000003 109.491 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.594 ' HE2' ' HD3' ' A' ' 74' ' ' LYS . 23.4 mttm -137.83 132.33 32.44 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.757 0.651 . . . . 64.310000000000002 112.757 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.503 HG23 ' HA3' ' A' ' 125' ' ' GLY . 32.8 p -136.09 -171.75 2.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.62 -0.718 . . . . 72.150000000000006 110.19 176.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.29 -8.92 57.93 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.796 0.331 . . . . 75.439999999999998 111.501 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -91.3 -38.5 12.61 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.777 0.322 . . . . 71.329999999999998 111.493 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.26 -148.27 11.96 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.127 -0.559 . . . . 24.23 112.994 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -154.5 156.74 37.24 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.254 0.465 . . . . 74.420000000000002 112.254 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.424 HG23 ' SD ' ' A' ' 106' ' ' MET . 12.2 p -153.49 150.34 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 116.213 -0.448 . . . . 71.340000000000003 111.288 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.2 t -110.58 118.02 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 110.399 -0.223 . . . . 74.5 110.399 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.475 HG11 ' CD2' ' A' ' 103' ' ' TYR . 33.6 m -124.78 177.24 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 120.808 0.337 . . . . 72.519999999999996 111.78 -177.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -79.73 144.88 33.25 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.853 0.359 . . . . 75.340000000000003 111.351 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.511 ' HB3' HG13 ' A' ' 73' ' ' VAL . . . -90.27 123.5 34.11 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.482 0.549 . . . . 75.349999999999994 112.482 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.441 ' HD3' ' CD2' ' A' ' 54' ' ' TYR . 43.3 mtpt -133.21 156.75 46.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.021 -0.536 . . . . 61.030000000000001 110.734 173.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -98.15 128.71 44.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.218 -0.446 . . . . 73.340000000000003 111.291 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.504 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -128.35 154.52 20.0 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.976 -0.63 . . . . 62.32 113.47 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.32 46.75 0.75 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.158 0.504 . . . . 44.340000000000003 111.54 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.644 HG22 ' ND2' ' A' ' 58' ' ' ASN . 28.5 m -95.58 159.79 31.83 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 116.09 -0.505 . . . . 74.209999999999994 111.564 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 95' ' ' MET . 38.6 Cg_exo -62.1 134.24 48.25 Favored 'Trans proline' 0 N--CA 1.487 1.104 0 C-N-CA 122.887 2.391 . . . . 74.120000000000005 113.059 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -53.79 134.5 42.32 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 120.775 0.322 . . . . 75.230000000000004 111.821 -175.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 76.49 27.88 60.61 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 120.722 -0.752 . . . . 73.25 112.745 -172.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.592 ' HE2' HD11 ' A' ' 29' ' ' ILE . 22.3 ttt -153.39 135.07 14.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.448 -0.575 . . . . 65.420000000000002 109.448 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.525 HD11 HG23 ' A' ' 28' ' ' VAL . 39.5 pt -128.03 144.27 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.47 0.652 . . . . 75.230000000000004 112.093 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.405 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 77.2 t80 -105.3 119.55 39.35 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.909 -0.587 . . . . 71.420000000000002 111.564 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.621 ' O ' ' HA ' ' A' ' 30' ' ' SER . 48.2 mt -117.34 128.96 25.67 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 109.916 -0.401 . . . . 73.099999999999994 109.916 172.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.431 ' HB2' HG13 ' A' ' 52' ' ' VAL . 47.8 Cg_exo -57.84 141.8 96.01 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.033 1.822 . . . . 73.409999999999997 112.576 176.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.546 ' HA ' ' HE2' ' A' ' 100' ' ' MET . 4.6 tpt -55.29 102.38 0.07 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.91 0.386 . . . . 75.519999999999996 111.501 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -158.97 179.65 34.46 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.59 -0.814 . . . . 74.540000000000006 113.52 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.599 ' HD3' ' HE2' ' A' ' 48' ' ' TYR . 36.5 Cg_endo -63.54 -26.44 69.8 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.529 2.152 . . . . 73.0 112.213 -176.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.475 ' CD2' HG11 ' A' ' 84' ' ' VAL . 26.9 m-85 -61.49 -48.99 78.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.784 0.802 . . . . 74.140000000000001 109.309 173.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.28 75.25 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.221 -0.899 . . . . 73.150000000000006 111.391 173.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 102' ' ' PRO . 8.7 m120 -62.92 -12.69 26.92 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 122.045 -0.409 . . . . 65.329999999999998 111.844 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.497 ' SD ' HD23 ' A' ' 140' ' ' LEU . 40.6 mtp -89.41 -15.02 34.18 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.576 -0.283 . . . . 75.019999999999996 111.464 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.8 -14.75 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 113.028 0.751 . . . . 73.310000000000002 113.028 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.494 HG23 ' OG ' ' A' ' 30' ' ' SER . 7.5 pt -104.25 178.16 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 O-C-N 121.854 -0.529 . . . . 75.519999999999996 111.861 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -91.12 111.19 47.23 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 116.084 -0.507 . . . . 74.120000000000005 110.52 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -85.45 7.16 5.25 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.494 2.129 . . . . 73.040000000000006 113.764 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.6 t -100.2 -19.83 16.22 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.426 0.528 . . . . 74.109999999999999 112.426 -175.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.8 t -61.2 149.01 38.94 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.619 0.6 . . . . 71.319999999999993 112.619 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -114.72 24.46 11.78 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.725 -0.671 . . . . 70.040000000000006 110.958 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.53 79.6 0.17 Allowed Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.275 -0.42 . . . . 74.510000000000005 113.89 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 68.9 p -100.03 16.0 25.42 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.65 -0.324 . . . . 75.349999999999994 111.783 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.94 -127.6 0.1 Allowed Glycine 0 CA--C 1.529 0.94 0 N-CA-C 114.631 0.612 . . . . 71.439999999999998 114.631 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 79.2 mtp -100.6 155.24 36.58 Favored Pre-proline 0 CA--C 1.539 0.543 0 O-C-N 122.457 -0.437 . . . . 74.099999999999994 111.758 -174.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -56.64 117.17 3.8 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.833 2.355 . . . . 62.310000000000002 113.319 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -137.73 126.84 24.39 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.179 -0.464 . . . . 74.140000000000001 110.399 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -75.83 82.23 2.76 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.702 0.63 . . . . 74.200000000000003 112.702 -174.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -154.18 145.98 23.41 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.133 -0.485 . . . . 75.319999999999993 111.385 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . -140.15 -164.16 9.79 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 116.064 -0.516 . . . . 73.230000000000004 112.982 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.4 t -89.04 123.69 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.816 0.341 . . . . 74.319999999999993 111.636 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 67.5 mttm -66.28 149.54 50.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.573 0.582 . . . . 75.420000000000002 112.573 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.503 ' HA3' HG23 ' A' ' 77' ' ' THR . . . -178.65 -155.86 15.59 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 115.926 -0.579 . . . . 64.439999999999998 112.963 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.412 HG23 ' SD ' ' A' ' 23' ' ' MET . 67.7 p -131.87 159.72 37.76 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 122.244 -0.562 . . . . 64.120000000000005 111.863 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.75 144.44 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 116.31 -0.405 . . . . 73.120000000000005 111.681 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.71 ' HB3' ' HA ' ' A' ' 23' ' ' MET . 13.8 pt-20 -164.84 168.61 17.56 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.314 -0.403 . . . . 75.450000000000003 111.015 173.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.706 ' HE3' HD21 ' A' ' 67' ' ' LEU . 34.7 ttmt -68.75 148.54 50.21 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.222 0.534 . . . . 72.109999999999999 112.182 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 t -146.19 155.95 43.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.088 -0.505 . . . . 74.340000000000003 111.126 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.31 -2.61 58.51 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.139 0.495 . . . . 72.129999999999995 110.99 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.89 173.32 3.67 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.667 0.617 . . . . 54.420000000000002 112.667 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -88.86 148.55 23.81 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.845 -0.616 . . . . 64.319999999999993 111.867 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.457 HG21 ' HG3' ' A' ' 72' ' ' ARG . 73.4 t -69.76 124.32 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.049 -0.523 . . . . 74.219999999999999 109.854 170.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 135' ' ' LEU . 10.3 mt -70.57 89.66 0.72 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.967 -0.293 . . . . 75.140000000000001 111.502 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 37.5 m -47.8 148.62 1.52 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.078 -0.51 . . . . 71.120000000000005 110.816 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.49 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 72.0 t -44.8 -45.15 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 112.465 0.543 . . . . 72.340000000000003 112.465 -173.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -72.15 -47.85 47.93 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.79 0.329 . . . . 73.439999999999998 111.712 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -55.91 -38.23 69.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.233 0.539 . . . . 74.5 110.501 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.497 HD23 ' SD ' ' A' ' 106' ' ' MET . 2.7 tt -61.18 -42.3 98.33 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.465 -0.788 . . . . 72.319999999999993 111.09 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 31.1 mt -56.83 -47.48 80.21 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.549 0.69 . . . . 73.150000000000006 110.387 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -77.04 -30.7 55.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.551 -0.75 . . . . 72.450000000000003 111.712 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.42 -41.4 97.09 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.753 0.279 . . . . 73.129999999999995 111.753 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.9 pt -75.84 -7.83 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.091 0.404 . . . . 73.319999999999993 112.091 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 109.43 9.01 26.11 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.193 -0.527 . . . . 63.439999999999998 114.155 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 121.621 0.725 . . . . 64.540000000000006 111.775 179.532 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.571 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.803 0.335 . . . . 75.400000000000006 111.826 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.45 137.07 4.46 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.116 -0.564 . . . . 63.43 112.79 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.5 m -157.7 167.0 31.31 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.97 0.414 . . . . 74.120000000000005 111.952 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.8 p -163.21 161.93 25.16 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.144 0.497 . . . . 62.32 111.881 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -124.91 138.24 54.25 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.976 -0.556 . . . . 75.230000000000004 110.112 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -128.03 132.16 49.12 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.691 0.626 . . . . 70.340000000000003 112.691 -166.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -170.63 121.98 0.61 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.293 -0.412 . . . . 73.230000000000004 111.313 174.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -96.55 -55.06 3.04 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 122.252 -0.28 . . . . 71.409999999999997 110.956 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 86.0 t60 43.38 88.89 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.503 1.297 . . . . 75.540000000000006 114.503 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -153.21 172.55 16.79 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.031 0.443 . . . . 74.420000000000002 111.788 174.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.9 p -150.71 -174.39 4.76 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.131 -0.486 . . . . 71.120000000000005 111.294 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.1 t -147.7 170.66 17.07 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 120.827 0.346 . . . . 75.329999999999998 111.552 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -119.2 149.3 18.12 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.631 -0.318 . . . . 71.510000000000005 112.617 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -101.25 -89.8 0.35 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 117.153 0.476 . . . . 73.420000000000002 112.002 -176.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 64.98 114.94 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 112.792 0.664 . . . . 75.409999999999997 112.792 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -140.72 112.95 7.86 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.367 -0.379 . . . . 72.010000000000005 111.154 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mp -105.25 166.61 10.29 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.826 0.676 . . . . 74.299999999999997 112.826 -176.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.64 167.34 20.25 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.895 -0.593 . . . . 73.530000000000001 111.374 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -123.42 179.85 4.59 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.2 -0.455 . . . . 75.349999999999994 110.96 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -135.5 143.22 45.68 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.084 0.469 . . . . 74.329999999999998 112.059 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.42 178.68 32.65 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.374 -0.441 . . . . 63.119999999999997 113.609 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -79.96 76.73 6.67 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.077 0.465 . . . . 73.540000000000006 111.064 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.0 ptm -87.49 148.65 24.84 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.158 -0.474 . . . . 72.200000000000003 110.444 174.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.436 HD11 ' HB3' ' A' ' 64' ' ' ALA . 40.1 mt -106.6 124.52 49.73 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.184 0.809 . . . . 75.549999999999997 113.184 -173.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -72.06 102.55 3.01 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.601 -1.182 . . . . 75.200000000000003 110.444 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.39 166.16 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.005 0.431 . . . . 75.209999999999994 111.898 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.618 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 37.1 tt0 -99.84 115.99 30.88 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.807 0.337 . . . . 72.329999999999998 110.436 172.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.566 HG22 HD11 ' A' ' 96' ' ' ILE . 21.2 t -90.46 110.96 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.077 -0.511 . . . . 74.319999999999993 111.724 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.62 HD11 ' HE1' ' A' ' 95' ' ' MET . 1.3 mt -100.09 153.22 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 120.838 0.351 . . . . 75.299999999999997 111.651 -177.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.1 t -120.07 103.63 9.45 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.903 0.383 . . . . 73.239999999999995 110.581 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -98.58 128.83 9.69 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 121.076 -0.583 . . . . 74.25 113.171 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -72.35 92.1 1.39 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.394 0.616 . . . . 75.140000000000001 111.248 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.0 p -92.53 -49.83 5.92 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.786 -0.643 . . . . 70.319999999999993 112.08 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.14 98.4 0.06 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.954 0.407 . . . . 75.329999999999998 111.655 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -62.77 -11.49 18.07 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.219 -0.446 . . . . 74.099999999999994 111.855 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -51.84 -32.72 32.99 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.232 0.456 . . . . 75.129999999999995 112.232 175.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.72 69.35 1.31 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.037 -0.602 . . . . 72.230000000000004 112.627 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.438 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . . . -166.63 168.77 14.2 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.634 -0.333 . . . . 75.5 111.568 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.5 p -76.06 -173.31 2.3 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.872 0.368 . . . . 64.530000000000001 110.557 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.559 ' HA ' ' CE2' ' A' ' 48' ' ' TYR . 14.3 p -71.98 -29.61 33.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.735 0.303 . . . . 71.329999999999998 111.368 175.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -63.86 -38.2 90.22 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.127 0.417 . . . . 75.409999999999997 112.127 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.48 -32.15 73.61 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.586 0.588 . . . . 71.549999999999997 112.586 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.59 ' HB2' ' HD2' ' A' ' 48' ' ' TYR . 1.2 mppt? -122.29 51.63 1.36 Allowed 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.981 -0.449 . . . . 73.239999999999995 112.15 -175.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.0 mt -70.94 86.47 0.71 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.265 0.555 . . . . 61.140000000000001 111.403 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.8 t -157.14 173.9 16.29 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.729 -0.669 . . . . 73.25 111.294 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -64.75 -29.97 70.97 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.805 0.336 . . . . 75.099999999999994 111.469 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -58.65 -26.25 63.58 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.951 0.405 . . . . 74.209999999999994 111.237 176.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.59 ' HD2' ' HB2' ' A' ' 43' ' ' LYS . 2.6 t80 -76.34 -38.17 56.28 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.461 0.648 . . . . 70.519999999999996 110.026 174.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -58.02 -62.94 1.45 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.425 -0.807 . . . . 72.109999999999999 110.435 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -70.68 0.89 6.07 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.54 0.57 . . . . 64.430000000000007 112.54 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.43 -34.64 11.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.59 0.589 . . . . 72.430000000000007 112.59 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.488 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 32.9 m -125.06 2.29 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 113.832 1.049 . . . . 73.420000000000002 113.832 -174.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.451 HD21 ' N ' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -89.76 34.22 0.84 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.005 0.743 . . . . 61.100000000000001 113.005 -176.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -150.24 159.31 44.53 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.626 -0.671 . . . . 73.319999999999993 112.448 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.27 132.4 45.91 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.949 -0.569 . . . . 72.019999999999996 110.9 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.745 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 35.2 mt-10 -87.86 114.96 24.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.208 0.528 . . . . 65.120000000000005 111.016 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.7 mt -111.49 148.46 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.582 -0.735 . . . . 72.209999999999994 111.478 -174.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -70.24 140.8 52.48 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 122.391 -0.193 . . . . 74.319999999999993 110.7 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.417 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 37.3 tt0 -54.71 -37.75 66.22 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.084 0.772 . . . . 74.329999999999998 113.084 -177.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.485 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 6.6 mm-40 -56.67 -53.59 55.96 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.152 -0.342 . . . . 74.299999999999997 111.485 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -63.31 -38.11 89.89 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.368 0.604 . . . . 73.219999999999999 110.447 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.417 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 52.5 t-105 -53.65 -45.63 70.3 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.36 -0.836 . . . . 75.549999999999997 111.513 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -69.87 -41.96 74.13 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.232 -0.44 . . . . 75.329999999999998 110.917 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.436 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -61.37 -37.3 82.89 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.546 0.573 . . . . 71.25 112.546 -178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.98 -6.16 58.85 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.319 -0.4 . . . . 72.299999999999997 111.799 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.09 50.62 64.42 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.505 -0.379 . . . . 63.109999999999999 112.848 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.474 ' HA ' ' HZ2' ' A' ' 129' ' ' LYS . 97.8 mt -90.88 160.3 15.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.473 0.654 . . . . 75.140000000000001 112.709 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.5 mp0 -125.32 143.24 51.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.015 -0.993 . . . . 74.299999999999997 110.419 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.16 94.88 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.599 0.714 . . . . 73.230000000000004 111.118 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.62 -6.69 7.47 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.133 -0.939 . . . . 35.210000000000001 114.182 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.44 -177.48 5.79 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.301 1.05 . . . . 71.329999999999998 111.678 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.407 ' HG3' HG21 ' A' ' 134' ' ' VAL . 2.8 mpt_? -105.8 123.48 48.03 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.329 0.492 . . . . 74.299999999999997 112.329 -174.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.586 HG13 ' HB3' ' A' ' 86' ' ' ALA . 26.6 m -114.21 148.71 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.044 -0.525 . . . . 75.400000000000006 110.871 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.447 ' HB2' HG23 ' A' ' 130' ' ' THR . 68.5 tttt -120.62 130.34 54.11 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.025 0.441 . . . . 75.5 111.261 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.9 134.84 49.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.27 -0.423 . . . . 74.109999999999999 111.356 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -125.91 140.53 52.56 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.925 0.393 . . . . 74.430000000000007 111.555 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.6 p -138.41 -172.22 3.23 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.952 0.501 . . . . 73.25 110.122 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.6 2.28 17.03 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.961 0.41 . . . . 63.109999999999999 111.29 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -101.18 -35.31 9.34 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.575 0.35 . . . . 73.329999999999998 111.455 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 163.45 -155.8 27.31 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.175 -0.536 . . . . 71.010000000000005 113.35 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.99 160.26 40.46 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.101 0.408 . . . . 64.439999999999998 112.101 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.5 p -160.57 150.61 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-N 116.041 -0.527 . . . . 74.129999999999995 111.296 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.417 HG21 ' HG3' ' A' ' 74' ' ' LYS . 33.1 t -109.9 123.49 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.22 0.208 . . . . 64.219999999999999 111.304 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.452 ' HA ' HG11 ' A' ' 134' ' ' VAL . 27.5 m -133.38 172.21 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.652 0.381 . . . . 74.200000000000003 111.627 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -75.91 143.73 41.5 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.145 0.498 . . . . 75.310000000000002 111.792 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.586 ' HB3' HG13 ' A' ' 73' ' ' VAL . . . -84.59 128.36 34.56 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.057 -0.52 . . . . 65.310000000000002 112.388 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -129.94 158.3 39.92 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.655 0.74 . . . . 75.120000000000005 111.887 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -101.44 102.49 13.29 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.256 -0.884 . . . . 73.219999999999999 109.617 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.745 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -99.64 -167.28 29.7 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.982 -0.627 . . . . 74.319999999999993 114.581 -170.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.53 9.37 42.61 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 122.846 0.459 . . . . 73.540000000000006 111.545 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.6 m -79.56 158.58 73.41 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 116.311 -0.404 . . . . 73.140000000000001 111.793 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.65 169.6 21.96 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.573 2.182 . . . . 73.439999999999998 112.653 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.485 ' HE2' ' HB3' ' A' ' 60' ' ' GLU . 49.2 tttm -65.91 148.75 51.3 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 120.732 0.301 . . . . 75.209999999999994 111.589 -177.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.12 30.46 76.93 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.261 -0.495 . . . . 61.340000000000003 112.816 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.62 ' HE1' HD11 ' A' ' 29' ' ' ILE . 13.2 ttt -153.63 136.97 15.75 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 122.62 -0.341 . . . . 70.129999999999995 110.319 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.566 HD11 HG22 ' A' ' 28' ' ' VAL . 40.3 pt -134.55 138.93 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.472 0.653 . . . . 75.310000000000002 112.021 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -101.44 123.37 45.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.722 -0.672 . . . . 75.109999999999999 111.176 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 30' ' ' SER . 40.2 mt -121.04 127.62 26.12 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 122.277 -0.265 . . . . 75.430000000000007 110.877 175.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.488 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 14.0 Cg_endo -57.37 142.42 95.0 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.476 2.117 . . . . 75.400000000000006 112.708 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.14 103.34 0.27 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.267 -0.424 . . . . 75.200000000000003 111.074 -176.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.69 -178.53 31.82 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.883 -0.675 . . . . 74.549999999999997 112.528 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.561 ' O ' ' HG2' ' A' ' 106' ' ' MET . 23.9 Cg_endo -60.71 -31.35 91.88 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.435 2.09 . . . . 65.120000000000005 111.695 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.441 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 4.8 m-85 -62.58 -53.4 55.15 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.612 -0.722 . . . . 74.140000000000001 110.314 175.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.31 -43.59 88.21 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.051 -0.522 . . . . 50.530000000000001 110.756 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -54.21 -26.39 28.18 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.014 0.526 . . . . 73.319999999999993 112.2 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.561 ' HG2' ' O ' ' A' ' 102' ' ' PRO . 84.6 mmm -66.58 -21.41 66.14 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.191 0.441 . . . . 74.209999999999994 112.191 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.7 m -132.08 -27.48 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 112.87 0.692 . . . . 74.530000000000001 112.87 -172.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.426 HG22 ' HB2' ' A' ' 30' ' ' SER . 1.5 pp -87.02 170.09 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-O 121.033 0.444 . . . . 74.230000000000004 111.308 -176.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' A' ' 111' ' ' SER . 12.6 t0 -99.76 117.09 64.16 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.382 -0.372 . . . . 70.420000000000002 111.131 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -66.42 -2.91 7.99 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.81 2.34 . . . . 63.340000000000003 113.756 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.429 ' HB2' ' OD2' ' A' ' 109' ' ' ASP . 16.5 m -77.98 22.91 0.27 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.009 0.374 . . . . 64.030000000000001 112.009 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.3 p -61.07 148.17 41.3 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.963 0.411 . . . . 74.239999999999995 112.037 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -58.45 128.16 35.77 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.75 0.648 . . . . 71.299999999999997 112.75 -172.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.75 -20.07 79.65 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.828 -0.701 . . . . 74.409999999999997 111.673 171.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 72.2 p -92.81 -75.32 0.49 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.625 0.37 . . . . 74.040000000000006 111.614 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 150.37 140.6 3.24 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 121.387 -0.435 . . . . 70.319999999999993 113.049 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 84.0 mmm -125.77 149.23 64.94 Favored Pre-proline 0 N--CA 1.473 0.703 0 O-C-N 122.632 -0.334 . . . . 74.519999999999996 111.755 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.78 165.26 32.68 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.909 2.406 . . . . 72.109999999999999 112.138 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 64.74 -165.43 0.24 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.066 0.46 . . . . 74.439999999999998 111.47 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -115.57 124.35 50.77 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.835 0.35 . . . . 72.430000000000007 111.136 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -124.71 107.65 11.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.084 0.468 . . . . 64.129999999999995 111.416 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -125.74 167.94 17.99 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 116.3 -0.409 . . . . 64.25 112.676 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.0 t -80.8 126.14 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.019 0.377 . . . . 60.439999999999998 112.019 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -62.32 145.78 52.89 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.152 0.427 . . . . 75.109999999999999 112.152 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -174.12 -163.42 27.49 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.393 -0.432 . . . . 63.119999999999997 112.884 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 54.5 p -126.24 142.69 51.43 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.628 -0.336 . . . . 73.010000000000005 111.3 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.0 p -132.01 143.25 40.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 120.9 0.381 . . . . 74.439999999999998 110.76 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.45 169.68 19.99 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.354 -0.385 . . . . 73.030000000000001 110.974 176.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.474 ' HZ2' ' HA ' ' A' ' 67' ' ' LEU . 24.8 ttmm -69.84 141.26 53.29 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.103 -0.373 . . . . 74.540000000000006 110.87 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.447 HG23 ' HB2' ' A' ' 74' ' ' LYS . 10.1 t -132.4 161.4 33.73 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.348 0.594 . . . . 74.430000000000007 112.187 -177.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.03 -18.02 41.24 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.642 -0.708 . . . . 73.219999999999999 111.11 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -69.68 152.51 44.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.581 0.705 . . . . 75.299999999999997 112.513 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.634 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -79.49 160.33 26.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.232 -0.894 . . . . 74.439999999999998 110.696 173.394 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.452 HG11 ' HA ' ' A' ' 84' ' ' VAL . 98.5 t -65.96 126.53 25.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 O-C-N 122.346 -0.222 . . . . 74.099999999999994 110.533 174.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.436 HD12 ' HG ' ' A' ' 140' ' ' LEU . 7.2 mt -56.06 131.83 48.53 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.07 0.462 . . . . 71.129999999999995 112.077 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.9 m -71.94 140.68 49.3 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.697 -0.482 . . . . 71.519999999999996 109.697 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.425 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 89.3 t -46.48 -49.45 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 112.54 0.57 . . . . 71.310000000000002 112.54 -175.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -71.78 -42.53 67.04 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.944 0.402 . . . . 75.349999999999994 111.327 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -55.98 -34.64 65.94 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.682 0.753 . . . . 72.0 110.581 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.436 ' HG ' HD12 ' A' ' 135' ' ' LEU . 2.6 tt -65.89 -42.5 90.19 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.249 -0.887 . . . . 75.430000000000007 110.827 174.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 29.3 mt -59.69 -36.53 76.68 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.373 0.606 . . . . 73.140000000000001 110.622 177.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -74.31 -39.53 62.82 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.718 -0.674 . . . . 75.420000000000002 110.944 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.42 -37.13 79.9 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.645 0.609 . . . . 73.349999999999994 112.645 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 146' ' ' SER . 2.9 pp -75.67 -1.68 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 112.7 0.63 . . . . 75.349999999999994 112.7 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 117.15 -60.51 0.44 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.461 -0.4 . . . . 72.349999999999994 113.281 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.474 ' H ' HD13 ' A' ' 144' ' ' ILE . 41.6 t . . . . . 0 N--CA 1.475 0.79 0 C-N-CA 122.673 0.389 . . . . 74.5 112.036 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.545 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.744 0.307 . . . . 72.420000000000002 111.247 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.32 154.92 30.03 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.063 -0.589 . . . . 61.409999999999997 113.475 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.8 p -150.88 -173.7 4.56 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.433 0.293 . . . . 74.150000000000006 110.557 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.2 t -143.21 159.72 41.78 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.252 0.548 . . . . 63.119999999999997 112.325 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -152.24 126.33 9.16 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.826 -0.625 . . . . 64.430000000000007 110.667 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.64 124.8 1.39 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.852 0.358 . . . . 74.230000000000004 111.864 -175.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -151.62 107.57 3.4 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.182 0.515 . . . . 74.439999999999998 112.017 177.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -128.32 97.66 4.81 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.149 0.5 . . . . 72.239999999999995 110.81 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -132.47 123.54 26.83 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.145 -0.479 . . . . 74.030000000000001 110.671 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -154.45 131.45 10.93 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 111.867 0.321 . . . . 71.209999999999994 111.867 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.0 t -142.52 122.55 13.67 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.54 -0.3 . . . . 75.319999999999993 110.879 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.0 p -110.48 158.99 17.91 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.462 0.542 . . . . 74.209999999999994 112.462 -175.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.9 143.43 5.58 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.871 -0.604 . . . . 60.32 112.017 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -141.97 98.52 3.35 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 117.414 0.607 . . . . 75.109999999999999 112.633 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.81 155.55 23.84 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.865 0.364 . . . . 72.209999999999994 111.399 173.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -136.7 120.54 17.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.118 0.485 . . . . 74.129999999999995 112.063 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.4 mp -127.37 176.25 7.58 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.319 -0.4 . . . . 75.0 111.024 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -161.57 176.83 10.61 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.948 0.404 . . . . 75.439999999999998 111.578 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -105.63 118.33 36.31 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.27 -0.423 . . . . 73.209999999999994 110.454 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -89.21 -40.49 12.83 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.424 0.527 . . . . 74.540000000000006 112.424 -175.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -149.15 129.36 3.03 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.666 -0.778 . . . . 71.329999999999998 113.417 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -145.36 88.28 1.85 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.977 0.418 . . . . 72.109999999999999 111.626 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.7 ptm -83.81 160.57 21.17 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.927 0.394 . . . . 74.340000000000003 111.425 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.6 mt -115.52 146.2 41.92 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.914 0.387 . . . . 73.010000000000005 111.86 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -92.4 125.21 36.95 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.389 0.614 . . . . 72.310000000000002 111.233 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 27.5 m -142.14 160.64 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.22 -0.9 . . . . 72.420000000000002 111.882 -173.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 34.6 tt0 -98.49 116.9 31.72 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.045 -0.409 . . . . 75.129999999999995 110.53 173.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.603 HG23 HD13 ' A' ' 96' ' ' ILE . 47.1 t -88.25 106.44 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.91 -0.586 . . . . 74.209999999999994 111.627 -176.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.792 HD11 ' HE1' ' A' ' 95' ' ' MET . 15.0 mt -91.91 158.1 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.837 0.351 . . . . 73.049999999999997 111.888 -177.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 62.2 m -140.29 94.47 2.75 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.085 0.469 . . . . 73.319999999999993 111.861 177.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.34 126.41 7.71 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.98 -0.555 . . . . 64.319999999999993 112.072 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -66.47 94.99 0.3 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.601 0.715 . . . . 74.519999999999996 111.58 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.5 p -101.97 -64.05 1.1 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.653 -0.703 . . . . 71.319999999999993 111.18 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.4 mp -92.84 7.95 41.63 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.125 0.417 . . . . 72.340000000000003 112.125 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -76.85 65.51 2.57 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.48 0.657 . . . . 73.239999999999995 110.056 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -83.29 21.09 1.18 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.592 0.59 . . . . 74.200000000000003 112.592 -173.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.48 53.86 5.8 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.372 -0.918 . . . . 72.540000000000006 112.4 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.6 160.89 34.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.713 0.292 . . . . 72.439999999999998 111.024 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.518 ' OG1' ' HG2' ' A' ' 42' ' ' GLU . 43.4 p -78.82 162.13 26.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.881 -0.415 . . . . 70.409999999999997 109.881 172.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.47 HG13 ' CE1' ' A' ' 48' ' ' TYR . 25.7 t -62.76 -31.72 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.055 0.455 . . . . 70.420000000000002 111.083 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.476 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 40.4 mt-10 -74.87 -14.61 60.69 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.922 -0.581 . . . . 74.25 112.233 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.518 ' HG2' ' OG1' ' A' ' 39' ' ' THR . 32.8 mm-40 -67.94 -28.52 67.55 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.176 0.512 . . . . 63.439999999999998 110.776 173.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -99.61 -68.06 0.82 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.05 -0.523 . . . . 72.439999999999998 111.823 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.476 ' HG ' ' HA ' ' A' ' 41' ' ' GLU . 77.7 mt 56.52 14.76 1.79 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.815 0.672 . . . . 74.230000000000004 112.815 -177.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.65 HG21 ' H ' ' A' ' 48' ' ' TYR . 4.2 t -79.7 157.7 27.12 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.473 0.546 . . . . 71.219999999999999 112.473 -177.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -58.04 -34.68 70.34 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.366 0.603 . . . . 74.329999999999998 110.384 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.61 -40.1 86.41 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.558 -0.746 . . . . 72.450000000000003 110.973 177.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.65 ' H ' HG21 ' A' ' 45' ' ' THR . 1.7 t80 -62.55 -39.08 92.49 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.151 0.5 . . . . 73.109999999999999 110.099 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -63.5 -68.1 0.37 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.826 -0.624 . . . . 71.319999999999993 110.314 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -55.09 -24.2 24.29 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.865 0.691 . . . . 74.219999999999999 112.865 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.54 -38.08 18.92 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.307 0.854 . . . . 74.319999999999993 113.307 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 48' ' ' TYR . 13.7 m -108.35 7.99 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 112.873 0.694 . . . . 75.340000000000003 112.873 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.467 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -98.53 18.98 15.38 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.44 0.904 . . . . 71.329999999999998 113.44 -175.881 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -135.65 159.39 41.79 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.98 0.733 . . . . 74.319999999999993 112.98 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.42 137.64 49.93 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.229 -0.896 . . . . 73.219999999999999 110.098 173.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.582 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 48.5 mt-10 -97.44 116.86 30.45 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.898 0.38 . . . . 73.310000000000002 111.626 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.491 ' HA ' HG21 ' A' ' 96' ' ' ILE . 4.1 mp -110.0 154.58 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 116.226 -0.443 . . . . 75.310000000000002 111.212 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -68.52 148.78 50.08 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.736 0.414 . . . . 75.439999999999998 111.442 176.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 9.2 tp10 -52.46 -47.59 66.36 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.311 0.485 . . . . 73.200000000000003 112.311 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.525 ' HA ' HD22 ' A' ' 63' ' ' ASN . 7.7 mm-40 -62.6 -42.1 99.37 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.337 0.495 . . . . 75.5 112.337 -176.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -71.18 -30.51 66.5 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.409 0.623 . . . . 73.239999999999995 110.555 174.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.464 ' HZ2' ' N ' ' A' ' 69' ' ' GLU . 58.6 t-105 -59.14 -52.71 64.55 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.514 -0.766 . . . . 71.239999999999995 111.739 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.525 HD22 ' HA ' ' A' ' 60' ' ' GLU . 5.8 p30 -71.74 -30.34 65.5 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.612 0.227 . . . . 74.329999999999998 111.612 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.54 -43.98 89.43 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.088 0.47 . . . . 73.200000000000003 111.827 177.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 98.0 mt -89.25 -4.92 58.0 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.275 -0.42 . . . . 73.219999999999999 112.033 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.72 50.49 66.96 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.218 -0.515 . . . . 75.409999999999997 112.967 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.467 HD22 ' HE2' ' A' ' 129' ' ' LYS . 86.9 mt -89.27 163.89 15.18 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.041 0.448 . . . . 70.319999999999993 112.162 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -150.52 118.77 6.37 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.192 -0.458 . . . . 65.519999999999996 110.208 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.464 ' N ' ' HZ2' ' A' ' 62' ' ' TRP . 2.2 mp0 -40.2 105.74 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.33 0.863 . . . . 74.129999999999995 113.33 -168.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.66 -10.88 10.38 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 115.289 -0.869 . . . . 74.340000000000003 113.672 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -80.64 176.45 9.79 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 117.889 0.844 . . . . 73.140000000000001 111.31 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -98.25 128.7 44.84 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.115 0.483 . . . . 74.340000000000003 112.045 -172.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 15.3 m -119.43 135.53 59.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 121.284 0.564 . . . . 73.230000000000004 111.723 174.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.526 ' HB3' ' HG3' ' A' ' 128' ' ' GLU . 5.4 tppp? -88.88 125.31 34.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.839 -0.619 . . . . 73.549999999999997 110.867 175.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 61.7 t -109.54 125.34 66.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.674 -0.491 . . . . 74.329999999999998 109.674 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -132.41 132.89 43.27 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.141 0.496 . . . . 73.439999999999998 112.143 -173.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.603 HG21 ' HA3' ' A' ' 125' ' ' GLY . 37.1 p -136.07 -170.58 2.67 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.922 -0.581 . . . . 60.32 110.943 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.05 -6.39 52.55 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.029 -0.532 . . . . 72.519999999999996 111.709 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.414 ' CZ ' ' HB2' ' A' ' 109' ' ' ASP . 98.9 m-85 -99.82 -45.14 5.83 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.769 0.319 . . . . 74.450000000000003 111.582 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.2 -152.4 10.22 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.781 -0.723 . . . . 73.310000000000002 113.336 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 15.4 pt-20 -152.08 152.1 31.93 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.057 0.456 . . . . 61.229999999999997 111.641 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.489 ' HB ' ' HB2' ' A' ' 106' ' ' MET . 8.8 p -152.36 153.88 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.389 -0.369 . . . . 73.010000000000005 111.48 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 t -108.8 120.48 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 122.22 0.208 . . . . 64.019999999999996 110.882 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.421 HG13 ' CD2' ' A' ' 103' ' ' TYR . 32.8 m -130.29 172.5 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 111.992 0.367 . . . . 72.540000000000006 111.992 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -76.36 136.9 39.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.278 -0.419 . . . . 75.219999999999999 111.025 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -87.19 127.81 35.15 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.394 0.516 . . . . 65.140000000000001 112.394 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 86.9 mttt -127.74 146.91 50.42 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.262 0.553 . . . . 65.25 110.673 172.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -84.68 126.96 33.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.875 -0.602 . . . . 75.219999999999999 110.122 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.582 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -118.86 -175.81 16.34 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.735 -0.745 . . . . 75.530000000000001 114.478 -173.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -92.74 9.35 35.41 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.617 0.722 . . . . 70.450000000000003 110.221 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.9 m -75.14 151.51 85.98 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 115.456 -0.793 . . . . 72.450000000000003 112.44 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.27 166.12 28.07 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.019 2.479 . . . . 65.319999999999993 112.943 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -66.14 147.04 53.93 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.769 0.319 . . . . 73.450000000000003 111.287 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 64.74 27.05 71.5 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.767 -0.73 . . . . 65.239999999999995 113.071 -174.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.792 ' HE1' HD11 ' A' ' 29' ' ' ILE . 21.6 ttt -152.11 136.39 16.69 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 122.218 -0.578 . . . . 74.310000000000002 110.406 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.603 HD13 HG23 ' A' ' 28' ' ' VAL . 39.9 pt -136.53 141.58 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 121.193 0.521 . . . . 75.129999999999995 111.975 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -101.46 132.11 47.24 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.858 0.361 . . . . 74.400000000000006 111.532 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.633 ' O ' ' HA ' ' A' ' 30' ' ' SER . 39.1 mt -127.89 136.66 29.33 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.245 -0.434 . . . . 73.299999999999997 110.427 173.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.512 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 31.1 Cg_endo -65.28 131.8 29.51 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.076 1.851 . . . . 73.430000000000007 112.254 172.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.472 ' HE3' HD12 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -54.73 104.0 0.1 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.875 0.369 . . . . 74.329999999999998 110.912 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.0 -175.52 28.01 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.925 -0.655 . . . . 54.409999999999997 112.918 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.435 ' O ' ' HG2' ' A' ' 106' ' ' MET . 19.5 Cg_endo -57.04 -34.91 98.58 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.99 2.46 . . . . 74.030000000000001 112.357 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.421 ' CD2' HG13 ' A' ' 84' ' ' VAL . 28.8 m-85 -64.77 -53.64 43.82 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.216 -0.447 . . . . 72.519999999999996 110.832 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.435 ' O ' HG21 ' A' ' 108' ' ' ILE . . . -58.29 -38.47 77.09 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.315 0.578 . . . . 62.509999999999998 111.104 175.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -55.17 -22.29 16.76 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.881 -0.599 . . . . 71.109999999999999 112.408 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.606 ' SD ' HD21 ' A' ' 140' ' ' LEU . 90.2 mmm -78.75 -15.19 58.74 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.222 0.453 . . . . 73.430000000000007 112.222 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.1 m -129.23 -18.36 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 113.179 0.807 . . . . 74.450000000000003 113.179 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.605 HG23 ' OG ' ' A' ' 30' ' ' SER . 12.9 pt -96.75 176.36 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 121.811 -0.556 . . . . 75.5 112.377 -177.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.586 ' H ' HG21 ' A' ' 123' ' ' VAL . 18.7 t0 -102.16 112.95 65.98 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.895 -0.593 . . . . 72.510000000000005 110.736 176.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.45 -1.06 11.22 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.507 2.138 . . . . 75.109999999999999 113.185 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.0 m -78.37 51.06 0.99 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.975 0.417 . . . . 73.430000000000007 111.387 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 72.7 p -98.37 95.06 7.09 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.456 0.539 . . . . 74.430000000000007 112.456 -174.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -98.46 138.72 35.27 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.151 -0.477 . . . . 74.549999999999997 110.628 174.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 138.21 158.26 7.72 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.275 -0.488 . . . . 63.020000000000003 112.465 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 57.6 p -76.65 -18.51 58.53 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.781 0.66 . . . . 72.129999999999995 112.781 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -143.49 138.37 8.12 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.654 -0.784 . . . . 72.540000000000006 113.958 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 86.3 mtp -90.54 155.7 45.85 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 122.433 0.293 . . . . 74.430000000000007 111.277 177.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.25 107.7 0.86 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.237 1.958 . . . . 74.25 112.205 176.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -65.84 -12.87 57.72 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.272 0.842 . . . . 73.109999999999999 113.272 -171.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -145.33 18.22 1.54 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.665 0.617 . . . . 75.540000000000006 112.665 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -137.77 155.72 48.75 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 120.631 0.253 . . . . 72.209999999999994 111.222 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.711 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . -151.06 -151.08 5.48 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.42 -0.895 . . . . 64.409999999999997 114.36 -175.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.586 HG21 ' H ' ' A' ' 109' ' ' ASP . 86.6 t -92.7 123.61 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 122.747 0.419 . . . . 65.209999999999994 111.431 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 95.9 mttt -72.78 150.54 42.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.111 0.482 . . . . 74.540000000000006 112.192 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.603 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -177.2 -140.89 3.81 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 116.015 -0.539 . . . . 63.039999999999999 113.024 -178.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 67.3 p -142.81 163.55 32.51 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.35 -0.5 . . . . 75.129999999999995 111.879 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.0 p -142.4 145.32 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 116.136 -0.484 . . . . 75.340000000000003 110.884 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.526 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 8.7 pt-20 -152.09 152.3 32.19 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.286 0.476 . . . . 72.239999999999995 112.286 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.467 ' HE2' HD22 ' A' ' 67' ' ' LEU . 9.5 tppt? -62.7 137.31 58.23 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.426 -0.352 . . . . 73.329999999999998 110.93 172.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.0 t -134.7 153.28 52.07 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.05 0.452 . . . . 72.219999999999999 111.957 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.27 6.66 46.17 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.507 0.67 . . . . 65.409999999999997 110.621 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -80.6 -175.96 5.51 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.447 0.641 . . . . 74.140000000000001 112.056 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -101.56 154.0 19.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.615 -0.721 . . . . 74.219999999999999 111.001 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.39 122.26 14.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 110.338 -0.245 . . . . 74.439999999999998 110.338 173.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 135' ' ' LEU . 3.3 mt -62.45 90.96 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.636 0.236 . . . . 74.030000000000001 111.636 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.1 m -46.05 147.66 0.99 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.164 -0.471 . . . . 75.129999999999995 111.669 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.537 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 85.8 t -45.74 -53.6 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 113.118 0.784 . . . . 61.350000000000001 113.118 -173.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.851 ' HD3' HD11 ' A' ' 141' ' ' LEU . 16.1 tppt? -72.49 -39.07 67.94 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.08 -0.387 . . . . 74.150000000000006 111.598 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -55.77 -38.17 69.51 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.666 0.746 . . . . 75.400000000000006 110.205 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.606 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.2 tt -63.76 -40.16 96.03 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.098 -0.955 . . . . 75.420000000000002 110.547 174.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.851 HD11 ' HD3' ' A' ' 138' ' ' LYS . 43.1 mt -61.55 -42.42 98.81 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.31 0.576 . . . . 75.450000000000003 110.285 175.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 138' ' ' LYS . 32.1 mm-40 -60.03 -46.29 89.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.744 -0.662 . . . . 73.230000000000004 110.573 176.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.63 -43.59 84.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.748 -0.66 . . . . 73.319999999999993 112.213 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 141' ' ' LEU . 2.7 pp -76.48 -20.91 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.263 0.468 . . . . 73.329999999999998 112.263 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.77 -48.99 0.25 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.568 -0.825 . . . . 72.430000000000007 113.939 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.1 t . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 121.126 0.489 . . . . 73.230000000000004 111.895 -176.709 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtm . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 120.811 0.339 . . . . 75.5 111.122 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -97.57 107.91 3.56 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.319 -0.467 . . . . 71.129999999999995 112.926 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.6 p -153.09 146.77 25.13 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.906 0.384 . . . . 73.430000000000007 111.21 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.9 p -147.21 127.16 13.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.179 0.514 . . . . 71.430000000000007 112.259 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -122.63 139.25 54.14 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.067 -0.515 . . . . 63.32 110.23 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -92.75 142.89 26.85 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.539 0.685 . . . . 72.450000000000003 112.398 -175.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -97.77 72.21 2.26 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.754 -0.657 . . . . 74.299999999999997 111.932 -175.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.68 129.94 40.99 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.159 -0.473 . . . . 55.240000000000002 111.817 177.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -133.73 154.71 50.76 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.853 0.359 . . . . 73.430000000000007 111.582 -175.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -76.82 122.76 25.25 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.833 0.349 . . . . 74.519999999999996 110.701 174.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.2 m -71.41 88.89 0.9 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.401 0.519 . . . . 65.030000000000001 112.401 -174.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.7 t -77.34 138.99 39.66 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.743 0.306 . . . . 65.230000000000004 110.573 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -101.26 -169.66 28.13 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.07 -0.586 . . . . 62.229999999999997 114.312 -174.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -99.4 114.79 27.9 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.853 0.359 . . . . 71.230000000000004 110.569 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -114.44 -158.88 0.68 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.747 0.308 . . . . 75.040000000000006 111.775 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -49.43 105.92 0.1 Allowed 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.308 0.575 . . . . 74.329999999999998 112.118 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.64 160.84 31.95 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.064 -0.516 . . . . 75.099999999999994 112.106 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 61.97 16.53 8.19 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.249 -0.432 . . . . 75.209999999999994 111.985 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -53.1 127.42 24.05 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.148 0.499 . . . . 74.439999999999998 111.965 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -146.17 -27.47 0.43 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.944 -0.571 . . . . 74.040000000000006 111.306 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.88 -134.53 12.97 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.066 -0.587 . . . . 75.340000000000003 113.125 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -167.96 93.55 0.38 Allowed 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.752 -0.264 . . . . 64.340000000000003 111.005 -177.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.1 ptm -78.76 147.34 33.4 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.132 0.491 . . . . 71.140000000000001 111.704 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.5 mt -116.34 131.42 56.95 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.188 -0.46 . . . . 73.040000000000006 112.109 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.689 ' HG3' HG23 ' A' ' 126' ' ' THR . 1.1 mp0 -73.03 136.58 45.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.505 0.669 . . . . 65.239999999999995 111.42 175.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 15.8 m -148.27 158.1 7.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.069 -0.969 . . . . 74.430000000000007 111.616 -172.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.609 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 32.7 tt0 -99.21 111.85 24.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.018 0.437 . . . . 75.430000000000007 110.183 172.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.496 HG23 HD11 ' A' ' 96' ' ' ILE . 39.6 t -88.48 107.86 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.812 -0.631 . . . . 74.219999999999999 111.497 -174.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.725 HD12 ' HE2' ' A' ' 95' ' ' MET . 3.9 mt -92.29 153.1 3.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.335 -0.393 . . . . 73.519999999999996 111.294 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 20.0 t -133.67 103.52 5.92 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.08 0.466 . . . . 64.340000000000003 111.151 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.48 115.1 5.05 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.076 -0.583 . . . . 75.519999999999996 113.364 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.4 ptt85 -82.26 75.99 9.16 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.426 0.632 . . . . 75.040000000000006 112.101 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.2 t -96.81 -27.51 14.68 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.963 -0.562 . . . . 74.319999999999993 111.394 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.558 HD13 ' N ' ' A' ' 35' ' ' ASN . 4.3 pp -106.3 -41.64 5.27 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.332 -0.394 . . . . 73.400000000000006 111.739 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.558 ' N ' HD13 ' A' ' 34' ' ' LEU . 7.2 t30 -82.15 85.07 6.85 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.113 0.482 . . . . 70.400000000000006 110.013 175.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -113.82 20.62 15.68 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.027 -0.533 . . . . 72.209999999999994 112.273 -175.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 156.74 -55.61 0.39 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.641 -0.79 . . . . 73.430000000000007 113.127 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.588 ' HB3' ' HD2' ' A' ' 43' ' ' LYS . . . -73.56 130.3 39.77 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 122.77 -0.253 . . . . 64.219999999999999 111.172 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.2 p -73.15 178.69 4.26 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.131 0.491 . . . . 43.149999999999999 110.912 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.472 HG21 HD22 ' A' ' 141' ' ' LEU . 8.9 m -62.05 -25.2 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 116.578 -0.283 . . . . 73.120000000000005 111.361 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.607 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 1.3 tm-20 -71.2 -50.91 28.1 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.869 0.366 . . . . 74.340000000000003 110.553 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.62 -20.09 44.53 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.934 0.397 . . . . 70.340000000000003 111.571 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.588 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 27.5 mtpp -126.69 30.57 5.49 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.144 0.424 . . . . 72.349999999999994 112.144 -175.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.607 ' HG ' ' HA ' ' A' ' 41' ' ' GLU . 47.7 mt -65.44 86.44 0.07 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.133 0.492 . . . . 72.329999999999998 111.468 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.443 HG21 ' H ' ' A' ' 48' ' ' TYR . 4.1 t -151.15 157.6 42.92 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.104 -0.498 . . . . 74.230000000000004 111.788 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -56.35 -28.11 58.02 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.302 0.572 . . . . 70.310000000000002 110.941 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -57.74 -45.4 85.89 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.821 -0.627 . . . . 62.43 110.779 173.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.449 ' O ' HG21 ' A' ' 52' ' ' VAL . 9.5 t80 -66.05 -37.34 85.58 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.293 0.568 . . . . 74.409999999999997 110.231 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -58.61 -62.78 1.61 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.599 -0.728 . . . . 74.430000000000007 111.038 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -55.24 -23.98 25.42 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.771 0.656 . . . . 75.140000000000001 112.771 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.515 ' HB2' HD22 ' A' ' 34' ' ' LEU . . . -81.68 -40.32 23.01 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.032 0.752 . . . . 73.530000000000001 113.032 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.449 HG21 ' O ' ' A' ' 48' ' ' TYR . 33.8 m -108.73 13.9 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 113.289 0.848 . . . . 74.409999999999997 113.289 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -104.04 26.1 9.16 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.52 0.934 . . . . 74.319999999999993 113.52 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -145.11 159.81 42.39 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.665 -0.647 . . . . 75.439999999999998 112.355 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.78 146.33 50.62 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.532 -0.758 . . . . 64.219999999999999 111.043 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.673 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 30.9 mt-10 -96.6 116.9 29.88 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.633 0.254 . . . . 75.219999999999999 111.516 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.508 ' HA ' HG23 ' A' ' 96' ' ' ILE . 4.2 mp -110.44 146.97 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 120.782 0.325 . . . . 72.530000000000001 111.255 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -64.19 145.82 55.33 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.593 -0.276 . . . . 71.140000000000001 110.845 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 32.2 tt0 -58.71 -40.76 84.59 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.78 0.659 . . . . 74.239999999999995 112.78 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -60.9 -51.14 70.53 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.955 0.354 . . . . 75.209999999999994 111.955 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -65.55 -36.0 82.52 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.468 0.651 . . . . 74.0 110.457 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.68 ' HA ' HD11 ' A' ' 67' ' ' LEU . 37.0 t-105 -52.91 -53.83 43.66 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.276 -0.874 . . . . 71.219999999999999 111.311 175.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -70.5 -29.69 66.27 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.004 -0.543 . . . . 71.430000000000007 111.394 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.24 -35.22 80.1 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.887 0.375 . . . . 75.25 111.624 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.0 mt -89.86 1.33 56.32 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.38 -0.373 . . . . 62.200000000000003 111.702 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.94 40.48 95.4 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.42 -0.419 . . . . 72.019999999999996 112.728 -177.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.68 HD11 ' HA ' ' A' ' 62' ' ' TRP . 18.4 mt -76.11 141.81 41.86 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.093 0.775 . . . . 71.439999999999998 113.093 -175.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 30.3 tt0 -106.51 147.1 29.79 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.28 -0.873 . . . . 72.120000000000005 109.673 169.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -63.77 102.73 0.49 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.495 0.664 . . . . 72.510000000000005 111.382 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.25 5.02 23.47 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 115.268 -0.878 . . . . 54.409999999999997 112.633 -172.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 68' ' ' GLN . 1.4 t0 -71.69 172.86 8.97 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.81 0.444 . . . . 74.239999999999995 110.838 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.47 124.48 49.67 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.28 0.562 . . . . 74.030000000000001 111.687 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.479 HG13 ' HB1' ' A' ' 86' ' ' ALA . 15.8 m -113.3 132.53 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.139 0.495 . . . . 74.129999999999995 111.481 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -100.66 109.98 22.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.584 0.707 . . . . 75.109999999999999 110.311 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 59.3 t -92.66 127.2 44.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.34 -0.845 . . . . 74.510000000000005 109.824 -175.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.498 ' HG2' ' CB ' ' A' ' 81' ' ' GLU . 46.4 mtpt -133.34 124.77 27.81 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.387 0.613 . . . . 74.140000000000001 112.397 -169.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.611 HG21 ' HA3' ' A' ' 125' ' ' GLY . 29.2 p -132.42 -171.66 2.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.712 -0.676 . . . . 74.329999999999998 111.033 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -76.56 -1.11 25.8 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.272 -0.422 . . . . 73.120000000000005 111.562 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -102.46 -34.71 9.04 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 111.811 0.3 . . . . 74.25 111.811 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.37 -167.1 39.7 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 112.258 -0.337 . . . . 71.430000000000007 112.258 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.498 ' CB ' ' HG2' ' A' ' 76' ' ' LYS . 16.4 pt-20 -143.48 144.11 31.85 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.376 0.588 . . . . 53.049999999999997 112.524 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 p -143.66 150.41 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.934 -0.575 . . . . 72.120000000000005 111.566 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.12 120.34 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 O-C-N 122.301 -0.249 . . . . 73.239999999999995 111.388 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.69 173.17 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 120.858 0.361 . . . . 75.040000000000006 111.966 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -78.28 140.49 38.84 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.038 0.447 . . . . 73.040000000000006 111.354 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.479 ' HB1' HG13 ' A' ' 73' ' ' VAL . . . -93.74 126.3 38.84 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.649 0.611 . . . . 64.019999999999996 112.649 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -125.18 145.66 49.86 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.114 0.483 . . . . 72.439999999999998 110.66 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -82.9 112.37 19.63 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.791 -0.448 . . . . 74.230000000000004 109.791 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.673 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -123.63 169.12 15.77 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.581 -0.818 . . . . 71.219999999999999 114.434 -171.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.85 73.89 6.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.116 0.484 . . . . 72.409999999999997 111.413 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.5 m -132.46 147.95 67.67 Favored Pre-proline 0 CA--C 1.539 0.558 0 CA-C-N 116.018 -0.537 . . . . 74.310000000000002 111.229 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.75 157.29 38.42 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.628 2.219 . . . . 73.400000000000006 112.563 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -64.07 145.34 56.09 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 122.116 -0.365 . . . . 75.409999999999997 111.099 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.532 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 62.59 27.8 70.33 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.047 -0.596 . . . . 63.100000000000001 112.677 -174.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.725 ' HE2' HD12 ' A' ' 29' ' ' ILE . 18.8 ttt -148.75 136.43 20.56 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.741 -0.466 . . . . 74.109999999999999 109.741 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' A' ' 57' ' ' ILE . 36.7 pt -137.92 144.68 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 121.294 0.568 . . . . 75.120000000000005 112.194 -176.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -105.4 133.38 50.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.229 -0.442 . . . . 74.120000000000005 111.494 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.572 ' O ' ' HA ' ' A' ' 30' ' ' SER . 48.8 mt -128.87 134.03 25.86 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 116.342 -0.39 . . . . 74.400000000000006 110.675 174.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.87 136.44 61.71 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 121.975 1.784 . . . . 73.349999999999994 112.231 174.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.31 107.93 0.63 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.898 0.38 . . . . 75.340000000000003 110.895 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.95 -174.61 26.87 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.124 -0.56 . . . . 72.519999999999996 112.487 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.78 -25.77 74.83 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.983 1.789 . . . . 75.219999999999999 111.853 -177.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.524 ' HA ' HD13 ' A' ' 140' ' ' LEU . 3.8 m-85 -71.19 -54.29 11.49 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.677 -0.692 . . . . 73.230000000000004 110.729 178.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.02 -33.35 73.13 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.097 -0.501 . . . . 71.430000000000007 110.617 175.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -58.25 -22.37 52.11 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.936 -0.574 . . . . 71.040000000000006 111.665 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.482 ' SD ' HD22 ' A' ' 140' ' ' LEU . 33.7 mtp -78.37 -29.61 47.51 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.506 -0.315 . . . . 73.340000000000003 111.41 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.8 m -111.94 -18.99 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 112.395 0.517 . . . . 74.239999999999995 112.395 -171.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.511 HG22 ' HB2' ' A' ' 30' ' ' SER . 12.2 pt -94.76 178.84 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.11 0.481 . . . . 74.200000000000003 111.495 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.516 ' H ' HG21 ' A' ' 123' ' ' VAL . 21.3 t70 -92.0 108.82 33.01 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 116.102 -0.499 . . . . 74.299999999999997 110.52 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.89 -6.34 17.34 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.436 2.091 . . . . 75.329999999999998 113.604 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.3 t -72.49 -39.48 67.64 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.038 0.447 . . . . 73.340000000000003 110.967 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.0 t -80.27 -172.03 3.3 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.244 0.545 . . . . 71.319999999999993 112.073 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -154.63 -29.66 0.11 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.066 -0.516 . . . . 61.439999999999998 111.674 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.73 77.2 1.24 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.767 -0.73 . . . . 71.219999999999999 111.471 -171.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.2 m -61.05 92.72 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.844 0.354 . . . . 75.230000000000004 111.712 -176.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.34 -62.28 2.66 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.399 -0.429 . . . . 62.43 113.184 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 22.0 mmt -136.79 139.95 30.46 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 120.932 0.396 . . . . 74.450000000000003 111.861 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -86.15 -15.08 4.7 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.871 2.381 . . . . 73.409999999999997 112.781 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 56.48 59.74 3.46 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.966 0.506 . . . . 74.0 111.668 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 45.71 79.99 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.135 0.574 . . . . 73.450000000000003 112.082 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.427 ' HZ2' ' HB3' ' A' ' 121' ' ' LYS . 4.9 ttpm? -167.07 134.79 2.51 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.181 -0.463 . . . . 75.310000000000002 111.926 -175.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -141.47 -176.2 15.61 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.739 -0.664 . . . . 72.109999999999999 112.442 173.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.516 HG21 ' H ' ' A' ' 109' ' ' ASP . 82.0 t -82.17 119.61 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.063 0.458 . . . . 63.299999999999997 111.661 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 95.8 mttt -73.12 154.01 40.54 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.512 0.56 . . . . 75.340000000000003 112.512 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.611 ' HA3' HG21 ' A' ' 77' ' ' THR . . . 177.81 -140.83 4.9 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.884 -0.598 . . . . 72.030000000000001 112.797 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.689 HG23 ' HG3' ' A' ' 25' ' ' GLU . 67.6 p -136.69 161.67 35.28 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.026 0.441 . . . . 74.540000000000006 111.164 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.79 143.84 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.247 0.546 . . . . 74.519999999999996 110.834 173.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -147.44 144.62 28.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.967 -0.561 . . . . 75.209999999999994 110.363 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.438 ' HD2' HD23 ' A' ' 67' ' ' LEU . 20.6 ttpp -81.87 143.23 31.85 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.19 -0.318 . . . . 73.329999999999998 110.262 176.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.0 t -132.16 156.8 45.77 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.597 0.962 . . . . 75.230000000000004 113.597 -168.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -83.29 -17.1 43.73 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.061 -0.972 . . . . 71.140000000000001 110.41 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -68.98 179.11 1.95 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.702 -0.681 . . . . 75.430000000000007 112.71 -175.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -98.83 159.84 14.68 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.672 -0.694 . . . . 73.540000000000006 111.702 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.8 t -73.97 136.12 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.466 -0.334 . . . . 74.230000000000004 110.908 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 11.9 mt -67.44 140.47 57.12 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.944 0.402 . . . . 72.030000000000001 111.531 178.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.6 m -86.24 148.84 25.46 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.616 -0.513 . . . . 72.310000000000002 109.616 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.462 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 86.1 t -46.8 -53.43 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 112.564 0.579 . . . . 75.450000000000003 112.564 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -72.25 -39.36 68.48 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 111.704 0.261 . . . . 74.530000000000001 111.704 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.79 -36.67 72.49 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.701 0.762 . . . . 72.129999999999995 110.09 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.524 HD13 ' HA ' ' A' ' 103' ' ' TYR . 4.4 tt -62.25 -43.84 97.9 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.968 -1.014 . . . . 74.040000000000006 110.728 172.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.472 HD22 HG21 ' A' ' 40' ' ' VAL . 66.6 mt -57.3 -45.16 84.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.205 0.526 . . . . 75.030000000000001 110.608 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -59.26 -40.84 87.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.799 -0.637 . . . . 74.409999999999997 111.1 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.4 -48.03 74.27 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.976 -0.556 . . . . 70.010000000000005 112.22 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.9 pp -75.64 -20.9 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 112.779 0.659 . . . . 74.340000000000003 112.779 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 139.61 -22.99 2.83 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.445 -0.883 . . . . 73.239999999999995 114.725 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.2 m . . . . . 0 N--CA 1.471 0.601 0 O-C-N 122.225 -0.574 . . . . 64.329999999999998 111.427 -178.045 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.555 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.852 0.358 . . . . 71.329999999999998 111.245 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 126.82 -178.15 16.97 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.294 -0.479 . . . . 71.430000000000007 113.799 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.5 p -172.41 130.8 0.58 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.873 0.469 . . . . 74.349999999999994 110.78 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 99.2 p -74.28 171.55 13.44 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.068 0.461 . . . . 73.329999999999998 112.09 -176.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -141.3 112.38 7.31 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.431 -0.35 . . . . 74.230000000000004 110.761 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -128.98 120.08 25.44 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.323 0.49 . . . . 65.120000000000005 112.323 -175.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -146.65 125.28 12.51 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.706 0.402 . . . . 74.340000000000003 111.366 174.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -148.03 145.43 28.48 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.49 0.316 . . . . 72.430000000000007 110.878 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -152.09 139.49 19.5 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.581 0.229 . . . . 75.109999999999999 111.192 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -139.37 144.87 38.38 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.287 0.235 . . . . 73.409999999999997 111.162 -176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.1 t -120.64 175.8 5.83 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.224 0.453 . . . . 71.420000000000002 112.224 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.3 t -94.1 179.69 5.24 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.849 0.357 . . . . 72.239999999999995 111.765 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.5 -110.05 2.64 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 114.551 0.58 . . . . 71.329999999999998 114.551 -173.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.448 ' H ' ' NE ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -118.99 178.48 4.48 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.888 0.699 . . . . 75.109999999999999 112.888 -170.55 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -101.82 172.19 7.08 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.021 -0.536 . . . . 63.43 111.315 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -107.23 118.44 36.73 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.393 -0.367 . . . . 73.439999999999998 110.155 173.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.42 166.61 21.84 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.532 0.567 . . . . 72.450000000000003 112.532 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -87.78 135.0 33.57 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.976 -0.556 . . . . 74.400000000000006 112.375 -172.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -94.82 101.4 13.2 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.998 0.428 . . . . 72.230000000000004 110.48 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -90.51 92.9 9.06 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.895 0.378 . . . . 75.530000000000001 111.145 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -137.3 119.1 1.83 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 121.417 -0.421 . . . . 74.049999999999997 112.598 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -81.57 86.25 6.39 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 122.532 -0.393 . . . . 75.430000000000007 111.394 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.2 ptp -82.17 166.72 19.4 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.249 0.547 . . . . 75.299999999999997 111.861 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.605 HD11 ' HB1' ' A' ' 64' ' ' ALA . 16.4 mt -122.27 139.28 53.97 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.004 -0.544 . . . . 73.109999999999999 111.58 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -79.29 118.25 21.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.309 0.576 . . . . 74.25 110.359 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 28.3 m -138.25 160.51 32.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.61 -0.723 . . . . 75.530000000000001 111.824 -173.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.717 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 72.2 tt0 -98.82 111.92 24.16 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.071 0.462 . . . . 75.25 110.438 175.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.521 HG22 HD11 ' A' ' 96' ' ' ILE . 43.1 t -87.45 105.81 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 115.797 -0.638 . . . . 75.439999999999998 111.72 -175.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.607 HD12 ' HE2' ' A' ' 95' ' ' MET . 2.9 mt -92.14 162.91 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.677 0.275 . . . . 75.120000000000005 111.265 -178.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.673 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 15.6 t -134.58 113.96 12.3 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.781 0.324 . . . . 73.230000000000004 111.826 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.46 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . -116.38 126.49 7.07 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.065 -0.588 . . . . 71.099999999999994 113.298 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.415 ' HD2' ' O ' ' A' ' 114' ' ' GLY . 19.8 mtp180 -67.26 95.41 0.42 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.985 0.421 . . . . 74.310000000000002 111.984 -176.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.1 p -82.66 -43.1 17.32 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.662 0.616 . . . . 74.120000000000005 112.662 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.01 151.23 31.2 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.565 0.579 . . . . 73.219999999999999 112.565 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -66.81 105.77 1.68 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.928 -0.578 . . . . 74.230000000000004 111.866 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 61.08 170.69 0.1 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.336 0.865 . . . . 73.540000000000006 113.336 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -80.09 144.81 26.41 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 115.489 -0.778 . . . . 63.130000000000003 114.06 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.649 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . . . -179.74 162.94 1.11 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.127 0.571 . . . . 70.420000000000002 110.523 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.3 p -75.08 156.06 36.49 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 110.383 -0.229 . . . . 74.430000000000007 110.383 172.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.1 m -56.9 -30.83 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 120.991 0.424 . . . . 73.239999999999995 111.308 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.566 ' HA ' HD21 ' A' ' 44' ' ' LEU . 42.4 tt0 -59.73 -37.67 79.57 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.117 -0.492 . . . . 71.540000000000006 111.399 177.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -66.84 -17.07 64.7 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.226 0.454 . . . . 74.140000000000001 112.226 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.649 ' HE3' ' HB2' ' A' ' 38' ' ' ALA . 86.0 mttt -134.11 33.57 3.37 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.547 0.573 . . . . 72.450000000000003 112.547 -174.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.566 HD21 ' HA ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -63.7 87.08 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.964 0.411 . . . . 75.430000000000007 110.627 176.46 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 t -155.22 172.62 17.86 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.26 -0.427 . . . . 73.040000000000006 112.018 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -56.64 -33.5 66.39 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.089 -0.505 . . . . 70.450000000000003 111.552 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.575 ' HA ' HD22 ' A' ' 50' ' ' ASN . 44.3 mt-10 -54.36 -47.27 72.79 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.151 0.5 . . . . 71.129999999999995 111.153 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.493 ' CD2' ' HB2' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -68.8 -23.08 64.24 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.939 0.4 . . . . 75.510000000000005 110.702 -179.481 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -88.17 2.08 52.96 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.033 0.383 . . . . 73.430000000000007 112.033 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.575 HD22 ' HA ' ' A' ' 47' ' ' GLU . 10.9 p30 -122.17 -48.31 2.11 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.483 -0.761 . . . . 72.340000000000003 111.948 170.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.68 -22.77 24.88 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.079 1.14 . . . . 75.230000000000004 114.079 -170.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.513 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 19.7 m -130.92 17.82 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 112.858 0.688 . . . . 70.319999999999993 112.858 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.583 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -102.0 17.16 23.9 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.612 0.597 . . . . 64.239999999999995 112.612 -174.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -140.93 162.79 34.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.142 0.496 . . . . 73.329999999999998 112.106 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -126.14 127.19 45.36 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.622 -0.717 . . . . 73.129999999999995 110.813 174.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -87.31 118.4 26.71 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.413 0.625 . . . . 64.329999999999998 110.892 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.03 154.92 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.162 -0.926 . . . . 75.439999999999998 111.828 -169.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -76.19 144.56 40.42 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.525 -0.307 . . . . 75.209999999999994 110.615 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.424 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 27.3 tt0 -63.39 -36.86 85.13 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.818 0.673 . . . . 75.299999999999997 112.818 -176.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -62.21 -47.69 83.33 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 122.174 -0.329 . . . . 73.019999999999996 111.413 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.47 ' HB3' HD12 ' A' ' 24' ' ' LEU . 47.0 m-20 -66.8 -36.5 82.52 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.308 0.575 . . . . 74.310000000000002 110.558 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.482 ' HZ2' ' N ' ' A' ' 69' ' ' GLU . 33.7 t-105 -53.11 -45.66 68.38 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.492 -0.776 . . . . 74.030000000000001 110.591 175.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -65.7 -41.02 92.86 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.714 -0.676 . . . . 63.439999999999998 110.961 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.605 ' HB1' HD11 ' A' ' 24' ' ' LEU . . . -61.0 -38.55 86.45 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.242 -0.435 . . . . 62.329999999999998 111.82 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.485 ' HG ' HD13 ' A' ' 24' ' ' LEU . 87.6 mt -85.71 -14.47 45.29 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.425 -0.352 . . . . 75.109999999999999 111.413 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.57 47.4 78.0 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.273 -0.489 . . . . 75.099999999999994 112.581 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.56 HD21 ' HD3' ' A' ' 129' ' ' LYS . 85.3 mt -84.49 164.85 18.56 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.559 0.695 . . . . 74.140000000000001 112.38 -175.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -136.11 123.61 22.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.55 -0.75 . . . . 72.239999999999995 109.905 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.482 ' N ' ' HZ2' ' A' ' 62' ' ' TRP . 48.7 mt-10 -49.88 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.563 0.696 . . . . 75.439999999999998 112.614 -172.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 130.2 0.04 5.55 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.387 -0.824 . . . . 62.409999999999997 114.036 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -90.39 -172.15 3.34 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 117.863 0.831 . . . . 73.019999999999996 112.292 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 72' ' ' ARG . 45.6 mtt180 -111.52 131.25 55.37 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.339 0.496 . . . . 71.239999999999995 112.339 -174.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.448 HG13 ' HB3' ' A' ' 86' ' ' ALA . 30.0 m -123.67 140.85 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.998 0.428 . . . . 64.420000000000002 111.578 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -98.65 131.84 44.51 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.25 0.548 . . . . 73.400000000000006 110.74 174.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.481 HG22 HD11 ' A' ' 98' ' ' ILE . 61.9 t -106.18 128.22 60.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.731 -0.668 . . . . 75.519999999999996 109.661 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.8 mtpt -131.06 127.55 38.45 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.51 0.672 . . . . 75.209999999999994 112.506 -171.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.576 HG21 ' HA3' ' A' ' 125' ' ' GLY . 31.0 p -136.37 -170.43 2.66 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.131 -0.941 . . . . 73.239999999999995 110.486 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.22 -13.74 60.16 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.683 0.277 . . . . 70.129999999999995 111.561 176.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -87.83 -38.02 16.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.96 0.409 . . . . 74.439999999999998 111.378 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.07 -157.73 28.75 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.866 -0.683 . . . . 70.310000000000002 113.521 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -144.24 141.82 30.09 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.758 0.313 . . . . 72.219999999999999 111.471 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.48 146.67 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.698 0.285 . . . . 73.540000000000006 111.655 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.0 t -105.4 117.21 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.544 0.211 . . . . 71.109999999999999 110.95 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.0 m -127.34 178.08 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 122.588 0.355 . . . . 74.25 111.821 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -83.2 144.09 30.02 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.911 0.386 . . . . 74.409999999999997 111.312 174.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HB3' HG13 ' A' ' 73' ' ' VAL . . . -90.34 135.74 33.49 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.625 0.602 . . . . 73.400000000000006 112.625 -177.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -133.04 158.23 43.26 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.583 0.706 . . . . 72.510000000000005 111.663 174.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -108.17 99.64 9.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.103 -0.953 . . . . 75.019999999999996 109.608 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.59 86.54 0.19 Allowed Glycine 0 CA--C 1.533 1.186 0 N-CA-C 116.631 1.412 . . . . 74.349999999999994 116.631 -166.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 65.72 -17.44 0.1 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 116.206 1.928 . . . . 72.209999999999994 116.206 161.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.0 m -78.15 148.66 75.14 Favored Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 121.716 -0.615 . . . . 73.439999999999998 112.425 -173.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -72.64 169.58 21.55 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.788 2.325 . . . . 73.230000000000004 112.705 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -68.33 146.58 53.14 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.871 0.367 . . . . 75.129999999999995 111.5 -177.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 68.72 18.02 71.75 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.277 -0.487 . . . . 74.0 113.28 -174.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.717 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 14.2 ttt -147.02 136.61 22.93 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 122.37 -0.488 . . . . 75.219999999999999 110.568 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.521 HD11 HG22 ' A' ' 28' ' ' VAL . 43.6 pt -135.91 144.97 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 121.082 0.468 . . . . 74.340000000000003 111.703 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.46 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 68.1 t80 -107.01 123.87 48.81 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.473 -0.33 . . . . 72.530000000000001 111.302 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.673 ' O ' ' HA ' ' A' ' 30' ' ' SER . 44.2 mt -120.37 127.46 26.3 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 120.805 0.336 . . . . 73.409999999999997 111.142 175.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.513 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 51.4 Cg_exo -57.18 136.9 79.23 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.285 1.99 . . . . 74.340000000000003 113.084 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.416 ' HE3' HD13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -60.46 105.69 0.46 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.212 -0.449 . . . . 75.019999999999996 110.878 -178.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.98 -174.25 30.6 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.912 -0.661 . . . . 70.310000000000002 112.542 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.445 ' O ' ' HG3' ' A' ' 106' ' ' MET . 14.8 Cg_endo -56.05 -36.01 95.55 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.521 2.148 . . . . 74.340000000000003 111.986 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.492 ' HA ' HD13 ' A' ' 140' ' ' LEU . 41.0 m-85 -61.83 -54.1 46.87 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.957 -0.565 . . . . 75.239999999999995 110.71 177.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -63.41 -33.53 75.76 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.165 0.507 . . . . 75.450000000000003 111.302 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.34 -15.03 45.8 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.124 -0.489 . . . . 75.109999999999999 111.892 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.523 ' SD ' HD22 ' A' ' 140' ' ' LEU . 41.5 mtp -83.66 -22.75 32.03 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.441 -0.345 . . . . 73.5 111.7 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.7 m -123.86 -18.45 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 113.129 0.788 . . . . 74.040000000000006 113.129 -171.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 104' ' ' ALA . 11.2 pt -96.22 177.62 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.381 0.61 . . . . 73.439999999999998 111.834 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.642 ' H ' HG21 ' A' ' 123' ' ' VAL . 16.7 t70 -98.94 104.9 28.21 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.806 -0.633 . . . . 64.040000000000006 110.131 175.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -83.36 26.88 0.63 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.489 2.126 . . . . 72.230000000000004 113.643 -175.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.9 t -121.0 -27.47 4.96 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 111.588 0.218 . . . . 72.209999999999994 111.588 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 t -66.72 99.73 0.63 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.119 0.485 . . . . 73.129999999999995 112.062 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 59.29 -85.57 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.228 0.611 . . . . 74.219999999999999 112.171 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.415 ' O ' ' HD2' ' A' ' 32' ' ' ARG . . . 95.26 -16.62 60.93 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.353 -0.451 . . . . 61.109999999999999 113.114 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 80.8 p -86.69 -179.45 6.58 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.888 0.375 . . . . 72.540000000000006 111.854 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.23 70.54 1.84 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.107 -0.568 . . . . 54.329999999999998 113.012 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 23.3 mmt -78.39 148.32 73.72 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.188 0.44 . . . . 64.409999999999997 112.188 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -91.39 17.22 1.41 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.076 2.518 . . . . 74.200000000000003 112.679 177.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -101.04 130.48 47.05 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.898 0.38 . . . . 72.510000000000005 111.511 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -83.85 67.95 9.76 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.159 0.504 . . . . 73.329999999999998 111.376 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -108.11 122.81 47.65 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.484 -0.326 . . . . 72.25 111.426 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -123.84 157.66 18.29 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 121.056 -0.592 . . . . 71.109999999999999 112.948 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.642 HG21 ' H ' ' A' ' 109' ' ' ASP . 58.3 t -78.19 122.13 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 121.0 0.429 . . . . 73.0 111.419 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.405 ' HD2' ' N ' ' A' ' 124' ' ' LYS . 12.1 mptt -69.47 131.27 44.48 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.906 0.384 . . . . 75.140000000000001 111.549 -177.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.576 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -160.66 -146.03 4.48 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.259 -0.496 . . . . 61.329999999999998 113.358 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 41.4 p -139.8 161.28 37.94 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.887 0.375 . . . . 75.340000000000003 111.542 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.0 p -139.74 144.6 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.132 0.491 . . . . 71.109999999999999 111.462 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.23 156.47 40.94 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.93 -0.577 . . . . 74.450000000000003 111.219 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.56 ' HD3' HD21 ' A' ' 67' ' ' LEU . 27.7 ttpp -90.12 136.95 32.74 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.89 -0.506 . . . . 72.219999999999999 110.586 174.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.3 t -138.34 157.52 46.08 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.092 0.472 . . . . 74.420000000000002 112.217 -173.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -83.02 -4.47 58.36 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.954 -0.566 . . . . 45.210000000000001 111.437 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -70.9 146.5 49.54 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.031 -0.531 . . . . 75.019999999999996 111.832 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.74 152.04 43.08 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.136 0.493 . . . . 74.239999999999995 111.926 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.89 121.9 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.522 -0.308 . . . . 74.109999999999999 110.587 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 135' ' ' LEU . 10.2 mt -62.73 94.24 0.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.005 0.372 . . . . 73.310000000000002 112.005 -178.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.1 m -53.56 150.69 6.6 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.156 -0.474 . . . . 72.109999999999999 110.72 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.544 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 67.9 t -45.09 -48.76 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 112.948 0.721 . . . . 64.209999999999994 112.948 -171.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -72.52 -44.07 62.69 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.213 -0.304 . . . . 72.430000000000007 111.653 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -56.34 -39.61 73.11 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.92 0.867 . . . . 74.219999999999999 110.107 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.523 HD22 ' SD ' ' A' ' 106' ' ' MET . 2.7 tt -60.3 -42.44 95.53 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.791 -1.095 . . . . 73.530000000000001 110.879 175.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 56.6 mt -56.02 -52.29 64.73 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.24 0.543 . . . . 74.540000000000006 110.508 176.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -64.33 -29.84 70.91 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.617 -0.719 . . . . 73.319999999999993 111.623 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -71.25 -40.43 71.02 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.387 0.514 . . . . 63.340000000000003 112.387 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.474 HD12 ' H ' ' A' ' 146' ' ' SER . 2.9 pp -91.05 -14.25 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 112.331 0.493 . . . . 74.439999999999998 112.331 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 133.96 -62.49 0.63 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.123 -0.56 . . . . 73.150000000000006 113.072 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.474 ' H ' HD12 ' A' ' 144' ' ' ILE . 43.3 t . . . . . 0 N--CA 1.472 0.665 0 O-C-N 122.49 -0.418 . . . . 74.019999999999996 111.482 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.746 0.308 . . . . 74.329999999999998 111.657 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -157.65 -152.07 6.24 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.189 -0.529 . . . . 72.239999999999995 112.736 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.6 t 56.97 -121.82 1.55 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 116.726 0.263 . . . . 74.319999999999993 111.065 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.3 t 55.9 28.38 12.47 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.673 0.62 . . . . 72.319999999999993 112.673 172.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -70.7 105.21 3.09 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.94 -0.475 . . . . 74.109999999999999 111.695 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.421 ' O ' ' HB2' ' A' ' 7' ' ' HIS . 97.0 m-70 -120.49 -178.58 3.73 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.769 0.319 . . . . 74.340000000000003 111.854 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.421 ' HB2' ' O ' ' A' ' 6' ' ' HIS . 1.5 m-70 72.05 167.43 0.31 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.36 0.664 . . . . 72.040000000000006 111.926 -177.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.0 m80 64.09 177.4 0.17 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.767 0.794 . . . . 74.120000000000005 112.434 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -132.13 -55.01 0.98 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.377 -0.829 . . . . 75.030000000000001 109.511 171.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -142.37 -47.8 0.34 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.971 -0.559 . . . . 73.420000000000002 110.617 172.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.9 p -125.78 -172.67 2.65 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.472 -0.331 . . . . 74.010000000000005 110.664 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.6 p -61.05 -45.94 92.73 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.83 0.348 . . . . 72.140000000000001 111.336 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.68 126.9 2.62 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.305 -0.474 . . . . 75.340000000000003 113.312 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -88.93 116.33 27.14 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.752 -0.263 . . . . 75.150000000000006 110.82 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.33 -72.73 0.17 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.686 0.279 . . . . 70.540000000000006 110.906 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -113.96 139.47 49.2 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.919 0.39 . . . . 74.349999999999994 111.33 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.4 127.74 50.08 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 110.021 -0.363 . . . . 75.420000000000002 110.021 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -82.64 11.02 6.29 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.338 0.495 . . . . 73.010000000000005 112.338 -173.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 57.13 32.57 21.92 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.227 0.537 . . . . 73.0 111.942 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.458 ' HG2' ' N ' ' A' ' 21' ' ' GLY . 23.5 tt0 -92.94 165.48 12.85 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.12 -0.491 . . . . 72.299999999999997 110.767 178.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.458 ' N ' ' HG2' ' A' ' 20' ' ' GLN . . . -55.65 133.2 50.04 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.225 -0.512 . . . . 74.010000000000005 112.862 176.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -63.27 96.88 0.11 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.748 0.309 . . . . 72.239999999999995 111.46 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.1 ptp -102.1 162.65 12.75 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.263 0.554 . . . . 74.219999999999999 111.688 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.568 HD11 ' HB1' ' A' ' 64' ' ' ALA . 20.2 mt -124.58 139.06 54.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.89 -0.596 . . . . 74.530000000000001 111.327 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -78.31 109.01 12.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.658 0.742 . . . . 74.219999999999999 110.618 174.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 34.8 m -132.22 159.13 43.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.731 -1.122 . . . . 70.150000000000006 111.849 -172.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.697 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 44.0 tt0 -99.27 117.62 34.13 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.106 0.479 . . . . 71.219999999999999 111.102 175.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.528 HG22 HD13 ' A' ' 96' ' ' ILE . 38.4 t -89.79 107.81 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.218 0.607 . . . . 73.549999999999997 111.578 -177.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.569 HD12 ' HE1' ' A' ' 95' ' ' MET . 2.5 mt -94.11 148.51 4.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 111.803 0.297 . . . . 75.219999999999999 111.803 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.577 ' OG ' HG23 ' A' ' 108' ' ' ILE . 73.7 m -109.97 106.93 16.64 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.055 0.455 . . . . 72.329999999999998 111.36 175.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.473 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . -86.4 100.29 2.51 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 121.256 -0.497 . . . . 73.519999999999996 113.139 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.724 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -71.43 98.94 1.9 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.464 0.649 . . . . 62.509999999999998 111.413 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.7 p -106.25 169.17 8.67 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.553 -0.749 . . . . 75.409999999999997 110.908 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.9 mp 60.24 93.08 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.346 0.593 . . . . 70.109999999999999 110.917 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -57.87 -177.79 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.54 0.941 . . . . 64.209999999999994 113.54 -172.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 73.63 -63.55 0.43 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.605 0.762 . . . . 75.430000000000007 111.605 -175.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.93 145.55 15.71 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.013 -0.613 . . . . 43.219999999999999 113.495 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.467 ' HB3' ' HD2' ' A' ' 43' ' ' LYS . . . -169.34 161.56 10.02 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.153 0.581 . . . . 70.420000000000002 110.135 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.8 p -81.77 166.92 19.61 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.265 -0.574 . . . . 75.030000000000001 109.908 174.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.6 t -54.8 -34.9 31.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.023 0.44 . . . . 62.350000000000001 111.271 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.461 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 43.6 tt0 -62.9 -43.14 99.59 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 116.02 -0.537 . . . . 74.400000000000006 112.348 -177.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.95 -26.46 68.59 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 122.101 -0.374 . . . . 74.310000000000002 111.747 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 26.8 mtpp -119.36 33.13 5.76 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.094 0.405 . . . . 72.019999999999996 112.094 -174.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.461 ' HG ' ' HA ' ' A' ' 41' ' ' GLU . 74.8 mt -65.84 85.65 0.08 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.288 0.566 . . . . 74.230000000000004 111.381 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.2 t -142.28 167.59 21.76 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.809 -0.632 . . . . 72.409999999999997 111.403 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -52.0 -42.77 63.25 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.058 0.456 . . . . 75.0 110.889 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -57.53 -33.44 68.09 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.218 0.451 . . . . 74.219999999999999 112.218 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -71.53 -26.53 62.69 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.498 0.666 . . . . 74.019999999999996 109.789 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.532 ' HD1' HG21 ' A' ' 137' ' ' VAL . 71.4 t80 -89.45 -2.31 58.34 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.616 -0.72 . . . . 72.430000000000007 110.902 175.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -101.66 -44.38 5.58 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.025 -0.422 . . . . 75.109999999999999 111.811 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.52 -64.0 1.29 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.316 0.858 . . . . 71.230000000000004 113.316 -172.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.459 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 32.9 m -79.07 21.8 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 113.338 0.866 . . . . 73.329999999999998 113.338 -170.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.609 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -108.0 11.17 28.04 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.073 0.768 . . . . 63.219999999999999 113.073 -172.546 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -133.2 166.28 22.82 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.598 0.713 . . . . 74.409999999999997 112.487 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.76 135.18 48.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.21 -0.905 . . . . 73.540000000000006 110.042 172.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.597 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 45.0 mt-10 -94.67 115.56 27.69 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.867 0.365 . . . . 64.510000000000005 111.285 177.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.428 HD13 ' N ' ' A' ' 57' ' ' ILE . 4.3 mp -109.79 150.93 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.062 -0.517 . . . . 74.5 110.831 -178.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -71.78 156.86 38.85 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.71 0.291 . . . . 72.230000000000004 111.418 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -54.74 -47.39 73.9 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.173 0.511 . . . . 71.129999999999995 111.864 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.5 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 17.3 mm-40 -56.41 -52.73 63.55 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.206 -0.452 . . . . 64.099999999999994 112.169 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -66.29 -36.57 83.31 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.007 0.432 . . . . 73.319999999999993 111.024 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -55.68 -48.79 74.47 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.96 -0.563 . . . . 75.200000000000003 111.103 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -66.71 -39.38 88.01 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.05 -0.523 . . . . 75.349999999999994 111.185 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.568 ' HB1' HD11 ' A' ' 24' ' ' LEU . . . -61.15 -35.05 76.04 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.058 0.392 . . . . 52.520000000000003 112.058 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.2 mt -89.55 -12.13 40.79 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.042 0.386 . . . . 73.299999999999997 112.042 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.36 48.32 83.22 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.09 -0.576 . . . . 71.299999999999997 112.782 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.662 HD22 ' HD3' ' A' ' 129' ' ' LYS . 92.1 mt -86.88 143.26 27.51 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.259 0.552 . . . . 74.030000000000001 112.474 -175.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -93.61 149.62 21.08 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.989 -0.551 . . . . 74.319999999999993 109.909 171.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -61.26 100.22 0.12 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.452 0.644 . . . . 74.340000000000003 111.279 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.76 29.18 7.05 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.333 -0.848 . . . . 74.030000000000001 112.841 -174.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -82.07 -178.27 6.95 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 122.598 -0.354 . . . . 61.32 111.158 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.598 HH21 ' HA ' ' A' ' 131' ' ' ASP . 24.2 mtm-85 -116.78 123.07 46.22 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.85 0.357 . . . . 73.409999999999997 111.068 -177.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.81 140.82 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.034 0.445 . . . . 75.140000000000001 112.178 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 31.7 ttmt -110.17 126.38 54.03 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.199 0.524 . . . . 71.549999999999997 111.318 174.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 47.0 t -101.07 132.09 47.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.87 -0.604 . . . . 63.049999999999997 110.97 177.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.414 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 4.1 mppt? -118.55 127.65 53.83 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.03 0.443 . . . . 74.209999999999994 111.392 174.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.692 HG21 ' HA3' ' A' ' 125' ' ' GLY . 40.7 p -127.25 -170.91 2.3 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.894 -0.594 . . . . 70.239999999999995 110.253 175.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -72.34 -11.34 60.66 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.87 0.367 . . . . 60.25 111.592 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -96.07 -40.54 9.18 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.087 0.403 . . . . 73.200000000000003 112.087 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.79 -146.95 8.76 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.636 -0.792 . . . . 44.229999999999997 113.744 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 14.0 pt-20 -152.13 153.41 33.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.781 0.324 . . . . 74.530000000000001 111.589 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 12.2 p -157.15 149.46 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 116.653 -0.249 . . . . 74.109999999999999 111.67 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.0 t -108.28 119.74 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 116.762 -0.199 . . . . 70.400000000000006 110.856 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.459 HG11 ' HD2' ' A' ' 103' ' ' TYR . 29.7 m -128.37 172.16 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-O 120.914 0.388 . . . . 74.549999999999997 111.727 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -77.43 143.47 38.56 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.022 0.439 . . . . 75.319999999999993 111.39 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.24 122.95 36.16 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.471 0.545 . . . . 70.430000000000007 112.471 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -123.63 157.86 32.8 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.161 0.505 . . . . 74.450000000000003 110.774 172.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -102.9 107.23 17.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.046 -0.525 . . . . 74.349999999999994 110.28 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.597 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -109.35 -175.18 21.24 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.852 -0.69 . . . . 74.409999999999997 114.171 -172.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -90.26 17.12 7.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.865 0.364 . . . . 74.019999999999996 111.439 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.69 151.87 93.48 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 116.45 -0.341 . . . . 72.430000000000007 111.52 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -67.71 154.49 73.12 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.453 2.102 . . . . 72.329999999999998 112.585 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.5 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 87.9 tttt -57.42 137.15 56.5 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.732 0.301 . . . . 74.409999999999997 111.609 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 71.84 26.92 71.67 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 120.817 -0.706 . . . . 71.239999999999995 113.031 -174.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.697 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 13.9 ttt -150.69 137.5 19.05 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 122.213 -0.58 . . . . 64.340000000000003 110.151 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.528 HD13 HG22 ' A' ' 28' ' ' VAL . 38.0 pt -133.53 144.84 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.355 0.598 . . . . 71.439999999999998 112.166 -178.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.473 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 66.4 t80 -105.78 127.33 53.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.969 -0.56 . . . . 72.329999999999998 111.452 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 30' ' ' SER . 46.1 mt -127.29 128.32 24.09 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 122.337 0.255 . . . . 73.310000000000002 110.563 174.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.459 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 37.1 Cg_exo -57.76 142.91 96.25 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.2 1.933 . . . . 70.209999999999994 112.704 177.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.532 ' HA ' ' HE3' ' A' ' 100' ' ' MET . 4.5 tpt -59.22 103.73 0.2 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.025 0.441 . . . . 72.120000000000005 111.435 -178.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.74 -178.08 34.4 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.678 -0.773 . . . . 71.430000000000007 112.893 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.52 ' O ' ' HG2' ' A' ' 106' ' ' MET . 18.8 Cg_endo -57.53 -34.63 98.34 Favored 'Trans proline' 0 N--CA 1.478 0.579 0 C-N-CA 122.76 2.307 . . . . 72.329999999999998 111.718 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.459 ' HD2' HG11 ' A' ' 84' ' ' VAL . 25.6 m-85 -58.73 -49.38 77.83 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.92 -0.582 . . . . 73.510000000000005 110.4 175.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.464 ' O ' HG21 ' A' ' 108' ' ' ILE . . . -63.06 -42.61 99.72 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.851 -0.613 . . . . 72.340000000000003 111.588 176.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -61.46 -7.46 3.14 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.663 0.616 . . . . 72.409999999999997 112.663 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.567 ' SD ' HD23 ' A' ' 140' ' ' LEU . 90.5 mmm -84.2 -20.21 32.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.772 0.32 . . . . 74.400000000000006 111.556 176.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.3 m -130.83 -12.1 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 113.271 0.841 . . . . 73.209999999999994 113.271 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.577 HG23 ' OG ' ' A' ' 30' ' ' SER . 8.8 pt -96.72 -179.05 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 121.725 -0.609 . . . . 73.450000000000003 112.254 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.594 ' H ' HG21 ' A' ' 123' ' ' VAL . 16.4 t70 -91.89 108.05 27.2 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.008 -0.542 . . . . 75.120000000000005 111.133 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.64 5.81 6.05 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.555 2.17 . . . . 70.219999999999999 113.574 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.0 t -73.57 -37.17 65.6 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.961 0.41 . . . . 65.129999999999995 111.012 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.7 t -82.27 154.88 25.14 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.074 0.464 . . . . 73.439999999999998 111.78 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -109.5 2.15 20.28 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.262 -0.426 . . . . 64.409999999999997 111.193 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.05 48.39 86.36 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.173 -0.537 . . . . 65.129999999999995 112.846 -176.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 85.3 m -97.35 140.75 31.34 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.791 0.329 . . . . 70.540000000000006 111.832 -176.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.76 -120.73 6.96 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.096 -0.573 . . . . 63.100000000000001 114.352 172.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.4 mmt -84.5 144.77 43.59 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 112.214 0.45 . . . . 63.240000000000002 112.214 -174.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -76.17 96.6 1.07 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.609 2.206 . . . . 73.219999999999999 113.231 -177.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -89.8 178.39 6.25 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.227 -0.442 . . . . 74.239999999999995 111.301 175.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -130.08 18.66 5.49 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.216 0.531 . . . . 72.239999999999995 110.872 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.402 ' NZ ' ' O ' ' A' ' 122' ' ' GLY . 27.1 tptp -83.4 141.3 31.83 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.995 -0.548 . . . . 75.340000000000003 111.272 -178.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.402 ' O ' ' NZ ' ' A' ' 121' ' ' LYS . . . -127.95 -179.63 15.97 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.197 -0.525 . . . . 70.219999999999999 113.323 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.594 HG21 ' H ' ' A' ' 109' ' ' ASP . 84.2 t -94.25 123.32 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 111.924 0.342 . . . . 70.530000000000001 111.924 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 54.9 mtmt -75.36 147.19 40.27 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.45 0.537 . . . . 63.409999999999997 112.45 -177.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.692 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -169.6 -157.97 12.8 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.88 -0.6 . . . . 73.200000000000003 112.658 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 45.8 p -124.69 138.72 54.28 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.257 -0.555 . . . . 74.219999999999999 111.586 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.3 p -126.64 144.57 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.883 0.373 . . . . 73.310000000000002 111.64 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.92 156.93 36.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.188 -0.46 . . . . 74.010000000000005 110.999 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.662 ' HD3' HD22 ' A' ' 67' ' ' LEU . 27.1 ttpp -72.24 141.56 48.96 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.908 0.385 . . . . 74.430000000000007 111.185 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.4 t -132.12 160.83 34.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.232 0.539 . . . . 73.150000000000006 112.089 -175.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.598 ' HA ' HH21 ' A' ' 72' ' ' ARG . 5.1 m-20 -92.21 -10.94 36.81 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.826 -0.625 . . . . 74.209999999999994 111.031 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.39 168.25 9.22 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.22 0.533 . . . . 75.120000000000005 112.12 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.433 ' HD2' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -86.81 152.71 22.25 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.097 -0.502 . . . . 75.319999999999993 110.915 175.664 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 83.8 t -63.08 129.31 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.63 0.252 . . . . 73.209999999999994 110.654 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 135' ' ' LEU . 8.9 mt -66.91 90.67 0.18 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.724 0.268 . . . . 75.030000000000001 111.724 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.8 m -49.38 148.88 2.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.068 -0.515 . . . . 73.530000000000001 110.967 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.532 HG21 ' HD1' ' A' ' 49' ' ' PHE . 90.5 t -45.18 -45.14 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 112.123 0.416 . . . . 74.120000000000005 112.123 -175.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -71.95 -43.92 64.45 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.391 -0.368 . . . . 74.540000000000006 111.837 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.42 ' HG2' ' HE3' ' A' ' 133' ' ' LYS . 4.3 tp10 -61.13 -32.47 72.17 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.486 0.66 . . . . 74.239999999999995 110.53 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.567 HD23 ' SD ' ' A' ' 106' ' ' MET . 1.4 tt -65.85 -37.91 87.44 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.376 -0.829 . . . . 75.239999999999995 110.654 176.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 29.6 mt -60.19 -43.96 95.46 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.581 0.705 . . . . 75.430000000000007 109.944 175.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -68.64 -37.07 79.41 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.226 -0.897 . . . . 74.510000000000005 111.615 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.03 -46.88 88.05 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.095 -0.502 . . . . 63.130000000000003 111.449 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.456 HD13 ' N ' ' A' ' 146' ' ' SER . 2.9 pp -79.86 -23.89 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.949 0.404 . . . . 72.519999999999996 111.368 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 67.77 50.52 41.41 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 114.545 0.578 . . . . 71.510000000000005 114.545 172.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.456 ' N ' HD13 ' A' ' 144' ' ' ILE . 37.1 t . . . . . 0 N--CA 1.475 0.803 0 O-C-N 122.325 -0.515 . . . . 74.310000000000002 111.634 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.556 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 120.908 0.385 . . . . 73.319999999999993 111.887 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.21 90.0 0.08 OUTLIER Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.441 -0.409 . . . . 72.209999999999994 112.648 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.1 p -62.73 107.39 0.96 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.952 0.406 . . . . 72.230000000000004 111.977 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.3 m -113.81 132.4 55.88 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.288 -0.415 . . . . 74.319999999999993 111.8 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -150.66 157.75 43.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.588 0.355 . . . . 74.230000000000004 111.106 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -142.14 125.53 16.62 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.023 0.44 . . . . 74.109999999999999 111.343 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -140.13 133.52 29.94 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.318 0.488 . . . . 74.519999999999996 112.318 -173.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -90.91 173.83 7.76 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.411 -0.359 . . . . 73.030000000000001 111.536 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -143.32 141.89 31.12 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.699 0.629 . . . . 75.219999999999999 112.699 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -131.72 111.67 11.87 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.676 -0.693 . . . . 74.239999999999995 109.677 169.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -63.62 -71.54 0.17 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.112 1.153 . . . . 60.509999999999998 114.112 -169.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.1 t 67.73 104.4 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 120.926 0.393 . . . . 71.319999999999993 111.468 -175.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -149.49 85.87 0.16 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.151 -0.547 . . . . 62.399999999999999 113.162 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -89.8 142.17 27.94 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 122.453 -0.439 . . . . 75.530000000000001 111.398 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -91.96 149.51 21.5 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.12 0.486 . . . . 73.150000000000006 112.064 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -109.69 114.38 27.92 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.939 0.4 . . . . 64.349999999999994 111.97 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mp -120.69 163.74 17.62 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.08 0.467 . . . . 71.209999999999994 112.086 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -133.58 169.0 17.64 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.945 -0.57 . . . . 74.439999999999998 110.656 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -103.61 111.5 23.99 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.947 0.403 . . . . 73.140000000000001 112.053 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 68.23 162.42 0.2 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.032 1.123 . . . . 71.209999999999994 114.032 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.74 167.07 38.34 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 114.226 -1.352 . . . . 65.530000000000001 111.566 176.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -77.65 103.09 7.37 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 117.557 0.679 . . . . 70.230000000000004 111.015 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.52 ' HB3' ' HB3' ' A' ' 128' ' ' GLU . 6.1 ptp -111.34 167.16 10.51 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.358 0.599 . . . . 71.319999999999993 111.914 176.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.434 HD13 ' HB3' ' A' ' 64' ' ' ALA . 19.0 mt -134.53 139.14 45.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 73.120000000000005 111.603 177.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -84.77 114.06 21.78 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.558 0.694 . . . . 74.150000000000006 110.886 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.435 HG11 ' HA2' ' A' ' 94' ' ' GLY . 34.5 m -134.97 167.17 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 114.959 -1.019 . . . . 75.010000000000005 112.338 -170.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -101.16 132.0 46.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.706 0.289 . . . . 73.420000000000002 110.45 171.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.47 111.15 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 112.154 0.427 . . . . 73.140000000000001 112.154 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.575 HD13 ' HE3' ' A' ' 95' ' ' MET . 0.1 OUTLIER -100.06 151.06 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.065 0.46 . . . . 73.329999999999998 111.213 174.838 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 74.3 m -124.53 110.0 13.93 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.975 0.417 . . . . 72.120000000000005 111.779 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.97 124.36 7.83 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.277 -0.487 . . . . 61.420000000000002 112.429 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -75.07 101.13 4.42 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.305 0.574 . . . . 62.399999999999999 112.133 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 t -132.21 176.43 8.4 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.752 -0.658 . . . . 75.200000000000003 110.389 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.738 HD23 ' HB3' ' A' ' 51' ' ' ALA . 51.4 tp 66.44 -70.66 0.1 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.951 0.405 . . . . 75.409999999999997 111.937 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -103.59 111.72 24.32 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.007 0.432 . . . . 74.25 111.427 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -108.02 -29.77 8.81 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.142 -0.481 . . . . 75.140000000000001 111.516 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.02 45.27 0.62 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.622 -0.799 . . . . 62.240000000000002 113.955 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.16 178.89 7.57 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.459 -0.436 . . . . 74.25 111.045 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.514 ' OG1' ' HG2' ' A' ' 42' ' ' GLU . 24.4 p -98.06 175.3 6.16 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 110.267 -0.271 . . . . 73.030000000000001 110.267 173.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.7 t -65.45 -39.46 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 120.823 0.344 . . . . 75.329999999999998 110.995 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -66.03 -42.12 90.02 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.847 0.356 . . . . 65.109999999999999 111.267 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.514 ' HG2' ' OG1' ' A' ' 39' ' ' THR . 19.6 mm-40 -53.39 -32.54 49.95 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.107 0.479 . . . . 72.129999999999995 111.761 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.535 ' O ' ' HB2' ' A' ' 48' ' ' TYR . 25.7 mtpp -123.78 25.41 8.07 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.15 -0.477 . . . . 72.219999999999999 111.176 -175.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.474 HD11 ' O ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -55.73 -13.24 1.59 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.526 0.73 . . . . 74.030000000000001 112.774 -175.179 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 t -58.51 178.35 0.11 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.065 0.765 . . . . 74.549999999999997 113.065 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -47.94 -35.98 11.64 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.797 -0.638 . . . . 74.019999999999996 112.589 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -56.02 -34.49 65.89 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.433 0.531 . . . . 73.010000000000005 112.433 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.535 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -76.58 -23.08 53.49 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.962 -0.461 . . . . 74.530000000000001 110.635 175.499 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.411 ' HD1' HG21 ' A' ' 137' ' ' VAL . 57.6 t80 -90.87 0.41 57.49 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 116.181 -0.463 . . . . 74.140000000000001 112.01 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 51' ' ' ALA . 29.8 p30 -121.66 -44.36 2.34 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.528 -0.733 . . . . 70.120000000000005 112.799 176.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.738 ' HB3' HD23 ' A' ' 34' ' ' LEU . . . -70.19 -30.95 68.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.682 0.993 . . . . 62.049999999999997 113.682 -172.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 33.0 m -118.19 16.1 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 112.769 0.655 . . . . 74.019999999999996 112.769 -177.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.565 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -104.87 17.64 23.76 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.868 0.692 . . . . 70.310000000000002 112.868 -174.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -141.3 168.53 19.55 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.065 0.46 . . . . 73.150000000000006 111.93 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.9 144.41 45.51 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.089 -0.505 . . . . 70.230000000000004 111.284 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 42.1 mt-10 -96.75 113.31 24.85 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.697 0.284 . . . . 74.439999999999998 111.189 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.454 HD13 ' N ' ' A' ' 57' ' ' ILE . 4.0 mp -110.43 147.01 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.368 -0.378 . . . . 74.049999999999997 110.82 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -65.79 143.24 57.62 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.665 -0.243 . . . . 71.420000000000002 110.971 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -58.3 -38.39 76.97 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.103 0.779 . . . . 65.519999999999996 113.103 -174.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -60.44 -48.05 83.45 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.957 -0.464 . . . . 75.010000000000005 110.99 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -63.9 -38.07 89.74 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.012 0.434 . . . . 74.319999999999993 110.837 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 35.8 t-105 -53.26 -51.49 62.1 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.43 0.633 . . . . 74.400000000000006 111.07 175.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -67.92 -35.76 79.01 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.751 -0.659 . . . . 73.439999999999998 111.294 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HB3' HD13 ' A' ' 24' ' ' LEU . . . -61.74 -39.9 93.2 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.185 0.516 . . . . 72.230000000000004 111.621 177.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.52 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 73.5 mt -79.46 -16.15 56.59 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.118 -0.492 . . . . 75.439999999999998 111.603 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.93 53.96 24.17 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.947 -0.644 . . . . 61.329999999999998 111.888 -173.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.624 HD23 ' HE3' ' A' ' 129' ' ' LYS . 96.2 mt -91.31 160.1 15.67 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.774 0.797 . . . . 72.439999999999998 112.932 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -129.51 127.81 41.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.999 -1.0 . . . . 73.420000000000002 109.394 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -50.8 98.8 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.096 0.776 . . . . 73.239999999999995 113.096 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.92 13.4 11.15 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 115.311 -0.859 . . . . 45.509999999999998 113.77 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.409 ' HA ' HH11 ' A' ' 72' ' ' ARG . 46.9 p-10 -88.67 -169.01 2.38 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 117.665 0.732 . . . . 65.400000000000006 112.33 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.617 ' HG3' HG21 ' A' ' 134' ' ' VAL . 2.4 mpt_? -109.1 127.7 54.37 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.913 0.387 . . . . 72.209999999999994 111.9 -173.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.1 m -124.4 138.47 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.023 0.439 . . . . 74.239999999999995 111.33 174.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.423 ' HE3' ' HG3' ' A' ' 132' ' ' GLU . 39.8 ttmt -102.7 125.66 49.52 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.965 0.412 . . . . 71.310000000000002 110.753 177.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.48 131.17 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.361 -0.607 . . . . 71.049999999999997 109.361 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -134.17 132.23 39.55 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.319 0.58 . . . . 75.430000000000007 112.249 -172.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.677 HG21 ' HA3' ' A' ' 125' ' ' GLY . 30.7 p -138.99 -171.22 3.04 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.961 -0.563 . . . . 63.149999999999999 111.626 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.05 -18.18 65.08 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.928 -0.578 . . . . 73.329999999999998 112.01 175.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.436 ' CZ ' ' HB2' ' A' ' 109' ' ' ASP . 98.5 m-85 -88.0 -55.36 3.79 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.911 0.386 . . . . 72.540000000000006 111.505 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.9 -154.17 11.23 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.944 -0.646 . . . . 71.120000000000005 112.93 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.07 154.12 50.41 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.2 0.524 . . . . 74.25 111.652 178.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -151.0 145.31 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.241 -0.436 . . . . 74.340000000000003 111.036 177.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.5 t -110.31 117.73 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.808 0.337 . . . . 65.019999999999996 111.099 177.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.51 173.95 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 115.966 -0.561 . . . . 75.209999999999994 111.365 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -78.0 133.32 38.0 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.011 0.434 . . . . 74.120000000000005 111.18 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.94 126.5 33.07 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.179 0.437 . . . . 74.120000000000005 112.179 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -132.01 152.03 51.39 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.368 0.604 . . . . 74.439999999999998 110.871 175.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -90.45 121.97 32.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.66 -0.7 . . . . 65.400000000000006 111.249 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.513 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -120.59 -178.5 16.09 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.122 -0.561 . . . . 74.409999999999997 113.801 -174.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -93.66 8.87 39.24 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 122.703 0.401 . . . . 64.420000000000002 111.73 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.1 m -64.17 152.88 87.06 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.473 -0.33 . . . . 75.299999999999997 111.786 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.05 157.71 58.94 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.393 2.062 . . . . 74.430000000000007 112.21 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -64.63 142.2 58.51 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.829 0.347 . . . . 70.129999999999995 111.544 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.435 ' HA2' HG11 ' A' ' 26' ' ' VAL . . . 73.18 25.94 71.95 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.881 -0.676 . . . . 43.409999999999997 112.745 -173.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.575 ' HE3' HD13 ' A' ' 29' ' ' ILE . 26.2 ttt -154.97 136.74 14.44 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.428 -0.454 . . . . 75.030000000000001 110.278 -179.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.2 pt -134.69 145.74 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.116 0.484 . . . . 70.219999999999999 112.264 -177.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.411 ' HA ' HG12 ' A' ' 29' ' ' ILE . 70.4 t80 -103.94 134.86 46.52 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.017 0.437 . . . . 74.129999999999995 111.379 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 30' ' ' SER . 48.3 mt -130.75 132.96 24.27 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.368 -0.378 . . . . 72.299999999999997 110.534 175.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.401 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 33.7 Cg_exo -61.65 129.05 26.43 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.058 1.839 . . . . 72.349999999999994 112.075 174.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.614 ' HE2' HD13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -57.73 104.8 0.2 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.029 0.443 . . . . 74.219999999999999 110.858 -176.417 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.25 -175.03 29.75 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.812 -0.708 . . . . 75.129999999999995 112.854 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.423 ' O ' ' HG2' ' A' ' 106' ' ' MET . 16.0 Cg_endo -56.56 -33.28 92.5 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.656 2.238 . . . . 65.430000000000007 112.254 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.458 ' HA ' HD11 ' A' ' 140' ' ' LEU . 37.5 m-85 -63.35 -50.97 67.89 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.092 0.472 . . . . 74.319999999999993 110.23 175.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -59.97 -41.48 92.04 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.167 -0.47 . . . . 61.039999999999999 111.801 176.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' A' ' 102' ' ' PRO . 91.7 m-20 -53.3 -29.16 32.01 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.15 0.426 . . . . 65.030000000000001 112.15 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.452 ' SD ' HD22 ' A' ' 140' ' ' LEU . 87.8 mmm -65.62 -24.15 66.99 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.29 -0.414 . . . . 75.25 112.112 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.5 -12.92 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 112.945 0.72 . . . . 71.400000000000006 112.945 -173.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.614 HD13 ' HE2' ' A' ' 100' ' ' MET . 6.9 pt -107.44 -179.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.868 -0.52 . . . . 63.340000000000003 111.738 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 29.4 t70 -105.1 108.02 60.29 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 116.141 -0.481 . . . . 64.230000000000004 110.563 173.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.97 13.81 2.07 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.619 2.213 . . . . 72.340000000000003 113.648 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.5 m -80.94 -17.88 48.99 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.856 0.36 . . . . 71.319999999999993 111.843 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.3 t -97.71 109.58 22.31 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.303 0.573 . . . . 74.219999999999999 111.843 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -75.78 76.63 2.73 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.184 0.516 . . . . 74.010000000000005 111.801 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.05 -166.67 18.34 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.903 -0.59 . . . . 75.329999999999998 114.013 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.8 p -137.32 -58.31 0.7 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.987 0.422 . . . . 65.099999999999994 111.234 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.72 113.01 3.19 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.041 -0.527 . . . . 63.409999999999997 111.948 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 84.9 mtp 68.01 159.28 0.14 Allowed Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 116.966 0.383 . . . . 71.109999999999999 111.241 -174.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -56.81 95.34 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.631 2.221 . . . . 75.25 113.72 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -113.27 -23.24 10.03 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.321 0.489 . . . . 75.299999999999997 112.321 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 61.9 -160.07 0.31 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.183 0.438 . . . . 75.209999999999994 112.183 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt 75.52 96.64 0.07 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.705 0.802 . . . . 73.349999999999994 112.701 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -111.66 -157.76 14.35 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.826 -0.624 . . . . 53.229999999999997 113.984 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.42 HG21 ' H ' ' A' ' 109' ' ' ASP . 58.1 t -92.93 133.73 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 122.836 0.454 . . . . 63.420000000000002 111.46 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -74.96 140.84 43.96 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.671 0.619 . . . . 75.200000000000003 112.671 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.677 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -169.62 -165.5 27.09 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.837 -0.62 . . . . 74.129999999999995 113.087 177.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 77.3 p -122.39 155.12 36.71 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.939 0.399 . . . . 70.430000000000007 111.486 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.1 p -129.88 142.77 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.657 -0.498 . . . . 63.340000000000003 109.657 173.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 8.8 pt-20 -143.21 147.65 35.21 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.251 0.834 . . . . 72.319999999999993 113.251 -174.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.624 ' HE3' HD23 ' A' ' 67' ' ' LEU . 1.8 tppp? -77.03 109.28 10.73 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.427 -0.806 . . . . 73.109999999999999 109.675 168.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.1 t -123.22 162.53 22.39 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.348 0.594 . . . . 74.340000000000003 112.456 -173.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.82 -12.14 59.78 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.397 -0.82 . . . . 71.439999999999998 111.209 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.423 ' HG3' ' HE3' ' A' ' 74' ' ' LYS . 6.2 mm-40 -61.1 160.26 10.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.684 0.754 . . . . 74.219999999999999 112.925 -176.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -95.15 160.22 14.66 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.425 -0.807 . . . . 74.109999999999999 110.917 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.617 HG21 ' HG3' ' A' ' 72' ' ' ARG . 71.9 t -72.25 136.42 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 120.733 0.302 . . . . 73.329999999999998 110.751 174.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.404 HD21 ' HG2' ' A' ' 139' ' ' GLU . 14.6 mt -73.4 132.29 42.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.544 -0.298 . . . . 74.340000000000003 111.441 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.4 t -73.15 147.83 44.45 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.208 -0.664 . . . . 74.319999999999993 109.208 170.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.411 HG21 ' HD1' ' A' ' 49' ' ' PHE . 99.3 t -46.05 -52.5 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 112.672 0.619 . . . . 70.340000000000003 112.672 -173.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -73.0 -35.41 66.82 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.04 -0.412 . . . . 73.519999999999996 111.723 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.404 ' HG2' HD21 ' A' ' 135' ' ' LEU . 48.1 tt0 -60.9 -33.83 73.73 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.747 0.784 . . . . 72.329999999999998 110.156 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.458 HD11 ' HA ' ' A' ' 103' ' ' TYR . 4.8 tt -60.37 -44.19 95.84 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.075 -0.966 . . . . 73.230000000000004 110.359 171.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.1 mt -61.56 -41.23 97.09 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.181 0.515 . . . . 71.319999999999993 110.19 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -64.41 -34.61 78.58 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.904 -0.589 . . . . 75.329999999999998 110.96 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.02 -36.05 82.22 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.369 -0.378 . . . . 54.530000000000001 111.801 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.405 HG13 ' H ' ' A' ' 146' ' ' SER . 33.8 pt -88.9 -16.29 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 111.96 0.356 . . . . 74.230000000000004 111.96 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 102.32 -5.94 52.75 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.381 -0.438 . . . . 60.130000000000003 113.953 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.405 ' H ' HG13 ' A' ' 144' ' ' ILE . 30.7 t . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 121.409 0.623 . . . . 74.319999999999993 111.902 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.1 mmm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 111.849 0.314 . . . . 74.349999999999994 111.849 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.19 118.23 0.43 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.602 -0.808 . . . . 70.25 113.398 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.2 p -89.87 98.57 11.85 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.713 0.292 . . . . 65.549999999999997 111.078 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.6 m -60.21 123.25 16.64 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.0 0.428 . . . . 75.040000000000006 112.018 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -93.19 154.26 18.15 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.449 -0.342 . . . . 73.530000000000001 110.961 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -128.69 138.48 52.17 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.897 0.379 . . . . 75.25 111.957 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -115.08 110.26 19.3 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.1 -0.5 . . . . 70.129999999999995 111.122 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.01 156.21 37.77 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.195 0.813 . . . . 62.310000000000002 113.195 -174.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -134.55 176.1 8.94 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.9 -0.591 . . . . 74.099999999999994 110.879 174.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -87.28 162.65 17.3 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.081 0.467 . . . . 74.329999999999998 111.297 174.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.7 m -75.81 84.72 2.78 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.473 -0.331 . . . . 74.230000000000004 111.315 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.6 p -99.16 176.57 5.5 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.837 0.351 . . . . 75.340000000000003 111.019 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.72 16.83 25.87 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 120.873 -0.679 . . . . 71.329999999999998 114.313 -176.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 44.0 mtt180 -73.91 101.8 3.9 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.68 0.753 . . . . 74.409999999999997 112.241 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -82.91 -165.24 1.02 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.084 -0.962 . . . . 75.109999999999999 111.626 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -147.67 -63.87 0.27 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.466 -0.334 . . . . 74.239999999999995 110.963 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.4 mp 70.17 115.84 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.803 0.668 . . . . 74.109999999999999 112.803 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 67.79 170.09 0.27 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.206 -0.906 . . . . 74.409999999999997 113.167 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -148.0 36.99 0.86 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.565 -0.743 . . . . 75.019999999999996 110.335 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -136.86 161.99 34.46 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.236 -0.438 . . . . 75.329999999999998 111.56 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.45 72.76 1.11 Allowed Glycine 0 CA--C 1.528 0.847 0 CA-C-N 116.243 -0.435 . . . . 75.439999999999998 113.297 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -99.13 136.69 38.72 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 122.357 -0.496 . . . . 75.150000000000006 112.044 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.433 ' SD ' HG23 ' A' ' 126' ' ' THR . 7.0 ptp -104.42 154.76 19.46 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.06 -0.518 . . . . 75.120000000000005 110.855 174.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.536 HD13 ' HG ' ' A' ' 65' ' ' LEU . 9.5 mt -104.84 127.36 52.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.028 0.442 . . . . 74.25 111.687 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -71.29 113.23 8.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.732 0.777 . . . . 75.209999999999994 111.865 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 35.3 m -134.09 157.62 41.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.71 -1.132 . . . . 73.239999999999995 111.742 -174.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 41.8 tt0 -98.74 117.88 34.21 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.905 0.383 . . . . 74.129999999999995 110.699 175.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.618 HG23 HD13 ' A' ' 96' ' ' ILE . 34.4 t -91.04 110.63 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.944 -0.571 . . . . 71.329999999999998 111.848 -173.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.725 HD12 ' HE1' ' A' ' 95' ' ' MET . 2.0 mt -95.72 159.92 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 122.06 -0.4 . . . . 75.310000000000002 111.731 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.3 t -122.87 111.71 16.99 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.949 0.404 . . . . 63.100000000000001 111.245 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.34 117.89 5.7 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.319 -0.467 . . . . 60.450000000000003 113.534 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.476 HH11 ' HA ' ' A' ' 32' ' ' ARG . 10.8 mmm180 -77.34 16.32 0.63 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.992 0.738 . . . . 74.120000000000005 112.992 -175.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.2 t -64.03 -41.48 97.41 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.987 0.422 . . . . 64.010000000000005 111.729 176.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.8 mp -110.64 164.05 13.12 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.091 0.472 . . . . 72.299999999999997 111.995 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.8 t30 59.58 92.31 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.354 -0.839 . . . . 72.319999999999993 112.446 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -91.79 3.3 55.43 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.91 -0.586 . . . . 74.439999999999998 110.587 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.51 47.94 0.16 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.958 -0.565 . . . . 74.430000000000007 112.065 -175.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.449 ' HB2' ' HG2' ' A' ' 42' ' ' GLU . . . -134.9 142.9 46.67 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.952 0.406 . . . . 72.400000000000006 111.602 -176.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.541 HG21 ' H ' ' A' ' 42' ' ' GLU . 5.6 t -67.1 156.98 34.75 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.511 -0.313 . . . . 75.209999999999994 111.237 175.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.5 m -59.5 -28.2 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.861 0.363 . . . . 75.120000000000005 111.144 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -66.58 -33.63 76.1 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.19 0.519 . . . . 74.439999999999998 110.576 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.541 ' H ' HG21 ' A' ' 39' ' ' THR . 5.9 tp10 -51.15 -37.77 48.21 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.789 -0.642 . . . . 75.340000000000003 111.371 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.615 ' HB2' ' CD2' ' A' ' 48' ' ' TYR . 2.7 mptp? -105.98 -62.26 1.4 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.22 -0.445 . . . . 74.140000000000001 110.629 176.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.1 tp 69.16 -31.43 0.21 Allowed 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.908 1.447 . . . . 74.200000000000003 114.908 172.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.9 t -54.58 154.42 4.87 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.587 0.588 . . . . 73.040000000000006 112.587 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.437 ' O ' ' HB3' ' A' ' 49' ' ' PHE . 46.2 tt0 -57.13 -26.82 61.15 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.902 0.334 . . . . 73.540000000000006 111.902 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.6 -36.32 69.27 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.859 0.361 . . . . 63.439999999999998 111.066 174.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.615 ' CD2' ' HB2' ' A' ' 43' ' ' LYS . 8.6 t80 -59.63 -41.23 90.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.55 0.691 . . . . 74.549999999999997 109.876 174.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.437 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 50.5 t80 -63.61 -65.15 0.72 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.24 -0.891 . . . . 63.240000000000002 110.554 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -58.0 -21.54 45.34 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.773 0.656 . . . . 73.439999999999998 112.773 -176.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.28 -32.19 33.32 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.031 0.752 . . . . 74.349999999999994 113.031 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 48' ' ' TYR . 32.7 m -116.93 4.88 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 113.27 0.841 . . . . 73.329999999999998 113.27 -175.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.413 ' ND2' ' CZ ' ' A' ' 103' ' ' TYR . 1.2 m-80 -94.58 28.34 2.66 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.377 0.88 . . . . 74.420000000000002 113.377 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.428 ' CE2' ' HE2' ' A' ' 87' ' ' LYS . 17.8 p90 -144.46 151.62 39.45 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.556 -0.715 . . . . 64.209999999999994 111.979 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.78 139.59 53.7 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.617 -0.72 . . . . 63.32 110.872 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.636 ' HG2' ' HE3' ' A' ' 87' ' ' LYS . 41.3 mt-10 -95.42 112.66 24.33 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.865 0.364 . . . . 73.430000000000007 111.423 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.442 HD13 ' N ' ' A' ' 57' ' ' ILE . 4.0 mp -109.17 145.67 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.275 -0.42 . . . . 74.200000000000003 110.518 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -61.81 151.93 32.92 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.284 0.564 . . . . 64.200000000000003 111.763 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.503 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 14.8 tm-20 -55.92 -52.94 62.36 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.705 -0.679 . . . . 71.420000000000002 111.964 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -55.75 -53.24 59.03 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.325 0.491 . . . . 70.239999999999995 112.325 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -61.09 -35.98 78.46 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.629 0.728 . . . . 75.219999999999999 110.663 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.503 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 43.0 t-105 -52.78 -53.84 42.52 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.023 -0.99 . . . . 74.239999999999995 111.769 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -73.53 -30.15 62.9 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.299 -0.409 . . . . 72.409999999999997 111.644 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.466 ' HB1' HD11 ' A' ' 24' ' ' LEU . . . -58.64 -34.85 71.66 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.032 0.444 . . . . 65.109999999999999 111.581 177.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.536 ' HG ' HD13 ' A' ' 24' ' ' LEU . 82.6 mt -89.64 -13.86 36.15 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.154 -0.475 . . . . 74.109999999999999 111.461 176.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.72 44.72 19.47 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.396 -0.431 . . . . 75.120000000000005 112.825 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.449 HD22 ' HB2' ' A' ' 129' ' ' LYS . 92.9 mt -85.1 149.97 25.18 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.509 0.671 . . . . 75.129999999999995 112.095 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -114.61 144.96 42.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.691 -0.686 . . . . 73.25 109.213 169.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -61.33 93.37 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.017 0.913 . . . . 73.109999999999999 111.697 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.0 -7.42 3.8 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 114.612 -1.176 . . . . 43.240000000000002 113.267 -175.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -69.35 178.53 2.36 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.04 0.756 . . . . 74.409999999999997 113.04 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.2 mtm-85 -113.61 139.63 48.86 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.688 -0.687 . . . . 73.519999999999996 110.512 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.35 139.64 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.472 0.653 . . . . 73.140000000000001 112.716 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -90.38 131.29 36.24 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.427 -0.806 . . . . 73.150000000000006 110.207 172.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.9 t -119.52 125.72 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.696 -0.483 . . . . 73.099999999999994 109.696 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.425 ' HG2' ' HB3' ' A' ' 81' ' ' GLU . 25.6 mtpp -133.9 131.59 39.3 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.991 0.737 . . . . 74.430000000000007 112.991 -171.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.627 HG21 ' HA3' ' A' ' 125' ' ' GLY . 30.3 p -140.1 -176.23 4.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.529 -0.759 . . . . 74.420000000000002 110.973 178.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.78 -11.4 60.82 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.365 -0.38 . . . . 74.349999999999994 111.681 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 109' ' ' ASP . 93.8 m-85 -89.31 -40.45 12.78 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.802 0.334 . . . . 72.430000000000007 111.296 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.05 -147.26 10.24 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.144 -0.55 . . . . 54.149999999999999 112.652 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.425 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 11.2 pt-20 -155.04 154.43 32.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.143 0.497 . . . . 71.319999999999993 112.218 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.3 p -149.51 155.32 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.999 -0.546 . . . . 75.319999999999993 111.169 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.83 116.94 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 122.382 -0.198 . . . . 74.230000000000004 111.017 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.5 176.28 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 116.496 -0.32 . . . . 75.209999999999994 111.267 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -77.68 160.4 28.5 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.203 0.525 . . . . 75.439999999999998 111.405 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.11 127.2 50.47 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.243 0.544 . . . . 73.329999999999998 111.734 -173.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.636 ' HE3' ' HG2' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -131.24 129.71 41.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.877 -0.601 . . . . 73.129999999999995 111.148 -178.776 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -79.88 98.65 7.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.035 -0.53 . . . . 74.209999999999994 110.828 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.536 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -96.56 161.01 22.01 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.989 -0.55 . . . . 72.450000000000003 114.018 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -87.63 15.24 7.04 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.358 0.599 . . . . 74.099999999999994 111.566 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.8 m -71.12 157.35 90.45 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 115.685 -0.689 . . . . 75.239999999999995 111.421 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.6 157.67 40.74 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.732 2.288 . . . . 72.25 113.723 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -62.59 145.64 53.93 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.282 -0.417 . . . . 75.010000000000005 111.35 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 61.99 32.45 82.22 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.843 -0.694 . . . . 72.519999999999996 112.716 -174.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.725 ' HE1' HD12 ' A' ' 29' ' ' ILE . 21.8 ttt -153.88 136.71 15.34 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.592 -0.358 . . . . 74.329999999999998 110.119 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.618 HD13 HG23 ' A' ' 28' ' ' VAL . 40.8 pt -134.84 150.9 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 121.288 0.566 . . . . 75.239999999999995 112.023 -177.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -112.13 130.9 55.74 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.016 -0.538 . . . . 74.349999999999994 111.241 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' A' ' 30' ' ' SER . 50.4 mt -130.3 128.5 22.7 Favored Pre-proline 0 N--CA 1.474 0.77 0 CA-C-O 120.548 0.213 . . . . 74.109999999999999 110.998 175.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.51 140.66 89.89 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.27 1.98 . . . . 72.25 112.899 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.457 ' HE3' HD13 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -60.01 105.84 0.44 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.122 0.486 . . . . 75.0 110.815 -178.646 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.91 -174.71 27.96 Favored Glycine 0 N--CA 1.46 0.273 0 C-N-CA 120.784 -0.722 . . . . 71.530000000000001 112.57 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.497 ' O ' ' HG2' ' A' ' 106' ' ' MET . 26.5 Cg_endo -61.74 -26.72 80.1 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.272 1.981 . . . . 74.340000000000003 111.563 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.434 ' HA ' HD13 ' A' ' 140' ' ' LEU . 4.1 m-85 -69.17 -53.44 20.04 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.56 -0.745 . . . . 74.150000000000006 110.782 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.436 ' O ' HG22 ' A' ' 108' ' ' ILE . . . -60.05 -39.78 87.16 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.268 -0.424 . . . . 62.310000000000002 110.748 174.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -54.71 -25.92 30.51 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.912 0.485 . . . . 74.129999999999995 112.042 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.623 ' SD ' HD23 ' A' ' 140' ' ' LEU . 89.9 mmm -67.28 -30.2 70.01 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.947 0.351 . . . . 73.040000000000006 111.947 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.07 -14.01 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 113.187 0.81 . . . . 62.420000000000002 113.187 -171.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.457 HD13 ' HE3' ' A' ' 100' ' ' MET . 8.8 pt -102.67 -178.91 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.163 0.506 . . . . 64.040000000000006 111.753 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 21.7 t70 -109.49 100.0 39.76 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 116.076 -0.511 . . . . 71.109999999999999 110.475 173.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -75.09 -2.91 13.17 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.444 2.096 . . . . 71.030000000000001 113.327 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.7 t -67.78 -28.15 67.36 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.983 0.42 . . . . 64.239999999999995 111.467 177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.0 t -104.08 156.44 17.87 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.694 0.627 . . . . 74.329999999999998 112.694 -177.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -108.37 -177.18 3.25 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.72 -0.673 . . . . 70.120000000000005 110.029 172.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.77 54.13 4.1 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.026 -0.607 . . . . 65.209999999999994 112.918 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.0 p -85.54 104.58 15.44 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.963 0.411 . . . . 74.319999999999993 111.385 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 139.66 -103.69 0.39 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.304 -0.475 . . . . 72.109999999999999 112.368 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 119' ' ' GLN . 91.1 mtp -86.74 142.71 34.77 Favored Pre-proline 0 CA--C 1.54 0.569 0 O-C-N 122.634 -0.333 . . . . 71.319999999999993 110.783 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.22 79.09 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.281 2.654 . . . . 75.219999999999999 113.954 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 119' ' ' GLN . 18.6 tt0 58.45 29.15 17.89 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.501 0.667 . . . . 75.299999999999997 111.851 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -95.07 144.97 25.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.939 -0.573 . . . . 71.450000000000003 111.38 177.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.3 mttt 67.66 138.79 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.655 0.741 . . . . 73.530000000000001 112.558 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . -134.29 -156.68 7.93 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.817 -0.629 . . . . 63.509999999999998 113.091 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.433 HG21 ' HA ' ' A' ' 108' ' ' ILE . 59.5 t -85.32 119.16 33.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.926 0.393 . . . . 73.510000000000005 111.487 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 67.5 mttm -67.46 148.88 50.95 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.245 0.545 . . . . 72.150000000000006 112.366 -177.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.627 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -177.25 -143.52 4.94 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 115.94 -0.573 . . . . 73.230000000000004 113.367 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.433 HG23 ' SD ' ' A' ' 23' ' ' MET . 76.5 p -139.3 159.98 40.88 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 122.398 -0.472 . . . . 73.040000000000006 111.769 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.7 p -144.99 145.02 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.103 0.478 . . . . 74.239999999999995 111.484 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -155.61 161.51 40.81 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.364 -0.38 . . . . 71.510000000000005 110.687 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.449 ' HB2' HD22 ' A' ' 67' ' ' LEU . 31.7 ttpt -79.91 131.15 35.78 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.755 -0.59 . . . . 75.25 110.197 173.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.7 t -118.01 156.25 28.88 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.644 0.609 . . . . 75.409999999999997 112.644 -172.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.02 -13.05 60.23 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.724 -0.671 . . . . 74.420000000000002 110.055 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -70.0 147.68 49.82 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.299 -0.864 . . . . 73.430000000000007 113.195 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.607 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -77.29 157.35 30.79 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.779 -1.1 . . . . 75.430000000000007 111.373 174.265 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.23 130.28 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.87 0.367 . . . . 74.349999999999994 110.826 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.1 mt -66.26 119.45 11.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 75.439999999999998 111.567 178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.424 ' HA ' ' HE2' ' A' ' 49' ' ' PHE . 29.9 t -66.27 148.44 51.85 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.596 -0.52 . . . . 74.319999999999993 109.596 168.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.498 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 62.7 t -46.26 -40.3 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 120.943 0.402 . . . . 75.219999999999999 111.583 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -72.79 -44.39 61.59 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.194 -0.457 . . . . 72.120000000000005 112.165 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -60.91 -36.03 78.21 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.672 0.749 . . . . 74.219999999999999 110.227 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.623 HD23 ' SD ' ' A' ' 106' ' ' MET . 2.5 tt -60.65 -38.87 86.3 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.415 -0.811 . . . . 71.209999999999994 110.799 174.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 54.0 mt -57.84 -47.52 82.42 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.467 0.651 . . . . 73.219999999999999 110.063 175.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.99 -30.7 71.71 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.662 -0.699 . . . . 75.450000000000003 111.449 178.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.1 -40.63 78.26 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.166 0.432 . . . . 74.230000000000004 112.166 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.456 HD11 ' H ' ' A' ' 146' ' ' SER . 2.9 pp -83.9 -18.75 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 112.094 0.405 . . . . 75.129999999999995 112.094 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 142.9 -46.6 0.85 Allowed Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.118 -0.563 . . . . 54.25 113.353 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.456 ' H ' HD11 ' A' ' 144' ' ' ILE . 16.0 m . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 121.035 0.445 . . . . 73.319999999999993 111.574 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 ptm . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.157 0.503 . . . . 63.32 111.645 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.53 153.57 2.65 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 121.197 -0.525 . . . . 72.319999999999993 112.84 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.2 p -168.72 120.45 0.78 Allowed 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.292 -0.534 . . . . 74.409999999999997 111.976 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.0 p -88.1 111.26 21.37 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.976 0.417 . . . . 75.120000000000005 110.432 175.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -79.0 152.55 30.9 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.221 -0.445 . . . . 73.540000000000006 111.851 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -119.91 164.65 15.73 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.013 0.435 . . . . 64.219999999999999 111.874 -176.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -142.28 174.46 10.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.63 0.372 . . . . 72.219999999999999 110.48 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -139.86 144.1 37.07 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.156 0.428 . . . . 62.350000000000001 112.156 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -114.36 141.2 47.94 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.343 -0.39 . . . . 72.5 111.334 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -92.66 138.09 31.8 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.588 -0.278 . . . . 75.329999999999998 110.712 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.8 p -154.39 128.21 8.77 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.38 0.511 . . . . 72.319999999999993 112.38 -176.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.7 t -165.55 136.04 3.69 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 116.258 -0.428 . . . . 75.120000000000005 111.082 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -160.41 75.38 0.19 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.977 -0.63 . . . . 60.340000000000003 113.052 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.459 ' HA ' ' HE ' ' A' ' 14' ' ' ARG . 5.2 mmp_? -109.95 117.8 34.75 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.446 -0.444 . . . . 75.099999999999994 110.931 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -107.64 -177.47 3.35 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.183 0.438 . . . . 73.409999999999997 112.183 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -124.17 126.28 45.88 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.316 0.488 . . . . 73.099999999999994 112.316 -175.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mp -116.35 128.51 55.6 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.323 -0.399 . . . . 75.230000000000004 110.476 171.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -107.44 155.9 19.54 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.575 0.583 . . . . 75.239999999999995 112.575 -175.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -119.89 166.31 13.47 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.733 -0.667 . . . . 75.310000000000002 110.719 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -131.86 -43.43 0.99 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.227 0.825 . . . . 74.530000000000001 113.227 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.52 166.41 35.36 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.559 -0.829 . . . . 54.439999999999998 113.45 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -119.25 121.84 40.57 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.47 0.545 . . . . 75.129999999999995 112.47 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.5 ptm -80.62 142.06 34.39 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.325 -0.398 . . . . 73.409999999999997 110.528 174.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mp -105.32 142.92 34.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.164 0.507 . . . . 75.420000000000002 112.281 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.417 ' HA ' HG23 ' A' ' 126' ' ' THR . 29.6 tt0 -81.14 112.12 18.21 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.809 -0.632 . . . . 74.299999999999997 110.898 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 33.3 m -128.09 160.19 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.809 0.338 . . . . 75.519999999999996 111.886 -174.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.69 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 86.9 tt0 -98.83 115.23 28.34 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.193 0.521 . . . . 72.549999999999997 110.594 175.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.533 HG22 HD13 ' A' ' 96' ' ' ILE . 39.5 t -88.22 113.9 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.708 -0.678 . . . . 71.299999999999997 111.751 -175.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.575 HD12 ' HE1' ' A' ' 95' ' ' MET . 2.8 mt -98.0 159.8 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.569 -0.287 . . . . 74.530000000000001 111.546 -178.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.563 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 71.5 m -126.17 106.13 9.34 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.964 0.411 . . . . 75.549999999999997 111.29 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.511 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . -95.28 126.86 8.91 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.039 -0.6 . . . . 75.540000000000006 113.597 -176.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -76.65 81.94 3.29 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.251 0.548 . . . . 74.409999999999997 111.589 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.9 t -96.73 -17.69 20.13 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.576 0.703 . . . . 72.420000000000002 110.149 170.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 65.2 tp -148.88 153.58 38.24 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.068 -0.969 . . . . 73.310000000000002 109.83 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 70.48 104.95 0.06 Allowed 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.635 0.605 . . . . 73.040000000000006 112.635 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -83.73 -28.27 28.36 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.624 0.725 . . . . 71.409999999999997 109.712 170.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.87 66.0 0.06 OUTLIER Glycine 0 CA--C 1.526 0.759 0 CA-C-N 114.911 -1.041 . . . . 73.439999999999998 111.479 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.69 162.93 30.94 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.316 0.579 . . . . 61.409999999999997 112.072 -174.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 47.1 p -85.93 169.49 13.22 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.996 -0.547 . . . . 64.530000000000001 110.314 173.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 m -68.39 -34.42 65.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.093 0.473 . . . . 62.109999999999999 110.404 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.812 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 4.0 tm-20 -71.46 -28.84 64.23 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.661 -0.699 . . . . 72.219999999999999 110.984 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.55 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -55.3 -29.12 57.6 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.104 -0.498 . . . . 71.540000000000006 110.919 175.221 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.55 ' HE2' ' HB3' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -107.35 -74.92 0.64 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.845 0.355 . . . . 74.430000000000007 111.899 174.832 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.812 ' HG ' ' HA ' ' A' ' 41' ' ' GLU . 26.2 mt 55.52 12.08 0.72 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.982 1.104 . . . . 73.200000000000003 113.982 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.4 t -72.02 160.12 33.03 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.918 -0.489 . . . . 71.200000000000003 110.545 174.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -58.34 -35.68 72.28 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.881 0.372 . . . . 74.010000000000005 111.036 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -53.95 -34.64 60.25 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.12 0.485 . . . . 71.439999999999998 111.268 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -64.78 -32.64 74.43 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.211 -0.449 . . . . 75.430000000000007 110.675 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.458 ' HD1' HG21 ' A' ' 137' ' ' VAL . 52.8 t80 -87.19 4.92 40.54 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.161 0.505 . . . . 75.25 111.673 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -121.44 -36.32 3.09 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.753 -0.592 . . . . 65.430000000000007 111.959 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.4 -56.0 8.7 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.796 0.665 . . . . 72.209999999999994 112.796 -175.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.573 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 34.4 m -96.16 17.16 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 113.078 0.77 . . . . 71.109999999999999 113.078 -173.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.576 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -102.46 19.38 19.04 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.709 0.633 . . . . 74.219999999999999 112.709 -174.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -144.23 171.14 14.72 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.889 -0.507 . . . . 74.530000000000001 112.045 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.55 136.39 44.94 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.884 -0.598 . . . . 72.0 111.388 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.612 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 42.5 mt-10 -86.66 117.28 25.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.088 0.471 . . . . 64.349999999999994 110.7 175.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 28.1 mt -113.52 143.43 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.819 -0.628 . . . . 74.25 111.897 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -66.38 145.07 56.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.495 0.188 . . . . 73.120000000000005 110.622 174.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -62.29 -32.62 73.37 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.529 0.566 . . . . 72.010000000000005 112.529 -176.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.55 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 17.7 mm-40 -58.87 -57.44 13.05 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.213 -0.304 . . . . 60.439999999999998 111.585 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.51 -37.29 85.46 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.345 0.593 . . . . 74.200000000000003 110.64 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.475 ' HA ' HD11 ' A' ' 67' ' ' LEU . 51.5 t-105 -53.43 -52.1 60.5 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.406 -0.815 . . . . 75.439999999999998 110.991 174.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -67.1 -38.65 86.04 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.679 -0.691 . . . . 74.319999999999993 111.35 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.27 -33.91 72.99 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.236 -0.438 . . . . 65.349999999999994 112.028 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -94.78 -7.61 39.93 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.083 0.401 . . . . 73.150000000000006 112.083 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.48 48.15 76.6 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.064 -0.588 . . . . 64.519999999999996 112.634 -177.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.521 HD23 ' HD3' ' A' ' 129' ' ' LYS . 84.8 mt -86.29 142.8 28.26 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.351 0.596 . . . . 75.420000000000002 112.34 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -110.51 151.36 27.67 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.416 -0.811 . . . . 74.150000000000006 109.545 172.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.6 104.31 0.64 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.329 0.585 . . . . 73.25 111.366 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 118.5 0.02 15.95 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-N 115.652 -0.704 . . . . 73.420000000000002 113.62 -176.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -68.65 172.13 6.72 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.304 0.573 . . . . 54.229999999999997 111.868 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.1 mtt85 -109.79 125.51 52.8 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.001 -0.545 . . . . 71.230000000000004 110.949 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.676 HG13 ' HB3' ' A' ' 86' ' ' ALA . 15.5 m -113.8 152.35 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.543 0.687 . . . . 75.209999999999994 111.844 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 47.1 tttp -124.05 120.86 33.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.606 -0.724 . . . . 74.209999999999994 110.388 -177.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.474 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 48.2 t -102.64 130.83 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 111.753 0.279 . . . . 64.239999999999995 111.753 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.91 127.73 53.76 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.631 -0.259 . . . . 74.239999999999995 110.748 175.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.781 HG21 ' HA3' ' A' ' 125' ' ' GLY . 25.4 p -130.81 -172.15 2.75 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.094 0.473 . . . . 73.329999999999998 111.259 177.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.77 -16.43 63.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.373 -0.376 . . . . 75.519999999999996 111.679 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -93.34 -47.07 7.07 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 111.888 0.329 . . . . 74.150000000000006 111.888 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.94 -156.95 19.98 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.879 -0.677 . . . . 54.009999999999998 113.266 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.474 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 5.2 pt-20 -133.72 161.23 35.25 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.14 0.495 . . . . 74.239999999999995 111.725 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.9 p -160.59 143.25 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.29 -0.414 . . . . 74.129999999999995 111.34 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.0 t -104.03 118.97 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 122.325 -0.234 . . . . 72.420000000000002 110.761 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.9 m -130.14 177.68 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.853 0.359 . . . . 75.25 111.687 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -80.21 144.11 33.22 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.19 0.519 . . . . 74.230000000000004 111.674 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.676 ' HB3' HG13 ' A' ' 73' ' ' VAL . . . -93.9 120.13 33.75 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.18 0.437 . . . . 73.230000000000004 112.18 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -131.9 150.31 52.19 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.203 0.525 . . . . 75.129999999999995 110.863 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -92.14 122.81 34.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.005 -0.543 . . . . 75.420000000000002 111.068 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.612 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -120.06 172.94 15.06 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.08 -0.581 . . . . 64.420000000000002 113.487 -176.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.9 9.82 9.17 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.81 0.338 . . . . 62.310000000000002 111.861 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.1 m -64.78 152.97 89.16 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.353 -0.385 . . . . 73.140000000000001 111.67 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.18 163.57 38.73 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.803 2.335 . . . . 70.030000000000001 113.218 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.55 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 84.6 tttt -63.88 133.07 52.64 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.406 -0.361 . . . . 73.129999999999995 111.694 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.446 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 77.44 24.37 65.7 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.97 -0.633 . . . . 72.219999999999999 113.198 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.69 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 18.2 ttt -149.78 137.09 19.81 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.374 -0.486 . . . . 74.209999999999994 110.471 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.533 HD13 HG22 ' A' ' 28' ' ' VAL . 39.5 pt -130.09 144.75 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.407 0.622 . . . . 75.420000000000002 112.03 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.511 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 74.6 t80 -106.69 119.36 39.1 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.961 -0.563 . . . . 73.340000000000003 111.383 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 30' ' ' SER . 44.4 mt -117.4 126.36 27.45 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 120.673 0.273 . . . . 75.329999999999998 110.801 175.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.573 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 19.5 Cg_endo -58.56 132.0 45.78 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.121 1.881 . . . . 75.209999999999994 111.934 175.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.453 ' HE2' HD12 ' A' ' 108' ' ' ILE . 6.9 tpp -51.51 115.42 1.61 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.17 0.51 . . . . 74.540000000000006 112.265 -176.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -169.03 178.53 42.24 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.786 -0.643 . . . . 72.0 112.496 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.482 ' O ' ' HG2' ' A' ' 106' ' ' MET . 11.9 Cg_endo -52.87 -33.8 63.01 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 122.853 2.369 . . . . 73.510000000000005 112.095 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -64.82 -47.64 77.29 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.738 -0.665 . . . . 74.230000000000004 110.608 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -64.21 -39.83 94.79 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.018 0.437 . . . . 62.43 111.197 175.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -64.03 -7.04 7.38 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.436 0.532 . . . . 71.329999999999998 112.436 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.636 ' SD ' HD23 ' A' ' 140' ' ' LEU . 95.8 mmm -82.62 -25.62 33.01 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.971 0.415 . . . . 73.209999999999994 111.311 173.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.4 m -120.98 -16.52 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 112.335 0.494 . . . . 74.109999999999999 112.335 -170.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.518 HG22 ' OG ' ' A' ' 30' ' ' SER . 5.9 pt -101.99 -178.43 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.102 0.477 . . . . 73.319999999999993 111.603 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -93.55 113.6 60.71 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 116.356 -0.384 . . . . 75.030000000000001 110.553 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -88.57 16.31 1.89 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.777 2.318 . . . . 74.209999999999994 113.653 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.0 t -121.87 25.52 9.13 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.294 0.569 . . . . 73.530000000000001 110.941 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 76.3 p -76.63 113.92 14.8 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.695 0.628 . . . . 73.299999999999997 112.695 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -115.41 -12.61 11.7 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.022 0.439 . . . . 75.349999999999994 110.349 170.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.11 152.26 40.74 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.996 -0.547 . . . . 71.409999999999997 112.829 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.1 m -73.48 74.87 1.44 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.467 0.651 . . . . 72.540000000000006 111.705 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -97.58 -57.02 1.06 Allowed Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.738 -0.664 . . . . 62.340000000000003 111.483 173.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.589 ' HA ' ' HE3' ' A' ' 117' ' ' MET . 22.3 mmt 66.75 174.65 0.07 OUTLIER Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 122.684 0.393 . . . . 73.530000000000001 111.65 174.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' ' 117' ' ' MET . 76.3 Cg_exo -56.04 23.46 0.03 OUTLIER 'Trans proline' 0 CA--C 1.554 1.525 0 C-N-CA 123.168 2.579 . . . . 63.420000000000002 116.224 177.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.445 ' H ' ' C ' ' A' ' 117' ' ' MET . 48.7 mt-30 -73.68 175.18 7.39 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.673 -0.642 . . . . 72.25 110.672 171.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -82.23 59.16 4.35 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.28 0.562 . . . . 70.230000000000004 112.249 -172.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -122.73 136.42 54.87 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.108 -0.496 . . . . 75.109999999999999 110.765 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -142.11 174.8 23.06 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.997 -0.62 . . . . 63.530000000000001 113.292 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.9 t -93.53 120.95 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 122.398 -0.472 . . . . 74.340000000000003 111.528 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 37.3 mtpt -65.63 155.87 34.55 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.73 0.776 . . . . 73.140000000000001 113.09 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.781 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -178.85 -151.39 9.56 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 114.966 -1.016 . . . . 64.5 112.449 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.417 HG23 ' HA ' ' A' ' 25' ' ' GLU . 45.1 p -141.09 147.79 39.1 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.424 -0.457 . . . . 73.129999999999995 111.538 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.0 p -125.43 144.58 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.291 0.567 . . . . 74.430000000000007 111.904 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -153.87 168.87 24.91 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.796 -0.638 . . . . 64.239999999999995 110.561 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.521 ' HD3' HD23 ' A' ' 67' ' ' LEU . 36.8 ttpt -99.72 139.16 35.78 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.13 0.491 . . . . 74.409999999999997 111.257 174.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.9 t -131.75 161.23 33.34 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.307 0.575 . . . . 63.0 111.968 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -90.18 -2.88 58.11 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.809 -0.632 . . . . 75.409999999999997 111.039 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.67 153.28 44.06 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.98 -0.554 . . . . 64.519999999999996 111.353 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.2 pptp? -87.47 156.86 19.37 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.064 0.459 . . . . 72.420000000000002 111.196 176.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.23 130.73 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.11 -0.495 . . . . 72.209999999999994 111.834 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.409 ' CD2' ' HG2' ' A' ' 139' ' ' GLU . 2.1 mt -61.74 101.09 0.17 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.411 -0.359 . . . . 74.109999999999999 111.223 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.3 m -52.43 143.2 15.75 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 110.783 -0.08 . . . . 65.109999999999999 110.783 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.458 HG21 ' HD1' ' A' ' 49' ' ' PHE . 68.4 t -45.88 -52.84 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 113.026 0.751 . . . . 73.420000000000002 113.026 -172.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -72.04 -39.96 68.73 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 122.101 -0.374 . . . . 74.299999999999997 111.905 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.409 ' HG2' ' CD2' ' A' ' 135' ' ' LEU . 42.3 tt0 -56.1 -36.21 67.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.622 0.725 . . . . 71.129999999999995 110.542 175.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.636 HD23 ' SD ' ' A' ' 106' ' ' MET . 3.7 tt -61.69 -40.96 96.83 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.136 -0.938 . . . . 75.319999999999993 110.5 174.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.4 mt -61.55 -44.27 97.34 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.29 0.566 . . . . 75.239999999999995 110.17 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -64.89 -31.66 73.0 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.783 -0.644 . . . . 73.439999999999998 111.135 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.35 -50.03 64.94 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.21 -0.45 . . . . 44.140000000000001 111.688 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.459 HD12 ' H ' ' A' ' 146' ' ' SER . 2.7 pp -76.62 -19.27 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.951 0.405 . . . . 73.519999999999996 111.768 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 122.44 -70.25 0.42 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.258 -0.496 . . . . 43.43 112.638 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.459 ' H ' HD12 ' A' ' 144' ' ' ILE . 44.9 t . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 121.2 0.524 . . . . 74.510000000000005 111.759 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.888 0.375 . . . . 74.200000000000003 111.395 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.66 161.97 23.13 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.194 -0.527 . . . . 52.530000000000001 113.81 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.7 p -104.07 146.13 29.16 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.982 0.42 . . . . 75.129999999999995 112.017 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.4 t -176.49 109.66 0.09 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.914 -0.584 . . . . 72.409999999999997 110.599 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -164.76 119.2 1.35 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.605 0.24 . . . . 75.049999999999997 111.423 -176.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -157.14 159.97 38.33 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.665 0.617 . . . . 71.209999999999994 112.665 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -165.61 165.52 18.75 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.169 -0.469 . . . . 72.310000000000002 110.986 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -132.96 153.75 51.14 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.002 0.742 . . . . 75.120000000000005 113.002 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -116.47 158.55 23.41 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.271 -0.877 . . . . 75.409999999999997 109.961 170.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -154.0 128.18 9.04 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.046 0.45 . . . . 75.239999999999995 111.439 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.4 p -158.46 97.9 1.51 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.201 -0.454 . . . . 74.510000000000005 111.098 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.6 m -118.08 128.3 54.62 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.392 -0.367 . . . . 70.150000000000006 111.722 -176.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.99 118.65 2.06 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.769 -0.729 . . . . 62.020000000000003 114.496 173.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -104.59 104.11 13.89 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.356 -0.609 . . . . 75.340000000000003 109.356 170.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 33.4 tt0 -96.05 173.3 7.49 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 112.434 0.531 . . . . 71.030000000000001 112.434 -170.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 91.5 m-20 86.98 137.71 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.645 1.178 . . . . 74.329999999999998 112.834 177.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.514 HD11 ' N ' ' A' ' 18' ' ' TYR . 3.1 tm? -132.45 145.02 50.88 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.309 -0.86 . . . . 70.25 109.622 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.514 ' N ' HD11 ' A' ' 17' ' ' LEU . 81.3 m-85 -80.04 109.05 14.13 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.922 0.392 . . . . 73.519999999999996 111.7 -177.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -93.5 152.11 19.28 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.031 0.443 . . . . 74.450000000000003 111.375 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -141.94 129.26 21.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.317 -0.401 . . . . 75.439999999999998 111.0 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.81 102.69 0.17 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.716 -0.754 . . . . 71.109999999999999 113.463 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -167.97 94.98 0.41 Allowed 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.474 -0.427 . . . . 74.540000000000006 111.512 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 14.8 ptm -90.01 165.92 13.76 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.928 0.394 . . . . 74.239999999999995 111.08 174.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.736 HD11 ' HB2' ' A' ' 64' ' ' ALA . 36.7 mt -127.74 148.29 50.42 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.787 0.662 . . . . 74.099999999999994 112.787 -176.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -90.85 122.02 33.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.341 -0.845 . . . . 64.439999999999998 110.219 171.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.37 157.79 37.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.727 -0.67 . . . . 75.329999999999998 112.156 -173.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.639 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 39.7 tt0 -99.93 115.2 29.1 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.233 -0.439 . . . . 74.5 109.999 172.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.516 HG23 HD13 ' A' ' 96' ' ' ILE . 51.0 t -89.03 116.13 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 115.996 -0.547 . . . . 72.329999999999998 112.014 -174.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.461 HD12 ' HE3' ' A' ' 95' ' ' MET . 1.1 mt -102.43 156.67 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.967 0.413 . . . . 71.019999999999996 111.535 -179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 72.3 m -126.89 104.4 8.01 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.94 0.4 . . . . 74.409999999999997 111.054 175.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -98.12 156.13 20.4 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 121.029 -0.605 . . . . 64.239999999999995 113.584 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -78.56 72.89 5.11 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.413 0.625 . . . . 75.030000000000001 112.131 -177.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.417 ' HG1' ' HB3' ' A' ' 99' ' ' PRO . 76.6 p -76.49 -39.24 53.71 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.42 0.629 . . . . 73.200000000000003 110.251 173.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.2 mt -107.17 163.29 13.13 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.392 -0.822 . . . . 73.510000000000005 110.288 171.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -65.89 110.99 3.07 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.042 0.448 . . . . 75.150000000000006 111.834 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -71.46 106.14 3.84 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.287 0.565 . . . . 74.519999999999996 110.222 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.11 -45.4 0.29 Allowed Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.836 -0.62 . . . . 64.510000000000005 111.859 -177.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.696 ' HB3' ' HD2' ' A' ' 43' ' ' LYS . . . -87.89 127.82 35.36 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.71 0.291 . . . . 71.019999999999996 110.777 175.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 78.5 p -71.04 161.67 30.75 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.828 0.347 . . . . 74.010000000000005 111.032 177.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.6 p -56.91 -32.63 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 111.617 0.229 . . . . 75.400000000000006 111.617 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.45 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 41.9 tt0 -62.33 -36.13 81.24 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.984 0.421 . . . . 74.519999999999996 111.055 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 39' ' ' THR . 42.8 mm-40 -65.34 -35.44 80.99 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.064 0.459 . . . . 75.129999999999995 111.414 172.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.696 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 26.2 mtpp -118.33 38.5 3.7 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.307 0.484 . . . . 74.439999999999998 112.307 -172.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.45 ' HG ' ' HA ' ' A' ' 41' ' ' GLU . 63.7 mt -66.17 82.52 0.08 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.195 0.522 . . . . 71.420000000000002 111.56 177.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.5 t -143.02 161.7 37.45 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.68 -0.691 . . . . 71.230000000000004 110.791 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -63.42 -28.97 70.34 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.338 0.589 . . . . 74.420000000000002 110.485 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -55.42 -41.72 73.18 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.654 -0.703 . . . . 73.299999999999997 111.08 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.509 ' O ' HG23 ' A' ' 52' ' ' VAL . 5.5 t80 -64.49 -37.87 89.05 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.929 -0.578 . . . . 72.439999999999998 110.533 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.502 ' HE2' ' HA ' ' A' ' 136' ' ' SER . 47.6 t80 -62.13 -66.86 0.47 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.983 -0.553 . . . . 74.200000000000003 110.724 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -55.82 -21.77 21.38 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.797 0.666 . . . . 61.420000000000002 112.797 -175.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.68 -36.23 32.6 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.901 0.704 . . . . 71.409999999999997 112.901 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 48' ' ' TYR . 33.2 m -116.83 17.66 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 113.14 0.793 . . . . 71.120000000000005 113.14 -174.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -102.66 26.01 8.49 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.143 0.794 . . . . 72.329999999999998 113.143 -177.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -147.71 164.27 34.08 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.472 0.545 . . . . 74.530000000000001 112.472 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.24 133.83 47.7 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.817 -0.629 . . . . 72.239999999999995 110.922 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.526 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 33.2 mt-10 -88.66 121.89 31.51 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.238 0.542 . . . . 72.219999999999999 110.931 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.5 mt -118.18 149.87 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 115.637 -0.71 . . . . 74.310000000000002 111.777 -171.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -72.44 154.1 41.05 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.654 0.264 . . . . 55.200000000000003 111.176 176.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.414 ' CD ' ' HZ1' ' A' ' 88' ' ' LYS . 10.6 tp10 -56.46 -46.11 80.51 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.948 0.404 . . . . 75.439999999999998 111.727 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.45 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 25.6 mm-40 -56.83 -55.69 31.18 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.002 0.43 . . . . 72.530000000000001 111.581 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.64 -36.25 80.24 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.218 0.532 . . . . 71.219999999999999 111.004 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -56.51 -53.74 53.93 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.731 -0.668 . . . . 74.219999999999999 111.747 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -74.03 -28.48 61.45 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.028 0.381 . . . . 72.030000000000001 112.028 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.736 ' HB2' HD11 ' A' ' 24' ' ' LEU . . . -63.33 -32.22 73.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.02 0.438 . . . . 72.349999999999994 111.453 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.475 HD13 HG12 ' A' ' 127' ' ' VAL . 74.7 mt -91.33 -4.75 55.5 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.164 -0.471 . . . . 73.109999999999999 111.665 176.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.03 46.26 94.94 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.427 -0.416 . . . . 71.420000000000002 112.828 -177.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.41 HD21 ' HB2' ' A' ' 129' ' ' LYS . 97.7 mt -85.32 156.48 20.89 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.428 0.899 . . . . 74.409999999999997 113.428 -175.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -127.92 145.37 50.98 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.615 -1.175 . . . . 72.120000000000005 109.0 173.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.01 100.42 0.16 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.454 0.645 . . . . 74.510000000000005 111.87 -176.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.08 -6.09 7.77 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.457 -0.792 . . . . 65.329999999999998 113.176 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -68.03 158.59 32.58 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.364 0.602 . . . . 72.510000000000005 112.072 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.5 mtm-85 -102.12 127.65 48.93 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.8 -0.636 . . . . 75.409999999999997 110.647 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.33 150.28 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.154 0.502 . . . . 73.439999999999998 112.029 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -114.49 136.99 52.4 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.257 0.551 . . . . 73.329999999999998 111.115 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 60.9 t -110.01 122.12 64.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.79 -0.641 . . . . 72.230000000000004 110.623 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -111.63 120.89 43.6 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.796 0.332 . . . . 71.049999999999997 111.505 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.724 HG21 ' HA3' ' A' ' 125' ' ' GLY . 27.6 p -122.53 -177.47 3.64 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.938 0.399 . . . . 73.439999999999998 110.902 176.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -70.69 -11.21 60.8 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.48 -0.327 . . . . 72.430000000000007 111.614 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -94.52 -48.68 6.0 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 111.749 0.277 . . . . 72.349999999999994 111.749 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -171.39 -154.31 9.72 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.577 -0.82 . . . . 74.530000000000001 113.603 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.51 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 12.2 pt-20 -154.78 141.88 19.35 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.877 0.37 . . . . 74.140000000000001 111.571 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.7 p -145.12 149.41 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 116.573 -0.285 . . . . 75.420000000000002 111.613 -178.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.49 117.38 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-O 120.527 0.203 . . . . 74.299999999999997 111.259 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.445 ' HA ' HG11 ' A' ' 134' ' ' VAL . 34.8 m -128.09 177.63 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 122.886 0.474 . . . . 70.219999999999999 111.488 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -82.62 142.85 31.41 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.044 0.449 . . . . 72.519999999999996 111.548 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.14 121.46 32.94 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.039 0.385 . . . . 74.209999999999994 112.039 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -131.6 157.65 43.1 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.166 0.508 . . . . 73.209999999999994 110.815 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.414 ' HZ1' ' CD ' ' A' ' 59' ' ' GLU . 32.2 ttmt -95.98 140.49 30.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.285 -0.416 . . . . 75.0 110.852 -178.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.526 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -141.02 -174.51 14.14 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.898 -0.668 . . . . 73.510000000000005 113.71 -177.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -94.69 32.24 1.65 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.958 0.408 . . . . 75.439999999999998 111.641 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.8 m -90.6 152.46 45.12 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.461 -0.336 . . . . 75.200000000000003 111.706 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.59 163.71 33.92 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.88 2.387 . . . . 64.450000000000003 113.366 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 86.6 tttt -66.87 143.05 57.09 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.468 -0.333 . . . . 75.030000000000001 111.293 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 69.57 21.42 76.23 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.876 -0.678 . . . . 63.420000000000002 113.098 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.639 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 15.7 ttt -149.41 136.54 19.82 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.894 -0.41 . . . . 71.340000000000003 109.894 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.516 HD13 HG23 ' A' ' 28' ' ' VAL . 37.4 pt -132.21 145.36 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-O 121.371 0.605 . . . . 73.340000000000003 112.108 -177.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -102.79 129.58 49.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.853 -0.612 . . . . 65.400000000000006 111.209 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.608 ' O ' ' HA ' ' A' ' 30' ' ' SER . 28.8 mt -126.17 131.57 24.01 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 120.571 0.224 . . . . 64.129999999999995 110.68 174.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.417 ' HB3' ' HG1' ' A' ' 33' ' ' THR . 54.2 Cg_exo -54.22 126.43 22.14 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.374 2.05 . . . . 73.430000000000007 112.196 175.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.82 99.81 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.849 0.357 . . . . 74.409999999999997 110.634 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.87 -175.24 24.13 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.776 -0.726 . . . . 74.530000000000001 113.018 -176.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.01 -26.02 66.29 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.212 1.941 . . . . 75.310000000000002 112.243 -176.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.485 ' HA ' HD13 ' A' ' 140' ' ' LEU . 4.6 m-85 -68.9 -54.24 16.6 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.676 -0.693 . . . . 74.109999999999999 110.516 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.474 ' O ' HG22 ' A' ' 108' ' ' ILE . . . -61.38 -34.13 74.82 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.925 -0.579 . . . . 74.549999999999997 110.632 175.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -60.31 -19.8 56.61 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.97 -0.559 . . . . 72.209999999999994 111.561 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.616 ' SD ' HD22 ' A' ' 140' ' ' LEU . 33.4 mtp -77.07 -28.03 54.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.797 0.332 . . . . 75.219999999999999 111.417 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.3 m -116.24 -18.11 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.048 0.759 . . . . 60.210000000000001 113.048 -171.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 104' ' ' ALA . 14.7 pt -95.14 -176.17 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 121.399 0.619 . . . . 71.439999999999998 112.375 -176.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.605 ' H ' HG21 ' A' ' 123' ' ' VAL . 24.2 t70 -116.5 116.03 39.34 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.577 -0.738 . . . . 74.010000000000005 110.653 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.19 17.91 1.58 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.652 2.234 . . . . 75.010000000000005 113.558 -178.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 21.1 t -92.73 14.58 16.78 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.847 0.356 . . . . 72.209999999999994 111.516 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 62.9 p -94.39 -171.31 2.48 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.077 0.399 . . . . 63.100000000000001 112.077 -179.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 18.9 t70 72.01 149.5 0.09 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.099 0.56 . . . . 70.150000000000006 112.137 176.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 160.38 -78.46 0.17 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.713 -0.756 . . . . 53.420000000000002 113.871 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.3 p -78.49 -65.37 0.99 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.747 0.647 . . . . 71.430000000000007 112.747 -173.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 117' ' ' MET . . . 164.79 -170.61 39.95 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.151 -0.547 . . . . 71.010000000000005 113.018 -178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.406 ' HB2' ' O ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER 70.23 148.1 0.12 Allowed Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 123.027 0.531 . . . . 75.030000000000001 111.276 -178.238 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.38 -44.25 39.57 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.424 2.082 . . . . 73.409999999999997 112.899 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 62.25 107.23 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.677 0.621 . . . . 74.140000000000001 112.677 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -76.81 70.43 3.27 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.372 0.606 . . . . 73.430000000000007 110.243 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -128.13 100.02 5.7 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.823 -0.626 . . . . 75.129999999999995 111.066 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -110.39 157.8 14.81 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 121.188 -0.529 . . . . 72.409999999999997 112.43 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.605 HG21 ' H ' ' A' ' 109' ' ' ASP . 84.3 t -86.73 121.02 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 122.465 -0.433 . . . . 70.420000000000002 111.284 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 48.3 mtpt -68.76 162.42 26.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.741 0.781 . . . . 74.150000000000006 113.047 -176.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.724 ' HA3' HG21 ' A' ' 77' ' ' THR . . . 174.17 -151.65 13.31 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 114.886 -1.052 . . . . 62.420000000000002 112.587 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 65.3 p -135.9 152.46 51.04 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.87 0.367 . . . . 73.519999999999996 111.037 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.475 HG12 HD13 ' A' ' 65' ' ' LEU . 14.6 p -132.25 144.76 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.144 0.497 . . . . 74.5 111.343 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -157.64 152.99 26.06 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.773 -0.649 . . . . 55.130000000000003 110.533 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.41 ' HB2' HD21 ' A' ' 67' ' ' LEU . 32.8 ttpt -79.0 139.29 38.23 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.16 0.505 . . . . 72.439999999999998 111.133 174.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.4 t -135.8 150.56 49.49 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.122 0.487 . . . . 73.209999999999994 111.729 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -80.33 -3.13 48.28 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.337 -0.392 . . . . 74.310000000000002 110.834 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -65.37 155.08 36.48 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.985 0.422 . . . . 75.209999999999994 111.83 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -79.12 150.98 31.62 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.999 0.428 . . . . 71.439999999999998 111.605 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.445 HG11 ' HA ' ' A' ' 84' ' ' VAL . 82.6 t -71.3 128.25 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.233 -0.439 . . . . 75.140000000000001 110.342 172.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 11.0 mt -63.47 133.22 53.53 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.979 0.419 . . . . 73.010000000000005 111.858 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.502 ' HA ' ' HE2' ' A' ' 49' ' ' PHE . 45.2 t -73.51 141.94 46.75 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.911 -0.403 . . . . 75.530000000000001 109.911 171.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.49 HG23 ' HD2' ' A' ' 49' ' ' PHE . 60.5 t -46.45 -46.96 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 112.744 0.646 . . . . 73.420000000000002 112.744 -174.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -72.38 -40.65 67.12 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.021 0.378 . . . . 65.340000000000003 112.021 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -64.61 -33.52 76.12 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.219 0.533 . . . . 70.239999999999995 110.534 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.616 HD22 ' SD ' ' A' ' 106' ' ' MET . 4.0 tt -56.22 -41.08 75.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.886 -0.597 . . . . 73.319999999999993 110.275 172.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.8 mt -60.02 -48.07 83.22 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.276 0.56 . . . . 72.510000000000005 110.263 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.3 -43.22 96.51 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.771 -0.649 . . . . 73.140000000000001 111.053 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.82 -45.63 89.53 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.087 -0.506 . . . . 71.140000000000001 112.183 -178.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.8 pp -77.65 -7.71 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 112.326 0.491 . . . . 72.25 112.326 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 129.59 -30.66 3.56 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.13 -0.557 . . . . 63.399999999999999 113.757 177.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 121.22 0.533 . . . . 74.239999999999995 111.511 -177.55 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.3 mtp . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 120.754 0.311 . . . . 74.140000000000001 111.281 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.37 142.16 13.03 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.294 -0.479 . . . . 54.409999999999997 112.984 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 94.9 p -128.05 157.35 40.93 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 122.512 -0.405 . . . . 64.010000000000005 111.208 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.2 p -81.28 116.09 20.97 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.145 0.497 . . . . 73.019999999999996 111.852 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -157.74 137.29 12.05 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.307 -0.406 . . . . 71.430000000000007 111.23 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -153.43 148.25 26.45 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.193 -0.458 . . . . 64.109999999999999 111.306 -175.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -142.6 125.43 16.05 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.309 0.485 . . . . 73.319999999999993 112.309 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -165.33 124.79 1.77 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.199 -0.455 . . . . 75.219999999999999 110.859 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -135.85 146.66 47.69 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.945 0.402 . . . . 75.299999999999997 111.676 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -91.46 117.09 29.39 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.342 -0.39 . . . . 75.319999999999993 110.946 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.3 m -110.41 131.42 55.07 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.733 0.302 . . . . 62.140000000000001 111.386 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.0 t -150.28 140.35 22.05 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.986 0.422 . . . . 74.549999999999997 111.852 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.52 154.41 21.06 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 116.345 -0.389 . . . . 73.219999999999999 112.279 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -117.41 102.83 9.54 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.337 0.568 . . . . 75.010000000000005 112.213 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.4 89.44 3.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.726 0.774 . . . . 75.019999999999996 110.481 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -100.09 103.53 15.04 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.773 -0.649 . . . . 72.439999999999998 110.954 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.0 mp -86.31 131.26 34.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.301 0.572 . . . . 73.239999999999995 111.398 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -117.57 136.96 52.91 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.547 -0.751 . . . . 74.439999999999998 110.868 -178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -148.42 125.82 11.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.827 0.346 . . . . 75.120000000000005 111.523 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -102.25 132.94 47.88 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.477 -0.329 . . . . 74.219999999999999 110.821 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.86 81.19 0.23 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.826 -0.702 . . . . 63.530000000000001 112.424 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -66.16 111.28 3.34 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.007 0.432 . . . . 74.140000000000001 111.711 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.501 ' HE2' ' HB ' ' A' ' 126' ' ' THR . 10.1 ptm -93.2 161.2 14.51 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.205 -0.452 . . . . 73.310000000000002 111.364 178.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.526 HD13 ' HG ' ' A' ' 65' ' ' LEU . 9.5 mt -110.3 141.37 43.39 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.971 0.415 . . . . 74.140000000000001 111.804 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -89.9 126.1 35.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.286 0.565 . . . . 74.349999999999994 111.298 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.561 HG13 ' HA2' ' A' ' 94' ' ' GLY . 35.1 m -140.95 163.0 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.546 -0.752 . . . . 74.530000000000001 111.892 -174.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 65.7 tt0 -99.18 117.74 34.34 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.962 0.411 . . . . 74.239999999999995 110.652 172.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.494 HG23 HD13 ' A' ' 96' ' ' ILE . 32.0 t -91.4 115.55 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.133 0.492 . . . . 72.519999999999996 111.714 -175.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.818 HD13 ' HE3' ' A' ' 95' ' ' MET . 1.7 mt -102.1 159.41 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.795 0.331 . . . . 74.349999999999994 110.824 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.72 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 33.7 t -150.37 132.15 15.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.73 0.3 . . . . 71.439999999999998 111.587 175.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.595 ' HA2' ' HB2' ' A' ' 100' ' ' MET . . . 159.3 -90.77 0.11 Allowed Glycine 0 CA--C 1.523 0.565 0 C-N-CA 119.817 -1.182 . . . . 55.310000000000002 114.91 175.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.502 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 5.3 mmp_? -48.99 81.73 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.116 1.525 . . . . 74.030000000000001 115.116 -165.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.5 p -149.94 -60.43 0.2 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.583 0.753 . . . . 71.409999999999997 109.253 166.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.4 mp -108.72 117.66 34.75 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.699 -0.682 . . . . 70.310000000000002 109.736 171.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -66.38 -37.28 84.9 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.748 0.308 . . . . 72.439999999999998 111.207 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -95.93 109.09 21.51 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.704 0.288 . . . . 75.140000000000001 110.227 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.475 ' O ' ' HE2' ' A' ' 43' ' ' LYS . . . -76.17 -59.87 3.25 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.54 -0.838 . . . . 51.310000000000002 114.085 -175.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 60.9 -166.26 0.21 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.717 0.294 . . . . 64.129999999999995 110.999 -173.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.9 p -105.97 170.64 7.79 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.008 0.432 . . . . 74.040000000000006 110.681 173.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.3 t -59.67 -34.56 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.236 0.541 . . . . 62.229999999999997 110.907 176.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -63.18 -35.71 81.23 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.917 -0.583 . . . . 74.230000000000004 111.489 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.96 -33.29 75.69 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.379 0.511 . . . . 73.25 112.379 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.475 ' HE2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -130.21 58.92 1.65 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.771 0.656 . . . . 74.540000000000006 112.771 -178.311 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.0 mt -71.76 83.69 0.9 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.197 0.522 . . . . 73.530000000000001 110.724 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.5 t -150.55 167.29 27.67 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.687 0.625 . . . . 71.409999999999997 112.687 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' HG3' ' ND2' ' A' ' 50' ' ' ASN . 14.1 tp10 -55.83 -35.53 66.49 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.837 -0.619 . . . . 71.420000000000002 110.918 177.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -54.06 -43.3 70.13 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.406 -0.361 . . . . 72.109999999999999 111.364 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -60.52 -31.97 71.02 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.266 0.555 . . . . 74.120000000000005 110.674 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -78.28 -28.83 47.66 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.924 -0.58 . . . . 73.319999999999993 111.541 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.405 ' ND2' ' HG3' ' A' ' 46' ' ' GLU . 41.7 m-80 -98.77 0.07 43.67 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.161 0.43 . . . . 72.129999999999995 112.161 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.23 -44.44 7.27 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.29 0.848 . . . . 74.420000000000002 113.29 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.417 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 34.2 m -127.19 17.93 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 114.412 1.264 . . . . 75.530000000000001 114.412 -167.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.619 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -101.06 18.01 20.89 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 121.62 -0.675 . . . . 74.409999999999997 112.135 -176.101 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -137.62 159.12 42.85 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.995 -0.44 . . . . 73.340000000000003 111.511 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.66 138.51 51.23 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.334 -0.394 . . . . 73.340000000000003 111.662 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.67 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 41.3 mt-10 -90.2 116.71 28.4 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.213 0.53 . . . . 63.130000000000003 111.003 177.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.565 ' HA ' HG21 ' A' ' 96' ' ' ILE . 35.8 mt -111.57 146.98 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 115.609 -0.723 . . . . 75.409999999999997 111.768 -171.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -67.1 142.95 56.93 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.94 0.4 . . . . 73.219999999999999 111.11 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -63.93 -36.53 84.24 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.792 0.664 . . . . 72.430000000000007 112.792 -175.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.55 -49.24 77.48 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.271 0.558 . . . . 72.439999999999998 110.918 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -66.72 -33.48 75.73 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.811 -0.632 . . . . 75.230000000000004 111.071 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.465 ' HA ' HD11 ' A' ' 67' ' ' LEU . 44.2 t-105 -57.05 -53.67 55.49 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.706 -0.679 . . . . 75.540000000000006 110.939 175.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -65.69 -37.15 85.68 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.977 -0.556 . . . . 64.030000000000001 111.542 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.41 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -59.62 -49.17 78.81 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.96 0.409 . . . . 74.140000000000001 111.848 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.526 ' HG ' HD13 ' A' ' 24' ' ' LEU . 95.0 mt -78.23 -4.51 48.12 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.319 -0.401 . . . . 72.409999999999997 111.74 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.76 45.76 93.57 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.255 -0.498 . . . . 54.25 112.761 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.495 ' HA ' ' HZ1' ' A' ' 129' ' ' LYS . 87.3 mt -80.75 153.39 27.83 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.153 0.501 . . . . 72.230000000000004 111.667 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -139.13 114.93 10.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 73.439999999999998 110.645 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -38.53 102.46 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.363 -0.835 . . . . 75.140000000000001 112.971 -171.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.6 -19.1 4.81 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 114.967 -1.015 . . . . 72.540000000000006 113.161 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -78.91 179.39 7.31 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.114 0.483 . . . . 73.310000000000002 111.958 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -107.5 134.51 50.43 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.356 0.598 . . . . 64.349999999999994 111.842 -175.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.504 HG13 ' HB1' ' A' ' 86' ' ' ALA . 14.5 m -115.97 135.99 54.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.967 -0.56 . . . . 73.150000000000006 111.164 174.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -102.17 140.14 36.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.88 -0.6 . . . . 74.140000000000001 110.584 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 41.5 t -122.43 136.2 60.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.329 -0.396 . . . . 64.219999999999999 110.084 -175.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.451 ' HZ1' ' CD ' ' A' ' 128' ' ' GLU . 39.7 mttt -138.68 126.56 22.36 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.058 0.392 . . . . 74.010000000000005 112.058 -173.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.639 HG21 ' HA3' ' A' ' 125' ' ' GLY . 30.8 p -137.1 -172.18 3.13 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.235 -0.439 . . . . 74.129999999999995 110.547 176.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -65.99 -12.97 58.9 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.216 0.451 . . . . 71.439999999999998 112.216 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -91.39 -34.71 14.75 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.116 0.413 . . . . 65.010000000000005 112.116 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.69 -159.47 31.39 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.226 -0.511 . . . . 72.319999999999993 113.16 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 11.4 pt-20 -137.37 154.01 50.09 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.026 0.441 . . . . 74.310000000000002 112.098 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.441 HG22 HD13 ' A' ' 135' ' ' LEU . 11.4 p -153.06 149.36 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 116.378 -0.374 . . . . 74.439999999999998 111.445 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 36.1 t -110.36 120.09 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 122.347 -0.221 . . . . 72.340000000000003 110.878 176.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.23 173.18 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.99 0.424 . . . . 74.230000000000004 111.956 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -76.6 139.16 40.53 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.01 0.433 . . . . 72.040000000000006 111.426 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.504 ' HB1' HG13 ' A' ' 73' ' ' VAL . . . -87.32 126.12 34.65 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.887 0.699 . . . . 64.099999999999994 112.887 -177.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -130.07 148.18 51.89 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.142 0.496 . . . . 73.510000000000005 110.864 172.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -87.66 124.03 33.12 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.918 -0.583 . . . . 74.140000000000001 109.879 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.67 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -124.33 171.74 16.6 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.87 -0.681 . . . . 62.119999999999997 114.065 -173.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.72 29.58 0.38 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.872 0.469 . . . . 71.230000000000004 112.228 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.9 m -91.21 152.03 43.56 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 116.507 -0.315 . . . . 73.319999999999993 111.653 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -72.6 177.15 7.85 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.689 2.259 . . . . 75.140000000000001 113.588 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -62.94 141.35 58.75 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.022 -0.536 . . . . 72.230000000000004 111.999 -177.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.561 ' HA2' HG13 ' A' ' 26' ' ' VAL . . . 58.31 34.28 73.78 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 120.862 -0.685 . . . . 72.109999999999999 112.805 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.818 ' HE3' HD13 ' A' ' 29' ' ' ILE . 16.7 ttt -150.92 136.73 18.11 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.633 -0.334 . . . . 73.439999999999998 110.321 -178.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.565 HG21 ' HA ' ' A' ' 57' ' ' ILE . 36.8 pt -137.65 146.59 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.136 0.493 . . . . 75.420000000000002 111.652 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -110.08 136.74 48.85 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.942 0.401 . . . . 75.230000000000004 111.272 177.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.72 ' O ' ' HA ' ' A' ' 30' ' ' SER . 45.6 mt -126.35 133.65 25.19 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 116.326 -0.397 . . . . 73.430000000000007 110.643 174.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.417 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 78.2 Cg_exo -52.13 141.82 47.01 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 121.904 1.736 . . . . 75.420000000000002 112.539 174.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.595 ' HB2' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -59.65 106.11 0.44 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.667 0.27 . . . . 74.430000000000007 110.976 -178.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.28 178.67 41.29 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 119.972 -1.108 . . . . 74.120000000000005 113.787 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.467 ' O ' ' HG2' ' A' ' 106' ' ' MET . 17.8 Cg_endo -57.98 -34.94 98.99 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.144 2.563 . . . . 74.329999999999998 112.82 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.5 ' HA ' HD13 ' A' ' 140' ' ' LEU . 53.1 m-85 -59.96 -50.14 74.94 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.109 0.481 . . . . 74.409999999999997 110.631 177.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.489 ' O ' HG22 ' A' ' 108' ' ' ILE . . . -65.29 -37.37 86.95 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.124 -0.489 . . . . 75.150000000000006 111.017 174.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.434 ' HB3' ' HA ' ' A' ' 102' ' ' PRO . 5.4 t30 -56.58 -20.09 19.15 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.763 0.425 . . . . 74.409999999999997 111.728 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.59 ' SD ' HD21 ' A' ' 140' ' ' LEU . 90.9 mmm -72.97 -24.05 60.74 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.807 0.336 . . . . 64.400000000000006 111.779 177.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.5 m -129.06 -9.03 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 113.027 0.751 . . . . 63.439999999999998 113.027 -171.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 104' ' ' ALA . 5.8 pt -104.91 -177.54 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.167 0.508 . . . . 75.120000000000005 111.531 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.412 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . 30.1 t70 -106.52 118.01 55.6 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 116.107 -0.497 . . . . 62.119999999999997 110.916 175.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 109' ' ' ASP . 3.5 Cg_exo -81.32 -1.25 10.99 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.855 2.37 . . . . 73.519999999999996 113.479 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -84.62 -41.61 16.19 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.058 0.392 . . . . 73.109999999999999 112.058 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.1 t -55.32 139.7 41.88 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.912 0.708 . . . . 74.420000000000002 112.912 -177.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.2 t70 60.08 -93.31 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.836 -0.62 . . . . 74.439999999999998 112.41 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.51 24.95 57.41 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 121.222 -0.513 . . . . 72.019999999999996 112.737 -172.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.6 m -132.26 -52.23 0.95 Allowed 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.638 -0.331 . . . . 74.5 111.526 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 139.07 44.78 0.07 OUTLIER Glycine 0 CA--C 1.526 0.761 0 C-N-CA 120.857 -0.687 . . . . 75.230000000000004 113.994 177.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.48 140.06 20.7 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 117.236 0.518 . . . . 74.430000000000007 111.777 176.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -84.81 52.17 3.38 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.179 2.586 . . . . 70.129999999999995 113.698 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -77.44 127.44 32.54 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.735 0.303 . . . . 74.530000000000001 111.098 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 121' ' ' LYS . 38.4 m-85 -87.24 168.67 13.0 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 120.853 0.358 . . . . 74.540000000000006 111.846 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.571 ' HG2' ' HE1' ' A' ' 95' ' ' MET . 69.9 mttt 70.1 162.12 0.23 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.674 -0.694 . . . . 74.010000000000005 111.23 -170.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -145.54 -134.37 2.69 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.303 -0.951 . . . . 71.230000000000004 114.009 -172.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.41 HG23 ' N ' ' A' ' 109' ' ' ASP . 52.5 t -100.3 118.63 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.806 0.336 . . . . 62.130000000000003 111.543 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.643 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 55.5 mtmt -72.82 155.41 39.96 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.274 0.559 . . . . 75.340000000000003 112.186 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.639 ' HA3' HG21 ' A' ' 77' ' ' THR . . . 177.84 -135.0 2.57 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.782 -0.645 . . . . 65.230000000000004 112.84 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.501 ' HB ' ' HE2' ' A' ' 23' ' ' MET . 60.8 p -140.55 154.84 46.67 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.269 0.47 . . . . 73.450000000000003 112.269 -177.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.1 p -133.97 147.98 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.931 -0.577 . . . . 73.25 110.677 175.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.451 ' CD ' ' HZ1' ' A' ' 76' ' ' LYS . 9.5 pt-20 -151.9 161.89 41.93 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.37 -0.377 . . . . 75.030000000000001 111.462 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.495 ' HZ1' ' HA ' ' A' ' 67' ' ' LEU . 17.6 ttmm -87.24 140.65 29.33 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 110.226 -0.287 . . . . 72.340000000000003 110.226 170.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.2 t -139.47 142.82 37.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.302 0.572 . . . . 73.219999999999999 111.864 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -75.31 -11.24 60.02 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.617 -0.72 . . . . 74.530000000000001 110.827 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -61.91 154.3 26.64 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.861 -0.609 . . . . 65.239999999999995 112.071 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -80.89 162.08 24.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.748 -0.66 . . . . 74.25 111.927 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 76.5 t -76.28 136.17 25.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.651 -0.704 . . . . 74.420000000000002 111.101 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.441 HD13 HG22 ' A' ' 82' ' ' VAL . 17.8 mt -59.65 133.58 56.23 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.502 -0.317 . . . . 72.239999999999995 111.298 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.6 t -76.76 143.77 39.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.691 -0.855 . . . . 75.109999999999999 108.691 169.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.3 t -48.26 -41.16 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.084 0.469 . . . . 75.219999999999999 111.899 -174.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -72.02 -41.6 67.36 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.026 -0.534 . . . . 71.450000000000003 111.65 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -58.52 -37.2 75.11 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.78 0.8 . . . . 71.519999999999996 110.15 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.59 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.5 tt -62.29 -38.3 88.82 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.05 -0.977 . . . . 74.310000000000002 111.033 176.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.0 mt -59.65 -41.55 90.79 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.486 0.66 . . . . 73.319999999999993 110.056 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -70.52 -30.02 66.67 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.518 -0.765 . . . . 62.210000000000001 111.608 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.44 -44.15 79.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.42 -0.354 . . . . 74.349999999999994 111.856 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.487 HD13 ' H ' ' A' ' 146' ' ' SER . 2.8 pp -76.13 -7.92 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 112.142 0.423 . . . . 74.329999999999998 112.142 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 125.9 -62.82 0.6 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.35 -0.453 . . . . 72.310000000000002 112.937 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.487 ' H ' HD13 ' A' ' 144' ' ' ILE . 87.8 p . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 121.196 0.522 . . . . 75.420000000000002 111.367 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.595 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.707 0.289 . . . . 74.340000000000003 111.215 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.05 79.87 1.66 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.217 -0.516 . . . . 72.319999999999993 113.156 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.9 p -87.96 166.01 14.81 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.141 0.496 . . . . 75.040000000000006 111.736 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.7 m -69.86 125.54 27.06 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.274 0.472 . . . . 70.349999999999994 112.274 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -134.18 110.64 9.69 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.398 -0.364 . . . . 74.230000000000004 110.647 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -71.39 146.07 48.95 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.923 0.392 . . . . 75.129999999999995 111.728 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -138.64 93.13 2.69 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.028 0.442 . . . . 74.140000000000001 111.003 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -95.98 119.74 35.02 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.184 -0.462 . . . . 74.530000000000001 110.521 -178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -67.4 -52.36 40.74 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.538 0.94 . . . . 61.439999999999998 113.538 -173.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 66.37 124.3 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.7 0.63 . . . . 75.340000000000003 112.7 179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.4 m -130.77 133.33 45.91 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 116.51 -0.314 . . . . 71.0 111.434 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.8 p -152.52 25.45 0.59 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 111.86 0.319 . . . . 71.409999999999997 111.86 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.35 136.33 39.67 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.23 -0.51 . . . . 74.430000000000007 112.941 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -162.15 112.14 1.53 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.123 0.487 . . . . 73.140000000000001 111.92 -174.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.41 -148.74 0.36 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.076 -0.511 . . . . 64.049999999999997 110.482 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 79.03 87.86 0.06 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.349 0.659 . . . . 74.099999999999994 112.742 174.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.97 -170.49 2.22 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.034 -0.53 . . . . 74.150000000000006 110.295 172.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -79.86 -22.68 42.63 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.242 0.46 . . . . 62.329999999999998 112.242 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 68.9 -28.08 0.16 Allowed 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.699 1.0 . . . . 73.540000000000006 113.699 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -75.06 103.05 5.09 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.971 -0.456 . . . . 64.150000000000006 112.028 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.39 -58.76 1.51 Allowed Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.221 -0.514 . . . . 62.109999999999999 112.286 174.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 68.3 t60 66.84 102.63 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.445 0.535 . . . . 74.030000000000001 112.445 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.2 ptp -82.38 164.02 21.31 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.26 0.553 . . . . 71.430000000000007 112.027 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.4 mt -127.37 131.64 50.31 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.768 -0.651 . . . . 75.340000000000003 111.104 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -73.13 111.11 7.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.865 0.364 . . . . 73.109999999999999 110.849 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.469 HG11 ' HA2' ' A' ' 94' ' ' GLY . 31.1 m -127.84 159.62 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.351 -0.386 . . . . 74.310000000000002 111.964 -174.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 35.4 tt0 -98.79 118.53 35.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.884 0.373 . . . . 61.530000000000001 110.605 174.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.504 HG22 HD13 ' A' ' 96' ' ' ILE . 40.1 t -93.23 108.16 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.109 -0.496 . . . . 75.329999999999998 111.74 -175.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.721 HD12 ' HE1' ' A' ' 95' ' ' MET . 1.3 mt -97.73 160.56 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.826 0.346 . . . . 75.319999999999993 111.234 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.619 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 74.3 m -136.5 100.48 4.37 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.078 0.466 . . . . 73.010000000000005 111.929 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.42 115.89 4.28 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.049 -0.596 . . . . 51.030000000000001 112.397 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.411 ' HA ' ' HB3' ' A' ' 100' ' ' MET . 31.5 mtm180 -60.35 102.83 0.19 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.132 0.491 . . . . 74.340000000000003 111.846 -178.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.9 p -132.34 -178.4 4.9 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.897 -0.592 . . . . 73.209999999999994 111.584 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.7 tp 66.44 12.53 8.74 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 122.892 0.477 . . . . 75.040000000000006 112.107 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 56.83 96.76 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.088 0.47 . . . . 64.310000000000002 111.855 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -71.97 -173.21 0.98 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.125 0.488 . . . . 74.209999999999994 111.921 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.65 -1.48 68.88 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.139 -0.553 . . . . 74.299999999999997 112.466 -174.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.579 ' HB2' ' HB2' ' A' ' 42' ' ' GLU . . . -132.7 135.77 45.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.444 0.298 . . . . 74.230000000000004 111.364 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.0 p -67.59 174.43 3.49 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.116 0.484 . . . . 74.450000000000003 110.486 174.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.0 m -61.17 -30.71 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 122.105 -0.372 . . . . 75.299999999999997 110.874 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.49 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 38.1 tt0 -73.34 -26.66 61.12 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.09 -0.505 . . . . 62.210000000000001 111.718 -176.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . 28.1 mm-40 -72.74 -12.72 61.12 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.971 0.415 . . . . 74.549999999999997 111.619 177.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.566 ' HE2' ' HB3' ' A' ' 38' ' ' ALA . 67.4 mttm -121.58 -68.49 0.89 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 116.672 -0.24 . . . . 74.439999999999998 111.268 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.49 ' HG ' ' HA ' ' A' ' 41' ' ' GLU . 71.5 mt 61.14 -14.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 114.992 1.479 . . . . 73.439999999999998 114.992 174.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.434 HG23 ' H ' ' A' ' 48' ' ' TYR . 3.3 t -55.15 155.46 4.77 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.793 0.664 . . . . 74.310000000000002 112.793 -176.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -49.62 -37.69 29.03 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.545 0.688 . . . . 73.239999999999995 110.255 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -54.48 -40.78 68.8 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.468 -0.787 . . . . 72.310000000000002 111.467 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.494 ' HE2' ' HD2' ' A' ' 43' ' ' LYS . 2.8 t80 -60.09 -36.78 78.16 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.431 0.634 . . . . 73.319999999999993 110.604 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.488 ' HD1' HG21 ' A' ' 137' ' ' VAL . 58.0 t80 -81.09 -7.57 59.59 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.59 -0.732 . . . . 60.32 112.046 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -118.43 2.17 11.82 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.877 -0.514 . . . . 64.420000000000002 111.814 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.09 -57.04 2.45 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.378 0.51 . . . . 73.349999999999994 112.378 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.463 HG22 ' HD2' ' A' ' 102' ' ' PRO . 34.7 m -108.33 20.48 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 112.873 0.694 . . . . 75.340000000000003 112.873 -173.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.616 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -104.08 18.48 21.96 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.66 0.615 . . . . 72.140000000000001 112.66 -172.363 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -141.55 165.13 28.33 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.223 0.535 . . . . 74.510000000000005 112.426 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.96 130.94 45.71 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.709 -0.678 . . . . 63.43 110.884 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.652 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 31.8 mt-10 -88.65 120.24 29.86 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.351 0.596 . . . . 74.510000000000005 111.638 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.1 mt -118.76 148.27 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.32 -0.855 . . . . 72.540000000000006 111.615 -170.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -75.42 142.73 42.98 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.771 0.32 . . . . 72.239999999999995 110.386 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 62' ' ' TRP . 27.0 tt0 -56.04 -36.97 68.6 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.481 0.548 . . . . 73.140000000000001 112.481 -174.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -54.66 -51.63 64.87 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 111.894 0.331 . . . . 71.230000000000004 111.894 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -69.7 -36.82 76.27 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.337 0.589 . . . . 75.430000000000007 110.579 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.462 ' HA ' HD11 ' A' ' 67' ' ' LEU . 31.0 t-105 -53.22 -52.08 60.08 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.466 -0.788 . . . . 73.239999999999995 111.69 176.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -65.62 -38.87 90.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.129 -0.487 . . . . 73.519999999999996 111.296 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.37 -43.4 88.43 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.169 0.509 . . . . 73.129999999999995 111.55 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.9 mt -79.91 -1.83 41.03 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.201 -0.454 . . . . 73.540000000000006 112.038 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.93 44.9 96.71 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.435 -0.412 . . . . 73.120000000000005 112.998 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.721 HD22 ' HD3' ' A' ' 129' ' ' LYS . 67.0 mt -87.04 142.51 27.87 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.032 0.752 . . . . 74.540000000000006 113.032 -175.614 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -115.0 150.11 36.35 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.942 -0.762 . . . . 72.319999999999993 108.942 170.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.31 103.9 0.11 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.168 0.509 . . . . 74.25 111.898 -177.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.51 -8.34 10.23 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 115.888 -0.596 . . . . 60.030000000000001 113.783 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.67 167.54 7.2 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.618 0.723 . . . . 62.100000000000001 112.665 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -113.08 126.52 55.56 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.295 -0.866 . . . . 71.120000000000005 111.36 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.443 HG13 ' HB1' ' A' ' 86' ' ' ALA . 21.1 m -114.51 139.24 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.175 0.512 . . . . 72.120000000000005 112.054 -178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.491 ' HG2' ' HD2' ' A' ' 76' ' ' LYS . 22.9 ttmm -103.18 111.84 24.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.072 -0.513 . . . . 74.129999999999995 110.395 177.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 47.9 t -96.68 126.25 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 116.468 -0.333 . . . . 70.030000000000001 111.523 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.549 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -117.72 139.64 50.76 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.061 0.458 . . . . 74.209999999999994 111.735 178.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.2 p -134.63 -171.9 2.89 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.402 -0.363 . . . . 72.25 110.246 173.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.23 -4.08 39.93 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 122.158 -0.339 . . . . 74.030000000000001 111.229 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -99.6 -48.33 4.78 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.714 0.293 . . . . 73.430000000000007 111.346 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.94 -158.21 19.75 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.136 -0.554 . . . . 62.100000000000001 112.779 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.549 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 8.8 pt-20 -144.68 160.22 41.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.265 0.555 . . . . 73.239999999999995 112.325 178.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.3 p -156.71 147.27 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.963 -0.562 . . . . 75.319999999999993 111.115 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.9 t -105.45 117.79 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 O-C-N 122.327 -0.233 . . . . 75.129999999999995 110.963 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 m -126.98 178.05 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.953 0.406 . . . . 70.120000000000005 111.826 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -82.43 140.17 33.57 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.023 0.439 . . . . 74.120000000000005 111.374 176.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.443 ' HB1' HG13 ' A' ' 73' ' ' VAL . . . -89.98 124.88 35.12 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.436 0.532 . . . . 70.129999999999995 112.436 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -122.57 159.04 28.6 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.279 0.561 . . . . 71.219999999999999 111.592 174.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.405 ' HD3' ' HB2' ' A' ' 59' ' ' GLU . 30.0 ttmt -99.61 114.88 28.21 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.81 -0.632 . . . . 73.340000000000003 110.282 175.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.652 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -119.82 -177.67 16.24 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.852 -0.689 . . . . 30.25 114.495 -172.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -89.26 34.43 0.8 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.209 0.603 . . . . 64.239999999999995 111.536 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.1 m -100.27 149.67 36.25 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 112.514 0.561 . . . . 74.230000000000004 112.514 -174.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.83 163.69 21.18 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.724 2.283 . . . . 74.129999999999995 112.4 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 52.0 tttm -68.72 146.91 52.54 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.105 -0.372 . . . . 72.239999999999995 111.352 -176.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.469 ' HA2' HG11 ' A' ' 26' ' ' VAL . . . 63.67 32.59 84.67 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.902 -0.666 . . . . 75.409999999999997 112.491 -174.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.721 ' HE1' HD12 ' A' ' 29' ' ' ILE . 21.6 ttt -152.37 136.32 16.38 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.911 -0.403 . . . . 74.349999999999994 109.911 -177.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.504 HD13 HG22 ' A' ' 28' ' ' VAL . 33.6 pt -137.74 138.6 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.431 0.634 . . . . 73.040000000000006 112.322 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -100.45 129.07 46.36 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.891 -0.595 . . . . 71.140000000000001 111.039 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.619 ' O ' ' HA ' ' A' ' 30' ' ' SER . 38.9 mt -122.42 132.63 24.23 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 120.523 0.201 . . . . 72.340000000000003 110.479 174.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.413 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 31.3 Cg_exo -60.43 127.19 22.04 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.04 1.826 . . . . 74.099999999999994 111.711 173.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.414 ' HE3' ' H ' ' A' ' 101' ' ' GLY . 6.1 tpt -54.07 111.81 0.84 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.98 0.419 . . . . 73.310000000000002 111.88 -175.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.414 ' H ' ' HE3' ' A' ' 100' ' ' MET . . . -163.02 -174.4 32.89 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.861 -0.685 . . . . 71.299999999999997 112.751 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.463 ' HD2' HG22 ' A' ' 52' ' ' VAL . 18.8 Cg_endo -56.54 -34.06 94.27 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.802 2.335 . . . . 71.219999999999999 112.157 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.413 ' HA ' HD13 ' A' ' 140' ' ' LEU . 46.8 m-85 -63.82 -53.82 44.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.888 -0.597 . . . . 71.319999999999993 111.059 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.465 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.58 -38.36 87.24 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.187 0.518 . . . . 72.5 111.136 175.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -57.59 -17.15 12.71 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.071 0.549 . . . . 73.310000000000002 112.454 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.544 ' SD ' HD22 ' A' ' 140' ' ' LEU . 87.5 mmm -77.19 -22.82 51.81 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.195 0.443 . . . . 73.439999999999998 112.195 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.1 m -123.23 -26.22 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 112.748 0.647 . . . . 75.329999999999998 112.748 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.545 HG22 ' OG ' ' A' ' 30' ' ' SER . 6.9 pt -84.01 179.36 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.892 0.377 . . . . 70.340000000000003 111.786 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -106.34 110.07 63.61 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.522 -0.308 . . . . 64.5 111.178 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -84.4 -6.49 10.03 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.58 2.187 . . . . 73.040000000000006 112.743 176.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.9 m -68.35 -46.93 68.79 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.411 -0.359 . . . . 62.439999999999998 111.489 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.4 t -65.5 148.58 51.49 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.738 0.304 . . . . 72.239999999999995 111.562 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -115.26 137.51 51.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.721 0.296 . . . . 62.350000000000001 111.351 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -130.43 128.7 5.64 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.014 -0.612 . . . . 61.009999999999998 113.283 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 77.8 p -107.3 124.27 49.54 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.608 -0.348 . . . . 74.150000000000006 111.686 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 123.95 -143.47 14.9 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.338 -0.458 . . . . 72.140000000000001 113.413 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.4 ptm -62.79 167.09 6.33 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 122.567 0.347 . . . . 75.140000000000001 111.829 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -49.58 -20.86 4.64 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.739 2.293 . . . . 74.430000000000007 113.221 174.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.412 ' HG2' ' N ' ' A' ' 120' ' ' PHE . 11.0 tt0 74.39 151.08 0.12 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.656 0.782 . . . . 73.129999999999995 112.779 173.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.412 ' N ' ' HG2' ' A' ' 119' ' ' GLN . 98.4 m-85 -95.69 -178.32 4.35 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.712 -0.676 . . . . 74.299999999999997 110.169 171.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.7 ' HE2' ' HA ' ' A' ' 121' ' ' LYS . 8.9 mmpt? 65.62 118.39 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.663 0.745 . . . . 74.319999999999993 111.729 -175.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -120.67 -174.41 15.1 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.406 -0.816 . . . . 63.130000000000003 113.381 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 66.2 t -84.53 118.7 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.816 0.341 . . . . 74.549999999999997 111.128 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 54.6 mtmt -76.01 156.01 34.43 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.575 0.703 . . . . 74.099999999999994 112.675 -176.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -177.18 -145.36 5.72 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.131 -0.94 . . . . 65.019999999999996 112.307 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 57.6 p -136.79 146.46 45.74 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.526 -0.396 . . . . 75.400000000000006 111.474 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.8 p -128.38 143.48 40.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.927 0.394 . . . . 73.129999999999995 111.153 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.52 148.29 30.05 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.319 -0.4 . . . . 73.299999999999997 110.814 176.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.721 ' HD3' HD22 ' A' ' 67' ' ' LEU . 28.7 ttpp -73.28 139.44 46.13 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.934 -0.395 . . . . 73.219999999999999 109.934 175.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.6 t -127.08 161.51 28.26 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.371 0.878 . . . . 64.340000000000003 113.371 -168.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -92.54 7.04 44.96 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.329 -0.85 . . . . 62.310000000000002 110.448 173.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -87.38 165.54 15.51 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.813 -0.63 . . . . 74.319999999999993 111.65 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.41 161.13 15.71 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.075 -0.511 . . . . 73.209999999999994 111.336 177.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 92.4 t -71.53 128.14 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.679 -0.237 . . . . 74.030000000000001 110.7 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.462 ' HA ' HD22 ' A' ' 135' ' ' LEU . 8.8 mt -65.24 88.3 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.776 0.322 . . . . 74.230000000000004 111.351 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.7 m -51.87 150.01 4.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.943 -0.572 . . . . 72.420000000000002 110.541 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.488 HG21 ' HD1' ' A' ' 49' ' ' PHE . 66.9 t -44.8 -48.78 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 113.063 0.764 . . . . 74.519999999999996 113.063 -168.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -73.1 -39.85 65.46 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.977 -0.452 . . . . 74.510000000000005 111.777 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -57.84 -36.33 72.13 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.772 0.796 . . . . 72.239999999999995 109.919 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.544 HD22 ' SD ' ' A' ' 106' ' ' MET . 3.1 tt -62.55 -42.57 99.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.851 -1.068 . . . . 74.239999999999995 110.677 174.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 50.9 mt -58.45 -54.89 41.91 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.364 0.602 . . . . 75.400000000000006 109.859 175.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -52.79 -39.55 62.43 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.482 -0.781 . . . . 75.439999999999998 111.378 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.88 -43.18 99.37 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.161 -0.472 . . . . 73.319999999999993 111.933 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.8 pp -87.74 -6.91 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 112.419 0.525 . . . . 74.219999999999999 112.419 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.85 -1.21 35.99 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.223 -0.513 . . . . 74.230000000000004 113.965 176.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 121.279 0.561 . . . . 75.530000000000001 111.697 179.533 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.9 mtp . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.531 0.205 . . . . 72.530000000000001 111.072 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.13 -169.54 13.33 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.055 -0.593 . . . . 64.150000000000006 113.217 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.1 p -160.3 138.22 9.85 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.865 0.364 . . . . 75.319999999999993 111.583 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.1 p -147.54 109.59 4.5 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.308 0.575 . . . . 74.109999999999999 111.167 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -125.52 42.87 3.19 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.006 -0.543 . . . . 75.540000000000006 110.63 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -43.57 142.37 1.2 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.7 -0.682 . . . . 70.400000000000006 112.741 177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -157.27 128.26 6.7 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.309 -0.405 . . . . 74.540000000000006 111.966 -174.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -168.14 127.18 1.22 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.435 -0.348 . . . . 55.219999999999999 111.128 174.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -166.59 116.44 0.92 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 111.986 0.365 . . . . 72.549999999999997 111.986 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -171.12 147.43 2.56 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.602 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.0 m -141.96 150.14 41.02 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.893 0.378 . . . . 73.400000000000006 111.642 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 95.7 p -137.88 174.91 10.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.038 0.447 . . . . 72.409999999999997 111.45 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.15 121.54 0.56 Allowed Glycine 0 CA--C 1.523 0.581 0 CA-C-N 116.041 -0.527 . . . . 71.530000000000001 111.881 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.36 162.64 36.76 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.209 0.528 . . . . 71.420000000000002 111.979 -175.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.57 141.5 46.64 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.843 -0.617 . . . . 74.319999999999993 112.049 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -94.85 119.83 34.06 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.946 0.403 . . . . 75.409999999999997 110.326 174.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 17' ' ' LEU . 3.0 mm? -73.44 156.71 37.98 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.383 0.611 . . . . 73.239999999999995 112.587 -173.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -100.6 138.43 37.67 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.575 -0.739 . . . . 74.25 111.224 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -115.09 160.36 19.74 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.819 0.342 . . . . 74.430000000000007 111.385 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -70.93 125.73 27.66 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.16 0.8 . . . . 74.109999999999999 113.16 -173.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.14 -130.26 26.94 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 115.566 -0.743 . . . . 72.030000000000001 114.955 169.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -153.37 79.97 1.17 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.673 0.273 . . . . 75.019999999999996 111.239 -173.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.5 ptm -87.28 143.3 27.33 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.865 0.364 . . . . 72.510000000000005 111.333 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.512 HD13 ' HG ' ' A' ' 65' ' ' LEU . 14.8 mt -96.96 132.66 42.53 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.463 0.542 . . . . 73.239999999999995 112.463 -176.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -83.06 109.75 17.4 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.313 0.578 . . . . 71.349999999999994 110.897 174.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.459 HG13 ' HA2' ' A' ' 94' ' ' GLY . 32.0 m -132.37 161.51 41.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.383 -0.826 . . . . 74.129999999999995 111.174 -174.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 33.2 tt0 -98.81 123.85 43.32 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.04 0.448 . . . . 73.340000000000003 111.174 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.43 117.13 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.913 -0.585 . . . . 74.319999999999993 111.907 -175.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.5 HD13 ' HE2' ' A' ' 95' ' ' MET . 1.2 mt -103.13 163.05 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 122.24 -0.288 . . . . 74.140000000000001 111.172 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 11.7 t -131.95 120.51 22.59 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.915 0.388 . . . . 72.340000000000003 111.492 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.88 135.43 12.85 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.093 -0.575 . . . . 73.200000000000003 113.178 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -54.06 -41.22 67.89 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.484 0.55 . . . . 75.109999999999999 112.484 -175.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.8 p 57.98 -74.93 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.366 0.876 . . . . 74.349999999999994 113.366 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 mp -71.66 -175.92 1.48 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.772 0.796 . . . . 62.219999999999999 112.911 -177.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.446 ' O ' ' NZ ' ' A' ' 43' ' ' LYS . 17.9 p-10 -72.05 116.63 12.68 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.608 -0.724 . . . . 73.519999999999996 112.827 -175.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 59.62 -172.05 0.12 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.884 0.698 . . . . 75.319999999999993 112.884 173.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.27 137.84 13.5 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 116.25 -0.432 . . . . 74.329999999999998 113.206 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.736 ' HB1' ' HE2' ' A' ' 43' ' ' LYS . . . -174.95 168.42 3.51 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.598 0.359 . . . . 75.329999999999998 111.453 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 p -88.77 176.9 6.88 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.788 -0.449 . . . . 74.010000000000005 109.788 172.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.478 HG11 ' CE1' ' A' ' 48' ' ' TYR . 21.8 m -64.2 -26.28 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.75 0.31 . . . . 73.340000000000003 111.294 176.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -67.77 -27.15 66.52 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.798 0.295 . . . . 73.230000000000004 111.798 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.44 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 3.6 mp0 -87.91 -13.2 42.54 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.004 0.431 . . . . 75.329999999999998 111.273 173.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.736 ' HE2' ' HB1' ' A' ' 38' ' ' ALA . 68.0 mttm -129.26 33.49 4.54 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.097 -0.501 . . . . 71.209999999999994 112.024 -176.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 40' ' ' VAL . 43.4 mt -66.65 84.99 0.11 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.445 0.64 . . . . 74.430000000000007 111.253 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.535 HG21 ' H ' ' A' ' 48' ' ' TYR . 7.6 t -144.35 152.62 40.98 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.453 -0.794 . . . . 64.200000000000003 110.826 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -58.33 -29.56 66.01 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.997 0.427 . . . . 61.329999999999998 110.821 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.437 ' HA ' HD22 ' A' ' 50' ' ' ASN . 42.3 tt0 -59.96 -40.48 89.21 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.174 -0.467 . . . . 72.219999999999999 111.301 176.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.568 ' HE2' ' HD2' ' A' ' 43' ' ' LYS . 5.6 t80 -61.76 -35.54 78.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.284 0.564 . . . . 72.450000000000003 109.982 178.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -61.6 -68.31 0.33 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.793 -0.64 . . . . 75.239999999999995 110.793 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.437 HD22 ' HA ' ' A' ' 47' ' ' GLU . 10.1 p30 -62.53 -15.1 48.88 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.145 0.424 . . . . 73.129999999999995 112.145 -176.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.412 ' O ' ' HG2' ' A' ' 99' ' ' PRO . . . -80.51 -48.53 12.64 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.576 0.584 . . . . 73.420000000000002 112.576 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.545 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 21.0 m -100.93 5.39 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 113.463 0.912 . . . . 71.140000000000001 113.463 -173.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.432 HD21 ' N ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -91.79 17.61 8.81 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.476 0.917 . . . . 73.25 113.476 -176.029 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -137.79 164.18 29.56 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.229 0.538 . . . . 74.319999999999993 112.158 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.77 144.23 51.11 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.652 -0.703 . . . . 74.510000000000005 110.654 173.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.713 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 86.3 mt-10 -95.32 115.67 27.74 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.603 0.24 . . . . 74.519999999999996 111.395 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.456 HD11 ' N ' ' A' ' 57' ' ' ILE . 4.2 mp -110.24 150.89 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 120.88 0.371 . . . . 73.019999999999996 110.966 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -70.11 154.88 41.39 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.826 0.451 . . . . 62.43 111.529 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -54.37 -48.93 70.92 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.485 0.55 . . . . 70.109999999999999 112.485 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -67.23 -44.8 78.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.798 0.332 . . . . 73.409999999999997 111.747 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.412 ' HB3' HD12 ' A' ' 24' ' ' LEU . 40.9 m-20 -67.1 -36.51 82.09 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.116 0.484 . . . . 74.239999999999995 111.324 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.6 t-105 -53.13 -54.21 39.07 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.705 -0.68 . . . . 74.140000000000001 111.282 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -71.74 -28.12 63.45 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.681 -0.69 . . . . 63.210000000000001 111.818 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.21 -37.66 83.78 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.162 0.506 . . . . 74.340000000000003 111.457 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.57 HD12 HG12 ' A' ' 127' ' ' VAL . 92.4 mt -88.41 -8.19 55.4 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.254 -0.43 . . . . 74.409999999999997 111.639 177.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.4 46.99 73.69 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.071 -0.585 . . . . 72.310000000000002 112.708 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.641 HD23 ' HE3' ' A' ' 129' ' ' LYS . 79.9 mt -86.16 152.3 22.95 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.129 0.49 . . . . 73.340000000000003 111.965 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.521 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 61.3 tt0 -119.62 145.58 46.31 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.097 -0.502 . . . . 74.329999999999998 109.789 172.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -56.35 110.11 0.71 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.113 0.482 . . . . 75.219999999999999 111.741 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.88 4.03 39.35 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 115.89 -0.595 . . . . 73.109999999999999 113.274 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.521 ' HB2' ' O ' ' A' ' 68' ' ' GLN . 0.5 OUTLIER -69.85 174.16 5.53 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.579 0.585 . . . . 75.409999999999997 112.579 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -105.42 123.74 48.39 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.042 -0.526 . . . . 74.420000000000002 110.689 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.424 HG12 ' HB3' ' A' ' 86' ' ' ALA . 17.9 m -118.35 144.48 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.331 0.586 . . . . 71.120000000000005 112.271 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.612 ' HD2' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -96.02 137.13 35.53 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.815 -0.63 . . . . 74.219999999999999 110.374 175.396 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 61.5 t -124.98 120.72 59.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.348 -0.612 . . . . 63.509999999999998 109.348 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.572 ' HZ2' ' HB3' ' A' ' 76' ' ' LYS . 4.8 mtpm? -129.88 132.15 46.32 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.098 0.475 . . . . 75.310000000000002 112.076 -171.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.702 HG21 ' HA3' ' A' ' 125' ' ' GLY . 30.8 p -135.81 -172.33 3.08 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.269 0.557 . . . . 75.319999999999993 111.072 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -72.21 -6.15 40.8 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.13 -0.486 . . . . 71.140000000000001 111.847 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -95.59 -52.6 4.05 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.789 0.328 . . . . 71.140000000000001 111.138 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.27 -162.59 27.84 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.349 -0.453 . . . . 64.349999999999994 112.7 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.612 ' HB2' ' HD2' ' A' ' 74' ' ' LYS . 0.4 OUTLIER -135.61 150.22 49.59 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.285 0.564 . . . . 65.439999999999998 112.141 178.671 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.44 HG21 ' HA ' ' A' ' 103' ' ' TYR . 8.8 p -143.84 153.56 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 116.02 -0.536 . . . . 75.209999999999994 111.245 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.6 t -112.78 121.76 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 122.211 0.205 . . . . 75.530000000000001 110.843 177.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.4 HG11 ' CD2' ' A' ' 103' ' ' TYR . 35.0 m -132.86 172.4 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.23 0.455 . . . . 73.329999999999998 112.23 -177.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -73.67 146.1 44.76 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.074 0.464 . . . . 75.099999999999994 110.998 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.424 ' HB3' HG12 ' A' ' 73' ' ' VAL . . . -96.31 119.54 34.98 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.625 0.602 . . . . 72.209999999999994 112.625 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -124.63 152.96 42.97 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.151 0.501 . . . . 75.349999999999994 110.678 172.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -96.11 114.9 26.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.18 -0.464 . . . . 73.530000000000001 110.042 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.713 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -113.86 -161.37 14.13 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.465 -0.874 . . . . 75.120000000000005 114.773 -170.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -93.79 23.2 4.94 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.12 0.485 . . . . 73.450000000000003 111.588 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.2 m -87.36 144.66 36.18 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.19 -0.459 . . . . 75.439999999999998 112.225 -175.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.89 174.71 12.37 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.646 2.231 . . . . 64.430000000000007 113.391 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -57.53 126.12 25.92 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.963 -0.562 . . . . 71.120000000000005 111.86 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.459 ' HA2' HG13 ' A' ' 26' ' ' VAL . . . 73.31 29.21 64.56 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.171 -0.538 . . . . 73.510000000000005 114.15 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.63 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 15.0 ttt -148.8 139.82 23.01 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.383 -0.481 . . . . 74.099999999999994 110.214 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.413 HG22 ' HA ' ' A' ' 57' ' ' ILE . 40.0 pt -134.06 148.88 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.401 0.619 . . . . 72.420000000000002 112.078 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -109.06 130.25 55.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.981 -0.554 . . . . 74.549999999999997 111.54 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 30' ' ' SER . 49.5 mt -123.26 129.58 24.87 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 120.858 0.361 . . . . 73.409999999999997 110.967 174.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.545 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 50.5 Cg_exo -57.66 142.28 95.73 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.406 2.071 . . . . 73.019999999999996 112.572 175.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.51 ' HA ' ' HE3' ' A' ' 100' ' ' MET . 4.2 tpt -59.44 107.05 0.52 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.173 0.511 . . . . 75.310000000000002 111.564 -177.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.41 -176.51 38.81 Favored Glycine 0 CA--C 1.521 0.406 0 C-N-CA 120.114 -1.041 . . . . 70.420000000000002 113.612 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.488 ' HG3' HG11 ' A' ' 137' ' ' VAL . 19.5 Cg_endo -57.28 -34.64 98.2 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.034 2.489 . . . . 64.140000000000001 111.941 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.44 ' HA ' HG21 ' A' ' 82' ' ' VAL . 72.1 m-85 -61.75 -51.49 68.12 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.659 -0.7 . . . . 74.040000000000006 110.704 177.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.424 ' O ' HG22 ' A' ' 108' ' ' ILE . . . -62.86 -36.43 83.25 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.202 -0.454 . . . . 62.399999999999999 111.152 175.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -56.68 -23.82 44.59 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.05 0.54 . . . . 72.349999999999994 111.963 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.498 ' SD ' HD22 ' A' ' 140' ' ' LEU . 86.2 mmm -74.24 -22.08 59.5 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.907 0.336 . . . . 65.409999999999997 111.907 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.5 -21.1 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 113.169 0.803 . . . . 61.219999999999999 113.169 -170.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.424 HG22 ' O ' ' A' ' 104' ' ' ALA . 7.0 pt -95.98 -179.42 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.282 0.563 . . . . 74.099999999999994 111.841 -177.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.461 ' H ' HG23 ' A' ' 123' ' ' VAL . 22.0 t70 -106.74 117.83 55.83 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 116.029 -0.532 . . . . 73.239999999999995 111.016 178.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.67 19.49 1.1 Allowed 'Trans proline' 0 CA--C 1.546 1.075 0 C-N-CA 122.963 2.442 . . . . 75.540000000000006 114.209 -177.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.8 t -97.66 14.88 25.2 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.997 -0.439 . . . . 75.109999999999999 111.253 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.9 p -65.33 114.74 4.98 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.152 0.427 . . . . 75.109999999999999 112.152 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -73.83 104.34 4.68 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.781 0.324 . . . . 73.319999999999993 111.548 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.83 -128.56 1.04 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.196 -0.526 . . . . 73.25 112.816 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.8 m 72.33 -48.22 0.68 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.918 0.71 . . . . 62.439999999999998 112.918 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -107.43 -96.06 2.44 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.224 -0.512 . . . . 64.409999999999997 114.052 -178.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.54 140.73 22.83 Favored Pre-proline 0 N--CA 1.472 0.638 0 N-CA-C 113.055 0.761 . . . . 72.299999999999997 113.055 -172.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -85.85 117.0 1.63 Allowed 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.053 2.502 . . . . 74.510000000000005 111.914 173.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -108.27 142.65 38.23 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.867 0.365 . . . . 73.439999999999998 111.845 -174.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -74.7 28.45 0.09 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.808 1.04 . . . . 74.209999999999994 113.808 -174.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.18 99.39 6.99 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.637 -0.664 . . . . 74.25 110.804 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -89.78 163.34 30.78 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.995 -0.622 . . . . 72.099999999999994 113.669 -175.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.461 HG23 ' H ' ' A' ' 109' ' ' ASP . 61.2 t -94.28 119.15 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 122.606 -0.35 . . . . 71.310000000000002 111.259 175.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.642 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 6.8 ttpt -66.78 152.82 44.79 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.409 0.623 . . . . 73.239999999999995 112.347 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.702 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -174.05 -144.67 4.89 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.553 -0.749 . . . . 60.109999999999999 112.635 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 65.9 p -140.97 160.23 40.51 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.488 0.315 . . . . 71.439999999999998 111.704 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.57 HG12 HD12 ' A' ' 65' ' ' LEU . 13.6 p -142.97 144.6 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 120.855 0.359 . . . . 71.349999999999994 111.311 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -154.95 165.0 38.08 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.246 0.546 . . . . 73.329999999999998 112.44 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.641 ' HE3' HD23 ' A' ' 67' ' ' LEU . 5.5 tppp? -70.51 138.77 51.32 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.107 -0.497 . . . . 74.099999999999994 111.11 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 t -144.54 149.82 36.5 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.437 0.637 . . . . 65.129999999999995 112.431 175.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -90.19 -5.55 56.29 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.609 -0.723 . . . . 71.109999999999999 111.009 176.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.474 ' CD ' ' HZ3' ' A' ' 74' ' ' LYS . 27.8 mt-10 -63.67 165.48 8.23 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.081 -0.509 . . . . 74.430000000000007 111.591 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -92.34 155.41 17.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.026 0.441 . . . . 75.140000000000001 111.095 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 99.1 t -58.9 127.74 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.237 -0.438 . . . . 73.349999999999994 110.979 173.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.37 86.83 0.83 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.717 0.294 . . . . 71.200000000000003 111.103 -178.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.5 m -44.49 141.74 1.85 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.774 -0.648 . . . . 71.030000000000001 111.908 -175.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 51.4 t -45.14 -50.11 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.879 0.696 . . . . 74.25 112.879 -172.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -70.5 -43.58 69.4 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.625 0.25 . . . . 75.530000000000001 111.435 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -55.14 -41.64 72.02 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.795 0.807 . . . . 72.510000000000005 110.381 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.498 HD22 ' SD ' ' A' ' 106' ' ' MET . 2.4 tt -61.22 -37.77 84.21 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.018 -0.992 . . . . 75.530000000000001 111.351 177.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 52.2 mt -59.35 -44.8 92.62 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.301 0.572 . . . . 75.239999999999995 110.506 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -76.53 -29.71 56.85 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.83 -0.623 . . . . 71.219999999999999 111.059 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.96 -39.15 84.63 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.177 -0.465 . . . . 75.200000000000003 112.074 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.418 HD11 ' H ' ' A' ' 146' ' ' SER . 2.8 pp -79.47 -11.35 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.111 0.412 . . . . 73.150000000000006 112.111 177.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 135.5 -64.56 0.58 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.247 -0.502 . . . . 74.349999999999994 113.082 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.418 ' H ' HD11 ' A' ' 144' ' ' ILE . 32.9 t . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 121.505 0.669 . . . . 73.299999999999997 112.2 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptp . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.101 0.477 . . . . 72.099999999999994 111.403 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -145.58 169.76 27.04 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.281 -0.485 . . . . 53.43 113.042 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.4 p -100.05 157.72 16.35 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.081 0.467 . . . . 73.209999999999994 111.553 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.2 m -150.54 99.63 2.77 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.039 0.447 . . . . 74.340000000000003 111.204 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -140.99 144.59 35.14 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.284 -0.416 . . . . 70.25 111.031 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -150.57 139.5 20.94 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.072 0.397 . . . . 64.310000000000002 112.072 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -141.74 105.18 4.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.208 0.528 . . . . 75.099999999999994 111.344 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -113.7 90.47 3.35 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.039 -0.413 . . . . 65.219999999999999 110.719 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -138.44 153.47 48.85 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.291 0.567 . . . . 74.530000000000001 111.879 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -139.86 95.8 2.96 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.621 -0.718 . . . . 74.430000000000007 110.292 173.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.5 p -66.33 93.39 0.22 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.921 0.391 . . . . 75.340000000000003 110.892 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.7 p -58.8 121.16 10.41 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.316 0.579 . . . . 74.400000000000006 112.259 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.61 83.14 0.18 Allowed Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.936 -0.574 . . . . 72.109999999999999 112.103 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -78.58 -47.11 17.85 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.671 0.272 . . . . 75.019999999999996 111.658 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 74.08 156.81 0.18 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.465 -0.789 . . . . 71.310000000000002 111.801 -173.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -157.81 20.11 0.26 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.972 0.415 . . . . 73.439999999999998 111.13 -177.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.18 173.07 6.47 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.224 0.535 . . . . 74.310000000000002 111.747 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -163.81 124.39 2.21 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.002 -0.544 . . . . 70.450000000000003 111.13 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -98.56 95.03 7.01 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.214 0.53 . . . . 74.010000000000005 111.334 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -89.53 87.14 6.94 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.106 0.479 . . . . 74.439999999999998 110.463 176.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.62 -177.03 14.96 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.157 -0.544 . . . . 71.340000000000003 113.83 -177.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -88.95 101.84 14.47 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 111.896 0.332 . . . . 72.329999999999998 111.896 -177.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 13.4 ptm -75.98 154.3 35.92 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.637 0.256 . . . . 74.540000000000006 110.93 174.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 mp -117.16 148.85 41.22 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.07 0.462 . . . . 74.099999999999994 112.179 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.39 128.01 34.57 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.569 0.699 . . . . 72.409999999999997 111.45 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.465 HG11 ' HA2' ' A' ' 94' ' ' GLY . 27.4 m -140.67 162.46 23.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.337 -0.847 . . . . 75.450000000000003 110.97 -176.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.725 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 41.9 tt0 -98.88 112.46 24.55 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.122 0.487 . . . . 75.510000000000005 110.127 175.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.3 t -86.98 119.26 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.782 -0.644 . . . . 73.109999999999999 111.87 -172.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 121' ' ' LYS . 2.8 mt -103.56 154.99 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.793 0.33 . . . . 75.120000000000005 111.531 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.632 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 11.4 t -133.78 107.66 8.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.942 0.401 . . . . 62.450000000000003 111.077 175.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -104.34 134.17 11.84 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 121.161 -0.542 . . . . 65.299999999999997 113.134 -177.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -77.39 82.07 3.86 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.159 0.504 . . . . 73.549999999999997 111.496 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 t -78.49 -33.8 47.92 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.989 -0.55 . . . . 75.5 110.883 174.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.55 109.36 20.32 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.793 -0.447 . . . . 72.219999999999999 109.793 173.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -79.84 -175.43 4.9 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.501 0.556 . . . . 73.340000000000003 112.501 -174.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 68.04 108.09 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.52 -0.763 . . . . 74.200000000000003 111.303 -173.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.29 101.7 0.41 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.568 -0.825 . . . . 63.340000000000003 112.706 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.716 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . . . -151.56 146.4 25.83 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.091 0.404 . . . . 74.219999999999999 112.091 -175.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 t -66.66 159.54 27.46 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.331 -0.395 . . . . 71.140000000000001 110.738 171.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.42 HG21 HG11 ' A' ' 137' ' ' VAL . 11.6 p -58.82 -27.47 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.758 0.313 . . . . 71.510000000000005 110.843 177.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -57.24 -32.25 66.37 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.157 -0.474 . . . . 64.430000000000007 111.441 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -72.3 -33.96 67.79 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.945 0.402 . . . . 71.25 111.803 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.716 ' HE2' ' HB3' ' A' ' 38' ' ' ALA . 1.5 mptp? -91.83 -70.53 0.68 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.554 -0.294 . . . . 75.340000000000003 111.549 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.6 mt 55.59 9.48 0.41 Allowed 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 113.892 1.071 . . . . 73.150000000000006 113.892 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 48' ' ' TYR . 6.2 t -81.86 156.04 25.04 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.105 -0.372 . . . . 63.310000000000002 111.606 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.62 -31.37 70.56 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.899 0.381 . . . . 75.310000000000002 110.584 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -58.11 -38.12 75.86 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.033 0.444 . . . . 73.25 111.039 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.539 ' O ' HG21 ' A' ' 52' ' ' VAL . 4.1 t80 -59.3 -44.02 92.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.289 0.566 . . . . 75.129999999999995 109.583 176.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.5 ' HD2' HG21 ' A' ' 137' ' ' VAL . 57.8 t80 -60.44 -60.51 3.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.572 -0.74 . . . . 64.439999999999998 110.16 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -53.08 -28.42 24.99 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.884 -0.598 . . . . 74.409999999999997 112.313 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.24 -37.87 25.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.271 0.841 . . . . 64.109999999999999 113.271 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 48' ' ' TYR . 19.3 m -109.76 9.61 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 113.494 0.924 . . . . 74.439999999999998 113.494 -172.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -98.38 25.91 5.9 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.061 0.763 . . . . 54.509999999999998 113.061 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.431 ' CD1' ' HD2' ' A' ' 87' ' ' LYS . 52.8 p90 -146.5 158.56 43.91 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.012 -0.43 . . . . 70.120000000000005 111.752 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.49 139.26 51.63 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.302 -0.408 . . . . 61.539999999999999 111.484 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.649 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 42.7 mt-10 -87.68 113.15 23.09 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.219 0.533 . . . . 73.540000000000006 110.943 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.8 mt -112.44 150.71 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.561 -0.745 . . . . 75.140000000000001 111.593 -171.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.655 ' ND2' HG22 ' A' ' 91' ' ' VAL . 1.9 m120 -72.19 135.17 46.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.498 -0.319 . . . . 72.030000000000001 110.976 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.505 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 37.4 tt0 -54.18 -40.17 67.3 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.629 0.603 . . . . 62.409999999999997 112.629 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -64.14 -49.56 71.66 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.543 0.572 . . . . 74.310000000000002 112.543 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -70.42 -29.4 66.0 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.657 0.742 . . . . 71.329999999999998 110.284 177.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.505 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 32.2 t-105 -55.83 -47.54 77.05 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.169 -0.923 . . . . 75.510000000000005 110.401 172.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -65.12 -41.44 94.87 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.848 -0.615 . . . . 73.349999999999994 111.037 174.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.95 -39.27 74.24 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 111.939 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.4 mt -88.03 -12.53 44.08 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.24 -0.437 . . . . 74.540000000000006 111.782 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.89 50.59 51.95 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.193 -0.527 . . . . 61.439999999999998 112.642 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.624 HD23 ' HE3' ' A' ' 129' ' ' LYS . 86.1 mt -88.65 155.21 19.74 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.471 0.653 . . . . 73.200000000000003 112.467 -176.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -127.14 151.95 47.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.619 -0.719 . . . . 74.439999999999998 109.501 173.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -63.52 98.68 0.18 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.525 0.678 . . . . 75.040000000000006 111.762 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.13 -17.92 5.91 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.119 -0.946 . . . . 72.109999999999999 112.888 -175.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -56.48 155.69 6.93 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.314 0.578 . . . . 73.439999999999998 112.242 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -94.89 123.08 38.15 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.746 -0.661 . . . . 73.530000000000001 110.66 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.49 HG13 ' HB1' ' A' ' 86' ' ' ALA . 31.6 m -116.5 147.38 19.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.018 0.437 . . . . 75.120000000000005 111.377 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.485 ' HB2' HG22 ' A' ' 83' ' ' VAL . 4.6 ttpm? -114.66 138.76 50.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.477 0.656 . . . . 72.200000000000003 110.969 176.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 57.7 t -116.95 134.33 60.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.45 -0.796 . . . . 73.219999999999999 109.669 -175.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -133.58 123.72 25.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.263 0.468 . . . . 70.439999999999998 112.263 -172.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.693 HG21 ' HA3' ' A' ' 125' ' ' GLY . 36.9 p -126.2 -172.26 2.58 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.209 -0.45 . . . . 74.519999999999996 110.703 174.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.63 -14.42 61.6 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.809 0.338 . . . . 74.239999999999995 111.151 175.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -84.51 -52.79 5.87 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.778 0.323 . . . . 73.329999999999998 111.376 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.08 -159.62 20.06 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.979 -0.629 . . . . 71.430000000000007 113.122 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 0.4 OUTLIER -143.61 153.16 42.24 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.034 0.445 . . . . 64.230000000000004 111.606 176.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.1 p -150.77 145.93 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.332 -0.395 . . . . 74.319999999999993 111.377 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 74' ' ' LYS . 60.9 t -107.34 118.93 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 120.532 0.206 . . . . 74.450000000000003 111.169 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.74 178.11 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 122.802 0.441 . . . . 75.409999999999997 111.576 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -81.65 146.73 29.9 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.221 0.534 . . . . 74.340000000000003 111.754 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.49 ' HB1' HG13 ' A' ' 73' ' ' VAL . . . -93.52 129.11 39.85 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.888 0.699 . . . . 75.340000000000003 112.888 -177.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.431 ' HD2' ' CD1' ' A' ' 54' ' ' TYR . 67.3 mttm -135.3 151.77 50.85 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.973 -0.558 . . . . 75.510000000000005 109.978 172.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -78.01 147.43 34.84 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.069 -0.394 . . . . 71.129999999999995 110.511 173.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.649 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -134.73 168.72 23.47 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.804 -0.712 . . . . 75.120000000000005 114.018 -175.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -89.22 23.95 2.32 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.365 0.602 . . . . 72.049999999999997 110.958 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.655 HG22 ' ND2' ' A' ' 58' ' ' ASN . 17.3 m -91.28 151.94 43.37 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 115.925 -0.579 . . . . 64.140000000000001 112.221 -175.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.19 145.57 55.04 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.098 2.532 . . . . 74.150000000000006 112.782 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -52.54 142.31 18.23 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.386 0.513 . . . . 74.439999999999998 112.386 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.465 ' HA2' HG11 ' A' ' 26' ' ' VAL . . . 71.55 25.79 74.49 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.806 -0.711 . . . . 64.040000000000006 113.195 -174.26 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' MET . . . . . 0.725 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 19.0 ttt -154.43 135.03 13.51 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.42 -0.459 . . . . 74.450000000000003 110.029 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.421 ' O ' HG13 ' A' ' 29' ' ' ILE . 41.8 pt -133.22 145.67 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 120.998 0.428 . . . . 74.319999999999993 112.154 -174.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -105.27 130.19 53.46 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.429 -0.351 . . . . 74.109999999999999 111.424 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 30' ' ' SER . 50.8 mt -125.31 130.34 24.17 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 120.776 0.322 . . . . 71.219999999999999 110.714 175.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.41 135.23 69.08 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.334 2.023 . . . . 62.32 112.853 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.448 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 5.1 tpt -54.14 109.7 0.51 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.262 -0.426 . . . . 74.329999999999998 111.904 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.62 -174.35 32.42 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.866 -0.683 . . . . 72.430000000000007 112.513 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.544 ' O ' ' HG2' ' A' ' 106' ' ' MET . 32.3 Cg_endo -65.11 -26.44 57.7 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.808 1.672 . . . . 74.120000000000005 111.57 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.497 ' HA ' HD11 ' A' ' 140' ' ' LEU . 4.6 m-85 -67.53 -53.85 24.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.6 -0.727 . . . . 73.099999999999994 110.496 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.476 ' O ' HG22 ' A' ' 108' ' ' ILE . . . -61.43 -40.61 95.07 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.075 -0.511 . . . . 72.219999999999999 110.798 174.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -53.52 -26.89 22.89 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.308 -0.405 . . . . 63.329999999999998 111.916 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.611 ' SD ' HD22 ' A' ' 140' ' ' LEU . 83.1 mmm -64.96 -34.33 78.16 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.754 0.311 . . . . 74.329999999999998 111.835 177.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.432 ' HB ' HG23 ' A' ' 77' ' ' THR . 27.1 m -115.82 -19.88 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.846 0.684 . . . . 74.120000000000005 112.846 -168.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.619 HG21 ' HB2' ' A' ' 30' ' ' SER . 10.1 pt -90.65 -176.21 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-O 121.177 0.513 . . . . 75.239999999999995 111.962 -178.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.591 ' N ' HG21 ' A' ' 123' ' ' VAL . 18.0 t70 -109.01 115.56 56.85 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.242 -0.435 . . . . 73.040000000000006 111.507 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -86.18 16.83 1.88 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.014 2.476 . . . . 75.299999999999997 113.78 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.1 t -85.16 -31.77 23.08 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.021 0.438 . . . . 75.450000000000003 111.291 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.8 t -85.49 145.14 27.55 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.141 0.496 . . . . 74.530000000000001 111.985 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -82.42 7.28 14.64 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.341 0.591 . . . . 63.25 110.648 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.53 3.0 32.88 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.447 -0.661 . . . . 51.399999999999999 111.447 -171.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 41.2 m 62.21 -70.88 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.653 0.781 . . . . 74.230000000000004 112.065 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -149.87 -100.67 0.22 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.635 -0.586 . . . . 73.340000000000003 111.635 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 58.5 mtp -111.37 145.19 32.05 Favored Pre-proline 0 CA--C 1.539 0.519 0 O-C-N 122.652 -0.322 . . . . 75.430000000000007 110.42 171.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.11 95.01 0.24 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 122.442 2.095 . . . . 74.519999999999996 114.263 -174.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -98.98 -168.58 1.65 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.155 -0.475 . . . . 73.439999999999998 109.808 170.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -71.08 82.24 0.69 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.652 0.739 . . . . 72.319999999999993 111.267 175.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.455 ' O ' HG12 ' A' ' 29' ' ' ILE . 33.2 mttm -132.19 -170.3 2.39 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 114.968 -1.014 . . . . 74.340000000000003 110.192 176.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 145.41 175.83 18.85 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.556 -0.83 . . . . 53.409999999999997 113.695 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.591 HG21 ' N ' ' A' ' 109' ' ' ASP . 62.0 t -93.82 121.29 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 112.226 0.454 . . . . 74.439999999999998 112.226 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.507 ' HD2' ' N ' ' A' ' 125' ' ' GLY . 0.3 OUTLIER -60.94 141.51 57.19 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.024 0.529 . . . . 75.010000000000005 111.923 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.693 ' HA3' HG21 ' A' ' 77' ' ' THR . . . -170.35 -147.26 5.48 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 116.221 -0.445 . . . . 63.340000000000003 113.087 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 57.2 p -138.7 159.16 42.78 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.775 0.43 . . . . 72.230000000000004 111.711 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -140.39 145.61 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.906 0.384 . . . . 72.310000000000002 111.374 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.66 154.78 32.1 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.379 -0.373 . . . . 73.519999999999996 111.502 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.624 ' HE3' HD23 ' A' ' 67' ' ' LEU . 36.1 ttmt -71.33 144.38 49.94 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.505 -0.554 . . . . 74.329999999999998 109.505 168.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.0 t -131.98 145.66 51.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 122.05 0.928 . . . . 54.109999999999999 113.355 -176.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -77.32 -10.67 59.58 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.422 -1.263 . . . . 73.340000000000003 111.621 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -82.11 -179.94 7.59 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.478 0.656 . . . . 75.409999999999997 112.503 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -97.25 154.85 17.14 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.741 -0.663 . . . . 74.209999999999994 111.192 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.8 134.35 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.798 0.333 . . . . 74.239999999999995 110.661 172.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 21.1 mt -70.42 125.43 26.76 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.13 0.418 . . . . 75.400000000000006 112.13 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.437 ' HA ' ' HE2' ' A' ' 49' ' ' PHE . 74.0 m -65.05 149.09 50.48 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.386 -0.598 . . . . 72.439999999999998 109.386 167.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.5 HG21 ' HD2' ' A' ' 49' ' ' PHE . 94.7 t -48.61 -48.02 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 111.85 0.315 . . . . 74.239999999999995 111.85 -175.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -72.44 -37.93 68.45 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.234 -0.291 . . . . 63.32 111.574 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -55.4 -40.52 71.51 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.846 0.831 . . . . 74.510000000000005 109.518 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.611 HD22 ' SD ' ' A' ' 106' ' ' MET . 4.0 tt -58.53 -46.15 87.39 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.4 -1.273 . . . . 73.109999999999999 111.236 173.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 39.6 mt -59.16 -42.91 91.87 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.523 0.677 . . . . 70.540000000000006 110.829 178.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -67.98 -36.9 80.81 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.447 -0.797 . . . . 72.120000000000005 111.087 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.36 -30.45 71.58 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.223 -0.444 . . . . 55.219999999999999 112.193 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.48 HD13 ' H ' ' A' ' 146' ' ' SER . 2.7 pp -98.33 2.57 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.173 0.511 . . . . 75.439999999999998 111.976 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 90.33 -58.91 3.46 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 116.195 -0.457 . . . . 62.049999999999997 113.643 176.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.48 ' H ' HD13 ' A' ' 144' ' ' ILE . 70.7 m . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 121.036 0.446 . . . . 72.430000000000007 111.555 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.0 ptm . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.349 0.595 . . . . 74.030000000000001 112.435 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.528 HD12 ' HG ' ' A' ' 65' ' ' LEU . 15.1 mt -107.85 138.24 44.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.934 -0.575 . . . . 61.240000000000002 111.421 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.451 ' HA ' HG22 ' A' ' 126' ' ' THR . 33.0 tt0 -78.45 114.39 17.32 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.915 0.388 . . . . 61.130000000000003 110.781 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 27.4 m -127.5 159.74 37.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.18 0.514 . . . . 52.240000000000002 111.921 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.725 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 57.0 tt0 -98.78 108.99 21.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.064 0.459 . . . . 63.299999999999997 110.073 175.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.428 HG22 HD11 ' A' ' 96' ' ' ILE . 33.6 t -83.59 110.32 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.667 -0.697 . . . . 75.129999999999995 111.611 -175.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 30' ' ' SER . 8.3 mt -92.39 162.05 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.882 0.373 . . . . 70.209999999999994 111.979 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.597 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 64.8 m -137.34 92.61 2.72 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.089 0.471 . . . . 73.310000000000002 111.577 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 C-N-CA 121.158 -0.544 . . . . 45.299999999999997 112.362 179.4 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 . . . . . 0 N--CA 1.47 0.539 0 CA-C-O 121.079 0.466 . . . . 73.430000000000007 111.022 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -23.52 64.14 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.327 -0.397 . . . . 74.040000000000006 111.195 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.495 ' HD1' HG23 ' A' ' 137' ' ' VAL . 55.3 t80 -94.4 -0.49 54.8 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.046 0.451 . . . . 63.43 112.015 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -121.48 -27.63 4.75 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.604 -0.685 . . . . 65.299999999999997 112.275 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' A' ' 99' ' ' PRO . . . -72.5 -62.9 1.28 Allowed 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.35 0.5 . . . . 73.239999999999995 112.35 -176.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.469 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 30.2 m -95.49 21.26 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 112.975 0.731 . . . . 65.120000000000005 112.975 -172.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.615 ' N ' HD22 ' A' ' 53' ' ' ASN . 0.8 OUTLIER -105.01 11.13 33.77 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.317 0.858 . . . . 72.219999999999999 113.317 -172.021 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.469 ' CD2' ' HD2' ' A' ' 87' ' ' LYS . 38.0 p90 -136.18 162.22 33.57 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.65 0.611 . . . . 70.430000000000007 112.65 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -126.83 130.0 49.38 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.66 -0.7 . . . . 73.140000000000001 111.004 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.592 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 43.6 mt-10 -87.38 117.55 26.23 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.167 0.508 . . . . 73.099999999999994 111.086 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 28.2 mt -112.79 142.54 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.663 -0.699 . . . . 73.519999999999996 111.501 -172.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.02 149.01 50.61 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.953 0.406 . . . . 73.439999999999998 111.502 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -53.83 -49.9 67.39 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.127 -0.488 . . . . 75.239999999999995 112.186 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -56.61 -51.66 67.81 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.723 0.296 . . . . 60.340000000000003 111.731 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -66.08 -35.76 81.37 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.097 0.475 . . . . 74.340000000000003 110.878 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -53.22 -50.14 65.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.846 -0.616 . . . . 74.329999999999998 111.009 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -71.31 -37.11 71.8 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.399 -0.364 . . . . 71.129999999999995 111.247 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.53 -33.0 70.84 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.189 0.44 . . . . 61.539999999999999 112.189 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.528 ' HG ' HD12 ' A' ' 24' ' ' LEU . 93.5 mt -90.2 -13.53 35.34 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.417 -0.356 . . . . 61.32 111.874 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.26 53.05 23.72 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.02 -0.609 . . . . 61.340000000000003 112.106 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.701 HD23 ' HE3' ' A' ' 129' ' ' LYS . 75.1 mt -92.3 137.43 32.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.499 0.666 . . . . 52.109999999999999 111.808 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -107.84 142.73 37.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.996 -0.547 . . . . 75.409999999999997 109.725 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -61.84 100.01 0.14 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.676 0.75 . . . . 74.109999999999999 110.997 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.53 -14.73 4.46 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 115.097 -0.956 . . . . 63.399999999999999 112.958 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -72.13 178.64 3.72 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.67 0.748 . . . . 75.400000000000006 112.554 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.429 ' HD3' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -131.74 147.99 52.54 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.42 -0.809 . . . . 72.049999999999997 110.242 175.646 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 86' ' ' ALA . 19.7 m -124.41 152.77 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.903 0.705 . . . . 65.400000000000006 112.903 -174.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -94.36 122.11 36.57 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.316 -0.856 . . . . 75.150000000000006 110.442 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.8 t -108.42 126.18 65.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.493 -0.321 . . . . 61.509999999999998 110.136 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -133.48 131.98 40.5 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.393 0.616 . . . . 71.430000000000007 112.586 -173.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.694 HG22 ' HA3' ' A' ' 125' ' ' GLY . 39.4 p -134.45 -171.23 2.71 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.495 -0.775 . . . . 52.420000000000002 110.603 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.69 -18.56 60.5 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.993 0.425 . . . . 75.109999999999999 110.664 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -80.91 -52.61 7.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.267 -0.424 . . . . 72.400000000000006 111.465 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.69 -150.55 7.62 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.781 -0.723 . . . . 55.229999999999997 113.349 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -148.49 154.39 39.76 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.77 0.319 . . . . 72.549999999999997 111.401 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.5 p -157.88 145.78 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-O 120.663 0.268 . . . . 45.049999999999997 111.534 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.5 t -102.31 116.56 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 122.42 -0.175 . . . . 71.129999999999995 110.637 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.0 m -125.74 166.68 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 120.901 0.381 . . . . 75.129999999999995 111.818 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -69.06 130.8 43.76 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.094 0.473 . . . . 75.409999999999997 111.452 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.57 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -81.99 120.07 24.79 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.39 -0.368 . . . . 63.299999999999997 111.813 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.469 ' HD2' ' CD2' ' A' ' 54' ' ' TYR . 67.7 mttm -132.43 157.26 45.03 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.025 0.441 . . . . 61.43 110.614 174.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -94.75 140.75 29.48 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.188 -0.46 . . . . 71.310000000000002 111.259 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.592 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -140.56 167.48 25.53 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.915 -0.66 . . . . 72.439999999999998 113.553 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.93 20.98 2.84 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.19 0.519 . . . . 72.319999999999993 111.948 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 m -73.7 153.61 89.4 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.118 -0.492 . . . . 63.329999999999998 111.16 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HG2' ' SD ' ' A' ' 95' ' ' MET . 35.1 Cg_endo -63.85 160.24 38.09 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.307 2.005 . . . . 64.099999999999994 112.837 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -63.86 147.29 52.24 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.03 0.443 . . . . 74.349999999999994 111.461 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 65.76 34.57 89.15 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.02 -0.609 . . . . 61.240000000000002 112.457 -175.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.725 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 23.0 ttt -157.86 137.28 11.91 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.559 -0.377 . . . . 75.310000000000002 110.519 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 28' ' ' VAL . 41.6 pt -134.81 143.95 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.05 0.452 . . . . 61.340000000000003 111.689 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -102.52 128.29 49.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.429 -0.351 . . . . 74.140000000000001 111.818 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 30' ' ' SER . 45.1 mt -124.8 133.57 24.9 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-O 120.812 0.339 . . . . 74.099999999999994 110.518 172.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.469 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 37.4 Cg_exo -59.62 130.11 33.89 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.228 1.952 . . . . 53.539999999999999 112.242 173.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.52 106.1 0.19 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 122.668 0.387 . . . . 51.109999999999999 111.406 -176.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -161.64 -172.54 29.14 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.927 -0.654 . . . . 43.43 112.928 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.429 ' HD2' HG21 ' A' ' 52' ' ' VAL . 15.1 Cg_endo -56.71 -37.39 97.92 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.079 2.519 . . . . 70.329999999999998 112.676 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.449 ' HA ' HD11 ' A' ' 140' ' ' LEU . 35.9 m-85 -60.47 -52.96 62.98 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.234 -0.439 . . . . 73.400000000000006 110.732 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.0 -40.43 93.5 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.266 -0.425 . . . . 75.209999999999994 110.948 175.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -52.06 -26.53 11.2 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.103 0.561 . . . . 74.140000000000001 112.157 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.638 ' SD ' HD21 ' A' ' 140' ' ' LEU . 92.0 mmm -67.12 -31.76 72.44 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 111.912 0.338 . . . . 72.140000000000001 111.912 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.423 ' HB ' HG23 ' A' ' 77' ' ' THR . 27.1 m -119.55 -13.74 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 112.906 0.706 . . . . 71.310000000000002 112.906 -171.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.53 HG21 ' OG ' ' A' ' 30' ' ' SER . 11.6 pt -100.87 -179.59 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.138 0.494 . . . . 52.32 111.766 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 CA--C 1.541 0.627 0 CA-C-N 116.144 -0.48 . . . . 75.120000000000005 110.615 174.018 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.844 0 CA-C-O 121.031 0.239 . . . . 73.430000000000007 113.395 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.9 t -85.98 123.52 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 120.925 0.393 . . . . 33.109999999999999 111.963 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 22.1 mmmt -61.54 148.27 42.72 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.201 0.524 . . . . 74.150000000000006 112.233 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.694 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -178.87 -151.47 9.63 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.946 -0.57 . . . . 61.520000000000003 113.205 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 25' ' ' GLU . 56.1 p -140.84 160.39 40.15 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.466 -0.432 . . . . 70.219999999999999 111.815 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.1 p -142.22 145.17 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.198 -0.455 . . . . 60.219999999999999 110.971 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -151.08 155.58 39.26 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.503 0.557 . . . . 73.439999999999998 112.503 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.701 ' HE3' HD23 ' A' ' 67' ' ' LEU . 3.1 tppp? -72.88 124.02 24.57 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.258 -0.428 . . . . 74.239999999999995 110.945 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.5 t -129.93 153.85 47.93 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.09 0.471 . . . . 61.140000000000001 111.661 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -82.73 -12.69 57.37 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.064 -0.517 . . . . 44.520000000000003 110.887 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -57.17 166.43 1.11 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.928 1.084 . . . . 73.409999999999997 113.928 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.661 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -86.46 144.14 27.42 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.215 -1.357 . . . . 64.439999999999998 111.16 173.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.37 128.98 22.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.671 -0.24 . . . . 73.439999999999998 110.474 170.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 135' ' ' LEU . 11.4 mt -61.4 109.04 1.04 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.588 0.218 . . . . 64.530000000000001 111.588 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 53.5 m -58.03 145.4 36.41 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.832 -0.432 . . . . 55.329999999999998 109.832 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.495 HG23 ' HD1' ' A' ' 49' ' ' PHE . 90.8 t -45.9 -47.27 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.549 0.574 . . . . 64.420000000000002 112.549 -173.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -72.66 -40.39 66.36 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 122.195 -0.315 . . . . 72.140000000000001 111.751 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -58.95 -36.07 74.19 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.617 0.723 . . . . 63.439999999999998 110.215 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.638 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.8 tt -59.66 -43.58 93.9 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.064 -0.971 . . . . 74.439999999999998 110.578 173.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 32.5 mt . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 121.436 0.636 . . . . 72.329999999999998 110.4 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.0 ptm . . . . . 0 CA--C 1.542 0.643 0 CA-C-O 120.801 0.334 . . . . 63.509999999999998 110.919 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.523 HD13 ' HB3' ' A' ' 61' ' ' ASP . 14.1 mt -102.25 130.35 48.9 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.252 0.464 . . . . 74.049999999999997 112.252 -175.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.448 ' HA ' HG22 ' A' ' 126' ' ' THR . 37.1 tt0 -75.23 114.65 13.98 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.197 -0.456 . . . . 62.530000000000001 110.273 175.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.2 m -126.19 159.94 34.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.155 -0.475 . . . . 62.140000000000001 111.756 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.721 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 37.4 tt0 -99.71 113.08 25.32 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.064 0.459 . . . . 71.530000000000001 110.393 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.404 HG22 HD11 ' A' ' 96' ' ' ILE . 46.1 t -88.48 119.24 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.849 -0.614 . . . . 71.030000000000001 112.182 -173.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -107.08 162.37 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.715 0.293 . . . . 74.310000000000002 111.38 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 66.0 m -131.99 106.77 8.24 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.105 0.479 . . . . 74.409999999999997 111.983 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 C-N-CA 121.149 -0.548 . . . . 40.409999999999997 112.314 177.04 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 121.008 0.432 . . . . 74.120000000000005 111.176 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.54 ' O ' HG22 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -70.45 -36.76 74.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.151 0.5 . . . . 73.540000000000006 110.324 -179.512 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -64.89 -64.94 0.74 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.012 -0.54 . . . . 73.430000000000007 111.1 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -55.74 -17.91 7.08 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.779 0.659 . . . . 65.230000000000004 112.779 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -88.4 -59.01 2.35 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.556 0.576 . . . . 64.420000000000002 112.556 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.63 HG21 ' HD2' ' A' ' 102' ' ' PRO . 20.1 m -96.71 15.33 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 113.225 0.824 . . . . 74.040000000000006 113.225 -171.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -99.16 13.76 31.8 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.89 0.7 . . . . 75.0 112.89 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -138.92 164.55 29.4 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.243 0.544 . . . . 74.049999999999997 111.984 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.63 146.39 51.85 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.723 -0.671 . . . . 74.439999999999998 110.857 175.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -97.62 110.6 23.13 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.774 0.321 . . . . 71.120000000000005 111.235 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.444 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.1 mp -110.35 141.96 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 120.864 0.364 . . . . 74.310000000000002 111.308 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -62.71 139.53 58.67 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.426 -0.352 . . . . 74.109999999999999 110.683 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 62' ' ' TRP . 31.1 tt0 -54.38 -31.85 55.77 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.485 0.55 . . . . 64.120000000000005 112.485 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.86 -55.46 32.71 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.825 0.345 . . . . 73.140000000000001 111.588 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.523 ' HB3' HD13 ' A' ' 24' ' ' LEU . 29.3 m-20 -66.23 -35.66 81.0 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.509 0.671 . . . . 61.329999999999998 110.325 176.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.423 ' HB3' ' HA ' ' A' ' 59' ' ' GLU . 47.8 t-105 -53.05 -48.33 67.74 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.85 -1.068 . . . . 72.349999999999994 111.042 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -69.57 -34.82 74.72 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.841 -0.618 . . . . 73.129999999999995 111.779 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -59.46 -52.02 67.39 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.127 0.489 . . . . 50.530000000000001 111.196 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.429 ' HG ' HD12 ' A' ' 24' ' ' LEU . 94.4 mt -75.96 -4.62 42.08 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.022 -0.535 . . . . 72.439999999999998 111.888 178.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.62 49.45 77.06 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.293 -0.48 . . . . 53.509999999999998 112.594 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.553 HD21 ' HB2' ' A' ' 129' ' ' LYS . 97.8 mt -86.78 161.26 18.46 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.015 0.912 . . . . 71.239999999999995 113.116 -175.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -136.53 151.97 49.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.61 -1.177 . . . . 74.109999999999999 109.452 173.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 mp0 -63.82 108.27 1.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.499 0.666 . . . . 74.349999999999994 111.444 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.87 -8.33 14.72 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.295 -0.866 . . . . 72.129999999999995 113.046 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -63.79 151.9 40.92 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.162 0.506 . . . . 71.5 111.992 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.607 HH21 ' HA ' ' A' ' 131' ' ' ASP . 25.8 mtm-85 -90.99 113.74 26.07 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.823 -0.626 . . . . 71.209999999999994 110.986 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.29 135.56 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.124 0.488 . . . . 74.549999999999997 111.888 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.436 ' HD3' ' HE3' ' A' ' 76' ' ' LYS . 34.6 ttmt -98.25 147.78 24.29 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.291 0.567 . . . . 74.430000000000007 111.124 174.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 57.1 t -122.27 131.77 72.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.498 -0.774 . . . . 65.239999999999995 109.427 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.436 ' HE3' ' HD3' ' A' ' 74' ' ' LYS . 20.1 mttt -125.23 125.3 43.37 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.002 0.43 . . . . 65.310000000000002 111.819 -176.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.706 HG22 ' HA3' ' A' ' 125' ' ' GLY . 25.0 p -138.37 -171.79 3.13 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.156 -0.474 . . . . 75.340000000000003 110.663 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.12 -16.63 63.13 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.925 0.393 . . . . 73.340000000000003 111.539 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -88.76 -21.0 24.04 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.196 0.443 . . . . 75.230000000000004 112.196 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.21 -151.46 23.73 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.266 -0.492 . . . . 73.109999999999999 112.857 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 10.3 pt-20 -144.71 149.66 35.98 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.137 0.494 . . . . 52.310000000000002 111.813 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -148.15 148.31 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 116.213 -0.449 . . . . 74.430000000000007 111.25 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -110.0 118.55 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.08 0.152 . . . . 52.340000000000003 110.843 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.461 HG12 ' HD2' ' A' ' 103' ' ' TYR . 33.9 m -128.9 178.27 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 122.699 0.399 . . . . 72.400000000000006 111.933 -177.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -83.06 146.02 28.95 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.106 0.479 . . . . 73.120000000000005 111.446 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.82 127.3 43.68 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.222 0.453 . . . . 73.099999999999994 112.222 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -129.34 142.33 50.85 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.367 0.603 . . . . 72.329999999999998 110.681 173.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -77.72 123.1 26.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.585 -0.734 . . . . 63.039999999999999 111.183 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -126.05 165.98 19.01 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.347 -0.454 . . . . 72.329999999999998 113.507 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -85.84 15.07 5.15 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.546 0.572 . . . . 54.43 112.546 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.3 m -65.66 154.83 87.63 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 112.051 0.389 . . . . 60.43 112.051 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.99 149.54 90.3 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.525 2.15 . . . . 72.5 112.616 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -63.9 144.14 57.31 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.748 0.309 . . . . 64.549999999999997 111.532 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.23 22.07 78.52 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.121 -0.561 . . . . 51.420000000000002 112.923 -174.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.721 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 23.9 ttt -154.0 136.47 15.05 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 122.495 -0.415 . . . . 72.209999999999994 109.985 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 28' ' ' VAL . 43.2 pt -134.37 150.07 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.412 0.625 . . . . 60.409999999999997 112.313 -175.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -106.47 129.25 54.47 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.835 -0.62 . . . . 75.25 110.827 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 30' ' ' SER . 40.8 mt -124.3 132.29 24.28 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 120.633 0.254 . . . . 50.310000000000002 110.657 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -57.86 128.54 29.41 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.19 1.926 . . . . 64.209999999999994 112.169 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.76 113.33 1.43 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.829 0.347 . . . . 72.239999999999995 111.267 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.45 -169.77 27.39 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.686 -0.768 . . . . 64.319999999999993 112.742 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.63 ' HD2' HG21 ' A' ' 52' ' ' VAL . 31.5 Cg_endo -65.15 -27.54 56.8 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.065 1.843 . . . . 70.409999999999997 111.482 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.495 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 3.4 m-85 -68.25 -53.8 22.11 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.825 -0.625 . . . . 64.340000000000003 110.249 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.78 -38.12 80.98 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.016 -0.538 . . . . 75.400000000000006 110.99 174.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -54.5 -23.43 16.28 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.365 0.505 . . . . 73.430000000000007 112.365 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 102' ' ' PRO . 77.9 mmm -78.17 -12.6 60.01 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.988 0.366 . . . . 61.310000000000002 111.988 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.7 m -137.39 -13.88 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 113.088 0.773 . . . . 65.129999999999995 113.088 -173.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.546 HG21 ' OG ' ' A' ' 30' ' ' SER . 1.5 pp -105.78 172.18 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 122.081 -0.387 . . . . 71.420000000000002 111.206 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.442 ' N ' HG21 ' A' ' 123' ' ' VAL . 18.9 t0 . . . . . 0 CA--C 1.542 0.645 0 CA-C-O 120.902 0.382 . . . . 65.209999999999994 111.981 -176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.854 0 CA-C-O 120.81 0.117 . . . . 70.409999999999997 113.107 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.442 HG21 ' N ' ' A' ' 109' ' ' ASP . 98.3 t -87.17 130.05 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 O-C-N 122.692 -0.299 . . . . 63.420000000000002 111.561 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -70.12 145.95 51.21 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.274 0.559 . . . . 71.010000000000005 112.241 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.706 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -173.89 -155.47 11.99 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.72 -0.673 . . . . 75.230000000000004 112.693 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.448 HG22 ' HA ' ' A' ' 25' ' ' GLU . 79.1 p -135.64 158.59 43.99 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 122.322 -0.517 . . . . 61.340000000000003 111.961 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.4 p -133.57 144.6 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 121.035 0.445 . . . . 71.420000000000002 111.008 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -152.54 150.76 29.91 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.456 -0.338 . . . . 73.200000000000003 111.393 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HB2' HD21 ' A' ' 67' ' ' LEU . 29.0 ttpt -83.53 127.46 33.74 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.994 -0.441 . . . . 74.030000000000001 110.219 170.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.5 t -126.24 156.19 40.67 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.339 0.59 . . . . 73.420000000000002 112.325 -172.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.607 ' HA ' HH21 ' A' ' 72' ' ' ARG . 8.5 p-10 -82.32 -5.6 58.7 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.002 -0.545 . . . . 74.400000000000006 111.22 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -69.36 157.19 37.52 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.943 -0.571 . . . . 74.209999999999994 111.372 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -88.3 157.51 18.73 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.91 0.385 . . . . 72.120000000000005 111.37 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 91.2 t -69.31 138.26 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 116.325 -0.398 . . . . 72.409999999999997 110.951 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 135' ' ' LEU . 14.6 mt -70.88 133.76 46.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.698 0.285 . . . . 73.299999999999997 111.464 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 44.7 t -78.42 145.72 34.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.464 -0.569 . . . . 70.420000000000002 109.464 171.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.558 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 96.5 t -46.39 -45.95 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 111.86 0.319 . . . . 63.009999999999998 111.86 -177.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.435 ' HA ' HD12 ' A' ' 141' ' ' LEU . 25.1 ttpp -71.25 -41.25 70.33 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.691 0.281 . . . . 72.420000000000002 111.422 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -55.91 -37.03 68.36 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.918 0.866 . . . . 62.439999999999998 109.611 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.487 HD11 ' HA ' ' A' ' 103' ' ' TYR . 1.0 OUTLIER -68.85 -38.39 79.74 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.528 -1.215 . . . . 74.340000000000003 111.002 176.935 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 53.9 mt . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 121.609 0.718 . . . . 74.209999999999994 110.227 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 10.4 ptm . . . . . 0 CA--C 1.541 0.598 0 CA-C-O 120.757 0.313 . . . . 73.239999999999995 111.304 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.545 HD12 ' HG ' ' A' ' 65' ' ' LEU . 17.1 mt -118.05 133.83 55.54 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.648 0.61 . . . . 75.239999999999995 112.648 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -79.57 119.08 22.04 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.941 -0.572 . . . . 33.509999999999998 110.2 173.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 m -133.87 161.3 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.953 0.406 . . . . 72.129999999999995 111.91 -175.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 31.5 tt0 -99.22 113.43 25.69 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.946 0.403 . . . . 74.120000000000005 110.373 174.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.489 HG22 HD11 ' A' ' 96' ' ' ILE . 45.4 t -89.65 112.93 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.231 0.539 . . . . 65.049999999999997 111.861 -173.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.31 159.36 3.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.923 0.392 . . . . 75.409999999999997 111.745 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 75.2 m -135.43 104.65 5.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.085 0.469 . . . . 74.140000000000001 111.303 175.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.444 0 C-N-CA 120.963 -0.636 . . . . 62.310000000000002 112.372 -179.305 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 121.213 0.53 . . . . 73.209999999999994 111.34 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -65.1 -27.4 68.73 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.915 -0.584 . . . . 74.150000000000006 110.494 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -83.25 -9.18 59.27 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.941 -0.572 . . . . 73.310000000000002 111.745 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -116.89 -0.49 12.23 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.948 0.404 . . . . 70.319999999999993 111.64 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.81 -52.34 4.12 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.867 0.691 . . . . 71.340000000000003 112.867 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.464 HG21 ' HD2' ' A' ' 102' ' ' PRO . 35.5 m -116.35 19.86 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 113.445 0.906 . . . . 31.300000000000001 113.445 -172.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.654 ' N ' HD22 ' A' ' 53' ' ' ASN . 0.7 OUTLIER -100.73 18.57 19.03 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.898 0.703 . . . . 74.409999999999997 112.898 -171.478 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.462 ' CD1' ' HD2' ' A' ' 87' ' ' LYS . 47.1 p90 -144.6 165.58 27.6 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.462 0.542 . . . . 75.040000000000006 112.462 -174.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.32 142.51 49.37 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.623 -0.717 . . . . 73.549999999999997 110.685 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 44.5 mt-10 -101.04 118.48 37.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.938 0.399 . . . . 75.230000000000004 111.475 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.497 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.8 mp -110.55 152.12 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 116.179 -0.464 . . . . 61.210000000000001 111.302 -177.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -68.44 153.77 43.12 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.671 0.388 . . . . 74.209999999999994 111.347 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -57.67 -46.33 84.39 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.115 0.483 . . . . 75.239999999999995 112.096 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.92 -47.9 82.87 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.79 0.329 . . . . 65.099999999999994 111.694 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -65.84 -35.92 82.01 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.199 0.524 . . . . 75.049999999999997 111.165 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.424 ' HZ2' ' N ' ' A' ' 69' ' ' GLU . 40.4 t-105 -55.55 -54.05 48.86 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.78 -0.645 . . . . 75.109999999999999 110.919 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -64.61 -33.83 76.85 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.048 -0.524 . . . . 71.329999999999998 111.475 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.511 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -60.15 -43.8 95.47 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.912 0.387 . . . . 32.299999999999997 111.947 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.642 HD11 HG13 ' A' ' 127' ' ' VAL . 93.4 mt -84.6 -9.25 58.46 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.001 0.371 . . . . 60.450000000000003 112.001 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.3 45.68 68.49 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.117 -0.563 . . . . 75.510000000000005 112.637 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.66 HD23 ' HE2' ' A' ' 129' ' ' LYS . 74.0 mt -83.37 166.63 18.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.385 0.612 . . . . 55.5 112.071 -177.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -147.25 121.39 9.49 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.853 -0.612 . . . . 71.510000000000005 109.898 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.424 ' N ' ' HZ2' ' A' ' 62' ' ' TRP . 43.0 mt-10 -44.52 98.62 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.283 0.846 . . . . 74.209999999999994 113.283 -169.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.79 -4.24 8.56 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 115.084 -0.962 . . . . 75.319999999999993 113.735 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.02 -176.61 5.59 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 117.8 0.8 . . . . 63.219999999999999 112.05 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.487 ' HG3' HG23 ' A' ' 134' ' ' VAL . 8.8 mpt_? -107.19 123.61 48.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.125 -0.489 . . . . 61.340000000000003 111.813 -176.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.3 m -115.42 145.04 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.307 0.575 . . . . 64.299999999999997 111.516 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.78 ' HD3' ' HE3' ' A' ' 76' ' ' LYS . 24.0 ttmm -108.73 146.99 32.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.813 -0.63 . . . . 73.230000000000004 110.534 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 64.5 t -130.55 129.57 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.269 -0.423 . . . . 62.219999999999999 110.704 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.78 ' HE3' ' HD3' ' A' ' 74' ' ' LYS . 38.7 mttt -130.94 125.54 33.7 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.929 0.395 . . . . 75.129999999999995 112.058 -175.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.668 HG22 ' HA3' ' A' ' 125' ' ' GLY . 42.6 p -126.45 -171.06 2.31 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 116.507 -0.315 . . . . 62.350000000000001 110.557 177.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.63 -6.46 52.12 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.901 0.382 . . . . 63.130000000000003 111.528 175.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -91.98 -60.78 1.77 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.869 0.366 . . . . 72.030000000000001 110.776 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.33 -144.45 4.03 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.221 -0.514 . . . . 73.25 112.796 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 0.3 OUTLIER -154.52 159.28 40.86 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 117.12 0.46 . . . . 52.43 111.204 178.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 106' ' ' MET . 8.8 p -157.46 144.45 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 111.928 0.344 . . . . 62.420000000000002 111.928 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.8 t -105.54 118.52 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 122.48 0.312 . . . . 71.129999999999995 110.587 174.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.49 HG12 ' HD2' ' A' ' 103' ' ' TYR . 35.3 m -128.18 176.5 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 120.996 0.427 . . . . 72.439999999999998 112.06 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -79.49 140.98 37.13 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.976 0.417 . . . . 73.439999999999998 111.34 176.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.8 126.16 36.78 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.758 0.651 . . . . 63.240000000000002 112.758 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 62.3 mttm -126.84 143.71 51.18 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.199 0.523 . . . . 74.400000000000006 110.901 173.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -88.78 121.36 31.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.973 -0.558 . . . . 74.030000000000001 110.573 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.4 -179.62 15.8 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.711 -0.757 . . . . 73.349999999999994 114.21 -174.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -90.66 18.9 5.85 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.958 0.409 . . . . 70.430000000000007 111.353 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.1 m -72.49 151.83 91.76 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.251 -0.431 . . . . 71.530000000000001 111.896 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -62.04 160.57 29.47 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 122.755 2.303 . . . . 74.450000000000003 113.61 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -69.0 138.76 54.78 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.824 0.345 . . . . 73.109999999999999 111.453 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.06 26.59 73.98 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.968 -0.634 . . . . 61.329999999999998 112.298 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.528 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 23.5 ttt -149.8 136.61 19.4 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.653 -0.322 . . . . 73.540000000000006 110.297 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 28' ' ' VAL . 39.8 pt -135.25 146.81 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 121.263 0.554 . . . . 71.239999999999995 111.851 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -106.17 130.15 54.1 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.177 -0.465 . . . . 73.239999999999995 111.564 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 30' ' ' SER . 44.9 mt -124.32 132.06 24.26 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 120.753 0.311 . . . . 72.140000000000001 110.629 173.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.425 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 37.6 Cg_exo -58.91 131.88 44.35 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.229 1.953 . . . . 73.299999999999997 112.368 173.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.7 tpt -51.39 107.94 0.22 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 111.906 0.335 . . . . 65.450000000000003 111.906 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.14 -176.84 38.37 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.574 -0.822 . . . . 61.539999999999999 113.413 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.464 ' HD2' HG21 ' A' ' 52' ' ' VAL . 15.2 Cg_endo -55.92 -35.44 94.18 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.169 2.579 . . . . 72.450000000000003 112.952 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.49 ' HD2' HG12 ' A' ' 84' ' ' VAL . 30.7 m-85 -61.87 -51.56 67.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.057 0.456 . . . . 74.219999999999999 110.634 177.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -62.0 -38.3 88.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.099 0.476 . . . . 54.350000000000001 111.04 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -54.55 -26.17 30.45 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.898 0.479 . . . . 75.409999999999997 112.006 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.584 ' SD ' HD21 ' A' ' 140' ' ' LEU . 84.9 mmm -69.54 -16.78 63.5 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.347 0.499 . . . . 73.25 112.347 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.84 -19.03 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 113.472 0.916 . . . . 73.349999999999994 113.472 -174.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.583 HG21 ' OG ' ' A' ' 30' ' ' SER . 8.0 pt -98.5 179.96 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 112.852 0.686 . . . . 75.140000000000001 112.852 -175.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.9 t70 . . . . . 0 CA--C 1.545 0.774 0 CA-C-N 115.874 -0.603 . . . . 72.340000000000003 111.03 176.929 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.634 0 CA-C-O 120.778 0.099 . . . . 71.010000000000005 112.928 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 93.5 t -80.12 118.08 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 122.533 -0.392 . . . . 72.340000000000003 111.07 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 39.3 mtpt -67.31 155.55 38.63 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.657 0.741 . . . . 71.120000000000005 112.913 -177.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.668 ' HA3' HG22 ' A' ' 77' ' ' THR . . . 179.68 -147.85 7.75 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.055 -0.975 . . . . 72.430000000000007 112.144 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 45.1 p -138.51 153.3 48.75 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 122.292 -0.534 . . . . 72.420000000000002 111.757 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.642 HG13 HD11 ' A' ' 65' ' ' LEU . 14.8 p -128.11 145.24 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.138 -0.483 . . . . 61.299999999999997 110.254 175.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 7.3 pt-20 -148.69 151.31 34.7 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.81 0.67 . . . . 74.310000000000002 112.81 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.66 ' HE2' HD23 ' A' ' 67' ' ' LEU . 14.5 tppt? -69.51 106.38 2.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.535 -0.757 . . . . 63.439999999999998 109.966 167.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.1 t -100.8 161.8 13.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.451 0.643 . . . . 70.010000000000005 112.34 -176.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -100.53 0.7 39.98 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.554 -0.748 . . . . 71.540000000000006 110.62 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -88.39 179.52 6.31 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.07 0.767 . . . . 74.299999999999997 113.07 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -100.26 161.61 13.49 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.292 -0.867 . . . . 71.219999999999999 111.609 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.487 HG23 ' HG3' ' A' ' 72' ' ' ARG . 93.3 t -70.1 137.64 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 120.771 0.32 . . . . 64.340000000000003 111.56 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 135' ' ' LEU . 6.5 mt -77.81 98.04 5.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.679 -0.237 . . . . 70.239999999999995 111.219 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 70.9 p -55.19 153.68 6.59 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.696 0.284 . . . . 75.129999999999995 111.45 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.559 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 86.8 t -45.8 -53.73 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.971 0.73 . . . . 74.349999999999994 112.971 -172.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -72.35 -42.0 65.82 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.23 0.456 . . . . 73.340000000000003 112.23 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -56.51 -39.99 74.26 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.564 0.697 . . . . 60.210000000000001 109.977 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.584 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.3 tt -60.58 -41.62 95.05 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.071 -0.968 . . . . 64.209999999999994 110.772 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 68.3 mt . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 121.173 0.511 . . . . 70.319999999999993 110.818 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 8.8 ptm . . . . . 0 CA--C 1.539 0.557 0 CA-C-O 120.926 0.393 . . . . 72.340000000000003 110.769 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.581 HD11 ' HB3' ' A' ' 64' ' ' ALA . 32.6 mt -90.53 132.13 35.87 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.831 0.678 . . . . 74.239999999999995 112.831 -173.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -78.74 118.56 20.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.52 -0.764 . . . . 61.450000000000003 111.04 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 35.4 m -139.32 164.38 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.992 -1.004 . . . . 75.120000000000005 112.027 -173.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 34.8 tt0 -99.47 121.85 41.73 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.858 0.361 . . . . 42.32 110.435 171.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.478 HG22 HD11 ' A' ' 96' ' ' ILE . 39.3 t -96.42 110.2 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.258 -0.428 . . . . 74.239999999999995 111.608 -175.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.507 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 2.9 mt -95.73 161.06 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.927 0.394 . . . . 74.109999999999999 111.905 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.616 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 73.5 m -129.33 95.44 4.03 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.01 0.434 . . . . 72.25 111.212 174.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.696 0 C-N-CA 121.097 -0.573 . . . . 60.539999999999999 113.078 -178.493 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 CA--C 1.538 0.509 0 CA-C-O 121.154 0.502 . . . . 72.329999999999998 110.579 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.492 ' O ' HG22 ' A' ' 52' ' ' VAL . 13.0 t80 -65.5 -43.09 91.22 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.893 -0.594 . . . . 74.109999999999999 110.4 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.481 ' HD1' HG23 ' A' ' 137' ' ' VAL . 75.4 t80 -58.65 -62.07 2.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.716 -0.674 . . . . 63.539999999999999 110.452 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -59.96 -23.89 63.95 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.621 0.6 . . . . 61.140000000000001 112.621 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.78 -33.01 58.07 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.795 0.665 . . . . 73.430000000000007 112.795 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.553 HG21 ' HD2' ' A' ' 102' ' ' PRO . 30.5 m -123.49 14.8 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 113.575 0.954 . . . . 75.230000000000004 113.575 -173.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -96.57 19.66 11.93 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.963 0.727 . . . . 75.129999999999995 112.963 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -145.5 159.21 43.44 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.897 -0.502 . . . . 71.310000000000002 112.279 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.38 141.59 51.98 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.787 -0.642 . . . . 43.329999999999998 110.687 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.786 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 41.5 mt-10 -97.9 111.98 24.08 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.838 0.351 . . . . 71.349999999999994 111.272 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.9 mp -110.88 149.9 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.333 -0.394 . . . . 73.439999999999998 111.032 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -74.45 144.8 44.09 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.548 0.213 . . . . 65.010000000000005 110.438 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.438 ' HA ' ' HB3' ' A' ' 62' ' ' TRP . 27.6 tt0 -55.33 -32.91 62.89 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.314 0.487 . . . . 75.349999999999994 112.314 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.598 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 17.3 mm-40 -54.97 -57.08 13.11 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 111.977 0.362 . . . . 74.5 111.977 175.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.02 -34.99 78.93 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.441 0.639 . . . . 55.25 110.45 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.517 ' HA ' HD12 ' A' ' 67' ' ' LEU . 43.3 t-105 -53.08 -50.27 64.72 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.171 -0.922 . . . . 75.409999999999997 111.478 177.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -69.13 -39.1 79.07 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.155 -0.475 . . . . 71.010000000000005 111.462 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.581 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -56.27 -34.33 66.33 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.245 0.461 . . . . 42.32 112.245 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.0 mt -91.84 -18.32 23.99 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.377 -0.374 . . . . 75.340000000000003 111.849 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.03 46.33 10.57 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.154 -0.546 . . . . 54.140000000000001 112.657 -176.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.683 HD23 ' HD3' ' A' ' 129' ' ' LYS . 91.6 mt -84.09 143.19 29.87 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.271 0.558 . . . . 70.150000000000006 112.424 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -101.09 156.15 17.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.013 -0.54 . . . . 74.439999999999998 110.645 170.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.35 93.21 1.49 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.735 0.779 . . . . 65.310000000000002 111.11 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.76 -3.62 8.61 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 114.777 -1.101 . . . . 72.430000000000007 112.113 -171.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.47 173.79 1.5 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.23 0.538 . . . . 71.109999999999999 112.093 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -113.86 124.47 52.3 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.267 -0.424 . . . . 74.329999999999998 111.353 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.642 HG13 ' HB2' ' A' ' 86' ' ' ALA . 17.5 m -114.33 142.11 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.333 0.587 . . . . 74.120000000000005 112.232 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.581 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 38.5 ttmt -99.47 147.31 25.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.857 -0.611 . . . . 74.439999999999998 110.172 173.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -128.54 124.03 60.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.239 -0.652 . . . . 53.25 109.239 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.581 ' HD2' ' HD2' ' A' ' 74' ' ' LYS . 6.5 mtpm? -133.93 130.12 37.28 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.546 0.573 . . . . 55.240000000000002 112.546 -170.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.742 HG22 ' HA3' ' A' ' 125' ' ' GLY . 25.0 p -136.62 -171.23 2.86 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.797 -0.638 . . . . 55.450000000000003 110.545 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.91 -14.91 63.27 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.961 -0.563 . . . . 63.520000000000003 111.853 175.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -89.2 -38.64 14.11 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 111.796 0.295 . . . . 72.120000000000005 111.796 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.31 -160.93 34.6 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.345 -0.455 . . . . 62.039999999999999 112.979 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.19 149.85 51.04 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.267 0.556 . . . . 64.230000000000004 112.202 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.525 HG23 HD12 ' A' ' 135' ' ' LEU . 12.5 p -147.46 147.26 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.142 -0.481 . . . . 74.299999999999997 110.948 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -111.12 119.07 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 122.31 -0.244 . . . . 71.040000000000006 110.997 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.465 ' HA ' HG13 ' A' ' 134' ' ' VAL . 34.3 m -129.57 174.25 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 111.921 0.341 . . . . 73.019999999999996 111.921 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -75.37 143.38 42.83 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.97 0.414 . . . . 73.430000000000007 111.458 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.642 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -94.5 122.12 36.75 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.216 0.45 . . . . 32.229999999999997 112.216 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -128.33 141.17 51.51 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.304 0.573 . . . . 65.329999999999998 111.08 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.419 ' HD3' ' HB2' ' A' ' 59' ' ' GLU . 35.3 ttmt -80.11 103.99 10.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.717 -0.674 . . . . 75.209999999999994 110.689 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.786 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -100.51 -163.9 28.29 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 121.256 -0.497 . . . . 71.549999999999997 114.298 -172.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -111.25 32.45 5.32 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.365 0.602 . . . . 51.420000000000002 111.292 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.1 m -92.37 158.41 38.86 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.974 -0.557 . . . . 63.240000000000002 111.817 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.97 163.14 37.59 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.302 2.001 . . . . 72.010000000000005 112.859 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.598 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 78.8 tttt -63.32 143.34 57.88 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.767 0.318 . . . . 71.430000000000007 111.574 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 68.22 28.78 73.18 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.877 -0.678 . . . . 63.409999999999997 112.961 -175.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.51 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 23.5 ttt -154.62 137.0 14.95 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.472 -0.428 . . . . 74.239999999999995 110.309 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.478 HD11 HG22 ' A' ' 28' ' ' VAL . 41.9 pt -134.87 144.37 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.359 0.6 . . . . 72.409999999999997 112.082 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -106.09 124.19 49.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.021 -0.536 . . . . 51.420000000000002 111.415 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 30' ' ' SER . 54.4 mt -121.02 131.45 24.48 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.559 -0.291 . . . . 73.239999999999995 110.427 174.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.402 ' HB2' HG12 ' A' ' 52' ' ' VAL . 31.7 Cg_exo -60.48 138.82 82.89 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.14 1.893 . . . . 65.319999999999993 112.399 175.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.7 104.73 0.16 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.444 -0.344 . . . . 62.409999999999997 110.839 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.97 -173.84 25.91 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.712 -0.756 . . . . 63.030000000000001 113.107 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.553 ' HD2' HG21 ' A' ' 52' ' ' VAL . 34.8 Cg_endo -64.7 -31.59 58.56 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.352 2.035 . . . . 73.430000000000007 111.566 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.502 ' HA ' HD11 ' A' ' 140' ' ' LEU . 8.2 m-85 -62.85 -48.17 80.2 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.701 -0.681 . . . . 74.230000000000004 110.146 175.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -59.64 -43.55 93.81 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.911 -0.586 . . . . 72.010000000000005 111.517 173.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -54.89 -20.1 8.06 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.536 0.569 . . . . 73.409999999999997 112.536 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.547 ' SD ' HD21 ' A' ' 140' ' ' LEU . 88.5 mmm -69.45 -31.56 69.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.858 0.361 . . . . 72.109999999999999 111.435 177.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.453 ' HB ' HG23 ' A' ' 77' ' ' THR . 31.0 m -123.59 -8.36 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 113.293 0.849 . . . . 65.420000000000002 113.293 -171.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.558 HG21 ' OG ' ' A' ' 30' ' ' SER . 8.0 pt -106.05 177.48 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.565 0.698 . . . . 71.409999999999997 112.452 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.416 ' H ' HG21 ' A' ' 123' ' ' VAL . 25.7 t70 . . . . . 0 CA--C 1.543 0.683 0 CA-C-N 115.544 -0.753 . . . . 64.099999999999994 110.67 175.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . . . . . . 0 CA--C 1.524 0.597 0 CA-C-O 121.15 0.305 . . . . 72.439999999999998 113.133 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.416 HG21 ' H ' ' A' ' 109' ' ' ASP . 89.5 t -86.89 122.28 38.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.633 0.254 . . . . 72.150000000000006 111.515 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 68.0 mttm -71.71 147.32 47.52 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.463 0.649 . . . . 75.510000000000005 112.35 -177.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.742 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -175.15 -138.59 2.8 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.479 -0.782 . . . . 73.099999999999994 112.527 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 57.3 p -140.43 158.64 43.7 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.06 0.457 . . . . 73.5 111.748 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.1 p -135.29 145.23 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.988 -0.551 . . . . 64.209999999999994 110.472 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.519 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 5.9 pt-20 -149.04 155.21 40.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.684 0.278 . . . . 62.420000000000002 111.383 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.683 ' HD3' HD23 ' A' ' 67' ' ' LEU . 28.0 ttpp -85.68 133.54 34.02 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.607 -0.516 . . . . 73.519999999999996 109.607 168.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.6 t -130.72 161.08 32.46 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.601 0.715 . . . . 55.509999999999998 112.858 -171.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.09 -21.31 33.73 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.409 -0.814 . . . . 74.329999999999998 110.164 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -61.73 157.21 18.38 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.847 -0.615 . . . . 73.319999999999993 112.579 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.532 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -90.52 162.29 15.1 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.912 -0.585 . . . . 74.340000000000003 111.1 179.33 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 84' ' ' VAL . 98.4 t -65.81 133.23 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.458 -0.337 . . . . 72.439999999999998 111.035 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.525 HD12 HG23 ' A' ' 82' ' ' VAL . 13.2 mt -63.01 138.28 58.51 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.134 0.492 . . . . 74.450000000000003 111.405 177.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.0 t -85.41 144.93 27.72 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.087 -0.709 . . . . 64.129999999999995 109.087 170.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.481 HG23 ' HD1' ' A' ' 49' ' ' PHE . 86.5 t -48.46 -47.05 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 112.093 0.405 . . . . 71.409999999999997 112.093 -175.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -67.83 -41.46 82.99 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.958 0.408 . . . . 64.450000000000003 111.525 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -62.14 -33.52 74.64 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.581 0.705 . . . . 72.400000000000006 110.404 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.547 HD21 ' SD ' ' A' ' 106' ' ' MET . 1.9 tt -66.63 -34.29 77.55 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.127 -0.942 . . . . 63.219999999999999 110.85 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 56.0 mt . . . . . 0 N--CA 1.472 0.673 0 CA-C-O 121.633 0.73 . . . . 73.530000000000001 109.943 175.144 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 7.8 ptp . . . . . 0 CA--C 1.539 0.531 0 CA-C-O 120.997 0.427 . . . . 63.43 111.219 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.495 HD12 ' HG ' ' A' ' 65' ' ' LEU . 25.3 mt -121.46 127.02 50.66 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.129 0.49 . . . . 74.420000000000002 111.813 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -71.7 115.61 11.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.585 -0.734 . . . . 64.530000000000001 111.02 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 27.8 m -128.51 160.07 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.55 0.574 . . . . 63.140000000000001 112.55 -174.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.618 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 52.9 tt0 -99.27 117.32 33.45 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.945 0.402 . . . . 63.130000000000003 110.696 174.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.502 HG22 HD11 ' A' ' 96' ' ' ILE . 40.9 t -92.35 108.51 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.142 0.496 . . . . 50.5 112.121 -175.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -102.24 146.95 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.936 0.398 . . . . 75.049999999999997 112.027 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 73.6 m -106.6 104.42 14.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.157 -0.474 . . . . 73.430000000000007 111.667 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . . . . . . 0 CA--C 1.522 0.528 0 C-N-CA 120.885 -0.674 . . . . 40.210000000000001 112.894 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 CA--C 1.538 0.507 0 CA-C-O 120.733 0.302 . . . . 72.430000000000007 111.223 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -58.18 -40.02 80.4 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.298 0.57 . . . . 72.109999999999999 109.849 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -64.52 -62.03 1.85 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.559 -0.746 . . . . 75.299999999999997 110.306 176.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -64.62 -4.31 4.03 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.09 0.774 . . . . 74.319999999999993 113.09 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.22 -33.01 14.86 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.61 0.596 . . . . 51.25 112.61 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.58 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 34.8 m -129.48 20.15 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 113.15 0.796 . . . . 64.420000000000002 113.15 -173.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -103.02 21.53 15.56 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.124 0.787 . . . . 62.049999999999997 113.124 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -140.89 158.43 43.96 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.168 0.509 . . . . 71.150000000000006 112.143 -177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.89 138.79 51.13 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.909 -0.587 . . . . 72.510000000000005 110.853 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.667 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 39.6 mt-10 -93.78 112.66 24.56 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.637 0.256 . . . . 71.400000000000006 111.361 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.3 mp -109.81 146.06 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 116.529 -0.305 . . . . 55.25 110.764 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -68.43 143.92 54.88 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.811 0.339 . . . . 72.310000000000002 111.399 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -47.46 -40.05 17.31 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.117 0.567 . . . . 74.420000000000002 112.251 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -58.37 -54.35 47.97 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.087 0.47 . . . . 74.230000000000004 111.399 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -66.37 -33.67 76.25 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.227 0.537 . . . . 73.209999999999994 110.915 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 46.2 t-105 -54.16 -54.23 42.51 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.693 -0.685 . . . . 73.439999999999998 111.429 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -69.42 -36.38 76.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.525 -0.307 . . . . 74.400000000000006 111.66 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.444 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -59.64 -34.65 73.07 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.983 0.42 . . . . 71.120000000000005 111.88 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.495 ' HG ' HD12 ' A' ' 24' ' ' LEU . 94.6 mt -90.91 -12.17 36.9 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.473 -0.331 . . . . 74.310000000000002 111.751 177.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.12 46.51 50.49 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.123 -0.561 . . . . 70.120000000000005 112.657 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.494 ' HA ' ' HZ1' ' A' ' 129' ' ' LYS . 93.7 mt -86.6 159.51 19.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.616 0.722 . . . . 73.400000000000006 112.078 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -140.87 134.78 30.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.184 -0.916 . . . . 74.409999999999997 109.129 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -56.17 97.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.631 0.729 . . . . 74.049999999999997 112.094 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 143.28 -22.9 2.23 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.15 -0.932 . . . . 54.240000000000002 113.956 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -86.25 178.0 7.31 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 118.251 1.026 . . . . 71.420000000000002 112.627 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.664 HH11 HG23 ' A' ' 134' ' ' VAL . 60.9 mtt-85 -109.52 139.95 43.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.812 -0.631 . . . . 65.329999999999998 112.003 -169.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 86' ' ' ALA . 31.4 m -124.06 140.03 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.921 -0.581 . . . . 61.43 111.212 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -107.99 131.25 54.76 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.921 0.391 . . . . 73.510000000000005 110.896 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 50.5 t -106.81 130.47 58.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.397 -0.365 . . . . 54.100000000000001 111.026 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.506 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -117.18 127.88 54.55 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.017 0.437 . . . . 54.43 111.307 177.475 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.646 HG22 ' HA3' ' A' ' 125' ' ' GLY . 21.4 p -135.53 -172.52 3.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.057 0.456 . . . . 62.130000000000003 110.57 175.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -71.29 -5.62 33.69 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.293 -0.412 . . . . 75.319999999999993 111.963 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -99.81 -20.55 16.15 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.026 0.38 . . . . 51.549999999999997 112.026 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 146.6 -151.63 23.87 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.982 -0.627 . . . . 43.439999999999998 113.202 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.506 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 9.5 pt-20 -140.3 149.94 43.41 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.8 0.333 . . . . 54.130000000000003 111.553 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.449 HG23 ' SD ' ' A' ' 106' ' ' MET . 12.8 p -149.11 148.67 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.528 -0.305 . . . . 74.219999999999999 111.135 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.07 117.71 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 120.542 0.21 . . . . 73.219999999999999 111.349 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.4 m -129.84 176.44 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.646 0.379 . . . . 55.549999999999997 111.657 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -79.66 145.97 32.72 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.016 0.436 . . . . 74.510000000000005 111.565 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.413 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -88.76 115.86 26.61 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 112.591 0.589 . . . . 74.319999999999993 112.591 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -113.27 157.39 21.84 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.621 0.725 . . . . 64.230000000000004 111.228 171.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -100.11 112.57 24.88 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.386 -0.825 . . . . 62.539999999999999 110.547 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.667 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -107.92 171.77 16.54 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.147 -0.549 . . . . 73.140000000000001 114.147 -174.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.61 18.34 13.07 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.32 0.581 . . . . 43.5 110.752 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.404 HG11 ' HB2' ' A' ' 97' ' ' PHE . 27.8 m -79.1 155.85 77.05 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.852 -0.613 . . . . 71.400000000000006 111.99 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.03 153.17 53.52 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.404 2.069 . . . . 75.340000000000003 112.588 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -62.65 148.75 45.44 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 122.161 -0.337 . . . . 75.040000000000006 111.151 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 66.17 27.29 72.84 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.521 -0.847 . . . . 74.310000000000002 112.41 -174.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.618 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 20.9 ttt -149.27 137.01 20.38 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.632 -0.507 . . . . 63.229999999999997 109.632 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 28' ' ' VAL . 38.9 pt -132.99 141.54 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 121.249 0.547 . . . . 72.239999999999995 111.864 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.493 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 59.1 t80 -101.87 118.38 36.8 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.966 -0.561 . . . . 73.209999999999994 111.369 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 30' ' ' SER . 51.5 mt -119.97 124.37 27.91 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.623 -0.262 . . . . 71.319999999999993 110.612 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.58 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 11.5 Cg_endo -55.82 137.23 77.98 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.184 1.922 . . . . 71.430000000000007 112.258 176.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.08 103.27 0.16 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.329 -0.396 . . . . 72.230000000000004 110.948 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.59 -176.12 24.85 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.559 -0.829 . . . . 75.430000000000007 112.87 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.51 ' HA ' HD22 ' A' ' 105' ' ' ASN . 22.4 Cg_endo -62.13 -28.03 79.4 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.023 1.815 . . . . 64.0 111.446 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.504 ' HA ' HD11 ' A' ' 140' ' ' LEU . 8.4 m-85 -66.89 -49.88 64.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.617 -0.72 . . . . 73.310000000000002 110.134 175.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.38 -40.09 81.37 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.854 -0.612 . . . . 73.319999999999993 111.443 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.51 HD22 ' HA ' ' A' ' 102' ' ' PRO . 91.0 m-20 -56.71 -25.11 53.52 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.214 0.53 . . . . 72.409999999999997 111.808 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.449 ' SD ' HG23 ' A' ' 82' ' ' VAL . 35.3 mtp -73.58 -21.53 60.31 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.912 -0.586 . . . . 73.010000000000005 112.313 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.5 m -133.67 -5.96 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.453 0.908 . . . . 71.319999999999993 113.453 -173.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 109' ' ' ASP . 1.6 pp -111.13 172.65 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.957 -0.464 . . . . 70.519999999999996 111.665 -177.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.472 ' N ' HG21 ' A' ' 123' ' ' VAL . 11.6 t70 . . . . . 0 CA--C 1.543 0.707 0 CA-C-N 116.252 -0.431 . . . . 70.209999999999994 111.636 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.6 0 N-CA-C 113.877 0.311 . . . . 74.019999999999996 113.877 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.472 HG21 ' N ' ' A' ' 109' ' ' ASP . 57.7 t -94.2 120.29 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 122.633 -0.333 . . . . 53.299999999999997 110.987 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 39.0 mtpt -73.83 153.5 39.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.015 0.912 . . . . 53.020000000000003 112.779 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.646 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -174.88 -150.1 7.6 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 114.323 -1.308 . . . . 44.350000000000001 111.346 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 44.0 p -132.87 146.95 52.26 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.449 0.625 . . . . 60.100000000000001 111.873 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -121.67 144.01 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.085 -0.507 . . . . 64.120000000000005 110.905 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -149.74 152.4 35.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.921 -0.581 . . . . 72.530000000000001 110.811 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.494 ' HZ1' ' HA ' ' A' ' 67' ' ' LEU . 19.6 ttmm -73.04 134.95 44.81 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.363 -0.606 . . . . 63.310000000000002 109.363 170.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.7 t -126.52 158.84 35.09 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.036 0.754 . . . . 72.519999999999996 113.036 -172.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -85.46 -15.78 41.81 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.11 -0.95 . . . . 74.519999999999996 110.911 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.466 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 19.2 mm-40 -73.81 156.08 38.16 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.496 0.665 . . . . 75.430000000000007 112.587 -177.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.02 156.99 29.8 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.29 -0.868 . . . . 75.430000000000007 111.309 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.664 HG23 HH11 ' A' ' 72' ' ' ARG . 70.4 t -69.7 131.03 34.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 109.85 -0.426 . . . . 71.439999999999998 109.85 173.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.43 HD13 ' HG ' ' A' ' 140' ' ' LEU . 13.5 mt -63.21 132.33 51.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.081 0.467 . . . . 71.450000000000003 112.099 -177.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 65.6 m -75.97 146.07 39.86 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.41 -0.589 . . . . 61.420000000000002 109.41 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 87.5 t -46.76 -50.98 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 112.859 0.689 . . . . 73.120000000000005 112.859 -172.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -72.92 -38.76 66.74 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.057 -0.402 . . . . 64.209999999999994 111.745 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -58.42 -37.7 75.91 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.745 0.783 . . . . 73.319999999999993 110.038 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.504 HD11 ' HA ' ' A' ' 103' ' ' TYR . 5.1 tt -59.59 -42.66 93.03 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.905 -1.043 . . . . 61.109999999999999 110.72 174.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 50.6 mt . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 121.205 0.526 . . . . 73.140000000000001 110.395 177.977 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.53 ' HA ' ' HB3' ' A' ' 128' ' ' GLU . 8.7 ptp . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 112.959 0.726 . . . . 73.230000000000004 112.959 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 64' ' ' ALA . 13.5 mt -117.39 140.34 49.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.123 -0.944 . . . . 61.530000000000001 110.887 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -79.26 110.33 14.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.669 0.747 . . . . 64.209999999999994 110.974 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 35.0 m -133.51 162.32 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.872 -1.058 . . . . 64.530000000000001 111.873 -171.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.579 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 28.3 tt0 -100.08 117.72 34.94 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.067 0.46 . . . . 55.240000000000002 110.531 172.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 96' ' ' ILE . 41.0 t -90.62 110.07 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.315 0.646 . . . . 72.409999999999997 111.457 -175.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.448 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 8.3 mt -91.98 152.21 3.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.871 0.367 . . . . 55.119999999999997 111.768 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.717 ' HB2' HG21 ' A' ' 108' ' ' ILE . 23.1 t -123.63 93.28 3.89 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.946 0.403 . . . . 74.430000000000007 110.081 172.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 100' ' ' MET . . . . . . . . 0 CA--C 1.522 0.498 0 C-N-CA 121.135 -0.555 . . . . 31.420000000000002 113.501 -175.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 CA--C 1.542 0.646 0 CA-C-O 120.761 0.315 . . . . 70.530000000000001 111.445 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -25.86 67.02 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.443 0.64 . . . . 71.400000000000006 109.973 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.401 ' HE1' ' HA ' ' A' ' 136' ' ' SER . 55.7 t80 -86.33 -17.5 34.37 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.864 -0.607 . . . . 74.430000000000007 111.052 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -84.61 -43.23 14.63 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.902 -0.498 . . . . 73.420000000000002 112.067 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.85 -63.78 1.33 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.69 0.996 . . . . 71.519999999999996 113.69 -170.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.509 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 28.3 m -88.31 20.95 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 113.661 0.985 . . . . 72.219999999999999 113.661 -167.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -105.24 12.22 32.11 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.175 0.806 . . . . 75.430000000000007 113.175 -173.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -137.31 164.74 27.84 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.817 -0.552 . . . . 74.140000000000001 111.834 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.54 141.39 52.06 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.849 -0.614 . . . . 64.340000000000003 111.182 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 97' ' ' PHE . 61.8 mt-10 -94.09 112.73 24.58 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.093 -0.503 . . . . 73.439999999999998 111.12 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.436 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.3 mp -109.89 145.76 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.501 -0.318 . . . . 73.5 110.665 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -66.51 151.83 46.44 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.659 0.266 . . . . 70.120000000000005 111.012 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 34.9 tt0 -57.76 -41.96 83.03 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.425 0.528 . . . . 45.340000000000003 112.425 -177.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -63.36 -48.52 77.59 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.785 0.326 . . . . 74.230000000000004 111.817 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -65.25 -36.77 85.16 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.12 0.486 . . . . 74.230000000000004 110.605 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.43 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 39.9 t-105 -52.92 -49.39 66.08 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.861 -0.608 . . . . 63.32 110.905 174.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -66.54 -40.56 89.14 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.782 -0.644 . . . . 71.140000000000001 111.167 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.465 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -60.77 -39.44 88.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.124 0.487 . . . . 62.43 111.95 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.515 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 68.4 mt -80.6 -10.44 59.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.069 -0.514 . . . . 72.540000000000006 111.461 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.49 40.24 97.52 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.404 -0.427 . . . . 74.230000000000004 112.652 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.515 ' HG ' ' HB2' ' A' ' 65' ' ' LEU . 96.1 mt -78.11 161.07 27.66 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.73 0.776 . . . . 63.130000000000003 112.572 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -138.63 130.49 27.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.328 -0.851 . . . . 75.120000000000005 109.59 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -55.51 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.59 0.71 . . . . 74.540000000000006 112.115 -174.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.57 -19.45 1.85 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-N 115.14 -0.936 . . . . 70.109999999999999 113.479 -176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -89.51 -169.95 2.67 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 117.683 0.741 . . . . 74.129999999999995 112.224 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.472 ' HD3' ' H ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -135.59 162.06 33.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.168 0.508 . . . . 73.519999999999996 111.977 -174.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.558 HG13 ' HB2' ' A' ' 86' ' ' ALA . 23.8 m -132.22 154.86 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.329 0.585 . . . . 72.109999999999999 112.36 -176.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.443 ' HB2' HG21 ' A' ' 130' ' ' THR . 12.5 tppt? -97.98 129.74 44.85 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.516 -0.765 . . . . 73.030000000000001 110.486 173.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 44.7 t -116.16 123.21 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 122.251 0.22 . . . . 55.119999999999997 110.445 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -124.46 124.85 43.19 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.952 0.406 . . . . 64.239999999999995 112.042 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.648 HG22 ' HA3' ' A' ' 125' ' ' GLY . 25.0 p -132.15 -171.43 2.63 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.061 0.458 . . . . 74.239999999999995 111.396 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -71.78 -2.77 18.8 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 112.666 0.617 . . . . 75.430000000000007 112.666 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -106.75 -40.45 5.51 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.931 0.396 . . . . 71.430000000000007 111.863 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.72 -149.0 10.53 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.98 -0.629 . . . . 63.039999999999999 112.633 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 11.4 pt-20 -149.36 150.09 31.91 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.385 0.612 . . . . 64.439999999999998 112.289 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 106' ' ' MET . 7.8 p -144.0 155.91 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.799 -0.637 . . . . 74.129999999999995 110.568 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.2 t -116.98 115.61 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.623 0.249 . . . . 64.510000000000005 110.722 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.23 168.65 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 116.263 -0.426 . . . . 74.540000000000006 111.668 -175.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -72.83 132.05 43.07 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.827 0.346 . . . . 74.310000000000002 111.364 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.558 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -86.24 121.94 29.54 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 111.978 0.362 . . . . 70.030000000000001 111.978 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -133.78 150.19 51.44 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.213 0.53 . . . . 71.400000000000006 111.319 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -85.41 103.47 14.34 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.947 -0.57 . . . . 44.549999999999997 110.357 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -120.08 -165.81 13.01 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 115.522 0.969 . . . . 64.340000000000003 115.522 -168.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -86.33 77.53 9.48 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.408 0.683 . . . . 64.120000000000005 111.869 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.7 m -149.05 152.37 36.3 Favored Pre-proline 0 N--CA 1.474 0.727 0 CA-C-N 115.443 -0.799 . . . . 75.439999999999998 111.655 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.55 168.52 16.19 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.779 2.32 . . . . 73.200000000000003 112.161 172.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -67.39 144.46 55.78 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.885 -0.509 . . . . 74.450000000000003 111.759 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 75.13 18.92 80.05 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.29 -0.481 . . . . 43.340000000000003 113.376 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.579 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 22.0 ttt -152.92 136.91 16.31 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.264 -0.551 . . . . 75.450000000000003 110.649 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.536 HD11 HG22 ' A' ' 28' ' ' VAL . 37.9 pt -132.53 150.72 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 121.179 0.514 . . . . 72.030000000000001 111.703 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.526 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 59.2 t80 -112.6 130.69 55.94 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.284 -0.416 . . . . 74.200000000000003 111.888 -176.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 30' ' ' SER . 40.1 mt -125.77 132.03 24.19 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 120.59 0.233 . . . . 55.32 110.795 173.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.509 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 51.2 Cg_exo -57.49 141.37 95.07 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.492 2.128 . . . . 74.319999999999993 112.789 176.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.442 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -61.03 103.68 0.3 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.799 0.333 . . . . 65.129999999999995 110.807 -178.524 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.26 -178.68 38.62 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.664 -0.779 . . . . 54.549999999999997 113.109 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.482 ' O ' ' HG2' ' A' ' 106' ' ' MET . 11.2 Cg_endo -54.62 -31.67 71.49 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.949 2.433 . . . . 75.310000000000002 112.668 -177.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.487 ' HA ' HD11 ' A' ' 140' ' ' LEU . 43.2 m-85 -66.09 -50.56 63.67 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.837 0.351 . . . . 70.530000000000001 110.843 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -62.06 -38.4 88.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.007 0.432 . . . . 74.209999999999994 110.778 174.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -53.09 -26.67 17.1 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.106 0.562 . . . . 71.510000000000005 112.241 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.623 ' SD ' HD21 ' A' ' 140' ' ' LEU . 86.9 mmm -73.85 -20.73 60.35 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.097 0.406 . . . . 73.349999999999994 112.097 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.81 -7.24 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 113.1 0.778 . . . . 73.239999999999995 113.1 -173.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.717 HG21 ' HB2' ' A' ' 30' ' ' SER . 11.4 pt -105.7 179.76 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 121.878 -0.514 . . . . 72.310000000000002 111.594 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.589 ' H ' HG21 ' A' ' 123' ' ' VAL . 22.4 t70 . . . . . 0 CA--C 1.54 0.585 0 CA-C-N 116.295 -0.411 . . . . 73.25 110.838 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . . . . . . 0 CA--C 1.526 0.777 0 CA-C-O 120.73 0.072 . . . . 53.409999999999997 112.93 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.589 HG21 ' H ' ' A' ' 109' ' ' ASP . 93.2 t -85.09 126.86 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.913 0.387 . . . . 74.530000000000001 111.324 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 21.7 mtpp -75.08 160.19 30.79 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.771 0.656 . . . . 72.340000000000003 112.771 -174.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.648 ' HA3' HG22 ' A' ' 77' ' ' THR . . . 171.94 -151.53 15.15 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 116.064 -0.516 . . . . 74.230000000000004 113.882 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 70.8 p -137.32 159.82 40.85 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 122.381 -0.482 . . . . 55.420000000000002 111.609 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.9 p -148.88 144.07 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 112.047 0.388 . . . . 74.530000000000001 112.047 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 23' ' ' MET . 9.1 pt-20 -153.35 159.65 42.51 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.881 0.472 . . . . 64.120000000000005 110.904 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -83.31 144.11 29.92 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.147 0.498 . . . . 24.100000000000001 111.377 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.443 HG21 ' HB2' ' A' ' 74' ' ' LYS . 4.0 t -150.03 161.84 41.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.861 -0.609 . . . . 52.520000000000003 111.653 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -76.62 -8.0 56.37 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.394 -0.366 . . . . 73.540000000000006 111.28 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -50.2 152.71 1.66 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.528 0.566 . . . . 71.420000000000002 112.528 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.591 ' HD2' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -87.31 146.75 25.8 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.838 -0.619 . . . . 72.540000000000006 111.604 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 71.9 t -68.84 131.97 33.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.799 0.333 . . . . 61.240000000000002 110.585 172.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.446 HD13 ' HG ' ' A' ' 140' ' ' LEU . 17.9 mt -66.98 147.29 53.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.858 0.361 . . . . 52.43 111.307 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.401 ' HA ' ' HE1' ' A' ' 49' ' ' PHE . 46.7 t -90.44 151.28 21.47 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.248 -0.649 . . . . 65.5 109.248 169.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.494 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 73.8 t -48.91 -47.34 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.002 0.43 . . . . 73.5 111.54 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -72.69 -40.41 66.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.296 -0.411 . . . . 74.230000000000004 111.979 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -60.36 -33.71 72.83 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.849 0.833 . . . . 73.019999999999996 110.249 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.623 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.5 tt -65.62 -39.35 91.4 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.914 -1.039 . . . . 71.319999999999993 110.379 174.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 57.1 mt . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 121.091 0.472 . . . . 72.25 110.386 175.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.721 ' HA ' ' HB3' ' A' ' 128' ' ' GLU . 10.0 ptp . . . . . 0 N--CA 1.466 0.337 0 CA-C-O 121.603 0.716 . . . . 65.349999999999994 112.477 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.604 HD13 ' HB3' ' A' ' 61' ' ' ASP . 10.0 mt -103.11 131.68 49.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.289 -0.869 . . . . 73.5 110.838 175.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -78.01 106.8 10.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.052 0.929 . . . . 74.129999999999995 111.176 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.429 HG12 ' HA2' ' A' ' 94' ' ' GLY . 32.9 m -132.58 166.85 28.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.392 -1.276 . . . . 73.230000000000004 111.947 -170.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 31.1 tt0 -103.4 123.05 46.12 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.115 0.483 . . . . 75.109999999999999 110.891 171.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.531 HG22 HD11 ' A' ' 96' ' ' ILE . 36.7 t -93.74 114.08 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 115.917 -0.583 . . . . 63.130000000000003 111.725 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.493 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 3.1 mt -98.99 161.5 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 112.244 0.461 . . . . 65.549999999999997 112.244 -176.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.63 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 75.0 m -127.76 105.65 8.6 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.242 -0.436 . . . . 62.530000000000001 110.907 174.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.404 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . . . . . . 0 CA--C 1.526 0.726 0 C-N-CA 121.174 -0.536 . . . . 73.25 113.593 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 N--CA 1.472 0.67 0 CA-C-O 120.826 0.346 . . . . 74.209999999999994 111.366 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.625 ' HE2' ' HD3' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -76.05 -23.02 55.07 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.989 0.423 . . . . 73.019999999999996 111.405 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.435 ' CD2' ' ND2' ' A' ' 53' ' ' ASN . 38.4 t80 -75.2 -69.34 0.48 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.325 0.583 . . . . 74.109999999999999 111.116 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -63.51 -8.19 8.84 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.943 0.72 . . . . 72.319999999999993 112.943 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.03 -34.28 13.77 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.632 0.975 . . . . 60.509999999999998 113.632 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 48' ' ' TYR . 28.8 m -131.92 7.58 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 N-CA-C 114.014 1.116 . . . . 75.319999999999993 114.014 -173.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.435 ' ND2' ' CD2' ' A' ' 49' ' ' PHE . 3.6 m-20 -90.71 20.58 4.59 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.105 0.78 . . . . 71.519999999999996 113.105 -174.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.442 ' CD2' ' HD3' ' A' ' 87' ' ' LYS . 26.3 p90 -140.1 152.75 46.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.166 0.507 . . . . 71.239999999999995 111.829 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -119.44 135.63 54.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.703 -0.681 . . . . 72.5 110.1 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.524 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 36.0 mt-10 -97.47 115.11 27.17 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.89 0.376 . . . . 73.329999999999998 111.085 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 58' ' ' ASN . 4.2 mp -109.13 156.73 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.169 0.509 . . . . 74.030000000000001 110.734 -177.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.659 ' ND2' HG23 ' A' ' 91' ' ' VAL . 3.1 m120 -63.57 151.78 40.54 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.893 -0.594 . . . . 71.340000000000003 111.308 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 30.1 tt0 -67.16 -41.3 86.25 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 111.847 0.314 . . . . 75.530000000000001 111.847 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -63.9 -49.54 72.26 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.84 0.352 . . . . 75.420000000000002 111.178 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.604 ' HB3' HD13 ' A' ' 24' ' ' LEU . 58.8 m-20 -65.96 -31.02 71.69 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.05 0.452 . . . . 72.349999999999994 111.349 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.427 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 62.7 t-105 -54.45 -54.58 38.93 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.308 0.575 . . . . 74.140000000000001 111.22 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -70.66 -29.8 66.24 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.993 -0.549 . . . . 52.310000000000002 111.14 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.76 -39.36 84.58 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.917 0.389 . . . . 35.25 111.453 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 128' ' ' GLU . 94.0 mt -88.54 -13.25 40.59 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.447 -0.342 . . . . 73.239999999999995 111.748 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.24 42.61 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.98 -0.628 . . . . 55.130000000000003 112.439 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.723 HD23 ' HE3' ' A' ' 129' ' ' LYS . 90.5 mt -85.36 158.79 20.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.611 0.72 . . . . 73.409999999999997 112.026 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -135.09 130.0 34.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.26 -0.882 . . . . 75.010000000000005 109.062 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.81 90.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.712 0.768 . . . . 61.340000000000003 111.917 -172.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.68 -7.33 2.47 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 114.765 -1.107 . . . . 74.109999999999999 114.38 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -90.71 -175.6 4.45 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 118.527 1.163 . . . . 73.439999999999998 112.735 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.484 ' HG3' HG23 ' A' ' 134' ' ' VAL . 8.5 mpt_? -106.05 133.87 50.08 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.261 0.553 . . . . 73.299999999999997 112.426 -172.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 86' ' ' ALA . 28.1 m -126.25 144.39 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.021 -0.536 . . . . 74.25 111.392 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.623 ' HD3' ' HE2' ' A' ' 76' ' ' LYS . 23.1 ttmm -105.32 151.06 24.62 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.111 0.481 . . . . 74.019999999999996 110.934 177.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.45 137.24 56.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.907 -0.588 . . . . 74.340000000000003 109.491 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.623 ' HE2' ' HD3' ' A' ' 74' ' ' LYS . 23.4 mttm -137.83 132.33 32.44 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.757 0.651 . . . . 61.299999999999997 112.757 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.537 HG22 ' HA3' ' A' ' 125' ' ' GLY . 32.8 p -136.09 -171.75 2.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.62 -0.718 . . . . 72.150000000000006 110.19 176.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.29 -8.92 57.93 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.796 0.331 . . . . 73.049999999999997 111.501 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -91.3 -38.5 12.61 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.777 0.322 . . . . 71.329999999999998 111.493 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.26 -148.27 11.96 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.127 -0.559 . . . . 24.23 112.994 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -154.5 156.74 37.24 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.254 0.465 . . . . 54.149999999999999 112.254 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -153.49 150.34 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 116.213 -0.448 . . . . 64.5 111.288 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.2 t -110.58 118.02 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 110.399 -0.223 . . . . 74.5 110.399 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.483 HG12 ' CD2' ' A' ' 103' ' ' TYR . 33.6 m -124.78 177.24 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 120.808 0.337 . . . . 72.519999999999996 111.78 -177.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -79.73 144.88 33.25 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.853 0.359 . . . . 72.209999999999994 111.351 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.536 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -90.27 123.5 34.11 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.482 0.549 . . . . 72.109999999999999 112.482 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.442 ' HD3' ' CD2' ' A' ' 54' ' ' TYR . 43.3 mtpt -133.21 156.75 46.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.021 -0.536 . . . . 61.030000000000001 110.734 173.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -98.15 128.71 44.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.218 -0.446 . . . . 73.340000000000003 111.291 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.524 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -128.35 154.52 20.0 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.976 -0.63 . . . . 62.32 113.47 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.32 46.75 0.75 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.158 0.504 . . . . 44.340000000000003 111.54 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.659 HG23 ' ND2' ' A' ' 58' ' ' ASN . 28.5 m -95.58 159.79 31.83 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 116.09 -0.505 . . . . 72.010000000000005 111.564 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . 0.432 ' O ' ' HB3' ' A' ' 95' ' ' MET . 38.6 Cg_exo -62.1 134.24 48.25 Favored 'Trans proline' 0 N--CA 1.487 1.104 0 C-N-CA 122.887 2.391 . . . . 65.0 113.059 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -53.79 134.5 42.32 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 120.775 0.322 . . . . 74.430000000000007 111.821 -175.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.429 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 76.49 27.88 60.61 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 120.722 -0.752 . . . . 73.25 112.745 -172.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.537 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 22.3 ttt -153.39 135.07 14.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.448 -0.575 . . . . 64.409999999999997 109.448 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.531 HD11 HG22 ' A' ' 28' ' ' VAL . 39.5 pt -128.03 144.27 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.47 0.652 . . . . 70.310000000000002 112.093 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.404 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 77.2 t80 -105.3 119.55 39.35 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.909 -0.587 . . . . 71.420000000000002 111.564 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.63 ' O ' ' HA ' ' A' ' 30' ' ' SER . 48.2 mt -117.34 128.96 25.67 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 109.916 -0.401 . . . . 64.239999999999995 109.916 172.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.455 ' HB2' HG12 ' A' ' 52' ' ' VAL . 47.8 Cg_exo -57.84 141.8 96.01 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.033 1.822 . . . . 73.409999999999997 112.576 176.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.6 tpt -55.29 102.38 0.07 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.91 0.386 . . . . 72.430000000000007 111.501 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -158.97 179.65 34.46 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.59 -0.814 . . . . 74.540000000000006 113.52 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.625 ' HD3' ' HE2' ' A' ' 48' ' ' TYR . 36.5 Cg_endo -63.54 -26.44 69.8 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.529 2.152 . . . . 73.0 112.213 -176.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.483 ' CD2' HG12 ' A' ' 84' ' ' VAL . 26.9 m-85 -61.49 -48.99 78.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.784 0.802 . . . . 73.329999999999998 109.309 173.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.28 75.25 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.221 -0.899 . . . . 73.150000000000006 111.391 173.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' A' ' 102' ' ' PRO . 8.7 m120 -62.92 -12.69 26.92 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 122.045 -0.409 . . . . 65.329999999999998 111.844 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.51 ' SD ' HD21 ' A' ' 140' ' ' LEU . 40.6 mtp -89.41 -15.02 34.18 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.576 -0.283 . . . . 75.019999999999996 111.464 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.8 -14.75 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 113.028 0.751 . . . . 73.310000000000002 113.028 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.505 HG21 ' OG ' ' A' ' 30' ' ' SER . 7.5 pt -104.25 178.16 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 O-C-N 121.854 -0.529 . . . . 75.519999999999996 111.861 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 CA--C 1.542 0.67 0 CA-C-N 116.084 -0.507 . . . . 74.120000000000005 110.52 175.154 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . . . . . . 0 CA--C 1.526 0.752 0 CA-C-O 121.009 0.227 . . . . 54.530000000000001 112.982 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.4 t -89.04 123.69 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.816 0.341 . . . . 74.319999999999993 111.636 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 67.5 mttm -66.28 149.54 50.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.573 0.582 . . . . 73.510000000000005 112.573 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.537 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -178.65 -155.86 15.59 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 115.926 -0.579 . . . . 55.520000000000003 112.963 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.42 HG21 ' SD ' ' A' ' 23' ' ' MET . 67.7 p -131.87 159.72 37.76 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 122.244 -0.562 . . . . 64.120000000000005 111.863 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.75 144.44 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 116.31 -0.405 . . . . 71.109999999999999 111.681 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.721 ' HB3' ' HA ' ' A' ' 23' ' ' MET . 13.8 pt-20 -164.84 168.61 17.56 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.314 -0.403 . . . . 72.340000000000003 111.015 173.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.723 ' HE3' HD23 ' A' ' 67' ' ' LEU . 34.7 ttmt -68.75 148.54 50.21 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.222 0.534 . . . . 71.439999999999998 112.182 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 t -146.19 155.95 43.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.088 -0.505 . . . . 74.340000000000003 111.126 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.31 -2.61 58.51 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.139 0.495 . . . . 72.129999999999995 110.99 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.89 173.32 3.67 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.667 0.617 . . . . 53.109999999999999 112.667 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -88.86 148.55 23.81 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.845 -0.616 . . . . 64.319999999999993 111.867 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.484 HG23 ' HG3' ' A' ' 72' ' ' ARG . 73.4 t -69.76 124.32 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.049 -0.523 . . . . 62.119999999999997 109.854 170.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 135' ' ' LEU . 10.3 mt -70.57 89.66 0.72 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.967 -0.293 . . . . 61.409999999999997 111.502 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 37.5 m -47.8 148.62 1.52 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.078 -0.51 . . . . 71.120000000000005 110.816 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.494 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 72.0 t -44.8 -45.15 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 112.465 0.543 . . . . 72.340000000000003 112.465 -173.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -72.15 -47.85 47.93 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.79 0.329 . . . . 55.240000000000002 111.712 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -55.91 -38.23 69.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.233 0.539 . . . . 61.409999999999997 110.501 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.51 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.7 tt -61.18 -42.3 98.33 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.465 -0.788 . . . . 72.319999999999993 111.09 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 31.1 mt . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 121.549 0.69 . . . . 64.430000000000007 110.387 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.0 ptm . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 120.682 0.277 . . . . 64.519999999999996 110.444 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.1 mt -106.6 124.52 49.73 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.184 0.809 . . . . 72.150000000000006 113.184 -173.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -72.06 102.55 3.01 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.601 -1.182 . . . . 71.430000000000007 110.444 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.39 166.16 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.005 0.431 . . . . 75.209999999999994 111.898 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.636 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 37.1 tt0 -99.84 115.99 30.88 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.807 0.337 . . . . 72.329999999999998 110.436 172.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.559 HG22 HD11 ' A' ' 96' ' ' ILE . 21.2 t -90.46 110.96 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.077 -0.511 . . . . 74.319999999999993 111.724 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 mt -100.09 153.22 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 120.838 0.351 . . . . 72.219999999999999 111.651 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.1 t -120.07 103.63 9.45 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.903 0.383 . . . . 73.239999999999995 110.581 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.566 0 C-N-CA 121.076 -0.583 . . . . 74.25 113.171 -177.482 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 120.951 0.405 . . . . 73.230000000000004 111.237 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.472 ' O ' HG22 ' A' ' 52' ' ' VAL . 2.6 t80 -76.34 -38.17 56.28 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.461 0.648 . . . . 70.519999999999996 110.026 174.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -58.02 -62.94 1.45 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.425 -0.807 . . . . 72.109999999999999 110.435 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -70.68 0.89 6.07 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.54 0.57 . . . . 53.310000000000002 112.54 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.43 -34.64 11.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.59 0.589 . . . . 72.329999999999998 112.59 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.495 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 32.9 m -125.06 2.29 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 113.832 1.049 . . . . 73.420000000000002 113.832 -174.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -89.76 34.22 0.84 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.005 0.743 . . . . 61.100000000000001 113.005 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -150.24 159.31 44.53 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.626 -0.671 . . . . 73.319999999999993 112.448 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.27 132.4 45.91 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.949 -0.569 . . . . 41.530000000000001 110.9 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.763 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 35.2 mt-10 -87.86 114.96 24.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.208 0.528 . . . . 65.120000000000005 111.016 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.7 mt -111.49 148.46 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.582 -0.735 . . . . 72.209999999999994 111.478 -174.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -70.24 140.8 52.48 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 122.391 -0.193 . . . . 74.319999999999993 110.7 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 37.3 tt0 -54.71 -37.75 66.22 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.084 0.772 . . . . 74.329999999999998 113.084 -177.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.511 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 6.6 mm-40 -56.67 -53.59 55.96 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.152 -0.342 . . . . 74.299999999999997 111.485 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -63.31 -38.11 89.89 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.368 0.604 . . . . 51.329999999999998 110.447 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.43 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 52.5 t-105 -53.65 -45.63 70.3 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.36 -0.836 . . . . 75.549999999999997 111.513 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -69.87 -41.96 74.13 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.232 -0.44 . . . . 75.200000000000003 110.917 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.3 82.89 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.546 0.573 . . . . 70.340000000000003 112.546 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.405 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 89.4 mt -86.98 -6.16 58.85 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.319 -0.4 . . . . 72.299999999999997 111.799 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.09 50.62 64.42 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.505 -0.379 . . . . 52.210000000000001 112.848 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.405 ' HG ' ' HB2' ' A' ' 65' ' ' LEU . 97.8 mt -90.88 160.3 15.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.473 0.654 . . . . 73.040000000000006 112.709 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.5 mp0 -125.32 143.24 51.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.015 -0.993 . . . . 74.299999999999997 110.419 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.16 94.88 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.599 0.714 . . . . 61.350000000000001 111.118 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.62 -6.69 7.47 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.133 -0.939 . . . . 24.219999999999999 114.182 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.44 -177.48 5.79 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.301 1.05 . . . . 54.329999999999998 111.678 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.424 ' HG3' HG23 ' A' ' 134' ' ' VAL . 2.8 mpt_? -105.8 123.48 48.03 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.329 0.492 . . . . 74.299999999999997 112.329 -174.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.632 HG13 ' HB2' ' A' ' 86' ' ' ALA . 26.6 m -114.21 148.71 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.044 -0.525 . . . . 70.349999999999994 110.871 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.448 ' HB2' HG21 ' A' ' 130' ' ' THR . 68.5 tttt -120.62 130.34 54.11 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.025 0.441 . . . . 74.319999999999993 111.261 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.9 134.84 49.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.27 -0.423 . . . . 74.109999999999999 111.356 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -125.91 140.53 52.56 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.925 0.393 . . . . 70.430000000000007 111.555 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.6 p -138.41 -172.22 3.23 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.952 0.501 . . . . 73.25 110.122 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.6 2.28 17.03 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.961 0.41 . . . . 63.109999999999999 111.29 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -101.18 -35.31 9.34 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.575 0.35 . . . . 72.230000000000004 111.455 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 163.45 -155.8 27.31 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.175 -0.536 . . . . 61.219999999999999 113.35 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.99 160.26 40.46 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.101 0.408 . . . . 64.439999999999998 112.101 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.5 p -160.57 150.61 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-N 116.041 -0.527 . . . . 62.240000000000002 111.296 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.435 HG22 ' HG3' ' A' ' 74' ' ' LYS . 33.1 t -109.9 123.49 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.22 0.208 . . . . 64.219999999999999 111.304 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.485 ' HA ' HG13 ' A' ' 134' ' ' VAL . 27.5 m -133.38 172.21 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.652 0.381 . . . . 40.210000000000001 111.627 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -75.91 143.73 41.5 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.145 0.498 . . . . 75.310000000000002 111.792 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.632 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -84.59 128.36 34.56 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.057 -0.52 . . . . 63.219999999999999 112.388 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -129.94 158.3 39.92 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.655 0.74 . . . . 75.120000000000005 111.887 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -101.44 102.49 13.29 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.256 -0.884 . . . . 73.219999999999999 109.617 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.763 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -99.64 -167.28 29.7 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.982 -0.627 . . . . 71.5 114.581 -170.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.53 9.37 42.61 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 122.846 0.459 . . . . 73.540000000000006 111.545 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.6 m -79.56 158.58 73.41 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 116.311 -0.404 . . . . 70.219999999999999 111.793 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.65 169.6 21.96 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.573 2.182 . . . . 63.43 112.653 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.511 ' HE2' ' HB3' ' A' ' 60' ' ' GLU . 49.2 tttm -65.91 148.75 51.3 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 120.732 0.301 . . . . 74.540000000000006 111.589 -177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.12 30.46 76.93 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.261 -0.495 . . . . 61.340000000000003 112.816 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.636 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 13.2 ttt -153.63 136.97 15.75 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 122.62 -0.341 . . . . 70.129999999999995 110.319 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.559 HD11 HG22 ' A' ' 28' ' ' VAL . 40.3 pt -134.55 138.93 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.472 0.653 . . . . 73.400000000000006 112.021 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -101.44 123.37 45.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.722 -0.672 . . . . 74.540000000000006 111.176 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 30' ' ' SER . 40.2 mt -121.04 127.62 26.12 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 122.277 -0.265 . . . . 73.310000000000002 110.877 175.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.495 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 14.0 Cg_endo -57.37 142.42 95.0 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.476 2.117 . . . . 74.340000000000003 112.708 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.14 103.34 0.27 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.267 -0.424 . . . . 75.200000000000003 111.074 -176.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.69 -178.53 31.82 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.883 -0.675 . . . . 42.119999999999997 112.528 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.573 ' O ' ' HG2' ' A' ' 106' ' ' MET . 23.9 Cg_endo -60.71 -31.35 91.88 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.435 2.09 . . . . 60.210000000000001 111.695 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.499 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 4.8 m-85 -62.58 -53.4 55.15 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.612 -0.722 . . . . 74.140000000000001 110.314 175.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.31 -43.59 88.21 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.051 -0.522 . . . . 50.530000000000001 110.756 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -54.21 -26.39 28.18 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.014 0.526 . . . . 72.109999999999999 112.2 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.573 ' HG2' ' O ' ' A' ' 102' ' ' PRO . 84.6 mmm -66.58 -21.41 66.14 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.191 0.441 . . . . 63.119999999999997 112.191 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.7 m -132.08 -27.48 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 112.87 0.692 . . . . 64.439999999999998 112.87 -172.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' A' ' 30' ' ' SER . 1.5 pp -87.02 170.09 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-O 121.033 0.444 . . . . 64.329999999999998 111.308 -176.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.409 ' C ' HD12 ' A' ' 108' ' ' ILE . 12.6 t0 . . . . . 0 CA--C 1.544 0.738 0 CA-C-N 116.382 -0.372 . . . . 70.420000000000002 111.131 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.667 0 N-CA-C 112.676 -0.17 . . . . 60.439999999999998 112.676 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.0 t -80.8 126.14 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.019 0.377 . . . . 41.009999999999998 112.019 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -62.32 145.78 52.89 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.152 0.427 . . . . 75.109999999999999 112.152 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -174.12 -163.42 27.49 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.393 -0.432 . . . . 42.329999999999998 112.884 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 54.5 p -126.24 142.69 51.43 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.628 -0.336 . . . . 61.520000000000003 111.3 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.0 p -132.01 143.25 40.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 120.9 0.381 . . . . 34.399999999999999 110.76 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.45 169.68 19.99 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.354 -0.385 . . . . 65.519999999999996 110.974 176.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -69.84 141.26 53.29 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.103 -0.373 . . . . 71.209999999999994 110.87 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 74' ' ' LYS . 10.1 t -132.4 161.4 33.73 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.348 0.594 . . . . 74.430000000000007 112.187 -177.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.03 -18.02 41.24 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.642 -0.708 . . . . 73.219999999999999 111.11 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -69.68 152.51 44.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.581 0.705 . . . . 75.299999999999997 112.513 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.718 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -79.49 160.33 26.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.232 -0.894 . . . . 54.549999999999997 110.696 173.394 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.485 HG13 ' HA ' ' A' ' 84' ' ' VAL . 98.5 t -65.96 126.53 25.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 O-C-N 122.346 -0.222 . . . . 74.099999999999994 110.533 174.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.451 HD13 ' HG ' ' A' ' 140' ' ' LEU . 7.2 mt -56.06 131.83 48.53 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.07 0.462 . . . . 52.439999999999998 112.077 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.9 m -71.94 140.68 49.3 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.697 -0.482 . . . . 64.329999999999998 109.697 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.43 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 89.3 t -46.48 -49.45 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 112.54 0.57 . . . . 71.310000000000002 112.54 -175.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -71.78 -42.53 67.04 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.944 0.402 . . . . 73.349999999999994 111.327 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -55.98 -34.64 65.94 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.682 0.753 . . . . 72.0 110.581 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.451 ' HG ' HD13 ' A' ' 135' ' ' LEU . 2.6 tt -65.89 -42.5 90.19 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.249 -0.887 . . . . 75.430000000000007 110.827 174.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 29.3 mt . . . . . 0 N--CA 1.472 0.67 0 CA-C-O 121.373 0.606 . . . . 73.140000000000001 110.622 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.7 ptm . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 120.927 0.394 . . . . 72.120000000000005 111.425 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.6 mt -115.52 146.2 41.92 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.914 0.387 . . . . 73.010000000000005 111.86 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -92.4 125.21 36.95 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.389 0.614 . . . . 70.239999999999995 111.233 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 27.5 m -142.14 160.64 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.22 -0.9 . . . . 53.020000000000003 111.882 -173.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 34.6 tt0 -98.49 116.9 31.72 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.045 -0.409 . . . . 74.310000000000002 110.53 173.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.615 HG22 HD11 ' A' ' 96' ' ' ILE . 47.1 t -88.25 106.44 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.91 -0.586 . . . . 51.530000000000001 111.627 -176.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.722 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 15.0 mt -91.91 158.1 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.837 0.351 . . . . 73.049999999999997 111.888 -177.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 62.2 m -140.29 94.47 2.75 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.085 0.469 . . . . 62.25 111.861 177.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.664 0 CA-C-N 115.98 -0.555 . . . . 64.319999999999993 112.072 178.507 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 CA--C 1.534 0.333 0 CA-C-O 120.708 0.289 . . . . 72.450000000000003 110.973 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.585 ' O ' HG22 ' A' ' 52' ' ' VAL . 1.7 t80 -62.55 -39.08 92.49 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.151 0.5 . . . . 73.109999999999999 110.099 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -63.5 -68.1 0.37 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.826 -0.624 . . . . 65.230000000000004 110.314 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -55.09 -24.2 24.29 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.865 0.691 . . . . 72.409999999999997 112.865 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.54 -38.08 18.92 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.307 0.854 . . . . 74.319999999999993 113.307 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 48' ' ' TYR . 13.7 m -108.35 7.99 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 112.873 0.694 . . . . 63.140000000000001 112.873 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -98.53 18.98 15.38 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.44 0.904 . . . . 71.329999999999998 113.44 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -135.65 159.39 41.79 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.98 0.733 . . . . 70.340000000000003 112.98 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.42 137.64 49.93 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.229 -0.896 . . . . 73.219999999999999 110.098 173.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.595 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 48.5 mt-10 -97.44 116.86 30.45 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.898 0.38 . . . . 73.299999999999997 111.626 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.5 ' HA ' HG22 ' A' ' 96' ' ' ILE . 4.1 mp -110.0 154.58 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 116.226 -0.443 . . . . 74.25 111.212 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.405 ' N ' HG22 ' A' ' 57' ' ' ILE . 27.1 t-20 -68.52 148.78 50.08 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.736 0.414 . . . . 54.439999999999998 111.442 176.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 9.2 tp10 -52.46 -47.59 66.36 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.311 0.485 . . . . 73.200000000000003 112.311 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -62.6 -42.1 99.37 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.337 0.495 . . . . 65.239999999999995 112.337 -176.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -71.18 -30.51 66.5 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.409 0.623 . . . . 73.239999999999995 110.555 174.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.458 ' HZ2' ' N ' ' A' ' 69' ' ' GLU . 58.6 t-105 -59.14 -52.71 64.55 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.514 -0.766 . . . . 71.099999999999994 111.739 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -71.74 -30.34 65.5 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.612 0.227 . . . . 73.120000000000005 111.612 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.54 -43.98 89.43 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.088 0.47 . . . . 73.200000000000003 111.827 177.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 98.0 mt -89.25 -4.92 58.0 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.275 -0.42 . . . . 73.219999999999999 112.033 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.72 50.49 66.96 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.218 -0.515 . . . . 75.409999999999997 112.967 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.429 HD23 ' HE2' ' A' ' 129' ' ' LYS . 86.9 mt -89.27 163.89 15.18 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.041 0.448 . . . . 63.219999999999999 112.162 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -150.52 118.77 6.37 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.192 -0.458 . . . . 65.230000000000004 110.208 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.458 ' N ' ' HZ2' ' A' ' 62' ' ' TRP . 2.2 mp0 -40.2 105.74 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.33 0.863 . . . . 70.310000000000002 113.33 -168.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.66 -10.88 10.38 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 115.289 -0.869 . . . . 74.340000000000003 113.672 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -80.64 176.45 9.79 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 117.889 0.844 . . . . 73.140000000000001 111.31 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' A' ' 72' ' ' ARG . 3.1 mpt_? -98.25 128.7 44.84 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.115 0.483 . . . . 71.200000000000003 112.045 -172.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 86' ' ' ALA . 15.3 m -119.43 135.53 59.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 121.284 0.564 . . . . 71.349999999999994 111.723 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.553 ' HB3' ' HG3' ' A' ' 128' ' ' GLU . 5.4 tppp? -88.88 125.31 34.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.839 -0.619 . . . . 73.549999999999997 110.867 175.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 61.7 t -109.54 125.34 66.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.674 -0.491 . . . . 74.329999999999998 109.674 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -132.41 132.89 43.27 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.141 0.496 . . . . 64.299999999999997 112.143 -173.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.623 HG22 ' HA3' ' A' ' 125' ' ' GLY . 37.1 p -136.07 -170.58 2.67 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.922 -0.581 . . . . 60.32 110.943 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.05 -6.39 52.55 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.029 -0.532 . . . . 72.519999999999996 111.709 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.412 ' CZ ' ' HB2' ' A' ' 109' ' ' ASP . 98.9 m-85 -99.82 -45.14 5.83 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.769 0.319 . . . . 74.150000000000006 111.582 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.2 -152.4 10.22 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.781 -0.723 . . . . 73.310000000000002 113.336 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 15.4 pt-20 -152.08 152.1 31.93 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.057 0.456 . . . . 61.039999999999999 111.641 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 106' ' ' MET . 8.8 p -152.36 153.88 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.389 -0.369 . . . . 64.230000000000004 111.48 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 t -108.8 120.48 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 122.22 0.208 . . . . 52.32 110.882 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.431 HG12 ' CD2' ' A' ' 103' ' ' TYR . 32.8 m -130.29 172.5 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 111.992 0.367 . . . . 72.540000000000006 111.992 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -76.36 136.9 39.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.278 -0.419 . . . . 75.219999999999999 111.025 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -87.19 127.81 35.15 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.394 0.516 . . . . 65.140000000000001 112.394 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 86.9 mttt -127.74 146.91 50.42 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.262 0.553 . . . . 53.020000000000003 110.673 172.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -84.68 126.96 33.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.875 -0.602 . . . . 52.210000000000001 110.122 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.595 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -118.86 -175.81 16.34 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.735 -0.745 . . . . 75.530000000000001 114.478 -173.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -92.74 9.35 35.41 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.617 0.722 . . . . 70.450000000000003 110.221 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.9 m -75.14 151.51 85.98 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 115.456 -0.793 . . . . 62.229999999999997 112.44 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.27 166.12 28.07 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.019 2.479 . . . . 65.319999999999993 112.943 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -66.14 147.04 53.93 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.769 0.319 . . . . 73.450000000000003 111.287 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 64.74 27.05 71.5 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.767 -0.73 . . . . 65.239999999999995 113.071 -174.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.541 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 21.6 ttt -152.11 136.39 16.69 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 122.218 -0.578 . . . . 71.200000000000003 110.406 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.615 HD11 HG22 ' A' ' 28' ' ' VAL . 39.9 pt -136.53 141.58 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 121.193 0.521 . . . . 71.209999999999994 111.975 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -101.46 132.11 47.24 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.858 0.361 . . . . 73.109999999999999 111.532 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 30' ' ' SER . 39.1 mt -127.89 136.66 29.33 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.245 -0.434 . . . . 61.210000000000001 110.427 173.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.535 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 31.1 Cg_endo -65.28 131.8 29.51 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.076 1.851 . . . . 73.430000000000007 112.254 172.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.73 104.0 0.1 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.875 0.369 . . . . 74.329999999999998 110.912 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.0 -175.52 28.01 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.925 -0.655 . . . . 54.409999999999997 112.918 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.447 ' O ' ' HG2' ' A' ' 106' ' ' MET . 19.5 Cg_endo -57.04 -34.91 98.58 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.99 2.46 . . . . 70.430000000000007 112.357 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.431 ' CD2' HG12 ' A' ' 84' ' ' VAL . 28.8 m-85 -64.77 -53.64 43.82 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.216 -0.447 . . . . 72.319999999999993 110.832 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -58.29 -38.47 77.09 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.315 0.578 . . . . 54.329999999999998 111.104 175.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -55.17 -22.29 16.76 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.881 -0.599 . . . . 60.030000000000001 112.408 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.63 ' SD ' HD21 ' A' ' 140' ' ' LEU . 90.2 mmm -78.75 -15.19 58.74 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.222 0.453 . . . . 73.430000000000007 112.222 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.1 m -129.23 -18.36 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 113.179 0.807 . . . . 44.549999999999997 113.179 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.608 HG21 ' OG ' ' A' ' 30' ' ' SER . 12.9 pt -96.75 176.36 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 121.811 -0.556 . . . . 71.010000000000005 112.377 -177.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.592 ' H ' HG21 ' A' ' 123' ' ' VAL . 18.7 t0 . . . . . 0 CA--C 1.543 0.687 0 CA-C-N 115.895 -0.593 . . . . 72.510000000000005 110.736 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.722 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . . . . . . 0 CA--C 1.53 0.97 0 N-CA-C 114.36 0.504 . . . . 64.409999999999997 114.36 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.592 HG21 ' H ' ' A' ' 109' ' ' ASP . 86.6 t -92.7 123.61 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 122.747 0.419 . . . . 65.209999999999994 111.431 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 95.9 mttt -72.78 150.54 42.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.111 0.482 . . . . 72.129999999999995 112.192 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.623 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -177.2 -140.89 3.81 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 116.015 -0.539 . . . . 63.039999999999999 113.024 -178.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 67.3 p -142.81 163.55 32.51 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.35 -0.5 . . . . 72.310000000000002 111.879 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.0 p -142.4 145.32 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 116.136 -0.484 . . . . 71.439999999999998 110.884 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.553 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 8.7 pt-20 -152.09 152.3 32.19 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.286 0.476 . . . . 72.239999999999995 112.286 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.429 ' HE2' HD23 ' A' ' 67' ' ' LEU . 9.5 tppt? -62.7 137.31 58.23 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.426 -0.352 . . . . 53.119999999999997 110.93 172.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.0 t -134.7 153.28 52.07 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.05 0.452 . . . . 72.219999999999999 111.957 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.27 6.66 46.17 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.507 0.67 . . . . 65.409999999999997 110.621 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -80.6 -175.96 5.51 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.447 0.641 . . . . 65.519999999999996 112.056 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -101.56 154.0 19.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.615 -0.721 . . . . 64.430000000000007 111.001 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.39 122.26 14.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 110.338 -0.245 . . . . 65.049999999999997 110.338 173.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 135' ' ' LEU . 3.3 mt -62.45 90.96 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.636 0.236 . . . . 74.030000000000001 111.636 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.1 m -46.05 147.66 0.99 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.164 -0.471 . . . . 61.350000000000001 111.669 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.544 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 85.8 t -45.74 -53.6 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 113.118 0.784 . . . . 61.350000000000001 113.118 -173.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.853 ' HD3' HD12 ' A' ' 141' ' ' LEU . 16.1 tppt? -72.49 -39.07 67.94 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.08 -0.387 . . . . 71.239999999999995 111.598 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -55.77 -38.17 69.51 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.666 0.746 . . . . 75.400000000000006 110.205 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.63 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.2 tt -63.76 -40.16 96.03 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.098 -0.955 . . . . 75.420000000000002 110.547 174.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.853 HD12 ' HD3' ' A' ' 138' ' ' LYS . 43.1 mt . . . . . 0 N--CA 1.47 0.568 0 CA-C-O 121.31 0.576 . . . . 75.450000000000003 110.285 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.1 ptm . . . . . 0 CA--C 1.539 0.522 0 CA-C-O 121.132 0.491 . . . . 55.450000000000003 111.704 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.5 mt -116.34 131.42 56.95 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.188 -0.46 . . . . 64.120000000000005 112.109 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.7 ' HG3' HG22 ' A' ' 126' ' ' THR . 1.1 mp0 -73.03 136.58 45.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.505 0.669 . . . . 60.299999999999997 111.42 175.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 15.8 m -148.27 158.1 7.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.069 -0.969 . . . . 50.409999999999997 111.616 -172.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.631 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 32.7 tt0 -99.21 111.85 24.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.018 0.437 . . . . 73.340000000000003 110.183 172.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.512 HG22 HD11 ' A' ' 96' ' ' ILE . 39.6 t -88.48 107.86 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.812 -0.631 . . . . 73.230000000000004 111.497 -174.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.9 mt -92.29 153.1 3.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.335 -0.393 . . . . 72.230000000000004 111.294 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 20.0 t -133.67 103.52 5.92 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.08 0.466 . . . . 63.439999999999998 111.151 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.837 0 C-N-CA 121.076 -0.583 . . . . 75.519999999999996 113.364 -177.819 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 CA--C 1.541 0.621 0 CA-C-O 121.106 0.479 . . . . 62.43 110.779 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.459 ' O ' HG22 ' A' ' 52' ' ' VAL . 9.5 t80 -66.05 -37.34 85.58 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.293 0.568 . . . . 74.409999999999997 110.231 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.404 ' HD1' HG23 ' A' ' 137' ' ' VAL . 65.5 t80 -58.61 -62.78 1.61 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.599 -0.728 . . . . 74.430000000000007 111.038 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -55.24 -23.98 25.42 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.771 0.656 . . . . 75.140000000000001 112.771 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.68 -40.32 23.01 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.032 0.752 . . . . 73.530000000000001 113.032 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 48' ' ' TYR . 33.8 m -108.73 13.9 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 113.289 0.848 . . . . 74.409999999999997 113.289 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -104.04 26.1 9.16 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.52 0.934 . . . . 63.229999999999997 113.52 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -145.11 159.81 42.39 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.665 -0.647 . . . . 75.439999999999998 112.355 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.78 146.33 50.62 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.532 -0.758 . . . . 52.350000000000001 111.043 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.667 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 30.9 mt-10 -96.6 116.9 29.88 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.633 0.254 . . . . 75.219999999999999 111.516 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.52 ' HA ' HG22 ' A' ' 96' ' ' ILE . 4.2 mp -110.44 146.97 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 120.782 0.325 . . . . 71.400000000000006 111.255 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -64.19 145.82 55.33 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.593 -0.276 . . . . 71.140000000000001 110.845 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 32.2 tt0 -58.71 -40.76 84.59 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.78 0.659 . . . . 72.310000000000002 112.78 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -60.9 -51.14 70.53 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.955 0.354 . . . . 72.019999999999996 111.955 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -65.55 -36.0 82.52 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.468 0.651 . . . . 74.0 110.457 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.713 ' HA ' HD12 ' A' ' 67' ' ' LEU . 37.0 t-105 -52.91 -53.83 43.66 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.276 -0.874 . . . . 65.540000000000006 111.311 175.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -70.5 -29.69 66.27 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.004 -0.543 . . . . 71.430000000000007 111.394 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.24 -35.22 80.1 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.887 0.375 . . . . 75.25 111.624 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.0 mt -89.86 1.33 56.32 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.38 -0.373 . . . . 62.200000000000003 111.702 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.94 40.48 95.4 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.42 -0.419 . . . . 72.019999999999996 112.728 -177.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.713 HD12 ' HA ' ' A' ' 62' ' ' TRP . 18.4 mt -76.11 141.81 41.86 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.093 0.775 . . . . 71.439999999999998 113.093 -175.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.526 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 30.3 tt0 -106.51 147.1 29.79 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.28 -0.873 . . . . 72.120000000000005 109.673 169.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -63.77 102.73 0.49 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.495 0.664 . . . . 61.450000000000003 111.382 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.25 5.02 23.47 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 115.268 -0.878 . . . . 44.439999999999998 112.633 -172.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 68' ' ' GLN . 1.4 t0 -71.69 172.86 8.97 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.81 0.444 . . . . 74.239999999999995 110.838 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.47 124.48 49.67 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.28 0.562 . . . . 74.030000000000001 111.687 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 86' ' ' ALA . 15.8 m -113.3 132.53 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.139 0.495 . . . . 74.129999999999995 111.481 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -100.66 109.98 22.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.584 0.707 . . . . 54.299999999999997 110.311 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 59.3 t -92.66 127.2 44.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.34 -0.845 . . . . 74.510000000000005 109.824 -175.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.521 ' HG2' ' CB ' ' A' ' 81' ' ' GLU . 46.4 mtpt -133.34 124.77 27.81 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.387 0.613 . . . . 62.119999999999997 112.397 -169.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.627 HG22 ' HA3' ' A' ' 125' ' ' GLY . 29.2 p -132.42 -171.66 2.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.712 -0.676 . . . . 74.329999999999998 111.033 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -76.56 -1.11 25.8 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.272 -0.422 . . . . 73.120000000000005 111.562 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -102.46 -34.71 9.04 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 111.811 0.3 . . . . 74.25 111.811 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.37 -167.1 39.7 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 112.258 -0.337 . . . . 71.430000000000007 112.258 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.521 ' CB ' ' HG2' ' A' ' 76' ' ' LYS . 16.4 pt-20 -143.48 144.11 31.85 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.376 0.588 . . . . 53.049999999999997 112.524 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 p -143.66 150.41 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.934 -0.575 . . . . 72.120000000000005 111.566 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.12 120.34 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 O-C-N 122.301 -0.249 . . . . 73.239999999999995 111.388 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.69 173.17 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 120.858 0.361 . . . . 75.040000000000006 111.966 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -78.28 140.49 38.84 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.038 0.447 . . . . 73.040000000000006 111.354 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.457 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -93.74 126.3 38.84 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.649 0.611 . . . . 64.019999999999996 112.649 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -125.18 145.66 49.86 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.114 0.483 . . . . 72.439999999999998 110.66 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -82.9 112.37 19.63 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.791 -0.448 . . . . 63.439999999999998 109.791 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.667 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -123.63 169.12 15.77 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.581 -0.818 . . . . 71.219999999999999 114.434 -171.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.85 73.89 6.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.116 0.484 . . . . 64.319999999999993 111.413 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.5 m -132.46 147.95 67.67 Favored Pre-proline 0 CA--C 1.539 0.558 0 CA-C-N 116.018 -0.537 . . . . 71.109999999999999 111.229 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.75 157.29 38.42 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.628 2.219 . . . . 72.150000000000006 112.563 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -64.07 145.34 56.09 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 122.116 -0.365 . . . . 72.439999999999998 111.099 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.529 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 62.59 27.8 70.33 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.047 -0.596 . . . . 62.32 112.677 -174.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.631 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 18.8 ttt -148.75 136.43 20.56 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.741 -0.466 . . . . 64.200000000000003 109.741 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.52 HG22 ' HA ' ' A' ' 57' ' ' ILE . 36.7 pt -137.92 144.68 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 121.294 0.568 . . . . 73.120000000000005 112.194 -176.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -105.4 133.38 50.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.229 -0.442 . . . . 52.32 111.494 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 30' ' ' SER . 48.8 mt -128.87 134.03 25.86 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 116.342 -0.39 . . . . 64.019999999999996 110.675 174.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.87 136.44 61.71 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 121.975 1.784 . . . . 73.349999999999994 112.231 174.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.31 107.93 0.63 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.898 0.38 . . . . 75.340000000000003 110.895 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.95 -174.61 26.87 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.124 -0.56 . . . . 72.519999999999996 112.487 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.78 -25.77 74.83 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.983 1.789 . . . . 75.219999999999999 111.853 -177.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.539 ' HA ' HD11 ' A' ' 140' ' ' LEU . 3.8 m-85 -71.19 -54.29 11.49 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.677 -0.692 . . . . 73.230000000000004 110.729 178.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.02 -33.35 73.13 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.097 -0.501 . . . . 71.430000000000007 110.617 175.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -58.25 -22.37 52.11 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.936 -0.574 . . . . 53.539999999999999 111.665 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.502 ' SD ' HD21 ' A' ' 140' ' ' LEU . 33.7 mtp -78.37 -29.61 47.51 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.506 -0.315 . . . . 73.340000000000003 111.41 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.8 m -111.94 -18.99 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 112.395 0.517 . . . . 74.239999999999995 112.395 -171.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.563 HG21 ' HB2' ' A' ' 30' ' ' SER . 12.2 pt -94.76 178.84 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.11 0.481 . . . . 74.099999999999994 111.495 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.52 ' H ' HG21 ' A' ' 123' ' ' VAL . 21.3 t70 . . . . . 0 CA--C 1.54 0.583 0 CA-C-N 116.102 -0.499 . . . . 74.299999999999997 110.52 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.686 0 N-CA-C 112.442 -0.263 . . . . 72.109999999999999 112.442 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.52 HG21 ' H ' ' A' ' 109' ' ' ASP . 82.0 t -82.17 119.61 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.063 0.458 . . . . 63.299999999999997 111.661 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 95.8 mttt -73.12 154.01 40.54 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.512 0.56 . . . . 75.340000000000003 112.512 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.627 ' HA3' HG22 ' A' ' 77' ' ' THR . . . 177.81 -140.83 4.9 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.884 -0.598 . . . . 63.350000000000001 112.797 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.7 HG22 ' HG3' ' A' ' 25' ' ' GLU . 67.6 p -136.69 161.67 35.28 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.026 0.441 . . . . 74.540000000000006 111.164 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.79 143.84 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.247 0.546 . . . . 74.519999999999996 110.834 173.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -147.44 144.62 28.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.967 -0.561 . . . . 62.240000000000002 110.363 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.509 ' HD2' HD23 ' A' ' 67' ' ' LEU . 20.6 ttpp -81.87 143.23 31.85 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.19 -0.318 . . . . 73.329999999999998 110.262 176.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.0 t -132.16 156.8 45.77 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.597 0.962 . . . . 55.439999999999998 113.597 -168.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -83.29 -17.1 43.73 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.061 -0.972 . . . . 53.020000000000003 110.41 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -68.98 179.11 1.95 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.702 -0.681 . . . . 54.240000000000002 112.71 -175.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -98.83 159.84 14.68 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.672 -0.694 . . . . 73.540000000000006 111.702 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.8 t -73.97 136.12 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.466 -0.334 . . . . 74.230000000000004 110.908 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 135' ' ' LEU . 11.9 mt -67.44 140.47 57.12 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.944 0.402 . . . . 71.219999999999999 111.531 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.6 m -86.24 148.84 25.46 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.616 -0.513 . . . . 72.310000000000002 109.616 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.47 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 86.1 t -46.8 -53.43 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 112.564 0.579 . . . . 75.450000000000003 112.564 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -72.25 -39.36 68.48 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 111.704 0.261 . . . . 73.120000000000005 111.704 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.79 -36.67 72.49 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.701 0.762 . . . . 72.129999999999995 110.09 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.539 HD11 ' HA ' ' A' ' 103' ' ' TYR . 4.4 tt -62.25 -43.84 97.9 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.968 -1.014 . . . . 70.239999999999995 110.728 172.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 66.6 mt . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 121.205 0.526 . . . . 53.420000000000002 110.608 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.2 ptp . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 121.249 0.547 . . . . 75.299999999999997 111.861 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.579 HD11 ' HB3' ' A' ' 64' ' ' ALA . 16.4 mt -122.27 139.28 53.97 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.004 -0.544 . . . . 43.439999999999998 111.58 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -79.29 118.25 21.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.309 0.576 . . . . 74.25 110.359 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 28.3 m -138.25 160.51 32.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.61 -0.723 . . . . 71.129999999999995 111.824 -173.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.726 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 72.2 tt0 -98.82 111.92 24.16 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.071 0.462 . . . . 75.25 110.438 175.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.522 HG22 HD11 ' A' ' 96' ' ' ILE . 43.1 t -87.45 105.81 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 115.797 -0.638 . . . . 75.439999999999998 111.72 -175.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 mt -92.14 162.91 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.677 0.275 . . . . 74.340000000000003 111.265 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.686 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 15.6 t -134.58 113.96 12.3 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.781 0.324 . . . . 73.230000000000004 111.826 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . . . . . . 0 CA--C 1.528 0.878 0 C-N-CA 121.065 -0.588 . . . . 54.439999999999998 113.298 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 121.151 0.5 . . . . 71.129999999999995 111.153 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -68.8 -23.08 64.24 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.939 0.4 . . . . 74.340000000000003 110.702 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -88.17 2.08 52.96 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.033 0.383 . . . . 73.430000000000007 112.033 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -122.17 -48.31 2.11 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.483 -0.761 . . . . 72.340000000000003 111.948 170.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.68 -22.77 24.88 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.079 1.14 . . . . 75.230000000000004 114.079 -170.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.519 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 19.7 m -130.92 17.82 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 112.858 0.688 . . . . 54.520000000000003 112.858 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -102.0 17.16 23.9 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.612 0.597 . . . . 63.200000000000003 112.612 -174.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -140.93 162.79 34.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.142 0.496 . . . . 73.329999999999998 112.106 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -126.14 127.19 45.36 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.622 -0.717 . . . . 52.030000000000001 110.813 174.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -87.31 118.4 26.71 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.413 0.625 . . . . 64.329999999999998 110.892 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.03 154.92 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.162 -0.926 . . . . 75.439999999999998 111.828 -169.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -76.19 144.56 40.42 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.525 -0.307 . . . . 75.209999999999994 110.615 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 27.3 tt0 -63.39 -36.86 85.13 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.818 0.673 . . . . 75.299999999999997 112.818 -176.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -62.21 -47.69 83.33 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 122.174 -0.329 . . . . 62.399999999999999 111.413 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.461 ' HB3' HD13 ' A' ' 24' ' ' LEU . 47.0 m-20 -66.8 -36.5 82.52 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.308 0.575 . . . . 74.310000000000002 110.558 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.48 ' HZ2' ' N ' ' A' ' 69' ' ' GLU . 33.7 t-105 -53.11 -45.66 68.38 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.492 -0.776 . . . . 74.030000000000001 110.591 175.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -65.7 -41.02 92.86 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.714 -0.676 . . . . 61.140000000000001 110.961 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.579 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -61.0 -38.55 86.45 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.242 -0.435 . . . . 62.329999999999998 111.82 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.483 ' HG ' HD12 ' A' ' 24' ' ' LEU . 87.6 mt -85.71 -14.47 45.29 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.425 -0.352 . . . . 65.439999999999998 111.413 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.57 47.4 78.0 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.273 -0.489 . . . . 75.099999999999994 112.581 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.568 HD23 ' HD3' ' A' ' 129' ' ' LYS . 85.3 mt -84.49 164.85 18.56 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.559 0.695 . . . . 71.030000000000001 112.38 -175.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -136.11 123.61 22.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.55 -0.75 . . . . 72.239999999999995 109.905 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.48 ' N ' ' HZ2' ' A' ' 62' ' ' TRP . 48.7 mt-10 -49.88 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.563 0.696 . . . . 71.430000000000007 112.614 -172.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 130.2 0.04 5.55 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.387 -0.824 . . . . 45.43 114.036 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -90.39 -172.15 3.34 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 117.863 0.831 . . . . 73.019999999999996 112.292 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.45 HH11 ' HD2' ' A' ' 72' ' ' ARG . 45.6 mtt180 -111.52 131.25 55.37 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.339 0.496 . . . . 71.239999999999995 112.339 -174.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.45 HG13 ' HB2' ' A' ' 86' ' ' ALA . 30.0 m -123.67 140.85 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.998 0.428 . . . . 64.420000000000002 111.578 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.415 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 38.3 ttmt -98.65 131.84 44.51 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.25 0.548 . . . . 73.400000000000006 110.74 174.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.531 HG21 HD11 ' A' ' 98' ' ' ILE . 61.9 t -106.18 128.22 60.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.731 -0.668 . . . . 75.519999999999996 109.661 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.415 ' HG3' ' HG2' ' A' ' 74' ' ' LYS . 38.8 mtpt -131.06 127.55 38.45 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.51 0.672 . . . . 72.200000000000003 112.506 -171.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.6 HG22 ' HA3' ' A' ' 125' ' ' GLY . 31.0 p -136.37 -170.43 2.66 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.131 -0.941 . . . . 62.439999999999998 110.486 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.22 -13.74 60.16 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.683 0.277 . . . . 70.129999999999995 111.561 176.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -87.83 -38.02 16.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.96 0.409 . . . . 74.430000000000007 111.378 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.07 -157.73 28.75 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.866 -0.683 . . . . 52.119999999999997 113.521 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -144.24 141.82 30.09 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.758 0.313 . . . . 72.219999999999999 111.471 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.48 146.67 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.698 0.285 . . . . 63.140000000000001 111.655 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.0 t -105.4 117.21 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.544 0.211 . . . . 71.109999999999999 110.95 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.0 m -127.34 178.08 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 122.588 0.355 . . . . 71.409999999999997 111.821 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -83.2 144.09 30.02 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.911 0.386 . . . . 74.409999999999997 111.312 174.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.45 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -90.34 135.74 33.49 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.625 0.602 . . . . 64.530000000000001 112.625 -177.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -133.04 158.23 43.26 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.583 0.706 . . . . 45.0 111.663 174.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -108.17 99.64 9.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.103 -0.953 . . . . 52.420000000000002 109.608 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.59 86.54 0.19 Allowed Glycine 0 CA--C 1.533 1.186 0 N-CA-C 116.631 1.412 . . . . 44.329999999999998 116.631 -166.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 65.72 -17.44 0.1 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 116.206 1.928 . . . . 61.399999999999999 116.206 161.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.0 m -78.15 148.66 75.14 Favored Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 121.716 -0.615 . . . . 73.219999999999999 112.425 -173.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -72.64 169.58 21.55 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.788 2.325 . . . . 73.230000000000004 112.705 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -68.33 146.58 53.14 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.871 0.367 . . . . 75.129999999999995 111.5 -177.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 68.72 18.02 71.75 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.277 -0.487 . . . . 74.0 113.28 -174.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.726 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 14.2 ttt -147.02 136.61 22.93 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 122.37 -0.488 . . . . 75.219999999999999 110.568 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.522 HD11 HG22 ' A' ' 28' ' ' VAL . 43.6 pt -135.91 144.97 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 121.082 0.468 . . . . 64.0 111.703 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.459 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 68.1 t80 -107.01 123.87 48.81 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.473 -0.33 . . . . 72.530000000000001 111.302 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.686 ' O ' ' HA ' ' A' ' 30' ' ' SER . 44.2 mt -120.37 127.46 26.3 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 120.805 0.336 . . . . 73.409999999999997 111.142 175.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.519 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 51.4 Cg_exo -57.18 136.9 79.23 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.285 1.99 . . . . 74.340000000000003 113.084 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.46 105.69 0.46 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.212 -0.449 . . . . 73.239999999999995 110.878 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.98 -174.25 30.6 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.912 -0.661 . . . . 70.310000000000002 112.542 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.467 ' O ' ' HG3' ' A' ' 106' ' ' MET . 14.8 Cg_endo -56.05 -36.01 95.55 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.521 2.148 . . . . 74.340000000000003 111.986 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.507 ' HA ' HD11 ' A' ' 140' ' ' LEU . 41.0 m-85 -61.83 -54.1 46.87 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.957 -0.565 . . . . 73.439999999999998 110.71 177.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -63.41 -33.53 75.76 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.165 0.507 . . . . 72.430000000000007 111.302 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.34 -15.03 45.8 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.124 -0.489 . . . . 75.109999999999999 111.892 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.541 ' SD ' HD21 ' A' ' 140' ' ' LEU . 41.5 mtp -83.66 -22.75 32.03 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.441 -0.345 . . . . 73.0 111.7 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.7 m -123.86 -18.45 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 113.129 0.788 . . . . 74.040000000000006 113.129 -171.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 104' ' ' ALA . 11.2 pt -96.22 177.62 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.381 0.61 . . . . 63.5 111.834 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.632 ' H ' HG21 ' A' ' 123' ' ' VAL . 16.7 t70 . . . . . 0 CA--C 1.54 0.559 0 CA-C-N 115.806 -0.633 . . . . 64.040000000000006 110.131 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.661 0 N-CA-C 112.948 -0.061 . . . . 71.109999999999999 112.948 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.632 HG21 ' H ' ' A' ' 109' ' ' ASP . 58.3 t -78.19 122.13 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 121.0 0.429 . . . . 73.0 111.419 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 124' ' ' LYS . 12.1 mptt -69.47 131.27 44.48 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.906 0.384 . . . . 75.140000000000001 111.549 -177.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.6 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -160.66 -146.03 4.48 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.259 -0.496 . . . . 61.299999999999997 113.358 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 41.4 p -139.8 161.28 37.94 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.887 0.375 . . . . 75.340000000000003 111.542 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.0 p -139.74 144.6 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.132 0.491 . . . . 65.439999999999998 111.462 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.23 156.47 40.94 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.93 -0.577 . . . . 74.450000000000003 111.219 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.568 ' HD3' HD23 ' A' ' 67' ' ' LEU . 27.7 ttpp -90.12 136.95 32.74 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.89 -0.506 . . . . 72.219999999999999 110.586 174.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.3 t -138.34 157.52 46.08 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.092 0.472 . . . . 74.420000000000002 112.217 -173.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -83.02 -4.47 58.36 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.954 -0.566 . . . . 40.130000000000003 111.437 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -70.9 146.5 49.54 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.031 -0.531 . . . . 75.019999999999996 111.832 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.74 152.04 43.08 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.136 0.493 . . . . 73.430000000000007 111.926 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.89 121.9 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.522 -0.308 . . . . 74.109999999999999 110.587 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 135' ' ' LEU . 10.2 mt -62.73 94.24 0.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.005 0.372 . . . . 73.310000000000002 112.005 -178.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.1 m -53.56 150.69 6.6 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.156 -0.474 . . . . 72.109999999999999 110.72 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.55 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 67.9 t -45.09 -48.76 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 112.948 0.721 . . . . 64.209999999999994 112.948 -171.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -72.52 -44.07 62.69 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.213 -0.304 . . . . 70.120000000000005 111.653 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -56.34 -39.61 73.11 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.92 0.867 . . . . 72.120000000000005 110.107 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.541 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.7 tt -60.3 -42.44 95.53 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.791 -1.095 . . . . 70.430000000000007 110.879 175.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 56.6 mt . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 121.24 0.543 . . . . 52.210000000000001 110.508 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.1 ptp . . . . . 0 N--CA 1.467 0.398 0 CA-C-O 121.263 0.554 . . . . 74.219999999999999 111.688 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.552 HD11 ' HB3' ' A' ' 64' ' ' ALA . 20.2 mt -124.58 139.06 54.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.89 -0.596 . . . . 74.530000000000001 111.327 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -78.31 109.01 12.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.658 0.742 . . . . 74.219999999999999 110.618 174.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 34.8 m -132.22 159.13 43.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.731 -1.122 . . . . 70.150000000000006 111.849 -172.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.734 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 44.0 tt0 -99.27 117.62 34.13 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.106 0.479 . . . . 71.219999999999999 111.102 175.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.54 HG22 HD11 ' A' ' 96' ' ' ILE . 38.4 t -89.79 107.81 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.218 0.607 . . . . 65.340000000000003 111.578 -177.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.407 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 2.5 mt -94.11 148.51 4.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 111.803 0.297 . . . . 75.219999999999999 111.803 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.645 ' OG ' HG21 ' A' ' 108' ' ' ILE . 73.7 m -109.97 106.93 16.64 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.055 0.455 . . . . 54.240000000000002 111.36 175.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.486 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . . . . . . 0 CA--C 1.523 0.561 0 C-N-CA 121.256 -0.497 . . . . 73.519999999999996 113.139 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 . . . . . 0 CA--C 1.537 0.458 0 N-CA-C 112.218 0.451 . . . . 74.219999999999999 112.218 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -71.53 -26.53 62.69 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.498 0.666 . . . . 74.019999999999996 109.789 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.54 ' HD1' HG23 ' A' ' 137' ' ' VAL . 71.4 t80 -89.45 -2.31 58.34 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.616 -0.72 . . . . 72.25 110.902 175.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -101.66 -44.38 5.58 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.025 -0.422 . . . . 75.109999999999999 111.811 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.52 -64.0 1.29 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.316 0.858 . . . . 71.230000000000004 113.316 -172.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 32.9 m -79.07 21.8 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 113.338 0.866 . . . . 73.329999999999998 113.338 -170.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.629 ' N ' HD22 ' A' ' 53' ' ' ASN . 0.7 OUTLIER -108.0 11.17 28.04 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.073 0.768 . . . . 63.219999999999999 113.073 -172.546 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -133.2 166.28 22.82 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.598 0.713 . . . . 71.439999999999998 112.487 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.76 135.18 48.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.21 -0.905 . . . . 63.32 110.042 172.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.604 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 45.0 mt-10 -94.67 115.56 27.69 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.867 0.365 . . . . 61.310000000000002 111.285 177.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.3 mp -109.79 150.93 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.062 -0.517 . . . . 73.329999999999998 110.831 -178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -71.78 156.86 38.85 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.71 0.291 . . . . 62.439999999999998 111.418 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -54.74 -47.39 73.9 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.173 0.511 . . . . 71.129999999999995 111.864 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.5 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 17.3 mm-40 -56.41 -52.73 63.55 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.206 -0.452 . . . . 64.099999999999994 112.169 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -66.29 -36.57 83.31 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.007 0.432 . . . . 53.200000000000003 111.024 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -55.68 -48.79 74.47 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.96 -0.563 . . . . 74.340000000000003 111.103 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -66.71 -39.38 88.01 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.05 -0.523 . . . . 75.349999999999994 111.185 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.552 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -61.15 -35.05 76.04 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.058 0.392 . . . . 52.049999999999997 112.058 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.2 mt -89.55 -12.13 40.79 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.042 0.386 . . . . 73.299999999999997 112.042 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.36 48.32 83.22 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.09 -0.576 . . . . 61.210000000000001 112.782 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.668 HD23 ' HD3' ' A' ' 129' ' ' LYS . 92.1 mt -86.88 143.26 27.51 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.259 0.552 . . . . 65.219999999999999 112.474 -175.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -93.61 149.62 21.08 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.989 -0.551 . . . . 74.319999999999993 109.909 171.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -61.26 100.22 0.12 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.452 0.644 . . . . 74.340000000000003 111.279 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.76 29.18 7.05 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.333 -0.848 . . . . 74.030000000000001 112.841 -174.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -82.07 -178.27 6.95 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 122.598 -0.354 . . . . 52.009999999999998 111.158 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.632 HH21 ' HA ' ' A' ' 131' ' ' ASP . 24.2 mtm-85 -116.78 123.07 46.22 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.85 0.357 . . . . 63.439999999999998 111.068 -177.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.81 140.82 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.034 0.445 . . . . 75.140000000000001 112.178 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 31.7 ttmt -110.17 126.38 54.03 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.199 0.524 . . . . 71.129999999999995 111.318 174.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.523 HG11 HG21 ' A' ' 28' ' ' VAL . 47.0 t -101.07 132.09 47.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.87 -0.604 . . . . 62.350000000000001 110.97 177.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.445 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 4.1 mppt? -118.55 127.65 53.83 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.03 0.443 . . . . 74.209999999999994 111.392 174.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.718 HG22 ' HA3' ' A' ' 125' ' ' GLY . 40.7 p -127.25 -170.91 2.3 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.894 -0.594 . . . . 55.240000000000002 110.253 175.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -72.34 -11.34 60.66 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.87 0.367 . . . . 60.25 111.592 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -96.07 -40.54 9.18 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.087 0.403 . . . . 72.150000000000006 112.087 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.79 -146.95 8.76 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.636 -0.792 . . . . 44.229999999999997 113.744 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 14.0 pt-20 -152.13 153.41 33.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.781 0.324 . . . . 74.530000000000001 111.589 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 12.2 p -157.15 149.46 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 116.653 -0.249 . . . . 74.109999999999999 111.67 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.0 t -108.28 119.74 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 116.762 -0.199 . . . . 70.400000000000006 110.856 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.462 HG12 ' CD2' ' A' ' 103' ' ' TYR . 29.7 m -128.37 172.16 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-O 120.914 0.388 . . . . 73.329999999999998 111.727 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -77.43 143.47 38.56 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.022 0.439 . . . . 72.409999999999997 111.39 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.24 122.95 36.16 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.471 0.545 . . . . 70.430000000000007 112.471 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -123.63 157.86 32.8 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.161 0.505 . . . . 74.450000000000003 110.774 172.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -102.9 107.23 17.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.046 -0.525 . . . . 71.030000000000001 110.28 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.604 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -109.35 -175.18 21.24 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.852 -0.69 . . . . 74.409999999999997 114.171 -172.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -90.26 17.12 7.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.865 0.364 . . . . 74.019999999999996 111.439 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.69 151.87 93.48 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 116.45 -0.341 . . . . 62.340000000000003 111.52 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -67.71 154.49 73.12 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.453 2.102 . . . . 72.329999999999998 112.585 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.5 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 87.9 tttt -57.42 137.15 56.5 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.732 0.301 . . . . 74.409999999999997 111.609 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 71.84 26.92 71.67 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 120.817 -0.706 . . . . 31.43 113.031 -174.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.734 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 13.9 ttt -150.69 137.5 19.05 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 122.213 -0.58 . . . . 64.340000000000003 110.151 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.54 HD11 HG22 ' A' ' 28' ' ' VAL . 38.0 pt -133.53 144.84 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.355 0.598 . . . . 54.229999999999997 112.166 -178.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.486 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 66.4 t80 -105.78 127.33 53.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.969 -0.56 . . . . 72.329999999999998 111.452 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 30' ' ' SER . 46.1 mt -127.29 128.32 24.09 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 122.337 0.255 . . . . 73.310000000000002 110.563 174.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.453 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 37.1 Cg_exo -57.76 142.91 96.25 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.2 1.933 . . . . 51.409999999999997 112.704 177.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.5 tpt -59.22 103.73 0.2 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.025 0.441 . . . . 72.120000000000005 111.435 -178.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.74 -178.08 34.4 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.678 -0.773 . . . . 71.329999999999998 112.893 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.537 ' O ' ' HG2' ' A' ' 106' ' ' MET . 18.8 Cg_endo -57.53 -34.63 98.34 Favored 'Trans proline' 0 N--CA 1.478 0.579 0 C-N-CA 122.76 2.307 . . . . 72.329999999999998 111.718 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.462 ' CD2' HG12 ' A' ' 84' ' ' VAL . 25.6 m-85 -58.73 -49.38 77.83 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.92 -0.582 . . . . 73.200000000000003 110.4 175.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -63.06 -42.61 99.72 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.851 -0.613 . . . . 72.340000000000003 111.588 176.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -61.46 -7.46 3.14 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.663 0.616 . . . . 72.409999999999997 112.663 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.579 ' SD ' HD21 ' A' ' 140' ' ' LEU . 90.5 mmm -84.2 -20.21 32.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.772 0.32 . . . . 74.400000000000006 111.556 176.11 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.3 m -130.83 -12.1 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 113.271 0.841 . . . . 63.240000000000002 113.271 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.645 HG21 ' OG ' ' A' ' 30' ' ' SER . 8.8 pt -96.72 -179.05 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 121.725 -0.609 . . . . 70.109999999999999 112.254 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.603 ' H ' HG21 ' A' ' 123' ' ' VAL . 16.4 t70 . . . . . 0 CA--C 1.543 0.697 0 CA-C-N 116.008 -0.542 . . . . 75.120000000000005 111.133 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . . . . . . 0 CA--C 1.527 0.837 0 CA-C-O 120.849 0.139 . . . . 61.530000000000001 113.323 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' H ' ' A' ' 109' ' ' ASP . 84.2 t -94.25 123.32 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 111.924 0.342 . . . . 53.530000000000001 111.924 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 54.9 mtmt -75.36 147.19 40.27 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.45 0.537 . . . . 63.100000000000001 112.45 -177.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.718 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -169.6 -157.97 12.8 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.88 -0.6 . . . . 65.230000000000004 112.658 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 45.8 p -124.69 138.72 54.28 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.257 -0.555 . . . . 72.420000000000002 111.586 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.3 p -126.64 144.57 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.883 0.373 . . . . 73.310000000000002 111.64 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.92 156.93 36.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.188 -0.46 . . . . 74.010000000000005 110.999 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.668 ' HD3' HD23 ' A' ' 67' ' ' LEU . 27.1 ttpp -72.24 141.56 48.96 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.908 0.385 . . . . 74.430000000000007 111.185 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.4 t -132.12 160.83 34.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.232 0.539 . . . . 73.150000000000006 112.089 -175.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.632 ' HA ' HH21 ' A' ' 72' ' ' ARG . 5.1 m-20 -92.21 -10.94 36.81 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.826 -0.625 . . . . 73.310000000000002 111.031 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.39 168.25 9.22 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.22 0.533 . . . . 75.120000000000005 112.12 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -86.81 152.71 22.25 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.097 -0.502 . . . . 74.409999999999997 110.915 175.664 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 83.8 t -63.08 129.31 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.63 0.252 . . . . 73.209999999999994 110.654 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 135' ' ' LEU . 8.9 mt -66.91 90.67 0.18 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.724 0.268 . . . . 63.450000000000003 111.724 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.8 m -49.38 148.88 2.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.068 -0.515 . . . . 71.25 110.967 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.54 HG23 ' HD1' ' A' ' 49' ' ' PHE . 90.5 t -45.18 -45.14 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 112.123 0.416 . . . . 64.209999999999994 112.123 -175.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -71.95 -43.92 64.45 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.391 -0.368 . . . . 74.530000000000001 111.837 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.435 ' HG2' ' HE3' ' A' ' 133' ' ' LYS . 4.3 tp10 -61.13 -32.47 72.17 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.486 0.66 . . . . 74.140000000000001 110.53 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.579 HD21 ' SD ' ' A' ' 106' ' ' MET . 1.4 tt -65.85 -37.91 87.44 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.376 -0.829 . . . . 75.239999999999995 110.654 176.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 29.6 mt . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 121.581 0.705 . . . . 75.430000000000007 109.944 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.556 ' HB3' ' HB3' ' A' ' 128' ' ' GLU . 6.1 ptp . . . . . 0 N--CA 1.468 0.446 0 CA-C-O 121.358 0.599 . . . . 71.319999999999993 111.914 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.0 mt -134.53 139.14 45.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 71.030000000000001 111.603 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -84.77 114.06 21.78 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.558 0.694 . . . . 50.140000000000001 110.886 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.444 HG12 ' HA2' ' A' ' 94' ' ' GLY . 34.5 m -134.97 167.17 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 114.959 -1.019 . . . . 42.32 112.338 -170.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -101.16 132.0 46.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.706 0.289 . . . . 73.420000000000002 110.45 171.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.47 111.15 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 112.154 0.427 . . . . 70.239999999999995 112.154 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -100.06 151.06 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.065 0.46 . . . . 73.329999999999998 111.213 174.838 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 74.3 m -124.53 110.0 13.93 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.975 0.417 . . . . 50.539999999999999 111.779 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.747 0 C-N-CA 121.277 -0.487 . . . . 60.530000000000001 112.429 178.903 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 CA--C 1.543 0.69 0 N-CA-C 112.433 0.531 . . . . 73.010000000000005 112.433 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.58 -23.08 53.49 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.962 -0.461 . . . . 74.530000000000001 110.635 175.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.422 ' HD1' HG23 ' A' ' 137' ' ' VAL . 57.6 t80 -90.87 0.41 57.49 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 116.181 -0.463 . . . . 71.510000000000005 112.01 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 51' ' ' ALA . 29.8 p30 -121.66 -44.36 2.34 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.528 -0.733 . . . . 52.310000000000002 112.799 176.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.444 ' N ' ' OD1' ' A' ' 50' ' ' ASN . . . -70.19 -30.95 68.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.682 0.993 . . . . 62.049999999999997 113.682 -172.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 33.0 m -118.19 16.1 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 112.769 0.655 . . . . 72.010000000000005 112.769 -177.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -104.87 17.64 23.76 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.868 0.692 . . . . 70.310000000000002 112.868 -174.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -141.3 168.53 19.55 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.065 0.46 . . . . 65.409999999999997 111.93 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.9 144.41 45.51 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.089 -0.505 . . . . 70.230000000000004 111.284 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.522 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 42.1 mt-10 -96.75 113.31 24.85 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.697 0.284 . . . . 65.349999999999994 111.189 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.0 mp -110.43 147.01 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.368 -0.378 . . . . 70.209999999999994 110.82 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -65.79 143.24 57.62 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.665 -0.243 . . . . 71.420000000000002 110.971 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 30.4 tt0 -58.3 -38.39 76.97 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.103 0.779 . . . . 61.240000000000002 113.103 -174.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -60.44 -48.05 83.45 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.957 -0.464 . . . . 75.010000000000005 110.99 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -63.9 -38.07 89.74 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.012 0.434 . . . . 72.239999999999995 110.837 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.41 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 35.8 t-105 -53.26 -51.49 62.1 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.43 0.633 . . . . 74.400000000000006 111.07 175.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -67.92 -35.76 79.01 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.751 -0.659 . . . . 62.25 111.294 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.9 93.2 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.185 0.516 . . . . 72.230000000000004 111.621 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.533 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 73.5 mt -79.46 -16.15 56.59 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.118 -0.492 . . . . 63.5 111.603 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.93 53.96 24.17 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.947 -0.644 . . . . 61.329999999999998 111.888 -173.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.629 HD23 ' HE3' ' A' ' 129' ' ' LYS . 96.2 mt -91.31 160.1 15.67 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.774 0.797 . . . . 72.310000000000002 112.932 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -129.51 127.81 41.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.999 -1.0 . . . . 73.420000000000002 109.394 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -50.8 98.8 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.096 0.776 . . . . 73.239999999999995 113.096 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.92 13.4 11.15 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 115.311 -0.859 . . . . 45.509999999999998 113.77 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.436 ' HA ' HH11 ' A' ' 72' ' ' ARG . 46.9 p-10 -88.67 -169.01 2.38 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 117.665 0.732 . . . . 55.409999999999997 112.33 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.644 ' HG3' HG23 ' A' ' 134' ' ' VAL . 2.4 mpt_? -109.1 127.7 54.37 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.913 0.387 . . . . 72.209999999999994 111.9 -173.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.1 m -124.4 138.47 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.023 0.439 . . . . 74.239999999999995 111.33 174.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.438 ' HE3' ' HG3' ' A' ' 132' ' ' GLU . 39.8 ttmt -102.7 125.66 49.52 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.965 0.412 . . . . 52.039999999999999 110.753 177.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.48 131.17 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.361 -0.607 . . . . 62.350000000000001 109.361 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -134.17 132.23 39.55 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.319 0.58 . . . . 75.319999999999993 112.249 -172.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.704 HG22 ' HA3' ' A' ' 125' ' ' GLY . 30.7 p -138.99 -171.22 3.04 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.961 -0.563 . . . . 63.149999999999999 111.626 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.05 -18.18 65.08 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.928 -0.578 . . . . 60.200000000000003 112.01 175.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 109' ' ' ASP . 98.5 m-85 -88.0 -55.36 3.79 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.911 0.386 . . . . 63.420000000000002 111.505 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.9 -154.17 11.23 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.944 -0.646 . . . . 71.120000000000005 112.93 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.07 154.12 50.41 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.2 0.524 . . . . 65.310000000000002 111.652 178.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -151.0 145.31 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.241 -0.436 . . . . 74.299999999999997 111.036 177.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.5 t -110.31 117.73 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.808 0.337 . . . . 44.310000000000002 111.099 177.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.51 173.95 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 115.966 -0.561 . . . . 75.209999999999994 111.365 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -78.0 133.32 38.0 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.011 0.434 . . . . 72.230000000000004 111.18 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.94 126.5 33.07 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.179 0.437 . . . . 54.240000000000002 112.179 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -132.01 152.03 51.39 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.368 0.604 . . . . 74.439999999999998 110.871 175.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -90.45 121.97 32.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.66 -0.7 . . . . 65.400000000000006 111.249 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.522 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -120.59 -178.5 16.09 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.122 -0.561 . . . . 65.430000000000007 113.801 -174.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -93.66 8.87 39.24 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 122.703 0.401 . . . . 64.420000000000002 111.73 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.1 m -64.17 152.88 87.06 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.473 -0.33 . . . . 75.299999999999997 111.786 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.05 157.71 58.94 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.393 2.062 . . . . 74.430000000000007 112.21 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -64.63 142.2 58.51 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.829 0.347 . . . . 70.129999999999995 111.544 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.444 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 73.18 25.94 71.95 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.881 -0.676 . . . . 43.409999999999997 112.745 -173.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.2 ttt -154.97 136.74 14.44 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.428 -0.454 . . . . 75.030000000000001 110.278 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.2 pt -134.69 145.74 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.116 0.484 . . . . 55.43 112.264 -177.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.413 ' HA ' HG12 ' A' ' 29' ' ' ILE . 70.4 t80 -103.94 134.86 46.52 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.017 0.437 . . . . 74.129999999999995 111.379 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.656 ' O ' ' HA ' ' A' ' 30' ' ' SER . 48.3 mt -130.75 132.96 24.27 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.368 -0.378 . . . . 65.019999999999996 110.534 175.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.401 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 33.7 Cg_exo -61.65 129.05 26.43 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.058 1.839 . . . . 72.349999999999994 112.075 174.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.492 ' HE3' HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -57.73 104.8 0.2 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.029 0.443 . . . . 72.099999999999994 110.858 -176.417 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.25 -175.03 29.75 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.812 -0.708 . . . . 52.219999999999999 112.854 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.439 ' O ' ' HG2' ' A' ' 106' ' ' MET . 16.0 Cg_endo -56.56 -33.28 92.5 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.656 2.238 . . . . 65.430000000000007 112.254 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.463 ' HA ' HD11 ' A' ' 140' ' ' LEU . 37.5 m-85 -63.35 -50.97 67.89 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.092 0.472 . . . . 72.150000000000006 110.23 175.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -59.97 -41.48 92.04 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.167 -0.47 . . . . 61.039999999999999 111.801 176.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.423 HD22 ' HA ' ' A' ' 102' ' ' PRO . 91.7 m-20 -53.3 -29.16 32.01 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.15 0.426 . . . . 63.340000000000003 112.15 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.483 ' SD ' HD21 ' A' ' 140' ' ' LEU . 87.8 mmm -65.62 -24.15 66.99 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.29 -0.414 . . . . 75.25 112.112 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.5 -12.92 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 112.945 0.72 . . . . 62.030000000000001 112.945 -173.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.492 HD11 ' HE3' ' A' ' 100' ' ' MET . 6.9 pt -107.44 -179.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.868 -0.52 . . . . 63.340000000000003 111.738 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 29.4 t70 . . . . . 0 CA--C 1.543 0.684 0 CA-C-N 116.141 -0.481 . . . . 63.420000000000002 110.563 173.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.987 0 N-CA-C 113.984 0.354 . . . . 33.439999999999998 113.984 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.41 HG21 ' H ' ' A' ' 109' ' ' ASP . 58.1 t -92.93 133.73 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 122.836 0.454 . . . . 63.420000000000002 111.46 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -74.96 140.84 43.96 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.671 0.619 . . . . 74.439999999999998 112.671 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.704 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -169.62 -165.5 27.09 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.837 -0.62 . . . . 74.129999999999995 113.087 177.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 77.3 p -122.39 155.12 36.71 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.939 0.399 . . . . 70.430000000000007 111.486 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.1 p -129.88 142.77 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.657 -0.498 . . . . 62.539999999999999 109.657 173.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 8.8 pt-20 -143.21 147.65 35.21 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.251 0.834 . . . . 72.209999999999994 113.251 -174.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.629 ' HE3' HD23 ' A' ' 67' ' ' LEU . 1.8 tppp? -77.03 109.28 10.73 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.427 -0.806 . . . . 72.010000000000005 109.675 168.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.1 t -123.22 162.53 22.39 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.348 0.594 . . . . 74.340000000000003 112.456 -173.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.82 -12.14 59.78 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.397 -0.82 . . . . 71.439999999999998 111.209 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.438 ' HG3' ' HE3' ' A' ' 74' ' ' LYS . 6.2 mm-40 -61.1 160.26 10.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.684 0.754 . . . . 74.219999999999999 112.925 -176.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -95.15 160.22 14.66 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.425 -0.807 . . . . 74.109999999999999 110.917 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.644 HG23 ' HG3' ' A' ' 72' ' ' ARG . 71.9 t -72.25 136.42 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 120.733 0.302 . . . . 62.240000000000002 110.751 174.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.6 mt -73.4 132.29 42.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.544 -0.298 . . . . 73.200000000000003 111.441 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.4 t -73.15 147.83 44.45 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.208 -0.664 . . . . 73.200000000000003 109.208 170.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.422 HG23 ' HD1' ' A' ' 49' ' ' PHE . 99.3 t -46.05 -52.5 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 112.672 0.619 . . . . 70.340000000000003 112.672 -173.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -73.0 -35.41 66.82 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.04 -0.412 . . . . 73.519999999999996 111.723 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -60.9 -33.83 73.73 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.747 0.784 . . . . 72.109999999999999 110.156 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.483 HD21 ' SD ' ' A' ' 106' ' ' MET . 4.8 tt -60.37 -44.19 95.84 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.075 -0.966 . . . . 72.430000000000007 110.359 171.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.1 mt . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 121.181 0.515 . . . . 71.030000000000001 110.19 177.019 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.438 ' SD ' HG21 ' A' ' 126' ' ' THR . 7.0 ptp . . . . . 0 N--CA 1.469 0.493 0 CA-C-O 120.872 0.367 . . . . 74.549999999999997 110.855 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.557 HD12 ' HG ' ' A' ' 65' ' ' LEU . 9.5 mt -104.84 127.36 52.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.028 0.442 . . . . 74.25 111.687 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -71.29 113.23 8.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.732 0.777 . . . . 71.329999999999998 111.865 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 35.3 m -134.09 157.62 41.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.71 -1.132 . . . . 73.109999999999999 111.742 -174.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 41.8 tt0 -98.74 117.88 34.21 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.905 0.383 . . . . 74.129999999999995 110.699 175.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.634 HG22 HD11 ' A' ' 96' ' ' ILE . 34.4 t -91.04 110.63 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.944 -0.571 . . . . 71.329999999999998 111.848 -173.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.51 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 2.0 mt -95.72 159.92 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 122.06 -0.4 . . . . 71.219999999999999 111.731 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.3 t -122.87 111.71 16.99 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.949 0.404 . . . . 63.100000000000001 111.245 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.728 0 C-N-CA 121.319 -0.467 . . . . 60.450000000000003 113.534 -178.766 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 120.859 0.361 . . . . 61.229999999999997 111.066 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.524 ' O ' HG22 ' A' ' 52' ' ' VAL . 8.6 t80 -59.63 -41.23 90.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.55 0.691 . . . . 74.430000000000007 109.876 174.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.437 ' HE2' ' HA ' ' A' ' 136' ' ' SER . 50.5 t80 -63.61 -65.15 0.72 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.24 -0.891 . . . . 54.25 110.554 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -58.0 -21.54 45.34 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.773 0.656 . . . . 73.439999999999998 112.773 -176.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.28 -32.19 33.32 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.031 0.752 . . . . 45.210000000000001 113.031 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 48' ' ' TYR . 32.7 m -116.93 4.88 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 113.27 0.841 . . . . 73.329999999999998 113.27 -175.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -94.58 28.34 2.66 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.377 0.88 . . . . 74.420000000000002 113.377 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.446 ' CE2' ' HE2' ' A' ' 87' ' ' LYS . 17.8 p90 -144.46 151.62 39.45 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.556 -0.715 . . . . 64.209999999999994 111.979 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.78 139.59 53.7 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.617 -0.72 . . . . 32.130000000000003 110.872 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.662 ' HG2' ' HE3' ' A' ' 87' ' ' LYS . 41.3 mt-10 -95.42 112.66 24.33 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.865 0.364 . . . . 73.430000000000007 111.423 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.0 mp -109.17 145.67 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.275 -0.42 . . . . 70.340000000000003 110.518 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -61.81 151.93 32.92 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.284 0.564 . . . . 52.109999999999999 111.763 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 14.8 tm-20 -55.92 -52.94 62.36 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.705 -0.679 . . . . 61.409999999999997 111.964 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -55.75 -53.24 59.03 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.325 0.491 . . . . 70.239999999999995 112.325 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -61.09 -35.98 78.46 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.629 0.728 . . . . 75.219999999999999 110.663 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.519 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 43.0 t-105 -52.78 -53.84 42.52 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.023 -0.99 . . . . 73.439999999999998 111.769 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -73.53 -30.15 62.9 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.299 -0.409 . . . . 70.310000000000002 111.644 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.439 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -58.64 -34.85 71.66 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.032 0.444 . . . . 65.099999999999994 111.581 177.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.557 ' HG ' HD12 ' A' ' 24' ' ' LEU . 82.6 mt -89.64 -13.86 36.15 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.154 -0.475 . . . . 43.240000000000002 111.461 176.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.72 44.72 19.47 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.396 -0.431 . . . . 72.040000000000006 112.825 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' A' ' 129' ' ' LYS . 92.9 mt -85.1 149.97 25.18 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.509 0.671 . . . . 72.219999999999999 112.095 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -114.61 144.96 42.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.691 -0.686 . . . . 70.150000000000006 109.213 169.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -61.33 93.37 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.017 0.913 . . . . 61.229999999999997 111.697 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.0 -7.42 3.8 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 114.612 -1.176 . . . . 43.240000000000002 113.267 -175.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -69.35 178.53 2.36 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.04 0.756 . . . . 74.409999999999997 113.04 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.2 mtm-85 -113.61 139.63 48.86 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.688 -0.687 . . . . 73.519999999999996 110.512 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.35 139.64 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.472 0.653 . . . . 73.140000000000001 112.716 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -90.38 131.29 36.24 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.427 -0.806 . . . . 72.120000000000005 110.207 172.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.9 t -119.52 125.72 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.696 -0.483 . . . . 73.099999999999994 109.696 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.459 ' HG2' ' HB3' ' A' ' 81' ' ' GLU . 25.6 mtpp -133.9 131.59 39.3 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.991 0.737 . . . . 73.299999999999997 112.991 -171.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.652 HG22 ' HA3' ' A' ' 125' ' ' GLY . 30.3 p -140.1 -176.23 4.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.529 -0.759 . . . . 71.219999999999999 110.973 178.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.78 -11.4 60.82 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.365 -0.38 . . . . 71.040000000000006 111.681 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 109' ' ' ASP . 93.8 m-85 -89.31 -40.45 12.78 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.802 0.334 . . . . 71.430000000000007 111.296 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.05 -147.26 10.24 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.144 -0.55 . . . . 43.420000000000002 112.652 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.459 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 11.2 pt-20 -155.04 154.43 32.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.143 0.497 . . . . 71.319999999999993 112.218 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.3 p -149.51 155.32 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.999 -0.546 . . . . 73.049999999999997 111.169 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.83 116.94 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 122.382 -0.198 . . . . 74.219999999999999 111.017 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.5 176.28 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 116.496 -0.32 . . . . 72.430000000000007 111.267 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -77.68 160.4 28.5 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.203 0.525 . . . . 75.439999999999998 111.405 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.11 127.2 50.47 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.243 0.544 . . . . 60.450000000000003 111.734 -173.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.662 ' HE3' ' HG2' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -131.24 129.71 41.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.877 -0.601 . . . . 55.32 111.148 -178.776 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -79.88 98.65 7.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.035 -0.53 . . . . 73.099999999999994 110.828 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.553 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -96.56 161.01 22.01 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.989 -0.55 . . . . 45.43 114.018 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -87.63 15.24 7.04 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.358 0.599 . . . . 62.109999999999999 111.566 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.8 m -71.12 157.35 90.45 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 115.685 -0.689 . . . . 74.200000000000003 111.421 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.6 157.67 40.74 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.732 2.288 . . . . 70.310000000000002 113.723 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -62.59 145.64 53.93 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.282 -0.417 . . . . 74.439999999999998 111.35 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 61.99 32.45 82.22 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.843 -0.694 . . . . 72.519999999999996 112.716 -174.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.484 ' HA ' ' H ' ' A' ' 27' ' ' GLU . 21.8 ttt -153.88 136.71 15.34 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.592 -0.358 . . . . 63.43 110.119 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.634 HD11 HG22 ' A' ' 28' ' ' VAL . 40.8 pt -134.84 150.9 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 121.288 0.566 . . . . 72.430000000000007 112.023 -177.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -112.13 130.9 55.74 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.016 -0.538 . . . . 61.020000000000003 111.241 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 30' ' ' SER . 50.4 mt -130.3 128.5 22.7 Favored Pre-proline 0 N--CA 1.474 0.77 0 CA-C-O 120.548 0.213 . . . . 74.109999999999999 110.998 175.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.51 140.66 89.89 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.27 1.98 . . . . 72.25 112.899 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.01 105.84 0.44 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.122 0.486 . . . . 75.0 110.815 -178.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.91 -174.71 27.96 Favored Glycine 0 N--CA 1.46 0.273 0 C-N-CA 120.784 -0.722 . . . . 71.530000000000001 112.57 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.512 ' O ' ' HG2' ' A' ' 106' ' ' MET . 26.5 Cg_endo -61.74 -26.72 80.1 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.272 1.981 . . . . 53.240000000000002 111.563 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.463 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 4.1 m-85 -69.17 -53.44 20.04 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.56 -0.745 . . . . 74.150000000000006 110.782 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -60.05 -39.78 87.16 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.268 -0.424 . . . . 43.520000000000003 110.748 174.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -54.71 -25.92 30.51 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.912 0.485 . . . . 70.25 112.042 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.645 ' SD ' HD21 ' A' ' 140' ' ' LEU . 89.9 mmm -67.28 -30.2 70.01 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.947 0.351 . . . . 73.040000000000006 111.947 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.07 -14.01 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 113.187 0.81 . . . . 54.520000000000003 113.187 -171.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 104' ' ' ALA . 8.8 pt -102.67 -178.91 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.163 0.506 . . . . 62.049999999999997 111.753 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 21.7 t70 . . . . . 0 CA--C 1.543 0.696 0 CA-C-N 116.076 -0.511 . . . . 33.43 110.475 173.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . . . . . . 0 CA--C 1.522 0.507 0 CA-C-O 120.957 0.199 . . . . 63.509999999999998 113.091 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' A' ' 108' ' ' ILE . 59.5 t -85.32 119.16 33.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.926 0.393 . . . . 71.310000000000002 111.487 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 67.5 mttm -67.46 148.88 50.95 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.245 0.545 . . . . 65.239999999999995 112.366 -177.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.652 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -177.25 -143.52 4.94 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 115.94 -0.573 . . . . 53.210000000000001 113.367 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.438 HG21 ' SD ' ' A' ' 23' ' ' MET . 76.5 p -139.3 159.98 40.88 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 122.398 -0.472 . . . . 65.239999999999995 111.769 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.7 p -144.99 145.02 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.103 0.478 . . . . 74.239999999999995 111.484 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -155.61 161.51 40.81 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.364 -0.38 . . . . 71.510000000000005 110.687 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.441 ' HB2' HD21 ' A' ' 67' ' ' LEU . 31.7 ttpt -79.91 131.15 35.78 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.755 -0.59 . . . . 75.25 110.197 173.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.7 t -118.01 156.25 28.88 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.644 0.609 . . . . 61.100000000000001 112.644 -172.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.02 -13.05 60.23 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.724 -0.671 . . . . 74.420000000000002 110.055 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -70.0 147.68 49.82 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.299 -0.864 . . . . 63.520000000000003 113.195 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.713 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -77.29 157.35 30.79 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.779 -1.1 . . . . 75.430000000000007 111.373 174.265 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.23 130.28 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.87 0.367 . . . . 74.349999999999994 110.826 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.1 mt -66.26 119.45 11.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 71.510000000000005 111.567 178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.437 ' HA ' ' HE2' ' A' ' 49' ' ' PHE . 29.9 t -66.27 148.44 51.85 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.596 -0.52 . . . . 74.319999999999993 109.596 168.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.505 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 62.7 t -46.26 -40.3 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 120.943 0.402 . . . . 75.219999999999999 111.583 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -72.79 -44.39 61.59 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.194 -0.457 . . . . 61.420000000000002 112.165 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -60.91 -36.03 78.21 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.672 0.749 . . . . 74.219999999999999 110.227 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.645 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.5 tt -60.65 -38.87 86.3 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.415 -0.811 . . . . 71.209999999999994 110.799 174.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 54.0 mt . . . . . 0 N--CA 1.47 0.525 0 CA-C-O 121.467 0.651 . . . . 73.219999999999999 110.063 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.5 ptm . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 120.478 0.18 . . . . 73.409999999999997 110.528 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mp -105.32 142.92 34.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.164 0.507 . . . . 64.319999999999993 112.281 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.409 ' HA ' HG22 ' A' ' 126' ' ' THR . 29.6 tt0 -81.14 112.12 18.21 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.809 -0.632 . . . . 74.299999999999997 110.898 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 33.3 m -128.09 160.19 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.809 0.338 . . . . 71.219999999999999 111.886 -174.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.701 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 86.9 tt0 -98.83 115.23 28.34 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.193 0.521 . . . . 72.549999999999997 110.594 175.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.553 HG22 HD11 ' A' ' 96' ' ' ILE . 39.5 t -88.22 113.9 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.708 -0.678 . . . . 63.210000000000001 111.751 -175.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 mt -98.0 159.8 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.569 -0.287 . . . . 74.530000000000001 111.546 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 71.5 m -126.17 106.13 9.34 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.964 0.411 . . . . 55.340000000000003 111.29 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . . . . . . 0 CA--C 1.524 0.651 0 C-N-CA 121.039 -0.6 . . . . 75.540000000000006 113.597 -176.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 121.12 0.485 . . . . 71.439999999999998 111.268 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -64.78 -32.64 74.43 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.211 -0.449 . . . . 75.430000000000007 110.675 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.478 ' HD1' HG23 ' A' ' 137' ' ' VAL . 52.8 t80 -87.19 4.92 40.54 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.161 0.505 . . . . 75.25 111.673 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -121.44 -36.32 3.09 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.753 -0.592 . . . . 44.210000000000001 111.959 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.4 -56.0 8.7 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.796 0.665 . . . . 72.209999999999994 112.796 -175.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.6 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 34.4 m -96.16 17.16 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 113.078 0.77 . . . . 65.010000000000005 113.078 -173.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -102.46 19.38 19.04 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.709 0.633 . . . . 74.219999999999999 112.709 -174.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -144.23 171.14 14.72 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.889 -0.507 . . . . 70.329999999999998 112.045 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.55 136.39 44.94 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.884 -0.598 . . . . 72.0 111.388 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.627 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 42.5 mt-10 -86.66 117.28 25.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.088 0.471 . . . . 60.340000000000003 110.7 175.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 28.1 mt -113.52 143.43 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.819 -0.628 . . . . 73.25 111.897 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -66.38 145.07 56.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.495 0.188 . . . . 73.120000000000005 110.622 174.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -62.29 -32.62 73.37 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.529 0.566 . . . . 62.340000000000003 112.529 -176.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.551 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 17.7 mm-40 -58.87 -57.44 13.05 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.213 -0.304 . . . . 54.039999999999999 111.585 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.51 -37.29 85.46 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.345 0.593 . . . . 74.200000000000003 110.64 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.496 ' HA ' HD12 ' A' ' 67' ' ' LEU . 51.5 t-105 -53.43 -52.1 60.5 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.406 -0.815 . . . . 72.549999999999997 110.991 174.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -67.1 -38.65 86.04 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.679 -0.691 . . . . 63.520000000000003 111.35 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.27 -33.91 72.99 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.236 -0.438 . . . . 65.349999999999994 112.028 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -94.78 -7.61 39.93 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.083 0.401 . . . . 73.150000000000006 112.083 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.48 48.15 76.6 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.064 -0.588 . . . . 64.519999999999996 112.634 -177.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.524 HD23 ' HD3' ' A' ' 129' ' ' LYS . 84.8 mt -86.29 142.8 28.26 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.351 0.596 . . . . 73.209999999999994 112.34 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -110.51 151.36 27.67 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.416 -0.811 . . . . 74.150000000000006 109.545 172.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.6 104.31 0.64 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.329 0.585 . . . . 72.209999999999994 111.366 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 118.5 0.02 15.95 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-N 115.652 -0.704 . . . . 73.420000000000002 113.62 -176.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -68.65 172.13 6.72 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.304 0.573 . . . . 51.43 111.868 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 133' ' ' LYS . 74.1 mtt85 -109.79 125.51 52.8 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.001 -0.545 . . . . 63.210000000000001 110.949 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.691 HG13 ' HB2' ' A' ' 86' ' ' ALA . 15.5 m -113.8 152.35 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.543 0.687 . . . . 75.209999999999994 111.844 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.432 ' HZ2' ' CG2' ' A' ' 83' ' ' VAL . 47.1 tttp -124.05 120.86 33.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.606 -0.724 . . . . 74.209999999999994 110.388 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 48.2 t -102.64 130.83 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 111.753 0.279 . . . . 61.549999999999997 111.753 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.91 127.73 53.76 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.631 -0.259 . . . . 72.120000000000005 110.748 175.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.814 HG22 ' HA3' ' A' ' 125' ' ' GLY . 25.4 p -130.81 -172.15 2.75 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.094 0.473 . . . . 73.329999999999998 111.259 177.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.77 -16.43 63.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.373 -0.376 . . . . 73.200000000000003 111.679 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -93.34 -47.07 7.07 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 111.888 0.329 . . . . 71.329999999999998 111.888 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.94 -156.95 19.98 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.879 -0.677 . . . . 52.520000000000003 113.266 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 5.2 pt-20 -133.72 161.23 35.25 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.14 0.495 . . . . 74.239999999999995 111.725 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.9 p -160.59 143.25 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.29 -0.414 . . . . 74.129999999999995 111.34 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.432 ' CG2' ' HZ2' ' A' ' 74' ' ' LYS . 45.0 t -104.03 118.97 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 122.325 -0.234 . . . . 72.420000000000002 110.761 176.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.9 m -130.14 177.68 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.853 0.359 . . . . 75.25 111.687 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -80.21 144.11 33.22 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.19 0.519 . . . . 74.230000000000004 111.674 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.691 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -93.9 120.13 33.75 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.18 0.437 . . . . 64.230000000000004 112.18 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -131.9 150.31 52.19 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.203 0.525 . . . . 74.319999999999993 110.863 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -92.14 122.81 34.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.005 -0.543 . . . . 75.409999999999997 111.068 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.627 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -120.06 172.94 15.06 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.08 -0.581 . . . . 64.420000000000002 113.487 -176.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.9 9.82 9.17 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.81 0.338 . . . . 62.310000000000002 111.861 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.1 m -64.78 152.97 89.16 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.353 -0.385 . . . . 71.150000000000006 111.67 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.18 163.57 38.73 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.803 2.335 . . . . 65.200000000000003 113.218 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.551 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 84.6 tttt -63.88 133.07 52.64 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.406 -0.361 . . . . 73.129999999999995 111.694 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 77.44 24.37 65.7 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.97 -0.633 . . . . 72.219999999999999 113.198 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.701 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 18.2 ttt -149.78 137.09 19.81 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.374 -0.486 . . . . 74.209999999999994 110.471 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.553 HD11 HG22 ' A' ' 28' ' ' VAL . 39.5 pt -130.09 144.75 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.407 0.622 . . . . 64.230000000000004 112.03 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.52 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 74.6 t80 -106.69 119.36 39.1 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.961 -0.563 . . . . 73.340000000000003 111.383 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' A' ' 30' ' ' SER . 44.4 mt -117.4 126.36 27.45 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 120.673 0.273 . . . . 70.209999999999994 110.801 175.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.6 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 19.5 Cg_endo -58.56 132.0 45.78 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.121 1.881 . . . . 75.209999999999994 111.934 175.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.9 tpp -51.51 115.42 1.61 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.17 0.51 . . . . 74.540000000000006 112.265 -176.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -169.03 178.53 42.24 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.786 -0.643 . . . . 61.350000000000001 112.496 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.494 ' O ' ' HG2' ' A' ' 106' ' ' MET . 11.9 Cg_endo -52.87 -33.8 63.01 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 122.853 2.369 . . . . 60.039999999999999 112.095 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -64.82 -47.64 77.29 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.738 -0.665 . . . . 74.230000000000004 110.608 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.501 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -64.21 -39.83 94.79 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.018 0.437 . . . . 62.43 111.197 175.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -64.03 -7.04 7.38 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.436 0.532 . . . . 63.420000000000002 112.436 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.66 ' SD ' HD21 ' A' ' 140' ' ' LEU . 95.8 mmm -82.62 -25.62 33.01 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.971 0.415 . . . . 73.209999999999994 111.311 173.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.4 m -120.98 -16.52 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 112.335 0.494 . . . . 65.439999999999998 112.335 -170.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.539 HG21 ' OG ' ' A' ' 30' ' ' SER . 5.9 pt -101.99 -178.43 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.102 0.477 . . . . 72.319999999999993 111.603 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.2 t70 . . . . . 0 CA--C 1.545 0.779 0 CA-C-N 116.356 -0.384 . . . . 75.030000000000001 110.553 173.82 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.773 0 CA-C-O 120.913 0.174 . . . . 63.240000000000002 113.292 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.9 t -93.53 120.95 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 122.398 -0.472 . . . . 74.340000000000003 111.528 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.608 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 37.3 mtpt -65.63 155.87 34.55 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.73 0.776 . . . . 72.349999999999994 113.09 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.814 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -178.85 -151.39 9.56 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 114.966 -1.016 . . . . 51.229999999999997 112.449 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.409 HG22 ' HA ' ' A' ' 25' ' ' GLU . 45.1 p -141.09 147.79 39.1 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.424 -0.457 . . . . 73.129999999999995 111.538 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.0 p -125.43 144.58 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.291 0.567 . . . . 74.430000000000007 111.904 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -153.87 168.87 24.91 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.796 -0.638 . . . . 55.439999999999998 110.561 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.524 ' HD3' HD23 ' A' ' 67' ' ' LEU . 36.8 ttpt -99.72 139.16 35.78 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.13 0.491 . . . . 74.409999999999997 111.257 174.269 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.9 t -131.75 161.23 33.34 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.307 0.575 . . . . 52.530000000000001 111.968 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -90.18 -2.88 58.11 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.809 -0.632 . . . . 75.409999999999997 111.039 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.67 153.28 44.06 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.98 -0.554 . . . . 64.519999999999996 111.353 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 3.2 pptp? -87.47 156.86 19.37 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.064 0.459 . . . . 72.120000000000005 111.196 176.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.23 130.73 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.11 -0.495 . . . . 71.420000000000002 111.834 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 135' ' ' LEU . 2.1 mt -61.74 101.09 0.17 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.411 -0.359 . . . . 62.420000000000002 111.223 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.3 m -52.43 143.2 15.75 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 110.783 -0.08 . . . . 65.109999999999999 110.783 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.478 HG23 ' HD1' ' A' ' 49' ' ' PHE . 68.4 t -45.88 -52.84 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 113.026 0.751 . . . . 73.420000000000002 113.026 -172.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -72.04 -39.96 68.73 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 122.101 -0.374 . . . . 74.299999999999997 111.905 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.4 ' HG2' ' CD2' ' A' ' 135' ' ' LEU . 42.3 tt0 -56.1 -36.21 67.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.622 0.725 . . . . 71.129999999999995 110.542 175.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.66 HD21 ' SD ' ' A' ' 106' ' ' MET . 3.7 tt -61.69 -40.96 96.83 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.136 -0.938 . . . . 63.340000000000003 110.5 174.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.4 mt . . . . . 0 N--CA 1.469 0.507 0 CA-C-O 121.29 0.566 . . . . 75.239999999999995 110.17 174.761 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 14.8 ptm . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 120.928 0.394 . . . . 74.239999999999995 111.08 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.707 HD11 ' HB3' ' A' ' 64' ' ' ALA . 36.7 mt -127.74 148.29 50.42 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.787 0.662 . . . . 72.129999999999995 112.787 -176.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -90.85 122.02 33.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.341 -0.845 . . . . 64.439999999999998 110.219 171.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.37 157.79 37.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.727 -0.67 . . . . 73.310000000000002 112.156 -173.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.661 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 39.7 tt0 -99.93 115.2 29.1 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.233 -0.439 . . . . 74.5 109.999 172.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.53 HG22 HD11 ' A' ' 96' ' ' ILE . 51.0 t -89.03 116.13 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 115.996 -0.547 . . . . 64.219999999999999 112.014 -174.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 mt -102.43 156.67 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.967 0.413 . . . . 71.019999999999996 111.535 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 72.3 m -126.89 104.4 8.01 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.94 0.4 . . . . 52.420000000000002 111.054 175.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.553 0 C-N-CA 121.029 -0.605 . . . . 53.039999999999999 113.584 -176.083 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 121.137 0.494 . . . . 73.299999999999997 111.08 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.53 ' O ' HG22 ' A' ' 52' ' ' VAL . 5.5 t80 -64.49 -37.87 89.05 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.929 -0.578 . . . . 72.439999999999998 110.533 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.513 ' HE2' ' HA ' ' A' ' 136' ' ' SER . 47.6 t80 -62.13 -66.86 0.47 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.983 -0.553 . . . . 74.200000000000003 110.724 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -55.82 -21.77 21.38 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.797 0.666 . . . . 61.420000000000002 112.797 -175.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.68 -36.23 32.6 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.901 0.704 . . . . 44.130000000000003 112.901 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 48' ' ' TYR . 33.2 m -116.83 17.66 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 113.14 0.793 . . . . 41.299999999999997 113.14 -174.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -102.66 26.01 8.49 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.143 0.794 . . . . 72.329999999999998 113.143 -177.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -147.71 164.27 34.08 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.472 0.545 . . . . 74.530000000000001 112.472 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.24 133.83 47.7 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.817 -0.629 . . . . 64.420000000000002 110.922 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.538 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 33.2 mt-10 -88.66 121.89 31.51 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.238 0.542 . . . . 72.219999999999999 110.931 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.5 mt -118.18 149.87 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 115.637 -0.71 . . . . 71.549999999999997 111.777 -171.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -72.44 154.1 41.05 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.654 0.264 . . . . 54.219999999999999 111.176 176.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -56.46 -46.11 80.51 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.948 0.404 . . . . 75.439999999999998 111.727 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.45 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 25.6 mm-40 -56.83 -55.69 31.18 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.002 0.43 . . . . 72.530000000000001 111.581 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.64 -36.25 80.24 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.218 0.532 . . . . 64.519999999999996 111.004 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -56.51 -53.74 53.93 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.731 -0.668 . . . . 74.219999999999999 111.747 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -74.03 -28.48 61.45 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.028 0.381 . . . . 72.030000000000001 112.028 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.707 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -63.33 -32.22 73.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.02 0.438 . . . . 63.299999999999997 111.453 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.491 HD11 HG13 ' A' ' 127' ' ' VAL . 74.7 mt -91.33 -4.75 55.5 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.164 -0.471 . . . . 71.349999999999994 111.665 176.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.03 46.26 94.94 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.427 -0.416 . . . . 60.030000000000001 112.828 -177.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 129' ' ' LYS . 97.7 mt -85.32 156.48 20.89 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.428 0.899 . . . . 73.040000000000006 113.428 -175.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -127.92 145.37 50.98 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.615 -1.175 . . . . 72.120000000000005 109.0 173.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.01 100.42 0.16 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.454 0.645 . . . . 65.040000000000006 111.87 -176.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.08 -6.09 7.77 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.457 -0.792 . . . . 65.329999999999998 113.176 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -68.03 158.59 32.58 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.364 0.602 . . . . 70.409999999999997 112.072 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.5 mtm-85 -102.12 127.65 48.93 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.8 -0.636 . . . . 65.230000000000004 110.647 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.33 150.28 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.154 0.502 . . . . 72.200000000000003 112.029 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -114.49 136.99 52.4 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.257 0.551 . . . . 62.219999999999999 111.115 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 60.9 t -110.01 122.12 64.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.79 -0.641 . . . . 71.319999999999993 110.623 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -111.63 120.89 43.6 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.796 0.332 . . . . 71.049999999999997 111.505 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.748 HG22 ' HA3' ' A' ' 125' ' ' GLY . 27.6 p -122.53 -177.47 3.64 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.938 0.399 . . . . 61.43 110.902 176.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -70.69 -11.21 60.8 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.48 -0.327 . . . . 72.430000000000007 111.614 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -94.52 -48.68 6.0 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 111.749 0.277 . . . . 72.349999999999994 111.749 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -171.39 -154.31 9.72 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.577 -0.82 . . . . 74.530000000000001 113.603 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 12.2 pt-20 -154.78 141.88 19.35 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.877 0.37 . . . . 71.319999999999993 111.571 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.7 p -145.12 149.41 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 116.573 -0.285 . . . . 61.109999999999999 111.613 -178.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.49 117.38 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-O 120.527 0.203 . . . . 74.299999999999997 111.259 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.459 ' HA ' HG13 ' A' ' 134' ' ' VAL . 34.8 m -128.09 177.63 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 122.886 0.474 . . . . 70.219999999999999 111.488 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -82.62 142.85 31.41 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.044 0.449 . . . . 72.519999999999996 111.548 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.14 121.46 32.94 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.039 0.385 . . . . 73.219999999999999 112.039 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -131.6 157.65 43.1 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.166 0.508 . . . . 73.209999999999994 110.815 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -95.98 140.49 30.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.285 -0.416 . . . . 72.329999999999998 110.852 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.538 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -141.02 -174.51 14.14 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.898 -0.668 . . . . 73.510000000000005 113.71 -177.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -94.69 32.24 1.65 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.958 0.408 . . . . 45.219999999999999 111.641 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.8 m -90.6 152.46 45.12 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.461 -0.336 . . . . 75.200000000000003 111.706 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.59 163.71 33.92 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.88 2.387 . . . . 64.450000000000003 113.366 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 86.6 tttt -66.87 143.05 57.09 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.468 -0.333 . . . . 75.030000000000001 111.293 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 69.57 21.42 76.23 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.876 -0.678 . . . . 63.420000000000002 113.098 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.661 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 15.7 ttt -149.41 136.54 19.82 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.894 -0.41 . . . . 71.340000000000003 109.894 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.53 HD11 HG22 ' A' ' 28' ' ' VAL . 37.4 pt -132.21 145.36 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-O 121.371 0.605 . . . . 70.400000000000006 112.108 -177.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -102.79 129.58 49.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.853 -0.612 . . . . 65.400000000000006 111.209 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 30' ' ' SER . 28.8 mt -126.17 131.57 24.01 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 120.571 0.224 . . . . 63.32 110.68 174.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.22 126.43 22.14 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.374 2.05 . . . . 73.430000000000007 112.196 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.82 99.81 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.849 0.357 . . . . 74.409999999999997 110.634 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.87 -175.24 24.13 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.776 -0.726 . . . . 74.150000000000006 113.018 -176.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.413 ' O ' ' HG3' ' A' ' 106' ' ' MET . 29.9 Cg_endo -64.01 -26.02 66.29 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.212 1.941 . . . . 75.310000000000002 112.243 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.499 ' HA ' HD11 ' A' ' 140' ' ' LEU . 4.6 m-85 -68.9 -54.24 16.6 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.676 -0.693 . . . . 74.109999999999999 110.516 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.508 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.38 -34.13 74.82 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.925 -0.579 . . . . 73.150000000000006 110.632 175.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -60.31 -19.8 56.61 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.97 -0.559 . . . . 72.209999999999994 111.561 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.612 ' SD ' HD21 ' A' ' 140' ' ' LEU . 33.4 mtp -77.07 -28.03 54.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.797 0.332 . . . . 75.219999999999999 111.417 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.3 m -116.24 -18.11 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.048 0.759 . . . . 54.219999999999999 113.048 -171.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 104' ' ' ALA . 14.7 pt -95.14 -176.17 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 121.399 0.619 . . . . 71.430000000000007 112.375 -176.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.603 ' H ' HG21 ' A' ' 123' ' ' VAL . 24.2 t70 . . . . . 0 CA--C 1.542 0.639 0 CA-C-N 115.577 -0.738 . . . . 72.450000000000003 110.653 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.553 0 N-CA-C 112.43 -0.268 . . . . 72.409999999999997 112.43 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' H ' ' A' ' 109' ' ' ASP . 84.3 t -86.73 121.02 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 122.465 -0.433 . . . . 70.420000000000002 111.284 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 48.3 mtpt -68.76 162.42 26.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.741 0.781 . . . . 73.140000000000001 113.047 -176.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.748 ' HA3' HG22 ' A' ' 77' ' ' THR . . . 174.17 -151.65 13.31 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 114.886 -1.052 . . . . 62.420000000000002 112.587 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 65.3 p -135.9 152.46 51.04 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.87 0.367 . . . . 73.519999999999996 111.037 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.491 HG13 HD11 ' A' ' 65' ' ' LEU . 14.6 p -132.25 144.76 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.144 0.497 . . . . 50.229999999999997 111.343 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -157.64 152.99 26.06 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.773 -0.649 . . . . 55.130000000000003 110.533 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.422 ' HB2' HD21 ' A' ' 67' ' ' LEU . 32.8 ttpt -79.0 139.29 38.23 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.16 0.505 . . . . 63.109999999999999 111.133 174.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.4 t -135.8 150.56 49.49 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.122 0.487 . . . . 73.209999999999994 111.729 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -80.33 -3.13 48.28 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.337 -0.392 . . . . 71.120000000000005 110.834 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -65.37 155.08 36.48 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.985 0.422 . . . . 73.040000000000006 111.83 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -79.12 150.98 31.62 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.999 0.428 . . . . 71.439999999999998 111.605 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 84' ' ' VAL . 82.6 t -71.3 128.25 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.233 -0.439 . . . . 62.299999999999997 110.342 172.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 135' ' ' LEU . 11.0 mt -63.47 133.22 53.53 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.979 0.419 . . . . 61.520000000000003 111.858 -177.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.513 ' HA ' ' HE2' ' A' ' 49' ' ' PHE . 45.2 t -73.51 141.94 46.75 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.911 -0.403 . . . . 73.299999999999997 109.911 171.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.506 HG23 ' HD2' ' A' ' 49' ' ' PHE . 60.5 t -46.45 -46.96 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 112.744 0.646 . . . . 73.209999999999994 112.744 -174.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -72.38 -40.65 67.12 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.021 0.378 . . . . 54.340000000000003 112.021 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -64.61 -33.52 76.12 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.219 0.533 . . . . 60.119999999999997 110.534 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.612 HD21 ' SD ' ' A' ' 106' ' ' MET . 4.0 tt -56.22 -41.08 75.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.886 -0.597 . . . . 65.219999999999999 110.275 172.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.8 mt . . . . . 0 CA--C 1.537 0.463 0 CA-C-O 121.276 0.56 . . . . 71.019999999999996 110.263 176.691 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.497 ' HE2' ' HB ' ' A' ' 126' ' ' THR . 10.1 ptm . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 120.961 0.41 . . . . 71.140000000000001 111.364 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.532 HD12 ' HG ' ' A' ' 65' ' ' LEU . 9.5 mt -110.3 141.37 43.39 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.971 0.415 . . . . 73.150000000000006 111.804 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -89.9 126.1 35.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.286 0.565 . . . . 74.349999999999994 111.298 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.565 HG12 ' HA2' ' A' ' 94' ' ' GLY . 35.1 m -140.95 163.0 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.546 -0.752 . . . . 74.530000000000001 111.892 -174.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 65.7 tt0 -99.18 117.74 34.34 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.962 0.411 . . . . 64.109999999999999 110.652 172.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.504 HG22 HD11 ' A' ' 96' ' ' ILE . 32.0 t -91.4 115.55 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.133 0.492 . . . . 72.519999999999996 111.714 -175.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.407 HD11 ' CE ' ' A' ' 95' ' ' MET . 1.7 mt -102.1 159.41 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.795 0.331 . . . . 74.109999999999999 110.824 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.73 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 33.7 t -150.37 132.15 15.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.73 0.3 . . . . 71.439999999999998 111.587 175.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.576 ' HA2' ' HB2' ' A' ' 100' ' ' MET . . . . . . . . 0 CA--C 1.523 0.565 0 C-N-CA 119.817 -1.182 . . . . 42.439999999999998 114.91 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 120.643 0.259 . . . . 72.109999999999999 111.364 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -60.52 -31.97 71.02 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.266 0.555 . . . . 72.120000000000005 110.674 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -78.28 -28.83 47.66 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.924 -0.58 . . . . 72.129999999999995 111.541 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -98.77 0.07 43.67 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.161 0.43 . . . . 72.129999999999995 112.161 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.23 -44.44 7.27 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.29 0.848 . . . . 73.519999999999996 113.29 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.2 m -127.19 17.93 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 114.412 1.264 . . . . 65.219999999999999 114.412 -167.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -101.06 18.01 20.89 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 121.62 -0.675 . . . . 74.409999999999997 112.135 -176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -137.62 159.12 42.85 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.995 -0.44 . . . . 53.130000000000003 111.511 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.66 138.51 51.23 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.334 -0.394 . . . . 73.340000000000003 111.662 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.684 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 41.3 mt-10 -90.2 116.71 28.4 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.213 0.53 . . . . 54.520000000000003 111.003 177.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.607 ' HA ' HG22 ' A' ' 96' ' ' ILE . 35.8 mt -111.57 146.98 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 115.609 -0.723 . . . . 72.209999999999994 111.768 -171.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -67.1 142.95 56.93 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.94 0.4 . . . . 62.520000000000003 111.11 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -63.93 -36.53 84.24 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.792 0.664 . . . . 72.140000000000001 112.792 -175.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.55 -49.24 77.48 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.271 0.558 . . . . 50.539999999999999 110.918 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -66.72 -33.48 75.73 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.811 -0.632 . . . . 75.230000000000004 111.071 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.486 ' HA ' HD12 ' A' ' 67' ' ' LEU . 44.2 t-105 -57.05 -53.67 55.49 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.706 -0.679 . . . . 75.540000000000006 110.939 175.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -65.69 -37.15 85.68 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.977 -0.556 . . . . 60.210000000000001 111.542 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.62 -49.17 78.81 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.96 0.409 . . . . 74.140000000000001 111.848 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.532 ' HG ' HD12 ' A' ' 24' ' ' LEU . 95.0 mt -78.23 -4.51 48.12 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.319 -0.401 . . . . 55.210000000000001 111.74 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.76 45.76 93.57 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.255 -0.498 . . . . 54.25 112.761 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 62' ' ' TRP . 87.3 mt -80.75 153.39 27.83 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.153 0.501 . . . . 72.230000000000004 111.667 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -139.13 114.93 10.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 73.439999999999998 110.645 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -38.53 102.46 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.363 -0.835 . . . . 75.140000000000001 112.971 -171.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.6 -19.1 4.81 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 114.967 -1.015 . . . . 72.540000000000006 113.161 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -78.91 179.39 7.31 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.114 0.483 . . . . 73.310000000000002 111.958 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -107.5 134.51 50.43 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.356 0.598 . . . . 64.349999999999994 111.842 -175.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.573 HG13 ' HB2' ' A' ' 86' ' ' ALA . 14.5 m -115.97 135.99 54.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.967 -0.56 . . . . 73.150000000000006 111.164 174.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.42 ' HB3' ' HG3' ' A' ' 128' ' ' GLU . 72.3 tttt -102.17 140.14 36.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.88 -0.6 . . . . 50.329999999999998 110.584 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 41.5 t -122.43 136.2 60.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.329 -0.396 . . . . 63.039999999999999 110.084 -175.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -138.68 126.56 22.36 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.058 0.392 . . . . 61.009999999999998 112.058 -173.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.661 HG22 ' HA3' ' A' ' 125' ' ' GLY . 30.8 p -137.1 -172.18 3.13 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.235 -0.439 . . . . 72.400000000000006 110.547 176.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -65.99 -12.97 58.9 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.216 0.451 . . . . 62.409999999999997 112.216 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -91.39 -34.71 14.75 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.116 0.413 . . . . 65.010000000000005 112.116 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.69 -159.47 31.39 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.226 -0.511 . . . . 72.120000000000005 113.16 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 11.4 pt-20 -137.37 154.01 50.09 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.026 0.441 . . . . 70.319999999999993 112.098 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.443 HG23 HD12 ' A' ' 135' ' ' LEU . 11.4 p -153.06 149.36 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 116.378 -0.374 . . . . 74.439999999999998 111.445 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 36.1 t -110.36 120.09 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 122.347 -0.221 . . . . 72.340000000000003 110.878 176.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.23 173.18 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.99 0.424 . . . . 72.040000000000006 111.956 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -76.6 139.16 40.53 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.01 0.433 . . . . 72.040000000000006 111.426 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.573 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -87.32 126.12 34.65 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.887 0.699 . . . . 64.099999999999994 112.887 -177.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -130.07 148.18 51.89 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.142 0.496 . . . . 73.510000000000005 110.864 172.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -87.66 124.03 33.12 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.918 -0.583 . . . . 73.099999999999994 109.879 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -124.33 171.74 16.6 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.87 -0.681 . . . . 62.119999999999997 114.065 -173.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.72 29.58 0.38 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.872 0.469 . . . . 71.230000000000004 112.228 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.9 m -91.21 152.03 43.56 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 116.507 -0.315 . . . . 65.340000000000003 111.653 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -72.6 177.15 7.85 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.689 2.259 . . . . 51.450000000000003 113.588 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -62.94 141.35 58.75 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.022 -0.536 . . . . 62.219999999999999 111.999 -177.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 58.31 34.28 73.78 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 120.862 -0.685 . . . . 70.230000000000004 112.805 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.501 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 16.7 ttt -150.92 136.73 18.11 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.633 -0.334 . . . . 71.25 110.321 -178.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.607 HG22 ' HA ' ' A' ' 57' ' ' ILE . 36.8 pt -137.65 146.59 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.136 0.493 . . . . 74.140000000000001 111.652 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -110.08 136.74 48.85 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.942 0.401 . . . . 75.230000000000004 111.272 177.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 30' ' ' SER . 45.6 mt -126.35 133.65 25.19 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 116.326 -0.397 . . . . 73.430000000000007 110.643 174.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.13 141.82 47.01 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 121.904 1.736 . . . . 72.310000000000002 112.539 174.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.576 ' HB2' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -59.65 106.11 0.44 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.667 0.27 . . . . 54.240000000000002 110.976 -178.771 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.28 178.67 41.29 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 119.972 -1.108 . . . . 74.120000000000005 113.787 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.521 ' HA ' ' HB3' ' A' ' 105' ' ' ASN . 17.8 Cg_endo -57.98 -34.94 98.99 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.144 2.563 . . . . 74.329999999999998 112.82 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.512 ' HA ' HD11 ' A' ' 140' ' ' LEU . 53.1 m-85 -59.96 -50.14 74.94 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.109 0.481 . . . . 74.409999999999997 110.631 177.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.543 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -65.29 -37.37 86.95 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.124 -0.489 . . . . 75.150000000000006 111.017 174.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 102' ' ' PRO . 5.4 t30 -56.58 -20.09 19.15 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.763 0.425 . . . . 74.239999999999995 111.728 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.607 ' SD ' HD21 ' A' ' 140' ' ' LEU . 90.9 mmm -72.97 -24.05 60.74 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.807 0.336 . . . . 62.25 111.779 177.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.5 m -129.06 -9.03 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 113.027 0.751 . . . . 63.210000000000001 113.027 -171.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.555 HD13 ' HB3' ' A' ' 30' ' ' SER . 5.8 pt -104.91 -177.54 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.167 0.508 . . . . 75.120000000000005 111.531 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.421 ' N ' HG21 ' A' ' 123' ' ' VAL . 30.1 t70 . . . . . 0 CA--C 1.542 0.649 0 CA-C-N 116.107 -0.497 . . . . 62.119999999999997 110.916 175.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 N-CA-C 114.009 0.364 . . . . 31.32 114.009 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.421 HG21 ' N ' ' A' ' 109' ' ' ASP . 52.5 t -100.3 118.63 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.806 0.336 . . . . 61.439999999999998 111.543 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 55.5 mtmt -72.82 155.41 39.96 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.274 0.559 . . . . 75.340000000000003 112.186 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.661 ' HA3' HG22 ' A' ' 77' ' ' THR . . . 177.84 -135.0 2.57 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.782 -0.645 . . . . 65.230000000000004 112.84 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.497 ' HB ' ' HE2' ' A' ' 23' ' ' MET . 60.8 p -140.55 154.84 46.67 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.269 0.47 . . . . 52.039999999999999 112.269 -177.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.1 p -133.97 147.98 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.931 -0.577 . . . . 52.109999999999999 110.677 175.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.42 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 9.5 pt-20 -151.9 161.89 41.93 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.37 -0.377 . . . . 70.450000000000003 111.462 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.431 ' NZ ' ' HA ' ' A' ' 67' ' ' LEU . 17.6 ttmm -87.24 140.65 29.33 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 110.226 -0.287 . . . . 72.340000000000003 110.226 170.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.2 t -139.47 142.82 37.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.302 0.572 . . . . 73.219999999999999 111.864 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -75.31 -11.24 60.02 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.617 -0.72 . . . . 71.310000000000002 110.827 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -61.91 154.3 26.64 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.861 -0.609 . . . . 65.239999999999995 112.071 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -80.89 162.08 24.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.748 -0.66 . . . . 62.509999999999998 111.927 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 76.5 t -76.28 136.17 25.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.651 -0.704 . . . . 74.420000000000002 111.101 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.443 HD12 HG23 ' A' ' 82' ' ' VAL . 17.8 mt -59.65 133.58 56.23 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.502 -0.317 . . . . 72.239999999999995 111.298 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.6 t -76.76 143.77 39.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.691 -0.855 . . . . 75.109999999999999 108.691 169.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.3 t -48.26 -41.16 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.084 0.469 . . . . 41.399999999999999 111.899 -174.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -72.02 -41.6 67.36 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.026 -0.534 . . . . 64.430000000000007 111.65 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -58.52 -37.2 75.11 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.78 0.8 . . . . 71.519999999999996 110.15 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.607 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.5 tt -62.29 -38.3 88.82 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.05 -0.977 . . . . 71.409999999999997 111.033 176.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.0 mt . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 121.486 0.66 . . . . 73.140000000000001 110.056 176.077 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.2 ptp . . . . . 0 CA--C 1.539 0.551 0 CA-C-O 121.26 0.553 . . . . 71.430000000000007 112.027 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.4 mt -127.37 131.64 50.31 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.768 -0.651 . . . . 54.210000000000001 111.104 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -73.13 111.11 7.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.865 0.364 . . . . 54.350000000000001 110.849 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.475 HG12 ' HA2' ' A' ' 94' ' ' GLY . 31.1 m -127.84 159.62 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.351 -0.386 . . . . 65.129999999999995 111.964 -174.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 35.4 tt0 -98.79 118.53 35.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.884 0.373 . . . . 61.530000000000001 110.605 174.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.51 HG22 HD11 ' A' ' 96' ' ' ILE . 40.1 t -93.23 108.16 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.109 -0.496 . . . . 61.130000000000003 111.74 -175.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 mt -97.73 160.56 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.826 0.346 . . . . 72.450000000000003 111.234 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.631 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 74.3 m -136.5 100.48 4.37 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.078 0.466 . . . . 73.010000000000005 111.929 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.58 0 C-N-CA 121.049 -0.596 . . . . 51.030000000000001 112.397 178.129 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 CA--C 1.542 0.647 0 CA-C-O 120.832 0.348 . . . . 72.310000000000002 111.467 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -60.09 -36.78 78.16 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.431 0.634 . . . . 70.25 110.604 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.502 ' HD1' HG23 ' A' ' 137' ' ' VAL . 58.0 t80 -81.09 -7.57 59.59 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.59 -0.732 . . . . 55.200000000000003 112.046 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -118.43 2.17 11.82 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.877 -0.514 . . . . 63.130000000000003 111.814 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.09 -57.04 2.45 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.378 0.51 . . . . 73.349999999999994 112.378 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.495 HG21 ' HD2' ' A' ' 102' ' ' PRO . 34.7 m -108.33 20.48 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 112.873 0.694 . . . . 73.519999999999996 112.873 -173.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.64 ' N ' HD22 ' A' ' 53' ' ' ASN . 0.7 OUTLIER -104.08 18.48 21.96 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.66 0.615 . . . . 72.140000000000001 112.66 -172.363 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -141.55 165.13 28.33 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.223 0.535 . . . . 74.510000000000005 112.426 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.96 130.94 45.71 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.709 -0.678 . . . . 63.43 110.884 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.67 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 31.8 mt-10 -88.65 120.24 29.86 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.351 0.596 . . . . 74.510000000000005 111.638 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.1 mt -118.76 148.27 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.32 -0.855 . . . . 72.340000000000003 111.615 -170.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -75.42 142.73 42.98 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.771 0.32 . . . . 72.239999999999995 110.386 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.444 ' HA ' ' HB3' ' A' ' 62' ' ' TRP . 27.0 tt0 -56.04 -36.97 68.6 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.481 0.548 . . . . 71.239999999999995 112.481 -174.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.417 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 80.7 mm-40 -54.66 -51.63 64.87 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 111.894 0.331 . . . . 63.520000000000003 111.894 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -69.7 -36.82 76.27 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.337 0.589 . . . . 75.430000000000007 110.579 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.487 ' HA ' HD12 ' A' ' 67' ' ' LEU . 31.0 t-105 -53.22 -52.08 60.08 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.466 -0.788 . . . . 73.239999999999995 111.69 176.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -65.62 -38.87 90.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.129 -0.487 . . . . 70.310000000000002 111.296 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.37 -43.4 88.43 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.169 0.509 . . . . 73.129999999999995 111.55 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.9 mt -79.91 -1.83 41.03 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.201 -0.454 . . . . 73.540000000000006 112.038 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.93 44.9 96.71 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.435 -0.412 . . . . 35.130000000000003 112.998 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.753 HD23 ' HD3' ' A' ' 129' ' ' LYS . 67.0 mt -87.04 142.51 27.87 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.032 0.752 . . . . 74.540000000000006 113.032 -175.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -115.0 150.11 36.35 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.942 -0.762 . . . . 65.340000000000003 108.942 170.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.31 103.9 0.11 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.168 0.509 . . . . 74.25 111.898 -177.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.51 -8.34 10.23 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 115.888 -0.596 . . . . 60.030000000000001 113.783 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.67 167.54 7.2 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.618 0.723 . . . . 62.100000000000001 112.665 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -113.08 126.52 55.56 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.295 -0.866 . . . . 61.329999999999998 111.36 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.446 HG13 ' HB2' ' A' ' 86' ' ' ALA . 21.1 m -114.51 139.24 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.175 0.512 . . . . 72.120000000000005 112.054 -178.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.519 ' HG2' ' HD2' ' A' ' 76' ' ' LYS . 22.9 ttmm -103.18 111.84 24.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.072 -0.513 . . . . 60.450000000000003 110.395 177.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 47.9 t -96.68 126.25 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 116.468 -0.333 . . . . 55.409999999999997 111.523 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.568 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -117.72 139.64 50.76 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.061 0.458 . . . . 65.409999999999997 111.735 178.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.2 p -134.63 -171.9 2.89 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.402 -0.363 . . . . 42.409999999999997 110.246 173.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.23 -4.08 39.93 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 122.158 -0.339 . . . . 64.109999999999999 111.229 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -99.6 -48.33 4.78 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.714 0.293 . . . . 73.329999999999998 111.346 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.94 -158.21 19.75 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.136 -0.554 . . . . 62.100000000000001 112.779 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.568 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 8.8 pt-20 -144.68 160.22 41.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.265 0.555 . . . . 73.239999999999995 112.325 178.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.3 p -156.71 147.27 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.963 -0.562 . . . . 75.319999999999993 111.115 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.9 t -105.45 117.79 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 O-C-N 122.327 -0.233 . . . . 74.510000000000005 110.963 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 m -126.98 178.05 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.953 0.406 . . . . 70.120000000000005 111.826 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -82.43 140.17 33.57 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.023 0.439 . . . . 74.120000000000005 111.374 176.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.446 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -89.98 124.88 35.12 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.436 0.532 . . . . 70.129999999999995 112.436 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -122.57 159.04 28.6 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.279 0.561 . . . . 62.43 111.592 174.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.402 ' HD3' ' HB2' ' A' ' 59' ' ' GLU . 30.0 ttmt -99.61 114.88 28.21 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.81 -0.632 . . . . 73.340000000000003 110.282 175.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.67 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -119.82 -177.67 16.24 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.852 -0.689 . . . . 24.530000000000001 114.495 -172.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -89.26 34.43 0.8 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.209 0.603 . . . . 64.239999999999995 111.536 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.1 m -100.27 149.67 36.25 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 112.514 0.561 . . . . 74.230000000000004 112.514 -174.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.83 163.69 21.18 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.724 2.283 . . . . 74.129999999999995 112.4 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 60' ' ' GLU . 52.0 tttm -68.72 146.91 52.54 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.105 -0.372 . . . . 72.239999999999995 111.352 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.475 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 63.67 32.59 84.67 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.902 -0.666 . . . . 75.409999999999997 112.491 -174.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.449 ' HA ' ' H ' ' A' ' 27' ' ' GLU . 21.6 ttt -152.37 136.32 16.38 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.911 -0.403 . . . . 74.349999999999994 109.911 -177.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.51 HD11 HG22 ' A' ' 28' ' ' VAL . 33.6 pt -137.74 138.6 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.431 0.634 . . . . 73.040000000000006 112.322 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -100.45 129.07 46.36 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.891 -0.595 . . . . 61.539999999999999 111.039 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 30' ' ' SER . 38.9 mt -122.42 132.63 24.23 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 120.523 0.201 . . . . 72.340000000000003 110.479 174.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.417 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 31.3 Cg_exo -60.43 127.19 22.04 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.04 1.826 . . . . 74.099999999999994 111.711 173.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.408 ' HE3' ' HB3' ' A' ' 104' ' ' ALA . 6.1 tpt -54.07 111.81 0.84 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.98 0.419 . . . . 73.310000000000002 111.88 -175.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.02 -174.4 32.89 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.861 -0.685 . . . . 64.230000000000004 112.751 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.495 ' HD2' HG21 ' A' ' 52' ' ' VAL . 18.8 Cg_endo -56.54 -34.06 94.27 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.802 2.335 . . . . 71.219999999999999 112.157 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.419 ' HA ' HD11 ' A' ' 140' ' ' LEU . 46.8 m-85 -63.82 -53.82 44.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.888 -0.597 . . . . 71.319999999999993 111.059 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.505 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.58 -38.36 87.24 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.187 0.518 . . . . 50.450000000000003 111.136 175.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -57.59 -17.15 12.71 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.071 0.549 . . . . 64.109999999999999 112.454 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.571 ' SD ' HD21 ' A' ' 140' ' ' LEU . 87.5 mmm -77.19 -22.82 51.81 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.195 0.443 . . . . 72.349999999999994 112.195 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.1 m -123.23 -26.22 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 112.748 0.647 . . . . 73.450000000000003 112.748 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.547 HG21 ' OG ' ' A' ' 30' ' ' SER . 6.9 pt -84.01 179.36 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.892 0.377 . . . . 62.210000000000001 111.786 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 CA--C 1.54 0.577 0 CA-C-N 116.522 -0.308 . . . . 64.129999999999995 111.178 178.068 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.434 0 CA-C-O 121.029 0.239 . . . . 63.130000000000003 113.381 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 66.2 t -84.53 118.7 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.816 0.341 . . . . 74.549999999999997 111.128 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 54.6 mtmt -76.01 156.01 34.43 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.575 0.703 . . . . 74.099999999999994 112.675 -176.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -177.18 -145.36 5.72 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.131 -0.94 . . . . 65.019999999999996 112.307 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 57.6 p -136.79 146.46 45.74 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.526 -0.396 . . . . 75.400000000000006 111.474 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.8 p -128.38 143.48 40.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.927 0.394 . . . . 73.129999999999995 111.153 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.52 148.29 30.05 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.319 -0.4 . . . . 73.299999999999997 110.814 176.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.753 ' HD3' HD23 ' A' ' 67' ' ' LEU . 28.7 ttpp -73.28 139.44 46.13 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.934 -0.395 . . . . 71.519999999999996 109.934 175.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.6 t -127.08 161.51 28.26 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.371 0.878 . . . . 64.340000000000003 113.371 -168.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -92.54 7.04 44.96 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.329 -0.85 . . . . 62.310000000000002 110.448 173.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -87.38 165.54 15.51 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.813 -0.63 . . . . 74.319999999999993 111.65 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.41 161.13 15.71 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.075 -0.511 . . . . 73.209999999999994 111.336 177.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 92.4 t -71.53 128.14 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.679 -0.237 . . . . 74.030000000000001 110.7 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.521 HD23 ' HA ' ' A' ' 135' ' ' LEU . 8.8 mt -65.24 88.3 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.776 0.322 . . . . 72.040000000000006 111.351 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.7 m -51.87 150.01 4.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.943 -0.572 . . . . 65.109999999999999 110.541 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.502 HG23 ' HD1' ' A' ' 49' ' ' PHE . 66.9 t -44.8 -48.78 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 113.063 0.764 . . . . 74.519999999999996 113.063 -168.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -73.1 -39.85 65.46 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.977 -0.452 . . . . 52.140000000000001 111.777 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -57.84 -36.33 72.13 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.772 0.796 . . . . 70.129999999999995 109.919 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.571 HD21 ' SD ' ' A' ' 106' ' ' MET . 3.1 tt -62.55 -42.57 99.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.851 -1.068 . . . . 73.010000000000005 110.677 174.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 50.9 mt . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 121.364 0.602 . . . . 73.5 109.859 175.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.5 ptm . . . . . 0 CA--C 1.541 0.608 0 CA-C-O 120.865 0.364 . . . . 72.510000000000005 111.333 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.512 HD12 ' HG ' ' A' ' 65' ' ' LEU . 14.8 mt -96.96 132.66 42.53 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.463 0.542 . . . . 72.349999999999994 112.463 -176.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -83.06 109.75 17.4 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.313 0.578 . . . . 64.129999999999995 110.897 174.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.465 HG12 ' HA2' ' A' ' 94' ' ' GLY . 32.0 m -132.37 161.51 41.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.383 -0.826 . . . . 71.329999999999998 111.174 -174.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.662 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 33.2 tt0 -98.81 123.85 43.32 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.04 0.448 . . . . 52.109999999999999 111.174 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.43 117.13 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.913 -0.585 . . . . 65.540000000000006 111.907 -175.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 mt -103.13 163.05 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 122.24 -0.288 . . . . 73.439999999999998 111.172 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 11.7 t -131.95 120.51 22.59 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.915 0.388 . . . . 70.530000000000001 111.492 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.933 0 C-N-CA 121.093 -0.575 . . . . 64.230000000000004 113.178 -179.114 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 . . . . . 0 CA--C 1.536 0.432 0 CA-C-O 120.629 0.252 . . . . 65.329999999999998 111.301 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.531 ' O ' HG22 ' A' ' 52' ' ' VAL . 5.6 t80 -61.76 -35.54 78.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.284 0.564 . . . . 72.450000000000003 109.982 178.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -61.6 -68.31 0.33 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.793 -0.64 . . . . 64.310000000000002 110.793 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -62.53 -15.1 48.88 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.145 0.424 . . . . 73.129999999999995 112.145 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' A' ' 99' ' ' PRO . . . -80.51 -48.53 12.64 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.576 0.584 . . . . 64.200000000000003 112.576 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.537 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 21.0 m -100.93 5.39 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 113.463 0.912 . . . . 71.140000000000001 113.463 -173.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -91.79 17.61 8.81 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.476 0.917 . . . . 73.25 113.476 -176.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -137.79 164.18 29.56 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.229 0.538 . . . . 74.319999999999993 112.158 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.77 144.23 51.11 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.652 -0.703 . . . . 62.119999999999997 110.654 173.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.721 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 86.3 mt-10 -95.32 115.67 27.74 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.603 0.24 . . . . 74.519999999999996 111.395 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.457 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.2 mp -110.24 150.89 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 120.88 0.371 . . . . 70.099999999999994 110.966 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -70.11 154.88 41.39 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.826 0.451 . . . . 62.43 111.529 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -54.37 -48.93 70.92 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.485 0.55 . . . . 70.109999999999999 112.485 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -67.23 -44.8 78.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.798 0.332 . . . . 62.549999999999997 111.747 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.407 ' HB3' HD13 ' A' ' 24' ' ' LEU . 40.9 m-20 -67.1 -36.51 82.09 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.116 0.484 . . . . 54.009999999999998 111.324 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.6 t-105 -53.13 -54.21 39.07 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.705 -0.68 . . . . 73.219999999999999 111.282 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -71.74 -28.12 63.45 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.681 -0.69 . . . . 63.210000000000001 111.818 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.21 -37.66 83.78 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.162 0.506 . . . . 74.340000000000003 111.457 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.584 HD11 HG13 ' A' ' 127' ' ' VAL . 92.4 mt -88.41 -8.19 55.4 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.254 -0.43 . . . . 70.099999999999994 111.639 177.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.4 46.99 73.69 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.071 -0.585 . . . . 72.310000000000002 112.708 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.672 HD23 ' HE3' ' A' ' 129' ' ' LYS . 79.9 mt -86.16 152.3 22.95 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.129 0.49 . . . . 73.340000000000003 111.965 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.529 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 61.3 tt0 -119.62 145.58 46.31 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.097 -0.502 . . . . 61.229999999999997 109.789 172.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -56.35 110.11 0.71 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.113 0.482 . . . . 75.219999999999999 111.741 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.88 4.03 39.35 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 115.89 -0.595 . . . . 73.109999999999999 113.274 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 68' ' ' GLN . 0.5 OUTLIER -69.85 174.16 5.53 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.579 0.585 . . . . 75.409999999999997 112.579 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -105.42 123.74 48.39 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.042 -0.526 . . . . 74.420000000000002 110.689 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' A' ' 86' ' ' ALA . 17.9 m -118.35 144.48 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.331 0.586 . . . . 61.409999999999997 112.271 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.618 ' HD2' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -96.02 137.13 35.53 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.815 -0.63 . . . . 71.299999999999997 110.374 175.396 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 61.5 t -124.98 120.72 59.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.348 -0.612 . . . . 63.240000000000002 109.348 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.406 ' HG2' ' CB ' ' A' ' 81' ' ' GLU . 4.8 mtpm? -129.88 132.15 46.32 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.098 0.475 . . . . 72.340000000000003 112.076 -171.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.726 HG22 ' HA3' ' A' ' 125' ' ' GLY . 30.8 p -135.81 -172.33 3.08 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.269 0.557 . . . . 75.319999999999993 111.072 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -72.21 -6.15 40.8 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.13 -0.486 . . . . 71.140000000000001 111.847 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -95.59 -52.6 4.05 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.789 0.328 . . . . 62.149999999999999 111.138 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.27 -162.59 27.84 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.349 -0.453 . . . . 54.439999999999998 112.7 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.618 ' HB2' ' HD2' ' A' ' 74' ' ' LYS . 0.4 OUTLIER -135.61 150.22 49.59 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.285 0.564 . . . . 65.439999999999998 112.141 178.671 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 103' ' ' TYR . 8.8 p -143.84 153.56 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 116.02 -0.536 . . . . 75.209999999999994 111.245 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.6 t -112.78 121.76 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 122.211 0.205 . . . . 75.530000000000001 110.843 177.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.409 HG12 ' CD2' ' A' ' 103' ' ' TYR . 35.0 m -132.86 172.4 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.23 0.455 . . . . 55.409999999999997 112.23 -177.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -73.67 146.1 44.76 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.074 0.464 . . . . 75.099999999999994 110.998 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.456 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -96.31 119.54 34.98 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.625 0.602 . . . . 72.209999999999994 112.625 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -124.63 152.96 42.97 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.151 0.501 . . . . 71.310000000000002 110.678 172.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -96.11 114.9 26.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.18 -0.464 . . . . 73.530000000000001 110.042 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.721 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -113.86 -161.37 14.13 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.465 -0.874 . . . . 75.120000000000005 114.773 -170.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -93.79 23.2 4.94 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.12 0.485 . . . . 55.240000000000002 111.588 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.2 m -87.36 144.66 36.18 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.19 -0.459 . . . . 61.329999999999998 112.225 -175.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.89 174.71 12.37 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.646 2.231 . . . . 54.340000000000003 113.391 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -57.53 126.12 25.92 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.963 -0.562 . . . . 53.509999999999998 111.86 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.465 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 73.31 29.21 64.56 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.171 -0.538 . . . . 63.020000000000003 114.15 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.646 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 15.0 ttt -148.8 139.82 23.01 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.383 -0.481 . . . . 73.299999999999997 110.214 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.432 HG22 ' HA ' ' A' ' 57' ' ' ILE . 40.0 pt -134.06 148.88 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.401 0.619 . . . . 65.239999999999995 112.078 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -109.06 130.25 55.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.981 -0.554 . . . . 64.129999999999995 111.54 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 30' ' ' SER . 49.5 mt -123.26 129.58 24.87 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 120.858 0.361 . . . . 73.409999999999997 110.967 174.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.537 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 50.5 Cg_exo -57.66 142.28 95.73 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.406 2.071 . . . . 65.230000000000004 112.572 175.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.2 tpt -59.44 107.05 0.52 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.173 0.511 . . . . 75.310000000000002 111.564 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.41 -176.51 38.81 Favored Glycine 0 CA--C 1.521 0.406 0 C-N-CA 120.114 -1.041 . . . . 33.329999999999998 113.612 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.517 ' HG3' HG13 ' A' ' 137' ' ' VAL . 19.5 Cg_endo -57.28 -34.64 98.2 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.034 2.489 . . . . 54.119999999999997 111.941 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.468 ' HA ' HG21 ' A' ' 82' ' ' VAL . 72.1 m-85 -61.75 -51.49 68.12 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.659 -0.7 . . . . 62.100000000000001 110.704 177.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -62.86 -36.43 83.25 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.202 -0.454 . . . . 62.399999999999999 111.152 175.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -56.68 -23.82 44.59 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.05 0.54 . . . . 72.349999999999994 111.963 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.538 ' SD ' HD21 ' A' ' 140' ' ' LEU . 86.2 mmm -74.24 -22.08 59.5 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.907 0.336 . . . . 63.310000000000002 111.907 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.5 -21.1 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 113.169 0.803 . . . . 61.219999999999999 113.169 -170.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 104' ' ' ALA . 7.0 pt -95.98 -179.42 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.282 0.563 . . . . 74.099999999999994 111.841 -177.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.446 ' H ' HG21 ' A' ' 123' ' ' VAL . 22.0 t70 . . . . . 0 CA--C 1.545 0.754 0 CA-C-N 116.029 -0.532 . . . . 73.239999999999995 111.016 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.681 0 CA-C-O 121.115 0.286 . . . . 54.25 113.669 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.446 HG21 ' H ' ' A' ' 109' ' ' ASP . 61.2 t -94.28 119.15 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 122.606 -0.35 . . . . 71.310000000000002 111.259 175.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 6.8 ttpt -66.78 152.82 44.79 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.409 0.623 . . . . 72.120000000000005 112.347 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.726 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -174.05 -144.67 4.89 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.553 -0.749 . . . . 60.109999999999999 112.635 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 65.9 p -140.97 160.23 40.51 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.488 0.315 . . . . 71.129999999999995 111.704 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.584 HG13 HD11 ' A' ' 65' ' ' LEU . 13.6 p -142.97 144.6 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 120.855 0.359 . . . . 64.010000000000005 111.311 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -154.95 165.0 38.08 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.246 0.546 . . . . 73.329999999999998 112.44 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.672 ' HE3' HD23 ' A' ' 67' ' ' LEU . 5.5 tppp? -70.51 138.77 51.32 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.107 -0.497 . . . . 74.099999999999994 111.11 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 t -144.54 149.82 36.5 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.437 0.637 . . . . 60.520000000000003 112.431 175.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -90.19 -5.55 56.29 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.609 -0.723 . . . . 64.439999999999998 111.009 176.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.41 ' CD ' ' HZ1' ' A' ' 74' ' ' LYS . 27.8 mt-10 -63.67 165.48 8.23 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.081 -0.509 . . . . 74.430000000000007 111.591 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -92.34 155.41 17.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.026 0.441 . . . . 53.520000000000003 111.095 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 99.1 t -58.9 127.74 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.237 -0.438 . . . . 73.349999999999994 110.979 173.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.37 86.83 0.83 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.717 0.294 . . . . 71.200000000000003 111.103 -178.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.5 m -44.49 141.74 1.85 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.774 -0.648 . . . . 61.219999999999999 111.908 -175.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.517 HG13 ' HG3' ' A' ' 102' ' ' PRO . 51.4 t -45.14 -50.11 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.879 0.696 . . . . 40.030000000000001 112.879 -172.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -70.5 -43.58 69.4 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.625 0.25 . . . . 75.530000000000001 111.435 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -55.14 -41.64 72.02 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.795 0.807 . . . . 72.510000000000005 110.381 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.538 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.4 tt -61.22 -37.77 84.21 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.018 -0.992 . . . . 73.519999999999996 111.351 177.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 52.2 mt . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 121.301 0.572 . . . . 75.239999999999995 110.506 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' MET . . . . . 0.442 ' HE2' ' HB ' ' A' ' 126' ' ' THR . 13.4 ptm . . . . . 0 CA--C 1.538 0.511 0 CA-C-O 120.637 0.256 . . . . 64.349999999999994 110.93 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 mp -117.16 148.85 41.22 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.07 0.462 . . . . 74.099999999999994 112.179 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.39 128.01 34.57 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.569 0.699 . . . . 72.409999999999997 111.45 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.465 HG12 ' HA2' ' A' ' 94' ' ' GLY . 27.4 m -140.67 162.46 23.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.337 -0.847 . . . . 62.520000000000003 110.97 -176.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.731 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 41.9 tt0 -98.88 112.46 24.55 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.122 0.487 . . . . 71.340000000000003 110.127 175.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.3 t -86.98 119.26 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.782 -0.644 . . . . 73.109999999999999 111.87 -172.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 96' ' ' ILE . 2.8 mt -103.56 154.99 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.793 0.33 . . . . 60.240000000000002 111.531 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.671 ' HB2' HG21 ' A' ' 108' ' ' ILE . 11.4 t -133.78 107.66 8.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.942 0.401 . . . . 62.450000000000003 111.077 175.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.603 0 C-N-CA 121.161 -0.542 . . . . 65.299999999999997 113.134 -177.44 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 CA--C 1.536 0.437 0 CA-C-O 121.033 0.444 . . . . 73.25 111.039 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.548 ' O ' HG22 ' A' ' 52' ' ' VAL . 4.1 t80 -59.3 -44.02 92.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.289 0.566 . . . . 65.299999999999997 109.583 176.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.508 ' HD2' HG23 ' A' ' 137' ' ' VAL . 57.8 t80 -60.44 -60.51 3.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.572 -0.74 . . . . 64.439999999999998 110.16 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -53.08 -28.42 24.99 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.884 -0.598 . . . . 74.409999999999997 112.313 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.24 -37.87 25.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.271 0.841 . . . . 44.32 113.271 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 48' ' ' TYR . 19.3 m -109.76 9.61 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 113.494 0.924 . . . . 60.240000000000002 113.494 -172.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -98.38 25.91 5.9 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.061 0.763 . . . . 54.509999999999998 113.061 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.432 ' CD1' ' HD2' ' A' ' 87' ' ' LYS . 52.8 p90 -146.5 158.56 43.91 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.012 -0.43 . . . . 64.0 111.752 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.49 139.26 51.63 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.302 -0.408 . . . . 61.539999999999999 111.484 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.673 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 42.7 mt-10 -87.68 113.15 23.09 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.219 0.533 . . . . 71.109999999999999 110.943 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.8 mt -112.44 150.71 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.561 -0.745 . . . . 75.140000000000001 111.593 -171.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.668 ' ND2' HG23 ' A' ' 91' ' ' VAL . 1.9 m120 -72.19 135.17 46.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.498 -0.319 . . . . 72.030000000000001 110.976 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 37.4 tt0 -54.18 -40.17 67.3 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.629 0.603 . . . . 61.119999999999997 112.629 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -64.14 -49.56 71.66 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.543 0.572 . . . . 60.100000000000001 112.543 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -70.42 -29.4 66.0 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.657 0.742 . . . . 71.329999999999998 110.284 177.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.514 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 32.2 t-105 -55.83 -47.54 77.05 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.169 -0.923 . . . . 75.510000000000005 110.401 172.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -65.12 -41.44 94.87 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.848 -0.615 . . . . 61.0 111.037 174.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.95 -39.27 74.24 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 111.939 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.4 mt -88.03 -12.53 44.08 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.24 -0.437 . . . . 74.430000000000007 111.782 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.89 50.59 51.95 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.193 -0.527 . . . . 53.310000000000002 112.642 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.627 HD23 ' HE3' ' A' ' 129' ' ' LYS . 86.1 mt -88.65 155.21 19.74 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.471 0.653 . . . . 72.510000000000005 112.467 -176.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -127.14 151.95 47.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.619 -0.719 . . . . 74.439999999999998 109.501 173.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -63.52 98.68 0.18 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.525 0.678 . . . . 75.040000000000006 111.762 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.13 -17.92 5.91 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.119 -0.946 . . . . 51.340000000000003 112.888 -175.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -56.48 155.69 6.93 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.314 0.578 . . . . 73.439999999999998 112.242 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -94.89 123.08 38.15 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.746 -0.661 . . . . 73.530000000000001 110.66 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 86' ' ' ALA . 31.6 m -116.5 147.38 19.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.018 0.437 . . . . 74.510000000000005 111.377 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.481 ' HB2' HG22 ' A' ' 83' ' ' VAL . 4.6 ttpm? -114.66 138.76 50.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.477 0.656 . . . . 72.200000000000003 110.969 176.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 57.7 t -116.95 134.33 60.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.45 -0.796 . . . . 73.219999999999999 109.669 -175.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -133.58 123.72 25.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.263 0.468 . . . . 70.439999999999998 112.263 -172.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.716 HG22 ' HA3' ' A' ' 125' ' ' GLY . 36.9 p -126.2 -172.26 2.58 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.209 -0.45 . . . . 70.409999999999997 110.703 174.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.63 -14.42 61.6 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.809 0.338 . . . . 74.239999999999995 111.151 175.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -84.51 -52.79 5.87 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.778 0.323 . . . . 72.329999999999998 111.376 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.08 -159.62 20.06 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.979 -0.629 . . . . 71.430000000000007 113.122 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 0.4 OUTLIER -143.61 153.16 42.24 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.034 0.445 . . . . 64.230000000000004 111.606 176.57 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.1 p -150.77 145.93 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.332 -0.395 . . . . 74.319999999999993 111.377 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 74' ' ' LYS . 60.9 t -107.34 118.93 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 120.532 0.206 . . . . 54.140000000000001 111.169 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.74 178.11 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 122.802 0.441 . . . . 75.409999999999997 111.576 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -81.65 146.73 29.9 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.221 0.534 . . . . 74.340000000000003 111.754 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.512 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -93.52 129.11 39.85 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.888 0.699 . . . . 75.340000000000003 112.888 -177.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.432 ' HD2' ' CD1' ' A' ' 54' ' ' TYR . 67.3 mttm -135.3 151.77 50.85 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.973 -0.558 . . . . 65.299999999999997 109.978 172.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -78.01 147.43 34.84 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.069 -0.394 . . . . 64.049999999999997 110.511 173.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.673 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -134.73 168.72 23.47 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.804 -0.712 . . . . 63.130000000000003 114.018 -175.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -89.22 23.95 2.32 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.365 0.602 . . . . 60.310000000000002 110.958 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.668 HG23 ' ND2' ' A' ' 58' ' ' ASN . 17.3 m -91.28 151.94 43.37 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 115.925 -0.579 . . . . 63.350000000000001 112.221 -175.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.19 145.57 55.04 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.098 2.532 . . . . 45.32 112.782 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -52.54 142.31 18.23 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.386 0.513 . . . . 73.239999999999995 112.386 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.465 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 71.55 25.79 74.49 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.806 -0.711 . . . . 64.040000000000006 113.195 -174.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' MET . . . . . 0.731 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 19.0 ttt -154.43 135.03 13.51 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.42 -0.459 . . . . 74.299999999999997 110.029 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.42 ' O ' HG13 ' A' ' 29' ' ' ILE . 41.8 pt -133.22 145.67 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 120.998 0.428 . . . . 74.319999999999993 112.154 -174.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -105.27 130.19 53.46 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.429 -0.351 . . . . 72.129999999999995 111.424 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.641 ' O ' ' HA ' ' A' ' 30' ' ' SER . 50.8 mt -125.31 130.34 24.17 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 120.776 0.322 . . . . 71.219999999999999 110.714 175.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.41 135.23 69.08 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.334 2.023 . . . . 62.32 112.853 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.445 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 5.1 tpt -54.14 109.7 0.51 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.262 -0.426 . . . . 70.140000000000001 111.904 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.62 -174.35 32.42 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.866 -0.683 . . . . 55.240000000000002 112.513 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.557 ' O ' ' HG2' ' A' ' 106' ' ' MET . 32.3 Cg_endo -65.11 -26.44 57.7 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.808 1.672 . . . . 74.120000000000005 111.57 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.509 ' HA ' HD11 ' A' ' 140' ' ' LEU . 4.6 m-85 -67.53 -53.85 24.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.6 -0.727 . . . . 73.099999999999994 110.496 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.526 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.43 -40.61 95.07 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.075 -0.511 . . . . 44.200000000000003 110.798 174.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -53.52 -26.89 22.89 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.308 -0.405 . . . . 63.329999999999998 111.916 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.646 ' SD ' HD21 ' A' ' 140' ' ' LEU . 83.1 mmm -64.96 -34.33 78.16 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.754 0.311 . . . . 70.010000000000005 111.835 177.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.447 ' HB ' HG23 ' A' ' 77' ' ' THR . 27.1 m -115.82 -19.88 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.846 0.684 . . . . 64.409999999999997 112.846 -168.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.671 HG21 ' HB2' ' A' ' 30' ' ' SER . 10.1 pt -90.65 -176.21 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-O 121.177 0.513 . . . . 75.239999999999995 111.962 -178.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.599 ' N ' HG21 ' A' ' 123' ' ' VAL . 18.0 t70 . . . . . 0 CA--C 1.542 0.661 0 CA-C-N 116.242 -0.435 . . . . 73.040000000000006 111.507 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.544 0 CA-C-O 121.261 0.367 . . . . 53.32 113.695 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.599 HG21 ' N ' ' A' ' 109' ' ' ASP . 62.0 t -93.82 121.29 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 112.226 0.454 . . . . 52.210000000000001 112.226 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.51 ' HD2' ' N ' ' A' ' 125' ' ' GLY . 0.3 OUTLIER -60.94 141.51 57.19 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.024 0.529 . . . . 73.099999999999994 111.923 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . 0.716 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -170.35 -147.26 5.48 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 116.221 -0.445 . . . . 63.340000000000003 113.087 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.442 ' HB ' ' HE2' ' A' ' 23' ' ' MET . 57.2 p -138.7 159.16 42.78 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.775 0.43 . . . . 72.230000000000004 111.711 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -140.39 145.61 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.906 0.384 . . . . 41.450000000000003 111.374 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.66 154.78 32.1 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.379 -0.373 . . . . 73.519999999999996 111.502 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.627 ' HE3' HD23 ' A' ' 67' ' ' LEU . 36.1 ttmt -71.33 144.38 49.94 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.505 -0.554 . . . . 65.420000000000002 109.505 168.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.448 HG21 HG13 ' A' ' 83' ' ' VAL . 6.0 t -131.98 145.66 51.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 122.05 0.928 . . . . 54.109999999999999 113.355 -176.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -77.32 -10.67 59.58 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.422 -1.263 . . . . 72.310000000000002 111.621 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -82.11 -179.94 7.59 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.478 0.656 . . . . 75.409999999999997 112.503 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -97.25 154.85 17.14 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.741 -0.663 . . . . 72.030000000000001 111.192 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.8 134.35 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.798 0.333 . . . . 64.030000000000001 110.661 172.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 21.1 mt -70.42 125.43 26.76 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.13 0.418 . . . . 75.400000000000006 112.13 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.447 ' HA ' ' HE2' ' A' ' 49' ' ' PHE . 74.0 m -65.05 149.09 50.48 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.386 -0.598 . . . . 72.439999999999998 109.386 167.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.508 HG23 ' HD2' ' A' ' 49' ' ' PHE . 94.7 t -48.61 -48.02 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 111.85 0.315 . . . . 74.239999999999995 111.85 -175.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -72.44 -37.93 68.45 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.234 -0.291 . . . . 61.049999999999997 111.574 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -55.4 -40.52 71.51 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.846 0.831 . . . . 74.510000000000005 109.518 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.646 HD21 ' SD ' ' A' ' 106' ' ' MET . 4.0 tt -58.53 -46.15 87.39 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.4 -1.273 . . . . 71.319999999999993 111.236 173.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 39.6 mt . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 121.523 0.677 . . . . 70.219999999999999 110.829 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.896 0.379 . . . . 74.329999999999998 111.037 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.64 122.89 0.76 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.173 -0.537 . . . . 55.200000000000003 113.422 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.8 p -157.83 131.79 8.05 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.921 0.391 . . . . 63.399999999999999 111.14 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.9 p -162.12 132.59 4.87 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.398 -0.364 . . . . 41.219999999999999 110.875 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -168.26 177.14 5.58 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.941 0.4 . . . . 72.530000000000001 111.824 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -119.87 138.62 53.3 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.313 -0.403 . . . . 71.450000000000003 111.121 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -123.21 125.6 45.4 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.841 0.353 . . . . 54.130000000000003 111.441 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -90.78 158.27 16.94 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.899 0.381 . . . . 75.120000000000005 111.336 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -123.46 87.73 2.79 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.791 -0.448 . . . . 74.109999999999999 109.791 173.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -113.32 132.78 55.44 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.329 0.585 . . . . 70.420000000000002 112.447 -174.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.1 m -135.67 -175.23 3.89 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.46 -0.791 . . . . 73.150000000000006 109.903 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.8 t -145.61 130.31 18.03 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.647 0.61 . . . . 74.230000000000004 112.647 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.69 106.66 2.96 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.71 -0.556 . . . . 72.409999999999997 111.71 172.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -120.2 137.35 54.24 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.112 0.412 . . . . 63.5 112.112 -174.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -80.99 143.82 32.27 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.196 -0.456 . . . . 64.140000000000001 110.839 174.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -157.62 121.05 4.04 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.684 0.278 . . . . 65.129999999999995 111.455 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 mp -105.8 135.49 47.13 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.799 0.333 . . . . 73.409999999999997 111.173 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -114.48 140.0 49.08 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.146 0.498 . . . . 74.510000000000005 111.408 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -98.64 -53.61 3.26 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.052 0.39 . . . . 62.439999999999998 112.052 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 57.27 87.13 0.07 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.274 0.559 . . . . 73.230000000000004 110.539 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.95 -159.9 35.29 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.121 -0.49 . . . . 53.149999999999999 114.172 -174.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -151.96 115.07 4.7 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.9 0.48 . . . . 71.420000000000002 110.889 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.0 ptm -76.42 145.89 39.02 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.349 0.595 . . . . 74.030000000000001 112.435 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.528 HD12 ' HG ' ' A' ' 65' ' ' LEU . 15.1 mt -107.85 138.24 44.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.934 -0.575 . . . . 61.240000000000002 111.421 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.451 ' HA ' HG22 ' A' ' 126' ' ' THR . 33.0 tt0 -78.45 114.39 17.32 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.915 0.388 . . . . 61.130000000000003 110.781 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 27.4 m -127.5 159.74 37.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.18 0.514 . . . . 52.240000000000002 111.921 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.725 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 57.0 tt0 -98.78 108.99 21.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.064 0.459 . . . . 63.299999999999997 110.073 175.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.428 HG22 HD11 ' A' ' 96' ' ' ILE . 33.6 t -83.59 110.32 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.667 -0.697 . . . . 75.129999999999995 111.611 -175.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 121' ' ' LYS . 8.3 mt -92.39 162.05 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.882 0.373 . . . . 70.209999999999994 111.979 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.597 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 64.8 m -137.34 92.61 2.72 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.089 0.471 . . . . 73.310000000000002 111.577 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.3 133.32 11.55 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.158 -0.544 . . . . 45.299999999999997 112.362 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 32' ' ' ARG . 15.2 ttm180 -74.41 83.94 1.96 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 117.297 0.549 . . . . 70.239999999999995 112.248 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.7 p -92.01 -52.29 4.78 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.168 0.508 . . . . 71.129999999999995 110.399 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -84.3 103.33 13.39 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.357 -0.608 . . . . 72.310000000000002 109.357 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -69.06 136.17 51.94 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.216 0.532 . . . . 42.439999999999998 112.23 -175.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.578 ' NE2' ' SD ' ' A' ' 100' ' ' MET . 78.8 mt-30 -91.72 -161.38 0.82 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.613 -0.721 . . . . 74.409999999999997 112.358 -174.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 36' ' ' GLN . . . 118.79 -13.67 11.62 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.638 -0.585 . . . . 72.420000000000002 111.638 -174.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.497 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . . . -135.52 174.24 10.83 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 122.699 0.4 . . . . 63.039999999999999 111.142 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.8 p -87.86 162.01 17.19 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.846 0.355 . . . . 72.310000000000002 110.79 174.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.4 m -61.52 -24.72 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.998 0.428 . . . . 72.010000000000005 111.208 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 36.5 tt0 -72.35 -44.53 62.47 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.129 0.49 . . . . 72.109999999999999 110.644 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.454 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 11.6 tp10 -63.12 -33.37 75.3 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.501 0.667 . . . . 71.239999999999995 110.781 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.497 ' HE2' ' HB3' ' A' ' 38' ' ' ALA . 68.3 mttm -105.29 36.3 2.54 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.802 -0.635 . . . . 73.299999999999997 111.146 175.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 0.5 OUTLIER -67.32 84.68 0.16 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.281 0.563 . . . . 73.219999999999999 110.779 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.7 t -150.07 171.95 16.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.827 -0.624 . . . . 54.130000000000003 111.429 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -64.69 -27.45 68.93 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.595 -0.275 . . . . 60.130000000000003 111.649 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -53.89 -46.72 71.46 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.079 0.466 . . . . 73.430000000000007 111.022 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.435 ' HE2' ' HD2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -68.96 -23.52 64.14 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.327 -0.397 . . . . 74.040000000000006 111.195 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.495 ' HD1' HG23 ' A' ' 137' ' ' VAL . 55.3 t80 -94.4 -0.49 54.8 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.046 0.451 . . . . 63.43 112.015 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -121.48 -27.63 4.75 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.604 -0.685 . . . . 65.299999999999997 112.275 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' A' ' 99' ' ' PRO . . . -72.5 -62.9 1.28 Allowed 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.35 0.5 . . . . 73.239999999999995 112.35 -176.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.469 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 30.2 m -95.49 21.26 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 112.975 0.731 . . . . 65.120000000000005 112.975 -172.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.615 ' N ' HD22 ' A' ' 53' ' ' ASN . 0.8 OUTLIER -105.01 11.13 33.77 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.317 0.858 . . . . 72.219999999999999 113.317 -172.021 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.469 ' CD2' ' HD2' ' A' ' 87' ' ' LYS . 38.0 p90 -136.18 162.22 33.57 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.65 0.611 . . . . 70.430000000000007 112.65 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -126.83 130.0 49.38 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.66 -0.7 . . . . 73.140000000000001 111.004 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.592 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 43.6 mt-10 -87.38 117.55 26.23 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.167 0.508 . . . . 73.099999999999994 111.086 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 28.2 mt -112.79 142.54 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.663 -0.699 . . . . 73.519999999999996 111.501 -172.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.02 149.01 50.61 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.953 0.406 . . . . 73.439999999999998 111.502 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -53.83 -49.9 67.39 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.127 -0.488 . . . . 75.239999999999995 112.186 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -56.61 -51.66 67.81 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.723 0.296 . . . . 60.340000000000003 111.731 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -66.08 -35.76 81.37 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.097 0.475 . . . . 74.340000000000003 110.878 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -53.22 -50.14 65.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.846 -0.616 . . . . 74.329999999999998 111.009 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -71.31 -37.11 71.8 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.399 -0.364 . . . . 71.129999999999995 111.247 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.53 -33.0 70.84 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.189 0.44 . . . . 61.539999999999999 112.189 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.528 ' HG ' HD12 ' A' ' 24' ' ' LEU . 93.5 mt -90.2 -13.53 35.34 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.417 -0.356 . . . . 61.32 111.874 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.26 53.05 23.72 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.02 -0.609 . . . . 61.340000000000003 112.106 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.701 HD23 ' HE3' ' A' ' 129' ' ' LYS . 75.1 mt -92.3 137.43 32.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.499 0.666 . . . . 52.109999999999999 111.808 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -107.84 142.73 37.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.996 -0.547 . . . . 75.409999999999997 109.725 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -61.84 100.01 0.14 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.676 0.75 . . . . 74.109999999999999 110.997 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.53 -14.73 4.46 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 115.097 -0.956 . . . . 63.399999999999999 112.958 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -72.13 178.64 3.72 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.67 0.748 . . . . 75.400000000000006 112.554 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.429 ' HD3' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -131.74 147.99 52.54 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.42 -0.809 . . . . 72.049999999999997 110.242 175.646 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 86' ' ' ALA . 19.7 m -124.41 152.77 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.903 0.705 . . . . 65.400000000000006 112.903 -174.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -94.36 122.11 36.57 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.316 -0.856 . . . . 75.150000000000006 110.442 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.8 t -108.42 126.18 65.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.493 -0.321 . . . . 61.509999999999998 110.136 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -133.48 131.98 40.5 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.393 0.616 . . . . 71.430000000000007 112.586 -173.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.694 HG22 ' HA3' ' A' ' 125' ' ' GLY . 39.4 p -134.45 -171.23 2.71 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.495 -0.775 . . . . 52.420000000000002 110.603 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.69 -18.56 60.5 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.993 0.425 . . . . 75.109999999999999 110.664 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -80.91 -52.61 7.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.267 -0.424 . . . . 72.400000000000006 111.465 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.69 -150.55 7.62 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.781 -0.723 . . . . 55.229999999999997 113.349 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -148.49 154.39 39.76 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.77 0.319 . . . . 72.549999999999997 111.401 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.5 p -157.88 145.78 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-O 120.663 0.268 . . . . 45.049999999999997 111.534 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.5 t -102.31 116.56 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 122.42 -0.175 . . . . 71.129999999999995 110.637 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.0 m -125.74 166.68 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 120.901 0.381 . . . . 75.129999999999995 111.818 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -69.06 130.8 43.76 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.094 0.473 . . . . 75.409999999999997 111.452 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.57 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -81.99 120.07 24.79 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.39 -0.368 . . . . 63.299999999999997 111.813 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.469 ' HD2' ' CD2' ' A' ' 54' ' ' TYR . 67.7 mttm -132.43 157.26 45.03 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.025 0.441 . . . . 61.43 110.614 174.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -94.75 140.75 29.48 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.188 -0.46 . . . . 71.310000000000002 111.259 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.592 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -140.56 167.48 25.53 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.915 -0.66 . . . . 72.439999999999998 113.553 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.93 20.98 2.84 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.19 0.519 . . . . 72.319999999999993 111.948 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 m -73.7 153.61 89.4 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.118 -0.492 . . . . 63.329999999999998 111.16 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HG2' ' SD ' ' A' ' 95' ' ' MET . 35.1 Cg_endo -63.85 160.24 38.09 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.307 2.005 . . . . 64.099999999999994 112.837 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -63.86 147.29 52.24 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.03 0.443 . . . . 74.349999999999994 111.461 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 65.76 34.57 89.15 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.02 -0.609 . . . . 61.240000000000002 112.457 -175.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.725 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 23.0 ttt -157.86 137.28 11.91 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.559 -0.377 . . . . 75.310000000000002 110.519 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 28' ' ' VAL . 41.6 pt -134.81 143.95 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.05 0.452 . . . . 61.340000000000003 111.689 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -102.52 128.29 49.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.429 -0.351 . . . . 74.140000000000001 111.818 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 30' ' ' SER . 45.1 mt -124.8 133.57 24.9 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-O 120.812 0.339 . . . . 74.099999999999994 110.518 172.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.469 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 37.4 Cg_exo -59.62 130.11 33.89 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.228 1.952 . . . . 53.539999999999999 112.242 173.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.578 ' SD ' ' NE2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -54.52 106.1 0.19 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 122.668 0.387 . . . . 51.109999999999999 111.406 -176.45 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -161.64 -172.54 29.14 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.927 -0.654 . . . . 43.43 112.928 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.429 ' HD2' HG21 ' A' ' 52' ' ' VAL . 15.1 Cg_endo -56.71 -37.39 97.92 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.079 2.519 . . . . 70.329999999999998 112.676 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.449 ' HA ' HD11 ' A' ' 140' ' ' LEU . 35.9 m-85 -60.47 -52.96 62.98 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.234 -0.439 . . . . 73.400000000000006 110.732 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.0 -40.43 93.5 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.266 -0.425 . . . . 75.209999999999994 110.948 175.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -52.06 -26.53 11.2 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.103 0.561 . . . . 74.140000000000001 112.157 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.638 ' SD ' HD21 ' A' ' 140' ' ' LEU . 92.0 mmm -67.12 -31.76 72.44 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 111.912 0.338 . . . . 72.140000000000001 111.912 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.423 ' HB ' HG23 ' A' ' 77' ' ' THR . 27.1 m -119.55 -13.74 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 112.906 0.706 . . . . 71.310000000000002 112.906 -171.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.53 HG21 ' OG ' ' A' ' 30' ' ' SER . 11.6 pt -100.87 -179.59 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.138 0.494 . . . . 52.32 111.766 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . 27.0 t70 -97.85 115.63 65.74 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 116.144 -0.48 . . . . 75.120000000000005 110.615 174.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 109' ' ' ASP . 3.0 Cg_endo -82.14 4.83 6.75 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.933 2.422 . . . . 75.010000000000005 113.466 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.1 t -91.87 -29.67 16.58 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.023 0.379 . . . . 53.109999999999999 112.023 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 109' ' ' ASP . 8.0 t -60.68 -177.3 0.07 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.779 0.659 . . . . 51.119999999999997 112.779 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -61.1 -27.37 68.32 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.43 0.53 . . . . 72.409999999999997 112.43 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 53.29 28.01 33.85 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.377 -0.44 . . . . 44.439999999999998 113.318 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.9 m -133.22 129.86 38.29 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.481 0.312 . . . . 71.519999999999996 111.025 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 163.84 149.18 5.66 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 121.282 -0.485 . . . . 32.32 112.772 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 95.7 mmm -81.63 147.2 58.63 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 120.817 0.341 . . . . 63.43 111.185 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.78 91.27 0.36 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.432 2.088 . . . . 64.239999999999995 113.496 -173.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -130.99 -56.64 1.04 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.118 -0.492 . . . . 73.109999999999999 110.522 173.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -160.34 -159.64 0.71 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.738 -0.664 . . . . 74.209999999999994 109.772 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.524 ' O ' HG23 ' A' ' 29' ' ' ILE . 7.1 tmtm? 70.84 98.1 0.07 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.156 0.503 . . . . 74.310000000000002 111.508 174.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.68 -180.0 26.92 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.743 -0.741 . . . . 73.430000000000007 113.395 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.9 t -85.98 123.52 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 120.925 0.393 . . . . 33.109999999999999 111.963 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 22.1 mmmt -61.54 148.27 42.72 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.201 0.524 . . . . 74.150000000000006 112.233 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.694 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -178.87 -151.47 9.63 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.946 -0.57 . . . . 61.520000000000003 113.205 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 25' ' ' GLU . 56.1 p -140.84 160.39 40.15 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.466 -0.432 . . . . 70.219999999999999 111.815 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.1 p -142.22 145.17 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.198 -0.455 . . . . 60.219999999999999 110.971 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -151.08 155.58 39.26 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.503 0.557 . . . . 73.439999999999998 112.503 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.701 ' HE3' HD23 ' A' ' 67' ' ' LEU . 3.1 tppp? -72.88 124.02 24.57 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.258 -0.428 . . . . 74.239999999999995 110.945 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.5 t -129.93 153.85 47.93 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.09 0.471 . . . . 61.140000000000001 111.661 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -82.73 -12.69 57.37 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.064 -0.517 . . . . 44.520000000000003 110.887 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -57.17 166.43 1.11 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.928 1.084 . . . . 73.409999999999997 113.928 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.661 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -86.46 144.14 27.42 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.215 -1.357 . . . . 64.439999999999998 111.16 173.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.37 128.98 22.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.671 -0.24 . . . . 73.439999999999998 110.474 170.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 135' ' ' LEU . 11.4 mt -61.4 109.04 1.04 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.588 0.218 . . . . 64.530000000000001 111.588 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 53.5 m -58.03 145.4 36.41 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.832 -0.432 . . . . 55.329999999999998 109.832 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.495 HG23 ' HD1' ' A' ' 49' ' ' PHE . 90.8 t -45.9 -47.27 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.549 0.574 . . . . 64.420000000000002 112.549 -173.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -72.66 -40.39 66.36 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 122.195 -0.315 . . . . 72.140000000000001 111.751 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -58.95 -36.07 74.19 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.617 0.723 . . . . 63.439999999999998 110.215 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.638 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.8 tt -59.66 -43.58 93.9 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.064 -0.971 . . . . 74.439999999999998 110.578 173.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 32.5 mt -60.47 -44.59 95.73 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.436 0.636 . . . . 72.329999999999998 110.4 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -66.36 -33.12 75.01 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.862 -0.608 . . . . 65.109999999999999 111.018 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.63 -40.02 76.8 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.614 0.598 . . . . 60.130000000000003 112.614 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.2 -8.96 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.518 0.562 . . . . 63.399999999999999 112.518 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 133.03 -18.9 4.44 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.011 -0.614 . . . . 74.299999999999997 113.725 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.473 0.681 0 O-C-N 122.175 -0.603 . . . . 65.519999999999996 111.403 -179.029 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.1 mtp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.81 0.338 . . . . 54.420000000000002 111.276 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.16 179.17 21.34 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 116.408 -0.36 . . . . 63.240000000000002 112.643 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.7 p -134.85 168.76 18.48 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 122.304 -0.527 . . . . 52.340000000000003 111.618 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.2 t -143.47 146.74 33.66 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.965 0.412 . . . . 71.109999999999999 111.092 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -138.6 56.75 1.7 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.161 0.505 . . . . 74.540000000000006 110.41 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -70.35 99.98 1.66 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.492 0.663 . . . . 73.219999999999999 111.578 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -165.77 127.51 1.95 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.571 -0.74 . . . . 74.510000000000005 110.384 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -159.08 143.68 15.61 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.653 0.263 . . . . 64.230000000000004 111.13 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -81.35 -41.64 21.73 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.828 0.347 . . . . 64.400000000000006 111.085 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.1 t60 60.31 -1.57 0.2 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.276 0.843 . . . . 73.219999999999999 113.276 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.4 p -80.5 91.49 5.76 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.949 -0.469 . . . . 62.229999999999997 111.68 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.2 t -168.94 96.54 0.36 Allowed 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.145 -0.479 . . . . 53.229999999999997 111.176 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.43 177.77 31.08 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 121.182 -0.532 . . . . 32.32 113.325 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -158.21 177.63 11.07 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.152 0.501 . . . . 71.239999999999995 111.561 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -110.35 154.08 24.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.009 -0.541 . . . . 61.409999999999997 110.103 174.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -124.34 159.8 29.52 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.266 0.839 . . . . 74.109999999999999 113.266 -169.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mp -104.89 139.0 40.27 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.385 -0.825 . . . . 71.200000000000003 110.702 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -76.98 125.53 29.46 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.2 0.524 . . . . 72.140000000000001 112.047 -176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -118.12 129.67 55.67 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.961 -0.563 . . . . 52.420000000000002 110.903 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -144.76 121.86 11.45 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.163 0.431 . . . . 72.040000000000006 112.163 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.76 93.05 0.72 Allowed Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.882 -0.599 . . . . 60.219999999999999 112.905 174.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -66.43 90.15 0.15 Allowed 'General case' 0 CA--C 1.539 0.519 0 O-C-N 122.575 -0.367 . . . . 74.200000000000003 111.76 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.0 ptm -65.17 140.7 58.8 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.801 0.334 . . . . 63.509999999999998 110.919 174.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.523 HD13 ' HB3' ' A' ' 61' ' ' ASP . 14.1 mt -102.25 130.35 48.9 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.252 0.464 . . . . 74.049999999999997 112.252 -175.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.448 ' HA ' HG22 ' A' ' 126' ' ' THR . 37.1 tt0 -75.23 114.65 13.98 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.197 -0.456 . . . . 62.530000000000001 110.273 175.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.2 m -126.19 159.94 34.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.155 -0.475 . . . . 62.140000000000001 111.756 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.721 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 37.4 tt0 -99.71 113.08 25.32 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.064 0.459 . . . . 71.530000000000001 110.393 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.404 HG22 HD11 ' A' ' 96' ' ' ILE . 46.1 t -88.48 119.24 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.849 -0.614 . . . . 71.030000000000001 112.182 -173.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -107.08 162.37 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.715 0.293 . . . . 74.310000000000002 111.38 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 66.0 m -131.99 106.77 8.24 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.105 0.479 . . . . 74.409999999999997 111.983 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -92.99 111.3 4.07 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.149 -0.548 . . . . 40.409999999999997 112.314 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 54.8 ttp180 -81.87 77.81 8.66 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.297 0.57 . . . . 75.209999999999994 111.445 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.1 t -99.71 -29.12 12.83 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.939 -0.573 . . . . 54.439999999999998 111.523 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.67 HD21 ' HG2' ' A' ' 47' ' ' GLU . 2.8 tm? -83.11 -63.31 1.39 Allowed 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.222 0.534 . . . . 63.409999999999997 111.045 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 17.3 p-10 -94.09 55.0 1.99 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.178 0.436 . . . . 73.239999999999995 112.178 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 32' ' ' ARG . 48.3 mt-30 -64.79 -28.24 69.44 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.706 0.632 . . . . 43.530000000000001 112.706 -176.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.26 14.27 3.02 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.465 -0.874 . . . . 32.219999999999999 114.45 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 35' ' ' ASN . . . -146.17 155.28 42.61 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 117.47 0.635 . . . . 71.439999999999998 112.04 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.0 p -86.01 170.68 12.05 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.378 -0.374 . . . . 73.310000000000002 111.314 175.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.25 -44.81 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.938 0.399 . . . . 73.209999999999994 111.692 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -58.61 -23.66 59.36 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.338 0.496 . . . . 73.519999999999996 112.338 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -80.68 -26.06 37.83 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.929 0.395 . . . . 74.319999999999993 111.744 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.441 ' HB2' ' CD2' ' A' ' 48' ' ' TYR . 27.8 mtpp -125.75 42.63 3.25 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.244 -0.434 . . . . 50.229999999999997 112.019 -172.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.11 80.01 0.5 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.215 0.531 . . . . 72.319999999999993 111.528 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.2 t -151.83 174.33 13.7 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.273 -0.421 . . . . 44.210000000000001 111.865 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' HG2' ' ND2' ' A' ' 50' ' ' ASN . 40.0 tt0 -55.37 -34.33 64.22 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.91 0.386 . . . . 74.319999999999993 111.733 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.67 ' HG2' HD21 ' A' ' 34' ' ' LEU . 33.8 tt0 -53.49 -43.3 68.1 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.008 0.432 . . . . 74.120000000000005 111.176 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.54 ' O ' HG22 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -70.45 -36.76 74.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.151 0.5 . . . . 73.540000000000006 110.324 -179.512 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -64.89 -64.94 0.74 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.012 -0.54 . . . . 73.430000000000007 111.1 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.431 ' ND2' ' HG2' ' A' ' 46' ' ' GLU . 72.0 m-20 -55.74 -17.91 7.08 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.779 0.659 . . . . 65.230000000000004 112.779 -176.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -88.4 -59.01 2.35 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.556 0.576 . . . . 64.420000000000002 112.556 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.63 HG21 ' HD2' ' A' ' 102' ' ' PRO . 20.1 m -96.71 15.33 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 113.225 0.824 . . . . 74.040000000000006 113.225 -171.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -99.16 13.76 31.8 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.89 0.7 . . . . 75.0 112.89 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -138.92 164.55 29.4 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.243 0.544 . . . . 74.049999999999997 111.984 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.63 146.39 51.85 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.723 -0.671 . . . . 74.439999999999998 110.857 175.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -97.62 110.6 23.13 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.774 0.321 . . . . 71.120000000000005 111.235 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.444 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.1 mp -110.35 141.96 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 120.864 0.364 . . . . 74.310000000000002 111.308 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -62.71 139.53 58.67 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.426 -0.352 . . . . 74.109999999999999 110.683 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 62' ' ' TRP . 31.1 tt0 -54.38 -31.85 55.77 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.485 0.55 . . . . 64.120000000000005 112.485 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.86 -55.46 32.71 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.825 0.345 . . . . 73.140000000000001 111.588 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.523 ' HB3' HD13 ' A' ' 24' ' ' LEU . 29.3 m-20 -66.23 -35.66 81.0 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.509 0.671 . . . . 61.329999999999998 110.325 176.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.423 ' HB3' ' HA ' ' A' ' 59' ' ' GLU . 47.8 t-105 -53.05 -48.33 67.74 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.85 -1.068 . . . . 72.349999999999994 111.042 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -69.57 -34.82 74.72 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.841 -0.618 . . . . 73.129999999999995 111.779 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -59.46 -52.02 67.39 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.127 0.489 . . . . 50.530000000000001 111.196 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.429 ' HG ' HD12 ' A' ' 24' ' ' LEU . 94.4 mt -75.96 -4.62 42.08 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.022 -0.535 . . . . 72.439999999999998 111.888 178.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.62 49.45 77.06 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.293 -0.48 . . . . 53.509999999999998 112.594 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.553 HD21 ' HB2' ' A' ' 129' ' ' LYS . 97.8 mt -86.78 161.26 18.46 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.015 0.912 . . . . 71.239999999999995 113.116 -175.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -136.53 151.97 49.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.61 -1.177 . . . . 74.109999999999999 109.452 173.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 mp0 -63.82 108.27 1.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.499 0.666 . . . . 74.349999999999994 111.444 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.87 -8.33 14.72 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.295 -0.866 . . . . 72.129999999999995 113.046 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -63.79 151.9 40.92 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.162 0.506 . . . . 71.5 111.992 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.607 HH21 ' HA ' ' A' ' 131' ' ' ASP . 25.8 mtm-85 -90.99 113.74 26.07 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.823 -0.626 . . . . 71.209999999999994 110.986 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.29 135.56 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.124 0.488 . . . . 74.549999999999997 111.888 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.436 ' HD3' ' HE3' ' A' ' 76' ' ' LYS . 34.6 ttmt -98.25 147.78 24.29 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.291 0.567 . . . . 74.430000000000007 111.124 174.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 57.1 t -122.27 131.77 72.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.498 -0.774 . . . . 65.239999999999995 109.427 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.436 ' HE3' ' HD3' ' A' ' 74' ' ' LYS . 20.1 mttt -125.23 125.3 43.37 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.002 0.43 . . . . 65.310000000000002 111.819 -176.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.706 HG22 ' HA3' ' A' ' 125' ' ' GLY . 25.0 p -138.37 -171.79 3.13 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.156 -0.474 . . . . 75.340000000000003 110.663 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.12 -16.63 63.13 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.925 0.393 . . . . 73.340000000000003 111.539 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -88.76 -21.0 24.04 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.196 0.443 . . . . 75.230000000000004 112.196 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.21 -151.46 23.73 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.266 -0.492 . . . . 73.109999999999999 112.857 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 10.3 pt-20 -144.71 149.66 35.98 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.137 0.494 . . . . 52.310000000000002 111.813 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -148.15 148.31 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 116.213 -0.449 . . . . 74.430000000000007 111.25 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -110.0 118.55 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.08 0.152 . . . . 52.340000000000003 110.843 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.461 HG12 ' HD2' ' A' ' 103' ' ' TYR . 33.9 m -128.9 178.27 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 122.699 0.399 . . . . 72.400000000000006 111.933 -177.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -83.06 146.02 28.95 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.106 0.479 . . . . 73.120000000000005 111.446 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.82 127.3 43.68 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.222 0.453 . . . . 73.099999999999994 112.222 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -129.34 142.33 50.85 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.367 0.603 . . . . 72.329999999999998 110.681 173.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -77.72 123.1 26.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.585 -0.734 . . . . 63.039999999999999 111.183 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -126.05 165.98 19.01 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.347 -0.454 . . . . 72.329999999999998 113.507 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -85.84 15.07 5.15 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.546 0.572 . . . . 54.43 112.546 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.3 m -65.66 154.83 87.63 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 112.051 0.389 . . . . 60.43 112.051 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.99 149.54 90.3 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.525 2.15 . . . . 72.5 112.616 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -63.9 144.14 57.31 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.748 0.309 . . . . 64.549999999999997 111.532 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.23 22.07 78.52 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.121 -0.561 . . . . 51.420000000000002 112.923 -174.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.721 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 23.9 ttt -154.0 136.47 15.05 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 122.495 -0.415 . . . . 72.209999999999994 109.985 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 28' ' ' VAL . 43.2 pt -134.37 150.07 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.412 0.625 . . . . 60.409999999999997 112.313 -175.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -106.47 129.25 54.47 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.835 -0.62 . . . . 75.25 110.827 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 30' ' ' SER . 40.8 mt -124.3 132.29 24.28 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 120.633 0.254 . . . . 50.310000000000002 110.657 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -57.86 128.54 29.41 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.19 1.926 . . . . 64.209999999999994 112.169 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.76 113.33 1.43 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.829 0.347 . . . . 72.239999999999995 111.267 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.45 -169.77 27.39 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.686 -0.768 . . . . 64.319999999999993 112.742 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.63 ' HD2' HG21 ' A' ' 52' ' ' VAL . 31.5 Cg_endo -65.15 -27.54 56.8 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.065 1.843 . . . . 70.409999999999997 111.482 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.495 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 3.4 m-85 -68.25 -53.8 22.11 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.825 -0.625 . . . . 64.340000000000003 110.249 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.78 -38.12 80.98 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.016 -0.538 . . . . 75.400000000000006 110.99 174.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -54.5 -23.43 16.28 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.365 0.505 . . . . 73.430000000000007 112.365 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 102' ' ' PRO . 77.9 mmm -78.17 -12.6 60.01 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.988 0.366 . . . . 61.310000000000002 111.988 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.7 m -137.39 -13.88 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 113.088 0.773 . . . . 65.129999999999995 113.088 -173.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.546 HG21 ' OG ' ' A' ' 30' ' ' SER . 1.5 pp -105.78 172.18 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 122.081 -0.387 . . . . 71.420000000000002 111.206 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.442 ' N ' HG21 ' A' ' 123' ' ' VAL . 18.9 t0 -94.63 109.81 45.58 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-O 120.902 0.382 . . . . 65.209999999999994 111.981 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.94 8.64 4.35 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.71 2.273 . . . . 71.439999999999998 113.375 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.9 m -79.74 -6.15 56.68 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.127 0.489 . . . . 70.010000000000005 110.858 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 48.5 p -81.93 142.43 32.46 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.949 -0.569 . . . . 63.020000000000003 112.322 -175.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.95 -64.06 1.12 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.214 -0.448 . . . . 74.310000000000002 111.001 175.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 61.55 -111.45 3.9 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 116.306 -0.406 . . . . 71.409999999999997 113.522 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.8 m 70.46 -67.03 0.26 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.215 0.606 . . . . 75.150000000000006 112.563 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 117' ' ' MET . . . -91.92 131.53 10.83 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.179 -0.534 . . . . 64.109999999999999 113.519 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 116' ' ' GLY . 47.7 mtt 75.71 158.02 0.16 Allowed Pre-proline 0 N--CA 1.476 0.844 0 N-CA-C 113.217 0.821 . . . . 75.129999999999995 113.217 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.4 96.21 0.79 Allowed 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.452 2.101 . . . . 73.299999999999997 112.748 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -84.8 115.65 22.84 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.042 0.448 . . . . 75.120000000000005 111.33 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -89.38 -176.36 5.04 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.326 -0.397 . . . . 62.549999999999997 111.249 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.554 ' HB2' ' NZ ' ' A' ' 121' ' ' LYS . 0.1 OUTLIER 65.52 131.82 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.316 0.579 . . . . 72.409999999999997 111.623 -174.416 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -128.68 -160.94 10.5 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.137 -0.554 . . . . 70.409999999999997 113.107 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.442 HG21 ' N ' ' A' ' 109' ' ' ASP . 98.3 t -87.17 130.05 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 O-C-N 122.692 -0.299 . . . . 63.420000000000002 111.561 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -70.12 145.95 51.21 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.274 0.559 . . . . 71.010000000000005 112.241 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.706 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -173.89 -155.47 11.99 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.72 -0.673 . . . . 75.230000000000004 112.693 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.448 HG22 ' HA ' ' A' ' 25' ' ' GLU . 79.1 p -135.64 158.59 43.99 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 122.322 -0.517 . . . . 61.340000000000003 111.961 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.4 p -133.57 144.6 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 121.035 0.445 . . . . 71.420000000000002 111.008 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -152.54 150.76 29.91 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.456 -0.338 . . . . 73.200000000000003 111.393 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HB2' HD21 ' A' ' 67' ' ' LEU . 29.0 ttpt -83.53 127.46 33.74 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.994 -0.441 . . . . 74.030000000000001 110.219 170.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.5 t -126.24 156.19 40.67 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.339 0.59 . . . . 73.420000000000002 112.325 -172.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.607 ' HA ' HH21 ' A' ' 72' ' ' ARG . 8.5 p-10 -82.32 -5.6 58.7 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.002 -0.545 . . . . 74.400000000000006 111.22 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -69.36 157.19 37.52 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.943 -0.571 . . . . 74.209999999999994 111.372 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -88.3 157.51 18.73 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.91 0.385 . . . . 72.120000000000005 111.37 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 91.2 t -69.31 138.26 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 116.325 -0.398 . . . . 72.409999999999997 110.951 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 135' ' ' LEU . 14.6 mt -70.88 133.76 46.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.698 0.285 . . . . 73.299999999999997 111.464 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 44.7 t -78.42 145.72 34.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.464 -0.569 . . . . 70.420000000000002 109.464 171.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.558 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 96.5 t -46.39 -45.95 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 111.86 0.319 . . . . 63.009999999999998 111.86 -177.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.435 ' HA ' HD12 ' A' ' 141' ' ' LEU . 25.1 ttpp -71.25 -41.25 70.33 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.691 0.281 . . . . 72.420000000000002 111.422 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -55.91 -37.03 68.36 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.918 0.866 . . . . 62.439999999999998 109.611 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.487 HD11 ' HA ' ' A' ' 103' ' ' TYR . 1.0 OUTLIER -68.85 -38.39 79.74 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.528 -1.215 . . . . 74.340000000000003 111.002 176.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 53.9 mt -59.25 -49.51 77.55 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.609 0.718 . . . . 74.209999999999994 110.227 176.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -65.29 -30.04 70.86 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.017 -0.992 . . . . 72.319999999999993 111.317 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.28 -51.37 45.71 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 111.963 0.357 . . . . 63.130000000000003 111.963 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 146' ' ' SER . 2.9 pp -75.59 -22.44 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 112.139 0.422 . . . . 74.099999999999994 112.139 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 122.76 -64.73 0.52 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.251 -0.5 . . . . 64.409999999999997 113.088 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.402 ' N ' HD12 ' A' ' 144' ' ' ILE . 48.9 m . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 120.924 0.392 . . . . 60.109999999999999 111.657 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.0 mtm . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.656 0.265 . . . . 75.340000000000003 111.282 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.24 39.19 3.33 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.27 -0.49 . . . . 75.329999999999998 113.308 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.1 p -86.15 -70.27 0.61 Allowed 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.509 -0.406 . . . . 74.299999999999997 111.606 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.0 t -91.81 -51.98 4.96 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.974 0.416 . . . . 63.25 110.978 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -65.69 90.76 0.12 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.121 0.486 . . . . 73.530000000000001 110.768 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -74.9 126.37 30.83 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.858 -0.61 . . . . 73.219999999999999 111.369 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -125.26 123.47 39.59 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.947 -0.57 . . . . 70.439999999999998 109.984 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -54.1 140.74 30.98 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.883 0.373 . . . . 72.430000000000007 111.267 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -74.24 70.11 1.61 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.557 0.577 . . . . 64.200000000000003 112.557 -169.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -90.26 -69.64 0.71 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.147 0.499 . . . . 73.530000000000001 110.045 175.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.1 p -108.66 -36.63 6.12 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.228 0.537 . . . . 63.409999999999997 110.401 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.9 t -141.1 -170.62 3.09 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.694 -0.684 . . . . 61.329999999999998 111.139 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.0 -44.48 0.74 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.55 -1.02 . . . . 44.229999999999997 110.55 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -165.38 112.8 0.97 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.871 -0.789 . . . . 71.400000000000006 108.871 170.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 15' ' ' GLU . 0.8 OUTLIER -70.03 -17.96 63.28 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.133 1.16 . . . . 74.230000000000004 114.133 -167.599 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -78.44 102.8 7.99 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.153 0.427 . . . . 64.400000000000006 112.153 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -120.14 -179.61 3.99 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.524 0.678 . . . . 72.420000000000002 112.281 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -130.32 147.87 52.08 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.562 -0.745 . . . . 73.25 111.064 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -130.47 -179.27 5.17 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.087 0.402 . . . . 64.5 112.087 -175.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -148.5 163.92 35.75 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.994 0.425 . . . . 72.109999999999999 112.121 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.22 142.99 11.57 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.388 -0.434 . . . . 72.019999999999996 113.876 175.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -148.93 89.91 1.71 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 122.579 -0.365 . . . . 42.140000000000001 111.243 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 10.4 ptm -77.85 166.01 23.43 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.757 0.313 . . . . 73.239999999999995 111.304 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.545 HD12 ' HG ' ' A' ' 65' ' ' LEU . 17.1 mt -118.05 133.83 55.54 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.648 0.61 . . . . 75.239999999999995 112.648 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -79.57 119.08 22.04 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.941 -0.572 . . . . 33.509999999999998 110.2 173.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 m -133.87 161.3 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.953 0.406 . . . . 72.129999999999995 111.91 -175.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 31.5 tt0 -99.22 113.43 25.69 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.946 0.403 . . . . 74.120000000000005 110.373 174.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.489 HG22 HD11 ' A' ' 96' ' ' ILE . 45.4 t -89.65 112.93 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.231 0.539 . . . . 65.049999999999997 111.861 -173.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.31 159.36 3.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.923 0.392 . . . . 75.409999999999997 111.745 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 75.2 m -135.43 104.65 5.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.085 0.469 . . . . 74.140000000000001 111.303 175.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.8 119.09 4.77 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.963 -0.636 . . . . 62.310000000000002 112.372 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -62.3 94.9 0.06 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.738 0.78 . . . . 73.329999999999998 111.825 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.565 HG23 HD23 ' A' ' 34' ' ' LEU . 5.0 t -127.04 -175.38 3.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.978 -1.01 . . . . 71.200000000000003 109.926 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.711 HD21 ' HB1' ' A' ' 51' ' ' ALA . 4.2 mm? 61.88 28.89 17.67 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 111.755 0.28 . . . . 72.409999999999997 111.755 -177.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.6 t30 72.64 89.21 0.1 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.48 0.712 . . . . 53.140000000000001 112.395 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 60.13 -80.71 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.604 0.762 . . . . 74.129999999999995 112.083 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 177.19 54.11 0.07 OUTLIER Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.709 -0.678 . . . . 72.040000000000006 112.883 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.88 154.59 29.62 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.647 0.26 . . . . 42.119999999999997 111.358 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.7 p -68.81 171.33 8.05 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.135 0.493 . . . . 72.340000000000003 111.206 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.675 HG21 HD11 ' A' ' 141' ' ' LEU . 17.7 m -63.76 -26.47 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.505 -0.316 . . . . 74.219999999999999 111.555 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.45 -38.0 77.6 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.993 0.368 . . . . 71.030000000000001 111.993 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.81 -36.12 67.08 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.816 0.341 . . . . 65.040000000000006 111.261 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.523 ' HZ1' HD12 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -131.12 51.67 2.12 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.103 0.478 . . . . 62.450000000000003 111.321 177.746 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.82 83.25 0.91 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.301 0.572 . . . . 72.510000000000005 110.045 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.423 HG23 ' HB2' ' A' ' 47' ' ' GLU . 2.7 t -152.74 169.29 23.11 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.716 -0.675 . . . . 64.120000000000005 111.579 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -53.93 -32.92 55.21 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.175 0.512 . . . . 64.430000000000007 111.389 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.423 ' HB2' HG23 ' A' ' 45' ' ' THR . 20.4 mm-40 -53.61 -42.89 68.17 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.213 0.53 . . . . 73.209999999999994 111.34 176.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -65.1 -27.4 68.73 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.915 -0.584 . . . . 74.150000000000006 110.494 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -83.25 -9.18 59.27 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.941 -0.572 . . . . 73.310000000000002 111.745 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -116.89 -0.49 12.23 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.948 0.404 . . . . 70.319999999999993 111.64 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.711 ' HB1' HD21 ' A' ' 34' ' ' LEU . . . -95.81 -52.34 4.12 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.867 0.691 . . . . 71.340000000000003 112.867 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.464 HG21 ' HD2' ' A' ' 102' ' ' PRO . 35.5 m -116.35 19.86 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 113.445 0.906 . . . . 31.300000000000001 113.445 -172.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.654 ' N ' HD22 ' A' ' 53' ' ' ASN . 0.7 OUTLIER -100.73 18.57 19.03 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.898 0.703 . . . . 74.409999999999997 112.898 -171.478 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.462 ' CD1' ' HD2' ' A' ' 87' ' ' LYS . 47.1 p90 -144.6 165.58 27.6 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.462 0.542 . . . . 75.040000000000006 112.462 -174.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.32 142.51 49.37 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.623 -0.717 . . . . 73.549999999999997 110.685 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 44.5 mt-10 -101.04 118.48 37.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.938 0.399 . . . . 75.230000000000004 111.475 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.497 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.8 mp -110.55 152.12 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 116.179 -0.464 . . . . 61.210000000000001 111.302 -177.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -68.44 153.77 43.12 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.671 0.388 . . . . 74.209999999999994 111.347 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -57.67 -46.33 84.39 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.115 0.483 . . . . 75.239999999999995 112.096 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.92 -47.9 82.87 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.79 0.329 . . . . 65.099999999999994 111.694 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -65.84 -35.92 82.01 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.199 0.524 . . . . 75.049999999999997 111.165 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.424 ' HZ2' ' N ' ' A' ' 69' ' ' GLU . 40.4 t-105 -55.55 -54.05 48.86 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.78 -0.645 . . . . 75.109999999999999 110.919 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -64.61 -33.83 76.85 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.048 -0.524 . . . . 71.329999999999998 111.475 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.511 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -60.15 -43.8 95.47 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.912 0.387 . . . . 32.299999999999997 111.947 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.642 HD11 HG13 ' A' ' 127' ' ' VAL . 93.4 mt -84.6 -9.25 58.46 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.001 0.371 . . . . 60.450000000000003 112.001 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.3 45.68 68.49 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.117 -0.563 . . . . 75.510000000000005 112.637 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.66 HD23 ' HE2' ' A' ' 129' ' ' LYS . 74.0 mt -83.37 166.63 18.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.385 0.612 . . . . 55.5 112.071 -177.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -147.25 121.39 9.49 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.853 -0.612 . . . . 71.510000000000005 109.898 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.424 ' N ' ' HZ2' ' A' ' 62' ' ' TRP . 43.0 mt-10 -44.52 98.62 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.283 0.846 . . . . 74.209999999999994 113.283 -169.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.79 -4.24 8.56 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 115.084 -0.962 . . . . 75.319999999999993 113.735 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.02 -176.61 5.59 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 117.8 0.8 . . . . 63.219999999999999 112.05 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.487 ' HG3' HG23 ' A' ' 134' ' ' VAL . 8.8 mpt_? -107.19 123.61 48.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.125 -0.489 . . . . 61.340000000000003 111.813 -176.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.3 m -115.42 145.04 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.307 0.575 . . . . 64.299999999999997 111.516 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.78 ' HD3' ' HE3' ' A' ' 76' ' ' LYS . 24.0 ttmm -108.73 146.99 32.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.813 -0.63 . . . . 73.230000000000004 110.534 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 64.5 t -130.55 129.57 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.269 -0.423 . . . . 62.219999999999999 110.704 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.78 ' HE3' ' HD3' ' A' ' 74' ' ' LYS . 38.7 mttt -130.94 125.54 33.7 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.929 0.395 . . . . 75.129999999999995 112.058 -175.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.668 HG22 ' HA3' ' A' ' 125' ' ' GLY . 42.6 p -126.45 -171.06 2.31 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 116.507 -0.315 . . . . 62.350000000000001 110.557 177.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.63 -6.46 52.12 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.901 0.382 . . . . 63.130000000000003 111.528 175.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -91.98 -60.78 1.77 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.869 0.366 . . . . 72.030000000000001 110.776 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.33 -144.45 4.03 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.221 -0.514 . . . . 73.25 112.796 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 0.3 OUTLIER -154.52 159.28 40.86 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 117.12 0.46 . . . . 52.43 111.204 178.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 106' ' ' MET . 8.8 p -157.46 144.45 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 111.928 0.344 . . . . 62.420000000000002 111.928 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.8 t -105.54 118.52 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 122.48 0.312 . . . . 71.129999999999995 110.587 174.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.49 HG12 ' HD2' ' A' ' 103' ' ' TYR . 35.3 m -128.18 176.5 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 120.996 0.427 . . . . 72.439999999999998 112.06 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -79.49 140.98 37.13 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.976 0.417 . . . . 73.439999999999998 111.34 176.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.8 126.16 36.78 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.758 0.651 . . . . 63.240000000000002 112.758 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 62.3 mttm -126.84 143.71 51.18 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.199 0.523 . . . . 74.400000000000006 110.901 173.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -88.78 121.36 31.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.973 -0.558 . . . . 74.030000000000001 110.573 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.4 -179.62 15.8 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.711 -0.757 . . . . 73.349999999999994 114.21 -174.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -90.66 18.9 5.85 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.958 0.409 . . . . 70.430000000000007 111.353 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.1 m -72.49 151.83 91.76 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.251 -0.431 . . . . 71.530000000000001 111.896 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -62.04 160.57 29.47 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 122.755 2.303 . . . . 74.450000000000003 113.61 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -69.0 138.76 54.78 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.824 0.345 . . . . 73.109999999999999 111.453 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.06 26.59 73.98 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.968 -0.634 . . . . 61.329999999999998 112.298 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.528 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 23.5 ttt -149.8 136.61 19.4 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.653 -0.322 . . . . 73.540000000000006 110.297 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 28' ' ' VAL . 39.8 pt -135.25 146.81 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 121.263 0.554 . . . . 71.239999999999995 111.851 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -106.17 130.15 54.1 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.177 -0.465 . . . . 73.239999999999995 111.564 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 30' ' ' SER . 44.9 mt -124.32 132.06 24.26 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 120.753 0.311 . . . . 72.140000000000001 110.629 173.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.425 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 37.6 Cg_exo -58.91 131.88 44.35 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.229 1.953 . . . . 73.299999999999997 112.368 173.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.7 tpt -51.39 107.94 0.22 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 111.906 0.335 . . . . 65.450000000000003 111.906 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.14 -176.84 38.37 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.574 -0.822 . . . . 61.539999999999999 113.413 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.464 ' HD2' HG21 ' A' ' 52' ' ' VAL . 15.2 Cg_endo -55.92 -35.44 94.18 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.169 2.579 . . . . 72.450000000000003 112.952 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.49 ' HD2' HG12 ' A' ' 84' ' ' VAL . 30.7 m-85 -61.87 -51.56 67.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.057 0.456 . . . . 74.219999999999999 110.634 177.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -62.0 -38.3 88.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.099 0.476 . . . . 54.350000000000001 111.04 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -54.55 -26.17 30.45 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.898 0.479 . . . . 75.409999999999997 112.006 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.584 ' SD ' HD21 ' A' ' 140' ' ' LEU . 84.9 mmm -69.54 -16.78 63.5 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.347 0.499 . . . . 73.25 112.347 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.84 -19.03 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 113.472 0.916 . . . . 73.349999999999994 113.472 -174.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.583 HG21 ' OG ' ' A' ' 30' ' ' SER . 8.0 pt -98.5 179.96 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 112.852 0.686 . . . . 75.140000000000001 112.852 -175.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -104.2 117.5 59.24 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 115.874 -0.603 . . . . 72.340000000000003 111.03 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -84.49 9.2 4.23 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.832 2.355 . . . . 71.0 113.959 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.9 m -83.04 32.75 0.44 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 120.844 0.354 . . . . 71.010000000000005 111.728 -177.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.7 p -79.12 2.11 21.98 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.389 0.885 . . . . 72.409999999999997 113.389 -171.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -70.82 135.28 48.0 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.146 0.498 . . . . 64.030000000000001 112.199 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.63 9.74 71.42 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.178 -0.465 . . . . 65.439999999999998 113.555 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.5 p -102.1 144.03 31.18 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.211 -0.581 . . . . 43.310000000000002 111.797 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -114.45 132.2 10.32 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.071 -0.513 . . . . 55.229999999999997 112.088 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 90.3 mmm 67.15 134.41 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 122.915 0.486 . . . . 73.400000000000006 111.623 -175.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.54 -39.86 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.668 2.245 . . . . 73.400000000000006 113.921 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' A' ' 120' ' ' PHE . 39.4 tt0 65.95 150.81 0.05 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.098 0.559 . . . . 55.140000000000001 111.435 -174.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.43 ' N ' ' HG2' ' A' ' 119' ' ' GLN . 93.3 m-85 -74.84 77.73 2.12 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.972 -0.455 . . . . 64.510000000000005 112.043 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.09 164.56 38.26 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.014 0.435 . . . . 75.099999999999994 111.116 172.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -144.95 -175.92 18.51 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.049 -0.596 . . . . 71.010000000000005 112.928 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 93.5 t -80.12 118.08 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 122.533 -0.392 . . . . 72.340000000000003 111.07 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 39.3 mtpt -67.31 155.55 38.63 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.657 0.741 . . . . 71.120000000000005 112.913 -177.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.668 ' HA3' HG22 ' A' ' 77' ' ' THR . . . 179.68 -147.85 7.75 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.055 -0.975 . . . . 72.430000000000007 112.144 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 45.1 p -138.51 153.3 48.75 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 122.292 -0.534 . . . . 72.420000000000002 111.757 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.642 HG13 HD11 ' A' ' 65' ' ' LEU . 14.8 p -128.11 145.24 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.138 -0.483 . . . . 61.299999999999997 110.254 175.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 7.3 pt-20 -148.69 151.31 34.7 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.81 0.67 . . . . 74.310000000000002 112.81 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.66 ' HE2' HD23 ' A' ' 67' ' ' LEU . 14.5 tppt? -69.51 106.38 2.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.535 -0.757 . . . . 63.439999999999998 109.966 167.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.1 t -100.8 161.8 13.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.451 0.643 . . . . 70.010000000000005 112.34 -176.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -100.53 0.7 39.98 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.554 -0.748 . . . . 71.540000000000006 110.62 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -88.39 179.52 6.31 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.07 0.767 . . . . 74.299999999999997 113.07 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -100.26 161.61 13.49 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.292 -0.867 . . . . 71.219999999999999 111.609 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.487 HG23 ' HG3' ' A' ' 72' ' ' ARG . 93.3 t -70.1 137.64 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 120.771 0.32 . . . . 64.340000000000003 111.56 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 135' ' ' LEU . 6.5 mt -77.81 98.04 5.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.679 -0.237 . . . . 70.239999999999995 111.219 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 70.9 p -55.19 153.68 6.59 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.696 0.284 . . . . 75.129999999999995 111.45 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.559 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 86.8 t -45.8 -53.73 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.971 0.73 . . . . 74.349999999999994 112.971 -172.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -72.35 -42.0 65.82 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.23 0.456 . . . . 73.340000000000003 112.23 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -56.51 -39.99 74.26 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.564 0.697 . . . . 60.210000000000001 109.977 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.584 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.3 tt -60.58 -41.62 95.05 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.071 -0.968 . . . . 64.209999999999994 110.772 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.675 HD11 HG21 ' A' ' 40' ' ' VAL . 68.3 mt -58.59 -55.23 37.69 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.173 0.511 . . . . 70.319999999999993 110.818 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -64.72 -30.96 71.98 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.815 -0.63 . . . . 70.439999999999998 111.432 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.1 -52.44 64.89 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.349 -0.387 . . . . 70.109999999999999 111.634 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 146' ' ' SER . 2.9 pp -81.49 -18.1 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 112.333 0.494 . . . . 74.310000000000002 112.333 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 119.39 -68.28 0.37 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.336 -0.459 . . . . 63.229999999999997 113.062 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.413 ' N ' HD12 ' A' ' 144' ' ' ILE . 49.4 m . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 121.048 0.451 . . . . 73.420000000000002 111.503 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.482 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.761 0.315 . . . . 74.129999999999995 111.101 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.07 124.71 0.82 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.33 -0.462 . . . . 32.130000000000003 112.41 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.9 p -103.29 114.7 29.19 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.086 0.443 . . . . 72.230000000000004 112.169 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.1 m -99.57 -179.26 4.15 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.302 -0.408 . . . . 75.310000000000002 110.259 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -152.53 153.43 33.44 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.503 0.557 . . . . 63.520000000000003 112.503 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -155.7 138.73 15.45 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.572 -0.74 . . . . 63.009999999999998 110.783 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -160.91 142.49 12.04 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.221 0.209 . . . . 70.120000000000005 110.5 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -163.7 141.33 7.36 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.477 0.917 . . . . 73.310000000000002 113.477 -174.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -120.95 167.7 12.29 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.927 -0.579 . . . . 63.350000000000001 109.679 169.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -149.54 138.56 21.2 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.857 0.36 . . . . 73.349999999999994 111.954 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.6 m -107.71 142.56 37.52 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.385 -0.37 . . . . 72.0 110.826 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.2 p -140.97 132.78 27.44 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.742 0.306 . . . . 65.239999999999995 111.261 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.95 138.83 2.51 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.445 -0.884 . . . . 43.439999999999998 114.049 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -134.04 126.5 30.31 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.771 0.428 . . . . 75.319999999999993 110.356 174.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -82.3 167.38 18.64 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.085 0.402 . . . . 75.129999999999995 112.085 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -51.02 131.41 26.99 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.589 0.589 . . . . 75.430000000000007 112.589 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 17' ' ' LEU . 3.2 mm? -90.21 129.11 36.5 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.863 -0.608 . . . . 51.32 111.239 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 56.39 -163.06 0.17 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.894 0.701 . . . . 74.219999999999999 112.894 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -117.36 -175.03 2.72 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.264 -0.425 . . . . 74.120000000000005 111.354 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -95.12 158.53 15.42 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.158 0.504 . . . . 72.439999999999998 112.091 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.92 -147.05 18.0 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.903 -0.665 . . . . 44.149999999999999 113.725 172.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -151.8 117.62 5.46 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.717 0.294 . . . . 64.25 111.721 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 8.8 ptm -88.62 139.55 30.36 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.926 0.393 . . . . 72.340000000000003 110.769 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.581 HD11 ' HB3' ' A' ' 64' ' ' ALA . 32.6 mt -90.53 132.13 35.87 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.831 0.678 . . . . 74.239999999999995 112.831 -173.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -78.74 118.56 20.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.52 -0.764 . . . . 61.450000000000003 111.04 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 35.4 m -139.32 164.38 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.992 -1.004 . . . . 75.120000000000005 112.027 -173.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 34.8 tt0 -99.47 121.85 41.73 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.858 0.361 . . . . 42.32 110.435 171.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.478 HG22 HD11 ' A' ' 96' ' ' ILE . 39.3 t -96.42 110.2 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.258 -0.428 . . . . 74.239999999999995 111.608 -175.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.507 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 2.9 mt -95.73 161.06 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.927 0.394 . . . . 74.109999999999999 111.905 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.616 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 73.5 m -129.33 95.44 4.03 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.01 0.434 . . . . 72.25 111.212 174.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.67 124.32 6.55 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.097 -0.573 . . . . 60.539999999999999 113.078 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -71.7 86.09 0.92 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.033 0.444 . . . . 45.149999999999999 111.592 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.5 p -69.12 -49.37 57.69 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.138 0.494 . . . . 71.099999999999994 111.085 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.8 mt -73.3 110.14 7.35 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.97 -0.559 . . . . 64.540000000000006 111.03 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -62.21 -22.06 65.63 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.474 0.546 . . . . 73.109999999999999 112.474 -177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -85.05 -22.62 28.92 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.049 0.389 . . . . 74.140000000000001 112.049 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.79 -97.51 0.57 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.941 -0.647 . . . . 70.430000000000007 112.293 -173.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 62.12 -172.06 0.15 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.297 0.48 . . . . 71.5 112.297 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.5 p -99.38 -176.58 3.33 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.747 -0.464 . . . . 73.420000000000002 109.747 170.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.11 -37.3 76.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.047 0.388 . . . . 73.030000000000001 112.047 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -72.31 -17.63 61.85 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.87 0.693 . . . . 73.310000000000002 112.87 -174.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . 1.2 mp0 -70.73 -49.91 41.87 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.997 0.427 . . . . 74.140000000000001 110.271 170.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -101.95 55.96 0.81 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.438 -0.347 . . . . 62.310000000000002 110.811 173.395 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.9 tp -74.56 27.05 0.08 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.363 0.601 . . . . 63.420000000000002 112.174 -175.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 43' ' ' LYS . 3.1 t -86.34 161.0 18.93 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.161 0.505 . . . . 74.420000000000002 112.229 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.45 -29.43 67.78 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.203 0.525 . . . . 71.099999999999994 110.756 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -55.9 -36.71 67.97 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.759 -0.655 . . . . 72.329999999999998 110.579 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.492 ' O ' HG22 ' A' ' 52' ' ' VAL . 13.0 t80 -65.5 -43.09 91.22 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.893 -0.594 . . . . 74.109999999999999 110.4 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.481 ' HD1' HG23 ' A' ' 137' ' ' VAL . 75.4 t80 -58.65 -62.07 2.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.716 -0.674 . . . . 63.539999999999999 110.452 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -59.96 -23.89 63.95 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.621 0.6 . . . . 61.140000000000001 112.621 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.78 -33.01 58.07 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.795 0.665 . . . . 73.430000000000007 112.795 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.553 HG21 ' HD2' ' A' ' 102' ' ' PRO . 30.5 m -123.49 14.8 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 113.575 0.954 . . . . 75.230000000000004 113.575 -173.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -96.57 19.66 11.93 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.963 0.727 . . . . 75.129999999999995 112.963 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -145.5 159.21 43.44 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.897 -0.502 . . . . 71.310000000000002 112.279 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.38 141.59 51.98 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.787 -0.642 . . . . 43.329999999999998 110.687 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.786 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 41.5 mt-10 -97.9 111.98 24.08 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.838 0.351 . . . . 71.349999999999994 111.272 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.9 mp -110.88 149.9 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.333 -0.394 . . . . 73.439999999999998 111.032 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -74.45 144.8 44.09 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.548 0.213 . . . . 65.010000000000005 110.438 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.438 ' HA ' ' HB3' ' A' ' 62' ' ' TRP . 27.6 tt0 -55.33 -32.91 62.89 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.314 0.487 . . . . 75.349999999999994 112.314 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.598 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 17.3 mm-40 -54.97 -57.08 13.11 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 111.977 0.362 . . . . 74.5 111.977 175.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.02 -34.99 78.93 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.441 0.639 . . . . 55.25 110.45 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.517 ' HA ' HD12 ' A' ' 67' ' ' LEU . 43.3 t-105 -53.08 -50.27 64.72 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.171 -0.922 . . . . 75.409999999999997 111.478 177.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -69.13 -39.1 79.07 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.155 -0.475 . . . . 71.010000000000005 111.462 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.581 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -56.27 -34.33 66.33 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.245 0.461 . . . . 42.32 112.245 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.0 mt -91.84 -18.32 23.99 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.377 -0.374 . . . . 75.340000000000003 111.849 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.03 46.33 10.57 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.154 -0.546 . . . . 54.140000000000001 112.657 -176.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.683 HD23 ' HD3' ' A' ' 129' ' ' LYS . 91.6 mt -84.09 143.19 29.87 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.271 0.558 . . . . 70.150000000000006 112.424 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -101.09 156.15 17.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.013 -0.54 . . . . 74.439999999999998 110.645 170.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.35 93.21 1.49 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.735 0.779 . . . . 65.310000000000002 111.11 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.76 -3.62 8.61 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 114.777 -1.101 . . . . 72.430000000000007 112.113 -171.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.47 173.79 1.5 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.23 0.538 . . . . 71.109999999999999 112.093 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -113.86 124.47 52.3 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.267 -0.424 . . . . 74.329999999999998 111.353 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.642 HG13 ' HB2' ' A' ' 86' ' ' ALA . 17.5 m -114.33 142.11 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.333 0.587 . . . . 74.120000000000005 112.232 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.581 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 38.5 ttmt -99.47 147.31 25.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.857 -0.611 . . . . 74.439999999999998 110.172 173.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -128.54 124.03 60.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.239 -0.652 . . . . 53.25 109.239 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.581 ' HD2' ' HD2' ' A' ' 74' ' ' LYS . 6.5 mtpm? -133.93 130.12 37.28 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.546 0.573 . . . . 55.240000000000002 112.546 -170.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.742 HG22 ' HA3' ' A' ' 125' ' ' GLY . 25.0 p -136.62 -171.23 2.86 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.797 -0.638 . . . . 55.450000000000003 110.545 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.91 -14.91 63.27 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.961 -0.563 . . . . 63.520000000000003 111.853 175.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -89.2 -38.64 14.11 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 111.796 0.295 . . . . 72.120000000000005 111.796 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.31 -160.93 34.6 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.345 -0.455 . . . . 62.039999999999999 112.979 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.19 149.85 51.04 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.267 0.556 . . . . 64.230000000000004 112.202 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.525 HG23 HD12 ' A' ' 135' ' ' LEU . 12.5 p -147.46 147.26 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.142 -0.481 . . . . 74.299999999999997 110.948 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -111.12 119.07 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 122.31 -0.244 . . . . 71.040000000000006 110.997 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.465 ' HA ' HG13 ' A' ' 134' ' ' VAL . 34.3 m -129.57 174.25 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 111.921 0.341 . . . . 73.019999999999996 111.921 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -75.37 143.38 42.83 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.97 0.414 . . . . 73.430000000000007 111.458 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.642 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -94.5 122.12 36.75 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.216 0.45 . . . . 32.229999999999997 112.216 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -128.33 141.17 51.51 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.304 0.573 . . . . 65.329999999999998 111.08 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.419 ' HD3' ' HB2' ' A' ' 59' ' ' GLU . 35.3 ttmt -80.11 103.99 10.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.717 -0.674 . . . . 75.209999999999994 110.689 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.786 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -100.51 -163.9 28.29 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 121.256 -0.497 . . . . 71.549999999999997 114.298 -172.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -111.25 32.45 5.32 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.365 0.602 . . . . 51.420000000000002 111.292 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.1 m -92.37 158.41 38.86 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.974 -0.557 . . . . 63.240000000000002 111.817 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.97 163.14 37.59 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.302 2.001 . . . . 72.010000000000005 112.859 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.598 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 78.8 tttt -63.32 143.34 57.88 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.767 0.318 . . . . 71.430000000000007 111.574 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 68.22 28.78 73.18 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.877 -0.678 . . . . 63.409999999999997 112.961 -175.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.51 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 23.5 ttt -154.62 137.0 14.95 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.472 -0.428 . . . . 74.239999999999995 110.309 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.478 HD11 HG22 ' A' ' 28' ' ' VAL . 41.9 pt -134.87 144.37 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.359 0.6 . . . . 72.409999999999997 112.082 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -106.09 124.19 49.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.021 -0.536 . . . . 51.420000000000002 111.415 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 30' ' ' SER . 54.4 mt -121.02 131.45 24.48 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.559 -0.291 . . . . 73.239999999999995 110.427 174.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.402 ' HB2' HG12 ' A' ' 52' ' ' VAL . 31.7 Cg_exo -60.48 138.82 82.89 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.14 1.893 . . . . 65.319999999999993 112.399 175.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.7 104.73 0.16 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.444 -0.344 . . . . 62.409999999999997 110.839 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.97 -173.84 25.91 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.712 -0.756 . . . . 63.030000000000001 113.107 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.553 ' HD2' HG21 ' A' ' 52' ' ' VAL . 34.8 Cg_endo -64.7 -31.59 58.56 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.352 2.035 . . . . 73.430000000000007 111.566 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.502 ' HA ' HD11 ' A' ' 140' ' ' LEU . 8.2 m-85 -62.85 -48.17 80.2 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.701 -0.681 . . . . 74.230000000000004 110.146 175.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -59.64 -43.55 93.81 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.911 -0.586 . . . . 72.010000000000005 111.517 173.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -54.89 -20.1 8.06 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.536 0.569 . . . . 73.409999999999997 112.536 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.547 ' SD ' HD21 ' A' ' 140' ' ' LEU . 88.5 mmm -69.45 -31.56 69.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.858 0.361 . . . . 72.109999999999999 111.435 177.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.453 ' HB ' HG23 ' A' ' 77' ' ' THR . 31.0 m -123.59 -8.36 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 113.293 0.849 . . . . 65.420000000000002 113.293 -171.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.558 HG21 ' OG ' ' A' ' 30' ' ' SER . 8.0 pt -106.05 177.48 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.565 0.698 . . . . 71.409999999999997 112.452 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.542 ' O ' HG22 ' A' ' 112' ' ' THR . 25.7 t70 -102.21 122.87 45.27 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 115.544 -0.753 . . . . 64.099999999999994 110.67 175.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.99 18.41 0.64 Allowed 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.846 2.364 . . . . 71.120000000000005 114.304 -176.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 61.8 m -114.4 -16.16 12.0 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.516 0.561 . . . . 74.510000000000005 112.516 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 109' ' ' ASP . 3.4 t -71.98 -41.68 67.39 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.732 0.642 . . . . 61.32 112.732 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -86.37 103.07 14.59 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.053 0.454 . . . . 72.209999999999994 111.525 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.77 -45.32 0.07 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.367 -0.444 . . . . 53.119999999999997 113.025 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 76.9 p -114.08 -171.8 1.97 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.019 0.438 . . . . 62.140000000000001 111.018 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.68 104.59 1.1 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 120.892 -0.67 . . . . 72.019999999999996 112.483 174.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 49.6 tpp -69.61 116.8 46.84 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 120.735 0.302 . . . . 34.43 110.804 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -80.96 -19.17 8.49 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.127 2.552 . . . . 71.120000000000005 113.772 -175.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -129.55 153.43 48.04 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.998 0.428 . . . . 73.200000000000003 112.14 -172.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -78.76 90.58 4.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.06 0.457 . . . . 74.319999999999993 111.106 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -135.82 136.18 40.43 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.33 -0.396 . . . . 54.140000000000001 110.978 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . -136.32 -171.2 12.21 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.946 -0.645 . . . . 72.439999999999998 113.133 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.416 HG21 ' H ' ' A' ' 109' ' ' ASP . 89.5 t -86.89 122.28 38.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.633 0.254 . . . . 72.150000000000006 111.515 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 68.0 mttm -71.71 147.32 47.52 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.463 0.649 . . . . 75.510000000000005 112.35 -177.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.742 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -175.15 -138.59 2.8 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.479 -0.782 . . . . 73.099999999999994 112.527 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 57.3 p -140.43 158.64 43.7 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.06 0.457 . . . . 73.5 111.748 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.1 p -135.29 145.23 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.988 -0.551 . . . . 64.209999999999994 110.472 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.519 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 5.9 pt-20 -149.04 155.21 40.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.684 0.278 . . . . 62.420000000000002 111.383 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.683 ' HD3' HD23 ' A' ' 67' ' ' LEU . 28.0 ttpp -85.68 133.54 34.02 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.607 -0.516 . . . . 73.519999999999996 109.607 168.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.6 t -130.72 161.08 32.46 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.601 0.715 . . . . 55.509999999999998 112.858 -171.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.09 -21.31 33.73 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.409 -0.814 . . . . 74.329999999999998 110.164 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -61.73 157.21 18.38 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.847 -0.615 . . . . 73.319999999999993 112.579 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.532 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -90.52 162.29 15.1 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.912 -0.585 . . . . 74.340000000000003 111.1 179.33 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 84' ' ' VAL . 98.4 t -65.81 133.23 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.458 -0.337 . . . . 72.439999999999998 111.035 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.525 HD12 HG23 ' A' ' 82' ' ' VAL . 13.2 mt -63.01 138.28 58.51 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.134 0.492 . . . . 74.450000000000003 111.405 177.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.0 t -85.41 144.93 27.72 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.087 -0.709 . . . . 64.129999999999995 109.087 170.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.481 HG23 ' HD1' ' A' ' 49' ' ' PHE . 86.5 t -48.46 -47.05 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 112.093 0.405 . . . . 71.409999999999997 112.093 -175.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -67.83 -41.46 82.99 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.958 0.408 . . . . 64.450000000000003 111.525 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -62.14 -33.52 74.64 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.581 0.705 . . . . 72.400000000000006 110.404 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.547 HD21 ' SD ' ' A' ' 106' ' ' MET . 1.9 tt -66.63 -34.29 77.55 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.127 -0.942 . . . . 63.219999999999999 110.85 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.06 -41.58 92.64 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.633 0.73 . . . . 73.530000000000001 109.943 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -66.49 -35.89 81.39 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.464 -0.789 . . . . 65.510000000000005 110.675 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.76 -44.1 86.86 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.259 0.466 . . . . 53.329999999999998 112.259 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.9 pp -77.62 -8.63 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 120.86 0.362 . . . . 72.209999999999994 111.949 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 83.69 38.4 10.65 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 114.41 0.524 . . . . 23.25 114.41 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.474 0.768 0 CA-C-N 117.464 0.632 . . . . 51.530000000000001 111.349 176.673 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.496 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 120.725 0.298 . . . . 71.25 111.354 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 155.83 79.07 0.02 OUTLIER Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.129 -0.558 . . . . 54.409999999999997 112.929 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.4 p -76.77 126.24 30.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.115 0.483 . . . . 73.540000000000006 111.865 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.2 m -83.86 151.56 25.06 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.988 0.423 . . . . 61.32 111.728 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -157.89 138.8 13.19 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.309 -0.405 . . . . 73.109999999999999 111.043 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -120.62 144.81 47.94 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.983 0.42 . . . . 71.230000000000004 111.959 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -85.0 154.95 21.79 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.22 -0.445 . . . . 63.140000000000001 111.229 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -124.85 143.41 50.84 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.876 0.369 . . . . 63.539999999999999 111.869 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -154.84 151.99 29.27 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.582 -0.281 . . . . 74.400000000000006 111.304 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -114.11 116.63 29.43 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.063 0.459 . . . . 75.129999999999995 110.993 175.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.4 m -76.84 97.99 4.72 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.921 0.391 . . . . 64.120000000000005 111.028 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.7 m -105.37 121.69 44.41 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.374 -0.375 . . . . 74.019999999999996 111.31 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -136.48 -163.78 9.96 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.315 -0.469 . . . . 72.519999999999996 113.244 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -117.99 -176.99 3.16 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.014 0.435 . . . . 63.549999999999997 111.654 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.13 170.5 8.22 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.371 0.605 . . . . 74.439999999999998 112.506 -175.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -105.84 114.24 28.27 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.97 -0.559 . . . . 73.530000000000001 111.007 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 17' ' ' LEU . 6.8 mp -78.53 162.08 26.57 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.982 0.42 . . . . 72.209999999999994 112.063 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -92.87 125.24 37.38 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.211 0.529 . . . . 64.109999999999999 112.104 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -107.74 142.32 37.93 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.094 -0.503 . . . . 73.239999999999995 110.766 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -96.69 94.83 7.53 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.021 0.439 . . . . 65.540000000000006 111.124 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.65 112.69 0.28 Allowed Glycine 0 CA--C 1.529 0.933 0 CA-C-N 116.152 -0.476 . . . . 73.409999999999997 112.845 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -96.63 113.69 25.27 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.488 -0.419 . . . . 61.43 111.9 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 7.8 ptp -81.23 167.18 19.88 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.997 0.427 . . . . 63.43 111.219 176.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.495 HD12 ' HG ' ' A' ' 65' ' ' LEU . 25.3 mt -121.46 127.02 50.66 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.129 0.49 . . . . 74.420000000000002 111.813 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -71.7 115.61 11.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.585 -0.734 . . . . 64.530000000000001 111.02 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 27.8 m -128.51 160.07 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.55 0.574 . . . . 63.140000000000001 112.55 -174.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.618 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 52.9 tt0 -99.27 117.32 33.45 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.945 0.402 . . . . 63.130000000000003 110.696 174.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.502 HG22 HD11 ' A' ' 96' ' ' ILE . 40.9 t -92.35 108.51 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.142 0.496 . . . . 50.5 112.121 -175.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -102.24 146.95 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.936 0.398 . . . . 75.049999999999997 112.027 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 73.6 m -106.6 104.42 14.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.157 -0.474 . . . . 73.430000000000007 111.667 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . -73.11 94.67 0.71 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.885 -0.674 . . . . 40.210000000000001 112.894 178.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -68.64 89.49 0.38 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.39 0.614 . . . . 72.319999999999993 111.607 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.6 p -110.19 172.98 6.54 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.85 -0.613 . . . . 53.530000000000001 111.105 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.408 ' HG ' ' HG2' ' A' ' 36' ' ' GLN . 33.5 tp 73.45 -48.94 0.68 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.308 0.643 . . . . 71.019999999999996 112.182 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 60.47 95.06 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.621 0.724 . . . . 73.409999999999997 111.762 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.518 ' HG3' ' HE3' ' A' ' 43' ' ' LYS . 76.4 mm-40 -134.65 -51.59 0.8 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.805 -0.634 . . . . 72.010000000000005 111.785 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.68 -7.69 61.4 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.11 -0.567 . . . . 53.109999999999999 113.567 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.36 145.13 33.59 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 122.554 0.341 . . . . 74.140000000000001 111.71 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.2 t -61.34 153.8 25.7 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.659 -0.246 . . . . 72.239999999999995 110.942 173.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.3 m -57.14 -30.89 35.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 120.714 0.292 . . . . 75.150000000000006 111.282 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.404 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 41.2 tt0 -60.65 -33.27 72.55 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.162 -0.472 . . . . 63.340000000000003 111.863 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -56.17 -40.73 74.35 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.179 0.514 . . . . 61.450000000000003 110.519 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.565 ' HB2' ' CD2' ' A' ' 48' ' ' TYR . 63.9 mttm -104.9 -65.1 1.06 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.585 0.587 . . . . 54.450000000000003 112.585 -173.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.404 ' HG ' ' HA ' ' A' ' 41' ' ' GLU . 67.0 mt 48.35 20.81 0.31 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 113.215 0.82 . . . . 73.040000000000006 113.215 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.545 HG23 ' H ' ' A' ' 48' ' ' TYR . 6.5 t -80.35 156.4 26.74 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.654 0.264 . . . . 74.120000000000005 111.487 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -50.04 -38.7 39.05 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.105 0.479 . . . . 75.409999999999997 111.371 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -60.97 -37.84 83.82 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.086 -0.506 . . . . 72.430000000000007 111.223 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.565 ' CD2' ' HB2' ' A' ' 43' ' ' LYS . 1.7 t80 -58.18 -40.02 80.4 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.298 0.57 . . . . 72.109999999999999 109.849 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -64.52 -62.03 1.85 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.559 -0.746 . . . . 75.299999999999997 110.306 176.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -64.62 -4.31 4.03 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.09 0.774 . . . . 74.319999999999993 113.09 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.22 -33.01 14.86 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.61 0.596 . . . . 51.25 112.61 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.58 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 34.8 m -129.48 20.15 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 113.15 0.796 . . . . 64.420000000000002 113.15 -173.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -103.02 21.53 15.56 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.124 0.787 . . . . 62.049999999999997 113.124 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -140.89 158.43 43.96 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.168 0.509 . . . . 71.150000000000006 112.143 -177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.89 138.79 51.13 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.909 -0.587 . . . . 72.510000000000005 110.853 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.667 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 39.6 mt-10 -93.78 112.66 24.56 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.637 0.256 . . . . 71.400000000000006 111.361 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.3 mp -109.81 146.06 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 116.529 -0.305 . . . . 55.25 110.764 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -68.43 143.92 54.88 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.811 0.339 . . . . 72.310000000000002 111.399 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -47.46 -40.05 17.31 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.117 0.567 . . . . 74.420000000000002 112.251 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -58.37 -54.35 47.97 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.087 0.47 . . . . 74.230000000000004 111.399 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -66.37 -33.67 76.25 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.227 0.537 . . . . 73.209999999999994 110.915 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 46.2 t-105 -54.16 -54.23 42.51 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.693 -0.685 . . . . 73.439999999999998 111.429 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -69.42 -36.38 76.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.525 -0.307 . . . . 74.400000000000006 111.66 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.444 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -59.64 -34.65 73.07 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.983 0.42 . . . . 71.120000000000005 111.88 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.495 ' HG ' HD12 ' A' ' 24' ' ' LEU . 94.6 mt -90.91 -12.17 36.9 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.473 -0.331 . . . . 74.310000000000002 111.751 177.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.12 46.51 50.49 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.123 -0.561 . . . . 70.120000000000005 112.657 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.494 ' HA ' ' HZ1' ' A' ' 129' ' ' LYS . 93.7 mt -86.6 159.51 19.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.616 0.722 . . . . 73.400000000000006 112.078 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -140.87 134.78 30.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.184 -0.916 . . . . 74.409999999999997 109.129 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -56.17 97.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.631 0.729 . . . . 74.049999999999997 112.094 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 143.28 -22.9 2.23 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.15 -0.932 . . . . 54.240000000000002 113.956 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -86.25 178.0 7.31 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 118.251 1.026 . . . . 71.420000000000002 112.627 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.664 HH11 HG23 ' A' ' 134' ' ' VAL . 60.9 mtt-85 -109.52 139.95 43.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.812 -0.631 . . . . 65.329999999999998 112.003 -169.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 86' ' ' ALA . 31.4 m -124.06 140.03 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.921 -0.581 . . . . 61.43 111.212 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -107.99 131.25 54.76 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.921 0.391 . . . . 73.510000000000005 110.896 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 50.5 t -106.81 130.47 58.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.397 -0.365 . . . . 54.100000000000001 111.026 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.506 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -117.18 127.88 54.55 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.017 0.437 . . . . 54.43 111.307 177.475 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.646 HG22 ' HA3' ' A' ' 125' ' ' GLY . 21.4 p -135.53 -172.52 3.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.057 0.456 . . . . 62.130000000000003 110.57 175.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -71.29 -5.62 33.69 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.293 -0.412 . . . . 75.319999999999993 111.963 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -99.81 -20.55 16.15 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.026 0.38 . . . . 51.549999999999997 112.026 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 146.6 -151.63 23.87 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.982 -0.627 . . . . 43.439999999999998 113.202 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.506 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 9.5 pt-20 -140.3 149.94 43.41 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.8 0.333 . . . . 54.130000000000003 111.553 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.449 HG23 ' SD ' ' A' ' 106' ' ' MET . 12.8 p -149.11 148.67 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.528 -0.305 . . . . 74.219999999999999 111.135 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.07 117.71 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 120.542 0.21 . . . . 73.219999999999999 111.349 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.4 m -129.84 176.44 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.646 0.379 . . . . 55.549999999999997 111.657 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -79.66 145.97 32.72 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.016 0.436 . . . . 74.510000000000005 111.565 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.413 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -88.76 115.86 26.61 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 112.591 0.589 . . . . 74.319999999999993 112.591 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -113.27 157.39 21.84 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.621 0.725 . . . . 64.230000000000004 111.228 171.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -100.11 112.57 24.88 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.386 -0.825 . . . . 62.539999999999999 110.547 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.667 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -107.92 171.77 16.54 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.147 -0.549 . . . . 73.140000000000001 114.147 -174.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.61 18.34 13.07 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.32 0.581 . . . . 43.5 110.752 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.404 HG11 ' HB2' ' A' ' 97' ' ' PHE . 27.8 m -79.1 155.85 77.05 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.852 -0.613 . . . . 71.400000000000006 111.99 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.03 153.17 53.52 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.404 2.069 . . . . 75.340000000000003 112.588 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -62.65 148.75 45.44 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 122.161 -0.337 . . . . 75.040000000000006 111.151 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 66.17 27.29 72.84 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.521 -0.847 . . . . 74.310000000000002 112.41 -174.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.618 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 20.9 ttt -149.27 137.01 20.38 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.632 -0.507 . . . . 63.229999999999997 109.632 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 28' ' ' VAL . 38.9 pt -132.99 141.54 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 121.249 0.547 . . . . 72.239999999999995 111.864 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.493 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 59.1 t80 -101.87 118.38 36.8 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.966 -0.561 . . . . 73.209999999999994 111.369 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 30' ' ' SER . 51.5 mt -119.97 124.37 27.91 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.623 -0.262 . . . . 71.319999999999993 110.612 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.58 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 11.5 Cg_endo -55.82 137.23 77.98 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.184 1.922 . . . . 71.430000000000007 112.258 176.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.08 103.27 0.16 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.329 -0.396 . . . . 72.230000000000004 110.948 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.59 -176.12 24.85 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.559 -0.829 . . . . 75.430000000000007 112.87 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.51 ' HA ' HD22 ' A' ' 105' ' ' ASN . 22.4 Cg_endo -62.13 -28.03 79.4 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.023 1.815 . . . . 64.0 111.446 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.504 ' HA ' HD11 ' A' ' 140' ' ' LEU . 8.4 m-85 -66.89 -49.88 64.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.617 -0.72 . . . . 73.310000000000002 110.134 175.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.38 -40.09 81.37 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.854 -0.612 . . . . 73.319999999999993 111.443 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.51 HD22 ' HA ' ' A' ' 102' ' ' PRO . 91.0 m-20 -56.71 -25.11 53.52 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.214 0.53 . . . . 72.409999999999997 111.808 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.449 ' SD ' HG23 ' A' ' 82' ' ' VAL . 35.3 mtp -73.58 -21.53 60.31 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.912 -0.586 . . . . 73.010000000000005 112.313 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.5 m -133.67 -5.96 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.453 0.908 . . . . 71.319999999999993 113.453 -173.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 109' ' ' ASP . 1.6 pp -111.13 172.65 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.957 -0.464 . . . . 70.519999999999996 111.665 -177.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.472 ' N ' HG21 ' A' ' 123' ' ' VAL . 11.6 t70 -96.83 120.11 62.36 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 116.252 -0.431 . . . . 70.209999999999994 111.636 -177.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -86.9 2.04 7.19 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.562 2.175 . . . . 71.239999999999995 113.396 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.0 m -86.71 0.05 55.39 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.945 0.402 . . . . 53.310000000000002 111.595 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 54.4 p -68.31 82.66 0.24 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.299 0.571 . . . . 65.209999999999994 110.992 175.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -66.12 113.93 4.87 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.058 -0.519 . . . . 75.340000000000003 110.877 -176.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.93 75.95 0.88 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 114.16 0.424 . . . . 74.040000000000006 114.16 -174.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 63.0 p -124.49 36.99 4.5 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.237 0.541 . . . . 71.530000000000001 111.144 175.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.33 10.24 18.01 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 116.181 -0.463 . . . . 72.420000000000002 113.283 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.493 ' N ' ' SD ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -68.64 147.04 97.98 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 112.215 0.45 . . . . 73.420000000000002 112.215 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.25 121.34 7.7 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.694 2.263 . . . . 54.310000000000002 113.319 -175.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -80.62 41.64 0.57 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.764 0.793 . . . . 71.329999999999998 111.028 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -137.02 -14.49 1.57 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.282 -0.872 . . . . 73.319999999999993 111.296 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -87.55 127.9 35.25 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.68 0.276 . . . . 71.450000000000003 110.803 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -124.1 177.65 16.67 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.649 -0.786 . . . . 74.019999999999996 113.877 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.472 HG21 ' N ' ' A' ' 109' ' ' ASP . 57.7 t -94.2 120.29 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 122.633 -0.333 . . . . 53.299999999999997 110.987 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 39.0 mtpt -73.83 153.5 39.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.015 0.912 . . . . 53.020000000000003 112.779 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.646 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -174.88 -150.1 7.6 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 114.323 -1.308 . . . . 44.350000000000001 111.346 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 44.0 p -132.87 146.95 52.26 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.449 0.625 . . . . 60.100000000000001 111.873 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -121.67 144.01 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.085 -0.507 . . . . 64.120000000000005 110.905 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -149.74 152.4 35.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.921 -0.581 . . . . 72.530000000000001 110.811 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.494 ' HZ1' ' HA ' ' A' ' 67' ' ' LEU . 19.6 ttmm -73.04 134.95 44.81 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.363 -0.606 . . . . 63.310000000000002 109.363 170.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.7 t -126.52 158.84 35.09 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.036 0.754 . . . . 72.519999999999996 113.036 -172.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -85.46 -15.78 41.81 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.11 -0.95 . . . . 74.519999999999996 110.911 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.466 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 19.2 mm-40 -73.81 156.08 38.16 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.496 0.665 . . . . 75.430000000000007 112.587 -177.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.02 156.99 29.8 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.29 -0.868 . . . . 75.430000000000007 111.309 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.664 HG23 HH11 ' A' ' 72' ' ' ARG . 70.4 t -69.7 131.03 34.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 109.85 -0.426 . . . . 71.439999999999998 109.85 173.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.43 HD13 ' HG ' ' A' ' 140' ' ' LEU . 13.5 mt -63.21 132.33 51.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.081 0.467 . . . . 71.450000000000003 112.099 -177.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 65.6 m -75.97 146.07 39.86 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.41 -0.589 . . . . 61.420000000000002 109.41 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 87.5 t -46.76 -50.98 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 112.859 0.689 . . . . 73.120000000000005 112.859 -172.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -72.92 -38.76 66.74 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.057 -0.402 . . . . 64.209999999999994 111.745 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -58.42 -37.7 75.91 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.745 0.783 . . . . 73.319999999999993 110.038 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.504 HD11 ' HA ' ' A' ' 103' ' ' TYR . 5.1 tt -59.59 -42.66 93.03 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.905 -1.043 . . . . 61.109999999999999 110.72 174.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 50.6 mt -58.03 -46.99 84.42 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.205 0.526 . . . . 73.140000000000001 110.395 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.89 -33.48 74.29 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.946 -0.57 . . . . 74.340000000000003 111.169 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.21 -45.01 62.08 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.547 0.573 . . . . 54.100000000000001 112.547 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.05 -8.95 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 112.855 0.687 . . . . 75.519999999999996 112.855 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.43 -43.14 0.86 Allowed Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.925 -0.655 . . . . 73.200000000000003 113.234 177.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.6 m . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 121.136 0.493 . . . . 55.109999999999999 111.139 -179.143 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.535 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.834 0.349 . . . . 73.109999999999999 111.423 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.51 166.08 24.52 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.309 -0.472 . . . . 51.229999999999997 113.092 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.2 p -155.84 108.79 2.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.27 0.557 . . . . 72.150000000000006 111.538 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 t -79.0 155.0 29.05 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.295 -0.411 . . . . 60.119999999999997 111.129 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -156.27 90.25 1.18 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.328 0.585 . . . . 72.019999999999996 112.299 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -117.25 124.72 49.73 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.9 0.381 . . . . 74.349999999999994 110.533 174.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -132.69 131.8 41.68 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.118 0.485 . . . . 74.409999999999997 111.745 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -152.03 140.52 20.63 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.035 -0.53 . . . . 73.409999999999997 110.299 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -140.29 144.87 36.63 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.602 0.593 . . . . 75.510000000000005 112.602 -173.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -145.32 124.37 12.82 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.878 -0.601 . . . . 75.329999999999998 110.648 172.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.2 p -150.89 133.56 15.7 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.318 -0.401 . . . . 54.439999999999998 110.705 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.4 m -152.64 132.46 13.24 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.107 0.41 . . . . 73.5 112.107 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.74 172.96 21.43 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 112.013 -0.435 . . . . 51.399999999999999 112.013 172.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -160.6 134.93 7.28 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.084 -0.656 . . . . 74.329999999999998 112.366 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -89.42 -179.13 5.76 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.609 -0.723 . . . . 70.209999999999994 112.054 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -140.7 159.26 42.59 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.244 -0.435 . . . . 73.140000000000001 110.147 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.1 tt -46.8 129.68 11.58 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.138 0.494 . . . . 75.140000000000001 111.662 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -90.5 138.08 31.84 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.802 0.667 . . . . 75.239999999999995 112.802 -173.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -84.98 -179.81 7.14 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.075 -0.511 . . . . 74.349999999999994 110.859 173.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -81.06 -46.7 14.6 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.802 0.668 . . . . 75.219999999999999 112.802 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.17 -59.56 4.88 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.968 -0.634 . . . . 62.25 111.965 -173.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 30.7 t60 64.83 84.71 0.15 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.173 0.589 . . . . 73.400000000000006 111.752 174.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.53 ' HA ' ' HB3' ' A' ' 128' ' ' GLU . 8.7 ptp -78.67 152.46 31.65 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.959 0.726 . . . . 73.230000000000004 112.959 -177.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 64' ' ' ALA . 13.5 mt -117.39 140.34 49.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.123 -0.944 . . . . 61.530000000000001 110.887 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -79.26 110.33 14.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.669 0.747 . . . . 64.209999999999994 110.974 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 35.0 m -133.51 162.32 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.872 -1.058 . . . . 64.530000000000001 111.873 -171.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.579 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 28.3 tt0 -100.08 117.72 34.94 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.067 0.46 . . . . 55.240000000000002 110.531 172.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 96' ' ' ILE . 41.0 t -90.62 110.07 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.315 0.646 . . . . 72.409999999999997 111.457 -175.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.448 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 8.3 mt -91.98 152.21 3.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.871 0.367 . . . . 55.119999999999997 111.768 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.717 ' HB2' HG21 ' A' ' 108' ' ' ILE . 23.1 t -123.63 93.28 3.89 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.946 0.403 . . . . 74.430000000000007 110.081 172.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 100' ' ' MET . . . -80.66 143.56 24.62 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.135 -0.555 . . . . 31.420000000000002 113.501 -175.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 -65.99 82.08 0.08 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.423 0.63 . . . . 74.209999999999994 111.394 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 57.0 p -103.02 131.72 49.8 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.833 -0.621 . . . . 74.219999999999999 111.382 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.8 mp 62.68 -179.01 0.14 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.228 0.537 . . . . 73.099999999999994 111.224 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -88.44 117.78 27.61 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.539 -0.3 . . . . 72.230000000000004 111.367 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.402 ' HB3' ' H ' ' A' ' 37' ' ' GLY . 2.3 mp0 -77.45 -154.14 0.06 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.3 -0.409 . . . . 75.239999999999995 110.425 173.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.402 ' H ' ' HB3' ' A' ' 36' ' ' GLN . . . 82.73 -57.97 5.03 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.641 -0.79 . . . . 64.120000000000005 112.586 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.418 ' HB3' ' HD2' ' A' ' 43' ' ' LYS . . . -68.93 142.53 54.7 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.814 0.34 . . . . 74.319999999999993 111.762 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.6 p -67.58 155.48 39.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.766 0.317 . . . . 72.349999999999994 110.419 173.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.548 HG21 HD21 ' A' ' 141' ' ' LEU . 30.2 m -58.0 -24.78 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.063 0.458 . . . . 63.340000000000003 110.271 175.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 25.0 tt0 -62.89 -51.98 64.87 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.752 -0.658 . . . . 74.530000000000001 110.884 174.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -56.53 -44.42 80.82 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.228 0.537 . . . . 71.319999999999993 111.295 175.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.418 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 26.4 mtpp -98.48 31.13 2.95 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.88 -0.6 . . . . 70.099999999999994 111.399 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -67.09 82.8 0.12 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.089 0.471 . . . . 74.109999999999999 110.515 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 t -145.23 159.63 42.72 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.964 0.412 . . . . 55.439999999999998 111.905 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -53.98 -30.75 48.42 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.03 -0.532 . . . . 71.319999999999993 111.565 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.73 -36.48 76.67 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.761 0.315 . . . . 70.530000000000001 111.445 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -25.86 67.02 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.443 0.64 . . . . 71.400000000000006 109.973 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.401 ' HE1' ' HA ' ' A' ' 136' ' ' SER . 55.7 t80 -86.33 -17.5 34.37 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.864 -0.607 . . . . 74.430000000000007 111.052 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -84.61 -43.23 14.63 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.902 -0.498 . . . . 73.420000000000002 112.067 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.85 -63.78 1.33 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.69 0.996 . . . . 71.519999999999996 113.69 -170.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.509 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 28.3 m -88.31 20.95 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 113.661 0.985 . . . . 72.219999999999999 113.661 -167.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -105.24 12.22 32.11 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.175 0.806 . . . . 75.430000000000007 113.175 -173.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -137.31 164.74 27.84 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.817 -0.552 . . . . 74.140000000000001 111.834 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.54 141.39 52.06 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.849 -0.614 . . . . 64.340000000000003 111.182 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 97' ' ' PHE . 61.8 mt-10 -94.09 112.73 24.58 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.093 -0.503 . . . . 73.439999999999998 111.12 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.436 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.3 mp -109.89 145.76 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.501 -0.318 . . . . 73.5 110.665 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -66.51 151.83 46.44 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.659 0.266 . . . . 70.120000000000005 111.012 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 34.9 tt0 -57.76 -41.96 83.03 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.425 0.528 . . . . 45.340000000000003 112.425 -177.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -63.36 -48.52 77.59 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.785 0.326 . . . . 74.230000000000004 111.817 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -65.25 -36.77 85.16 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.12 0.486 . . . . 74.230000000000004 110.605 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.43 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 39.9 t-105 -52.92 -49.39 66.08 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.861 -0.608 . . . . 63.32 110.905 174.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -66.54 -40.56 89.14 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.782 -0.644 . . . . 71.140000000000001 111.167 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.465 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -60.77 -39.44 88.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.124 0.487 . . . . 62.43 111.95 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.515 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 68.4 mt -80.6 -10.44 59.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.069 -0.514 . . . . 72.540000000000006 111.461 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.49 40.24 97.52 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.404 -0.427 . . . . 74.230000000000004 112.652 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.515 ' HG ' ' HB2' ' A' ' 65' ' ' LEU . 96.1 mt -78.11 161.07 27.66 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.73 0.776 . . . . 63.130000000000003 112.572 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -138.63 130.49 27.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.328 -0.851 . . . . 75.120000000000005 109.59 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -55.51 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.59 0.71 . . . . 74.540000000000006 112.115 -174.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.57 -19.45 1.85 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-N 115.14 -0.936 . . . . 70.109999999999999 113.479 -176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -89.51 -169.95 2.67 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 117.683 0.741 . . . . 74.129999999999995 112.224 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.472 ' HD3' ' H ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -135.59 162.06 33.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.168 0.508 . . . . 73.519999999999996 111.977 -174.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.558 HG13 ' HB2' ' A' ' 86' ' ' ALA . 23.8 m -132.22 154.86 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.329 0.585 . . . . 72.109999999999999 112.36 -176.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.443 ' HB2' HG21 ' A' ' 130' ' ' THR . 12.5 tppt? -97.98 129.74 44.85 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.516 -0.765 . . . . 73.030000000000001 110.486 173.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 44.7 t -116.16 123.21 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 122.251 0.22 . . . . 55.119999999999997 110.445 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -124.46 124.85 43.19 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.952 0.406 . . . . 64.239999999999995 112.042 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.648 HG22 ' HA3' ' A' ' 125' ' ' GLY . 25.0 p -132.15 -171.43 2.63 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.061 0.458 . . . . 74.239999999999995 111.396 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -71.78 -2.77 18.8 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 112.666 0.617 . . . . 75.430000000000007 112.666 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -106.75 -40.45 5.51 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.931 0.396 . . . . 71.430000000000007 111.863 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.72 -149.0 10.53 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.98 -0.629 . . . . 63.039999999999999 112.633 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 11.4 pt-20 -149.36 150.09 31.91 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.385 0.612 . . . . 64.439999999999998 112.289 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 106' ' ' MET . 7.8 p -144.0 155.91 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.799 -0.637 . . . . 74.129999999999995 110.568 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.2 t -116.98 115.61 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.623 0.249 . . . . 64.510000000000005 110.722 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.23 168.65 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 116.263 -0.426 . . . . 74.540000000000006 111.668 -175.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -72.83 132.05 43.07 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.827 0.346 . . . . 74.310000000000002 111.364 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.558 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -86.24 121.94 29.54 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 111.978 0.362 . . . . 70.030000000000001 111.978 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -133.78 150.19 51.44 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.213 0.53 . . . . 71.400000000000006 111.319 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -85.41 103.47 14.34 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.947 -0.57 . . . . 44.549999999999997 110.357 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -120.08 -165.81 13.01 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 115.522 0.969 . . . . 64.340000000000003 115.522 -168.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -86.33 77.53 9.48 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.408 0.683 . . . . 64.120000000000005 111.869 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.7 m -149.05 152.37 36.3 Favored Pre-proline 0 N--CA 1.474 0.727 0 CA-C-N 115.443 -0.799 . . . . 75.439999999999998 111.655 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.55 168.52 16.19 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.779 2.32 . . . . 73.200000000000003 112.161 172.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -67.39 144.46 55.78 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.885 -0.509 . . . . 74.450000000000003 111.759 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 75.13 18.92 80.05 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.29 -0.481 . . . . 43.340000000000003 113.376 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.579 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 22.0 ttt -152.92 136.91 16.31 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.264 -0.551 . . . . 75.450000000000003 110.649 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.536 HD11 HG22 ' A' ' 28' ' ' VAL . 37.9 pt -132.53 150.72 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 121.179 0.514 . . . . 72.030000000000001 111.703 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.526 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 59.2 t80 -112.6 130.69 55.94 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.284 -0.416 . . . . 74.200000000000003 111.888 -176.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 30' ' ' SER . 40.1 mt -125.77 132.03 24.19 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 120.59 0.233 . . . . 55.32 110.795 173.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.509 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 51.2 Cg_exo -57.49 141.37 95.07 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.492 2.128 . . . . 74.319999999999993 112.789 176.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.442 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -61.03 103.68 0.3 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.799 0.333 . . . . 65.129999999999995 110.807 -178.524 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.26 -178.68 38.62 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.664 -0.779 . . . . 54.549999999999997 113.109 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.482 ' O ' ' HG2' ' A' ' 106' ' ' MET . 11.2 Cg_endo -54.62 -31.67 71.49 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.949 2.433 . . . . 75.310000000000002 112.668 -177.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.487 ' HA ' HD11 ' A' ' 140' ' ' LEU . 43.2 m-85 -66.09 -50.56 63.67 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.837 0.351 . . . . 70.530000000000001 110.843 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -62.06 -38.4 88.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.007 0.432 . . . . 74.209999999999994 110.778 174.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -53.09 -26.67 17.1 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.106 0.562 . . . . 71.510000000000005 112.241 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.623 ' SD ' HD21 ' A' ' 140' ' ' LEU . 86.9 mmm -73.85 -20.73 60.35 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.097 0.406 . . . . 73.349999999999994 112.097 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.81 -7.24 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 113.1 0.778 . . . . 73.239999999999995 113.1 -173.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.717 HG21 ' HB2' ' A' ' 30' ' ' SER . 11.4 pt -105.7 179.76 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 121.878 -0.514 . . . . 72.310000000000002 111.594 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.589 ' H ' HG21 ' A' ' 123' ' ' VAL . 22.4 t70 -91.11 110.95 45.86 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 116.295 -0.411 . . . . 73.25 110.838 175.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.84 -13.96 21.67 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.365 2.043 . . . . 72.400000000000006 112.625 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.4 m -62.14 -69.22 0.26 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.398 -0.365 . . . . 61.140000000000001 110.885 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.9 p 49.49 -163.87 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 112.719 0.637 . . . . 64.519999999999996 112.719 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -149.06 157.48 43.43 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.628 -0.26 . . . . 74.349999999999994 110.563 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.96 -22.9 60.82 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.301 -0.476 . . . . 63.5 113.844 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.4 p -86.24 -71.87 0.52 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.957 0.378 . . . . 74.420000000000002 111.774 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.07 146.02 18.49 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.405 -0.426 . . . . 70.530000000000001 113.137 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 81.1 mtp -86.88 150.31 49.97 Favored Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 122.507 -0.408 . . . . 70.340000000000003 111.708 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.31 -176.18 3.07 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.501 2.134 . . . . 63.32 112.565 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 64.85 167.02 0.17 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.362 0.601 . . . . 75.420000000000002 112.481 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -73.06 110.69 7.54 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.383 0.611 . . . . 71.439999999999998 111.724 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -146.81 138.92 24.68 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.0 0.428 . . . . 71.239999999999995 111.552 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . -142.9 -177.17 17.65 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.296 -0.478 . . . . 53.409999999999997 112.93 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.589 HG21 ' H ' ' A' ' 109' ' ' ASP . 93.2 t -85.09 126.86 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.913 0.387 . . . . 74.530000000000001 111.324 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 21.7 mtpp -75.08 160.19 30.79 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.771 0.656 . . . . 72.340000000000003 112.771 -174.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.648 ' HA3' HG22 ' A' ' 77' ' ' THR . . . 171.94 -151.53 15.15 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 116.064 -0.516 . . . . 74.230000000000004 113.882 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 70.8 p -137.32 159.82 40.85 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 122.381 -0.482 . . . . 55.420000000000002 111.609 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.9 p -148.88 144.07 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 112.047 0.388 . . . . 74.530000000000001 112.047 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 23' ' ' MET . 9.1 pt-20 -153.35 159.65 42.51 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.881 0.472 . . . . 64.120000000000005 110.904 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -83.31 144.11 29.92 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.147 0.498 . . . . 24.100000000000001 111.377 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.443 HG21 ' HB2' ' A' ' 74' ' ' LYS . 4.0 t -150.03 161.84 41.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.861 -0.609 . . . . 52.520000000000003 111.653 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -76.62 -8.0 56.37 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.394 -0.366 . . . . 73.540000000000006 111.28 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -50.2 152.71 1.66 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.528 0.566 . . . . 71.420000000000002 112.528 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.591 ' HD2' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -87.31 146.75 25.8 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.838 -0.619 . . . . 72.540000000000006 111.604 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 71.9 t -68.84 131.97 33.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.799 0.333 . . . . 61.240000000000002 110.585 172.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.446 HD13 ' HG ' ' A' ' 140' ' ' LEU . 17.9 mt -66.98 147.29 53.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.858 0.361 . . . . 52.43 111.307 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.401 ' HA ' ' HE1' ' A' ' 49' ' ' PHE . 46.7 t -90.44 151.28 21.47 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.248 -0.649 . . . . 65.5 109.248 169.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.494 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 73.8 t -48.91 -47.34 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.002 0.43 . . . . 73.5 111.54 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -72.69 -40.41 66.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.296 -0.411 . . . . 74.230000000000004 111.979 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -60.36 -33.71 72.83 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.849 0.833 . . . . 73.019999999999996 110.249 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.623 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.5 tt -65.62 -39.35 91.4 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.914 -1.039 . . . . 71.319999999999993 110.379 174.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.548 HD21 HG21 ' A' ' 40' ' ' VAL . 57.1 mt -60.22 -47.82 84.35 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.091 0.472 . . . . 72.25 110.386 175.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -57.84 -35.11 70.46 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.879 -0.6 . . . . 72.420000000000002 111.01 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.26 -46.77 66.46 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.166 0.432 . . . . 75.230000000000004 112.166 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.443 HD11 ' HB2' ' A' ' 146' ' ' SER . 2.7 pp -81.57 -4.81 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 112.184 0.439 . . . . 71.400000000000006 112.184 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 86.31 40.28 7.47 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.391 -0.433 . . . . 71.150000000000006 114.147 174.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.443 ' HB2' HD11 ' A' ' 144' ' ' ILE . 48.2 t . . . . . 0 N--CA 1.476 0.833 0 CA-C-N 116.985 0.392 . . . . 53.32 111.286 175.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.878 0.37 . . . . 70.329999999999998 111.549 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -153.08 151.41 23.2 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.289 -0.481 . . . . 62.130000000000003 113.047 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.5 t -153.18 104.24 2.78 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.532 -0.393 . . . . 65.209999999999994 111.289 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.9 p -93.2 79.48 4.5 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.55 0.69 . . . . 70.030000000000001 111.51 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.1 p-80 -87.83 105.04 17.14 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.711 0.767 . . . . 74.030000000000001 110.834 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -102.56 165.9 10.82 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.708 -0.678 . . . . 75.030000000000001 112.616 -172.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -148.64 137.03 21.2 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.704 -0.68 . . . . 74.239999999999995 110.657 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -130.43 101.54 5.78 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.202 0.525 . . . . 74.030000000000001 112.162 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -146.64 141.24 26.68 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.097 -0.501 . . . . 70.120000000000005 110.82 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -150.07 103.75 3.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.162 -0.472 . . . . 71.549999999999997 110.461 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.5 p -137.62 143.85 41.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.032 0.444 . . . . 75.120000000000005 112.04 -175.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.8 m -155.36 146.05 22.22 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.188 -0.46 . . . . 61.450000000000003 110.964 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.3 172.02 31.48 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.117 -0.563 . . . . 53.520000000000003 112.911 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -143.01 108.41 5.04 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.917 0.389 . . . . 73.400000000000006 111.336 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -161.22 92.1 0.89 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.077 0.465 . . . . 73.340000000000003 111.075 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -118.62 107.96 14.36 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.2 -0.454 . . . . 74.209999999999994 111.28 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.94 160.97 14.87 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.004 0.43 . . . . 64.510000000000005 111.409 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -75.97 167.48 21.8 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.87 0.367 . . . . 64.329999999999998 111.762 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -165.52 113.47 0.98 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.321 -0.4 . . . . 72.239999999999995 110.827 175.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -125.54 128.41 47.92 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.555 -0.293 . . . . 71.439999999999998 111.413 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -175.39 162.87 32.53 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 116.269 -0.423 . . . . 64.409999999999997 112.671 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -157.79 98.53 1.64 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.964 0.412 . . . . 72.439999999999998 111.549 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.721 ' HA ' ' HB3' ' A' ' 128' ' ' GLU . 10.0 ptp -81.86 154.6 25.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.603 0.716 . . . . 65.349999999999994 112.477 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.604 HD13 ' HB3' ' A' ' 61' ' ' ASP . 10.0 mt -103.11 131.68 49.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.289 -0.869 . . . . 73.5 110.838 175.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -78.01 106.8 10.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.052 0.929 . . . . 74.129999999999995 111.176 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.429 HG12 ' HA2' ' A' ' 94' ' ' GLY . 32.9 m -132.58 166.85 28.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.392 -1.276 . . . . 73.230000000000004 111.947 -170.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 31.1 tt0 -103.4 123.05 46.12 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.115 0.483 . . . . 75.109999999999999 110.891 171.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.531 HG22 HD11 ' A' ' 96' ' ' ILE . 36.7 t -93.74 114.08 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 115.917 -0.583 . . . . 63.130000000000003 111.725 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.493 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 3.1 mt -98.99 161.5 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 112.244 0.461 . . . . 65.549999999999997 112.244 -176.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.63 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 75.0 m -127.76 105.65 8.6 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.242 -0.436 . . . . 62.530000000000001 110.907 174.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.404 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . -108.1 135.24 12.69 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.174 -0.536 . . . . 73.25 113.593 -176.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.486 ' HD3' ' HA ' ' A' ' 35' ' ' ASN . 39.1 ttm180 -64.79 95.84 0.16 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.668 0.618 . . . . 74.519999999999996 112.668 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 47.0 p -89.28 -19.59 25.14 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.319 -0.401 . . . . 73.109999999999999 110.683 170.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.1 mt -111.08 113.22 25.6 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.962 -0.563 . . . . 61.329999999999998 110.207 174.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 88.2 m-20 -80.25 -24.38 40.17 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.302 0.482 . . . . 63.43 112.302 -176.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -70.56 114.91 9.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.821 0.343 . . . . 75.140000000000001 111.207 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -75.58 72.0 1.78 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.821 -0.704 . . . . 72.019999999999996 112.874 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.622 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . . . -114.53 172.27 7.13 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.123 0.487 . . . . 73.340000000000003 111.603 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.6 p -86.27 163.42 17.74 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.23 -0.441 . . . . 74.230000000000004 111.348 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.7 t -58.85 -38.59 73.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.279 0.561 . . . . 74.030000000000001 110.257 173.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -58.78 -44.09 90.58 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.559 -0.746 . . . . 63.299999999999997 111.226 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 4.5 tp10 -60.32 -32.57 71.36 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.236 0.541 . . . . 74.349999999999994 111.847 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.622 ' HE2' ' HB3' ' A' ' 38' ' ' ALA . 65.9 mttm -112.58 31.44 6.34 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.756 0.651 . . . . 74.310000000000002 112.756 -174.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.3 mt -64.11 83.8 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.235 0.541 . . . . 64.019999999999996 111.331 175.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 t -170.71 -179.25 2.83 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.773 -0.649 . . . . 74.310000000000002 111.079 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -58.09 -26.67 62.87 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 111.924 0.342 . . . . 63.299999999999997 111.924 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -54.15 -40.91 67.87 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.826 0.346 . . . . 74.209999999999994 111.366 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.625 ' HE2' ' HD3' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -76.05 -23.02 55.07 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.989 0.423 . . . . 73.019999999999996 111.405 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.435 ' CD2' ' ND2' ' A' ' 53' ' ' ASN . 38.4 t80 -75.2 -69.34 0.48 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.325 0.583 . . . . 74.109999999999999 111.116 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -63.51 -8.19 8.84 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.943 0.72 . . . . 72.319999999999993 112.943 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.03 -34.28 13.77 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.632 0.975 . . . . 60.509999999999998 113.632 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 48' ' ' TYR . 28.8 m -131.92 7.58 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 N-CA-C 114.014 1.116 . . . . 75.319999999999993 114.014 -173.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.435 ' ND2' ' CD2' ' A' ' 49' ' ' PHE . 3.6 m-20 -90.71 20.58 4.59 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.105 0.78 . . . . 71.519999999999996 113.105 -174.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.442 ' CD2' ' HD3' ' A' ' 87' ' ' LYS . 26.3 p90 -140.1 152.75 46.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.166 0.507 . . . . 71.239999999999995 111.829 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -119.44 135.63 54.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.703 -0.681 . . . . 72.5 110.1 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.524 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 36.0 mt-10 -97.47 115.11 27.17 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.89 0.376 . . . . 73.329999999999998 111.085 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 58' ' ' ASN . 4.2 mp -109.13 156.73 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.169 0.509 . . . . 74.030000000000001 110.734 -177.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.659 ' ND2' HG23 ' A' ' 91' ' ' VAL . 3.1 m120 -63.57 151.78 40.54 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.893 -0.594 . . . . 71.340000000000003 111.308 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 30.1 tt0 -67.16 -41.3 86.25 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 111.847 0.314 . . . . 75.530000000000001 111.847 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -63.9 -49.54 72.26 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.84 0.352 . . . . 75.420000000000002 111.178 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.604 ' HB3' HD13 ' A' ' 24' ' ' LEU . 58.8 m-20 -65.96 -31.02 71.69 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.05 0.452 . . . . 72.349999999999994 111.349 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.427 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 62.7 t-105 -54.45 -54.58 38.93 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.308 0.575 . . . . 74.140000000000001 111.22 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -70.66 -29.8 66.24 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.993 -0.549 . . . . 52.310000000000002 111.14 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.76 -39.36 84.58 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.917 0.389 . . . . 35.25 111.453 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 128' ' ' GLU . 94.0 mt -88.54 -13.25 40.59 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.447 -0.342 . . . . 73.239999999999995 111.748 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.24 42.61 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.98 -0.628 . . . . 55.130000000000003 112.439 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.723 HD23 ' HE3' ' A' ' 129' ' ' LYS . 90.5 mt -85.36 158.79 20.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.611 0.72 . . . . 73.409999999999997 112.026 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -135.09 130.0 34.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.26 -0.882 . . . . 75.010000000000005 109.062 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.81 90.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.712 0.768 . . . . 61.340000000000003 111.917 -172.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.68 -7.33 2.47 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 114.765 -1.107 . . . . 74.109999999999999 114.38 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -90.71 -175.6 4.45 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 118.527 1.163 . . . . 73.439999999999998 112.735 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.484 ' HG3' HG23 ' A' ' 134' ' ' VAL . 8.5 mpt_? -106.05 133.87 50.08 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.261 0.553 . . . . 73.299999999999997 112.426 -172.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 86' ' ' ALA . 28.1 m -126.25 144.39 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.021 -0.536 . . . . 74.25 111.392 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.623 ' HD3' ' HE2' ' A' ' 76' ' ' LYS . 23.1 ttmm -105.32 151.06 24.62 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.111 0.481 . . . . 74.019999999999996 110.934 177.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.45 137.24 56.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.907 -0.588 . . . . 74.340000000000003 109.491 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.623 ' HE2' ' HD3' ' A' ' 74' ' ' LYS . 23.4 mttm -137.83 132.33 32.44 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.757 0.651 . . . . 61.299999999999997 112.757 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.537 HG22 ' HA3' ' A' ' 125' ' ' GLY . 32.8 p -136.09 -171.75 2.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.62 -0.718 . . . . 72.150000000000006 110.19 176.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.29 -8.92 57.93 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.796 0.331 . . . . 73.049999999999997 111.501 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -91.3 -38.5 12.61 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.777 0.322 . . . . 71.329999999999998 111.493 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.26 -148.27 11.96 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.127 -0.559 . . . . 24.23 112.994 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -154.5 156.74 37.24 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.254 0.465 . . . . 54.149999999999999 112.254 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -153.49 150.34 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 116.213 -0.448 . . . . 64.5 111.288 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.2 t -110.58 118.02 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 110.399 -0.223 . . . . 74.5 110.399 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.483 HG12 ' CD2' ' A' ' 103' ' ' TYR . 33.6 m -124.78 177.24 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 120.808 0.337 . . . . 72.519999999999996 111.78 -177.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -79.73 144.88 33.25 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.853 0.359 . . . . 72.209999999999994 111.351 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.536 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -90.27 123.5 34.11 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.482 0.549 . . . . 72.109999999999999 112.482 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.442 ' HD3' ' CD2' ' A' ' 54' ' ' TYR . 43.3 mtpt -133.21 156.75 46.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.021 -0.536 . . . . 61.030000000000001 110.734 173.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -98.15 128.71 44.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.218 -0.446 . . . . 73.340000000000003 111.291 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.524 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -128.35 154.52 20.0 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.976 -0.63 . . . . 62.32 113.47 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.32 46.75 0.75 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.158 0.504 . . . . 44.340000000000003 111.54 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.659 HG23 ' ND2' ' A' ' 58' ' ' ASN . 28.5 m -95.58 159.79 31.83 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 116.09 -0.505 . . . . 72.010000000000005 111.564 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.432 ' O ' ' HB3' ' A' ' 95' ' ' MET . 38.6 Cg_exo -62.1 134.24 48.25 Favored 'Trans proline' 0 N--CA 1.487 1.104 0 C-N-CA 122.887 2.391 . . . . 65.0 113.059 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -53.79 134.5 42.32 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 120.775 0.322 . . . . 74.430000000000007 111.821 -175.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.429 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 76.49 27.88 60.61 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 120.722 -0.752 . . . . 73.25 112.745 -172.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.537 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 22.3 ttt -153.39 135.07 14.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.448 -0.575 . . . . 64.409999999999997 109.448 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.531 HD11 HG22 ' A' ' 28' ' ' VAL . 39.5 pt -128.03 144.27 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.47 0.652 . . . . 70.310000000000002 112.093 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.404 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 77.2 t80 -105.3 119.55 39.35 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.909 -0.587 . . . . 71.420000000000002 111.564 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.63 ' O ' ' HA ' ' A' ' 30' ' ' SER . 48.2 mt -117.34 128.96 25.67 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 109.916 -0.401 . . . . 64.239999999999995 109.916 172.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.455 ' HB2' HG12 ' A' ' 52' ' ' VAL . 47.8 Cg_exo -57.84 141.8 96.01 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.033 1.822 . . . . 73.409999999999997 112.576 176.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.6 tpt -55.29 102.38 0.07 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.91 0.386 . . . . 72.430000000000007 111.501 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -158.97 179.65 34.46 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.59 -0.814 . . . . 74.540000000000006 113.52 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.625 ' HD3' ' HE2' ' A' ' 48' ' ' TYR . 36.5 Cg_endo -63.54 -26.44 69.8 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.529 2.152 . . . . 73.0 112.213 -176.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.483 ' CD2' HG12 ' A' ' 84' ' ' VAL . 26.9 m-85 -61.49 -48.99 78.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.784 0.802 . . . . 73.329999999999998 109.309 173.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.28 75.25 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.221 -0.899 . . . . 73.150000000000006 111.391 173.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' A' ' 102' ' ' PRO . 8.7 m120 -62.92 -12.69 26.92 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 122.045 -0.409 . . . . 65.329999999999998 111.844 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.51 ' SD ' HD21 ' A' ' 140' ' ' LEU . 40.6 mtp -89.41 -15.02 34.18 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.576 -0.283 . . . . 75.019999999999996 111.464 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.8 -14.75 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 113.028 0.751 . . . . 73.310000000000002 113.028 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.505 HG21 ' OG ' ' A' ' 30' ' ' SER . 7.5 pt -104.25 178.16 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 O-C-N 121.854 -0.529 . . . . 75.519999999999996 111.861 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -91.12 111.19 47.23 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 116.084 -0.507 . . . . 74.120000000000005 110.52 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -85.45 7.16 5.25 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.494 2.129 . . . . 73.040000000000006 113.764 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.6 t -100.2 -19.83 16.22 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.426 0.528 . . . . 73.400000000000006 112.426 -175.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.8 t -61.2 149.01 38.94 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.619 0.6 . . . . 63.140000000000001 112.619 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -114.72 24.46 11.78 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.725 -0.671 . . . . 70.040000000000006 110.958 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.53 79.6 0.17 Allowed Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.275 -0.42 . . . . 52.420000000000002 113.89 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 68.9 p -100.03 16.0 25.42 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.65 -0.324 . . . . 64.329999999999998 111.783 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.94 -127.6 0.1 Allowed Glycine 0 CA--C 1.529 0.94 0 N-CA-C 114.631 0.612 . . . . 70.319999999999993 114.631 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 79.2 mtp -100.6 155.24 36.58 Favored Pre-proline 0 CA--C 1.539 0.543 0 O-C-N 122.457 -0.437 . . . . 62.140000000000001 111.758 -174.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -56.64 117.17 3.8 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.833 2.355 . . . . 62.310000000000002 113.319 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -137.73 126.84 24.39 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.179 -0.464 . . . . 61.039999999999999 110.399 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -75.83 82.23 2.76 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.702 0.63 . . . . 74.200000000000003 112.702 -174.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -154.18 145.98 23.41 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.133 -0.485 . . . . 74.439999999999998 111.385 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . -140.15 -164.16 9.79 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 116.064 -0.516 . . . . 54.530000000000001 112.982 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.4 t -89.04 123.69 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.816 0.341 . . . . 74.319999999999993 111.636 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 67.5 mttm -66.28 149.54 50.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.573 0.582 . . . . 73.510000000000005 112.573 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.537 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -178.65 -155.86 15.59 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 115.926 -0.579 . . . . 55.520000000000003 112.963 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.42 HG21 ' SD ' ' A' ' 23' ' ' MET . 67.7 p -131.87 159.72 37.76 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 122.244 -0.562 . . . . 64.120000000000005 111.863 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.75 144.44 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 116.31 -0.405 . . . . 71.109999999999999 111.681 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.721 ' HB3' ' HA ' ' A' ' 23' ' ' MET . 13.8 pt-20 -164.84 168.61 17.56 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.314 -0.403 . . . . 72.340000000000003 111.015 173.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.723 ' HE3' HD23 ' A' ' 67' ' ' LEU . 34.7 ttmt -68.75 148.54 50.21 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.222 0.534 . . . . 71.439999999999998 112.182 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 t -146.19 155.95 43.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.088 -0.505 . . . . 74.340000000000003 111.126 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.31 -2.61 58.51 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.139 0.495 . . . . 72.129999999999995 110.99 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.89 173.32 3.67 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.667 0.617 . . . . 53.109999999999999 112.667 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -88.86 148.55 23.81 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.845 -0.616 . . . . 64.319999999999993 111.867 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.484 HG23 ' HG3' ' A' ' 72' ' ' ARG . 73.4 t -69.76 124.32 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.049 -0.523 . . . . 62.119999999999997 109.854 170.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 135' ' ' LEU . 10.3 mt -70.57 89.66 0.72 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.967 -0.293 . . . . 61.409999999999997 111.502 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 37.5 m -47.8 148.62 1.52 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.078 -0.51 . . . . 71.120000000000005 110.816 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.494 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 72.0 t -44.8 -45.15 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 112.465 0.543 . . . . 72.340000000000003 112.465 -173.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -72.15 -47.85 47.93 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.79 0.329 . . . . 55.240000000000002 111.712 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -55.91 -38.23 69.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.233 0.539 . . . . 61.409999999999997 110.501 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.51 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.7 tt -61.18 -42.3 98.33 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.465 -0.788 . . . . 72.319999999999993 111.09 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 31.1 mt -56.83 -47.48 80.21 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.549 0.69 . . . . 64.430000000000007 110.387 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -77.04 -30.7 55.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.551 -0.75 . . . . 72.450000000000003 111.712 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.42 -41.4 97.09 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.753 0.279 . . . . 73.129999999999995 111.753 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.9 pt -75.84 -7.83 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.091 0.404 . . . . 71.450000000000003 112.091 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 109.43 9.01 26.11 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.193 -0.527 . . . . 63.439999999999998 114.155 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 121.621 0.725 . . . . 55.039999999999999 111.775 179.532 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.571 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.803 0.335 . . . . 75.400000000000006 111.826 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.45 137.07 4.46 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.116 -0.564 . . . . 63.43 112.79 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.5 m -157.7 167.0 31.31 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.97 0.414 . . . . 71.5 111.952 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.8 p -163.21 161.93 25.16 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.144 0.497 . . . . 62.32 111.881 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -124.91 138.24 54.25 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.976 -0.556 . . . . 75.230000000000004 110.112 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -128.03 132.16 49.12 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.691 0.626 . . . . 70.340000000000003 112.691 -166.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -170.63 121.98 0.61 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.293 -0.412 . . . . 64.310000000000002 111.313 174.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -96.55 -55.06 3.04 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 122.252 -0.28 . . . . 71.409999999999997 110.956 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 86.0 t60 43.38 88.89 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.503 1.297 . . . . 75.540000000000006 114.503 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -153.21 172.55 16.79 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.031 0.443 . . . . 53.350000000000001 111.788 174.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.9 p -150.71 -174.39 4.76 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.131 -0.486 . . . . 71.120000000000005 111.294 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.1 t -147.7 170.66 17.07 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 120.827 0.346 . . . . 71.219999999999999 111.552 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -119.2 149.3 18.12 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.631 -0.318 . . . . 65.129999999999995 112.617 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -101.25 -89.8 0.35 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 117.153 0.476 . . . . 70.329999999999998 112.002 -176.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 64.98 114.94 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 112.792 0.664 . . . . 75.409999999999997 112.792 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -140.72 112.95 7.86 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.367 -0.379 . . . . 72.010000000000005 111.154 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mp -105.25 166.61 10.29 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.826 0.676 . . . . 74.299999999999997 112.826 -176.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.64 167.34 20.25 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.895 -0.593 . . . . 73.530000000000001 111.374 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -123.42 179.85 4.59 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.2 -0.455 . . . . 71.129999999999995 110.96 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -135.5 143.22 45.68 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.084 0.469 . . . . 74.329999999999998 112.059 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.42 178.68 32.65 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.374 -0.441 . . . . 63.119999999999997 113.609 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -79.96 76.73 6.67 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.077 0.465 . . . . 54.219999999999999 111.064 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.0 ptm -87.49 148.65 24.84 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.158 -0.474 . . . . 64.519999999999996 110.444 174.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.1 mt -106.6 124.52 49.73 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.184 0.809 . . . . 72.150000000000006 113.184 -173.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -72.06 102.55 3.01 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.601 -1.182 . . . . 71.430000000000007 110.444 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.39 166.16 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.005 0.431 . . . . 75.209999999999994 111.898 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.636 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 37.1 tt0 -99.84 115.99 30.88 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.807 0.337 . . . . 72.329999999999998 110.436 172.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.559 HG22 HD11 ' A' ' 96' ' ' ILE . 21.2 t -90.46 110.96 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.077 -0.511 . . . . 74.319999999999993 111.724 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 mt -100.09 153.22 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 120.838 0.351 . . . . 72.219999999999999 111.651 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.1 t -120.07 103.63 9.45 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.903 0.383 . . . . 73.239999999999995 110.581 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -98.58 128.83 9.69 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 121.076 -0.583 . . . . 74.25 113.171 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -72.35 92.1 1.39 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.394 0.616 . . . . 75.140000000000001 111.248 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.0 p -92.53 -49.83 5.92 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.786 -0.643 . . . . 70.319999999999993 112.08 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.14 98.4 0.06 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.954 0.407 . . . . 61.340000000000003 111.655 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -62.77 -11.49 18.07 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.219 -0.446 . . . . 74.099999999999994 111.855 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -51.84 -32.72 32.99 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.232 0.456 . . . . 73.150000000000006 112.232 175.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.72 69.35 1.31 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.037 -0.602 . . . . 72.230000000000004 112.627 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.454 ' HB3' ' HD2' ' A' ' 43' ' ' LYS . . . -166.63 168.77 14.2 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.634 -0.333 . . . . 71.120000000000005 111.568 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.5 p -76.06 -173.31 2.3 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.872 0.368 . . . . 64.530000000000001 110.557 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.569 ' HA ' ' CE2' ' A' ' 48' ' ' TYR . 14.3 p -71.98 -29.61 33.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.735 0.303 . . . . 71.329999999999998 111.368 175.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -63.86 -38.2 90.22 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.127 0.417 . . . . 75.409999999999997 112.127 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.48 -32.15 73.61 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.586 0.588 . . . . 71.109999999999999 112.586 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.606 ' HB2' ' HD2' ' A' ' 48' ' ' TYR . 1.2 mppt? -122.29 51.63 1.36 Allowed 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.981 -0.449 . . . . 53.109999999999999 112.15 -175.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.0 mt -70.94 86.47 0.71 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.265 0.555 . . . . 45.539999999999999 111.403 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.8 t -157.14 173.9 16.29 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.729 -0.669 . . . . 73.25 111.294 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -64.75 -29.97 70.97 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.805 0.336 . . . . 75.099999999999994 111.469 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -58.65 -26.25 63.58 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.951 0.405 . . . . 73.230000000000004 111.237 176.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.606 ' HD2' ' HB2' ' A' ' 43' ' ' LYS . 2.6 t80 -76.34 -38.17 56.28 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.461 0.648 . . . . 70.519999999999996 110.026 174.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -58.02 -62.94 1.45 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.425 -0.807 . . . . 72.109999999999999 110.435 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -70.68 0.89 6.07 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.54 0.57 . . . . 53.310000000000002 112.54 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.43 -34.64 11.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.59 0.589 . . . . 72.329999999999998 112.59 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.495 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 32.9 m -125.06 2.29 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 113.832 1.049 . . . . 73.420000000000002 113.832 -174.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -89.76 34.22 0.84 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.005 0.743 . . . . 61.100000000000001 113.005 -176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -150.24 159.31 44.53 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.626 -0.671 . . . . 73.319999999999993 112.448 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.27 132.4 45.91 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.949 -0.569 . . . . 41.530000000000001 110.9 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.763 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 35.2 mt-10 -87.86 114.96 24.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.208 0.528 . . . . 65.120000000000005 111.016 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.7 mt -111.49 148.46 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.582 -0.735 . . . . 72.209999999999994 111.478 -174.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -70.24 140.8 52.48 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 122.391 -0.193 . . . . 74.319999999999993 110.7 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 37.3 tt0 -54.71 -37.75 66.22 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.084 0.772 . . . . 74.329999999999998 113.084 -177.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 6.6 mm-40 -56.67 -53.59 55.96 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.152 -0.342 . . . . 74.299999999999997 111.485 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -63.31 -38.11 89.89 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.368 0.604 . . . . 51.329999999999998 110.447 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.43 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 52.5 t-105 -53.65 -45.63 70.3 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.36 -0.836 . . . . 75.549999999999997 111.513 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -69.87 -41.96 74.13 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.232 -0.44 . . . . 75.200000000000003 110.917 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.3 82.89 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.546 0.573 . . . . 70.340000000000003 112.546 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.405 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 89.4 mt -86.98 -6.16 58.85 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.319 -0.4 . . . . 72.299999999999997 111.799 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.09 50.62 64.42 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.505 -0.379 . . . . 52.210000000000001 112.848 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.405 ' HG ' ' HB2' ' A' ' 65' ' ' LEU . 97.8 mt -90.88 160.3 15.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.473 0.654 . . . . 73.040000000000006 112.709 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.5 mp0 -125.32 143.24 51.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.015 -0.993 . . . . 74.299999999999997 110.419 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.16 94.88 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.599 0.714 . . . . 61.350000000000001 111.118 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.62 -6.69 7.47 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.133 -0.939 . . . . 24.219999999999999 114.182 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.44 -177.48 5.79 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.301 1.05 . . . . 54.329999999999998 111.678 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.424 ' HG3' HG23 ' A' ' 134' ' ' VAL . 2.8 mpt_? -105.8 123.48 48.03 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.329 0.492 . . . . 74.299999999999997 112.329 -174.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.632 HG13 ' HB2' ' A' ' 86' ' ' ALA . 26.6 m -114.21 148.71 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.044 -0.525 . . . . 70.349999999999994 110.871 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.448 ' HB2' HG21 ' A' ' 130' ' ' THR . 68.5 tttt -120.62 130.34 54.11 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.025 0.441 . . . . 74.319999999999993 111.261 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.9 134.84 49.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.27 -0.423 . . . . 74.109999999999999 111.356 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -125.91 140.53 52.56 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.925 0.393 . . . . 70.430000000000007 111.555 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.6 p -138.41 -172.22 3.23 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.952 0.501 . . . . 73.25 110.122 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.6 2.28 17.03 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.961 0.41 . . . . 63.109999999999999 111.29 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -101.18 -35.31 9.34 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.575 0.35 . . . . 72.230000000000004 111.455 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 163.45 -155.8 27.31 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.175 -0.536 . . . . 61.219999999999999 113.35 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.99 160.26 40.46 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.101 0.408 . . . . 64.439999999999998 112.101 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.5 p -160.57 150.61 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-N 116.041 -0.527 . . . . 62.240000000000002 111.296 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.435 HG22 ' HG3' ' A' ' 74' ' ' LYS . 33.1 t -109.9 123.49 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.22 0.208 . . . . 64.219999999999999 111.304 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.485 ' HA ' HG13 ' A' ' 134' ' ' VAL . 27.5 m -133.38 172.21 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.652 0.381 . . . . 40.210000000000001 111.627 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -75.91 143.73 41.5 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.145 0.498 . . . . 75.310000000000002 111.792 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.632 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -84.59 128.36 34.56 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.057 -0.52 . . . . 63.219999999999999 112.388 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -129.94 158.3 39.92 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.655 0.74 . . . . 75.120000000000005 111.887 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -101.44 102.49 13.29 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.256 -0.884 . . . . 73.219999999999999 109.617 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.763 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -99.64 -167.28 29.7 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.982 -0.627 . . . . 71.5 114.581 -170.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.53 9.37 42.61 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 122.846 0.459 . . . . 73.540000000000006 111.545 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.6 m -79.56 158.58 73.41 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 116.311 -0.404 . . . . 70.219999999999999 111.793 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.65 169.6 21.96 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.573 2.182 . . . . 63.43 112.653 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.511 ' HE2' ' HB3' ' A' ' 60' ' ' GLU . 49.2 tttm -65.91 148.75 51.3 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 120.732 0.301 . . . . 74.540000000000006 111.589 -177.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.12 30.46 76.93 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.261 -0.495 . . . . 61.340000000000003 112.816 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.636 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 13.2 ttt -153.63 136.97 15.75 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 122.62 -0.341 . . . . 70.129999999999995 110.319 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.559 HD11 HG22 ' A' ' 28' ' ' VAL . 40.3 pt -134.55 138.93 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.472 0.653 . . . . 73.400000000000006 112.021 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -101.44 123.37 45.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.722 -0.672 . . . . 74.540000000000006 111.176 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 30' ' ' SER . 40.2 mt -121.04 127.62 26.12 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 122.277 -0.265 . . . . 73.310000000000002 110.877 175.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.495 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 14.0 Cg_endo -57.37 142.42 95.0 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.476 2.117 . . . . 74.340000000000003 112.708 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.14 103.34 0.27 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.267 -0.424 . . . . 75.200000000000003 111.074 -176.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.69 -178.53 31.82 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.883 -0.675 . . . . 42.119999999999997 112.528 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.573 ' O ' ' HG2' ' A' ' 106' ' ' MET . 23.9 Cg_endo -60.71 -31.35 91.88 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.435 2.09 . . . . 60.210000000000001 111.695 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.499 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 4.8 m-85 -62.58 -53.4 55.15 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.612 -0.722 . . . . 74.140000000000001 110.314 175.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.31 -43.59 88.21 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.051 -0.522 . . . . 50.530000000000001 110.756 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -54.21 -26.39 28.18 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.014 0.526 . . . . 72.109999999999999 112.2 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.573 ' HG2' ' O ' ' A' ' 102' ' ' PRO . 84.6 mmm -66.58 -21.41 66.14 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.191 0.441 . . . . 63.119999999999997 112.191 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.7 m -132.08 -27.48 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 112.87 0.692 . . . . 64.439999999999998 112.87 -172.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' A' ' 30' ' ' SER . 1.5 pp -87.02 170.09 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-O 121.033 0.444 . . . . 64.329999999999998 111.308 -176.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.419 ' OD2' ' HB2' ' A' ' 111' ' ' SER . 12.6 t0 -99.76 117.09 64.16 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.382 -0.372 . . . . 70.420000000000002 111.131 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -66.42 -2.91 7.99 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.81 2.34 . . . . 63.340000000000003 113.756 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.419 ' HB2' ' OD2' ' A' ' 109' ' ' ASP . 16.5 m -77.98 22.91 0.27 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.009 0.374 . . . . 64.030000000000001 112.009 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.3 p -61.07 148.17 41.3 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.963 0.411 . . . . 73.019999999999996 112.037 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -58.45 128.16 35.77 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.75 0.648 . . . . 71.299999999999997 112.75 -172.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.75 -20.07 79.65 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.828 -0.701 . . . . 74.409999999999997 111.673 171.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 72.2 p -92.81 -75.32 0.49 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.625 0.37 . . . . 74.040000000000006 111.614 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 150.37 140.6 3.24 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 121.387 -0.435 . . . . 62.100000000000001 113.049 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.401 ' HA ' ' HD3' ' A' ' 118' ' ' PRO . 84.0 mmm -125.77 149.23 64.94 Favored Pre-proline 0 N--CA 1.473 0.703 0 O-C-N 122.632 -0.334 . . . . 72.019999999999996 111.755 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 117' ' ' MET . 7.1 Cg_exo -73.78 165.26 32.68 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.909 2.406 . . . . 45.340000000000003 112.138 173.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 64.74 -165.43 0.24 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.066 0.46 . . . . 73.340000000000003 111.47 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -115.57 124.35 50.77 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.835 0.35 . . . . 71.530000000000001 111.136 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -124.71 107.65 11.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.084 0.468 . . . . 64.129999999999995 111.416 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -125.74 167.94 17.99 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 116.3 -0.409 . . . . 60.439999999999998 112.676 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.0 t -80.8 126.14 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.019 0.377 . . . . 41.009999999999998 112.019 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -62.32 145.78 52.89 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.152 0.427 . . . . 75.109999999999999 112.152 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -174.12 -163.42 27.49 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.393 -0.432 . . . . 42.329999999999998 112.884 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 54.5 p -126.24 142.69 51.43 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.628 -0.336 . . . . 61.520000000000003 111.3 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.0 p -132.01 143.25 40.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 120.9 0.381 . . . . 34.399999999999999 110.76 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.45 169.68 19.99 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.354 -0.385 . . . . 65.519999999999996 110.974 176.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -69.84 141.26 53.29 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.103 -0.373 . . . . 71.209999999999994 110.87 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 74' ' ' LYS . 10.1 t -132.4 161.4 33.73 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.348 0.594 . . . . 74.430000000000007 112.187 -177.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.03 -18.02 41.24 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.642 -0.708 . . . . 73.219999999999999 111.11 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -69.68 152.51 44.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.581 0.705 . . . . 75.299999999999997 112.513 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.718 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -79.49 160.33 26.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.232 -0.894 . . . . 54.549999999999997 110.696 173.394 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.485 HG13 ' HA ' ' A' ' 84' ' ' VAL . 98.5 t -65.96 126.53 25.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 O-C-N 122.346 -0.222 . . . . 74.099999999999994 110.533 174.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.451 HD13 ' HG ' ' A' ' 140' ' ' LEU . 7.2 mt -56.06 131.83 48.53 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.07 0.462 . . . . 52.439999999999998 112.077 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.9 m -71.94 140.68 49.3 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.697 -0.482 . . . . 64.329999999999998 109.697 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.43 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 89.3 t -46.48 -49.45 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 112.54 0.57 . . . . 71.310000000000002 112.54 -175.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -71.78 -42.53 67.04 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.944 0.402 . . . . 73.349999999999994 111.327 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -55.98 -34.64 65.94 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.682 0.753 . . . . 72.0 110.581 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.451 ' HG ' HD13 ' A' ' 135' ' ' LEU . 2.6 tt -65.89 -42.5 90.19 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.249 -0.887 . . . . 75.430000000000007 110.827 174.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 29.3 mt -59.69 -36.53 76.68 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.373 0.606 . . . . 73.140000000000001 110.622 177.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -74.31 -39.53 62.82 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.718 -0.674 . . . . 75.420000000000002 110.944 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.42 -37.13 79.9 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.645 0.609 . . . . 73.349999999999994 112.645 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.511 HD12 ' H ' ' A' ' 146' ' ' SER . 2.9 pp -75.67 -1.68 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 112.7 0.63 . . . . 72.230000000000004 112.7 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 117.15 -60.51 0.44 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.461 -0.4 . . . . 34.439999999999998 113.281 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.511 ' H ' HD12 ' A' ' 144' ' ' ILE . 41.6 t . . . . . 0 N--CA 1.475 0.79 0 C-N-CA 122.673 0.389 . . . . 74.5 112.036 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.494 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.744 0.307 . . . . 72.329999999999998 111.247 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.32 154.92 30.03 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.063 -0.589 . . . . 52.130000000000003 113.475 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.8 p -150.88 -173.7 4.56 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.433 0.293 . . . . 61.020000000000003 110.557 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.2 t -143.21 159.72 41.78 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.252 0.548 . . . . 63.119999999999997 112.325 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -152.24 126.33 9.16 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.826 -0.625 . . . . 64.430000000000007 110.667 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -166.64 124.8 1.39 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.852 0.358 . . . . 53.409999999999997 111.864 -175.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -151.62 107.57 3.4 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.182 0.515 . . . . 74.439999999999998 112.017 177.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -128.32 97.66 4.81 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.149 0.5 . . . . 72.239999999999995 110.81 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -132.47 123.54 26.83 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.145 -0.479 . . . . 71.329999999999998 110.671 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -154.45 131.45 10.93 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 111.867 0.321 . . . . 71.209999999999994 111.867 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.0 t -142.52 122.55 13.67 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.54 -0.3 . . . . 75.319999999999993 110.879 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.0 p -110.48 158.99 17.91 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.462 0.542 . . . . 74.209999999999994 112.462 -175.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.9 143.43 5.58 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.871 -0.604 . . . . 60.32 112.017 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -141.97 98.52 3.35 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 117.414 0.607 . . . . 72.329999999999998 112.633 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.81 155.55 23.84 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.865 0.364 . . . . 72.209999999999994 111.399 173.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -136.7 120.54 17.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.118 0.485 . . . . 72.329999999999998 112.063 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.4 mp -127.37 176.25 7.58 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.319 -0.4 . . . . 75.0 111.024 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -161.57 176.83 10.61 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.948 0.404 . . . . 75.010000000000005 111.578 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -105.63 118.33 36.31 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.27 -0.423 . . . . 72.430000000000007 110.454 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -89.21 -40.49 12.83 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.424 0.527 . . . . 74.299999999999997 112.424 -175.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -149.15 129.36 3.03 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.666 -0.778 . . . . 71.329999999999998 113.417 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -145.36 88.28 1.85 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.977 0.418 . . . . 72.109999999999999 111.626 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.7 ptm -83.81 160.57 21.17 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.927 0.394 . . . . 72.120000000000005 111.425 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.6 mt -115.52 146.2 41.92 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.914 0.387 . . . . 73.010000000000005 111.86 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -92.4 125.21 36.95 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.389 0.614 . . . . 70.239999999999995 111.233 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 27.5 m -142.14 160.64 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.22 -0.9 . . . . 53.020000000000003 111.882 -173.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 34.6 tt0 -98.49 116.9 31.72 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.045 -0.409 . . . . 74.310000000000002 110.53 173.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.615 HG22 HD11 ' A' ' 96' ' ' ILE . 47.1 t -88.25 106.44 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.91 -0.586 . . . . 51.530000000000001 111.627 -176.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.722 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 15.0 mt -91.91 158.1 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.837 0.351 . . . . 73.049999999999997 111.888 -177.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 62.2 m -140.29 94.47 2.75 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.085 0.469 . . . . 62.25 111.861 177.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.34 126.41 7.71 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.98 -0.555 . . . . 64.319999999999993 112.072 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -66.47 94.99 0.3 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.601 0.715 . . . . 72.540000000000006 111.58 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.5 p -101.97 -64.05 1.1 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.653 -0.703 . . . . 71.319999999999993 111.18 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.402 ' CD2' ' HA ' ' A' ' 48' ' ' TYR . 8.4 mp -92.84 7.95 41.63 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.125 0.417 . . . . 72.329999999999998 112.125 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -76.85 65.51 2.57 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.48 0.657 . . . . 71.349999999999994 110.056 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -83.29 21.09 1.18 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.592 0.59 . . . . 74.200000000000003 112.592 -173.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.48 53.86 5.8 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.372 -0.918 . . . . 72.540000000000006 112.4 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.6 160.89 34.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.713 0.292 . . . . 72.439999999999998 111.024 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.529 ' OG1' ' HG2' ' A' ' 42' ' ' GLU . 43.4 p -78.82 162.13 26.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.881 -0.415 . . . . 70.409999999999997 109.881 172.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.486 HG13 ' CE1' ' A' ' 48' ' ' TYR . 25.7 t -62.76 -31.72 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.055 0.455 . . . . 61.240000000000002 111.083 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.493 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 40.4 mt-10 -74.87 -14.61 60.69 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.922 -0.581 . . . . 60.109999999999999 112.233 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.529 ' HG2' ' OG1' ' A' ' 39' ' ' THR . 32.8 mm-40 -67.94 -28.52 67.55 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.176 0.512 . . . . 63.439999999999998 110.776 173.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.412 ' HB3' HG22 ' A' ' 45' ' ' THR . 4.9 mptp? -99.61 -68.06 0.82 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.05 -0.523 . . . . 72.219999999999999 111.823 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.493 ' HG ' ' HA ' ' A' ' 41' ' ' GLU . 77.7 mt 56.52 14.76 1.79 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.815 0.672 . . . . 73.109999999999999 112.815 -177.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.693 HG23 ' H ' ' A' ' 48' ' ' TYR . 4.2 t -79.7 157.7 27.12 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.473 0.546 . . . . 71.219999999999999 112.473 -177.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -58.04 -34.68 70.34 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.366 0.603 . . . . 74.329999999999998 110.384 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.61 -40.1 86.41 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.558 -0.746 . . . . 72.450000000000003 110.973 177.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.693 ' H ' HG23 ' A' ' 45' ' ' THR . 1.7 t80 -62.55 -39.08 92.49 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.151 0.5 . . . . 73.109999999999999 110.099 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -63.5 -68.1 0.37 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.826 -0.624 . . . . 65.230000000000004 110.314 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -55.09 -24.2 24.29 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.865 0.691 . . . . 72.409999999999997 112.865 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.54 -38.08 18.92 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.307 0.854 . . . . 74.319999999999993 113.307 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 48' ' ' TYR . 13.7 m -108.35 7.99 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 112.873 0.694 . . . . 63.140000000000001 112.873 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -98.53 18.98 15.38 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.44 0.904 . . . . 71.329999999999998 113.44 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -135.65 159.39 41.79 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.98 0.733 . . . . 70.340000000000003 112.98 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.42 137.64 49.93 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.229 -0.896 . . . . 73.219999999999999 110.098 173.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.595 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 48.5 mt-10 -97.44 116.86 30.45 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.898 0.38 . . . . 73.299999999999997 111.626 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.5 ' HA ' HG22 ' A' ' 96' ' ' ILE . 4.1 mp -110.0 154.58 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 116.226 -0.443 . . . . 74.25 111.212 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.405 ' N ' HG22 ' A' ' 57' ' ' ILE . 27.1 t-20 -68.52 148.78 50.08 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.736 0.414 . . . . 54.439999999999998 111.442 176.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 9.2 tp10 -52.46 -47.59 66.36 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.311 0.485 . . . . 73.200000000000003 112.311 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -62.6 -42.1 99.37 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.337 0.495 . . . . 65.239999999999995 112.337 -176.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -71.18 -30.51 66.5 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.409 0.623 . . . . 73.239999999999995 110.555 174.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.458 ' HZ2' ' N ' ' A' ' 69' ' ' GLU . 58.6 t-105 -59.14 -52.71 64.55 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.514 -0.766 . . . . 71.099999999999994 111.739 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -71.74 -30.34 65.5 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.612 0.227 . . . . 73.120000000000005 111.612 178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.54 -43.98 89.43 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.088 0.47 . . . . 73.200000000000003 111.827 177.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 98.0 mt -89.25 -4.92 58.0 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.275 -0.42 . . . . 73.219999999999999 112.033 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.72 50.49 66.96 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.218 -0.515 . . . . 75.409999999999997 112.967 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.429 HD23 ' HE2' ' A' ' 129' ' ' LYS . 86.9 mt -89.27 163.89 15.18 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.041 0.448 . . . . 63.219999999999999 112.162 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -150.52 118.77 6.37 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.192 -0.458 . . . . 65.230000000000004 110.208 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.458 ' N ' ' HZ2' ' A' ' 62' ' ' TRP . 2.2 mp0 -40.2 105.74 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.33 0.863 . . . . 70.310000000000002 113.33 -168.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.66 -10.88 10.38 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 115.289 -0.869 . . . . 74.340000000000003 113.672 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -80.64 176.45 9.79 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 117.889 0.844 . . . . 73.140000000000001 111.31 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' A' ' 72' ' ' ARG . 3.1 mpt_? -98.25 128.7 44.84 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.115 0.483 . . . . 71.200000000000003 112.045 -172.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 86' ' ' ALA . 15.3 m -119.43 135.53 59.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 121.284 0.564 . . . . 71.349999999999994 111.723 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.553 ' HB3' ' HG3' ' A' ' 128' ' ' GLU . 5.4 tppp? -88.88 125.31 34.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.839 -0.619 . . . . 73.549999999999997 110.867 175.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 61.7 t -109.54 125.34 66.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.674 -0.491 . . . . 74.329999999999998 109.674 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -132.41 132.89 43.27 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.141 0.496 . . . . 64.299999999999997 112.143 -173.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.623 HG22 ' HA3' ' A' ' 125' ' ' GLY . 37.1 p -136.07 -170.58 2.67 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.922 -0.581 . . . . 60.32 110.943 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.05 -6.39 52.55 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.029 -0.532 . . . . 72.519999999999996 111.709 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.412 ' CZ ' ' HB2' ' A' ' 109' ' ' ASP . 98.9 m-85 -99.82 -45.14 5.83 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.769 0.319 . . . . 74.150000000000006 111.582 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.2 -152.4 10.22 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.781 -0.723 . . . . 73.310000000000002 113.336 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 15.4 pt-20 -152.08 152.1 31.93 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.057 0.456 . . . . 61.039999999999999 111.641 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 106' ' ' MET . 8.8 p -152.36 153.88 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.389 -0.369 . . . . 64.230000000000004 111.48 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 t -108.8 120.48 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 122.22 0.208 . . . . 52.32 110.882 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.431 HG12 ' CD2' ' A' ' 103' ' ' TYR . 32.8 m -130.29 172.5 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 111.992 0.367 . . . . 72.540000000000006 111.992 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -76.36 136.9 39.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.278 -0.419 . . . . 75.219999999999999 111.025 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -87.19 127.81 35.15 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.394 0.516 . . . . 65.140000000000001 112.394 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 86.9 mttt -127.74 146.91 50.42 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.262 0.553 . . . . 53.020000000000003 110.673 172.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -84.68 126.96 33.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.875 -0.602 . . . . 52.210000000000001 110.122 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.595 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -118.86 -175.81 16.34 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.735 -0.745 . . . . 75.530000000000001 114.478 -173.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -92.74 9.35 35.41 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.617 0.722 . . . . 70.450000000000003 110.221 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.9 m -75.14 151.51 85.98 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 115.456 -0.793 . . . . 62.229999999999997 112.44 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.27 166.12 28.07 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.019 2.479 . . . . 65.319999999999993 112.943 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -66.14 147.04 53.93 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.769 0.319 . . . . 73.450000000000003 111.287 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 64.74 27.05 71.5 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.767 -0.73 . . . . 65.239999999999995 113.071 -174.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.541 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 21.6 ttt -152.11 136.39 16.69 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 122.218 -0.578 . . . . 71.200000000000003 110.406 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.615 HD11 HG22 ' A' ' 28' ' ' VAL . 39.9 pt -136.53 141.58 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 121.193 0.521 . . . . 71.209999999999994 111.975 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -101.46 132.11 47.24 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.858 0.361 . . . . 73.109999999999999 111.532 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 30' ' ' SER . 39.1 mt -127.89 136.66 29.33 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.245 -0.434 . . . . 61.210000000000001 110.427 173.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.535 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 31.1 Cg_endo -65.28 131.8 29.51 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.076 1.851 . . . . 73.430000000000007 112.254 172.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.73 104.0 0.1 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.875 0.369 . . . . 74.329999999999998 110.912 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.0 -175.52 28.01 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.925 -0.655 . . . . 54.409999999999997 112.918 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.447 ' O ' ' HG2' ' A' ' 106' ' ' MET . 19.5 Cg_endo -57.04 -34.91 98.58 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.99 2.46 . . . . 70.430000000000007 112.357 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.431 ' CD2' HG12 ' A' ' 84' ' ' VAL . 28.8 m-85 -64.77 -53.64 43.82 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.216 -0.447 . . . . 72.319999999999993 110.832 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -58.29 -38.47 77.09 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.315 0.578 . . . . 54.329999999999998 111.104 175.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -55.17 -22.29 16.76 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.881 -0.599 . . . . 60.030000000000001 112.408 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.63 ' SD ' HD21 ' A' ' 140' ' ' LEU . 90.2 mmm -78.75 -15.19 58.74 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.222 0.453 . . . . 73.430000000000007 112.222 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.1 m -129.23 -18.36 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 113.179 0.807 . . . . 44.549999999999997 113.179 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.608 HG21 ' OG ' ' A' ' 30' ' ' SER . 12.9 pt -96.75 176.36 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 121.811 -0.556 . . . . 71.010000000000005 112.377 -177.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.592 ' H ' HG21 ' A' ' 123' ' ' VAL . 18.7 t0 -102.16 112.95 65.98 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.895 -0.593 . . . . 72.510000000000005 110.736 176.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.45 -1.06 11.22 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.507 2.138 . . . . 75.109999999999999 113.185 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.0 m -78.37 51.06 0.99 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.975 0.417 . . . . 71.25 111.387 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 72.7 p -98.37 95.06 7.09 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.456 0.539 . . . . 74.430000000000007 112.456 -174.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -98.46 138.72 35.27 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.151 -0.477 . . . . 74.549999999999997 110.628 174.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 138.21 158.26 7.72 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.275 -0.488 . . . . 40.219999999999999 112.465 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 57.6 p -76.65 -18.51 58.53 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.781 0.66 . . . . 61.009999999999998 112.781 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -143.49 138.37 8.12 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.654 -0.784 . . . . 72.540000000000006 113.958 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 86.3 mtp -90.54 155.7 45.85 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 122.433 0.293 . . . . 65.319999999999993 111.277 177.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.25 107.7 0.86 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.237 1.958 . . . . 74.25 112.205 176.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -65.84 -12.87 57.72 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.272 0.842 . . . . 70.120000000000005 113.272 -171.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -145.33 18.22 1.54 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.665 0.617 . . . . 75.329999999999998 112.665 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -137.77 155.72 48.75 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 120.631 0.253 . . . . 61.399999999999999 111.222 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.722 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . -151.06 -151.08 5.48 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.42 -0.895 . . . . 64.409999999999997 114.36 -175.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.592 HG21 ' H ' ' A' ' 109' ' ' ASP . 86.6 t -92.7 123.61 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 122.747 0.419 . . . . 65.209999999999994 111.431 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 95.9 mttt -72.78 150.54 42.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.111 0.482 . . . . 72.129999999999995 112.192 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.623 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -177.2 -140.89 3.81 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 116.015 -0.539 . . . . 63.039999999999999 113.024 -178.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 67.3 p -142.81 163.55 32.51 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.35 -0.5 . . . . 72.310000000000002 111.879 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.0 p -142.4 145.32 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 116.136 -0.484 . . . . 71.439999999999998 110.884 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.553 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 8.7 pt-20 -152.09 152.3 32.19 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.286 0.476 . . . . 72.239999999999995 112.286 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.429 ' HE2' HD23 ' A' ' 67' ' ' LEU . 9.5 tppt? -62.7 137.31 58.23 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.426 -0.352 . . . . 53.119999999999997 110.93 172.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.0 t -134.7 153.28 52.07 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.05 0.452 . . . . 72.219999999999999 111.957 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.27 6.66 46.17 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.507 0.67 . . . . 65.409999999999997 110.621 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -80.6 -175.96 5.51 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.447 0.641 . . . . 65.519999999999996 112.056 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -101.56 154.0 19.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.615 -0.721 . . . . 64.430000000000007 111.001 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.39 122.26 14.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 110.338 -0.245 . . . . 65.049999999999997 110.338 173.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 135' ' ' LEU . 3.3 mt -62.45 90.96 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.636 0.236 . . . . 74.030000000000001 111.636 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.1 m -46.05 147.66 0.99 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.164 -0.471 . . . . 61.350000000000001 111.669 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.544 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 85.8 t -45.74 -53.6 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 113.118 0.784 . . . . 61.350000000000001 113.118 -173.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.853 ' HD3' HD12 ' A' ' 141' ' ' LEU . 16.1 tppt? -72.49 -39.07 67.94 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.08 -0.387 . . . . 71.239999999999995 111.598 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -55.77 -38.17 69.51 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.666 0.746 . . . . 75.400000000000006 110.205 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.63 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.2 tt -63.76 -40.16 96.03 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.098 -0.955 . . . . 75.420000000000002 110.547 174.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.853 HD12 ' HD3' ' A' ' 138' ' ' LYS . 43.1 mt -61.55 -42.42 98.81 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.31 0.576 . . . . 75.450000000000003 110.285 175.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 138' ' ' LYS . 32.1 mm-40 -60.03 -46.29 89.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.744 -0.662 . . . . 73.230000000000004 110.573 176.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.63 -43.59 84.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.748 -0.66 . . . . 73.319999999999993 112.213 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 141' ' ' LEU . 2.7 pp -76.48 -20.91 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.263 0.468 . . . . 73.329999999999998 112.263 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.77 -48.99 0.25 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.568 -0.825 . . . . 72.430000000000007 113.939 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.1 t . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 121.126 0.489 . . . . 70.549999999999997 111.895 -176.709 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtm . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 120.811 0.339 . . . . 52.520000000000003 111.122 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -97.57 107.91 3.56 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.319 -0.467 . . . . 71.129999999999995 112.926 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.6 p -153.09 146.77 25.13 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.906 0.384 . . . . 73.430000000000007 111.21 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.9 p -147.21 127.16 13.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.179 0.514 . . . . 45.109999999999999 112.259 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -122.63 139.25 54.14 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.067 -0.515 . . . . 63.32 110.23 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -92.75 142.89 26.85 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.539 0.685 . . . . 72.450000000000003 112.398 -175.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -97.77 72.21 2.26 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.754 -0.657 . . . . 73.219999999999999 111.932 -175.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.68 129.94 40.99 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.159 -0.473 . . . . 51.0 111.817 177.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -133.73 154.71 50.76 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.853 0.359 . . . . 73.430000000000007 111.582 -175.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -76.82 122.76 25.25 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.833 0.349 . . . . 74.519999999999996 110.701 174.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.2 m -71.41 88.89 0.9 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.401 0.519 . . . . 65.030000000000001 112.401 -174.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.7 t -77.34 138.99 39.66 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.743 0.306 . . . . 51.210000000000001 110.573 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -101.26 -169.66 28.13 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.07 -0.586 . . . . 62.229999999999997 114.312 -174.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -99.4 114.79 27.9 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.853 0.359 . . . . 71.230000000000004 110.569 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -114.44 -158.88 0.68 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.747 0.308 . . . . 72.150000000000006 111.775 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -49.43 105.92 0.1 Allowed 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.308 0.575 . . . . 74.329999999999998 112.118 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.64 160.84 31.95 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.064 -0.516 . . . . 73.450000000000003 112.106 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 61.97 16.53 8.19 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.249 -0.432 . . . . 75.209999999999994 111.985 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -53.1 127.42 24.05 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.148 0.499 . . . . 74.439999999999998 111.965 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -146.17 -27.47 0.43 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.944 -0.571 . . . . 74.040000000000006 111.306 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.88 -134.53 12.97 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.066 -0.587 . . . . 61.229999999999997 113.125 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -167.96 93.55 0.38 Allowed 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.752 -0.264 . . . . 64.340000000000003 111.005 -177.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.1 ptm -78.76 147.34 33.4 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.132 0.491 . . . . 55.450000000000003 111.704 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.5 mt -116.34 131.42 56.95 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.188 -0.46 . . . . 64.120000000000005 112.109 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.7 ' HG3' HG22 ' A' ' 126' ' ' THR . 1.1 mp0 -73.03 136.58 45.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.505 0.669 . . . . 60.299999999999997 111.42 175.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 15.8 m -148.27 158.1 7.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.069 -0.969 . . . . 50.409999999999997 111.616 -172.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.631 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 32.7 tt0 -99.21 111.85 24.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.018 0.437 . . . . 73.340000000000003 110.183 172.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.512 HG22 HD11 ' A' ' 96' ' ' ILE . 39.6 t -88.48 107.86 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.812 -0.631 . . . . 73.230000000000004 111.497 -174.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.9 mt -92.29 153.1 3.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.335 -0.393 . . . . 72.230000000000004 111.294 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 20.0 t -133.67 103.52 5.92 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.08 0.466 . . . . 63.439999999999998 111.151 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.48 115.1 5.05 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.076 -0.583 . . . . 75.519999999999996 113.364 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.4 ptt85 -82.26 75.99 9.16 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.426 0.632 . . . . 73.120000000000005 112.101 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.2 t -96.81 -27.51 14.68 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.963 -0.562 . . . . 54.530000000000001 111.394 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.575 HD22 ' HB1' ' A' ' 51' ' ' ALA . 4.3 pp -106.3 -41.64 5.27 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.332 -0.394 . . . . 65.430000000000007 111.739 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.571 ' N ' HD12 ' A' ' 34' ' ' LEU . 7.2 t30 -82.15 85.07 6.85 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.113 0.482 . . . . 53.109999999999999 110.013 175.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -113.82 20.62 15.68 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.027 -0.533 . . . . 72.209999999999994 112.273 -175.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 156.74 -55.61 0.39 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.641 -0.79 . . . . 73.430000000000007 113.127 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HB3' ' HD2' ' A' ' 43' ' ' LYS . . . -73.56 130.3 39.77 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 122.77 -0.253 . . . . 61.409999999999997 111.172 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.2 p -73.15 178.69 4.26 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.131 0.491 . . . . 35.140000000000001 110.912 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.48 HG21 HD21 ' A' ' 141' ' ' LEU . 8.9 m -62.05 -25.2 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 116.578 -0.283 . . . . 70.430000000000007 111.361 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.609 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 1.3 tm-20 -71.2 -50.91 28.1 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.869 0.366 . . . . 72.439999999999998 110.553 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.62 -20.09 44.53 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.934 0.397 . . . . 70.340000000000003 111.571 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.566 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 27.5 mtpp -126.69 30.57 5.49 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.144 0.424 . . . . 54.530000000000001 112.144 -175.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.609 ' HG ' ' HA ' ' A' ' 41' ' ' GLU . 47.7 mt -65.44 86.44 0.07 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.133 0.492 . . . . 64.400000000000006 111.468 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.491 HG23 ' H ' ' A' ' 48' ' ' TYR . 4.1 t -151.15 157.6 42.92 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.104 -0.498 . . . . 74.219999999999999 111.788 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -56.35 -28.11 58.02 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.302 0.572 . . . . 63.409999999999997 110.941 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -57.74 -45.4 85.89 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.821 -0.627 . . . . 62.43 110.779 173.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.491 ' H ' HG23 ' A' ' 45' ' ' THR . 9.5 t80 -66.05 -37.34 85.58 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.293 0.568 . . . . 74.409999999999997 110.231 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.404 ' HD1' HG23 ' A' ' 137' ' ' VAL . 65.5 t80 -58.61 -62.78 1.61 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.599 -0.728 . . . . 74.430000000000007 111.038 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -55.24 -23.98 25.42 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.771 0.656 . . . . 75.140000000000001 112.771 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.575 ' HB1' HD22 ' A' ' 34' ' ' LEU . . . -81.68 -40.32 23.01 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.032 0.752 . . . . 73.530000000000001 113.032 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 48' ' ' TYR . 33.8 m -108.73 13.9 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 113.289 0.848 . . . . 74.409999999999997 113.289 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -104.04 26.1 9.16 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.52 0.934 . . . . 63.229999999999997 113.52 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -145.11 159.81 42.39 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.665 -0.647 . . . . 75.439999999999998 112.355 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.78 146.33 50.62 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.532 -0.758 . . . . 52.350000000000001 111.043 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.667 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 30.9 mt-10 -96.6 116.9 29.88 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.633 0.254 . . . . 75.219999999999999 111.516 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.52 ' HA ' HG22 ' A' ' 96' ' ' ILE . 4.2 mp -110.44 146.97 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 120.782 0.325 . . . . 71.400000000000006 111.255 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -64.19 145.82 55.33 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.593 -0.276 . . . . 71.140000000000001 110.845 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 32.2 tt0 -58.71 -40.76 84.59 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.78 0.659 . . . . 72.310000000000002 112.78 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -60.9 -51.14 70.53 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.955 0.354 . . . . 72.019999999999996 111.955 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -65.55 -36.0 82.52 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.468 0.651 . . . . 74.0 110.457 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.713 ' HA ' HD12 ' A' ' 67' ' ' LEU . 37.0 t-105 -52.91 -53.83 43.66 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.276 -0.874 . . . . 65.540000000000006 111.311 175.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -70.5 -29.69 66.27 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.004 -0.543 . . . . 71.430000000000007 111.394 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.24 -35.22 80.1 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.887 0.375 . . . . 75.25 111.624 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.0 mt -89.86 1.33 56.32 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.38 -0.373 . . . . 62.200000000000003 111.702 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.94 40.48 95.4 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.42 -0.419 . . . . 72.019999999999996 112.728 -177.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.713 HD12 ' HA ' ' A' ' 62' ' ' TRP . 18.4 mt -76.11 141.81 41.86 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.093 0.775 . . . . 71.439999999999998 113.093 -175.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.526 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 30.3 tt0 -106.51 147.1 29.79 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.28 -0.873 . . . . 72.120000000000005 109.673 169.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -63.77 102.73 0.49 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.495 0.664 . . . . 61.450000000000003 111.382 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.25 5.02 23.47 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 115.268 -0.878 . . . . 44.439999999999998 112.633 -172.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 68' ' ' GLN . 1.4 t0 -71.69 172.86 8.97 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.81 0.444 . . . . 74.239999999999995 110.838 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.47 124.48 49.67 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.28 0.562 . . . . 74.030000000000001 111.687 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 86' ' ' ALA . 15.8 m -113.3 132.53 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.139 0.495 . . . . 74.129999999999995 111.481 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -100.66 109.98 22.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.584 0.707 . . . . 54.299999999999997 110.311 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 59.3 t -92.66 127.2 44.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.34 -0.845 . . . . 74.510000000000005 109.824 -175.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.521 ' HG2' ' CB ' ' A' ' 81' ' ' GLU . 46.4 mtpt -133.34 124.77 27.81 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.387 0.613 . . . . 62.119999999999997 112.397 -169.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.627 HG22 ' HA3' ' A' ' 125' ' ' GLY . 29.2 p -132.42 -171.66 2.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.712 -0.676 . . . . 74.329999999999998 111.033 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -76.56 -1.11 25.8 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.272 -0.422 . . . . 73.120000000000005 111.562 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -102.46 -34.71 9.04 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 111.811 0.3 . . . . 74.25 111.811 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.37 -167.1 39.7 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 112.258 -0.337 . . . . 71.430000000000007 112.258 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.521 ' CB ' ' HG2' ' A' ' 76' ' ' LYS . 16.4 pt-20 -143.48 144.11 31.85 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.376 0.588 . . . . 53.049999999999997 112.524 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 p -143.66 150.41 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.934 -0.575 . . . . 72.120000000000005 111.566 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.12 120.34 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 O-C-N 122.301 -0.249 . . . . 73.239999999999995 111.388 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.69 173.17 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 120.858 0.361 . . . . 75.040000000000006 111.966 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -78.28 140.49 38.84 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.038 0.447 . . . . 73.040000000000006 111.354 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.457 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -93.74 126.3 38.84 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.649 0.611 . . . . 64.019999999999996 112.649 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -125.18 145.66 49.86 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.114 0.483 . . . . 72.439999999999998 110.66 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -82.9 112.37 19.63 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.791 -0.448 . . . . 63.439999999999998 109.791 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.667 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -123.63 169.12 15.77 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.581 -0.818 . . . . 71.219999999999999 114.434 -171.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.85 73.89 6.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.116 0.484 . . . . 64.319999999999993 111.413 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.5 m -132.46 147.95 67.67 Favored Pre-proline 0 CA--C 1.539 0.558 0 CA-C-N 116.018 -0.537 . . . . 71.109999999999999 111.229 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.75 157.29 38.42 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.628 2.219 . . . . 72.150000000000006 112.563 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -64.07 145.34 56.09 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 122.116 -0.365 . . . . 72.439999999999998 111.099 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.529 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 62.59 27.8 70.33 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.047 -0.596 . . . . 62.32 112.677 -174.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.631 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 18.8 ttt -148.75 136.43 20.56 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.741 -0.466 . . . . 64.200000000000003 109.741 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.52 HG22 ' HA ' ' A' ' 57' ' ' ILE . 36.7 pt -137.92 144.68 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 121.294 0.568 . . . . 73.120000000000005 112.194 -176.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -105.4 133.38 50.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.229 -0.442 . . . . 52.32 111.494 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 30' ' ' SER . 48.8 mt -128.87 134.03 25.86 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 116.342 -0.39 . . . . 64.019999999999996 110.675 174.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.87 136.44 61.71 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 121.975 1.784 . . . . 73.349999999999994 112.231 174.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.31 107.93 0.63 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.898 0.38 . . . . 75.340000000000003 110.895 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.95 -174.61 26.87 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.124 -0.56 . . . . 72.519999999999996 112.487 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.78 -25.77 74.83 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.983 1.789 . . . . 75.219999999999999 111.853 -177.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.539 ' HA ' HD11 ' A' ' 140' ' ' LEU . 3.8 m-85 -71.19 -54.29 11.49 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.677 -0.692 . . . . 73.230000000000004 110.729 178.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.02 -33.35 73.13 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.097 -0.501 . . . . 71.430000000000007 110.617 175.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -58.25 -22.37 52.11 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.936 -0.574 . . . . 53.539999999999999 111.665 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.502 ' SD ' HD21 ' A' ' 140' ' ' LEU . 33.7 mtp -78.37 -29.61 47.51 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.506 -0.315 . . . . 73.340000000000003 111.41 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.8 m -111.94 -18.99 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 112.395 0.517 . . . . 74.239999999999995 112.395 -171.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.563 HG21 ' HB2' ' A' ' 30' ' ' SER . 12.2 pt -94.76 178.84 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.11 0.481 . . . . 74.099999999999994 111.495 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.52 ' H ' HG21 ' A' ' 123' ' ' VAL . 21.3 t70 -92.0 108.82 33.01 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 116.102 -0.499 . . . . 74.299999999999997 110.52 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.89 -6.34 17.34 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.436 2.091 . . . . 72.409999999999997 113.604 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.3 t -72.49 -39.48 67.64 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.038 0.447 . . . . 72.219999999999999 110.967 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.0 t -80.27 -172.03 3.3 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.244 0.545 . . . . 53.43 112.073 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -154.63 -29.66 0.11 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.066 -0.516 . . . . 61.439999999999998 111.674 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.73 77.2 1.24 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.767 -0.73 . . . . 71.219999999999999 111.471 -171.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.2 m -61.05 92.72 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.844 0.354 . . . . 62.43 111.712 -176.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.34 -62.28 2.66 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.399 -0.429 . . . . 62.43 113.184 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 22.0 mmt -136.79 139.95 30.46 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 120.932 0.396 . . . . 74.450000000000003 111.861 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -86.15 -15.08 4.7 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.871 2.381 . . . . 72.209999999999994 112.781 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 56.48 59.74 3.46 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.966 0.506 . . . . 74.0 111.668 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 45.71 79.99 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.135 0.574 . . . . 73.450000000000003 112.082 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -167.07 134.79 2.51 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.181 -0.463 . . . . 75.310000000000002 111.926 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -141.47 -176.2 15.61 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.739 -0.664 . . . . 72.109999999999999 112.442 173.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.52 HG21 ' H ' ' A' ' 109' ' ' ASP . 82.0 t -82.17 119.61 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.063 0.458 . . . . 63.299999999999997 111.661 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 95.8 mttt -73.12 154.01 40.54 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.512 0.56 . . . . 75.340000000000003 112.512 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.627 ' HA3' HG22 ' A' ' 77' ' ' THR . . . 177.81 -140.83 4.9 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.884 -0.598 . . . . 63.350000000000001 112.797 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.7 HG22 ' HG3' ' A' ' 25' ' ' GLU . 67.6 p -136.69 161.67 35.28 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.026 0.441 . . . . 74.540000000000006 111.164 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.79 143.84 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.247 0.546 . . . . 74.519999999999996 110.834 173.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -147.44 144.62 28.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.967 -0.561 . . . . 62.240000000000002 110.363 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.509 ' HD2' HD23 ' A' ' 67' ' ' LEU . 20.6 ttpp -81.87 143.23 31.85 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.19 -0.318 . . . . 73.329999999999998 110.262 176.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.0 t -132.16 156.8 45.77 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.597 0.962 . . . . 55.439999999999998 113.597 -168.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -83.29 -17.1 43.73 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.061 -0.972 . . . . 53.020000000000003 110.41 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -68.98 179.11 1.95 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.702 -0.681 . . . . 54.240000000000002 112.71 -175.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -98.83 159.84 14.68 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.672 -0.694 . . . . 73.540000000000006 111.702 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.8 t -73.97 136.12 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.466 -0.334 . . . . 74.230000000000004 110.908 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 135' ' ' LEU . 11.9 mt -67.44 140.47 57.12 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.944 0.402 . . . . 71.219999999999999 111.531 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.6 m -86.24 148.84 25.46 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.616 -0.513 . . . . 72.310000000000002 109.616 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.47 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 86.1 t -46.8 -53.43 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 112.564 0.579 . . . . 75.450000000000003 112.564 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -72.25 -39.36 68.48 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 111.704 0.261 . . . . 73.120000000000005 111.704 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.79 -36.67 72.49 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.701 0.762 . . . . 72.129999999999995 110.09 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.539 HD11 ' HA ' ' A' ' 103' ' ' TYR . 4.4 tt -62.25 -43.84 97.9 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.968 -1.014 . . . . 70.239999999999995 110.728 172.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.48 HD21 HG21 ' A' ' 40' ' ' VAL . 66.6 mt -57.3 -45.16 84.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.205 0.526 . . . . 53.420000000000002 110.608 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -59.26 -40.84 87.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.799 -0.637 . . . . 74.409999999999997 111.1 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.4 -48.03 74.27 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.976 -0.556 . . . . 54.009999999999998 112.22 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.9 pp -75.64 -20.9 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 112.779 0.659 . . . . 74.340000000000003 112.779 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 139.61 -22.99 2.83 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.445 -0.883 . . . . 73.239999999999995 114.725 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.2 m . . . . . 0 N--CA 1.471 0.601 0 O-C-N 122.225 -0.574 . . . . 64.329999999999998 111.427 -178.045 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.516 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.852 0.358 . . . . 71.329999999999998 111.245 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 126.82 -178.15 16.97 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.294 -0.479 . . . . 51.020000000000003 113.799 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.5 p -172.41 130.8 0.58 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.873 0.469 . . . . 62.439999999999998 110.78 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 99.2 p -74.28 171.55 13.44 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.068 0.461 . . . . 73.329999999999998 112.09 -176.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -141.3 112.38 7.31 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.431 -0.35 . . . . 74.230000000000004 110.761 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -128.98 120.08 25.44 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.323 0.49 . . . . 65.120000000000005 112.323 -175.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -146.65 125.28 12.51 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.706 0.402 . . . . 74.019999999999996 111.366 174.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -148.03 145.43 28.48 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.49 0.316 . . . . 72.430000000000007 110.878 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -152.09 139.49 19.5 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.581 0.229 . . . . 65.219999999999999 111.192 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -139.37 144.87 38.38 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.287 0.235 . . . . 73.409999999999997 111.162 -176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.1 t -120.64 175.8 5.83 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.224 0.453 . . . . 63.030000000000001 112.224 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.3 t -94.1 179.69 5.24 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.849 0.357 . . . . 72.239999999999995 111.765 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.5 -110.05 2.64 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 114.551 0.58 . . . . 53.520000000000003 114.551 -173.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.535 ' H ' ' NE ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -118.99 178.48 4.48 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.888 0.699 . . . . 70.420000000000002 112.888 -170.55 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -101.82 172.19 7.08 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.021 -0.536 . . . . 63.43 111.315 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -107.23 118.44 36.73 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.393 -0.367 . . . . 72.120000000000005 110.155 173.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.42 166.61 21.84 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.532 0.567 . . . . 64.200000000000003 112.532 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -87.78 135.0 33.57 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.976 -0.556 . . . . 74.109999999999999 112.375 -172.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -94.82 101.4 13.2 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.998 0.428 . . . . 72.230000000000004 110.48 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -90.51 92.9 9.06 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.895 0.378 . . . . 72.209999999999994 111.145 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -137.3 119.1 1.83 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 121.417 -0.421 . . . . 74.049999999999997 112.598 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -81.57 86.25 6.39 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 122.532 -0.393 . . . . 73.420000000000002 111.394 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.2 ptp -82.17 166.72 19.4 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.249 0.547 . . . . 75.299999999999997 111.861 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.579 HD11 ' HB3' ' A' ' 64' ' ' ALA . 16.4 mt -122.27 139.28 53.97 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.004 -0.544 . . . . 43.439999999999998 111.58 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -79.29 118.25 21.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.309 0.576 . . . . 74.25 110.359 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 28.3 m -138.25 160.51 32.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.61 -0.723 . . . . 71.129999999999995 111.824 -173.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.726 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 72.2 tt0 -98.82 111.92 24.16 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.071 0.462 . . . . 75.25 110.438 175.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.522 HG22 HD11 ' A' ' 96' ' ' ILE . 43.1 t -87.45 105.81 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 115.797 -0.638 . . . . 75.439999999999998 111.72 -175.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 mt -92.14 162.91 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.677 0.275 . . . . 74.340000000000003 111.265 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.686 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 15.6 t -134.58 113.96 12.3 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.781 0.324 . . . . 73.230000000000004 111.826 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . -116.38 126.49 7.07 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.065 -0.588 . . . . 54.439999999999998 113.298 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.43 ' HD2' ' O ' ' A' ' 114' ' ' GLY . 19.8 mtp180 -67.26 95.41 0.42 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.985 0.421 . . . . 74.310000000000002 111.984 -176.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.1 p -82.66 -43.1 17.32 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.662 0.616 . . . . 74.120000000000005 112.662 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.01 151.23 31.2 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.565 0.579 . . . . 63.119999999999997 112.565 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -66.81 105.77 1.68 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.928 -0.578 . . . . 73.140000000000001 111.866 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 61.08 170.69 0.1 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.336 0.865 . . . . 73.540000000000006 113.336 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -80.09 144.81 26.41 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 115.489 -0.778 . . . . 52.240000000000002 114.06 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.736 ' HB3' ' HE3' ' A' ' 43' ' ' LYS . . . -179.74 162.94 1.11 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.127 0.571 . . . . 70.420000000000002 110.523 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.3 p -75.08 156.06 36.49 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 110.383 -0.229 . . . . 74.430000000000007 110.383 172.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.1 m -56.9 -30.83 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 120.991 0.424 . . . . 73.239999999999995 111.308 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.586 ' HA ' HD23 ' A' ' 44' ' ' LEU . 42.4 tt0 -59.73 -37.67 79.57 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.117 -0.492 . . . . 52.229999999999997 111.399 177.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -66.84 -17.07 64.7 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.226 0.454 . . . . 71.310000000000002 112.226 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.736 ' HE3' ' HB3' ' A' ' 38' ' ' ALA . 86.0 mttt -134.11 33.57 3.37 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.547 0.573 . . . . 72.450000000000003 112.547 -174.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -63.7 87.08 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.964 0.411 . . . . 75.430000000000007 110.627 176.46 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 t -155.22 172.62 17.86 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.26 -0.427 . . . . 73.040000000000006 112.018 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -56.64 -33.5 66.39 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.089 -0.505 . . . . 70.450000000000003 111.552 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -54.36 -47.27 72.79 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.151 0.5 . . . . 71.129999999999995 111.153 176.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.513 ' CD2' ' HB2' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -68.8 -23.08 64.24 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.939 0.4 . . . . 74.340000000000003 110.702 -179.481 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -88.17 2.08 52.96 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.033 0.383 . . . . 73.430000000000007 112.033 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -122.17 -48.31 2.11 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.483 -0.761 . . . . 72.340000000000003 111.948 170.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.68 -22.77 24.88 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.079 1.14 . . . . 75.230000000000004 114.079 -170.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.519 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 19.7 m -130.92 17.82 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 112.858 0.688 . . . . 54.520000000000003 112.858 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -102.0 17.16 23.9 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.612 0.597 . . . . 63.200000000000003 112.612 -174.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -140.93 162.79 34.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.142 0.496 . . . . 73.329999999999998 112.106 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -126.14 127.19 45.36 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.622 -0.717 . . . . 52.030000000000001 110.813 174.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -87.31 118.4 26.71 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.413 0.625 . . . . 64.329999999999998 110.892 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.03 154.92 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.162 -0.926 . . . . 75.439999999999998 111.828 -169.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -76.19 144.56 40.42 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.525 -0.307 . . . . 75.209999999999994 110.615 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 27.3 tt0 -63.39 -36.86 85.13 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.818 0.673 . . . . 75.299999999999997 112.818 -176.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -62.21 -47.69 83.33 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 122.174 -0.329 . . . . 62.399999999999999 111.413 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.461 ' HB3' HD13 ' A' ' 24' ' ' LEU . 47.0 m-20 -66.8 -36.5 82.52 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.308 0.575 . . . . 74.310000000000002 110.558 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.48 ' HZ2' ' N ' ' A' ' 69' ' ' GLU . 33.7 t-105 -53.11 -45.66 68.38 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.492 -0.776 . . . . 74.030000000000001 110.591 175.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -65.7 -41.02 92.86 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.714 -0.676 . . . . 61.140000000000001 110.961 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.579 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -61.0 -38.55 86.45 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.242 -0.435 . . . . 62.329999999999998 111.82 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.483 ' HG ' HD12 ' A' ' 24' ' ' LEU . 87.6 mt -85.71 -14.47 45.29 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.425 -0.352 . . . . 65.439999999999998 111.413 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.57 47.4 78.0 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.273 -0.489 . . . . 75.099999999999994 112.581 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.568 HD23 ' HD3' ' A' ' 129' ' ' LYS . 85.3 mt -84.49 164.85 18.56 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.559 0.695 . . . . 71.030000000000001 112.38 -175.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -136.11 123.61 22.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.55 -0.75 . . . . 72.239999999999995 109.905 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.48 ' N ' ' HZ2' ' A' ' 62' ' ' TRP . 48.7 mt-10 -49.88 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.563 0.696 . . . . 71.430000000000007 112.614 -172.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 130.2 0.04 5.55 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.387 -0.824 . . . . 45.43 114.036 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -90.39 -172.15 3.34 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 117.863 0.831 . . . . 73.019999999999996 112.292 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.45 HH11 ' HD2' ' A' ' 72' ' ' ARG . 45.6 mtt180 -111.52 131.25 55.37 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.339 0.496 . . . . 71.239999999999995 112.339 -174.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.45 HG13 ' HB2' ' A' ' 86' ' ' ALA . 30.0 m -123.67 140.85 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.998 0.428 . . . . 64.420000000000002 111.578 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.415 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 38.3 ttmt -98.65 131.84 44.51 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.25 0.548 . . . . 73.400000000000006 110.74 174.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.531 HG21 HD11 ' A' ' 98' ' ' ILE . 61.9 t -106.18 128.22 60.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.731 -0.668 . . . . 75.519999999999996 109.661 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.415 ' HG3' ' HG2' ' A' ' 74' ' ' LYS . 38.8 mtpt -131.06 127.55 38.45 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.51 0.672 . . . . 72.200000000000003 112.506 -171.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.6 HG22 ' HA3' ' A' ' 125' ' ' GLY . 31.0 p -136.37 -170.43 2.66 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.131 -0.941 . . . . 62.439999999999998 110.486 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.22 -13.74 60.16 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.683 0.277 . . . . 70.129999999999995 111.561 176.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -87.83 -38.02 16.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.96 0.409 . . . . 74.430000000000007 111.378 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.07 -157.73 28.75 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.866 -0.683 . . . . 52.119999999999997 113.521 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -144.24 141.82 30.09 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.758 0.313 . . . . 72.219999999999999 111.471 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.48 146.67 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.698 0.285 . . . . 63.140000000000001 111.655 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.0 t -105.4 117.21 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.544 0.211 . . . . 71.109999999999999 110.95 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.0 m -127.34 178.08 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 122.588 0.355 . . . . 71.409999999999997 111.821 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -83.2 144.09 30.02 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.911 0.386 . . . . 74.409999999999997 111.312 174.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.45 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -90.34 135.74 33.49 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.625 0.602 . . . . 64.530000000000001 112.625 -177.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -133.04 158.23 43.26 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.583 0.706 . . . . 45.0 111.663 174.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -108.17 99.64 9.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.103 -0.953 . . . . 52.420000000000002 109.608 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.59 86.54 0.19 Allowed Glycine 0 CA--C 1.533 1.186 0 N-CA-C 116.631 1.412 . . . . 44.329999999999998 116.631 -166.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 65.72 -17.44 0.1 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 116.206 1.928 . . . . 61.399999999999999 116.206 161.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.0 m -78.15 148.66 75.14 Favored Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 121.716 -0.615 . . . . 73.219999999999999 112.425 -173.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -72.64 169.58 21.55 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.788 2.325 . . . . 73.230000000000004 112.705 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -68.33 146.58 53.14 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.871 0.367 . . . . 75.129999999999995 111.5 -177.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 68.72 18.02 71.75 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.277 -0.487 . . . . 74.0 113.28 -174.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.726 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 14.2 ttt -147.02 136.61 22.93 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 122.37 -0.488 . . . . 75.219999999999999 110.568 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.522 HD11 HG22 ' A' ' 28' ' ' VAL . 43.6 pt -135.91 144.97 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 121.082 0.468 . . . . 64.0 111.703 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.459 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 68.1 t80 -107.01 123.87 48.81 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.473 -0.33 . . . . 72.530000000000001 111.302 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.686 ' O ' ' HA ' ' A' ' 30' ' ' SER . 44.2 mt -120.37 127.46 26.3 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 120.805 0.336 . . . . 73.409999999999997 111.142 175.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.519 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 51.4 Cg_exo -57.18 136.9 79.23 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.285 1.99 . . . . 74.340000000000003 113.084 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.46 105.69 0.46 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.212 -0.449 . . . . 73.239999999999995 110.878 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.98 -174.25 30.6 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.912 -0.661 . . . . 70.310000000000002 112.542 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.467 ' O ' ' HG3' ' A' ' 106' ' ' MET . 14.8 Cg_endo -56.05 -36.01 95.55 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.521 2.148 . . . . 74.340000000000003 111.986 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.507 ' HA ' HD11 ' A' ' 140' ' ' LEU . 41.0 m-85 -61.83 -54.1 46.87 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.957 -0.565 . . . . 73.439999999999998 110.71 177.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -63.41 -33.53 75.76 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.165 0.507 . . . . 72.430000000000007 111.302 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.34 -15.03 45.8 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.124 -0.489 . . . . 75.109999999999999 111.892 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.541 ' SD ' HD21 ' A' ' 140' ' ' LEU . 41.5 mtp -83.66 -22.75 32.03 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.441 -0.345 . . . . 73.0 111.7 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.7 m -123.86 -18.45 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 113.129 0.788 . . . . 74.040000000000006 113.129 -171.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 104' ' ' ALA . 11.2 pt -96.22 177.62 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.381 0.61 . . . . 63.5 111.834 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.632 ' H ' HG21 ' A' ' 123' ' ' VAL . 16.7 t70 -98.94 104.9 28.21 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.806 -0.633 . . . . 64.040000000000006 110.131 175.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -83.36 26.88 0.63 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.489 2.126 . . . . 72.230000000000004 113.643 -175.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.9 t -121.0 -27.47 4.96 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 111.588 0.218 . . . . 63.420000000000002 111.588 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 t -66.72 99.73 0.63 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.119 0.485 . . . . 64.109999999999999 112.062 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 59.29 -85.57 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.228 0.611 . . . . 73.200000000000003 112.171 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.43 ' O ' ' HD2' ' A' ' 32' ' ' ARG . . . 95.26 -16.62 60.93 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.353 -0.451 . . . . 61.109999999999999 113.114 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 80.8 p -86.69 -179.45 6.58 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.888 0.375 . . . . 62.530000000000001 111.854 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.23 70.54 1.84 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.107 -0.568 . . . . 51.409999999999997 113.012 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 23.3 mmt -78.39 148.32 73.72 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.188 0.44 . . . . 53.25 112.188 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -91.39 17.22 1.41 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.076 2.518 . . . . 74.200000000000003 112.679 177.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -101.04 130.48 47.05 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.898 0.38 . . . . 61.310000000000002 111.511 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -83.85 67.95 9.76 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.159 0.504 . . . . 73.219999999999999 111.376 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -108.11 122.81 47.65 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.484 -0.326 . . . . 72.25 111.426 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -123.84 157.66 18.29 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 121.056 -0.592 . . . . 71.109999999999999 112.948 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.632 HG21 ' H ' ' A' ' 109' ' ' ASP . 58.3 t -78.19 122.13 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 121.0 0.429 . . . . 73.0 111.419 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 124' ' ' LYS . 12.1 mptt -69.47 131.27 44.48 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.906 0.384 . . . . 75.140000000000001 111.549 -177.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.6 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -160.66 -146.03 4.48 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.259 -0.496 . . . . 61.299999999999997 113.358 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 41.4 p -139.8 161.28 37.94 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.887 0.375 . . . . 75.340000000000003 111.542 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.0 p -139.74 144.6 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.132 0.491 . . . . 65.439999999999998 111.462 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.23 156.47 40.94 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.93 -0.577 . . . . 74.450000000000003 111.219 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.568 ' HD3' HD23 ' A' ' 67' ' ' LEU . 27.7 ttpp -90.12 136.95 32.74 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.89 -0.506 . . . . 72.219999999999999 110.586 174.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.3 t -138.34 157.52 46.08 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.092 0.472 . . . . 74.420000000000002 112.217 -173.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -83.02 -4.47 58.36 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.954 -0.566 . . . . 40.130000000000003 111.437 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -70.9 146.5 49.54 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.031 -0.531 . . . . 75.019999999999996 111.832 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.74 152.04 43.08 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.136 0.493 . . . . 73.430000000000007 111.926 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.89 121.9 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.522 -0.308 . . . . 74.109999999999999 110.587 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 135' ' ' LEU . 10.2 mt -62.73 94.24 0.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.005 0.372 . . . . 73.310000000000002 112.005 -178.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.1 m -53.56 150.69 6.6 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.156 -0.474 . . . . 72.109999999999999 110.72 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.55 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 67.9 t -45.09 -48.76 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 112.948 0.721 . . . . 64.209999999999994 112.948 -171.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -72.52 -44.07 62.69 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.213 -0.304 . . . . 70.120000000000005 111.653 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -56.34 -39.61 73.11 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.92 0.867 . . . . 72.120000000000005 110.107 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.541 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.7 tt -60.3 -42.44 95.53 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.791 -1.095 . . . . 70.430000000000007 110.879 175.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 56.6 mt -56.02 -52.29 64.73 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.24 0.543 . . . . 52.210000000000001 110.508 176.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -64.33 -29.84 70.91 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.617 -0.719 . . . . 73.319999999999993 111.623 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -71.25 -40.43 71.02 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.387 0.514 . . . . 63.340000000000003 112.387 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.469 HD12 ' H ' ' A' ' 146' ' ' SER . 2.9 pp -91.05 -14.25 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 112.331 0.493 . . . . 74.439999999999998 112.331 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 133.96 -62.49 0.63 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.123 -0.56 . . . . 65.510000000000005 113.072 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.469 ' H ' HD12 ' A' ' 144' ' ' ILE . 43.3 t . . . . . 0 N--CA 1.472 0.665 0 O-C-N 122.49 -0.418 . . . . 74.019999999999996 111.482 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.746 0.308 . . . . 74.329999999999998 111.657 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -157.65 -152.07 6.24 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.189 -0.529 . . . . 63.009999999999998 112.736 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.6 t 56.97 -121.82 1.55 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 116.726 0.263 . . . . 72.310000000000002 111.065 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.3 t 55.9 28.38 12.47 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.673 0.62 . . . . 71.549999999999997 112.673 172.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -70.7 105.21 3.09 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.94 -0.475 . . . . 74.109999999999999 111.695 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.423 ' O ' ' HB2' ' A' ' 7' ' ' HIS . 97.0 m-70 -120.49 -178.58 3.73 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.769 0.319 . . . . 74.340000000000003 111.854 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 6' ' ' HIS . 1.5 m-70 72.05 167.43 0.31 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.36 0.664 . . . . 62.200000000000003 111.926 -177.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.0 m80 64.09 177.4 0.17 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.767 0.794 . . . . 74.120000000000005 112.434 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -132.13 -55.01 0.98 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.377 -0.829 . . . . 71.450000000000003 109.511 171.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -142.37 -47.8 0.34 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.971 -0.559 . . . . 73.420000000000002 110.617 172.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.9 p -125.78 -172.67 2.65 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.472 -0.331 . . . . 74.010000000000005 110.664 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.6 p -61.05 -45.94 92.73 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.83 0.348 . . . . 71.209999999999994 111.336 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.68 126.9 2.62 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.305 -0.474 . . . . 75.340000000000003 113.312 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -88.93 116.33 27.14 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.752 -0.263 . . . . 75.150000000000006 110.82 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.33 -72.73 0.17 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.686 0.279 . . . . 65.439999999999998 110.906 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -113.96 139.47 49.2 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.919 0.39 . . . . 72.349999999999994 111.33 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -122.4 127.74 50.08 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 110.021 -0.363 . . . . 75.420000000000002 110.021 178.336 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -82.64 11.02 6.29 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.338 0.495 . . . . 73.010000000000005 112.338 -173.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 57.13 32.57 21.92 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.227 0.537 . . . . 54.109999999999999 111.942 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.472 ' HG2' ' N ' ' A' ' 21' ' ' GLY . 23.5 tt0 -92.94 165.48 12.85 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.12 -0.491 . . . . 65.049999999999997 110.767 178.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.472 ' N ' ' HG2' ' A' ' 20' ' ' GLN . . . -55.65 133.2 50.04 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.225 -0.512 . . . . 74.010000000000005 112.862 176.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -63.27 96.88 0.11 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.748 0.309 . . . . 72.239999999999995 111.46 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.1 ptp -102.1 162.65 12.75 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.263 0.554 . . . . 74.219999999999999 111.688 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.552 HD11 ' HB3' ' A' ' 64' ' ' ALA . 20.2 mt -124.58 139.06 54.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.89 -0.596 . . . . 74.530000000000001 111.327 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -78.31 109.01 12.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.658 0.742 . . . . 74.219999999999999 110.618 174.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 34.8 m -132.22 159.13 43.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.731 -1.122 . . . . 70.150000000000006 111.849 -172.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.734 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 44.0 tt0 -99.27 117.62 34.13 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.106 0.479 . . . . 71.219999999999999 111.102 175.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.54 HG22 HD11 ' A' ' 96' ' ' ILE . 38.4 t -89.79 107.81 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.218 0.607 . . . . 65.340000000000003 111.578 -177.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.407 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 2.5 mt -94.11 148.51 4.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 111.803 0.297 . . . . 75.219999999999999 111.803 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.645 ' OG ' HG21 ' A' ' 108' ' ' ILE . 73.7 m -109.97 106.93 16.64 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.055 0.455 . . . . 54.240000000000002 111.36 175.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.486 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . -86.4 100.29 2.51 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 121.256 -0.497 . . . . 73.519999999999996 113.139 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.806 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -71.43 98.94 1.9 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.464 0.649 . . . . 62.509999999999998 111.413 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.7 p -106.25 169.17 8.67 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.553 -0.749 . . . . 75.409999999999997 110.908 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.9 mp 60.24 93.08 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.346 0.593 . . . . 54.409999999999997 110.917 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -57.87 -177.79 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.54 0.941 . . . . 64.209999999999994 113.54 -172.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 73.63 -63.55 0.43 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.605 0.762 . . . . 72.230000000000004 111.605 -175.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.93 145.55 15.71 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.013 -0.613 . . . . 12.33 113.495 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.51 ' HB3' ' HD2' ' A' ' 43' ' ' LYS . . . -169.34 161.56 10.02 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.153 0.581 . . . . 42.520000000000003 110.135 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.8 p -81.77 166.92 19.61 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.265 -0.574 . . . . 74.340000000000003 109.908 174.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.6 t -54.8 -34.9 31.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.023 0.44 . . . . 41.219999999999999 111.271 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.48 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 43.6 tt0 -62.9 -43.14 99.59 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 116.02 -0.537 . . . . 74.400000000000006 112.348 -177.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.433 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 1.4 mp0 -63.95 -26.46 68.59 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 122.101 -0.374 . . . . 72.099999999999994 111.747 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.51 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 26.8 mtpp -119.36 33.13 5.76 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.094 0.405 . . . . 70.510000000000005 112.094 -174.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.48 ' HG ' ' HA ' ' A' ' 41' ' ' GLU . 74.8 mt -65.84 85.65 0.08 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.288 0.566 . . . . 74.150000000000006 111.381 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.2 t -142.28 167.59 21.76 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.809 -0.632 . . . . 63.219999999999999 111.403 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -52.0 -42.77 63.25 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.058 0.456 . . . . 75.0 110.889 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -57.53 -33.44 68.09 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.218 0.451 . . . . 74.219999999999999 112.218 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.413 ' CD2' ' HB2' ' A' ' 43' ' ' LYS . 1.4 t80 -71.53 -26.53 62.69 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.498 0.666 . . . . 74.019999999999996 109.789 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.54 ' HD1' HG23 ' A' ' 137' ' ' VAL . 71.4 t80 -89.45 -2.31 58.34 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.616 -0.72 . . . . 72.25 110.902 175.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -101.66 -44.38 5.58 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.025 -0.422 . . . . 75.109999999999999 111.811 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.52 -64.0 1.29 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.316 0.858 . . . . 71.230000000000004 113.316 -172.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 32.9 m -79.07 21.8 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 113.338 0.866 . . . . 73.329999999999998 113.338 -170.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.629 ' N ' HD22 ' A' ' 53' ' ' ASN . 0.7 OUTLIER -108.0 11.17 28.04 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.073 0.768 . . . . 63.219999999999999 113.073 -172.546 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -133.2 166.28 22.82 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.598 0.713 . . . . 71.439999999999998 112.487 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.76 135.18 48.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.21 -0.905 . . . . 63.32 110.042 172.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.604 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 45.0 mt-10 -94.67 115.56 27.69 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.867 0.365 . . . . 61.310000000000002 111.285 177.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.3 mp -109.79 150.93 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.062 -0.517 . . . . 73.329999999999998 110.831 -178.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -71.78 156.86 38.85 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.71 0.291 . . . . 62.439999999999998 111.418 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -54.74 -47.39 73.9 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.173 0.511 . . . . 71.129999999999995 111.864 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.5 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 17.3 mm-40 -56.41 -52.73 63.55 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.206 -0.452 . . . . 64.099999999999994 112.169 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -66.29 -36.57 83.31 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.007 0.432 . . . . 53.200000000000003 111.024 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -55.68 -48.79 74.47 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.96 -0.563 . . . . 74.340000000000003 111.103 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -66.71 -39.38 88.01 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.05 -0.523 . . . . 75.349999999999994 111.185 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.552 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -61.15 -35.05 76.04 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.058 0.392 . . . . 52.049999999999997 112.058 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.2 mt -89.55 -12.13 40.79 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.042 0.386 . . . . 73.299999999999997 112.042 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.36 48.32 83.22 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.09 -0.576 . . . . 61.210000000000001 112.782 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.668 HD23 ' HD3' ' A' ' 129' ' ' LYS . 92.1 mt -86.88 143.26 27.51 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.259 0.552 . . . . 65.219999999999999 112.474 -175.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -93.61 149.62 21.08 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.989 -0.551 . . . . 74.319999999999993 109.909 171.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -61.26 100.22 0.12 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.452 0.644 . . . . 74.340000000000003 111.279 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.76 29.18 7.05 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.333 -0.848 . . . . 74.030000000000001 112.841 -174.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -82.07 -178.27 6.95 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 122.598 -0.354 . . . . 52.009999999999998 111.158 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.632 HH21 ' HA ' ' A' ' 131' ' ' ASP . 24.2 mtm-85 -116.78 123.07 46.22 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.85 0.357 . . . . 63.439999999999998 111.068 -177.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.81 140.82 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.034 0.445 . . . . 75.140000000000001 112.178 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 31.7 ttmt -110.17 126.38 54.03 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.199 0.524 . . . . 71.129999999999995 111.318 174.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.523 HG11 HG21 ' A' ' 28' ' ' VAL . 47.0 t -101.07 132.09 47.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.87 -0.604 . . . . 62.350000000000001 110.97 177.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.445 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 4.1 mppt? -118.55 127.65 53.83 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.03 0.443 . . . . 74.209999999999994 111.392 174.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.718 HG22 ' HA3' ' A' ' 125' ' ' GLY . 40.7 p -127.25 -170.91 2.3 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.894 -0.594 . . . . 55.240000000000002 110.253 175.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -72.34 -11.34 60.66 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.87 0.367 . . . . 60.25 111.592 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -96.07 -40.54 9.18 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.087 0.403 . . . . 72.150000000000006 112.087 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.79 -146.95 8.76 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.636 -0.792 . . . . 44.229999999999997 113.744 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 14.0 pt-20 -152.13 153.41 33.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.781 0.324 . . . . 74.530000000000001 111.589 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 12.2 p -157.15 149.46 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 116.653 -0.249 . . . . 74.109999999999999 111.67 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.0 t -108.28 119.74 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 116.762 -0.199 . . . . 70.400000000000006 110.856 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.462 HG12 ' CD2' ' A' ' 103' ' ' TYR . 29.7 m -128.37 172.16 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-O 120.914 0.388 . . . . 73.329999999999998 111.727 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -77.43 143.47 38.56 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.022 0.439 . . . . 72.409999999999997 111.39 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.24 122.95 36.16 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.471 0.545 . . . . 70.430000000000007 112.471 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -123.63 157.86 32.8 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.161 0.505 . . . . 74.450000000000003 110.774 172.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -102.9 107.23 17.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.046 -0.525 . . . . 71.030000000000001 110.28 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.604 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -109.35 -175.18 21.24 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.852 -0.69 . . . . 74.409999999999997 114.171 -172.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -90.26 17.12 7.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.865 0.364 . . . . 74.019999999999996 111.439 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.69 151.87 93.48 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 116.45 -0.341 . . . . 62.340000000000003 111.52 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -67.71 154.49 73.12 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.453 2.102 . . . . 72.329999999999998 112.585 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.5 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 87.9 tttt -57.42 137.15 56.5 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.732 0.301 . . . . 74.409999999999997 111.609 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 71.84 26.92 71.67 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 120.817 -0.706 . . . . 31.43 113.031 -174.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.734 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 13.9 ttt -150.69 137.5 19.05 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 122.213 -0.58 . . . . 64.340000000000003 110.151 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.54 HD11 HG22 ' A' ' 28' ' ' VAL . 38.0 pt -133.53 144.84 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.355 0.598 . . . . 54.229999999999997 112.166 -178.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.486 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 66.4 t80 -105.78 127.33 53.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.969 -0.56 . . . . 72.329999999999998 111.452 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 30' ' ' SER . 46.1 mt -127.29 128.32 24.09 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 122.337 0.255 . . . . 73.310000000000002 110.563 174.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.453 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 37.1 Cg_exo -57.76 142.91 96.25 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.2 1.933 . . . . 51.409999999999997 112.704 177.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.5 tpt -59.22 103.73 0.2 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.025 0.441 . . . . 72.120000000000005 111.435 -178.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.74 -178.08 34.4 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.678 -0.773 . . . . 71.329999999999998 112.893 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.537 ' O ' ' HG2' ' A' ' 106' ' ' MET . 18.8 Cg_endo -57.53 -34.63 98.34 Favored 'Trans proline' 0 N--CA 1.478 0.579 0 C-N-CA 122.76 2.307 . . . . 72.329999999999998 111.718 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.462 ' CD2' HG12 ' A' ' 84' ' ' VAL . 25.6 m-85 -58.73 -49.38 77.83 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.92 -0.582 . . . . 73.200000000000003 110.4 175.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -63.06 -42.61 99.72 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.851 -0.613 . . . . 72.340000000000003 111.588 176.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -61.46 -7.46 3.14 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.663 0.616 . . . . 72.409999999999997 112.663 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.579 ' SD ' HD21 ' A' ' 140' ' ' LEU . 90.5 mmm -84.2 -20.21 32.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.772 0.32 . . . . 74.400000000000006 111.556 176.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.3 m -130.83 -12.1 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 113.271 0.841 . . . . 63.240000000000002 113.271 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.645 HG21 ' OG ' ' A' ' 30' ' ' SER . 8.8 pt -96.72 -179.05 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 121.725 -0.609 . . . . 70.109999999999999 112.254 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.603 ' H ' HG21 ' A' ' 123' ' ' VAL . 16.4 t70 -91.89 108.05 27.2 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.008 -0.542 . . . . 75.120000000000005 111.133 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.64 5.81 6.05 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.555 2.17 . . . . 65.040000000000006 113.574 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.0 t -73.57 -37.17 65.6 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.961 0.41 . . . . 65.129999999999995 111.012 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.7 t -82.27 154.88 25.14 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.074 0.464 . . . . 54.409999999999997 111.78 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -109.5 2.15 20.28 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.262 -0.426 . . . . 64.409999999999997 111.193 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.05 48.39 86.36 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.173 -0.537 . . . . 65.129999999999995 112.846 -176.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 85.3 m -97.35 140.75 31.34 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.791 0.329 . . . . 43.329999999999998 111.832 -176.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.76 -120.73 6.96 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.096 -0.573 . . . . 63.100000000000001 114.352 172.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.4 mmt -84.5 144.77 43.59 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 112.214 0.45 . . . . 53.229999999999997 112.214 -174.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -76.17 96.6 1.07 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.609 2.206 . . . . 71.310000000000002 113.231 -177.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -89.8 178.39 6.25 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.227 -0.442 . . . . 71.019999999999996 111.301 175.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -130.08 18.66 5.49 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.216 0.531 . . . . 72.239999999999995 110.872 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.4 ' NZ ' ' O ' ' A' ' 122' ' ' GLY . 27.1 tptp -83.4 141.3 31.83 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.995 -0.548 . . . . 73.230000000000004 111.272 -178.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . -127.95 -179.63 15.97 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.197 -0.525 . . . . 61.530000000000001 113.323 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' H ' ' A' ' 109' ' ' ASP . 84.2 t -94.25 123.32 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 111.924 0.342 . . . . 53.530000000000001 111.924 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 54.9 mtmt -75.36 147.19 40.27 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.45 0.537 . . . . 63.100000000000001 112.45 -177.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.718 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -169.6 -157.97 12.8 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.88 -0.6 . . . . 65.230000000000004 112.658 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 45.8 p -124.69 138.72 54.28 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.257 -0.555 . . . . 72.420000000000002 111.586 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.3 p -126.64 144.57 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.883 0.373 . . . . 73.310000000000002 111.64 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.92 156.93 36.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.188 -0.46 . . . . 74.010000000000005 110.999 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.668 ' HD3' HD23 ' A' ' 67' ' ' LEU . 27.1 ttpp -72.24 141.56 48.96 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.908 0.385 . . . . 74.430000000000007 111.185 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.4 t -132.12 160.83 34.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.232 0.539 . . . . 73.150000000000006 112.089 -175.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.632 ' HA ' HH21 ' A' ' 72' ' ' ARG . 5.1 m-20 -92.21 -10.94 36.81 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.826 -0.625 . . . . 73.310000000000002 111.031 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.39 168.25 9.22 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.22 0.533 . . . . 75.120000000000005 112.12 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -86.81 152.71 22.25 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.097 -0.502 . . . . 74.409999999999997 110.915 175.664 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 83.8 t -63.08 129.31 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.63 0.252 . . . . 73.209999999999994 110.654 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 135' ' ' LEU . 8.9 mt -66.91 90.67 0.18 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.724 0.268 . . . . 63.450000000000003 111.724 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.8 m -49.38 148.88 2.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.068 -0.515 . . . . 71.25 110.967 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.54 HG23 ' HD1' ' A' ' 49' ' ' PHE . 90.5 t -45.18 -45.14 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 112.123 0.416 . . . . 64.209999999999994 112.123 -175.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -71.95 -43.92 64.45 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.391 -0.368 . . . . 74.530000000000001 111.837 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.435 ' HG2' ' HE3' ' A' ' 133' ' ' LYS . 4.3 tp10 -61.13 -32.47 72.17 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.486 0.66 . . . . 74.140000000000001 110.53 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.579 HD21 ' SD ' ' A' ' 106' ' ' MET . 1.4 tt -65.85 -37.91 87.44 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.376 -0.829 . . . . 75.239999999999995 110.654 176.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 29.6 mt -60.19 -43.96 95.46 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.581 0.705 . . . . 75.430000000000007 109.944 175.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -68.64 -37.07 79.41 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.226 -0.897 . . . . 72.420000000000002 111.615 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.03 -46.88 88.05 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.095 -0.502 . . . . 31.43 111.449 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.458 HD12 ' N ' ' A' ' 146' ' ' SER . 2.9 pp -79.86 -23.89 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.949 0.404 . . . . 63.25 111.368 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 67.77 50.52 41.41 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 114.545 0.578 . . . . 71.510000000000005 114.545 172.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.458 ' N ' HD12 ' A' ' 144' ' ' ILE . 37.1 t . . . . . 0 N--CA 1.475 0.803 0 O-C-N 122.325 -0.515 . . . . 34.310000000000002 111.634 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 120.908 0.385 . . . . 73.319999999999993 111.887 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.21 90.0 0.08 OUTLIER Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.441 -0.409 . . . . 72.209999999999994 112.648 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.1 p -62.73 107.39 0.96 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.952 0.406 . . . . 71.530000000000001 111.977 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.3 m -113.81 132.4 55.88 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.288 -0.415 . . . . 72.140000000000001 111.8 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -150.66 157.75 43.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.588 0.355 . . . . 64.109999999999999 111.106 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -142.14 125.53 16.62 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.023 0.44 . . . . 55.32 111.343 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -140.13 133.52 29.94 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.318 0.488 . . . . 74.519999999999996 112.318 -173.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -90.91 173.83 7.76 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.411 -0.359 . . . . 73.030000000000001 111.536 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -143.32 141.89 31.12 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.699 0.629 . . . . 75.219999999999999 112.699 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -131.72 111.67 11.87 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.676 -0.693 . . . . 74.239999999999995 109.677 169.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -63.62 -71.54 0.17 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.112 1.153 . . . . 60.509999999999998 114.112 -169.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.1 t 67.73 104.4 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 120.926 0.393 . . . . 71.109999999999999 111.468 -175.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -149.49 85.87 0.16 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.151 -0.547 . . . . 53.25 113.162 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -89.8 142.17 27.94 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 122.453 -0.439 . . . . 75.530000000000001 111.398 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -91.96 149.51 21.5 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.12 0.486 . . . . 73.150000000000006 112.064 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -109.69 114.38 27.92 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.939 0.4 . . . . 61.229999999999997 111.97 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mp -120.69 163.74 17.62 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.08 0.467 . . . . 52.219999999999999 112.086 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -133.58 169.0 17.64 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.945 -0.57 . . . . 74.439999999999998 110.656 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -103.61 111.5 23.99 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.947 0.403 . . . . 73.140000000000001 112.053 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 68.23 162.42 0.2 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.032 1.123 . . . . 71.120000000000005 114.032 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.74 167.07 38.34 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 114.226 -1.352 . . . . 65.530000000000001 111.566 176.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -77.65 103.09 7.37 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 117.557 0.679 . . . . 51.340000000000003 111.015 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.556 ' HB3' ' HB3' ' A' ' 128' ' ' GLU . 6.1 ptp -111.34 167.16 10.51 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.358 0.599 . . . . 71.319999999999993 111.914 176.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.0 mt -134.53 139.14 45.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 71.030000000000001 111.603 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -84.77 114.06 21.78 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.558 0.694 . . . . 50.140000000000001 110.886 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.444 HG12 ' HA2' ' A' ' 94' ' ' GLY . 34.5 m -134.97 167.17 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 114.959 -1.019 . . . . 42.32 112.338 -170.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -101.16 132.0 46.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.706 0.289 . . . . 73.420000000000002 110.45 171.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.47 111.15 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 112.154 0.427 . . . . 70.239999999999995 112.154 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -100.06 151.06 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.065 0.46 . . . . 73.329999999999998 111.213 174.838 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 74.3 m -124.53 110.0 13.93 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.975 0.417 . . . . 50.539999999999999 111.779 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.97 124.36 7.83 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.277 -0.487 . . . . 60.530000000000001 112.429 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -75.07 101.13 4.42 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.305 0.574 . . . . 62.399999999999999 112.133 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 t -132.21 176.43 8.4 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.752 -0.658 . . . . 51.25 110.389 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.747 HD22 ' HB3' ' A' ' 51' ' ' ALA . 51.4 tp 66.44 -70.66 0.1 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.951 0.405 . . . . 70.120000000000005 111.937 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -103.59 111.72 24.32 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.007 0.432 . . . . 74.109999999999999 111.427 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -108.02 -29.77 8.81 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.142 -0.481 . . . . 72.409999999999997 111.516 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.02 45.27 0.62 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.622 -0.799 . . . . 62.240000000000002 113.955 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.16 178.89 7.57 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.459 -0.436 . . . . 54.43 111.045 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.529 ' OG1' ' HG2' ' A' ' 42' ' ' GLU . 24.4 p -98.06 175.3 6.16 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 110.267 -0.271 . . . . 60.0 110.267 173.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.7 t -65.45 -39.46 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 120.823 0.344 . . . . 65.519999999999996 110.995 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -66.03 -42.12 90.02 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.847 0.356 . . . . 65.109999999999999 111.267 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.529 ' HG2' ' OG1' ' A' ' 39' ' ' THR . 19.6 mm-40 -53.39 -32.54 49.95 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.107 0.479 . . . . 72.129999999999995 111.761 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 48' ' ' TYR . 25.7 mtpp -123.78 25.41 8.07 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.15 -0.477 . . . . 51.100000000000001 111.176 -175.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.531 HD13 ' O ' ' A' ' 44' ' ' LEU . 0.3 OUTLIER -55.73 -13.24 1.59 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.526 0.73 . . . . 71.409999999999997 112.774 -175.179 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 t -58.51 178.35 0.11 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.065 0.765 . . . . 74.549999999999997 113.065 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -47.94 -35.98 11.64 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.797 -0.638 . . . . 74.019999999999996 112.589 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -56.02 -34.49 65.89 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.433 0.531 . . . . 73.010000000000005 112.433 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.533 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -76.58 -23.08 53.49 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.962 -0.461 . . . . 74.530000000000001 110.635 175.499 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.422 ' HD1' HG23 ' A' ' 137' ' ' VAL . 57.6 t80 -90.87 0.41 57.49 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 116.181 -0.463 . . . . 71.510000000000005 112.01 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 51' ' ' ALA . 29.8 p30 -121.66 -44.36 2.34 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.528 -0.733 . . . . 52.310000000000002 112.799 176.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.747 ' HB3' HD22 ' A' ' 34' ' ' LEU . . . -70.19 -30.95 68.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.682 0.993 . . . . 62.049999999999997 113.682 -172.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 33.0 m -118.19 16.1 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 112.769 0.655 . . . . 72.010000000000005 112.769 -177.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -104.87 17.64 23.76 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.868 0.692 . . . . 70.310000000000002 112.868 -174.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -141.3 168.53 19.55 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.065 0.46 . . . . 65.409999999999997 111.93 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.9 144.41 45.51 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.089 -0.505 . . . . 70.230000000000004 111.284 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.522 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 42.1 mt-10 -96.75 113.31 24.85 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.697 0.284 . . . . 65.349999999999994 111.189 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.0 mp -110.43 147.01 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.368 -0.378 . . . . 70.209999999999994 110.82 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -65.79 143.24 57.62 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.665 -0.243 . . . . 71.420000000000002 110.971 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 30.4 tt0 -58.3 -38.39 76.97 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.103 0.779 . . . . 61.240000000000002 113.103 -174.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -60.44 -48.05 83.45 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.957 -0.464 . . . . 75.010000000000005 110.99 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -63.9 -38.07 89.74 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.012 0.434 . . . . 72.239999999999995 110.837 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.41 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 35.8 t-105 -53.26 -51.49 62.1 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.43 0.633 . . . . 74.400000000000006 111.07 175.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -67.92 -35.76 79.01 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.751 -0.659 . . . . 62.25 111.294 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.9 93.2 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.185 0.516 . . . . 72.230000000000004 111.621 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.533 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 73.5 mt -79.46 -16.15 56.59 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.118 -0.492 . . . . 63.5 111.603 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.93 53.96 24.17 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.947 -0.644 . . . . 61.329999999999998 111.888 -173.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.629 HD23 ' HE3' ' A' ' 129' ' ' LYS . 96.2 mt -91.31 160.1 15.67 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.774 0.797 . . . . 72.310000000000002 112.932 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -129.51 127.81 41.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.999 -1.0 . . . . 73.420000000000002 109.394 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -50.8 98.8 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.096 0.776 . . . . 73.239999999999995 113.096 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.92 13.4 11.15 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 115.311 -0.859 . . . . 45.509999999999998 113.77 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.436 ' HA ' HH11 ' A' ' 72' ' ' ARG . 46.9 p-10 -88.67 -169.01 2.38 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 117.665 0.732 . . . . 55.409999999999997 112.33 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.644 ' HG3' HG23 ' A' ' 134' ' ' VAL . 2.4 mpt_? -109.1 127.7 54.37 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.913 0.387 . . . . 72.209999999999994 111.9 -173.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.1 m -124.4 138.47 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.023 0.439 . . . . 74.239999999999995 111.33 174.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.438 ' HE3' ' HG3' ' A' ' 132' ' ' GLU . 39.8 ttmt -102.7 125.66 49.52 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.965 0.412 . . . . 52.039999999999999 110.753 177.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.48 131.17 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.361 -0.607 . . . . 62.350000000000001 109.361 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -134.17 132.23 39.55 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.319 0.58 . . . . 75.319999999999993 112.249 -172.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.704 HG22 ' HA3' ' A' ' 125' ' ' GLY . 30.7 p -138.99 -171.22 3.04 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.961 -0.563 . . . . 63.149999999999999 111.626 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.05 -18.18 65.08 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.928 -0.578 . . . . 60.200000000000003 112.01 175.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 109' ' ' ASP . 98.5 m-85 -88.0 -55.36 3.79 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.911 0.386 . . . . 63.420000000000002 111.505 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.9 -154.17 11.23 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.944 -0.646 . . . . 71.120000000000005 112.93 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.07 154.12 50.41 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.2 0.524 . . . . 65.310000000000002 111.652 178.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -151.0 145.31 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.241 -0.436 . . . . 74.299999999999997 111.036 177.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.5 t -110.31 117.73 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.808 0.337 . . . . 44.310000000000002 111.099 177.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.51 173.95 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 115.966 -0.561 . . . . 75.209999999999994 111.365 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -78.0 133.32 38.0 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.011 0.434 . . . . 72.230000000000004 111.18 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.94 126.5 33.07 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.179 0.437 . . . . 54.240000000000002 112.179 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -132.01 152.03 51.39 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.368 0.604 . . . . 74.439999999999998 110.871 175.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -90.45 121.97 32.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.66 -0.7 . . . . 65.400000000000006 111.249 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.522 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -120.59 -178.5 16.09 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.122 -0.561 . . . . 65.430000000000007 113.801 -174.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -93.66 8.87 39.24 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 122.703 0.401 . . . . 64.420000000000002 111.73 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.1 m -64.17 152.88 87.06 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.473 -0.33 . . . . 75.299999999999997 111.786 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.05 157.71 58.94 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.393 2.062 . . . . 74.430000000000007 112.21 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -64.63 142.2 58.51 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.829 0.347 . . . . 70.129999999999995 111.544 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.444 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 73.18 25.94 71.95 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.881 -0.676 . . . . 43.409999999999997 112.745 -173.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.2 ttt -154.97 136.74 14.44 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.428 -0.454 . . . . 75.030000000000001 110.278 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.2 pt -134.69 145.74 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.116 0.484 . . . . 55.43 112.264 -177.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.413 ' HA ' HG12 ' A' ' 29' ' ' ILE . 70.4 t80 -103.94 134.86 46.52 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.017 0.437 . . . . 74.129999999999995 111.379 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.656 ' O ' ' HA ' ' A' ' 30' ' ' SER . 48.3 mt -130.75 132.96 24.27 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.368 -0.378 . . . . 65.019999999999996 110.534 175.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.401 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 33.7 Cg_exo -61.65 129.05 26.43 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.058 1.839 . . . . 72.349999999999994 112.075 174.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.492 ' HE3' HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -57.73 104.8 0.2 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.029 0.443 . . . . 72.099999999999994 110.858 -176.417 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.25 -175.03 29.75 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.812 -0.708 . . . . 52.219999999999999 112.854 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.439 ' O ' ' HG2' ' A' ' 106' ' ' MET . 16.0 Cg_endo -56.56 -33.28 92.5 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.656 2.238 . . . . 65.430000000000007 112.254 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.463 ' HA ' HD11 ' A' ' 140' ' ' LEU . 37.5 m-85 -63.35 -50.97 67.89 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.092 0.472 . . . . 72.150000000000006 110.23 175.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -59.97 -41.48 92.04 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.167 -0.47 . . . . 61.039999999999999 111.801 176.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.423 HD22 ' HA ' ' A' ' 102' ' ' PRO . 91.7 m-20 -53.3 -29.16 32.01 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.15 0.426 . . . . 63.340000000000003 112.15 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.483 ' SD ' HD21 ' A' ' 140' ' ' LEU . 87.8 mmm -65.62 -24.15 66.99 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.29 -0.414 . . . . 75.25 112.112 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.5 -12.92 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 112.945 0.72 . . . . 62.030000000000001 112.945 -173.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.492 HD11 ' HE3' ' A' ' 100' ' ' MET . 6.9 pt -107.44 -179.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.868 -0.52 . . . . 63.340000000000003 111.738 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 29.4 t70 -105.1 108.02 60.29 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 116.141 -0.481 . . . . 63.420000000000002 110.563 173.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.97 13.81 2.07 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.619 2.213 . . . . 72.340000000000003 113.648 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.5 m -80.94 -17.88 48.99 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.856 0.36 . . . . 71.319999999999993 111.843 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.3 t -97.71 109.58 22.31 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.303 0.573 . . . . 74.219999999999999 111.843 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -75.78 76.63 2.73 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.184 0.516 . . . . 74.010000000000005 111.801 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.05 -166.67 18.34 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.903 -0.59 . . . . 75.329999999999998 114.013 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.8 p -137.32 -58.31 0.7 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.987 0.422 . . . . 62.210000000000001 111.234 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.72 113.01 3.19 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.041 -0.527 . . . . 63.409999999999997 111.948 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 84.9 mtp 68.01 159.28 0.14 Allowed Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 116.966 0.383 . . . . 71.109999999999999 111.241 -174.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -56.81 95.34 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.631 2.221 . . . . 75.25 113.72 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -113.27 -23.24 10.03 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.321 0.489 . . . . 75.299999999999997 112.321 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 61.9 -160.07 0.31 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.183 0.438 . . . . 75.209999999999994 112.183 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt 75.52 96.64 0.07 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.705 0.802 . . . . 63.130000000000003 112.701 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -111.66 -157.76 14.35 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.826 -0.624 . . . . 33.439999999999998 113.984 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.41 HG21 ' H ' ' A' ' 109' ' ' ASP . 58.1 t -92.93 133.73 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 122.836 0.454 . . . . 63.420000000000002 111.46 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -74.96 140.84 43.96 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.671 0.619 . . . . 74.439999999999998 112.671 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.704 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -169.62 -165.5 27.09 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.837 -0.62 . . . . 74.129999999999995 113.087 177.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 77.3 p -122.39 155.12 36.71 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.939 0.399 . . . . 70.430000000000007 111.486 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.1 p -129.88 142.77 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.657 -0.498 . . . . 62.539999999999999 109.657 173.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 8.8 pt-20 -143.21 147.65 35.21 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.251 0.834 . . . . 72.209999999999994 113.251 -174.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.629 ' HE3' HD23 ' A' ' 67' ' ' LEU . 1.8 tppp? -77.03 109.28 10.73 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.427 -0.806 . . . . 72.010000000000005 109.675 168.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.1 t -123.22 162.53 22.39 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.348 0.594 . . . . 74.340000000000003 112.456 -173.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.82 -12.14 59.78 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.397 -0.82 . . . . 71.439999999999998 111.209 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.438 ' HG3' ' HE3' ' A' ' 74' ' ' LYS . 6.2 mm-40 -61.1 160.26 10.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.684 0.754 . . . . 74.219999999999999 112.925 -176.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -95.15 160.22 14.66 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.425 -0.807 . . . . 74.109999999999999 110.917 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.644 HG23 ' HG3' ' A' ' 72' ' ' ARG . 71.9 t -72.25 136.42 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 120.733 0.302 . . . . 62.240000000000002 110.751 174.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.6 mt -73.4 132.29 42.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.544 -0.298 . . . . 73.200000000000003 111.441 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.4 t -73.15 147.83 44.45 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.208 -0.664 . . . . 73.200000000000003 109.208 170.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.422 HG23 ' HD1' ' A' ' 49' ' ' PHE . 99.3 t -46.05 -52.5 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 112.672 0.619 . . . . 70.340000000000003 112.672 -173.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -73.0 -35.41 66.82 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.04 -0.412 . . . . 73.519999999999996 111.723 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -60.9 -33.83 73.73 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.747 0.784 . . . . 72.109999999999999 110.156 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.483 HD21 ' SD ' ' A' ' 106' ' ' MET . 4.8 tt -60.37 -44.19 95.84 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.075 -0.966 . . . . 72.430000000000007 110.359 171.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.1 mt -61.56 -41.23 97.09 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.181 0.515 . . . . 71.030000000000001 110.19 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -64.41 -34.61 78.58 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.904 -0.589 . . . . 75.329999999999998 110.96 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.02 -36.05 82.22 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.369 -0.378 . . . . 54.25 111.801 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.49 HG13 ' H ' ' A' ' 146' ' ' SER . 33.8 pt -88.9 -16.29 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 111.96 0.356 . . . . 74.230000000000004 111.96 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 102.32 -5.94 52.75 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.381 -0.438 . . . . 53.310000000000002 113.953 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.49 ' H ' HG13 ' A' ' 144' ' ' ILE . 30.7 t . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 121.409 0.623 . . . . 61.5 111.902 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.1 mmm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 111.849 0.314 . . . . 74.349999999999994 111.849 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.19 118.23 0.43 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.602 -0.808 . . . . 70.25 113.398 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.2 p -89.87 98.57 11.85 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.713 0.292 . . . . 65.540000000000006 111.078 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.6 m -60.21 123.25 16.64 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.0 0.428 . . . . 75.030000000000001 112.018 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -93.19 154.26 18.15 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.449 -0.342 . . . . 72.349999999999994 110.961 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -128.69 138.48 52.17 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.897 0.379 . . . . 75.25 111.957 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -115.08 110.26 19.3 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.1 -0.5 . . . . 53.25 111.122 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -74.01 156.21 37.77 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.195 0.813 . . . . 51.200000000000003 113.195 -174.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -134.55 176.1 8.94 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.9 -0.591 . . . . 73.400000000000006 110.879 174.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -87.28 162.65 17.3 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.081 0.467 . . . . 74.329999999999998 111.297 174.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.7 m -75.81 84.72 2.78 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.473 -0.331 . . . . 74.230000000000004 111.315 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.6 p -99.16 176.57 5.5 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.837 0.351 . . . . 75.340000000000003 111.019 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.72 16.83 25.87 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 120.873 -0.679 . . . . 71.329999999999998 114.313 -176.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 44.0 mtt180 -73.91 101.8 3.9 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.68 0.753 . . . . 73.340000000000003 112.241 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -82.91 -165.24 1.02 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.084 -0.962 . . . . 75.109999999999999 111.626 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -147.67 -63.87 0.27 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.466 -0.334 . . . . 73.340000000000003 110.963 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.4 mp 70.17 115.84 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.803 0.668 . . . . 74.109999999999999 112.803 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 67.79 170.09 0.27 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.206 -0.906 . . . . 73.310000000000002 113.167 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -148.0 36.99 0.86 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.565 -0.743 . . . . 73.439999999999998 110.335 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -136.86 161.99 34.46 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.236 -0.438 . . . . 74.099999999999994 111.56 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.45 72.76 1.11 Allowed Glycine 0 CA--C 1.528 0.847 0 CA-C-N 116.243 -0.435 . . . . 63.130000000000003 113.297 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -99.13 136.69 38.72 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 122.357 -0.496 . . . . 75.150000000000006 112.044 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.438 ' SD ' HG21 ' A' ' 126' ' ' THR . 7.0 ptp -104.42 154.76 19.46 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.06 -0.518 . . . . 74.549999999999997 110.855 174.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.557 HD12 ' HG ' ' A' ' 65' ' ' LEU . 9.5 mt -104.84 127.36 52.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.028 0.442 . . . . 74.25 111.687 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -71.29 113.23 8.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.732 0.777 . . . . 71.329999999999998 111.865 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 35.3 m -134.09 157.62 41.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.71 -1.132 . . . . 73.109999999999999 111.742 -174.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 41.8 tt0 -98.74 117.88 34.21 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.905 0.383 . . . . 74.129999999999995 110.699 175.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.634 HG22 HD11 ' A' ' 96' ' ' ILE . 34.4 t -91.04 110.63 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.944 -0.571 . . . . 71.329999999999998 111.848 -173.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.51 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 2.0 mt -95.72 159.92 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 122.06 -0.4 . . . . 71.219999999999999 111.731 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.3 t -122.87 111.71 16.99 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.949 0.404 . . . . 63.100000000000001 111.245 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.34 117.89 5.7 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.319 -0.467 . . . . 60.450000000000003 113.534 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.497 HH11 ' HA ' ' A' ' 32' ' ' ARG . 10.8 mmm180 -77.34 16.32 0.63 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.992 0.738 . . . . 74.120000000000005 112.992 -175.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.2 t -64.03 -41.48 97.41 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.987 0.422 . . . . 63.439999999999998 111.729 176.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.8 mp -110.64 164.05 13.12 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.091 0.472 . . . . 72.299999999999997 111.995 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.8 t30 59.58 92.31 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.354 -0.839 . . . . 72.319999999999993 112.446 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -91.79 3.3 55.43 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.91 -0.586 . . . . 74.439999999999998 110.587 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.51 47.94 0.16 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.958 -0.565 . . . . 74.430000000000007 112.065 -175.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.42 ' HB1' ' HG2' ' A' ' 42' ' ' GLU . . . -134.9 142.9 46.67 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.952 0.406 . . . . 31.440000000000001 111.602 -176.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.579 HG23 ' H ' ' A' ' 42' ' ' GLU . 5.6 t -67.1 156.98 34.75 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.511 -0.313 . . . . 74.239999999999995 111.237 175.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.5 m -59.5 -28.2 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.861 0.363 . . . . 54.219999999999999 111.144 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -66.58 -33.63 76.1 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.19 0.519 . . . . 74.25 110.576 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.579 ' H ' HG23 ' A' ' 39' ' ' THR . 5.9 tp10 -51.15 -37.77 48.21 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.789 -0.642 . . . . 75.340000000000003 111.371 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.626 ' HB2' ' CD2' ' A' ' 48' ' ' TYR . 2.7 mptp? -105.98 -62.26 1.4 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.22 -0.445 . . . . 73.420000000000002 110.629 176.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.1 tp 69.16 -31.43 0.21 Allowed 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.908 1.447 . . . . 64.319999999999993 114.908 172.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.9 t -54.58 154.42 4.87 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.587 0.588 . . . . 73.040000000000006 112.587 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 49' ' ' PHE . 46.2 tt0 -57.13 -26.82 61.15 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.902 0.334 . . . . 73.540000000000006 111.902 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.6 -36.32 69.27 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.859 0.361 . . . . 61.229999999999997 111.066 174.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.626 ' CD2' ' HB2' ' A' ' 43' ' ' LYS . 8.6 t80 -59.63 -41.23 90.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.55 0.691 . . . . 74.430000000000007 109.876 174.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.45 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 50.5 t80 -63.61 -65.15 0.72 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.24 -0.891 . . . . 54.25 110.554 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -58.0 -21.54 45.34 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.773 0.656 . . . . 73.439999999999998 112.773 -176.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.28 -32.19 33.32 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.031 0.752 . . . . 45.210000000000001 113.031 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 48' ' ' TYR . 32.7 m -116.93 4.88 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 113.27 0.841 . . . . 73.329999999999998 113.27 -175.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -94.58 28.34 2.66 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.377 0.88 . . . . 74.420000000000002 113.377 -177.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.446 ' CE2' ' HE2' ' A' ' 87' ' ' LYS . 17.8 p90 -144.46 151.62 39.45 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.556 -0.715 . . . . 64.209999999999994 111.979 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.78 139.59 53.7 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.617 -0.72 . . . . 32.130000000000003 110.872 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.662 ' HG2' ' HE3' ' A' ' 87' ' ' LYS . 41.3 mt-10 -95.42 112.66 24.33 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.865 0.364 . . . . 73.430000000000007 111.423 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.0 mp -109.17 145.67 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.275 -0.42 . . . . 70.340000000000003 110.518 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -61.81 151.93 32.92 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.284 0.564 . . . . 52.109999999999999 111.763 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 14.8 tm-20 -55.92 -52.94 62.36 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.705 -0.679 . . . . 61.409999999999997 111.964 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -55.75 -53.24 59.03 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.325 0.491 . . . . 70.239999999999995 112.325 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -61.09 -35.98 78.46 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.629 0.728 . . . . 75.219999999999999 110.663 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.519 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 43.0 t-105 -52.78 -53.84 42.52 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.023 -0.99 . . . . 73.439999999999998 111.769 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -73.53 -30.15 62.9 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.299 -0.409 . . . . 70.310000000000002 111.644 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.439 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -58.64 -34.85 71.66 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.032 0.444 . . . . 65.099999999999994 111.581 177.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.557 ' HG ' HD12 ' A' ' 24' ' ' LEU . 82.6 mt -89.64 -13.86 36.15 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.154 -0.475 . . . . 43.240000000000002 111.461 176.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.72 44.72 19.47 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.396 -0.431 . . . . 72.040000000000006 112.825 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' A' ' 129' ' ' LYS . 92.9 mt -85.1 149.97 25.18 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.509 0.671 . . . . 72.219999999999999 112.095 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -114.61 144.96 42.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.691 -0.686 . . . . 70.150000000000006 109.213 169.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -61.33 93.37 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.017 0.913 . . . . 61.229999999999997 111.697 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.0 -7.42 3.8 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 114.612 -1.176 . . . . 43.240000000000002 113.267 -175.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -69.35 178.53 2.36 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.04 0.756 . . . . 74.409999999999997 113.04 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.2 mtm-85 -113.61 139.63 48.86 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.688 -0.687 . . . . 73.519999999999996 110.512 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.35 139.64 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.472 0.653 . . . . 73.140000000000001 112.716 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -90.38 131.29 36.24 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.427 -0.806 . . . . 72.120000000000005 110.207 172.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.9 t -119.52 125.72 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.696 -0.483 . . . . 73.099999999999994 109.696 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.459 ' HG2' ' HB3' ' A' ' 81' ' ' GLU . 25.6 mtpp -133.9 131.59 39.3 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.991 0.737 . . . . 73.299999999999997 112.991 -171.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.652 HG22 ' HA3' ' A' ' 125' ' ' GLY . 30.3 p -140.1 -176.23 4.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.529 -0.759 . . . . 71.219999999999999 110.973 178.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.78 -11.4 60.82 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.365 -0.38 . . . . 71.040000000000006 111.681 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 109' ' ' ASP . 93.8 m-85 -89.31 -40.45 12.78 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.802 0.334 . . . . 71.430000000000007 111.296 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.05 -147.26 10.24 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.144 -0.55 . . . . 43.420000000000002 112.652 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.459 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 11.2 pt-20 -155.04 154.43 32.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.143 0.497 . . . . 71.319999999999993 112.218 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.3 p -149.51 155.32 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.999 -0.546 . . . . 73.049999999999997 111.169 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.83 116.94 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 122.382 -0.198 . . . . 74.219999999999999 111.017 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.5 176.28 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 116.496 -0.32 . . . . 72.430000000000007 111.267 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -77.68 160.4 28.5 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.203 0.525 . . . . 75.439999999999998 111.405 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.11 127.2 50.47 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.243 0.544 . . . . 60.450000000000003 111.734 -173.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.662 ' HE3' ' HG2' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -131.24 129.71 41.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.877 -0.601 . . . . 55.32 111.148 -178.776 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -79.88 98.65 7.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.035 -0.53 . . . . 73.099999999999994 110.828 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.553 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -96.56 161.01 22.01 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.989 -0.55 . . . . 45.43 114.018 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -87.63 15.24 7.04 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.358 0.599 . . . . 62.109999999999999 111.566 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.8 m -71.12 157.35 90.45 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 115.685 -0.689 . . . . 74.200000000000003 111.421 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.6 157.67 40.74 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.732 2.288 . . . . 70.310000000000002 113.723 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -62.59 145.64 53.93 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.282 -0.417 . . . . 74.439999999999998 111.35 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 61.99 32.45 82.22 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.843 -0.694 . . . . 72.519999999999996 112.716 -174.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.484 ' HA ' ' H ' ' A' ' 27' ' ' GLU . 21.8 ttt -153.88 136.71 15.34 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.592 -0.358 . . . . 63.43 110.119 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.634 HD11 HG22 ' A' ' 28' ' ' VAL . 40.8 pt -134.84 150.9 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 121.288 0.566 . . . . 72.430000000000007 112.023 -177.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -112.13 130.9 55.74 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.016 -0.538 . . . . 61.020000000000003 111.241 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 30' ' ' SER . 50.4 mt -130.3 128.5 22.7 Favored Pre-proline 0 N--CA 1.474 0.77 0 CA-C-O 120.548 0.213 . . . . 74.109999999999999 110.998 175.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.51 140.66 89.89 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.27 1.98 . . . . 72.25 112.899 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.423 ' HG3' ' NH1' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -60.01 105.84 0.44 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.122 0.486 . . . . 75.0 110.815 -178.646 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.91 -174.71 27.96 Favored Glycine 0 N--CA 1.46 0.273 0 C-N-CA 120.784 -0.722 . . . . 71.530000000000001 112.57 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.512 ' O ' ' HG2' ' A' ' 106' ' ' MET . 26.5 Cg_endo -61.74 -26.72 80.1 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.272 1.981 . . . . 53.240000000000002 111.563 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.463 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 4.1 m-85 -69.17 -53.44 20.04 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.56 -0.745 . . . . 74.150000000000006 110.782 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -60.05 -39.78 87.16 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.268 -0.424 . . . . 43.520000000000003 110.748 174.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -54.71 -25.92 30.51 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.912 0.485 . . . . 70.25 112.042 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.645 ' SD ' HD21 ' A' ' 140' ' ' LEU . 89.9 mmm -67.28 -30.2 70.01 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.947 0.351 . . . . 73.040000000000006 111.947 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.07 -14.01 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 113.187 0.81 . . . . 54.520000000000003 113.187 -171.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 104' ' ' ALA . 8.8 pt -102.67 -178.91 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.163 0.506 . . . . 62.049999999999997 111.753 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 21.7 t70 -109.49 100.0 39.76 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 116.076 -0.511 . . . . 33.43 110.475 173.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -75.09 -2.91 13.17 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.444 2.096 . . . . 71.030000000000001 113.327 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.7 t -67.78 -28.15 67.36 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.983 0.42 . . . . 64.239999999999995 111.467 177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.0 t -104.08 156.44 17.87 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.694 0.627 . . . . 73.209999999999994 112.694 -177.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -108.37 -177.18 3.25 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.72 -0.673 . . . . 70.120000000000005 110.029 172.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.77 54.13 4.1 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.026 -0.607 . . . . 65.209999999999994 112.918 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.0 p -85.54 104.58 15.44 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.963 0.411 . . . . 74.030000000000001 111.385 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 139.66 -103.69 0.39 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.304 -0.475 . . . . 55.25 112.368 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 119' ' ' GLN . 91.1 mtp -86.74 142.71 34.77 Favored Pre-proline 0 CA--C 1.54 0.569 0 O-C-N 122.634 -0.333 . . . . 71.319999999999993 110.783 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.22 79.09 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.281 2.654 . . . . 70.120000000000005 113.954 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 119' ' ' GLN . 18.6 tt0 58.45 29.15 17.89 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.501 0.667 . . . . 72.230000000000004 111.851 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -95.07 144.97 25.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.939 -0.573 . . . . 71.450000000000003 111.38 177.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.3 mttt 67.66 138.79 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.655 0.741 . . . . 70.030000000000001 112.558 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . -134.29 -156.68 7.93 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.817 -0.629 . . . . 63.509999999999998 113.091 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' A' ' 108' ' ' ILE . 59.5 t -85.32 119.16 33.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.926 0.393 . . . . 71.310000000000002 111.487 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 67.5 mttm -67.46 148.88 50.95 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.245 0.545 . . . . 65.239999999999995 112.366 -177.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.652 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -177.25 -143.52 4.94 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 115.94 -0.573 . . . . 53.210000000000001 113.367 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.438 HG21 ' SD ' ' A' ' 23' ' ' MET . 76.5 p -139.3 159.98 40.88 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 122.398 -0.472 . . . . 65.239999999999995 111.769 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.7 p -144.99 145.02 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.103 0.478 . . . . 74.239999999999995 111.484 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -155.61 161.51 40.81 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.364 -0.38 . . . . 71.510000000000005 110.687 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.441 ' HB2' HD21 ' A' ' 67' ' ' LEU . 31.7 ttpt -79.91 131.15 35.78 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.755 -0.59 . . . . 75.25 110.197 173.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.7 t -118.01 156.25 28.88 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.644 0.609 . . . . 61.100000000000001 112.644 -172.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.02 -13.05 60.23 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.724 -0.671 . . . . 74.420000000000002 110.055 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -70.0 147.68 49.82 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.299 -0.864 . . . . 63.520000000000003 113.195 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.713 ' HD3' ' H ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -77.29 157.35 30.79 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.779 -1.1 . . . . 75.430000000000007 111.373 174.265 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.23 130.28 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.87 0.367 . . . . 74.349999999999994 110.826 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.1 mt -66.26 119.45 11.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 71.510000000000005 111.567 178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.437 ' HA ' ' HE2' ' A' ' 49' ' ' PHE . 29.9 t -66.27 148.44 51.85 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.596 -0.52 . . . . 74.319999999999993 109.596 168.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.505 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 62.7 t -46.26 -40.3 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 120.943 0.402 . . . . 75.219999999999999 111.583 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -72.79 -44.39 61.59 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.194 -0.457 . . . . 61.420000000000002 112.165 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -60.91 -36.03 78.21 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.672 0.749 . . . . 74.219999999999999 110.227 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.645 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.5 tt -60.65 -38.87 86.3 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.415 -0.811 . . . . 71.209999999999994 110.799 174.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 54.0 mt -57.84 -47.52 82.42 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.467 0.651 . . . . 73.219999999999999 110.063 175.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.99 -30.7 71.71 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.662 -0.699 . . . . 75.239999999999995 111.449 178.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.1 -40.63 78.26 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.166 0.432 . . . . 74.230000000000004 112.166 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.46 HD12 ' H ' ' A' ' 146' ' ' SER . 2.9 pp -83.9 -18.75 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 112.094 0.405 . . . . 75.129999999999995 112.094 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 142.9 -46.6 0.85 Allowed Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.118 -0.563 . . . . 54.25 113.353 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' A' ' 141' ' ' LEU . 16.0 m . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 121.035 0.445 . . . . 73.319999999999993 111.574 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 ptm . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.157 0.503 . . . . 62.210000000000001 111.645 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.53 153.57 2.65 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 121.197 -0.525 . . . . 63.439999999999998 112.84 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.2 p -168.72 120.45 0.78 Allowed 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.292 -0.534 . . . . 71.230000000000004 111.976 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.0 p -88.1 111.26 21.37 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.976 0.417 . . . . 74.140000000000001 110.432 175.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -79.0 152.55 30.9 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.221 -0.445 . . . . 73.540000000000006 111.851 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -119.91 164.65 15.73 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.013 0.435 . . . . 64.219999999999999 111.874 -176.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -142.28 174.46 10.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.63 0.372 . . . . 72.219999999999999 110.48 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -139.86 144.1 37.07 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.156 0.428 . . . . 62.340000000000003 112.156 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -114.36 141.2 47.94 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.343 -0.39 . . . . 72.129999999999995 111.334 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -92.66 138.09 31.8 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.588 -0.278 . . . . 75.329999999999998 110.712 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.8 p -154.39 128.21 8.77 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.38 0.511 . . . . 54.140000000000001 112.38 -176.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.7 t -165.55 136.04 3.69 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 116.258 -0.428 . . . . 73.319999999999993 111.082 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -160.41 75.38 0.19 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.977 -0.63 . . . . 55.310000000000002 113.052 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.492 ' HA ' ' HE ' ' A' ' 14' ' ' ARG . 5.2 mmp_? -109.95 117.8 34.75 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.446 -0.444 . . . . 74.340000000000003 110.931 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -107.64 -177.47 3.35 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.183 0.438 . . . . 73.409999999999997 112.183 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -124.17 126.28 45.88 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.316 0.488 . . . . 73.099999999999994 112.316 -175.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mp -116.35 128.51 55.6 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.323 -0.399 . . . . 75.230000000000004 110.476 171.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -107.44 155.9 19.54 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.575 0.583 . . . . 74.420000000000002 112.575 -175.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -119.89 166.31 13.47 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.733 -0.667 . . . . 75.310000000000002 110.719 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -131.86 -43.43 0.99 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.227 0.825 . . . . 74.530000000000001 113.227 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.52 166.41 35.36 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.559 -0.829 . . . . 54.439999999999998 113.45 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -119.25 121.84 40.57 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.47 0.545 . . . . 75.129999999999995 112.47 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.5 ptm -80.62 142.06 34.39 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.325 -0.398 . . . . 73.409999999999997 110.528 174.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mp -105.32 142.92 34.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.164 0.507 . . . . 64.319999999999993 112.281 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.409 ' HA ' HG22 ' A' ' 126' ' ' THR . 29.6 tt0 -81.14 112.12 18.21 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.809 -0.632 . . . . 74.299999999999997 110.898 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 33.3 m -128.09 160.19 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.809 0.338 . . . . 71.219999999999999 111.886 -174.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.701 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 86.9 tt0 -98.83 115.23 28.34 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.193 0.521 . . . . 72.549999999999997 110.594 175.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.553 HG22 HD11 ' A' ' 96' ' ' ILE . 39.5 t -88.22 113.9 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.708 -0.678 . . . . 63.210000000000001 111.751 -175.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 mt -98.0 159.8 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.569 -0.287 . . . . 74.530000000000001 111.546 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 71.5 m -126.17 106.13 9.34 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.964 0.411 . . . . 55.340000000000003 111.29 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . -95.28 126.86 8.91 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.039 -0.6 . . . . 75.540000000000006 113.597 -176.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -76.65 81.94 3.29 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.251 0.548 . . . . 72.239999999999995 111.589 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.9 t -96.73 -17.69 20.13 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.576 0.703 . . . . 72.420000000000002 110.149 170.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 65.2 tp -148.88 153.58 38.24 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.068 -0.969 . . . . 73.310000000000002 109.83 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 70.48 104.95 0.06 Allowed 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.635 0.605 . . . . 64.519999999999996 112.635 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -83.73 -28.27 28.36 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.624 0.725 . . . . 63.219999999999999 109.712 170.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.87 66.0 0.06 OUTLIER Glycine 0 CA--C 1.526 0.759 0 CA-C-N 114.911 -1.041 . . . . 73.439999999999998 111.479 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.408 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . . . -134.69 162.93 30.94 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.316 0.579 . . . . 60.130000000000003 112.072 -174.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 47.1 p -85.93 169.49 13.22 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.996 -0.547 . . . . 64.530000000000001 110.314 173.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 m -68.39 -34.42 65.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.093 0.473 . . . . 52.399999999999999 110.404 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.83 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 4.0 tm-20 -71.46 -28.84 64.23 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.661 -0.699 . . . . 72.219999999999999 110.984 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.578 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -55.3 -29.12 57.6 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.104 -0.498 . . . . 71.540000000000006 110.919 175.221 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -107.35 -74.92 0.64 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.845 0.355 . . . . 71.109999999999999 111.899 174.832 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.83 ' HG ' ' HA ' ' A' ' 41' ' ' GLU . 26.2 mt 55.52 12.08 0.72 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.982 1.104 . . . . 72.099999999999994 113.982 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.4 t -72.02 160.12 33.03 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.918 -0.489 . . . . 51.119999999999997 110.545 174.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -58.34 -35.68 72.28 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.881 0.372 . . . . 74.010000000000005 111.036 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -53.95 -34.64 60.25 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.12 0.485 . . . . 71.439999999999998 111.268 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.402 ' CD2' ' HB2' ' A' ' 43' ' ' LYS . 2.5 t80 -64.78 -32.64 74.43 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.211 -0.449 . . . . 75.430000000000007 110.675 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.478 ' HD1' HG23 ' A' ' 137' ' ' VAL . 52.8 t80 -87.19 4.92 40.54 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.161 0.505 . . . . 75.25 111.673 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -121.44 -36.32 3.09 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.753 -0.592 . . . . 44.210000000000001 111.959 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.4 -56.0 8.7 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.796 0.665 . . . . 72.209999999999994 112.796 -175.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.6 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 34.4 m -96.16 17.16 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 113.078 0.77 . . . . 65.010000000000005 113.078 -173.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -102.46 19.38 19.04 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.709 0.633 . . . . 74.219999999999999 112.709 -174.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -144.23 171.14 14.72 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.889 -0.507 . . . . 70.329999999999998 112.045 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.55 136.39 44.94 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.884 -0.598 . . . . 72.0 111.388 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.627 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 42.5 mt-10 -86.66 117.28 25.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.088 0.471 . . . . 60.340000000000003 110.7 175.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 28.1 mt -113.52 143.43 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.819 -0.628 . . . . 73.25 111.897 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -66.38 145.07 56.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.495 0.188 . . . . 73.120000000000005 110.622 174.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -62.29 -32.62 73.37 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.529 0.566 . . . . 62.340000000000003 112.529 -176.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.551 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 17.7 mm-40 -58.87 -57.44 13.05 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.213 -0.304 . . . . 54.039999999999999 111.585 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.51 -37.29 85.46 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.345 0.593 . . . . 74.200000000000003 110.64 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.496 ' HA ' HD12 ' A' ' 67' ' ' LEU . 51.5 t-105 -53.43 -52.1 60.5 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.406 -0.815 . . . . 72.549999999999997 110.991 174.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -67.1 -38.65 86.04 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.679 -0.691 . . . . 63.520000000000003 111.35 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.27 -33.91 72.99 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.236 -0.438 . . . . 65.349999999999994 112.028 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -94.78 -7.61 39.93 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.083 0.401 . . . . 73.150000000000006 112.083 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.48 48.15 76.6 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.064 -0.588 . . . . 64.519999999999996 112.634 -177.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.524 HD23 ' HD3' ' A' ' 129' ' ' LYS . 84.8 mt -86.29 142.8 28.26 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.351 0.596 . . . . 73.209999999999994 112.34 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -110.51 151.36 27.67 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.416 -0.811 . . . . 74.150000000000006 109.545 172.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.6 104.31 0.64 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.329 0.585 . . . . 72.209999999999994 111.366 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 118.5 0.02 15.95 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-N 115.652 -0.704 . . . . 73.420000000000002 113.62 -176.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -68.65 172.13 6.72 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.304 0.573 . . . . 51.43 111.868 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 133' ' ' LYS . 74.1 mtt85 -109.79 125.51 52.8 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.001 -0.545 . . . . 63.210000000000001 110.949 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.691 HG13 ' HB2' ' A' ' 86' ' ' ALA . 15.5 m -113.8 152.35 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.543 0.687 . . . . 75.209999999999994 111.844 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.432 ' HZ2' ' CG2' ' A' ' 83' ' ' VAL . 47.1 tttp -124.05 120.86 33.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.606 -0.724 . . . . 74.209999999999994 110.388 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 48.2 t -102.64 130.83 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 111.753 0.279 . . . . 61.549999999999997 111.753 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.91 127.73 53.76 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.631 -0.259 . . . . 72.120000000000005 110.748 175.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.814 HG22 ' HA3' ' A' ' 125' ' ' GLY . 25.4 p -130.81 -172.15 2.75 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.094 0.473 . . . . 73.329999999999998 111.259 177.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.77 -16.43 63.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.373 -0.376 . . . . 73.200000000000003 111.679 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -93.34 -47.07 7.07 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 111.888 0.329 . . . . 71.329999999999998 111.888 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.94 -156.95 19.98 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.879 -0.677 . . . . 52.520000000000003 113.266 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 5.2 pt-20 -133.72 161.23 35.25 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.14 0.495 . . . . 74.239999999999995 111.725 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.9 p -160.59 143.25 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.29 -0.414 . . . . 74.129999999999995 111.34 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.432 ' CG2' ' HZ2' ' A' ' 74' ' ' LYS . 45.0 t -104.03 118.97 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 122.325 -0.234 . . . . 72.420000000000002 110.761 176.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.9 m -130.14 177.68 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.853 0.359 . . . . 75.25 111.687 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -80.21 144.11 33.22 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.19 0.519 . . . . 74.230000000000004 111.674 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.691 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -93.9 120.13 33.75 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.18 0.437 . . . . 64.230000000000004 112.18 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -131.9 150.31 52.19 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.203 0.525 . . . . 74.319999999999993 110.863 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -92.14 122.81 34.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.005 -0.543 . . . . 75.409999999999997 111.068 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.627 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -120.06 172.94 15.06 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.08 -0.581 . . . . 64.420000000000002 113.487 -176.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.9 9.82 9.17 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.81 0.338 . . . . 62.310000000000002 111.861 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.1 m -64.78 152.97 89.16 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.353 -0.385 . . . . 71.150000000000006 111.67 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.18 163.57 38.73 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.803 2.335 . . . . 65.200000000000003 113.218 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.551 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 84.6 tttt -63.88 133.07 52.64 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.406 -0.361 . . . . 73.129999999999995 111.694 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 77.44 24.37 65.7 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.97 -0.633 . . . . 72.219999999999999 113.198 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.701 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 18.2 ttt -149.78 137.09 19.81 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.374 -0.486 . . . . 74.209999999999994 110.471 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.553 HD11 HG22 ' A' ' 28' ' ' VAL . 39.5 pt -130.09 144.75 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.407 0.622 . . . . 64.230000000000004 112.03 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.52 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 74.6 t80 -106.69 119.36 39.1 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.961 -0.563 . . . . 73.340000000000003 111.383 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' A' ' 30' ' ' SER . 44.4 mt -117.4 126.36 27.45 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 120.673 0.273 . . . . 70.209999999999994 110.801 175.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.6 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 19.5 Cg_endo -58.56 132.0 45.78 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.121 1.881 . . . . 75.209999999999994 111.934 175.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.9 tpp -51.51 115.42 1.61 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.17 0.51 . . . . 74.540000000000006 112.265 -176.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -169.03 178.53 42.24 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.786 -0.643 . . . . 61.350000000000001 112.496 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.494 ' O ' ' HG2' ' A' ' 106' ' ' MET . 11.9 Cg_endo -52.87 -33.8 63.01 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 122.853 2.369 . . . . 60.039999999999999 112.095 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -64.82 -47.64 77.29 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.738 -0.665 . . . . 74.230000000000004 110.608 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.501 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -64.21 -39.83 94.79 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.018 0.437 . . . . 62.43 111.197 175.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -64.03 -7.04 7.38 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.436 0.532 . . . . 63.420000000000002 112.436 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.66 ' SD ' HD21 ' A' ' 140' ' ' LEU . 95.8 mmm -82.62 -25.62 33.01 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.971 0.415 . . . . 73.209999999999994 111.311 173.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.4 m -120.98 -16.52 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 112.335 0.494 . . . . 65.439999999999998 112.335 -170.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.539 HG21 ' OG ' ' A' ' 30' ' ' SER . 5.9 pt -101.99 -178.43 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.102 0.477 . . . . 72.319999999999993 111.603 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -93.55 113.6 60.71 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 116.356 -0.384 . . . . 75.030000000000001 110.553 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -88.57 16.31 1.89 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.777 2.318 . . . . 73.219999999999999 113.653 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.0 t -121.87 25.52 9.13 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.294 0.569 . . . . 53.420000000000002 110.941 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 76.3 p -76.63 113.92 14.8 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.695 0.628 . . . . 73.299999999999997 112.695 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -115.41 -12.61 11.7 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.022 0.439 . . . . 75.349999999999994 110.349 170.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.11 152.26 40.74 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.996 -0.547 . . . . 71.409999999999997 112.829 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.1 m -73.48 74.87 1.44 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.467 0.651 . . . . 72.540000000000006 111.705 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -97.58 -57.02 1.06 Allowed Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.738 -0.664 . . . . 62.340000000000003 111.483 173.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.505 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 22.3 mmt 66.75 174.65 0.07 OUTLIER Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 122.684 0.393 . . . . 73.409999999999997 111.65 174.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 117' ' ' MET . 76.3 Cg_exo -56.04 23.46 0.03 OUTLIER 'Trans proline' 0 CA--C 1.554 1.525 0 C-N-CA 123.168 2.579 . . . . 63.420000000000002 116.224 177.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.417 ' H ' ' C ' ' A' ' 117' ' ' MET . 48.7 mt-30 -73.68 175.18 7.39 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.673 -0.642 . . . . 61.140000000000001 110.672 171.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -82.23 59.16 4.35 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.28 0.562 . . . . 65.400000000000006 112.249 -172.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -122.73 136.42 54.87 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.108 -0.496 . . . . 75.109999999999999 110.765 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -142.11 174.8 23.06 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.997 -0.62 . . . . 63.240000000000002 113.292 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.9 t -93.53 120.95 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 122.398 -0.472 . . . . 74.340000000000003 111.528 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.608 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 37.3 mtpt -65.63 155.87 34.55 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.73 0.776 . . . . 72.349999999999994 113.09 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.814 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -178.85 -151.39 9.56 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 114.966 -1.016 . . . . 51.229999999999997 112.449 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.409 HG22 ' HA ' ' A' ' 25' ' ' GLU . 45.1 p -141.09 147.79 39.1 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.424 -0.457 . . . . 73.129999999999995 111.538 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.0 p -125.43 144.58 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.291 0.567 . . . . 74.430000000000007 111.904 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -153.87 168.87 24.91 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.796 -0.638 . . . . 55.439999999999998 110.561 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.524 ' HD3' HD23 ' A' ' 67' ' ' LEU . 36.8 ttpt -99.72 139.16 35.78 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.13 0.491 . . . . 74.409999999999997 111.257 174.269 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.9 t -131.75 161.23 33.34 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.307 0.575 . . . . 52.530000000000001 111.968 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -90.18 -2.88 58.11 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.809 -0.632 . . . . 75.409999999999997 111.039 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.67 153.28 44.06 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.98 -0.554 . . . . 64.519999999999996 111.353 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 3.2 pptp? -87.47 156.86 19.37 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.064 0.459 . . . . 72.120000000000005 111.196 176.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.23 130.73 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.11 -0.495 . . . . 71.420000000000002 111.834 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 135' ' ' LEU . 2.1 mt -61.74 101.09 0.17 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.411 -0.359 . . . . 62.420000000000002 111.223 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.3 m -52.43 143.2 15.75 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 110.783 -0.08 . . . . 65.109999999999999 110.783 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.478 HG23 ' HD1' ' A' ' 49' ' ' PHE . 68.4 t -45.88 -52.84 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 113.026 0.751 . . . . 73.420000000000002 113.026 -172.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -72.04 -39.96 68.73 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 122.101 -0.374 . . . . 74.299999999999997 111.905 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.4 ' HG2' ' CD2' ' A' ' 135' ' ' LEU . 42.3 tt0 -56.1 -36.21 67.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.622 0.725 . . . . 71.129999999999995 110.542 175.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.66 HD21 ' SD ' ' A' ' 106' ' ' MET . 3.7 tt -61.69 -40.96 96.83 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.136 -0.938 . . . . 63.340000000000003 110.5 174.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.4 mt -61.55 -44.27 97.34 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.29 0.566 . . . . 75.239999999999995 110.17 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -64.89 -31.66 73.0 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.783 -0.644 . . . . 73.439999999999998 111.135 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.35 -50.03 64.94 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.21 -0.45 . . . . 31.199999999999999 111.688 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.456 HD12 ' H ' ' A' ' 146' ' ' SER . 2.7 pp -76.62 -19.27 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.951 0.405 . . . . 73.519999999999996 111.768 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 122.44 -70.25 0.42 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.258 -0.496 . . . . 22.440000000000001 112.638 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.456 ' H ' HD12 ' A' ' 144' ' ' ILE . 44.9 t . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 121.2 0.524 . . . . 74.510000000000005 111.759 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.888 0.375 . . . . 54.520000000000003 111.395 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.66 161.97 23.13 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.194 -0.527 . . . . 34.450000000000003 113.81 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.7 p -104.07 146.13 29.16 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.982 0.42 . . . . 71.439999999999998 112.017 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.4 t -176.49 109.66 0.09 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.914 -0.584 . . . . 72.409999999999997 110.599 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -164.76 119.2 1.35 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.605 0.24 . . . . 75.049999999999997 111.423 -176.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -157.14 159.97 38.33 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.665 0.617 . . . . 71.209999999999994 112.665 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -165.61 165.52 18.75 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.169 -0.469 . . . . 72.310000000000002 110.986 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -132.96 153.75 51.14 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.002 0.742 . . . . 71.219999999999999 113.002 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -116.47 158.55 23.41 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.271 -0.877 . . . . 61.409999999999997 109.961 170.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -154.0 128.18 9.04 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.046 0.45 . . . . 75.239999999999995 111.439 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.4 p -158.46 97.9 1.51 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.201 -0.454 . . . . 73.230000000000004 111.098 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.6 m -118.08 128.3 54.62 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.392 -0.367 . . . . 63.43 111.722 -176.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.99 118.65 2.06 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.769 -0.729 . . . . 41.539999999999999 114.496 173.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -104.59 104.11 13.89 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.356 -0.609 . . . . 73.140000000000001 109.356 170.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 33.4 tt0 -96.05 173.3 7.49 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 112.434 0.531 . . . . 62.310000000000002 112.434 -170.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 91.5 m-20 86.98 137.71 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.645 1.178 . . . . 72.140000000000001 112.834 177.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.529 HD13 ' N ' ' A' ' 18' ' ' TYR . 3.1 tm? -132.45 145.02 50.88 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.309 -0.86 . . . . 70.25 109.622 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.529 ' N ' HD13 ' A' ' 17' ' ' LEU . 81.3 m-85 -80.04 109.05 14.13 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.922 0.392 . . . . 61.240000000000002 111.7 -177.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -93.5 152.11 19.28 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.031 0.443 . . . . 74.450000000000003 111.375 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -141.94 129.26 21.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.317 -0.401 . . . . 71.230000000000004 111.0 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.81 102.69 0.17 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.716 -0.754 . . . . 71.109999999999999 113.463 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -167.97 94.98 0.41 Allowed 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.474 -0.427 . . . . 74.540000000000006 111.512 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 14.8 ptm -90.01 165.92 13.76 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.928 0.394 . . . . 74.239999999999995 111.08 174.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.707 HD11 ' HB3' ' A' ' 64' ' ' ALA . 36.7 mt -127.74 148.29 50.42 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.787 0.662 . . . . 72.129999999999995 112.787 -176.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -90.85 122.02 33.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.341 -0.845 . . . . 64.439999999999998 110.219 171.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.37 157.79 37.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.727 -0.67 . . . . 73.310000000000002 112.156 -173.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.661 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 39.7 tt0 -99.93 115.2 29.1 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.233 -0.439 . . . . 74.5 109.999 172.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.53 HG22 HD11 ' A' ' 96' ' ' ILE . 51.0 t -89.03 116.13 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 115.996 -0.547 . . . . 64.219999999999999 112.014 -174.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 mt -102.43 156.67 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.967 0.413 . . . . 71.019999999999996 111.535 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 72.3 m -126.89 104.4 8.01 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.94 0.4 . . . . 52.420000000000002 111.054 175.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -98.12 156.13 20.4 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 121.029 -0.605 . . . . 53.039999999999999 113.584 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.4 ' H ' ' HG2' ' A' ' 32' ' ' ARG . 29.9 ptt180 -78.56 72.89 5.11 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.413 0.625 . . . . 75.030000000000001 112.131 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 76.6 p -76.49 -39.24 53.71 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.42 0.629 . . . . 73.200000000000003 110.251 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.2 mt -107.17 163.29 13.13 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.392 -0.822 . . . . 73.219999999999999 110.288 171.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -65.89 110.99 3.07 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.042 0.448 . . . . 61.240000000000002 111.834 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -71.46 106.14 3.84 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.287 0.565 . . . . 72.140000000000001 110.222 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.11 -45.4 0.29 Allowed Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.836 -0.62 . . . . 63.109999999999999 111.859 -177.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.686 ' HB3' ' HD2' ' A' ' 43' ' ' LYS . . . -87.89 127.82 35.36 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.71 0.291 . . . . 64.430000000000007 110.777 175.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 78.5 p -71.04 161.67 30.75 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.828 0.347 . . . . 74.010000000000005 111.032 177.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.6 p -56.91 -32.63 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 111.617 0.229 . . . . 61.240000000000002 111.617 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.452 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 41.9 tt0 -62.33 -36.13 81.24 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.984 0.421 . . . . 65.310000000000002 111.055 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 39' ' ' THR . 42.8 mm-40 -65.34 -35.44 80.99 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.064 0.459 . . . . 75.129999999999995 111.414 172.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.686 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 26.2 mtpp -118.33 38.5 3.7 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.307 0.484 . . . . 65.200000000000003 112.307 -172.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.452 ' HG ' ' HA ' ' A' ' 41' ' ' GLU . 63.7 mt -66.17 82.52 0.08 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.195 0.522 . . . . 70.310000000000002 111.56 177.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.5 t -143.02 161.7 37.45 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.68 -0.691 . . . . 62.329999999999998 110.791 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -63.42 -28.97 70.34 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.338 0.589 . . . . 74.420000000000002 110.485 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -55.42 -41.72 73.18 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.654 -0.703 . . . . 73.299999999999997 111.08 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.53 ' O ' HG22 ' A' ' 52' ' ' VAL . 5.5 t80 -64.49 -37.87 89.05 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.929 -0.578 . . . . 72.439999999999998 110.533 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.513 ' HE2' ' HA ' ' A' ' 136' ' ' SER . 47.6 t80 -62.13 -66.86 0.47 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.983 -0.553 . . . . 74.200000000000003 110.724 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -55.82 -21.77 21.38 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.797 0.666 . . . . 61.420000000000002 112.797 -175.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.68 -36.23 32.6 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.901 0.704 . . . . 44.130000000000003 112.901 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 48' ' ' TYR . 33.2 m -116.83 17.66 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 113.14 0.793 . . . . 41.299999999999997 113.14 -174.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -102.66 26.01 8.49 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.143 0.794 . . . . 72.329999999999998 113.143 -177.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -147.71 164.27 34.08 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.472 0.545 . . . . 74.530000000000001 112.472 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.24 133.83 47.7 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.817 -0.629 . . . . 64.420000000000002 110.922 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.538 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 33.2 mt-10 -88.66 121.89 31.51 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.238 0.542 . . . . 72.219999999999999 110.931 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.5 mt -118.18 149.87 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 115.637 -0.71 . . . . 71.549999999999997 111.777 -171.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -72.44 154.1 41.05 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.654 0.264 . . . . 54.219999999999999 111.176 176.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -56.46 -46.11 80.51 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.948 0.404 . . . . 75.439999999999998 111.727 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.45 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 25.6 mm-40 -56.83 -55.69 31.18 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.002 0.43 . . . . 72.530000000000001 111.581 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.64 -36.25 80.24 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.218 0.532 . . . . 64.519999999999996 111.004 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -56.51 -53.74 53.93 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.731 -0.668 . . . . 74.219999999999999 111.747 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -74.03 -28.48 61.45 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.028 0.381 . . . . 72.030000000000001 112.028 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.707 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -63.33 -32.22 73.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.02 0.438 . . . . 63.299999999999997 111.453 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.491 HD11 HG13 ' A' ' 127' ' ' VAL . 74.7 mt -91.33 -4.75 55.5 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.164 -0.471 . . . . 71.349999999999994 111.665 176.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.03 46.26 94.94 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.427 -0.416 . . . . 60.030000000000001 112.828 -177.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 129' ' ' LYS . 97.7 mt -85.32 156.48 20.89 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.428 0.899 . . . . 73.040000000000006 113.428 -175.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -127.92 145.37 50.98 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.615 -1.175 . . . . 72.120000000000005 109.0 173.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.01 100.42 0.16 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.454 0.645 . . . . 65.040000000000006 111.87 -176.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.08 -6.09 7.77 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.457 -0.792 . . . . 65.329999999999998 113.176 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -68.03 158.59 32.58 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.364 0.602 . . . . 70.409999999999997 112.072 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.5 mtm-85 -102.12 127.65 48.93 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.8 -0.636 . . . . 65.230000000000004 110.647 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.33 150.28 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.154 0.502 . . . . 72.200000000000003 112.029 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -114.49 136.99 52.4 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.257 0.551 . . . . 62.219999999999999 111.115 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 60.9 t -110.01 122.12 64.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.79 -0.641 . . . . 71.319999999999993 110.623 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -111.63 120.89 43.6 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.796 0.332 . . . . 71.049999999999997 111.505 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.748 HG22 ' HA3' ' A' ' 125' ' ' GLY . 27.6 p -122.53 -177.47 3.64 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.938 0.399 . . . . 61.43 110.902 176.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -70.69 -11.21 60.8 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.48 -0.327 . . . . 72.430000000000007 111.614 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -94.52 -48.68 6.0 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 111.749 0.277 . . . . 72.349999999999994 111.749 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -171.39 -154.31 9.72 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.577 -0.82 . . . . 74.530000000000001 113.603 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 12.2 pt-20 -154.78 141.88 19.35 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.877 0.37 . . . . 71.319999999999993 111.571 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.7 p -145.12 149.41 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 116.573 -0.285 . . . . 61.109999999999999 111.613 -178.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.49 117.38 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-O 120.527 0.203 . . . . 74.299999999999997 111.259 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.459 ' HA ' HG13 ' A' ' 134' ' ' VAL . 34.8 m -128.09 177.63 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 122.886 0.474 . . . . 70.219999999999999 111.488 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -82.62 142.85 31.41 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.044 0.449 . . . . 72.519999999999996 111.548 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.14 121.46 32.94 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.039 0.385 . . . . 73.219999999999999 112.039 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -131.6 157.65 43.1 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.166 0.508 . . . . 73.209999999999994 110.815 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -95.98 140.49 30.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.285 -0.416 . . . . 72.329999999999998 110.852 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.538 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -141.02 -174.51 14.14 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.898 -0.668 . . . . 73.510000000000005 113.71 -177.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -94.69 32.24 1.65 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.958 0.408 . . . . 45.219999999999999 111.641 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.8 m -90.6 152.46 45.12 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.461 -0.336 . . . . 75.200000000000003 111.706 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.59 163.71 33.92 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.88 2.387 . . . . 64.450000000000003 113.366 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 86.6 tttt -66.87 143.05 57.09 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.468 -0.333 . . . . 75.030000000000001 111.293 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 69.57 21.42 76.23 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.876 -0.678 . . . . 63.420000000000002 113.098 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.661 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 15.7 ttt -149.41 136.54 19.82 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.894 -0.41 . . . . 71.340000000000003 109.894 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.53 HD11 HG22 ' A' ' 28' ' ' VAL . 37.4 pt -132.21 145.36 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-O 121.371 0.605 . . . . 70.400000000000006 112.108 -177.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -102.79 129.58 49.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.853 -0.612 . . . . 65.400000000000006 111.209 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 30' ' ' SER . 28.8 mt -126.17 131.57 24.01 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 120.571 0.224 . . . . 63.32 110.68 174.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.22 126.43 22.14 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.374 2.05 . . . . 73.430000000000007 112.196 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.82 99.81 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.849 0.357 . . . . 74.409999999999997 110.634 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.87 -175.24 24.13 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.776 -0.726 . . . . 74.150000000000006 113.018 -176.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.413 ' O ' ' HG3' ' A' ' 106' ' ' MET . 29.9 Cg_endo -64.01 -26.02 66.29 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.212 1.941 . . . . 75.310000000000002 112.243 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.499 ' HA ' HD11 ' A' ' 140' ' ' LEU . 4.6 m-85 -68.9 -54.24 16.6 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.676 -0.693 . . . . 74.109999999999999 110.516 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.508 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.38 -34.13 74.82 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.925 -0.579 . . . . 73.150000000000006 110.632 175.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -60.31 -19.8 56.61 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.97 -0.559 . . . . 72.209999999999994 111.561 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.612 ' SD ' HD21 ' A' ' 140' ' ' LEU . 33.4 mtp -77.07 -28.03 54.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.797 0.332 . . . . 75.219999999999999 111.417 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.3 m -116.24 -18.11 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.048 0.759 . . . . 54.219999999999999 113.048 -171.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 104' ' ' ALA . 14.7 pt -95.14 -176.17 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 121.399 0.619 . . . . 71.430000000000007 112.375 -176.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.603 ' H ' HG21 ' A' ' 123' ' ' VAL . 24.2 t70 -116.5 116.03 39.34 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.577 -0.738 . . . . 72.450000000000003 110.653 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.19 17.91 1.58 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.652 2.234 . . . . 75.010000000000005 113.558 -178.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 21.1 t -92.73 14.58 16.78 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.847 0.356 . . . . 43.539999999999999 111.516 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 113' ' ' ASP . 62.9 p -94.39 -171.31 2.48 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.077 0.399 . . . . 62.039999999999999 112.077 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 112' ' ' THR . 18.9 t70 72.01 149.5 0.09 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.099 0.56 . . . . 70.150000000000006 112.137 176.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 160.38 -78.46 0.17 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.713 -0.756 . . . . 34.240000000000002 113.871 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.3 p -78.49 -65.37 0.99 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.747 0.647 . . . . 70.140000000000001 112.747 -173.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 117' ' ' MET . . . 164.79 -170.61 39.95 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.151 -0.547 . . . . 71.010000000000005 113.018 -178.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER 70.23 148.1 0.12 Allowed Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 123.027 0.531 . . . . 72.239999999999995 111.276 -178.238 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.38 -44.25 39.57 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.424 2.082 . . . . 44.310000000000002 112.899 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 62.25 107.23 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.677 0.621 . . . . 71.109999999999999 112.677 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -76.81 70.43 3.27 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.372 0.606 . . . . 73.430000000000007 110.243 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -128.13 100.02 5.7 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.823 -0.626 . . . . 63.409999999999997 111.066 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -110.39 157.8 14.81 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 121.188 -0.529 . . . . 72.409999999999997 112.43 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' H ' ' A' ' 109' ' ' ASP . 84.3 t -86.73 121.02 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 122.465 -0.433 . . . . 70.420000000000002 111.284 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 48.3 mtpt -68.76 162.42 26.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.741 0.781 . . . . 73.140000000000001 113.047 -176.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.748 ' HA3' HG22 ' A' ' 77' ' ' THR . . . 174.17 -151.65 13.31 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 114.886 -1.052 . . . . 62.420000000000002 112.587 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 65.3 p -135.9 152.46 51.04 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.87 0.367 . . . . 73.519999999999996 111.037 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.491 HG13 HD11 ' A' ' 65' ' ' LEU . 14.6 p -132.25 144.76 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.144 0.497 . . . . 50.229999999999997 111.343 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -157.64 152.99 26.06 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.773 -0.649 . . . . 55.130000000000003 110.533 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.422 ' HB2' HD21 ' A' ' 67' ' ' LEU . 32.8 ttpt -79.0 139.29 38.23 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.16 0.505 . . . . 63.109999999999999 111.133 174.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.4 t -135.8 150.56 49.49 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.122 0.487 . . . . 73.209999999999994 111.729 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -80.33 -3.13 48.28 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.337 -0.392 . . . . 71.120000000000005 110.834 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -65.37 155.08 36.48 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.985 0.422 . . . . 73.040000000000006 111.83 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -79.12 150.98 31.62 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.999 0.428 . . . . 71.439999999999998 111.605 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 84' ' ' VAL . 82.6 t -71.3 128.25 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.233 -0.439 . . . . 62.299999999999997 110.342 172.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 135' ' ' LEU . 11.0 mt -63.47 133.22 53.53 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.979 0.419 . . . . 61.520000000000003 111.858 -177.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.513 ' HA ' ' HE2' ' A' ' 49' ' ' PHE . 45.2 t -73.51 141.94 46.75 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.911 -0.403 . . . . 73.299999999999997 109.911 171.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.506 HG23 ' HD2' ' A' ' 49' ' ' PHE . 60.5 t -46.45 -46.96 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 112.744 0.646 . . . . 73.209999999999994 112.744 -174.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -72.38 -40.65 67.12 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.021 0.378 . . . . 54.340000000000003 112.021 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -64.61 -33.52 76.12 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.219 0.533 . . . . 60.119999999999997 110.534 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.612 HD21 ' SD ' ' A' ' 106' ' ' MET . 4.0 tt -56.22 -41.08 75.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.886 -0.597 . . . . 65.219999999999999 110.275 172.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.8 mt -60.02 -48.07 83.22 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.276 0.56 . . . . 71.019999999999996 110.263 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.3 -43.22 96.51 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.771 -0.649 . . . . 73.140000000000001 111.053 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.82 -45.63 89.53 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.087 -0.506 . . . . 60.210000000000001 112.183 -178.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.8 pp -77.65 -7.71 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 112.326 0.491 . . . . 62.240000000000002 112.326 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 129.59 -30.66 3.56 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.13 -0.557 . . . . 62.0 113.757 177.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 121.22 0.533 . . . . 74.239999999999995 111.511 -177.55 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.3 mtp . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 120.754 0.311 . . . . 74.140000000000001 111.281 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.37 142.16 13.03 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.294 -0.479 . . . . 41.299999999999997 112.984 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 94.9 p -128.05 157.35 40.93 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 122.512 -0.405 . . . . 62.520000000000003 111.208 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.2 p -81.28 116.09 20.97 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.145 0.497 . . . . 73.019999999999996 111.852 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -157.74 137.29 12.05 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.307 -0.406 . . . . 63.240000000000002 111.23 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -153.43 148.25 26.45 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.193 -0.458 . . . . 62.450000000000003 111.306 -175.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -142.6 125.43 16.05 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.309 0.485 . . . . 64.040000000000006 112.309 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -165.33 124.79 1.77 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.199 -0.455 . . . . 73.120000000000005 110.859 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -135.85 146.66 47.69 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.945 0.402 . . . . 75.299999999999997 111.676 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -91.46 117.09 29.39 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.342 -0.39 . . . . 71.530000000000001 110.946 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.3 m -110.41 131.42 55.07 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.733 0.302 . . . . 62.140000000000001 111.386 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.0 t -150.28 140.35 22.05 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.986 0.422 . . . . 74.549999999999997 111.852 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.52 154.41 21.06 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 116.345 -0.389 . . . . 73.219999999999999 112.279 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -117.41 102.83 9.54 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.337 0.568 . . . . 75.010000000000005 112.213 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -105.4 89.44 3.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.726 0.774 . . . . 75.019999999999996 110.481 175.009 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -100.09 103.53 15.04 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.773 -0.649 . . . . 61.210000000000001 110.954 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.0 mp -86.31 131.26 34.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.301 0.572 . . . . 70.5 111.398 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -117.57 136.96 52.91 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.547 -0.751 . . . . 74.439999999999998 110.868 -178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -148.42 125.82 11.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.827 0.346 . . . . 63.009999999999998 111.523 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -102.25 132.94 47.88 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.477 -0.329 . . . . 70.219999999999999 110.821 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.86 81.19 0.23 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.826 -0.702 . . . . 63.530000000000001 112.424 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -66.16 111.28 3.34 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.007 0.432 . . . . 65.340000000000003 111.711 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.497 ' HE2' ' HB ' ' A' ' 126' ' ' THR . 10.1 ptm -93.2 161.2 14.51 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.205 -0.452 . . . . 71.140000000000001 111.364 178.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.532 HD12 ' HG ' ' A' ' 65' ' ' LEU . 9.5 mt -110.3 141.37 43.39 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.971 0.415 . . . . 73.150000000000006 111.804 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -89.9 126.1 35.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.286 0.565 . . . . 74.349999999999994 111.298 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.565 HG12 ' HA2' ' A' ' 94' ' ' GLY . 35.1 m -140.95 163.0 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.546 -0.752 . . . . 74.530000000000001 111.892 -174.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 65.7 tt0 -99.18 117.74 34.34 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.962 0.411 . . . . 64.109999999999999 110.652 172.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.504 HG22 HD11 ' A' ' 96' ' ' ILE . 32.0 t -91.4 115.55 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.133 0.492 . . . . 72.519999999999996 111.714 -175.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.55 HD11 ' HE2' ' A' ' 95' ' ' MET . 1.7 mt -102.1 159.41 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.795 0.331 . . . . 74.109999999999999 110.824 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.73 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 33.7 t -150.37 132.15 15.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.73 0.3 . . . . 71.439999999999998 111.587 175.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.576 ' HA2' ' HB2' ' A' ' 100' ' ' MET . . . 159.3 -90.77 0.11 Allowed Glycine 0 CA--C 1.523 0.565 0 C-N-CA 119.817 -1.182 . . . . 42.439999999999998 114.91 175.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.465 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 5.3 mmp_? -48.99 81.73 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.116 1.525 . . . . 72.019999999999996 115.116 -165.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.41 HG21 ' HB3' ' A' ' 99' ' ' PRO . 32.5 p -149.94 -60.43 0.2 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.583 0.753 . . . . 71.409999999999997 109.253 166.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.415 ' N ' HD12 ' A' ' 34' ' ' LEU . 6.4 mp -108.72 117.66 34.75 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.699 -0.682 . . . . 65.310000000000002 109.736 171.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -66.38 -37.28 84.9 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.748 0.308 . . . . 72.439999999999998 111.207 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -95.93 109.09 21.51 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.704 0.288 . . . . 75.140000000000001 110.227 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.485 ' O ' ' HE2' ' A' ' 43' ' ' LYS . . . -76.17 -59.87 3.25 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.54 -0.838 . . . . 51.310000000000002 114.085 -175.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 60.9 -166.26 0.21 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.717 0.294 . . . . 64.129999999999995 110.999 -173.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.9 p -105.97 170.64 7.79 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.008 0.432 . . . . 71.040000000000006 110.681 173.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.3 t -59.67 -34.56 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.236 0.541 . . . . 62.229999999999997 110.907 176.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -63.18 -35.71 81.23 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.917 -0.583 . . . . 74.230000000000004 111.489 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.96 -33.29 75.69 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.379 0.511 . . . . 73.25 112.379 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -130.21 58.92 1.65 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.771 0.656 . . . . 65.239999999999995 112.771 -178.311 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.0 mt -71.76 83.69 0.9 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.197 0.522 . . . . 72.25 110.724 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.5 t -150.55 167.29 27.67 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.687 0.625 . . . . 71.409999999999997 112.687 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.41 ' HG3' ' ND2' ' A' ' 50' ' ' ASN . 14.1 tp10 -55.83 -35.53 66.49 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.837 -0.619 . . . . 71.420000000000002 110.918 177.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -54.06 -43.3 70.13 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.406 -0.361 . . . . 72.109999999999999 111.364 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -60.52 -31.97 71.02 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.266 0.555 . . . . 72.120000000000005 110.674 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -78.28 -28.83 47.66 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.924 -0.58 . . . . 72.129999999999995 111.541 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.41 ' ND2' ' HG3' ' A' ' 46' ' ' GLU . 41.7 m-80 -98.77 0.07 43.67 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.161 0.43 . . . . 72.129999999999995 112.161 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.23 -44.44 7.27 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.29 0.848 . . . . 73.519999999999996 113.29 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.2 m -127.19 17.93 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 114.412 1.264 . . . . 65.219999999999999 114.412 -167.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -101.06 18.01 20.89 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 121.62 -0.675 . . . . 74.409999999999997 112.135 -176.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -137.62 159.12 42.85 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.995 -0.44 . . . . 53.130000000000003 111.511 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.66 138.51 51.23 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.334 -0.394 . . . . 73.340000000000003 111.662 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.684 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 41.3 mt-10 -90.2 116.71 28.4 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.213 0.53 . . . . 54.520000000000003 111.003 177.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.607 ' HA ' HG22 ' A' ' 96' ' ' ILE . 35.8 mt -111.57 146.98 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 115.609 -0.723 . . . . 72.209999999999994 111.768 -171.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -67.1 142.95 56.93 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.94 0.4 . . . . 62.520000000000003 111.11 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -63.93 -36.53 84.24 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.792 0.664 . . . . 72.140000000000001 112.792 -175.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.55 -49.24 77.48 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.271 0.558 . . . . 50.539999999999999 110.918 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -66.72 -33.48 75.73 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.811 -0.632 . . . . 75.230000000000004 111.071 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.486 ' HA ' HD12 ' A' ' 67' ' ' LEU . 44.2 t-105 -57.05 -53.67 55.49 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.706 -0.679 . . . . 75.540000000000006 110.939 175.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -65.69 -37.15 85.68 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.977 -0.556 . . . . 60.210000000000001 111.542 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.62 -49.17 78.81 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.96 0.409 . . . . 74.140000000000001 111.848 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.532 ' HG ' HD12 ' A' ' 24' ' ' LEU . 95.0 mt -78.23 -4.51 48.12 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.319 -0.401 . . . . 55.210000000000001 111.74 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.76 45.76 93.57 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.255 -0.498 . . . . 54.25 112.761 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 62' ' ' TRP . 87.3 mt -80.75 153.39 27.83 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.153 0.501 . . . . 72.230000000000004 111.667 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -139.13 114.93 10.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 73.439999999999998 110.645 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -38.53 102.46 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.363 -0.835 . . . . 75.140000000000001 112.971 -171.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.6 -19.1 4.81 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 114.967 -1.015 . . . . 72.540000000000006 113.161 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -78.91 179.39 7.31 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.114 0.483 . . . . 73.310000000000002 111.958 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -107.5 134.51 50.43 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.356 0.598 . . . . 64.349999999999994 111.842 -175.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.573 HG13 ' HB2' ' A' ' 86' ' ' ALA . 14.5 m -115.97 135.99 54.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.967 -0.56 . . . . 73.150000000000006 111.164 174.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.42 ' HB3' ' HG3' ' A' ' 128' ' ' GLU . 72.3 tttt -102.17 140.14 36.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.88 -0.6 . . . . 50.329999999999998 110.584 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 41.5 t -122.43 136.2 60.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.329 -0.396 . . . . 63.039999999999999 110.084 -175.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -138.68 126.56 22.36 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.058 0.392 . . . . 61.009999999999998 112.058 -173.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.661 HG22 ' HA3' ' A' ' 125' ' ' GLY . 30.8 p -137.1 -172.18 3.13 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.235 -0.439 . . . . 72.400000000000006 110.547 176.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -65.99 -12.97 58.9 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.216 0.451 . . . . 62.409999999999997 112.216 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -91.39 -34.71 14.75 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.116 0.413 . . . . 65.010000000000005 112.116 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.69 -159.47 31.39 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.226 -0.511 . . . . 72.120000000000005 113.16 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 11.4 pt-20 -137.37 154.01 50.09 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.026 0.441 . . . . 70.319999999999993 112.098 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.443 HG23 HD12 ' A' ' 135' ' ' LEU . 11.4 p -153.06 149.36 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 116.378 -0.374 . . . . 74.439999999999998 111.445 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 36.1 t -110.36 120.09 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 122.347 -0.221 . . . . 72.340000000000003 110.878 176.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.23 173.18 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.99 0.424 . . . . 72.040000000000006 111.956 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -76.6 139.16 40.53 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.01 0.433 . . . . 72.040000000000006 111.426 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.573 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -87.32 126.12 34.65 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.887 0.699 . . . . 64.099999999999994 112.887 -177.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -130.07 148.18 51.89 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.142 0.496 . . . . 73.510000000000005 110.864 172.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -87.66 124.03 33.12 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.918 -0.583 . . . . 73.099999999999994 109.879 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -124.33 171.74 16.6 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.87 -0.681 . . . . 62.119999999999997 114.065 -173.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.72 29.58 0.38 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.872 0.469 . . . . 71.230000000000004 112.228 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.9 m -91.21 152.03 43.56 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 116.507 -0.315 . . . . 65.340000000000003 111.653 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -72.6 177.15 7.85 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.689 2.259 . . . . 51.450000000000003 113.588 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -62.94 141.35 58.75 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.022 -0.536 . . . . 62.219999999999999 111.999 -177.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 58.31 34.28 73.78 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 120.862 -0.685 . . . . 70.230000000000004 112.805 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.597 ' HE3' ' HG2' ' A' ' 121' ' ' LYS . 16.7 ttt -150.92 136.73 18.11 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.633 -0.334 . . . . 71.25 110.321 -178.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.607 HG22 ' HA ' ' A' ' 57' ' ' ILE . 36.8 pt -137.65 146.59 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.136 0.493 . . . . 74.140000000000001 111.652 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -110.08 136.74 48.85 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.942 0.401 . . . . 75.230000000000004 111.272 177.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 30' ' ' SER . 45.6 mt -126.35 133.65 25.19 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 116.326 -0.397 . . . . 73.430000000000007 110.643 174.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.41 ' HB3' HG21 ' A' ' 33' ' ' THR . 78.2 Cg_exo -52.13 141.82 47.01 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 121.904 1.736 . . . . 72.310000000000002 112.539 174.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.576 ' HB2' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -59.65 106.11 0.44 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.667 0.27 . . . . 54.240000000000002 110.976 -178.771 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.28 178.67 41.29 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 119.972 -1.108 . . . . 74.120000000000005 113.787 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.521 ' HA ' ' HB3' ' A' ' 105' ' ' ASN . 17.8 Cg_endo -57.98 -34.94 98.99 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.144 2.563 . . . . 74.329999999999998 112.82 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.512 ' HA ' HD11 ' A' ' 140' ' ' LEU . 53.1 m-85 -59.96 -50.14 74.94 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.109 0.481 . . . . 74.409999999999997 110.631 177.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.543 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -65.29 -37.37 86.95 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.124 -0.489 . . . . 75.150000000000006 111.017 174.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 102' ' ' PRO . 5.4 t30 -56.58 -20.09 19.15 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.763 0.425 . . . . 74.239999999999995 111.728 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.607 ' SD ' HD21 ' A' ' 140' ' ' LEU . 90.9 mmm -72.97 -24.05 60.74 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.807 0.336 . . . . 62.25 111.779 177.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.5 m -129.06 -9.03 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 113.027 0.751 . . . . 63.210000000000001 113.027 -171.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.555 HD13 ' HB3' ' A' ' 30' ' ' SER . 5.8 pt -104.91 -177.54 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.167 0.508 . . . . 75.120000000000005 111.531 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.5 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . 30.1 t70 -106.52 118.01 55.6 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 116.107 -0.497 . . . . 62.119999999999997 110.916 175.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 109' ' ' ASP . 3.5 Cg_exo -81.32 -1.25 10.99 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.855 2.37 . . . . 73.439999999999998 113.479 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -84.62 -41.61 16.19 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.058 0.392 . . . . 60.149999999999999 112.058 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.1 t -55.32 139.7 41.88 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.912 0.708 . . . . 74.420000000000002 112.912 -177.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.2 t70 60.08 -93.31 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.836 -0.62 . . . . 74.439999999999998 112.41 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.51 24.95 57.41 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 121.222 -0.513 . . . . 72.019999999999996 112.737 -172.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.6 m -132.26 -52.23 0.95 Allowed 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.638 -0.331 . . . . 63.509999999999998 111.526 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 139.07 44.78 0.07 OUTLIER Glycine 0 CA--C 1.526 0.761 0 C-N-CA 120.857 -0.687 . . . . 75.230000000000004 113.994 177.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.48 140.06 20.7 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 117.236 0.518 . . . . 74.430000000000007 111.777 176.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -84.81 52.17 3.38 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.179 2.586 . . . . 70.129999999999995 113.698 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -77.44 127.44 32.54 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.735 0.303 . . . . 74.530000000000001 111.098 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.416 ' O ' ' HB2' ' A' ' 121' ' ' LYS . 38.4 m-85 -87.24 168.67 13.0 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 120.853 0.358 . . . . 74.540000000000006 111.846 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.597 ' HG2' ' HE3' ' A' ' 95' ' ' MET . 69.9 mttt 70.1 162.12 0.23 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.674 -0.694 . . . . 74.010000000000005 111.23 -170.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -145.54 -134.37 2.69 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.303 -0.951 . . . . 31.32 114.009 -172.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.421 HG21 ' N ' ' A' ' 109' ' ' ASP . 52.5 t -100.3 118.63 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.806 0.336 . . . . 61.439999999999998 111.543 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 55.5 mtmt -72.82 155.41 39.96 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.274 0.559 . . . . 75.340000000000003 112.186 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.661 ' HA3' HG22 ' A' ' 77' ' ' THR . . . 177.84 -135.0 2.57 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.782 -0.645 . . . . 65.230000000000004 112.84 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.497 ' HB ' ' HE2' ' A' ' 23' ' ' MET . 60.8 p -140.55 154.84 46.67 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.269 0.47 . . . . 52.039999999999999 112.269 -177.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.1 p -133.97 147.98 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.931 -0.577 . . . . 52.109999999999999 110.677 175.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.42 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 9.5 pt-20 -151.9 161.89 41.93 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.37 -0.377 . . . . 70.450000000000003 111.462 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.431 ' NZ ' ' HA ' ' A' ' 67' ' ' LEU . 17.6 ttmm -87.24 140.65 29.33 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 110.226 -0.287 . . . . 72.340000000000003 110.226 170.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.2 t -139.47 142.82 37.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.302 0.572 . . . . 73.219999999999999 111.864 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -75.31 -11.24 60.02 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.617 -0.72 . . . . 71.310000000000002 110.827 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -61.91 154.3 26.64 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.861 -0.609 . . . . 65.239999999999995 112.071 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -80.89 162.08 24.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.748 -0.66 . . . . 62.509999999999998 111.927 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 76.5 t -76.28 136.17 25.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.651 -0.704 . . . . 74.420000000000002 111.101 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.443 HD12 HG23 ' A' ' 82' ' ' VAL . 17.8 mt -59.65 133.58 56.23 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.502 -0.317 . . . . 72.239999999999995 111.298 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.6 t -76.76 143.77 39.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.691 -0.855 . . . . 75.109999999999999 108.691 169.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.3 t -48.26 -41.16 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.084 0.469 . . . . 41.399999999999999 111.899 -174.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -72.02 -41.6 67.36 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.026 -0.534 . . . . 64.430000000000007 111.65 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -58.52 -37.2 75.11 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.78 0.8 . . . . 71.519999999999996 110.15 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.607 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.5 tt -62.29 -38.3 88.82 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.05 -0.977 . . . . 71.409999999999997 111.033 176.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.0 mt -59.65 -41.55 90.79 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.486 0.66 . . . . 73.140000000000001 110.056 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -70.52 -30.02 66.67 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.518 -0.765 . . . . 62.210000000000001 111.608 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.44 -44.15 79.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.42 -0.354 . . . . 63.200000000000003 111.856 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.496 HD12 ' H ' ' A' ' 146' ' ' SER . 2.8 pp -76.13 -7.92 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 112.142 0.423 . . . . 74.329999999999998 112.142 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 125.9 -62.82 0.6 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.35 -0.453 . . . . 72.310000000000002 112.937 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.496 ' H ' HD12 ' A' ' 144' ' ' ILE . 87.8 p . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 121.196 0.522 . . . . 75.420000000000002 111.367 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.516 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.707 0.289 . . . . 74.340000000000003 111.215 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.05 79.87 1.66 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.217 -0.516 . . . . 72.319999999999993 113.156 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.9 p -87.96 166.01 14.81 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.141 0.496 . . . . 73.519999999999996 111.736 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.7 m -69.86 125.54 27.06 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.274 0.472 . . . . 53.420000000000002 112.274 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -134.18 110.64 9.69 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.398 -0.364 . . . . 64.120000000000005 110.647 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -71.39 146.07 48.95 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.923 0.392 . . . . 75.129999999999995 111.728 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -138.64 93.13 2.69 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.028 0.442 . . . . 61.130000000000003 111.003 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -95.98 119.74 35.02 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.184 -0.462 . . . . 74.530000000000001 110.521 -178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.401 ' O ' ' HB3' ' A' ' 10' ' ' HIS . 20.9 p80 -67.4 -52.36 40.74 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.538 0.94 . . . . 61.439999999999998 113.538 -173.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.401 ' HB3' ' O ' ' A' ' 9' ' ' HIS . 8.0 t-80 66.37 124.3 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.7 0.63 . . . . 73.400000000000006 112.7 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.4 m -130.77 133.33 45.91 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 116.51 -0.314 . . . . 63.439999999999998 111.434 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.8 p -152.52 25.45 0.59 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 111.86 0.319 . . . . 71.409999999999997 111.86 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.35 136.33 39.67 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.23 -0.51 . . . . 71.0 112.941 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -162.15 112.14 1.53 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.123 0.487 . . . . 73.140000000000001 111.92 -174.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.41 -148.74 0.36 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.076 -0.511 . . . . 61.350000000000001 110.482 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 79.03 87.86 0.06 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.349 0.659 . . . . 71.209999999999994 112.742 174.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.97 -170.49 2.22 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.034 -0.53 . . . . 74.150000000000006 110.295 172.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -79.86 -22.68 42.63 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.242 0.46 . . . . 61.200000000000003 112.242 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 68.9 -28.08 0.16 Allowed 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.699 1.0 . . . . 72.340000000000003 113.699 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -75.06 103.05 5.09 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.971 -0.456 . . . . 64.150000000000006 112.028 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.39 -58.76 1.51 Allowed Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.221 -0.514 . . . . 54.539999999999999 112.286 174.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 68.3 t60 66.84 102.63 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.445 0.535 . . . . 74.030000000000001 112.445 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.2 ptp -82.38 164.02 21.31 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.26 0.553 . . . . 71.430000000000007 112.027 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.4 mt -127.37 131.64 50.31 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.768 -0.651 . . . . 54.210000000000001 111.104 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -73.13 111.11 7.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.865 0.364 . . . . 54.350000000000001 110.849 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.475 HG12 ' HA2' ' A' ' 94' ' ' GLY . 31.1 m -127.84 159.62 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.351 -0.386 . . . . 65.129999999999995 111.964 -174.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 35.4 tt0 -98.79 118.53 35.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.884 0.373 . . . . 61.530000000000001 110.605 174.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.51 HG22 HD11 ' A' ' 96' ' ' ILE . 40.1 t -93.23 108.16 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.109 -0.496 . . . . 61.130000000000003 111.74 -175.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 mt -97.73 160.56 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.826 0.346 . . . . 72.450000000000003 111.234 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.631 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 74.3 m -136.5 100.48 4.37 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.078 0.466 . . . . 73.010000000000005 111.929 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.42 115.89 4.28 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.049 -0.596 . . . . 51.030000000000001 112.397 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.428 ' HA ' ' HB3' ' A' ' 100' ' ' MET . 31.5 mtm180 -60.35 102.83 0.19 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.132 0.491 . . . . 74.340000000000003 111.846 -178.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.9 p -132.34 -178.4 4.9 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.897 -0.592 . . . . 62.039999999999999 111.584 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.7 tp 66.44 12.53 8.74 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 122.892 0.477 . . . . 65.420000000000002 112.107 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 56.83 96.76 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.088 0.47 . . . . 64.310000000000002 111.855 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -71.97 -173.21 0.98 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.125 0.488 . . . . 54.329999999999998 111.921 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.65 -1.48 68.88 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.139 -0.553 . . . . 63.399999999999999 112.466 -174.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.626 ' HB1' ' HB2' ' A' ' 42' ' ' GLU . . . -132.7 135.77 45.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.444 0.298 . . . . 55.340000000000003 111.364 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.0 p -67.59 174.43 3.49 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.116 0.484 . . . . 64.120000000000005 110.486 174.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.0 m -61.17 -30.71 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 122.105 -0.372 . . . . 75.299999999999997 110.874 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.502 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 38.1 tt0 -73.34 -26.66 61.12 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.09 -0.505 . . . . 61.020000000000003 111.718 -176.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.626 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 28.1 mm-40 -72.74 -12.72 61.12 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.971 0.415 . . . . 74.549999999999997 111.619 177.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.557 ' HE2' ' HB3' ' A' ' 38' ' ' ALA . 67.4 mttm -121.58 -68.49 0.89 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 116.672 -0.24 . . . . 74.439999999999998 111.268 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.502 ' HG ' ' HA ' ' A' ' 41' ' ' GLU . 71.5 mt 61.14 -14.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 114.992 1.479 . . . . 73.439999999999998 114.992 174.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.461 HG23 ' H ' ' A' ' 48' ' ' TYR . 3.3 t -55.15 155.46 4.77 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.793 0.664 . . . . 74.310000000000002 112.793 -176.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -49.62 -37.69 29.03 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.545 0.688 . . . . 73.239999999999995 110.255 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -54.48 -40.78 68.8 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.468 -0.787 . . . . 72.310000000000002 111.467 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.497 ' HE2' ' HD2' ' A' ' 43' ' ' LYS . 2.8 t80 -60.09 -36.78 78.16 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.431 0.634 . . . . 70.25 110.604 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.502 ' HD1' HG23 ' A' ' 137' ' ' VAL . 58.0 t80 -81.09 -7.57 59.59 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.59 -0.732 . . . . 55.200000000000003 112.046 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -118.43 2.17 11.82 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.877 -0.514 . . . . 63.130000000000003 111.814 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.09 -57.04 2.45 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.378 0.51 . . . . 73.349999999999994 112.378 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.495 HG21 ' HD2' ' A' ' 102' ' ' PRO . 34.7 m -108.33 20.48 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 112.873 0.694 . . . . 73.519999999999996 112.873 -173.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.64 ' N ' HD22 ' A' ' 53' ' ' ASN . 0.7 OUTLIER -104.08 18.48 21.96 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.66 0.615 . . . . 72.140000000000001 112.66 -172.363 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -141.55 165.13 28.33 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.223 0.535 . . . . 74.510000000000005 112.426 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.96 130.94 45.71 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.709 -0.678 . . . . 63.43 110.884 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.67 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 31.8 mt-10 -88.65 120.24 29.86 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.351 0.596 . . . . 74.510000000000005 111.638 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.1 mt -118.76 148.27 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.32 -0.855 . . . . 72.340000000000003 111.615 -170.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -75.42 142.73 42.98 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.771 0.32 . . . . 72.239999999999995 110.386 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.444 ' HA ' ' HB3' ' A' ' 62' ' ' TRP . 27.0 tt0 -56.04 -36.97 68.6 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.481 0.548 . . . . 71.239999999999995 112.481 -174.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.417 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 80.7 mm-40 -54.66 -51.63 64.87 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 111.894 0.331 . . . . 63.520000000000003 111.894 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -69.7 -36.82 76.27 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.337 0.589 . . . . 75.430000000000007 110.579 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.487 ' HA ' HD12 ' A' ' 67' ' ' LEU . 31.0 t-105 -53.22 -52.08 60.08 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.466 -0.788 . . . . 73.239999999999995 111.69 176.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -65.62 -38.87 90.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.129 -0.487 . . . . 70.310000000000002 111.296 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.37 -43.4 88.43 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.169 0.509 . . . . 73.129999999999995 111.55 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.9 mt -79.91 -1.83 41.03 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.201 -0.454 . . . . 73.540000000000006 112.038 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.93 44.9 96.71 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.435 -0.412 . . . . 35.130000000000003 112.998 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.753 HD23 ' HD3' ' A' ' 129' ' ' LYS . 67.0 mt -87.04 142.51 27.87 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.032 0.752 . . . . 74.540000000000006 113.032 -175.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -115.0 150.11 36.35 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.942 -0.762 . . . . 65.340000000000003 108.942 170.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.31 103.9 0.11 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.168 0.509 . . . . 74.25 111.898 -177.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.51 -8.34 10.23 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 115.888 -0.596 . . . . 60.030000000000001 113.783 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.67 167.54 7.2 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.618 0.723 . . . . 62.100000000000001 112.665 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -113.08 126.52 55.56 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.295 -0.866 . . . . 61.329999999999998 111.36 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.446 HG13 ' HB2' ' A' ' 86' ' ' ALA . 21.1 m -114.51 139.24 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.175 0.512 . . . . 72.120000000000005 112.054 -178.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.519 ' HG2' ' HD2' ' A' ' 76' ' ' LYS . 22.9 ttmm -103.18 111.84 24.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.072 -0.513 . . . . 60.450000000000003 110.395 177.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 47.9 t -96.68 126.25 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 116.468 -0.333 . . . . 55.409999999999997 111.523 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.568 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -117.72 139.64 50.76 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.061 0.458 . . . . 65.409999999999997 111.735 178.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.2 p -134.63 -171.9 2.89 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.402 -0.363 . . . . 42.409999999999997 110.246 173.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.23 -4.08 39.93 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 122.158 -0.339 . . . . 64.109999999999999 111.229 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -99.6 -48.33 4.78 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.714 0.293 . . . . 73.329999999999998 111.346 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.94 -158.21 19.75 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.136 -0.554 . . . . 62.100000000000001 112.779 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.568 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 8.8 pt-20 -144.68 160.22 41.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.265 0.555 . . . . 73.239999999999995 112.325 178.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.3 p -156.71 147.27 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.963 -0.562 . . . . 75.319999999999993 111.115 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.9 t -105.45 117.79 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 O-C-N 122.327 -0.233 . . . . 74.510000000000005 110.963 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 m -126.98 178.05 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.953 0.406 . . . . 70.120000000000005 111.826 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -82.43 140.17 33.57 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.023 0.439 . . . . 74.120000000000005 111.374 176.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.446 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -89.98 124.88 35.12 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.436 0.532 . . . . 70.129999999999995 112.436 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -122.57 159.04 28.6 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.279 0.561 . . . . 62.43 111.592 174.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.402 ' HD3' ' HB2' ' A' ' 59' ' ' GLU . 30.0 ttmt -99.61 114.88 28.21 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.81 -0.632 . . . . 73.340000000000003 110.282 175.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.67 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -119.82 -177.67 16.24 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.852 -0.689 . . . . 24.530000000000001 114.495 -172.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -89.26 34.43 0.8 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.209 0.603 . . . . 64.239999999999995 111.536 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.1 m -100.27 149.67 36.25 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 112.514 0.561 . . . . 74.230000000000004 112.514 -174.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.83 163.69 21.18 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.724 2.283 . . . . 74.129999999999995 112.4 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 60' ' ' GLU . 52.0 tttm -68.72 146.91 52.54 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.105 -0.372 . . . . 72.239999999999995 111.352 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.475 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 63.67 32.59 84.67 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.902 -0.666 . . . . 75.409999999999997 112.491 -174.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.449 ' HA ' ' H ' ' A' ' 27' ' ' GLU . 21.6 ttt -152.37 136.32 16.38 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.911 -0.403 . . . . 74.349999999999994 109.911 -177.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.51 HD11 HG22 ' A' ' 28' ' ' VAL . 33.6 pt -137.74 138.6 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.431 0.634 . . . . 73.040000000000006 112.322 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -100.45 129.07 46.36 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.891 -0.595 . . . . 61.539999999999999 111.039 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 30' ' ' SER . 38.9 mt -122.42 132.63 24.23 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 120.523 0.201 . . . . 72.340000000000003 110.479 174.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.417 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 31.3 Cg_exo -60.43 127.19 22.04 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.04 1.826 . . . . 74.099999999999994 111.711 173.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.428 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 6.1 tpt -54.07 111.81 0.84 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.98 0.419 . . . . 73.310000000000002 111.88 -175.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.02 -174.4 32.89 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.861 -0.685 . . . . 64.230000000000004 112.751 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.495 ' HD2' HG21 ' A' ' 52' ' ' VAL . 18.8 Cg_endo -56.54 -34.06 94.27 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.802 2.335 . . . . 71.219999999999999 112.157 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.419 ' HA ' HD11 ' A' ' 140' ' ' LEU . 46.8 m-85 -63.82 -53.82 44.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.888 -0.597 . . . . 71.319999999999993 111.059 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.505 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.58 -38.36 87.24 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.187 0.518 . . . . 50.450000000000003 111.136 175.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -57.59 -17.15 12.71 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.071 0.549 . . . . 64.109999999999999 112.454 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.571 ' SD ' HD21 ' A' ' 140' ' ' LEU . 87.5 mmm -77.19 -22.82 51.81 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.195 0.443 . . . . 72.349999999999994 112.195 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.1 m -123.23 -26.22 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 112.748 0.647 . . . . 73.450000000000003 112.748 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.547 HG21 ' OG ' ' A' ' 30' ' ' SER . 6.9 pt -84.01 179.36 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.892 0.377 . . . . 62.210000000000001 111.786 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -106.34 110.07 63.61 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.522 -0.308 . . . . 64.129999999999995 111.178 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -84.4 -6.49 10.03 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.58 2.187 . . . . 73.040000000000006 112.743 176.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.9 m -68.35 -46.93 68.79 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.411 -0.359 . . . . 62.229999999999997 111.489 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.4 t -65.5 148.58 51.49 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.738 0.304 . . . . 72.239999999999995 111.562 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -115.26 137.51 51.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.721 0.296 . . . . 51.140000000000001 111.351 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -130.43 128.7 5.64 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.014 -0.612 . . . . 51.140000000000001 113.283 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 77.8 p -107.3 124.27 49.54 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.608 -0.348 . . . . 73.510000000000005 111.686 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 123.95 -143.47 14.9 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.338 -0.458 . . . . 72.140000000000001 113.413 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.401 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 24.4 ptm -62.79 167.09 6.33 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 122.567 0.347 . . . . 75.140000000000001 111.829 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 117' ' ' MET . 85.2 Cg_exo -49.58 -20.86 4.64 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.739 2.293 . . . . 74.430000000000007 113.221 174.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.418 ' HG2' ' N ' ' A' ' 120' ' ' PHE . 11.0 tt0 74.39 151.08 0.12 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.656 0.782 . . . . 72.310000000000002 112.779 173.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.418 ' N ' ' HG2' ' A' ' 119' ' ' GLN . 98.4 m-85 -95.69 -178.32 4.35 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.712 -0.676 . . . . 65.439999999999998 110.169 171.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.71 ' HE2' ' HA ' ' A' ' 121' ' ' LYS . 8.9 mmpt? 65.62 118.39 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.663 0.745 . . . . 72.219999999999999 111.729 -175.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -120.67 -174.41 15.1 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.406 -0.816 . . . . 63.130000000000003 113.381 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 66.2 t -84.53 118.7 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.816 0.341 . . . . 74.549999999999997 111.128 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 54.6 mtmt -76.01 156.01 34.43 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.575 0.703 . . . . 74.099999999999994 112.675 -176.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -177.18 -145.36 5.72 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.131 -0.94 . . . . 65.019999999999996 112.307 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 57.6 p -136.79 146.46 45.74 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.526 -0.396 . . . . 75.400000000000006 111.474 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.8 p -128.38 143.48 40.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.927 0.394 . . . . 73.129999999999995 111.153 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.52 148.29 30.05 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.319 -0.4 . . . . 73.299999999999997 110.814 176.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.753 ' HD3' HD23 ' A' ' 67' ' ' LEU . 28.7 ttpp -73.28 139.44 46.13 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.934 -0.395 . . . . 71.519999999999996 109.934 175.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.6 t -127.08 161.51 28.26 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.371 0.878 . . . . 64.340000000000003 113.371 -168.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -92.54 7.04 44.96 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.329 -0.85 . . . . 62.310000000000002 110.448 173.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -87.38 165.54 15.51 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.813 -0.63 . . . . 74.319999999999993 111.65 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.41 161.13 15.71 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.075 -0.511 . . . . 73.209999999999994 111.336 177.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 92.4 t -71.53 128.14 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.679 -0.237 . . . . 74.030000000000001 110.7 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.521 HD23 ' HA ' ' A' ' 135' ' ' LEU . 8.8 mt -65.24 88.3 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.776 0.322 . . . . 72.040000000000006 111.351 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.7 m -51.87 150.01 4.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.943 -0.572 . . . . 65.109999999999999 110.541 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.502 HG23 ' HD1' ' A' ' 49' ' ' PHE . 66.9 t -44.8 -48.78 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 113.063 0.764 . . . . 74.519999999999996 113.063 -168.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -73.1 -39.85 65.46 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.977 -0.452 . . . . 52.140000000000001 111.777 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -57.84 -36.33 72.13 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.772 0.796 . . . . 70.129999999999995 109.919 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.571 HD21 ' SD ' ' A' ' 106' ' ' MET . 3.1 tt -62.55 -42.57 99.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.851 -1.068 . . . . 73.010000000000005 110.677 174.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 50.9 mt -58.45 -54.89 41.91 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.364 0.602 . . . . 73.5 109.859 175.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -52.79 -39.55 62.43 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.482 -0.781 . . . . 71.209999999999994 111.378 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.88 -43.18 99.37 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.161 -0.472 . . . . 41.039999999999999 111.933 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.8 pp -87.74 -6.91 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 112.419 0.525 . . . . 74.219999999999999 112.419 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.85 -1.21 35.99 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.223 -0.513 . . . . 51.539999999999999 113.965 176.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 121.279 0.561 . . . . 75.530000000000001 111.697 179.533 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.9 mtp . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.531 0.205 . . . . 72.530000000000001 111.072 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.13 -169.54 13.33 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.055 -0.593 . . . . 64.150000000000006 113.217 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.1 p -160.3 138.22 9.85 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.865 0.364 . . . . 75.319999999999993 111.583 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.1 p -147.54 109.59 4.5 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.308 0.575 . . . . 51.229999999999997 111.167 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -125.52 42.87 3.19 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.006 -0.543 . . . . 75.540000000000006 110.63 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -43.57 142.37 1.2 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.7 -0.682 . . . . 70.400000000000006 112.741 177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -157.27 128.26 6.7 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.309 -0.405 . . . . 62.039999999999999 111.966 -174.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -168.14 127.18 1.22 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.435 -0.348 . . . . 55.219999999999999 111.128 174.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -166.59 116.44 0.92 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 111.986 0.365 . . . . 72.549999999999997 111.986 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -171.12 147.43 2.56 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.602 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.0 m -141.96 150.14 41.02 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.893 0.378 . . . . 52.219999999999999 111.642 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 95.7 p -137.88 174.91 10.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.038 0.447 . . . . 64.129999999999995 111.45 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.15 121.54 0.56 Allowed Glycine 0 CA--C 1.523 0.581 0 CA-C-N 116.041 -0.527 . . . . 71.530000000000001 111.881 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.36 162.64 36.76 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.209 0.528 . . . . 71.420000000000002 111.979 -175.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.57 141.5 46.64 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.843 -0.617 . . . . 72.329999999999998 112.049 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -94.85 119.83 34.06 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.946 0.403 . . . . 75.409999999999997 110.326 174.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.437 ' N ' HD22 ' A' ' 17' ' ' LEU . 3.0 mm? -73.44 156.71 37.98 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.383 0.611 . . . . 61.439999999999998 112.587 -173.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -100.6 138.43 37.67 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.575 -0.739 . . . . 74.25 111.224 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -115.09 160.36 19.74 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.819 0.342 . . . . 74.430000000000007 111.385 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -70.93 125.73 27.66 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.16 0.8 . . . . 65.209999999999994 113.16 -173.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.14 -130.26 26.94 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 115.566 -0.743 . . . . 72.030000000000001 114.955 169.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -153.37 79.97 1.17 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.673 0.273 . . . . 75.019999999999996 111.239 -173.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.5 ptm -87.28 143.3 27.33 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.865 0.364 . . . . 72.510000000000005 111.333 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.512 HD12 ' HG ' ' A' ' 65' ' ' LEU . 14.8 mt -96.96 132.66 42.53 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.463 0.542 . . . . 72.349999999999994 112.463 -176.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -83.06 109.75 17.4 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.313 0.578 . . . . 64.129999999999995 110.897 174.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.465 HG12 ' HA2' ' A' ' 94' ' ' GLY . 32.0 m -132.37 161.51 41.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.383 -0.826 . . . . 71.329999999999998 111.174 -174.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.662 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 33.2 tt0 -98.81 123.85 43.32 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.04 0.448 . . . . 52.109999999999999 111.174 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.43 117.13 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.913 -0.585 . . . . 65.540000000000006 111.907 -175.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 mt -103.13 163.05 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 122.24 -0.288 . . . . 73.439999999999998 111.172 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 11.7 t -131.95 120.51 22.59 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.915 0.388 . . . . 70.530000000000001 111.492 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.88 135.43 12.85 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.093 -0.575 . . . . 64.230000000000004 113.178 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -54.06 -41.22 67.89 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.484 0.55 . . . . 74.010000000000005 112.484 -175.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.8 p 57.98 -74.93 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.366 0.876 . . . . 74.349999999999994 113.366 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 mp -71.66 -175.92 1.48 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.772 0.796 . . . . 54.25 112.911 -177.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -72.05 116.63 12.68 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.608 -0.724 . . . . 73.519999999999996 112.827 -175.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 59.62 -172.05 0.12 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.884 0.698 . . . . 75.319999999999993 112.884 173.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.27 137.84 13.5 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 116.25 -0.432 . . . . 72.129999999999995 113.206 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.828 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . . . -174.95 168.42 3.51 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.598 0.359 . . . . 70.200000000000003 111.453 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 p -88.77 176.9 6.88 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.788 -0.449 . . . . 74.010000000000005 109.788 172.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.496 HG12 ' CE1' ' A' ' 48' ' ' TYR . 21.8 m -64.2 -26.28 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.75 0.31 . . . . 51.409999999999997 111.294 176.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -67.77 -27.15 66.52 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.798 0.295 . . . . 70.219999999999999 111.798 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.497 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 3.6 mp0 -87.91 -13.2 42.54 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.004 0.431 . . . . 74.420000000000002 111.273 173.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.828 ' HE2' ' HB3' ' A' ' 38' ' ' ALA . 68.0 mttm -129.26 33.49 4.54 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.097 -0.501 . . . . 71.209999999999994 112.024 -176.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 40' ' ' VAL . 43.4 mt -66.65 84.99 0.11 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.445 0.64 . . . . 62.030000000000001 111.253 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.58 HG23 ' H ' ' A' ' 48' ' ' TYR . 7.6 t -144.35 152.62 40.98 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.453 -0.794 . . . . 42.329999999999998 110.826 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -58.33 -29.56 66.01 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.997 0.427 . . . . 54.200000000000003 110.821 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -59.96 -40.48 89.21 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.174 -0.467 . . . . 65.329999999999998 111.301 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.581 ' HE2' ' HD2' ' A' ' 43' ' ' LYS . 5.6 t80 -61.76 -35.54 78.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.284 0.564 . . . . 72.450000000000003 109.982 178.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -61.6 -68.31 0.33 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.793 -0.64 . . . . 64.310000000000002 110.793 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -62.53 -15.1 48.88 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.145 0.424 . . . . 73.129999999999995 112.145 -176.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' A' ' 99' ' ' PRO . . . -80.51 -48.53 12.64 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.576 0.584 . . . . 64.200000000000003 112.576 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.537 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 21.0 m -100.93 5.39 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 113.463 0.912 . . . . 71.140000000000001 113.463 -173.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -91.79 17.61 8.81 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.476 0.917 . . . . 73.25 113.476 -176.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -137.79 164.18 29.56 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.229 0.538 . . . . 74.319999999999993 112.158 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.77 144.23 51.11 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.652 -0.703 . . . . 62.119999999999997 110.654 173.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.721 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 86.3 mt-10 -95.32 115.67 27.74 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.603 0.24 . . . . 74.519999999999996 111.395 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.457 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.2 mp -110.24 150.89 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 120.88 0.371 . . . . 70.099999999999994 110.966 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -70.11 154.88 41.39 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.826 0.451 . . . . 62.43 111.529 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -54.37 -48.93 70.92 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.485 0.55 . . . . 70.109999999999999 112.485 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -67.23 -44.8 78.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.798 0.332 . . . . 62.549999999999997 111.747 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.407 ' HB3' HD13 ' A' ' 24' ' ' LEU . 40.9 m-20 -67.1 -36.51 82.09 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.116 0.484 . . . . 54.009999999999998 111.324 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.6 t-105 -53.13 -54.21 39.07 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.705 -0.68 . . . . 73.219999999999999 111.282 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -71.74 -28.12 63.45 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.681 -0.69 . . . . 63.210000000000001 111.818 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.21 -37.66 83.78 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.162 0.506 . . . . 74.340000000000003 111.457 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.584 HD11 HG13 ' A' ' 127' ' ' VAL . 92.4 mt -88.41 -8.19 55.4 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.254 -0.43 . . . . 70.099999999999994 111.639 177.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.4 46.99 73.69 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.071 -0.585 . . . . 72.310000000000002 112.708 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.672 HD23 ' HE3' ' A' ' 129' ' ' LYS . 79.9 mt -86.16 152.3 22.95 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.129 0.49 . . . . 73.340000000000003 111.965 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.529 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 61.3 tt0 -119.62 145.58 46.31 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.097 -0.502 . . . . 61.229999999999997 109.789 172.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -56.35 110.11 0.71 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.113 0.482 . . . . 75.219999999999999 111.741 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.88 4.03 39.35 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 115.89 -0.595 . . . . 73.109999999999999 113.274 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 68' ' ' GLN . 0.5 OUTLIER -69.85 174.16 5.53 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.579 0.585 . . . . 75.409999999999997 112.579 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -105.42 123.74 48.39 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.042 -0.526 . . . . 74.420000000000002 110.689 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' A' ' 86' ' ' ALA . 17.9 m -118.35 144.48 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.331 0.586 . . . . 61.409999999999997 112.271 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.618 ' HD2' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -96.02 137.13 35.53 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.815 -0.63 . . . . 71.299999999999997 110.374 175.396 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 61.5 t -124.98 120.72 59.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.348 -0.612 . . . . 63.240000000000002 109.348 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.406 ' HG2' ' CB ' ' A' ' 81' ' ' GLU . 4.8 mtpm? -129.88 132.15 46.32 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.098 0.475 . . . . 72.340000000000003 112.076 -171.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.726 HG22 ' HA3' ' A' ' 125' ' ' GLY . 30.8 p -135.81 -172.33 3.08 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.269 0.557 . . . . 75.319999999999993 111.072 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -72.21 -6.15 40.8 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.13 -0.486 . . . . 71.140000000000001 111.847 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -95.59 -52.6 4.05 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.789 0.328 . . . . 62.149999999999999 111.138 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.27 -162.59 27.84 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.349 -0.453 . . . . 54.439999999999998 112.7 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.618 ' HB2' ' HD2' ' A' ' 74' ' ' LYS . 0.4 OUTLIER -135.61 150.22 49.59 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.285 0.564 . . . . 65.439999999999998 112.141 178.671 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 103' ' ' TYR . 8.8 p -143.84 153.56 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 116.02 -0.536 . . . . 75.209999999999994 111.245 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.6 t -112.78 121.76 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 122.211 0.205 . . . . 75.530000000000001 110.843 177.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.409 HG12 ' CD2' ' A' ' 103' ' ' TYR . 35.0 m -132.86 172.4 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.23 0.455 . . . . 55.409999999999997 112.23 -177.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -73.67 146.1 44.76 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.074 0.464 . . . . 75.099999999999994 110.998 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.456 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -96.31 119.54 34.98 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.625 0.602 . . . . 72.209999999999994 112.625 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -124.63 152.96 42.97 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.151 0.501 . . . . 71.310000000000002 110.678 172.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -96.11 114.9 26.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.18 -0.464 . . . . 73.530000000000001 110.042 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.721 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -113.86 -161.37 14.13 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.465 -0.874 . . . . 75.120000000000005 114.773 -170.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -93.79 23.2 4.94 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.12 0.485 . . . . 55.240000000000002 111.588 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.2 m -87.36 144.66 36.18 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.19 -0.459 . . . . 61.329999999999998 112.225 -175.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.89 174.71 12.37 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.646 2.231 . . . . 54.340000000000003 113.391 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -57.53 126.12 25.92 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.963 -0.562 . . . . 53.509999999999998 111.86 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.465 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 73.31 29.21 64.56 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.171 -0.538 . . . . 63.020000000000003 114.15 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.646 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 15.0 ttt -148.8 139.82 23.01 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.383 -0.481 . . . . 73.299999999999997 110.214 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.432 HG22 ' HA ' ' A' ' 57' ' ' ILE . 40.0 pt -134.06 148.88 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.401 0.619 . . . . 65.239999999999995 112.078 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -109.06 130.25 55.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.981 -0.554 . . . . 64.129999999999995 111.54 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 30' ' ' SER . 49.5 mt -123.26 129.58 24.87 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 120.858 0.361 . . . . 73.409999999999997 110.967 174.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.537 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 50.5 Cg_exo -57.66 142.28 95.73 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.406 2.071 . . . . 65.230000000000004 112.572 175.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.2 tpt -59.44 107.05 0.52 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.173 0.511 . . . . 75.310000000000002 111.564 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.41 -176.51 38.81 Favored Glycine 0 CA--C 1.521 0.406 0 C-N-CA 120.114 -1.041 . . . . 33.329999999999998 113.612 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.517 ' HG3' HG13 ' A' ' 137' ' ' VAL . 19.5 Cg_endo -57.28 -34.64 98.2 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.034 2.489 . . . . 54.119999999999997 111.941 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.468 ' HA ' HG21 ' A' ' 82' ' ' VAL . 72.1 m-85 -61.75 -51.49 68.12 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.659 -0.7 . . . . 62.100000000000001 110.704 177.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -62.86 -36.43 83.25 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.202 -0.454 . . . . 62.399999999999999 111.152 175.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -56.68 -23.82 44.59 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.05 0.54 . . . . 72.349999999999994 111.963 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.538 ' SD ' HD21 ' A' ' 140' ' ' LEU . 86.2 mmm -74.24 -22.08 59.5 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.907 0.336 . . . . 63.310000000000002 111.907 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.5 -21.1 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 113.169 0.803 . . . . 61.219999999999999 113.169 -170.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 104' ' ' ALA . 7.0 pt -95.98 -179.42 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.282 0.563 . . . . 74.099999999999994 111.841 -177.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.446 ' H ' HG21 ' A' ' 123' ' ' VAL . 22.0 t70 -106.74 117.83 55.83 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 116.029 -0.532 . . . . 73.239999999999995 111.016 178.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.67 19.49 1.1 Allowed 'Trans proline' 0 CA--C 1.546 1.075 0 C-N-CA 122.963 2.442 . . . . 75.540000000000006 114.209 -177.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.8 t -97.66 14.88 25.2 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.997 -0.439 . . . . 64.239999999999995 111.253 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.9 p -65.33 114.74 4.98 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.152 0.427 . . . . 73.030000000000001 112.152 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -73.83 104.34 4.68 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.781 0.324 . . . . 63.340000000000003 111.548 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.83 -128.56 1.04 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.196 -0.526 . . . . 73.25 112.816 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.8 m 72.33 -48.22 0.68 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.918 0.71 . . . . 62.439999999999998 112.918 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -107.43 -96.06 2.44 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.224 -0.512 . . . . 64.409999999999997 114.052 -178.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.54 140.73 22.83 Favored Pre-proline 0 N--CA 1.472 0.638 0 N-CA-C 113.055 0.761 . . . . 72.299999999999997 113.055 -172.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -85.85 117.0 1.63 Allowed 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.053 2.502 . . . . 73.120000000000005 111.914 173.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -108.27 142.65 38.23 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.867 0.365 . . . . 61.119999999999997 111.845 -174.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -74.7 28.45 0.09 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.808 1.04 . . . . 74.209999999999994 113.808 -174.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.18 99.39 6.99 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.637 -0.664 . . . . 65.420000000000002 110.804 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -89.78 163.34 30.78 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.995 -0.622 . . . . 54.25 113.669 -175.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.446 HG21 ' H ' ' A' ' 109' ' ' ASP . 61.2 t -94.28 119.15 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 122.606 -0.35 . . . . 71.310000000000002 111.259 175.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 6.8 ttpt -66.78 152.82 44.79 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.409 0.623 . . . . 72.120000000000005 112.347 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.726 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -174.05 -144.67 4.89 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.553 -0.749 . . . . 60.109999999999999 112.635 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 65.9 p -140.97 160.23 40.51 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.488 0.315 . . . . 71.129999999999995 111.704 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.584 HG13 HD11 ' A' ' 65' ' ' LEU . 13.6 p -142.97 144.6 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 120.855 0.359 . . . . 64.010000000000005 111.311 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -154.95 165.0 38.08 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.246 0.546 . . . . 73.329999999999998 112.44 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.672 ' HE3' HD23 ' A' ' 67' ' ' LEU . 5.5 tppp? -70.51 138.77 51.32 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.107 -0.497 . . . . 74.099999999999994 111.11 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 t -144.54 149.82 36.5 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.437 0.637 . . . . 60.520000000000003 112.431 175.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -90.19 -5.55 56.29 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.609 -0.723 . . . . 64.439999999999998 111.009 176.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.41 ' CD ' ' HZ1' ' A' ' 74' ' ' LYS . 27.8 mt-10 -63.67 165.48 8.23 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.081 -0.509 . . . . 74.430000000000007 111.591 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -92.34 155.41 17.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.026 0.441 . . . . 53.520000000000003 111.095 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 99.1 t -58.9 127.74 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.237 -0.438 . . . . 73.349999999999994 110.979 173.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.37 86.83 0.83 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.717 0.294 . . . . 71.200000000000003 111.103 -178.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.5 m -44.49 141.74 1.85 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.774 -0.648 . . . . 61.219999999999999 111.908 -175.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.517 HG13 ' HG3' ' A' ' 102' ' ' PRO . 51.4 t -45.14 -50.11 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.879 0.696 . . . . 40.030000000000001 112.879 -172.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -70.5 -43.58 69.4 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.625 0.25 . . . . 75.530000000000001 111.435 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -55.14 -41.64 72.02 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.795 0.807 . . . . 72.510000000000005 110.381 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.538 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.4 tt -61.22 -37.77 84.21 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.018 -0.992 . . . . 73.519999999999996 111.351 177.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 52.2 mt -59.35 -44.8 92.62 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.301 0.572 . . . . 75.239999999999995 110.506 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -76.53 -29.71 56.85 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.83 -0.623 . . . . 71.219999999999999 111.059 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.96 -39.15 84.63 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.177 -0.465 . . . . 75.200000000000003 112.074 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.404 HD12 ' H ' ' A' ' 146' ' ' SER . 2.8 pp -79.47 -11.35 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.111 0.412 . . . . 73.150000000000006 112.111 177.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 135.5 -64.56 0.58 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.247 -0.502 . . . . 71.409999999999997 113.082 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 141' ' ' LEU . 32.9 t . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 121.505 0.669 . . . . 73.219999999999999 112.2 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptp . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.101 0.477 . . . . 72.099999999999994 111.403 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -145.58 169.76 27.04 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.281 -0.485 . . . . 53.43 113.042 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.4 p -100.05 157.72 16.35 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.081 0.467 . . . . 52.350000000000001 111.553 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.2 m -150.54 99.63 2.77 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.039 0.447 . . . . 74.340000000000003 111.204 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -140.99 144.59 35.14 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.284 -0.416 . . . . 65.310000000000002 111.031 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -150.57 139.5 20.94 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.072 0.397 . . . . 64.310000000000002 112.072 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -141.74 105.18 4.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.208 0.528 . . . . 75.099999999999994 111.344 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -113.7 90.47 3.35 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.039 -0.413 . . . . 64.230000000000004 110.719 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -138.44 153.47 48.85 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.291 0.567 . . . . 73.040000000000006 111.879 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -139.86 95.8 2.96 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.621 -0.718 . . . . 74.400000000000006 110.292 173.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.5 p -66.33 93.39 0.22 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.921 0.391 . . . . 75.340000000000003 110.892 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.7 p -58.8 121.16 10.41 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.316 0.579 . . . . 71.129999999999995 112.259 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.61 83.14 0.18 Allowed Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.936 -0.574 . . . . 72.109999999999999 112.103 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -78.58 -47.11 17.85 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.671 0.272 . . . . 75.019999999999996 111.658 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 74.08 156.81 0.18 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.465 -0.789 . . . . 64.430000000000007 111.801 -173.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -157.81 20.11 0.26 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.972 0.415 . . . . 73.329999999999998 111.13 -177.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.18 173.07 6.47 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.224 0.535 . . . . 74.310000000000002 111.747 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -163.81 124.39 2.21 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.002 -0.544 . . . . 70.450000000000003 111.13 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -98.56 95.03 7.01 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.214 0.53 . . . . 72.400000000000006 111.334 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -89.53 87.14 6.94 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.106 0.479 . . . . 44.32 110.463 176.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.62 -177.03 14.96 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.157 -0.544 . . . . 32.350000000000001 113.83 -177.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -88.95 101.84 14.47 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 111.896 0.332 . . . . 54.229999999999997 111.896 -177.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.442 ' HE2' ' HB ' ' A' ' 126' ' ' THR . 13.4 ptm -75.98 154.3 35.92 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.637 0.256 . . . . 64.349999999999994 110.93 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 mp -117.16 148.85 41.22 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.07 0.462 . . . . 74.099999999999994 112.179 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.39 128.01 34.57 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.569 0.699 . . . . 72.409999999999997 111.45 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.465 HG12 ' HA2' ' A' ' 94' ' ' GLY . 27.4 m -140.67 162.46 23.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.337 -0.847 . . . . 62.520000000000003 110.97 -176.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.731 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 41.9 tt0 -98.88 112.46 24.55 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.122 0.487 . . . . 71.340000000000003 110.127 175.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.3 t -86.98 119.26 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.782 -0.644 . . . . 73.109999999999999 111.87 -172.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 121' ' ' LYS . 2.8 mt -103.56 154.99 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.793 0.33 . . . . 60.240000000000002 111.531 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.671 ' HB2' HG21 ' A' ' 108' ' ' ILE . 11.4 t -133.78 107.66 8.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.942 0.401 . . . . 62.450000000000003 111.077 175.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -104.34 134.17 11.84 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 121.161 -0.542 . . . . 65.299999999999997 113.134 -177.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -77.39 82.07 3.86 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.159 0.504 . . . . 73.549999999999997 111.496 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 t -78.49 -33.8 47.92 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.989 -0.55 . . . . 74.430000000000007 110.883 174.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.55 109.36 20.32 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.793 -0.447 . . . . 61.310000000000002 109.793 173.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -79.84 -175.43 4.9 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.501 0.556 . . . . 73.340000000000003 112.501 -174.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 68.04 108.09 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.52 -0.763 . . . . 74.200000000000003 111.303 -173.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.29 101.7 0.41 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.568 -0.825 . . . . 63.340000000000003 112.706 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . . . -151.56 146.4 25.83 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.091 0.404 . . . . 74.219999999999999 112.091 -175.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 t -66.66 159.54 27.46 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.331 -0.395 . . . . 71.140000000000001 110.738 171.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.445 HG21 HG11 ' A' ' 137' ' ' VAL . 11.6 p -58.82 -27.47 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.758 0.313 . . . . 71.319999999999993 110.843 177.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -57.24 -32.25 66.37 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.157 -0.474 . . . . 54.539999999999999 111.441 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -72.3 -33.96 67.79 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.945 0.402 . . . . 71.25 111.803 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.66 ' HE2' ' HB3' ' A' ' 38' ' ' ALA . 1.5 mptp? -91.83 -70.53 0.68 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.554 -0.294 . . . . 75.340000000000003 111.549 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.6 mt 55.59 9.48 0.41 Allowed 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 113.892 1.071 . . . . 73.150000000000006 113.892 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.536 HG23 ' H ' ' A' ' 48' ' ' TYR . 6.2 t -81.86 156.04 25.04 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.105 -0.372 . . . . 61.200000000000003 111.606 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.62 -31.37 70.56 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.899 0.381 . . . . 74.430000000000007 110.584 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -58.11 -38.12 75.86 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.033 0.444 . . . . 73.25 111.039 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.548 ' O ' HG22 ' A' ' 52' ' ' VAL . 4.1 t80 -59.3 -44.02 92.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.289 0.566 . . . . 65.299999999999997 109.583 176.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.508 ' HD2' HG23 ' A' ' 137' ' ' VAL . 57.8 t80 -60.44 -60.51 3.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.572 -0.74 . . . . 64.439999999999998 110.16 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -53.08 -28.42 24.99 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.884 -0.598 . . . . 74.409999999999997 112.313 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.24 -37.87 25.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.271 0.841 . . . . 44.32 113.271 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 48' ' ' TYR . 19.3 m -109.76 9.61 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 113.494 0.924 . . . . 60.240000000000002 113.494 -172.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -98.38 25.91 5.9 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.061 0.763 . . . . 54.509999999999998 113.061 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.432 ' CD1' ' HD2' ' A' ' 87' ' ' LYS . 52.8 p90 -146.5 158.56 43.91 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.012 -0.43 . . . . 64.0 111.752 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.49 139.26 51.63 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.302 -0.408 . . . . 61.539999999999999 111.484 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.673 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 42.7 mt-10 -87.68 113.15 23.09 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.219 0.533 . . . . 71.109999999999999 110.943 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.8 mt -112.44 150.71 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.561 -0.745 . . . . 75.140000000000001 111.593 -171.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.668 ' ND2' HG23 ' A' ' 91' ' ' VAL . 1.9 m120 -72.19 135.17 46.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.498 -0.319 . . . . 72.030000000000001 110.976 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 37.4 tt0 -54.18 -40.17 67.3 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.629 0.603 . . . . 61.119999999999997 112.629 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -64.14 -49.56 71.66 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.543 0.572 . . . . 60.100000000000001 112.543 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -70.42 -29.4 66.0 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.657 0.742 . . . . 71.329999999999998 110.284 177.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.514 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 32.2 t-105 -55.83 -47.54 77.05 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.169 -0.923 . . . . 75.510000000000005 110.401 172.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -65.12 -41.44 94.87 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.848 -0.615 . . . . 61.0 111.037 174.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.95 -39.27 74.24 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.164 -0.471 . . . . 73.140000000000001 111.939 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.4 mt -88.03 -12.53 44.08 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.24 -0.437 . . . . 74.430000000000007 111.782 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.89 50.59 51.95 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.193 -0.527 . . . . 53.310000000000002 112.642 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.627 HD23 ' HE3' ' A' ' 129' ' ' LYS . 86.1 mt -88.65 155.21 19.74 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.471 0.653 . . . . 72.510000000000005 112.467 -176.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -127.14 151.95 47.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.619 -0.719 . . . . 74.439999999999998 109.501 173.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -63.52 98.68 0.18 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.525 0.678 . . . . 75.040000000000006 111.762 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.13 -17.92 5.91 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.119 -0.946 . . . . 51.340000000000003 112.888 -175.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -56.48 155.69 6.93 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.314 0.578 . . . . 73.439999999999998 112.242 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -94.89 123.08 38.15 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.746 -0.661 . . . . 73.530000000000001 110.66 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 86' ' ' ALA . 31.6 m -116.5 147.38 19.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.018 0.437 . . . . 74.510000000000005 111.377 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.481 ' HB2' HG22 ' A' ' 83' ' ' VAL . 4.6 ttpm? -114.66 138.76 50.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.477 0.656 . . . . 72.200000000000003 110.969 176.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 57.7 t -116.95 134.33 60.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.45 -0.796 . . . . 73.219999999999999 109.669 -175.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -133.58 123.72 25.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.263 0.468 . . . . 70.439999999999998 112.263 -172.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.716 HG22 ' HA3' ' A' ' 125' ' ' GLY . 36.9 p -126.2 -172.26 2.58 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.209 -0.45 . . . . 70.409999999999997 110.703 174.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.63 -14.42 61.6 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.809 0.338 . . . . 74.239999999999995 111.151 175.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -84.51 -52.79 5.87 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.778 0.323 . . . . 72.329999999999998 111.376 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.08 -159.62 20.06 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.979 -0.629 . . . . 71.430000000000007 113.122 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 0.4 OUTLIER -143.61 153.16 42.24 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.034 0.445 . . . . 64.230000000000004 111.606 176.57 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.1 p -150.77 145.93 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.332 -0.395 . . . . 74.319999999999993 111.377 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 74' ' ' LYS . 60.9 t -107.34 118.93 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 120.532 0.206 . . . . 54.140000000000001 111.169 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.74 178.11 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 122.802 0.441 . . . . 75.409999999999997 111.576 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -81.65 146.73 29.9 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.221 0.534 . . . . 74.340000000000003 111.754 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.512 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -93.52 129.11 39.85 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.888 0.699 . . . . 75.340000000000003 112.888 -177.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.432 ' HD2' ' CD1' ' A' ' 54' ' ' TYR . 67.3 mttm -135.3 151.77 50.85 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.973 -0.558 . . . . 65.299999999999997 109.978 172.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -78.01 147.43 34.84 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.069 -0.394 . . . . 64.049999999999997 110.511 173.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.673 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -134.73 168.72 23.47 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.804 -0.712 . . . . 63.130000000000003 114.018 -175.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -89.22 23.95 2.32 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.365 0.602 . . . . 60.310000000000002 110.958 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.668 HG23 ' ND2' ' A' ' 58' ' ' ASN . 17.3 m -91.28 151.94 43.37 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 115.925 -0.579 . . . . 63.350000000000001 112.221 -175.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.19 145.57 55.04 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.098 2.532 . . . . 45.32 112.782 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -52.54 142.31 18.23 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.386 0.513 . . . . 73.239999999999995 112.386 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.465 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 71.55 25.79 74.49 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.806 -0.711 . . . . 64.040000000000006 113.195 -174.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' MET . . . . . 0.731 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 19.0 ttt -154.43 135.03 13.51 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.42 -0.459 . . . . 74.299999999999997 110.029 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.42 ' O ' HG13 ' A' ' 29' ' ' ILE . 41.8 pt -133.22 145.67 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 120.998 0.428 . . . . 74.319999999999993 112.154 -174.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -105.27 130.19 53.46 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.429 -0.351 . . . . 72.129999999999995 111.424 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.641 ' O ' ' HA ' ' A' ' 30' ' ' SER . 50.8 mt -125.31 130.34 24.17 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 120.776 0.322 . . . . 71.219999999999999 110.714 175.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.41 135.23 69.08 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.334 2.023 . . . . 62.32 112.853 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.445 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 5.1 tpt -54.14 109.7 0.51 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.262 -0.426 . . . . 70.140000000000001 111.904 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.62 -174.35 32.42 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.866 -0.683 . . . . 55.240000000000002 112.513 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.557 ' O ' ' HG2' ' A' ' 106' ' ' MET . 32.3 Cg_endo -65.11 -26.44 57.7 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.808 1.672 . . . . 74.120000000000005 111.57 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.509 ' HA ' HD11 ' A' ' 140' ' ' LEU . 4.6 m-85 -67.53 -53.85 24.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.6 -0.727 . . . . 73.099999999999994 110.496 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.526 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.43 -40.61 95.07 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.075 -0.511 . . . . 44.200000000000003 110.798 174.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -53.52 -26.89 22.89 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.308 -0.405 . . . . 63.329999999999998 111.916 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.646 ' SD ' HD21 ' A' ' 140' ' ' LEU . 83.1 mmm -64.96 -34.33 78.16 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.754 0.311 . . . . 70.010000000000005 111.835 177.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.447 ' HB ' HG23 ' A' ' 77' ' ' THR . 27.1 m -115.82 -19.88 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.846 0.684 . . . . 64.409999999999997 112.846 -168.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.671 HG21 ' HB2' ' A' ' 30' ' ' SER . 10.1 pt -90.65 -176.21 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-O 121.177 0.513 . . . . 75.239999999999995 111.962 -178.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.599 ' N ' HG21 ' A' ' 123' ' ' VAL . 18.0 t70 -109.01 115.56 56.85 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.242 -0.435 . . . . 73.040000000000006 111.507 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -86.18 16.83 1.88 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.014 2.476 . . . . 75.299999999999997 113.78 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.1 t -85.16 -31.77 23.08 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.021 0.438 . . . . 73.329999999999998 111.291 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.8 t -85.49 145.14 27.55 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.141 0.496 . . . . 71.409999999999997 111.985 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -82.42 7.28 14.64 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.341 0.591 . . . . 63.25 110.648 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.53 3.0 32.88 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.447 -0.661 . . . . 51.399999999999999 111.447 -171.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 41.2 m 62.21 -70.88 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.653 0.781 . . . . 74.230000000000004 112.065 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -149.87 -100.67 0.22 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.635 -0.586 . . . . 73.340000000000003 111.635 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 58.5 mtp -111.37 145.19 32.05 Favored Pre-proline 0 CA--C 1.539 0.519 0 O-C-N 122.652 -0.322 . . . . 61.409999999999997 110.42 171.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.11 95.01 0.24 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 122.442 2.095 . . . . 51.109999999999999 114.263 -174.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -98.98 -168.58 1.65 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.155 -0.475 . . . . 73.439999999999998 109.808 170.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -71.08 82.24 0.69 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.652 0.739 . . . . 54.299999999999997 111.267 175.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.453 ' O ' HG12 ' A' ' 29' ' ' ILE . 33.2 mttm -132.19 -170.3 2.39 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 114.968 -1.014 . . . . 62.140000000000001 110.192 176.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 145.41 175.83 18.85 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.556 -0.83 . . . . 53.32 113.695 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.599 HG21 ' N ' ' A' ' 109' ' ' ASP . 62.0 t -93.82 121.29 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 112.226 0.454 . . . . 52.210000000000001 112.226 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.51 ' HD2' ' N ' ' A' ' 125' ' ' GLY . 0.3 OUTLIER -60.94 141.51 57.19 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.024 0.529 . . . . 73.099999999999994 111.923 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.716 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -170.35 -147.26 5.48 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 116.221 -0.445 . . . . 63.340000000000003 113.087 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.442 ' HB ' ' HE2' ' A' ' 23' ' ' MET . 57.2 p -138.7 159.16 42.78 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.775 0.43 . . . . 72.230000000000004 111.711 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -140.39 145.61 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.906 0.384 . . . . 41.450000000000003 111.374 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.66 154.78 32.1 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.379 -0.373 . . . . 73.519999999999996 111.502 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.627 ' HE3' HD23 ' A' ' 67' ' ' LEU . 36.1 ttmt -71.33 144.38 49.94 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.505 -0.554 . . . . 65.420000000000002 109.505 168.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.448 HG21 HG13 ' A' ' 83' ' ' VAL . 6.0 t -131.98 145.66 51.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 122.05 0.928 . . . . 54.109999999999999 113.355 -176.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -77.32 -10.67 59.58 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.422 -1.263 . . . . 72.310000000000002 111.621 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -82.11 -179.94 7.59 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.478 0.656 . . . . 75.409999999999997 112.503 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -97.25 154.85 17.14 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.741 -0.663 . . . . 72.030000000000001 111.192 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.8 134.35 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.798 0.333 . . . . 64.030000000000001 110.661 172.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 21.1 mt -70.42 125.43 26.76 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.13 0.418 . . . . 75.400000000000006 112.13 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.447 ' HA ' ' HE2' ' A' ' 49' ' ' PHE . 74.0 m -65.05 149.09 50.48 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.386 -0.598 . . . . 72.439999999999998 109.386 167.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.508 HG23 ' HD2' ' A' ' 49' ' ' PHE . 94.7 t -48.61 -48.02 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 111.85 0.315 . . . . 74.239999999999995 111.85 -175.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -72.44 -37.93 68.45 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.234 -0.291 . . . . 61.049999999999997 111.574 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -55.4 -40.52 71.51 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.846 0.831 . . . . 74.510000000000005 109.518 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.646 HD21 ' SD ' ' A' ' 106' ' ' MET . 4.0 tt -58.53 -46.15 87.39 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.4 -1.273 . . . . 71.319999999999993 111.236 173.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 39.6 mt -59.16 -42.91 91.87 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.523 0.677 . . . . 70.219999999999999 110.829 178.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -67.98 -36.9 80.81 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.447 -0.797 . . . . 72.120000000000005 111.087 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.36 -30.45 71.58 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.223 -0.444 . . . . 55.219999999999999 112.193 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.513 HD12 ' H ' ' A' ' 146' ' ' SER . 2.7 pp -98.33 2.57 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.173 0.511 . . . . 75.439999999999998 111.976 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 90.33 -58.91 3.46 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 116.195 -0.457 . . . . 42.399999999999999 113.643 176.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.513 ' H ' HD12 ' A' ' 144' ' ' ILE . 70.7 m . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 121.036 0.446 . . . . 72.430000000000007 111.555 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.0 ptm . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.349 0.595 . . . . 74.03 112.435 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.528 HD12 ' HG ' ' A' ' 65' ' ' LEU . 15.1 mt -107.85 138.24 44.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.934 -0.575 . . . . 61.24 111.421 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.451 ' HA ' HG22 ' A' ' 126' ' ' THR . 33.0 tt0 -78.45 114.39 17.32 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.915 0.388 . . . . 61.13 110.781 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 27.4 m -127.5 159.74 37.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.18 0.514 . . . . 52.24 111.921 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.725 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 57.0 tt0 -98.78 108.99 21.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.064 0.459 . . . . 63.3 110.073 175.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.428 HG22 HD11 ' A' ' 96' ' ' ILE . 33.6 t -83.59 110.32 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.667 -0.697 . . . . 75.13 111.611 -175.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 30' ' ' SER . 8.3 mt -92.39 162.05 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.882 0.373 . . . . 70.21 111.979 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.597 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 64.8 m -137.34 92.61 2.72 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.089 0.471 . . . . 73.31 111.577 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 C-N-CA 121.158 -0.544 . . . . 45.3 112.362 179.4 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 . . . . . 0 N--CA 1.47 0.539 0 CA-C-O 121.079 0.466 . . . . 73.43 111.022 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.96 -23.52 64.14 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.327 -0.397 . . . . 74.04 111.195 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.495 ' HD1' HG23 ' A' ' 137' ' ' VAL . 55.3 t80 -94.4 -0.49 54.8 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.046 0.451 . . . . 63.43 112.015 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -121.48 -27.63 4.75 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.604 -0.685 . . . . 65.3 112.275 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' A' ' 99' ' ' PRO . . . -72.5 -62.9 1.28 Allowed 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.35 0.5 . . . . 73.24 112.35 -176.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.469 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 30.2 m -95.49 21.26 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 112.975 0.731 . . . . 65.12 112.975 -172.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.615 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -105.01 11.13 33.77 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.317 0.858 . . . . 72.22 113.317 -172.021 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.469 ' CD2' ' HD2' ' A' ' 87' ' ' LYS . 38.0 p90 -136.18 162.22 33.57 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.65 0.611 . . . . 70.43 112.65 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -126.83 130.0 49.38 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.66 -0.7 . . . . 73.14 111.004 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.592 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 43.6 mt-10 -87.38 117.55 26.23 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.167 0.508 . . . . 73.1 111.086 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 28.2 mt -112.79 142.54 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.663 -0.699 . . . . 73.52 111.501 -172.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.02 149.01 50.61 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.953 0.406 . . . . 73.44 111.502 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -53.83 -49.9 67.39 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.127 -0.488 . . . . 75.24 112.186 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -56.61 -51.66 67.81 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.723 0.296 . . . . 60.34 111.731 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -66.08 -35.76 81.37 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.097 0.475 . . . . 74.34 110.878 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -53.22 -50.14 65.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.846 -0.616 . . . . 74.33 111.009 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -71.31 -37.11 71.8 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.399 -0.364 . . . . 71.13 111.247 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.53 -33.0 70.84 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.189 0.44 . . . . 61.54 112.189 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.528 ' HG ' HD12 ' A' ' 24' ' ' LEU . 93.5 mt -90.2 -13.53 35.34 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.417 -0.356 . . . . 61.32 111.874 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.26 53.05 23.72 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.02 -0.609 . . . . 61.34 112.106 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.701 HD23 ' HE3' ' A' ' 129' ' ' LYS . 75.1 mt -92.3 137.43 32.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.499 0.666 . . . . 52.11 111.808 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -107.84 142.73 37.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.996 -0.547 . . . . 75.41 109.725 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -61.84 100.01 0.14 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.676 0.75 . . . . 74.11 110.997 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.53 -14.73 4.46 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 115.097 -0.956 . . . . 63.4 112.958 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -72.13 178.64 3.72 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.67 0.748 . . . . 75.4 112.554 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.429 ' HD3' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -131.74 147.99 52.54 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.42 -0.809 . . . . 72.05 110.242 175.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 86' ' ' ALA . 19.7 m -124.41 152.77 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.903 0.705 . . . . 65.4 112.903 -174.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -94.36 122.11 36.57 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.316 -0.856 . . . . 75.15 110.442 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.8 t -108.42 126.18 65.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.493 -0.321 . . . . 61.51 110.136 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -133.48 131.98 40.5 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.393 0.616 . . . . 71.43 112.586 -173.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.694 HG22 ' HA3' ' A' ' 125' ' ' GLY . 39.4 p -134.45 -171.23 2.71 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.495 -0.775 . . . . 52.42 110.603 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.69 -18.56 60.5 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.993 0.425 . . . . 75.11 110.664 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -80.91 -52.61 7.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.267 -0.424 . . . . 72.4 111.465 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.69 -150.55 7.62 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.781 -0.723 . . . . 55.23 113.349 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -148.49 154.39 39.76 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.77 0.319 . . . . 72.55 111.401 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.5 p -157.88 145.78 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-O 120.663 0.268 . . . . 45.05 111.534 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.5 t -102.31 116.56 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 122.42 -0.175 . . . . 71.13 110.637 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.0 m -125.74 166.68 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 120.901 0.381 . . . . 75.13 111.818 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -69.06 130.8 43.76 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.094 0.473 . . . . 75.41 111.452 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.57 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -81.99 120.07 24.79 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.39 -0.368 . . . . 63.3 111.813 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.469 ' HD2' ' CD2' ' A' ' 54' ' ' TYR . 67.7 mttm -132.43 157.26 45.03 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.025 0.441 . . . . 61.43 110.614 174.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -94.75 140.75 29.48 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.188 -0.46 . . . . 71.31 111.259 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.592 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -140.56 167.48 25.53 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.915 -0.66 . . . . 72.44 113.553 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.93 20.98 2.84 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.19 0.519 . . . . 72.32 111.948 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 m -73.7 153.61 89.4 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.118 -0.492 . . . . 63.33 111.16 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HG2' ' SD ' ' A' ' 95' ' ' MET . 35.1 Cg_endo -63.85 160.24 38.09 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.307 2.005 . . . . 64.1 112.837 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -63.86 147.29 52.24 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.03 0.443 . . . . 74.35 111.461 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 65.76 34.57 89.15 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.02 -0.609 . . . . 61.24 112.457 -175.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.725 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 23.0 ttt -157.86 137.28 11.91 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.559 -0.377 . . . . 75.31 110.519 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 28' ' ' VAL . 41.6 pt -134.81 143.95 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.05 0.452 . . . . 61.34 111.689 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -102.52 128.29 49.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.429 -0.351 . . . . 74.14 111.818 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 30' ' ' SER . 45.1 mt -124.8 133.57 24.9 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-O 120.812 0.339 . . . . 74.1 110.518 172.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.469 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 37.4 Cg_exo -59.62 130.11 33.89 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.228 1.952 . . . . 53.54 112.242 173.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.52 106.1 0.19 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 122.668 0.387 . . . . 51.11 111.406 -176.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -161.64 -172.54 29.14 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.927 -0.654 . . . . 43.43 112.928 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.429 ' HD2' HG21 ' A' ' 52' ' ' VAL . 15.1 Cg_endo -56.71 -37.39 97.92 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.079 2.519 . . . . 70.33 112.676 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.449 ' HA ' HD11 ' A' ' 140' ' ' LEU . 35.9 m-85 -60.47 -52.96 62.98 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.234 -0.439 . . . . 73.4 110.732 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.0 -40.43 93.5 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.266 -0.425 . . . . 75.21 110.948 175.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -52.06 -26.53 11.2 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.103 0.561 . . . . 74.14 112.157 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.638 ' SD ' HD21 ' A' ' 140' ' ' LEU . 92.0 mmm -67.12 -31.76 72.44 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 111.912 0.338 . . . . 72.14 111.912 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.423 ' HB ' HG23 ' A' ' 77' ' ' THR . 27.1 m -119.55 -13.74 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 112.906 0.706 . . . . 71.31 112.906 -171.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.53 HG21 ' OG ' ' A' ' 30' ' ' SER . 11.6 pt -100.87 -179.59 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.138 0.494 . . . . 52.32 111.766 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 CA--C 1.541 0.627 0 CA-C-N 116.144 -0.48 . . . . 75.12 110.615 174.018 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.844 0 CA-C-O 121.031 0.239 . . . . 73.43 113.395 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.9 t -85.98 123.52 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 120.925 0.393 . . . . 33.11 111.963 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 22.1 mmmt -61.54 148.27 42.72 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.201 0.524 . . . . 74.15 112.233 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.694 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -178.87 -151.47 9.63 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.946 -0.57 . . . . 61.52 113.205 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 25' ' ' GLU . 56.1 p -140.84 160.39 40.15 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.466 -0.432 . . . . 70.22 111.815 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.1 p -142.22 145.17 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.198 -0.455 . . . . 60.22 110.971 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -151.08 155.58 39.26 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.503 0.557 . . . . 73.44 112.503 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.701 ' HE3' HD23 ' A' ' 67' ' ' LEU . 3.1 tppp? -72.88 124.02 24.57 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.258 -0.428 . . . . 74.24 110.945 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.5 t -129.93 153.85 47.93 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.09 0.471 . . . . 61.14 111.661 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -82.73 -12.69 57.37 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.064 -0.517 . . . . 44.52 110.887 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -57.17 166.43 1.11 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.928 1.084 . . . . 73.41 113.928 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.661 ' H ' ' HD3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -86.46 144.14 27.42 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.215 -1.357 . . . . 64.44 111.16 173.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.37 128.98 22.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.671 -0.24 . . . . 73.44 110.474 170.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 135' ' ' LEU . 11.4 mt -61.4 109.04 1.04 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.588 0.218 . . . . 64.53 111.588 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 53.5 m -58.03 145.4 36.41 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.832 -0.432 . . . . 55.33 109.832 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.495 HG23 ' HD1' ' A' ' 49' ' ' PHE . 90.8 t -45.9 -47.27 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.549 0.574 . . . . 64.42 112.549 -173.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -72.66 -40.39 66.36 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 122.195 -0.315 . . . . 72.14 111.751 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -58.95 -36.07 74.19 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.617 0.723 . . . . 63.44 110.215 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.638 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.8 tt -59.66 -43.58 93.9 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.064 -0.971 . . . . 74.44 110.578 173.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 32.5 mt . . . . . 0 N--CA 1.472 0.668 0 CA-C-O 121.436 0.636 . . . . 72.33 110.4 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.0 ptm . . . . . 0 CA--C 1.542 0.643 0 CA-C-O 120.801 0.334 . . . . 63.51 110.919 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.523 HD13 ' HB3' ' A' ' 61' ' ' ASP . 14.1 mt -102.25 130.35 48.9 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.252 0.464 . . . . 74.05 112.252 -175.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.448 ' HA ' HG22 ' A' ' 126' ' ' THR . 37.1 tt0 -75.23 114.65 13.98 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.197 -0.456 . . . . 62.53 110.273 175.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.2 m -126.19 159.94 34.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.155 -0.475 . . . . 62.14 111.756 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.721 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 37.4 tt0 -99.71 113.08 25.32 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.064 0.459 . . . . 71.53 110.393 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.404 HG22 HD11 ' A' ' 96' ' ' ILE . 46.1 t -88.48 119.24 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.849 -0.614 . . . . 71.03 112.182 -173.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -107.08 162.37 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.715 0.293 . . . . 74.31 111.38 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 66.0 m -131.99 106.77 8.24 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.105 0.479 . . . . 74.41 111.983 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 C-N-CA 121.149 -0.548 . . . . 40.41 112.314 177.04 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 . . . . . 0 N--CA 1.468 0.45 0 CA-C-O 121.008 0.432 . . . . 74.12 111.176 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.54 ' O ' HG22 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -70.45 -36.76 74.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.151 0.5 . . . . 73.54 110.324 -179.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -64.89 -64.94 0.74 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.012 -0.54 . . . . 73.43 111.1 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -55.74 -17.91 7.08 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.779 0.659 . . . . 65.23 112.779 -176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -88.4 -59.01 2.35 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.556 0.576 . . . . 64.42 112.556 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.63 HG21 ' HD2' ' A' ' 102' ' ' PRO . 20.1 m -96.71 15.33 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 113.225 0.824 . . . . 74.04 113.225 -171.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -99.16 13.76 31.8 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.89 0.7 . . . . 75.0 112.89 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -138.92 164.55 29.4 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.243 0.544 . . . . 74.05 111.984 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.63 146.39 51.85 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.723 -0.671 . . . . 74.44 110.857 175.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -97.62 110.6 23.13 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.774 0.321 . . . . 71.12 111.235 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.444 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.1 mp -110.35 141.96 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 120.864 0.364 . . . . 74.31 111.308 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -62.71 139.53 58.67 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.426 -0.352 . . . . 74.11 110.683 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 62' ' ' TRP . 31.1 tt0 -54.38 -31.85 55.77 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.485 0.55 . . . . 64.12 112.485 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.86 -55.46 32.71 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.825 0.345 . . . . 73.14 111.588 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.523 ' HB3' HD13 ' A' ' 24' ' ' LEU . 29.3 m-20 -66.23 -35.66 81.0 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.509 0.671 . . . . 61.33 110.325 176.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.423 ' HB3' ' HA ' ' A' ' 59' ' ' GLU . 47.8 t-105 -53.05 -48.33 67.74 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.85 -1.068 . . . . 72.35 111.042 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -69.57 -34.82 74.72 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.841 -0.618 . . . . 73.13 111.779 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -59.46 -52.02 67.39 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.127 0.489 . . . . 50.53 111.196 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.429 ' HG ' HD12 ' A' ' 24' ' ' LEU . 94.4 mt -75.96 -4.62 42.08 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.022 -0.535 . . . . 72.44 111.888 178.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.62 49.45 77.06 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.293 -0.48 . . . . 53.51 112.594 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.553 HD21 ' HB2' ' A' ' 129' ' ' LYS . 97.8 mt -86.78 161.26 18.46 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.015 0.912 . . . . 71.24 113.116 -175.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -136.53 151.97 49.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.61 -1.177 . . . . 74.11 109.452 173.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 mp0 -63.82 108.27 1.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.499 0.666 . . . . 74.35 111.444 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.87 -8.33 14.72 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.295 -0.866 . . . . 72.13 113.046 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -63.79 151.9 40.92 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.162 0.506 . . . . 71.5 111.992 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.607 HH21 ' HA ' ' A' ' 131' ' ' ASP . 25.8 mtm-85 -90.99 113.74 26.07 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.823 -0.626 . . . . 71.21 110.986 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.29 135.56 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.124 0.488 . . . . 74.55 111.888 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.436 ' HD3' ' HE3' ' A' ' 76' ' ' LYS . 34.6 ttmt -98.25 147.78 24.29 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.291 0.567 . . . . 74.43 111.124 174.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 57.1 t -122.27 131.77 72.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.498 -0.774 . . . . 65.24 109.427 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.436 ' HE3' ' HD3' ' A' ' 74' ' ' LYS . 20.1 mttt -125.23 125.3 43.37 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.002 0.43 . . . . 65.31 111.819 -176.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.706 HG22 ' HA3' ' A' ' 125' ' ' GLY . 25.0 p -138.37 -171.79 3.13 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.156 -0.474 . . . . 75.34 110.663 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.12 -16.63 63.13 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.925 0.393 . . . . 73.34 111.539 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -88.76 -21.0 24.04 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.196 0.443 . . . . 75.23 112.196 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.21 -151.46 23.73 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.266 -0.492 . . . . 73.11 112.857 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 10.3 pt-20 -144.71 149.66 35.98 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.137 0.494 . . . . 52.31 111.813 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -148.15 148.31 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 116.213 -0.449 . . . . 74.43 111.25 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -110.0 118.55 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.08 0.152 . . . . 52.34 110.843 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.461 HG12 ' HD2' ' A' ' 103' ' ' TYR . 33.9 m -128.9 178.27 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 122.699 0.399 . . . . 72.4 111.933 -177.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -83.06 146.02 28.95 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.106 0.479 . . . . 73.12 111.446 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.82 127.3 43.68 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.222 0.453 . . . . 73.1 112.222 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -129.34 142.33 50.85 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.367 0.603 . . . . 72.33 110.681 173.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -77.72 123.1 26.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.585 -0.734 . . . . 63.04 111.183 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -126.05 165.98 19.01 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.347 -0.454 . . . . 72.33 113.507 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -85.84 15.07 5.15 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.546 0.572 . . . . 54.43 112.546 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.3 m -65.66 154.83 87.63 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 112.051 0.389 . . . . 60.43 112.051 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.99 149.54 90.3 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.525 2.15 . . . . 72.5 112.616 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -63.9 144.14 57.31 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.748 0.309 . . . . 64.55 111.532 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.23 22.07 78.52 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.121 -0.561 . . . . 51.42 112.923 -174.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.721 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 23.9 ttt -154.0 136.47 15.05 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 122.495 -0.415 . . . . 72.21 109.985 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 28' ' ' VAL . 43.2 pt -134.37 150.07 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.412 0.625 . . . . 60.41 112.313 -175.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -106.47 129.25 54.47 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.835 -0.62 . . . . 75.25 110.827 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 30' ' ' SER . 40.8 mt -124.3 132.29 24.28 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 120.633 0.254 . . . . 50.31 110.657 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -57.86 128.54 29.41 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.19 1.926 . . . . 64.21 112.169 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.76 113.33 1.43 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.829 0.347 . . . . 72.24 111.267 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.45 -169.77 27.39 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.686 -0.768 . . . . 64.32 112.742 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.63 ' HD2' HG21 ' A' ' 52' ' ' VAL . 31.5 Cg_endo -65.15 -27.54 56.8 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.065 1.843 . . . . 70.41 111.482 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.495 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 3.4 m-85 -68.25 -53.8 22.11 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.825 -0.625 . . . . 64.34 110.249 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.78 -38.12 80.98 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.016 -0.538 . . . . 75.4 110.99 174.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -54.5 -23.43 16.28 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.365 0.505 . . . . 73.43 112.365 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 102' ' ' PRO . 77.9 mmm -78.17 -12.6 60.01 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.988 0.366 . . . . 61.31 111.988 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.7 m -137.39 -13.88 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 113.088 0.773 . . . . 65.13 113.088 -173.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.546 HG21 ' OG ' ' A' ' 30' ' ' SER . 1.5 pp -105.78 172.18 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 122.081 -0.387 . . . . 71.42 111.206 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.442 ' N ' HG21 ' A' ' 123' ' ' VAL . 18.9 t0 . . . . . 0 CA--C 1.542 0.645 0 CA-C-O 120.902 0.382 . . . . 65.21 111.981 -176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.854 0 CA-C-O 120.81 0.117 . . . . 70.41 113.107 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.442 HG21 ' N ' ' A' ' 109' ' ' ASP . 98.3 t -87.17 130.05 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 O-C-N 122.692 -0.299 . . . . 63.42 111.561 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -70.12 145.95 51.21 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.274 0.559 . . . . 71.01 112.241 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.706 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -173.89 -155.47 11.99 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.72 -0.673 . . . . 75.23 112.693 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.448 HG22 ' HA ' ' A' ' 25' ' ' GLU . 79.1 p -135.64 158.59 43.99 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 122.322 -0.517 . . . . 61.34 111.961 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.4 p -133.57 144.6 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 121.035 0.445 . . . . 71.42 111.008 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -152.54 150.76 29.91 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.456 -0.338 . . . . 73.2 111.393 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HB2' HD21 ' A' ' 67' ' ' LEU . 29.0 ttpt -83.53 127.46 33.74 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.994 -0.441 . . . . 74.03 110.219 170.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.5 t -126.24 156.19 40.67 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.339 0.59 . . . . 73.42 112.325 -172.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.607 ' HA ' HH21 ' A' ' 72' ' ' ARG . 8.5 p-10 -82.32 -5.6 58.7 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.002 -0.545 . . . . 74.4 111.22 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -69.36 157.19 37.52 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.943 -0.571 . . . . 74.21 111.372 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -88.3 157.51 18.73 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.91 0.385 . . . . 72.12 111.37 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 91.2 t -69.31 138.26 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 116.325 -0.398 . . . . 72.41 110.951 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 135' ' ' LEU . 14.6 mt -70.88 133.76 46.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.698 0.285 . . . . 73.3 111.464 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 44.7 t -78.42 145.72 34.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.464 -0.569 . . . . 70.42 109.464 171.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.558 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 96.5 t -46.39 -45.95 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 111.86 0.319 . . . . 63.01 111.86 -177.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.435 ' HA ' HD12 ' A' ' 141' ' ' LEU . 25.1 ttpp -71.25 -41.25 70.33 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.691 0.281 . . . . 72.42 111.422 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -55.91 -37.03 68.36 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.918 0.866 . . . . 62.44 109.611 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.487 HD11 ' HA ' ' A' ' 103' ' ' TYR . 1.0 OUTLIER -68.85 -38.39 79.74 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.528 -1.215 . . . . 74.34 111.002 176.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 53.9 mt . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 121.609 0.718 . . . . 74.21 110.227 176.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 10.4 ptm . . . . . 0 CA--C 1.541 0.598 0 CA-C-O 120.757 0.313 . . . . 73.24 111.304 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.545 HD12 ' HG ' ' A' ' 65' ' ' LEU . 17.1 mt -118.05 133.83 55.54 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.648 0.61 . . . . 75.24 112.648 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -79.57 119.08 22.04 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.941 -0.572 . . . . 33.51 110.2 173.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 m -133.87 161.3 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.953 0.406 . . . . 72.13 111.91 -175.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 31.5 tt0 -99.22 113.43 25.69 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.946 0.403 . . . . 74.12 110.373 174.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.489 HG22 HD11 ' A' ' 96' ' ' ILE . 45.4 t -89.65 112.93 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.231 0.539 . . . . 65.05 111.861 -173.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.31 159.36 3.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.923 0.392 . . . . 75.41 111.745 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 75.2 m -135.43 104.65 5.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.085 0.469 . . . . 74.14 111.303 175.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.444 0 C-N-CA 120.963 -0.636 . . . . 62.31 112.372 -179.305 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 121.213 0.53 . . . . 73.21 111.34 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -65.1 -27.4 68.73 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.915 -0.584 . . . . 74.15 110.494 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -83.25 -9.18 59.27 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.941 -0.572 . . . . 73.31 111.745 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -116.89 -0.49 12.23 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.948 0.404 . . . . 70.32 111.64 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.81 -52.34 4.12 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.867 0.691 . . . . 71.34 112.867 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.464 HG21 ' HD2' ' A' ' 102' ' ' PRO . 35.5 m -116.35 19.86 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 113.445 0.906 . . . . 31.3 113.445 -172.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.654 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -100.73 18.57 19.03 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.898 0.703 . . . . 74.41 112.898 -171.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.462 ' CD1' ' HD2' ' A' ' 87' ' ' LYS . 47.1 p90 -144.6 165.58 27.6 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.462 0.542 . . . . 75.04 112.462 -174.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.32 142.51 49.37 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.623 -0.717 . . . . 73.55 110.685 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 44.5 mt-10 -101.04 118.48 37.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.938 0.399 . . . . 75.23 111.475 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.497 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.8 mp -110.55 152.12 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 116.179 -0.464 . . . . 61.21 111.302 -177.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -68.44 153.77 43.12 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.671 0.388 . . . . 74.21 111.347 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -57.67 -46.33 84.39 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.115 0.483 . . . . 75.24 112.096 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.92 -47.9 82.87 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.79 0.329 . . . . 65.1 111.694 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -65.84 -35.92 82.01 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.199 0.524 . . . . 75.05 111.165 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.424 ' HZ2' ' N ' ' A' ' 69' ' ' GLU . 40.4 t-105 -55.55 -54.05 48.86 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.78 -0.645 . . . . 75.11 110.919 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -64.61 -33.83 76.85 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.048 -0.524 . . . . 71.33 111.475 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.511 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -60.15 -43.8 95.47 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.912 0.387 . . . . 32.3 111.947 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.642 HD11 HG13 ' A' ' 127' ' ' VAL . 93.4 mt -84.6 -9.25 58.46 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.001 0.371 . . . . 60.45 112.001 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.3 45.68 68.49 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.117 -0.563 . . . . 75.51 112.637 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.66 HD23 ' HE2' ' A' ' 129' ' ' LYS . 74.0 mt -83.37 166.63 18.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.385 0.612 . . . . 55.5 112.071 -177.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -147.25 121.39 9.49 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.853 -0.612 . . . . 71.51 109.898 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.424 ' N ' ' HZ2' ' A' ' 62' ' ' TRP . 43.0 mt-10 -44.52 98.62 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.283 0.846 . . . . 74.21 113.283 -169.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.79 -4.24 8.56 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 115.084 -0.962 . . . . 75.32 113.735 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.02 -176.61 5.59 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 117.8 0.8 . . . . 63.22 112.05 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.487 ' HG3' HG23 ' A' ' 134' ' ' VAL . 8.8 mpt_? -107.19 123.61 48.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.125 -0.489 . . . . 61.34 111.813 -176.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.3 m -115.42 145.04 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.307 0.575 . . . . 64.3 111.516 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.78 ' HD3' ' HE3' ' A' ' 76' ' ' LYS . 24.0 ttmm -108.73 146.99 32.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.813 -0.63 . . . . 73.23 110.534 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 64.5 t -130.55 129.57 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.269 -0.423 . . . . 62.22 110.704 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.78 ' HE3' ' HD3' ' A' ' 74' ' ' LYS . 38.7 mttt -130.94 125.54 33.7 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.929 0.395 . . . . 75.13 112.058 -175.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.668 HG22 ' HA3' ' A' ' 125' ' ' GLY . 42.6 p -126.45 -171.06 2.31 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 116.507 -0.315 . . . . 62.35 110.557 177.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.63 -6.46 52.12 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.901 0.382 . . . . 63.13 111.528 175.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -91.98 -60.78 1.77 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.869 0.366 . . . . 72.03 110.776 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.33 -144.45 4.03 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.221 -0.514 . . . . 73.25 112.796 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 0.3 OUTLIER -154.52 159.28 40.86 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 117.12 0.46 . . . . 52.43 111.204 178.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 106' ' ' MET . 8.8 p -157.46 144.45 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 111.928 0.344 . . . . 62.42 111.928 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.8 t -105.54 118.52 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 122.48 0.312 . . . . 71.13 110.587 174.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.49 HG12 ' HD2' ' A' ' 103' ' ' TYR . 35.3 m -128.18 176.5 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 120.996 0.427 . . . . 72.44 112.06 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -79.49 140.98 37.13 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.976 0.417 . . . . 73.44 111.34 176.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.8 126.16 36.78 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.758 0.651 . . . . 63.24 112.758 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 62.3 mttm -126.84 143.71 51.18 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.199 0.523 . . . . 74.4 110.901 173.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -88.78 121.36 31.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.973 -0.558 . . . . 74.03 110.573 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.4 -179.62 15.8 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.711 -0.757 . . . . 73.35 114.21 -174.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -90.66 18.9 5.85 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.958 0.409 . . . . 70.43 111.353 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.1 m -72.49 151.83 91.76 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.251 -0.431 . . . . 71.53 111.896 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -62.04 160.57 29.47 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 122.755 2.303 . . . . 74.45 113.61 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -69.0 138.76 54.78 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.824 0.345 . . . . 73.11 111.453 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.06 26.59 73.98 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.968 -0.634 . . . . 61.33 112.298 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.528 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 23.5 ttt -149.8 136.61 19.4 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.653 -0.322 . . . . 73.54 110.297 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 28' ' ' VAL . 39.8 pt -135.25 146.81 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 121.263 0.554 . . . . 71.24 111.851 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -106.17 130.15 54.1 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.177 -0.465 . . . . 73.24 111.564 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 30' ' ' SER . 44.9 mt -124.32 132.06 24.26 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 120.753 0.311 . . . . 72.14 110.629 173.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.425 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 37.6 Cg_exo -58.91 131.88 44.35 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.229 1.953 . . . . 73.3 112.368 173.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.7 tpt -51.39 107.94 0.22 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 111.906 0.335 . . . . 65.45 111.906 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.14 -176.84 38.37 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.574 -0.822 . . . . 61.54 113.413 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.464 ' HD2' HG21 ' A' ' 52' ' ' VAL . 15.2 Cg_endo -55.92 -35.44 94.18 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.169 2.579 . . . . 72.45 112.952 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.49 ' HD2' HG12 ' A' ' 84' ' ' VAL . 30.7 m-85 -61.87 -51.56 67.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.057 0.456 . . . . 74.22 110.634 177.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -62.0 -38.3 88.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.099 0.476 . . . . 54.35 111.04 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -54.55 -26.17 30.45 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.898 0.479 . . . . 75.41 112.006 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.584 ' SD ' HD21 ' A' ' 140' ' ' LEU . 84.9 mmm -69.54 -16.78 63.5 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.347 0.499 . . . . 73.25 112.347 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.84 -19.03 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 113.472 0.916 . . . . 73.35 113.472 -174.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.583 HG21 ' OG ' ' A' ' 30' ' ' SER . 8.0 pt -98.5 179.96 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 112.852 0.686 . . . . 75.14 112.852 -175.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.9 t70 . . . . . 0 CA--C 1.545 0.774 0 CA-C-N 115.874 -0.603 . . . . 72.34 111.03 176.929 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.634 0 CA-C-O 120.778 0.099 . . . . 71.01 112.928 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 93.5 t -80.12 118.08 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 122.533 -0.392 . . . . 72.34 111.07 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 39.3 mtpt -67.31 155.55 38.63 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.657 0.741 . . . . 71.12 112.913 -177.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.668 ' HA3' HG22 ' A' ' 77' ' ' THR . . . 179.68 -147.85 7.75 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.055 -0.975 . . . . 72.43 112.144 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 45.1 p -138.51 153.3 48.75 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 122.292 -0.534 . . . . 72.42 111.757 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.642 HG13 HD11 ' A' ' 65' ' ' LEU . 14.8 p -128.11 145.24 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.138 -0.483 . . . . 61.3 110.254 175.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 7.3 pt-20 -148.69 151.31 34.7 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.81 0.67 . . . . 74.31 112.81 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.66 ' HE2' HD23 ' A' ' 67' ' ' LEU . 14.5 tppt? -69.51 106.38 2.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.535 -0.757 . . . . 63.44 109.966 167.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.1 t -100.8 161.8 13.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.451 0.643 . . . . 70.01 112.34 -176.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -100.53 0.7 39.98 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.554 -0.748 . . . . 71.54 110.62 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -88.39 179.52 6.31 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.07 0.767 . . . . 74.3 113.07 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -100.26 161.61 13.49 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.292 -0.867 . . . . 71.22 111.609 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.487 HG23 ' HG3' ' A' ' 72' ' ' ARG . 93.3 t -70.1 137.64 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 120.771 0.32 . . . . 64.34 111.56 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 135' ' ' LEU . 6.5 mt -77.81 98.04 5.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.679 -0.237 . . . . 70.24 111.219 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 70.9 p -55.19 153.68 6.59 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.696 0.284 . . . . 75.13 111.45 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.559 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 86.8 t -45.8 -53.73 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.971 0.73 . . . . 74.35 112.971 -172.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -72.35 -42.0 65.82 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.23 0.456 . . . . 73.34 112.23 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -56.51 -39.99 74.26 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.564 0.697 . . . . 60.21 109.977 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.584 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.3 tt -60.58 -41.62 95.05 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.071 -0.968 . . . . 64.21 110.772 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 68.3 mt . . . . . 0 N--CA 1.472 0.633 0 CA-C-O 121.173 0.511 . . . . 70.32 110.818 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 8.8 ptm . . . . . 0 CA--C 1.539 0.557 0 CA-C-O 120.926 0.393 . . . . 72.34 110.769 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.581 HD11 ' HB3' ' A' ' 64' ' ' ALA . 32.6 mt -90.53 132.13 35.87 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.831 0.678 . . . . 74.24 112.831 -173.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -78.74 118.56 20.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.52 -0.764 . . . . 61.45 111.04 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 35.4 m -139.32 164.38 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.992 -1.004 . . . . 75.12 112.027 -173.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 34.8 tt0 -99.47 121.85 41.73 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.858 0.361 . . . . 42.32 110.435 171.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.478 HG22 HD11 ' A' ' 96' ' ' ILE . 39.3 t -96.42 110.2 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.258 -0.428 . . . . 74.24 111.608 -175.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.507 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 2.9 mt -95.73 161.06 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.927 0.394 . . . . 74.11 111.905 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.616 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 73.5 m -129.33 95.44 4.03 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.01 0.434 . . . . 72.25 111.212 174.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.696 0 C-N-CA 121.097 -0.573 . . . . 60.54 113.078 -178.493 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 CA--C 1.538 0.509 0 CA-C-O 121.154 0.502 . . . . 72.33 110.579 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.492 ' O ' HG22 ' A' ' 52' ' ' VAL . 13.0 t80 -65.5 -43.09 91.22 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.893 -0.594 . . . . 74.11 110.4 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.481 ' HD1' HG23 ' A' ' 137' ' ' VAL . 75.4 t80 -58.65 -62.07 2.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.716 -0.674 . . . . 63.54 110.452 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -59.96 -23.89 63.95 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.621 0.6 . . . . 61.14 112.621 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.78 -33.01 58.07 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.795 0.665 . . . . 73.43 112.795 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.553 HG21 ' HD2' ' A' ' 102' ' ' PRO . 30.5 m -123.49 14.8 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 113.575 0.954 . . . . 75.23 113.575 -173.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -96.57 19.66 11.93 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.963 0.727 . . . . 75.13 112.963 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -145.5 159.21 43.44 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.897 -0.502 . . . . 71.31 112.279 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.38 141.59 51.98 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.787 -0.642 . . . . 43.33 110.687 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.786 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 41.5 mt-10 -97.9 111.98 24.08 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.838 0.351 . . . . 71.35 111.272 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.9 mp -110.88 149.9 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.333 -0.394 . . . . 73.44 111.032 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -74.45 144.8 44.09 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.548 0.213 . . . . 65.01 110.438 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.438 ' HA ' ' HB3' ' A' ' 62' ' ' TRP . 27.6 tt0 -55.33 -32.91 62.89 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.314 0.487 . . . . 75.35 112.314 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.598 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 17.3 mm-40 -54.97 -57.08 13.11 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 111.977 0.362 . . . . 74.5 111.977 175.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.02 -34.99 78.93 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.441 0.639 . . . . 55.25 110.45 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.517 ' HA ' HD12 ' A' ' 67' ' ' LEU . 43.3 t-105 -53.08 -50.27 64.72 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.171 -0.922 . . . . 75.41 111.478 177.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -69.13 -39.1 79.07 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.155 -0.475 . . . . 71.01 111.462 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.581 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -56.27 -34.33 66.33 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.245 0.461 . . . . 42.32 112.245 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.0 mt -91.84 -18.32 23.99 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.377 -0.374 . . . . 75.34 111.849 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.03 46.33 10.57 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.154 -0.546 . . . . 54.14 112.657 -176.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.683 HD23 ' HD3' ' A' ' 129' ' ' LYS . 91.6 mt -84.09 143.19 29.87 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.271 0.558 . . . . 70.15 112.424 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -101.09 156.15 17.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.013 -0.54 . . . . 74.44 110.645 170.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.35 93.21 1.49 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.735 0.779 . . . . 65.31 111.11 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.76 -3.62 8.61 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 114.777 -1.101 . . . . 72.43 112.113 -171.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.47 173.79 1.5 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.23 0.538 . . . . 71.11 112.093 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -113.86 124.47 52.3 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.267 -0.424 . . . . 74.33 111.353 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.642 HG13 ' HB2' ' A' ' 86' ' ' ALA . 17.5 m -114.33 142.11 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.333 0.587 . . . . 74.12 112.232 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.581 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 38.5 ttmt -99.47 147.31 25.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.857 -0.611 . . . . 74.44 110.172 173.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -128.54 124.03 60.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.239 -0.652 . . . . 53.25 109.239 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.581 ' HD2' ' HD2' ' A' ' 74' ' ' LYS . 6.5 mtpm? -133.93 130.12 37.28 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.546 0.573 . . . . 55.24 112.546 -170.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.742 HG22 ' HA3' ' A' ' 125' ' ' GLY . 25.0 p -136.62 -171.23 2.86 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.797 -0.638 . . . . 55.45 110.545 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.91 -14.91 63.27 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.961 -0.563 . . . . 63.52 111.853 175.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -89.2 -38.64 14.11 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 111.796 0.295 . . . . 72.12 111.796 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.31 -160.93 34.6 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.345 -0.455 . . . . 62.04 112.979 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.19 149.85 51.04 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.267 0.556 . . . . 64.23 112.202 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.525 HG23 HD12 ' A' ' 135' ' ' LEU . 12.5 p -147.46 147.26 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.142 -0.481 . . . . 74.3 110.948 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -111.12 119.07 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 122.31 -0.244 . . . . 71.04 110.997 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.465 ' HA ' HG13 ' A' ' 134' ' ' VAL . 34.3 m -129.57 174.25 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 111.921 0.341 . . . . 73.02 111.921 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -75.37 143.38 42.83 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.97 0.414 . . . . 73.43 111.458 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.642 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -94.5 122.12 36.75 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.216 0.45 . . . . 32.23 112.216 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -128.33 141.17 51.51 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.304 0.573 . . . . 65.33 111.08 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.419 ' HD3' ' HB2' ' A' ' 59' ' ' GLU . 35.3 ttmt -80.11 103.99 10.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.717 -0.674 . . . . 75.21 110.689 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.786 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -100.51 -163.9 28.29 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 121.256 -0.497 . . . . 71.55 114.298 -172.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -111.25 32.45 5.32 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.365 0.602 . . . . 51.42 111.292 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.1 m -92.37 158.41 38.86 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.974 -0.557 . . . . 63.24 111.817 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.97 163.14 37.59 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.302 2.001 . . . . 72.01 112.859 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.598 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 78.8 tttt -63.32 143.34 57.88 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.767 0.318 . . . . 71.43 111.574 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 68.22 28.78 73.18 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.877 -0.678 . . . . 63.41 112.961 -175.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.51 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 23.5 ttt -154.62 137.0 14.95 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.472 -0.428 . . . . 74.24 110.309 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.478 HD11 HG22 ' A' ' 28' ' ' VAL . 41.9 pt -134.87 144.37 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.359 0.6 . . . . 72.41 112.082 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -106.09 124.19 49.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.021 -0.536 . . . . 51.42 111.415 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 30' ' ' SER . 54.4 mt -121.02 131.45 24.48 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.559 -0.291 . . . . 73.24 110.427 174.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.402 ' HB2' HG12 ' A' ' 52' ' ' VAL . 31.7 Cg_exo -60.48 138.82 82.89 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.14 1.893 . . . . 65.32 112.399 175.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.7 104.73 0.16 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.444 -0.344 . . . . 62.41 110.839 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.97 -173.84 25.91 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.712 -0.756 . . . . 63.03 113.107 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.553 ' HD2' HG21 ' A' ' 52' ' ' VAL . 34.8 Cg_endo -64.7 -31.59 58.56 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.352 2.035 . . . . 73.43 111.566 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.502 ' HA ' HD11 ' A' ' 140' ' ' LEU . 8.2 m-85 -62.85 -48.17 80.2 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.701 -0.681 . . . . 74.23 110.146 175.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -59.64 -43.55 93.81 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.911 -0.586 . . . . 72.01 111.517 173.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -54.89 -20.1 8.06 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.536 0.569 . . . . 73.41 112.536 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.547 ' SD ' HD21 ' A' ' 140' ' ' LEU . 88.5 mmm -69.45 -31.56 69.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.858 0.361 . . . . 72.11 111.435 177.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.453 ' HB ' HG23 ' A' ' 77' ' ' THR . 31.0 m -123.59 -8.36 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 113.293 0.849 . . . . 65.42 113.293 -171.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.558 HG21 ' OG ' ' A' ' 30' ' ' SER . 8.0 pt -106.05 177.48 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.565 0.698 . . . . 71.41 112.452 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.416 ' H ' HG21 ' A' ' 123' ' ' VAL . 25.7 t70 . . . . . 0 CA--C 1.543 0.683 0 CA-C-N 115.544 -0.753 . . . . 64.1 110.67 175.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . . . . . . 0 CA--C 1.524 0.597 0 CA-C-O 121.15 0.305 . . . . 72.44 113.133 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.416 HG21 ' H ' ' A' ' 109' ' ' ASP . 89.5 t -86.89 122.28 38.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.633 0.254 . . . . 72.15 111.515 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 68.0 mttm -71.71 147.32 47.52 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.463 0.649 . . . . 75.51 112.35 -177.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.742 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -175.15 -138.59 2.8 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.479 -0.782 . . . . 73.1 112.527 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 57.3 p -140.43 158.64 43.7 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.06 0.457 . . . . 73.5 111.748 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.1 p -135.29 145.23 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.988 -0.551 . . . . 64.21 110.472 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.519 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 5.9 pt-20 -149.04 155.21 40.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.684 0.278 . . . . 62.42 111.383 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.683 ' HD3' HD23 ' A' ' 67' ' ' LEU . 28.0 ttpp -85.68 133.54 34.02 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.607 -0.516 . . . . 73.52 109.607 168.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.6 t -130.72 161.08 32.46 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.601 0.715 . . . . 55.51 112.858 -171.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.09 -21.31 33.73 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.409 -0.814 . . . . 74.33 110.164 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -61.73 157.21 18.38 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.847 -0.615 . . . . 73.32 112.579 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.532 ' H ' ' HD3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -90.52 162.29 15.1 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.912 -0.585 . . . . 74.34 111.1 179.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 84' ' ' VAL . 98.4 t -65.81 133.23 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.458 -0.337 . . . . 72.44 111.035 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.525 HD12 HG23 ' A' ' 82' ' ' VAL . 13.2 mt -63.01 138.28 58.51 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.134 0.492 . . . . 74.45 111.405 177.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.0 t -85.41 144.93 27.72 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.087 -0.709 . . . . 64.13 109.087 170.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.481 HG23 ' HD1' ' A' ' 49' ' ' PHE . 86.5 t -48.46 -47.05 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 112.093 0.405 . . . . 71.41 112.093 -175.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -67.83 -41.46 82.99 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.958 0.408 . . . . 64.45 111.525 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -62.14 -33.52 74.64 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.581 0.705 . . . . 72.4 110.404 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.547 HD21 ' SD ' ' A' ' 106' ' ' MET . 1.9 tt -66.63 -34.29 77.55 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.127 -0.942 . . . . 63.22 110.85 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 56.0 mt . . . . . 0 N--CA 1.472 0.673 0 CA-C-O 121.633 0.73 . . . . 73.53 109.943 175.144 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 7.8 ptp . . . . . 0 CA--C 1.539 0.531 0 CA-C-O 120.997 0.427 . . . . 63.43 111.219 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.495 HD12 ' HG ' ' A' ' 65' ' ' LEU . 25.3 mt -121.46 127.02 50.66 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.129 0.49 . . . . 74.42 111.813 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -71.7 115.61 11.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.585 -0.734 . . . . 64.53 111.02 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 27.8 m -128.51 160.07 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.55 0.574 . . . . 63.14 112.55 -174.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.618 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 52.9 tt0 -99.27 117.32 33.45 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.945 0.402 . . . . 63.13 110.696 174.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.502 HG22 HD11 ' A' ' 96' ' ' ILE . 40.9 t -92.35 108.51 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.142 0.496 . . . . 50.5 112.121 -175.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -102.24 146.95 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.936 0.398 . . . . 75.05 112.027 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 73.6 m -106.6 104.42 14.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.157 -0.474 . . . . 73.43 111.667 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . . . . . . 0 CA--C 1.522 0.528 0 C-N-CA 120.885 -0.674 . . . . 40.21 112.894 178.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 . . . . . 0 CA--C 1.538 0.507 0 CA-C-O 120.733 0.302 . . . . 72.43 111.223 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -58.18 -40.02 80.4 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.298 0.57 . . . . 72.11 109.849 178.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -64.52 -62.03 1.85 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.559 -0.746 . . . . 75.3 110.306 176.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -64.62 -4.31 4.03 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.09 0.774 . . . . 74.32 113.09 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.22 -33.01 14.86 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.61 0.596 . . . . 51.25 112.61 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.58 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 34.8 m -129.48 20.15 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 113.15 0.796 . . . . 64.42 113.15 -173.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -103.02 21.53 15.56 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.124 0.787 . . . . 62.05 113.124 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -140.89 158.43 43.96 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.168 0.509 . . . . 71.15 112.143 -177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.89 138.79 51.13 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.909 -0.587 . . . . 72.51 110.853 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.667 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 39.6 mt-10 -93.78 112.66 24.56 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.637 0.256 . . . . 71.4 111.361 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.3 mp -109.81 146.06 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 116.529 -0.305 . . . . 55.25 110.764 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -68.43 143.92 54.88 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.811 0.339 . . . . 72.31 111.399 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -47.46 -40.05 17.31 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.117 0.567 . . . . 74.42 112.251 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -58.37 -54.35 47.97 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.087 0.47 . . . . 74.23 111.399 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -66.37 -33.67 76.25 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.227 0.537 . . . . 73.21 110.915 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 46.2 t-105 -54.16 -54.23 42.51 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.693 -0.685 . . . . 73.44 111.429 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -69.42 -36.38 76.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.525 -0.307 . . . . 74.4 111.66 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.444 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -59.64 -34.65 73.07 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.983 0.42 . . . . 71.12 111.88 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.495 ' HG ' HD12 ' A' ' 24' ' ' LEU . 94.6 mt -90.91 -12.17 36.9 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.473 -0.331 . . . . 74.31 111.751 177.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.12 46.51 50.49 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.123 -0.561 . . . . 70.12 112.657 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.494 ' HA ' ' HZ1' ' A' ' 129' ' ' LYS . 93.7 mt -86.6 159.51 19.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.616 0.722 . . . . 73.4 112.078 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -140.87 134.78 30.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.184 -0.916 . . . . 74.41 109.129 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -56.17 97.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.631 0.729 . . . . 74.05 112.094 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 143.28 -22.9 2.23 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.15 -0.932 . . . . 54.24 113.956 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -86.25 178.0 7.31 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 118.251 1.026 . . . . 71.42 112.627 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.664 HH11 HG23 ' A' ' 134' ' ' VAL . 60.9 mtt-85 -109.52 139.95 43.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.812 -0.631 . . . . 65.33 112.003 -169.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 86' ' ' ALA . 31.4 m -124.06 140.03 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.921 -0.581 . . . . 61.43 111.212 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -107.99 131.25 54.76 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.921 0.391 . . . . 73.51 110.896 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 50.5 t -106.81 130.47 58.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.397 -0.365 . . . . 54.1 111.026 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.506 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -117.18 127.88 54.55 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.017 0.437 . . . . 54.43 111.307 177.475 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.646 HG22 ' HA3' ' A' ' 125' ' ' GLY . 21.4 p -135.53 -172.52 3.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.057 0.456 . . . . 62.13 110.57 175.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -71.29 -5.62 33.69 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.293 -0.412 . . . . 75.32 111.963 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -99.81 -20.55 16.15 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.026 0.38 . . . . 51.55 112.026 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 146.6 -151.63 23.87 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.982 -0.627 . . . . 43.44 113.202 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.506 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 9.5 pt-20 -140.3 149.94 43.41 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.8 0.333 . . . . 54.13 111.553 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.449 HG23 ' SD ' ' A' ' 106' ' ' MET . 12.8 p -149.11 148.67 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.528 -0.305 . . . . 74.22 111.135 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.07 117.71 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 120.542 0.21 . . . . 73.22 111.349 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.4 m -129.84 176.44 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.646 0.379 . . . . 55.55 111.657 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -79.66 145.97 32.72 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.016 0.436 . . . . 74.51 111.565 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.413 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -88.76 115.86 26.61 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 112.591 0.589 . . . . 74.32 112.591 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -113.27 157.39 21.84 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.621 0.725 . . . . 64.23 111.228 171.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -100.11 112.57 24.88 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.386 -0.825 . . . . 62.54 110.547 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.667 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -107.92 171.77 16.54 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.147 -0.549 . . . . 73.14 114.147 -174.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.61 18.34 13.07 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.32 0.581 . . . . 43.5 110.752 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.404 HG11 ' HB2' ' A' ' 97' ' ' PHE . 27.8 m -79.1 155.85 77.05 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.852 -0.613 . . . . 71.4 111.99 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.03 153.17 53.52 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.404 2.069 . . . . 75.34 112.588 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -62.65 148.75 45.44 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 122.161 -0.337 . . . . 75.04 111.151 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 66.17 27.29 72.84 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.521 -0.847 . . . . 74.31 112.41 -174.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.618 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 20.9 ttt -149.27 137.01 20.38 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.632 -0.507 . . . . 63.23 109.632 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 28' ' ' VAL . 38.9 pt -132.99 141.54 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 121.249 0.547 . . . . 72.24 111.864 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.493 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 59.1 t80 -101.87 118.38 36.8 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.966 -0.561 . . . . 73.21 111.369 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 30' ' ' SER . 51.5 mt -119.97 124.37 27.91 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.623 -0.262 . . . . 71.32 110.612 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.58 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 11.5 Cg_endo -55.82 137.23 77.98 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.184 1.922 . . . . 71.43 112.258 176.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.08 103.27 0.16 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.329 -0.396 . . . . 72.23 110.948 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.59 -176.12 24.85 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.559 -0.829 . . . . 75.43 112.87 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.51 ' HA ' HD22 ' A' ' 105' ' ' ASN . 22.4 Cg_endo -62.13 -28.03 79.4 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.023 1.815 . . . . 64.0 111.446 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.504 ' HA ' HD11 ' A' ' 140' ' ' LEU . 8.4 m-85 -66.89 -49.88 64.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.617 -0.72 . . . . 73.31 110.134 175.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.38 -40.09 81.37 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.854 -0.612 . . . . 73.32 111.443 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.51 HD22 ' HA ' ' A' ' 102' ' ' PRO . 91.0 m-20 -56.71 -25.11 53.52 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.214 0.53 . . . . 72.41 111.808 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.449 ' SD ' HG23 ' A' ' 82' ' ' VAL . 35.3 mtp -73.58 -21.53 60.31 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.912 -0.586 . . . . 73.01 112.313 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.5 m -133.67 -5.96 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.453 0.908 . . . . 71.32 113.453 -173.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 109' ' ' ASP . 1.6 pp -111.13 172.65 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.957 -0.464 . . . . 70.52 111.665 -177.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.472 ' N ' HG21 ' A' ' 123' ' ' VAL . 11.6 t70 . . . . . 0 CA--C 1.543 0.707 0 CA-C-N 116.252 -0.431 . . . . 70.21 111.636 -177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.6 0 N-CA-C 113.877 0.311 . . . . 74.02 113.877 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.472 HG21 ' N ' ' A' ' 109' ' ' ASP . 57.7 t -94.2 120.29 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 122.633 -0.333 . . . . 53.3 110.987 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 39.0 mtpt -73.83 153.5 39.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.015 0.912 . . . . 53.02 112.779 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.646 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -174.88 -150.1 7.6 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 114.323 -1.308 . . . . 44.35 111.346 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 44.0 p -132.87 146.95 52.26 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.449 0.625 . . . . 60.1 111.873 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -121.67 144.01 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.085 -0.507 . . . . 64.12 110.905 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -149.74 152.4 35.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.921 -0.581 . . . . 72.53 110.811 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.494 ' HZ1' ' HA ' ' A' ' 67' ' ' LEU . 19.6 ttmm -73.04 134.95 44.81 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.363 -0.606 . . . . 63.31 109.363 170.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.7 t -126.52 158.84 35.09 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.036 0.754 . . . . 72.52 113.036 -172.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -85.46 -15.78 41.81 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.11 -0.95 . . . . 74.52 110.911 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.466 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 19.2 mm-40 -73.81 156.08 38.16 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.496 0.665 . . . . 75.43 112.587 -177.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.02 156.99 29.8 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.29 -0.868 . . . . 75.43 111.309 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.664 HG23 HH11 ' A' ' 72' ' ' ARG . 70.4 t -69.7 131.03 34.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 109.85 -0.426 . . . . 71.44 109.85 173.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.43 HD13 ' HG ' ' A' ' 140' ' ' LEU . 13.5 mt -63.21 132.33 51.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.081 0.467 . . . . 71.45 112.099 -177.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 65.6 m -75.97 146.07 39.86 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.41 -0.589 . . . . 61.42 109.41 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 87.5 t -46.76 -50.98 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 112.859 0.689 . . . . 73.12 112.859 -172.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -72.92 -38.76 66.74 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.057 -0.402 . . . . 64.21 111.745 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -58.42 -37.7 75.91 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.745 0.783 . . . . 73.32 110.038 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.504 HD11 ' HA ' ' A' ' 103' ' ' TYR . 5.1 tt -59.59 -42.66 93.03 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.905 -1.043 . . . . 61.11 110.72 174.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 50.6 mt . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 121.205 0.526 . . . . 73.14 110.395 177.977 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.53 ' HA ' ' HB3' ' A' ' 128' ' ' GLU . 8.7 ptp . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 112.959 0.726 . . . . 73.23 112.959 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 64' ' ' ALA . 13.5 mt -117.39 140.34 49.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.123 -0.944 . . . . 61.53 110.887 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -79.26 110.33 14.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.669 0.747 . . . . 64.21 110.974 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 35.0 m -133.51 162.32 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.872 -1.058 . . . . 64.53 111.873 -171.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.579 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 28.3 tt0 -100.08 117.72 34.94 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.067 0.46 . . . . 55.24 110.531 172.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 96' ' ' ILE . 41.0 t -90.62 110.07 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.315 0.646 . . . . 72.41 111.457 -175.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.448 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 8.3 mt -91.98 152.21 3.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.871 0.367 . . . . 55.12 111.768 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.717 ' HB2' HG21 ' A' ' 108' ' ' ILE . 23.1 t -123.63 93.28 3.89 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.946 0.403 . . . . 74.43 110.081 172.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 100' ' ' MET . . . . . . . . 0 CA--C 1.522 0.498 0 C-N-CA 121.135 -0.555 . . . . 31.42 113.501 -175.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 . . . . . 0 CA--C 1.542 0.646 0 CA-C-O 120.761 0.315 . . . . 70.53 111.445 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -25.86 67.02 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.443 0.64 . . . . 71.4 109.973 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.401 ' HE1' ' HA ' ' A' ' 136' ' ' SER . 55.7 t80 -86.33 -17.5 34.37 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.864 -0.607 . . . . 74.43 111.052 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -84.61 -43.23 14.63 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.902 -0.498 . . . . 73.42 112.067 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.85 -63.78 1.33 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.69 0.996 . . . . 71.52 113.69 -170.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.509 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 28.3 m -88.31 20.95 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 113.661 0.985 . . . . 72.22 113.661 -167.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.617 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -105.24 12.22 32.11 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.175 0.806 . . . . 75.43 113.175 -173.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -137.31 164.74 27.84 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.817 -0.552 . . . . 74.14 111.834 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.54 141.39 52.06 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.849 -0.614 . . . . 64.34 111.182 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 97' ' ' PHE . 61.8 mt-10 -94.09 112.73 24.58 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.093 -0.503 . . . . 73.44 111.12 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.436 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.3 mp -109.89 145.76 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.501 -0.318 . . . . 73.5 110.665 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -66.51 151.83 46.44 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.659 0.266 . . . . 70.12 111.012 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 34.9 tt0 -57.76 -41.96 83.03 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.425 0.528 . . . . 45.34 112.425 -177.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -63.36 -48.52 77.59 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.785 0.326 . . . . 74.23 111.817 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -65.25 -36.77 85.16 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.12 0.486 . . . . 74.23 110.605 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.43 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 39.9 t-105 -52.92 -49.39 66.08 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.861 -0.608 . . . . 63.32 110.905 174.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -66.54 -40.56 89.14 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.782 -0.644 . . . . 71.14 111.167 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.465 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -60.77 -39.44 88.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.124 0.487 . . . . 62.43 111.95 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.515 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 68.4 mt -80.6 -10.44 59.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.069 -0.514 . . . . 72.54 111.461 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.49 40.24 97.52 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.404 -0.427 . . . . 74.23 112.652 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.515 ' HG ' ' HB2' ' A' ' 65' ' ' LEU . 96.1 mt -78.11 161.07 27.66 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.73 0.776 . . . . 63.13 112.572 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -138.63 130.49 27.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.328 -0.851 . . . . 75.12 109.59 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -55.51 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.59 0.71 . . . . 74.54 112.115 -174.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.57 -19.45 1.85 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-N 115.14 -0.936 . . . . 70.11 113.479 -176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -89.51 -169.95 2.67 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 117.683 0.741 . . . . 74.13 112.224 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.472 ' H ' ' HD3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -135.59 162.06 33.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.168 0.508 . . . . 73.52 111.977 -174.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.558 HG13 ' HB2' ' A' ' 86' ' ' ALA . 23.8 m -132.22 154.86 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.329 0.585 . . . . 72.11 112.36 -176.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.443 ' HB2' HG21 ' A' ' 130' ' ' THR . 12.5 tppt? -97.98 129.74 44.85 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.516 -0.765 . . . . 73.03 110.486 173.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 44.7 t -116.16 123.21 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 122.251 0.22 . . . . 55.12 110.445 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -124.46 124.85 43.19 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.952 0.406 . . . . 64.24 112.042 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.648 HG22 ' HA3' ' A' ' 125' ' ' GLY . 25.0 p -132.15 -171.43 2.63 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.061 0.458 . . . . 74.24 111.396 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -71.78 -2.77 18.8 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 112.666 0.617 . . . . 75.43 112.666 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -106.75 -40.45 5.51 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.931 0.396 . . . . 71.43 111.863 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.72 -149.0 10.53 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.98 -0.629 . . . . 63.04 112.633 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 11.4 pt-20 -149.36 150.09 31.91 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.385 0.612 . . . . 64.44 112.289 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 106' ' ' MET . 7.8 p -144.0 155.91 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.799 -0.637 . . . . 74.13 110.568 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.2 t -116.98 115.61 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.623 0.249 . . . . 64.51 110.722 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.23 168.65 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 116.263 -0.426 . . . . 74.54 111.668 -175.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -72.83 132.05 43.07 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.827 0.346 . . . . 74.31 111.364 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.558 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -86.24 121.94 29.54 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 111.978 0.362 . . . . 70.03 111.978 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -133.78 150.19 51.44 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.213 0.53 . . . . 71.4 111.319 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -85.41 103.47 14.34 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.947 -0.57 . . . . 44.55 110.357 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -120.08 -165.81 13.01 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 115.522 0.969 . . . . 64.34 115.522 -168.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -86.33 77.53 9.48 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.408 0.683 . . . . 64.12 111.869 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.7 m -149.05 152.37 36.3 Favored Pre-proline 0 N--CA 1.474 0.727 0 CA-C-N 115.443 -0.799 . . . . 75.44 111.655 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.55 168.52 16.19 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.779 2.32 . . . . 73.2 112.161 172.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -67.39 144.46 55.78 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.885 -0.509 . . . . 74.45 111.759 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 75.13 18.92 80.05 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.29 -0.481 . . . . 43.34 113.376 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.579 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 22.0 ttt -152.92 136.91 16.31 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.264 -0.551 . . . . 75.45 110.649 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.536 HD11 HG22 ' A' ' 28' ' ' VAL . 37.9 pt -132.53 150.72 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 121.179 0.514 . . . . 72.03 111.703 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.526 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 59.2 t80 -112.6 130.69 55.94 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.284 -0.416 . . . . 74.2 111.888 -176.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 30' ' ' SER . 40.1 mt -125.77 132.03 24.19 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 120.59 0.233 . . . . 55.32 110.795 173.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.509 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 51.2 Cg_exo -57.49 141.37 95.07 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.492 2.128 . . . . 74.32 112.789 176.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.442 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -61.03 103.68 0.3 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.799 0.333 . . . . 65.13 110.807 -178.524 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.26 -178.68 38.62 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.664 -0.779 . . . . 54.55 113.109 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.482 ' O ' ' HG2' ' A' ' 106' ' ' MET . 11.2 Cg_endo -54.62 -31.67 71.49 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.949 2.433 . . . . 75.31 112.668 -177.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.487 ' HA ' HD11 ' A' ' 140' ' ' LEU . 43.2 m-85 -66.09 -50.56 63.67 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.837 0.351 . . . . 70.53 110.843 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -62.06 -38.4 88.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.007 0.432 . . . . 74.21 110.778 174.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -53.09 -26.67 17.1 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.106 0.562 . . . . 71.51 112.241 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.623 ' SD ' HD21 ' A' ' 140' ' ' LEU . 86.9 mmm -73.85 -20.73 60.35 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.097 0.406 . . . . 73.35 112.097 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.81 -7.24 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 113.1 0.778 . . . . 73.24 113.1 -173.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.717 HG21 ' HB2' ' A' ' 30' ' ' SER . 11.4 pt -105.7 179.76 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 121.878 -0.514 . . . . 72.31 111.594 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.589 ' H ' HG21 ' A' ' 123' ' ' VAL . 22.4 t70 . . . . . 0 CA--C 1.54 0.585 0 CA-C-N 116.295 -0.411 . . . . 73.25 110.838 175.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . . . . . . 0 CA--C 1.526 0.777 0 CA-C-O 120.73 0.072 . . . . 53.41 112.93 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.589 HG21 ' H ' ' A' ' 109' ' ' ASP . 93.2 t -85.09 126.86 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.913 0.387 . . . . 74.53 111.324 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 21.7 mtpp -75.08 160.19 30.79 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.771 0.656 . . . . 72.34 112.771 -174.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.648 ' HA3' HG22 ' A' ' 77' ' ' THR . . . 171.94 -151.53 15.15 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 116.064 -0.516 . . . . 74.23 113.882 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 70.8 p -137.32 159.82 40.85 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 122.381 -0.482 . . . . 55.42 111.609 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.9 p -148.88 144.07 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 112.047 0.388 . . . . 74.53 112.047 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 23' ' ' MET . 9.1 pt-20 -153.35 159.65 42.51 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.881 0.472 . . . . 64.12 110.904 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -83.31 144.11 29.92 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.147 0.498 . . . . 24.1 111.377 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.443 HG21 ' HB2' ' A' ' 74' ' ' LYS . 4.0 t -150.03 161.84 41.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.861 -0.609 . . . . 52.52 111.653 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -76.62 -8.0 56.37 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.394 -0.366 . . . . 73.54 111.28 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -50.2 152.71 1.66 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.528 0.566 . . . . 71.42 112.528 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.591 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -87.31 146.75 25.8 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.838 -0.619 . . . . 72.54 111.604 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 71.9 t -68.84 131.97 33.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.799 0.333 . . . . 61.24 110.585 172.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.446 HD13 ' HG ' ' A' ' 140' ' ' LEU . 17.9 mt -66.98 147.29 53.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.858 0.361 . . . . 52.43 111.307 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.401 ' HA ' ' HE1' ' A' ' 49' ' ' PHE . 46.7 t -90.44 151.28 21.47 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.248 -0.649 . . . . 65.5 109.248 169.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.494 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 73.8 t -48.91 -47.34 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.002 0.43 . . . . 73.5 111.54 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -72.69 -40.41 66.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.296 -0.411 . . . . 74.23 111.979 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -60.36 -33.71 72.83 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.849 0.833 . . . . 73.02 110.249 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.623 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.5 tt -65.62 -39.35 91.4 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.914 -1.039 . . . . 71.32 110.379 174.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 57.1 mt . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 121.091 0.472 . . . . 72.25 110.386 175.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.721 ' HA ' ' HB3' ' A' ' 128' ' ' GLU . 10.0 ptp . . . . . 0 N--CA 1.466 0.337 0 CA-C-O 121.603 0.716 . . . . 65.35 112.477 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.604 HD13 ' HB3' ' A' ' 61' ' ' ASP . 10.0 mt -103.11 131.68 49.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.289 -0.869 . . . . 73.5 110.838 175.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -78.01 106.8 10.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.052 0.929 . . . . 74.13 111.176 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.429 HG12 ' HA2' ' A' ' 94' ' ' GLY . 32.9 m -132.58 166.85 28.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.392 -1.276 . . . . 73.23 111.947 -170.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 31.1 tt0 -103.4 123.05 46.12 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.115 0.483 . . . . 75.11 110.891 171.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.531 HG22 HD11 ' A' ' 96' ' ' ILE . 36.7 t -93.74 114.08 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 115.917 -0.583 . . . . 63.13 111.725 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.493 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 3.1 mt -98.99 161.5 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 112.244 0.461 . . . . 65.55 112.244 -176.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.63 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 75.0 m -127.76 105.65 8.6 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.242 -0.436 . . . . 62.53 110.907 174.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.404 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . . . . . . 0 CA--C 1.526 0.726 0 C-N-CA 121.174 -0.536 . . . . 73.25 113.593 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 . . . . . 0 N--CA 1.472 0.67 0 CA-C-O 120.826 0.346 . . . . 74.21 111.366 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.625 ' HE2' ' HD3' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -76.05 -23.02 55.07 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.989 0.423 . . . . 73.02 111.405 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -75.2 -69.34 0.48 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.325 0.583 . . . . 74.11 111.116 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -63.51 -8.19 8.84 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.943 0.72 . . . . 72.32 112.943 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.03 -34.28 13.77 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.632 0.975 . . . . 60.51 113.632 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 48' ' ' TYR . 28.8 m -131.92 7.58 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 N-CA-C 114.014 1.116 . . . . 75.32 114.014 -173.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.594 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -90.71 20.58 4.59 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.105 0.78 . . . . 71.52 113.105 -174.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.442 ' CD2' ' HD3' ' A' ' 87' ' ' LYS . 26.3 p90 -140.1 152.75 46.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.166 0.507 . . . . 71.24 111.829 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -119.44 135.63 54.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.703 -0.681 . . . . 72.5 110.1 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.524 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 36.0 mt-10 -97.47 115.11 27.17 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.89 0.376 . . . . 73.33 111.085 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 58' ' ' ASN . 4.2 mp -109.13 156.73 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.169 0.509 . . . . 74.03 110.734 -177.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.659 ' ND2' HG23 ' A' ' 91' ' ' VAL . 3.1 m120 -63.57 151.78 40.54 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.893 -0.594 . . . . 71.34 111.308 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 30.1 tt0 -67.16 -41.3 86.25 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 111.847 0.314 . . . . 75.53 111.847 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -63.9 -49.54 72.26 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.84 0.352 . . . . 75.42 111.178 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.604 ' HB3' HD13 ' A' ' 24' ' ' LEU . 58.8 m-20 -65.96 -31.02 71.69 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.05 0.452 . . . . 72.35 111.349 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.427 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 62.7 t-105 -54.45 -54.58 38.93 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.308 0.575 . . . . 74.14 111.22 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -70.66 -29.8 66.24 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.993 -0.549 . . . . 52.31 111.14 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.76 -39.36 84.58 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.917 0.389 . . . . 35.25 111.453 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 128' ' ' GLU . 94.0 mt -88.54 -13.25 40.59 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.447 -0.342 . . . . 73.24 111.748 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.24 42.61 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.98 -0.628 . . . . 55.13 112.439 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.723 HD23 ' HE3' ' A' ' 129' ' ' LYS . 90.5 mt -85.36 158.79 20.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.611 0.72 . . . . 73.41 112.026 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -135.09 130.0 34.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.26 -0.882 . . . . 75.01 109.062 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.81 90.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.712 0.768 . . . . 61.34 111.917 -172.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.68 -7.33 2.47 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 114.765 -1.107 . . . . 74.11 114.38 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -90.71 -175.6 4.45 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 118.527 1.163 . . . . 73.44 112.735 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.484 ' HG3' HG23 ' A' ' 134' ' ' VAL . 8.5 mpt_? -106.05 133.87 50.08 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.261 0.553 . . . . 73.3 112.426 -172.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 86' ' ' ALA . 28.1 m -126.25 144.39 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.021 -0.536 . . . . 74.25 111.392 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.623 ' HD3' ' HE2' ' A' ' 76' ' ' LYS . 23.1 ttmm -105.32 151.06 24.62 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.111 0.481 . . . . 74.02 110.934 177.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.45 137.24 56.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.907 -0.588 . . . . 74.34 109.491 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.623 ' HE2' ' HD3' ' A' ' 74' ' ' LYS . 23.4 mttm -137.83 132.33 32.44 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.757 0.651 . . . . 61.3 112.757 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.537 HG22 ' HA3' ' A' ' 125' ' ' GLY . 32.8 p -136.09 -171.75 2.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.62 -0.718 . . . . 72.15 110.19 176.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.29 -8.92 57.93 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.796 0.331 . . . . 73.05 111.501 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -91.3 -38.5 12.61 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.777 0.322 . . . . 71.33 111.493 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.26 -148.27 11.96 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.127 -0.559 . . . . 24.23 112.994 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -154.5 156.74 37.24 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.254 0.465 . . . . 54.15 112.254 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -153.49 150.34 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 116.213 -0.448 . . . . 64.5 111.288 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.2 t -110.58 118.02 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 110.399 -0.223 . . . . 74.5 110.399 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.483 HG12 ' CD2' ' A' ' 103' ' ' TYR . 33.6 m -124.78 177.24 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 120.808 0.337 . . . . 72.52 111.78 -177.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -79.73 144.88 33.25 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.853 0.359 . . . . 72.21 111.351 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.536 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -90.27 123.5 34.11 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.482 0.549 . . . . 72.11 112.482 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.442 ' HD3' ' CD2' ' A' ' 54' ' ' TYR . 43.3 mtpt -133.21 156.75 46.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.021 -0.536 . . . . 61.03 110.734 173.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -98.15 128.71 44.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.218 -0.446 . . . . 73.34 111.291 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.524 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -128.35 154.52 20.0 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.976 -0.63 . . . . 62.32 113.47 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.32 46.75 0.75 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.158 0.504 . . . . 44.34 111.54 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.659 HG23 ' ND2' ' A' ' 58' ' ' ASN . 28.5 m -95.58 159.79 31.83 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 116.09 -0.505 . . . . 72.01 111.564 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . 0.432 ' O ' ' HB3' ' A' ' 95' ' ' MET . 38.6 Cg_exo -62.1 134.24 48.25 Favored 'Trans proline' 0 N--CA 1.487 1.104 0 C-N-CA 122.887 2.391 . . . . 65.0 113.059 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -53.79 134.5 42.32 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 120.775 0.322 . . . . 74.43 111.821 -175.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.429 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 76.49 27.88 60.61 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 120.722 -0.752 . . . . 73.25 112.745 -172.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.537 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 22.3 ttt -153.39 135.07 14.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.448 -0.575 . . . . 64.41 109.448 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.531 HD11 HG22 ' A' ' 28' ' ' VAL . 39.5 pt -128.03 144.27 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.47 0.652 . . . . 70.31 112.093 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.404 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 77.2 t80 -105.3 119.55 39.35 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.909 -0.587 . . . . 71.42 111.564 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.63 ' O ' ' HA ' ' A' ' 30' ' ' SER . 48.2 mt -117.34 128.96 25.67 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 109.916 -0.401 . . . . 64.24 109.916 172.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.455 ' HB2' HG12 ' A' ' 52' ' ' VAL . 47.8 Cg_exo -57.84 141.8 96.01 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.033 1.822 . . . . 73.41 112.576 176.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.6 tpt -55.29 102.38 0.07 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.91 0.386 . . . . 72.43 111.501 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -158.97 179.65 34.46 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.59 -0.814 . . . . 74.54 113.52 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.625 ' HD3' ' HE2' ' A' ' 48' ' ' TYR . 36.5 Cg_endo -63.54 -26.44 69.8 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.529 2.152 . . . . 73.0 112.213 -176.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.483 ' CD2' HG12 ' A' ' 84' ' ' VAL . 26.9 m-85 -61.49 -48.99 78.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.784 0.802 . . . . 73.33 109.309 173.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.28 75.25 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.221 -0.899 . . . . 73.15 111.391 173.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' A' ' 102' ' ' PRO . 8.7 m120 -62.92 -12.69 26.92 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 122.045 -0.409 . . . . 65.33 111.844 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.51 ' SD ' HD21 ' A' ' 140' ' ' LEU . 40.6 mtp -89.41 -15.02 34.18 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.576 -0.283 . . . . 75.02 111.464 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.8 -14.75 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 113.028 0.751 . . . . 73.31 113.028 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.505 HG21 ' OG ' ' A' ' 30' ' ' SER . 7.5 pt -104.25 178.16 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 O-C-N 121.854 -0.529 . . . . 75.52 111.861 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.3 t70 . . . . . 0 CA--C 1.542 0.67 0 CA-C-N 116.084 -0.507 . . . . 74.12 110.52 175.154 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . . . . . . 0 CA--C 1.526 0.752 0 CA-C-O 121.009 0.227 . . . . 54.53 112.982 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.4 t -89.04 123.69 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.816 0.341 . . . . 74.32 111.636 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 67.5 mttm -66.28 149.54 50.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.573 0.582 . . . . 73.51 112.573 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.537 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -178.65 -155.86 15.59 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 115.926 -0.579 . . . . 55.52 112.963 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.42 HG21 ' SD ' ' A' ' 23' ' ' MET . 67.7 p -131.87 159.72 37.76 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 122.244 -0.562 . . . . 64.12 111.863 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.75 144.44 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 116.31 -0.405 . . . . 71.11 111.681 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.721 ' HB3' ' HA ' ' A' ' 23' ' ' MET . 13.8 pt-20 -164.84 168.61 17.56 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.314 -0.403 . . . . 72.34 111.015 173.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.723 ' HE3' HD23 ' A' ' 67' ' ' LEU . 34.7 ttmt -68.75 148.54 50.21 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.222 0.534 . . . . 71.44 112.182 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 t -146.19 155.95 43.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.088 -0.505 . . . . 74.34 111.126 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.31 -2.61 58.51 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.139 0.495 . . . . 72.13 110.99 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.89 173.32 3.67 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.667 0.617 . . . . 53.11 112.667 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -88.86 148.55 23.81 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.845 -0.616 . . . . 64.32 111.867 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.484 HG23 ' HG3' ' A' ' 72' ' ' ARG . 73.4 t -69.76 124.32 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.049 -0.523 . . . . 62.12 109.854 170.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 135' ' ' LEU . 10.3 mt -70.57 89.66 0.72 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.967 -0.293 . . . . 61.41 111.502 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 37.5 m -47.8 148.62 1.52 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.078 -0.51 . . . . 71.12 110.816 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.494 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 72.0 t -44.8 -45.15 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 112.465 0.543 . . . . 72.34 112.465 -173.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -72.15 -47.85 47.93 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.79 0.329 . . . . 55.24 111.712 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -55.91 -38.23 69.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.233 0.539 . . . . 61.41 110.501 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.51 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.7 tt -61.18 -42.3 98.33 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.465 -0.788 . . . . 72.32 111.09 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 31.1 mt . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 121.549 0.69 . . . . 64.43 110.387 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.0 ptm . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 120.682 0.277 . . . . 64.52 110.444 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.1 mt -106.6 124.52 49.73 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.184 0.809 . . . . 72.15 113.184 -173.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -72.06 102.55 3.01 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.601 -1.182 . . . . 71.43 110.444 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.39 166.16 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.005 0.431 . . . . 75.21 111.898 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.636 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 37.1 tt0 -99.84 115.99 30.88 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.807 0.337 . . . . 72.33 110.436 172.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.559 HG22 HD11 ' A' ' 96' ' ' ILE . 21.2 t -90.46 110.96 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.077 -0.511 . . . . 74.32 111.724 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 mt -100.09 153.22 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 120.838 0.351 . . . . 72.22 111.651 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.1 t -120.07 103.63 9.45 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.903 0.383 . . . . 73.24 110.581 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.566 0 C-N-CA 121.076 -0.583 . . . . 74.25 113.171 -177.482 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 120.951 0.405 . . . . 73.23 111.237 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.472 ' O ' HG22 ' A' ' 52' ' ' VAL . 2.6 t80 -76.34 -38.17 56.28 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.461 0.648 . . . . 70.52 110.026 174.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -58.02 -62.94 1.45 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.425 -0.807 . . . . 72.11 110.435 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -70.68 0.89 6.07 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.54 0.57 . . . . 53.31 112.54 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.43 -34.64 11.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.59 0.589 . . . . 72.33 112.59 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.495 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 32.9 m -125.06 2.29 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 113.832 1.049 . . . . 73.42 113.832 -174.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.47 HD22 ' N ' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -89.76 34.22 0.84 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.005 0.743 . . . . 61.1 113.005 -176.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -150.24 159.31 44.53 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.626 -0.671 . . . . 73.32 112.448 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.27 132.4 45.91 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.949 -0.569 . . . . 41.53 110.9 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.763 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 35.2 mt-10 -87.86 114.96 24.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.208 0.528 . . . . 65.12 111.016 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.7 mt -111.49 148.46 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.582 -0.735 . . . . 72.21 111.478 -174.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -70.24 140.8 52.48 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 122.391 -0.193 . . . . 74.32 110.7 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 37.3 tt0 -54.71 -37.75 66.22 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.084 0.772 . . . . 74.33 113.084 -177.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.511 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 6.6 mm-40 -56.67 -53.59 55.96 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.152 -0.342 . . . . 74.3 111.485 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -63.31 -38.11 89.89 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.368 0.604 . . . . 51.33 110.447 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.43 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 52.5 t-105 -53.65 -45.63 70.3 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.36 -0.836 . . . . 75.55 111.513 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -69.87 -41.96 74.13 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.232 -0.44 . . . . 75.2 110.917 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.3 82.89 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.546 0.573 . . . . 70.34 112.546 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.405 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 89.4 mt -86.98 -6.16 58.85 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.319 -0.4 . . . . 72.3 111.799 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.09 50.62 64.42 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.505 -0.379 . . . . 52.21 112.848 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.405 ' HG ' ' HB2' ' A' ' 65' ' ' LEU . 97.8 mt -90.88 160.3 15.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.473 0.654 . . . . 73.04 112.709 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.5 mp0 -125.32 143.24 51.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.015 -0.993 . . . . 74.3 110.419 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.16 94.88 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.599 0.714 . . . . 61.35 111.118 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.62 -6.69 7.47 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.133 -0.939 . . . . 24.22 114.182 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.44 -177.48 5.79 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.301 1.05 . . . . 54.33 111.678 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.424 ' HG3' HG23 ' A' ' 134' ' ' VAL . 2.8 mpt_? -105.8 123.48 48.03 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.329 0.492 . . . . 74.3 112.329 -174.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.632 HG13 ' HB2' ' A' ' 86' ' ' ALA . 26.6 m -114.21 148.71 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.044 -0.525 . . . . 70.35 110.871 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.448 ' HB2' HG21 ' A' ' 130' ' ' THR . 68.5 tttt -120.62 130.34 54.11 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.025 0.441 . . . . 74.32 111.261 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.9 134.84 49.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.27 -0.423 . . . . 74.11 111.356 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -125.91 140.53 52.56 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.925 0.393 . . . . 70.43 111.555 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.6 p -138.41 -172.22 3.23 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.952 0.501 . . . . 73.25 110.122 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.6 2.28 17.03 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.961 0.41 . . . . 63.11 111.29 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -101.18 -35.31 9.34 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.575 0.35 . . . . 72.23 111.455 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 163.45 -155.8 27.31 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.175 -0.536 . . . . 61.22 113.35 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.99 160.26 40.46 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.101 0.408 . . . . 64.44 112.101 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.5 p -160.57 150.61 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-N 116.041 -0.527 . . . . 62.24 111.296 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.435 HG22 ' HG3' ' A' ' 74' ' ' LYS . 33.1 t -109.9 123.49 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.22 0.208 . . . . 64.22 111.304 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.485 ' HA ' HG13 ' A' ' 134' ' ' VAL . 27.5 m -133.38 172.21 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.652 0.381 . . . . 40.21 111.627 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -75.91 143.73 41.5 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.145 0.498 . . . . 75.31 111.792 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.632 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -84.59 128.36 34.56 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.057 -0.52 . . . . 63.22 112.388 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -129.94 158.3 39.92 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.655 0.74 . . . . 75.12 111.887 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -101.44 102.49 13.29 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.256 -0.884 . . . . 73.22 109.617 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.763 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -99.64 -167.28 29.7 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.982 -0.627 . . . . 71.5 114.581 -170.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.53 9.37 42.61 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 122.846 0.459 . . . . 73.54 111.545 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.6 m -79.56 158.58 73.41 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 116.311 -0.404 . . . . 70.22 111.793 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.65 169.6 21.96 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.573 2.182 . . . . 63.43 112.653 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.511 ' HE2' ' HB3' ' A' ' 60' ' ' GLU . 49.2 tttm -65.91 148.75 51.3 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 120.732 0.301 . . . . 74.54 111.589 -177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.12 30.46 76.93 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.261 -0.495 . . . . 61.34 112.816 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.636 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 13.2 ttt -153.63 136.97 15.75 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 122.62 -0.341 . . . . 70.13 110.319 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.559 HD11 HG22 ' A' ' 28' ' ' VAL . 40.3 pt -134.55 138.93 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.472 0.653 . . . . 73.4 112.021 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -101.44 123.37 45.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.722 -0.672 . . . . 74.54 111.176 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 30' ' ' SER . 40.2 mt -121.04 127.62 26.12 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 122.277 -0.265 . . . . 73.31 110.877 175.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.495 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 14.0 Cg_endo -57.37 142.42 95.0 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.476 2.117 . . . . 74.34 112.708 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.14 103.34 0.27 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.267 -0.424 . . . . 75.2 111.074 -176.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.69 -178.53 31.82 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.883 -0.675 . . . . 42.12 112.528 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.573 ' O ' ' HG2' ' A' ' 106' ' ' MET . 23.9 Cg_endo -60.71 -31.35 91.88 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.435 2.09 . . . . 60.21 111.695 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.499 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 4.8 m-85 -62.58 -53.4 55.15 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.612 -0.722 . . . . 74.14 110.314 175.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.31 -43.59 88.21 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.051 -0.522 . . . . 50.53 110.756 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -54.21 -26.39 28.18 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.014 0.526 . . . . 72.11 112.2 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.573 ' HG2' ' O ' ' A' ' 102' ' ' PRO . 84.6 mmm -66.58 -21.41 66.14 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.191 0.441 . . . . 63.12 112.191 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.7 m -132.08 -27.48 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 112.87 0.692 . . . . 64.44 112.87 -172.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' A' ' 30' ' ' SER . 1.5 pp -87.02 170.09 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-O 121.033 0.444 . . . . 64.33 111.308 -176.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.409 ' C ' HD12 ' A' ' 108' ' ' ILE . 12.6 t0 . . . . . 0 CA--C 1.544 0.738 0 CA-C-N 116.382 -0.372 . . . . 70.42 111.131 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.667 0 N-CA-C 112.676 -0.17 . . . . 60.44 112.676 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.0 t -80.8 126.14 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.019 0.377 . . . . 41.01 112.019 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -62.32 145.78 52.89 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.152 0.427 . . . . 75.11 112.152 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -174.12 -163.42 27.49 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.393 -0.432 . . . . 42.33 112.884 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 54.5 p -126.24 142.69 51.43 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.628 -0.336 . . . . 61.52 111.3 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.0 p -132.01 143.25 40.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 120.9 0.381 . . . . 34.4 110.76 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.45 169.68 19.99 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.354 -0.385 . . . . 65.52 110.974 176.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -69.84 141.26 53.29 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.103 -0.373 . . . . 71.21 110.87 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 74' ' ' LYS . 10.1 t -132.4 161.4 33.73 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.348 0.594 . . . . 74.43 112.187 -177.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.03 -18.02 41.24 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.642 -0.708 . . . . 73.22 111.11 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -69.68 152.51 44.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.581 0.705 . . . . 75.3 112.513 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.718 ' H ' ' HD3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -79.49 160.33 26.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.232 -0.894 . . . . 54.55 110.696 173.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.485 HG13 ' HA ' ' A' ' 84' ' ' VAL . 98.5 t -65.96 126.53 25.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 O-C-N 122.346 -0.222 . . . . 74.1 110.533 174.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.451 HD13 ' HG ' ' A' ' 140' ' ' LEU . 7.2 mt -56.06 131.83 48.53 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.07 0.462 . . . . 52.44 112.077 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.9 m -71.94 140.68 49.3 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.697 -0.482 . . . . 64.33 109.697 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.43 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 89.3 t -46.48 -49.45 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 112.54 0.57 . . . . 71.31 112.54 -175.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -71.78 -42.53 67.04 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.944 0.402 . . . . 73.35 111.327 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -55.98 -34.64 65.94 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.682 0.753 . . . . 72.0 110.581 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.451 ' HG ' HD13 ' A' ' 135' ' ' LEU . 2.6 tt -65.89 -42.5 90.19 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.249 -0.887 . . . . 75.43 110.827 174.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 29.3 mt . . . . . 0 N--CA 1.472 0.67 0 CA-C-O 121.373 0.606 . . . . 73.14 110.622 177.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.7 ptm . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 120.927 0.394 . . . . 72.12 111.425 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.6 mt -115.52 146.2 41.92 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.914 0.387 . . . . 73.01 111.86 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -92.4 125.21 36.95 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.389 0.614 . . . . 70.24 111.233 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 27.5 m -142.14 160.64 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.22 -0.9 . . . . 53.02 111.882 -173.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 34.6 tt0 -98.49 116.9 31.72 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.045 -0.409 . . . . 74.31 110.53 173.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.615 HG22 HD11 ' A' ' 96' ' ' ILE . 47.1 t -88.25 106.44 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.91 -0.586 . . . . 51.53 111.627 -176.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.722 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 15.0 mt -91.91 158.1 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.837 0.351 . . . . 73.05 111.888 -177.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 62.2 m -140.29 94.47 2.75 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.085 0.469 . . . . 62.25 111.861 177.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.664 0 CA-C-N 115.98 -0.555 . . . . 64.32 112.072 178.507 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 CA--C 1.534 0.333 0 CA-C-O 120.708 0.289 . . . . 72.45 110.973 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.585 ' O ' HG22 ' A' ' 52' ' ' VAL . 1.7 t80 -62.55 -39.08 92.49 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.151 0.5 . . . . 73.11 110.099 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -63.5 -68.1 0.37 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.826 -0.624 . . . . 65.23 110.314 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -55.09 -24.2 24.29 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.865 0.691 . . . . 72.41 112.865 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.54 -38.08 18.92 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.307 0.854 . . . . 74.32 113.307 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 48' ' ' TYR . 13.7 m -108.35 7.99 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 112.873 0.694 . . . . 63.14 112.873 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.481 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -98.53 18.98 15.38 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.44 0.904 . . . . 71.33 113.44 -175.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -135.65 159.39 41.79 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.98 0.733 . . . . 70.34 112.98 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.42 137.64 49.93 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.229 -0.896 . . . . 73.22 110.098 173.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.595 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 48.5 mt-10 -97.44 116.86 30.45 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.898 0.38 . . . . 73.3 111.626 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.5 ' HA ' HG22 ' A' ' 96' ' ' ILE . 4.1 mp -110.0 154.58 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 116.226 -0.443 . . . . 74.25 111.212 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.405 ' N ' HG22 ' A' ' 57' ' ' ILE . 27.1 t-20 -68.52 148.78 50.08 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.736 0.414 . . . . 54.44 111.442 176.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 9.2 tp10 -52.46 -47.59 66.36 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.311 0.485 . . . . 73.2 112.311 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.55 ' HA ' HD21 ' A' ' 63' ' ' ASN . 7.7 mm-40 -62.6 -42.1 99.37 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.337 0.495 . . . . 65.24 112.337 -176.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -71.18 -30.51 66.5 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.409 0.623 . . . . 73.24 110.555 174.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.458 ' HZ2' ' N ' ' A' ' 69' ' ' GLU . 58.6 t-105 -59.14 -52.71 64.55 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.514 -0.766 . . . . 71.1 111.739 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.55 HD21 ' HA ' ' A' ' 60' ' ' GLU . 5.8 p30 -71.74 -30.34 65.5 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.612 0.227 . . . . 73.12 111.612 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.54 -43.98 89.43 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.088 0.47 . . . . 73.2 111.827 177.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 98.0 mt -89.25 -4.92 58.0 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.275 -0.42 . . . . 73.22 112.033 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.72 50.49 66.96 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.218 -0.515 . . . . 75.41 112.967 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.429 HD23 ' HE2' ' A' ' 129' ' ' LYS . 86.9 mt -89.27 163.89 15.18 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.041 0.448 . . . . 63.22 112.162 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -150.52 118.77 6.37 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.192 -0.458 . . . . 65.23 110.208 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.458 ' N ' ' HZ2' ' A' ' 62' ' ' TRP . 2.2 mp0 -40.2 105.74 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.33 0.863 . . . . 70.31 113.33 -168.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.66 -10.88 10.38 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 115.289 -0.869 . . . . 74.34 113.672 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -80.64 176.45 9.79 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 117.889 0.844 . . . . 73.14 111.31 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' A' ' 72' ' ' ARG . 3.1 mpt_? -98.25 128.7 44.84 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.115 0.483 . . . . 71.2 112.045 -172.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 86' ' ' ALA . 15.3 m -119.43 135.53 59.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 121.284 0.564 . . . . 71.35 111.723 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.553 ' HB3' ' HG3' ' A' ' 128' ' ' GLU . 5.4 tppp? -88.88 125.31 34.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.839 -0.619 . . . . 73.55 110.867 175.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 61.7 t -109.54 125.34 66.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.674 -0.491 . . . . 74.33 109.674 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -132.41 132.89 43.27 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.141 0.496 . . . . 64.3 112.143 -173.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.623 HG22 ' HA3' ' A' ' 125' ' ' GLY . 37.1 p -136.07 -170.58 2.67 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.922 -0.581 . . . . 60.32 110.943 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.05 -6.39 52.55 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.029 -0.532 . . . . 72.52 111.709 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.412 ' CZ ' ' HB2' ' A' ' 109' ' ' ASP . 98.9 m-85 -99.82 -45.14 5.83 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.769 0.319 . . . . 74.15 111.582 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.2 -152.4 10.22 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.781 -0.723 . . . . 73.31 113.336 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 15.4 pt-20 -152.08 152.1 31.93 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.057 0.456 . . . . 61.04 111.641 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 106' ' ' MET . 8.8 p -152.36 153.88 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.389 -0.369 . . . . 64.23 111.48 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 t -108.8 120.48 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 122.22 0.208 . . . . 52.32 110.882 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.431 HG12 ' CD2' ' A' ' 103' ' ' TYR . 32.8 m -130.29 172.5 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 111.992 0.367 . . . . 72.54 111.992 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -76.36 136.9 39.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.278 -0.419 . . . . 75.22 111.025 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -87.19 127.81 35.15 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.394 0.516 . . . . 65.14 112.394 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 86.9 mttt -127.74 146.91 50.42 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.262 0.553 . . . . 53.02 110.673 172.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -84.68 126.96 33.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.875 -0.602 . . . . 52.21 110.122 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.595 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -118.86 -175.81 16.34 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.735 -0.745 . . . . 75.53 114.478 -173.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -92.74 9.35 35.41 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.617 0.722 . . . . 70.45 110.221 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.9 m -75.14 151.51 85.98 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 115.456 -0.793 . . . . 62.23 112.44 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.27 166.12 28.07 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.019 2.479 . . . . 65.32 112.943 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -66.14 147.04 53.93 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.769 0.319 . . . . 73.45 111.287 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 64.74 27.05 71.5 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.767 -0.73 . . . . 65.24 113.071 -174.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.541 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 21.6 ttt -152.11 136.39 16.69 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 122.218 -0.578 . . . . 71.2 110.406 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.615 HD11 HG22 ' A' ' 28' ' ' VAL . 39.9 pt -136.53 141.58 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 121.193 0.521 . . . . 71.21 111.975 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -101.46 132.11 47.24 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.858 0.361 . . . . 73.11 111.532 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 30' ' ' SER . 39.1 mt -127.89 136.66 29.33 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.245 -0.434 . . . . 61.21 110.427 173.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.535 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 31.1 Cg_endo -65.28 131.8 29.51 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.076 1.851 . . . . 73.43 112.254 172.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.73 104.0 0.1 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.875 0.369 . . . . 74.33 110.912 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.0 -175.52 28.01 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.925 -0.655 . . . . 54.41 112.918 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.447 ' O ' ' HG2' ' A' ' 106' ' ' MET . 19.5 Cg_endo -57.04 -34.91 98.58 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.99 2.46 . . . . 70.43 112.357 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.431 ' CD2' HG12 ' A' ' 84' ' ' VAL . 28.8 m-85 -64.77 -53.64 43.82 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.216 -0.447 . . . . 72.32 110.832 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -58.29 -38.47 77.09 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.315 0.578 . . . . 54.33 111.104 175.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -55.17 -22.29 16.76 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.881 -0.599 . . . . 60.03 112.408 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.63 ' SD ' HD21 ' A' ' 140' ' ' LEU . 90.2 mmm -78.75 -15.19 58.74 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.222 0.453 . . . . 73.43 112.222 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.1 m -129.23 -18.36 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 113.179 0.807 . . . . 44.55 113.179 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.608 HG21 ' OG ' ' A' ' 30' ' ' SER . 12.9 pt -96.75 176.36 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 121.811 -0.556 . . . . 71.01 112.377 -177.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.592 ' H ' HG21 ' A' ' 123' ' ' VAL . 18.7 t0 . . . . . 0 CA--C 1.543 0.687 0 CA-C-N 115.895 -0.593 . . . . 72.51 110.736 176.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.722 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . . . . . . 0 CA--C 1.53 0.97 0 N-CA-C 114.36 0.504 . . . . 64.41 114.36 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.592 HG21 ' H ' ' A' ' 109' ' ' ASP . 86.6 t -92.7 123.61 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 122.747 0.419 . . . . 65.21 111.431 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 95.9 mttt -72.78 150.54 42.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.111 0.482 . . . . 72.13 112.192 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.623 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -177.2 -140.89 3.81 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 116.015 -0.539 . . . . 63.04 113.024 -178.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 67.3 p -142.81 163.55 32.51 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.35 -0.5 . . . . 72.31 111.879 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.0 p -142.4 145.32 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 116.136 -0.484 . . . . 71.44 110.884 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.553 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 8.7 pt-20 -152.09 152.3 32.19 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.286 0.476 . . . . 72.24 112.286 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.429 ' HE2' HD23 ' A' ' 67' ' ' LEU . 9.5 tppt? -62.7 137.31 58.23 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.426 -0.352 . . . . 53.12 110.93 172.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.0 t -134.7 153.28 52.07 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.05 0.452 . . . . 72.22 111.957 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.27 6.66 46.17 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.507 0.67 . . . . 65.41 110.621 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -80.6 -175.96 5.51 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.447 0.641 . . . . 65.52 112.056 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -101.56 154.0 19.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.615 -0.721 . . . . 64.43 111.001 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.39 122.26 14.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 110.338 -0.245 . . . . 65.05 110.338 173.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 135' ' ' LEU . 3.3 mt -62.45 90.96 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.636 0.236 . . . . 74.03 111.636 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.1 m -46.05 147.66 0.99 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.164 -0.471 . . . . 61.35 111.669 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.544 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 85.8 t -45.74 -53.6 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 113.118 0.784 . . . . 61.35 113.118 -173.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.853 ' HD3' HD12 ' A' ' 141' ' ' LEU . 16.1 tppt? -72.49 -39.07 67.94 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.08 -0.387 . . . . 71.24 111.598 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -55.77 -38.17 69.51 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.666 0.746 . . . . 75.4 110.205 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.63 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.2 tt -63.76 -40.16 96.03 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.098 -0.955 . . . . 75.42 110.547 174.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.853 HD12 ' HD3' ' A' ' 138' ' ' LYS . 43.1 mt . . . . . 0 N--CA 1.47 0.568 0 CA-C-O 121.31 0.576 . . . . 75.45 110.285 175.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.1 ptm . . . . . 0 CA--C 1.539 0.522 0 CA-C-O 121.132 0.491 . . . . 55.45 111.704 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.5 mt -116.34 131.42 56.95 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.188 -0.46 . . . . 64.12 112.109 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.7 ' HG3' HG22 ' A' ' 126' ' ' THR . 1.1 mp0 -73.03 136.58 45.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.505 0.669 . . . . 60.3 111.42 175.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 15.8 m -148.27 158.1 7.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.069 -0.969 . . . . 50.41 111.616 -172.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.631 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 32.7 tt0 -99.21 111.85 24.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.018 0.437 . . . . 73.34 110.183 172.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.512 HG22 HD11 ' A' ' 96' ' ' ILE . 39.6 t -88.48 107.86 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.812 -0.631 . . . . 73.23 111.497 -174.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.9 mt -92.29 153.1 3.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.335 -0.393 . . . . 72.23 111.294 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 20.0 t -133.67 103.52 5.92 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.08 0.466 . . . . 63.44 111.151 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.837 0 C-N-CA 121.076 -0.583 . . . . 75.52 113.364 -177.819 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 CA--C 1.541 0.621 0 CA-C-O 121.106 0.479 . . . . 62.43 110.779 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.459 ' O ' HG22 ' A' ' 52' ' ' VAL . 9.5 t80 -66.05 -37.34 85.58 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.293 0.568 . . . . 74.41 110.231 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.404 ' HD1' HG23 ' A' ' 137' ' ' VAL . 65.5 t80 -58.61 -62.78 1.61 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.599 -0.728 . . . . 74.43 111.038 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -55.24 -23.98 25.42 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.771 0.656 . . . . 75.14 112.771 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.68 -40.32 23.01 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.032 0.752 . . . . 73.53 113.032 -176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 48' ' ' TYR . 33.8 m -108.73 13.9 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 113.289 0.848 . . . . 74.41 113.289 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -104.04 26.1 9.16 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.52 0.934 . . . . 63.23 113.52 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -145.11 159.81 42.39 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.665 -0.647 . . . . 75.44 112.355 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.78 146.33 50.62 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.532 -0.758 . . . . 52.35 111.043 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.667 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 30.9 mt-10 -96.6 116.9 29.88 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.633 0.254 . . . . 75.22 111.516 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.52 ' HA ' HG22 ' A' ' 96' ' ' ILE . 4.2 mp -110.44 146.97 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 120.782 0.325 . . . . 71.4 111.255 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -64.19 145.82 55.33 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.593 -0.276 . . . . 71.14 110.845 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 32.2 tt0 -58.71 -40.76 84.59 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.78 0.659 . . . . 72.31 112.78 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -60.9 -51.14 70.53 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.955 0.354 . . . . 72.02 111.955 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -65.55 -36.0 82.52 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.468 0.651 . . . . 74.0 110.457 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.713 ' HA ' HD12 ' A' ' 67' ' ' LEU . 37.0 t-105 -52.91 -53.83 43.66 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.276 -0.874 . . . . 65.54 111.311 175.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -70.5 -29.69 66.27 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.004 -0.543 . . . . 71.43 111.394 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.24 -35.22 80.1 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.887 0.375 . . . . 75.25 111.624 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.0 mt -89.86 1.33 56.32 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.38 -0.373 . . . . 62.2 111.702 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.94 40.48 95.4 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.42 -0.419 . . . . 72.02 112.728 -177.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.713 HD12 ' HA ' ' A' ' 62' ' ' TRP . 18.4 mt -76.11 141.81 41.86 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.093 0.775 . . . . 71.44 113.093 -175.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.526 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 30.3 tt0 -106.51 147.1 29.79 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.28 -0.873 . . . . 72.12 109.673 169.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -63.77 102.73 0.49 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.495 0.664 . . . . 61.45 111.382 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.25 5.02 23.47 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 115.268 -0.878 . . . . 44.44 112.633 -172.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 68' ' ' GLN . 1.4 t0 -71.69 172.86 8.97 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.81 0.444 . . . . 74.24 110.838 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.47 124.48 49.67 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.28 0.562 . . . . 74.03 111.687 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 86' ' ' ALA . 15.8 m -113.3 132.53 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.139 0.495 . . . . 74.13 111.481 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -100.66 109.98 22.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.584 0.707 . . . . 54.3 110.311 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 59.3 t -92.66 127.2 44.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.34 -0.845 . . . . 74.51 109.824 -175.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.521 ' HG2' ' CB ' ' A' ' 81' ' ' GLU . 46.4 mtpt -133.34 124.77 27.81 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.387 0.613 . . . . 62.12 112.397 -169.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.627 HG22 ' HA3' ' A' ' 125' ' ' GLY . 29.2 p -132.42 -171.66 2.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.712 -0.676 . . . . 74.33 111.033 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -76.56 -1.11 25.8 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.272 -0.422 . . . . 73.12 111.562 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -102.46 -34.71 9.04 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 111.811 0.3 . . . . 74.25 111.811 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.37 -167.1 39.7 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 112.258 -0.337 . . . . 71.43 112.258 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.521 ' CB ' ' HG2' ' A' ' 76' ' ' LYS . 16.4 pt-20 -143.48 144.11 31.85 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.376 0.588 . . . . 53.05 112.524 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 p -143.66 150.41 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.934 -0.575 . . . . 72.12 111.566 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.12 120.34 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 O-C-N 122.301 -0.249 . . . . 73.24 111.388 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.69 173.17 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 120.858 0.361 . . . . 75.04 111.966 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -78.28 140.49 38.84 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.038 0.447 . . . . 73.04 111.354 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.457 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -93.74 126.3 38.84 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.649 0.611 . . . . 64.02 112.649 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -125.18 145.66 49.86 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.114 0.483 . . . . 72.44 110.66 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -82.9 112.37 19.63 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.791 -0.448 . . . . 63.44 109.791 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.667 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -123.63 169.12 15.77 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.581 -0.818 . . . . 71.22 114.434 -171.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.85 73.89 6.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.116 0.484 . . . . 64.32 111.413 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.5 m -132.46 147.95 67.67 Favored Pre-proline 0 CA--C 1.539 0.558 0 CA-C-N 116.018 -0.537 . . . . 71.11 111.229 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.75 157.29 38.42 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.628 2.219 . . . . 72.15 112.563 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -64.07 145.34 56.09 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 122.116 -0.365 . . . . 72.44 111.099 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.529 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 62.59 27.8 70.33 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.047 -0.596 . . . . 62.32 112.677 -174.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.631 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 18.8 ttt -148.75 136.43 20.56 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.741 -0.466 . . . . 64.2 109.741 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.52 HG22 ' HA ' ' A' ' 57' ' ' ILE . 36.7 pt -137.92 144.68 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 121.294 0.568 . . . . 73.12 112.194 -176.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -105.4 133.38 50.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.229 -0.442 . . . . 52.32 111.494 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 30' ' ' SER . 48.8 mt -128.87 134.03 25.86 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 116.342 -0.39 . . . . 64.02 110.675 174.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.87 136.44 61.71 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 121.975 1.784 . . . . 73.35 112.231 174.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.31 107.93 0.63 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.898 0.38 . . . . 75.34 110.895 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.95 -174.61 26.87 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.124 -0.56 . . . . 72.52 112.487 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.78 -25.77 74.83 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.983 1.789 . . . . 75.22 111.853 -177.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.539 ' HA ' HD11 ' A' ' 140' ' ' LEU . 3.8 m-85 -71.19 -54.29 11.49 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.677 -0.692 . . . . 73.23 110.729 178.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.02 -33.35 73.13 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.097 -0.501 . . . . 71.43 110.617 175.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -58.25 -22.37 52.11 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.936 -0.574 . . . . 53.54 111.665 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.502 ' SD ' HD21 ' A' ' 140' ' ' LEU . 33.7 mtp -78.37 -29.61 47.51 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.506 -0.315 . . . . 73.34 111.41 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.8 m -111.94 -18.99 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 112.395 0.517 . . . . 74.24 112.395 -171.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.563 HG21 ' HB2' ' A' ' 30' ' ' SER . 12.2 pt -94.76 178.84 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.11 0.481 . . . . 74.1 111.495 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.52 ' H ' HG21 ' A' ' 123' ' ' VAL . 21.3 t70 . . . . . 0 CA--C 1.54 0.583 0 CA-C-N 116.102 -0.499 . . . . 74.3 110.52 176.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.686 0 N-CA-C 112.442 -0.263 . . . . 72.11 112.442 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.52 HG21 ' H ' ' A' ' 109' ' ' ASP . 82.0 t -82.17 119.61 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.063 0.458 . . . . 63.3 111.661 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 95.8 mttt -73.12 154.01 40.54 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.512 0.56 . . . . 75.34 112.512 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.627 ' HA3' HG22 ' A' ' 77' ' ' THR . . . 177.81 -140.83 4.9 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.884 -0.598 . . . . 63.35 112.797 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.7 HG22 ' HG3' ' A' ' 25' ' ' GLU . 67.6 p -136.69 161.67 35.28 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.026 0.441 . . . . 74.54 111.164 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.79 143.84 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.247 0.546 . . . . 74.52 110.834 173.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -147.44 144.62 28.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.967 -0.561 . . . . 62.24 110.363 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.509 ' HD2' HD23 ' A' ' 67' ' ' LEU . 20.6 ttpp -81.87 143.23 31.85 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.19 -0.318 . . . . 73.33 110.262 176.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.0 t -132.16 156.8 45.77 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.597 0.962 . . . . 55.44 113.597 -168.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -83.29 -17.1 43.73 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.061 -0.972 . . . . 53.02 110.41 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -68.98 179.11 1.95 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.702 -0.681 . . . . 54.24 112.71 -175.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -98.83 159.84 14.68 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.672 -0.694 . . . . 73.54 111.702 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.8 t -73.97 136.12 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.466 -0.334 . . . . 74.23 110.908 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 135' ' ' LEU . 11.9 mt -67.44 140.47 57.12 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.944 0.402 . . . . 71.22 111.531 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.6 m -86.24 148.84 25.46 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.616 -0.513 . . . . 72.31 109.616 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.47 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 86.1 t -46.8 -53.43 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 112.564 0.579 . . . . 75.45 112.564 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -72.25 -39.36 68.48 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 111.704 0.261 . . . . 73.12 111.704 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.79 -36.67 72.49 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.701 0.762 . . . . 72.13 110.09 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.539 HD11 ' HA ' ' A' ' 103' ' ' TYR . 4.4 tt -62.25 -43.84 97.9 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.968 -1.014 . . . . 70.24 110.728 172.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 66.6 mt . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 121.205 0.526 . . . . 53.42 110.608 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.2 ptp . . . . . 0 N--CA 1.47 0.533 0 CA-C-O 121.249 0.547 . . . . 75.3 111.861 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.579 HD11 ' HB3' ' A' ' 64' ' ' ALA . 16.4 mt -122.27 139.28 53.97 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.004 -0.544 . . . . 43.44 111.58 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -79.29 118.25 21.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.309 0.576 . . . . 74.25 110.359 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 28.3 m -138.25 160.51 32.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.61 -0.723 . . . . 71.13 111.824 -173.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.726 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 72.2 tt0 -98.82 111.92 24.16 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.071 0.462 . . . . 75.25 110.438 175.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.522 HG22 HD11 ' A' ' 96' ' ' ILE . 43.1 t -87.45 105.81 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 115.797 -0.638 . . . . 75.44 111.72 -175.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 mt -92.14 162.91 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.677 0.275 . . . . 74.34 111.265 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.686 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 15.6 t -134.58 113.96 12.3 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.781 0.324 . . . . 73.23 111.826 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . . . . . . 0 CA--C 1.528 0.878 0 C-N-CA 121.065 -0.588 . . . . 54.44 113.298 -178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.628 ' HA ' HD21 ' A' ' 50' ' ' ASN . 44.3 mt-10 . . . . . 0 N--CA 1.472 0.656 0 CA-C-O 121.151 0.5 . . . . 71.13 111.153 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -68.8 -23.08 64.24 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.939 0.4 . . . . 74.34 110.702 -179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -88.17 2.08 52.96 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.033 0.383 . . . . 73.43 112.033 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.628 HD21 ' HA ' ' A' ' 47' ' ' GLU . 10.9 p30 -122.17 -48.31 2.11 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.483 -0.761 . . . . 72.34 111.948 170.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.68 -22.77 24.88 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.079 1.14 . . . . 75.23 114.079 -170.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.519 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 19.7 m -130.92 17.82 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 112.858 0.688 . . . . 54.52 112.858 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.607 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -102.0 17.16 23.9 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.612 0.597 . . . . 63.2 112.612 -174.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -140.93 162.79 34.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.142 0.496 . . . . 73.33 112.106 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -126.14 127.19 45.36 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.622 -0.717 . . . . 52.03 110.813 174.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -87.31 118.4 26.71 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.413 0.625 . . . . 64.33 110.892 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.03 154.92 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.162 -0.926 . . . . 75.44 111.828 -169.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -76.19 144.56 40.42 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.525 -0.307 . . . . 75.21 110.615 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 27.3 tt0 -63.39 -36.86 85.13 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.818 0.673 . . . . 75.3 112.818 -176.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -62.21 -47.69 83.33 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 122.174 -0.329 . . . . 62.4 111.413 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.461 ' HB3' HD13 ' A' ' 24' ' ' LEU . 47.0 m-20 -66.8 -36.5 82.52 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.308 0.575 . . . . 74.31 110.558 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.48 ' HZ2' ' N ' ' A' ' 69' ' ' GLU . 33.7 t-105 -53.11 -45.66 68.38 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.492 -0.776 . . . . 74.03 110.591 175.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -65.7 -41.02 92.86 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.714 -0.676 . . . . 61.14 110.961 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.579 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -61.0 -38.55 86.45 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.242 -0.435 . . . . 62.33 111.82 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.483 ' HG ' HD12 ' A' ' 24' ' ' LEU . 87.6 mt -85.71 -14.47 45.29 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.425 -0.352 . . . . 65.44 111.413 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.57 47.4 78.0 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.273 -0.489 . . . . 75.1 112.581 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.568 HD23 ' HD3' ' A' ' 129' ' ' LYS . 85.3 mt -84.49 164.85 18.56 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.559 0.695 . . . . 71.03 112.38 -175.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -136.11 123.61 22.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.55 -0.75 . . . . 72.24 109.905 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.48 ' N ' ' HZ2' ' A' ' 62' ' ' TRP . 48.7 mt-10 -49.88 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.563 0.696 . . . . 71.43 112.614 -172.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 130.2 0.04 5.55 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.387 -0.824 . . . . 45.43 114.036 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -90.39 -172.15 3.34 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 117.863 0.831 . . . . 73.02 112.292 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.45 HH11 ' HD2' ' A' ' 72' ' ' ARG . 45.6 mtt180 -111.52 131.25 55.37 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.339 0.496 . . . . 71.24 112.339 -174.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.45 HG13 ' HB2' ' A' ' 86' ' ' ALA . 30.0 m -123.67 140.85 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.998 0.428 . . . . 64.42 111.578 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.415 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 38.3 ttmt -98.65 131.84 44.51 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.25 0.548 . . . . 73.4 110.74 174.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.531 HG21 HD11 ' A' ' 98' ' ' ILE . 61.9 t -106.18 128.22 60.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.731 -0.668 . . . . 75.52 109.661 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.415 ' HG3' ' HG2' ' A' ' 74' ' ' LYS . 38.8 mtpt -131.06 127.55 38.45 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.51 0.672 . . . . 72.2 112.506 -171.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.6 HG22 ' HA3' ' A' ' 125' ' ' GLY . 31.0 p -136.37 -170.43 2.66 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.131 -0.941 . . . . 62.44 110.486 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.22 -13.74 60.16 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.683 0.277 . . . . 70.13 111.561 176.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -87.83 -38.02 16.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.96 0.409 . . . . 74.43 111.378 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.07 -157.73 28.75 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.866 -0.683 . . . . 52.12 113.521 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -144.24 141.82 30.09 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.758 0.313 . . . . 72.22 111.471 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.48 146.67 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.698 0.285 . . . . 63.14 111.655 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.0 t -105.4 117.21 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.544 0.211 . . . . 71.11 110.95 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.0 m -127.34 178.08 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 122.588 0.355 . . . . 71.41 111.821 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -83.2 144.09 30.02 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.911 0.386 . . . . 74.41 111.312 174.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.45 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -90.34 135.74 33.49 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.625 0.602 . . . . 64.53 112.625 -177.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -133.04 158.23 43.26 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.583 0.706 . . . . 45.0 111.663 174.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -108.17 99.64 9.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.103 -0.953 . . . . 52.42 109.608 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.59 86.54 0.19 Allowed Glycine 0 CA--C 1.533 1.186 0 N-CA-C 116.631 1.412 . . . . 44.33 116.631 -166.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 65.72 -17.44 0.1 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 116.206 1.928 . . . . 61.4 116.206 161.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.0 m -78.15 148.66 75.14 Favored Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 121.716 -0.615 . . . . 73.22 112.425 -173.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -72.64 169.58 21.55 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.788 2.325 . . . . 73.23 112.705 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -68.33 146.58 53.14 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.871 0.367 . . . . 75.13 111.5 -177.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 68.72 18.02 71.75 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.277 -0.487 . . . . 74.0 113.28 -174.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.726 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 14.2 ttt -147.02 136.61 22.93 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 122.37 -0.488 . . . . 75.22 110.568 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.522 HD11 HG22 ' A' ' 28' ' ' VAL . 43.6 pt -135.91 144.97 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 121.082 0.468 . . . . 64.0 111.703 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.459 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 68.1 t80 -107.01 123.87 48.81 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.473 -0.33 . . . . 72.53 111.302 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.686 ' O ' ' HA ' ' A' ' 30' ' ' SER . 44.2 mt -120.37 127.46 26.3 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 120.805 0.336 . . . . 73.41 111.142 175.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.519 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 51.4 Cg_exo -57.18 136.9 79.23 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.285 1.99 . . . . 74.34 113.084 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.46 105.69 0.46 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.212 -0.449 . . . . 73.24 110.878 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.98 -174.25 30.6 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.912 -0.661 . . . . 70.31 112.542 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.467 ' O ' ' HG3' ' A' ' 106' ' ' MET . 14.8 Cg_endo -56.05 -36.01 95.55 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.521 2.148 . . . . 74.34 111.986 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.507 ' HA ' HD11 ' A' ' 140' ' ' LEU . 41.0 m-85 -61.83 -54.1 46.87 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.957 -0.565 . . . . 73.44 110.71 177.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -63.41 -33.53 75.76 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.165 0.507 . . . . 72.43 111.302 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.34 -15.03 45.8 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.124 -0.489 . . . . 75.11 111.892 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.541 ' SD ' HD21 ' A' ' 140' ' ' LEU . 41.5 mtp -83.66 -22.75 32.03 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.441 -0.345 . . . . 73.0 111.7 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.7 m -123.86 -18.45 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 113.129 0.788 . . . . 74.04 113.129 -171.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 104' ' ' ALA . 11.2 pt -96.22 177.62 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.381 0.61 . . . . 63.5 111.834 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.632 ' H ' HG21 ' A' ' 123' ' ' VAL . 16.7 t70 . . . . . 0 CA--C 1.54 0.559 0 CA-C-N 115.806 -0.633 . . . . 64.04 110.131 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.661 0 N-CA-C 112.948 -0.061 . . . . 71.11 112.948 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.632 HG21 ' H ' ' A' ' 109' ' ' ASP . 58.3 t -78.19 122.13 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 121.0 0.429 . . . . 73.0 111.419 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 124' ' ' LYS . 12.1 mptt -69.47 131.27 44.48 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.906 0.384 . . . . 75.14 111.549 -177.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.6 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -160.66 -146.03 4.48 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.259 -0.496 . . . . 61.3 113.358 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 41.4 p -139.8 161.28 37.94 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.887 0.375 . . . . 75.34 111.542 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.0 p -139.74 144.6 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.132 0.491 . . . . 65.44 111.462 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.23 156.47 40.94 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.93 -0.577 . . . . 74.45 111.219 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.568 ' HD3' HD23 ' A' ' 67' ' ' LEU . 27.7 ttpp -90.12 136.95 32.74 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.89 -0.506 . . . . 72.22 110.586 174.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.3 t -138.34 157.52 46.08 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.092 0.472 . . . . 74.42 112.217 -173.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -83.02 -4.47 58.36 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.954 -0.566 . . . . 40.13 111.437 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -70.9 146.5 49.54 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.031 -0.531 . . . . 75.02 111.832 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.74 152.04 43.08 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.136 0.493 . . . . 73.43 111.926 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.89 121.9 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.522 -0.308 . . . . 74.11 110.587 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 135' ' ' LEU . 10.2 mt -62.73 94.24 0.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.005 0.372 . . . . 73.31 112.005 -178.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.1 m -53.56 150.69 6.6 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.156 -0.474 . . . . 72.11 110.72 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.55 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 67.9 t -45.09 -48.76 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 112.948 0.721 . . . . 64.21 112.948 -171.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -72.52 -44.07 62.69 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.213 -0.304 . . . . 70.12 111.653 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -56.34 -39.61 73.11 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.92 0.867 . . . . 72.12 110.107 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.541 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.7 tt -60.3 -42.44 95.53 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.791 -1.095 . . . . 70.43 110.879 175.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 56.6 mt . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 121.24 0.543 . . . . 52.21 110.508 176.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.1 ptp . . . . . 0 N--CA 1.467 0.398 0 CA-C-O 121.263 0.554 . . . . 74.22 111.688 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.552 HD11 ' HB3' ' A' ' 64' ' ' ALA . 20.2 mt -124.58 139.06 54.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.89 -0.596 . . . . 74.53 111.327 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -78.31 109.01 12.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.658 0.742 . . . . 74.22 110.618 174.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 34.8 m -132.22 159.13 43.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.731 -1.122 . . . . 70.15 111.849 -172.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.734 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 44.0 tt0 -99.27 117.62 34.13 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.106 0.479 . . . . 71.22 111.102 175.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.54 HG22 HD11 ' A' ' 96' ' ' ILE . 38.4 t -89.79 107.81 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.218 0.607 . . . . 65.34 111.578 -177.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.407 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 2.5 mt -94.11 148.51 4.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 111.803 0.297 . . . . 75.22 111.803 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.645 ' OG ' HG21 ' A' ' 108' ' ' ILE . 73.7 m -109.97 106.93 16.64 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.055 0.455 . . . . 54.24 111.36 175.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.486 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . . . . . . 0 CA--C 1.523 0.561 0 C-N-CA 121.256 -0.497 . . . . 73.52 113.139 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 . . . . . 0 CA--C 1.537 0.458 0 N-CA-C 112.218 0.451 . . . . 74.22 112.218 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -71.53 -26.53 62.69 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.498 0.666 . . . . 74.02 109.789 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.54 ' HD1' HG23 ' A' ' 137' ' ' VAL . 71.4 t80 -89.45 -2.31 58.34 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.616 -0.72 . . . . 72.25 110.902 175.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -101.66 -44.38 5.58 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.025 -0.422 . . . . 75.11 111.811 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.52 -64.0 1.29 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.316 0.858 . . . . 71.23 113.316 -172.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 32.9 m -79.07 21.8 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 113.338 0.866 . . . . 73.33 113.338 -170.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.629 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -108.0 11.17 28.04 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.073 0.768 . . . . 63.22 113.073 -172.546 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -133.2 166.28 22.82 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.598 0.713 . . . . 71.44 112.487 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.76 135.18 48.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.21 -0.905 . . . . 63.32 110.042 172.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.604 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 45.0 mt-10 -94.67 115.56 27.69 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.867 0.365 . . . . 61.31 111.285 177.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.3 mp -109.79 150.93 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.062 -0.517 . . . . 73.33 110.831 -178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -71.78 156.86 38.85 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.71 0.291 . . . . 62.44 111.418 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -54.74 -47.39 73.9 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.173 0.511 . . . . 71.13 111.864 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.5 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 17.3 mm-40 -56.41 -52.73 63.55 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.206 -0.452 . . . . 64.1 112.169 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -66.29 -36.57 83.31 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.007 0.432 . . . . 53.2 111.024 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -55.68 -48.79 74.47 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.96 -0.563 . . . . 74.34 111.103 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -66.71 -39.38 88.01 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.05 -0.523 . . . . 75.35 111.185 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.552 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -61.15 -35.05 76.04 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.058 0.392 . . . . 52.05 112.058 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.2 mt -89.55 -12.13 40.79 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.042 0.386 . . . . 73.3 112.042 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.36 48.32 83.22 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.09 -0.576 . . . . 61.21 112.782 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.668 HD23 ' HD3' ' A' ' 129' ' ' LYS . 92.1 mt -86.88 143.26 27.51 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.259 0.552 . . . . 65.22 112.474 -175.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -93.61 149.62 21.08 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.989 -0.551 . . . . 74.32 109.909 171.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -61.26 100.22 0.12 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.452 0.644 . . . . 74.34 111.279 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.76 29.18 7.05 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.333 -0.848 . . . . 74.03 112.841 -174.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -82.07 -178.27 6.95 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 122.598 -0.354 . . . . 52.01 111.158 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.632 HH21 ' HA ' ' A' ' 131' ' ' ASP . 24.2 mtm-85 -116.78 123.07 46.22 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.85 0.357 . . . . 63.44 111.068 -177.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.81 140.82 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.034 0.445 . . . . 75.14 112.178 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 31.7 ttmt -110.17 126.38 54.03 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.199 0.524 . . . . 71.13 111.318 174.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.523 HG11 HG21 ' A' ' 28' ' ' VAL . 47.0 t -101.07 132.09 47.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.87 -0.604 . . . . 62.35 110.97 177.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.445 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 4.1 mppt? -118.55 127.65 53.83 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.03 0.443 . . . . 74.21 111.392 174.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.718 HG22 ' HA3' ' A' ' 125' ' ' GLY . 40.7 p -127.25 -170.91 2.3 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.894 -0.594 . . . . 55.24 110.253 175.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -72.34 -11.34 60.66 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.87 0.367 . . . . 60.25 111.592 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -96.07 -40.54 9.18 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.087 0.403 . . . . 72.15 112.087 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.79 -146.95 8.76 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.636 -0.792 . . . . 44.23 113.744 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 14.0 pt-20 -152.13 153.41 33.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.781 0.324 . . . . 74.53 111.589 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 12.2 p -157.15 149.46 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 116.653 -0.249 . . . . 74.11 111.67 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.0 t -108.28 119.74 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 116.762 -0.199 . . . . 70.4 110.856 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.462 HG12 ' CD2' ' A' ' 103' ' ' TYR . 29.7 m -128.37 172.16 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-O 120.914 0.388 . . . . 73.33 111.727 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -77.43 143.47 38.56 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.022 0.439 . . . . 72.41 111.39 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.24 122.95 36.16 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.471 0.545 . . . . 70.43 112.471 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -123.63 157.86 32.8 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.161 0.505 . . . . 74.45 110.774 172.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -102.9 107.23 17.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.046 -0.525 . . . . 71.03 110.28 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.604 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -109.35 -175.18 21.24 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.852 -0.69 . . . . 74.41 114.171 -172.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -90.26 17.12 7.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.865 0.364 . . . . 74.02 111.439 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.69 151.87 93.48 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 116.45 -0.341 . . . . 62.34 111.52 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -67.71 154.49 73.12 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.453 2.102 . . . . 72.33 112.585 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.5 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 87.9 tttt -57.42 137.15 56.5 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.732 0.301 . . . . 74.41 111.609 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 71.84 26.92 71.67 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 120.817 -0.706 . . . . 31.43 113.031 -174.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.734 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 13.9 ttt -150.69 137.5 19.05 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 122.213 -0.58 . . . . 64.34 110.151 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.54 HD11 HG22 ' A' ' 28' ' ' VAL . 38.0 pt -133.53 144.84 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.355 0.598 . . . . 54.23 112.166 -178.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.486 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 66.4 t80 -105.78 127.33 53.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.969 -0.56 . . . . 72.33 111.452 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 30' ' ' SER . 46.1 mt -127.29 128.32 24.09 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 122.337 0.255 . . . . 73.31 110.563 174.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.453 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 37.1 Cg_exo -57.76 142.91 96.25 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.2 1.933 . . . . 51.41 112.704 177.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.5 tpt -59.22 103.73 0.2 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.025 0.441 . . . . 72.12 111.435 -178.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.74 -178.08 34.4 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.678 -0.773 . . . . 71.33 112.893 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.537 ' O ' ' HG2' ' A' ' 106' ' ' MET . 18.8 Cg_endo -57.53 -34.63 98.34 Favored 'Trans proline' 0 N--CA 1.478 0.579 0 C-N-CA 122.76 2.307 . . . . 72.33 111.718 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.462 ' CD2' HG12 ' A' ' 84' ' ' VAL . 25.6 m-85 -58.73 -49.38 77.83 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.92 -0.582 . . . . 73.2 110.4 175.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -63.06 -42.61 99.72 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.851 -0.613 . . . . 72.34 111.588 176.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -61.46 -7.46 3.14 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.663 0.616 . . . . 72.41 112.663 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.579 ' SD ' HD21 ' A' ' 140' ' ' LEU . 90.5 mmm -84.2 -20.21 32.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.772 0.32 . . . . 74.4 111.556 176.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.3 m -130.83 -12.1 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 113.271 0.841 . . . . 63.24 113.271 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.645 HG21 ' OG ' ' A' ' 30' ' ' SER . 8.8 pt -96.72 -179.05 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 121.725 -0.609 . . . . 70.11 112.254 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.603 ' H ' HG21 ' A' ' 123' ' ' VAL . 16.4 t70 . . . . . 0 CA--C 1.543 0.697 0 CA-C-N 116.008 -0.542 . . . . 75.12 111.133 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . . . . . . 0 CA--C 1.527 0.837 0 CA-C-O 120.849 0.139 . . . . 61.53 113.323 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' H ' ' A' ' 109' ' ' ASP . 84.2 t -94.25 123.32 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 111.924 0.342 . . . . 53.53 111.924 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 54.9 mtmt -75.36 147.19 40.27 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.45 0.537 . . . . 63.1 112.45 -177.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.718 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -169.6 -157.97 12.8 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.88 -0.6 . . . . 65.23 112.658 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 45.8 p -124.69 138.72 54.28 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.257 -0.555 . . . . 72.42 111.586 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.3 p -126.64 144.57 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.883 0.373 . . . . 73.31 111.64 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.92 156.93 36.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.188 -0.46 . . . . 74.01 110.999 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.668 ' HD3' HD23 ' A' ' 67' ' ' LEU . 27.1 ttpp -72.24 141.56 48.96 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.908 0.385 . . . . 74.43 111.185 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.4 t -132.12 160.83 34.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.232 0.539 . . . . 73.15 112.089 -175.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.632 ' HA ' HH21 ' A' ' 72' ' ' ARG . 5.1 m-20 -92.21 -10.94 36.81 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.826 -0.625 . . . . 73.31 111.031 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.39 168.25 9.22 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.22 0.533 . . . . 75.12 112.12 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.445 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -86.81 152.71 22.25 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.097 -0.502 . . . . 74.41 110.915 175.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 83.8 t -63.08 129.31 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.63 0.252 . . . . 73.21 110.654 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 135' ' ' LEU . 8.9 mt -66.91 90.67 0.18 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.724 0.268 . . . . 63.45 111.724 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.8 m -49.38 148.88 2.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.068 -0.515 . . . . 71.25 110.967 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.54 HG23 ' HD1' ' A' ' 49' ' ' PHE . 90.5 t -45.18 -45.14 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 112.123 0.416 . . . . 64.21 112.123 -175.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -71.95 -43.92 64.45 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.391 -0.368 . . . . 74.53 111.837 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.435 ' HG2' ' HE3' ' A' ' 133' ' ' LYS . 4.3 tp10 -61.13 -32.47 72.17 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.486 0.66 . . . . 74.14 110.53 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.579 HD21 ' SD ' ' A' ' 106' ' ' MET . 1.4 tt -65.85 -37.91 87.44 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.376 -0.829 . . . . 75.24 110.654 176.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 29.6 mt . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 121.581 0.705 . . . . 75.43 109.944 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.556 ' HB3' ' HB3' ' A' ' 128' ' ' GLU . 6.1 ptp . . . . . 0 N--CA 1.468 0.446 0 CA-C-O 121.358 0.599 . . . . 71.32 111.914 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.0 mt -134.53 139.14 45.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 71.03 111.603 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -84.77 114.06 21.78 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.558 0.694 . . . . 50.14 110.886 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.444 HG12 ' HA2' ' A' ' 94' ' ' GLY . 34.5 m -134.97 167.17 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 114.959 -1.019 . . . . 42.32 112.338 -170.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -101.16 132.0 46.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.706 0.289 . . . . 73.42 110.45 171.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.47 111.15 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 112.154 0.427 . . . . 70.24 112.154 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -100.06 151.06 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.065 0.46 . . . . 73.33 111.213 174.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 74.3 m -124.53 110.0 13.93 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.975 0.417 . . . . 50.54 111.779 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.747 0 C-N-CA 121.277 -0.487 . . . . 60.53 112.429 178.903 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 CA--C 1.543 0.69 0 N-CA-C 112.433 0.531 . . . . 73.01 112.433 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.58 -23.08 53.49 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.962 -0.461 . . . . 74.53 110.635 175.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.422 ' HD1' HG23 ' A' ' 137' ' ' VAL . 57.6 t80 -90.87 0.41 57.49 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 116.181 -0.463 . . . . 71.51 112.01 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 51' ' ' ALA . 29.8 p30 -121.66 -44.36 2.34 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.528 -0.733 . . . . 52.31 112.799 176.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.444 ' N ' ' OD1' ' A' ' 50' ' ' ASN . . . -70.19 -30.95 68.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.682 0.993 . . . . 62.05 113.682 -172.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 33.0 m -118.19 16.1 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 112.769 0.655 . . . . 72.01 112.769 -177.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.579 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -104.87 17.64 23.76 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.868 0.692 . . . . 70.31 112.868 -174.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -141.3 168.53 19.55 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.065 0.46 . . . . 65.41 111.93 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.9 144.41 45.51 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.089 -0.505 . . . . 70.23 111.284 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.522 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 42.1 mt-10 -96.75 113.31 24.85 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.697 0.284 . . . . 65.35 111.189 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.0 mp -110.43 147.01 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.368 -0.378 . . . . 70.21 110.82 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -65.79 143.24 57.62 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.665 -0.243 . . . . 71.42 110.971 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 30.4 tt0 -58.3 -38.39 76.97 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.103 0.779 . . . . 61.24 113.103 -174.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -60.44 -48.05 83.45 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.957 -0.464 . . . . 75.01 110.99 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -63.9 -38.07 89.74 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.012 0.434 . . . . 72.24 110.837 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.41 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 35.8 t-105 -53.26 -51.49 62.1 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.43 0.633 . . . . 74.4 111.07 175.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -67.92 -35.76 79.01 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.751 -0.659 . . . . 62.25 111.294 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.9 93.2 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.185 0.516 . . . . 72.23 111.621 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.533 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 73.5 mt -79.46 -16.15 56.59 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.118 -0.492 . . . . 63.5 111.603 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.93 53.96 24.17 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.947 -0.644 . . . . 61.33 111.888 -173.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.629 HD23 ' HE3' ' A' ' 129' ' ' LYS . 96.2 mt -91.31 160.1 15.67 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.774 0.797 . . . . 72.31 112.932 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -129.51 127.81 41.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.999 -1.0 . . . . 73.42 109.394 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -50.8 98.8 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.096 0.776 . . . . 73.24 113.096 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.92 13.4 11.15 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 115.311 -0.859 . . . . 45.51 113.77 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.436 ' HA ' HH11 ' A' ' 72' ' ' ARG . 46.9 p-10 -88.67 -169.01 2.38 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 117.665 0.732 . . . . 55.41 112.33 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.644 ' HG3' HG23 ' A' ' 134' ' ' VAL . 2.4 mpt_? -109.1 127.7 54.37 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.913 0.387 . . . . 72.21 111.9 -173.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.1 m -124.4 138.47 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.023 0.439 . . . . 74.24 111.33 174.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.438 ' HE3' ' HG3' ' A' ' 132' ' ' GLU . 39.8 ttmt -102.7 125.66 49.52 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.965 0.412 . . . . 52.04 110.753 177.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.48 131.17 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.361 -0.607 . . . . 62.35 109.361 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -134.17 132.23 39.55 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.319 0.58 . . . . 75.32 112.249 -172.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.704 HG22 ' HA3' ' A' ' 125' ' ' GLY . 30.7 p -138.99 -171.22 3.04 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.961 -0.563 . . . . 63.15 111.626 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.05 -18.18 65.08 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.928 -0.578 . . . . 60.2 112.01 175.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 109' ' ' ASP . 98.5 m-85 -88.0 -55.36 3.79 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.911 0.386 . . . . 63.42 111.505 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.9 -154.17 11.23 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.944 -0.646 . . . . 71.12 112.93 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.07 154.12 50.41 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.2 0.524 . . . . 65.31 111.652 178.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -151.0 145.31 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.241 -0.436 . . . . 74.3 111.036 177.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.5 t -110.31 117.73 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.808 0.337 . . . . 44.31 111.099 177.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.51 173.95 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 115.966 -0.561 . . . . 75.21 111.365 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -78.0 133.32 38.0 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.011 0.434 . . . . 72.23 111.18 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.94 126.5 33.07 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.179 0.437 . . . . 54.24 112.179 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -132.01 152.03 51.39 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.368 0.604 . . . . 74.44 110.871 175.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -90.45 121.97 32.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.66 -0.7 . . . . 65.4 111.249 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.522 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -120.59 -178.5 16.09 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.122 -0.561 . . . . 65.43 113.801 -174.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -93.66 8.87 39.24 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 122.703 0.401 . . . . 64.42 111.73 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.1 m -64.17 152.88 87.06 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.473 -0.33 . . . . 75.3 111.786 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.05 157.71 58.94 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.393 2.062 . . . . 74.43 112.21 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -64.63 142.2 58.51 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.829 0.347 . . . . 70.13 111.544 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.444 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 73.18 25.94 71.95 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.881 -0.676 . . . . 43.41 112.745 -173.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.2 ttt -154.97 136.74 14.44 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.428 -0.454 . . . . 75.03 110.278 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.2 pt -134.69 145.74 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.116 0.484 . . . . 55.43 112.264 -177.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.413 ' HA ' HG12 ' A' ' 29' ' ' ILE . 70.4 t80 -103.94 134.86 46.52 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.017 0.437 . . . . 74.13 111.379 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.656 ' O ' ' HA ' ' A' ' 30' ' ' SER . 48.3 mt -130.75 132.96 24.27 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.368 -0.378 . . . . 65.02 110.534 175.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.401 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 33.7 Cg_exo -61.65 129.05 26.43 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.058 1.839 . . . . 72.35 112.075 174.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.492 ' HE3' HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -57.73 104.8 0.2 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.029 0.443 . . . . 72.1 110.858 -176.417 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.25 -175.03 29.75 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.812 -0.708 . . . . 52.22 112.854 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.439 ' O ' ' HG2' ' A' ' 106' ' ' MET . 16.0 Cg_endo -56.56 -33.28 92.5 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.656 2.238 . . . . 65.43 112.254 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.463 ' HA ' HD11 ' A' ' 140' ' ' LEU . 37.5 m-85 -63.35 -50.97 67.89 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.092 0.472 . . . . 72.15 110.23 175.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -59.97 -41.48 92.04 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.167 -0.47 . . . . 61.04 111.801 176.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.423 HD22 ' HA ' ' A' ' 102' ' ' PRO . 91.7 m-20 -53.3 -29.16 32.01 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.15 0.426 . . . . 63.34 112.15 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.483 ' SD ' HD21 ' A' ' 140' ' ' LEU . 87.8 mmm -65.62 -24.15 66.99 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.29 -0.414 . . . . 75.25 112.112 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.5 -12.92 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 112.945 0.72 . . . . 62.03 112.945 -173.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.492 HD11 ' HE3' ' A' ' 100' ' ' MET . 6.9 pt -107.44 -179.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.868 -0.52 . . . . 63.34 111.738 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 29.4 t70 . . . . . 0 CA--C 1.543 0.684 0 CA-C-N 116.141 -0.481 . . . . 63.42 110.563 173.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.987 0 N-CA-C 113.984 0.354 . . . . 33.44 113.984 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.41 HG21 ' H ' ' A' ' 109' ' ' ASP . 58.1 t -92.93 133.73 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 122.836 0.454 . . . . 63.42 111.46 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -74.96 140.84 43.96 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.671 0.619 . . . . 74.44 112.671 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.704 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -169.62 -165.5 27.09 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.837 -0.62 . . . . 74.13 113.087 177.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 77.3 p -122.39 155.12 36.71 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.939 0.399 . . . . 70.43 111.486 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.1 p -129.88 142.77 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.657 -0.498 . . . . 62.54 109.657 173.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 8.8 pt-20 -143.21 147.65 35.21 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.251 0.834 . . . . 72.21 113.251 -174.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.629 ' HE3' HD23 ' A' ' 67' ' ' LEU . 1.8 tppp? -77.03 109.28 10.73 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.427 -0.806 . . . . 72.01 109.675 168.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.1 t -123.22 162.53 22.39 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.348 0.594 . . . . 74.34 112.456 -173.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.82 -12.14 59.78 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.397 -0.82 . . . . 71.44 111.209 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.438 ' HG3' ' HE3' ' A' ' 74' ' ' LYS . 6.2 mm-40 -61.1 160.26 10.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.684 0.754 . . . . 74.22 112.925 -176.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -95.15 160.22 14.66 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.425 -0.807 . . . . 74.11 110.917 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.644 HG23 ' HG3' ' A' ' 72' ' ' ARG . 71.9 t -72.25 136.42 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 120.733 0.302 . . . . 62.24 110.751 174.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.6 mt -73.4 132.29 42.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.544 -0.298 . . . . 73.2 111.441 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.4 t -73.15 147.83 44.45 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.208 -0.664 . . . . 73.2 109.208 170.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.422 HG23 ' HD1' ' A' ' 49' ' ' PHE . 99.3 t -46.05 -52.5 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 112.672 0.619 . . . . 70.34 112.672 -173.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -73.0 -35.41 66.82 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.04 -0.412 . . . . 73.52 111.723 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -60.9 -33.83 73.73 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.747 0.784 . . . . 72.11 110.156 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.483 HD21 ' SD ' ' A' ' 106' ' ' MET . 4.8 tt -60.37 -44.19 95.84 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.075 -0.966 . . . . 72.43 110.359 171.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.1 mt . . . . . 0 CA--C 1.538 0.488 0 CA-C-O 121.181 0.515 . . . . 71.03 110.19 177.019 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.438 ' SD ' HG21 ' A' ' 126' ' ' THR . 7.0 ptp . . . . . 0 N--CA 1.469 0.493 0 CA-C-O 120.872 0.367 . . . . 74.55 110.855 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.557 HD12 ' HG ' ' A' ' 65' ' ' LEU . 9.5 mt -104.84 127.36 52.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.028 0.442 . . . . 74.25 111.687 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -71.29 113.23 8.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.732 0.777 . . . . 71.33 111.865 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 35.3 m -134.09 157.62 41.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.71 -1.132 . . . . 73.11 111.742 -174.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 41.8 tt0 -98.74 117.88 34.21 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.905 0.383 . . . . 74.13 110.699 175.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.634 HG22 HD11 ' A' ' 96' ' ' ILE . 34.4 t -91.04 110.63 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.944 -0.571 . . . . 71.33 111.848 -173.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.51 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 2.0 mt -95.72 159.92 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 122.06 -0.4 . . . . 71.22 111.731 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.3 t -122.87 111.71 16.99 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.949 0.404 . . . . 63.1 111.245 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.728 0 C-N-CA 121.319 -0.467 . . . . 60.45 113.534 -178.766 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 120.859 0.361 . . . . 61.23 111.066 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.524 ' O ' HG22 ' A' ' 52' ' ' VAL . 8.6 t80 -59.63 -41.23 90.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.55 0.691 . . . . 74.43 109.876 174.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.437 ' HE2' ' HA ' ' A' ' 136' ' ' SER . 50.5 t80 -63.61 -65.15 0.72 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.24 -0.891 . . . . 54.25 110.554 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -58.0 -21.54 45.34 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.773 0.656 . . . . 73.44 112.773 -176.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.28 -32.19 33.32 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.031 0.752 . . . . 45.21 113.031 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 48' ' ' TYR . 32.7 m -116.93 4.88 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 113.27 0.841 . . . . 73.33 113.27 -175.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.421 HD22 ' N ' ' A' ' 53' ' ' ASN . 1.2 m-80 -94.58 28.34 2.66 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.377 0.88 . . . . 74.42 113.377 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.446 ' CE2' ' HE2' ' A' ' 87' ' ' LYS . 17.8 p90 -144.46 151.62 39.45 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.556 -0.715 . . . . 64.21 111.979 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.78 139.59 53.7 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.617 -0.72 . . . . 32.13 110.872 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.662 ' HG2' ' HE3' ' A' ' 87' ' ' LYS . 41.3 mt-10 -95.42 112.66 24.33 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.865 0.364 . . . . 73.43 111.423 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.0 mp -109.17 145.67 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.275 -0.42 . . . . 70.34 110.518 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -61.81 151.93 32.92 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.284 0.564 . . . . 52.11 111.763 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 14.8 tm-20 -55.92 -52.94 62.36 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.705 -0.679 . . . . 61.41 111.964 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -55.75 -53.24 59.03 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.325 0.491 . . . . 70.24 112.325 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -61.09 -35.98 78.46 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.629 0.728 . . . . 75.22 110.663 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.519 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 43.0 t-105 -52.78 -53.84 42.52 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.023 -0.99 . . . . 73.44 111.769 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -73.53 -30.15 62.9 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.299 -0.409 . . . . 70.31 111.644 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.439 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -58.64 -34.85 71.66 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.032 0.444 . . . . 65.1 111.581 177.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.557 ' HG ' HD12 ' A' ' 24' ' ' LEU . 82.6 mt -89.64 -13.86 36.15 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.154 -0.475 . . . . 43.24 111.461 176.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.72 44.72 19.47 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.396 -0.431 . . . . 72.04 112.825 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' A' ' 129' ' ' LYS . 92.9 mt -85.1 149.97 25.18 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.509 0.671 . . . . 72.22 112.095 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -114.61 144.96 42.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.691 -0.686 . . . . 70.15 109.213 169.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -61.33 93.37 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.017 0.913 . . . . 61.23 111.697 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.0 -7.42 3.8 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 114.612 -1.176 . . . . 43.24 113.267 -175.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -69.35 178.53 2.36 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.04 0.756 . . . . 74.41 113.04 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.2 mtm-85 -113.61 139.63 48.86 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.688 -0.687 . . . . 73.52 110.512 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.35 139.64 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.472 0.653 . . . . 73.14 112.716 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -90.38 131.29 36.24 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.427 -0.806 . . . . 72.12 110.207 172.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.9 t -119.52 125.72 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.696 -0.483 . . . . 73.1 109.696 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.459 ' HG2' ' HB3' ' A' ' 81' ' ' GLU . 25.6 mtpp -133.9 131.59 39.3 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.991 0.737 . . . . 73.3 112.991 -171.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.652 HG22 ' HA3' ' A' ' 125' ' ' GLY . 30.3 p -140.1 -176.23 4.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.529 -0.759 . . . . 71.22 110.973 178.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.78 -11.4 60.82 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.365 -0.38 . . . . 71.04 111.681 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 109' ' ' ASP . 93.8 m-85 -89.31 -40.45 12.78 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.802 0.334 . . . . 71.43 111.296 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.05 -147.26 10.24 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.144 -0.55 . . . . 43.42 112.652 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.459 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 11.2 pt-20 -155.04 154.43 32.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.143 0.497 . . . . 71.32 112.218 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.3 p -149.51 155.32 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.999 -0.546 . . . . 73.05 111.169 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.83 116.94 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 122.382 -0.198 . . . . 74.22 111.017 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.5 176.28 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 116.496 -0.32 . . . . 72.43 111.267 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -77.68 160.4 28.5 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.203 0.525 . . . . 75.44 111.405 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.11 127.2 50.47 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.243 0.544 . . . . 60.45 111.734 -173.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.662 ' HE3' ' HG2' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -131.24 129.71 41.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.877 -0.601 . . . . 55.32 111.148 -178.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -79.88 98.65 7.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.035 -0.53 . . . . 73.1 110.828 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.553 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -96.56 161.01 22.01 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.989 -0.55 . . . . 45.43 114.018 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -87.63 15.24 7.04 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.358 0.599 . . . . 62.11 111.566 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.8 m -71.12 157.35 90.45 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 115.685 -0.689 . . . . 74.2 111.421 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.6 157.67 40.74 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.732 2.288 . . . . 70.31 113.723 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -62.59 145.64 53.93 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.282 -0.417 . . . . 74.44 111.35 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 61.99 32.45 82.22 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.843 -0.694 . . . . 72.52 112.716 -174.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.484 ' HA ' ' H ' ' A' ' 27' ' ' GLU . 21.8 ttt -153.88 136.71 15.34 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.592 -0.358 . . . . 63.43 110.119 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.634 HD11 HG22 ' A' ' 28' ' ' VAL . 40.8 pt -134.84 150.9 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 121.288 0.566 . . . . 72.43 112.023 -177.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -112.13 130.9 55.74 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.016 -0.538 . . . . 61.02 111.241 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 30' ' ' SER . 50.4 mt -130.3 128.5 22.7 Favored Pre-proline 0 N--CA 1.474 0.77 0 CA-C-O 120.548 0.213 . . . . 74.11 110.998 175.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.51 140.66 89.89 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.27 1.98 . . . . 72.25 112.899 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.01 105.84 0.44 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.122 0.486 . . . . 75.0 110.815 -178.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.91 -174.71 27.96 Favored Glycine 0 N--CA 1.46 0.273 0 C-N-CA 120.784 -0.722 . . . . 71.53 112.57 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.512 ' O ' ' HG2' ' A' ' 106' ' ' MET . 26.5 Cg_endo -61.74 -26.72 80.1 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.272 1.981 . . . . 53.24 111.563 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.463 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 4.1 m-85 -69.17 -53.44 20.04 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.56 -0.745 . . . . 74.15 110.782 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -60.05 -39.78 87.16 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.268 -0.424 . . . . 43.52 110.748 174.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -54.71 -25.92 30.51 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.912 0.485 . . . . 70.25 112.042 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.645 ' SD ' HD21 ' A' ' 140' ' ' LEU . 89.9 mmm -67.28 -30.2 70.01 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.947 0.351 . . . . 73.04 111.947 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.07 -14.01 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 113.187 0.81 . . . . 54.52 113.187 -171.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 104' ' ' ALA . 8.8 pt -102.67 -178.91 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.163 0.506 . . . . 62.05 111.753 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 21.7 t70 . . . . . 0 CA--C 1.543 0.696 0 CA-C-N 116.076 -0.511 . . . . 33.43 110.475 173.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . . . . . . 0 CA--C 1.522 0.507 0 CA-C-O 120.957 0.199 . . . . 63.51 113.091 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' A' ' 108' ' ' ILE . 59.5 t -85.32 119.16 33.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.926 0.393 . . . . 71.31 111.487 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 67.5 mttm -67.46 148.88 50.95 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.245 0.545 . . . . 65.24 112.366 -177.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.652 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -177.25 -143.52 4.94 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 115.94 -0.573 . . . . 53.21 113.367 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.438 HG21 ' SD ' ' A' ' 23' ' ' MET . 76.5 p -139.3 159.98 40.88 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 122.398 -0.472 . . . . 65.24 111.769 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.7 p -144.99 145.02 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.103 0.478 . . . . 74.24 111.484 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -155.61 161.51 40.81 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.364 -0.38 . . . . 71.51 110.687 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.441 ' HB2' HD21 ' A' ' 67' ' ' LEU . 31.7 ttpt -79.91 131.15 35.78 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.755 -0.59 . . . . 75.25 110.197 173.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.7 t -118.01 156.25 28.88 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.644 0.609 . . . . 61.1 112.644 -172.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.02 -13.05 60.23 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.724 -0.671 . . . . 74.42 110.055 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -70.0 147.68 49.82 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.299 -0.864 . . . . 63.52 113.195 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.713 ' H ' ' HD3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -77.29 157.35 30.79 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.779 -1.1 . . . . 75.43 111.373 174.265 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.23 130.28 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.87 0.367 . . . . 74.35 110.826 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.1 mt -66.26 119.45 11.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 71.51 111.567 178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.437 ' HA ' ' HE2' ' A' ' 49' ' ' PHE . 29.9 t -66.27 148.44 51.85 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.596 -0.52 . . . . 74.32 109.596 168.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.505 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 62.7 t -46.26 -40.3 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 120.943 0.402 . . . . 75.22 111.583 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -72.79 -44.39 61.59 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.194 -0.457 . . . . 61.42 112.165 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -60.91 -36.03 78.21 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.672 0.749 . . . . 74.22 110.227 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.645 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.5 tt -60.65 -38.87 86.3 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.415 -0.811 . . . . 71.21 110.799 174.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 54.0 mt . . . . . 0 N--CA 1.47 0.525 0 CA-C-O 121.467 0.651 . . . . 73.22 110.063 175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.5 ptm . . . . . 0 CA--C 1.539 0.523 0 CA-C-O 120.478 0.18 . . . . 73.41 110.528 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mp -105.32 142.92 34.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.164 0.507 . . . . 64.32 112.281 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.409 ' HA ' HG22 ' A' ' 126' ' ' THR . 29.6 tt0 -81.14 112.12 18.21 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.809 -0.632 . . . . 74.3 110.898 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 33.3 m -128.09 160.19 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.809 0.338 . . . . 71.22 111.886 -174.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.701 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 86.9 tt0 -98.83 115.23 28.34 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.193 0.521 . . . . 72.55 110.594 175.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.553 HG22 HD11 ' A' ' 96' ' ' ILE . 39.5 t -88.22 113.9 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.708 -0.678 . . . . 63.21 111.751 -175.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 mt -98.0 159.8 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.569 -0.287 . . . . 74.53 111.546 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 71.5 m -126.17 106.13 9.34 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.964 0.411 . . . . 55.34 111.29 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . . . . . . 0 CA--C 1.524 0.651 0 C-N-CA 121.039 -0.6 . . . . 75.54 113.597 -176.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 121.12 0.485 . . . . 71.44 111.268 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -64.78 -32.64 74.43 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.211 -0.449 . . . . 75.43 110.675 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.478 ' HD1' HG23 ' A' ' 137' ' ' VAL . 52.8 t80 -87.19 4.92 40.54 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.161 0.505 . . . . 75.25 111.673 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -121.44 -36.32 3.09 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.753 -0.592 . . . . 44.21 111.959 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.4 -56.0 8.7 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.796 0.665 . . . . 72.21 112.796 -175.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.6 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 34.4 m -96.16 17.16 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 113.078 0.77 . . . . 65.01 113.078 -173.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.596 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -102.46 19.38 19.04 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.709 0.633 . . . . 74.22 112.709 -174.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -144.23 171.14 14.72 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.889 -0.507 . . . . 70.33 112.045 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.55 136.39 44.94 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.884 -0.598 . . . . 72.0 111.388 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.627 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 42.5 mt-10 -86.66 117.28 25.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.088 0.471 . . . . 60.34 110.7 175.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 28.1 mt -113.52 143.43 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.819 -0.628 . . . . 73.25 111.897 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -66.38 145.07 56.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.495 0.188 . . . . 73.12 110.622 174.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -62.29 -32.62 73.37 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.529 0.566 . . . . 62.34 112.529 -176.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.551 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 17.7 mm-40 -58.87 -57.44 13.05 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.213 -0.304 . . . . 54.04 111.585 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.51 -37.29 85.46 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.345 0.593 . . . . 74.2 110.64 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.496 ' HA ' HD12 ' A' ' 67' ' ' LEU . 51.5 t-105 -53.43 -52.1 60.5 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.406 -0.815 . . . . 72.55 110.991 174.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -67.1 -38.65 86.04 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.679 -0.691 . . . . 63.52 111.35 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.27 -33.91 72.99 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.236 -0.438 . . . . 65.35 112.028 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -94.78 -7.61 39.93 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.083 0.401 . . . . 73.15 112.083 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.48 48.15 76.6 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.064 -0.588 . . . . 64.52 112.634 -177.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.524 HD23 ' HD3' ' A' ' 129' ' ' LYS . 84.8 mt -86.29 142.8 28.26 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.351 0.596 . . . . 73.21 112.34 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -110.51 151.36 27.67 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.416 -0.811 . . . . 74.15 109.545 172.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.6 104.31 0.64 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.329 0.585 . . . . 72.21 111.366 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 118.5 0.02 15.95 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-N 115.652 -0.704 . . . . 73.42 113.62 -176.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -68.65 172.13 6.72 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.304 0.573 . . . . 51.43 111.868 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 133' ' ' LYS . 74.1 mtt85 -109.79 125.51 52.8 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.001 -0.545 . . . . 63.21 110.949 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.691 HG13 ' HB2' ' A' ' 86' ' ' ALA . 15.5 m -113.8 152.35 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.543 0.687 . . . . 75.21 111.844 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.432 ' HZ2' ' CG2' ' A' ' 83' ' ' VAL . 47.1 tttp -124.05 120.86 33.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.606 -0.724 . . . . 74.21 110.388 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 48.2 t -102.64 130.83 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 111.753 0.279 . . . . 61.55 111.753 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.91 127.73 53.76 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.631 -0.259 . . . . 72.12 110.748 175.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.814 HG22 ' HA3' ' A' ' 125' ' ' GLY . 25.4 p -130.81 -172.15 2.75 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.094 0.473 . . . . 73.33 111.259 177.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.77 -16.43 63.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.373 -0.376 . . . . 73.2 111.679 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -93.34 -47.07 7.07 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 111.888 0.329 . . . . 71.33 111.888 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.94 -156.95 19.98 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.879 -0.677 . . . . 52.52 113.266 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 5.2 pt-20 -133.72 161.23 35.25 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.14 0.495 . . . . 74.24 111.725 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.9 p -160.59 143.25 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.29 -0.414 . . . . 74.13 111.34 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.432 ' CG2' ' HZ2' ' A' ' 74' ' ' LYS . 45.0 t -104.03 118.97 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 122.325 -0.234 . . . . 72.42 110.761 176.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.9 m -130.14 177.68 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.853 0.359 . . . . 75.25 111.687 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -80.21 144.11 33.22 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.19 0.519 . . . . 74.23 111.674 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.691 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -93.9 120.13 33.75 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.18 0.437 . . . . 64.23 112.18 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -131.9 150.31 52.19 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.203 0.525 . . . . 74.32 110.863 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -92.14 122.81 34.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.005 -0.543 . . . . 75.41 111.068 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.627 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -120.06 172.94 15.06 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.08 -0.581 . . . . 64.42 113.487 -176.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.9 9.82 9.17 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.81 0.338 . . . . 62.31 111.861 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.1 m -64.78 152.97 89.16 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.353 -0.385 . . . . 71.15 111.67 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.18 163.57 38.73 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.803 2.335 . . . . 65.2 113.218 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.551 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 84.6 tttt -63.88 133.07 52.64 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.406 -0.361 . . . . 73.13 111.694 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 77.44 24.37 65.7 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.97 -0.633 . . . . 72.22 113.198 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.701 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 18.2 ttt -149.78 137.09 19.81 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.374 -0.486 . . . . 74.21 110.471 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.553 HD11 HG22 ' A' ' 28' ' ' VAL . 39.5 pt -130.09 144.75 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.407 0.622 . . . . 64.23 112.03 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.52 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 74.6 t80 -106.69 119.36 39.1 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.961 -0.563 . . . . 73.34 111.383 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' A' ' 30' ' ' SER . 44.4 mt -117.4 126.36 27.45 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 120.673 0.273 . . . . 70.21 110.801 175.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.6 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 19.5 Cg_endo -58.56 132.0 45.78 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.121 1.881 . . . . 75.21 111.934 175.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.9 tpp -51.51 115.42 1.61 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.17 0.51 . . . . 74.54 112.265 -176.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -169.03 178.53 42.24 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.786 -0.643 . . . . 61.35 112.496 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.494 ' O ' ' HG2' ' A' ' 106' ' ' MET . 11.9 Cg_endo -52.87 -33.8 63.01 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 122.853 2.369 . . . . 60.04 112.095 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -64.82 -47.64 77.29 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.738 -0.665 . . . . 74.23 110.608 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.501 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -64.21 -39.83 94.79 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.018 0.437 . . . . 62.43 111.197 175.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -64.03 -7.04 7.38 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.436 0.532 . . . . 63.42 112.436 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.66 ' SD ' HD21 ' A' ' 140' ' ' LEU . 95.8 mmm -82.62 -25.62 33.01 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.971 0.415 . . . . 73.21 111.311 173.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.4 m -120.98 -16.52 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 112.335 0.494 . . . . 65.44 112.335 -170.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.539 HG21 ' OG ' ' A' ' 30' ' ' SER . 5.9 pt -101.99 -178.43 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.102 0.477 . . . . 72.32 111.603 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.2 t70 . . . . . 0 CA--C 1.545 0.779 0 CA-C-N 116.356 -0.384 . . . . 75.03 110.553 173.82 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.773 0 CA-C-O 120.913 0.174 . . . . 63.24 113.292 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.9 t -93.53 120.95 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 122.398 -0.472 . . . . 74.34 111.528 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.608 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 37.3 mtpt -65.63 155.87 34.55 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.73 0.776 . . . . 72.35 113.09 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.814 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -178.85 -151.39 9.56 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 114.966 -1.016 . . . . 51.23 112.449 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.409 HG22 ' HA ' ' A' ' 25' ' ' GLU . 45.1 p -141.09 147.79 39.1 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.424 -0.457 . . . . 73.13 111.538 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.0 p -125.43 144.58 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.291 0.567 . . . . 74.43 111.904 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -153.87 168.87 24.91 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.796 -0.638 . . . . 55.44 110.561 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.524 ' HD3' HD23 ' A' ' 67' ' ' LEU . 36.8 ttpt -99.72 139.16 35.78 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.13 0.491 . . . . 74.41 111.257 174.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.9 t -131.75 161.23 33.34 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.307 0.575 . . . . 52.53 111.968 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -90.18 -2.88 58.11 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.809 -0.632 . . . . 75.41 111.039 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.67 153.28 44.06 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.98 -0.554 . . . . 64.52 111.353 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 3.2 pptp? -87.47 156.86 19.37 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.064 0.459 . . . . 72.12 111.196 176.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.23 130.73 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.11 -0.495 . . . . 71.42 111.834 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 135' ' ' LEU . 2.1 mt -61.74 101.09 0.17 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.411 -0.359 . . . . 62.42 111.223 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.3 m -52.43 143.2 15.75 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 110.783 -0.08 . . . . 65.11 110.783 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.478 HG23 ' HD1' ' A' ' 49' ' ' PHE . 68.4 t -45.88 -52.84 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 113.026 0.751 . . . . 73.42 113.026 -172.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -72.04 -39.96 68.73 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 122.101 -0.374 . . . . 74.3 111.905 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.4 ' HG2' ' CD2' ' A' ' 135' ' ' LEU . 42.3 tt0 -56.1 -36.21 67.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.622 0.725 . . . . 71.13 110.542 175.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.66 HD21 ' SD ' ' A' ' 106' ' ' MET . 3.7 tt -61.69 -40.96 96.83 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.136 -0.938 . . . . 63.34 110.5 174.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.4 mt . . . . . 0 N--CA 1.469 0.507 0 CA-C-O 121.29 0.566 . . . . 75.24 110.17 174.761 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 14.8 ptm . . . . . 0 CA--C 1.539 0.537 0 CA-C-O 120.928 0.394 . . . . 74.24 111.08 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.707 HD11 ' HB3' ' A' ' 64' ' ' ALA . 36.7 mt -127.74 148.29 50.42 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.787 0.662 . . . . 72.13 112.787 -176.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -90.85 122.02 33.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.341 -0.845 . . . . 64.44 110.219 171.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.37 157.79 37.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.727 -0.67 . . . . 73.31 112.156 -173.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.661 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 39.7 tt0 -99.93 115.2 29.1 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.233 -0.439 . . . . 74.5 109.999 172.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.53 HG22 HD11 ' A' ' 96' ' ' ILE . 51.0 t -89.03 116.13 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 115.996 -0.547 . . . . 64.22 112.014 -174.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 mt -102.43 156.67 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.967 0.413 . . . . 71.02 111.535 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 72.3 m -126.89 104.4 8.01 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.94 0.4 . . . . 52.42 111.054 175.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.553 0 C-N-CA 121.029 -0.605 . . . . 53.04 113.584 -176.083 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 121.137 0.494 . . . . 73.3 111.08 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.53 ' O ' HG22 ' A' ' 52' ' ' VAL . 5.5 t80 -64.49 -37.87 89.05 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.929 -0.578 . . . . 72.44 110.533 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.513 ' HE2' ' HA ' ' A' ' 136' ' ' SER . 47.6 t80 -62.13 -66.86 0.47 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.983 -0.553 . . . . 74.2 110.724 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -55.82 -21.77 21.38 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.797 0.666 . . . . 61.42 112.797 -175.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.68 -36.23 32.6 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.901 0.704 . . . . 44.13 112.901 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 48' ' ' TYR . 33.2 m -116.83 17.66 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 113.14 0.793 . . . . 41.3 113.14 -174.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -102.66 26.01 8.49 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.143 0.794 . . . . 72.33 113.143 -177.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -147.71 164.27 34.08 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.472 0.545 . . . . 74.53 112.472 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.24 133.83 47.7 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.817 -0.629 . . . . 64.42 110.922 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.538 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 33.2 mt-10 -88.66 121.89 31.51 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.238 0.542 . . . . 72.22 110.931 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.5 mt -118.18 149.87 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 115.637 -0.71 . . . . 71.55 111.777 -171.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -72.44 154.1 41.05 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.654 0.264 . . . . 54.22 111.176 176.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -56.46 -46.11 80.51 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.948 0.404 . . . . 75.44 111.727 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.45 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 25.6 mm-40 -56.83 -55.69 31.18 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.002 0.43 . . . . 72.53 111.581 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.64 -36.25 80.24 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.218 0.532 . . . . 64.52 111.004 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -56.51 -53.74 53.93 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.731 -0.668 . . . . 74.22 111.747 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -74.03 -28.48 61.45 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.028 0.381 . . . . 72.03 112.028 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.707 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -63.33 -32.22 73.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.02 0.438 . . . . 63.3 111.453 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.491 HD11 HG13 ' A' ' 127' ' ' VAL . 74.7 mt -91.33 -4.75 55.5 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.164 -0.471 . . . . 71.35 111.665 176.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.03 46.26 94.94 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.427 -0.416 . . . . 60.03 112.828 -177.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 129' ' ' LYS . 97.7 mt -85.32 156.48 20.89 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.428 0.899 . . . . 73.04 113.428 -175.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -127.92 145.37 50.98 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.615 -1.175 . . . . 72.12 109.0 173.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.01 100.42 0.16 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.454 0.645 . . . . 65.04 111.87 -176.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.08 -6.09 7.77 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.457 -0.792 . . . . 65.33 113.176 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -68.03 158.59 32.58 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.364 0.602 . . . . 70.41 112.072 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.5 mtm-85 -102.12 127.65 48.93 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.8 -0.636 . . . . 65.23 110.647 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.33 150.28 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.154 0.502 . . . . 72.2 112.029 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -114.49 136.99 52.4 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.257 0.551 . . . . 62.22 111.115 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 60.9 t -110.01 122.12 64.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.79 -0.641 . . . . 71.32 110.623 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -111.63 120.89 43.6 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.796 0.332 . . . . 71.05 111.505 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.748 HG22 ' HA3' ' A' ' 125' ' ' GLY . 27.6 p -122.53 -177.47 3.64 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.938 0.399 . . . . 61.43 110.902 176.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -70.69 -11.21 60.8 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.48 -0.327 . . . . 72.43 111.614 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -94.52 -48.68 6.0 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 111.749 0.277 . . . . 72.35 111.749 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -171.39 -154.31 9.72 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.577 -0.82 . . . . 74.53 113.603 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 12.2 pt-20 -154.78 141.88 19.35 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.877 0.37 . . . . 71.32 111.571 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.7 p -145.12 149.41 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 116.573 -0.285 . . . . 61.11 111.613 -178.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.49 117.38 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-O 120.527 0.203 . . . . 74.3 111.259 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.459 ' HA ' HG13 ' A' ' 134' ' ' VAL . 34.8 m -128.09 177.63 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 122.886 0.474 . . . . 70.22 111.488 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -82.62 142.85 31.41 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.044 0.449 . . . . 72.52 111.548 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.14 121.46 32.94 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.039 0.385 . . . . 73.22 112.039 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -131.6 157.65 43.1 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.166 0.508 . . . . 73.21 110.815 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -95.98 140.49 30.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.285 -0.416 . . . . 72.33 110.852 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.538 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -141.02 -174.51 14.14 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.898 -0.668 . . . . 73.51 113.71 -177.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -94.69 32.24 1.65 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.958 0.408 . . . . 45.22 111.641 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.8 m -90.6 152.46 45.12 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.461 -0.336 . . . . 75.2 111.706 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.59 163.71 33.92 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.88 2.387 . . . . 64.45 113.366 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 86.6 tttt -66.87 143.05 57.09 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.468 -0.333 . . . . 75.03 111.293 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 69.57 21.42 76.23 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.876 -0.678 . . . . 63.42 113.098 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.661 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 15.7 ttt -149.41 136.54 19.82 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.894 -0.41 . . . . 71.34 109.894 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.53 HD11 HG22 ' A' ' 28' ' ' VAL . 37.4 pt -132.21 145.36 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-O 121.371 0.605 . . . . 70.4 112.108 -177.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -102.79 129.58 49.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.853 -0.612 . . . . 65.4 111.209 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 30' ' ' SER . 28.8 mt -126.17 131.57 24.01 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 120.571 0.224 . . . . 63.32 110.68 174.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.22 126.43 22.14 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.374 2.05 . . . . 73.43 112.196 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.82 99.81 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.849 0.357 . . . . 74.41 110.634 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.87 -175.24 24.13 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.776 -0.726 . . . . 74.15 113.018 -176.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.413 ' O ' ' HG3' ' A' ' 106' ' ' MET . 29.9 Cg_endo -64.01 -26.02 66.29 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.212 1.941 . . . . 75.31 112.243 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.499 ' HA ' HD11 ' A' ' 140' ' ' LEU . 4.6 m-85 -68.9 -54.24 16.6 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.676 -0.693 . . . . 74.11 110.516 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.508 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.38 -34.13 74.82 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.925 -0.579 . . . . 73.15 110.632 175.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -60.31 -19.8 56.61 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.97 -0.559 . . . . 72.21 111.561 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.612 ' SD ' HD21 ' A' ' 140' ' ' LEU . 33.4 mtp -77.07 -28.03 54.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.797 0.332 . . . . 75.22 111.417 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.3 m -116.24 -18.11 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.048 0.759 . . . . 54.22 113.048 -171.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 104' ' ' ALA . 14.7 pt -95.14 -176.17 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 121.399 0.619 . . . . 71.43 112.375 -176.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.603 ' H ' HG21 ' A' ' 123' ' ' VAL . 24.2 t70 . . . . . 0 CA--C 1.542 0.639 0 CA-C-N 115.577 -0.738 . . . . 72.45 110.653 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.553 0 N-CA-C 112.43 -0.268 . . . . 72.41 112.43 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' H ' ' A' ' 109' ' ' ASP . 84.3 t -86.73 121.02 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 122.465 -0.433 . . . . 70.42 111.284 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 48.3 mtpt -68.76 162.42 26.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.741 0.781 . . . . 73.14 113.047 -176.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.748 ' HA3' HG22 ' A' ' 77' ' ' THR . . . 174.17 -151.65 13.31 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 114.886 -1.052 . . . . 62.42 112.587 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 65.3 p -135.9 152.46 51.04 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.87 0.367 . . . . 73.52 111.037 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.491 HG13 HD11 ' A' ' 65' ' ' LEU . 14.6 p -132.25 144.76 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.144 0.497 . . . . 50.23 111.343 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -157.64 152.99 26.06 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.773 -0.649 . . . . 55.13 110.533 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.422 ' HB2' HD21 ' A' ' 67' ' ' LEU . 32.8 ttpt -79.0 139.29 38.23 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.16 0.505 . . . . 63.11 111.133 174.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.4 t -135.8 150.56 49.49 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.122 0.487 . . . . 73.21 111.729 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -80.33 -3.13 48.28 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.337 -0.392 . . . . 71.12 110.834 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -65.37 155.08 36.48 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.985 0.422 . . . . 73.04 111.83 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -79.12 150.98 31.62 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.999 0.428 . . . . 71.44 111.605 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 84' ' ' VAL . 82.6 t -71.3 128.25 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.233 -0.439 . . . . 62.3 110.342 172.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 135' ' ' LEU . 11.0 mt -63.47 133.22 53.53 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.979 0.419 . . . . 61.52 111.858 -177.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.513 ' HA ' ' HE2' ' A' ' 49' ' ' PHE . 45.2 t -73.51 141.94 46.75 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.911 -0.403 . . . . 73.3 109.911 171.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.506 HG23 ' HD2' ' A' ' 49' ' ' PHE . 60.5 t -46.45 -46.96 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 112.744 0.646 . . . . 73.21 112.744 -174.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -72.38 -40.65 67.12 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.021 0.378 . . . . 54.34 112.021 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -64.61 -33.52 76.12 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.219 0.533 . . . . 60.12 110.534 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.612 HD21 ' SD ' ' A' ' 106' ' ' MET . 4.0 tt -56.22 -41.08 75.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.886 -0.597 . . . . 65.22 110.275 172.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.8 mt . . . . . 0 CA--C 1.537 0.463 0 CA-C-O 121.276 0.56 . . . . 71.02 110.263 176.691 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.497 ' HE2' ' HB ' ' A' ' 126' ' ' THR . 10.1 ptm . . . . . 0 CA--C 1.539 0.55 0 CA-C-O 120.961 0.41 . . . . 71.14 111.364 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.532 HD12 ' HG ' ' A' ' 65' ' ' LEU . 9.5 mt -110.3 141.37 43.39 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.971 0.415 . . . . 73.15 111.804 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -89.9 126.1 35.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.286 0.565 . . . . 74.35 111.298 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.565 HG12 ' HA2' ' A' ' 94' ' ' GLY . 35.1 m -140.95 163.0 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.546 -0.752 . . . . 74.53 111.892 -174.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 65.7 tt0 -99.18 117.74 34.34 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.962 0.411 . . . . 64.11 110.652 172.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.504 HG22 HD11 ' A' ' 96' ' ' ILE . 32.0 t -91.4 115.55 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.133 0.492 . . . . 72.52 111.714 -175.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.407 HD11 ' CE ' ' A' ' 95' ' ' MET . 1.7 mt -102.1 159.41 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.795 0.331 . . . . 74.11 110.824 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.73 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 33.7 t -150.37 132.15 15.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.73 0.3 . . . . 71.44 111.587 175.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.576 ' HA2' ' HB2' ' A' ' 100' ' ' MET . . . . . . . . 0 CA--C 1.523 0.565 0 C-N-CA 119.817 -1.182 . . . . 42.44 114.91 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 120.643 0.259 . . . . 72.11 111.364 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -60.52 -31.97 71.02 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.266 0.555 . . . . 72.12 110.674 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -78.28 -28.83 47.66 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.924 -0.58 . . . . 72.13 111.541 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -98.77 0.07 43.67 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.161 0.43 . . . . 72.13 112.161 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.23 -44.44 7.27 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.29 0.848 . . . . 73.52 113.29 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.2 m -127.19 17.93 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 114.412 1.264 . . . . 65.22 114.412 -167.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.64 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -101.06 18.01 20.89 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 121.62 -0.675 . . . . 74.41 112.135 -176.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -137.62 159.12 42.85 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.995 -0.44 . . . . 53.13 111.511 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.66 138.51 51.23 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.334 -0.394 . . . . 73.34 111.662 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.684 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 41.3 mt-10 -90.2 116.71 28.4 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.213 0.53 . . . . 54.52 111.003 177.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.607 ' HA ' HG22 ' A' ' 96' ' ' ILE . 35.8 mt -111.57 146.98 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 115.609 -0.723 . . . . 72.21 111.768 -171.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -67.1 142.95 56.93 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.94 0.4 . . . . 62.52 111.11 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -63.93 -36.53 84.24 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.792 0.664 . . . . 72.14 112.792 -175.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.55 -49.24 77.48 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.271 0.558 . . . . 50.54 110.918 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -66.72 -33.48 75.73 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.811 -0.632 . . . . 75.23 111.071 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.486 ' HA ' HD12 ' A' ' 67' ' ' LEU . 44.2 t-105 -57.05 -53.67 55.49 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.706 -0.679 . . . . 75.54 110.939 175.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -65.69 -37.15 85.68 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.977 -0.556 . . . . 60.21 111.542 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.62 -49.17 78.81 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.96 0.409 . . . . 74.14 111.848 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.532 ' HG ' HD12 ' A' ' 24' ' ' LEU . 95.0 mt -78.23 -4.51 48.12 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.319 -0.401 . . . . 55.21 111.74 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.76 45.76 93.57 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.255 -0.498 . . . . 54.25 112.761 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 62' ' ' TRP . 87.3 mt -80.75 153.39 27.83 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.153 0.501 . . . . 72.23 111.667 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -139.13 114.93 10.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.645 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -38.53 102.46 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.363 -0.835 . . . . 75.14 112.971 -171.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.6 -19.1 4.81 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 114.967 -1.015 . . . . 72.54 113.161 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -78.91 179.39 7.31 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.114 0.483 . . . . 73.31 111.958 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -107.5 134.51 50.43 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.356 0.598 . . . . 64.35 111.842 -175.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.573 HG13 ' HB2' ' A' ' 86' ' ' ALA . 14.5 m -115.97 135.99 54.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.967 -0.56 . . . . 73.15 111.164 174.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.42 ' HB3' ' HG3' ' A' ' 128' ' ' GLU . 72.3 tttt -102.17 140.14 36.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.88 -0.6 . . . . 50.33 110.584 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 41.5 t -122.43 136.2 60.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.329 -0.396 . . . . 63.04 110.084 -175.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -138.68 126.56 22.36 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.058 0.392 . . . . 61.01 112.058 -173.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.661 HG22 ' HA3' ' A' ' 125' ' ' GLY . 30.8 p -137.1 -172.18 3.13 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.235 -0.439 . . . . 72.4 110.547 176.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -65.99 -12.97 58.9 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.216 0.451 . . . . 62.41 112.216 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -91.39 -34.71 14.75 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.116 0.413 . . . . 65.01 112.116 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.69 -159.47 31.39 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.226 -0.511 . . . . 72.12 113.16 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 11.4 pt-20 -137.37 154.01 50.09 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.026 0.441 . . . . 70.32 112.098 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.443 HG23 HD12 ' A' ' 135' ' ' LEU . 11.4 p -153.06 149.36 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 116.378 -0.374 . . . . 74.44 111.445 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 36.1 t -110.36 120.09 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 122.347 -0.221 . . . . 72.34 110.878 176.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.23 173.18 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.99 0.424 . . . . 72.04 111.956 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -76.6 139.16 40.53 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.01 0.433 . . . . 72.04 111.426 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.573 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -87.32 126.12 34.65 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.887 0.699 . . . . 64.1 112.887 -177.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -130.07 148.18 51.89 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.142 0.496 . . . . 73.51 110.864 172.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -87.66 124.03 33.12 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.918 -0.583 . . . . 73.1 109.879 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -124.33 171.74 16.6 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.87 -0.681 . . . . 62.12 114.065 -173.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.72 29.58 0.38 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.872 0.469 . . . . 71.23 112.228 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.9 m -91.21 152.03 43.56 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 116.507 -0.315 . . . . 65.34 111.653 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -72.6 177.15 7.85 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.689 2.259 . . . . 51.45 113.588 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -62.94 141.35 58.75 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.022 -0.536 . . . . 62.22 111.999 -177.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 58.31 34.28 73.78 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 120.862 -0.685 . . . . 70.23 112.805 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.501 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 16.7 ttt -150.92 136.73 18.11 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.633 -0.334 . . . . 71.25 110.321 -178.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.607 HG22 ' HA ' ' A' ' 57' ' ' ILE . 36.8 pt -137.65 146.59 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.136 0.493 . . . . 74.14 111.652 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -110.08 136.74 48.85 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.942 0.401 . . . . 75.23 111.272 177.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 30' ' ' SER . 45.6 mt -126.35 133.65 25.19 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 116.326 -0.397 . . . . 73.43 110.643 174.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -52.13 141.82 47.01 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 121.904 1.736 . . . . 72.31 112.539 174.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.576 ' HB2' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -59.65 106.11 0.44 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.667 0.27 . . . . 54.24 110.976 -178.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.28 178.67 41.29 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 119.972 -1.108 . . . . 74.12 113.787 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.521 ' HA ' ' HB3' ' A' ' 105' ' ' ASN . 17.8 Cg_endo -57.98 -34.94 98.99 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.144 2.563 . . . . 74.33 112.82 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.512 ' HA ' HD11 ' A' ' 140' ' ' LEU . 53.1 m-85 -59.96 -50.14 74.94 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.109 0.481 . . . . 74.41 110.631 177.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.543 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -65.29 -37.37 86.95 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.124 -0.489 . . . . 75.15 111.017 174.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 102' ' ' PRO . 5.4 t30 -56.58 -20.09 19.15 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.763 0.425 . . . . 74.24 111.728 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.607 ' SD ' HD21 ' A' ' 140' ' ' LEU . 90.9 mmm -72.97 -24.05 60.74 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.807 0.336 . . . . 62.25 111.779 177.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.5 m -129.06 -9.03 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 113.027 0.751 . . . . 63.21 113.027 -171.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.555 HD13 ' HB3' ' A' ' 30' ' ' SER . 5.8 pt -104.91 -177.54 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.167 0.508 . . . . 75.12 111.531 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.421 ' N ' HG21 ' A' ' 123' ' ' VAL . 30.1 t70 . . . . . 0 CA--C 1.542 0.649 0 CA-C-N 116.107 -0.497 . . . . 62.12 110.916 175.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 N-CA-C 114.009 0.364 . . . . 31.32 114.009 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.421 HG21 ' N ' ' A' ' 109' ' ' ASP . 52.5 t -100.3 118.63 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.806 0.336 . . . . 61.44 111.543 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 55.5 mtmt -72.82 155.41 39.96 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.274 0.559 . . . . 75.34 112.186 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.661 ' HA3' HG22 ' A' ' 77' ' ' THR . . . 177.84 -135.0 2.57 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.782 -0.645 . . . . 65.23 112.84 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.497 ' HB ' ' HE2' ' A' ' 23' ' ' MET . 60.8 p -140.55 154.84 46.67 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.269 0.47 . . . . 52.04 112.269 -177.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.1 p -133.97 147.98 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.931 -0.577 . . . . 52.11 110.677 175.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.42 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 9.5 pt-20 -151.9 161.89 41.93 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.37 -0.377 . . . . 70.45 111.462 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.431 ' NZ ' ' HA ' ' A' ' 67' ' ' LEU . 17.6 ttmm -87.24 140.65 29.33 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 110.226 -0.287 . . . . 72.34 110.226 170.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.2 t -139.47 142.82 37.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.302 0.572 . . . . 73.22 111.864 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -75.31 -11.24 60.02 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.617 -0.72 . . . . 71.31 110.827 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -61.91 154.3 26.64 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.861 -0.609 . . . . 65.24 112.071 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -80.89 162.08 24.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.748 -0.66 . . . . 62.51 111.927 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 76.5 t -76.28 136.17 25.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.651 -0.704 . . . . 74.42 111.101 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.443 HD12 HG23 ' A' ' 82' ' ' VAL . 17.8 mt -59.65 133.58 56.23 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.502 -0.317 . . . . 72.24 111.298 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.6 t -76.76 143.77 39.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.691 -0.855 . . . . 75.11 108.691 169.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.3 t -48.26 -41.16 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.084 0.469 . . . . 41.4 111.899 -174.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -72.02 -41.6 67.36 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.026 -0.534 . . . . 64.43 111.65 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -58.52 -37.2 75.11 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.78 0.8 . . . . 71.52 110.15 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.607 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.5 tt -62.29 -38.3 88.82 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.05 -0.977 . . . . 71.41 111.033 176.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.0 mt . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 121.486 0.66 . . . . 73.14 110.056 176.077 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.2 ptp . . . . . 0 CA--C 1.539 0.551 0 CA-C-O 121.26 0.553 . . . . 71.43 112.027 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.4 mt -127.37 131.64 50.31 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.768 -0.651 . . . . 54.21 111.104 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -73.13 111.11 7.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.865 0.364 . . . . 54.35 110.849 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.475 HG12 ' HA2' ' A' ' 94' ' ' GLY . 31.1 m -127.84 159.62 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.351 -0.386 . . . . 65.13 111.964 -174.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 35.4 tt0 -98.79 118.53 35.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.884 0.373 . . . . 61.53 110.605 174.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.51 HG22 HD11 ' A' ' 96' ' ' ILE . 40.1 t -93.23 108.16 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.109 -0.496 . . . . 61.13 111.74 -175.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 mt -97.73 160.56 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.826 0.346 . . . . 72.45 111.234 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.631 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 74.3 m -136.5 100.48 4.37 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.078 0.466 . . . . 73.01 111.929 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.58 0 C-N-CA 121.049 -0.596 . . . . 51.03 112.397 178.129 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 . . . . . 0 CA--C 1.542 0.647 0 CA-C-O 120.832 0.348 . . . . 72.31 111.467 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -60.09 -36.78 78.16 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.431 0.634 . . . . 70.25 110.604 178.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.502 ' HD1' HG23 ' A' ' 137' ' ' VAL . 58.0 t80 -81.09 -7.57 59.59 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.59 -0.732 . . . . 55.2 112.046 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -118.43 2.17 11.82 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.877 -0.514 . . . . 63.13 111.814 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.09 -57.04 2.45 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.378 0.51 . . . . 73.35 112.378 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.495 HG21 ' HD2' ' A' ' 102' ' ' PRO . 34.7 m -108.33 20.48 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 112.873 0.694 . . . . 73.52 112.873 -173.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.64 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -104.08 18.48 21.96 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.66 0.615 . . . . 72.14 112.66 -172.363 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -141.55 165.13 28.33 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.223 0.535 . . . . 74.51 112.426 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.96 130.94 45.71 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.709 -0.678 . . . . 63.43 110.884 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.67 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 31.8 mt-10 -88.65 120.24 29.86 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.351 0.596 . . . . 74.51 111.638 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.1 mt -118.76 148.27 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.32 -0.855 . . . . 72.34 111.615 -170.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -75.42 142.73 42.98 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.771 0.32 . . . . 72.24 110.386 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.444 ' HA ' ' HB3' ' A' ' 62' ' ' TRP . 27.0 tt0 -56.04 -36.97 68.6 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.481 0.548 . . . . 71.24 112.481 -174.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.417 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 80.7 mm-40 -54.66 -51.63 64.87 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 111.894 0.331 . . . . 63.52 111.894 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -69.7 -36.82 76.27 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.337 0.589 . . . . 75.43 110.579 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.487 ' HA ' HD12 ' A' ' 67' ' ' LEU . 31.0 t-105 -53.22 -52.08 60.08 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.466 -0.788 . . . . 73.24 111.69 176.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -65.62 -38.87 90.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.129 -0.487 . . . . 70.31 111.296 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.37 -43.4 88.43 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.169 0.509 . . . . 73.13 111.55 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.9 mt -79.91 -1.83 41.03 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.201 -0.454 . . . . 73.54 112.038 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.93 44.9 96.71 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.435 -0.412 . . . . 35.13 112.998 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.753 HD23 ' HD3' ' A' ' 129' ' ' LYS . 67.0 mt -87.04 142.51 27.87 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.032 0.752 . . . . 74.54 113.032 -175.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -115.0 150.11 36.35 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.942 -0.762 . . . . 65.34 108.942 170.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.31 103.9 0.11 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.168 0.509 . . . . 74.25 111.898 -177.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.51 -8.34 10.23 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 115.888 -0.596 . . . . 60.03 113.783 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.67 167.54 7.2 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.618 0.723 . . . . 62.1 112.665 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -113.08 126.52 55.56 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.295 -0.866 . . . . 61.33 111.36 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.446 HG13 ' HB2' ' A' ' 86' ' ' ALA . 21.1 m -114.51 139.24 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.175 0.512 . . . . 72.12 112.054 -178.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.519 ' HG2' ' HD2' ' A' ' 76' ' ' LYS . 22.9 ttmm -103.18 111.84 24.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.072 -0.513 . . . . 60.45 110.395 177.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 47.9 t -96.68 126.25 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 116.468 -0.333 . . . . 55.41 111.523 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.568 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -117.72 139.64 50.76 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.061 0.458 . . . . 65.41 111.735 178.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.2 p -134.63 -171.9 2.89 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.402 -0.363 . . . . 42.41 110.246 173.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.23 -4.08 39.93 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 122.158 -0.339 . . . . 64.11 111.229 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -99.6 -48.33 4.78 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.714 0.293 . . . . 73.33 111.346 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.94 -158.21 19.75 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.136 -0.554 . . . . 62.1 112.779 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.568 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 8.8 pt-20 -144.68 160.22 41.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.265 0.555 . . . . 73.24 112.325 178.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.3 p -156.71 147.27 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.963 -0.562 . . . . 75.32 111.115 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.9 t -105.45 117.79 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 O-C-N 122.327 -0.233 . . . . 74.51 110.963 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 m -126.98 178.05 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.953 0.406 . . . . 70.12 111.826 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -82.43 140.17 33.57 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.023 0.439 . . . . 74.12 111.374 176.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.446 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -89.98 124.88 35.12 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.436 0.532 . . . . 70.13 112.436 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -122.57 159.04 28.6 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.279 0.561 . . . . 62.43 111.592 174.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.402 ' HD3' ' HB2' ' A' ' 59' ' ' GLU . 30.0 ttmt -99.61 114.88 28.21 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.81 -0.632 . . . . 73.34 110.282 175.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.67 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -119.82 -177.67 16.24 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.852 -0.689 . . . . 24.53 114.495 -172.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -89.26 34.43 0.8 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.209 0.603 . . . . 64.24 111.536 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.1 m -100.27 149.67 36.25 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 112.514 0.561 . . . . 74.23 112.514 -174.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.83 163.69 21.18 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.724 2.283 . . . . 74.13 112.4 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 60' ' ' GLU . 52.0 tttm -68.72 146.91 52.54 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.105 -0.372 . . . . 72.24 111.352 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.475 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 63.67 32.59 84.67 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.902 -0.666 . . . . 75.41 112.491 -174.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.449 ' HA ' ' H ' ' A' ' 27' ' ' GLU . 21.6 ttt -152.37 136.32 16.38 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.911 -0.403 . . . . 74.35 109.911 -177.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.51 HD11 HG22 ' A' ' 28' ' ' VAL . 33.6 pt -137.74 138.6 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.431 0.634 . . . . 73.04 112.322 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -100.45 129.07 46.36 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.891 -0.595 . . . . 61.54 111.039 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 30' ' ' SER . 38.9 mt -122.42 132.63 24.23 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 120.523 0.201 . . . . 72.34 110.479 174.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.417 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 31.3 Cg_exo -60.43 127.19 22.04 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.04 1.826 . . . . 74.1 111.711 173.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.408 ' HE3' ' HB3' ' A' ' 104' ' ' ALA . 6.1 tpt -54.07 111.81 0.84 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.98 0.419 . . . . 73.31 111.88 -175.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.02 -174.4 32.89 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.861 -0.685 . . . . 64.23 112.751 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.495 ' HD2' HG21 ' A' ' 52' ' ' VAL . 18.8 Cg_endo -56.54 -34.06 94.27 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.802 2.335 . . . . 71.22 112.157 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.419 ' HA ' HD11 ' A' ' 140' ' ' LEU . 46.8 m-85 -63.82 -53.82 44.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.888 -0.597 . . . . 71.32 111.059 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.505 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.58 -38.36 87.24 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.187 0.518 . . . . 50.45 111.136 175.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -57.59 -17.15 12.71 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.071 0.549 . . . . 64.11 112.454 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.571 ' SD ' HD21 ' A' ' 140' ' ' LEU . 87.5 mmm -77.19 -22.82 51.81 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.195 0.443 . . . . 72.35 112.195 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.1 m -123.23 -26.22 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 112.748 0.647 . . . . 73.45 112.748 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.547 HG21 ' OG ' ' A' ' 30' ' ' SER . 6.9 pt -84.01 179.36 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.892 0.377 . . . . 62.21 111.786 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.0 t70 . . . . . 0 CA--C 1.54 0.577 0 CA-C-N 116.522 -0.308 . . . . 64.13 111.178 178.068 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.434 0 CA-C-O 121.029 0.239 . . . . 63.13 113.381 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 66.2 t -84.53 118.7 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.816 0.341 . . . . 74.55 111.128 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 54.6 mtmt -76.01 156.01 34.43 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.575 0.703 . . . . 74.1 112.675 -176.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -177.18 -145.36 5.72 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.131 -0.94 . . . . 65.02 112.307 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 57.6 p -136.79 146.46 45.74 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.526 -0.396 . . . . 75.4 111.474 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.8 p -128.38 143.48 40.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.927 0.394 . . . . 73.13 111.153 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.52 148.29 30.05 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.319 -0.4 . . . . 73.3 110.814 176.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.753 ' HD3' HD23 ' A' ' 67' ' ' LEU . 28.7 ttpp -73.28 139.44 46.13 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.934 -0.395 . . . . 71.52 109.934 175.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.6 t -127.08 161.51 28.26 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.371 0.878 . . . . 64.34 113.371 -168.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -92.54 7.04 44.96 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.329 -0.85 . . . . 62.31 110.448 173.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -87.38 165.54 15.51 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.813 -0.63 . . . . 74.32 111.65 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.41 161.13 15.71 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.075 -0.511 . . . . 73.21 111.336 177.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 92.4 t -71.53 128.14 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.679 -0.237 . . . . 74.03 110.7 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.521 HD23 ' HA ' ' A' ' 135' ' ' LEU . 8.8 mt -65.24 88.3 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.776 0.322 . . . . 72.04 111.351 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.7 m -51.87 150.01 4.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.943 -0.572 . . . . 65.11 110.541 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.502 HG23 ' HD1' ' A' ' 49' ' ' PHE . 66.9 t -44.8 -48.78 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 113.063 0.764 . . . . 74.52 113.063 -168.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -73.1 -39.85 65.46 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.977 -0.452 . . . . 52.14 111.777 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -57.84 -36.33 72.13 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.772 0.796 . . . . 70.13 109.919 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.571 HD21 ' SD ' ' A' ' 106' ' ' MET . 3.1 tt -62.55 -42.57 99.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.851 -1.068 . . . . 73.01 110.677 174.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 50.9 mt . . . . . 0 N--CA 1.469 0.502 0 CA-C-O 121.364 0.602 . . . . 73.5 109.859 175.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.5 ptm . . . . . 0 CA--C 1.541 0.608 0 CA-C-O 120.865 0.364 . . . . 72.51 111.333 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.512 HD12 ' HG ' ' A' ' 65' ' ' LEU . 14.8 mt -96.96 132.66 42.53 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.463 0.542 . . . . 72.35 112.463 -176.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -83.06 109.75 17.4 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.313 0.578 . . . . 64.13 110.897 174.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.465 HG12 ' HA2' ' A' ' 94' ' ' GLY . 32.0 m -132.37 161.51 41.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.383 -0.826 . . . . 71.33 111.174 -174.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.662 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 33.2 tt0 -98.81 123.85 43.32 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.04 0.448 . . . . 52.11 111.174 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.43 117.13 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.913 -0.585 . . . . 65.54 111.907 -175.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 mt -103.13 163.05 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 122.24 -0.288 . . . . 73.44 111.172 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 11.7 t -131.95 120.51 22.59 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.915 0.388 . . . . 70.53 111.492 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.933 0 C-N-CA 121.093 -0.575 . . . . 64.23 113.178 -179.114 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' HD21 ' A' ' 50' ' ' ASN . 42.3 tt0 . . . . . 0 CA--C 1.536 0.432 0 CA-C-O 120.629 0.252 . . . . 65.33 111.301 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.531 ' O ' HG22 ' A' ' 52' ' ' VAL . 5.6 t80 -61.76 -35.54 78.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.284 0.564 . . . . 72.45 109.982 178.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -61.6 -68.31 0.33 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.793 -0.64 . . . . 64.31 110.793 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.466 HD21 ' HA ' ' A' ' 47' ' ' GLU . 10.1 p30 -62.53 -15.1 48.88 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.145 0.424 . . . . 73.13 112.145 -176.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' A' ' 99' ' ' PRO . . . -80.51 -48.53 12.64 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.576 0.584 . . . . 64.2 112.576 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.537 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 21.0 m -100.93 5.39 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 113.463 0.912 . . . . 71.14 113.463 -173.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.451 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -91.79 17.61 8.81 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.476 0.917 . . . . 73.25 113.476 -176.029 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -137.79 164.18 29.56 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.229 0.538 . . . . 74.32 112.158 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.77 144.23 51.11 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.652 -0.703 . . . . 62.12 110.654 173.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.721 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 86.3 mt-10 -95.32 115.67 27.74 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.603 0.24 . . . . 74.52 111.395 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.457 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.2 mp -110.24 150.89 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 120.88 0.371 . . . . 70.1 110.966 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -70.11 154.88 41.39 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.826 0.451 . . . . 62.43 111.529 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -54.37 -48.93 70.92 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.485 0.55 . . . . 70.11 112.485 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -67.23 -44.8 78.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.798 0.332 . . . . 62.55 111.747 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.407 ' HB3' HD13 ' A' ' 24' ' ' LEU . 40.9 m-20 -67.1 -36.51 82.09 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.116 0.484 . . . . 54.01 111.324 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.6 t-105 -53.13 -54.21 39.07 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.705 -0.68 . . . . 73.22 111.282 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -71.74 -28.12 63.45 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.681 -0.69 . . . . 63.21 111.818 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.21 -37.66 83.78 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.162 0.506 . . . . 74.34 111.457 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.584 HD11 HG13 ' A' ' 127' ' ' VAL . 92.4 mt -88.41 -8.19 55.4 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.254 -0.43 . . . . 70.1 111.639 177.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.4 46.99 73.69 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.071 -0.585 . . . . 72.31 112.708 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.672 HD23 ' HE3' ' A' ' 129' ' ' LYS . 79.9 mt -86.16 152.3 22.95 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.129 0.49 . . . . 73.34 111.965 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.529 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 61.3 tt0 -119.62 145.58 46.31 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.097 -0.502 . . . . 61.23 109.789 172.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -56.35 110.11 0.71 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.113 0.482 . . . . 75.22 111.741 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.88 4.03 39.35 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 115.89 -0.595 . . . . 73.11 113.274 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 68' ' ' GLN . 0.5 OUTLIER -69.85 174.16 5.53 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.579 0.585 . . . . 75.41 112.579 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -105.42 123.74 48.39 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.042 -0.526 . . . . 74.42 110.689 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' A' ' 86' ' ' ALA . 17.9 m -118.35 144.48 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.331 0.586 . . . . 61.41 112.271 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.618 ' HD2' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -96.02 137.13 35.53 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.815 -0.63 . . . . 71.3 110.374 175.396 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 61.5 t -124.98 120.72 59.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.348 -0.612 . . . . 63.24 109.348 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.406 ' HG2' ' CB ' ' A' ' 81' ' ' GLU . 4.8 mtpm? -129.88 132.15 46.32 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.098 0.475 . . . . 72.34 112.076 -171.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.726 HG22 ' HA3' ' A' ' 125' ' ' GLY . 30.8 p -135.81 -172.33 3.08 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.269 0.557 . . . . 75.32 111.072 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -72.21 -6.15 40.8 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.13 -0.486 . . . . 71.14 111.847 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -95.59 -52.6 4.05 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.789 0.328 . . . . 62.15 111.138 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.27 -162.59 27.84 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.349 -0.453 . . . . 54.44 112.7 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.618 ' HB2' ' HD2' ' A' ' 74' ' ' LYS . 0.4 OUTLIER -135.61 150.22 49.59 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.285 0.564 . . . . 65.44 112.141 178.671 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 103' ' ' TYR . 8.8 p -143.84 153.56 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 116.02 -0.536 . . . . 75.21 111.245 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.6 t -112.78 121.76 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 122.211 0.205 . . . . 75.53 110.843 177.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.409 HG12 ' CD2' ' A' ' 103' ' ' TYR . 35.0 m -132.86 172.4 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.23 0.455 . . . . 55.41 112.23 -177.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -73.67 146.1 44.76 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.074 0.464 . . . . 75.1 110.998 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.456 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -96.31 119.54 34.98 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.625 0.602 . . . . 72.21 112.625 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -124.63 152.96 42.97 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.151 0.501 . . . . 71.31 110.678 172.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -96.11 114.9 26.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.18 -0.464 . . . . 73.53 110.042 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.721 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -113.86 -161.37 14.13 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.465 -0.874 . . . . 75.12 114.773 -170.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -93.79 23.2 4.94 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.12 0.485 . . . . 55.24 111.588 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.2 m -87.36 144.66 36.18 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.19 -0.459 . . . . 61.33 112.225 -175.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.89 174.71 12.37 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.646 2.231 . . . . 54.34 113.391 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -57.53 126.12 25.92 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.963 -0.562 . . . . 53.51 111.86 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.465 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 73.31 29.21 64.56 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.171 -0.538 . . . . 63.02 114.15 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.646 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 15.0 ttt -148.8 139.82 23.01 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.383 -0.481 . . . . 73.3 110.214 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.432 HG22 ' HA ' ' A' ' 57' ' ' ILE . 40.0 pt -134.06 148.88 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.401 0.619 . . . . 65.24 112.078 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -109.06 130.25 55.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.981 -0.554 . . . . 64.13 111.54 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 30' ' ' SER . 49.5 mt -123.26 129.58 24.87 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 120.858 0.361 . . . . 73.41 110.967 174.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.537 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 50.5 Cg_exo -57.66 142.28 95.73 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.406 2.071 . . . . 65.23 112.572 175.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.2 tpt -59.44 107.05 0.52 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.173 0.511 . . . . 75.31 111.564 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.41 -176.51 38.81 Favored Glycine 0 CA--C 1.521 0.406 0 C-N-CA 120.114 -1.041 . . . . 33.33 113.612 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.517 ' HG3' HG13 ' A' ' 137' ' ' VAL . 19.5 Cg_endo -57.28 -34.64 98.2 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.034 2.489 . . . . 54.12 111.941 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.468 ' HA ' HG21 ' A' ' 82' ' ' VAL . 72.1 m-85 -61.75 -51.49 68.12 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.659 -0.7 . . . . 62.1 110.704 177.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -62.86 -36.43 83.25 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.202 -0.454 . . . . 62.4 111.152 175.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -56.68 -23.82 44.59 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.05 0.54 . . . . 72.35 111.963 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.538 ' SD ' HD21 ' A' ' 140' ' ' LEU . 86.2 mmm -74.24 -22.08 59.5 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.907 0.336 . . . . 63.31 111.907 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.5 -21.1 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 113.169 0.803 . . . . 61.22 113.169 -170.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 104' ' ' ALA . 7.0 pt -95.98 -179.42 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.282 0.563 . . . . 74.1 111.841 -177.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.446 ' H ' HG21 ' A' ' 123' ' ' VAL . 22.0 t70 . . . . . 0 CA--C 1.545 0.754 0 CA-C-N 116.029 -0.532 . . . . 73.24 111.016 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.681 0 CA-C-O 121.115 0.286 . . . . 54.25 113.669 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.446 HG21 ' H ' ' A' ' 109' ' ' ASP . 61.2 t -94.28 119.15 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 122.606 -0.35 . . . . 71.31 111.259 175.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 6.8 ttpt -66.78 152.82 44.79 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.409 0.623 . . . . 72.12 112.347 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.726 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -174.05 -144.67 4.89 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.553 -0.749 . . . . 60.11 112.635 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 65.9 p -140.97 160.23 40.51 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.488 0.315 . . . . 71.13 111.704 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.584 HG13 HD11 ' A' ' 65' ' ' LEU . 13.6 p -142.97 144.6 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 120.855 0.359 . . . . 64.01 111.311 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -154.95 165.0 38.08 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.246 0.546 . . . . 73.33 112.44 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.672 ' HE3' HD23 ' A' ' 67' ' ' LEU . 5.5 tppp? -70.51 138.77 51.32 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.107 -0.497 . . . . 74.1 111.11 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 t -144.54 149.82 36.5 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.437 0.637 . . . . 60.52 112.431 175.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -90.19 -5.55 56.29 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.609 -0.723 . . . . 64.44 111.009 176.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.41 ' CD ' ' HZ1' ' A' ' 74' ' ' LYS . 27.8 mt-10 -63.67 165.48 8.23 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.081 -0.509 . . . . 74.43 111.591 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -92.34 155.41 17.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.026 0.441 . . . . 53.52 111.095 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 99.1 t -58.9 127.74 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.237 -0.438 . . . . 73.35 110.979 173.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.37 86.83 0.83 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.717 0.294 . . . . 71.2 111.103 -178.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.5 m -44.49 141.74 1.85 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.774 -0.648 . . . . 61.22 111.908 -175.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.517 HG13 ' HG3' ' A' ' 102' ' ' PRO . 51.4 t -45.14 -50.11 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.879 0.696 . . . . 40.03 112.879 -172.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -70.5 -43.58 69.4 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.625 0.25 . . . . 75.53 111.435 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -55.14 -41.64 72.02 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.795 0.807 . . . . 72.51 110.381 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.538 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.4 tt -61.22 -37.77 84.21 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.018 -0.992 . . . . 73.52 111.351 177.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 52.2 mt . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 121.301 0.572 . . . . 75.24 110.506 177.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' MET . . . . . 0.442 ' HE2' ' HB ' ' A' ' 126' ' ' THR . 13.4 ptm . . . . . 0 CA--C 1.538 0.511 0 CA-C-O 120.637 0.256 . . . . 64.35 110.93 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 mp -117.16 148.85 41.22 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.07 0.462 . . . . 74.1 112.179 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.39 128.01 34.57 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.569 0.699 . . . . 72.41 111.45 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.465 HG12 ' HA2' ' A' ' 94' ' ' GLY . 27.4 m -140.67 162.46 23.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.337 -0.847 . . . . 62.52 110.97 -176.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.731 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 41.9 tt0 -98.88 112.46 24.55 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.122 0.487 . . . . 71.34 110.127 175.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.3 t -86.98 119.26 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.782 -0.644 . . . . 73.11 111.87 -172.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 96' ' ' ILE . 2.8 mt -103.56 154.99 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.793 0.33 . . . . 60.24 111.531 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.671 ' HB2' HG21 ' A' ' 108' ' ' ILE . 11.4 t -133.78 107.66 8.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.942 0.401 . . . . 62.45 111.077 175.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.603 0 C-N-CA 121.161 -0.542 . . . . 65.3 113.134 -177.44 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 CA--C 1.536 0.437 0 CA-C-O 121.033 0.444 . . . . 73.25 111.039 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.548 ' O ' HG22 ' A' ' 52' ' ' VAL . 4.1 t80 -59.3 -44.02 92.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.289 0.566 . . . . 65.3 109.583 176.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.508 ' HD2' HG23 ' A' ' 137' ' ' VAL . 57.8 t80 -60.44 -60.51 3.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.572 -0.74 . . . . 64.44 110.16 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -53.08 -28.42 24.99 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.884 -0.598 . . . . 74.41 112.313 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.24 -37.87 25.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.271 0.841 . . . . 44.32 113.271 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 48' ' ' TYR . 19.3 m -109.76 9.61 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 113.494 0.924 . . . . 60.24 113.494 -172.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -98.38 25.91 5.9 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.061 0.763 . . . . 54.51 113.061 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.432 ' CD1' ' HD2' ' A' ' 87' ' ' LYS . 52.8 p90 -146.5 158.56 43.91 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.012 -0.43 . . . . 64.0 111.752 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.49 139.26 51.63 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.302 -0.408 . . . . 61.54 111.484 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.673 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 42.7 mt-10 -87.68 113.15 23.09 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.219 0.533 . . . . 71.11 110.943 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.8 mt -112.44 150.71 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.561 -0.745 . . . . 75.14 111.593 -171.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.668 ' ND2' HG23 ' A' ' 91' ' ' VAL . 1.9 m120 -72.19 135.17 46.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.498 -0.319 . . . . 72.03 110.976 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 37.4 tt0 -54.18 -40.17 67.3 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.629 0.603 . . . . 61.12 112.629 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -64.14 -49.56 71.66 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.543 0.572 . . . . 60.1 112.543 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -70.42 -29.4 66.0 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.657 0.742 . . . . 71.33 110.284 177.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.514 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 32.2 t-105 -55.83 -47.54 77.05 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.169 -0.923 . . . . 75.51 110.401 172.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -65.12 -41.44 94.87 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.848 -0.615 . . . . 61.0 111.037 174.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.95 -39.27 74.24 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.164 -0.471 . . . . 73.14 111.939 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.4 mt -88.03 -12.53 44.08 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.24 -0.437 . . . . 74.43 111.782 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.89 50.59 51.95 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.193 -0.527 . . . . 53.31 112.642 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.627 HD23 ' HE3' ' A' ' 129' ' ' LYS . 86.1 mt -88.65 155.21 19.74 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.471 0.653 . . . . 72.51 112.467 -176.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -127.14 151.95 47.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.619 -0.719 . . . . 74.44 109.501 173.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -63.52 98.68 0.18 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.525 0.678 . . . . 75.04 111.762 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.13 -17.92 5.91 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.119 -0.946 . . . . 51.34 112.888 -175.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -56.48 155.69 6.93 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.314 0.578 . . . . 73.44 112.242 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -94.89 123.08 38.15 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.746 -0.661 . . . . 73.53 110.66 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 86' ' ' ALA . 31.6 m -116.5 147.38 19.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.018 0.437 . . . . 74.51 111.377 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.481 ' HB2' HG22 ' A' ' 83' ' ' VAL . 4.6 ttpm? -114.66 138.76 50.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.477 0.656 . . . . 72.2 110.969 176.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 57.7 t -116.95 134.33 60.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.45 -0.796 . . . . 73.22 109.669 -175.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -133.58 123.72 25.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.263 0.468 . . . . 70.44 112.263 -172.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.716 HG22 ' HA3' ' A' ' 125' ' ' GLY . 36.9 p -126.2 -172.26 2.58 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.209 -0.45 . . . . 70.41 110.703 174.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.63 -14.42 61.6 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.809 0.338 . . . . 74.24 111.151 175.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -84.51 -52.79 5.87 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.778 0.323 . . . . 72.33 111.376 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.08 -159.62 20.06 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.979 -0.629 . . . . 71.43 113.122 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 0.4 OUTLIER -143.61 153.16 42.24 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.034 0.445 . . . . 64.23 111.606 176.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.1 p -150.77 145.93 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.332 -0.395 . . . . 74.32 111.377 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 74' ' ' LYS . 60.9 t -107.34 118.93 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 120.532 0.206 . . . . 54.14 111.169 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.74 178.11 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 122.802 0.441 . . . . 75.41 111.576 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -81.65 146.73 29.9 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.221 0.534 . . . . 74.34 111.754 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.512 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -93.52 129.11 39.85 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.888 0.699 . . . . 75.34 112.888 -177.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.432 ' HD2' ' CD1' ' A' ' 54' ' ' TYR . 67.3 mttm -135.3 151.77 50.85 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.973 -0.558 . . . . 65.3 109.978 172.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -78.01 147.43 34.84 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.069 -0.394 . . . . 64.05 110.511 173.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.673 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -134.73 168.72 23.47 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.804 -0.712 . . . . 63.13 114.018 -175.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -89.22 23.95 2.32 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.365 0.602 . . . . 60.31 110.958 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.668 HG23 ' ND2' ' A' ' 58' ' ' ASN . 17.3 m -91.28 151.94 43.37 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 115.925 -0.579 . . . . 63.35 112.221 -175.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.19 145.57 55.04 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.098 2.532 . . . . 45.32 112.782 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -52.54 142.31 18.23 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.386 0.513 . . . . 73.24 112.386 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.465 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 71.55 25.79 74.49 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.806 -0.711 . . . . 64.04 113.195 -174.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' MET . . . . . 0.731 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 19.0 ttt -154.43 135.03 13.51 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.42 -0.459 . . . . 74.3 110.029 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.42 ' O ' HG13 ' A' ' 29' ' ' ILE . 41.8 pt -133.22 145.67 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 120.998 0.428 . . . . 74.32 112.154 -174.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -105.27 130.19 53.46 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.429 -0.351 . . . . 72.13 111.424 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.641 ' O ' ' HA ' ' A' ' 30' ' ' SER . 50.8 mt -125.31 130.34 24.17 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 120.776 0.322 . . . . 71.22 110.714 175.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.41 135.23 69.08 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.334 2.023 . . . . 62.32 112.853 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.445 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 5.1 tpt -54.14 109.7 0.51 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.262 -0.426 . . . . 70.14 111.904 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.62 -174.35 32.42 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.866 -0.683 . . . . 55.24 112.513 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.557 ' O ' ' HG2' ' A' ' 106' ' ' MET . 32.3 Cg_endo -65.11 -26.44 57.7 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.808 1.672 . . . . 74.12 111.57 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.509 ' HA ' HD11 ' A' ' 140' ' ' LEU . 4.6 m-85 -67.53 -53.85 24.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.6 -0.727 . . . . 73.1 110.496 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.526 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.43 -40.61 95.07 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.075 -0.511 . . . . 44.2 110.798 174.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -53.52 -26.89 22.89 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.308 -0.405 . . . . 63.33 111.916 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.646 ' SD ' HD21 ' A' ' 140' ' ' LEU . 83.1 mmm -64.96 -34.33 78.16 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.754 0.311 . . . . 70.01 111.835 177.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.447 ' HB ' HG23 ' A' ' 77' ' ' THR . 27.1 m -115.82 -19.88 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.846 0.684 . . . . 64.41 112.846 -168.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.671 HG21 ' HB2' ' A' ' 30' ' ' SER . 10.1 pt -90.65 -176.21 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-O 121.177 0.513 . . . . 75.24 111.962 -178.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.599 ' N ' HG21 ' A' ' 123' ' ' VAL . 18.0 t70 . . . . . 0 CA--C 1.542 0.661 0 CA-C-N 116.242 -0.435 . . . . 73.04 111.507 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.544 0 CA-C-O 121.261 0.367 . . . . 53.32 113.695 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.599 HG21 ' N ' ' A' ' 109' ' ' ASP . 62.0 t -93.82 121.29 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 112.226 0.454 . . . . 52.21 112.226 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.51 ' HD2' ' N ' ' A' ' 125' ' ' GLY . 0.3 OUTLIER -60.94 141.51 57.19 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.024 0.529 . . . . 73.1 111.923 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . 0.716 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -170.35 -147.26 5.48 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 116.221 -0.445 . . . . 63.34 113.087 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.442 ' HB ' ' HE2' ' A' ' 23' ' ' MET . 57.2 p -138.7 159.16 42.78 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.775 0.43 . . . . 72.23 111.711 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -140.39 145.61 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.906 0.384 . . . . 41.45 111.374 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.66 154.78 32.1 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.379 -0.373 . . . . 73.52 111.502 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.627 ' HE3' HD23 ' A' ' 67' ' ' LEU . 36.1 ttmt -71.33 144.38 49.94 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.505 -0.554 . . . . 65.42 109.505 168.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.448 HG21 HG13 ' A' ' 83' ' ' VAL . 6.0 t -131.98 145.66 51.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 122.05 0.928 . . . . 54.11 113.355 -176.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -77.32 -10.67 59.58 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.422 -1.263 . . . . 72.31 111.621 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -82.11 -179.94 7.59 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.478 0.656 . . . . 75.41 112.503 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -97.25 154.85 17.14 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.741 -0.663 . . . . 72.03 111.192 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.8 134.35 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.798 0.333 . . . . 64.03 110.661 172.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 21.1 mt -70.42 125.43 26.76 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.13 0.418 . . . . 75.4 112.13 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.447 ' HA ' ' HE2' ' A' ' 49' ' ' PHE . 74.0 m -65.05 149.09 50.48 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.386 -0.598 . . . . 72.44 109.386 167.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.508 HG23 ' HD2' ' A' ' 49' ' ' PHE . 94.7 t -48.61 -48.02 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 111.85 0.315 . . . . 74.24 111.85 -175.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -72.44 -37.93 68.45 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.234 -0.291 . . . . 61.05 111.574 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -55.4 -40.52 71.51 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.846 0.831 . . . . 74.51 109.518 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.646 HD21 ' SD ' ' A' ' 106' ' ' MET . 4.0 tt -58.53 -46.15 87.39 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.4 -1.273 . . . . 71.32 111.236 173.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 39.6 mt . . . . . 0 N--CA 1.474 0.733 0 CA-C-O 121.523 0.677 . . . . 70.22 110.829 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.896 0.379 . . . . 74.33 111.037 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.64 122.89 0.76 Allowed Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.173 -0.537 . . . . 55.2 113.422 178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.8 p -157.83 131.79 8.05 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.921 0.391 . . . . 63.4 111.14 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 77.9 p -162.12 132.59 4.87 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 116.398 -0.364 . . . . 41.22 110.875 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 30.0 p-80 -168.26 177.14 5.58 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.941 0.4 . . . . 72.53 111.824 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -119.87 138.62 53.3 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.313 -0.403 . . . . 71.45 111.121 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -123.21 125.6 45.4 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.841 0.353 . . . . 54.13 111.441 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -90.78 158.27 16.94 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.899 0.381 . . . . 75.12 111.336 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -123.46 87.73 2.79 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.791 -0.448 . . . . 74.11 109.791 173.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -113.32 132.78 55.44 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.329 0.585 . . . . 70.42 112.447 -174.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.1 m -135.67 -175.23 3.89 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.46 -0.791 . . . . 73.15 109.903 175.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 35.8 t -145.61 130.31 18.03 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.647 0.61 . . . . 74.23 112.647 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -84.69 106.66 2.96 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.71 -0.556 . . . . 72.41 111.71 172.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 19.6 mmm180 -120.2 137.35 54.24 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.112 0.412 . . . . 63.5 112.112 -174.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -80.99 143.82 32.27 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.196 -0.456 . . . . 64.14 110.839 174.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -157.62 121.05 4.04 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.684 0.278 . . . . 65.13 111.455 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.9 mp -105.8 135.49 47.13 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.799 0.333 . . . . 73.41 111.173 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -114.48 140.0 49.08 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.146 0.498 . . . . 74.51 111.408 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -98.64 -53.61 3.26 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.052 0.39 . . . . 62.44 112.052 -176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 57.27 87.13 0.07 Allowed 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.274 0.559 . . . . 73.23 110.539 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.95 -159.9 35.29 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.121 -0.49 . . . . 53.15 114.172 -174.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -151.96 115.07 4.7 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.9 0.48 . . . . 71.42 110.889 -178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.0 ptm -76.42 145.89 39.02 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.349 0.595 . . . . 74.03 112.435 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.528 HD12 ' HG ' ' A' ' 65' ' ' LEU . 15.1 mt -107.85 138.24 44.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.934 -0.575 . . . . 61.24 111.421 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.451 ' HA ' HG22 ' A' ' 126' ' ' THR . 33.0 tt0 -78.45 114.39 17.32 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.915 0.388 . . . . 61.13 110.781 177.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 27.4 m -127.5 159.74 37.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.18 0.514 . . . . 52.24 111.921 -176.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.725 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 57.0 tt0 -98.78 108.99 21.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.064 0.459 . . . . 63.3 110.073 175.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.428 HG22 HD11 ' A' ' 96' ' ' ILE . 33.6 t -83.59 110.32 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 115.667 -0.697 . . . . 75.13 111.611 -175.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 121' ' ' LYS . 8.3 mt -92.39 162.05 2.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.882 0.373 . . . . 70.21 111.979 -176.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.597 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 64.8 m -137.34 92.61 2.72 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.089 0.471 . . . . 73.31 111.577 175.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -94.3 133.32 11.55 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.158 -0.544 . . . . 45.3 112.362 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 32' ' ' ARG . 15.2 ttm180 -74.41 83.94 1.96 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 117.297 0.549 . . . . 70.24 112.248 -175.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.7 p -92.01 -52.29 4.78 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.168 0.508 . . . . 71.13 110.399 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -84.3 103.33 13.39 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.357 -0.608 . . . . 72.31 109.357 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -69.06 136.17 51.94 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.216 0.532 . . . . 42.44 112.23 -175.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.578 ' NE2' ' SD ' ' A' ' 100' ' ' MET . 78.8 mt-30 -91.72 -161.38 0.82 Allowed 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.613 -0.721 . . . . 74.41 112.358 -174.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' H ' ' HB3' ' A' ' 36' ' ' GLN . . . 118.79 -13.67 11.62 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.638 -0.585 . . . . 72.42 111.638 -174.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.497 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . . . -135.52 174.24 10.83 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 122.699 0.4 . . . . 63.04 111.142 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.8 p -87.86 162.01 17.19 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.846 0.355 . . . . 72.31 110.79 174.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 33.4 m -61.52 -24.72 34.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-O 120.998 0.428 . . . . 72.01 111.208 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 36.5 tt0 -72.35 -44.53 62.47 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.129 0.49 . . . . 72.11 110.644 174.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.454 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 11.6 tp10 -63.12 -33.37 75.3 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.501 0.667 . . . . 71.24 110.781 176.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.497 ' HE2' ' HB3' ' A' ' 38' ' ' ALA . 68.3 mttm -105.29 36.3 2.54 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.802 -0.635 . . . . 73.3 111.146 175.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 0.5 OUTLIER -67.32 84.68 0.16 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.281 0.563 . . . . 73.22 110.779 -179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.7 t -150.07 171.95 16.04 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.827 -0.624 . . . . 54.13 111.429 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -64.69 -27.45 68.93 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.595 -0.275 . . . . 60.13 111.649 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -53.89 -46.72 71.46 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.079 0.466 . . . . 73.43 111.022 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.435 ' HE2' ' HD2' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -68.96 -23.52 64.14 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 116.327 -0.397 . . . . 74.04 111.195 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.495 ' HD1' HG23 ' A' ' 137' ' ' VAL . 55.3 t80 -94.4 -0.49 54.8 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-O 121.046 0.451 . . . . 63.43 112.015 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -121.48 -27.63 4.75 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.604 -0.685 . . . . 65.3 112.275 175.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' A' ' 99' ' ' PRO . . . -72.5 -62.9 1.28 Allowed 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 112.35 0.5 . . . . 73.24 112.35 -176.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.469 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 30.2 m -95.49 21.26 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 112.975 0.731 . . . . 65.12 112.975 -172.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.615 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -105.01 11.13 33.77 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.317 0.858 . . . . 72.22 113.317 -172.021 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.469 ' CD2' ' HD2' ' A' ' 87' ' ' LYS . 38.0 p90 -136.18 162.22 33.57 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 112.65 0.611 . . . . 70.43 112.65 -176.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -126.83 130.0 49.38 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 115.66 -0.7 . . . . 73.14 111.004 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.592 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 43.6 mt-10 -87.38 117.55 26.23 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.167 0.508 . . . . 73.1 111.086 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 28.2 mt -112.79 142.54 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.663 -0.699 . . . . 73.52 111.501 -172.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -65.02 149.01 50.61 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.953 0.406 . . . . 73.44 111.502 178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -53.83 -49.9 67.39 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.127 -0.488 . . . . 75.24 112.186 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -56.61 -51.66 67.81 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.723 0.296 . . . . 60.34 111.731 -177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -66.08 -35.76 81.37 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.097 0.475 . . . . 74.34 110.878 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -53.22 -50.14 65.34 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.846 -0.616 . . . . 74.33 111.009 176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -71.31 -37.11 71.8 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 116.399 -0.364 . . . . 71.13 111.247 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.53 -33.0 70.84 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.189 0.44 . . . . 61.54 112.189 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.528 ' HG ' HD12 ' A' ' 24' ' ' LEU . 93.5 mt -90.2 -13.53 35.34 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.417 -0.356 . . . . 61.32 111.874 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.26 53.05 23.72 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 121.02 -0.609 . . . . 61.34 112.106 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.701 HD23 ' HE3' ' A' ' 129' ' ' LYS . 75.1 mt -92.3 137.43 32.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.499 0.666 . . . . 52.11 111.808 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -107.84 142.73 37.45 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.996 -0.547 . . . . 75.41 109.725 172.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -61.84 100.01 0.14 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.676 0.75 . . . . 74.11 110.997 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.53 -14.73 4.46 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 115.097 -0.956 . . . . 63.4 112.958 -173.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -72.13 178.64 3.72 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.67 0.748 . . . . 75.4 112.554 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.429 ' HD3' ' N ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -131.74 147.99 52.54 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.42 -0.809 . . . . 72.05 110.242 175.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.57 HG13 ' HB2' ' A' ' 86' ' ' ALA . 19.7 m -124.41 152.77 30.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.903 0.705 . . . . 65.4 112.903 -174.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -94.36 122.11 36.57 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.316 -0.856 . . . . 75.15 110.442 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.8 t -108.42 126.18 65.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.493 -0.321 . . . . 61.51 110.136 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -133.48 131.98 40.5 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 121.393 0.616 . . . . 71.43 112.586 -173.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.694 HG22 ' HA3' ' A' ' 125' ' ' GLY . 39.4 p -134.45 -171.23 2.71 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.495 -0.775 . . . . 52.42 110.603 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.69 -18.56 60.5 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.993 0.425 . . . . 75.11 110.664 175.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -80.91 -52.61 7.27 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.267 -0.424 . . . . 72.4 111.465 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.69 -150.55 7.62 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 120.781 -0.723 . . . . 55.23 113.349 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -148.49 154.39 39.76 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.77 0.319 . . . . 72.55 111.401 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.5 p -157.88 145.78 9.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-O 120.663 0.268 . . . . 45.05 111.534 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 27.5 t -102.31 116.56 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 O-C-N 122.42 -0.175 . . . . 71.13 110.637 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.0 m -125.74 166.68 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 120.901 0.381 . . . . 75.13 111.818 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -69.06 130.8 43.76 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.094 0.473 . . . . 75.41 111.452 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.57 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -81.99 120.07 24.79 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.39 -0.368 . . . . 63.3 111.813 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.469 ' HD2' ' CD2' ' A' ' 54' ' ' TYR . 67.7 mttm -132.43 157.26 45.03 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.025 0.441 . . . . 61.43 110.614 174.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -94.75 140.75 29.48 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.188 -0.46 . . . . 71.31 111.259 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.592 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -140.56 167.48 25.53 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.915 -0.66 . . . . 72.44 113.553 -177.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.93 20.98 2.84 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.19 0.519 . . . . 72.32 111.948 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.3 m -73.7 153.61 89.4 Favored Pre-proline 0 CA--C 1.543 0.691 0 CA-C-N 116.118 -0.492 . . . . 63.33 111.16 177.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.483 ' HG2' ' SD ' ' A' ' 95' ' ' MET . 35.1 Cg_endo -63.85 160.24 38.09 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.307 2.005 . . . . 64.1 112.837 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -63.86 147.29 52.24 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 121.03 0.443 . . . . 74.35 111.461 -178.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 65.76 34.57 89.15 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.02 -0.609 . . . . 61.24 112.457 -175.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.725 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 23.0 ttt -157.86 137.28 11.91 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 122.559 -0.377 . . . . 75.31 110.519 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.428 HD11 HG22 ' A' ' 28' ' ' VAL . 41.6 pt -134.81 143.95 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.05 0.452 . . . . 61.34 111.689 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -102.52 128.29 49.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.429 -0.351 . . . . 74.14 111.818 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 30' ' ' SER . 45.1 mt -124.8 133.57 24.9 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-O 120.812 0.339 . . . . 74.1 110.518 172.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.469 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 37.4 Cg_exo -59.62 130.11 33.89 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 122.228 1.952 . . . . 53.54 112.242 173.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.578 ' SD ' ' NE2' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -54.52 106.1 0.19 Allowed 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 122.668 0.387 . . . . 51.11 111.406 -176.45 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -161.64 -172.54 29.14 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.927 -0.654 . . . . 43.43 112.928 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.429 ' HD2' HG21 ' A' ' 52' ' ' VAL . 15.1 Cg_endo -56.71 -37.39 97.92 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.079 2.519 . . . . 70.33 112.676 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.449 ' HA ' HD11 ' A' ' 140' ' ' LEU . 35.9 m-85 -60.47 -52.96 62.98 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.234 -0.439 . . . . 73.4 110.732 176.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.0 -40.43 93.5 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.266 -0.425 . . . . 75.21 110.948 175.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -52.06 -26.53 11.2 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.103 0.561 . . . . 74.14 112.157 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.638 ' SD ' HD21 ' A' ' 140' ' ' LEU . 92.0 mmm -67.12 -31.76 72.44 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 111.912 0.338 . . . . 72.14 111.912 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.423 ' HB ' HG23 ' A' ' 77' ' ' THR . 27.1 m -119.55 -13.74 9.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 112.906 0.706 . . . . 71.31 112.906 -171.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.53 HG21 ' OG ' ' A' ' 30' ' ' SER . 11.6 pt -100.87 -179.59 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.138 0.494 . . . . 52.32 111.766 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . 27.0 t70 -97.85 115.63 65.74 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 116.144 -0.48 . . . . 75.12 110.615 174.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 109' ' ' ASP . 3.0 Cg_endo -82.14 4.83 6.75 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.933 2.422 . . . . 75.01 113.466 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.1 t -91.87 -29.67 16.58 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.023 0.379 . . . . 53.11 112.023 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.437 HG22 ' O ' ' A' ' 109' ' ' ASP . 8.0 t -60.68 -177.3 0.07 Allowed 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.779 0.659 . . . . 51.12 112.779 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -61.1 -27.37 68.32 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.43 0.53 . . . . 72.41 112.43 -177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 53.29 28.01 33.85 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 121.377 -0.44 . . . . 44.44 113.318 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.9 m -133.22 129.86 38.29 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.481 0.312 . . . . 71.52 111.025 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 163.84 149.18 5.66 Favored Glycine 0 CA--C 1.524 0.618 0 C-N-CA 121.282 -0.485 . . . . 32.32 112.772 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 95.7 mmm -81.63 147.2 58.63 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-O 120.817 0.341 . . . . 63.43 111.185 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -67.78 91.27 0.36 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.432 2.088 . . . . 64.24 113.496 -173.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -130.99 -56.64 1.04 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.118 -0.492 . . . . 73.11 110.522 173.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -160.34 -159.64 0.71 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.738 -0.664 . . . . 74.21 109.772 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.524 ' O ' HG23 ' A' ' 29' ' ' ILE . 7.1 tmtm? 70.84 98.1 0.07 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.156 0.503 . . . . 74.31 111.508 174.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -150.68 -180.0 26.92 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 120.743 -0.741 . . . . 73.43 113.395 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 86.9 t -85.98 123.52 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-O 120.925 0.393 . . . . 33.11 111.963 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 22.1 mmmt -61.54 148.27 42.72 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.201 0.524 . . . . 74.15 112.233 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.694 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -178.87 -151.47 9.63 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 115.946 -0.57 . . . . 61.52 113.205 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.451 HG22 ' HA ' ' A' ' 25' ' ' GLU . 56.1 p -140.84 160.39 40.15 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.466 -0.432 . . . . 70.22 111.815 -178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.1 p -142.22 145.17 24.11 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 CA-C-N 116.198 -0.455 . . . . 60.22 110.971 177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -151.08 155.58 39.26 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.503 0.557 . . . . 73.44 112.503 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.701 ' HE3' HD23 ' A' ' 67' ' ' LEU . 3.1 tppp? -72.88 124.02 24.57 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.258 -0.428 . . . . 74.24 110.945 174.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.5 t -129.93 153.85 47.93 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.09 0.471 . . . . 61.14 111.661 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -82.73 -12.69 57.37 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.064 -0.517 . . . . 44.52 110.887 176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -57.17 166.43 1.11 Allowed 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 113.928 1.084 . . . . 73.41 113.928 -175.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.661 ' H ' ' HD3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -86.46 144.14 27.42 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 114.215 -1.357 . . . . 64.44 111.16 173.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.5 t -60.37 128.98 22.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.671 -0.24 . . . . 73.44 110.474 170.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 135' ' ' LEU . 11.4 mt -61.4 109.04 1.04 Allowed 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 111.588 0.218 . . . . 64.53 111.588 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 53.5 m -58.03 145.4 36.41 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.832 -0.432 . . . . 55.33 109.832 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.495 HG23 ' HD1' ' A' ' 49' ' ' PHE . 90.8 t -45.9 -47.27 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 112.549 0.574 . . . . 64.42 112.549 -173.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -72.66 -40.39 66.36 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 122.195 -0.315 . . . . 72.14 111.751 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -58.95 -36.07 74.19 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.617 0.723 . . . . 63.44 110.215 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.638 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.8 tt -59.66 -43.58 93.9 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.064 -0.971 . . . . 74.44 110.578 173.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 32.5 mt -60.47 -44.59 95.73 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.436 0.636 . . . . 72.33 110.4 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -66.36 -33.12 75.01 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.862 -0.608 . . . . 65.11 111.018 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.63 -40.02 76.8 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.614 0.598 . . . . 60.13 112.614 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.2 -8.96 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 112.518 0.562 . . . . 63.4 112.518 -178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 133.03 -18.9 4.44 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 121.011 -0.614 . . . . 74.3 113.725 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 N--CA 1.473 0.681 0 O-C-N 122.175 -0.603 . . . . 65.52 111.403 -179.029 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.1 mtp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.81 0.338 . . . . 54.42 111.276 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.16 179.17 21.34 Favored Glycine 0 CA--C 1.529 0.952 0 CA-C-N 116.408 -0.36 . . . . 63.24 112.643 -177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.7 p -134.85 168.76 18.48 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 122.304 -0.527 . . . . 52.34 111.618 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.2 t -143.47 146.74 33.66 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.965 0.412 . . . . 71.11 111.092 177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -138.6 56.75 1.7 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.161 0.505 . . . . 74.54 110.41 177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -70.35 99.98 1.66 Allowed 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.492 0.663 . . . . 73.22 111.578 -178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -165.77 127.51 1.95 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.571 -0.74 . . . . 74.51 110.384 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -159.08 143.68 15.61 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.653 0.263 . . . . 64.23 111.13 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -81.35 -41.64 21.73 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.828 0.347 . . . . 64.4 111.085 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.1 t60 60.31 -1.57 0.2 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.276 0.843 . . . . 73.22 113.276 176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.4 p -80.5 91.49 5.76 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.949 -0.469 . . . . 62.23 111.68 -178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.2 t -168.94 96.54 0.36 Allowed 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.145 -0.479 . . . . 53.23 111.176 177.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.43 177.77 31.08 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 121.182 -0.532 . . . . 32.32 113.325 -179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -158.21 177.63 11.07 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.152 0.501 . . . . 71.24 111.561 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -110.35 154.08 24.01 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.009 -0.541 . . . . 61.41 110.103 174.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -124.34 159.8 29.52 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 113.266 0.839 . . . . 74.11 113.266 -169.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mp -104.89 139.0 40.27 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.385 -0.825 . . . . 71.2 110.702 174.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -76.98 125.53 29.46 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.2 0.524 . . . . 72.14 112.047 -176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -118.12 129.67 55.67 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.961 -0.563 . . . . 52.42 110.903 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -144.76 121.86 11.45 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.163 0.431 . . . . 72.04 112.163 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 128.76 93.05 0.72 Allowed Glycine 0 CA--C 1.526 0.73 0 CA-C-N 115.882 -0.599 . . . . 60.22 112.905 174.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -66.43 90.15 0.15 Allowed 'General case' 0 CA--C 1.539 0.519 0 O-C-N 122.575 -0.367 . . . . 74.2 111.76 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.0 ptm -65.17 140.7 58.8 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.801 0.334 . . . . 63.51 110.919 174.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.523 HD13 ' HB3' ' A' ' 61' ' ' ASP . 14.1 mt -102.25 130.35 48.9 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 112.252 0.464 . . . . 74.05 112.252 -175.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.448 ' HA ' HG22 ' A' ' 126' ' ' THR . 37.1 tt0 -75.23 114.65 13.98 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.197 -0.456 . . . . 62.53 110.273 175.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.2 m -126.19 159.94 34.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.155 -0.475 . . . . 62.14 111.756 -177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.721 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 37.4 tt0 -99.71 113.08 25.32 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.064 0.459 . . . . 71.53 110.393 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.404 HG22 HD11 ' A' ' 96' ' ' ILE . 46.1 t -88.48 119.24 35.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 115.849 -0.614 . . . . 71.03 112.182 -173.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -107.08 162.37 5.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 120.715 0.293 . . . . 74.31 111.38 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 66.0 m -131.99 106.77 8.24 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.105 0.479 . . . . 74.41 111.983 179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -92.99 111.3 4.07 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 121.149 -0.548 . . . . 40.41 112.314 177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.423 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 54.8 ttp180 -81.87 77.81 8.66 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 121.297 0.57 . . . . 75.21 111.445 -177.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.1 t -99.71 -29.12 12.83 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.939 -0.573 . . . . 54.44 111.523 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.67 HD21 ' HG2' ' A' ' 47' ' ' GLU . 2.8 tm? -83.11 -63.31 1.39 Allowed 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.222 0.534 . . . . 63.41 111.045 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 38' ' ' ALA . 17.3 p-10 -94.09 55.0 1.99 Allowed 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.178 0.436 . . . . 73.24 112.178 -176.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 32' ' ' ARG . 48.3 mt-30 -64.79 -28.24 69.44 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 112.706 0.632 . . . . 43.53 112.706 -176.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -140.26 14.27 3.02 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 120.465 -0.874 . . . . 32.22 114.45 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 35' ' ' ASN . . . -146.17 155.28 42.61 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 117.47 0.635 . . . . 71.44 112.04 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.0 p -86.01 170.68 12.05 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.378 -0.374 . . . . 73.31 111.314 175.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.3 t -57.25 -44.81 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-O 120.938 0.399 . . . . 73.21 111.692 -177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -58.61 -23.66 59.36 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 112.338 0.496 . . . . 73.52 112.338 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.5 mm-40 -80.68 -26.06 37.83 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.929 0.395 . . . . 74.32 111.744 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.441 ' HB2' ' HD2' ' A' ' 48' ' ' TYR . 27.8 mtpp -125.75 42.63 3.25 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.244 -0.434 . . . . 50.23 112.019 -172.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 95.2 mt -70.11 80.01 0.5 Allowed 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.215 0.531 . . . . 72.32 111.528 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.2 t -151.83 174.33 13.7 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.273 -0.421 . . . . 44.21 111.865 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' HG2' ' ND2' ' A' ' 50' ' ' ASN . 40.0 tt0 -55.37 -34.33 64.22 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.91 0.386 . . . . 74.32 111.733 -179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.67 ' HG2' HD21 ' A' ' 34' ' ' LEU . 33.8 tt0 -53.49 -43.3 68.1 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.008 0.432 . . . . 74.12 111.176 177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.54 ' O ' HG22 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -70.45 -36.76 74.12 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.151 0.5 . . . . 73.54 110.324 -179.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -64.89 -64.94 0.74 Allowed 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 116.012 -0.54 . . . . 73.43 111.1 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.431 ' ND2' ' HG2' ' A' ' 46' ' ' GLU . 72.0 m-20 -55.74 -17.91 7.08 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.779 0.659 . . . . 65.23 112.779 -176.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -88.4 -59.01 2.35 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.556 0.576 . . . . 64.42 112.556 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.63 HG21 ' HD2' ' A' ' 102' ' ' PRO . 20.1 m -96.71 15.33 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 N-CA-C 113.225 0.824 . . . . 74.04 113.225 -171.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -99.16 13.76 31.8 Favored 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.89 0.7 . . . . 75.0 112.89 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -138.92 164.55 29.4 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.243 0.544 . . . . 74.05 111.984 178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.63 146.39 51.85 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.723 -0.671 . . . . 74.44 110.857 175.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -97.62 110.6 23.13 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.774 0.321 . . . . 71.12 111.235 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.444 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.1 mp -110.35 141.96 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-O 120.864 0.364 . . . . 74.31 111.308 -178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -62.71 139.53 58.67 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.426 -0.352 . . . . 74.11 110.683 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 62' ' ' TRP . 31.1 tt0 -54.38 -31.85 55.77 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.485 0.55 . . . . 64.12 112.485 -177.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -60.86 -55.46 32.71 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 120.825 0.345 . . . . 73.14 111.588 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.523 ' HB3' HD13 ' A' ' 24' ' ' LEU . 29.3 m-20 -66.23 -35.66 81.0 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.509 0.671 . . . . 61.33 110.325 176.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.423 ' HB3' ' HA ' ' A' ' 59' ' ' GLU . 47.8 t-105 -53.05 -48.33 67.74 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 114.85 -1.068 . . . . 72.35 111.042 174.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -69.57 -34.82 74.72 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.841 -0.618 . . . . 73.13 111.779 178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -59.46 -52.02 67.39 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.127 0.489 . . . . 50.53 111.196 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.429 ' HG ' HD12 ' A' ' 24' ' ' LEU . 94.4 mt -75.96 -4.62 42.08 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.022 -0.535 . . . . 72.44 111.888 178.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.62 49.45 77.06 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 121.293 -0.48 . . . . 53.51 112.594 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.553 HD21 ' HB2' ' A' ' 129' ' ' LYS . 97.8 mt -86.78 161.26 18.46 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 122.015 0.912 . . . . 71.24 113.116 -175.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -136.53 151.97 49.99 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.61 -1.177 . . . . 74.11 109.452 173.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.3 mp0 -63.82 108.27 1.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.499 0.666 . . . . 74.35 111.444 -175.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 117.87 -8.33 14.72 Favored Glycine 0 CA--C 1.529 0.938 0 CA-C-N 115.295 -0.866 . . . . 72.13 113.046 -174.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -63.79 151.9 40.92 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.162 0.506 . . . . 71.5 111.992 176.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.607 HH21 ' HA ' ' A' ' 131' ' ' ASP . 25.8 mtm-85 -90.99 113.74 26.07 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.823 -0.626 . . . . 71.21 110.986 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.29 135.56 53.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-O 121.124 0.488 . . . . 74.55 111.888 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.436 ' HD3' ' HE3' ' A' ' 76' ' ' LYS . 34.6 ttmt -98.25 147.78 24.29 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.291 0.567 . . . . 74.43 111.124 174.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 57.1 t -122.27 131.77 72.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.498 -0.774 . . . . 65.24 109.427 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.436 ' HE3' ' HD3' ' A' ' 74' ' ' LYS . 20.1 mttt -125.23 125.3 43.37 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.002 0.43 . . . . 65.31 111.819 -176.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.706 HG22 ' HA3' ' A' ' 125' ' ' GLY . 25.0 p -138.37 -171.79 3.13 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 116.156 -0.474 . . . . 75.34 110.663 176.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.12 -16.63 63.13 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.925 0.393 . . . . 73.34 111.539 176.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -88.76 -21.0 24.04 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.196 0.443 . . . . 75.23 112.196 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.21 -151.46 23.73 Favored Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.266 -0.492 . . . . 73.11 112.857 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 10.3 pt-20 -144.71 149.66 35.98 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.137 0.494 . . . . 52.31 111.813 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -148.15 148.31 16.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 116.213 -0.449 . . . . 74.43 111.25 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -110.0 118.55 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 122.08 0.152 . . . . 52.34 110.843 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.461 HG12 ' HD2' ' A' ' 103' ' ' TYR . 33.9 m -128.9 178.27 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 122.699 0.399 . . . . 72.4 111.933 -177.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -83.06 146.02 28.95 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.106 0.479 . . . . 73.12 111.446 175.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -97.82 127.3 43.68 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.222 0.453 . . . . 73.1 112.222 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -129.34 142.33 50.85 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.367 0.603 . . . . 72.33 110.681 173.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -77.72 123.1 26.26 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.585 -0.734 . . . . 63.04 111.183 -176.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -126.05 165.98 19.01 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.347 -0.454 . . . . 72.33 113.507 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -85.84 15.07 5.15 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.546 0.572 . . . . 54.43 112.546 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.3 m -65.66 154.83 87.63 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 112.051 0.389 . . . . 60.43 112.051 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.99 149.54 90.3 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 122.525 2.15 . . . . 72.5 112.616 177.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -63.9 144.14 57.31 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.748 0.309 . . . . 64.55 111.532 -176.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 71.23 22.07 78.52 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 121.121 -0.561 . . . . 51.42 112.923 -174.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.721 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 23.9 ttt -154.0 136.47 15.05 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 122.495 -0.415 . . . . 72.21 109.985 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 28' ' ' VAL . 43.2 pt -134.37 150.07 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 CA-C-O 121.412 0.625 . . . . 60.41 112.313 -175.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -106.47 129.25 54.47 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.835 -0.62 . . . . 75.25 110.827 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.57 ' O ' ' HA ' ' A' ' 30' ' ' SER . 40.8 mt -124.3 132.29 24.28 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-O 120.633 0.254 . . . . 50.31 110.657 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -57.86 128.54 29.41 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.19 1.926 . . . . 64.21 112.169 173.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.76 113.33 1.43 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.829 0.347 . . . . 72.24 111.267 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.45 -169.77 27.39 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 120.686 -0.768 . . . . 64.32 112.742 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.63 ' HD2' HG21 ' A' ' 52' ' ' VAL . 31.5 Cg_endo -65.15 -27.54 56.8 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.065 1.843 . . . . 70.41 111.482 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.495 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 3.4 m-85 -68.25 -53.8 22.11 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.825 -0.625 . . . . 64.34 110.249 177.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.78 -38.12 80.98 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.016 -0.538 . . . . 75.4 110.99 174.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -54.5 -23.43 16.28 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.365 0.505 . . . . 73.43 112.365 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.515 ' HG2' ' O ' ' A' ' 102' ' ' PRO . 77.9 mmm -78.17 -12.6 60.01 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.988 0.366 . . . . 61.31 111.988 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.7 m -137.39 -13.88 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 113.088 0.773 . . . . 65.13 113.088 -173.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.546 HG21 ' OG ' ' A' ' 30' ' ' SER . 1.5 pp -105.78 172.18 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 O-C-N 122.081 -0.387 . . . . 71.42 111.206 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.442 ' N ' HG21 ' A' ' 123' ' ' VAL . 18.9 t0 -94.63 109.81 45.58 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-O 120.902 0.382 . . . . 65.21 111.981 -176.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.94 8.64 4.35 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.71 2.273 . . . . 71.44 113.375 -179.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.9 m -79.74 -6.15 56.68 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.127 0.489 . . . . 70.01 110.858 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 48.5 p -81.93 142.43 32.46 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.949 -0.569 . . . . 63.02 112.322 -175.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.95 -64.06 1.12 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.214 -0.448 . . . . 74.31 111.001 175.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 61.55 -111.45 3.9 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 116.306 -0.406 . . . . 71.41 113.522 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.8 m 70.46 -67.03 0.26 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.215 0.606 . . . . 75.15 112.563 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 117' ' ' MET . . . -91.92 131.53 10.83 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.179 -0.534 . . . . 64.11 113.519 -178.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 116' ' ' GLY . 47.7 mtt 75.71 158.02 0.16 Allowed Pre-proline 0 N--CA 1.476 0.844 0 N-CA-C 113.217 0.821 . . . . 75.13 113.217 176.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -83.4 96.21 0.79 Allowed 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.452 2.101 . . . . 73.3 112.748 -176.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -84.8 115.65 22.84 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.042 0.448 . . . . 75.12 111.33 178.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -89.38 -176.36 5.04 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.326 -0.397 . . . . 62.55 111.249 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.554 ' NZ ' ' HB2' ' A' ' 121' ' ' LYS . 0.1 OUTLIER 65.52 131.82 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.316 0.579 . . . . 72.41 111.623 -174.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -128.68 -160.94 10.5 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.137 -0.554 . . . . 70.41 113.107 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.442 HG21 ' N ' ' A' ' 109' ' ' ASP . 98.3 t -87.17 130.05 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 O-C-N 122.692 -0.299 . . . . 63.42 111.561 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -70.12 145.95 51.21 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.274 0.559 . . . . 71.01 112.241 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.706 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -173.89 -155.47 11.99 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.72 -0.673 . . . . 75.23 112.693 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.448 HG22 ' HA ' ' A' ' 25' ' ' GLU . 79.1 p -135.64 158.59 43.99 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 122.322 -0.517 . . . . 61.34 111.961 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.4 p -133.57 144.6 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 CA-C-O 121.035 0.445 . . . . 71.42 111.008 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -152.54 150.76 29.91 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.456 -0.338 . . . . 73.2 111.393 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HB2' HD21 ' A' ' 67' ' ' LEU . 29.0 ttpt -83.53 127.46 33.74 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.994 -0.441 . . . . 74.03 110.219 170.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.5 t -126.24 156.19 40.67 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.339 0.59 . . . . 73.42 112.325 -172.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.607 ' HA ' HH21 ' A' ' 72' ' ' ARG . 8.5 p-10 -82.32 -5.6 58.7 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 116.002 -0.545 . . . . 74.4 111.22 177.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -69.36 157.19 37.52 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.943 -0.571 . . . . 74.21 111.372 175.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -88.3 157.51 18.73 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 120.91 0.385 . . . . 72.12 111.37 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 91.2 t -69.31 138.26 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 116.325 -0.398 . . . . 72.41 110.951 176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 135' ' ' LEU . 14.6 mt -70.88 133.76 46.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.698 0.285 . . . . 73.3 111.464 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 44.7 t -78.42 145.72 34.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.464 -0.569 . . . . 70.42 109.464 171.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.558 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 96.5 t -46.39 -45.95 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 111.86 0.319 . . . . 63.01 111.86 -177.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.435 ' HA ' HD12 ' A' ' 141' ' ' LEU . 25.1 ttpp -71.25 -41.25 70.33 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 120.691 0.281 . . . . 72.42 111.422 179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -55.91 -37.03 68.36 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.918 0.866 . . . . 62.44 109.611 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.487 HD11 ' HA ' ' A' ' 103' ' ' TYR . 1.0 OUTLIER -68.85 -38.39 79.74 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.528 -1.215 . . . . 74.34 111.002 176.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 53.9 mt -59.25 -49.51 77.55 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.609 0.718 . . . . 74.21 110.227 176.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -65.29 -30.04 70.86 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.017 -0.992 . . . . 72.32 111.317 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -68.28 -51.37 45.71 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 111.963 0.357 . . . . 63.13 111.963 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.402 HD12 ' N ' ' A' ' 146' ' ' SER . 2.9 pp -75.59 -22.44 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 N-CA-C 112.139 0.422 . . . . 74.1 112.139 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 122.76 -64.73 0.52 Allowed Glycine 0 CA--C 1.526 0.759 0 C-N-CA 121.251 -0.5 . . . . 64.41 113.088 177.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.402 ' N ' HD12 ' A' ' 144' ' ' ILE . 48.9 m . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 120.924 0.392 . . . . 60.11 111.657 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.0 mtm . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.656 0.265 . . . . 75.34 111.282 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.24 39.19 3.33 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 121.27 -0.49 . . . . 75.33 113.308 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 87.1 p -86.15 -70.27 0.61 Allowed 'General case' 0 N--CA 1.472 0.638 0 O-C-N 122.509 -0.406 . . . . 74.3 111.606 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.0 t -91.81 -51.98 4.96 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.974 0.416 . . . . 63.25 110.978 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.1 t-80 -65.69 90.76 0.12 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.121 0.486 . . . . 73.53 110.768 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -74.9 126.37 30.83 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.858 -0.61 . . . . 73.22 111.369 -177.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -125.26 123.47 39.59 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.947 -0.57 . . . . 70.44 109.984 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -54.1 140.74 30.98 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.883 0.373 . . . . 72.43 111.267 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -74.24 70.11 1.61 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 112.557 0.577 . . . . 64.2 112.557 -169.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -90.26 -69.64 0.71 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.147 0.499 . . . . 73.53 110.045 175.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.1 p -108.66 -36.63 6.12 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.228 0.537 . . . . 63.41 110.401 173.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.9 t -141.1 -170.62 3.09 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.694 -0.684 . . . . 61.33 111.139 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.0 -44.48 0.74 Allowed Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.55 -1.02 . . . . 44.23 110.55 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 21.2 ttt180 -165.38 112.8 0.97 Allowed 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 108.871 -0.789 . . . . 71.4 108.871 170.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 15' ' ' GLU . 0.8 OUTLIER -70.03 -17.96 63.28 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.133 1.16 . . . . 74.23 114.133 -167.599 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -78.44 102.8 7.99 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.153 0.427 . . . . 64.4 112.153 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -120.14 -179.61 3.99 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.524 0.678 . . . . 72.42 112.281 177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -130.32 147.87 52.08 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.562 -0.745 . . . . 73.25 111.064 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -130.47 -179.27 5.17 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.087 0.402 . . . . 64.5 112.087 -175.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -148.5 163.92 35.75 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.994 0.425 . . . . 72.11 112.121 -177.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.22 142.99 11.57 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 121.388 -0.434 . . . . 72.02 113.876 175.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -148.93 89.91 1.71 Allowed 'General case' 0 CA--C 1.541 0.612 0 O-C-N 122.579 -0.365 . . . . 42.14 111.243 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 10.4 ptm -77.85 166.01 23.43 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.757 0.313 . . . . 73.24 111.304 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.545 HD12 ' HG ' ' A' ' 65' ' ' LEU . 17.1 mt -118.05 133.83 55.54 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 112.648 0.61 . . . . 75.24 112.648 -178.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -79.57 119.08 22.04 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.941 -0.572 . . . . 33.51 110.2 173.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.2 m -133.87 161.3 41.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 120.953 0.406 . . . . 72.13 111.91 -175.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 31.5 tt0 -99.22 113.43 25.69 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.946 0.403 . . . . 74.12 110.373 174.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.489 HG22 HD11 ' A' ' 96' ' ' ILE . 45.4 t -89.65 112.93 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 121.231 0.539 . . . . 65.05 111.861 -173.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.7 mt -97.31 159.36 3.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.923 0.392 . . . . 75.41 111.745 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.609 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 75.2 m -135.43 104.65 5.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.085 0.469 . . . . 74.14 111.303 175.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -81.8 119.09 4.77 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.963 -0.636 . . . . 62.31 112.372 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -62.3 94.9 0.06 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.738 0.78 . . . . 73.33 111.825 -178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.565 HG23 HD23 ' A' ' 34' ' ' LEU . 5.0 t -127.04 -175.38 3.41 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.978 -1.01 . . . . 71.2 109.926 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.711 HD21 ' HB1' ' A' ' 51' ' ' ALA . 4.2 mm? 61.88 28.89 17.67 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 111.755 0.28 . . . . 72.41 111.755 -177.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 6.6 t30 72.64 89.21 0.1 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.48 0.712 . . . . 53.14 112.395 179.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 60.13 -80.71 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.604 0.762 . . . . 74.13 112.083 176.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 177.19 54.11 0.07 OUTLIER Glycine 0 CA--C 1.528 0.867 0 CA-C-N 115.709 -0.678 . . . . 72.04 112.883 -175.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.88 154.59 29.62 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.647 0.26 . . . . 42.12 111.358 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.7 p -68.81 171.33 8.05 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.135 0.493 . . . . 72.34 111.206 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.675 HG21 HD11 ' A' ' 141' ' ' LEU . 17.7 m -63.76 -26.47 40.71 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 116.505 -0.316 . . . . 74.22 111.555 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -69.45 -38.0 77.6 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 111.993 0.368 . . . . 71.03 111.993 -178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.81 -36.12 67.08 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.816 0.341 . . . . 65.04 111.261 176.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.523 ' HZ1' HD12 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -131.12 51.67 2.12 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.103 0.478 . . . . 62.45 111.321 177.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.82 83.25 0.91 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.301 0.572 . . . . 72.51 110.045 179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.423 HG23 ' HB2' ' A' ' 47' ' ' GLU . 2.7 t -152.74 169.29 23.11 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.716 -0.675 . . . . 64.12 111.579 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -53.93 -32.92 55.21 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.175 0.512 . . . . 64.43 111.389 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.423 ' HB2' HG23 ' A' ' 45' ' ' THR . 20.4 mm-40 -53.61 -42.89 68.17 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.213 0.53 . . . . 73.21 111.34 176.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -65.1 -27.4 68.73 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.915 -0.584 . . . . 74.15 110.494 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -83.25 -9.18 59.27 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.941 -0.572 . . . . 73.31 111.745 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -116.89 -0.49 12.23 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-O 120.948 0.404 . . . . 70.32 111.64 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.711 ' HB1' HD21 ' A' ' 34' ' ' LEU . . . -95.81 -52.34 4.12 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.867 0.691 . . . . 71.34 112.867 -177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.464 HG21 ' HD2' ' A' ' 102' ' ' PRO . 35.5 m -116.35 19.86 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 113.445 0.906 . . . . 31.3 113.445 -172.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.654 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -100.73 18.57 19.03 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 112.898 0.703 . . . . 74.41 112.898 -171.478 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.462 ' CD1' ' HD2' ' A' ' 87' ' ' LYS . 47.1 p90 -144.6 165.58 27.6 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.462 0.542 . . . . 75.04 112.462 -174.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -132.32 142.51 49.37 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.623 -0.717 . . . . 73.55 110.685 176.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 87' ' ' LYS . 44.5 mt-10 -101.04 118.48 37.08 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.938 0.399 . . . . 75.23 111.475 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.497 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.8 mp -110.55 152.12 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-N 116.179 -0.464 . . . . 61.21 111.302 -177.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -68.44 153.77 43.12 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 122.671 0.388 . . . . 74.21 111.347 177.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -57.67 -46.33 84.39 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 121.115 0.483 . . . . 75.24 112.096 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.92 -47.9 82.87 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.79 0.329 . . . . 65.1 111.694 -178.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -65.84 -35.92 82.01 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.199 0.524 . . . . 75.05 111.165 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.424 ' HZ2' ' N ' ' A' ' 69' ' ' GLU . 40.4 t-105 -55.55 -54.05 48.86 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.78 -0.645 . . . . 75.11 110.919 176.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -64.61 -33.83 76.85 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.048 -0.524 . . . . 71.33 111.475 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.511 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -60.15 -43.8 95.47 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.912 0.387 . . . . 32.3 111.947 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.642 HD11 HG13 ' A' ' 127' ' ' VAL . 93.4 mt -84.6 -9.25 58.46 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.001 0.371 . . . . 60.45 112.001 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 68.3 45.68 68.49 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.117 -0.563 . . . . 75.51 112.637 -177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.66 HD23 ' HE2' ' A' ' 129' ' ' LYS . 74.0 mt -83.37 166.63 18.26 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.385 0.612 . . . . 55.5 112.071 -177.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -147.25 121.39 9.49 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.853 -0.612 . . . . 71.51 109.898 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.424 ' N ' ' HZ2' ' A' ' 62' ' ' TRP . 43.0 mt-10 -44.52 98.62 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.283 0.846 . . . . 74.21 113.283 -169.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.79 -4.24 8.56 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-N 115.084 -0.962 . . . . 75.32 113.735 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -80.02 -176.61 5.59 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 117.8 0.8 . . . . 63.22 112.05 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.487 ' HG3' HG23 ' A' ' 134' ' ' VAL . 8.8 mpt_? -107.19 123.61 48.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.125 -0.489 . . . . 61.34 111.813 -176.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.3 m -115.42 145.04 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-O 121.307 0.575 . . . . 64.3 111.516 175.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.78 ' HD3' ' HE3' ' A' ' 76' ' ' LYS . 24.0 ttmm -108.73 146.99 32.65 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.813 -0.63 . . . . 73.23 110.534 178.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 64.5 t -130.55 129.57 64.49 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 116.269 -0.423 . . . . 62.22 110.704 -175.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.78 ' HE3' ' HD3' ' A' ' 74' ' ' LYS . 38.7 mttt -130.94 125.54 33.7 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.929 0.395 . . . . 75.13 112.058 -175.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.668 HG22 ' HA3' ' A' ' 125' ' ' GLY . 42.6 p -126.45 -171.06 2.31 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 116.507 -0.315 . . . . 62.35 110.557 177.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.63 -6.46 52.12 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.901 0.382 . . . . 63.13 111.528 175.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -91.98 -60.78 1.77 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 120.869 0.366 . . . . 72.03 110.776 177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -163.33 -144.45 4.03 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.221 -0.514 . . . . 73.25 112.796 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 0.3 OUTLIER -154.52 159.28 40.86 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 117.12 0.46 . . . . 52.43 111.204 178.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 106' ' ' MET . 8.8 p -157.46 144.45 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 111.928 0.344 . . . . 62.42 111.928 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.8 t -105.54 118.52 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 122.48 0.312 . . . . 71.13 110.587 174.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.49 HG12 ' HD2' ' A' ' 103' ' ' TYR . 35.3 m -128.18 176.5 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 120.996 0.427 . . . . 72.44 112.06 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -79.49 140.98 37.13 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.976 0.417 . . . . 73.44 111.34 176.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.8 126.16 36.78 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.758 0.651 . . . . 63.24 112.758 -177.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 62.3 mttm -126.84 143.71 51.18 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.199 0.523 . . . . 74.4 110.901 173.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -88.78 121.36 31.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.973 -0.558 . . . . 74.03 110.573 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -125.4 -179.62 15.8 Favored Glycine 0 CA--C 1.525 0.708 0 C-N-CA 120.711 -0.757 . . . . 73.35 114.21 -174.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -90.66 18.9 5.85 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.958 0.409 . . . . 70.43 111.353 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.1 m -72.49 151.83 91.76 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.251 -0.431 . . . . 71.53 111.896 -178.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -62.04 160.57 29.47 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 122.755 2.303 . . . . 74.45 113.61 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -69.0 138.76 54.78 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.824 0.345 . . . . 73.11 111.453 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 68.06 26.59 73.98 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 120.968 -0.634 . . . . 61.33 112.298 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.528 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 23.5 ttt -149.8 136.61 19.4 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 122.653 -0.322 . . . . 73.54 110.297 -177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.489 HD11 HG22 ' A' ' 28' ' ' VAL . 39.8 pt -135.25 146.81 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 121.263 0.554 . . . . 71.24 111.851 -177.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -106.17 130.15 54.1 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.177 -0.465 . . . . 73.24 111.564 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 30' ' ' SER . 44.9 mt -124.32 132.06 24.26 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-O 120.753 0.311 . . . . 72.14 110.629 173.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.425 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 37.6 Cg_exo -58.91 131.88 44.35 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 122.229 1.953 . . . . 73.3 112.368 173.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.7 tpt -51.39 107.94 0.22 Allowed 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 111.906 0.335 . . . . 65.45 111.906 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.14 -176.84 38.37 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.574 -0.822 . . . . 61.54 113.413 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.464 ' HD2' HG21 ' A' ' 52' ' ' VAL . 15.2 Cg_endo -55.92 -35.44 94.18 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.169 2.579 . . . . 72.45 112.952 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.49 ' HD2' HG12 ' A' ' 84' ' ' VAL . 30.7 m-85 -61.87 -51.56 67.7 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.057 0.456 . . . . 74.22 110.634 177.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -62.0 -38.3 88.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 121.099 0.476 . . . . 54.35 111.04 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -54.55 -26.17 30.45 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 122.898 0.479 . . . . 75.41 112.006 178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.584 ' SD ' HD21 ' A' ' 140' ' ' LEU . 84.9 mmm -69.54 -16.78 63.5 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 112.347 0.499 . . . . 73.25 112.347 178.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 31.2 m -131.84 -19.03 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 N-CA-C 113.472 0.916 . . . . 73.35 113.472 -174.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.583 HG21 ' OG ' ' A' ' 30' ' ' SER . 8.0 pt -98.5 179.96 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 112.852 0.686 . . . . 75.14 112.852 -175.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -104.2 117.5 59.24 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 115.874 -0.603 . . . . 72.34 111.03 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -84.49 9.2 4.23 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.832 2.355 . . . . 71.0 113.959 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.9 m -83.04 32.75 0.44 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-O 120.844 0.354 . . . . 71.01 111.728 -177.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 82.7 p -79.12 2.11 21.98 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.389 0.885 . . . . 72.41 113.389 -171.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -70.82 135.28 48.0 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.146 0.498 . . . . 64.03 112.199 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 87.63 9.74 71.42 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-N 116.178 -0.465 . . . . 65.44 113.555 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 36.5 p -102.1 144.03 31.18 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.211 -0.581 . . . . 43.31 111.797 -178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -114.45 132.2 10.32 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 116.071 -0.513 . . . . 55.23 112.088 175.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 90.3 mmm 67.15 134.41 0.04 OUTLIER Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 122.915 0.486 . . . . 73.4 111.623 -175.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.54 -39.86 0.12 Allowed 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.668 2.245 . . . . 73.4 113.921 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' A' ' 120' ' ' PHE . 39.4 tt0 65.95 150.81 0.05 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.098 0.559 . . . . 55.14 111.435 -174.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.43 ' N ' ' HG2' ' A' ' 119' ' ' GLN . 93.3 m-85 -74.84 77.73 2.12 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 121.972 -0.455 . . . . 64.51 112.043 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.09 164.56 38.26 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.014 0.435 . . . . 75.1 111.116 172.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -144.95 -175.92 18.51 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.049 -0.596 . . . . 71.01 112.928 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 93.5 t -80.12 118.08 27.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 O-C-N 122.533 -0.392 . . . . 72.34 111.07 177.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 39.3 mtpt -67.31 155.55 38.63 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 121.657 0.741 . . . . 71.12 112.913 -177.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.668 ' HA3' HG22 ' A' ' 77' ' ' THR . . . 179.68 -147.85 7.75 Favored Glycine 0 CA--C 1.525 0.7 0 CA-C-N 115.055 -0.975 . . . . 72.43 112.144 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 45.1 p -138.51 153.3 48.75 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 122.292 -0.534 . . . . 72.42 111.757 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.642 HG13 HD11 ' A' ' 65' ' ' LEU . 14.8 p -128.11 145.24 35.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 116.138 -0.483 . . . . 61.3 110.254 175.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 7.3 pt-20 -148.69 151.31 34.7 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.81 0.67 . . . . 74.31 112.81 -176.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.66 ' HE2' HD23 ' A' ' 67' ' ' LEU . 14.5 tppt? -69.51 106.38 2.97 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.535 -0.757 . . . . 63.44 109.966 167.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.1 t -100.8 161.8 13.35 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.451 0.643 . . . . 70.01 112.34 -176.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -100.53 0.7 39.98 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.554 -0.748 . . . . 71.54 110.62 177.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -88.39 179.52 6.31 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.07 0.767 . . . . 74.3 113.07 -177.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -100.26 161.61 13.49 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.292 -0.867 . . . . 71.22 111.609 177.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.487 HG23 ' HG3' ' A' ' 72' ' ' ARG . 93.3 t -70.1 137.64 23.62 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 120.771 0.32 . . . . 64.34 111.56 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 135' ' ' LEU . 6.5 mt -77.81 98.04 5.43 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.679 -0.237 . . . . 70.24 111.219 176.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 70.9 p -55.19 153.68 6.59 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.696 0.284 . . . . 75.13 111.45 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.559 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 86.8 t -45.8 -53.73 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 112.971 0.73 . . . . 74.35 112.971 -172.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -72.35 -42.0 65.82 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.23 0.456 . . . . 73.34 112.23 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -56.51 -39.99 74.26 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.564 0.697 . . . . 60.21 109.977 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.584 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.3 tt -60.58 -41.62 95.05 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 115.071 -0.968 . . . . 64.21 110.772 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.675 HD11 HG21 ' A' ' 40' ' ' VAL . 68.3 mt -58.59 -55.23 37.69 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.173 0.511 . . . . 70.32 110.818 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -64.72 -30.96 71.98 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.815 -0.63 . . . . 70.44 111.432 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.1 -52.44 64.89 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 116.349 -0.387 . . . . 70.11 111.634 176.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 146' ' ' SER . 2.9 pp -81.49 -18.1 11.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 112.333 0.494 . . . . 74.31 112.333 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 119.39 -68.28 0.37 Allowed Glycine 0 CA--C 1.524 0.649 0 C-N-CA 121.336 -0.459 . . . . 63.23 113.062 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.413 ' N ' HD12 ' A' ' 144' ' ' ILE . 49.4 m . . . . . 0 N--CA 1.472 0.672 0 CA-C-O 121.048 0.451 . . . . 73.42 111.503 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.482 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.761 0.315 . . . . 74.13 111.101 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.07 124.71 0.82 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 121.33 -0.462 . . . . 32.13 112.41 -178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 79.9 p -103.29 114.7 29.19 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.086 0.443 . . . . 72.23 112.169 -175.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 58.1 m -99.57 -179.26 4.15 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.302 -0.408 . . . . 75.31 110.259 172.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -152.53 153.43 33.44 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.503 0.557 . . . . 63.52 112.503 -176.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 28.2 p-80 -155.7 138.73 15.45 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.572 -0.74 . . . . 63.01 110.783 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -160.91 142.49 12.04 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.221 0.209 . . . . 70.12 110.5 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.1 p80 -163.7 141.33 7.36 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.477 0.917 . . . . 73.31 113.477 -174.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -120.95 167.7 12.29 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.927 -0.579 . . . . 63.35 109.679 169.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -149.54 138.56 21.2 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.857 0.36 . . . . 73.35 111.954 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.6 m -107.71 142.56 37.52 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 116.385 -0.37 . . . . 72.0 110.826 177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 92.2 p -140.97 132.78 27.44 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 120.742 0.306 . . . . 65.24 111.261 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.95 138.83 2.51 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.445 -0.884 . . . . 43.44 114.049 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -134.04 126.5 30.31 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.771 0.428 . . . . 75.32 110.356 174.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.1 mm-40 -82.3 167.38 18.64 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.085 0.402 . . . . 75.13 112.085 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -51.02 131.41 26.99 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.589 0.589 . . . . 75.43 112.589 -178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 17' ' ' LEU . 3.2 mm? -90.21 129.11 36.5 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.863 -0.608 . . . . 51.32 111.239 178.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 56.39 -163.06 0.17 Allowed 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.894 0.701 . . . . 74.22 112.894 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -117.36 -175.03 2.72 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.264 -0.425 . . . . 74.12 111.354 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -95.12 158.53 15.42 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.158 0.504 . . . . 72.44 112.091 178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 144.92 -147.05 18.0 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.903 -0.665 . . . . 44.15 113.725 172.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -151.8 117.62 5.46 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.717 0.294 . . . . 64.25 111.721 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 8.8 ptm -88.62 139.55 30.36 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.926 0.393 . . . . 72.34 110.769 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.581 HD11 ' HB3' ' A' ' 64' ' ' ALA . 32.6 mt -90.53 132.13 35.87 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.831 0.678 . . . . 74.24 112.831 -173.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -78.74 118.56 20.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.52 -0.764 . . . . 61.45 111.04 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 35.4 m -139.32 164.38 24.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 114.992 -1.004 . . . . 75.12 112.027 -173.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 34.8 tt0 -99.47 121.85 41.73 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.858 0.361 . . . . 42.32 110.435 171.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.478 HG22 HD11 ' A' ' 96' ' ' ILE . 39.3 t -96.42 110.2 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.258 -0.428 . . . . 74.24 111.608 -175.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.507 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 2.9 mt -95.73 161.06 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-O 120.927 0.394 . . . . 74.11 111.905 -177.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.616 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 73.5 m -129.33 95.44 4.03 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.01 0.434 . . . . 72.25 111.212 174.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.67 124.32 6.55 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 121.097 -0.573 . . . . 60.54 113.078 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -71.7 86.09 0.92 Allowed 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 121.033 0.444 . . . . 45.15 111.592 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.5 p -69.12 -49.37 57.69 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.138 0.494 . . . . 71.1 111.085 177.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 90.8 mt -73.3 110.14 7.35 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.97 -0.559 . . . . 64.54 111.03 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -62.21 -22.06 65.63 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.474 0.546 . . . . 73.11 112.474 -177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -85.05 -22.62 28.92 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.049 0.389 . . . . 74.14 112.049 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.79 -97.51 0.57 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 120.941 -0.647 . . . . 70.43 112.293 -173.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 62.12 -172.06 0.15 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.297 0.48 . . . . 71.5 112.297 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.5 p -99.38 -176.58 3.33 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 109.747 -0.464 . . . . 73.42 109.747 170.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.11 -37.3 76.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.047 0.388 . . . . 73.03 112.047 -176.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -72.31 -17.63 61.85 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.87 0.693 . . . . 73.31 112.87 -174.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . 1.2 mp0 -70.73 -49.91 41.87 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.997 0.427 . . . . 74.14 110.271 170.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -101.95 55.96 0.81 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.438 -0.347 . . . . 62.31 110.811 173.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.9 tp -74.56 27.05 0.08 Allowed 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 121.363 0.601 . . . . 63.42 112.174 -175.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 43' ' ' LYS . 3.1 t -86.34 161.0 18.93 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.161 0.505 . . . . 74.42 112.229 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -59.45 -29.43 67.78 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.203 0.525 . . . . 71.1 110.756 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -55.9 -36.71 67.97 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.759 -0.655 . . . . 72.33 110.579 176.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.492 ' O ' HG22 ' A' ' 52' ' ' VAL . 13.0 t80 -65.5 -43.09 91.22 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.893 -0.594 . . . . 74.11 110.4 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.481 ' HD1' HG23 ' A' ' 137' ' ' VAL . 75.4 t80 -58.65 -62.07 2.14 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 115.716 -0.674 . . . . 63.54 110.452 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -59.96 -23.89 63.95 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.621 0.6 . . . . 61.14 112.621 -178.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -76.78 -33.01 58.07 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.795 0.665 . . . . 73.43 112.795 -177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.553 HG21 ' HD2' ' A' ' 102' ' ' PRO . 30.5 m -123.49 14.8 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 113.575 0.954 . . . . 75.23 113.575 -173.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -96.57 19.66 11.93 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 112.963 0.727 . . . . 75.13 112.963 -178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -145.5 159.21 43.44 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.897 -0.502 . . . . 71.31 112.279 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.38 141.59 51.98 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.787 -0.642 . . . . 43.33 110.687 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.786 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 41.5 mt-10 -97.9 111.98 24.08 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.838 0.351 . . . . 71.35 111.272 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.9 mp -110.88 149.9 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 116.333 -0.394 . . . . 73.44 111.032 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -74.45 144.8 44.09 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-O 120.548 0.213 . . . . 65.01 110.438 174.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.438 ' HA ' ' HB3' ' A' ' 62' ' ' TRP . 27.6 tt0 -55.33 -32.91 62.89 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.314 0.487 . . . . 75.35 112.314 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.598 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 17.3 mm-40 -54.97 -57.08 13.11 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 111.977 0.362 . . . . 74.5 111.977 175.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -67.02 -34.99 78.93 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.441 0.639 . . . . 55.25 110.45 177.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.517 ' HA ' HD12 ' A' ' 67' ' ' LEU . 43.3 t-105 -53.08 -50.27 64.72 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.171 -0.922 . . . . 75.41 111.478 177.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -69.13 -39.1 79.07 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.155 -0.475 . . . . 71.01 111.462 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.581 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -56.27 -34.33 66.33 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 112.245 0.461 . . . . 42.32 112.245 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.0 mt -91.84 -18.32 23.99 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 116.377 -0.374 . . . . 75.34 111.849 177.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.03 46.33 10.57 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.154 -0.546 . . . . 54.14 112.657 -176.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.683 HD23 ' HD3' ' A' ' 129' ' ' LYS . 91.6 mt -84.09 143.19 29.87 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.271 0.558 . . . . 70.15 112.424 -176.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -101.09 156.15 17.58 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.013 -0.54 . . . . 74.44 110.645 170.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -72.35 93.21 1.49 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.735 0.779 . . . . 65.31 111.11 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 124.76 -3.62 8.61 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 114.777 -1.101 . . . . 72.43 112.113 -171.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.47 173.79 1.5 Allowed 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.23 0.538 . . . . 71.11 112.093 177.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -113.86 124.47 52.3 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.267 -0.424 . . . . 74.33 111.353 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.642 HG13 ' HB2' ' A' ' 86' ' ' ALA . 17.5 m -114.33 142.11 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.333 0.587 . . . . 74.12 112.232 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.581 ' HD2' ' HD2' ' A' ' 76' ' ' LYS . 38.5 ttmt -99.47 147.31 25.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.857 -0.611 . . . . 74.44 110.172 173.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -128.54 124.03 60.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.239 -0.652 . . . . 53.25 109.239 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.581 ' HD2' ' HD2' ' A' ' 74' ' ' LYS . 6.5 mtpm? -133.93 130.12 37.28 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.546 0.573 . . . . 55.24 112.546 -170.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.742 HG22 ' HA3' ' A' ' 125' ' ' GLY . 25.0 p -136.62 -171.23 2.86 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.797 -0.638 . . . . 55.45 110.545 178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.91 -14.91 63.27 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.961 -0.563 . . . . 63.52 111.853 175.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -89.2 -38.64 14.11 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 111.796 0.295 . . . . 72.12 111.796 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.31 -160.93 34.6 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 121.345 -0.455 . . . . 62.04 112.979 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.19 149.85 51.04 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.267 0.556 . . . . 64.23 112.202 179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.525 HG23 HD12 ' A' ' 135' ' ' LEU . 12.5 p -147.46 147.26 17.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 116.142 -0.481 . . . . 74.3 110.948 178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -111.12 119.07 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 O-C-N 122.31 -0.244 . . . . 71.04 110.997 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.465 ' HA ' HG13 ' A' ' 134' ' ' VAL . 34.3 m -129.57 174.25 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 111.921 0.341 . . . . 73.02 111.921 -176.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -75.37 143.38 42.83 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 120.97 0.414 . . . . 73.43 111.458 177.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.642 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -94.5 122.12 36.75 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.216 0.45 . . . . 32.23 112.216 -178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -128.33 141.17 51.51 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.304 0.573 . . . . 65.33 111.08 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.419 ' HD3' ' HB2' ' A' ' 59' ' ' GLU . 35.3 ttmt -80.11 103.99 10.37 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.717 -0.674 . . . . 75.21 110.689 -178.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.786 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -100.51 -163.9 28.29 Favored Glycine 0 CA--C 1.523 0.592 0 C-N-CA 121.256 -0.497 . . . . 71.55 114.298 -172.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -111.25 32.45 5.32 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.365 0.602 . . . . 51.42 111.292 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.1 m -92.37 158.41 38.86 Favored Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 115.974 -0.557 . . . . 63.24 111.817 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.97 163.14 37.59 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.302 2.001 . . . . 72.01 112.859 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.598 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 78.8 tttt -63.32 143.34 57.88 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.767 0.318 . . . . 71.43 111.574 -178.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 68.22 28.78 73.18 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 120.877 -0.678 . . . . 63.41 112.961 -175.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.51 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 23.5 ttt -154.62 137.0 14.95 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 122.472 -0.428 . . . . 74.24 110.309 -177.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.478 HD11 HG22 ' A' ' 28' ' ' VAL . 41.9 pt -134.87 144.37 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 CA-C-O 121.359 0.6 . . . . 72.41 112.082 -178.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -106.09 124.19 49.19 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.021 -0.536 . . . . 51.42 111.415 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.616 ' O ' ' HA ' ' A' ' 30' ' ' SER . 54.4 mt -121.02 131.45 24.48 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 116.559 -0.291 . . . . 73.24 110.427 174.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.402 ' HB2' HG12 ' A' ' 52' ' ' VAL . 31.7 Cg_exo -60.48 138.82 82.89 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.14 1.893 . . . . 65.32 112.399 175.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.7 104.73 0.16 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 116.444 -0.344 . . . . 62.41 110.839 -178.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.97 -173.84 25.91 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 120.712 -0.756 . . . . 63.03 113.107 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.553 ' HD2' HG21 ' A' ' 52' ' ' VAL . 34.8 Cg_endo -64.7 -31.59 58.56 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.352 2.035 . . . . 73.43 111.566 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.502 ' HA ' HD11 ' A' ' 140' ' ' LEU . 8.2 m-85 -62.85 -48.17 80.2 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.701 -0.681 . . . . 74.23 110.146 175.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -59.64 -43.55 93.81 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.911 -0.586 . . . . 72.01 111.517 173.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -54.89 -20.1 8.06 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 112.536 0.569 . . . . 73.41 112.536 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.547 ' SD ' HD21 ' A' ' 140' ' ' LEU . 88.5 mmm -69.45 -31.56 69.95 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.858 0.361 . . . . 72.11 111.435 177.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.453 ' HB ' HG23 ' A' ' 77' ' ' THR . 31.0 m -123.59 -8.36 7.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 113.293 0.849 . . . . 65.42 113.293 -171.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.558 HG21 ' OG ' ' A' ' 30' ' ' SER . 8.0 pt -106.05 177.48 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 121.565 0.698 . . . . 71.41 112.452 -177.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.542 ' O ' HG22 ' A' ' 112' ' ' THR . 25.7 t70 -102.21 122.87 45.27 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 115.544 -0.753 . . . . 64.1 110.67 175.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -75.99 18.41 0.64 Allowed 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.846 2.364 . . . . 71.12 114.304 -176.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 61.8 m -114.4 -16.16 12.0 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 112.516 0.561 . . . . 74.51 112.516 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 109' ' ' ASP . 3.4 t -71.98 -41.68 67.39 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.732 0.642 . . . . 61.32 112.732 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -86.37 103.07 14.59 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.053 0.454 . . . . 72.21 111.525 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -138.77 -45.32 0.07 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.367 -0.444 . . . . 53.12 113.025 178.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 76.9 p -114.08 -171.8 1.97 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.019 0.438 . . . . 62.14 111.018 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.68 104.59 1.1 Allowed Glycine 0 CA--C 1.527 0.795 0 C-N-CA 120.892 -0.67 . . . . 72.02 112.483 174.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 49.6 tpp -69.61 116.8 46.84 Favored Pre-proline 0 CA--C 1.541 0.609 0 CA-C-O 120.735 0.302 . . . . 34.43 110.804 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -80.96 -19.17 8.49 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.127 2.552 . . . . 71.12 113.772 -175.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -129.55 153.43 48.04 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.998 0.428 . . . . 73.2 112.14 -172.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -78.76 90.58 4.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.06 0.457 . . . . 74.32 111.106 175.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -135.82 136.18 40.43 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.33 -0.396 . . . . 54.14 110.978 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . -136.32 -171.2 12.21 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.946 -0.645 . . . . 72.44 113.133 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.416 HG21 ' H ' ' A' ' 109' ' ' ASP . 89.5 t -86.89 122.28 38.7 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.633 0.254 . . . . 72.15 111.515 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 68.0 mttm -71.71 147.32 47.52 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.463 0.649 . . . . 75.51 112.35 -177.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.742 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -175.15 -138.59 2.8 Favored Glycine 0 CA--C 1.53 0.985 0 CA-C-N 115.479 -0.782 . . . . 73.1 112.527 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 57.3 p -140.43 158.64 43.7 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.06 0.457 . . . . 73.5 111.748 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.1 p -135.29 145.23 32.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 CA-C-N 115.988 -0.551 . . . . 64.21 110.472 175.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.519 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 5.9 pt-20 -149.04 155.21 40.43 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.684 0.278 . . . . 62.42 111.383 -177.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.683 ' HD3' HD23 ' A' ' 67' ' ' LEU . 28.0 ttpp -85.68 133.54 34.02 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 109.607 -0.516 . . . . 73.52 109.607 168.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.6 t -130.72 161.08 32.46 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.601 0.715 . . . . 55.51 112.858 -171.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.09 -21.31 33.73 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.409 -0.814 . . . . 74.33 110.164 176.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -61.73 157.21 18.38 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.847 -0.615 . . . . 73.32 112.579 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.532 ' H ' ' HD3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -90.52 162.29 15.1 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.912 -0.585 . . . . 74.34 111.1 179.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.465 HG13 ' HA ' ' A' ' 84' ' ' VAL . 98.4 t -65.81 133.23 31.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 116.458 -0.337 . . . . 72.44 111.035 175.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.525 HD12 HG23 ' A' ' 82' ' ' VAL . 13.2 mt -63.01 138.28 58.51 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.134 0.492 . . . . 74.45 111.405 177.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 39.0 t -85.41 144.93 27.72 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.087 -0.709 . . . . 64.13 109.087 170.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.481 HG23 ' HD1' ' A' ' 49' ' ' PHE . 86.5 t -48.46 -47.05 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 112.093 0.405 . . . . 71.41 112.093 -175.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -67.83 -41.46 82.99 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.958 0.408 . . . . 64.45 111.525 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -62.14 -33.52 74.64 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.581 0.705 . . . . 72.4 110.404 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.547 HD21 ' SD ' ' A' ' 106' ' ' MET . 1.9 tt -66.63 -34.29 77.55 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.127 -0.942 . . . . 63.22 110.85 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.06 -41.58 92.64 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.633 0.73 . . . . 73.53 109.943 175.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -66.49 -35.89 81.39 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.464 -0.789 . . . . 65.51 110.675 175.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.76 -44.1 86.86 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.259 0.466 . . . . 53.33 112.259 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.9 pp -77.62 -8.63 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 120.86 0.362 . . . . 72.21 111.949 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 83.69 38.4 10.65 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 114.41 0.524 . . . . 23.25 114.41 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.474 0.768 0 CA-C-N 117.464 0.632 . . . . 51.53 111.349 176.673 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.496 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 120.725 0.298 . . . . 71.25 111.354 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 155.83 79.07 0.02 OUTLIER Glycine 0 CA--C 1.528 0.897 0 C-N-CA 121.129 -0.558 . . . . 54.41 112.929 178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.4 p -76.77 126.24 30.65 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.115 0.483 . . . . 73.54 111.865 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.2 m -83.86 151.56 25.06 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 120.988 0.423 . . . . 61.32 111.728 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -157.89 138.8 13.19 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.309 -0.405 . . . . 73.11 111.043 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -120.62 144.81 47.94 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 120.983 0.42 . . . . 71.23 111.959 -178.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -85.0 154.95 21.79 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.22 -0.445 . . . . 63.14 111.229 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -124.85 143.41 50.84 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.876 0.369 . . . . 63.54 111.869 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -154.84 151.99 29.27 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.582 -0.281 . . . . 74.4 111.304 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -114.11 116.63 29.43 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.063 0.459 . . . . 75.13 110.993 175.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 57.4 m -76.84 97.99 4.72 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.921 0.391 . . . . 64.12 111.028 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 44.7 m -105.37 121.69 44.41 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 116.374 -0.375 . . . . 74.02 111.31 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -136.48 -163.78 9.96 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 121.315 -0.469 . . . . 72.52 113.244 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -117.99 -176.99 3.16 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.014 0.435 . . . . 63.55 111.654 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.13 170.5 8.22 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 121.371 0.605 . . . . 74.44 112.506 -175.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -105.84 114.24 28.27 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.97 -0.559 . . . . 73.53 111.007 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 17' ' ' LEU . 6.8 mp -78.53 162.08 26.57 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.982 0.42 . . . . 72.21 112.063 -178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -92.87 125.24 37.38 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-O 121.211 0.529 . . . . 64.11 112.104 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -107.74 142.32 37.93 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 116.094 -0.503 . . . . 73.24 110.766 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -96.69 94.83 7.53 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.021 0.439 . . . . 65.54 111.124 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.65 112.69 0.28 Allowed Glycine 0 CA--C 1.529 0.933 0 CA-C-N 116.152 -0.476 . . . . 73.41 112.845 -178.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -96.63 113.69 25.27 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.488 -0.419 . . . . 61.43 111.9 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 7.8 ptp -81.23 167.18 19.88 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.997 0.427 . . . . 63.43 111.219 176.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.495 HD12 ' HG ' ' A' ' 65' ' ' LEU . 25.3 mt -121.46 127.02 50.66 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.129 0.49 . . . . 74.42 111.813 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -71.7 115.61 11.09 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.585 -0.734 . . . . 64.53 111.02 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 27.8 m -128.51 160.07 39.29 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 N-CA-C 112.55 0.574 . . . . 63.14 112.55 -174.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.618 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 52.9 tt0 -99.27 117.32 33.45 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.945 0.402 . . . . 63.13 110.696 174.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.502 HG22 HD11 ' A' ' 96' ' ' ILE . 40.9 t -92.35 108.51 20.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.142 0.496 . . . . 50.5 112.121 -175.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -102.24 146.95 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-O 120.936 0.398 . . . . 75.05 112.027 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 73.6 m -106.6 104.42 14.1 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.157 -0.474 . . . . 73.43 111.667 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.485 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . -73.11 94.67 0.71 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.885 -0.674 . . . . 40.21 112.894 178.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -68.64 89.49 0.38 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.39 0.614 . . . . 72.32 111.607 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.6 p -110.19 172.98 6.54 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.85 -0.613 . . . . 53.53 111.105 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.408 ' HG ' ' HG2' ' A' ' 36' ' ' GLN . 33.5 tp 73.45 -48.94 0.68 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.308 0.643 . . . . 71.02 112.182 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 60.47 95.06 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.621 0.724 . . . . 73.41 111.762 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.518 ' HG3' ' HE3' ' A' ' 43' ' ' LYS . 76.4 mm-40 -134.65 -51.59 0.8 Allowed 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.805 -0.634 . . . . 72.01 111.785 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.68 -7.69 61.4 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.11 -0.567 . . . . 53.11 113.567 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.36 145.13 33.59 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 122.554 0.341 . . . . 74.14 111.71 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.2 t -61.34 153.8 25.7 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.659 -0.246 . . . . 72.24 110.942 173.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.3 m -57.14 -30.89 35.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-O 120.714 0.292 . . . . 75.15 111.282 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.404 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 41.2 tt0 -60.65 -33.27 72.55 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.162 -0.472 . . . . 63.34 111.863 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -56.17 -40.73 74.35 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.179 0.514 . . . . 61.45 110.519 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.565 ' HB2' ' CD2' ' A' ' 48' ' ' TYR . 63.9 mttm -104.9 -65.1 1.06 Allowed 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.585 0.587 . . . . 54.45 112.585 -173.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.404 ' HG ' ' HA ' ' A' ' 41' ' ' GLU . 67.0 mt 48.35 20.81 0.31 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 113.215 0.82 . . . . 73.04 113.215 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.545 HG23 ' H ' ' A' ' 48' ' ' TYR . 6.5 t -80.35 156.4 26.74 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.654 0.264 . . . . 74.12 111.487 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -50.04 -38.7 39.05 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.105 0.479 . . . . 75.41 111.371 178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -60.97 -37.84 83.82 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.086 -0.506 . . . . 72.43 111.223 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.565 ' CD2' ' HB2' ' A' ' 43' ' ' LYS . 1.7 t80 -58.18 -40.02 80.4 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.298 0.57 . . . . 72.11 109.849 178.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -64.52 -62.03 1.85 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.559 -0.746 . . . . 75.3 110.306 176.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -64.62 -4.31 4.03 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.09 0.774 . . . . 74.32 113.09 -176.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.22 -33.01 14.86 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.61 0.596 . . . . 51.25 112.61 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.58 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 34.8 m -129.48 20.15 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 113.15 0.796 . . . . 64.42 113.15 -173.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -103.02 21.53 15.56 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.124 0.787 . . . . 62.05 113.124 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -140.89 158.43 43.96 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.168 0.509 . . . . 71.15 112.143 -177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.89 138.79 51.13 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.909 -0.587 . . . . 72.51 110.853 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.667 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 39.6 mt-10 -93.78 112.66 24.56 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.637 0.256 . . . . 71.4 111.361 178.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.3 mp -109.81 146.06 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 116.529 -0.305 . . . . 55.25 110.764 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.5 t-20 -68.43 143.92 54.88 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.811 0.339 . . . . 72.31 111.399 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -47.46 -40.05 17.31 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.117 0.567 . . . . 74.42 112.251 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -58.37 -54.35 47.97 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.087 0.47 . . . . 74.23 111.399 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -66.37 -33.67 76.25 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.227 0.537 . . . . 73.21 110.915 178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 46.2 t-105 -54.16 -54.23 42.51 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.693 -0.685 . . . . 73.44 111.429 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -69.42 -36.38 76.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.525 -0.307 . . . . 74.4 111.66 178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.444 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -59.64 -34.65 73.07 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.983 0.42 . . . . 71.12 111.88 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.495 ' HG ' HD12 ' A' ' 24' ' ' LEU . 94.6 mt -90.91 -12.17 36.9 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.473 -0.331 . . . . 74.31 111.751 177.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 70.12 46.51 50.49 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.123 -0.561 . . . . 70.12 112.657 -177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.494 ' HA ' ' HZ1' ' A' ' 129' ' ' LYS . 93.7 mt -86.6 159.51 19.21 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.616 0.722 . . . . 73.4 112.078 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -140.87 134.78 30.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.184 -0.916 . . . . 74.41 109.129 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -56.17 97.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.631 0.729 . . . . 74.05 112.094 -174.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 143.28 -22.9 2.23 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-N 115.15 -0.932 . . . . 54.24 113.956 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -86.25 178.0 7.31 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 118.251 1.026 . . . . 71.42 112.627 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.664 HH11 HG23 ' A' ' 134' ' ' VAL . 60.9 mtt-85 -109.52 139.95 43.88 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 115.812 -0.631 . . . . 65.33 112.003 -169.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.413 HG13 ' HB2' ' A' ' 86' ' ' ALA . 31.4 m -124.06 140.03 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-N 115.921 -0.581 . . . . 61.43 111.212 177.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -107.99 131.25 54.76 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.921 0.391 . . . . 73.51 110.896 176.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 50.5 t -106.81 130.47 58.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.397 -0.365 . . . . 54.1 111.026 178.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.506 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -117.18 127.88 54.55 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.017 0.437 . . . . 54.43 111.307 177.475 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.646 HG22 ' HA3' ' A' ' 125' ' ' GLY . 21.4 p -135.53 -172.52 3.11 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.057 0.456 . . . . 62.13 110.57 175.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -71.29 -5.62 33.69 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.293 -0.412 . . . . 75.32 111.963 177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -99.81 -20.55 16.15 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 112.026 0.38 . . . . 51.55 112.026 177.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 146.6 -151.63 23.87 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.982 -0.627 . . . . 43.44 113.202 178.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.506 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 9.5 pt-20 -140.3 149.94 43.41 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 120.8 0.333 . . . . 54.13 111.553 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.449 HG23 ' SD ' ' A' ' 106' ' ' MET . 12.8 p -149.11 148.67 15.55 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.528 -0.305 . . . . 74.22 111.135 177.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 t -112.07 117.71 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-O 120.542 0.21 . . . . 73.22 111.349 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.4 m -129.84 176.44 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 122.646 0.379 . . . . 55.55 111.657 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -79.66 145.97 32.72 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.016 0.436 . . . . 74.51 111.565 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.413 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -88.76 115.86 26.61 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 112.591 0.589 . . . . 74.32 112.591 -178.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -113.27 157.39 21.84 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.621 0.725 . . . . 64.23 111.228 171.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -100.11 112.57 24.88 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.386 -0.825 . . . . 62.54 110.547 178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.667 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -107.92 171.77 16.54 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.147 -0.549 . . . . 73.14 114.147 -174.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -95.61 18.34 13.07 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.32 0.581 . . . . 43.5 110.752 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.404 HG11 ' HB2' ' A' ' 97' ' ' PHE . 27.8 m -79.1 155.85 77.05 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.852 -0.613 . . . . 71.4 111.99 -177.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.03 153.17 53.52 Favored 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.404 2.069 . . . . 75.34 112.588 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -62.65 148.75 45.44 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 122.161 -0.337 . . . . 75.04 111.151 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 66.17 27.29 72.84 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 120.521 -0.847 . . . . 74.31 112.41 -174.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.618 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 20.9 ttt -149.27 137.01 20.38 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.632 -0.507 . . . . 63.23 109.632 179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 28' ' ' VAL . 38.9 pt -132.99 141.54 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-O 121.249 0.547 . . . . 72.24 111.864 -178.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.493 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 59.1 t80 -101.87 118.38 36.8 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.966 -0.561 . . . . 73.21 111.369 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 30' ' ' SER . 51.5 mt -119.97 124.37 27.91 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 116.623 -0.262 . . . . 71.32 110.612 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.58 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 11.5 Cg_endo -55.82 137.23 77.98 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.184 1.922 . . . . 71.43 112.258 176.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.08 103.27 0.16 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.329 -0.396 . . . . 72.23 110.948 -175.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.59 -176.12 24.85 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 120.559 -0.829 . . . . 75.43 112.87 -178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.51 ' HA ' HD22 ' A' ' 105' ' ' ASN . 22.4 Cg_endo -62.13 -28.03 79.4 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.023 1.815 . . . . 64.0 111.446 -178.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.504 ' HA ' HD11 ' A' ' 140' ' ' LEU . 8.4 m-85 -66.89 -49.88 64.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.617 -0.72 . . . . 73.31 110.134 175.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.38 -40.09 81.37 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.854 -0.612 . . . . 73.32 111.443 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.51 HD22 ' HA ' ' A' ' 102' ' ' PRO . 91.0 m-20 -56.71 -25.11 53.52 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.214 0.53 . . . . 72.41 111.808 -178.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.449 ' SD ' HG23 ' A' ' 82' ' ' VAL . 35.3 mtp -73.58 -21.53 60.31 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.912 -0.586 . . . . 73.01 112.313 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.5 m -133.67 -5.96 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.453 0.908 . . . . 71.32 113.453 -173.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 109' ' ' ASP . 1.6 pp -111.13 172.65 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 121.957 -0.464 . . . . 70.52 111.665 -177.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.472 ' N ' HG21 ' A' ' 123' ' ' VAL . 11.6 t70 -96.83 120.11 62.36 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 116.252 -0.431 . . . . 70.21 111.636 -177.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -86.9 2.04 7.19 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 122.562 2.175 . . . . 71.24 113.396 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 51.0 m -86.71 0.05 55.39 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.945 0.402 . . . . 53.31 111.595 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 54.4 p -68.31 82.66 0.24 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 121.299 0.571 . . . . 65.21 110.992 175.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -66.12 113.93 4.87 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 116.058 -0.519 . . . . 75.34 110.877 -176.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -72.93 75.95 0.88 Allowed Glycine 0 CA--C 1.528 0.871 0 N-CA-C 114.16 0.424 . . . . 74.04 114.16 -174.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 63.0 p -124.49 36.99 4.5 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.237 0.541 . . . . 71.53 111.144 175.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.33 10.24 18.01 Favored Glycine 0 CA--C 1.526 0.775 0 CA-C-N 116.181 -0.463 . . . . 72.42 113.283 -177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.493 ' SD ' ' N ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -68.64 147.04 97.98 Favored Pre-proline 0 CA--C 1.538 0.519 0 N-CA-C 112.215 0.45 . . . . 73.42 112.215 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.25 121.34 7.7 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.694 2.263 . . . . 54.31 113.319 -175.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -80.62 41.64 0.57 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-O 121.764 0.793 . . . . 71.33 111.028 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -137.02 -14.49 1.57 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.282 -0.872 . . . . 73.32 111.296 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -87.55 127.9 35.25 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.68 0.276 . . . . 71.45 110.803 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -124.1 177.65 16.67 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 120.649 -0.786 . . . . 74.02 113.877 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.472 HG21 ' N ' ' A' ' 109' ' ' ASP . 57.7 t -94.2 120.29 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 O-C-N 122.633 -0.333 . . . . 53.3 110.987 175.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 39.0 mtpt -73.83 153.5 39.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.015 0.912 . . . . 53.02 112.779 -177.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.646 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -174.88 -150.1 7.6 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 114.323 -1.308 . . . . 44.35 111.346 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 44.0 p -132.87 146.95 52.26 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 117.449 0.625 . . . . 60.1 111.873 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -121.67 144.01 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.085 -0.507 . . . . 64.12 110.905 177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -149.74 152.4 35.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.921 -0.581 . . . . 72.53 110.811 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.494 ' HZ1' ' HA ' ' A' ' 67' ' ' LEU . 19.6 ttmm -73.04 134.95 44.81 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 109.363 -0.606 . . . . 63.31 109.363 170.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.7 t -126.52 158.84 35.09 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.036 0.754 . . . . 72.52 113.036 -172.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -85.46 -15.78 41.81 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.11 -0.95 . . . . 74.52 110.911 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.466 ' O ' ' HD2' ' A' ' 72' ' ' ARG . 19.2 mm-40 -73.81 156.08 38.16 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.496 0.665 . . . . 75.43 112.587 -177.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.02 156.99 29.8 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 115.29 -0.868 . . . . 75.43 111.309 179.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.664 HG23 HH11 ' A' ' 72' ' ' ARG . 70.4 t -69.7 131.03 34.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 109.85 -0.426 . . . . 71.44 109.85 173.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.43 HD13 ' HG ' ' A' ' 140' ' ' LEU . 13.5 mt -63.21 132.33 51.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.081 0.467 . . . . 71.45 112.099 -177.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 65.6 m -75.97 146.07 39.86 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.41 -0.589 . . . . 61.42 109.41 171.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 87.5 t -46.76 -50.98 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 N-CA-C 112.859 0.689 . . . . 73.12 112.859 -172.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -72.92 -38.76 66.74 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.057 -0.402 . . . . 64.21 111.745 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -58.42 -37.7 75.91 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.745 0.783 . . . . 73.32 110.038 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.504 HD11 ' HA ' ' A' ' 103' ' ' TYR . 5.1 tt -59.59 -42.66 93.03 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.905 -1.043 . . . . 61.11 110.72 174.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 50.6 mt -58.03 -46.99 84.42 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.205 0.526 . . . . 73.14 110.395 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -61.89 -33.48 74.29 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.946 -0.57 . . . . 74.34 111.169 177.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.21 -45.01 62.08 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.547 0.573 . . . . 54.1 112.547 178.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.05 -8.95 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 112.855 0.687 . . . . 75.52 112.855 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 147.43 -43.14 0.86 Allowed Glycine 0 CA--C 1.525 0.689 0 C-N-CA 120.925 -0.655 . . . . 73.2 113.234 177.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 44.6 m . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 121.136 0.493 . . . . 55.11 111.139 -179.143 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.535 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.834 0.349 . . . . 73.11 111.423 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.51 166.08 24.52 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 121.309 -0.472 . . . . 51.23 113.092 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.2 p -155.84 108.79 2.69 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.27 0.557 . . . . 72.15 111.538 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.1 t -79.0 155.0 29.05 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 116.295 -0.411 . . . . 60.12 111.129 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -156.27 90.25 1.18 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.328 0.585 . . . . 72.02 112.299 -178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -117.25 124.72 49.73 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.9 0.381 . . . . 74.35 110.533 174.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 -132.69 131.8 41.68 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.118 0.485 . . . . 74.41 111.745 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.6 t-80 -152.03 140.52 20.63 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.035 -0.53 . . . . 73.41 110.299 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -140.29 144.87 36.63 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.602 0.593 . . . . 75.51 112.602 -173.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -145.32 124.37 12.82 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.878 -0.601 . . . . 75.33 110.648 172.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.2 p -150.89 133.56 15.7 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.318 -0.401 . . . . 54.44 110.705 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.4 m -152.64 132.46 13.24 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.107 0.41 . . . . 73.5 112.107 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -103.74 172.96 21.43 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 112.013 -0.435 . . . . 51.4 112.013 172.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -160.6 134.93 7.28 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 122.084 -0.656 . . . . 74.33 112.366 -179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -89.42 -179.13 5.76 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.609 -0.723 . . . . 70.21 112.054 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -140.7 159.26 42.59 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.244 -0.435 . . . . 73.14 110.147 -178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.1 tt -46.8 129.68 11.58 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.138 0.494 . . . . 75.14 111.662 -178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -90.5 138.08 31.84 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.802 0.667 . . . . 75.24 112.802 -173.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -84.98 -179.81 7.14 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.075 -0.511 . . . . 74.35 110.859 173.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -81.06 -46.7 14.6 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.802 0.668 . . . . 75.22 112.802 -175.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.17 -59.56 4.88 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.968 -0.634 . . . . 62.25 111.965 -173.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 30.7 t60 64.83 84.71 0.15 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.173 0.589 . . . . 73.4 111.752 174.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.53 ' HA ' ' HB3' ' A' ' 128' ' ' GLU . 8.7 ptp -78.67 152.46 31.65 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.959 0.726 . . . . 73.23 112.959 -177.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 64' ' ' ALA . 13.5 mt -117.39 140.34 49.7 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.123 -0.944 . . . . 61.53 110.887 175.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -79.26 110.33 14.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.669 0.747 . . . . 64.21 110.974 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 35.0 m -133.51 162.32 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 114.872 -1.058 . . . . 64.53 111.873 -171.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.579 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 28.3 tt0 -100.08 117.72 34.94 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.067 0.46 . . . . 55.24 110.531 172.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.536 HG22 HD11 ' A' ' 96' ' ' ILE . 41.0 t -90.62 110.07 21.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.315 0.646 . . . . 72.41 111.457 -175.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.448 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 8.3 mt -91.98 152.21 3.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.871 0.367 . . . . 55.12 111.768 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.717 ' HB2' HG21 ' A' ' 108' ' ' ILE . 23.1 t -123.63 93.28 3.89 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.946 0.403 . . . . 74.43 110.081 172.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 100' ' ' MET . . . -80.66 143.56 24.62 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.135 -0.555 . . . . 31.42 113.501 -175.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.8 ttt180 -65.99 82.08 0.08 Allowed 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.423 0.63 . . . . 74.21 111.394 -178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 57.0 p -103.02 131.72 49.8 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.833 -0.621 . . . . 74.22 111.382 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.8 mp 62.68 -179.01 0.14 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.228 0.537 . . . . 73.1 111.224 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -88.44 117.78 27.61 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.539 -0.3 . . . . 72.23 111.367 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.402 ' HB3' ' H ' ' A' ' 37' ' ' GLY . 2.3 mp0 -77.45 -154.14 0.06 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 116.3 -0.409 . . . . 75.24 110.425 173.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.402 ' H ' ' HB3' ' A' ' 36' ' ' GLN . . . 82.73 -57.97 5.03 Favored Glycine 0 CA--C 1.525 0.703 0 C-N-CA 120.641 -0.79 . . . . 64.12 112.586 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.418 ' HB3' ' HD2' ' A' ' 43' ' ' LYS . . . -68.93 142.53 54.7 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 120.814 0.34 . . . . 74.32 111.762 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.6 p -67.58 155.48 39.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.766 0.317 . . . . 72.35 110.419 173.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.548 HG21 HD21 ' A' ' 141' ' ' LEU . 30.2 m -58.0 -24.78 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-O 121.063 0.458 . . . . 63.34 110.271 175.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 44' ' ' LEU . 25.0 tt0 -62.89 -51.98 64.87 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.752 -0.658 . . . . 74.53 110.884 174.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.2 mm-40 -56.53 -44.42 80.82 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.228 0.537 . . . . 71.32 111.295 175.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.418 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 26.4 mtpp -98.48 31.13 2.95 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.88 -0.6 . . . . 70.1 111.399 -178.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 41' ' ' GLU . 0.1 OUTLIER -67.09 82.8 0.12 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.089 0.471 . . . . 74.11 110.515 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.9 t -145.23 159.63 42.72 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.964 0.412 . . . . 55.44 111.905 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -53.98 -30.75 48.42 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 116.03 -0.532 . . . . 71.32 111.565 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -59.73 -36.48 76.67 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.761 0.315 . . . . 70.53 111.445 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -25.86 67.02 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.443 0.64 . . . . 71.4 109.973 176.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.401 ' HE1' ' HA ' ' A' ' 136' ' ' SER . 55.7 t80 -86.33 -17.5 34.37 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.864 -0.607 . . . . 74.43 111.052 177.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -84.61 -43.23 14.63 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.902 -0.498 . . . . 73.42 112.067 178.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.85 -63.78 1.33 Allowed 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.69 0.996 . . . . 71.52 113.69 -170.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.509 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 28.3 m -88.31 20.95 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 113.661 0.985 . . . . 72.22 113.661 -167.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.617 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -105.24 12.22 32.11 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 113.175 0.806 . . . . 75.43 113.175 -173.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 21.1 p90 -137.31 164.74 27.84 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.817 -0.552 . . . . 74.14 111.834 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -125.54 141.39 52.06 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.849 -0.614 . . . . 64.34 111.182 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.526 ' HB2' ' HB3' ' A' ' 97' ' ' PHE . 61.8 mt-10 -94.09 112.73 24.58 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 116.093 -0.503 . . . . 73.44 111.12 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.436 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.3 mp -109.89 145.76 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.501 -0.318 . . . . 73.5 110.665 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -66.51 151.83 46.44 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.659 0.266 . . . . 70.12 111.012 177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 34.9 tt0 -57.76 -41.96 83.03 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.425 0.528 . . . . 45.34 112.425 -177.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -63.36 -48.52 77.59 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.785 0.326 . . . . 74.23 111.817 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -65.25 -36.77 85.16 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.12 0.486 . . . . 74.23 110.605 176.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.43 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 39.9 t-105 -52.92 -49.39 66.08 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.861 -0.608 . . . . 63.32 110.905 174.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -66.54 -40.56 89.14 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.782 -0.644 . . . . 71.14 111.167 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.465 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -60.77 -39.44 88.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.124 0.487 . . . . 62.43 111.95 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.515 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 68.4 mt -80.6 -10.44 59.74 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 116.069 -0.514 . . . . 72.54 111.461 178.018 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.49 40.24 97.52 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 121.404 -0.427 . . . . 74.23 112.652 -177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.515 ' HG ' ' HB2' ' A' ' 65' ' ' LEU . 96.1 mt -78.11 161.07 27.66 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.73 0.776 . . . . 63.13 112.572 -175.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -138.63 130.49 27.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.328 -0.851 . . . . 75.12 109.59 177.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -55.51 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.59 0.71 . . . . 74.54 112.115 -174.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.57 -19.45 1.85 Allowed Glycine 0 CA--C 1.532 1.152 0 CA-C-N 115.14 -0.936 . . . . 70.11 113.479 -176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.0 p30 -89.51 -169.95 2.67 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 117.683 0.741 . . . . 74.13 112.224 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.472 ' H ' ' HD3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -135.59 162.06 33.77 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.168 0.508 . . . . 73.52 111.977 -174.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.558 HG13 ' HB2' ' A' ' 86' ' ' ALA . 23.8 m -132.22 154.86 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.329 0.585 . . . . 72.11 112.36 -176.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.443 ' HB2' HG21 ' A' ' 130' ' ' THR . 12.5 tppt? -97.98 129.74 44.85 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.516 -0.765 . . . . 73.03 110.486 173.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 44.7 t -116.16 123.21 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 122.251 0.22 . . . . 55.12 110.445 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -124.46 124.85 43.19 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.952 0.406 . . . . 64.24 112.042 -176.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.648 HG22 ' HA3' ' A' ' 125' ' ' GLY . 25.0 p -132.15 -171.43 2.63 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.061 0.458 . . . . 74.24 111.396 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -71.78 -2.77 18.8 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 112.666 0.617 . . . . 75.43 112.666 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -106.75 -40.45 5.51 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.931 0.396 . . . . 71.43 111.863 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.72 -149.0 10.53 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.98 -0.629 . . . . 63.04 112.633 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 11.4 pt-20 -149.36 150.09 31.91 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.385 0.612 . . . . 64.44 112.289 178.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 106' ' ' MET . 7.8 p -144.0 155.91 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.799 -0.637 . . . . 74.13 110.568 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.2 t -116.98 115.61 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-O 120.623 0.249 . . . . 64.51 110.722 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.7 m -129.23 168.65 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 116.263 -0.426 . . . . 74.54 111.668 -175.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -72.83 132.05 43.07 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.827 0.346 . . . . 74.31 111.364 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.558 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -86.24 121.94 29.54 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 111.978 0.362 . . . . 70.03 111.978 -179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -133.78 150.19 51.44 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.213 0.53 . . . . 71.4 111.319 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -85.41 103.47 14.34 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.947 -0.57 . . . . 44.55 110.357 -178.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.496 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -120.08 -165.81 13.01 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 115.522 0.969 . . . . 64.34 115.522 -168.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -86.33 77.53 9.48 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.408 0.683 . . . . 64.12 111.869 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.7 m -149.05 152.37 36.3 Favored Pre-proline 0 N--CA 1.474 0.727 0 CA-C-N 115.443 -0.799 . . . . 75.44 111.655 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.55 168.52 16.19 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.779 2.32 . . . . 73.2 112.161 172.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 52.6 tttm -67.39 144.46 55.78 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 121.885 -0.509 . . . . 74.45 111.759 -176.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 75.13 18.92 80.05 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 121.29 -0.481 . . . . 43.34 113.376 -175.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.579 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 22.0 ttt -152.92 136.91 16.31 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.264 -0.551 . . . . 75.45 110.649 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.536 HD11 HG22 ' A' ' 28' ' ' VAL . 37.9 pt -132.53 150.72 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 121.179 0.514 . . . . 72.03 111.703 -177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.526 ' HB3' ' HB2' ' A' ' 56' ' ' GLU . 59.2 t80 -112.6 130.69 55.94 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.284 -0.416 . . . . 74.2 111.888 -176.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 30' ' ' SER . 40.1 mt -125.77 132.03 24.19 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-O 120.59 0.233 . . . . 55.32 110.795 173.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.509 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 51.2 Cg_exo -57.49 141.37 95.07 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.492 2.128 . . . . 74.32 112.789 176.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.442 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -61.03 103.68 0.3 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.799 0.333 . . . . 65.13 110.807 -178.524 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.26 -178.68 38.62 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.664 -0.779 . . . . 54.55 113.109 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.482 ' O ' ' HG2' ' A' ' 106' ' ' MET . 11.2 Cg_endo -54.62 -31.67 71.49 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.949 2.433 . . . . 75.31 112.668 -177.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.487 ' HA ' HD11 ' A' ' 140' ' ' LEU . 43.2 m-85 -66.09 -50.56 63.67 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.837 0.351 . . . . 70.53 110.843 177.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -62.06 -38.4 88.64 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.007 0.432 . . . . 74.21 110.778 174.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -53.09 -26.67 17.1 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.106 0.562 . . . . 71.51 112.241 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.623 ' SD ' HD21 ' A' ' 140' ' ' LEU . 86.9 mmm -73.85 -20.73 60.35 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 112.097 0.406 . . . . 73.35 112.097 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.8 m -128.81 -7.24 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 113.1 0.778 . . . . 73.24 113.1 -173.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.717 HG21 ' HB2' ' A' ' 30' ' ' SER . 11.4 pt -105.7 179.76 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 O-C-N 121.878 -0.514 . . . . 72.31 111.594 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.589 ' H ' HG21 ' A' ' 123' ' ' VAL . 22.4 t70 -91.11 110.95 45.86 Favored Pre-proline 0 CA--C 1.54 0.585 0 CA-C-N 116.295 -0.411 . . . . 73.25 110.838 175.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.84 -13.96 21.67 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.365 2.043 . . . . 72.4 112.625 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.4 m -62.14 -69.22 0.26 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.398 -0.365 . . . . 61.14 110.885 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 41.9 p 49.49 -163.87 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 112.719 0.637 . . . . 64.52 112.719 178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -149.06 157.48 43.43 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.628 -0.26 . . . . 74.35 110.563 177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -60.96 -22.9 60.82 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.301 -0.476 . . . . 63.5 113.844 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.4 p -86.24 -71.87 0.52 Allowed 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 116.957 0.378 . . . . 74.42 111.774 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.07 146.02 18.49 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.405 -0.426 . . . . 70.53 113.137 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 81.1 mtp -86.88 150.31 49.97 Favored Pre-proline 0 CA--C 1.543 0.677 0 O-C-N 122.507 -0.408 . . . . 70.34 111.708 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.31 -176.18 3.07 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.501 2.134 . . . . 63.32 112.565 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 64.85 167.02 0.17 Allowed 'General case' 0 N--CA 1.477 0.922 0 CA-C-O 121.362 0.601 . . . . 75.42 112.481 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.7 p90 -73.06 110.69 7.54 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 121.383 0.611 . . . . 71.44 111.724 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -146.81 138.92 24.68 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 121.0 0.428 . . . . 71.24 111.552 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.448 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . -142.9 -177.17 17.65 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 121.296 -0.478 . . . . 53.41 112.93 176.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.589 HG21 ' H ' ' A' ' 109' ' ' ASP . 93.2 t -85.09 126.86 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 120.913 0.387 . . . . 74.53 111.324 177.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 21.7 mtpp -75.08 160.19 30.79 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.771 0.656 . . . . 72.34 112.771 -174.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.648 ' HA3' HG22 ' A' ' 77' ' ' THR . . . 171.94 -151.53 15.15 Favored Glycine 0 CA--C 1.534 1.242 0 CA-C-N 116.064 -0.516 . . . . 74.23 113.882 -178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 70.8 p -137.32 159.82 40.85 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 122.381 -0.482 . . . . 55.42 111.609 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.9 p -148.88 144.07 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 112.047 0.388 . . . . 74.53 112.047 177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.53 ' HB3' ' HA ' ' A' ' 23' ' ' MET . 9.1 pt-20 -153.35 159.65 42.51 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.881 0.472 . . . . 64.12 110.904 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -83.31 144.11 29.92 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.147 0.498 . . . . 24.1 111.377 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.443 HG21 ' HB2' ' A' ' 74' ' ' LYS . 4.0 t -150.03 161.84 41.56 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 115.861 -0.609 . . . . 52.52 111.653 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -76.62 -8.0 56.37 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 116.394 -0.366 . . . . 73.54 111.28 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -50.2 152.71 1.66 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.528 0.566 . . . . 71.42 112.528 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.591 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -87.31 146.75 25.8 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.838 -0.619 . . . . 72.54 111.604 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 71.9 t -68.84 131.97 33.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 120.799 0.333 . . . . 61.24 110.585 172.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.446 HD13 ' HG ' ' A' ' 140' ' ' LEU . 17.9 mt -66.98 147.29 53.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.858 0.361 . . . . 52.43 111.307 178.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.401 ' HA ' ' HE1' ' A' ' 49' ' ' PHE . 46.7 t -90.44 151.28 21.47 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.248 -0.649 . . . . 65.5 109.248 169.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.494 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 73.8 t -48.91 -47.34 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 CA-C-O 121.002 0.43 . . . . 73.5 111.54 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -72.69 -40.41 66.24 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 116.296 -0.411 . . . . 74.23 111.979 177.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -60.36 -33.71 72.83 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 121.849 0.833 . . . . 73.02 110.249 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.623 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.5 tt -65.62 -39.35 91.4 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 114.914 -1.039 . . . . 71.32 110.379 174.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.548 HD21 HG21 ' A' ' 40' ' ' VAL . 57.1 mt -60.22 -47.82 84.35 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.091 0.472 . . . . 72.25 110.386 175.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -57.84 -35.11 70.46 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.879 -0.6 . . . . 72.42 111.01 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.26 -46.77 66.46 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 112.166 0.432 . . . . 75.23 112.166 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.443 HD11 ' HB2' ' A' ' 146' ' ' SER . 2.7 pp -81.57 -4.81 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 112.184 0.439 . . . . 71.4 112.184 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 86.31 40.28 7.47 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 121.391 -0.433 . . . . 71.15 114.147 174.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.443 ' HB2' HD11 ' A' ' 144' ' ' ILE . 48.2 t . . . . . 0 N--CA 1.476 0.833 0 CA-C-N 116.985 0.392 . . . . 53.32 111.286 175.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.427 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.414 0 CA-C-O 120.878 0.37 . . . . 70.33 111.549 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -153.08 151.41 23.2 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.289 -0.481 . . . . 62.13 113.047 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.5 t -153.18 104.24 2.78 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 122.532 -0.393 . . . . 65.21 111.289 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.9 p -93.2 79.48 4.5 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.55 0.69 . . . . 70.03 111.51 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -87.83 105.04 17.14 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.711 0.767 . . . . 74.03 110.834 -179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -102.56 165.9 10.82 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.708 -0.678 . . . . 75.03 112.616 -172.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -148.64 137.03 21.2 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.704 -0.68 . . . . 74.24 110.657 -178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -130.43 101.54 5.78 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.202 0.525 . . . . 74.03 112.162 -177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -146.64 141.24 26.68 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.097 -0.501 . . . . 70.12 110.82 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -150.07 103.75 3.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.162 -0.472 . . . . 71.55 110.461 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 93.5 p -137.62 143.85 41.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.032 0.444 . . . . 75.12 112.04 -175.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.8 m -155.36 146.05 22.22 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.188 -0.46 . . . . 61.45 110.964 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -94.3 172.02 31.48 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.117 -0.563 . . . . 53.52 112.911 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -143.01 108.41 5.04 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 120.917 0.389 . . . . 73.4 111.336 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -161.22 92.1 0.89 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.077 0.465 . . . . 73.34 111.075 178.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -118.62 107.96 14.36 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.2 -0.454 . . . . 74.21 111.28 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -105.94 160.97 14.87 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.004 0.43 . . . . 64.51 111.409 178.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -75.97 167.48 21.8 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 120.87 0.367 . . . . 64.33 111.762 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -165.52 113.47 0.98 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.321 -0.4 . . . . 72.24 110.827 175.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -125.54 128.41 47.92 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.555 -0.293 . . . . 71.44 111.413 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -175.39 162.87 32.53 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 116.269 -0.423 . . . . 64.41 112.671 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -157.79 98.53 1.64 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.964 0.412 . . . . 72.44 111.549 -177.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.721 ' HA ' ' HB3' ' A' ' 128' ' ' GLU . 10.0 ptp -81.86 154.6 25.78 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.603 0.716 . . . . 65.35 112.477 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.604 HD13 ' HB3' ' A' ' 61' ' ' ASP . 10.0 mt -103.11 131.68 49.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.289 -0.869 . . . . 73.5 110.838 175.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -78.01 106.8 10.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 122.052 0.929 . . . . 74.13 111.176 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.429 HG12 ' HA2' ' A' ' 94' ' ' GLY . 32.9 m -132.58 166.85 28.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 114.392 -1.276 . . . . 73.23 111.947 -170.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 31.1 tt0 -103.4 123.05 46.12 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 121.115 0.483 . . . . 75.11 110.891 171.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.531 HG22 HD11 ' A' ' 96' ' ' ILE . 36.7 t -93.74 114.08 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 115.917 -0.583 . . . . 63.13 111.725 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.493 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 3.1 mt -98.99 161.5 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 112.244 0.461 . . . . 65.55 112.244 -176.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.63 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 75.0 m -127.76 105.65 8.6 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 116.242 -0.436 . . . . 62.53 110.907 174.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.404 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . -108.1 135.24 12.69 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.174 -0.536 . . . . 73.25 113.593 -176.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.486 ' HD3' ' HA ' ' A' ' 35' ' ' ASN . 39.1 ttm180 -64.79 95.84 0.16 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.668 0.618 . . . . 74.52 112.668 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 47.0 p -89.28 -19.59 25.14 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.319 -0.401 . . . . 73.11 110.683 170.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.1 mt -111.08 113.22 25.6 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 115.962 -0.563 . . . . 61.33 110.207 174.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 32' ' ' ARG . 88.2 m-20 -80.25 -24.38 40.17 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 112.302 0.482 . . . . 63.43 112.302 -176.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -70.56 114.91 9.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.821 0.343 . . . . 75.14 111.207 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -75.58 72.0 1.78 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.821 -0.704 . . . . 72.02 112.874 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.622 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . . . -114.53 172.27 7.13 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.123 0.487 . . . . 73.34 111.603 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 67.6 p -86.27 163.42 17.74 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.23 -0.441 . . . . 74.23 111.348 177.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.7 t -58.85 -38.59 73.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.279 0.561 . . . . 74.03 110.257 173.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -58.78 -44.09 90.58 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.559 -0.746 . . . . 63.3 111.226 176.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.43 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 4.5 tp10 -60.32 -32.57 71.36 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.236 0.541 . . . . 74.35 111.847 178.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.622 ' HE2' ' HB3' ' A' ' 38' ' ' ALA . 65.9 mttm -112.58 31.44 6.34 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.756 0.651 . . . . 74.31 112.756 -174.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 83.3 mt -64.11 83.8 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.235 0.541 . . . . 64.02 111.331 175.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.4 t -170.71 -179.25 2.83 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.773 -0.649 . . . . 74.31 111.079 -178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -58.09 -26.67 62.87 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 111.924 0.342 . . . . 63.3 111.924 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -54.15 -40.91 67.87 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.826 0.346 . . . . 74.21 111.366 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.625 ' HE2' ' HD3' ' A' ' 102' ' ' PRO . 0.3 OUTLIER -76.05 -23.02 55.07 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.989 0.423 . . . . 73.02 111.405 179.202 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -75.2 -69.34 0.48 Allowed 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.325 0.583 . . . . 74.11 111.116 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -63.51 -8.19 8.84 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.943 0.72 . . . . 72.32 112.943 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.03 -34.28 13.77 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.632 0.975 . . . . 60.51 113.632 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 48' ' ' TYR . 28.8 m -131.92 7.58 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 N-CA-C 114.014 1.116 . . . . 75.32 114.014 -173.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.594 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -90.71 20.58 4.59 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.105 0.78 . . . . 71.52 113.105 -174.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.442 ' CD2' ' HD3' ' A' ' 87' ' ' LYS . 26.3 p90 -140.1 152.75 46.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.166 0.507 . . . . 71.24 111.829 -177.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -119.44 135.63 54.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.703 -0.681 . . . . 72.5 110.1 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.524 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 36.0 mt-10 -97.47 115.11 27.17 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.89 0.376 . . . . 73.33 111.085 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 58' ' ' ASN . 4.2 mp -109.13 156.73 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.169 0.509 . . . . 74.03 110.734 -177.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.659 ' ND2' HG23 ' A' ' 91' ' ' VAL . 3.1 m120 -63.57 151.78 40.54 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.893 -0.594 . . . . 71.34 111.308 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 30.1 tt0 -67.16 -41.3 86.25 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 111.847 0.314 . . . . 75.53 111.847 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -63.9 -49.54 72.26 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.84 0.352 . . . . 75.42 111.178 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.604 ' HB3' HD13 ' A' ' 24' ' ' LEU . 58.8 m-20 -65.96 -31.02 71.69 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 121.05 0.452 . . . . 72.35 111.349 177.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.427 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 62.7 t-105 -54.45 -54.58 38.93 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.308 0.575 . . . . 74.14 111.22 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -70.66 -29.8 66.24 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.993 -0.549 . . . . 52.31 111.14 177.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.76 -39.36 84.58 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.917 0.389 . . . . 35.25 111.453 177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.47 HD13 ' HA ' ' A' ' 128' ' ' GLU . 94.0 mt -88.54 -13.25 40.59 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.447 -0.342 . . . . 73.24 111.748 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.86 48.24 42.61 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.98 -0.628 . . . . 55.13 112.439 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.723 HD23 ' HE3' ' A' ' 129' ' ' LYS . 90.5 mt -85.36 158.79 20.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.611 0.72 . . . . 73.41 112.026 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -135.09 130.0 34.84 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.26 -0.882 . . . . 75.01 109.062 178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.81 90.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.712 0.768 . . . . 61.34 111.917 -172.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.68 -7.33 2.47 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-N 114.765 -1.107 . . . . 74.11 114.38 -177.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -90.71 -175.6 4.45 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 118.527 1.163 . . . . 73.44 112.735 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.484 ' HG3' HG23 ' A' ' 134' ' ' VAL . 8.5 mpt_? -106.05 133.87 50.08 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.261 0.553 . . . . 73.3 112.426 -172.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 86' ' ' ALA . 28.1 m -126.25 144.39 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 116.021 -0.536 . . . . 74.25 111.392 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.623 ' HD3' ' HE2' ' A' ' 76' ' ' LYS . 23.1 ttmm -105.32 151.06 24.62 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.111 0.481 . . . . 74.02 110.934 177.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.4 t -130.45 137.24 56.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.907 -0.588 . . . . 74.34 109.491 -178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.623 ' HE2' ' HD3' ' A' ' 74' ' ' LYS . 23.4 mttm -137.83 132.33 32.44 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.757 0.651 . . . . 61.3 112.757 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.537 HG22 ' HA3' ' A' ' 125' ' ' GLY . 32.8 p -136.09 -171.75 2.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.62 -0.718 . . . . 72.15 110.19 176.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.29 -8.92 57.93 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.796 0.331 . . . . 73.05 111.501 175.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -91.3 -38.5 12.61 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.777 0.322 . . . . 71.33 111.493 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.26 -148.27 11.96 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.127 -0.559 . . . . 24.23 112.994 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -154.5 156.74 37.24 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.254 0.465 . . . . 54.15 112.254 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 p -153.49 150.34 12.48 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.8 0 CA-C-N 116.213 -0.448 . . . . 64.5 111.288 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.2 t -110.58 118.02 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 N-CA-C 110.399 -0.223 . . . . 74.5 110.399 175.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.483 HG12 ' CD2' ' A' ' 103' ' ' TYR . 33.6 m -124.78 177.24 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 120.808 0.337 . . . . 72.52 111.78 -177.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -79.73 144.88 33.25 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.853 0.359 . . . . 72.21 111.351 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.536 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -90.27 123.5 34.11 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 112.482 0.549 . . . . 72.11 112.482 -178.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.442 ' HD3' ' CD2' ' A' ' 54' ' ' TYR . 43.3 mtpt -133.21 156.75 46.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.021 -0.536 . . . . 61.03 110.734 173.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -98.15 128.71 44.79 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.218 -0.446 . . . . 73.34 111.291 -177.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.524 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -128.35 154.52 20.0 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 120.976 -0.63 . . . . 62.32 113.47 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -79.32 46.75 0.75 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.158 0.504 . . . . 44.34 111.54 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.659 HG23 ' ND2' ' A' ' 58' ' ' ASN . 28.5 m -95.58 159.79 31.83 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 116.09 -0.505 . . . . 72.01 111.564 -177.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.432 ' O ' ' HB3' ' A' ' 95' ' ' MET . 38.6 Cg_exo -62.1 134.24 48.25 Favored 'Trans proline' 0 N--CA 1.487 1.104 0 C-N-CA 122.887 2.391 . . . . 65.0 113.059 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -53.79 134.5 42.32 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 120.775 0.322 . . . . 74.43 111.821 -175.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.429 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 76.49 27.88 60.61 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 120.722 -0.752 . . . . 73.25 112.745 -172.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.537 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 22.3 ttt -153.39 135.07 14.46 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.448 -0.575 . . . . 64.41 109.448 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.531 HD11 HG22 ' A' ' 28' ' ' VAL . 39.5 pt -128.03 144.27 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.47 0.652 . . . . 70.31 112.093 -174.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.404 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 77.2 t80 -105.3 119.55 39.35 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.909 -0.587 . . . . 71.42 111.564 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.63 ' O ' ' HA ' ' A' ' 30' ' ' SER . 48.2 mt -117.34 128.96 25.67 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 109.916 -0.401 . . . . 64.24 109.916 172.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.455 ' HB2' HG12 ' A' ' 52' ' ' VAL . 47.8 Cg_exo -57.84 141.8 96.01 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 122.033 1.822 . . . . 73.41 112.576 176.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.6 tpt -55.29 102.38 0.07 Allowed 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.91 0.386 . . . . 72.43 111.501 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -158.97 179.65 34.46 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.59 -0.814 . . . . 74.54 113.52 -178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.625 ' HD3' ' HE2' ' A' ' 48' ' ' TYR . 36.5 Cg_endo -63.54 -26.44 69.8 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 122.529 2.152 . . . . 73.0 112.213 -176.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.483 ' CD2' HG12 ' A' ' 84' ' ' VAL . 26.9 m-85 -61.49 -48.99 78.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.784 0.802 . . . . 73.33 109.309 173.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.59 -33.28 75.25 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.221 -0.899 . . . . 73.15 111.391 173.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' A' ' 102' ' ' PRO . 8.7 m120 -62.92 -12.69 26.92 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 122.045 -0.409 . . . . 65.33 111.844 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.51 ' SD ' HD21 ' A' ' 140' ' ' LEU . 40.6 mtp -89.41 -15.02 34.18 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.576 -0.283 . . . . 75.02 111.464 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.3 m -128.8 -14.75 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 113.028 0.751 . . . . 73.31 113.028 -175.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.505 HG21 ' OG ' ' A' ' 30' ' ' SER . 7.5 pt -104.25 178.16 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 O-C-N 121.854 -0.529 . . . . 75.52 111.861 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -91.12 111.19 47.23 Favored Pre-proline 0 CA--C 1.542 0.67 0 CA-C-N 116.084 -0.507 . . . . 74.12 110.52 175.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -85.45 7.16 5.25 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.494 2.129 . . . . 73.04 113.764 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.6 t -100.2 -19.83 16.22 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 112.426 0.528 . . . . 73.4 112.426 -175.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 1.8 t -61.2 149.01 38.94 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.619 0.6 . . . . 63.14 112.619 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -114.72 24.46 11.78 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.725 -0.671 . . . . 70.04 110.958 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -67.53 79.6 0.17 Allowed Glycine 0 CA--C 1.529 0.967 0 CA-C-N 116.275 -0.42 . . . . 52.42 113.89 -178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 68.9 p -100.03 16.0 25.42 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 122.65 -0.324 . . . . 64.33 111.783 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.94 -127.6 0.1 Allowed Glycine 0 CA--C 1.529 0.94 0 N-CA-C 114.631 0.612 . . . . 70.32 114.631 -173.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 79.2 mtp -100.6 155.24 36.58 Favored Pre-proline 0 CA--C 1.539 0.543 0 O-C-N 122.457 -0.437 . . . . 62.14 111.758 -174.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -56.64 117.17 3.8 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.833 2.355 . . . . 62.31 113.319 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -137.73 126.84 24.39 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.179 -0.464 . . . . 61.04 110.399 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -75.83 82.23 2.76 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 112.702 0.63 . . . . 74.2 112.702 -174.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -154.18 145.98 23.41 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.133 -0.485 . . . . 74.44 111.385 172.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.493 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . -140.15 -164.16 9.79 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 116.064 -0.516 . . . . 54.53 112.982 177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.4 t -89.04 123.69 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 120.816 0.341 . . . . 74.32 111.636 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 67.5 mttm -66.28 149.54 50.2 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.573 0.582 . . . . 73.51 112.573 -177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.537 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -178.65 -155.86 15.59 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 115.926 -0.579 . . . . 55.52 112.963 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.42 HG21 ' SD ' ' A' ' 23' ' ' MET . 67.7 p -131.87 159.72 37.76 Favored 'General case' 0 N--CA 1.475 0.825 0 O-C-N 122.244 -0.562 . . . . 64.12 111.863 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.75 144.44 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 CA-C-N 116.31 -0.405 . . . . 71.11 111.681 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.721 ' HB3' ' HA ' ' A' ' 23' ' ' MET . 13.8 pt-20 -164.84 168.61 17.56 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 116.314 -0.403 . . . . 72.34 111.015 173.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.723 ' HE3' HD23 ' A' ' 67' ' ' LEU . 34.7 ttmt -68.75 148.54 50.21 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.222 0.534 . . . . 71.44 112.182 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 t -146.19 155.95 43.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.088 -0.505 . . . . 74.34 111.126 175.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -89.31 -2.61 58.51 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.139 0.495 . . . . 72.13 110.99 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.89 173.32 3.67 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.667 0.617 . . . . 53.11 112.667 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -88.86 148.55 23.81 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.845 -0.616 . . . . 64.32 111.867 -179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.484 HG23 ' HG3' ' A' ' 72' ' ' ARG . 73.4 t -69.76 124.32 25.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.049 -0.523 . . . . 62.12 109.854 170.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 135' ' ' LEU . 10.3 mt -70.57 89.66 0.72 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.967 -0.293 . . . . 61.41 111.502 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 37.5 m -47.8 148.62 1.52 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.078 -0.51 . . . . 71.12 110.816 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.494 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 72.0 t -44.8 -45.15 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 112.465 0.543 . . . . 72.34 112.465 -173.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -72.15 -47.85 47.93 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 120.79 0.329 . . . . 55.24 111.712 178.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -55.91 -38.23 69.96 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.233 0.539 . . . . 61.41 110.501 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.51 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.7 tt -61.18 -42.3 98.33 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.465 -0.788 . . . . 72.32 111.09 177.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 31.1 mt -56.83 -47.48 80.21 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.549 0.69 . . . . 64.43 110.387 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -77.04 -30.7 55.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.551 -0.75 . . . . 72.45 111.712 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.42 -41.4 97.09 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 111.753 0.279 . . . . 73.13 111.753 178.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.9 pt -75.84 -7.83 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 112.091 0.404 . . . . 71.45 112.091 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 109.43 9.01 26.11 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.193 -0.527 . . . . 63.44 114.155 177.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.473 0.701 0 CA-C-O 121.621 0.725 . . . . 55.04 111.775 179.532 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.571 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 120.803 0.335 . . . . 75.4 111.826 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -166.45 137.07 4.46 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.116 -0.564 . . . . 63.43 112.79 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.5 m -157.7 167.0 31.31 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 120.97 0.414 . . . . 71.5 111.952 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 87.8 p -163.21 161.93 25.16 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.144 0.497 . . . . 62.32 111.881 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.5 m80 -124.91 138.24 54.25 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.976 -0.556 . . . . 75.23 110.112 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.9 t60 -128.03 132.16 49.12 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.691 0.626 . . . . 70.34 112.691 -166.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.3 p-80 -170.63 121.98 0.61 Allowed 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 116.293 -0.412 . . . . 64.31 111.313 174.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -96.55 -55.06 3.04 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 122.252 -0.28 . . . . 71.41 110.956 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 86.0 t60 43.38 88.89 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.503 1.297 . . . . 75.54 114.503 170.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -153.21 172.55 16.79 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-O 121.031 0.443 . . . . 53.35 111.788 174.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.9 p -150.71 -174.39 4.76 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.131 -0.486 . . . . 71.12 111.294 -178.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.1 t -147.7 170.66 17.07 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 120.827 0.346 . . . . 71.22 111.552 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -119.2 149.3 18.12 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.631 -0.318 . . . . 65.13 112.617 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -101.25 -89.8 0.35 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 117.153 0.476 . . . . 70.33 112.002 -176.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 64.98 114.94 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 112.792 0.664 . . . . 75.41 112.792 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -140.72 112.95 7.86 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.367 -0.379 . . . . 72.01 111.154 -178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mp -105.25 166.61 10.29 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.826 0.676 . . . . 74.3 112.826 -176.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.64 167.34 20.25 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 115.895 -0.593 . . . . 73.53 111.374 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -123.42 179.85 4.59 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.2 -0.455 . . . . 71.13 110.96 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -135.5 143.22 45.68 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.084 0.469 . . . . 74.33 112.059 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 98.42 178.68 32.65 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.374 -0.441 . . . . 63.12 113.609 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -79.96 76.73 6.67 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.077 0.465 . . . . 54.22 111.064 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.0 ptm -87.49 148.65 24.84 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 116.158 -0.474 . . . . 64.52 110.444 174.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 40.1 mt -106.6 124.52 49.73 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.184 0.809 . . . . 72.15 113.184 -173.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -72.06 102.55 3.01 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.601 -1.182 . . . . 71.43 110.444 176.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.3 m -119.39 166.16 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-O 121.005 0.431 . . . . 75.21 111.898 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.636 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 37.1 tt0 -99.84 115.99 30.88 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.807 0.337 . . . . 72.33 110.436 172.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.559 HG22 HD11 ' A' ' 96' ' ' ILE . 21.2 t -90.46 110.96 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 116.077 -0.511 . . . . 74.32 111.724 -175.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 mt -100.09 153.22 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 120.838 0.351 . . . . 72.22 111.651 -177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.1 t -120.07 103.63 9.45 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.903 0.383 . . . . 73.24 110.581 175.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -98.58 128.83 9.69 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 121.076 -0.583 . . . . 74.25 113.171 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -72.35 92.1 1.39 Allowed 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.394 0.616 . . . . 75.14 111.248 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.0 p -92.53 -49.83 5.92 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.786 -0.643 . . . . 70.32 112.08 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -60.14 98.4 0.06 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.954 0.407 . . . . 61.34 111.655 178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -62.77 -11.49 18.07 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 116.219 -0.446 . . . . 74.1 111.855 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -51.84 -32.72 32.99 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.232 0.456 . . . . 73.15 112.232 175.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 59.72 69.35 1.31 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.037 -0.602 . . . . 72.23 112.627 -176.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.454 ' HB3' ' HD2' ' A' ' 43' ' ' LYS . . . -166.63 168.77 14.2 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.634 -0.333 . . . . 71.12 111.568 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.5 p -76.06 -173.31 2.3 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.872 0.368 . . . . 64.53 110.557 176.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.569 ' HA ' ' CE2' ' A' ' 48' ' ' TYR . 14.3 p -71.98 -29.61 33.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 CA-C-O 120.735 0.303 . . . . 71.33 111.368 175.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -63.86 -38.2 90.22 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.127 0.417 . . . . 75.41 112.127 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -65.48 -32.15 73.61 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.586 0.588 . . . . 71.11 112.586 178.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.606 ' HB2' ' HD2' ' A' ' 48' ' ' TYR . 1.2 mppt? -122.29 51.63 1.36 Allowed 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.981 -0.449 . . . . 53.11 112.15 -175.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.0 mt -70.94 86.47 0.71 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.265 0.555 . . . . 45.54 111.403 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.8 t -157.14 173.9 16.29 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.729 -0.669 . . . . 73.25 111.294 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -64.75 -29.97 70.97 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.805 0.336 . . . . 75.1 111.469 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -58.65 -26.25 63.58 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.951 0.405 . . . . 73.23 111.237 176.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.606 ' HD2' ' HB2' ' A' ' 43' ' ' LYS . 2.6 t80 -76.34 -38.17 56.28 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.461 0.648 . . . . 70.52 110.026 174.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -58.02 -62.94 1.45 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.425 -0.807 . . . . 72.11 110.435 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -70.68 0.89 6.07 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.54 0.57 . . . . 53.31 112.54 -177.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.43 -34.64 11.44 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.59 0.589 . . . . 72.33 112.59 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.495 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 32.9 m -125.06 2.29 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 113.832 1.049 . . . . 73.42 113.832 -174.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.47 HD22 ' N ' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -89.76 34.22 0.84 Allowed 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.005 0.743 . . . . 61.1 113.005 -176.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -150.24 159.31 44.53 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 121.626 -0.671 . . . . 73.32 112.448 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.27 132.4 45.91 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.949 -0.569 . . . . 41.53 110.9 176.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.763 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 35.2 mt-10 -87.86 114.96 24.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.208 0.528 . . . . 65.12 111.016 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.7 mt -111.49 148.46 14.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-N 115.582 -0.735 . . . . 72.21 111.478 -174.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -70.24 140.8 52.48 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 122.391 -0.193 . . . . 74.32 110.7 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.43 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 37.3 tt0 -54.71 -37.75 66.22 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.084 0.772 . . . . 74.33 113.084 -177.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.511 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 6.6 mm-40 -56.67 -53.59 55.96 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.152 -0.342 . . . . 74.3 111.485 176.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -63.31 -38.11 89.89 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.368 0.604 . . . . 51.33 110.447 176.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.43 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 52.5 t-105 -53.65 -45.63 70.3 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.36 -0.836 . . . . 75.55 111.513 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -69.87 -41.96 74.13 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.232 -0.44 . . . . 75.2 110.917 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.37 -37.3 82.89 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.546 0.573 . . . . 70.34 112.546 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.405 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 89.4 mt -86.98 -6.16 58.85 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.319 -0.4 . . . . 72.3 111.799 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.09 50.62 64.42 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 121.505 -0.379 . . . . 52.21 112.848 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.405 ' HG ' ' HB2' ' A' ' 65' ' ' LEU . 97.8 mt -90.88 160.3 15.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.473 0.654 . . . . 73.04 112.709 -175.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.5 mp0 -125.32 143.24 51.06 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.015 -0.993 . . . . 74.3 110.419 177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -63.16 94.88 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.599 0.714 . . . . 61.35 111.118 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.62 -6.69 7.47 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-N 115.133 -0.939 . . . . 24.22 114.182 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.44 -177.48 5.79 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.301 1.05 . . . . 54.33 111.678 178.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.424 ' HG3' HG23 ' A' ' 134' ' ' VAL . 2.8 mpt_? -105.8 123.48 48.03 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.329 0.492 . . . . 74.3 112.329 -174.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.632 HG13 ' HB2' ' A' ' 86' ' ' ALA . 26.6 m -114.21 148.71 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.044 -0.525 . . . . 70.35 110.871 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.448 ' HB2' HG21 ' A' ' 130' ' ' THR . 68.5 tttt -120.62 130.34 54.11 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.025 0.441 . . . . 74.32 111.261 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.8 t -108.9 134.84 49.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.27 -0.423 . . . . 74.11 111.356 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -125.91 140.53 52.56 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.925 0.393 . . . . 70.43 111.555 175.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 42.6 p -138.41 -172.22 3.23 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.952 0.501 . . . . 73.25 110.122 173.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -77.6 2.28 17.03 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 120.961 0.41 . . . . 63.11 111.29 174.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -101.18 -35.31 9.34 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 122.575 0.35 . . . . 72.23 111.455 176.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 163.45 -155.8 27.31 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.175 -0.536 . . . . 61.22 113.35 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.99 160.26 40.46 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.101 0.408 . . . . 64.44 112.101 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.5 p -160.57 150.61 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 CA-C-N 116.041 -0.527 . . . . 62.24 111.296 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.435 HG22 ' HG3' ' A' ' 74' ' ' LYS . 33.1 t -109.9 123.49 65.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 122.22 0.208 . . . . 64.22 111.304 177.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.485 ' HA ' HG13 ' A' ' 134' ' ' VAL . 27.5 m -133.38 172.21 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 122.652 0.381 . . . . 40.21 111.627 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -75.91 143.73 41.5 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.145 0.498 . . . . 75.31 111.792 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.632 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -84.59 128.36 34.56 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.057 -0.52 . . . . 63.22 112.388 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -129.94 158.3 39.92 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.655 0.74 . . . . 75.12 111.887 173.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt -101.44 102.49 13.29 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.256 -0.884 . . . . 73.22 109.617 176.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.763 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -99.64 -167.28 29.7 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.982 -0.627 . . . . 71.5 114.581 -170.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -97.53 9.37 42.61 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 122.846 0.459 . . . . 73.54 111.545 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.6 m -79.56 158.58 73.41 Favored Pre-proline 0 CA--C 1.542 0.651 0 CA-C-N 116.311 -0.404 . . . . 70.22 111.793 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.65 169.6 21.96 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.573 2.182 . . . . 63.43 112.653 174.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.511 ' HE2' ' HB3' ' A' ' 60' ' ' GLU . 49.2 tttm -65.91 148.75 51.3 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 120.732 0.301 . . . . 74.54 111.589 -177.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 66.12 30.46 76.93 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.261 -0.495 . . . . 61.34 112.816 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.636 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 13.2 ttt -153.63 136.97 15.75 Favored 'General case' 0 CA--C 1.541 0.604 0 O-C-N 122.62 -0.341 . . . . 70.13 110.319 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.559 HD11 HG22 ' A' ' 28' ' ' VAL . 40.3 pt -134.55 138.93 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-O 121.472 0.653 . . . . 73.4 112.021 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -101.44 123.37 45.39 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.722 -0.672 . . . . 74.54 111.176 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 30' ' ' SER . 40.2 mt -121.04 127.62 26.12 Favored Pre-proline 0 CA--C 1.541 0.618 0 O-C-N 122.277 -0.265 . . . . 73.31 110.877 175.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.495 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 14.0 Cg_endo -57.37 142.42 95.0 Favored 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 122.476 2.117 . . . . 74.34 112.708 177.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.14 103.34 0.27 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.267 -0.424 . . . . 75.2 111.074 -176.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.69 -178.53 31.82 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.883 -0.675 . . . . 42.12 112.528 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.573 ' O ' ' HG2' ' A' ' 106' ' ' MET . 23.9 Cg_endo -60.71 -31.35 91.88 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.435 2.09 . . . . 60.21 111.695 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.499 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 4.8 m-85 -62.58 -53.4 55.15 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.612 -0.722 . . . . 74.14 110.314 175.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.31 -43.59 88.21 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.051 -0.522 . . . . 50.53 110.756 174.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -54.21 -26.39 28.18 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.014 0.526 . . . . 72.11 112.2 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.573 ' HG2' ' O ' ' A' ' 102' ' ' PRO . 84.6 mmm -66.58 -21.41 66.14 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.191 0.441 . . . . 63.12 112.191 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.7 m -132.08 -27.48 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 112.87 0.692 . . . . 64.44 112.87 -172.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.445 HG21 ' HB2' ' A' ' 30' ' ' SER . 1.5 pp -87.02 170.09 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-O 121.033 0.444 . . . . 64.33 111.308 -176.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.419 ' OD2' ' HB2' ' A' ' 111' ' ' SER . 12.6 t0 -99.76 117.09 64.16 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.382 -0.372 . . . . 70.42 111.131 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -66.42 -2.91 7.99 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.81 2.34 . . . . 63.34 113.756 -176.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.419 ' HB2' ' OD2' ' A' ' 109' ' ' ASP . 16.5 m -77.98 22.91 0.27 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.009 0.374 . . . . 64.03 112.009 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 63.3 p -61.07 148.17 41.3 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 120.963 0.411 . . . . 73.02 112.037 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -58.45 128.16 35.77 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 112.75 0.648 . . . . 71.3 112.75 -172.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -74.75 -20.07 79.65 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.828 -0.701 . . . . 74.41 111.673 171.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 72.2 p -92.81 -75.32 0.49 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 122.625 0.37 . . . . 74.04 111.614 177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 150.37 140.6 3.24 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 121.387 -0.435 . . . . 62.1 113.049 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.401 ' HA ' ' HD3' ' A' ' 118' ' ' PRO . 84.0 mmm -125.77 149.23 64.94 Favored Pre-proline 0 N--CA 1.473 0.703 0 O-C-N 122.632 -0.334 . . . . 72.02 111.755 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 117' ' ' MET . 7.1 Cg_exo -73.78 165.26 32.68 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.909 2.406 . . . . 45.34 112.138 173.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 64.74 -165.43 0.24 Allowed 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.066 0.46 . . . . 73.34 111.47 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -115.57 124.35 50.77 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 120.835 0.35 . . . . 71.53 111.136 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -124.71 107.65 11.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.084 0.468 . . . . 64.13 111.416 175.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -125.74 167.94 17.99 Favored Glycine 0 CA--C 1.525 0.667 0 CA-C-N 116.3 -0.409 . . . . 60.44 112.676 176.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 77.0 t -80.8 126.14 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 N-CA-C 112.019 0.377 . . . . 41.01 112.019 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -62.32 145.78 52.89 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.152 0.427 . . . . 75.11 112.152 178.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -174.12 -163.42 27.49 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.393 -0.432 . . . . 42.33 112.884 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 54.5 p -126.24 142.69 51.43 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 122.628 -0.336 . . . . 61.52 111.3 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.0 p -132.01 143.25 40.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 120.9 0.381 . . . . 34.4 110.76 174.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.45 169.68 19.99 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.354 -0.385 . . . . 65.52 110.974 176.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -69.84 141.26 53.29 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.103 -0.373 . . . . 71.21 110.87 178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.448 HG21 ' HB2' ' A' ' 74' ' ' LYS . 10.1 t -132.4 161.4 33.73 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.348 0.594 . . . . 74.43 112.187 -177.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -83.03 -18.02 41.24 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.642 -0.708 . . . . 73.22 111.11 179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -69.68 152.51 44.6 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.581 0.705 . . . . 75.3 112.513 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.718 ' H ' ' HD3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -79.49 160.33 26.59 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.232 -0.894 . . . . 54.55 110.696 173.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.485 HG13 ' HA ' ' A' ' 84' ' ' VAL . 98.5 t -65.96 126.53 25.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.342 0 O-C-N 122.346 -0.222 . . . . 74.1 110.533 174.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.451 HD13 ' HG ' ' A' ' 140' ' ' LEU . 7.2 mt -56.06 131.83 48.53 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.07 0.462 . . . . 52.44 112.077 -176.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 12.9 m -71.94 140.68 49.3 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 109.697 -0.482 . . . . 64.33 109.697 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.43 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 89.3 t -46.48 -49.45 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 112.54 0.57 . . . . 71.31 112.54 -175.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -71.78 -42.53 67.04 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.944 0.402 . . . . 73.35 111.327 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -55.98 -34.64 65.94 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.682 0.753 . . . . 72.0 110.581 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.451 ' HG ' HD13 ' A' ' 135' ' ' LEU . 2.6 tt -65.89 -42.5 90.19 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.249 -0.887 . . . . 75.43 110.827 174.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 29.3 mt -59.69 -36.53 76.68 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.373 0.606 . . . . 73.14 110.622 177.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -74.31 -39.53 62.82 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.718 -0.674 . . . . 75.42 110.944 177.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.42 -37.13 79.9 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.645 0.609 . . . . 73.35 112.645 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.511 HD12 ' H ' ' A' ' 146' ' ' SER . 2.9 pp -75.67 -1.68 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 112.7 0.63 . . . . 72.23 112.7 -178.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 117.15 -60.51 0.44 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.461 -0.4 . . . . 34.44 113.281 177.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.511 ' H ' HD12 ' A' ' 144' ' ' ILE . 41.6 t . . . . . 0 N--CA 1.475 0.79 0 C-N-CA 122.673 0.389 . . . . 74.5 112.036 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.494 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.744 0.307 . . . . 72.33 111.247 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.32 154.92 30.03 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.063 -0.589 . . . . 52.13 113.475 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.8 p -150.88 -173.7 4.56 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.433 0.293 . . . . 61.02 110.557 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.2 t -143.21 159.72 41.78 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.252 0.548 . . . . 63.12 112.325 -177.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.9 p-80 -152.24 126.33 9.16 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.826 -0.625 . . . . 64.43 110.667 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.64 124.8 1.39 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.852 0.358 . . . . 53.41 111.864 -175.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.8 m80 -151.62 107.57 3.4 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.182 0.515 . . . . 74.44 112.017 177.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 -128.32 97.66 4.81 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.149 0.5 . . . . 72.24 110.81 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -132.47 123.54 26.83 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.145 -0.479 . . . . 71.33 110.671 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -154.45 131.45 10.93 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 111.867 0.321 . . . . 71.21 111.867 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.0 t -142.52 122.55 13.67 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.54 -0.3 . . . . 75.32 110.879 178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 84.0 p -110.48 158.99 17.91 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 112.462 0.542 . . . . 74.21 112.462 -175.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -179.9 143.43 5.58 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-N 115.871 -0.604 . . . . 60.32 112.017 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -141.97 98.52 3.35 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 117.414 0.607 . . . . 72.33 112.633 -176.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.81 155.55 23.84 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.865 0.364 . . . . 72.21 111.399 173.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -136.7 120.54 17.45 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.118 0.485 . . . . 72.33 112.063 -178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.4 mp -127.37 176.25 7.58 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.319 -0.4 . . . . 75.0 111.024 176.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -161.57 176.83 10.61 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.948 0.404 . . . . 75.01 111.578 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -105.63 118.33 36.31 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.27 -0.423 . . . . 72.43 110.454 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -89.21 -40.49 12.83 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.424 0.527 . . . . 74.3 112.424 -175.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -149.15 129.36 3.03 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 120.666 -0.778 . . . . 71.33 113.417 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -145.36 88.28 1.85 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.977 0.418 . . . . 72.11 111.626 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.7 ptm -83.81 160.57 21.17 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 120.927 0.394 . . . . 72.12 111.425 176.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.6 mt -115.52 146.2 41.92 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 120.914 0.387 . . . . 73.01 111.86 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -92.4 125.21 36.95 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.389 0.614 . . . . 70.24 111.233 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 27.5 m -142.14 160.64 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 115.22 -0.9 . . . . 53.02 111.882 -173.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 34.6 tt0 -98.49 116.9 31.72 Favored 'General case' 0 N--CA 1.469 0.523 0 O-C-N 122.045 -0.409 . . . . 74.31 110.53 173.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.615 HG22 HD11 ' A' ' 96' ' ' ILE . 47.1 t -88.25 106.44 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 115.91 -0.586 . . . . 51.53 111.627 -176.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.722 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 15.0 mt -91.91 158.1 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 120.837 0.351 . . . . 73.05 111.888 -177.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 62.2 m -140.29 94.47 2.75 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.085 0.469 . . . . 62.25 111.861 177.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -85.34 126.41 7.71 Favored Glycine 0 CA--C 1.525 0.664 0 CA-C-N 115.98 -0.555 . . . . 64.32 112.072 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -66.47 94.99 0.3 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.601 0.715 . . . . 72.54 111.58 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.5 p -101.97 -64.05 1.1 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 115.653 -0.703 . . . . 71.32 111.18 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.402 ' CD2' ' HA ' ' A' ' 48' ' ' TYR . 8.4 mp -92.84 7.95 41.63 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.125 0.417 . . . . 72.33 112.125 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -76.85 65.51 2.57 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.48 0.657 . . . . 71.35 110.056 178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -83.29 21.09 1.18 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.592 0.59 . . . . 74.2 112.592 -173.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.48 53.86 5.8 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.372 -0.918 . . . . 72.54 112.4 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.6 160.89 34.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.713 0.292 . . . . 72.44 111.024 -178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.529 ' OG1' ' HG2' ' A' ' 42' ' ' GLU . 43.4 p -78.82 162.13 26.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.881 -0.415 . . . . 70.41 109.881 172.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.486 HG13 ' CE1' ' A' ' 48' ' ' TYR . 25.7 t -62.76 -31.72 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.055 0.455 . . . . 61.24 111.083 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.493 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 40.4 mt-10 -74.87 -14.61 60.69 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.922 -0.581 . . . . 60.11 112.233 -178.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.529 ' HG2' ' OG1' ' A' ' 39' ' ' THR . 32.8 mm-40 -67.94 -28.52 67.55 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.176 0.512 . . . . 63.44 110.776 173.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.412 ' HB3' HG22 ' A' ' 45' ' ' THR . 4.9 mptp? -99.61 -68.06 0.82 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.05 -0.523 . . . . 72.22 111.823 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.493 ' HG ' ' HA ' ' A' ' 41' ' ' GLU . 77.7 mt 56.52 14.76 1.79 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 112.815 0.672 . . . . 73.11 112.815 -177.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.693 HG23 ' H ' ' A' ' 48' ' ' TYR . 4.2 t -79.7 157.7 27.12 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 112.473 0.546 . . . . 71.22 112.473 -177.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -58.04 -34.68 70.34 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.366 0.603 . . . . 74.33 110.384 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.61 -40.1 86.41 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 115.558 -0.746 . . . . 72.45 110.973 177.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.693 ' H ' HG23 ' A' ' 45' ' ' THR . 1.7 t80 -62.55 -39.08 92.49 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.151 0.5 . . . . 73.11 110.099 -179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -63.5 -68.1 0.37 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.826 -0.624 . . . . 65.23 110.314 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -55.09 -24.2 24.29 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.865 0.691 . . . . 72.41 112.865 -175.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.54 -38.08 18.92 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.307 0.854 . . . . 74.32 113.307 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 48' ' ' TYR . 13.7 m -108.35 7.99 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 112.873 0.694 . . . . 63.14 112.873 -175.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.481 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -98.53 18.98 15.38 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 113.44 0.904 . . . . 71.33 113.44 -175.881 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -135.65 159.39 41.79 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.98 0.733 . . . . 70.34 112.98 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -130.42 137.64 49.93 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 115.229 -0.896 . . . . 73.22 110.098 173.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.595 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 48.5 mt-10 -97.44 116.86 30.45 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.898 0.38 . . . . 73.3 111.626 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.5 ' HA ' HG22 ' A' ' 96' ' ' ILE . 4.1 mp -110.0 154.58 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 116.226 -0.443 . . . . 74.25 111.212 -177.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.405 ' N ' HG22 ' A' ' 57' ' ' ILE . 27.1 t-20 -68.52 148.78 50.08 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.736 0.414 . . . . 54.44 111.442 176.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 9.2 tp10 -52.46 -47.59 66.36 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.311 0.485 . . . . 73.2 112.311 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.55 ' HA ' HD21 ' A' ' 63' ' ' ASN . 7.7 mm-40 -62.6 -42.1 99.37 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.337 0.495 . . . . 65.24 112.337 -176.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -71.18 -30.51 66.5 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.409 0.623 . . . . 73.24 110.555 174.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.458 ' HZ2' ' N ' ' A' ' 69' ' ' GLU . 58.6 t-105 -59.14 -52.71 64.55 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.514 -0.766 . . . . 71.1 111.739 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.55 HD21 ' HA ' ' A' ' 60' ' ' GLU . 5.8 p30 -71.74 -30.34 65.5 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 111.612 0.227 . . . . 73.12 111.612 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.54 -43.98 89.43 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.088 0.47 . . . . 73.2 111.827 177.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 98.0 mt -89.25 -4.92 58.0 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.275 -0.42 . . . . 73.22 112.033 178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 60.72 50.49 66.96 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 121.218 -0.515 . . . . 75.41 112.967 -177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.429 HD23 ' HE2' ' A' ' 129' ' ' LYS . 86.9 mt -89.27 163.89 15.18 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 121.041 0.448 . . . . 63.22 112.162 -178.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -150.52 118.77 6.37 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.192 -0.458 . . . . 65.23 110.208 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.458 ' N ' ' HZ2' ' A' ' 62' ' ' TRP . 2.2 mp0 -40.2 105.74 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.33 0.863 . . . . 70.31 113.33 -168.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 120.66 -10.88 10.38 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-N 115.289 -0.869 . . . . 74.34 113.672 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -80.64 176.45 9.79 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 117.889 0.844 . . . . 73.14 111.31 176.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.402 ' HD2' ' N ' ' A' ' 72' ' ' ARG . 3.1 mpt_? -98.25 128.7 44.84 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.115 0.483 . . . . 71.2 112.045 -172.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 86' ' ' ALA . 15.3 m -119.43 135.53 59.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 CA-C-O 121.284 0.564 . . . . 71.35 111.723 174.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.553 ' HB3' ' HG3' ' A' ' 128' ' ' GLU . 5.4 tppp? -88.88 125.31 34.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.839 -0.619 . . . . 73.55 110.867 175.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 61.7 t -109.54 125.34 66.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 109.674 -0.491 . . . . 74.33 109.674 178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -132.41 132.89 43.27 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.141 0.496 . . . . 64.3 112.143 -173.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.623 HG22 ' HA3' ' A' ' 125' ' ' GLY . 37.1 p -136.07 -170.58 2.67 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.922 -0.581 . . . . 60.32 110.943 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.05 -6.39 52.55 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 116.029 -0.532 . . . . 72.52 111.709 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.412 ' CZ ' ' HB2' ' A' ' 109' ' ' ASP . 98.9 m-85 -99.82 -45.14 5.83 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.769 0.319 . . . . 74.15 111.582 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.2 -152.4 10.22 Favored Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.781 -0.723 . . . . 73.31 113.336 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 15.4 pt-20 -152.08 152.1 31.93 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.057 0.456 . . . . 61.04 111.641 -178.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 106' ' ' MET . 8.8 p -152.36 153.88 8.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 116.389 -0.369 . . . . 64.23 111.48 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 t -108.8 120.48 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 122.22 0.208 . . . . 52.32 110.882 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.431 HG12 ' CD2' ' A' ' 103' ' ' TYR . 32.8 m -130.29 172.5 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 111.992 0.367 . . . . 72.54 111.992 -178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -76.36 136.9 39.53 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.278 -0.419 . . . . 75.22 111.025 174.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.448 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -87.19 127.81 35.15 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.394 0.516 . . . . 65.14 112.394 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 86.9 mttt -127.74 146.91 50.42 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.262 0.553 . . . . 53.02 110.673 172.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 33.0 ttmt -84.68 126.96 33.83 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.875 -0.602 . . . . 52.21 110.122 176.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.595 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -118.86 -175.81 16.34 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.735 -0.745 . . . . 75.53 114.478 -173.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -92.74 9.35 35.41 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.617 0.722 . . . . 70.45 110.221 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.9 m -75.14 151.51 85.98 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 115.456 -0.793 . . . . 62.23 112.44 -176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.27 166.12 28.07 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.019 2.479 . . . . 65.32 112.943 176.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -66.14 147.04 53.93 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 120.769 0.319 . . . . 73.45 111.287 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 64.74 27.05 71.5 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.767 -0.73 . . . . 65.24 113.071 -174.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.541 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 21.6 ttt -152.11 136.39 16.69 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 122.218 -0.578 . . . . 71.2 110.406 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.615 HD11 HG22 ' A' ' 28' ' ' VAL . 39.9 pt -136.53 141.58 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-O 121.193 0.521 . . . . 71.21 111.975 -177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -101.46 132.11 47.24 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 120.858 0.361 . . . . 73.11 111.532 179.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 30' ' ' SER . 39.1 mt -127.89 136.66 29.33 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 116.245 -0.434 . . . . 61.21 110.427 173.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.535 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 31.1 Cg_endo -65.28 131.8 29.51 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.076 1.851 . . . . 73.43 112.254 172.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.73 104.0 0.1 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.875 0.369 . . . . 74.33 110.912 -179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.0 -175.52 28.01 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.925 -0.655 . . . . 54.41 112.918 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.447 ' O ' ' HG2' ' A' ' 106' ' ' MET . 19.5 Cg_endo -57.04 -34.91 98.58 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.99 2.46 . . . . 70.43 112.357 -178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.431 ' CD2' HG12 ' A' ' 84' ' ' VAL . 28.8 m-85 -64.77 -53.64 43.82 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.216 -0.447 . . . . 72.32 110.832 177.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -58.29 -38.47 77.09 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.315 0.578 . . . . 54.33 111.104 175.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -55.17 -22.29 16.76 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 115.881 -0.599 . . . . 60.03 112.408 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.63 ' SD ' HD21 ' A' ' 140' ' ' LEU . 90.2 mmm -78.75 -15.19 58.74 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.222 0.453 . . . . 73.43 112.222 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 23.1 m -129.23 -18.36 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.691 0 N-CA-C 113.179 0.807 . . . . 44.55 113.179 -176.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.608 HG21 ' OG ' ' A' ' 30' ' ' SER . 12.9 pt -96.75 176.36 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 O-C-N 121.811 -0.556 . . . . 71.01 112.377 -177.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.592 ' H ' HG21 ' A' ' 123' ' ' VAL . 18.7 t0 -102.16 112.95 65.98 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.895 -0.593 . . . . 72.51 110.736 176.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -79.45 -1.06 11.22 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 122.507 2.138 . . . . 75.11 113.185 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.0 m -78.37 51.06 0.99 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.975 0.417 . . . . 71.25 111.387 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 72.7 p -98.37 95.06 7.09 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 112.456 0.539 . . . . 74.43 112.456 -174.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -98.46 138.72 35.27 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.151 -0.477 . . . . 74.55 110.628 174.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 138.21 158.26 7.72 Favored Glycine 0 CA--C 1.526 0.741 0 C-N-CA 121.275 -0.488 . . . . 40.22 112.465 -176.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 57.6 p -76.65 -18.51 58.53 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.781 0.66 . . . . 61.01 112.781 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -143.49 138.37 8.12 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 120.654 -0.784 . . . . 72.54 113.958 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 86.3 mtp -90.54 155.7 45.85 Favored Pre-proline 0 CA--C 1.542 0.639 0 C-N-CA 122.433 0.293 . . . . 65.32 111.277 177.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -64.25 107.7 0.86 Allowed 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 122.237 1.958 . . . . 74.25 112.205 176.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -65.84 -12.87 57.72 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.272 0.842 . . . . 70.12 113.272 -171.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -145.33 18.22 1.54 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.665 0.617 . . . . 75.33 112.665 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -137.77 155.72 48.75 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 120.631 0.253 . . . . 61.4 111.222 177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.722 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . -151.06 -151.08 5.48 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.42 -0.895 . . . . 64.41 114.36 -175.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.592 HG21 ' H ' ' A' ' 109' ' ' ASP . 86.6 t -92.7 123.61 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 122.747 0.419 . . . . 65.21 111.431 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 95.9 mttt -72.78 150.54 42.69 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 121.111 0.482 . . . . 72.13 112.192 -176.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.623 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -177.2 -140.89 3.81 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-N 116.015 -0.539 . . . . 63.04 113.024 -178.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 67.3 p -142.81 163.55 32.51 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 122.35 -0.5 . . . . 72.31 111.879 -178.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.0 p -142.4 145.32 23.71 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 CA-C-N 116.136 -0.484 . . . . 71.44 110.884 176.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.553 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 8.7 pt-20 -152.09 152.3 32.19 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.286 0.476 . . . . 72.24 112.286 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.429 ' HE2' HD23 ' A' ' 67' ' ' LEU . 9.5 tppt? -62.7 137.31 58.23 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 116.426 -0.352 . . . . 53.12 110.93 172.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.0 t -134.7 153.28 52.07 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-O 121.05 0.452 . . . . 72.22 111.957 177.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.27 6.66 46.17 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.507 0.67 . . . . 65.41 110.621 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -80.6 -175.96 5.51 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.447 0.641 . . . . 65.52 112.056 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -101.56 154.0 19.24 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.615 -0.721 . . . . 64.43 111.001 177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 93.1 t -64.39 122.26 14.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 110.338 -0.245 . . . . 65.05 110.338 173.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.407 ' HA ' HD23 ' A' ' 135' ' ' LEU . 3.3 mt -62.45 90.96 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 111.636 0.236 . . . . 74.03 111.636 -176.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.1 m -46.05 147.66 0.99 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.164 -0.471 . . . . 61.35 111.669 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.544 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 85.8 t -45.74 -53.6 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 N-CA-C 113.118 0.784 . . . . 61.35 113.118 -173.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.853 ' HD3' HD12 ' A' ' 141' ' ' LEU . 16.1 tppt? -72.49 -39.07 67.94 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.08 -0.387 . . . . 71.24 111.598 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -55.77 -38.17 69.51 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-O 121.666 0.746 . . . . 75.4 110.205 176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.63 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.2 tt -63.76 -40.16 96.03 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 115.098 -0.955 . . . . 75.42 110.547 174.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.853 HD12 ' HD3' ' A' ' 138' ' ' LYS . 43.1 mt -61.55 -42.42 98.81 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 121.31 0.576 . . . . 75.45 110.285 175.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 138' ' ' LYS . 32.1 mm-40 -60.03 -46.29 89.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.744 -0.662 . . . . 73.23 110.573 176.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.63 -43.59 84.94 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.748 -0.66 . . . . 73.32 112.213 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 141' ' ' LEU . 2.7 pp -76.48 -20.91 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 112.263 0.468 . . . . 73.33 112.263 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 166.77 -48.99 0.25 Allowed Glycine 0 CA--C 1.528 0.856 0 C-N-CA 120.568 -0.825 . . . . 72.43 113.939 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.1 t . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 121.126 0.489 . . . . 70.55 111.895 -176.709 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtm . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 120.811 0.339 . . . . 52.52 111.122 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -97.57 107.91 3.56 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.319 -0.467 . . . . 71.13 112.926 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.6 p -153.09 146.77 25.13 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.906 0.384 . . . . 73.43 111.21 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.9 p -147.21 127.16 13.59 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.179 0.514 . . . . 45.11 112.259 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.2 m170 -122.63 139.25 54.14 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.067 -0.515 . . . . 63.32 110.23 171.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -92.75 142.89 26.85 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.539 0.685 . . . . 72.45 112.398 -175.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -97.77 72.21 2.26 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.754 -0.657 . . . . 73.22 111.932 -175.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.68 129.94 40.99 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 116.159 -0.473 . . . . 51.0 111.817 177.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -133.73 154.71 50.76 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.853 0.359 . . . . 73.43 111.582 -175.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.0 m170 -76.82 122.76 25.25 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.833 0.349 . . . . 74.52 110.701 174.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.2 m -71.41 88.89 0.9 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.401 0.519 . . . . 65.03 112.401 -174.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.7 t -77.34 138.99 39.66 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.743 0.306 . . . . 51.21 110.573 175.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -101.26 -169.66 28.13 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.07 -0.586 . . . . 62.23 114.312 -174.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -99.4 114.79 27.9 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 120.853 0.359 . . . . 71.23 110.569 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -114.44 -158.88 0.68 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.747 0.308 . . . . 72.15 111.775 -177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -49.43 105.92 0.1 Allowed 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 121.308 0.575 . . . . 74.33 112.118 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 32.3 mt -71.64 160.84 31.95 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.064 -0.516 . . . . 73.45 112.106 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 61.97 16.53 8.19 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 116.249 -0.432 . . . . 75.21 111.985 -178.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -53.1 127.42 24.05 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.148 0.499 . . . . 74.44 111.965 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -146.17 -27.47 0.43 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.944 -0.571 . . . . 74.04 111.306 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.88 -134.53 12.97 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 121.066 -0.587 . . . . 61.23 113.125 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -167.96 93.55 0.38 Allowed 'General case' 0 N--CA 1.468 0.464 0 O-C-N 122.752 -0.264 . . . . 64.34 111.005 -177.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.1 ptm -78.76 147.34 33.4 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.132 0.491 . . . . 55.45 111.704 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.5 mt -116.34 131.42 56.95 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.188 -0.46 . . . . 64.12 112.109 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.7 ' HG3' HG22 ' A' ' 126' ' ' THR . 1.1 mp0 -73.03 136.58 45.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.505 0.669 . . . . 60.3 111.42 175.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 15.8 m -148.27 158.1 7.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.069 -0.969 . . . . 50.41 111.616 -172.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.631 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 32.7 tt0 -99.21 111.85 24.14 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.018 0.437 . . . . 73.34 110.183 172.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.512 HG22 HD11 ' A' ' 96' ' ' ILE . 39.6 t -88.48 107.86 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-N 115.812 -0.631 . . . . 73.23 111.497 -174.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.9 mt -92.29 153.1 3.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.335 -0.393 . . . . 72.23 111.294 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 20.0 t -133.67 103.52 5.92 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.08 0.466 . . . . 63.44 111.151 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.48 115.1 5.05 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.076 -0.583 . . . . 75.52 113.364 -177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.4 ptt85 -82.26 75.99 9.16 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.426 0.632 . . . . 73.12 112.101 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.2 t -96.81 -27.51 14.68 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.963 -0.562 . . . . 54.53 111.394 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.575 HD22 ' HB1' ' A' ' 51' ' ' ALA . 4.3 pp -106.3 -41.64 5.27 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.332 -0.394 . . . . 65.43 111.739 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.571 ' N ' HD12 ' A' ' 34' ' ' LEU . 7.2 t30 -82.15 85.07 6.85 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.113 0.482 . . . . 53.11 110.013 175.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -113.82 20.62 15.68 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 116.027 -0.533 . . . . 72.21 112.273 -175.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 156.74 -55.61 0.39 Allowed Glycine 0 CA--C 1.524 0.627 0 C-N-CA 120.641 -0.79 . . . . 73.43 113.127 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HB3' ' HD2' ' A' ' 43' ' ' LYS . . . -73.56 130.3 39.77 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 122.77 -0.253 . . . . 61.41 111.172 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.2 p -73.15 178.69 4.26 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.131 0.491 . . . . 35.14 110.912 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.48 HG21 HD21 ' A' ' 141' ' ' LEU . 8.9 m -62.05 -25.2 36.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 116.578 -0.283 . . . . 70.43 111.361 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.609 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 1.3 tm-20 -71.2 -50.91 28.1 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.869 0.366 . . . . 72.44 110.553 -178.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -58.62 -20.09 44.53 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 120.934 0.397 . . . . 70.34 111.571 174.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.566 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 27.5 mtpp -126.69 30.57 5.49 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.144 0.424 . . . . 54.53 112.144 -175.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.609 ' HG ' ' HA ' ' A' ' 41' ' ' GLU . 47.7 mt -65.44 86.44 0.07 Allowed 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.133 0.492 . . . . 64.4 111.468 176.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.491 HG23 ' H ' ' A' ' 48' ' ' TYR . 4.1 t -151.15 157.6 42.92 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-N 116.104 -0.498 . . . . 74.22 111.788 178.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -56.35 -28.11 58.02 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.302 0.572 . . . . 63.41 110.941 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -57.74 -45.4 85.89 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.821 -0.627 . . . . 62.43 110.779 173.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.491 ' H ' HG23 ' A' ' 45' ' ' THR . 9.5 t80 -66.05 -37.34 85.58 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.293 0.568 . . . . 74.41 110.231 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.404 ' HD1' HG23 ' A' ' 137' ' ' VAL . 65.5 t80 -58.61 -62.78 1.61 Allowed 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.599 -0.728 . . . . 74.43 111.038 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -55.24 -23.98 25.42 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.771 0.656 . . . . 75.14 112.771 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.575 ' HB1' HD22 ' A' ' 34' ' ' LEU . . . -81.68 -40.32 23.01 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 113.032 0.752 . . . . 73.53 113.032 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 48' ' ' TYR . 33.8 m -108.73 13.9 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 113.289 0.848 . . . . 74.41 113.289 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -104.04 26.1 9.16 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.52 0.934 . . . . 63.23 113.52 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -145.11 159.81 42.39 Favored 'General case' 0 N--CA 1.467 0.425 0 O-C-N 121.665 -0.647 . . . . 75.44 112.355 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.78 146.33 50.62 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.532 -0.758 . . . . 52.35 111.043 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.667 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 30.9 mt-10 -96.6 116.9 29.88 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.633 0.254 . . . . 75.22 111.516 177.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.52 ' HA ' HG22 ' A' ' 96' ' ' ILE . 4.2 mp -110.44 146.97 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 120.782 0.325 . . . . 71.4 111.255 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -64.19 145.82 55.33 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.593 -0.276 . . . . 71.14 110.845 175.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.442 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 32.2 tt0 -58.71 -40.76 84.59 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.78 0.659 . . . . 72.31 112.78 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -60.9 -51.14 70.53 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 111.955 0.354 . . . . 72.02 111.955 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -65.55 -36.0 82.52 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.468 0.651 . . . . 74.0 110.457 176.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.713 ' HA ' HD12 ' A' ' 67' ' ' LEU . 37.0 t-105 -52.91 -53.83 43.66 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.276 -0.874 . . . . 65.54 111.311 175.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -70.5 -29.69 66.27 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 116.004 -0.543 . . . . 71.43 111.394 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.24 -35.22 80.1 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.887 0.375 . . . . 75.25 111.624 177.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 84.0 mt -89.86 1.33 56.32 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.38 -0.373 . . . . 62.2 111.702 177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 58.94 40.48 95.4 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.42 -0.419 . . . . 72.02 112.728 -177.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.713 HD12 ' HA ' ' A' ' 62' ' ' TRP . 18.4 mt -76.11 141.81 41.86 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.093 0.775 . . . . 71.44 113.093 -175.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.526 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 30.3 tt0 -106.51 147.1 29.79 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.28 -0.873 . . . . 72.12 109.673 169.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -63.77 102.73 0.49 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.495 0.664 . . . . 61.45 111.382 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 113.25 5.02 23.47 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 115.268 -0.878 . . . . 44.44 112.633 -172.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 68' ' ' GLN . 1.4 t0 -71.69 172.86 8.97 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.81 0.444 . . . . 74.24 110.838 178.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.47 124.48 49.67 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.28 0.562 . . . . 74.03 111.687 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.457 HG13 ' HB2' ' A' ' 86' ' ' ALA . 15.8 m -113.3 132.53 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.139 0.495 . . . . 74.13 111.481 177.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -100.66 109.98 22.07 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.584 0.707 . . . . 54.3 110.311 175.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 59.3 t -92.66 127.2 44.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.34 -0.845 . . . . 74.51 109.824 -175.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.521 ' HG2' ' CB ' ' A' ' 81' ' ' GLU . 46.4 mtpt -133.34 124.77 27.81 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.387 0.613 . . . . 62.12 112.397 -169.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.627 HG22 ' HA3' ' A' ' 125' ' ' GLY . 29.2 p -132.42 -171.66 2.71 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.712 -0.676 . . . . 74.33 111.033 -178.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -76.56 -1.11 25.8 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 116.272 -0.422 . . . . 73.12 111.562 176.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -102.46 -34.71 9.04 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 111.811 0.3 . . . . 74.25 111.811 178.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 167.37 -167.1 39.7 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 112.258 -0.337 . . . . 71.43 112.258 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.521 ' CB ' ' HG2' ' A' ' 76' ' ' LYS . 16.4 pt-20 -143.48 144.11 31.85 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.376 0.588 . . . . 53.05 112.524 178.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.8 p -143.66 150.41 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 115.934 -0.575 . . . . 72.12 111.566 -176.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.9 t -107.12 120.34 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 O-C-N 122.301 -0.249 . . . . 73.24 111.388 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 34.8 m -130.69 173.17 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 120.858 0.361 . . . . 75.04 111.966 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -78.28 140.49 38.84 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 121.038 0.447 . . . . 73.04 111.354 176.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.457 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -93.74 126.3 38.84 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.649 0.611 . . . . 64.02 112.649 -177.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -125.18 145.66 49.86 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.114 0.483 . . . . 72.44 110.66 172.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -82.9 112.37 19.63 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.791 -0.448 . . . . 63.44 109.791 177.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.667 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -123.63 169.12 15.77 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.581 -0.818 . . . . 71.22 114.434 -171.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -79.85 73.89 6.6 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.116 0.484 . . . . 64.32 111.413 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.5 m -132.46 147.95 67.67 Favored Pre-proline 0 CA--C 1.539 0.558 0 CA-C-N 116.018 -0.537 . . . . 71.11 111.229 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -60.75 157.29 38.42 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.628 2.219 . . . . 72.15 112.563 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -64.07 145.34 56.09 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 122.116 -0.365 . . . . 72.44 111.099 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.529 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 62.59 27.8 70.33 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.047 -0.596 . . . . 62.32 112.677 -174.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.631 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 18.8 ttt -148.75 136.43 20.56 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 109.741 -0.466 . . . . 64.2 109.741 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.52 HG22 ' HA ' ' A' ' 57' ' ' ILE . 36.7 pt -137.92 144.68 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-O 121.294 0.568 . . . . 73.12 112.194 -176.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -105.4 133.38 50.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.229 -0.442 . . . . 52.32 111.494 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 30' ' ' SER . 48.8 mt -128.87 134.03 25.86 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 116.342 -0.39 . . . . 64.02 110.675 174.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.87 136.44 61.71 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 121.975 1.784 . . . . 73.35 112.231 174.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.31 107.93 0.63 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 120.898 0.38 . . . . 75.34 110.895 -178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.95 -174.61 26.87 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.124 -0.56 . . . . 72.52 112.487 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.78 -25.77 74.83 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.983 1.789 . . . . 75.22 111.853 -177.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.539 ' HA ' HD11 ' A' ' 140' ' ' LEU . 3.8 m-85 -71.19 -54.29 11.49 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.677 -0.692 . . . . 73.23 110.729 178.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.02 -33.35 73.13 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.097 -0.501 . . . . 71.43 110.617 175.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -58.25 -22.37 52.11 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.936 -0.574 . . . . 53.54 111.665 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.502 ' SD ' HD21 ' A' ' 140' ' ' LEU . 33.7 mtp -78.37 -29.61 47.51 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.506 -0.315 . . . . 73.34 111.41 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.8 m -111.94 -18.99 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 N-CA-C 112.395 0.517 . . . . 74.24 112.395 -171.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.563 HG21 ' HB2' ' A' ' 30' ' ' SER . 12.2 pt -94.76 178.84 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.11 0.481 . . . . 74.1 111.495 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.52 ' H ' HG21 ' A' ' 123' ' ' VAL . 21.3 t70 -92.0 108.82 33.01 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 116.102 -0.499 . . . . 74.3 110.52 176.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.89 -6.34 17.34 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 122.436 2.091 . . . . 72.41 113.604 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 42.3 t -72.49 -39.48 67.64 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.038 0.447 . . . . 72.22 110.967 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 13.0 t -80.27 -172.03 3.3 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.244 0.545 . . . . 53.43 112.073 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -154.63 -29.66 0.11 Allowed 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 116.066 -0.516 . . . . 61.44 111.674 -178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 86.73 77.2 1.24 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 120.767 -0.73 . . . . 71.22 111.471 -171.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.2 m -61.05 92.72 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.844 0.354 . . . . 62.43 111.712 -176.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 75.34 -62.28 2.66 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 121.399 -0.429 . . . . 62.43 113.184 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 22.0 mmt -136.79 139.95 30.46 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-O 120.932 0.396 . . . . 74.45 111.861 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -86.15 -15.08 4.7 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.871 2.381 . . . . 72.21 112.781 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 56.48 59.74 3.46 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.966 0.506 . . . . 74.0 111.668 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 45.71 79.99 0.05 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.135 0.574 . . . . 73.45 112.082 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 4.9 ttpm? -167.07 134.79 2.51 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.181 -0.463 . . . . 75.31 111.926 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -141.47 -176.2 15.61 Favored Glycine 0 CA--C 1.525 0.686 0 CA-C-N 115.739 -0.664 . . . . 72.11 112.442 173.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.52 HG21 ' H ' ' A' ' 109' ' ' ASP . 82.0 t -82.17 119.61 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 CA-C-O 121.063 0.458 . . . . 63.3 111.661 179.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 95.8 mttt -73.12 154.01 40.54 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 112.512 0.56 . . . . 75.34 112.512 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.627 ' HA3' HG22 ' A' ' 77' ' ' THR . . . 177.81 -140.83 4.9 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 115.884 -0.598 . . . . 63.35 112.797 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.7 HG22 ' HG3' ' A' ' 25' ' ' GLU . 67.6 p -136.69 161.67 35.28 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.026 0.441 . . . . 74.54 111.164 -178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -137.79 143.84 32.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-O 121.247 0.546 . . . . 74.52 110.834 173.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -147.44 144.62 28.77 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.967 -0.561 . . . . 62.24 110.363 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.509 ' HD2' HD23 ' A' ' 67' ' ' LEU . 20.6 ttpp -81.87 143.23 31.85 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 122.19 -0.318 . . . . 73.33 110.262 176.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.0 t -132.16 156.8 45.77 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 113.597 0.962 . . . . 55.44 113.597 -168.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -83.29 -17.1 43.73 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.061 -0.972 . . . . 53.02 110.41 176.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -68.98 179.11 1.95 Allowed 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.702 -0.681 . . . . 54.24 112.71 -175.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -98.83 159.84 14.68 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.672 -0.694 . . . . 73.54 111.702 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 84.8 t -73.97 136.12 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-N 116.466 -0.334 . . . . 74.23 110.908 173.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 135' ' ' LEU . 11.9 mt -67.44 140.47 57.12 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.944 0.402 . . . . 71.22 111.531 178.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.6 m -86.24 148.84 25.46 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.616 -0.513 . . . . 72.31 109.616 171.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.47 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 86.1 t -46.8 -53.43 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 N-CA-C 112.564 0.579 . . . . 75.45 112.564 -173.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -72.25 -39.36 68.48 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 111.704 0.261 . . . . 73.12 111.704 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.79 -36.67 72.49 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.701 0.762 . . . . 72.13 110.09 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.539 HD11 ' HA ' ' A' ' 103' ' ' TYR . 4.4 tt -62.25 -43.84 97.9 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.968 -1.014 . . . . 70.24 110.728 172.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.48 HD21 HG21 ' A' ' 40' ' ' VAL . 66.6 mt -57.3 -45.16 84.42 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.205 0.526 . . . . 53.42 110.608 178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -59.26 -40.84 87.28 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.799 -0.637 . . . . 74.41 111.1 177.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.4 -48.03 74.27 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.976 -0.556 . . . . 54.01 112.22 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.9 pp -75.64 -20.9 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 112.779 0.659 . . . . 74.34 112.779 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 139.61 -22.99 2.83 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.445 -0.883 . . . . 73.24 114.725 175.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.2 m . . . . . 0 N--CA 1.471 0.601 0 O-C-N 122.225 -0.574 . . . . 64.33 111.427 -178.045 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.516 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 120.852 0.358 . . . . 71.33 111.245 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 126.82 -178.15 16.97 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.294 -0.479 . . . . 51.02 113.799 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.5 p -172.41 130.8 0.58 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.873 0.469 . . . . 62.44 110.78 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 99.2 p -74.28 171.55 13.44 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.068 0.461 . . . . 73.33 112.09 -176.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 74.3 t60 -141.3 112.38 7.31 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.431 -0.35 . . . . 74.23 110.761 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -128.98 120.08 25.44 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 112.323 0.49 . . . . 65.12 112.323 -175.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.4 m170 -146.65 125.28 12.51 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.706 0.402 . . . . 74.02 111.366 174.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -148.03 145.43 28.48 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.49 0.316 . . . . 72.43 110.878 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -152.09 139.49 19.5 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 120.581 0.229 . . . . 65.22 111.192 179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -139.37 144.87 38.38 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.287 0.235 . . . . 73.41 111.162 -176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.1 t -120.64 175.8 5.83 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.224 0.453 . . . . 63.03 112.224 -178.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.3 t -94.1 179.69 5.24 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.849 0.357 . . . . 72.24 111.765 -178.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.5 -110.05 2.64 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 114.551 0.58 . . . . 53.52 114.551 -173.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.535 ' H ' ' NE ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -118.99 178.48 4.48 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 112.888 0.699 . . . . 70.42 112.888 -170.55 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.8 mp0 -101.82 172.19 7.08 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 116.021 -0.536 . . . . 63.43 111.315 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -107.23 118.44 36.73 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 116.393 -0.367 . . . . 72.12 110.155 173.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.42 166.61 21.84 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.532 0.567 . . . . 64.2 112.532 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -87.78 135.0 33.57 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.976 -0.556 . . . . 74.11 112.375 -172.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -94.82 101.4 13.2 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.998 0.428 . . . . 72.23 110.48 173.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -90.51 92.9 9.06 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.895 0.378 . . . . 72.21 111.145 179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -137.3 119.1 1.83 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 121.417 -0.421 . . . . 74.05 112.598 179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -81.57 86.25 6.39 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 122.532 -0.393 . . . . 73.42 111.394 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 6.2 ptp -82.17 166.72 19.4 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.249 0.547 . . . . 75.3 111.861 177.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.579 HD11 ' HB3' ' A' ' 64' ' ' ALA . 16.4 mt -122.27 139.28 53.97 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.004 -0.544 . . . . 43.44 111.58 177.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -79.29 118.25 21.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.309 0.576 . . . . 74.25 110.359 174.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 28.3 m -138.25 160.51 32.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.61 -0.723 . . . . 71.13 111.824 -173.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.726 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 72.2 tt0 -98.82 111.92 24.16 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.071 0.462 . . . . 75.25 110.438 175.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.522 HG22 HD11 ' A' ' 96' ' ' ILE . 43.1 t -87.45 105.81 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-N 115.797 -0.638 . . . . 75.44 111.72 -175.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 mt -92.14 162.91 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.677 0.275 . . . . 74.34 111.265 -178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.686 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 15.6 t -134.58 113.96 12.3 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 120.781 0.324 . . . . 73.23 111.826 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.459 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . -116.38 126.49 7.07 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 121.065 -0.588 . . . . 54.44 113.298 -178.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.43 ' HD2' ' O ' ' A' ' 114' ' ' GLY . 19.8 mtp180 -67.26 95.41 0.42 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.985 0.421 . . . . 74.31 111.984 -176.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.1 p -82.66 -43.1 17.32 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.662 0.616 . . . . 74.12 112.662 -178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -61.01 151.23 31.2 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.565 0.579 . . . . 63.12 112.565 -178.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.8 m-20 -66.81 105.77 1.68 Allowed 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.928 -0.578 . . . . 73.14 111.866 -178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 61.08 170.69 0.1 Allowed 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.336 0.865 . . . . 73.54 113.336 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -80.09 144.81 26.41 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 115.489 -0.778 . . . . 52.24 114.06 -176.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.736 ' HB3' ' HE3' ' A' ' 43' ' ' LYS . . . -179.74 162.94 1.11 Allowed 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.127 0.571 . . . . 70.42 110.523 179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.3 p -75.08 156.06 36.49 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 110.383 -0.229 . . . . 74.43 110.383 172.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.1 m -56.9 -30.83 34.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-O 120.991 0.424 . . . . 73.24 111.308 179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.586 ' HA ' HD23 ' A' ' 44' ' ' LEU . 42.4 tt0 -59.73 -37.67 79.57 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.117 -0.492 . . . . 52.23 111.399 177.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -66.84 -17.07 64.7 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 112.226 0.454 . . . . 71.31 112.226 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.736 ' HE3' ' HB3' ' A' ' 38' ' ' ALA . 86.0 mttt -134.11 33.57 3.37 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.547 0.573 . . . . 72.45 112.547 -174.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.586 HD23 ' HA ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -63.7 87.08 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 120.964 0.411 . . . . 75.43 110.627 176.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 6.9 t -155.22 172.62 17.86 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.26 -0.427 . . . . 73.04 112.018 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -56.64 -33.5 66.39 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 116.089 -0.505 . . . . 70.45 111.552 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.628 ' HA ' HD21 ' A' ' 50' ' ' ASN . 44.3 mt-10 -54.36 -47.27 72.79 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.151 0.5 . . . . 71.13 111.153 176.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.513 ' CD2' ' HB2' ' A' ' 43' ' ' LYS . 0.5 OUTLIER -68.8 -23.08 64.24 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.939 0.4 . . . . 74.34 110.702 -179.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -88.17 2.08 52.96 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.033 0.383 . . . . 73.43 112.033 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.628 HD21 ' HA ' ' A' ' 47' ' ' GLU . 10.9 p30 -122.17 -48.31 2.11 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 121.483 -0.761 . . . . 72.34 111.948 170.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.68 -22.77 24.88 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.079 1.14 . . . . 75.23 114.079 -170.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.519 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 19.7 m -130.92 17.82 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 N-CA-C 112.858 0.688 . . . . 54.52 112.858 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.607 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -102.0 17.16 23.9 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 112.612 0.597 . . . . 63.2 112.612 -174.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -140.93 162.79 34.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.142 0.496 . . . . 73.33 112.106 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -126.14 127.19 45.36 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 115.622 -0.717 . . . . 52.03 110.813 174.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -87.31 118.4 26.71 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.413 0.625 . . . . 64.33 110.892 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 37.3 mt -117.03 154.92 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-N 115.162 -0.926 . . . . 75.44 111.828 -169.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -76.19 144.56 40.42 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.525 -0.307 . . . . 75.21 110.615 175.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 27.3 tt0 -63.39 -36.86 85.13 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.818 0.673 . . . . 75.3 112.818 -176.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -62.21 -47.69 83.33 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 122.174 -0.329 . . . . 62.4 111.413 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.461 ' HB3' HD13 ' A' ' 24' ' ' LEU . 47.0 m-20 -66.8 -36.5 82.52 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.308 0.575 . . . . 74.31 110.558 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.48 ' HZ2' ' N ' ' A' ' 69' ' ' GLU . 33.7 t-105 -53.11 -45.66 68.38 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.492 -0.776 . . . . 74.03 110.591 175.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -65.7 -41.02 92.86 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.714 -0.676 . . . . 61.14 110.961 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.579 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -61.0 -38.55 86.45 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.242 -0.435 . . . . 62.33 111.82 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.483 ' HG ' HD12 ' A' ' 24' ' ' LEU . 87.6 mt -85.71 -14.47 45.29 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.425 -0.352 . . . . 65.44 111.413 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.57 47.4 78.0 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 121.273 -0.489 . . . . 75.1 112.581 -178.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.568 HD23 ' HD3' ' A' ' 129' ' ' LYS . 85.3 mt -84.49 164.85 18.56 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.559 0.695 . . . . 71.03 112.38 -175.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -136.11 123.61 22.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.55 -0.75 . . . . 72.24 109.905 178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.48 ' N ' ' HZ2' ' A' ' 62' ' ' TRP . 48.7 mt-10 -49.88 96.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.563 0.696 . . . . 71.43 112.614 -172.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 130.2 0.04 5.55 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.387 -0.824 . . . . 45.43 114.036 -179.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -90.39 -172.15 3.34 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 117.863 0.831 . . . . 73.02 112.292 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.45 HH11 ' HD2' ' A' ' 72' ' ' ARG . 45.6 mtt180 -111.52 131.25 55.37 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.339 0.496 . . . . 71.24 112.339 -174.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.45 HG13 ' HB2' ' A' ' 86' ' ' ALA . 30.0 m -123.67 140.85 45.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 120.998 0.428 . . . . 64.42 111.578 175.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.415 ' HG2' ' HG3' ' A' ' 76' ' ' LYS . 38.3 ttmt -98.65 131.84 44.51 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.25 0.548 . . . . 73.4 110.74 174.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.531 HG21 HD11 ' A' ' 98' ' ' ILE . 61.9 t -106.18 128.22 60.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.731 -0.668 . . . . 75.52 109.661 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.415 ' HG3' ' HG2' ' A' ' 74' ' ' LYS . 38.8 mtpt -131.06 127.55 38.45 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.51 0.672 . . . . 72.2 112.506 -171.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.6 HG22 ' HA3' ' A' ' 125' ' ' GLY . 31.0 p -136.37 -170.43 2.66 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.131 -0.941 . . . . 62.44 110.486 -178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -76.22 -13.74 60.16 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 120.683 0.277 . . . . 70.13 111.561 176.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -87.83 -38.02 16.04 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.96 0.409 . . . . 74.43 111.378 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.07 -157.73 28.75 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.866 -0.683 . . . . 52.12 113.521 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -144.24 141.82 30.09 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.758 0.313 . . . . 72.22 111.471 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.48 146.67 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 120.698 0.285 . . . . 63.14 111.655 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 31.0 t -105.4 117.21 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 CA-C-O 120.544 0.211 . . . . 71.11 110.95 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.0 m -127.34 178.08 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 122.588 0.355 . . . . 71.41 111.821 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -83.2 144.09 30.02 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 120.911 0.386 . . . . 74.41 111.312 174.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.45 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -90.34 135.74 33.49 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.625 0.602 . . . . 64.53 112.625 -177.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -133.04 158.23 43.26 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.583 0.706 . . . . 45.0 111.663 174.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.2 ttmt -108.17 99.64 9.05 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.103 -0.953 . . . . 52.42 109.608 175.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.59 86.54 0.19 Allowed Glycine 0 CA--C 1.533 1.186 0 N-CA-C 116.631 1.412 . . . . 44.33 116.631 -166.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 65.72 -17.44 0.1 Allowed 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 116.206 1.928 . . . . 61.4 116.206 161.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.0 m -78.15 148.66 75.14 Favored Pre-proline 0 CA--C 1.544 0.749 0 O-C-N 121.716 -0.615 . . . . 73.22 112.425 -173.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -72.64 169.58 21.55 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.788 2.325 . . . . 73.23 112.705 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -68.33 146.58 53.14 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.871 0.367 . . . . 75.13 111.5 -177.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 68.72 18.02 71.75 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 121.277 -0.487 . . . . 74.0 113.28 -174.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.726 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 14.2 ttt -147.02 136.61 22.93 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 122.37 -0.488 . . . . 75.22 110.568 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.522 HD11 HG22 ' A' ' 28' ' ' VAL . 43.6 pt -135.91 144.97 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-O 121.082 0.468 . . . . 64.0 111.703 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.459 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 68.1 t80 -107.01 123.87 48.81 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.473 -0.33 . . . . 72.53 111.302 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.686 ' O ' ' HA ' ' A' ' 30' ' ' SER . 44.2 mt -120.37 127.46 26.3 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-O 120.805 0.336 . . . . 73.41 111.142 175.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.519 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 51.4 Cg_exo -57.18 136.9 79.23 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.285 1.99 . . . . 74.34 113.084 177.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.46 105.69 0.46 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.212 -0.449 . . . . 73.24 110.878 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.98 -174.25 30.6 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.912 -0.661 . . . . 70.31 112.542 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.467 ' O ' ' HG3' ' A' ' 106' ' ' MET . 14.8 Cg_endo -56.05 -36.01 95.55 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.521 2.148 . . . . 74.34 111.986 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.507 ' HA ' HD11 ' A' ' 140' ' ' LEU . 41.0 m-85 -61.83 -54.1 46.87 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.957 -0.565 . . . . 73.44 110.71 177.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -63.41 -33.53 75.76 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.165 0.507 . . . . 72.43 111.302 177.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -62.34 -15.03 45.8 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.124 -0.489 . . . . 75.11 111.892 -177.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.541 ' SD ' HD21 ' A' ' 140' ' ' LEU . 41.5 mtp -83.66 -22.75 32.03 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.441 -0.345 . . . . 73.0 111.7 179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 28.7 m -123.86 -18.45 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 N-CA-C 113.129 0.788 . . . . 74.04 113.129 -171.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.448 HG23 ' O ' ' A' ' 104' ' ' ALA . 11.2 pt -96.22 177.62 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.381 0.61 . . . . 63.5 111.834 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.632 ' H ' HG21 ' A' ' 123' ' ' VAL . 16.7 t70 -98.94 104.9 28.21 Favored Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.806 -0.633 . . . . 64.04 110.131 175.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -83.36 26.88 0.63 Allowed 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 122.489 2.126 . . . . 72.23 113.643 -175.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.9 t -121.0 -27.47 4.96 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 111.588 0.218 . . . . 63.42 111.588 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 3.6 t -66.72 99.73 0.63 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.119 0.485 . . . . 64.11 112.062 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 59.29 -85.57 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.228 0.611 . . . . 73.2 112.171 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.43 ' O ' ' HD2' ' A' ' 32' ' ' ARG . . . 95.26 -16.62 60.93 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.353 -0.451 . . . . 61.11 113.114 -178.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 80.8 p -86.69 -179.45 6.58 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.888 0.375 . . . . 62.53 111.854 -178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.23 70.54 1.84 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.107 -0.568 . . . . 51.41 113.012 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 23.3 mmt -78.39 148.32 73.72 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.188 0.44 . . . . 53.25 112.188 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -91.39 17.22 1.41 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.076 2.518 . . . . 74.2 112.679 177.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 80.4 mm-40 -101.04 130.48 47.05 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 120.898 0.38 . . . . 61.31 111.511 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -83.85 67.95 9.76 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.159 0.504 . . . . 73.22 111.376 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -108.11 122.81 47.65 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 116.484 -0.326 . . . . 72.25 111.426 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -123.84 157.66 18.29 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 121.056 -0.592 . . . . 71.11 112.948 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.632 HG21 ' H ' ' A' ' 109' ' ' ASP . 58.3 t -78.19 122.13 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-O 121.0 0.429 . . . . 73.0 111.419 178.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.423 ' HD2' ' N ' ' A' ' 124' ' ' LYS . 12.1 mptt -69.47 131.27 44.48 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.906 0.384 . . . . 75.14 111.549 -177.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.6 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -160.66 -146.03 4.48 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.259 -0.496 . . . . 61.3 113.358 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 41.4 p -139.8 161.28 37.94 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.887 0.375 . . . . 75.34 111.542 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.0 p -139.74 144.6 28.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.132 0.491 . . . . 65.44 111.462 177.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.23 156.47 40.94 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.93 -0.577 . . . . 74.45 111.219 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.568 ' HD3' HD23 ' A' ' 67' ' ' LEU . 27.7 ttpp -90.12 136.95 32.74 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 121.89 -0.506 . . . . 72.22 110.586 174.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.3 t -138.34 157.52 46.08 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.092 0.472 . . . . 74.42 112.217 -173.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -83.02 -4.47 58.36 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.954 -0.566 . . . . 40.13 111.437 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -70.9 146.5 49.54 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.031 -0.531 . . . . 75.02 111.832 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.74 152.04 43.08 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.136 0.493 . . . . 73.43 111.926 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 79.8 t -65.89 121.9 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.522 -0.308 . . . . 74.11 110.587 173.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 135' ' ' LEU . 10.2 mt -62.73 94.24 0.06 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.005 0.372 . . . . 73.31 112.005 -178.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 45.1 m -53.56 150.69 6.6 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.156 -0.474 . . . . 72.11 110.72 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.55 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 67.9 t -45.09 -48.76 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 N-CA-C 112.948 0.721 . . . . 64.21 112.948 -171.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -72.52 -44.07 62.69 Favored 'General case' 0 N--CA 1.472 0.634 0 O-C-N 122.213 -0.304 . . . . 70.12 111.653 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -56.34 -39.61 73.11 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.92 0.867 . . . . 72.12 110.107 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.541 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.7 tt -60.3 -42.44 95.53 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 114.791 -1.095 . . . . 70.43 110.879 175.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 56.6 mt -56.02 -52.29 64.73 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.24 0.543 . . . . 52.21 110.508 176.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -64.33 -29.84 70.91 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.617 -0.719 . . . . 73.32 111.623 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -71.25 -40.43 71.02 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.387 0.514 . . . . 63.34 112.387 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.469 HD12 ' H ' ' A' ' 146' ' ' SER . 2.9 pp -91.05 -14.25 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 112.331 0.493 . . . . 74.44 112.331 179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 133.96 -62.49 0.63 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 121.123 -0.56 . . . . 65.51 113.072 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.469 ' H ' HD12 ' A' ' 144' ' ' ILE . 43.3 t . . . . . 0 N--CA 1.472 0.665 0 O-C-N 122.49 -0.418 . . . . 74.02 111.482 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.746 0.308 . . . . 74.33 111.657 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -157.65 -152.07 6.24 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.189 -0.529 . . . . 63.01 112.736 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.6 t 56.97 -121.82 1.55 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 116.726 0.263 . . . . 72.31 111.065 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.3 t 55.9 28.38 12.47 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.673 0.62 . . . . 71.55 112.673 172.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 49.8 m80 -70.7 105.21 3.09 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.94 -0.475 . . . . 74.11 111.695 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.423 ' O ' ' HB2' ' A' ' 7' ' ' HIS . 97.0 m-70 -120.49 -178.58 3.73 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 120.769 0.319 . . . . 74.34 111.854 178.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.423 ' HB2' ' O ' ' A' ' 6' ' ' HIS . 1.5 m-70 72.05 167.43 0.31 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.36 0.664 . . . . 62.2 111.926 -177.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.0 m80 64.09 177.4 0.17 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.767 0.794 . . . . 74.12 112.434 -177.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -132.13 -55.01 0.98 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.377 -0.829 . . . . 71.45 109.511 171.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -142.37 -47.8 0.34 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.971 -0.559 . . . . 73.42 110.617 172.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.9 p -125.78 -172.67 2.65 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 116.472 -0.331 . . . . 74.01 110.664 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 67.6 p -61.05 -45.94 92.73 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.83 0.348 . . . . 71.21 111.336 176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.68 126.9 2.62 Favored Glycine 0 CA--C 1.528 0.847 0 C-N-CA 121.305 -0.474 . . . . 75.34 113.312 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.9 mtt180 -88.93 116.33 27.14 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 122.752 -0.263 . . . . 75.15 110.82 177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -68.33 -72.73 0.17 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 120.686 0.279 . . . . 65.44 110.906 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -113.96 139.47 49.2 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.919 0.39 . . . . 72.35 111.33 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.442 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -122.4 127.74 50.08 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 110.021 -0.363 . . . . 75.42 110.021 178.336 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -82.64 11.02 6.29 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 112.338 0.495 . . . . 73.01 112.338 -173.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 57.13 32.57 21.92 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.227 0.537 . . . . 54.11 111.942 178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.472 ' HG2' ' N ' ' A' ' 21' ' ' GLY . 23.5 tt0 -92.94 165.48 12.85 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 116.12 -0.491 . . . . 65.05 110.767 178.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.472 ' N ' ' HG2' ' A' ' 20' ' ' GLN . . . -55.65 133.2 50.04 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.225 -0.512 . . . . 74.01 112.862 176.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 60.6 t60 -63.27 96.88 0.11 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.748 0.309 . . . . 72.24 111.46 -177.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.1 ptp -102.1 162.65 12.75 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.263 0.554 . . . . 74.22 111.688 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.552 HD11 ' HB3' ' A' ' 64' ' ' ALA . 20.2 mt -124.58 139.06 54.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.89 -0.596 . . . . 74.53 111.327 176.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -78.31 109.01 12.06 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.658 0.742 . . . . 74.22 110.618 174.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 34.8 m -132.22 159.13 43.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 114.731 -1.122 . . . . 70.15 111.849 -172.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.734 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 44.0 tt0 -99.27 117.62 34.13 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.106 0.479 . . . . 71.22 111.102 175.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.54 HG22 HD11 ' A' ' 96' ' ' ILE . 38.4 t -89.79 107.81 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 123.218 0.607 . . . . 65.34 111.578 -177.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.407 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 2.5 mt -94.11 148.51 4.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 111.803 0.297 . . . . 75.22 111.803 -177.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.645 ' OG ' HG21 ' A' ' 108' ' ' ILE . 73.7 m -109.97 106.93 16.64 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.055 0.455 . . . . 54.24 111.36 175.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.486 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . -86.4 100.29 2.51 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 121.256 -0.497 . . . . 73.52 113.139 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.806 ' HD3' ' H ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -71.43 98.94 1.9 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.464 0.649 . . . . 62.51 111.413 179.819 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.7 p -106.25 169.17 8.67 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.553 -0.749 . . . . 75.41 110.908 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.9 mp 60.24 93.08 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.346 0.593 . . . . 54.41 110.917 -175.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -57.87 -177.79 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 113.54 0.941 . . . . 64.21 113.54 -172.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 73.63 -63.55 0.43 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.605 0.762 . . . . 72.23 111.605 -175.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.93 145.55 15.71 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.013 -0.613 . . . . 12.33 113.495 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.51 ' HB3' ' HD2' ' A' ' 43' ' ' LYS . . . -169.34 161.56 10.02 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.153 0.581 . . . . 42.52 110.135 178.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.8 p -81.77 166.92 19.61 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 120.265 -0.574 . . . . 74.34 109.908 174.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.6 t -54.8 -34.9 31.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.023 0.44 . . . . 41.22 111.271 -177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.48 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 43.6 tt0 -62.9 -43.14 99.59 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 116.02 -0.537 . . . . 74.4 112.348 -177.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.433 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 1.4 mp0 -63.95 -26.46 68.59 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 122.101 -0.374 . . . . 72.1 111.747 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.51 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 26.8 mtpp -119.36 33.13 5.76 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 112.094 0.405 . . . . 70.51 112.094 -174.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.48 ' HG ' ' HA ' ' A' ' 41' ' ' GLU . 74.8 mt -65.84 85.65 0.08 Allowed 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.288 0.566 . . . . 74.15 111.381 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.2 t -142.28 167.59 21.76 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.809 -0.632 . . . . 63.22 111.403 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -52.0 -42.77 63.25 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.058 0.456 . . . . 75.0 110.889 178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -57.53 -33.44 68.09 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.218 0.451 . . . . 74.22 112.218 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.413 ' CD2' ' HB2' ' A' ' 43' ' ' LYS . 1.4 t80 -71.53 -26.53 62.69 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.498 0.666 . . . . 74.02 109.789 177.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.54 ' HD1' HG23 ' A' ' 137' ' ' VAL . 71.4 t80 -89.45 -2.31 58.34 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.616 -0.72 . . . . 72.25 110.902 175.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -101.66 -44.38 5.58 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.025 -0.422 . . . . 75.11 111.811 177.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -79.52 -64.0 1.29 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.316 0.858 . . . . 71.23 113.316 -172.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.453 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 32.9 m -79.07 21.8 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 113.338 0.866 . . . . 73.33 113.338 -170.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.629 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -108.0 11.17 28.04 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 113.073 0.768 . . . . 63.22 113.073 -172.546 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -133.2 166.28 22.82 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.598 0.713 . . . . 71.44 112.487 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.76 135.18 48.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.21 -0.905 . . . . 63.32 110.042 172.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.604 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 45.0 mt-10 -94.67 115.56 27.69 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.867 0.365 . . . . 61.31 111.285 177.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.3 mp -109.79 150.93 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.062 -0.517 . . . . 73.33 110.831 -178.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -71.78 156.86 38.85 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 120.71 0.291 . . . . 62.44 111.418 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -54.74 -47.39 73.9 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.173 0.511 . . . . 71.13 111.864 179.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.5 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 17.3 mm-40 -56.41 -52.73 63.55 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.206 -0.452 . . . . 64.1 112.169 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -66.29 -36.57 83.31 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.007 0.432 . . . . 53.2 111.024 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -55.68 -48.79 74.47 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.96 -0.563 . . . . 74.34 111.103 176.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -66.71 -39.38 88.01 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.05 -0.523 . . . . 75.35 111.185 176.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.552 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -61.15 -35.05 76.04 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.058 0.392 . . . . 52.05 112.058 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.2 mt -89.55 -12.13 40.79 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.042 0.386 . . . . 73.3 112.042 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 62.36 48.32 83.22 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 121.09 -0.576 . . . . 61.21 112.782 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.668 HD23 ' HD3' ' A' ' 129' ' ' LYS . 92.1 mt -86.88 143.26 27.51 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.259 0.552 . . . . 65.22 112.474 -175.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -93.61 149.62 21.08 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.989 -0.551 . . . . 74.32 109.909 171.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -61.26 100.22 0.12 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.452 0.644 . . . . 74.34 111.279 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.76 29.18 7.05 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-N 115.333 -0.848 . . . . 74.03 112.841 -174.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -82.07 -178.27 6.95 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 122.598 -0.354 . . . . 52.01 111.158 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.632 HH21 ' HA ' ' A' ' 131' ' ' ASP . 24.2 mtm-85 -116.78 123.07 46.22 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.85 0.357 . . . . 63.44 111.068 -177.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.81 140.82 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-O 121.034 0.445 . . . . 75.14 112.178 -178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 31.7 ttmt -110.17 126.38 54.03 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.199 0.524 . . . . 71.13 111.318 174.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.523 HG11 HG21 ' A' ' 28' ' ' VAL . 47.0 t -101.07 132.09 47.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 115.87 -0.604 . . . . 62.35 110.97 177.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.445 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 4.1 mppt? -118.55 127.65 53.83 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.03 0.443 . . . . 74.21 111.392 174.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.718 HG22 ' HA3' ' A' ' 125' ' ' GLY . 40.7 p -127.25 -170.91 2.3 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.894 -0.594 . . . . 55.24 110.253 175.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -72.34 -11.34 60.66 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 120.87 0.367 . . . . 60.25 111.592 176.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -96.07 -40.54 9.18 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.087 0.403 . . . . 72.15 112.087 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 174.79 -146.95 8.76 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 120.636 -0.792 . . . . 44.23 113.744 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.507 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 14.0 pt-20 -152.13 153.41 33.85 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.781 0.324 . . . . 74.53 111.589 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 12.2 p -157.15 149.46 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 116.653 -0.249 . . . . 74.11 111.67 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 19.0 t -108.28 119.74 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 116.762 -0.199 . . . . 70.4 110.856 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.462 HG12 ' CD2' ' A' ' 103' ' ' TYR . 29.7 m -128.37 172.16 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-O 120.914 0.388 . . . . 73.33 111.727 -178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -77.43 143.47 38.56 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 121.022 0.439 . . . . 72.41 111.39 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -93.24 122.95 36.16 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.471 0.545 . . . . 70.43 112.471 -177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -123.63 157.86 32.8 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.161 0.505 . . . . 74.45 110.774 172.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -102.9 107.23 17.99 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.046 -0.525 . . . . 71.03 110.28 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.604 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -109.35 -175.18 21.24 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.852 -0.69 . . . . 74.41 114.171 -172.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -90.26 17.12 7.48 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.865 0.364 . . . . 74.02 111.439 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.4 m -71.69 151.87 93.48 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 116.45 -0.341 . . . . 62.34 111.52 -178.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -67.71 154.49 73.12 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.453 2.102 . . . . 72.33 112.585 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.5 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 87.9 tttt -57.42 137.15 56.5 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 120.732 0.301 . . . . 74.41 111.609 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 71.84 26.92 71.67 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 120.817 -0.706 . . . . 31.43 113.031 -174.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.734 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 13.9 ttt -150.69 137.5 19.05 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 122.213 -0.58 . . . . 64.34 110.151 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.54 HD11 HG22 ' A' ' 28' ' ' VAL . 38.0 pt -133.53 144.84 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.355 0.598 . . . . 54.23 112.166 -178.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.486 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 66.4 t80 -105.78 127.33 53.03 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.969 -0.56 . . . . 72.33 111.452 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.485 ' O ' ' HA ' ' A' ' 30' ' ' SER . 46.1 mt -127.29 128.32 24.09 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 122.337 0.255 . . . . 73.31 110.563 174.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.453 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 37.1 Cg_exo -57.76 142.91 96.25 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 122.2 1.933 . . . . 51.41 112.704 177.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.5 tpt -59.22 103.73 0.2 Allowed 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.025 0.441 . . . . 72.12 111.435 -178.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.74 -178.08 34.4 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.678 -0.773 . . . . 71.33 112.893 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.537 ' O ' ' HG2' ' A' ' 106' ' ' MET . 18.8 Cg_endo -57.53 -34.63 98.34 Favored 'Trans proline' 0 N--CA 1.478 0.579 0 C-N-CA 122.76 2.307 . . . . 72.33 111.718 -178.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.462 ' CD2' HG12 ' A' ' 84' ' ' VAL . 25.6 m-85 -58.73 -49.38 77.83 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.92 -0.582 . . . . 73.2 110.4 175.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -63.06 -42.61 99.72 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.851 -0.613 . . . . 72.34 111.588 176.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -61.46 -7.46 3.14 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.663 0.616 . . . . 72.41 112.663 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.579 ' SD ' HD21 ' A' ' 140' ' ' LEU . 90.5 mmm -84.2 -20.21 32.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.772 0.32 . . . . 74.4 111.556 176.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.3 m -130.83 -12.1 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 113.271 0.841 . . . . 63.24 113.271 -173.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.645 HG21 ' OG ' ' A' ' 30' ' ' SER . 8.8 pt -96.72 -179.05 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 O-C-N 121.725 -0.609 . . . . 70.11 112.254 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.603 ' H ' HG21 ' A' ' 123' ' ' VAL . 16.4 t70 -91.89 108.05 27.2 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 116.008 -0.542 . . . . 75.12 111.133 179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -81.64 5.81 6.05 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.555 2.17 . . . . 65.04 113.574 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.0 t -73.57 -37.17 65.6 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.961 0.41 . . . . 65.13 111.012 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 5.7 t -82.27 154.88 25.14 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.074 0.464 . . . . 54.41 111.78 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -109.5 2.15 20.28 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.262 -0.426 . . . . 64.41 111.193 177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.05 48.39 86.36 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 121.173 -0.537 . . . . 65.13 112.846 -176.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 85.3 m -97.35 140.75 31.34 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.791 0.329 . . . . 43.33 111.832 -176.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 101.76 -120.73 6.96 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 121.096 -0.573 . . . . 63.1 114.352 172.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.4 mmt -84.5 144.77 43.59 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 112.214 0.45 . . . . 53.23 112.214 -174.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -76.17 96.6 1.07 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.609 2.206 . . . . 71.31 113.231 -177.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -89.8 178.39 6.25 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.227 -0.442 . . . . 71.02 111.301 175.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -130.08 18.66 5.49 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.216 0.531 . . . . 72.24 110.872 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.4 ' NZ ' ' O ' ' A' ' 122' ' ' GLY . 27.1 tptp -83.4 141.3 31.83 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.995 -0.548 . . . . 73.23 111.272 -178.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . -127.95 -179.63 15.97 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.197 -0.525 . . . . 61.53 113.323 177.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' H ' ' A' ' 109' ' ' ASP . 84.2 t -94.25 123.32 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 111.924 0.342 . . . . 53.53 111.924 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.667 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 54.9 mtmt -75.36 147.19 40.27 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.45 0.537 . . . . 63.1 112.45 -177.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.718 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -169.6 -157.97 12.8 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 115.88 -0.6 . . . . 65.23 112.658 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 45.8 p -124.69 138.72 54.28 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 122.257 -0.555 . . . . 72.42 111.586 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.3 p -126.64 144.57 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.883 0.373 . . . . 73.31 111.64 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -154.92 156.93 36.97 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.188 -0.46 . . . . 74.01 110.999 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.668 ' HD3' HD23 ' A' ' 67' ' ' LEU . 27.1 ttpp -72.24 141.56 48.96 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.908 0.385 . . . . 74.43 111.185 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 8.4 t -132.12 160.83 34.87 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.232 0.539 . . . . 73.15 112.089 -175.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.632 ' HA ' HH21 ' A' ' 72' ' ' ARG . 5.1 m-20 -92.21 -10.94 36.81 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.826 -0.625 . . . . 73.31 111.031 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.39 168.25 9.22 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.22 0.533 . . . . 75.12 112.12 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.445 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -86.81 152.71 22.25 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.097 -0.502 . . . . 74.41 110.915 175.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 83.8 t -63.08 129.31 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.63 0.252 . . . . 73.21 110.654 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 135' ' ' LEU . 8.9 mt -66.91 90.67 0.18 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 111.724 0.268 . . . . 63.45 111.724 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.8 m -49.38 148.88 2.44 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.068 -0.515 . . . . 71.25 110.967 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.54 HG23 ' HD1' ' A' ' 49' ' ' PHE . 90.5 t -45.18 -45.14 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 112.123 0.416 . . . . 64.21 112.123 -175.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -71.95 -43.92 64.45 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.391 -0.368 . . . . 74.53 111.837 178.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.435 ' HG2' ' HE3' ' A' ' 133' ' ' LYS . 4.3 tp10 -61.13 -32.47 72.17 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 121.486 0.66 . . . . 74.14 110.53 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.579 HD21 ' SD ' ' A' ' 106' ' ' MET . 1.4 tt -65.85 -37.91 87.44 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.376 -0.829 . . . . 75.24 110.654 176.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 29.6 mt -60.19 -43.96 95.46 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.581 0.705 . . . . 75.43 109.944 175.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -68.64 -37.07 79.41 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.226 -0.897 . . . . 72.42 111.615 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -60.03 -46.88 88.05 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.095 -0.502 . . . . 31.43 111.449 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.458 HD12 ' N ' ' A' ' 146' ' ' SER . 2.9 pp -79.86 -23.89 11.93 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 120.949 0.404 . . . . 63.25 111.368 177.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 67.77 50.52 41.41 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 114.545 0.578 . . . . 71.51 114.545 172.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.458 ' N ' HD12 ' A' ' 144' ' ' ILE . 37.1 t . . . . . 0 N--CA 1.475 0.803 0 O-C-N 122.325 -0.515 . . . . 34.31 111.634 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 120.908 0.385 . . . . 73.32 111.887 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.21 90.0 0.08 OUTLIER Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.441 -0.409 . . . . 72.21 112.648 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 80.1 p -62.73 107.39 0.96 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 120.952 0.406 . . . . 71.53 111.977 -176.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.3 m -113.81 132.4 55.88 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.288 -0.415 . . . . 72.14 111.8 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -150.66 157.75 43.33 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 122.588 0.355 . . . . 64.11 111.106 175.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -142.14 125.53 16.62 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.023 0.44 . . . . 55.32 111.343 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -140.13 133.52 29.94 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 112.318 0.488 . . . . 74.52 112.318 -173.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 17.3 p-80 -90.91 173.83 7.76 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.411 -0.359 . . . . 73.03 111.536 178.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -143.32 141.89 31.12 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 112.699 0.629 . . . . 75.22 112.699 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -131.72 111.67 11.87 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.676 -0.693 . . . . 74.24 109.677 169.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -63.62 -71.54 0.17 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.112 1.153 . . . . 60.51 114.112 -169.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.1 t 67.73 104.4 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 120.926 0.393 . . . . 71.11 111.468 -175.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -149.49 85.87 0.16 Allowed Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.151 -0.547 . . . . 53.25 113.162 -178.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -89.8 142.17 27.94 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 122.453 -0.439 . . . . 75.53 111.398 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -91.96 149.51 21.5 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-O 121.12 0.486 . . . . 73.15 112.064 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -109.69 114.38 27.92 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.939 0.4 . . . . 61.23 111.97 -178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mp -120.69 163.74 17.62 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.08 0.467 . . . . 52.22 112.086 178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -133.58 169.0 17.64 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.945 -0.57 . . . . 74.44 110.656 -179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -103.61 111.5 23.99 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.947 0.403 . . . . 73.14 112.053 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 68.23 162.42 0.2 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.032 1.123 . . . . 71.12 114.032 176.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -164.74 167.07 38.34 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 114.226 -1.352 . . . . 65.53 111.566 176.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -77.65 103.09 7.37 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 117.557 0.679 . . . . 51.34 111.015 -177.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.556 ' HB3' ' HB3' ' A' ' 128' ' ' GLU . 6.1 ptp -111.34 167.16 10.51 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.358 0.599 . . . . 71.32 111.914 176.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 19.0 mt -134.53 139.14 45.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.741 -0.663 . . . . 71.03 111.603 177.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -84.77 114.06 21.78 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.558 0.694 . . . . 50.14 110.886 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.444 HG12 ' HA2' ' A' ' 94' ' ' GLY . 34.5 m -134.97 167.17 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 114.959 -1.019 . . . . 42.32 112.338 -170.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -101.16 132.0 46.84 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.706 0.289 . . . . 73.42 110.45 171.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.47 111.15 34.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 112.154 0.427 . . . . 70.24 112.154 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.544 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -100.06 151.06 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 CA-C-O 121.065 0.46 . . . . 73.33 111.213 174.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 74.3 m -124.53 110.0 13.93 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.975 0.417 . . . . 50.54 111.779 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -93.97 124.36 7.83 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 121.277 -0.487 . . . . 60.53 112.429 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -75.07 101.13 4.42 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.305 0.574 . . . . 62.4 112.133 -175.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 t -132.21 176.43 8.4 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.752 -0.658 . . . . 51.25 110.389 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.747 HD22 ' HB3' ' A' ' 51' ' ' ALA . 51.4 tp 66.44 -70.66 0.1 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.951 0.405 . . . . 70.12 111.937 -177.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -103.59 111.72 24.32 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.007 0.432 . . . . 74.11 111.427 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -108.02 -29.77 8.81 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.142 -0.481 . . . . 72.41 111.516 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -152.02 45.27 0.62 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 120.622 -0.799 . . . . 62.24 113.955 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.16 178.89 7.57 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 122.459 -0.436 . . . . 54.43 111.045 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.529 ' OG1' ' HG2' ' A' ' 42' ' ' GLU . 24.4 p -98.06 175.3 6.16 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 110.267 -0.271 . . . . 60.0 110.267 173.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 45.7 t -65.45 -39.46 85.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 120.823 0.344 . . . . 65.52 110.995 -178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -66.03 -42.12 90.02 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 120.847 0.356 . . . . 65.11 111.267 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.529 ' HG2' ' OG1' ' A' ' 39' ' ' THR . 19.6 mm-40 -53.39 -32.54 49.95 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.107 0.479 . . . . 72.13 111.761 179.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 48' ' ' TYR . 25.7 mtpp -123.78 25.41 8.07 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.15 -0.477 . . . . 51.1 111.176 -175.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.531 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -55.73 -13.24 1.59 Allowed 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.526 0.73 . . . . 71.41 112.774 -175.179 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 t -58.51 178.35 0.11 Allowed 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.065 0.765 . . . . 74.55 113.065 -177.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -47.94 -35.98 11.64 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.797 -0.638 . . . . 74.02 112.589 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -56.02 -34.49 65.89 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.433 0.531 . . . . 73.01 112.433 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.533 ' HB2' ' O ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -76.58 -23.08 53.49 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.962 -0.461 . . . . 74.53 110.635 175.499 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.422 ' HD1' HG23 ' A' ' 137' ' ' VAL . 57.6 t80 -90.87 0.41 57.49 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 116.181 -0.463 . . . . 71.51 112.01 -178.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.444 ' OD1' ' N ' ' A' ' 51' ' ' ALA . 29.8 p30 -121.66 -44.36 2.34 Favored 'General case' 0 N--CA 1.474 0.765 0 O-C-N 121.528 -0.733 . . . . 52.31 112.799 176.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.747 ' HB3' HD22 ' A' ' 34' ' ' LEU . . . -70.19 -30.95 68.2 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.682 0.993 . . . . 62.05 113.682 -172.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 33.0 m -118.19 16.1 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 112.769 0.655 . . . . 72.01 112.769 -177.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.579 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -104.87 17.64 23.76 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 112.868 0.692 . . . . 70.31 112.868 -174.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -141.3 168.53 19.55 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.065 0.46 . . . . 65.41 111.93 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -135.9 144.41 45.51 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.089 -0.505 . . . . 70.23 111.284 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.522 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 42.1 mt-10 -96.75 113.31 24.85 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.697 0.284 . . . . 65.35 111.189 177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.473 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.0 mp -110.43 147.01 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 116.368 -0.378 . . . . 70.21 110.82 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -65.79 143.24 57.62 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.665 -0.243 . . . . 71.42 110.971 176.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.41 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 30.4 tt0 -58.3 -38.39 76.97 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.103 0.779 . . . . 61.24 113.103 -174.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -60.44 -48.05 83.45 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.957 -0.464 . . . . 75.01 110.99 177.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -63.9 -38.07 89.74 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.012 0.434 . . . . 72.24 110.837 176.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.41 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 35.8 t-105 -53.26 -51.49 62.1 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.43 0.633 . . . . 74.4 111.07 175.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -67.92 -35.76 79.01 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.751 -0.659 . . . . 62.25 111.294 177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.9 93.2 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.185 0.516 . . . . 72.23 111.621 177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.533 ' HB2' ' HG ' ' A' ' 67' ' ' LEU . 73.5 mt -79.46 -16.15 56.59 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.118 -0.492 . . . . 63.5 111.603 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.93 53.96 24.17 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.947 -0.644 . . . . 61.33 111.888 -173.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.629 HD23 ' HE3' ' A' ' 129' ' ' LYS . 96.2 mt -91.31 160.1 15.67 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.774 0.797 . . . . 72.31 112.932 -176.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -129.51 127.81 41.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.999 -1.0 . . . . 73.42 109.394 178.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -50.8 98.8 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.096 0.776 . . . . 73.24 113.096 -171.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.92 13.4 11.15 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 115.311 -0.859 . . . . 45.51 113.77 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.436 ' HA ' HH11 ' A' ' 72' ' ' ARG . 46.9 p-10 -88.67 -169.01 2.38 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 117.665 0.732 . . . . 55.41 112.33 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.644 ' HG3' HG23 ' A' ' 134' ' ' VAL . 2.4 mpt_? -109.1 127.7 54.37 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.913 0.387 . . . . 72.21 111.9 -173.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 19.1 m -124.4 138.47 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-O 121.023 0.439 . . . . 74.24 111.33 174.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.438 ' HE3' ' HG3' ' A' ' 132' ' ' GLU . 39.8 ttmt -102.7 125.66 49.52 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.965 0.412 . . . . 52.04 110.753 177.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 46.5 t -104.48 131.17 54.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.361 -0.607 . . . . 62.35 109.361 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -134.17 132.23 39.55 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.319 0.58 . . . . 75.32 112.249 -172.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.704 HG22 ' HA3' ' A' ' 125' ' ' GLY . 30.7 p -138.99 -171.22 3.04 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.961 -0.563 . . . . 63.15 111.626 -177.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.05 -18.18 65.08 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 115.928 -0.578 . . . . 60.2 112.01 175.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 109' ' ' ASP . 98.5 m-85 -88.0 -55.36 3.79 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.911 0.386 . . . . 63.42 111.505 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.9 -154.17 11.23 Favored Glycine 0 CA--C 1.524 0.594 0 C-N-CA 120.944 -0.646 . . . . 71.12 112.93 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.07 154.12 50.41 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.2 0.524 . . . . 65.31 111.652 178.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.7 p -151.0 145.31 16.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 116.241 -0.436 . . . . 74.3 111.036 177.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.5 t -110.31 117.73 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 120.808 0.337 . . . . 44.31 111.099 177.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.2 m -125.51 173.95 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 CA-C-N 115.966 -0.561 . . . . 75.21 111.365 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -78.0 133.32 38.0 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.011 0.434 . . . . 72.23 111.18 176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -83.94 126.5 33.07 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.179 0.437 . . . . 54.24 112.179 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -132.01 152.03 51.39 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.368 0.604 . . . . 74.44 110.871 175.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -90.45 121.97 32.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.66 -0.7 . . . . 65.4 111.249 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.522 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -120.59 -178.5 16.09 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 121.122 -0.561 . . . . 65.43 113.801 -174.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -93.66 8.87 39.24 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 122.703 0.401 . . . . 64.42 111.73 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 28.1 m -64.17 152.88 87.06 Favored Pre-proline 0 CA--C 1.544 0.726 0 CA-C-N 116.473 -0.33 . . . . 75.3 111.786 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.05 157.71 58.94 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.393 2.062 . . . . 74.43 112.21 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -64.63 142.2 58.51 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.829 0.347 . . . . 70.13 111.544 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.444 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 73.18 25.94 71.95 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.881 -0.676 . . . . 43.41 112.745 -173.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . . . . . . . . . 26.2 ttt -154.97 136.74 14.44 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 122.428 -0.454 . . . . 75.03 110.278 -179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 49.2 pt -134.69 145.74 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-O 121.116 0.484 . . . . 55.43 112.264 -177.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.413 ' HA ' HG12 ' A' ' 29' ' ' ILE . 70.4 t80 -103.94 134.86 46.52 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.017 0.437 . . . . 74.13 111.379 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.656 ' O ' ' HA ' ' A' ' 30' ' ' SER . 48.3 mt -130.75 132.96 24.27 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.368 -0.378 . . . . 65.02 110.534 175.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.401 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 33.7 Cg_exo -61.65 129.05 26.43 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.058 1.839 . . . . 72.35 112.075 174.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.492 ' HE3' HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -57.73 104.8 0.2 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.029 0.443 . . . . 72.1 110.858 -176.417 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.25 -175.03 29.75 Favored Glycine 0 CA--C 1.523 0.594 0 C-N-CA 120.812 -0.708 . . . . 52.22 112.854 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.439 ' O ' ' HG2' ' A' ' 106' ' ' MET . 16.0 Cg_endo -56.56 -33.28 92.5 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.656 2.238 . . . . 65.43 112.254 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.463 ' HA ' HD11 ' A' ' 140' ' ' LEU . 37.5 m-85 -63.35 -50.97 67.89 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.092 0.472 . . . . 72.15 110.23 175.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -59.97 -41.48 92.04 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.167 -0.47 . . . . 61.04 111.801 176.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.423 HD22 ' HA ' ' A' ' 102' ' ' PRO . 91.7 m-20 -53.3 -29.16 32.01 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 112.15 0.426 . . . . 63.34 112.15 178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.483 ' SD ' HD21 ' A' ' 140' ' ' LEU . 87.8 mmm -65.62 -24.15 66.99 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.29 -0.414 . . . . 75.25 112.112 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.5 -12.92 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 112.945 0.72 . . . . 62.03 112.945 -173.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.492 HD11 ' HE3' ' A' ' 100' ' ' MET . 6.9 pt -107.44 -179.43 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 O-C-N 121.868 -0.52 . . . . 63.34 111.738 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 29.4 t70 -105.1 108.02 60.29 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 116.141 -0.481 . . . . 63.42 110.563 173.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.97 13.81 2.07 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.619 2.213 . . . . 72.34 113.648 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.5 m -80.94 -17.88 48.99 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.856 0.36 . . . . 71.32 111.843 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.3 t -97.71 109.58 22.31 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.303 0.573 . . . . 74.22 111.843 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -75.78 76.63 2.73 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.184 0.516 . . . . 74.01 111.801 178.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 62.05 -166.67 18.34 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-N 115.903 -0.59 . . . . 75.33 114.013 177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.8 p -137.32 -58.31 0.7 Allowed 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.987 0.422 . . . . 62.21 111.234 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.72 113.01 3.19 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.041 -0.527 . . . . 63.41 111.948 -178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 84.9 mtp 68.01 159.28 0.14 Allowed Pre-proline 0 CA--C 1.549 0.94 0 CA-C-N 116.966 0.383 . . . . 71.11 111.241 -174.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -56.81 95.34 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.631 2.221 . . . . 75.25 113.72 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -113.27 -23.24 10.03 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.321 0.489 . . . . 75.3 112.321 177.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 61.9 -160.07 0.31 Allowed 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.183 0.438 . . . . 75.21 112.183 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt 75.52 96.64 0.07 Allowed 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.705 0.802 . . . . 63.13 112.701 177.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -111.66 -157.76 14.35 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-N 115.826 -0.624 . . . . 33.44 113.984 -177.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.41 HG21 ' H ' ' A' ' 109' ' ' ASP . 58.1 t -92.93 133.73 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 122.836 0.454 . . . . 63.42 111.46 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -74.96 140.84 43.96 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 112.671 0.619 . . . . 74.44 112.671 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.704 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -169.62 -165.5 27.09 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 115.837 -0.62 . . . . 74.13 113.087 177.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 77.3 p -122.39 155.12 36.71 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.939 0.399 . . . . 70.43 111.486 179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.1 p -129.88 142.77 42.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 109.657 -0.498 . . . . 62.54 109.657 173.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.556 ' HB3' ' HB3' ' A' ' 23' ' ' MET . 8.8 pt-20 -143.21 147.65 35.21 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 113.251 0.834 . . . . 72.21 113.251 -174.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.629 ' HE3' HD23 ' A' ' 67' ' ' LEU . 1.8 tppp? -77.03 109.28 10.73 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.427 -0.806 . . . . 72.01 109.675 168.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.1 t -123.22 162.53 22.39 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.348 0.594 . . . . 74.34 112.456 -173.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -79.82 -12.14 59.78 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.397 -0.82 . . . . 71.44 111.209 178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.438 ' HG3' ' HE3' ' A' ' 74' ' ' LYS . 6.2 mm-40 -61.1 160.26 10.44 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.684 0.754 . . . . 74.22 112.925 -176.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -95.15 160.22 14.66 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.425 -0.807 . . . . 74.11 110.917 175.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.644 HG23 ' HG3' ' A' ' 72' ' ' ARG . 71.9 t -72.25 136.42 25.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-O 120.733 0.302 . . . . 62.24 110.751 174.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.6 mt -73.4 132.29 42.83 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.544 -0.298 . . . . 73.2 111.441 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 35.4 t -73.15 147.83 44.45 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 109.208 -0.664 . . . . 73.2 109.208 170.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.422 HG23 ' HD1' ' A' ' 49' ' ' PHE . 99.3 t -46.05 -52.5 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 N-CA-C 112.672 0.619 . . . . 70.34 112.672 -173.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -73.0 -35.41 66.82 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 122.04 -0.412 . . . . 73.52 111.723 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -60.9 -33.83 73.73 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.747 0.784 . . . . 72.11 110.156 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.483 HD21 ' SD ' ' A' ' 106' ' ' MET . 4.8 tt -60.37 -44.19 95.84 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.075 -0.966 . . . . 72.43 110.359 171.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.1 mt -61.56 -41.23 97.09 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.181 0.515 . . . . 71.03 110.19 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -64.41 -34.61 78.58 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.904 -0.589 . . . . 75.33 110.96 176.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.02 -36.05 82.22 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.369 -0.378 . . . . 54.25 111.801 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.49 HG13 ' H ' ' A' ' 146' ' ' SER . 33.8 pt -88.9 -16.29 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 111.96 0.356 . . . . 74.23 111.96 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 102.32 -5.94 52.75 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 121.381 -0.438 . . . . 53.31 113.953 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.49 ' H ' HG13 ' A' ' 144' ' ' ILE . 30.7 t . . . . . 0 N--CA 1.474 0.774 0 CA-C-O 121.409 0.623 . . . . 61.5 111.902 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.1 mmm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 111.849 0.314 . . . . 74.35 111.849 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.19 118.23 0.43 Allowed Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.602 -0.808 . . . . 70.25 113.398 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.2 p -89.87 98.57 11.85 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.713 0.292 . . . . 65.54 111.078 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.6 m -60.21 123.25 16.64 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.0 0.428 . . . . 75.03 112.018 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -93.19 154.26 18.15 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.449 -0.342 . . . . 72.35 110.961 178.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -128.69 138.48 52.17 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.897 0.379 . . . . 75.25 111.957 -178.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.0 p-80 -115.08 110.26 19.3 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 116.1 -0.5 . . . . 53.25 111.122 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -74.01 156.21 37.77 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.195 0.813 . . . . 51.2 113.195 -174.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -134.55 176.1 8.94 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.9 -0.591 . . . . 73.4 110.879 174.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -87.28 162.65 17.3 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.081 0.467 . . . . 74.33 111.297 174.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.7 m -75.81 84.72 2.78 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.473 -0.331 . . . . 74.23 111.315 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.6 p -99.16 176.57 5.5 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.837 0.351 . . . . 75.34 111.019 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.72 16.83 25.87 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 120.873 -0.679 . . . . 71.33 114.313 -176.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 44.0 mtt180 -73.91 101.8 3.9 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.68 0.753 . . . . 73.34 112.241 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -82.91 -165.24 1.02 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.084 -0.962 . . . . 75.11 111.626 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -147.67 -63.87 0.27 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.466 -0.334 . . . . 73.34 110.963 177.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.4 mp 70.17 115.84 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 112.803 0.668 . . . . 74.11 112.803 -178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 67.79 170.09 0.27 Allowed 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 115.206 -0.906 . . . . 73.31 113.167 178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -148.0 36.99 0.86 Allowed 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.565 -0.743 . . . . 73.44 110.335 178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -136.86 161.99 34.46 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.236 -0.438 . . . . 74.1 111.56 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.45 72.76 1.11 Allowed Glycine 0 CA--C 1.528 0.847 0 CA-C-N 116.243 -0.435 . . . . 63.13 113.297 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -99.13 136.69 38.72 Favored 'General case' 0 N--CA 1.469 0.494 0 O-C-N 122.357 -0.496 . . . . 75.15 112.044 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.438 ' SD ' HG21 ' A' ' 126' ' ' THR . 7.0 ptp -104.42 154.76 19.46 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.06 -0.518 . . . . 74.55 110.855 174.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.557 HD12 ' HG ' ' A' ' 65' ' ' LEU . 9.5 mt -104.84 127.36 52.62 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.028 0.442 . . . . 74.25 111.687 178.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -71.29 113.23 8.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.732 0.777 . . . . 71.33 111.865 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 35.3 m -134.09 157.62 41.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 114.71 -1.132 . . . . 73.11 111.742 -174.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 41.8 tt0 -98.74 117.88 34.21 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.905 0.383 . . . . 74.13 110.699 175.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.634 HG22 HD11 ' A' ' 96' ' ' ILE . 34.4 t -91.04 110.63 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.944 -0.571 . . . . 71.33 111.848 -173.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.51 ' HA ' ' HA3' ' A' ' 122' ' ' GLY . 2.0 mt -95.72 159.92 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 O-C-N 122.06 -0.4 . . . . 71.22 111.731 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 23.3 t -122.87 111.71 16.99 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.949 0.404 . . . . 63.1 111.245 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.34 117.89 5.7 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 121.319 -0.467 . . . . 60.45 113.534 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.497 HH11 ' HA ' ' A' ' 32' ' ' ARG . 10.8 mmm180 -77.34 16.32 0.63 Allowed 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 112.992 0.738 . . . . 74.12 112.992 -175.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.2 t -64.03 -41.48 97.41 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.987 0.422 . . . . 63.44 111.729 176.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.8 mp -110.64 164.05 13.12 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.091 0.472 . . . . 72.3 111.995 178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 48.8 t30 59.58 92.31 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.354 -0.839 . . . . 72.32 112.446 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -91.79 3.3 55.43 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.91 -0.586 . . . . 74.44 110.587 175.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 128.51 47.94 0.16 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 115.958 -0.565 . . . . 74.43 112.065 -175.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.42 ' HB1' ' HG2' ' A' ' 42' ' ' GLU . . . -134.9 142.9 46.67 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.952 0.406 . . . . 31.44 111.602 -176.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.579 HG23 ' H ' ' A' ' 42' ' ' GLU . 5.6 t -67.1 156.98 34.75 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 116.511 -0.313 . . . . 74.24 111.237 175.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.5 m -59.5 -28.2 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 120.861 0.363 . . . . 54.22 111.144 178.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -66.58 -33.63 76.1 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.19 0.519 . . . . 74.25 110.576 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.579 ' H ' HG23 ' A' ' 39' ' ' THR . 5.9 tp10 -51.15 -37.77 48.21 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.789 -0.642 . . . . 75.34 111.371 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.626 ' HB2' ' CD2' ' A' ' 48' ' ' TYR . 2.7 mptp? -105.98 -62.26 1.4 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 116.22 -0.445 . . . . 73.42 110.629 176.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 29.1 tp 69.16 -31.43 0.21 Allowed 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.908 1.447 . . . . 64.32 114.908 172.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.9 t -54.58 154.42 4.87 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.587 0.588 . . . . 73.04 112.587 -178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 49' ' ' PHE . 46.2 tt0 -57.13 -26.82 61.15 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 111.902 0.334 . . . . 73.54 111.902 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.6 -36.32 69.27 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 120.859 0.361 . . . . 61.23 111.066 174.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.626 ' CD2' ' HB2' ' A' ' 43' ' ' LYS . 8.6 t80 -59.63 -41.23 90.0 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.55 0.691 . . . . 74.43 109.876 174.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.45 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 50.5 t80 -63.61 -65.15 0.72 Allowed 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.24 -0.891 . . . . 54.25 110.554 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -58.0 -21.54 45.34 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 112.773 0.656 . . . . 73.44 112.773 -176.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -81.28 -32.19 33.32 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.031 0.752 . . . . 45.21 113.031 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 48' ' ' TYR . 32.7 m -116.93 4.88 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 N-CA-C 113.27 0.841 . . . . 73.33 113.27 -175.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.421 HD22 ' N ' ' A' ' 53' ' ' ASN . 1.2 m-80 -94.58 28.34 2.66 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.377 0.88 . . . . 74.42 113.377 -177.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.446 ' CE2' ' HE2' ' A' ' 87' ' ' LYS . 17.8 p90 -144.46 151.62 39.45 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.556 -0.715 . . . . 64.21 111.979 177.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -124.78 139.59 53.7 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.617 -0.72 . . . . 32.13 110.872 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.662 ' HG2' ' HE3' ' A' ' 87' ' ' LYS . 41.3 mt-10 -95.42 112.66 24.33 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 120.865 0.364 . . . . 73.43 111.423 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.441 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.0 mp -109.17 145.67 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-N 116.275 -0.42 . . . . 70.34 110.518 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -61.81 151.93 32.92 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.284 0.564 . . . . 52.11 111.763 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.519 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 14.8 tm-20 -55.92 -52.94 62.36 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.705 -0.679 . . . . 61.41 111.964 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -55.75 -53.24 59.03 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.325 0.491 . . . . 70.24 112.325 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -61.09 -35.98 78.46 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-O 121.629 0.728 . . . . 75.22 110.663 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.519 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 43.0 t-105 -52.78 -53.84 42.52 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 115.023 -0.99 . . . . 73.44 111.769 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -73.53 -30.15 62.9 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.299 -0.409 . . . . 70.31 111.644 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.439 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -58.64 -34.85 71.66 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.032 0.444 . . . . 65.1 111.581 177.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.557 ' HG ' HD12 ' A' ' 24' ' ' LEU . 82.6 mt -89.64 -13.86 36.15 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.154 -0.475 . . . . 43.24 111.461 176.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 75.72 44.72 19.47 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 121.396 -0.431 . . . . 72.04 112.825 -178.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' A' ' 129' ' ' LYS . 92.9 mt -85.1 149.97 25.18 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.509 0.671 . . . . 72.22 112.095 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -114.61 144.96 42.56 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.691 -0.686 . . . . 70.15 109.213 169.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -61.33 93.37 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.017 0.913 . . . . 61.23 111.697 -176.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.0 -7.42 3.8 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 114.612 -1.176 . . . . 43.24 113.267 -175.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -69.35 178.53 2.36 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.04 0.756 . . . . 74.41 113.04 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.2 mtm-85 -113.61 139.63 48.86 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.688 -0.687 . . . . 73.52 110.512 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.35 139.64 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 121.472 0.653 . . . . 73.14 112.716 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -90.38 131.29 36.24 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.427 -0.806 . . . . 72.12 110.207 172.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.9 t -119.52 125.72 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 109.696 -0.483 . . . . 73.1 109.696 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.459 ' HG2' ' HB3' ' A' ' 81' ' ' GLU . 25.6 mtpp -133.9 131.59 39.3 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.991 0.737 . . . . 73.3 112.991 -171.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.652 HG22 ' HA3' ' A' ' 125' ' ' GLY . 30.3 p -140.1 -176.23 4.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.529 -0.759 . . . . 71.22 110.973 178.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.78 -11.4 60.82 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.365 -0.38 . . . . 71.04 111.681 177.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.418 ' CZ ' ' HB2' ' A' ' 109' ' ' ASP . 93.8 m-85 -89.31 -40.45 12.78 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.802 0.334 . . . . 71.43 111.296 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.05 -147.26 10.24 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 121.144 -0.55 . . . . 43.42 112.652 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.459 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 11.2 pt-20 -155.04 154.43 32.46 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.143 0.497 . . . . 71.32 112.218 177.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.3 p -149.51 155.32 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.999 -0.546 . . . . 73.05 111.169 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 39.8 t -115.83 116.94 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 O-C-N 122.382 -0.198 . . . . 74.22 111.017 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.5 m -126.5 176.28 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 116.496 -0.32 . . . . 72.43 111.267 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -77.68 160.4 28.5 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.203 0.525 . . . . 75.44 111.405 175.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.11 127.2 50.47 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.243 0.544 . . . . 60.45 111.734 -173.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.662 ' HE3' ' HG2' ' A' ' 56' ' ' GLU . 0.2 OUTLIER -131.24 129.71 41.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.877 -0.601 . . . . 55.32 111.148 -178.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -79.88 98.65 7.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.035 -0.53 . . . . 73.1 110.828 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.553 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -96.56 161.01 22.01 Favored Glycine 0 CA--C 1.525 0.706 0 CA-C-N 115.989 -0.55 . . . . 45.43 114.018 -173.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -87.63 15.24 7.04 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.358 0.599 . . . . 62.11 111.566 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.8 m -71.12 157.35 90.45 Favored Pre-proline 0 CA--C 1.544 0.734 0 CA-C-N 115.685 -0.689 . . . . 74.2 111.421 177.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -61.6 157.67 40.74 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 122.732 2.288 . . . . 70.31 113.723 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -62.59 145.64 53.93 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 116.282 -0.417 . . . . 74.44 111.35 178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 61.99 32.45 82.22 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 120.843 -0.694 . . . . 72.52 112.716 -174.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.484 ' HA ' ' H ' ' A' ' 27' ' ' GLU . 21.8 ttt -153.88 136.71 15.34 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 122.592 -0.358 . . . . 63.43 110.119 -176.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.634 HD11 HG22 ' A' ' 28' ' ' VAL . 40.8 pt -134.84 150.9 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-O 121.288 0.566 . . . . 72.43 112.023 -177.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -112.13 130.9 55.74 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.016 -0.538 . . . . 61.02 111.241 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 30' ' ' SER . 50.4 mt -130.3 128.5 22.7 Favored Pre-proline 0 N--CA 1.474 0.77 0 CA-C-O 120.548 0.213 . . . . 74.11 110.998 175.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.51 140.66 89.89 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.27 1.98 . . . . 72.25 112.899 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.423 ' HG3' ' NH1' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -60.01 105.84 0.44 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.122 0.486 . . . . 75.0 110.815 -178.646 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -157.91 -174.71 27.96 Favored Glycine 0 N--CA 1.46 0.273 0 C-N-CA 120.784 -0.722 . . . . 71.53 112.57 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.512 ' O ' ' HG2' ' A' ' 106' ' ' MET . 26.5 Cg_endo -61.74 -26.72 80.1 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.272 1.981 . . . . 53.24 111.563 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.463 ' HD1' ' H ' ' A' ' 103' ' ' TYR . 4.1 m-85 -69.17 -53.44 20.04 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.56 -0.745 . . . . 74.15 110.782 177.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -60.05 -39.78 87.16 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 116.268 -0.424 . . . . 43.52 110.748 174.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -54.71 -25.92 30.51 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.912 0.485 . . . . 70.25 112.042 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.645 ' SD ' HD21 ' A' ' 140' ' ' LEU . 89.9 mmm -67.28 -30.2 70.01 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 111.947 0.351 . . . . 73.04 111.947 177.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.1 m -122.07 -14.01 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 113.187 0.81 . . . . 54.52 113.187 -171.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 104' ' ' ALA . 8.8 pt -102.67 -178.91 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.163 0.506 . . . . 62.05 111.753 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.418 ' HB2' ' CZ ' ' A' ' 79' ' ' PHE . 21.7 t70 -109.49 100.0 39.76 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-N 116.076 -0.511 . . . . 33.43 110.475 173.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -75.09 -2.91 13.17 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.444 2.096 . . . . 71.03 113.327 -178.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.7 t -67.78 -28.15 67.36 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.983 0.42 . . . . 64.24 111.467 177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.0 t -104.08 156.44 17.87 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.694 0.627 . . . . 73.21 112.694 -177.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -108.37 -177.18 3.25 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.72 -0.673 . . . . 70.12 110.029 172.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -78.77 54.13 4.1 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 121.026 -0.607 . . . . 65.21 112.918 178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 67.0 p -85.54 104.58 15.44 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.963 0.411 . . . . 74.03 111.385 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 139.66 -103.69 0.39 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.304 -0.475 . . . . 55.25 112.368 -178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.407 ' O ' ' N ' ' A' ' 119' ' ' GLN . 91.1 mtp -86.74 142.71 34.77 Favored Pre-proline 0 CA--C 1.54 0.569 0 O-C-N 122.634 -0.333 . . . . 71.32 110.783 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.22 79.09 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.281 2.654 . . . . 70.12 113.954 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 119' ' ' GLN . 18.6 tt0 58.45 29.15 17.89 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.501 0.667 . . . . 72.23 111.851 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -95.07 144.97 25.3 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.939 -0.573 . . . . 71.45 111.38 177.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.3 mttt 67.66 138.79 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.655 0.741 . . . . 70.03 112.558 -178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 29' ' ' ILE . . . -134.29 -156.68 7.93 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.817 -0.629 . . . . 63.51 113.091 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' A' ' 108' ' ' ILE . 59.5 t -85.32 119.16 33.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.926 0.393 . . . . 71.31 111.487 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 67.5 mttm -67.46 148.88 50.95 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.245 0.545 . . . . 65.24 112.366 -177.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.652 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -177.25 -143.52 4.94 Favored Glycine 0 CA--C 1.534 1.255 0 CA-C-N 115.94 -0.573 . . . . 53.21 113.367 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.438 HG21 ' SD ' ' A' ' 23' ' ' MET . 76.5 p -139.3 159.98 40.88 Favored 'General case' 0 N--CA 1.476 0.875 0 O-C-N 122.398 -0.472 . . . . 65.24 111.769 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.7 p -144.99 145.02 21.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-O 121.103 0.478 . . . . 74.24 111.484 176.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -155.61 161.51 40.81 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.364 -0.38 . . . . 71.51 110.687 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.441 ' HB2' HD21 ' A' ' 67' ' ' LEU . 31.7 ttpt -79.91 131.15 35.78 Favored 'General case' 0 N--CA 1.466 0.364 0 O-C-N 121.755 -0.59 . . . . 75.25 110.197 173.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 9.7 t -118.01 156.25 28.88 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.644 0.609 . . . . 61.1 112.644 -172.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -76.02 -13.05 60.23 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.724 -0.671 . . . . 74.42 110.055 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -70.0 147.68 49.82 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.299 -0.864 . . . . 63.52 113.195 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.713 ' H ' ' HD3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -77.29 157.35 30.79 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 114.779 -1.1 . . . . 75.43 111.373 174.265 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 69.8 t -68.23 130.28 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-O 120.87 0.367 . . . . 74.35 110.826 175.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.1 mt -66.26 119.45 11.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.349 -0.387 . . . . 71.51 111.567 178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.437 ' HA ' ' HE2' ' A' ' 49' ' ' PHE . 29.9 t -66.27 148.44 51.85 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.596 -0.52 . . . . 74.32 109.596 168.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.505 ' O ' ' HG ' ' A' ' 141' ' ' LEU . 62.7 t -46.26 -40.3 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-O 120.943 0.402 . . . . 75.22 111.583 -179.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -72.79 -44.39 61.59 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.194 -0.457 . . . . 61.42 112.165 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -60.91 -36.03 78.21 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.672 0.749 . . . . 74.22 110.227 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.645 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.5 tt -60.65 -38.87 86.3 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.415 -0.811 . . . . 71.21 110.799 174.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 54.0 mt -57.84 -47.52 82.42 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.467 0.651 . . . . 73.22 110.063 175.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -64.99 -30.7 71.71 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.662 -0.699 . . . . 75.24 111.449 178.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -69.1 -40.63 78.26 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.166 0.432 . . . . 74.23 112.166 178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.46 HD12 ' H ' ' A' ' 146' ' ' SER . 2.9 pp -83.9 -18.75 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 112.094 0.405 . . . . 75.13 112.094 179.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 142.9 -46.6 0.85 Allowed Glycine 0 CA--C 1.527 0.807 0 C-N-CA 121.118 -0.563 . . . . 54.25 113.353 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.48 ' HB2' ' HB3' ' A' ' 141' ' ' LEU . 16.0 m . . . . . 0 N--CA 1.47 0.557 0 CA-C-O 121.035 0.445 . . . . 73.32 111.574 -178.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 ptm . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.157 0.503 . . . . 62.21 111.645 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.53 153.57 2.65 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 121.197 -0.525 . . . . 63.44 112.84 -176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.2 p -168.72 120.45 0.78 Allowed 'General case' 0 N--CA 1.472 0.655 0 O-C-N 122.292 -0.534 . . . . 71.23 111.976 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 81.0 p -88.1 111.26 21.37 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 120.976 0.417 . . . . 74.14 110.432 175.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -79.0 152.55 30.9 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.221 -0.445 . . . . 73.54 111.851 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -119.91 164.65 15.73 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.013 0.435 . . . . 64.22 111.874 -176.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -142.28 174.46 10.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.63 0.372 . . . . 72.22 110.48 177.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.1 p-80 -139.86 144.1 37.07 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 112.156 0.428 . . . . 62.34 112.156 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 72.8 m-70 -114.36 141.2 47.94 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.343 -0.39 . . . . 72.13 111.334 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -92.66 138.09 31.8 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.588 -0.278 . . . . 75.33 110.712 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.8 p -154.39 128.21 8.77 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.38 0.511 . . . . 54.14 112.38 -176.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.7 t -165.55 136.04 3.69 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 116.258 -0.428 . . . . 73.32 111.082 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -160.41 75.38 0.19 Allowed Glycine 0 CA--C 1.527 0.816 0 C-N-CA 120.977 -0.63 . . . . 55.31 113.052 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.492 ' HA ' ' HE ' ' A' ' 14' ' ' ARG . 5.2 mmp_? -109.95 117.8 34.75 Favored 'General case' 0 N--CA 1.471 0.614 0 O-C-N 122.446 -0.444 . . . . 74.34 110.931 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -107.64 -177.47 3.35 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.183 0.438 . . . . 73.41 112.183 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -124.17 126.28 45.88 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.316 0.488 . . . . 73.1 112.316 -175.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.1 mp -116.35 128.51 55.6 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.323 -0.399 . . . . 75.23 110.476 171.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.9 p90 -107.44 155.9 19.54 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 112.575 0.583 . . . . 74.42 112.575 -175.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -119.89 166.31 13.47 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.733 -0.667 . . . . 75.31 110.719 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -131.86 -43.43 0.99 Allowed 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.227 0.825 . . . . 74.53 113.227 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.52 166.41 35.36 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.559 -0.829 . . . . 54.44 113.45 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -119.25 121.84 40.57 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.47 0.545 . . . . 75.13 112.47 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 12.5 ptm -80.62 142.06 34.39 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.325 -0.398 . . . . 73.41 110.528 174.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mp -105.32 142.92 34.24 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.164 0.507 . . . . 64.32 112.281 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.409 ' HA ' HG22 ' A' ' 126' ' ' THR . 29.6 tt0 -81.14 112.12 18.21 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 115.809 -0.632 . . . . 74.3 110.898 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 94' ' ' GLY . 33.3 m -128.09 160.19 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 120.809 0.338 . . . . 71.22 111.886 -174.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.701 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 86.9 tt0 -98.83 115.23 28.34 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.193 0.521 . . . . 72.55 110.594 175.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.553 HG22 HD11 ' A' ' 96' ' ' ILE . 39.5 t -88.22 113.9 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-N 115.708 -0.678 . . . . 63.21 111.751 -175.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 mt -98.0 159.8 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.569 -0.287 . . . . 74.53 111.546 -178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 71.5 m -126.17 106.13 9.34 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.964 0.411 . . . . 55.34 111.29 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.52 ' HA3' ' CZ ' ' A' ' 97' ' ' PHE . . . -95.28 126.86 8.91 Favored Glycine 0 CA--C 1.524 0.651 0 C-N-CA 121.039 -0.6 . . . . 75.54 113.597 -176.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -76.65 81.94 3.29 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.251 0.548 . . . . 72.24 111.589 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.9 t -96.73 -17.69 20.13 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.576 0.703 . . . . 72.42 110.149 170.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 65.2 tp -148.88 153.58 38.24 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.068 -0.969 . . . . 73.31 109.83 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 70.48 104.95 0.06 Allowed 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 112.635 0.605 . . . . 64.52 112.635 177.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -83.73 -28.27 28.36 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.624 0.725 . . . . 63.22 109.712 170.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 175.87 66.0 0.06 OUTLIER Glycine 0 CA--C 1.526 0.759 0 CA-C-N 114.911 -1.041 . . . . 73.44 111.479 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.408 ' CB ' ' HE3' ' A' ' 43' ' ' LYS . . . -134.69 162.93 30.94 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.316 0.579 . . . . 60.13 112.072 -174.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 47.1 p -85.93 169.49 13.22 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.996 -0.547 . . . . 64.53 110.314 173.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 4.7 m -68.39 -34.42 65.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-O 121.093 0.473 . . . . 52.4 110.404 176.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.83 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 4.0 tm-20 -71.46 -28.84 64.23 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.661 -0.699 . . . . 72.22 110.984 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.578 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . 0.9 OUTLIER -55.3 -29.12 57.6 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 116.104 -0.498 . . . . 71.54 110.919 175.221 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.578 ' HE2' ' HB3' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -107.35 -74.92 0.64 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.845 0.355 . . . . 71.11 111.899 174.832 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.83 ' HG ' ' HA ' ' A' ' 41' ' ' GLU . 26.2 mt 55.52 12.08 0.72 Allowed 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.982 1.104 . . . . 72.1 113.982 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.4 t -72.02 160.12 33.03 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 121.918 -0.489 . . . . 51.12 110.545 174.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -58.34 -35.68 72.28 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.881 0.372 . . . . 74.01 111.036 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -53.95 -34.64 60.25 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.12 0.485 . . . . 71.44 111.268 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.402 ' CD2' ' HB2' ' A' ' 43' ' ' LYS . 2.5 t80 -64.78 -32.64 74.43 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 116.211 -0.449 . . . . 75.43 110.675 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.478 ' HD1' HG23 ' A' ' 137' ' ' VAL . 52.8 t80 -87.19 4.92 40.54 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.161 0.505 . . . . 75.25 111.673 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -121.44 -36.32 3.09 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 121.753 -0.592 . . . . 44.21 111.959 176.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.4 -56.0 8.7 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.796 0.665 . . . . 72.21 112.796 -175.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.6 ' HA ' ' HG2' ' A' ' 99' ' ' PRO . 34.4 m -96.16 17.16 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 N-CA-C 113.078 0.77 . . . . 65.01 113.078 -173.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.596 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.8 OUTLIER -102.46 19.38 19.04 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.709 0.633 . . . . 74.22 112.709 -174.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -144.23 171.14 14.72 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.889 -0.507 . . . . 70.33 112.045 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -133.55 136.39 44.94 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.884 -0.598 . . . . 72.0 111.388 176.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.627 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 42.5 mt-10 -86.66 117.28 25.31 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.088 0.471 . . . . 60.34 110.7 175.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 28.1 mt -113.52 143.43 23.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 115.819 -0.628 . . . . 73.25 111.897 -173.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -66.38 145.07 56.12 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.495 0.188 . . . . 73.12 110.622 174.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -62.29 -32.62 73.37 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.529 0.566 . . . . 62.34 112.529 -176.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.551 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 17.7 mm-40 -58.87 -57.44 13.05 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 122.213 -0.304 . . . . 54.04 111.585 175.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.51 -37.29 85.46 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-O 121.345 0.593 . . . . 74.2 110.64 177.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.496 ' HA ' HD12 ' A' ' 67' ' ' LEU . 51.5 t-105 -53.43 -52.1 60.5 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.406 -0.815 . . . . 72.55 110.991 174.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -67.1 -38.65 86.04 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.679 -0.691 . . . . 63.52 111.35 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -60.27 -33.91 72.99 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.236 -0.438 . . . . 65.35 112.028 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -94.78 -7.61 39.93 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.083 0.401 . . . . 73.15 112.083 178.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 64.48 48.15 76.6 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 121.064 -0.588 . . . . 64.52 112.634 -177.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.524 HD23 ' HD3' ' A' ' 129' ' ' LYS . 84.8 mt -86.29 142.8 28.26 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.351 0.596 . . . . 73.21 112.34 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -110.51 151.36 27.67 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.416 -0.811 . . . . 74.15 109.545 172.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.6 104.31 0.64 Allowed 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 121.329 0.585 . . . . 72.21 111.366 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 118.5 0.02 15.95 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-N 115.652 -0.704 . . . . 73.42 113.62 -176.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -68.65 172.13 6.72 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.304 0.573 . . . . 51.43 111.868 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 133' ' ' LYS . 74.1 mtt85 -109.79 125.51 52.8 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.001 -0.545 . . . . 63.21 110.949 177.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.691 HG13 ' HB2' ' A' ' 86' ' ' ALA . 15.5 m -113.8 152.35 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.543 0.687 . . . . 75.21 111.844 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.432 ' HZ2' ' CG2' ' A' ' 83' ' ' VAL . 47.1 tttp -124.05 120.86 33.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.606 -0.724 . . . . 74.21 110.388 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 48.2 t -102.64 130.83 52.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 N-CA-C 111.753 0.279 . . . . 61.55 111.753 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -118.91 127.73 53.76 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 116.631 -0.259 . . . . 72.12 110.748 175.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.814 HG22 ' HA3' ' A' ' 125' ' ' GLY . 25.4 p -130.81 -172.15 2.75 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.094 0.473 . . . . 73.33 111.259 177.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.77 -16.43 63.8 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.373 -0.376 . . . . 73.2 111.679 176.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -93.34 -47.07 7.07 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 111.888 0.329 . . . . 71.33 111.888 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 178.94 -156.95 19.98 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 120.879 -0.677 . . . . 52.52 113.266 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 5.2 pt-20 -133.72 161.23 35.25 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.14 0.495 . . . . 74.24 111.725 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.9 p -160.59 143.25 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.29 -0.414 . . . . 74.13 111.34 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.432 ' CG2' ' HZ2' ' A' ' 74' ' ' LYS . 45.0 t -104.03 118.97 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 O-C-N 122.325 -0.234 . . . . 72.42 110.761 176.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.9 m -130.14 177.68 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 120.853 0.359 . . . . 75.25 111.687 -178.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -80.21 144.11 33.22 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.19 0.519 . . . . 74.23 111.674 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.691 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -93.9 120.13 33.75 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.18 0.437 . . . . 64.23 112.18 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -131.9 150.31 52.19 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.203 0.525 . . . . 74.32 110.863 175.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -92.14 122.81 34.98 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.005 -0.543 . . . . 75.41 111.068 -175.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.627 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -120.06 172.94 15.06 Favored Glycine 0 CA--C 1.522 0.53 0 C-N-CA 121.08 -0.581 . . . . 64.42 113.487 -176.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -82.9 9.82 9.17 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 120.81 0.338 . . . . 62.31 111.861 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 29.1 m -64.78 152.97 89.16 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.353 -0.385 . . . . 71.15 111.67 -179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.18 163.57 38.73 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 122.803 2.335 . . . . 65.2 113.218 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.551 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 84.6 tttt -63.88 133.07 52.64 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.406 -0.361 . . . . 73.13 111.694 -177.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 26' ' ' VAL . . . 77.44 24.37 65.7 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.97 -0.633 . . . . 72.22 113.198 -176.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.701 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 18.2 ttt -149.78 137.09 19.81 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.374 -0.486 . . . . 74.21 110.471 179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.553 HD11 HG22 ' A' ' 28' ' ' VAL . 39.5 pt -130.09 144.75 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 121.407 0.622 . . . . 64.23 112.03 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.52 ' CZ ' ' HA3' ' A' ' 31' ' ' GLY . 74.6 t80 -106.69 119.36 39.1 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.961 -0.563 . . . . 73.34 111.383 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' A' ' 30' ' ' SER . 44.4 mt -117.4 126.36 27.45 Favored Pre-proline 0 CA--C 1.537 0.457 0 CA-C-O 120.673 0.273 . . . . 70.21 110.801 175.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.6 ' HG2' ' HA ' ' A' ' 52' ' ' VAL . 19.5 Cg_endo -58.56 132.0 45.78 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.121 1.881 . . . . 75.21 111.934 175.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.9 tpp -51.51 115.42 1.61 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.17 0.51 . . . . 74.54 112.265 -176.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -169.03 178.53 42.24 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.786 -0.643 . . . . 61.35 112.496 179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.494 ' O ' ' HG2' ' A' ' 106' ' ' MET . 11.9 Cg_endo -52.87 -33.8 63.01 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 122.853 2.369 . . . . 60.04 112.095 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -64.82 -47.64 77.29 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.738 -0.665 . . . . 74.23 110.608 177.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.501 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -64.21 -39.83 94.79 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.018 0.437 . . . . 62.43 111.197 175.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -64.03 -7.04 7.38 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.436 0.532 . . . . 63.42 112.436 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.66 ' SD ' HD21 ' A' ' 140' ' ' LEU . 95.8 mmm -82.62 -25.62 33.01 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.971 0.415 . . . . 73.21 111.311 173.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 29.4 m -120.98 -16.52 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 112.335 0.494 . . . . 65.44 112.335 -170.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.539 HG21 ' OG ' ' A' ' 30' ' ' SER . 5.9 pt -101.99 -178.43 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.102 0.477 . . . . 72.32 111.603 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -93.55 113.6 60.71 Favored Pre-proline 0 CA--C 1.545 0.779 0 CA-C-N 116.356 -0.384 . . . . 75.03 110.553 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -88.57 16.31 1.89 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.777 2.318 . . . . 73.22 113.653 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.0 t -121.87 25.52 9.13 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.294 0.569 . . . . 53.42 110.941 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 76.3 p -76.63 113.92 14.8 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 112.695 0.628 . . . . 73.3 112.695 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -115.41 -12.61 11.7 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.022 0.439 . . . . 75.35 110.349 170.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -61.11 152.26 40.74 Favored Glycine 0 CA--C 1.524 0.605 0 CA-C-N 115.996 -0.547 . . . . 71.41 112.829 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 33.1 m -73.48 74.87 1.44 Allowed 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.467 0.651 . . . . 72.54 111.705 -177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -97.58 -57.02 1.06 Allowed Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.738 -0.664 . . . . 62.34 111.483 173.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.505 ' HB3' ' HD2' ' A' ' 118' ' ' PRO . 22.3 mmt 66.75 174.65 0.07 OUTLIER Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 122.684 0.393 . . . . 73.41 111.65 174.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 117' ' ' MET . 76.3 Cg_exo -56.04 23.46 0.03 OUTLIER 'Trans proline' 0 CA--C 1.554 1.525 0 C-N-CA 123.168 2.579 . . . . 63.42 116.224 177.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.417 ' H ' ' C ' ' A' ' 117' ' ' MET . 48.7 mt-30 -73.68 175.18 7.39 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.673 -0.642 . . . . 61.14 110.672 171.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -82.23 59.16 4.35 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-O 121.28 0.562 . . . . 65.4 112.249 -172.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -122.73 136.42 54.87 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.108 -0.496 . . . . 75.11 110.765 176.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -142.11 174.8 23.06 Favored Glycine 0 CA--C 1.526 0.773 0 C-N-CA 120.997 -0.62 . . . . 63.24 113.292 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 98.9 t -93.53 120.95 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 122.398 -0.472 . . . . 74.34 111.528 176.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.608 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 37.3 mtpt -65.63 155.87 34.55 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.73 0.776 . . . . 72.35 113.09 -178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.814 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -178.85 -151.39 9.56 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 114.966 -1.016 . . . . 51.23 112.449 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.409 HG22 ' HA ' ' A' ' 25' ' ' GLU . 45.1 p -141.09 147.79 39.1 Favored 'General case' 0 N--CA 1.474 0.754 0 O-C-N 122.424 -0.457 . . . . 73.13 111.538 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.0 p -125.43 144.58 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.291 0.567 . . . . 74.43 111.904 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -153.87 168.87 24.91 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.796 -0.638 . . . . 55.44 110.561 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.524 ' HD3' HD23 ' A' ' 67' ' ' LEU . 36.8 ttpt -99.72 139.16 35.78 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.13 0.491 . . . . 74.41 111.257 174.269 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.9 t -131.75 161.23 33.34 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.307 0.575 . . . . 52.53 111.968 -178.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -90.18 -2.88 58.11 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.809 -0.632 . . . . 75.41 111.039 177.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -68.67 153.28 44.06 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.98 -0.554 . . . . 64.52 111.353 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 3.2 pptp? -87.47 156.86 19.37 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 121.064 0.459 . . . . 72.12 111.196 176.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.23 130.73 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 CA-C-N 116.11 -0.495 . . . . 71.42 111.834 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 135' ' ' LEU . 2.1 mt -61.74 101.09 0.17 Allowed 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.411 -0.359 . . . . 62.42 111.223 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 49.3 m -52.43 143.2 15.75 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 110.783 -0.08 . . . . 65.11 110.783 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.478 HG23 ' HD1' ' A' ' 49' ' ' PHE . 68.4 t -45.88 -52.84 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 113.026 0.751 . . . . 73.42 113.026 -172.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -72.04 -39.96 68.73 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 122.101 -0.374 . . . . 74.3 111.905 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.4 ' HG2' ' CD2' ' A' ' 135' ' ' LEU . 42.3 tt0 -56.1 -36.21 67.91 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.622 0.725 . . . . 71.13 110.542 175.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.66 HD21 ' SD ' ' A' ' 106' ' ' MET . 3.7 tt -61.69 -40.96 96.83 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 115.136 -0.938 . . . . 63.34 110.5 174.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.4 mt -61.55 -44.27 97.34 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.29 0.566 . . . . 75.24 110.17 174.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -64.89 -31.66 73.0 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.783 -0.644 . . . . 73.44 111.135 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -66.35 -50.03 64.94 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.21 -0.45 . . . . 31.2 111.688 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.456 HD12 ' H ' ' A' ' 146' ' ' SER . 2.7 pp -76.62 -19.27 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 CA-C-O 120.951 0.405 . . . . 73.52 111.768 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 122.44 -70.25 0.42 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.258 -0.496 . . . . 22.44 112.638 178.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.456 ' H ' HD12 ' A' ' 144' ' ' ILE . 44.9 t . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 121.2 0.524 . . . . 74.51 111.759 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 120.888 0.375 . . . . 54.52 111.395 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.66 161.97 23.13 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.194 -0.527 . . . . 34.45 113.81 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 65.7 p -104.07 146.13 29.16 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.982 0.42 . . . . 71.44 112.017 -177.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 43.4 t -176.49 109.66 0.09 Allowed 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.914 -0.584 . . . . 72.41 110.599 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -164.76 119.2 1.35 Allowed 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.605 0.24 . . . . 75.05 111.423 -176.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -157.14 159.97 38.33 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.665 0.617 . . . . 71.21 112.665 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -165.61 165.52 18.75 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.169 -0.469 . . . . 72.31 110.986 177.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 49.6 m80 -132.96 153.75 51.14 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.002 0.742 . . . . 71.22 113.002 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -116.47 158.55 23.41 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.271 -0.877 . . . . 61.41 109.961 170.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -154.0 128.18 9.04 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.046 0.45 . . . . 75.24 111.439 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 42.4 p -158.46 97.9 1.51 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.201 -0.454 . . . . 73.23 111.098 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.6 m -118.08 128.3 54.62 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 116.392 -0.367 . . . . 63.43 111.722 -176.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.99 118.65 2.06 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 120.769 -0.729 . . . . 41.54 114.496 173.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -104.59 104.11 13.89 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 109.356 -0.609 . . . . 73.14 109.356 170.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 16' ' ' ASN . 33.4 tt0 -96.05 173.3 7.49 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 112.434 0.531 . . . . 62.31 112.434 -170.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 15' ' ' GLU . 91.5 m-20 86.98 137.71 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.645 1.178 . . . . 72.14 112.834 177.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.529 HD13 ' N ' ' A' ' 18' ' ' TYR . 3.1 tm? -132.45 145.02 50.88 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.309 -0.86 . . . . 70.25 109.622 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.529 ' N ' HD13 ' A' ' 17' ' ' LEU . 81.3 m-85 -80.04 109.05 14.13 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.922 0.392 . . . . 61.24 111.7 -177.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -93.5 152.11 19.28 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.031 0.443 . . . . 74.45 111.375 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -141.94 129.26 21.13 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 116.317 -0.401 . . . . 71.23 111.0 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -177.81 102.69 0.17 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 120.716 -0.754 . . . . 71.11 113.463 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -167.97 94.98 0.41 Allowed 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.474 -0.427 . . . . 74.54 111.512 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 14.8 ptm -90.01 165.92 13.76 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.928 0.394 . . . . 74.24 111.08 174.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.707 HD11 ' HB3' ' A' ' 64' ' ' ALA . 36.7 mt -127.74 148.29 50.42 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.787 0.662 . . . . 72.13 112.787 -176.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -90.85 122.02 33.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.341 -0.845 . . . . 64.44 110.219 171.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.3 m -136.37 157.79 37.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.727 -0.67 . . . . 73.31 112.156 -173.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.661 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 39.7 tt0 -99.93 115.2 29.1 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.233 -0.439 . . . . 74.5 109.999 172.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.53 HG22 HD11 ' A' ' 96' ' ' ILE . 51.0 t -89.03 116.13 30.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 CA-C-N 115.996 -0.547 . . . . 64.22 112.014 -174.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 mt -102.43 156.67 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-O 120.967 0.413 . . . . 71.02 111.535 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.617 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 72.3 m -126.89 104.4 8.01 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 120.94 0.4 . . . . 52.42 111.054 175.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -98.12 156.13 20.4 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 121.029 -0.605 . . . . 53.04 113.584 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.4 ' H ' ' HG2' ' A' ' 32' ' ' ARG . 29.9 ptt180 -78.56 72.89 5.11 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.413 0.625 . . . . 75.03 112.131 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 76.6 p -76.49 -39.24 53.71 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.42 0.629 . . . . 73.2 110.251 173.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.2 mt -107.17 163.29 13.13 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.392 -0.822 . . . . 73.22 110.288 171.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -65.89 110.99 3.07 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.042 0.448 . . . . 61.24 111.834 178.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -71.46 106.14 3.84 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.287 0.565 . . . . 72.14 110.222 175.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.11 -45.4 0.29 Allowed Glycine 0 CA--C 1.521 0.443 0 CA-C-N 115.836 -0.62 . . . . 63.11 111.859 -177.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.686 ' HB3' ' HD2' ' A' ' 43' ' ' LYS . . . -87.89 127.82 35.36 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.71 0.291 . . . . 64.43 110.777 175.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 78.5 p -71.04 161.67 30.75 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 120.828 0.347 . . . . 74.01 111.032 177.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.6 p -56.91 -32.63 39.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 N-CA-C 111.617 0.229 . . . . 61.24 111.617 178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.452 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 41.9 tt0 -62.33 -36.13 81.24 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 120.984 0.421 . . . . 65.31 111.055 175.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 39' ' ' THR . 42.8 mm-40 -65.34 -35.44 80.99 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.064 0.459 . . . . 75.13 111.414 172.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.686 ' HD2' ' HB3' ' A' ' 38' ' ' ALA . 26.2 mtpp -118.33 38.5 3.7 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.307 0.484 . . . . 65.2 112.307 -172.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.452 ' HG ' ' HA ' ' A' ' 41' ' ' GLU . 63.7 mt -66.17 82.52 0.08 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.195 0.522 . . . . 70.31 111.56 177.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.5 t -143.02 161.7 37.45 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.68 -0.691 . . . . 62.33 110.791 178.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -63.42 -28.97 70.34 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.338 0.589 . . . . 74.42 110.485 179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -55.42 -41.72 73.18 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 115.654 -0.703 . . . . 73.3 111.08 174.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.53 ' O ' HG22 ' A' ' 52' ' ' VAL . 5.5 t80 -64.49 -37.87 89.05 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.929 -0.578 . . . . 72.44 110.533 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.513 ' HE2' ' HA ' ' A' ' 136' ' ' SER . 47.6 t80 -62.13 -66.86 0.47 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.983 -0.553 . . . . 74.2 110.724 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -55.82 -21.77 21.38 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 112.797 0.666 . . . . 61.42 112.797 -175.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.68 -36.23 32.6 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.901 0.704 . . . . 44.13 112.901 -177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 48' ' ' TYR . 33.2 m -116.83 17.66 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 113.14 0.793 . . . . 41.3 113.14 -174.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -102.66 26.01 8.49 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.143 0.794 . . . . 72.33 113.143 -177.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -147.71 164.27 34.08 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.472 0.545 . . . . 74.53 112.472 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.24 133.83 47.7 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.817 -0.629 . . . . 64.42 110.922 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.538 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 33.2 mt-10 -88.66 121.89 31.51 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.238 0.542 . . . . 72.22 110.931 178.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 38.5 mt -118.18 149.87 20.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 CA-C-N 115.637 -0.71 . . . . 71.55 111.777 -171.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -72.44 154.1 41.05 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.654 0.264 . . . . 54.22 111.176 176.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -56.46 -46.11 80.51 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.948 0.404 . . . . 75.44 111.727 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.45 ' HB3' ' HE3' ' A' ' 93' ' ' LYS . 25.6 mm-40 -56.83 -55.69 31.18 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.002 0.43 . . . . 72.53 111.581 178.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -61.64 -36.25 80.24 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.218 0.532 . . . . 64.52 111.004 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 53.8 t-105 -56.51 -53.74 53.93 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.731 -0.668 . . . . 74.22 111.747 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -74.03 -28.48 61.45 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.028 0.381 . . . . 72.03 112.028 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.707 ' HB3' HD11 ' A' ' 24' ' ' LEU . . . -63.33 -32.22 73.58 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 121.02 0.438 . . . . 63.3 111.453 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.491 HD11 HG13 ' A' ' 127' ' ' VAL . 74.7 mt -91.33 -4.75 55.5 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 116.164 -0.471 . . . . 71.35 111.665 176.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 61.03 46.26 94.94 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.427 -0.416 . . . . 60.03 112.828 -177.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 129' ' ' LYS . 97.7 mt -85.32 156.48 20.89 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.428 0.899 . . . . 73.04 113.428 -175.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -127.92 145.37 50.98 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.615 -1.175 . . . . 72.12 109.0 173.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.01 100.42 0.16 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.454 0.645 . . . . 65.04 111.87 -176.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 126.08 -6.09 7.77 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 115.457 -0.792 . . . . 65.33 113.176 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -68.03 158.59 32.58 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.364 0.602 . . . . 70.41 112.072 177.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.5 mtm-85 -102.12 127.65 48.93 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.8 -0.636 . . . . 65.23 110.647 178.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.33 150.28 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.154 0.502 . . . . 72.2 112.029 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -114.49 136.99 52.4 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.257 0.551 . . . . 62.22 111.115 175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 60.9 t -110.01 122.12 64.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.79 -0.641 . . . . 71.32 110.623 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -111.63 120.89 43.6 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.796 0.332 . . . . 71.05 111.505 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.748 HG22 ' HA3' ' A' ' 125' ' ' GLY . 27.6 p -122.53 -177.47 3.64 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.938 0.399 . . . . 61.43 110.902 176.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -70.69 -11.21 60.8 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.48 -0.327 . . . . 72.43 111.614 176.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -94.52 -48.68 6.0 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 111.749 0.277 . . . . 72.35 111.749 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -171.39 -154.31 9.72 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 120.577 -0.82 . . . . 74.53 113.603 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 12.2 pt-20 -154.78 141.88 19.35 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-O 120.877 0.37 . . . . 71.32 111.571 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.7 p -145.12 149.41 16.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 CA-C-N 116.573 -0.285 . . . . 61.11 111.613 -178.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.49 117.38 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-O 120.527 0.203 . . . . 74.3 111.259 177.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.459 ' HA ' HG13 ' A' ' 134' ' ' VAL . 34.8 m -128.09 177.63 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 122.886 0.474 . . . . 70.22 111.488 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -82.62 142.85 31.41 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.044 0.449 . . . . 72.52 111.548 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -91.14 121.46 32.94 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.039 0.385 . . . . 73.22 112.039 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -131.6 157.65 43.1 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.166 0.508 . . . . 73.21 110.815 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -95.98 140.49 30.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.285 -0.416 . . . . 72.33 110.852 -178.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.538 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -141.02 -174.51 14.14 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.898 -0.668 . . . . 73.51 113.71 -177.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -94.69 32.24 1.65 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.958 0.408 . . . . 45.22 111.641 -177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.8 m -90.6 152.46 45.12 Favored Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 116.461 -0.336 . . . . 75.2 111.706 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.59 163.71 33.92 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 122.88 2.387 . . . . 64.45 113.366 178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 60' ' ' GLU . 86.6 tttt -66.87 143.05 57.09 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 116.468 -0.333 . . . . 75.03 111.293 -179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 69.57 21.42 76.23 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.876 -0.678 . . . . 63.42 113.098 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.661 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 15.7 ttt -149.41 136.54 19.82 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.894 -0.41 . . . . 71.34 109.894 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.53 HD11 HG22 ' A' ' 28' ' ' VAL . 37.4 pt -132.21 145.36 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-O 121.371 0.605 . . . . 70.4 112.108 -177.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -102.79 129.58 49.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.853 -0.612 . . . . 65.4 111.209 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.617 ' O ' ' HA ' ' A' ' 30' ' ' SER . 28.8 mt -126.17 131.57 24.01 Favored Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 120.571 0.224 . . . . 63.32 110.68 174.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -54.22 126.43 22.14 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 122.374 2.05 . . . . 73.43 112.196 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.82 99.81 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.849 0.357 . . . . 74.41 110.634 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -152.87 -175.24 24.13 Favored Glycine 0 CA--C 1.525 0.692 0 C-N-CA 120.776 -0.726 . . . . 74.15 113.018 -176.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.413 ' O ' ' HG3' ' A' ' 106' ' ' MET . 29.9 Cg_endo -64.01 -26.02 66.29 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.212 1.941 . . . . 75.31 112.243 -176.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.499 ' HA ' HD11 ' A' ' 140' ' ' LEU . 4.6 m-85 -68.9 -54.24 16.6 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.676 -0.693 . . . . 74.11 110.516 177.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.508 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.38 -34.13 74.82 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.925 -0.579 . . . . 73.15 110.632 175.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -60.31 -19.8 56.61 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.97 -0.559 . . . . 72.21 111.561 -178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.612 ' SD ' HD21 ' A' ' 140' ' ' LEU . 33.4 mtp -77.07 -28.03 54.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.797 0.332 . . . . 75.22 111.417 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 32.3 m -116.24 -18.11 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 113.048 0.759 . . . . 54.22 113.048 -171.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.508 HG23 ' O ' ' A' ' 104' ' ' ALA . 14.7 pt -95.14 -176.17 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 121.399 0.619 . . . . 71.43 112.375 -176.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.603 ' H ' HG21 ' A' ' 123' ' ' VAL . 24.2 t70 -116.5 116.03 39.34 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.577 -0.738 . . . . 72.45 110.653 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.19 17.91 1.58 Allowed 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.652 2.234 . . . . 75.01 113.558 -178.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 21.1 t -92.73 14.58 16.78 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.847 0.356 . . . . 43.54 111.516 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 113' ' ' ASP . 62.9 p -94.39 -171.31 2.48 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.077 0.399 . . . . 62.04 112.077 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 112' ' ' THR . 18.9 t70 72.01 149.5 0.09 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.099 0.56 . . . . 70.15 112.137 176.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 160.38 -78.46 0.17 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 120.713 -0.756 . . . . 34.24 113.871 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 71.3 p -78.49 -65.37 0.99 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 112.747 0.647 . . . . 70.14 112.747 -173.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 117' ' ' MET . . . 164.79 -170.61 39.95 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 121.151 -0.547 . . . . 71.01 113.018 -178.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.405 ' HB2' ' O ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER 70.23 148.1 0.12 Allowed Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 123.027 0.531 . . . . 72.24 111.276 -178.238 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.38 -44.25 39.57 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 122.424 2.082 . . . . 44.31 112.899 -177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 62.25 107.23 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.677 0.621 . . . . 71.11 112.677 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -76.81 70.43 3.27 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.372 0.606 . . . . 73.43 110.243 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -128.13 100.02 5.7 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.823 -0.626 . . . . 63.41 111.066 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -110.39 157.8 14.81 Favored Glycine 0 CA--C 1.523 0.553 0 C-N-CA 121.188 -0.529 . . . . 72.41 112.43 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.603 HG21 ' H ' ' A' ' 109' ' ' ASP . 84.3 t -86.73 121.02 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 122.465 -0.433 . . . . 70.42 111.284 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 48.3 mtpt -68.76 162.42 26.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.741 0.781 . . . . 73.14 113.047 -176.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.748 ' HA3' HG22 ' A' ' 77' ' ' THR . . . 174.17 -151.65 13.31 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-N 114.886 -1.052 . . . . 62.42 112.587 178.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 65.3 p -135.9 152.46 51.04 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.87 0.367 . . . . 73.52 111.037 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.491 HG13 HD11 ' A' ' 65' ' ' LEU . 14.6 p -132.25 144.76 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.144 0.497 . . . . 50.23 111.343 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -157.64 152.99 26.06 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.773 -0.649 . . . . 55.13 110.533 178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.422 ' HB2' HD21 ' A' ' 67' ' ' LEU . 32.8 ttpt -79.0 139.29 38.23 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.16 0.505 . . . . 63.11 111.133 174.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.4 t -135.8 150.56 49.49 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.122 0.487 . . . . 73.21 111.729 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -80.33 -3.13 48.28 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.337 -0.392 . . . . 71.12 110.834 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -65.37 155.08 36.48 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.985 0.422 . . . . 73.04 111.83 177.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -79.12 150.98 31.62 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.999 0.428 . . . . 71.44 111.605 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.459 HG13 ' HA ' ' A' ' 84' ' ' VAL . 82.6 t -71.3 128.25 34.22 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 116.233 -0.439 . . . . 62.3 110.342 172.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 135' ' ' LEU . 11.0 mt -63.47 133.22 53.53 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.979 0.419 . . . . 61.52 111.858 -177.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.513 ' HA ' ' HE2' ' A' ' 49' ' ' PHE . 45.2 t -73.51 141.94 46.75 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.911 -0.403 . . . . 73.3 109.911 171.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.506 HG23 ' HD2' ' A' ' 49' ' ' PHE . 60.5 t -46.45 -46.96 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 112.744 0.646 . . . . 73.21 112.744 -174.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -72.38 -40.65 67.12 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.021 0.378 . . . . 54.34 112.021 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -64.61 -33.52 76.12 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.219 0.533 . . . . 60.12 110.534 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.612 HD21 ' SD ' ' A' ' 106' ' ' MET . 4.0 tt -56.22 -41.08 75.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 115.886 -0.597 . . . . 65.22 110.275 172.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 35.8 mt -60.02 -48.07 83.22 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.276 0.56 . . . . 71.02 110.263 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -60.3 -43.22 96.51 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.771 -0.649 . . . . 73.14 111.053 178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.82 -45.63 89.53 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.087 -0.506 . . . . 60.21 112.183 -178.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.8 pp -77.65 -7.71 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 112.326 0.491 . . . . 62.24 112.326 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 129.59 -30.66 3.56 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 121.13 -0.557 . . . . 62.0 113.757 177.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.473 0.72 0 CA-C-O 121.22 0.533 . . . . 74.24 111.511 -177.55 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.3 mtp . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 120.754 0.311 . . . . 74.14 111.281 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.37 142.16 13.03 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.294 -0.479 . . . . 41.3 112.984 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 94.9 p -128.05 157.35 40.93 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 122.512 -0.405 . . . . 62.52 111.208 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.2 p -81.28 116.09 20.97 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 121.145 0.497 . . . . 73.02 111.852 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -157.74 137.29 12.05 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.307 -0.406 . . . . 63.24 111.23 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -153.43 148.25 26.45 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.193 -0.458 . . . . 62.45 111.306 -175.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -142.6 125.43 16.05 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.309 0.485 . . . . 64.04 112.309 -176.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -165.33 124.79 1.77 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.199 -0.455 . . . . 73.12 110.859 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -135.85 146.66 47.69 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.945 0.402 . . . . 75.3 111.676 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -91.46 117.09 29.39 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.342 -0.39 . . . . 71.53 110.946 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.3 m -110.41 131.42 55.07 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-O 120.733 0.302 . . . . 62.14 111.386 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 48.0 t -150.28 140.35 22.05 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-O 120.986 0.422 . . . . 74.55 111.852 179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -132.52 154.41 21.06 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 116.345 -0.389 . . . . 73.22 112.279 179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 78.1 mtp180 -117.41 102.83 9.54 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 117.337 0.568 . . . . 75.01 112.213 -178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' A' ' 15' ' ' GLU . 0.6 OUTLIER -105.4 89.44 3.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-O 121.726 0.774 . . . . 75.02 110.481 175.009 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -100.09 103.53 15.04 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.773 -0.649 . . . . 61.21 110.954 -176.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.0 mp -86.31 131.26 34.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.301 0.572 . . . . 70.5 111.398 179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -117.57 136.96 52.91 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.547 -0.751 . . . . 74.44 110.868 -178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -148.42 125.82 11.61 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 120.827 0.346 . . . . 63.01 111.523 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -102.25 132.94 47.88 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.477 -0.329 . . . . 70.22 110.821 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.86 81.19 0.23 Allowed Glycine 0 CA--C 1.527 0.831 0 C-N-CA 120.826 -0.702 . . . . 63.53 112.424 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -66.16 111.28 3.34 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.007 0.432 . . . . 65.34 111.711 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.497 ' HE2' ' HB ' ' A' ' 126' ' ' THR . 10.1 ptm -93.2 161.2 14.51 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.205 -0.452 . . . . 71.14 111.364 178.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.532 HD12 ' HG ' ' A' ' 65' ' ' LEU . 9.5 mt -110.3 141.37 43.39 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.971 0.415 . . . . 73.15 111.804 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -89.9 126.1 35.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.286 0.565 . . . . 74.35 111.298 176.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.565 HG12 ' HA2' ' A' ' 94' ' ' GLY . 35.1 m -140.95 163.0 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.546 -0.752 . . . . 74.53 111.892 -174.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 65.7 tt0 -99.18 117.74 34.34 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 120.962 0.411 . . . . 64.11 110.652 172.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.504 HG22 HD11 ' A' ' 96' ' ' ILE . 32.0 t -91.4 115.55 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-O 121.133 0.492 . . . . 72.52 111.714 -175.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.55 HD11 ' HE2' ' A' ' 95' ' ' MET . 1.7 mt -102.1 159.41 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.795 0.331 . . . . 74.11 110.824 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.73 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 33.7 t -150.37 132.15 15.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.73 0.3 . . . . 71.44 111.587 175.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.576 ' HA2' ' HB2' ' A' ' 100' ' ' MET . . . 159.3 -90.77 0.11 Allowed Glycine 0 CA--C 1.523 0.565 0 C-N-CA 119.817 -1.182 . . . . 42.44 114.91 175.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' ' 32' ' ' ARG . 5.3 mmp_? -48.99 81.73 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 115.116 1.525 . . . . 72.02 115.116 -165.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.41 HG21 ' HB3' ' A' ' 99' ' ' PRO . 32.5 p -149.94 -60.43 0.2 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.583 0.753 . . . . 71.41 109.253 166.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.415 HD12 ' N ' ' A' ' 34' ' ' LEU . 6.4 mp -108.72 117.66 34.75 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.699 -0.682 . . . . 65.31 109.736 171.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -66.38 -37.28 84.9 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.748 0.308 . . . . 72.44 111.207 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -95.93 109.09 21.51 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.704 0.288 . . . . 75.14 110.227 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.485 ' O ' ' HE2' ' A' ' 43' ' ' LYS . . . -76.17 -59.87 3.25 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.54 -0.838 . . . . 51.31 114.085 -175.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 60.9 -166.26 0.21 Allowed 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.717 0.294 . . . . 64.13 110.999 -173.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.9 p -105.97 170.64 7.79 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.008 0.432 . . . . 71.04 110.681 173.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.3 t -59.67 -34.56 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.236 0.541 . . . . 62.23 110.907 176.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -63.18 -35.71 81.23 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.917 -0.583 . . . . 74.23 111.489 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.96 -33.29 75.69 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 112.379 0.511 . . . . 73.25 112.379 177.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -130.21 58.92 1.65 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.771 0.656 . . . . 65.24 112.771 -178.311 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 78.0 mt -71.76 83.69 0.9 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.197 0.522 . . . . 72.25 110.724 173.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.5 t -150.55 167.29 27.67 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.687 0.625 . . . . 71.41 112.687 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.41 ' HG3' ' ND2' ' A' ' 50' ' ' ASN . 14.1 tp10 -55.83 -35.53 66.49 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.837 -0.619 . . . . 71.42 110.918 177.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -54.06 -43.3 70.13 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.406 -0.361 . . . . 72.11 111.364 177.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -60.52 -31.97 71.02 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 121.266 0.555 . . . . 72.12 110.674 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -78.28 -28.83 47.66 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.924 -0.58 . . . . 72.13 111.541 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.41 ' ND2' ' HG3' ' A' ' 46' ' ' GLU . 41.7 m-80 -98.77 0.07 43.67 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 112.161 0.43 . . . . 72.13 112.161 179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.23 -44.44 7.27 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.29 0.848 . . . . 73.52 113.29 -178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.2 m -127.19 17.93 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 114.412 1.264 . . . . 65.22 114.412 -167.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.64 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -101.06 18.01 20.89 Favored 'General case' 0 N--CA 1.481 1.084 0 O-C-N 121.62 -0.675 . . . . 74.41 112.135 -176.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -137.62 159.12 42.85 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.995 -0.44 . . . . 53.13 111.511 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.66 138.51 51.23 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.334 -0.394 . . . . 73.34 111.662 179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.684 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 41.3 mt-10 -90.2 116.71 28.4 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.213 0.53 . . . . 54.52 111.003 177.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.607 ' HA ' HG22 ' A' ' 96' ' ' ILE . 35.8 mt -111.57 146.98 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 115.609 -0.723 . . . . 72.21 111.768 -171.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -67.1 142.95 56.93 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.94 0.4 . . . . 62.52 111.11 175.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -63.93 -36.53 84.24 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 112.792 0.664 . . . . 72.14 112.792 -175.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -61.55 -49.24 77.48 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.271 0.558 . . . . 50.54 110.918 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -66.72 -33.48 75.73 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.811 -0.632 . . . . 75.23 111.071 177.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.486 ' HA ' HD12 ' A' ' 67' ' ' LEU . 44.2 t-105 -57.05 -53.67 55.49 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.706 -0.679 . . . . 75.54 110.939 175.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -65.69 -37.15 85.68 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.977 -0.556 . . . . 60.21 111.542 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.62 -49.17 78.81 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.96 0.409 . . . . 74.14 111.848 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.532 ' HG ' HD12 ' A' ' 24' ' ' LEU . 95.0 mt -78.23 -4.51 48.12 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.319 -0.401 . . . . 55.21 111.74 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 63.76 45.76 93.57 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.255 -0.498 . . . . 54.25 112.761 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.486 HD12 ' HA ' ' A' ' 62' ' ' TRP . 87.3 mt -80.75 153.39 27.83 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.153 0.501 . . . . 72.23 111.667 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -139.13 114.93 10.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 73.44 110.645 -177.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -38.53 102.46 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.363 -0.835 . . . . 75.14 112.971 -171.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.6 -19.1 4.81 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 114.967 -1.015 . . . . 72.54 113.161 -176.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.5 p-10 -78.91 179.39 7.31 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.114 0.483 . . . . 73.31 111.958 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -107.5 134.51 50.43 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.356 0.598 . . . . 64.35 111.842 -175.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.573 HG13 ' HB2' ' A' ' 86' ' ' ALA . 14.5 m -115.97 135.99 54.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.967 -0.56 . . . . 73.15 111.164 174.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.42 ' HB3' ' HG3' ' A' ' 128' ' ' GLU . 72.3 tttt -102.17 140.14 36.85 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.88 -0.6 . . . . 50.33 110.584 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 41.5 t -122.43 136.2 60.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.329 -0.396 . . . . 63.04 110.084 -175.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 39.7 mttt -138.68 126.56 22.36 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.058 0.392 . . . . 61.01 112.058 -173.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.661 HG22 ' HA3' ' A' ' 125' ' ' GLY . 30.8 p -137.1 -172.18 3.13 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.235 -0.439 . . . . 72.4 110.547 176.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -65.99 -12.97 58.9 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 112.216 0.451 . . . . 62.41 112.216 176.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -91.39 -34.71 14.75 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.116 0.413 . . . . 65.01 112.116 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.69 -159.47 31.39 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.226 -0.511 . . . . 72.12 113.16 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.402 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 11.4 pt-20 -137.37 154.01 50.09 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 121.026 0.441 . . . . 70.32 112.098 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.443 HG23 HD12 ' A' ' 135' ' ' LEU . 11.4 p -153.06 149.36 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 CA-C-N 116.378 -0.374 . . . . 74.44 111.445 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 36.1 t -110.36 120.09 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 122.347 -0.221 . . . . 72.34 110.878 176.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.23 173.18 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.99 0.424 . . . . 72.04 111.956 -178.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -76.6 139.16 40.53 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.01 0.433 . . . . 72.04 111.426 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.573 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -87.32 126.12 34.65 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.887 0.699 . . . . 64.1 112.887 -177.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -130.07 148.18 51.89 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.142 0.496 . . . . 73.51 110.864 172.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -87.66 124.03 33.12 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.918 -0.583 . . . . 73.1 109.879 174.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.684 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -124.33 171.74 16.6 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.87 -0.681 . . . . 62.12 114.065 -173.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -81.72 29.58 0.38 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 122.872 0.469 . . . . 71.23 112.228 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.9 m -91.21 152.03 43.56 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 116.507 -0.315 . . . . 65.34 111.653 -178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -72.6 177.15 7.85 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 122.689 2.259 . . . . 51.45 113.588 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -62.94 141.35 58.75 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.022 -0.536 . . . . 62.22 111.999 -177.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.565 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 58.31 34.28 73.78 Favored Glycine 0 C--N 1.34 0.772 0 C-N-CA 120.862 -0.685 . . . . 70.23 112.805 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.597 ' HE3' ' HG2' ' A' ' 121' ' ' LYS . 16.7 ttt -150.92 136.73 18.11 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 122.633 -0.334 . . . . 71.25 110.321 -178.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.607 HG22 ' HA ' ' A' ' 57' ' ' ILE . 36.8 pt -137.65 146.59 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 121.136 0.493 . . . . 74.14 111.652 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -110.08 136.74 48.85 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.942 0.401 . . . . 75.23 111.272 177.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.73 ' O ' ' HA ' ' A' ' 30' ' ' SER . 45.6 mt -126.35 133.65 25.19 Favored Pre-proline 0 CA--C 1.542 0.662 0 CA-C-N 116.326 -0.397 . . . . 73.43 110.643 174.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.41 ' HB3' HG21 ' A' ' 33' ' ' THR . 78.2 Cg_exo -52.13 141.82 47.01 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 121.904 1.736 . . . . 72.31 112.539 174.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.576 ' HB2' ' HA2' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -59.65 106.11 0.44 Allowed 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.667 0.27 . . . . 54.24 110.976 -178.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.28 178.67 41.29 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 119.972 -1.108 . . . . 74.12 113.787 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.521 ' HA ' ' HB3' ' A' ' 105' ' ' ASN . 17.8 Cg_endo -57.98 -34.94 98.99 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.144 2.563 . . . . 74.33 112.82 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.512 ' HA ' HD11 ' A' ' 140' ' ' LEU . 53.1 m-85 -59.96 -50.14 74.94 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.109 0.481 . . . . 74.41 110.631 177.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.543 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -65.29 -37.37 86.95 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.124 -0.489 . . . . 75.15 111.017 174.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 102' ' ' PRO . 5.4 t30 -56.58 -20.09 19.15 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.763 0.425 . . . . 74.24 111.728 177.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.607 ' SD ' HD21 ' A' ' 140' ' ' LEU . 90.9 mmm -72.97 -24.05 60.74 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.807 0.336 . . . . 62.25 111.779 177.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 30.5 m -129.06 -9.03 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 N-CA-C 113.027 0.751 . . . . 63.21 113.027 -171.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.555 HD13 ' HB3' ' A' ' 30' ' ' SER . 5.8 pt -104.91 -177.54 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 CA-C-O 121.167 0.508 . . . . 75.12 111.531 179.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.5 ' HA ' ' HD3' ' A' ' 110' ' ' PRO . 30.1 t70 -106.52 118.01 55.6 Favored Pre-proline 0 CA--C 1.542 0.649 0 CA-C-N 116.107 -0.497 . . . . 62.12 110.916 175.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 109' ' ' ASP . 3.5 Cg_exo -81.32 -1.25 10.99 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.855 2.37 . . . . 73.44 113.479 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.4 t -84.62 -41.61 16.19 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.058 0.392 . . . . 60.15 112.058 -177.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 10.1 t -55.32 139.7 41.88 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.912 0.708 . . . . 74.42 112.912 -177.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 32.2 t70 60.08 -93.31 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.836 -0.62 . . . . 74.44 112.41 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 58.51 24.95 57.41 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 121.222 -0.513 . . . . 72.02 112.737 -172.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 88.6 m -132.26 -52.23 0.95 Allowed 'General case' 0 N--CA 1.47 0.572 0 O-C-N 122.638 -0.331 . . . . 63.51 111.526 -175.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 139.07 44.78 0.07 OUTLIER Glycine 0 CA--C 1.526 0.761 0 C-N-CA 120.857 -0.687 . . . . 75.23 113.994 177.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.48 140.06 20.7 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-N 117.236 0.518 . . . . 74.43 111.777 176.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -84.81 52.17 3.38 Favored 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 123.179 2.586 . . . . 70.13 113.698 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -77.44 127.44 32.54 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 120.735 0.303 . . . . 74.53 111.098 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.416 ' O ' ' HB2' ' A' ' 121' ' ' LYS . 38.4 m-85 -87.24 168.67 13.0 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 120.853 0.358 . . . . 74.54 111.846 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.597 ' HG2' ' HE3' ' A' ' 95' ' ' MET . 69.9 mttt 70.1 162.12 0.23 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.674 -0.694 . . . . 74.01 111.23 -170.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -145.54 -134.37 2.69 Favored Glycine 0 CA--C 1.524 0.62 0 C-N-CA 120.303 -0.951 . . . . 31.32 114.009 -172.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.421 HG21 ' N ' ' A' ' 109' ' ' ASP . 52.5 t -100.3 118.63 47.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.806 0.336 . . . . 61.44 111.543 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.658 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 55.5 mtmt -72.82 155.41 39.96 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.274 0.559 . . . . 75.34 112.186 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.661 ' HA3' HG22 ' A' ' 77' ' ' THR . . . 177.84 -135.0 2.57 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.782 -0.645 . . . . 65.23 112.84 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.497 ' HB ' ' HE2' ' A' ' 23' ' ' MET . 60.8 p -140.55 154.84 46.67 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.269 0.47 . . . . 52.04 112.269 -177.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 12.1 p -133.97 147.98 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 115.931 -0.577 . . . . 52.11 110.677 175.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.42 ' HG3' ' HB3' ' A' ' 74' ' ' LYS . 9.5 pt-20 -151.9 161.89 41.93 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.37 -0.377 . . . . 70.45 111.462 -177.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.431 ' NZ ' ' HA ' ' A' ' 67' ' ' LEU . 17.6 ttmm -87.24 140.65 29.33 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 110.226 -0.287 . . . . 72.34 110.226 170.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 10.2 t -139.47 142.82 37.35 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.302 0.572 . . . . 73.22 111.864 177.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -75.31 -11.24 60.02 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.617 -0.72 . . . . 71.31 110.827 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -61.91 154.3 26.64 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.861 -0.609 . . . . 65.24 112.071 178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -80.89 162.08 24.1 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.748 -0.66 . . . . 62.51 111.927 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 76.5 t -76.28 136.17 25.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 115.651 -0.704 . . . . 74.42 111.101 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.443 HD12 HG23 ' A' ' 82' ' ' VAL . 17.8 mt -59.65 133.58 56.23 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.502 -0.317 . . . . 72.24 111.298 177.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.6 t -76.76 143.77 39.68 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.691 -0.855 . . . . 75.11 108.691 169.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 44.3 t -48.26 -41.16 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 121.084 0.469 . . . . 41.4 111.899 -174.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -72.02 -41.6 67.36 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 116.026 -0.534 . . . . 64.43 111.65 176.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -58.52 -37.2 75.11 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.78 0.8 . . . . 71.52 110.15 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.607 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.5 tt -62.29 -38.3 88.82 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.05 -0.977 . . . . 71.41 111.033 176.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.0 mt -59.65 -41.55 90.79 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.486 0.66 . . . . 73.14 110.056 176.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -70.52 -30.02 66.67 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 115.518 -0.765 . . . . 62.21 111.608 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -67.44 -44.15 79.4 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.42 -0.354 . . . . 63.2 111.856 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.496 HD12 ' H ' ' A' ' 146' ' ' SER . 2.8 pp -76.13 -7.92 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 112.142 0.423 . . . . 74.33 112.142 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 125.9 -62.82 0.6 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 121.35 -0.453 . . . . 72.31 112.937 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.496 ' H ' HD12 ' A' ' 144' ' ' ILE . 87.8 p . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 121.196 0.522 . . . . 75.42 111.367 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.516 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.707 0.289 . . . . 74.34 111.215 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -80.05 79.87 1.66 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.217 -0.516 . . . . 72.32 113.156 179.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.9 p -87.96 166.01 14.81 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.141 0.496 . . . . 73.52 111.736 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.7 m -69.86 125.54 27.06 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.274 0.472 . . . . 53.42 112.274 -177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -134.18 110.64 9.69 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.398 -0.364 . . . . 64.12 110.647 177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -71.39 146.07 48.95 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.923 0.392 . . . . 75.13 111.728 178.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -138.64 93.13 2.69 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.028 0.442 . . . . 61.13 111.003 -178.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.9 t60 -95.98 119.74 35.02 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.184 -0.462 . . . . 74.53 110.521 -178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.401 ' O ' ' HB3' ' A' ' 10' ' ' HIS . 20.9 p80 -67.4 -52.36 40.74 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.538 0.94 . . . . 61.44 113.538 -173.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.401 ' HB3' ' O ' ' A' ' 9' ' ' HIS . 8.0 t-80 66.37 124.3 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.7 0.63 . . . . 73.4 112.7 179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.4 m -130.77 133.33 45.91 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 116.51 -0.314 . . . . 63.44 111.434 176.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.8 p -152.52 25.45 0.59 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 111.86 0.319 . . . . 71.41 111.86 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.35 136.33 39.67 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.23 -0.51 . . . . 71.0 112.941 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 22.3 ptt180 -162.15 112.14 1.53 Allowed 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.123 0.487 . . . . 73.14 111.92 -174.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.41 -148.74 0.36 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.076 -0.511 . . . . 61.35 110.482 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 79.03 87.86 0.06 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.349 0.659 . . . . 71.21 112.742 174.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -94.97 -170.49 2.22 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.034 -0.53 . . . . 74.15 110.295 172.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -79.86 -22.68 42.63 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 112.242 0.46 . . . . 61.2 112.242 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 68.9 -28.08 0.16 Allowed 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 113.699 1.0 . . . . 72.34 113.699 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -75.06 103.05 5.09 Favored 'General case' 0 N--CA 1.468 0.475 0 O-C-N 121.971 -0.456 . . . . 64.15 112.028 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.39 -58.76 1.51 Allowed Glycine 0 CA--C 1.525 0.715 0 C-N-CA 121.221 -0.514 . . . . 54.54 112.286 174.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 68.3 t60 66.84 102.63 0.05 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.445 0.535 . . . . 74.03 112.445 178.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 9.2 ptp -82.38 164.02 21.31 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.26 0.553 . . . . 71.43 112.027 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.4 mt -127.37 131.64 50.31 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.768 -0.651 . . . . 54.21 111.104 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -73.13 111.11 7.94 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.865 0.364 . . . . 54.35 110.849 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.475 HG12 ' HA2' ' A' ' 94' ' ' GLY . 31.1 m -127.84 159.62 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 116.351 -0.386 . . . . 65.13 111.964 -174.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 35.4 tt0 -98.79 118.53 35.74 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.884 0.373 . . . . 61.53 110.605 174.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.51 HG22 HD11 ' A' ' 96' ' ' ILE . 40.1 t -93.23 108.16 20.07 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.109 -0.496 . . . . 61.13 111.74 -175.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 mt -97.73 160.56 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.826 0.346 . . . . 72.45 111.234 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.631 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 74.3 m -136.5 100.48 4.37 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.078 0.466 . . . . 73.01 111.929 178.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.42 115.89 4.28 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 121.049 -0.596 . . . . 51.03 112.397 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.428 ' HA ' ' HB3' ' A' ' 100' ' ' MET . 31.5 mtm180 -60.35 102.83 0.19 Allowed 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.132 0.491 . . . . 74.34 111.846 -178.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.9 p -132.34 -178.4 4.9 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.897 -0.592 . . . . 62.04 111.584 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 29.7 tp 66.44 12.53 8.74 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 122.892 0.477 . . . . 65.42 112.107 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 46.9 m-80 56.83 96.76 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.088 0.47 . . . . 64.31 111.855 -177.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -71.97 -173.21 0.98 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.125 0.488 . . . . 54.33 111.921 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 93.65 -1.48 68.88 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.139 -0.553 . . . . 63.4 112.466 -174.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.626 ' HB1' ' HB2' ' A' ' 42' ' ' GLU . . . -132.7 135.77 45.99 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.444 0.298 . . . . 55.34 111.364 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 31.0 p -67.59 174.43 3.49 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.116 0.484 . . . . 64.12 110.486 174.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 5.0 m -61.17 -30.71 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 122.105 -0.372 . . . . 75.3 110.874 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.502 ' HA ' ' HG ' ' A' ' 44' ' ' LEU . 38.1 tt0 -73.34 -26.66 61.12 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.09 -0.505 . . . . 61.02 111.718 -176.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.626 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 28.1 mm-40 -72.74 -12.72 61.12 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.971 0.415 . . . . 74.55 111.619 177.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.557 ' HE2' ' HB3' ' A' ' 38' ' ' ALA . 67.4 mttm -121.58 -68.49 0.89 Allowed 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 116.672 -0.24 . . . . 74.44 111.268 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.502 ' HG ' ' HA ' ' A' ' 41' ' ' GLU . 71.5 mt 61.14 -14.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 114.992 1.479 . . . . 73.44 114.992 174.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.461 HG23 ' H ' ' A' ' 48' ' ' TYR . 3.3 t -55.15 155.46 4.77 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 112.793 0.664 . . . . 74.31 112.793 -176.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -49.62 -37.69 29.03 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.545 0.688 . . . . 73.24 110.255 175.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -54.48 -40.78 68.8 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.468 -0.787 . . . . 72.31 111.467 177.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.497 ' HE2' ' HD2' ' A' ' 43' ' ' LYS . 2.8 t80 -60.09 -36.78 78.16 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.431 0.634 . . . . 70.25 110.604 178.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.502 ' HD1' HG23 ' A' ' 137' ' ' VAL . 58.0 t80 -81.09 -7.57 59.59 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.59 -0.732 . . . . 55.2 112.046 -176.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -118.43 2.17 11.82 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.877 -0.514 . . . . 63.13 111.814 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.09 -57.04 2.45 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.378 0.51 . . . . 73.35 112.378 -178.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.495 HG21 ' HD2' ' A' ' 102' ' ' PRO . 34.7 m -108.33 20.48 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 N-CA-C 112.873 0.694 . . . . 73.52 112.873 -173.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.64 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -104.08 18.48 21.96 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.66 0.615 . . . . 72.14 112.66 -172.363 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -141.55 165.13 28.33 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.223 0.535 . . . . 74.51 112.426 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.96 130.94 45.71 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.709 -0.678 . . . . 63.43 110.884 176.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.67 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 31.8 mt-10 -88.65 120.24 29.86 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.351 0.596 . . . . 74.51 111.638 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 19.1 mt -118.76 148.27 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.32 -0.855 . . . . 72.34 111.615 -170.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -75.42 142.73 42.98 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 120.771 0.32 . . . . 72.24 110.386 175.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.444 ' HA ' ' HB3' ' A' ' 62' ' ' TRP . 27.0 tt0 -56.04 -36.97 68.6 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.481 0.548 . . . . 71.24 112.481 -174.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.417 ' HB3' ' HE2' ' A' ' 93' ' ' LYS . 80.7 mm-40 -54.66 -51.63 64.87 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 111.894 0.331 . . . . 63.52 111.894 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -69.7 -36.82 76.27 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.337 0.589 . . . . 75.43 110.579 177.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.487 ' HA ' HD12 ' A' ' 67' ' ' LEU . 31.0 t-105 -53.22 -52.08 60.08 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.466 -0.788 . . . . 73.24 111.69 176.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -65.62 -38.87 90.63 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 116.129 -0.487 . . . . 70.31 111.296 179.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -58.37 -43.4 88.43 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.169 0.509 . . . . 73.13 111.55 178.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.9 mt -79.91 -1.83 41.03 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 116.201 -0.454 . . . . 73.54 112.038 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 59.93 44.9 96.71 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.435 -0.412 . . . . 35.13 112.998 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.753 HD23 ' HD3' ' A' ' 129' ' ' LYS . 67.0 mt -87.04 142.51 27.87 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.032 0.752 . . . . 74.54 113.032 -175.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -115.0 150.11 36.35 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.942 -0.762 . . . . 65.34 108.942 170.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -55.31 103.9 0.11 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.168 0.509 . . . . 74.25 111.898 -177.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 121.51 -8.34 10.23 Favored Glycine 0 CA--C 1.53 1.019 0 CA-C-N 115.888 -0.596 . . . . 60.03 113.783 -178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.67 167.54 7.2 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.618 0.723 . . . . 62.1 112.665 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.4 mtt180 -113.08 126.52 55.56 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.295 -0.866 . . . . 61.33 111.36 -175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.446 HG13 ' HB2' ' A' ' 86' ' ' ALA . 21.1 m -114.51 139.24 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 121.175 0.512 . . . . 72.12 112.054 -178.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.519 ' HG2' ' HD2' ' A' ' 76' ' ' LYS . 22.9 ttmm -103.18 111.84 24.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 116.072 -0.513 . . . . 60.45 110.395 177.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 47.9 t -96.68 126.25 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 116.468 -0.333 . . . . 55.41 111.523 -178.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.568 ' HG3' ' HB3' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -117.72 139.64 50.76 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.061 0.458 . . . . 65.41 111.735 178.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 46.2 p -134.63 -171.9 2.89 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 116.402 -0.363 . . . . 42.41 110.246 173.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.23 -4.08 39.93 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 122.158 -0.339 . . . . 64.11 111.229 175.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -99.6 -48.33 4.78 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.714 0.293 . . . . 73.33 111.346 179.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -176.94 -158.21 19.75 Favored Glycine 0 CA--C 1.523 0.579 0 C-N-CA 121.136 -0.554 . . . . 62.1 112.779 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.568 ' HB3' ' HG3' ' A' ' 76' ' ' LYS . 8.8 pt-20 -144.68 160.22 41.56 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.265 0.555 . . . . 73.24 112.325 178.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.3 p -156.71 147.27 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.963 -0.562 . . . . 75.32 111.115 178.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 44.9 t -105.45 117.79 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 O-C-N 122.327 -0.233 . . . . 74.51 110.963 177.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 33.7 m -126.98 178.05 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 CA-C-O 120.953 0.406 . . . . 70.12 111.826 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -82.43 140.17 33.57 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.023 0.439 . . . . 74.12 111.374 176.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.446 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -89.98 124.88 35.12 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.436 0.532 . . . . 70.13 112.436 -177.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -122.57 159.04 28.6 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.279 0.561 . . . . 62.43 111.592 174.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.402 ' HD3' ' HB2' ' A' ' 59' ' ' GLU . 30.0 ttmt -99.61 114.88 28.21 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.81 -0.632 . . . . 73.34 110.282 175.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.67 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -119.82 -177.67 16.24 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 120.852 -0.689 . . . . 24.53 114.495 -172.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -89.26 34.43 0.8 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.209 0.603 . . . . 64.24 111.536 -175.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.1 m -100.27 149.67 36.25 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 112.514 0.561 . . . . 74.23 112.514 -174.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.83 163.69 21.18 Favored 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 122.724 2.283 . . . . 74.13 112.4 174.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 60' ' ' GLU . 52.0 tttm -68.72 146.91 52.54 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.105 -0.372 . . . . 72.24 111.352 -176.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.475 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 63.67 32.59 84.67 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.902 -0.666 . . . . 75.41 112.491 -174.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.449 ' HA ' ' H ' ' A' ' 27' ' ' GLU . 21.6 ttt -152.37 136.32 16.38 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.911 -0.403 . . . . 74.35 109.911 -177.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.51 HD11 HG22 ' A' ' 28' ' ' VAL . 33.6 pt -137.74 138.6 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 CA-C-O 121.431 0.634 . . . . 73.04 112.322 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -100.45 129.07 46.36 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.891 -0.595 . . . . 61.54 111.039 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 30' ' ' SER . 38.9 mt -122.42 132.63 24.23 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 120.523 0.201 . . . . 72.34 110.479 174.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.417 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 31.3 Cg_exo -60.43 127.19 22.04 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 122.04 1.826 . . . . 74.1 111.711 173.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.428 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 6.1 tpt -54.07 111.81 0.84 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.98 0.419 . . . . 73.31 111.88 -175.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.02 -174.4 32.89 Favored Glycine 0 CA--C 1.523 0.569 0 C-N-CA 120.861 -0.685 . . . . 64.23 112.751 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.495 ' HD2' HG21 ' A' ' 52' ' ' VAL . 18.8 Cg_endo -56.54 -34.06 94.27 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 122.802 2.335 . . . . 71.22 112.157 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.419 ' HA ' HD11 ' A' ' 140' ' ' LEU . 46.8 m-85 -63.82 -53.82 44.7 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.888 -0.597 . . . . 71.32 111.059 177.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.505 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.58 -38.36 87.24 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.187 0.518 . . . . 50.45 111.136 175.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -57.59 -17.15 12.71 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.071 0.549 . . . . 64.11 112.454 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.571 ' SD ' HD21 ' A' ' 140' ' ' LEU . 87.5 mmm -77.19 -22.82 51.81 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.195 0.443 . . . . 72.35 112.195 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 20.1 m -123.23 -26.22 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 112.748 0.647 . . . . 73.45 112.748 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.547 HG21 ' OG ' ' A' ' 30' ' ' SER . 6.9 pt -84.01 179.36 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.892 0.377 . . . . 62.21 111.786 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -106.34 110.07 63.61 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.522 -0.308 . . . . 64.13 111.178 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -84.4 -6.49 10.03 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.58 2.187 . . . . 73.04 112.743 176.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 18.9 m -68.35 -46.93 68.79 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 116.411 -0.359 . . . . 62.23 111.489 -178.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.4 t -65.5 148.58 51.49 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.738 0.304 . . . . 72.24 111.562 178.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -115.26 137.51 51.96 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.721 0.296 . . . . 51.14 111.351 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -130.43 128.7 5.64 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 121.014 -0.612 . . . . 51.14 113.283 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 77.8 p -107.3 124.27 49.54 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.608 -0.348 . . . . 73.51 111.686 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 123.95 -143.47 14.9 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.338 -0.458 . . . . 72.14 113.413 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.401 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 24.4 ptm -62.79 167.09 6.33 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 122.567 0.347 . . . . 75.14 111.829 179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 117' ' ' MET . 85.2 Cg_exo -49.58 -20.86 4.64 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.739 2.293 . . . . 74.43 113.221 174.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.418 ' HG2' ' N ' ' A' ' 120' ' ' PHE . 11.0 tt0 74.39 151.08 0.12 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.656 0.782 . . . . 72.31 112.779 173.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.418 ' N ' ' HG2' ' A' ' 119' ' ' GLN . 98.4 m-85 -95.69 -178.32 4.35 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.712 -0.676 . . . . 65.44 110.169 171.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.71 ' HA ' ' HE2' ' A' ' 121' ' ' LYS . 8.9 mmpt? 65.62 118.39 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.663 0.745 . . . . 72.22 111.729 -175.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -120.67 -174.41 15.1 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.406 -0.816 . . . . 63.13 113.381 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 66.2 t -84.53 118.7 32.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 120.816 0.341 . . . . 74.55 111.128 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 54.6 mtmt -76.01 156.01 34.43 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.575 0.703 . . . . 74.1 112.675 -176.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -177.18 -145.36 5.72 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 115.131 -0.94 . . . . 65.02 112.307 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 57.6 p -136.79 146.46 45.74 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 122.526 -0.396 . . . . 75.4 111.474 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.8 p -128.38 143.48 40.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 120.927 0.394 . . . . 73.13 111.153 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -148.52 148.29 30.05 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.319 -0.4 . . . . 73.3 110.814 176.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.753 ' HD3' HD23 ' A' ' 67' ' ' LEU . 28.7 ttpp -73.28 139.44 46.13 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.934 -0.395 . . . . 71.52 109.934 175.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.6 t -127.08 161.51 28.26 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.371 0.878 . . . . 64.34 113.371 -168.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -92.54 7.04 44.96 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.329 -0.85 . . . . 62.31 110.448 173.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -87.38 165.54 15.51 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.813 -0.63 . . . . 74.32 111.65 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.41 161.13 15.71 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.075 -0.511 . . . . 73.21 111.336 177.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 92.4 t -71.53 128.14 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.679 -0.237 . . . . 74.03 110.7 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.521 HD23 ' HA ' ' A' ' 135' ' ' LEU . 8.8 mt -65.24 88.3 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.776 0.322 . . . . 72.04 111.351 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 51.7 m -51.87 150.01 4.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.943 -0.572 . . . . 65.11 110.541 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.502 HG23 ' HD1' ' A' ' 49' ' ' PHE . 66.9 t -44.8 -48.78 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 N-CA-C 113.063 0.764 . . . . 74.52 113.063 -168.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -73.1 -39.85 65.46 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.977 -0.452 . . . . 52.14 111.777 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -57.84 -36.33 72.13 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.772 0.796 . . . . 70.13 109.919 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.571 HD21 ' SD ' ' A' ' 106' ' ' MET . 3.1 tt -62.55 -42.57 99.62 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.851 -1.068 . . . . 73.01 110.677 174.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 50.9 mt -58.45 -54.89 41.91 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.364 0.602 . . . . 73.5 109.859 175.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -52.79 -39.55 62.43 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 115.482 -0.781 . . . . 71.21 111.378 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -61.88 -43.18 99.37 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 116.161 -0.472 . . . . 41.04 111.933 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.8 pp -87.74 -6.91 10.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 112.419 0.525 . . . . 74.22 112.419 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 106.85 -1.21 35.99 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.223 -0.513 . . . . 51.54 113.965 176.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.475 0.819 0 CA-C-O 121.279 0.561 . . . . 75.53 111.697 179.533 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 82.9 mtp . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.531 0.205 . . . . 72.53 111.072 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.13 -169.54 13.33 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.055 -0.593 . . . . 64.15 113.217 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 81.1 p -160.3 138.22 9.85 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 120.865 0.364 . . . . 75.32 111.583 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.1 p -147.54 109.59 4.5 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.308 0.575 . . . . 51.23 111.167 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.6 t60 -125.52 42.87 3.19 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 116.006 -0.543 . . . . 75.54 110.63 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -43.57 142.37 1.2 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.7 -0.682 . . . . 70.4 112.741 177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -157.27 128.26 6.7 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.309 -0.405 . . . . 62.04 111.966 -174.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -168.14 127.18 1.22 Allowed 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.435 -0.348 . . . . 55.22 111.128 174.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -166.59 116.44 0.92 Allowed 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 111.986 0.365 . . . . 72.55 111.986 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -171.12 147.43 2.56 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.228 -0.442 . . . . 74.34 110.602 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.0 m -141.96 150.14 41.02 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.893 0.378 . . . . 52.22 111.642 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 95.7 p -137.88 174.91 10.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.038 0.447 . . . . 64.13 111.45 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 165.15 121.54 0.56 Allowed Glycine 0 CA--C 1.523 0.581 0 CA-C-N 116.041 -0.527 . . . . 71.53 111.881 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.36 162.64 36.76 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 121.209 0.528 . . . . 71.42 111.979 -175.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -73.57 141.5 46.64 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.843 -0.617 . . . . 72.33 112.049 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -94.85 119.83 34.06 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.946 0.403 . . . . 75.41 110.326 174.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.437 ' N ' HD22 ' A' ' 17' ' ' LEU . 3.0 mm? -73.44 156.71 37.98 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.383 0.611 . . . . 61.44 112.587 -173.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -100.6 138.43 37.67 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.575 -0.739 . . . . 74.25 111.224 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -115.09 160.36 19.74 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.819 0.342 . . . . 74.43 111.385 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -70.93 125.73 27.66 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.16 0.8 . . . . 65.21 113.16 -173.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.14 -130.26 26.94 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 115.566 -0.743 . . . . 72.03 114.955 169.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -153.37 79.97 1.17 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.673 0.273 . . . . 75.02 111.239 -173.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 11.5 ptm -87.28 143.3 27.33 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.865 0.364 . . . . 72.51 111.333 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.512 HD12 ' HG ' ' A' ' 65' ' ' LEU . 14.8 mt -96.96 132.66 42.53 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.463 0.542 . . . . 72.35 112.463 -176.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -83.06 109.75 17.4 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.313 0.578 . . . . 64.13 110.897 174.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.465 HG12 ' HA2' ' A' ' 94' ' ' GLY . 32.0 m -132.37 161.51 41.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.383 -0.826 . . . . 71.33 111.174 -174.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.662 ' HA ' ' HA ' ' A' ' 124' ' ' LYS . 33.2 tt0 -98.81 123.85 43.32 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.04 0.448 . . . . 52.11 111.174 176.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.8 t -93.43 117.13 36.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-N 115.913 -0.585 . . . . 65.54 111.907 -175.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 mt -103.13 163.05 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 O-C-N 122.24 -0.288 . . . . 73.44 111.172 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.629 ' HA ' ' O ' ' A' ' 98' ' ' ILE . 11.7 t -131.95 120.51 22.59 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 120.915 0.388 . . . . 70.53 111.492 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -110.88 135.43 12.85 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.093 -0.575 . . . . 64.23 113.178 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -54.06 -41.22 67.89 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 112.484 0.55 . . . . 74.01 112.484 -175.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.8 p 57.98 -74.93 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 113.366 0.876 . . . . 74.35 113.366 178.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.7 mp -71.66 -175.92 1.48 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.772 0.796 . . . . 54.25 112.911 -177.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -72.05 116.63 12.68 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.608 -0.724 . . . . 73.52 112.827 -175.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 59.62 -172.05 0.12 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.884 0.698 . . . . 75.32 112.884 173.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.27 137.84 13.5 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 116.25 -0.432 . . . . 72.13 113.206 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.828 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . . . -174.95 168.42 3.51 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.598 0.359 . . . . 70.2 111.453 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 14.7 p -88.77 176.9 6.88 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.788 -0.449 . . . . 74.01 109.788 172.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.496 HG12 ' CE1' ' A' ' 48' ' ' TYR . 21.8 m -64.2 -26.28 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 120.75 0.31 . . . . 51.41 111.294 176.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -67.77 -27.15 66.52 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.798 0.295 . . . . 70.22 111.798 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.497 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 3.6 mp0 -87.91 -13.2 42.54 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.004 0.431 . . . . 74.42 111.273 173.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.828 ' HE2' ' HB3' ' A' ' 38' ' ' ALA . 68.0 mttm -129.26 33.49 4.54 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.097 -0.501 . . . . 71.21 112.024 -176.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 40' ' ' VAL . 43.4 mt -66.65 84.99 0.11 Allowed 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.445 0.64 . . . . 62.03 111.253 178.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.58 HG23 ' H ' ' A' ' 48' ' ' TYR . 7.6 t -144.35 152.62 40.98 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.453 -0.794 . . . . 42.33 110.826 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -58.33 -29.56 66.01 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.997 0.427 . . . . 54.2 110.821 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.466 ' HA ' HD21 ' A' ' 50' ' ' ASN . 42.3 tt0 -59.96 -40.48 89.21 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.174 -0.467 . . . . 65.33 111.301 176.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.581 ' HE2' ' HD2' ' A' ' 43' ' ' LYS . 5.6 t80 -61.76 -35.54 78.44 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.284 0.564 . . . . 72.45 109.982 178.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -61.6 -68.31 0.33 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.793 -0.64 . . . . 64.31 110.793 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.466 HD21 ' HA ' ' A' ' 47' ' ' GLU . 10.1 p30 -62.53 -15.1 48.88 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 112.145 0.424 . . . . 73.13 112.145 -176.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.422 ' O ' ' HG2' ' A' ' 99' ' ' PRO . . . -80.51 -48.53 12.64 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.576 0.584 . . . . 64.2 112.576 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.537 ' HA ' ' HB2' ' A' ' 99' ' ' PRO . 21.0 m -100.93 5.39 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 113.463 0.912 . . . . 71.14 113.463 -173.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.451 HD22 ' N ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -91.79 17.61 8.81 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.476 0.917 . . . . 73.25 113.476 -176.029 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -137.79 164.18 29.56 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.229 0.538 . . . . 74.32 112.158 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -128.77 144.23 51.11 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.652 -0.703 . . . . 62.12 110.654 173.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.721 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 86.3 mt-10 -95.32 115.67 27.74 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.603 0.24 . . . . 74.52 111.395 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.457 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.2 mp -110.24 150.89 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 120.88 0.371 . . . . 70.1 110.966 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -70.11 154.88 41.39 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.826 0.451 . . . . 62.43 111.529 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -54.37 -48.93 70.92 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.485 0.55 . . . . 70.11 112.485 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -67.23 -44.8 78.59 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 120.798 0.332 . . . . 62.55 111.747 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.407 ' HB3' HD13 ' A' ' 24' ' ' LEU . 40.9 m-20 -67.1 -36.51 82.09 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.116 0.484 . . . . 54.01 111.324 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 42.6 t-105 -53.13 -54.21 39.07 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.705 -0.68 . . . . 73.22 111.282 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -71.74 -28.12 63.45 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.681 -0.69 . . . . 63.21 111.818 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.21 -37.66 83.78 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.162 0.506 . . . . 74.34 111.457 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.584 HD11 HG13 ' A' ' 127' ' ' VAL . 92.4 mt -88.41 -8.19 55.4 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.254 -0.43 . . . . 70.1 111.639 177.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 66.4 46.99 73.69 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 121.071 -0.585 . . . . 72.31 112.708 -176.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.672 HD23 ' HE3' ' A' ' 129' ' ' LYS . 79.9 mt -86.16 152.3 22.95 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.129 0.49 . . . . 73.34 111.965 -177.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.529 ' O ' ' HB2' ' A' ' 71' ' ' ASP . 61.3 tt0 -119.62 145.58 46.31 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.097 -0.502 . . . . 61.23 109.789 172.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -56.35 110.11 0.71 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.113 0.482 . . . . 75.22 111.741 -178.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 105.88 4.03 39.35 Favored Glycine 0 CA--C 1.53 0.99 0 CA-C-N 115.89 -0.595 . . . . 73.11 113.274 -176.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 68' ' ' GLN . 0.5 OUTLIER -69.85 174.16 5.53 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.579 0.585 . . . . 75.41 112.579 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -105.42 123.74 48.39 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 116.042 -0.526 . . . . 74.42 110.689 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' A' ' 86' ' ' ALA . 17.9 m -118.35 144.48 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-O 121.331 0.586 . . . . 61.41 112.271 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.618 ' HD2' ' HB2' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -96.02 137.13 35.53 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.815 -0.63 . . . . 71.3 110.374 175.396 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 61.5 t -124.98 120.72 59.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.348 -0.612 . . . . 63.24 109.348 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.406 ' HG2' ' CB ' ' A' ' 81' ' ' GLU . 4.8 mtpm? -129.88 132.15 46.32 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.098 0.475 . . . . 72.34 112.076 -171.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.726 HG22 ' HA3' ' A' ' 125' ' ' GLY . 30.8 p -135.81 -172.33 3.08 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.269 0.557 . . . . 75.32 111.072 178.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -72.21 -6.15 40.8 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.13 -0.486 . . . . 71.14 111.847 176.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -95.59 -52.6 4.05 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.789 0.328 . . . . 62.15 111.138 176.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.27 -162.59 27.84 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 121.349 -0.453 . . . . 54.44 112.7 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.618 ' HB2' ' HD2' ' A' ' 74' ' ' LYS . 0.4 OUTLIER -135.61 150.22 49.59 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.285 0.564 . . . . 65.44 112.141 178.671 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.468 HG21 ' HA ' ' A' ' 103' ' ' TYR . 8.8 p -143.84 153.56 15.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 116.02 -0.536 . . . . 75.21 111.245 -179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 43.6 t -112.78 121.76 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 122.211 0.205 . . . . 75.53 110.843 177.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.409 HG12 ' CD2' ' A' ' 103' ' ' TYR . 35.0 m -132.86 172.4 16.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 N-CA-C 112.23 0.455 . . . . 55.41 112.23 -177.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -73.67 146.1 44.76 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.074 0.464 . . . . 75.1 110.998 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.456 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -96.31 119.54 34.98 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.625 0.602 . . . . 72.21 112.625 -178.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -124.63 152.96 42.97 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.151 0.501 . . . . 71.31 110.678 172.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 27.7 ttmt -96.11 114.9 26.64 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.18 -0.464 . . . . 73.53 110.042 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.721 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -113.86 -161.37 14.13 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.465 -0.874 . . . . 75.12 114.773 -170.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -93.79 23.2 4.94 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.12 0.485 . . . . 55.24 111.588 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.2 m -87.36 144.66 36.18 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.19 -0.459 . . . . 61.33 112.225 -175.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.89 174.71 12.37 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 122.646 2.231 . . . . 54.34 113.391 179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -57.53 126.12 25.92 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.963 -0.562 . . . . 53.51 111.86 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.465 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 73.31 29.21 64.56 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 121.171 -0.538 . . . . 63.02 114.15 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.646 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 15.0 ttt -148.8 139.82 23.01 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.383 -0.481 . . . . 73.3 110.214 179.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.432 HG22 ' HA ' ' A' ' 57' ' ' ILE . 40.0 pt -134.06 148.88 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-O 121.401 0.619 . . . . 65.24 112.078 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -109.06 130.25 55.48 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.981 -0.554 . . . . 64.13 111.54 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 30' ' ' SER . 49.5 mt -123.26 129.58 24.87 Favored Pre-proline 0 CA--C 1.543 0.675 0 CA-C-O 120.858 0.361 . . . . 73.41 110.967 174.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.537 ' HB2' ' HA ' ' A' ' 52' ' ' VAL . 50.5 Cg_exo -57.66 142.28 95.73 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.406 2.071 . . . . 65.23 112.572 175.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.2 tpt -59.44 107.05 0.52 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.173 0.511 . . . . 75.31 111.564 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -168.41 -176.51 38.81 Favored Glycine 0 CA--C 1.521 0.406 0 C-N-CA 120.114 -1.041 . . . . 33.33 113.612 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.517 ' HG3' HG13 ' A' ' 137' ' ' VAL . 19.5 Cg_endo -57.28 -34.64 98.2 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.034 2.489 . . . . 54.12 111.941 -178.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.468 ' HA ' HG21 ' A' ' 82' ' ' VAL . 72.1 m-85 -61.75 -51.49 68.12 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.659 -0.7 . . . . 62.1 110.704 177.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.471 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -62.86 -36.43 83.25 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.202 -0.454 . . . . 62.4 111.152 175.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -56.68 -23.82 44.59 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.05 0.54 . . . . 72.35 111.963 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.538 ' SD ' HD21 ' A' ' 140' ' ' LEU . 86.2 mmm -74.24 -22.08 59.5 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 111.907 0.336 . . . . 63.31 111.907 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 27.7 m -125.5 -21.1 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 113.169 0.803 . . . . 61.22 113.169 -170.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.471 HG23 ' O ' ' A' ' 104' ' ' ALA . 7.0 pt -95.98 -179.42 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-O 121.282 0.563 . . . . 74.1 111.841 -177.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.446 ' H ' HG21 ' A' ' 123' ' ' VAL . 22.0 t70 -106.74 117.83 55.83 Favored Pre-proline 0 CA--C 1.545 0.754 0 CA-C-N 116.029 -0.532 . . . . 73.24 111.016 178.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -80.67 19.49 1.1 Allowed 'Trans proline' 0 CA--C 1.546 1.075 0 C-N-CA 122.963 2.442 . . . . 75.54 114.209 -177.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.8 t -97.66 14.88 25.2 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 121.997 -0.439 . . . . 64.24 111.253 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 70.9 p -65.33 114.74 4.98 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.152 0.427 . . . . 73.03 112.152 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -73.83 104.34 4.68 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.781 0.324 . . . . 63.34 111.548 179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -81.83 -128.56 1.04 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 121.196 -0.526 . . . . 73.25 112.816 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 90.8 m 72.33 -48.22 0.68 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 112.918 0.71 . . . . 62.44 112.918 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -107.43 -96.06 2.44 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.224 -0.512 . . . . 64.41 114.052 -178.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.54 140.73 22.83 Favored Pre-proline 0 N--CA 1.472 0.638 0 N-CA-C 113.055 0.761 . . . . 72.3 113.055 -172.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -85.85 117.0 1.63 Allowed 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.053 2.502 . . . . 73.12 111.914 173.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -108.27 142.65 38.23 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.867 0.365 . . . . 61.12 111.845 -174.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -74.7 28.45 0.09 Allowed 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.808 1.04 . . . . 74.21 113.808 -174.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -79.18 99.39 6.99 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.637 -0.664 . . . . 65.42 110.804 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -89.78 163.34 30.78 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 120.995 -0.622 . . . . 54.25 113.669 -175.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.446 HG21 ' H ' ' A' ' 109' ' ' ASP . 61.2 t -94.28 119.15 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 O-C-N 122.606 -0.35 . . . . 71.31 111.259 175.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 27' ' ' GLU . 6.8 ttpt -66.78 152.82 44.79 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.409 0.623 . . . . 72.12 112.347 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.726 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -174.05 -144.67 4.89 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-N 115.553 -0.749 . . . . 60.11 112.635 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 65.9 p -140.97 160.23 40.51 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 122.488 0.315 . . . . 71.13 111.704 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.584 HG13 HD11 ' A' ' 65' ' ' LEU . 13.6 p -142.97 144.6 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 CA-C-O 120.855 0.359 . . . . 64.01 111.311 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -154.95 165.0 38.08 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.246 0.546 . . . . 73.33 112.44 178.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.672 ' HE3' HD23 ' A' ' 67' ' ' LEU . 5.5 tppp? -70.51 138.77 51.32 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.107 -0.497 . . . . 74.1 111.11 173.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 5.0 t -144.54 149.82 36.5 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.437 0.637 . . . . 60.52 112.431 175.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -90.19 -5.55 56.29 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.609 -0.723 . . . . 64.44 111.009 176.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.41 ' CD ' ' HZ1' ' A' ' 74' ' ' LYS . 27.8 mt-10 -63.67 165.48 8.23 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.081 -0.509 . . . . 74.43 111.591 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -92.34 155.41 17.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.026 0.441 . . . . 53.52 111.095 -178.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 99.1 t -58.9 127.74 18.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 CA-C-N 116.237 -0.438 . . . . 73.35 110.979 173.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.37 86.83 0.83 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.717 0.294 . . . . 71.2 111.103 -178.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 14.5 m -44.49 141.74 1.85 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.774 -0.648 . . . . 61.22 111.908 -175.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.517 HG13 ' HG3' ' A' ' 102' ' ' PRO . 51.4 t -45.14 -50.11 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 112.879 0.696 . . . . 40.03 112.879 -172.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -70.5 -43.58 69.4 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 120.625 0.25 . . . . 75.53 111.435 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -55.14 -41.64 72.02 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.795 0.807 . . . . 72.51 110.381 177.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.538 HD21 ' SD ' ' A' ' 106' ' ' MET . 2.4 tt -61.22 -37.77 84.21 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.018 -0.992 . . . . 73.52 111.351 177.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 52.2 mt -59.35 -44.8 92.62 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.301 0.572 . . . . 75.24 110.506 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -76.53 -29.71 56.85 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.83 -0.623 . . . . 71.22 111.059 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -59.96 -39.15 84.63 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.177 -0.465 . . . . 75.2 112.074 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.404 HD12 ' H ' ' A' ' 146' ' ' SER . 2.8 pp -79.47 -11.35 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.111 0.412 . . . . 73.15 112.111 177.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 135.5 -64.56 0.58 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.247 -0.502 . . . . 71.41 113.082 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 141' ' ' LEU . 32.9 t . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 121.505 0.669 . . . . 73.22 112.2 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptp . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.101 0.477 . . . . 72.1 111.403 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -145.58 169.76 27.04 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.281 -0.485 . . . . 53.43 113.042 179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.4 p -100.05 157.72 16.35 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.081 0.467 . . . . 52.35 111.553 -177.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 70.2 m -150.54 99.63 2.77 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.039 0.447 . . . . 74.34 111.204 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -140.99 144.59 35.14 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.284 -0.416 . . . . 65.31 111.031 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -150.57 139.5 20.94 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.072 0.397 . . . . 64.31 112.072 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 32.0 p80 -141.74 105.18 4.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.208 0.528 . . . . 75.1 111.344 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -113.7 90.47 3.35 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.039 -0.413 . . . . 64.23 110.719 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -138.44 153.47 48.85 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.291 0.567 . . . . 73.04 111.879 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -139.86 95.8 2.96 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.621 -0.718 . . . . 74.4 110.292 173.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.5 p -66.33 93.39 0.22 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.921 0.391 . . . . 75.34 110.892 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.7 p -58.8 121.16 10.41 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.316 0.579 . . . . 71.13 112.259 -177.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -148.61 83.14 0.18 Allowed Glycine 0 CA--C 1.522 0.524 0 CA-C-N 115.936 -0.574 . . . . 72.11 112.103 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -78.58 -47.11 17.85 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.671 0.272 . . . . 75.02 111.658 -177.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 74.08 156.81 0.18 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.465 -0.789 . . . . 64.43 111.801 -173.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -157.81 20.11 0.26 Allowed 'General case' 0 CA--C 1.542 0.652 0 CA-C-O 120.972 0.415 . . . . 73.33 111.13 -177.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.6 mp -106.18 173.07 6.47 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.224 0.535 . . . . 74.31 111.747 178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -163.81 124.39 2.21 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.002 -0.544 . . . . 70.45 111.13 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 59.2 t80 -98.56 95.03 7.01 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.214 0.53 . . . . 72.4 111.334 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -89.53 87.14 6.94 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.106 0.479 . . . . 44.32 110.463 176.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.62 -177.03 14.96 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.157 -0.544 . . . . 32.35 113.83 -177.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -88.95 101.84 14.47 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 111.896 0.332 . . . . 54.23 111.896 -177.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.442 ' HE2' ' HB ' ' A' ' 126' ' ' THR . 13.4 ptm -75.98 154.3 35.92 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.637 0.256 . . . . 64.35 110.93 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 mp -117.16 148.85 41.22 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.07 0.462 . . . . 74.1 112.179 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -85.39 128.01 34.57 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.569 0.699 . . . . 72.41 111.45 174.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.465 HG12 ' HA2' ' A' ' 94' ' ' GLY . 27.4 m -140.67 162.46 23.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.337 -0.847 . . . . 62.52 110.97 -176.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.731 ' HB3' ' HG3' ' A' ' 95' ' ' MET . 41.9 tt0 -98.88 112.46 24.55 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.122 0.487 . . . . 71.34 110.127 175.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.3 t -86.98 119.26 34.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.782 -0.644 . . . . 73.11 111.87 -172.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 121' ' ' LYS . 2.8 mt -103.56 154.99 5.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.793 0.33 . . . . 60.24 111.531 -178.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.671 ' HB2' HG21 ' A' ' 108' ' ' ILE . 11.4 t -133.78 107.66 8.02 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.942 0.401 . . . . 62.45 111.077 175.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -104.34 134.17 11.84 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 121.161 -0.542 . . . . 65.3 113.134 -177.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 25.7 ttm180 -77.39 82.07 3.86 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.159 0.504 . . . . 73.55 111.496 -178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.8 t -78.49 -33.8 47.92 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.989 -0.55 . . . . 74.43 110.883 174.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.9 mt -89.55 109.36 20.32 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.793 -0.447 . . . . 61.31 109.793 173.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -79.84 -175.43 4.9 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.501 0.556 . . . . 73.34 112.501 -174.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 85.9 mm-40 68.04 108.09 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.52 -0.763 . . . . 74.2 111.303 -173.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -62.29 101.7 0.41 Allowed Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.568 -0.825 . . . . 63.34 112.706 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HB3' ' HE2' ' A' ' 43' ' ' LYS . . . -151.56 146.4 25.83 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.091 0.404 . . . . 74.22 112.091 -175.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 t -66.66 159.54 27.46 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.331 -0.395 . . . . 71.14 110.738 171.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.445 HG21 HG11 ' A' ' 137' ' ' VAL . 11.6 p -58.82 -27.47 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-O 120.758 0.313 . . . . 71.32 110.843 177.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -57.24 -32.25 66.37 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 116.157 -0.474 . . . . 54.54 111.441 176.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -72.3 -33.96 67.79 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.945 0.402 . . . . 71.25 111.803 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.66 ' HE2' ' HB3' ' A' ' 38' ' ' ALA . 1.5 mptp? -91.83 -70.53 0.68 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.554 -0.294 . . . . 75.34 111.549 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 81.6 mt 55.59 9.48 0.41 Allowed 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 113.892 1.071 . . . . 73.15 113.892 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.536 HG23 ' H ' ' A' ' 48' ' ' TYR . 6.2 t -81.86 156.04 25.04 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 122.105 -0.372 . . . . 61.2 111.606 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -60.62 -31.37 70.56 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.899 0.381 . . . . 74.43 110.584 178.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -58.11 -38.12 75.86 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.033 0.444 . . . . 73.25 111.039 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.548 ' O ' HG22 ' A' ' 52' ' ' VAL . 4.1 t80 -59.3 -44.02 92.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.289 0.566 . . . . 65.3 109.583 176.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.508 ' HD2' HG23 ' A' ' 137' ' ' VAL . 57.8 t80 -60.44 -60.51 3.69 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.572 -0.74 . . . . 64.44 110.16 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -53.08 -28.42 24.99 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.884 -0.598 . . . . 74.41 112.313 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -82.24 -37.87 25.32 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.271 0.841 . . . . 44.32 113.271 -176.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 48' ' ' TYR . 19.3 m -109.76 9.61 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 113.494 0.924 . . . . 60.24 113.494 -172.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -98.38 25.91 5.9 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 113.061 0.763 . . . . 54.51 113.061 -177.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.432 ' CD1' ' HD2' ' A' ' 87' ' ' LYS . 52.8 p90 -146.5 158.56 43.91 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 122.012 -0.43 . . . . 64.0 111.752 177.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -129.49 139.26 51.63 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.302 -0.408 . . . . 61.54 111.484 178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.673 ' HB3' ' HA3' ' A' ' 89' ' ' GLY . 42.7 mt-10 -87.68 113.15 23.09 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.219 0.533 . . . . 71.11 110.943 176.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.8 mt -112.44 150.71 14.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.561 -0.745 . . . . 75.14 111.593 -171.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.668 ' ND2' HG23 ' A' ' 91' ' ' VAL . 1.9 m120 -72.19 135.17 46.03 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.498 -0.319 . . . . 72.03 110.976 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 62' ' ' TRP . 37.4 tt0 -54.18 -40.17 67.3 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 112.629 0.603 . . . . 61.12 112.629 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -64.14 -49.56 71.66 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 112.543 0.572 . . . . 60.1 112.543 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -70.42 -29.4 66.0 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-O 121.657 0.742 . . . . 71.33 110.284 177.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.514 ' HB3' ' O ' ' A' ' 59' ' ' GLU . 32.2 t-105 -55.83 -47.54 77.05 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.169 -0.923 . . . . 75.51 110.401 172.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -65.12 -41.44 94.87 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.848 -0.615 . . . . 61.0 111.037 174.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.95 -39.27 74.24 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 116.164 -0.471 . . . . 73.14 111.939 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.4 mt -88.03 -12.53 44.08 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.24 -0.437 . . . . 74.43 111.782 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 65.89 50.59 51.95 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.193 -0.527 . . . . 53.31 112.642 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.627 HD23 ' HE3' ' A' ' 129' ' ' LYS . 86.1 mt -88.65 155.21 19.74 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.471 0.653 . . . . 72.51 112.467 -176.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -127.14 151.95 47.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.619 -0.719 . . . . 74.44 109.501 173.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -63.52 98.68 0.18 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.525 0.678 . . . . 75.04 111.762 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.13 -17.92 5.91 Favored Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.119 -0.946 . . . . 51.34 112.888 -175.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -56.48 155.69 6.93 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.314 0.578 . . . . 73.44 112.242 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -94.89 123.08 38.15 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.746 -0.661 . . . . 73.53 110.66 178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 86' ' ' ALA . 31.6 m -116.5 147.38 19.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.018 0.437 . . . . 74.51 111.377 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.481 ' HB2' HG22 ' A' ' 83' ' ' VAL . 4.6 ttpm? -114.66 138.76 50.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.477 0.656 . . . . 72.2 110.969 176.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 81' ' ' GLU . 57.7 t -116.95 134.33 60.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.45 -0.796 . . . . 73.22 109.669 -175.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -133.58 123.72 25.62 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.263 0.468 . . . . 70.44 112.263 -172.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.716 HG22 ' HA3' ' A' ' 125' ' ' GLY . 36.9 p -126.2 -172.26 2.58 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 116.209 -0.45 . . . . 70.41 110.703 174.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.63 -14.42 61.6 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 120.809 0.338 . . . . 74.24 111.151 175.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -84.51 -52.79 5.87 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 120.778 0.323 . . . . 72.33 111.376 178.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.08 -159.62 20.06 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 120.979 -0.629 . . . . 71.43 113.122 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 75' ' ' VAL . 0.4 OUTLIER -143.61 153.16 42.24 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.034 0.445 . . . . 64.23 111.606 176.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.1 p -150.77 145.93 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.332 -0.395 . . . . 74.32 111.377 -178.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.481 HG22 ' HB2' ' A' ' 74' ' ' LYS . 60.9 t -107.34 118.93 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 CA-C-O 120.532 0.206 . . . . 54.14 111.169 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 35.2 m -130.74 178.11 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 122.802 0.441 . . . . 75.41 111.576 -179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -81.65 146.73 29.9 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.221 0.534 . . . . 74.34 111.754 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.512 ' HB2' HG13 ' A' ' 73' ' ' VAL . . . -93.52 129.11 39.85 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.888 0.699 . . . . 75.34 112.888 -177.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.432 ' HD2' ' CD1' ' A' ' 54' ' ' TYR . 67.3 mttm -135.3 151.77 50.85 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.973 -0.558 . . . . 65.3 109.978 172.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -78.01 147.43 34.84 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 122.069 -0.394 . . . . 64.05 110.511 173.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.673 ' HA3' ' HB3' ' A' ' 56' ' ' GLU . . . -134.73 168.72 23.47 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.804 -0.712 . . . . 63.13 114.018 -175.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -89.22 23.95 2.32 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.365 0.602 . . . . 60.31 110.958 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.668 HG23 ' ND2' ' A' ' 58' ' ' ASN . 17.3 m -91.28 151.94 43.37 Favored Pre-proline 0 CA--C 1.55 0.952 0 CA-C-N 115.925 -0.579 . . . . 63.35 112.221 -175.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.19 145.57 55.04 Favored 'Trans proline' 0 C--N 1.356 0.969 0 C-N-CA 123.098 2.532 . . . . 45.32 112.782 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -52.54 142.31 18.23 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.386 0.513 . . . . 73.24 112.386 -174.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.465 ' HA2' HG12 ' A' ' 26' ' ' VAL . . . 71.55 25.79 74.49 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 120.806 -0.711 . . . . 64.04 113.195 -174.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' MET . . . . . 0.731 ' HG3' ' HB3' ' A' ' 27' ' ' GLU . 19.0 ttt -154.43 135.03 13.51 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 122.42 -0.459 . . . . 74.3 110.029 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.42 ' O ' HG13 ' A' ' 29' ' ' ILE . 41.8 pt -133.22 145.67 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-O 120.998 0.428 . . . . 74.32 112.154 -174.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -105.27 130.19 53.46 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.429 -0.351 . . . . 72.13 111.424 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.641 ' O ' ' HA ' ' A' ' 30' ' ' SER . 50.8 mt -125.31 130.34 24.17 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 120.776 0.322 . . . . 71.22 110.714 175.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.41 135.23 69.08 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 122.334 2.023 . . . . 62.32 112.853 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.445 ' HA ' ' OG ' ' A' ' 30' ' ' SER . 5.1 tpt -54.14 109.7 0.51 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.262 -0.426 . . . . 70.14 111.904 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -162.62 -174.35 32.42 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.866 -0.683 . . . . 55.24 112.513 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.557 ' O ' ' HG2' ' A' ' 106' ' ' MET . 32.3 Cg_endo -65.11 -26.44 57.7 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.808 1.672 . . . . 74.12 111.57 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.509 ' HA ' HD11 ' A' ' 140' ' ' LEU . 4.6 m-85 -67.53 -53.85 24.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.6 -0.727 . . . . 73.1 110.496 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.526 ' O ' HG23 ' A' ' 108' ' ' ILE . . . -61.43 -40.61 95.07 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.075 -0.511 . . . . 44.2 110.798 174.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -53.52 -26.89 22.89 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.308 -0.405 . . . . 63.33 111.916 177.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.646 ' SD ' HD21 ' A' ' 140' ' ' LEU . 83.1 mmm -64.96 -34.33 78.16 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.754 0.311 . . . . 70.01 111.835 177.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.447 ' HB ' HG23 ' A' ' 77' ' ' THR . 27.1 m -115.82 -19.88 6.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.846 0.684 . . . . 64.41 112.846 -168.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.671 HG21 ' HB2' ' A' ' 30' ' ' SER . 10.1 pt -90.65 -176.21 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 CA-C-O 121.177 0.513 . . . . 75.24 111.962 -178.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.599 ' N ' HG21 ' A' ' 123' ' ' VAL . 18.0 t70 -109.01 115.56 56.85 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 116.242 -0.435 . . . . 73.04 111.507 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -86.18 16.83 1.88 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.014 2.476 . . . . 75.3 113.78 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.1 t -85.16 -31.77 23.08 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 121.021 0.438 . . . . 73.33 111.291 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 4.8 t -85.49 145.14 27.55 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.141 0.496 . . . . 71.41 111.985 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -82.42 7.28 14.64 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.341 0.591 . . . . 63.25 110.648 175.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 108.53 3.0 32.88 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.447 -0.661 . . . . 51.4 111.447 -171.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 41.2 m 62.21 -70.88 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.653 0.781 . . . . 74.23 112.065 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -149.87 -100.67 0.22 Allowed Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.635 -0.586 . . . . 73.34 111.635 177.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 58.5 mtp -111.37 145.19 32.05 Favored Pre-proline 0 CA--C 1.539 0.519 0 O-C-N 122.652 -0.322 . . . . 61.41 110.42 171.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.11 95.01 0.24 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 122.442 2.095 . . . . 51.11 114.263 -174.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -98.98 -168.58 1.65 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.155 -0.475 . . . . 73.44 109.808 170.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -71.08 82.24 0.69 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.652 0.739 . . . . 54.3 111.267 175.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.453 ' O ' HG12 ' A' ' 29' ' ' ILE . 33.2 mttm -132.19 -170.3 2.39 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 114.968 -1.014 . . . . 62.14 110.192 176.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 145.41 175.83 18.85 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.556 -0.83 . . . . 53.32 113.695 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.599 HG21 ' N ' ' A' ' 109' ' ' ASP . 62.0 t -93.82 121.29 44.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 N-CA-C 112.226 0.454 . . . . 52.21 112.226 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.51 ' HD2' ' N ' ' A' ' 125' ' ' GLY . 0.3 OUTLIER -60.94 141.51 57.19 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.024 0.529 . . . . 73.1 111.923 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.716 ' HA3' HG22 ' A' ' 77' ' ' THR . . . -170.35 -147.26 5.48 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-N 116.221 -0.445 . . . . 63.34 113.087 178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.442 ' HB ' ' HE2' ' A' ' 23' ' ' MET . 57.2 p -138.7 159.16 42.78 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.775 0.43 . . . . 72.23 111.711 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 14.5 p -140.39 145.61 25.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 120.906 0.384 . . . . 41.45 111.374 178.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.66 154.78 32.1 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.379 -0.373 . . . . 73.52 111.502 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.627 ' HE3' HD23 ' A' ' 67' ' ' LEU . 36.1 ttmt -71.33 144.38 49.94 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.505 -0.554 . . . . 65.42 109.505 168.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.448 HG21 HG13 ' A' ' 83' ' ' VAL . 6.0 t -131.98 145.66 51.61 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 122.05 0.928 . . . . 54.11 113.355 -176.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -77.32 -10.67 59.58 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.422 -1.263 . . . . 72.31 111.621 176.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -82.11 -179.94 7.59 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.478 0.656 . . . . 75.41 112.503 -174.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -97.25 154.85 17.14 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.741 -0.663 . . . . 72.03 111.192 178.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.8 134.35 30.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 120.798 0.333 . . . . 64.03 110.661 172.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 21.1 mt -70.42 125.43 26.76 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.13 0.418 . . . . 75.4 112.13 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.447 ' HA ' ' HE2' ' A' ' 49' ' ' PHE . 74.0 m -65.05 149.09 50.48 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.386 -0.598 . . . . 72.44 109.386 167.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.508 HG23 ' HD2' ' A' ' 49' ' ' PHE . 94.7 t -48.61 -48.02 14.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 111.85 0.315 . . . . 74.24 111.85 -175.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -72.44 -37.93 68.45 Favored 'General case' 0 CA--C 1.541 0.599 0 O-C-N 122.234 -0.291 . . . . 61.05 111.574 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -55.4 -40.52 71.51 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.846 0.831 . . . . 74.51 109.518 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.646 HD21 ' SD ' ' A' ' 106' ' ' MET . 4.0 tt -58.53 -46.15 87.39 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.4 -1.273 . . . . 71.32 111.236 173.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 137' ' ' VAL . 39.6 mt -59.16 -42.91 91.87 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.523 0.677 . . . . 70.22 110.829 178.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -67.98 -36.9 80.81 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.447 -0.797 . . . . 72.12 111.087 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.36 -30.45 71.58 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.223 -0.444 . . . . 55.22 112.193 -179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.513 HD12 ' H ' ' A' ' 146' ' ' SER . 2.7 pp -98.33 2.57 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-O 121.173 0.511 . . . . 75.44 111.976 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 90.33 -58.91 3.46 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 116.195 -0.457 . . . . 42.4 113.643 176.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.513 ' H ' HD12 ' A' ' 144' ' ' ILE . 70.7 m . . . . . 0 N--CA 1.476 0.873 0 CA-C-O 121.036 0.446 . . . . 72.43 111.555 -177.357 . . . . . . . . 1 1 . 1 stop_ save_